Citrus Sinensis ID: 003139
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 845 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LK35 | 855 | Receptor-like protein kin | yes | no | 0.983 | 0.971 | 0.744 | 0.0 | |
| Q9LX66 | 830 | Receptor-like protein kin | no | no | 0.969 | 0.986 | 0.520 | 0.0 | |
| Q9SJT0 | 871 | Probable receptor-like pr | no | no | 0.878 | 0.851 | 0.539 | 0.0 | |
| Q9T020 | 878 | Probable receptor-like pr | no | no | 0.944 | 0.908 | 0.513 | 0.0 | |
| Q9FN92 | 829 | Probable receptor-like pr | no | no | 0.937 | 0.955 | 0.517 | 0.0 | |
| Q9FLJ8 | 842 | Probable receptor-like pr | no | no | 0.918 | 0.921 | 0.509 | 0.0 | |
| Q9FLW0 | 824 | Probable receptor-like pr | no | no | 0.942 | 0.966 | 0.473 | 0.0 | |
| Q9SA72 | 849 | Probable receptor-like pr | no | no | 0.895 | 0.891 | 0.466 | 0.0 | |
| Q9SCZ4 | 895 | Receptor-like protein kin | no | no | 0.955 | 0.901 | 0.448 | 0.0 | |
| Q3E8W4 | 858 | Receptor-like protein kin | no | no | 0.950 | 0.935 | 0.426 | 0.0 |
| >sp|Q9LK35|THE1_ARATH Receptor-like protein kinase THESEUS 1 OS=Arabidopsis thaliana GN=THE1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 1267 bits (3278), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 633/850 (74%), Positives = 720/850 (84%), Gaps = 19/850 (2%)
Query: 14 LAVFLFELLCHK---SCVAFTPVDNYLIACGSSQKVTFQARTYVPDTEHSSLSMKSGNST 70
L V L+ L C+ S F P DNYLI+CGSSQ +TFQ R +VPD+ HSSL +K GNS+
Sbjct: 7 LLVLLWFLSCYTTTTSSALFNPPDNYLISCGSSQNITFQNRIFVPDSLHSSLVLKIGNSS 66
Query: 71 TA--SSNSSAPSPIYQSARIFSAAAFYKFEIEHKGRHWVRLYFYTLPGSNQHLNSASFTV 128
A ++++++ + IYQ+AR+FS+ A Y+F+I GRHW+RL+F + S +L SAS TV
Sbjct: 67 VATSTTSNNSTNSIYQTARVFSSLASYRFKITSLGRHWIRLHFSPINNSTWNLTSASITV 126
Query: 129 ATDKFVLLSNFTFKNYNSSFMFKEYAINVNSDALTLTFIPSNNSVAFVNAIEVVSVPDAI 188
T+ FVLL+NF+F N+N S++FKEY +NV S+ LTL+FIPSNNSV FVNAIEVVSVPD +
Sbjct: 127 VTEDFVLLNNFSFNNFNGSYIFKEYTVNVTSEFLTLSFIPSNNSVVFVNAIEVVSVPDNL 186
Query: 189 FPDQALALEPSASFSGLSDLGFETVYRLNMGGPLITAQNDTLGRTWENDETYLHVNSSAV 248
PDQALAL PS FSGLS L FETVYRLNMGGPL+T+QNDTLGR W+ND YLHVNSS +
Sbjct: 187 IPDQALALNPSTPFSGLSLLAFETVYRLNMGGPLLTSQNDTLGRQWDNDAEYLHVNSSVL 246
Query: 249 NVSVRPSAIRYTASVTAETAPNWVYATAEMMGDANVPEVNFNITWVLPVEPNFTYFVRVH 308
V+ PS+I+Y+ SVT ETAPN VYATA+ MGDANV +FN+TWVLPV+P+F YFVRVH
Sbjct: 247 VVTANPSSIKYSPSVTQETAPNMVYATADTMGDANVASPSFNVTWVLPVDPDFRYFVRVH 306
Query: 309 LCDIASLSMNNLVFNLYINDDIAQPSVDLSTLTNGLNVPYYKDFVCNASADSN-TLTVSV 367
CDI S ++N LVFNLY+NDD+A S+DLSTLTNGL VPY+KDF+ N S +S+ LTVSV
Sbjct: 307 FCDIVSQALNTLVFNLYVNDDLALGSLDLSTLTNGLKVPYFKDFISNGSVESSGVLTVSV 366
Query: 368 GPDSVADFTNATMNGLEVMKISNEARSLDGLSSVEGLLP-DKPSNKNKIGIIVGSVVGAV 426
GPDS AD TNATMNGLEV+KISNEA+SL G+SSV+ LLP S K +I+GS+VGAV
Sbjct: 367 GPDSQADITNATMNGLEVLKISNEAKSLSGVSSVKSLLPGGSGSKSKKKAVIIGSLVGAV 426
Query: 427 AAVALIGV-CYCWLLA---RKSKTPQQ---GHPWLPLPLYGNSQTMTKMSTTSQKSGTAS 479
+ LI V CYC L+A ++S +PQ+ GHPWLPLPLYG SQT+TK ST S KS TAS
Sbjct: 427 TLILLIAVCCYCCLVASRKQRSTSPQEGGNGHPWLPLPLYGLSQTLTK-STASHKSATAS 485
Query: 480 CISLASSNLGRLFMFQEILDATNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSE 539
CISLAS++LGR FMFQEI+DATNKFDES LLGVGGFGRVYKGTL+DGTKVAVKRGNPRSE
Sbjct: 486 CISLASTHLGRCFMFQEIMDATNKFDESSLLGVGGFGRVYKGTLEDGTKVAVKRGNPRSE 545
Query: 540 QGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSW 599
QG+AEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYG DLPPLSW
Sbjct: 546 QGMAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGADLPPLSW 605
Query: 600 KQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT 659
KQRLEICIGAARGLHYLHTGA+QSIIHRDVKTTNILLD+N VAKVADFGLSKTGP+LDQT
Sbjct: 606 KQRLEICIGAARGLHYLHTGASQSIIHRDVKTTNILLDENLVAKVADFGLSKTGPSLDQT 665
Query: 660 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEW 719
HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC RPALNPVLPREQVNIAEW
Sbjct: 666 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCCRPALNPVLPREQVNIAEW 725
Query: 720 AMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779
AM WQKKG+LDQIMDSNL GKVNPASLKKFGETAEKCLAE+GVDRPSMGDVLWNLEYALQ
Sbjct: 726 AMAWQKKGLLDQIMDSNLTGKVNPASLKKFGETAEKCLAEYGVDRPSMGDVLWNLEYALQ 785
Query: 780 LEETSSALMEPEDNSTNHIPCIQLTPLEPFDNSVSMIDV----RNSGTDDDGEDVATSAV 835
LEETSSALMEP+DNSTNHIP I + P+EPFDNS+S+ID +GTDDD ED TSAV
Sbjct: 786 LEETSSALMEPDDNSTNHIPGIPMAPMEPFDNSMSIIDRGGVNSGTGTDDDAEDATTSAV 845
Query: 836 FSQLVNPRGR 845
FSQLV+PRGR
Sbjct: 846 FSQLVHPRGR 855
|
Receptor-like protein kinase required for cell elongation during vegetative growth, mostly in a brassinosteroid-(BR-) independent manner. Mediates the response of growing plant cells to the perturbation of cellulose synthesis and may act as a cell-wall-integrity sensor. Controls ectopic-lignin accumulation in cellulose-deficient mutant backgrounds. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9LX66|HERK_ARATH Receptor-like protein kinase HERK 1 OS=Arabidopsis thaliana GN=HERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 838 bits (2164), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 444/853 (52%), Positives = 560/853 (65%), Gaps = 34/853 (3%)
Query: 4 MKLGKSVSVVLAVFLFELLCHKSCVAFTPVDNYLIACGSSQKVTFQARTYVPDTEHSSLS 63
M + K + +L + LLC C FTPVDNYLI CGS T R ++ D S L
Sbjct: 1 MGIEKFETFILISTISILLC--ICHGFTPVDNYLINCGSPTNGTLMGRIFLSDKLSSKL- 57
Query: 64 MKSGNSTTASSNSSAPSPIYQSARIFSAAAFYKFEIEHKGRHWVRLYFYTLPGSNQHLNS 123
+ S AS ++ S IY +AR+F+ + YKF + +GRHWVRLYF N + S
Sbjct: 58 LTSSKEILASVGGNSGSDIYHTARVFTEVSSYKFSVT-RGRHWVRLYFNPFDYQNFKMGS 116
Query: 124 ASFTVATDKFVLLSNFTFKNYNSSFMFKEYAINVNSDALTLTFIPSNNSVAFVNAIEVVS 183
A F V++ VLLS+FT SS + KEY++NV ++ L LTF PS+ S AFVNAIEV+S
Sbjct: 117 AKFAVSSQSHVLLSDFTV---TSSKVVKEYSLNVTTNDLVLTFTPSSGSFAFVNAIEVIS 173
Query: 184 VPDAIFPDQALALEPSASFSGLSDLGFETVYRLNMGGPLITAQNDTLGRTWENDETYLHV 243
+PD + + A F +S G ET++R+NMGGPL+ + NDTL RTW D +L
Sbjct: 174 IPDTLITGSPRFVGNPAQFPDMSMQGLETIHRVNMGGPLVASNNDTLTRTWVPDSEFLLE 233
Query: 244 NSSAVNVSVRPSAIRYTASVTAETAPNWVYATAEMMGDANVPEVNFNITWVLPVEPNFTY 303
+ A ++S + T ++AP VY + M A+ P FN+TW V+P F Y
Sbjct: 234 KNLAKSMSKFSTVNFVPGYATEDSAPRTVYGSCTEMNSADNPNSIFNVTWEFDVDPGFQY 293
Query: 304 FVRVHLCDIASLSMNNLVFNLYINDDIAQPSVDLSTLT-NGLNVPYYKDFVCNASADSNT 362
+ R H CDI SLS+N L FNLY++ +A +DLSTL N L Y DFV SN
Sbjct: 294 YFRFHFCDIVSLSLNQLYFNLYVDSMVAATDIDLSTLVDNTLAGAYSMDFVTQTPKGSNK 353
Query: 363 LTVSVGPDSV-ADFTNATMNGLEVMKISNEARSLDGLSSVEGLLPDKPSNKNKIGIIVGS 421
+ VS+GP +V D+ NA +NGLE+MK++N L + V G SN +G+IVGS
Sbjct: 354 VRVSIGPSTVHTDYPNAIVNGLEIMKMNNSKGQLSTGTFVPGSSSSSKSN---LGLIVGS 410
Query: 422 VVGAVAAVALIGVCYCWLLARKSKTPQQGHP--WLPLPLYGNSQTMTKMSTTSQKSGTAS 479
+G++ AV +G C+ +L +K K Q GH W+P + G S K +
Sbjct: 411 AIGSLLAVVFLGSCF--VLYKKRKRGQDGHSKTWMPFSINGTSM--------GSKYSNGT 460
Query: 480 CISLASSNLGRLFMFQEILDATNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSE 539
++ ++N F + DATN FDES +GVGGFG+VYKG L+DGTKVAVKRGNP+S+
Sbjct: 461 TLTSITTNANYRIPFAAVKDATNNFDESRNIGVGGFGKVYKGELNDGTKVAVKRGNPKSQ 520
Query: 540 QGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSW 599
QG+AEFRTEIEMLS+ RHRHLVSLIGYCDE +EMIL+YEYM NG ++SHLYG+ LP L+W
Sbjct: 521 QGLAEFRTEIEMLSQFRHRHLVSLIGYCDENNEMILIYEYMENGTVKSHLYGSGLPSLTW 580
Query: 600 KQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT 659
KQRLEICIGAARGLHYLHTG ++ +IHRDVK+ NILLD+NF+AKVADFGLSKTGP LDQT
Sbjct: 581 KQRLEICIGAARGLHYLHTGDSKPVIHRDVKSANILLDENFMAKVADFGLSKTGPELDQT 640
Query: 660 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEW 719
HVSTAVKGSFGYLDPEYFRRQQLT+KSDVYSFGVVL EVLC RP ++P LPRE VN+AEW
Sbjct: 641 HVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEW 700
Query: 720 AMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779
AM WQKKG LDQI+D +L G + P SL+KF ET EKCLA++GVDRPSMGDVLWNLEYALQ
Sbjct: 701 AMKWQKKGQLDQIIDQSLRGNIRPDSLRKFAETGEKCLADYGVDRPSMGDVLWNLEYALQ 760
Query: 780 LEETSSALM--EPEDNSTNHIPCI--QLTPLEPFDNSVSMIDVRN---SGTDDDGEDVAT 832
L+E A++ EPEDNSTN I + Q+ D SV++ + DD V+
Sbjct: 761 LQE---AVIDGEPEDNSTNMIGELPPQINNFSQGDTSVNVPGTAGRFEESSIDDLSGVSM 817
Query: 833 SAVFSQLVNPRGR 845
S VFSQLV GR
Sbjct: 818 SKVFSQLVKSEGR 830
|
Receptor-like protein kinase required for cell elongation during vegetative growth, mostly in a brassinosteroid-(BR-) independent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9SJT0|Y2214_ARATH Probable receptor-like protein kinase At2g21480 OS=Arabidopsis thaliana GN=At2g21480 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 812 bits (2097), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 416/771 (53%), Positives = 515/771 (66%), Gaps = 29/771 (3%)
Query: 29 AFTPVDNYLIACGS-SQKVTFQARTYVPDTEH-SSLSMKSGNSTTASSNSSAPSPIYQSA 86
F P D+ LI CGS S T + R + D+E + K +A + PSPIY +A
Sbjct: 50 GFKPADDILIDCGSKSSTKTPEGRVFKSDSETVQYIEAKDDIQVSAPPSDKLPSPIYLTA 109
Query: 87 RIFSAAAFYKFEIEHKGRHWVRLYFYTLPGSNQHLNSASFTVATDKFVLLSNFTFKNYNS 146
+IF A YKF + G HWVRL+F+ P L A+F+V T+K+VLL NF N N+
Sbjct: 110 KIFREEAIYKFHLTRPGWHWVRLHFFAFPNDKFDLQQATFSVLTEKYVLLHNFKLSNDNN 169
Query: 147 ---SFMFKEYAINVNSDALTLTFIPSNNSVAFVNAIEVVSVPDAIFPDQALALEPSASFS 203
+ + KEY +N+ L F P S AF+N IE+VS PD + D +L P FS
Sbjct: 170 DSQATVQKEYLLNMTDAQFALRFKPMKGSAAFINGIELVSAPDELISDAGTSLFPVNGFS 229
Query: 204 GLSDLGFETVYRLNMGGPLITAQNDTLGRTWENDETYLHVNSSAVNVSVRPSAIRYTASV 263
GLSD +++VYR+N+GGPLIT QNDTLGRTW D+ YL + A +V P+AI Y V
Sbjct: 230 GLSDYAYQSVYRVNVGGPLITPQNDTLGRTWTPDKEYLKDENLAKDVKTNPTAIIYPPGV 289
Query: 264 TAETAPNWVYATAEMMGDANVPEVNFNITWVLPVEPNFTYFVRVHLCDIASLSMNNLVFN 323
T AP VYAT M D+ + NFN+TW P P+F YF+R+H CDI S S+N+L FN
Sbjct: 290 TPLIAPQTVYATGAEMADSQTIDPNFNVTWNFPSNPSFHYFIRLHFCDIISKSLNDLYFN 349
Query: 324 LYINDDIAQPSVDLSTLTNGLNVPYYKDFVCNASADSNTLTVSVGP-DSVADFTNATMNG 382
+YIN A +DLST+ L+ PYYKD V N++ ++ L V +GP NA +NG
Sbjct: 350 VYINGKTAISGLDLSTVAGDLSAPYYKDIVVNSTLMTSELQVQIGPMGEDTGKKNAILNG 409
Query: 383 LEVMKISNEARSLDGLSSVEGLLPDKPSNKNKIGIIV--GSVVGAVAAVALIGVCYCWLL 440
+EV+K+SN SLDG V+G + ++ K G++ G V+ A V L + Y W
Sbjct: 410 VEVLKMSNSVNSLDGEFGVDG----QRASMGKQGMVATAGFVMMFGAFVGLGAMVYKW-- 463
Query: 441 ARKSKTPQQGHP------WLPLPLYGNSQTMTKMSTTSQKSGTASCISLASSNLGRLFMF 494
K PQ WL LP++ T T S KS + ++ LGR F
Sbjct: 464 ---KKRPQDWQKRNSFSSWL-LPIHAGDSTFMTSKTGSHKSNLYN----SALGLGRYFSL 515
Query: 495 QEILDATNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSK 554
E+ + T FD S ++GVGGFG VY GT+DDGT+VA+KRGNP+SEQGI EF TEI+MLSK
Sbjct: 516 SELQEVTKNFDASEIIGVGGFGNVYIGTIDDGTQVAIKRGNPQSEQGITEFHTEIQMLSK 575
Query: 555 LRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLH 614
LRHRHLVSLIGYCDE +EMILVYEYM+NGP R HLYG +L PL+WKQRLEICIGAARGLH
Sbjct: 576 LRHRHLVSLIGYCDENAEMILVYEYMSNGPFRDHLYGKNLSPLTWKQRLEICIGAARGLH 635
Query: 615 YLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDP 674
YLHTG AQ IIHRDVK+TNILLD+ VAKVADFGLSK A Q HVSTAVKGSFGYLDP
Sbjct: 636 YLHTGTAQGIIHRDVKSTNILLDEALVAKVADFGLSKD-VAFGQNHVSTAVKGSFGYLDP 694
Query: 675 EYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMD 734
EYFRRQQLT+KSDVYSFGVVL+E LC RPA+NP LPREQVN+AEWAM W++KG+L++I+D
Sbjct: 695 EYFRRQQLTDKSDVYSFGVVLLEALCARPAINPQLPREQVNLAEWAMLWKQKGLLEKIID 754
Query: 735 SNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLEETSS 785
+LVG VNP S+KKF E AEKCLA++GVDRP+MGDVLWNLEYALQL+E S
Sbjct: 755 PHLVGAVNPESMKKFAEAAEKCLADYGVDRPTMGDVLWNLEYALQLQEAFS 805
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9T020|Y4391_ARATH Probable receptor-like protein kinase At4g39110 OS=Arabidopsis thaliana GN=At4g39110 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 809 bits (2090), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 435/847 (51%), Positives = 542/847 (63%), Gaps = 49/847 (5%)
Query: 29 AFTPVDNYLIACGS-SQKVTFQARTYVPDTEH-SSLSMKSGNSTTASSNSSAPSPIYQSA 86
F P D+ LI CGS S T R + D E + K +A + SPIY +A
Sbjct: 51 GFKPADDILIDCGSKSSSKTPDGRVFKSDQETIQYIEAKEDIQVSAPPSDKVASPIYLTA 110
Query: 87 RIFSAAAFYKFEIEHKGRHWVRLYFYTLPGSNQHLNSASFTVATDKFVLLSNFTFKNYNS 146
RIF A YKF + G HWVRL+F P L A+F+V T+K+VLL NF N N+
Sbjct: 111 RIFREEATYKFHLTRPGWHWVRLHFLAFPNDKFDLQQATFSVLTEKYVLLHNFKISNNNN 170
Query: 147 ---SFMFKEYAINVNSDALTLTFIPSNNSVAFVNAIEVVSVPDAIFPDQALALEPSASFS 203
+ + KEY +N+ L F P +S AF+NAIEVVS PD + D AL P FS
Sbjct: 171 DSQAAVQKEYLVNMTDAQFALRFRPMKSSAAFINAIEVVSAPDELISDSGTALFPVIGFS 230
Query: 204 GLSDLGFETVYRLNMGGPLITAQNDTLGRTWENDETYLHVNSSAVNVSVRPSAIRYTASV 263
GLSD +++VYR+N+GGPLI QNDTLGRTW D+ +L + A +V PSAI+Y V
Sbjct: 231 GLSDYAYQSVYRVNVGGPLIMPQNDTLGRTWIPDKEFLKDENLAKDVKTTPSAIKYPPEV 290
Query: 264 TAETAPNWVYATAEMMGDANVPEVNFNITWVLPVEPNFTYFVRVHLCDIASLSMNNLVFN 323
T AP VYATA M ++ + NFN++W P P+F Y +R+H CDI S S+N+L FN
Sbjct: 291 TPLIAPQTVYATAVEMANSLTIDPNFNVSWNFPSNPSFNYLIRLHFCDIVSKSLNDLYFN 350
Query: 324 LYINDDIAQPSVDLSTLTNGLNVPYYKDFVCNASADSNTLTVSVGPDSVADFT-NATMNG 382
+YIN A +DLST+ L PYYKD V NA+ L V +GP T NA +NG
Sbjct: 351 VYINGKTAISGLDLSTVAGNLAAPYYKDIVVNATLMGPELQVQIGPMGEDTGTKNAILNG 410
Query: 383 LEVMKISNEARSLDGLSSVEGLLPDKPSNKNKIGIIV--GSVVGAVAAVALIGVCYCWLL 440
+EV+K+SN SLDG V+G + + K G++ G V+ A + L + Y W
Sbjct: 411 VEVLKMSNSVNSLDGEFGVDG----RTTGMGKHGMVATAGFVMMFGAFIGLGAMVYKW-- 464
Query: 441 ARKSKTPQQGHP------WLPLPLYGNSQTMTKMSTTSQKSGTASCISLASSNLGRLFMF 494
K PQ WL LP++ T SQKS + ++ LGR F
Sbjct: 465 ---KKRPQDWQKRNSFSSWL-LPIHAGDSTFMTSKGGSQKSNFYN----STLGLGRYFSL 516
Query: 495 QEILDATNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSK 554
E+ +AT F+ S ++GVGGFG VY GTLDDGTKVAVKRGNP+SEQGI EF+TEI+MLSK
Sbjct: 517 SELQEATKNFEASQIIGVGGFGNVYIGTLDDGTKVAVKRGNPQSEQGITEFQTEIQMLSK 576
Query: 555 LRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLH 614
LRHRHLVSLIGYCDE SEMILVYE+M+NGP R HLYG +L PL+WKQRLEICIG+ARGLH
Sbjct: 577 LRHRHLVSLIGYCDENSEMILVYEFMSNGPFRDHLYGKNLAPLTWKQRLEICIGSARGLH 636
Query: 615 YLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDP 674
YLHTG AQ IIHRDVK+TNILLD+ VAKVADFGLSK A Q HVSTAVKGSFGYLDP
Sbjct: 637 YLHTGTAQGIIHRDVKSTNILLDEALVAKVADFGLSKD-VAFGQNHVSTAVKGSFGYLDP 695
Query: 675 EYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMD 734
EYFRRQQLT+KSDVYSFGVVL+E LC RPA+NP LPREQVN+AEWAM W++KG+L++I+D
Sbjct: 696 EYFRRQQLTDKSDVYSFGVVLLEALCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIID 755
Query: 735 SNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQL---------EETSS 785
+L G +NP S+KKF E AEKCL ++GVDRP+MGDVLWNLEYALQL EET +
Sbjct: 756 PHLAGTINPESMKKFAEAAEKCLEDYGVDRPTMGDVLWNLEYALQLQEAFTQGKAEETEN 815
Query: 786 ALMEPEDNSTNHIPCIQLTPLEP--FDNSVSMIDV-----RNSGTDDDGEDVATSAVFSQ 838
A +P+ + +P +P+ P N + + V NSGT D + + +A+F+Q
Sbjct: 816 A--KPDVVTPGSVPVSDPSPITPSVTTNEAATVPVPAKVEENSGTAVD--EHSGTAMFTQ 871
Query: 839 LVNPRGR 845
N GR
Sbjct: 872 FANLNGR 878
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FN92|Y5597_ARATH Probable receptor-like protein kinase At5g59700 OS=Arabidopsis thaliana GN=At5g59700 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 798 bits (2062), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 432/835 (51%), Positives = 552/835 (66%), Gaps = 43/835 (5%)
Query: 27 CVAFTPVDNYLIACGSSQKVTFQARTYVPDTEHSSLSMKSGNSTTASSNSSAPSPIYQSA 86
C + PVDNYLI CGSS VT +R ++ D S+ + S N A+SN ++ S IYQ+A
Sbjct: 22 CYGYVPVDNYLINCGSSTNVTVTSRVFISDNLASNF-LTSPNEILAASNRNSNSDIYQTA 80
Query: 87 RIFSAAAFYKFEIEHKGRHWVRLYFYTLPGSNQHLNSASFTVATDKFVLLSNFTFKNYNS 146
RIF+ + Y+F + +GRHW+RL+F N + SA F+V+++ VLLS+FT S
Sbjct: 81 RIFTGISKYRFSVA-RGRHWIRLHFNPFQYQNFQMVSAKFSVSSETHVLLSDFTV----S 135
Query: 147 SFMFKEYAINVNSDALTLTFIPSNNSVAFVNAIEVVSVPDAIFP-DQALALEPSASFSGL 205
S + KEY++NV +D L LTF PS +S AF+NA+EVVSVPD +F D + A P F GL
Sbjct: 136 SRVMKEYSLNVATDHLELTFTPSGDSFAFLNALEVVSVPDTLFSGDPSFAGSP-GKFQGL 194
Query: 206 SDLGFETVYRLNMGGPLITAQNDTLGRTWENDETYLHVNSSAVNVSVRPSAIRYTASVTA 265
S ETVYR+NMGGP +T NDTL R WE D +L + +VS S T
Sbjct: 195 SWQALETVYRVNMGGPRVTPSNDTLSRIWEPDSEFLVEKNLVKSVSKIASVDYVPGFATE 254
Query: 266 ETAPNWVYATAEMMGDANVPEVNFNITWVLPVEPNFTYFVRVHLCDIASLSMNNLVFNLY 325
ETAP VY T M A+ P NFN+TW V+P F YF+R H CDI S ++N L FNLY
Sbjct: 255 ETAPRTVYGTCTEMNSADNPSSNFNVTWDFDVDPGFQYFLRFHFCDIVSKALNQLYFNLY 314
Query: 326 INDDIAQPSVDLST-LTNGLNVPYYKDFVCNASADSNTLTVSVGPDSV-ADFTNATMNGL 383
++ ++DLS+ L+N L+ Y DFV ++ + + VS+G SV D+ A +NGL
Sbjct: 315 VDSMDVVENLDLSSYLSNTLSGAYAMDFVTGSAKLTKRIRVSIGRSSVHTDYPTAILNGL 374
Query: 384 EVMKISNEARSLDGLSSVEGLLPDKPSN--KNKIGIIVGSVVGAVAAVALIGVCYCWLLA 441
E+MK++N L S+ LP S+ K +G+I+G +G++ A+ ++G + +L
Sbjct: 375 EIMKMNNSKSQL----SIGTFLPSGSSSTTKKNVGMIIGLTIGSLLALVVLGGFF--VLY 428
Query: 442 RKSKTPQQGHP--WLPLPLYGNSQTMTKMSTTSQKSGTASCISLASSNLGRLFMFQEILD 499
+K Q G+ W+PL G + + + S S ++ I L + + +
Sbjct: 429 KKRGRDQDGNSKTWIPLSSNGTTSSSNGTTLASIASNSSYRIPLVA-----------VKE 477
Query: 500 ATNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRH 559
ATN FDE+ +GVGGFG+VYKG L DGTKVAVKR NP+S+QG+AEFRTEIEMLS+ RHRH
Sbjct: 478 ATNSFDENRAIGVGGFGKVYKGELHDGTKVAVKRANPKSQQGLAEFRTEIEMLSQFRHRH 537
Query: 560 LVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTG 619
LVSLIGYCDE +EMILVYEYM NG L+SHLYG+ L LSWKQRLEICIG+ARGLHYLHTG
Sbjct: 538 LVSLIGYCDENNEMILVYEYMENGTLKSHLYGSGLLSLSWKQRLEICIGSARGLHYLHTG 597
Query: 620 AAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRR 679
A+ +IHRDVK+ NILLD+N +AKVADFGLSKTGP +DQTHVSTAVKGSFGYLDPEYFRR
Sbjct: 598 DAKPVIHRDVKSANILLDENLMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR 657
Query: 680 QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVG 739
QQLTEKSDVYSFGVV+ EVLC RP ++P L RE VN+AEWAM WQKKG L+ I+D +L G
Sbjct: 658 QQLTEKSDVYSFGVVMFEVLCARPVIDPTLTREMVNLAEWAMKWQKKGQLEHIIDPSLRG 717
Query: 740 KVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLEETSSALMEPEDNSTNHIP 799
K+ P SL+KFGET EKCLA++GVDRPSMGDVLWNLEYALQL+E + +PED STN I
Sbjct: 718 KIRPDSLRKFGETGEKCLADYGVDRPSMGDVLWNLEYALQLQE-AVVDGDPED-STNMIG 775
Query: 800 --CIQLTPLEPFDNSVSMIDVRNSGTDDDGEDVAT-------SAVFSQLVNPRGR 845
++ D SV+ V G D+ E S VFSQL+ GR
Sbjct: 776 ELPLRFNDYNHGDTSVNF-SVAKEGRFDEEESSVDDSSGVSMSKVFSQLIKSEGR 829
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FLJ8|Y5613_ARATH Probable receptor-like protein kinase At5g61350 OS=Arabidopsis thaliana GN=At5g61350 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 770 bits (1988), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 416/817 (50%), Positives = 539/817 (65%), Gaps = 41/817 (5%)
Query: 25 KSCVAFTPVDNYLIACGSSQKVTF-QARTYVPDTE-----HSSLSMKSGNSTTASSNSSA 78
KS +FTP DNYLI CGSS + R + D + + +K+ + ++S+A
Sbjct: 23 KSSSSFTPADNYLIDCGSSDETKLSDGRNFKSDQQSVAFLQTDEDIKTSVDSIPITDSNA 82
Query: 79 PS-PIYQSARIFSAAAFYKFEIEHKGRHWVRLYFYTLPGSNQHLNSASFTVATDKFVLLS 137
+ P+Y +ARIF+ + Y F I GRHW+RL+FY L +L ++ F+V TD VLL
Sbjct: 83 STLPLYLTARIFAGKSTYSFYISRPGRHWIRLHFYPLNHPLYNLTNSVFSVTTDTTVLLH 142
Query: 138 NFTFKNYNSSFMFKEYAINVNSDALTLTFIPSNNSVAFVNAIEVVSVPDAIFPDQALALE 197
+F+ + SS +FKEY I ++ L+L F P S AF+NA+E+VSVPD + PD A ++
Sbjct: 143 DFSAGD-TSSIVFKEYLIYA-AEKLSLYFKPHKGSTAFINAVEIVSVPDELVPDSASSVP 200
Query: 198 PSASFSGLSDLGFETVYRLNMGGPLITAQNDTLGRTWENDETYLHVNSSAVNVSVRPSAI 257
+ F GLS E ++R+N+GG LI+ + D L RTW +D+ Y + NV+V PS I
Sbjct: 201 QAPDFKGLSSFSLEILHRINIGGDLISPKIDPLSRTWLSDKPYNTFPEGSRNVTVDPSTI 260
Query: 258 RY-TASVTAETAPNWVYATAEMMGDANVPEVNFNITWVLPVEPNFTYFVRVHLCDIASLS 316
Y TA APN VYATAE M DA + NFN++W + V+ YF+R+H CDI S S
Sbjct: 261 TYPDGGATALIAPNPVYATAEEMADAQTSQPNFNLSWRMSVDFGHDYFIRLHFCDIVSKS 320
Query: 317 MNNLVFNLYINDDIAQPSVDLSTLTNGLNVPYYKDFVCNASADSN-TLTVSVGP--DSVA 373
+N+L+FN++IN A ++DLS+LT+ L YY DFV NAS +N ++ V VGP + +
Sbjct: 321 LNDLIFNVFINKLSAISALDLSSLTSALGTAYYADFVLNASTITNGSILVQVGPTPNLQS 380
Query: 374 DFTNATMNGLEVMKISNEARSLDGLSSVEGLLPDKPSNKNKIGIIVGSVVGAVAAVALIG 433
NA +NGLE+MK++N A SLDGL V+G + + + + +A A +G
Sbjct: 381 GKPNAILNGLEIMKLNNAAGSLDGLFGVDGKYKGPIGGMSSKKLAIAGIGFVMALTAFLG 440
Query: 434 VCYCWLLARKSKTPQQGHP------WLPLPLYGN---------SQTMTKMSTTSQKSGTA 478
V LL R + P+ WL LPL+ + T +MS K +
Sbjct: 441 VVV--LLVRWQRRPKDWQKQNSFSSWL-LPLHASHSSYISSKGGSTSRRMSIFGSKKSKS 497
Query: 479 SCISLASSN--LGRLFMFQEILDATNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNP 536
+ S SN LGR F F E+ AT FDE+ + GVGGFG+VY G +D GT+VA+KRG+
Sbjct: 498 NGFSSFFSNQGLGRYFPFTELQTATQNFDENAVCGVGGFGKVYIGEIDGGTQVAIKRGSQ 557
Query: 537 RSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTD--- 593
SEQGI EF+TEI+MLSKLRHRHLVSLIG+CDE EMILVYEYM+NGPLR HLYG+
Sbjct: 558 SSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDENKEMILVYEYMSNGPLRDHLYGSKEND 617
Query: 594 ---LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLS 650
+P LSWKQRLEICIG+ARGLHYLHTGAAQ IIHRDVKTTNILLD+N VAKV+DFGLS
Sbjct: 618 PNPIPTLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVSDFGLS 677
Query: 651 KTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLP 710
K P +D+ HVSTAVKGSFGYLDPEYFRRQQLT+KSDVYSFGVVL EVLC RP +NP LP
Sbjct: 678 KDAP-MDEGHVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARPVINPQLP 736
Query: 711 REQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDV 770
REQVN+AE+AM +KGML++I+D +VG ++ SL+KF E AEKCLAE+GVDRP MGDV
Sbjct: 737 REQVNLAEYAMNLHRKGMLEKIIDPKIVGTISKGSLRKFVEAAEKCLAEYGVDRPGMGDV 796
Query: 771 LWNLEYALQLEETSSALMEPEDNSTNHIPCIQLTPLE 807
LWNLEYALQL+E S+ + ED +T +I + L P E
Sbjct: 797 LWNLEYALQLQEASAQVDLSEDKTTMNIE-MDLIPGE 832
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FLW0|Y5241_ARATH Probable receptor-like protein kinase At5g24010 OS=Arabidopsis thaliana GN=At5g24010 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 703 bits (1815), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 401/847 (47%), Positives = 534/847 (63%), Gaps = 51/847 (6%)
Query: 16 VFLFELLCHKSCVAFTPVDNYLIACGSSQKVTF-QARTYVPDTEHSSLSMKSGNSTTASS 74
+F F L H S AFTP DNYLI GS+ +F R+++ D+ S S + + + S
Sbjct: 12 LFFFCPLLHLSFAAFTPTDNYLINSGSNTNTSFFTTRSFLSDSSEPGSSFLSTDRSISIS 71
Query: 75 NSSAPSP----IYQSARIFSAAAFYKFEIEHKGRHWVRLYFYTLPGSNQHLNSASFTVAT 130
+++ PSP +Y +AR+F YKF++ KG H++RL+F S +L SA F V
Sbjct: 72 DTN-PSPDSPVLYNTARVFPVGGSYKFQVTTKGTHFIRLHFAPFKASRFNLRSAKFRVLI 130
Query: 131 DKFVLLSNFTFKNYNSSFMFKEYAINVNSDALTLTFIPSNNS-VAFVNAIEVVSVPDAIF 189
+ F ++++F+ SS + KE+ + ++ L ++F+P S FVNA+EV S P
Sbjct: 131 NGFSVINSFS----TSSVVVKEFILKIDDPVLEISFLPFKASGFGFVNAVEVFSAPKDYI 186
Query: 190 PDQA--LALEPSAS-FSGLSDLGFETVYRLNMGGPLITAQNDTLGRTWENDETYLHVNSS 246
DQ L + SA FS LS ETV+R+N+GG +T NDTL RTW D+ YL + ++
Sbjct: 187 MDQGTKLVIPNSAQIFSNLSSQVLETVHRINVGGSKLTPFNDTLWRTWVVDDNYLLLRAA 246
Query: 247 AVNVSVRPSAIRYTASVTAETAPNWVYATA-EMMGDANVPEVNFNITWVLPV-EPNFTYF 304
A S T E AP+ VY TA EM D + FNI+W V E +
Sbjct: 247 ARRAWTTHSPNYQNGGATREIAPDNVYMTAQEMDRDNQELQARFNISWGFQVDEKRVLHL 306
Query: 305 VRVHLCDIASLSMNNLVFNLYINDDIAQPSVDLSTLT-NGLNVPYYKDFVCNASADSNTL 363
VR+H CDI S S+N L FN++IN+ +A VDLSTLT + L P Y DFV S S L
Sbjct: 307 VRLHFCDIVSSSLNQLYFNVFINEYLAFKDVDLSTLTFHVLASPLYIDFVAE-SDRSGML 365
Query: 364 TVSVGPDSVAD--FTNATMNGLEVMKISNEARSLDGLSSVEGLLPDKPSNKNKIGIIVGS 421
+SVGP +++ NA +NG+E+M+I + S V G +N + I+VGS
Sbjct: 366 RISVGPSDLSNPARVNALLNGVEIMRILSPVSS----EVVSG-------KRNVVWIVVGS 414
Query: 422 VVGAVAAVALIGVCYCWLLARKSKTPQQGHP--WLPLPLY-GNSQTMTKMSTTSQKSGTA 478
V+G ++L + L RK+ + W PL + G+S + T T S
Sbjct: 415 VLGGFVFLSLFFLSVLCLCRRKNNKTRSSESTGWTPLRRFRGSSNSRTTERTVSSSGYHT 474
Query: 479 SCISLASSNLGRLFMFQEILDATNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRS 538
IS F E+ TN FD SL++GVGGFG V++G+L D TKVAVKRG+P S
Sbjct: 475 LRIS-----------FAELQSGTNNFDRSLVIGVGGFGMVFRGSLKDNTKVAVKRGSPGS 523
Query: 539 EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLS 598
QG+ EF +EI +LSK+RHRHLVSL+GYC+E+SEMILVYEYM GPL+SHLYG+ PPLS
Sbjct: 524 RQGLPEFLSEITILSKIRHRHLVSLVGYCEEQSEMILVYEYMDKGPLKSHLYGSTNPPLS 583
Query: 599 WKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQ 658
WKQRLE+CIGAARGLHYLHTG++Q IIHRD+K+TNILLD+N+VAKVADFGLS++GP +D+
Sbjct: 584 WKQRLEVCIGAARGLHYLHTGSSQGIIHRDIKSTNILLDNNYVAKVADFGLSRSGPCIDE 643
Query: 659 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAE 718
THVST VKGSFGYLDPEYFRRQQLT+KSDVYSFGVVL EVLC RPA++P+L REQVN+AE
Sbjct: 644 THVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARPAVDPLLVREQVNLAE 703
Query: 719 WAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYAL 778
WA+ WQ+KGMLDQI+D N+ ++ P SLKKF ETAEKC A++GVDRP++GDVLWNLE+ L
Sbjct: 704 WAIEWQRKGMLDQIVDPNIADEIKPCSLKKFAETAEKCCADYGVDRPTIGDVLWNLEHVL 763
Query: 779 QLEETSSALMEPEDNSTNHIPCIQLTPLEPFDNSVSMIDVRNSGTDDDGEDVATSAVFSQ 838
QL+E+ + ED P T + N ++ R+ G G ++++ VFSQ
Sbjct: 764 QLQESGPLNIPEEDYGDVTDP---RTARQGLSNGSNI--ERDYGDGTSGI-ISSTQVFSQ 817
Query: 839 LVNPRGR 845
L+ GR
Sbjct: 818 LMTNAGR 824
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9SA72|Y1357_ARATH Probable receptor-like protein kinase At1g30570 OS=Arabidopsis thaliana GN=At1g30570 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 695 bits (1793), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 373/800 (46%), Positives = 500/800 (62%), Gaps = 43/800 (5%)
Query: 17 FLFELLCHKSCVAFTPVDNY--------LIACGSSQKVTFQARTYVPD-TEHSSLSMKSG 67
+L LLC + FT V Y L+ CGS+ RT+V D + + S++++
Sbjct: 8 YLEHLLC--VLIFFTYVIGYGEAQSKSFLVDCGSNATTEVDGRTWVGDLSPNKSVTLQGF 65
Query: 68 NSTTASSN--SSAPSPIYQSARIFSAAAFYKFEIEHKGRHWVRLYFYTLPGSNQHLNSAS 125
++ TAS++ SS + IY++AR+F A Y FE +G ++VRL+F N ++N +S
Sbjct: 66 DAITASTSKGSSVYAEIYKTARVFDAVLNYTFEGITQGNYFVRLHFSPFAIENHNVNESS 125
Query: 126 FTVATDKFVLLSNF---------------TFKNYNSSFMFKEYAINVNSDALTLTFIPSN 170
F+V D L+ + T N +S + KE+ + L L+FIP
Sbjct: 126 FSVFADGLRLMLDINIAGEIAHKNLILESTGHNATASSLVKEFLLPTGPGKLVLSFIPEK 185
Query: 171 NSVAFVNAIEVVSVPDAIFPDQALALEPSASFSGLSDLGFETVYRLNMGGPLITAQND-T 229
S FVNAIE+VSV D +F + + S GL G ET+YRLN+GGP + D
Sbjct: 186 GSFGFVNAIEIVSVDDKLFKESVTKVGGSEVELGLGGRGIETMYRLNVGGPKLGPSKDLK 245
Query: 230 LGRTWENDETYLHVNSSAVNVSVRPSAIRYTASVTAETAPNWVYATAEMMGDANVPEVNF 289
L RTWE D +Y+ + ++ V V S I Y + + AP VY TA MM + V E F
Sbjct: 246 LYRTWETDLSYMVIENAGVEVK-NSSNITYALADDSPVAPLLVYETARMMSNTEVLEKRF 304
Query: 290 NITWVLPVEPNFTYFVRVHLCDIASLSMNNLVFNLYINDDIAQPSVDLSTLTNGLNVPYY 349
NI+W V+PNF Y VR+H C++ N +F +YIN+ A + D+ G N Y
Sbjct: 305 NISWKFEVDPNFDYLVRLHFCELLVDKQNQRIFRIYINNQTAAGNFDIFAHAGGKNKGIY 364
Query: 350 KDFVCNASADSNTLTVSVGPDS-VADFTNATMNGLEVMKISNEAR--SLDGLSSVEGLLP 406
+D++ S+ ++ L + +GPDS V +A ++GLE+ K+S L S +
Sbjct: 365 QDYLDPVSSKNDVLWIQLGPDSSVGASGDALLSGLEIFKLSKNGNLAHLIRFDSTGHSVS 424
Query: 407 DKPSNKNKIGIIVGSVVGAVAAVALIG---VCYCWLLARKSKTPQQGHP-WLPLPLYGNS 462
D S I I VG+ + + +G VC C KS + P W PL L+ N+
Sbjct: 425 D--SKMRIIWISVGAGIAIIIFFVFLGILVVCLCKKRRSKSDESKNNPPGWRPLFLHVNN 482
Query: 463 QTMTKMSTTSQKSGTASCISLASSNLGRLFMFQEILDATNKFDESLLLGVGGFGRVYKGT 522
T +T G+ +LA+S +GR F EI AT FD+ L +GVGGFG+VY+G
Sbjct: 483 STANAKAT----GGSLRLNTLAASTMGRKFTLAEIRAATKNFDDGLAIGVGGFGKVYRGE 538
Query: 523 LDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMAN 582
L+DGT +A+KR P S+QG+AEF TEI MLS+LRHRHLVSLIG+CDE +EMILVYEYMAN
Sbjct: 539 LEDGTLIAIKRATPHSQQGLAEFETEIVMLSRLRHRHLVSLIGFCDEHNEMILVYEYMAN 598
Query: 583 GPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVA 642
G LRSHL+G++LPPLSWKQRLE CIG+ARGLHYLHTG+ + IIHRDVKTTNILLD+NFVA
Sbjct: 599 GTLRSHLFGSNLPPLSWKQRLEACIGSARGLHYLHTGSERGIIHRDVKTTNILLDENFVA 658
Query: 643 KVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTR 702
K++DFGLSK GP++D THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL E +C R
Sbjct: 659 KMSDFGLSKAGPSMDHTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEAVCAR 718
Query: 703 PALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGV 762
+NP LP++Q+N+AEWA++WQK+ L+ I+DSNL G +P SL+K+GE AEKCLA+ G
Sbjct: 719 AVINPTLPKDQINLAEWALSWQKQRNLESIIDSNLRGNYSPESLEKYGEIAEKCLADEGK 778
Query: 763 DRPSMGDVLWNLEYALQLEE 782
+RP MG+VLW+LEY LQ+ E
Sbjct: 779 NRPMMGEVLWSLEYVLQIHE 798
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9SCZ4|FERON_ARATH Receptor-like protein kinase FERONIA OS=Arabidopsis thaliana GN=FER PE=1 SV=1 | Back alignment and function description |
|---|
Score = 674 bits (1739), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 396/883 (44%), Positives = 527/883 (59%), Gaps = 76/883 (8%)
Query: 26 SCVAFTPVDNYLIACG--SSQKVTFQARTYVPDTEHSSLSMKSGNSTTA---SSNSSAPS 80
S ++P + L+ CG +S R ++ D + LS S +S T+ + + S P
Sbjct: 26 SAADYSPTEKILLNCGGGASNLTDTDNRIWISDVKSKFLSSSSEDSKTSPALTQDPSVPE 85
Query: 81 PIYQSARIFSAAAFYKFEIEHKGRHWVRLYFYTLPGSNQHLNSAS--FTVATDKFVLLSN 138
Y +AR+F + Y F + GR +VRLYFY P S LN+ + F+V+ + LL N
Sbjct: 86 VPYMTARVFRSPFTYTFPVA-SGRKFVRLYFY--PNSYDGLNATNSLFSVSFGPYTLLKN 142
Query: 139 F----TFKNYNSSFMFKEYAINVNSDALTLTFIPSN---NSVAFVNAIEVVSVPDAIFP- 190
F T + +F+ KE+ +NV L +TF P + N+ AFVN IEV S+PD
Sbjct: 143 FSASQTAEALTYAFIIKEFVVNVEGGTLNMTFTPESAPSNAYAFVNGIEVTSMPDMYSST 202
Query: 191 DQALAL-EPSASFSGLSDLGFETVYRLNMGGPLITAQNDT-LGRTWENDETYLHVNSSAV 248
D L + S S + + E VYRLN+GG I+ DT L R+W +D+ Y+ +
Sbjct: 203 DGTLTMVGSSGSVTIDNSTALENVYRLNVGGNDISPSADTGLYRSWYDDQPYIFGAGLGI 262
Query: 249 NVSVRPS-AIRYTASVTAETAPNWVYATAEMMGDANVPEVNFNITWVLPVEPNFTYFVRV 307
+ P+ I+Y AP VY+TA MG +N+N+TW+ ++ FTY VR+
Sbjct: 263 PETADPNMTIKYPTGTPTYVAPVDVYSTARSMGPTAQINLNYNLTWIFSIDSGFTYLVRL 322
Query: 308 HLCDIAS--LSMNNLVFNLYINDDIAQPSVDLSTLTNGLNVPYYKDFVCNASADSNT--- 362
H C+++S +N VF +Y+N+ A+P D+ T+ VP++KD+V N +
Sbjct: 323 HFCEVSSNITKINQRVFTIYLNNQTAEPEADVIAWTSSNGVPFHKDYVVNPPEGNGQQDL 382
Query: 363 -LTVSVGPDSVADFTNATMNGLEVMKISNEARSLDGLSSVEG----------LLPDKPSN 411
L + P + ++ ++ +NG+E+ K++ +L G + + G L P +
Sbjct: 383 WLALHPNPVNKPEYYDSLLNGVEIFKMNTSDGNLAGTNPIPGPQVTADPSKVLRPTTRKS 442
Query: 412 KNKIGIIVGSVVGAVAAVALIGVCYCWLLARKSKTPQQ-----GHPWLPLPLYGNSQTMT 466
K+ II G+ GAV +IG C R+ + Q WLPL LYGNS +
Sbjct: 443 KSNTAIIAGAASGAVVLALIIGFCVFGAYRRRKRGDYQPASDATSGWLPLSLYGNSHSAG 502
Query: 467 KMSTTSQKSGTASCISLASSNLGRLFMFQEILDATNKFDESLLLGVGGFGRVYKGTLDDG 526
T + T S S SNL R F F EI AT FDES +LGVGGFG+VY+G +D G
Sbjct: 503 SAKTNT----TGSYASSLPSNLCRHFSFAEIKAATKNFDESRVLGVGGFGKVYRGEIDGG 558
Query: 527 T-KVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPL 585
T KVA+KRGNP SEQG+ EF+TEIEMLSKLRHRHLVSLIGYC+E EMILVY+YMA+G +
Sbjct: 559 TTKVAIKRGNPMSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAHGTM 618
Query: 586 RSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVA 645
R HLY T P L WKQRLEICIGAARGLHYLHTGA +IIHRDVKTTNILLD+ +VAKV+
Sbjct: 619 REHLYKTQNPSLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVS 678
Query: 646 DFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPAL 705
DFGLSKTGP LD THVST VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL E LC RPAL
Sbjct: 679 DFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEALCARPAL 738
Query: 706 NPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRP 765
NP L +EQV++AEWA KKGMLDQI+D L GK+ P KKF ETA KC+ + G++RP
Sbjct: 739 NPTLAKEQVSLAEWAPYCYKKGMLDQIVDPYLKGKITPECFKKFAETAMKCVLDQGIERP 798
Query: 766 SMGDVLWNLEYALQLEETSSALMEPEDNSTNHIPCIQLTPLEPFDNSV------------ 813
SMGDVLWNLE+ALQL+E++ E+N + + ++ D +
Sbjct: 799 SMGDVLWNLEFALQLQESA------EENGKGVCGDMDMDEIKYDDGNCKGKNDKSSDVYE 852
Query: 814 -SMIDVRNSGTD----------DDGEDVATSAVFSQLVNPRGR 845
++ D R+SG D +D + + SAVFSQ++NP+GR
Sbjct: 853 GNVTDSRSSGIDMSIGGRSLASEDSDGLTPSAVFSQIMNPKGR 895
|
Receptor-like protein kinase that mediates the female control of male gamete delivery during fertilization, including growth cessation of compatible pollen tubes ensuring a reproductive isolation barriers. Required for cell elongation during vegetative growth, mostly in a brassinosteroids- (BR-) independent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3E8W4|ANX2_ARATH Receptor-like protein kinase ANXUR2 OS=Arabidopsis thaliana GN=ANX2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 661 bits (1705), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 374/876 (42%), Positives = 527/876 (60%), Gaps = 73/876 (8%)
Query: 18 LFELLCHKSCVAFTPVD----NYLIACGSSQKVTFQ-ARTYVPDTEHSSLSMKSGNSTTA 72
LF LC + +P + ++CG+S+ Q + + PDT+ +K+ N+ A
Sbjct: 8 LFSFLCFFYVLLVSPSQSNGQDISLSCGASEPAVDQDKKKWEPDTKF----LKTPNTVHA 63
Query: 73 SSNSSAPSPI----YQSARIFSAAAFYKFEIEHKGRHWVRLYFYTLPGSNQHLNSASFTV 128
+ PS + Y ++RIF+A A Y+ ++ RH +RL+FY + ++ + F+V
Sbjct: 64 PATYQDPSLLSTVPYMTSRIFTAPATYEIPVKGDKRHMLRLHFYPSTYTGLNILDSYFSV 123
Query: 129 ATDKFVLLSNF----TFKNYNSSFMFKEYAIN-VNSDALTLTFIPSNN---SVAFVNAIE 180
A + LLSNF T + +++ +EY++ D L++ F PS+ + AF+N IE
Sbjct: 124 AANDLTLLSNFSAAITCQALTQAYLVREYSLAPSEKDVLSIIFTPSDKHPKAFAFINGIE 183
Query: 181 VVSVPDAIFPDQALALEPSASFSGLSD-------LGFETVYRLNMGGPLITAQNDTLG-- 231
V+ +P+ L +AS G SD +T++RLN+GG I D+ G
Sbjct: 184 VIPMPE---------LFDTASLVGFSDQTSDTKTANLQTMFRLNVGGQDIPGSQDSGGLT 234
Query: 232 RTWENDETYLHVNSSAVNVSVRPS---AIRYTASVTAETAPNWVYATAEMMGDANVPEVN 288
RTW ND Y+ S+ + V+++ S I Y + TAP VY TA G +
Sbjct: 235 RTWYNDAPYIF--SAGLGVTLQASNNFRIDY-QKMPVSTAPADVYKTARSQGPNGDINMK 291
Query: 289 FNITWVLPVEPNFTYFVRVHLCDIASLSMNNLVFNLYINDDIAQPSV---DLSTLTNGLN 345
N+TW+ V+ NFTY +R+H C+ +N VFN++IN+ AQ D+ T G
Sbjct: 292 SNLTWMFQVDTNFTYIMRLHFCEFQLAKINQKVFNIFINNRTAQGDTNPADILGWTGGKG 351
Query: 346 VPYYKDFV----CNASADSNTLTVSVGPDSVA--DFTNATMNGLEVMKISNEARSLDG-- 397
+P YKD+ N +++ + P + ++ ++ +NGLE+ KI + ++L G
Sbjct: 352 IPTYKDYAIYVDANTGGGGEEISLQMTPSTFGQPEYYDSQLNGLEIFKI-DTMKNLAGPN 410
Query: 398 -----LSSVEGLLPDKPSNKNKIGIIVGSVVGAVAAVALIGVCYCWLLARKSKTPQQGHP 452
+ + E + D +K ++GS G VAAV +C+ ++ + H
Sbjct: 411 PKPSPMQANEDVKKDFQGDKRITAFVIGSA-GGVAAVLFCALCFTMYQRKRKFSGSDSHT 469
Query: 453 WLPLPLYGNSQTMTKMSTTSQKSGTASCISLASSNLGRLFMFQEILDATNKFDESLLLGV 512
LP+YGNS T ST S KS S +S ++ L R F EI T+ FDES ++GV
Sbjct: 470 SSWLPIYGNSHTSATKSTISGKSNNGSHLSNLAAGLCRRFSLSEIKHGTHNFDESNVIGV 529
Query: 513 GGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSE 572
GGFG+VYKG +D GTKVA+K+ NP SEQG+ EF TEIE+LS+LRH+HLVSLIGYCDE E
Sbjct: 530 GGFGKVYKGVIDGGTKVAIKKSNPNSEQGLNEFETEIELLSRLRHKHLVSLIGYCDEGGE 589
Query: 573 MILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTT 632
M L+Y+YM+ G LR HLY T P L+WK+RLEI IGAARGLHYLHTGA +IIHRDVKTT
Sbjct: 590 MCLIYDYMSLGTLREHLYNTKRPQLTWKRRLEIAIGAARGLHYLHTGAKYTIIHRDVKTT 649
Query: 633 NILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFG 692
NILLD+N+VAKV+DFGLSKTGP ++ HV+T VKGSFGYLDPEYFRRQQLTEKSDVYSFG
Sbjct: 650 NILLDENWVAKVSDFGLSKTGPNMNGGHVTTVVKGSFGYLDPEYFRRQQLTEKSDVYSFG 709
Query: 693 VVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGET 752
VVL EVLC RPALNP L +EQV++ +WAM ++KG L+ I+D NL GK+NP LKKF +T
Sbjct: 710 VVLFEVLCARPALNPSLSKEQVSLGDWAMNCKRKGTLEDIIDPNLKGKINPECLKKFADT 769
Query: 753 AEKCLAEHGVDRPSMGDVLWNLEYALQLEETSSALMEPEDNSTNHIPCIQLTPLEPFDNS 812
AEKCL++ G+DRP+MGDVLWNLE+ALQL+ET+ D S + P ++
Sbjct: 770 AEKCLSDSGLDRPTMGDVLWNLEFALQLQETA-------DGSRHRTPSNGGGSVDLGGGG 822
Query: 813 VSMIDVRNSGTDDDGEDVAT---SAVFSQLVNPRGR 845
+ ++G D G+D+++ S +FSQ+VNP+GR
Sbjct: 823 GGVTVNISAGESDLGDDLSSEENSGIFSQIVNPKGR 858
|
Receptor-like protein kinase that controls pollen tube behavior by directing rupture at proper timing to release the sperm cell. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 845 | ||||||
| 359493687 | 843 | PREDICTED: receptor-like protein kinase | 0.996 | 0.998 | 0.809 | 0.0 | |
| 224115046 | 847 | predicted protein [Populus trichocarpa] | 1.0 | 0.997 | 0.813 | 0.0 | |
| 449464774 | 839 | PREDICTED: receptor-like protein kinase | 0.986 | 0.994 | 0.812 | 0.0 | |
| 449476737 | 839 | PREDICTED: LOW QUALITY PROTEIN: receptor | 0.986 | 0.994 | 0.812 | 0.0 | |
| 356543264 | 843 | PREDICTED: receptor-like protein kinase | 0.965 | 0.967 | 0.811 | 0.0 | |
| 224123058 | 746 | predicted protein [Populus trichocarpa] | 0.880 | 0.997 | 0.820 | 0.0 | |
| 15239630 | 855 | receptor-like protein kinase THESEUS 1 [ | 0.983 | 0.971 | 0.744 | 0.0 | |
| 297796311 | 852 | hypothetical protein ARALYDRAFT_495518 [ | 0.969 | 0.961 | 0.750 | 0.0 | |
| 356542256 | 819 | PREDICTED: receptor-like protein kinase | 0.932 | 0.962 | 0.749 | 0.0 | |
| 224104501 | 833 | predicted protein [Populus trichocarpa] | 0.969 | 0.983 | 0.543 | 0.0 |
| >gi|359493687|ref|XP_003634651.1| PREDICTED: receptor-like protein kinase THESEUS 1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1414 bits (3660), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 685/846 (80%), Positives = 742/846 (87%), Gaps = 4/846 (0%)
Query: 1 MVKMKLGKSVSVVLAVFLFELLCHKSCVAFTPVDNYLIACGSSQKVTFQARTYVPDTEHS 60
M K+K G ++LAV L + H S +FTPVDNYLIACGSS+ +TFQ RT+VP+ + S
Sbjct: 1 MEKVKWGP---LILAVILLGFIGHGSYASFTPVDNYLIACGSSKNLTFQGRTFVPEVQSS 57
Query: 61 SLSMKSGNSTTASSNSSAPSPIYQSARIFSAAAFYKFEIEHKGRHWVRLYFYTLPGSNQH 120
+ GNS TA S+S+A PIYQSARIFS A YKFEIE +GRHWVRLYFY + S+
Sbjct: 58 IVLKSQGNSVTAVSSSTALPPIYQSARIFSGIASYKFEIEQEGRHWVRLYFYPISNSSHD 117
Query: 121 LNSASFTVATDKFVLLSNFTFKNYNSSFMFKEYAINVNSDALTLTFIPSNNSVAFVNAIE 180
L SAS TV TD FVLL+NFTFKNYN S++FKEYAINV SD LTLTFIPSNNSVAFVNAIE
Sbjct: 118 LTSASITVVTDSFVLLNNFTFKNYNRSYLFKEYAINVTSDTLTLTFIPSNNSVAFVNAIE 177
Query: 181 VVSVPDAIFPDQALALEPSASFSGLSDLGFETVYRLNMGGPLITAQNDTLGRTWENDETY 240
VVSVP+ IFPDQALAL PSA FSGLS+L ETVYRLNMGGPL+TAQNDTLGRTWENDE Y
Sbjct: 178 VVSVPNEIFPDQALALSPSAPFSGLSELALETVYRLNMGGPLLTAQNDTLGRTWENDEKY 237
Query: 241 LHVNSSAVNVSVRPSAIRYTASVTAETAPNWVYATAEMMGDAN-VPEVNFNITWVLPVEP 299
LHVNSSA N+SV P I+YT +VT ETAPN VY+TAE MG+AN V NFNITWV V+P
Sbjct: 238 LHVNSSAKNLSVNPGNIKYTTAVTTETAPNLVYSTAESMGNANNVSNGNFNITWVFSVDP 297
Query: 300 NFTYFVRVHLCDIASLSMNNLVFNLYINDDIAQPSVDLSTLTNGLNVPYYKDFVCNASAD 359
+F YFVRVH CDI S S+NNLVFNL+IN DIA S+DLS+LT L+VPYYKDF+ N+SAD
Sbjct: 298 DFMYFVRVHFCDILSTSLNNLVFNLFINSDIALESLDLSSLTGDLSVPYYKDFISNSSAD 357
Query: 360 SNTLTVSVGPDSVADFTNATMNGLEVMKISNEARSLDGLSSVEGLLPDKPSNKNKIGIIV 419
S+ LTVSVGPD++AD TNA MNGLE+M+ISN A+SLDGLSSVE LLP P+ +N IGII+
Sbjct: 358 SDVLTVSVGPDTMADVTNAIMNGLEIMRISNGAKSLDGLSSVESLLPQPPTKRNMIGIII 417
Query: 420 GSVVGAVAAVALIGVCYCWLLARKSKTPQQGHPWLPLPLYGNSQTMTKMSTTSQKSGTAS 479
G VVGA AV I +C C +A +SKTP QGHPWLPLPLYGNSQTMTKMSTTSQKSGTAS
Sbjct: 418 GCVVGASVAVVFIILCICCFVACRSKTPTQGHPWLPLPLYGNSQTMTKMSTTSQKSGTAS 477
Query: 480 CISLASSNLGRLFMFQEILDATNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSE 539
CISLAS+NLGRLFMFQEI+DATNKFDESLLLGVGGFGRVYKGTL+DGTKVAVKRGNPRSE
Sbjct: 478 CISLASTNLGRLFMFQEIMDATNKFDESLLLGVGGFGRVYKGTLEDGTKVAVKRGNPRSE 537
Query: 540 QGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSW 599
QG+AEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLP LSW
Sbjct: 538 QGLAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPSLSW 597
Query: 600 KQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT 659
KQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLD+NFVAKVADFGLSKTGPALDQT
Sbjct: 598 KQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDENFVAKVADFGLSKTGPALDQT 657
Query: 660 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEW 719
HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEW
Sbjct: 658 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEW 717
Query: 720 AMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779
AM+WQKKGMLDQIMD NLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ
Sbjct: 718 AMSWQKKGMLDQIMDPNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 777
Query: 780 LEETSSALMEPEDNSTNHIPCIQLTPLEPFDNSVSMIDVRNSGTDDDGEDVATSAVFSQL 839
LEETS AL EPEDNSTNHI IQLTP+E F+NSVSMID +SGTDDD ED ATSAVFSQL
Sbjct: 778 LEETSLALTEPEDNSTNHIAGIQLTPIEQFENSVSMIDGVHSGTDDDAEDAATSAVFSQL 837
Query: 840 VNPRGR 845
VNPRGR
Sbjct: 838 VNPRGR 843
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224115046|ref|XP_002316926.1| predicted protein [Populus trichocarpa] gi|222859991|gb|EEE97538.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1413 bits (3658), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 689/847 (81%), Positives = 748/847 (88%), Gaps = 2/847 (0%)
Query: 1 MVKMKLGKSVSVVLAVFLFELLCHK-SCVAFTPVDNYLIACGSSQKVTFQARTYVPDTEH 59
MV+MK + VV+A LFEL+ H S AFTP DNYLIACGSSQ VTFQ +TYVPD+ H
Sbjct: 1 MVRMKGESWLPVVVAFVLFELIGHNISFAAFTPPDNYLIACGSSQSVTFQGKTYVPDSGH 60
Query: 60 SSLSMKSGNSTTASSNSSAPSPIYQSARIFSAAAFYKFEIEHKGRHWVRLYFYTLPGSNQ 119
SS ++KSG S A SNSS PSPIYQSARIFS + YKF+I+ +GRHW+RLYFY +P S
Sbjct: 61 SSPTIKSGASVIAKSNSSFPSPIYQSARIFSGISSYKFDIKQEGRHWIRLYFYPIPNSGH 120
Query: 120 HLNSASFTVATDKFVLLSNFTFKNYNSSFMFKEYAINVNSDALTLTFIPSNNSVAFVNAI 179
+L S+ TVATD FVLL+NFTFKNYN S+MFKEYA+NV SD LTL+FI SNNSV FVNAI
Sbjct: 121 NLMSSLITVATDDFVLLNNFTFKNYNGSYMFKEYAVNVTSDTLTLSFIHSNNSVTFVNAI 180
Query: 180 EVVSVPDAIFPDQALALEPSASFSGLSDLGFETVYRLNMGGPLITAQNDTLGRTWENDET 239
EVVSVPD + PDQALA+ PS++ SGLS+L FETV+RLN GGPLITA+NDTLGR WEND
Sbjct: 181 EVVSVPDGVLPDQALAINPSSTVSGLSELAFETVFRLNTGGPLITAENDTLGRIWENDAK 240
Query: 240 YLHVNSSAVNVSVRPSAIRYTASVTAETAPNWVYATAEMMGDANVPEVNFNITWVLPVEP 299
YLHVNSSA+NVSV P++IRY A++T E APNWVYA+AE+MGDA V +NFNITWV V
Sbjct: 241 YLHVNSSALNVSVNPASIRYPATLTTEIAPNWVYASAEVMGDAKVANMNFNITWVFSVNQ 300
Query: 300 NFTYFVRVHLCDIASLSMNNLVFNLYINDDIAQPSVDLSTLTNGLNVPYYKDFVCNASAD 359
NF+YFVR H CDI S ++NNLVFNLYINDDIA S+DLST T GLNVPYYKDFV NAS D
Sbjct: 301 NFSYFVRAHFCDIVSKALNNLVFNLYINDDIAVESLDLSTFTGGLNVPYYKDFVSNASVD 360
Query: 360 SNTLTVSVGPDSVADFTNATMNGLEVMKISNEARSLDGLSSVEGLLPDKPSNKNKIGIIV 419
S+T TVS+GPD+ +D NA MNGLE+ KISNE +SLDGLSSVE +LP PS K KIGII+
Sbjct: 361 SDTFTVSIGPDTTSDMINAIMNGLEIFKISNEVKSLDGLSSVESVLPQSPSKKKKIGIII 420
Query: 420 GSVVGAVAAVALIGVCYCWLLARKSKTP-QQGHPWLPLPLYGNSQTMTKMSTTSQKSGTA 478
GS+VGA+ A LIG+CYC L AR+SKT Q HPWLPLPLYGNSQTMTKMSTTSQKSGTA
Sbjct: 421 GSIVGALGAFGLIGLCYCCLAARRSKTTTHQAHPWLPLPLYGNSQTMTKMSTTSQKSGTA 480
Query: 479 SCISLASSNLGRLFMFQEILDATNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRS 538
SCISLASSNLGRLF FQEIL+ATNKFDESLLLG+GGFGRVYKGTL+DGTKVAVKRGNPRS
Sbjct: 481 SCISLASSNLGRLFTFQEILNATNKFDESLLLGIGGFGRVYKGTLEDGTKVAVKRGNPRS 540
Query: 539 EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLS 598
EQG+AEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLS
Sbjct: 541 EQGLAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLS 600
Query: 599 WKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQ 658
WKQRLEICIGA RGLHYLHTGAAQSIIHRDVKTTNILLD++FVAKVADFGLSKTGPALDQ
Sbjct: 601 WKQRLEICIGAGRGLHYLHTGAAQSIIHRDVKTTNILLDESFVAKVADFGLSKTGPALDQ 660
Query: 659 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAE 718
THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAE
Sbjct: 661 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAE 720
Query: 719 WAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYAL 778
WAMTWQKKGMLDQIMDSNL GKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYAL
Sbjct: 721 WAMTWQKKGMLDQIMDSNLAGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYAL 780
Query: 779 QLEETSSALMEPEDNSTNHIPCIQLTPLEPFDNSVSMIDVRNSGTDDDGEDVATSAVFSQ 838
QLEETSSALMEPEDNSTNHIP I LTPLEPFDNS S+ID NSGT+DD EDVATSAVFSQ
Sbjct: 781 QLEETSSALMEPEDNSTNHIPGIPLTPLEPFDNSTSIIDGGNSGTEDDAEDVATSAVFSQ 840
Query: 839 LVNPRGR 845
LVNPRGR
Sbjct: 841 LVNPRGR 847
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449464774|ref|XP_004150104.1| PREDICTED: receptor-like protein kinase THESEUS 1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1410 bits (3649), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 681/838 (81%), Positives = 740/838 (88%), Gaps = 4/838 (0%)
Query: 9 SVSVVLAVFLFELLCHKSCVAFTPVDNYLIACGSSQKVTFQARTYVPDTEHSSLSMKSGN 68
S+S+VL+V LF +C S FTP+DNYLI+CGS+Q +TFQ RT+VPD+ HS LS +
Sbjct: 5 SMSMVLSVVLF--MCIGSYATFTPIDNYLISCGSTQNITFQGRTFVPDSGHSLLSNDGES 62
Query: 69 STTASSN-SSAPSPIYQSARIFSAAAFYKFEIEHKGRHWVRLYFYTLPGSNQHLNSASFT 127
S +S ++APSPIYQSAR+F++ A YKFEI +GRHWVRLYFY +P S ++L SAS T
Sbjct: 63 SVVVNSKGTTAPSPIYQSARVFTSIASYKFEIRKQGRHWVRLYFYPIPKSERNLASASIT 122
Query: 128 VATDKFVLLSNFTFKNYNSSFMFKEYAINVNSDALTLTFIPSNNSVAFVNAIEVVSVPDA 187
V T+KFVLL+NFTFKNYN SF+FKEYAINV SD+L LTFIPSN SV+FVNAIEVVSVPD
Sbjct: 123 VVTEKFVLLNNFTFKNYNGSFLFKEYAINVTSDSLILTFIPSNGSVSFVNAIEVVSVPDE 182
Query: 188 IFPDQALALEPSASFSGLSDLGFETVYRLNMGGPLITAQNDTLGRTWENDETYLHVNSSA 247
+ PDQALAL PSA FSG+S+L FETVYRLNMGGPL+T+QNDTLGR+WEND YLHVNSSA
Sbjct: 183 LIPDQALALNPSAPFSGISELAFETVYRLNMGGPLLTSQNDTLGRSWENDMKYLHVNSSA 242
Query: 248 VNVSVRPSAIRYTASVTAETAPNWVYATAEMMGDANVPEVNFNITWVLPVEPNFTYFVRV 307
VNVS P +I+Y A VT ETAPNWVYATA+ MGD NVP VNFN+TWV VEP+F YFVRV
Sbjct: 243 VNVSASPGSIKYHAGVTPETAPNWVYATADAMGDPNVPNVNFNLTWVFSVEPSFQYFVRV 302
Query: 308 HLCDIASLSMNNLVFNLYINDDIAQPSVDLSTLTNGLNVPYYKDFVCNASADSNTLTVSV 367
H CDI S ++NNLVFNLYIN D A S DLS+LT L VPYYKDF+ N SADS+TLTVSV
Sbjct: 303 HFCDIMSKALNNLVFNLYINSDNALGSFDLSSLTGDLGVPYYKDFISN-SADSSTLTVSV 361
Query: 368 GPDSVADFTNATMNGLEVMKISNEARSLDGLSSVEGLLPDKPSNKNKIGIIVGSVVGAVA 427
GPD++AD TNATMNGLE+MKISN+A SLDG SSV L PD PS KN I IIVGSV+GAV
Sbjct: 362 GPDTMADITNATMNGLEIMKISNQAGSLDGTSSVASLFPDAPSKKNNIAIIVGSVLGAVV 421
Query: 428 AVALIGVCYCWLLARKSKTPQQGHPWLPLPLYGNSQTMTKMSTTSQKSGTASCISLASSN 487
+ALI CYC + RKSKT Q HPWLPLPLYGNSQT+TK+STTSQKSGTAS ISLASS+
Sbjct: 422 GLALIVFCYCCFVGRKSKTTQPAHPWLPLPLYGNSQTITKVSTTSQKSGTASFISLASSS 481
Query: 488 LGRLFMFQEILDATNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRT 547
LGR F FQEILDATNKFDE+LLLGVGGFGRVYKGTL+DG KVAVKRGNPRSEQG+AEFRT
Sbjct: 482 LGRFFTFQEILDATNKFDENLLLGVGGFGRVYKGTLEDGMKVAVKRGNPRSEQGLAEFRT 541
Query: 548 EIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICI 607
EIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRL+ICI
Sbjct: 542 EIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLDICI 601
Query: 608 GAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKG 667
GAARGLHYLHTGAAQSIIHRDVKTTNILLD+NFVAKVADFGLSKTGP+LDQTHVSTAVKG
Sbjct: 602 GAARGLHYLHTGAAQSIIHRDVKTTNILLDENFVAKVADFGLSKTGPSLDQTHVSTAVKG 661
Query: 668 SFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKG 727
SFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKG
Sbjct: 662 SFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKG 721
Query: 728 MLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLEETSSAL 787
MLD IMD NLVGKVNPASLKKFGETAEKCLAE+GVDRPSMGDVLWNLEYALQLEETSSAL
Sbjct: 722 MLDHIMDPNLVGKVNPASLKKFGETAEKCLAEYGVDRPSMGDVLWNLEYALQLEETSSAL 781
Query: 788 MEPEDNSTNHIPCIQLTPLEPFDNSVSMIDVRNSGTDDDGEDVATSAVFSQLVNPRGR 845
MEPEDNSTNHIP IQLTPLEPFDNSVSMID NSGTDDD ED ATSAVFSQLVNPRGR
Sbjct: 782 MEPEDNSTNHIPTIQLTPLEPFDNSVSMIDGGNSGTDDDAEDAATSAVFSQLVNPRGR 839
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449476737|ref|XP_004154820.1| PREDICTED: LOW QUALITY PROTEIN: receptor-like protein kinase THESEUS 1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1409 bits (3648), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 681/838 (81%), Positives = 739/838 (88%), Gaps = 4/838 (0%)
Query: 9 SVSVVLAVFLFELLCHKSCVAFTPVDNYLIACGSSQKVTFQARTYVPDTEHSSLSMKSGN 68
S+S+VL+V LF +C S FTP+DNYLI+CGS+Q +TFQ RT+VPD+ HS LS +
Sbjct: 5 SMSMVLSVVLF--MCIGSYATFTPIDNYLISCGSTQNITFQGRTFVPDSGHSLLSNDGES 62
Query: 69 STTASSN-SSAPSPIYQSARIFSAAAFYKFEIEHKGRHWVRLYFYTLPGSNQHLNSASFT 127
S +S ++APSPIYQSAR+F++ A YKFEI +GRHWVRLYFY +P S ++L SAS T
Sbjct: 63 SVVVNSKGTTAPSPIYQSARVFTSIASYKFEIRKQGRHWVRLYFYPIPKSERNLASASIT 122
Query: 128 VATDKFVLLSNFTFKNYNSSFMFKEYAINVNSDALTLTFIPSNNSVAFVNAIEVVSVPDA 187
V T+KFVLL+NFTFKNYN SF+FKEYAINV SD+L LTFIPSN SV+FVNAIEVVSVPD
Sbjct: 123 VVTEKFVLLNNFTFKNYNGSFLFKEYAINVTSDSLILTFIPSNGSVSFVNAIEVVSVPDE 182
Query: 188 IFPDQALALEPSASFSGLSDLGFETVYRLNMGGPLITAQNDTLGRTWENDETYLHVNSSA 247
+ PDQALAL PSA FSG+S+L FETVYRLNMGGPL+T+QNDTLGR+WEND YLHVNSSA
Sbjct: 183 LIPDQALALNPSAPFSGISELAFETVYRLNMGGPLLTSQNDTLGRSWENDMKYLHVNSSA 242
Query: 248 VNVSVRPSAIRYTASVTAETAPNWVYATAEMMGDANVPEVNFNITWVLPVEPNFTYFVRV 307
VNVS P +I+Y A VT ETAPNWVYATA+ MGD NVP VNFN+TWV VEP F YFVRV
Sbjct: 243 VNVSASPGSIKYHAGVTPETAPNWVYATADAMGDPNVPNVNFNLTWVFSVEPXFQYFVRV 302
Query: 308 HLCDIASLSMNNLVFNLYINDDIAQPSVDLSTLTNGLNVPYYKDFVCNASADSNTLTVSV 367
H CDI S ++NNLVFNLYIN D A S DLS+LT L VPYYKDF+ N SADS+TLTVSV
Sbjct: 303 HFCDIMSKALNNLVFNLYINSDNALGSFDLSSLTGDLGVPYYKDFISN-SADSSTLTVSV 361
Query: 368 GPDSVADFTNATMNGLEVMKISNEARSLDGLSSVEGLLPDKPSNKNKIGIIVGSVVGAVA 427
GPD++AD TNATMNGLE+MKISN+A SLDG SSV L PD PS KN I IIVGSV+GAV
Sbjct: 362 GPDTMADITNATMNGLEIMKISNQAGSLDGTSSVASLFPDAPSKKNNIAIIVGSVLGAVV 421
Query: 428 AVALIGVCYCWLLARKSKTPQQGHPWLPLPLYGNSQTMTKMSTTSQKSGTASCISLASSN 487
+ALI CYC + RKSKT Q HPWLPLPLYGNSQT+TK+STTSQKSGTAS ISLASS+
Sbjct: 422 GLALIVFCYCCFVGRKSKTTQPAHPWLPLPLYGNSQTITKVSTTSQKSGTASFISLASSS 481
Query: 488 LGRLFMFQEILDATNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRT 547
LGR F FQEILDATNKFDE+LLLGVGGFGRVYKGTL+DG KVAVKRGNPRSEQG+AEFRT
Sbjct: 482 LGRFFTFQEILDATNKFDENLLLGVGGFGRVYKGTLEDGMKVAVKRGNPRSEQGLAEFRT 541
Query: 548 EIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICI 607
EIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRL+ICI
Sbjct: 542 EIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLDICI 601
Query: 608 GAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKG 667
GAARGLHYLHTGAAQSIIHRDVKTTNILLD+NFVAKVADFGLSKTGP+LDQTHVSTAVKG
Sbjct: 602 GAARGLHYLHTGAAQSIIHRDVKTTNILLDENFVAKVADFGLSKTGPSLDQTHVSTAVKG 661
Query: 668 SFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKG 727
SFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKG
Sbjct: 662 SFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKG 721
Query: 728 MLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLEETSSAL 787
MLD IMD NLVGKVNPASLKKFGETAEKCLAE+GVDRPSMGDVLWNLEYALQLEETSSAL
Sbjct: 722 MLDHIMDPNLVGKVNPASLKKFGETAEKCLAEYGVDRPSMGDVLWNLEYALQLEETSSAL 781
Query: 788 MEPEDNSTNHIPCIQLTPLEPFDNSVSMIDVRNSGTDDDGEDVATSAVFSQLVNPRGR 845
MEPEDNSTNHIP IQLTPLEPFDNSVSMID NSGTDDD ED ATSAVFSQLVNPRGR
Sbjct: 782 MEPEDNSTNHIPTIQLTPLEPFDNSVSMIDGGNSGTDDDAEDAATSAVFSQLVNPRGR 839
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356543264|ref|XP_003540082.1| PREDICTED: receptor-like protein kinase THESEUS 1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1341 bits (3470), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 664/818 (81%), Positives = 725/818 (88%), Gaps = 2/818 (0%)
Query: 30 FTPVDNYLIACGSSQKVTFQARTYVPDTEHSSLSMKSGNSTTASSNSSA-PSPIYQSARI 88
+TP D YLIACGSSQ VTFQ RT+VPD++HSSL MK+GNS ASSNSS+ P PIYQSAR+
Sbjct: 26 YTPPDRYLIACGSSQNVTFQGRTFVPDSQHSSLVMKTGNSVIASSNSSSAPLPIYQSARV 85
Query: 89 FSAAAFYKFEIEHKGRHWVRLYFYTLPGSNQHLNSASFTVATDKFVLLSNFTFKNYNSSF 148
F+ A Y+F+I+ +GRHWVRLYF +P S +L SAS TV TD FVLLSNFTF+ +N S+
Sbjct: 86 FTEKASYRFKIQQEGRHWVRLYFSPIPNSAHNLTSASLTVVTDDFVLLSNFTFRKFNGSY 145
Query: 149 MFKEYAINVNSDALTLTFIPSNNSVAFVNAIEVVSVPDAIFPDQALALEPSASFSGLSDL 208
MFKEYAINV SD L +TFIPSN SVAFVNAIEVVS+P+ +F D ALA+ P A+FSGLS+L
Sbjct: 146 MFKEYAINVTSDTLVVTFIPSNGSVAFVNAIEVVSMPNELFFDHALAVNPPATFSGLSEL 205
Query: 209 GFETVYRLNMGGPLITAQNDTLGRTWENDETYLHVNSSAVNVSVRPSAIRYTASVTAETA 268
FETVYRLNMGGPLITAQNDTLGRTW ND YLHVNSS +NVSV PS+I+Y +VT ETA
Sbjct: 206 AFETVYRLNMGGPLITAQNDTLGRTWVNDRKYLHVNSSVLNVSVNPSSIKYPVAVTPETA 265
Query: 269 PNWVYATAEMMGDANVPEVNFNITWVLPVEPNFTYFVRVHLCDIASLSMNNLVFNLYIND 328
PNWVYATAE MGDANV + NFNITWV V+PNF+YF+R H CDI S S+N LVFN+++N
Sbjct: 266 PNWVYATAEAMGDANVNDPNFNITWVFNVDPNFSYFIRAHFCDIMSKSLNTLVFNVFVNS 325
Query: 329 DIAQPSVDLSTLTNGLNVPYYKDFVCNASADSNTLTVSVGPDSVADFTNATMNGLEVMKI 388
DIA S D+S++TN L VPYYKDFV N+SADS+TLTVSVGPD+VADF NATMNGLE+MKI
Sbjct: 326 DIALQSFDISSITNDLAVPYYKDFVANSSADSSTLTVSVGPDTVADFPNATMNGLEIMKI 385
Query: 389 SNEARSLDGLSSVEGLLPDKPSNKNKIGIIVGSVVGAVAAVALIGVCYCWLLARKSKTP- 447
SN +SLDGL SV+ LLP S KN +G+IVG V A+AAVA++G+CYC L+ RKS++
Sbjct: 386 SNTLKSLDGLYSVDSLLPSSHSKKNMVGVIVGLAVVALAAVAMVGLCYCCLMRRKSESST 445
Query: 448 QQGHPWLPLPLYGNSQTMTKMSTTSQKSGTASCISLASSNLGRLFMFQEILDATNKFDES 507
QQGH WLPLPLYGNS TMTK ST SQKSGTASCISLASSNLGR F FQEILDA+NKFDE
Sbjct: 446 QQGHSWLPLPLYGNSLTMTKNSTISQKSGTASCISLASSNLGRFFSFQEILDASNKFDEK 505
Query: 508 LLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYC 567
LLLGVGGFGRVYKGTL+DGT VAVKRGNPRSEQG+AEFRTEIEMLSKLRH HLVSLIGYC
Sbjct: 506 LLLGVGGFGRVYKGTLEDGTNVAVKRGNPRSEQGLAEFRTEIEMLSKLRHCHLVSLIGYC 565
Query: 568 DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHR 627
DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHR
Sbjct: 566 DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHR 625
Query: 628 DVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSD 687
DVKTTNILLD+NFVAKVADFGLSKTGP+LDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSD
Sbjct: 626 DVKTTNILLDENFVAKVADFGLSKTGPSLDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSD 685
Query: 688 VYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLK 747
VYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMD NLVGKVNPASLK
Sbjct: 686 VYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDQNLVGKVNPASLK 745
Query: 748 KFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLEETSSALMEPEDNSTNHIPCIQLTPLE 807
KFGETAEKCLAEHGVDRPSMGDVLWNLEYALQL+ETSSALMEPEDNSTNHI IQLTPL+
Sbjct: 746 KFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLQETSSALMEPEDNSTNHITGIQLTPLD 805
Query: 808 PFDNSVSMIDVRNSGTDDDGEDVATSAVFSQLVNPRGR 845
FDNSVSMID NS TDDD EDVATSAVFSQLVNPRGR
Sbjct: 806 HFDNSVSMIDGGNSCTDDDTEDVATSAVFSQLVNPRGR 843
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224123058|ref|XP_002330430.1| predicted protein [Populus trichocarpa] gi|222871815|gb|EEF08946.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1268 bits (3280), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 611/745 (82%), Positives = 661/745 (88%), Gaps = 1/745 (0%)
Query: 26 SCVAFTPVDNYLIACGSSQKVTFQARTYVPDTEHSSLSMKSGNSTTASSNSSAPSPIYQS 85
S AFTP DNYL+ACGSSQ V FQ +TYVPD+ HSSL++ +G S A SNSS PSPIYQS
Sbjct: 2 SFAAFTPPDNYLVACGSSQNVIFQGKTYVPDSGHSSLTLNTGTSVAAKSNSSFPSPIYQS 61
Query: 86 ARIFSAAAFYKFEIEHKGRHWVRLYFYTLPGSNQHLNSASFTVATDKFVLLSNFTFKNYN 145
ARI S + YKF+I+ +GRHW+RLYFY +P S Q+L SAS TVATD FVLL+NFTFKNYN
Sbjct: 62 ARILSGISSYKFDIKQEGRHWIRLYFYPIPNSGQNLMSASITVATDDFVLLNNFTFKNYN 121
Query: 146 SSFMFKEYAINVNSDALTLTFIPSNNSVAFVNAIEVVSVPDAIFPDQALALEPSASFSGL 205
S+MFKEYA+NV SD LTL+FIPSNNSV F+NAIEVVS+PD +FPDQA+A+ PS FSGL
Sbjct: 122 GSYMFKEYAVNVTSDTLTLSFIPSNNSVTFINAIEVVSIPDQVFPDQAVAINPSTPFSGL 181
Query: 206 SDLGFETVYRLNMGGPLITAQNDTLGRTWENDETYLHVNSSAVNVSVRPSAIRYTASVTA 265
S+L FETV+RLN GGPLITA+NDTLGR WEND YLHVNSSA+NVSV P++IRY +VT
Sbjct: 182 SELAFETVFRLNTGGPLITAENDTLGRIWENDAKYLHVNSSALNVSVNPASIRYPPAVTT 241
Query: 266 ETAPNWVYATAEMMGDANVPEVNFNITWVLPVEPNFTYFVRVHLCDIASLSMNNLVFNLY 325
E APNWVYA+A++MGDANV +NFNITWV V NF YFVRVH CDI S ++NNLVFNLY
Sbjct: 242 EIAPNWVYASADVMGDANVANMNFNITWVFSVNQNFRYFVRVHFCDIVSKALNNLVFNLY 301
Query: 326 INDDIAQPSVDLSTLTNGLNVPYYKDFVCNASADSNTLTVSVGPDSVADFTNATMNGLEV 385
INDD A S+DLST T GL+VPYY+DFV NAS DS+T TVSVGPD D NATMNGLE+
Sbjct: 302 INDDNAVESLDLSTFTGGLSVPYYRDFVSNASVDSDTFTVSVGPDLTTDLANATMNGLEI 361
Query: 386 MKISNEARSLDGLSSVEGLLPDKPSNKNKIGIIVGSVVGAVAAVALIGVCYCWLLARKSK 445
KISNEA+SLDGLSSVE LLP P KNKIGII+GS+VGAV A LIG+CYC L A +SK
Sbjct: 362 FKISNEAKSLDGLSSVESLLPQSPLKKNKIGIIIGSIVGAVVAFGLIGLCYCCLAAHRSK 421
Query: 446 TP-QQGHPWLPLPLYGNSQTMTKMSTTSQKSGTASCISLASSNLGRLFMFQEILDATNKF 504
T Q HPWLPLPLYGNSQTMTKMSTTSQKSGTASCISL SSNLGRLF FQEILDATNKF
Sbjct: 422 TTTHQAHPWLPLPLYGNSQTMTKMSTTSQKSGTASCISLTSSNLGRLFTFQEILDATNKF 481
Query: 505 DESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLI 564
DESLLLGVGGFGRVYKGT++DGTKVAVKRGNPRSEQG+AEFRTEIEMLSKLRHRHLVSLI
Sbjct: 482 DESLLLGVGGFGRVYKGTVEDGTKVAVKRGNPRSEQGLAEFRTEIEMLSKLRHRHLVSLI 541
Query: 565 GYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSI 624
GYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSI
Sbjct: 542 GYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSI 601
Query: 625 IHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTE 684
IHRDVKTTNILLD+NFVAKVADFGLSKTGP+LDQTHVSTAVKGSFGYLDPEYFRRQQLTE
Sbjct: 602 IHRDVKTTNILLDENFVAKVADFGLSKTGPSLDQTHVSTAVKGSFGYLDPEYFRRQQLTE 661
Query: 685 KSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPA 744
KSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNL GKVNPA
Sbjct: 662 KSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLAGKVNPA 721
Query: 745 SLKKFGETAEKCLAEHGVDRPSMGD 769
SLKKFGETAEKCLAEHGVDRPSMGD
Sbjct: 722 SLKKFGETAEKCLAEHGVDRPSMGD 746
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15239630|ref|NP_200249.1| receptor-like protein kinase THESEUS 1 [Arabidopsis thaliana] gi|75335100|sp|Q9LK35.1|THE1_ARATH RecName: Full=Receptor-like protein kinase THESEUS 1; Flags: Precursor gi|8953753|dbj|BAA98098.1| receptor-protein kinase-like protein [Arabidopsis thaliana] gi|332009107|gb|AED96490.1| receptor-like protein kinase THESEUS 1 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1267 bits (3278), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 633/850 (74%), Positives = 720/850 (84%), Gaps = 19/850 (2%)
Query: 14 LAVFLFELLCHK---SCVAFTPVDNYLIACGSSQKVTFQARTYVPDTEHSSLSMKSGNST 70
L V L+ L C+ S F P DNYLI+CGSSQ +TFQ R +VPD+ HSSL +K GNS+
Sbjct: 7 LLVLLWFLSCYTTTTSSALFNPPDNYLISCGSSQNITFQNRIFVPDSLHSSLVLKIGNSS 66
Query: 71 TA--SSNSSAPSPIYQSARIFSAAAFYKFEIEHKGRHWVRLYFYTLPGSNQHLNSASFTV 128
A ++++++ + IYQ+AR+FS+ A Y+F+I GRHW+RL+F + S +L SAS TV
Sbjct: 67 VATSTTSNNSTNSIYQTARVFSSLASYRFKITSLGRHWIRLHFSPINNSTWNLTSASITV 126
Query: 129 ATDKFVLLSNFTFKNYNSSFMFKEYAINVNSDALTLTFIPSNNSVAFVNAIEVVSVPDAI 188
T+ FVLL+NF+F N+N S++FKEY +NV S+ LTL+FIPSNNSV FVNAIEVVSVPD +
Sbjct: 127 VTEDFVLLNNFSFNNFNGSYIFKEYTVNVTSEFLTLSFIPSNNSVVFVNAIEVVSVPDNL 186
Query: 189 FPDQALALEPSASFSGLSDLGFETVYRLNMGGPLITAQNDTLGRTWENDETYLHVNSSAV 248
PDQALAL PS FSGLS L FETVYRLNMGGPL+T+QNDTLGR W+ND YLHVNSS +
Sbjct: 187 IPDQALALNPSTPFSGLSLLAFETVYRLNMGGPLLTSQNDTLGRQWDNDAEYLHVNSSVL 246
Query: 249 NVSVRPSAIRYTASVTAETAPNWVYATAEMMGDANVPEVNFNITWVLPVEPNFTYFVRVH 308
V+ PS+I+Y+ SVT ETAPN VYATA+ MGDANV +FN+TWVLPV+P+F YFVRVH
Sbjct: 247 VVTANPSSIKYSPSVTQETAPNMVYATADTMGDANVASPSFNVTWVLPVDPDFRYFVRVH 306
Query: 309 LCDIASLSMNNLVFNLYINDDIAQPSVDLSTLTNGLNVPYYKDFVCNASADSN-TLTVSV 367
CDI S ++N LVFNLY+NDD+A S+DLSTLTNGL VPY+KDF+ N S +S+ LTVSV
Sbjct: 307 FCDIVSQALNTLVFNLYVNDDLALGSLDLSTLTNGLKVPYFKDFISNGSVESSGVLTVSV 366
Query: 368 GPDSVADFTNATMNGLEVMKISNEARSLDGLSSVEGLLP-DKPSNKNKIGIIVGSVVGAV 426
GPDS AD TNATMNGLEV+KISNEA+SL G+SSV+ LLP S K +I+GS+VGAV
Sbjct: 367 GPDSQADITNATMNGLEVLKISNEAKSLSGVSSVKSLLPGGSGSKSKKKAVIIGSLVGAV 426
Query: 427 AAVALIGV-CYCWLLA---RKSKTPQQ---GHPWLPLPLYGNSQTMTKMSTTSQKSGTAS 479
+ LI V CYC L+A ++S +PQ+ GHPWLPLPLYG SQT+TK ST S KS TAS
Sbjct: 427 TLILLIAVCCYCCLVASRKQRSTSPQEGGNGHPWLPLPLYGLSQTLTK-STASHKSATAS 485
Query: 480 CISLASSNLGRLFMFQEILDATNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSE 539
CISLAS++LGR FMFQEI+DATNKFDES LLGVGGFGRVYKGTL+DGTKVAVKRGNPRSE
Sbjct: 486 CISLASTHLGRCFMFQEIMDATNKFDESSLLGVGGFGRVYKGTLEDGTKVAVKRGNPRSE 545
Query: 540 QGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSW 599
QG+AEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYG DLPPLSW
Sbjct: 546 QGMAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGADLPPLSW 605
Query: 600 KQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT 659
KQRLEICIGAARGLHYLHTGA+QSIIHRDVKTTNILLD+N VAKVADFGLSKTGP+LDQT
Sbjct: 606 KQRLEICIGAARGLHYLHTGASQSIIHRDVKTTNILLDENLVAKVADFGLSKTGPSLDQT 665
Query: 660 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEW 719
HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC RPALNPVLPREQVNIAEW
Sbjct: 666 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCCRPALNPVLPREQVNIAEW 725
Query: 720 AMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779
AM WQKKG+LDQIMDSNL GKVNPASLKKFGETAEKCLAE+GVDRPSMGDVLWNLEYALQ
Sbjct: 726 AMAWQKKGLLDQIMDSNLTGKVNPASLKKFGETAEKCLAEYGVDRPSMGDVLWNLEYALQ 785
Query: 780 LEETSSALMEPEDNSTNHIPCIQLTPLEPFDNSVSMIDV----RNSGTDDDGEDVATSAV 835
LEETSSALMEP+DNSTNHIP I + P+EPFDNS+S+ID +GTDDD ED TSAV
Sbjct: 786 LEETSSALMEPDDNSTNHIPGIPMAPMEPFDNSMSIIDRGGVNSGTGTDDDAEDATTSAV 845
Query: 836 FSQLVNPRGR 845
FSQLV+PRGR
Sbjct: 846 FSQLVHPRGR 855
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297796311|ref|XP_002866040.1| hypothetical protein ARALYDRAFT_495518 [Arabidopsis lyrata subsp. lyrata] gi|297311875|gb|EFH42299.1| hypothetical protein ARALYDRAFT_495518 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1264 bits (3270), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 625/833 (75%), Positives = 706/833 (84%), Gaps = 14/833 (1%)
Query: 26 SCVAFTPVDNYLIACGSSQKVTFQARTYVPDTEHSSLSMKSG--NSTTASSNSSAPSPIY 83
S F P DNYLI+CGSSQ +TFQ R +VPD+ HSSL +K G + T+S+ S++ + IY
Sbjct: 21 SSALFNPPDNYLISCGSSQNITFQNRIFVPDSLHSSLVLKIGNSSVATSSTTSNSTNSIY 80
Query: 84 QSARIFSAAAFYKFEIEHKGRHWVRLYFYTLPGSNQHLNSASFTVATDKFVLLSNFTFKN 143
Q+AR+FS A Y+F+I GRHW+RL+F + S +L AS TV TD FVLL+NF+F N
Sbjct: 81 QTARVFSGLASYRFKITSLGRHWIRLHFSPIKNSTWNLTCASITVVTDDFVLLNNFSFNN 140
Query: 144 YNSSFMFKEYAINVNSDALTLTFIPSNNSVAFVNAIEVVSVPDAIFPDQALALEPSASFS 203
+N S++FKEY +NV S+ LTL+FIPSNNSV FVNAIEVVSVPD + PDQALAL PS FS
Sbjct: 141 FNGSYIFKEYTVNVTSEFLTLSFIPSNNSVVFVNAIEVVSVPDNLIPDQALALNPSTPFS 200
Query: 204 GLSDLGFETVYRLNMGGPLITAQNDTLGRTWENDETYLHVNSSAVNVSVRPSAIRYTASV 263
GLS L FETVYRLNMGGPL+T+QNDTLGR W+ND YLHVNSS + V+ PS+I+Y+ SV
Sbjct: 201 GLSQLAFETVYRLNMGGPLLTSQNDTLGRQWDNDAEYLHVNSSVLVVTANPSSIKYSPSV 260
Query: 264 TAETAPNWVYATAEMMGDANVPEVNFNITWVLPVEPNFTYFVRVHLCDIASLSMNNLVFN 323
T ETAPN VYATA+ MG+ANV +FN+TWVLPV+P F YFVRVH CDI S ++N LVFN
Sbjct: 261 TQETAPNMVYATADTMGEANVASPSFNVTWVLPVDPEFRYFVRVHFCDIVSQALNTLVFN 320
Query: 324 LYINDDIAQPSVDLSTLTNGLNVPYYKDFVCNASADSN-TLTVSVGPDSVADFTNATMNG 382
LY+NDD+A S+DLSTLTNGL VPY+KDF+ N S +S+ LTVSVGPDS AD TNATMNG
Sbjct: 321 LYVNDDLALGSLDLSTLTNGLKVPYFKDFISNGSVESSGVLTVSVGPDSQADITNATMNG 380
Query: 383 LEVMKISNEARSLDGLSSVEGLLPDKPSNKNKIGIIVGSVVGAVAAVALIGV-CYCWLLA 441
LEV+KISNEA+SL G+SSV+ L+P + K +I+GS VGAV V LI V CYC L A
Sbjct: 381 LEVLKISNEAKSLSGVSSVKSLVPGGSDKEKKKAVIIGSAVGAVTVVLLIAVCCYCCLAA 440
Query: 442 ---RKSKTPQQ---GHPWLPLPLYGNSQTMTKMSTTSQKSGTASCISLASSNLGRLFMFQ 495
++S +PQ+ GHPWLPLPLYG SQT+TK ST S KS TASCISLAS++LGR FMFQ
Sbjct: 441 SRKKRSTSPQEGGNGHPWLPLPLYGLSQTLTK-STASHKSATASCISLASTHLGRCFMFQ 499
Query: 496 EILDATNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKL 555
EI+DATNKFDES LLGVGGFGRVYKGTL+DGTKVAVKRGNPRSEQG+AEFRTEIEMLSKL
Sbjct: 500 EIMDATNKFDESSLLGVGGFGRVYKGTLEDGTKVAVKRGNPRSEQGMAEFRTEIEMLSKL 559
Query: 556 RHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHY 615
RHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYG DLPPLSWKQRLE+CIGAARGLHY
Sbjct: 560 RHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGADLPPLSWKQRLEVCIGAARGLHY 619
Query: 616 LHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPE 675
LHTGA+QSIIHRDVKTTNILLD+N VAKVADFGLSKTGP+LDQTHVSTAVKGSFGYLDPE
Sbjct: 620 LHTGASQSIIHRDVKTTNILLDENLVAKVADFGLSKTGPSLDQTHVSTAVKGSFGYLDPE 679
Query: 676 YFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDS 735
YFRRQQLTEKSDVYSFGVVLMEVLC RPALNPVLPREQVNIAEWAM WQKKG+LDQIMDS
Sbjct: 680 YFRRQQLTEKSDVYSFGVVLMEVLCCRPALNPVLPREQVNIAEWAMVWQKKGLLDQIMDS 739
Query: 736 NLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLEETSSALMEPEDNST 795
NL GKVNPASLKKFGETAEKCLAE+GVDRPSMGDVLWNLEYALQLEETSSALMEP+DNST
Sbjct: 740 NLTGKVNPASLKKFGETAEKCLAEYGVDRPSMGDVLWNLEYALQLEETSSALMEPDDNST 799
Query: 796 NHIPCIQLTPLEPFDNSVSMIDV---RNSGTDDDGEDVATSAVFSQLVNPRGR 845
NHIP I + P+EPFDNS+S+ID +GTDDD ED TSAVFSQLV+PRGR
Sbjct: 800 NHIPGIPMAPMEPFDNSMSIIDRGVNSGTGTDDDAEDATTSAVFSQLVHPRGR 852
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356542256|ref|XP_003539585.1| PREDICTED: receptor-like protein kinase THESEUS 1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1178 bits (3048), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 600/801 (74%), Positives = 675/801 (84%), Gaps = 13/801 (1%)
Query: 1 MVKMKLGKSVSVVLAVFLFELLCHKSCVAFTPVDNYLIACGSSQKVTFQARTYVPDTEHS 60
MV MKL K VS VL V+LF L + S FTP DNYLIACGSSQ +T Q RT+VPD++HS
Sbjct: 1 MVMMKLVKWVSFVLVVYLF--LVNGSFATFTPRDNYLIACGSSQSITSQDRTFVPDSQHS 58
Query: 61 SLSMKSGNSTTASSNSSAPSPIYQSARIFSAAAFYKFEIEHKGRHWVRLYFYTLPGSNQH 120
SL +K+GNS ASSNSS PSPIYQSARIF+ A Y+F++E +GRHW+RLYF LP S +
Sbjct: 59 SLKLKTGNSVVASSNSSVPSPIYQSARIFTEKASYRFQVE-EGRHWLRLYFSPLPNSAHN 117
Query: 121 LNSASFTVATDKFVLLSNFTFKNYNSSFMFKEYAINVNSDALTLTFIPSNNSVAFVNAIE 180
L +A+ TV TD FVLL NF+F+NYN S+MF+EYAINV SD T+TFIPSN SVAFVNAIE
Sbjct: 118 LTAAAITVVTDDFVLLCNFSFRNYNGSYMFREYAINVTSDTFTVTFIPSNGSVAFVNAIE 177
Query: 181 VVSVPDAIFPDQALALEPSASFSGLSDLGFETVYRLNMGGPLITAQNDTLGRTWENDETY 240
VVS+P+ +F DQALAL P+A+F+GLS+L FETVYRLN+GGPL+T QNDTLGRTWEND+ Y
Sbjct: 178 VVSMPNDLFVDQALALNPTAAFNGLSELAFETVYRLNIGGPLLTPQNDTLGRTWENDQKY 237
Query: 241 LHVNSSAVNVSVRPSAIRYTASVTAETAPNWVYATAEMMGDANVPEVNFNITWVLPVEPN 300
LHVNSS VSV PS+I+Y A VT ETAPNWVYAT+E+MGDANVP+ NFNITWV V+PN
Sbjct: 238 LHVNSSVTKVSVNPSSIKYHAGVTPETAPNWVYATSEVMGDANVPDSNFNITWVFSVDPN 297
Query: 301 FTYFVRVHLCDIASLSMNNLVFNLYINDDIAQPSVDLSTLTNGLNVPYYKDFVCNASADS 360
F+YF+RVH CDI S S+N LVFNL+IN DIA S+DLS++TN L VPYYKDFV NASADS
Sbjct: 298 FSYFIRVHFCDIISKSLNTLVFNLFINTDIALGSLDLSSITNDLAVPYYKDFVSNASADS 357
Query: 361 NTLTVSVGPDSVADFTNATMNGLEVMKISNEARSLDGLSSVEGLLPDKPSNKNKIGIIVG 420
N LTVSVGPDS+AD TNATMNGLEVMKISN +SLDGLSSV LLP S+K+K+GIIVG
Sbjct: 358 NILTVSVGPDSMADITNATMNGLEVMKISNAFKSLDGLSSVASLLPSSASSKSKMGIIVG 417
Query: 421 SVVGAVAAVALIGVCYCWLLARKSKTPQQGHPWLPLPLYGNSQTMTKMSTTSQKSGTASC 480
S VGA+AA+AL G+CYC L KSK+ QQGH WLPLPLYGNSQTMTKMSTTSQKS TAS
Sbjct: 418 SSVGAMAAIALAGLCYCCLGRFKSKSTQQGHSWLPLPLYGNSQTMTKMSTTSQKSATASI 477
Query: 481 ISLASSNLGRLFMFQEILDATNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQ 540
ISLASSNLGRLF FQEILDATNKFDE LLLGVGGFGRVYKGTL+DGT VAVKRGNPRSEQ
Sbjct: 478 ISLASSNLGRLFTFQEILDATNKFDEKLLLGVGGFGRVYKGTLEDGTNVAVKRGNPRSEQ 537
Query: 541 GIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWK 600
G+AEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWK
Sbjct: 538 GLAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWK 597
Query: 601 QRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH 660
QRLEICIGAARGLHYLHTGA+QSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH
Sbjct: 598 QRLEICIGAARGLHYLHTGASQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH 657
Query: 661 VSTAVKGSFGYLDPEYFRRQQ-------LTEKSDVYSFGVVLMEVLCTRPALNPVLPREQ 713
VSTAVKGSFGYLDPEYFRRQQ LTEKSDVYSFGVVL+EV+ RPAL+ LP E+
Sbjct: 658 VSTAVKGSFGYLDPEYFRRQQLTENQIHLTEKSDVYSFGVVLIEVISGRPALDHGLPTEK 717
Query: 714 VNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773
+N+A WAM + KG L QIMD N+VGK +SL K E A++CLAE+ ++RP +G VL
Sbjct: 718 INVATWAMNSEVKGQLHQIMDPNIVGKARVSSLNKVWEVAKRCLAENRINRPPIGFVLCC 777
Query: 774 LEYALQLEETSSALMEPEDNS 794
LE AL LE ++ A E+NS
Sbjct: 778 LEDALHLELSNIA---DEENS 795
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224104501|ref|XP_002313457.1| predicted protein [Populus trichocarpa] gi|222849865|gb|EEE87412.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 879 bits (2271), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 465/856 (54%), Positives = 578/856 (67%), Gaps = 37/856 (4%)
Query: 4 MKLGKSVSVVLAVFLFELLCHKSCVAFTPVDNYLIACGSSQKVTFQARTYVPDTEHSSLS 63
M G +V+ V L L+ FTPVDNYLI CGS T R +V D + +S+
Sbjct: 1 MMGGGGSRIVICVLLTVLILAFLSSGFTPVDNYLIDCGSPTNTTVGGRVFVAD-DSASIF 59
Query: 64 MKSGNSTTASSNSSAPS----PIYQSARIFSAAAFYKFEIEHKGRHWVRLYFYTLPGSNQ 119
+ + ST ASS+ S S P+YQ+ARIF + Y F I GRHW+RLYF +
Sbjct: 60 LSTPKSTLASSSKSVTSGDDSPLYQTARIFDGTSKYSFSIRQPGRHWIRLYFNPFVSGSY 119
Query: 120 HLNSASFTVATDKFVLLSNFTFKNYNSSFMFKEYAINVNSDALTLTFIPSNNSVAFVNAI 179
++ ASF V+T V LSNF+ K + + KE++ NV S L +TF PS NS AF+NA+
Sbjct: 120 DMSGASFDVSTPNHVFLSNFSVK----TSVVKEFSANVTSKDLVITFTPSGNSFAFLNAL 175
Query: 180 EVVSVPDAIFPDQALALEPSASFSGLSDLGFETVYRLNMGGPLITAQNDTLGRTWENDET 239
EVVSVPD + D A P+ F GLS ETVYR+NMGGP ++ +NDTLGRTW D++
Sbjct: 176 EVVSVPDELITDDAETFNPAGRFKGLSWQALETVYRVNMGGPTVSFENDTLGRTWVPDKS 235
Query: 240 YLHVNSSAVNVSVRPSAIRYTAS-VTAETAPNWVYATAEMMGDANVPEVNFNITWVLPVE 298
YL N+ A NVS +A++Y A T ++APN VY TA M N P NFN+TW V
Sbjct: 236 YLVGNNLATNVS-NIAAVKYVAGGATQDSAPNAVYGTAIRMNSENDPNSNFNVTWEFNVN 294
Query: 299 PNFTYFVRVHLCDIASLSMNNLVFNLYINDDIAQPSVDLSTLTNGLNVPYYKDFVCNASA 358
P F Y VR H CDI S S+NNL FN+YI+ + D S+ N L V +YKDFV A+
Sbjct: 295 PGFQYLVRFHFCDIVSSSLNNLYFNVYIDSWLVAEDEDPSSFANALAVAFYKDFVTAATV 354
Query: 359 DSNTLTVSVGPDSV--ADFTNATMNGLEVMKISNEARSLDGLSSVEGLLPD--KPSNKNK 414
SN L VS+GP + + NA +NGLE+MK++N L S+ G PD S+K
Sbjct: 355 -SNKLRVSIGPTNTIAVAYPNAILNGLEIMKMNNS------LGSLSGPAPDVSDSSSKKN 407
Query: 415 IGIIVGSVVGAVAAVALIGVCYCWLLARKSKTPQQGHP--WLPLPLYG-NSQTMTKMSTT 471
+G+IVG +GAV V L G+ + + R+ + +QG+ W+PL + G NS TM T
Sbjct: 408 VGVIVGLSIGAVILVVLAGIFFVFCRKRR-RLARQGNSKMWIPLSINGGNSHTMG----T 462
Query: 472 SQKSGTASCISLASSNLGRLFMFQEILDATNKFDESLLLGVGGFGRVYKGTLDDGTKVAV 531
+GT + + SNLG F + +ATN FDES ++G+GGFG+VYKG L+DGTKVAV
Sbjct: 463 KYSNGTTATLD---SNLGYCIPFAAVHEATNNFDESWVIGIGGFGKVYKGVLNDGTKVAV 519
Query: 532 KRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYG 591
KRGNPRS+QG+AEF+TEIEMLS+ RHRHLVSLIGYCDE++EMIL+YEYM NG L+SHLYG
Sbjct: 520 KRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKSHLYG 579
Query: 592 TDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSK 651
+ P L WK RLEICIGAARGLHYLHTG A+++IHRDVK+ NILLD+N +AKVADFGLSK
Sbjct: 580 SGSPSLCWKDRLEICIGAARGLHYLHTGYAKAVIHRDVKSANILLDENLMAKVADFGLSK 639
Query: 652 TGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPR 711
TGP +DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSD+YSFGVVL EVLC RP ++P LPR
Sbjct: 640 TGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDIYSFGVVLFEVLCARPVIDPSLPR 699
Query: 712 EQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVL 771
E VN+AEWAM WQK+G L++I+D LVGK+ P SL+KFGETAEKCLA+ GVDRPSMGDVL
Sbjct: 700 EMVNLAEWAMKWQKRGQLEEIIDPTLVGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVL 759
Query: 772 WNLEYALQLEETSSALMEPEDNSTNHIPCI--QLTPLEPFDNSVSMIDVRNSGTDDDGED 829
WNLEYALQL+E + L +PEDNS N I + Q+ D+SVS S DD
Sbjct: 760 WNLEYALQLQE-AVVLGDPEDNSINMIGELSPQINNFSHTDSSVSAAKFEASSVDDL-SG 817
Query: 830 VATSAVFSQLVNPRGR 845
V+ S VFSQLV GR
Sbjct: 818 VSMSRVFSQLVKSEGR 833
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 845 | ||||||
| TAIR|locus:2151349 | 855 | THE1 "THESEUS1" [Arabidopsis t | 0.983 | 0.971 | 0.721 | 0.0 | |
| TAIR|locus:2075346 | 830 | HERK1 "hercules receptor kinas | 0.970 | 0.987 | 0.507 | 1.5e-211 | |
| TAIR|locus:2136338 | 878 | AT4G39110 [Arabidopsis thalian | 0.978 | 0.941 | 0.492 | 4.9e-204 | |
| TAIR|locus:2050080 | 871 | AT2G21480 [Arabidopsis thalian | 0.956 | 0.927 | 0.495 | 7.9e-204 | |
| TAIR|locus:2163158 | 842 | AT5G61350 [Arabidopsis thalian | 0.381 | 0.382 | 0.693 | 6.7e-197 | |
| TAIR|locus:2174249 | 829 | AT5G59700 [Arabidopsis thalian | 0.874 | 0.891 | 0.522 | 1.5e-195 | |
| TAIR|locus:2204564 | 849 | HERK2 "hercules receptor kinas | 0.852 | 0.848 | 0.465 | 2.2e-169 | |
| TAIR|locus:2039717 | 815 | AT2G39360 [Arabidopsis thalian | 0.898 | 0.931 | 0.431 | 5.5e-164 | |
| TAIR|locus:2178707 | 824 | AT5G24010 [Arabidopsis thalian | 0.932 | 0.956 | 0.438 | 5.9e-160 | |
| TAIR|locus:2148830 | 858 | ANX2 "ANXUR2" [Arabidopsis tha | 0.778 | 0.766 | 0.449 | 2.3e-149 |
| TAIR|locus:2151349 THE1 "THESEUS1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 3120 (1103.4 bits), Expect = 0., P = 0.
Identities = 613/850 (72%), Positives = 688/850 (80%)
Query: 14 LAVFLFELLCHK---SCVAFTPVDNYLIACGSSQKVTFQARTYVPDTEHSSLSMKSGXXX 70
L V L+ L C+ S F P DNYLI+CGSSQ +TFQ R +VPD+ HSSL +K G
Sbjct: 7 LLVLLWFLSCYTTTTSSALFNPPDNYLISCGSSQNITFQNRIFVPDSLHSSLVLKIGNSS 66
Query: 71 XXXXXXX--XXXXIYQSARIFSAAAFYKFEIEHKGRHWVRLYFYTLPGSNQHLNSASFTV 128
IYQ+AR+FS+ A Y+F+I GRHW+RL+F + S +L SAS TV
Sbjct: 67 VATSTTSNNSTNSIYQTARVFSSLASYRFKITSLGRHWIRLHFSPINNSTWNLTSASITV 126
Query: 129 ATDKFVLLSNFTFKNYNSSFMFKEYAINVNSDALTLTFIPSNNSVAFVNAIEVVSVPDAI 188
T+ FVLL+NF+F N+N S++FKEY +NV S+ LTL+FIPSNNSV FVNAIEVVSVPD +
Sbjct: 127 VTEDFVLLNNFSFNNFNGSYIFKEYTVNVTSEFLTLSFIPSNNSVVFVNAIEVVSVPDNL 186
Query: 189 FPDQALALEPSASFSGLSDLGFETVYRLNMGGPLITAQNDTLGRTWENDETYLHVNSSAV 248
PDQALAL PS FSGLS L FETVYRLNMGGPL+T+QNDTLGR W+ND YLHVNSS +
Sbjct: 187 IPDQALALNPSTPFSGLSLLAFETVYRLNMGGPLLTSQNDTLGRQWDNDAEYLHVNSSVL 246
Query: 249 NVSVRPSAIRYTASVTAETAPNWVYATAEMMGDANVPEVNFNITWVLPVEPNFTYFVRVH 308
V+ PS+I+Y+ SVT ETAPN VYATA+ MGDANV +FN+TWVLPV+P+F YFVRVH
Sbjct: 247 VVTANPSSIKYSPSVTQETAPNMVYATADTMGDANVASPSFNVTWVLPVDPDFRYFVRVH 306
Query: 309 LCDIASLSMNNLVFNLYINDDIAQPSVDLSTLTNGLNVPYYKDFVCNASADSN-TLTVSV 367
CDI S ++N LVFNLY+NDD+A S+DLSTLTNGL VPY+KDF+ N S +S+ LTVSV
Sbjct: 307 FCDIVSQALNTLVFNLYVNDDLALGSLDLSTLTNGLKVPYFKDFISNGSVESSGVLTVSV 366
Query: 368 GPDSVADFTNATMNGLEVMKISNEARSLDGLSSVEGLLPDKPSNKNKXXXXXXXXXXXXX 427
GPDS AD TNATMNGLEV+KISNEA+SL G+SSV+ LLP +K+K
Sbjct: 367 GPDSQADITNATMNGLEVLKISNEAKSLSGVSSVKSLLPGGSGSKSKKKAVIIGSLVGAV 426
Query: 428 XXXXXXX--CYCWLLA-RK--SKTPQQG---HPWLPLPLYGNXXXXXXXXXXXXXXGTAS 479
CYC L+A RK S +PQ+G HPWLPLPLYG TAS
Sbjct: 427 TLILLIAVCCYCCLVASRKQRSTSPQEGGNGHPWLPLPLYG-LSQTLTKSTASHKSATAS 485
Query: 480 CISLASSNLGRLFMFQEILDATNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSE 539
CISLAS++LGR FMFQEI+DATNKFDES LLGVGGFGRVYKGTL+DGTKVAVKRGNPRSE
Sbjct: 486 CISLASTHLGRCFMFQEIMDATNKFDESSLLGVGGFGRVYKGTLEDGTKVAVKRGNPRSE 545
Query: 540 QGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSW 599
QG+AEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYG DLPPLSW
Sbjct: 546 QGMAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGADLPPLSW 605
Query: 600 KQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT 659
KQRLEICIGAARGLHYLHTGA+QSIIHRDVKTTNILLD+N VAKVADFGLSKTGP+LDQT
Sbjct: 606 KQRLEICIGAARGLHYLHTGASQSIIHRDVKTTNILLDENLVAKVADFGLSKTGPSLDQT 665
Query: 660 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEW 719
HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC RPALNPVLPREQVNIAEW
Sbjct: 666 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCCRPALNPVLPREQVNIAEW 725
Query: 720 AMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779
AM WQKKG+LDQIMDSNL GKVNPASLKKFGETAEKCLAE+GVDRPSMGDVLWNLEYALQ
Sbjct: 726 AMAWQKKGLLDQIMDSNLTGKVNPASLKKFGETAEKCLAEYGVDRPSMGDVLWNLEYALQ 785
Query: 780 LEETSSALMEPEDNSTNHIPCIQLTPLEPFDNSVSMID---VRN-SGTDDDGEDVATSAV 835
LEETSSALMEP+DNSTNHIP I + P+EPFDNS+S+ID V + +GTDDD ED TSAV
Sbjct: 786 LEETSSALMEPDDNSTNHIPGIPMAPMEPFDNSMSIIDRGGVNSGTGTDDDAEDATTSAV 845
Query: 836 FSQLVNPRGR 845
FSQLV+PRGR
Sbjct: 846 FSQLVHPRGR 855
|
|
| TAIR|locus:2075346 HERK1 "hercules receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2045 (724.9 bits), Expect = 1.5e-211, P = 1.5e-211
Identities = 432/852 (50%), Positives = 541/852 (63%)
Query: 4 MKLGKSVSVVLAVFLFELLCHKSCVAFTPVDNYLIACGSSQKVTFQARTYVPDTEHSSLS 63
M + K + +L + LLC C FTPVDNYLI CGS T R ++ D S L
Sbjct: 1 MGIEKFETFILISTISILLC--ICHGFTPVDNYLINCGSPTNGTLMGRIFLSDKLSSKL- 57
Query: 64 MKSGXXXXXXXXXXXXXXIYQSARIFSAAAFYKFEIEHKGRHWVRLYFYTLPGSNQHLNS 123
+ S IY +AR+F+ + YKF + +GRHWVRLYF N + S
Sbjct: 58 LTSSKEILASVGGNSGSDIYHTARVFTEVSSYKFSVT-RGRHWVRLYFNPFDYQNFKMGS 116
Query: 124 ASFTVATDKFVLLSNFTFKNYNSSFMFKEYAINVNSDALTLTFIPSNNSVAFVNAIEVVS 183
A F V++ VLLS+FT SS + KEY++NV ++ L LTF PS+ S AFVNAIEV+S
Sbjct: 117 AKFAVSSQSHVLLSDFTV---TSSKVVKEYSLNVTTNDLVLTFTPSSGSFAFVNAIEVIS 173
Query: 184 VPDAIFPDQALALEPSASFSGLSDLGFETVYRLNMGGPLITAQNDTLGRTWENDETYLHV 243
+PD + + A F +S G ET++R+NMGGPL+ + NDTL RTW D +L
Sbjct: 174 IPDTLITGSPRFVGNPAQFPDMSMQGLETIHRVNMGGPLVASNNDTLTRTWVPDSEFLLE 233
Query: 244 NSSAVNVSVRPSAIRYTAS-VTAETAPNWVYATAEMMGDANVPEVNFNITWVLPVEPNFT 302
+ A ++S + S + + T ++AP VY + M A+ P FN+TW V+P F
Sbjct: 234 KNLAKSMS-KFSTVNFVPGYATEDSAPRTVYGSCTEMNSADNPNSIFNVTWEFDVDPGFQ 292
Query: 303 YFVRVHLCDIASLSMNNLVFNLYINDDIAQPSVDLSTLT-NGLNVPYYKDFVCNASADSN 361
Y+ R H CDI SLS+N L FNLY++ +A +DLSTL N L Y DFV SN
Sbjct: 293 YYFRFHFCDIVSLSLNQLYFNLYVDSMVAATDIDLSTLVDNTLAGAYSMDFVTQTPKGSN 352
Query: 362 TLTVSVGPDSV-ADFTNATMNGLEVMKISNEARSLDGLSSVEGLLPDKPSNKNKXXXXXX 420
+ VS+GP +V D+ NA +NGLE+MK++N L + V G S+ +K
Sbjct: 353 KVRVSIGPSTVHTDYPNAIVNGLEIMKMNNSKGQLSTGTFVPG-----SSSSSKSNLGLI 407
Query: 421 XXXXXXXXXXXXXXCYCWLLARKSKTPQQGHP--WLPLPLYGNXXXXXXXXXXXXXXGTA 478
C++L +K K Q GH W+P + G GT
Sbjct: 408 VGSAIGSLLAVVFLGSCFVLYKKRKRGQDGHSKTWMPFSINGTSMGSKYSN------GTT 461
Query: 479 SCISLASSNLGRLFMFQEILDATNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRS 538
++ ++N F + DATN FDES +GVGGFG+VYKG L+DGTKVAVKRGNP+S
Sbjct: 462 --LTSITTNANYRIPFAAVKDATNNFDESRNIGVGGFGKVYKGELNDGTKVAVKRGNPKS 519
Query: 539 EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLS 598
+QG+AEFRTEIEMLS+ RHRHLVSLIGYCDE +EMIL+YEYM NG ++SHLYG+ LP L+
Sbjct: 520 QQGLAEFRTEIEMLSQFRHRHLVSLIGYCDENNEMILIYEYMENGTVKSHLYGSGLPSLT 579
Query: 599 WKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQ 658
WKQRLEICIGAARGLHYLHTG ++ +IHRDVK+ NILLD+NF+AKVADFGLSKTGP LDQ
Sbjct: 580 WKQRLEICIGAARGLHYLHTGDSKPVIHRDVKSANILLDENFMAKVADFGLSKTGPELDQ 639
Query: 659 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAE 718
THVSTAVKGSFGYLDPEYFRRQQLT+KSDVYSFGVVL EVLC RP ++P LPRE VN+AE
Sbjct: 640 THVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAE 699
Query: 719 WAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYAL 778
WAM WQKKG LDQI+D +L G + P SL+KF ET EKCLA++GVDRPSMGDVLWNLEYAL
Sbjct: 700 WAMKWQKKGQLDQIIDQSLRGNIRPDSLRKFAETGEKCLADYGVDRPSMGDVLWNLEYAL 759
Query: 779 QLEETSSALMEPEDNSTNHIPCI--QLTPLEPFDNSVSMIDVRN---SGTDDDGEDVATS 833
QL+E EPEDNSTN I + Q+ D SV++ + DD V+ S
Sbjct: 760 QLQEAVID-GEPEDNSTNMIGELPPQINNFSQGDTSVNVPGTAGRFEESSIDDLSGVSMS 818
Query: 834 AVFSQLVNPRGR 845
VFSQLV GR
Sbjct: 819 KVFSQLVKSEGR 830
|
|
| TAIR|locus:2136338 AT4G39110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1974 (699.9 bits), Expect = 4.9e-204, P = 4.9e-204
Identities = 427/867 (49%), Positives = 530/867 (61%)
Query: 9 SVSVVLAVFLFELLCHKSCVA---------FTPVDNYLIACGS-SQKVTFQARTYVPDTE 58
S++++LA+ LF S VA F P D+ LI CGS S T R + D E
Sbjct: 22 SMALLLAILLFLSGPSASAVAAAAVGPATGFKPADDILIDCGSKSSSKTPDGRVFKSDQE 81
Query: 59 HSS-LSMKSGXXXXXXXXXXXXXXIYQSARIFSAAAFYKFEIEHKGRHWVRLYFYTLPGS 117
+ K IY +ARIF A YKF + G HWVRL+F P
Sbjct: 82 TIQYIEAKEDIQVSAPPSDKVASPIYLTARIFREEATYKFHLTRPGWHWVRLHFLAFPND 141
Query: 118 NQHLNSASFTVATDKFVLLSNFTFKNYNS---SFMFKEYAINVNSDALTLTFIPSNNSVA 174
L A+F+V T+K+VLL NF N N+ + + KEY +N+ L F P +S A
Sbjct: 142 KFDLQQATFSVLTEKYVLLHNFKISNNNNDSQAAVQKEYLVNMTDAQFALRFRPMKSSAA 201
Query: 175 FVNAIEVVSVPDAIFPDQALALEPSASFSGLSDLGFETVYRLNMGGPLITAQNDTLGRTW 234
F+NAIEVVS PD + D AL P FSGLSD +++VYR+N+GGPLI QNDTLGRTW
Sbjct: 202 FINAIEVVSAPDELISDSGTALFPVIGFSGLSDYAYQSVYRVNVGGPLIMPQNDTLGRTW 261
Query: 235 ENDETYLHVNSSAVNVSVRPSAIRYTASVTAETAPNWVYATAEMMGDANVPEVNFNITWV 294
D+ +L + A +V PSAI+Y VT AP VYATA M ++ + NFN++W
Sbjct: 262 IPDKEFLKDENLAKDVKTTPSAIKYPPEVTPLIAPQTVYATAVEMANSLTIDPNFNVSWN 321
Query: 295 LPVEPNFTYFVRVHLCDIASLSMNNLVFNLYINDDIAQPSVDLSTLTNGLNVPYYKDFVC 354
P P+F Y +R+H CDI S S+N+L FN+YIN A +DLST+ L PYYKD V
Sbjct: 322 FPSNPSFNYLIRLHFCDIVSKSLNDLYFNVYINGKTAISGLDLSTVAGNLAAPYYKDIVV 381
Query: 355 NASADSNTLTVSVGPDSVADFT-NATMNGLEVMKISNEARSLDGLSSVEGLLPDKPSNKN 413
NA+ L V +GP T NA +NG+EV+K+SN SLDG V+G K+
Sbjct: 382 NATLMGPELQVQIGPMGEDTGTKNAILNGVEVLKMSNSVNSLDGEFGVDGRTTGM--GKH 439
Query: 414 KXXXXXXXXXXXXXXXXXXXXCYCWLLARKSKTPQQGHP-WLPLPLYGNXXXXXXXXXXX 472
Y W + + WL LP++
Sbjct: 440 GMVATAGFVMMFGAFIGLGAMVYKWKKRPQDWQKRNSFSSWL-LPIHAGDSTFMTSKGGS 498
Query: 473 XXXGTASCISLASSNLGRLFMFQEILDATNKFDESLLLGVGGFGRVYKGTLDDGTKVAVK 532
+ ++ LGR F E+ +AT F+ S ++GVGGFG VY GTLDDGTKVAVK
Sbjct: 499 QKSNFYN----STLGLGRYFSLSELQEATKNFEASQIIGVGGFGNVYIGTLDDGTKVAVK 554
Query: 533 RGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGT 592
RGNP+SEQGI EF+TEI+MLSKLRHRHLVSLIGYCDE SEMILVYE+M+NGP R HLYG
Sbjct: 555 RGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEFMSNGPFRDHLYGK 614
Query: 593 DLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKT 652
+L PL+WKQRLEICIG+ARGLHYLHTG AQ IIHRDVK+TNILLD+ VAKVADFGLSK
Sbjct: 615 NLAPLTWKQRLEICIGSARGLHYLHTGTAQGIIHRDVKSTNILLDEALVAKVADFGLSKD 674
Query: 653 GPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPRE 712
A Q HVSTAVKGSFGYLDPEYFRRQQLT+KSDVYSFGVVL+E LC RPA+NP LPRE
Sbjct: 675 -VAFGQNHVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLLEALCARPAINPQLPRE 733
Query: 713 QVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLW 772
QVN+AEWAM W++KG+L++I+D +L G +NP S+KKF E AEKCL ++GVDRP+MGDVLW
Sbjct: 734 QVNLAEWAMQWKRKGLLEKIIDPHLAGTINPESMKKFAEAAEKCLEDYGVDRPTMGDVLW 793
Query: 773 NLEYALQLEET-SSALMEPEDNST------NHIPCIQLTPLEPF--DNSVSMIDV----- 818
NLEYALQL+E + E +N+ +P +P+ P N + + V
Sbjct: 794 NLEYALQLQEAFTQGKAEETENAKPDVVTPGSVPVSDPSPITPSVTTNEAATVPVPAKVE 853
Query: 819 RNSGTDDDGEDVATSAVFSQLVNPRGR 845
NSGT D E T A+F+Q N GR
Sbjct: 854 ENSGTAVD-EHSGT-AMFTQFANLNGR 878
|
|
| TAIR|locus:2050080 AT2G21480 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1972 (699.2 bits), Expect = 7.9e-204, P = 7.9e-204
Identities = 411/829 (49%), Positives = 515/829 (62%)
Query: 30 FTPVDNYLIACGS-SQKVTFQARTYVPDTEHSS-LSMKSGXXXXXXXXXXXXXXIYQSAR 87
F P D+ LI CGS S T + R + D+E + K IY +A+
Sbjct: 51 FKPADDILIDCGSKSSTKTPEGRVFKSDSETVQYIEAKDDIQVSAPPSDKLPSPIYLTAK 110
Query: 88 IFSAAAFYKFEIEHKGRHWVRLYFYTLPGSNQHLNSASFTVATDKFVLLSNFTFKNYNS- 146
IF A YKF + G HWVRL+F+ P L A+F+V T+K+VLL NF N N+
Sbjct: 111 IFREEAIYKFHLTRPGWHWVRLHFFAFPNDKFDLQQATFSVLTEKYVLLHNFKLSNDNND 170
Query: 147 --SFMFKEYAINVNSDALTLTFIPSNNSVAFVNAIEVVSVPDAIFPDQALALEPSASFSG 204
+ + KEY +N+ L F P S AF+N IE+VS PD + D +L P FSG
Sbjct: 171 SQATVQKEYLLNMTDAQFALRFKPMKGSAAFINGIELVSAPDELISDAGTSLFPVNGFSG 230
Query: 205 LSDLGFETVYRLNMGGPLITAQNDTLGRTWENDETYLHVNSSAVNVSVRPSAIRYTASVT 264
LSD +++VYR+N+GGPLIT QNDTLGRTW D+ YL + A +V P+AI Y VT
Sbjct: 231 LSDYAYQSVYRVNVGGPLITPQNDTLGRTWTPDKEYLKDENLAKDVKTNPTAIIYPPGVT 290
Query: 265 AETAPNWVYATAEMMGDANVPEVNFNITWVLPVEPNFTYFVRVHLCDIASLSMNNLVFNL 324
AP VYAT M D+ + NFN+TW P P+F YF+R+H CDI S S+N+L FN+
Sbjct: 291 PLIAPQTVYATGAEMADSQTIDPNFNVTWNFPSNPSFHYFIRLHFCDIISKSLNDLYFNV 350
Query: 325 YINDDIAQPSVDLSTLTNGLNVPYYKDFVCNASADSNTLTVSVGP-DSVADFTNATMNGL 383
YIN A +DLST+ L+ PYYKD V N++ ++ L V +GP NA +NG+
Sbjct: 351 YINGKTAISGLDLSTVAGDLSAPYYKDIVVNSTLMTSELQVQIGPMGEDTGKKNAILNGV 410
Query: 384 EVMKISNEARSLDGLSSVEGLLPDKPSNKNKXXXXXXXXXXXXXXXXXXXXCYCWLLARK 443
EV+K+SN SLDG V+G K Y W +
Sbjct: 411 EVLKMSNSVNSLDGEFGVDGQRASM--GKQGMVATAGFVMMFGAFVGLGAMVYKWKKRPQ 468
Query: 444 SKTPQQGHP-WLPLPLYGNXXXXXXXXXXXXXXGTASCISLASSNLGRLFMFQEILDATN 502
+ WL LP++ + ++ LGR F E+ + T
Sbjct: 469 DWQKRNSFSSWL-LPIHAGDSTFMTSKTGSHKSNLYN----SALGLGRYFSLSELQEVTK 523
Query: 503 KFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVS 562
FD S ++GVGGFG VY GT+DDGT+VA+KRGNP+SEQGI EF TEI+MLSKLRHRHLVS
Sbjct: 524 NFDASEIIGVGGFGNVYIGTIDDGTQVAIKRGNPQSEQGITEFHTEIQMLSKLRHRHLVS 583
Query: 563 LIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQ 622
LIGYCDE +EMILVYEYM+NGP R HLYG +L PL+WKQRLEICIGAARGLHYLHTG AQ
Sbjct: 584 LIGYCDENAEMILVYEYMSNGPFRDHLYGKNLSPLTWKQRLEICIGAARGLHYLHTGTAQ 643
Query: 623 SIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQL 682
IIHRDVK+TNILLD+ VAKVADFGLSK A Q HVSTAVKGSFGYLDPEYFRRQQL
Sbjct: 644 GIIHRDVKSTNILLDEALVAKVADFGLSKD-VAFGQNHVSTAVKGSFGYLDPEYFRRQQL 702
Query: 683 TEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVN 742
T+KSDVYSFGVVL+E LC RPA+NP LPREQVN+AEWAM W++KG+L++I+D +LVG VN
Sbjct: 703 TDKSDVYSFGVVLLEALCARPAINPQLPREQVNLAEWAMLWKQKGLLEKIIDPHLVGAVN 762
Query: 743 PASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLEET-SSALMEPEDNST-NHIPC 800
P S+KKF E AEKCLA++GVDRP+MGDVLWNLEYALQL+E S E E+ T +
Sbjct: 763 PESMKKFAEAAEKCLADYGVDRPTMGDVLWNLEYALQLQEAFSQGKAEAEEVETPKPVAV 822
Query: 801 IQLTPLEPFDNSVSMIDVRNSGTD--DDG--EDVATSAVFSQLVNPRGR 845
P P + + + S T+ DD + + + +F+Q + GR
Sbjct: 823 PAAAPTSPAATTAAASERPVSQTEEKDDSTVDQHSGTTMFTQFASLNGR 871
|
|
| TAIR|locus:2163158 AT5G61350 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1180 (420.4 bits), Expect = 6.7e-197, Sum P(2) = 6.7e-197
Identities = 229/330 (69%), Positives = 269/330 (81%)
Query: 484 ASSNLGRLFMFQEILDATNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIA 543
++ LGR F F E+ AT FDE+ + GVGGFG+VY G +D GT+VA+KRG+ SEQGI
Sbjct: 505 SNQGLGRYFPFTELQTATQNFDENAVCGVGGFGKVYIGEIDGGTQVAIKRGSQSSEQGIN 564
Query: 544 EFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTD------LPPL 597
EF+TEI+MLSKLRHRHLVSLIG+CDE EMILVYEYM+NGPLR HLYG+ +P L
Sbjct: 565 EFQTEIQMLSKLRHRHLVSLIGFCDENKEMILVYEYMSNGPLRDHLYGSKENDPNPIPTL 624
Query: 598 SWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657
SWKQRLEICIG+ARGLHYLHTGAAQ IIHRDVKTTNILLD+N VAKV+DFGLSK P +D
Sbjct: 625 SWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVSDFGLSKDAP-MD 683
Query: 658 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIA 717
+ HVSTAVKGSFGYLDPEYFRRQQLT+KSDVYSFGVVL EVLC RP +NP LPREQVN+A
Sbjct: 684 EGHVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARPVINPQLPREQVNLA 743
Query: 718 EWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYA 777
E+AM +KGML++I+D +VG ++ SL+KF E AEKCLAE+GVDRP MGDVLWNLEYA
Sbjct: 744 EYAMNLHRKGMLEKIIDPKIVGTISKGSLRKFVEAAEKCLAEYGVDRPGMGDVLWNLEYA 803
Query: 778 LQLEETSSALMEPEDNSTNHIPCIQLTPLE 807
LQL+E S+ + ED +T +I + L P E
Sbjct: 804 LQLQEASAQVDLSEDKTTMNIE-MDLIPGE 832
|
|
| TAIR|locus:2174249 AT5G59700 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1894 (671.8 bits), Expect = 1.5e-195, P = 1.5e-195
Identities = 407/779 (52%), Positives = 514/779 (65%)
Query: 82 IYQSARIFSAAAFYKFEIEHKGRHWVRLYFYTLPGSNQHLNSASFTVATDKFVLLSNFTF 141
IYQ+ARIF+ + Y+F + +GRHW+RL+F N + SA F+V+++ VLLS+FT
Sbjct: 76 IYQTARIFTGISKYRFSVA-RGRHWIRLHFNPFQYQNFQMVSAKFSVSSETHVLLSDFTV 134
Query: 142 KNYNSSFMFKEYAINVNSDALTLTFIPSNNSVAFVNAIEVVSVPDAIFP-DQALALEPSA 200
SS + KEY++NV +D L LTF PS +S AF+NA+EVVSVPD +F D + A P
Sbjct: 135 ----SSRVMKEYSLNVATDHLELTFTPSGDSFAFLNALEVVSVPDTLFSGDPSFAGSPG- 189
Query: 201 SFSGLSDLGFETVYRLNMGGPLITAQNDTLGRTWENDETYLHVNSSAVNVSVRPSAIRYT 260
F GLS ETVYR+NMGGP +T NDTL R WE D +L V + V + +++ Y
Sbjct: 190 KFQGLSWQALETVYRVNMGGPRVTPSNDTLSRIWEPDSEFL-VEKNLVKSVSKIASVDYV 248
Query: 261 AS-VTAETAPNWVYATAEMMGDANVPEVNFNITWVLPVEPNFTYFVRVHLCDIASLSMNN 319
T ETAP VY T M A+ P NFN+TW V+P F YF+R H CDI S ++N
Sbjct: 249 PGFATEETAPRTVYGTCTEMNSADNPSSNFNVTWDFDVDPGFQYFLRFHFCDIVSKALNQ 308
Query: 320 LVFNLYIND-DIAQPSVDLST-LTNGLNVPYYKDFVCNASADSNTLTVSVGPDSV-ADFT 376
L FNLY++ D+ + ++DLS+ L+N L+ Y DFV ++ + + VS+G SV D+
Sbjct: 309 LYFNLYVDSMDVVE-NLDLSSYLSNTLSGAYAMDFVTGSAKLTKRIRVSIGRSSVHTDYP 367
Query: 377 NATMNGLEVMKISNEARSLDGLSSVEGLLPDKPSNKNKXXXXXXXXXXXXXXXXXXXXCY 436
A +NGLE+MK++N L S+ LP S+ K
Sbjct: 368 TAILNGLEIMKMNNSKSQL----SIGTFLPSGSSSTTKKNVGMIIGLTIGSLLALVVLGG 423
Query: 437 CWLLARKSKTPQQGHP--WLPLPLYGNXXXXXXXXXXXXXXGTASCISLASSNLGRLFMF 494
++L +K Q G+ W+PL G GT + S+AS++ R+ +
Sbjct: 424 FFVLYKKRGRDQDGNSKTWIPLSSNGTTSSSN---------GT-TLASIASNSSYRIPLV 473
Query: 495 QEILDATNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSK 554
+ +ATN FDE+ +GVGGFG+VYKG L DGTKVAVKR NP+S+QG+AEFRTEIEMLS+
Sbjct: 474 A-VKEATNSFDENRAIGVGGFGKVYKGELHDGTKVAVKRANPKSQQGLAEFRTEIEMLSQ 532
Query: 555 LRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLH 614
RHRHLVSLIGYCDE +EMILVYEYM NG L+SHLYG+ L LSWKQRLEICIG+ARGLH
Sbjct: 533 FRHRHLVSLIGYCDENNEMILVYEYMENGTLKSHLYGSGLLSLSWKQRLEICIGSARGLH 592
Query: 615 YLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDP 674
YLHTG A+ +IHRDVK+ NILLD+N +AKVADFGLSKTGP +DQTHVSTAVKGSFGYLDP
Sbjct: 593 YLHTGDAKPVIHRDVKSANILLDENLMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDP 652
Query: 675 EYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMD 734
EYFRRQQLTEKSDVYSFGVV+ EVLC RP ++P L RE VN+AEWAM WQKKG L+ I+D
Sbjct: 653 EYFRRQQLTEKSDVYSFGVVMFEVLCARPVIDPTLTREMVNLAEWAMKWQKKGQLEHIID 712
Query: 735 SNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLEETSSALMEPEDNS 794
+L GK+ P SL+KFGET EKCLA++GVDRPSMGDVLWNLEYALQL+E + +PED S
Sbjct: 713 PSLRGKIRPDSLRKFGETGEKCLADYGVDRPSMGDVLWNLEYALQLQE-AVVDGDPED-S 770
Query: 795 TNHIPCIQL--TPLEPFDNSVSMIDVRNSGTD------DDGEDVATSAVFSQLVNPRGR 845
TN I + L D SV+ + D DD V+ S VFSQL+ GR
Sbjct: 771 TNMIGELPLRFNDYNHGDTSVNFSVAKEGRFDEEESSVDDSSGVSMSKVFSQLIKSEGR 829
|
|
| TAIR|locus:2204564 HERK2 "hercules receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1647 (584.8 bits), Expect = 2.2e-169, P = 2.2e-169
Identities = 349/750 (46%), Positives = 465/750 (62%)
Query: 82 IYQSARIFSAAAFYKFEIEHKGRHWVRLYFYTLPGSNQHLNSASFTVATDKFVLLSNFTF 141
IY++AR+F A Y FE +G ++VRL+F N ++N +SF+V D L+ +
Sbjct: 82 IYKTARVFDAVLNYTFEGITQGNYFVRLHFSPFAIENHNVNESSFSVFADGLRLMLDINI 141
Query: 142 ------KN-------YNS--SFMFKEYAINVNSDALTLTFIPSNNSVAFVNAIEVVSVPD 186
KN +N+ S + KE+ + L L+FIP S FVNAIE+VSV D
Sbjct: 142 AGEIAHKNLILESTGHNATASSLVKEFLLPTGPGKLVLSFIPEKGSFGFVNAIEIVSVDD 201
Query: 187 AIFPDQALALEPSASFSGLSDLGFETVYRLNMGGPLITAQNDT-LGRTWENDETYLHVNS 245
+F + + S GL G ET+YRLN+GGP + D L RTWE D +Y+ + +
Sbjct: 202 KLFKESVTKVGGSEVELGLGGRGIETMYRLNVGGPKLGPSKDLKLYRTWETDLSYMVIEN 261
Query: 246 SAVNVSVRPSAIRYTASVTAETAPNWVYATAEMMGDANVPEVNFNITWVLPVEPNFTYFV 305
+ V V S I Y + + AP VY TA MM + V E FNI+W V+PNF Y V
Sbjct: 262 AGVEVK-NSSNITYALADDSPVAPLLVYETARMMSNTEVLEKRFNISWKFEVDPNFDYLV 320
Query: 306 RVHLCDIASLSMNNLVFNLYINDDIAQPSVDLSTLTNGLNVPYYKDFVCNASADSNTLTV 365
R+H C++ N +F +YIN+ A + D+ G N Y+D++ S+ ++ L +
Sbjct: 321 RLHFCELLVDKQNQRIFRIYINNQTAAGNFDIFAHAGGKNKGIYQDYLDPVSSKNDVLWI 380
Query: 366 SVGPDS-VADFTNATMNGLEVMKISNEARSLDGLSSVEGLLPDKPSNKNKXX--XXXXXX 422
+GPDS V +A ++GLE+ K+S +L L + +K +
Sbjct: 381 QLGPDSSVGASGDALLSGLEIFKLSKNG-NLAHLIRFDSTGHSVSDSKMRIIWISVGAGI 439
Query: 423 XXXXXXXXXXXXCYCWLLARKSKTPQ-QGHP--WLPLPLYGNXXXXXXXXXXXXXXGTAS 479
C R+SK+ + + +P W PL L+ N G+
Sbjct: 440 AIIIFFVFLGILVVCLCKKRRSKSDESKNNPPGWRPLFLHVNNSTANAKATG----GSLR 495
Query: 480 CISLASSNLGRLFMFQEILDATNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSE 539
+LA+S +GR F EI AT FD+ L +GVGGFG+VY+G L+DGT +A+KR P S+
Sbjct: 496 LNTLAASTMGRKFTLAEIRAATKNFDDGLAIGVGGFGKVYRGELEDGTLIAIKRATPHSQ 555
Query: 540 QGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSW 599
QG+AEF TEI MLS+LRHRHLVSLIG+CDE +EMILVYEYMANG LRSHL+G++LPPLSW
Sbjct: 556 QGLAEFETEIVMLSRLRHRHLVSLIGFCDEHNEMILVYEYMANGTLRSHLFGSNLPPLSW 615
Query: 600 KQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT 659
KQRLE CIG+ARGLHYLHTG+ + IIHRDVKTTNILLD+NFVAK++DFGLSK GP++D T
Sbjct: 616 KQRLEACIGSARGLHYLHTGSERGIIHRDVKTTNILLDENFVAKMSDFGLSKAGPSMDHT 675
Query: 660 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEW 719
HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL E +C R +NP LP++Q+N+AEW
Sbjct: 676 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEAVCARAVINPTLPKDQINLAEW 735
Query: 720 AMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779
A++WQK+ L+ I+DSNL G +P SL+K+GE AEKCLA+ G +RP MG+VLW+LEY LQ
Sbjct: 736 ALSWQKQRNLESIIDSNLRGNYSPESLEKYGEIAEKCLADEGKNRPMMGEVLWSLEYVLQ 795
Query: 780 LEETSSALMEPEDNSTNHIPCIQLTPLEPF 809
+ E E NS + ++ P E F
Sbjct: 796 IHEAWLRKQNGE-NSFSSSQAVEEAP-ESF 823
|
|
| TAIR|locus:2039717 AT2G39360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1596 (566.9 bits), Expect = 5.5e-164, P = 5.5e-164
Identities = 350/811 (43%), Positives = 493/811 (60%)
Query: 1 MVKMKLGKSVSVVLAVFLFELLC--HKSCVAFTPVDNYLIACGSSQKVTFQARTYVPDTE 58
M+ +KL + + FL LLC H S V+ D + I CGS VT RT+V D
Sbjct: 1 MINLKLFLELKLC---FLITLLCSSHISSVS----DTFFINCGSPTNVTVNNRTFVSD-- 51
Query: 59 HSSLSMKSGXXXXXXXXXXXXXXIYQSARIFS--AAAFYKFEIEHKGRHWVRLYFYTLPG 116
++L ++ ++Q+AR+FS +++ Y+F IE G +R+YF L
Sbjct: 52 -NNL-VQGFSVGTTDSNSGDESTLFQTARVFSDESSSTYRFPIEEHGWFLIRIYFLPLVS 109
Query: 117 SNQHLNSASFTVATDKFVLLSNFTFKNYNSSFMFKEYAINVNSDALTLTFIPSNNSVAFV 176
++Q L +A F+V+ F L+ + K +S + +EY +NV +D+L L F+P SV+F+
Sbjct: 110 ASQDLTTARFSVSAQNFTLIREY--KPSTTSVV-REYILNVTTDSLLLQFLPRTGSVSFI 166
Query: 177 NAIEVVSVPDAIFPDQALALEPSASFSGLSDLGFETVYRLNMGGPLITAQNDTLGRTWEN 236
NA+EV+ +P+ + P+ A + LS ETV R+NMG ++ D L R W++
Sbjct: 167 NALEVLRLPETLIPEDAKLIGTQKDLK-LSSHAMETVSRVNMGNLSVSRDQDKLWRQWDS 225
Query: 237 DETY-LHVNSSAVNVSVRPSAIRYTAS-VTAETAPNWVYATAEMMGDANVPEVNFNITWV 294
D Y H + +N+ A+ ++A +T + AP +VY TA + P N N+TW
Sbjct: 226 DSAYKAHFGTPVMNLK----AVNFSAGGITDDIAPVYVYGTATRLNSDLDPNTNANLTWT 281
Query: 295 LPVEPNFTYFVRVHLCDIA--SLSMNNLV-FNLYINDDIAQPSVDLSTLTNG-LNVPYYK 350
VEP F YFVR H C+I + F++++N + + ++D++ + NG P++
Sbjct: 282 FKVEPGFDYFVRFHFCNIIVDPFGFERQIRFDIFVNSEKVR-TIDMTEVLNGTFGAPFFV 340
Query: 351 DFVCN-ASADSNTLTVSVG-PDSVADFTNATMNGLEVMKISNEARSLDGLSSVEGLLPD- 407
D V A + L +S+G V+ + + +NG E+ K+SN+ RSLD ++ LPD
Sbjct: 341 DAVMRKAKSREGFLNLSIGLVMDVSSYPVSFINGFEISKLSNDKRSLDAFDAI---LPDG 397
Query: 408 KPSNK--NKXXXXXXXXXXXXXXXXXXXXCYCWLLARKSKTPQQGHPWLPLPLYGNXXXX 465
SNK N W RK + ++ + G+
Sbjct: 398 SSSNKSSNTSVGLIAGLSAALCVALVFGVVVSWWCIRKRR--RRNRQMQTVHSRGDDHQI 455
Query: 466 XXXXXXXXXXGTASCISLASSNLGRLFMFQEILDATNKFDESLLLGVGGFGRVYKGTLDD 525
T + +SS +G + I +AT+ FDESL++GVGGFG+VYKG L D
Sbjct: 456 KKNE-------TGESLIFSSSKIGYRYPLALIKEATDDFDESLVIGVGGFGKVYKGVLRD 508
Query: 526 GTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPL 585
T+VAVKRG P+S QG+AEF+TE+EML++ RHRHLVSLIGYCDE SEMI+VYEYM G L
Sbjct: 509 KTEVAVKRGAPQSRQGLAEFKTEVEMLTQFRHRHLVSLIGYCDENSEMIIVYEYMEKGTL 568
Query: 586 RSHLYGTD-LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKV 644
+ HLY D P LSW+QRLEIC+GAARGLHYLHTG+ ++IIHRDVK+ NILLDDNF+AKV
Sbjct: 569 KDHLYDLDDKPRLSWRQRLEICVGAARGLHYLHTGSTRAIIHRDVKSANILLDDNFMAKV 628
Query: 645 ADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPA 704
ADFGLSKTGP LDQTHVSTAVKGSFGYLDPEY RQQLTEKSDVYSFGVV++EV+C RP
Sbjct: 629 ADFGLSKTGPDLDQTHVSTAVKGSFGYLDPEYLTRQQLTEKSDVYSFGVVMLEVVCGRPV 688
Query: 705 LNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDR 764
++P LPRE+VN+ EWAM KKG L+ I+D LVGKV +KK+ E EKCL+++G++R
Sbjct: 689 IDPSLPREKVNLIEWAMKLVKKGKLEDIIDPFLVGKVKLEEVKKYCEVTEKCLSQNGIER 748
Query: 765 PSMGDVLWNLEYALQLE--ETSSALME--PE 791
P+MGD+LWNLE+ LQ++ + +A+++ PE
Sbjct: 749 PAMGDLLWNLEFMLQVQAKDEKAAMVDDKPE 779
|
|
| TAIR|locus:2178707 AT5G24010 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1558 (553.5 bits), Expect = 5.9e-160, P = 5.9e-160
Identities = 375/855 (43%), Positives = 496/855 (58%)
Query: 16 VFLFELLCHKSCVAFTPVDNYLIACGSSQKVTF-QARTYVPDTEH---SSLSMKSGXXXX 71
+F F L H S AFTP DNYLI GS+ +F R+++ D+ S LS
Sbjct: 12 LFFFCPLLHLSFAAFTPTDNYLINSGSNTNTSFFTTRSFLSDSSEPGSSFLSTDRSISIS 71
Query: 72 XXXXXXXXXXIYQSARIFSAAAFYKFEIEHKGRHWVRLYFYTLPGSNQHLNSASFTVATD 131
+Y +AR+F YKF++ KG H++RL+F S +L SA F V +
Sbjct: 72 DTNPSPDSPVLYNTARVFPVGGSYKFQVTTKGTHFIRLHFAPFKASRFNLRSAKFRVLIN 131
Query: 132 KFVLLSNFTFKNYNSSFMFKEYAINVNSDALTLTFIPSNNS-VAFVNAIEVVSVPDAIFP 190
F ++++F+ SS + KE+ + ++ L ++F+P S FVNA+EV S P
Sbjct: 132 GFSVINSFS----TSSVVVKEFILKIDDPVLEISFLPFKASGFGFVNAVEVFSAPKDYIM 187
Query: 191 DQA--LALEPSAS-FSGLSDLGFETVYRLNMGGPLITAQNDTLGRTWENDETYLHVNSSA 247
DQ L + SA FS LS ETV+R+N+GG +T NDTL RTW D+ YL + ++A
Sbjct: 188 DQGTKLVIPNSAQIFSNLSSQVLETVHRINVGGSKLTPFNDTLWRTWVVDDNYLLLRAAA 247
Query: 248 VNVSVRPSAIRYTASVTAETAPNWVYATA-EMMGDANVPEVNFNITWVLPVEPNFTYFVR 306
S T E AP+ VY TA EM D + FNI+W V+ R
Sbjct: 248 RRAWTTHSPNYQNGGATREIAPDNVYMTAQEMDRDNQELQARFNISWGFQVDEK-----R 302
Query: 307 VHLCDIASLSMNNLVFNLYINDDIAQPSVDLSTLTNGLNVPYYKDFVCNASADSNTLTVS 366
V L + L F DI S L+ L NV + +++ D +TLT
Sbjct: 303 V-------LHLVRLHFC-----DIVSSS--LNQLY--FNV-FINEYLAFKDVDLSTLTFH 345
Query: 367 V--GP---DSVADFTNATMNGLEV--MKISNEARS---LDGLSSVEGLLP---DKPSNKN 413
V P D VA+ + M + V +SN AR L+G+ + L P + S K
Sbjct: 346 VLASPLYIDFVAESDRSGMLRISVGPSDLSNPARVNALLNGVEIMRILSPVSSEVVSGKR 405
Query: 414 KXX--XXXXXXXXXXXXXXXXXXCYCWLLARKSKT-PQQGHPWLPLPLYGNXXXXXXXXX 470
C + +KT + W PL +
Sbjct: 406 NVVWIVVGSVLGGFVFLSLFFLSVLCLCRRKNNKTRSSESTGWTPLRRFRGSSNSRT--- 462
Query: 471 XXXXXGTASCISLASSNLGRLFMFQEILDATNKFDESLLLGVGGFGRVYKGTLDDGTKVA 530
T +S + + R+ F E+ TN FD SL++GVGGFG V++G+L D TKVA
Sbjct: 463 ------TERTVSSSGYHTLRI-SFAELQSGTNNFDRSLVIGVGGFGMVFRGSLKDNTKVA 515
Query: 531 VKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLY 590
VKRG+P S QG+ EF +EI +LSK+RHRHLVSL+GYC+E+SEMILVYEYM GPL+SHLY
Sbjct: 516 VKRGSPGSRQGLPEFLSEITILSKIRHRHLVSLVGYCEEQSEMILVYEYMDKGPLKSHLY 575
Query: 591 GTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLS 650
G+ PPLSWKQRLE+CIGAARGLHYLHTG++Q IIHRD+K+TNILLD+N+VAKVADFGLS
Sbjct: 576 GSTNPPLSWKQRLEVCIGAARGLHYLHTGSSQGIIHRDIKSTNILLDNNYVAKVADFGLS 635
Query: 651 KTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLP 710
++GP +D+THVST VKGSFGYLDPEYFRRQQLT+KSDVYSFGVVL EVLC RPA++P+L
Sbjct: 636 RSGPCIDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARPAVDPLLV 695
Query: 711 REQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDV 770
REQVN+AEWA+ WQ+KGMLDQI+D N+ ++ P SLKKF ETAEKC A++GVDRP++GDV
Sbjct: 696 REQVNLAEWAIEWQRKGMLDQIVDPNIADEIKPCSLKKFAETAEKCCADYGVDRPTIGDV 755
Query: 771 LWNLEYALQLEETSSALMEPEDNSTNHIPCIQLTPLEPFDNSVSMIDVRNSGTDDDGEDV 830
LWNLE+ LQL+E+ + ED P T + N S I+ R+ G G +
Sbjct: 756 LWNLEHVLQLQESGPLNIPEEDYGDVTDP---RTARQGLSNG-SNIE-RDYGDGTSGI-I 809
Query: 831 ATSAVFSQLVNPRGR 845
+++ VFSQL+ GR
Sbjct: 810 SSTQVFSQLMTNAGR 824
|
|
| TAIR|locus:2148830 ANX2 "ANXUR2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1458 (518.3 bits), Expect = 2.3e-149, P = 2.3e-149
Identities = 313/696 (44%), Positives = 424/696 (60%)
Query: 174 AFVNAIEVVSVPDAIFPDQALALEPSASFSGLSDLGFETVYRLNMGGPLITAQNDTLG-- 231
AF+N IEV+ +P+ +F D A + S S +T++RLN+GG I D+ G
Sbjct: 177 AFINGIEVIPMPE-LF-DTASLVGFSDQTSDTKTANLQTMFRLNVGGQDIPGSQDSGGLT 234
Query: 232 RTWENDETYLHVNSSAVNVSVRPS---AIRYTASVTAETAPNWVYATAEMMGDANVPEVN 288
RTW ND Y+ S+ + V+++ S I Y + TAP VY TA G +
Sbjct: 235 RTWYNDAPYIF--SAGLGVTLQASNNFRIDYQ-KMPVSTAPADVYKTARSQGPNGDINMK 291
Query: 289 FNITWVLPVEPNFTYFVRVHLCDIASLSMNNLVFNLYINDDIAQPSV---DLSTLTNGLN 345
N+TW+ V+ NFTY +R+H C+ +N VFN++IN+ AQ D+ T G
Sbjct: 292 SNLTWMFQVDTNFTYIMRLHFCEFQLAKINQKVFNIFINNRTAQGDTNPADILGWTGGKG 351
Query: 346 VPYYKDFV----CNASADSNTLTVSVGPDSVA--DFTNATMNGLEVMKISNEARSLDG-- 397
+P YKD+ N +++ + P + ++ ++ +NGLE+ KI ++L G
Sbjct: 352 IPTYKDYAIYVDANTGGGGEEISLQMTPSTFGQPEYYDSQLNGLEIFKIDT-MKNLAGPN 410
Query: 398 -----LSSVEGLLPDKPSNKNKXXXXXXXXXXXXXXXXXXXXCYCWLLARKSKTPQQGHP 452
+ + E + D +K + C+ ++ + H
Sbjct: 411 PKPSPMQANEDVKKDFQGDK-RITAFVIGSAGGVAAVLFCALCFTMYQRKRKFSGSDSHT 469
Query: 453 WLPLPLYGNXXXXXXXXXXXXXXGTASCISLASSNLGRLFMFQEILDATNKFDESLLLGV 512
LP+YGN S +S ++ L R F EI T+ FDES ++GV
Sbjct: 470 SSWLPIYGNSHTSATKSTISGKSNNGSHLSNLAAGLCRRFSLSEIKHGTHNFDESNVIGV 529
Query: 513 GGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSE 572
GGFG+VYKG +D GTKVA+K+ NP SEQG+ EF TEIE+LS+LRH+HLVSLIGYCDE E
Sbjct: 530 GGFGKVYKGVIDGGTKVAIKKSNPNSEQGLNEFETEIELLSRLRHKHLVSLIGYCDEGGE 589
Query: 573 MILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTT 632
M L+Y+YM+ G LR HLY T P L+WK+RLEI IGAARGLHYLHTGA +IIHRDVKTT
Sbjct: 590 MCLIYDYMSLGTLREHLYNTKRPQLTWKRRLEIAIGAARGLHYLHTGAKYTIIHRDVKTT 649
Query: 633 NILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFG 692
NILLD+N+VAKV+DFGLSKTGP ++ HV+T VKGSFGYLDPEYFRRQQLTEKSDVYSFG
Sbjct: 650 NILLDENWVAKVSDFGLSKTGPNMNGGHVTTVVKGSFGYLDPEYFRRQQLTEKSDVYSFG 709
Query: 693 VVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGET 752
VVL EVLC RPALNP L +EQV++ +WAM ++KG L+ I+D NL GK+NP LKKF +T
Sbjct: 710 VVLFEVLCARPALNPSLSKEQVSLGDWAMNCKRKGTLEDIIDPNLKGKINPECLKKFADT 769
Query: 753 AEKCLAEHGVDRPSMGDVLWNLEYALQLEETSSALMEPEDNSTNHIPCIQLTPLEPFDNS 812
AEKCL++ G+DRP+MGDVLWNLE+ALQL+ET+ D S + P ++
Sbjct: 770 AEKCLSDSGLDRPTMGDVLWNLEFALQLQETA-------DGSRHRTPSNGGGSVDLGGGG 822
Query: 813 VSMIDVRNSGTDDDGEDVAT---SAVFSQLVNPRGR 845
+ ++G D G+D+++ S +FSQ+VNP+GR
Sbjct: 823 GGVTVNISAGESDLGDDLSSEENSGIFSQIVNPKGR 858
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9LK35 | THE1_ARATH | 2, ., 7, ., 1, 1, ., - | 0.7447 | 0.9834 | 0.9719 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 845 | |||
| pfam12819 | 335 | pfam12819, Malectin_like, Carbohydrate-binding pro | 6e-54 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 9e-54 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-53 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-53 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-52 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-49 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-45 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-44 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-41 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-32 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-32 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-31 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-31 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-31 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 8e-31 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-30 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-30 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-29 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-28 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-28 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-27 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-27 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-27 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-27 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-27 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 9e-27 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-26 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-26 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-25 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-25 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-24 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-24 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-24 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-24 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-24 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 6e-24 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-23 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-23 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-23 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-23 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-23 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-23 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-23 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 8e-23 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-22 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-22 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-22 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-22 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-22 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-22 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-22 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-22 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-22 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-22 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-22 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-22 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-22 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 8e-22 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 9e-22 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-21 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-21 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-21 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-21 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-21 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 9e-21 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-20 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-20 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-20 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-20 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-20 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-20 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-20 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-20 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-20 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 8e-20 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-19 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-19 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-18 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-18 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-18 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-18 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-18 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-18 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-18 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-18 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 8e-18 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-17 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-17 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-17 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-17 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-17 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 7e-17 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 8e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-16 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-16 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-16 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-16 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-15 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-15 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-15 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-15 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 4e-15 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-15 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-14 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-14 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-14 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-14 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-14 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-14 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-14 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-14 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-13 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-13 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-13 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-13 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-13 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 5e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-13 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-13 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 7e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 8e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-13 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 9e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 9e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-12 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-12 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-12 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-12 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 8e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-11 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-11 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-11 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 9e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-10 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 7e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 8e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 8e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 9e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-09 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-09 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 6e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 9e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-08 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-08 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 7e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 9e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-07 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-07 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-07 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-07 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 7e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 7e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-06 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-06 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 4e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 8e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 8e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-05 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-05 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 6e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 9e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 1e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 1e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-04 | |
| pfam11721 | 164 | pfam11721, Malectin, Di-glucose binding within end | 2e-04 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 5e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.002 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.003 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.003 |
| >gnl|CDD|221790 pfam12819, Malectin_like, Carbohydrate-binding protein of the ER | Back alignment and domain information |
|---|
Score = 190 bits (484), Expect = 6e-54
Identities = 88/370 (23%), Positives = 141/370 (38%), Gaps = 54/370 (14%)
Query: 38 IACGSSQKVTFQA----RTYVPDTEHSSLSMKSGNSTTASSNSSAP--SPIYQSARIF-- 89
I CG ++ T+V D +G S S +S+ S Y++ R F
Sbjct: 1 IDCGLPSNESYTDPSTGITWVSDAGFID----TGKSGNISKENSSSFLSKPYKTLRSFPD 56
Query: 90 SAAAFYKFEI--EHKGRHWVRLYFYTLPGSNQHLNSASFTVATDKFVLLSNFTF------ 141
Y + ++ +R F G+ LNS S + D L
Sbjct: 57 GKRNCYTLPVTPGKGTKYLIRATFL--YGNYDGLNSVSSPPSFD---LYLGVNLWTTVNL 111
Query: 142 KNYNSSFMFKEYAINV-NSDALTLTFIPSNNSVAFVNAIEVVSVPDAIFPDQALALEPSA 200
N + + KEY I+V SD L++ + + F++A+E+ +PD+++P
Sbjct: 112 SNDSGDSVVKEYIIHVTKSDTLSVCLVNTGTGTPFISALELRPLPDSLYP---------- 161
Query: 201 SFSGLSDLGFETVYRLNMG--GPLITAQNDTLGRTWENDETYLHVNSSAVNVSVRPSAIR 258
S + V RLN G I +D R WE + +S ++
Sbjct: 162 --SSGGSQALKLVARLNFGGSEGTIRYPDDVYDRIWEPF----FSSPGWSQIST-SLSVD 214
Query: 259 YTASVTAETAPNWVYATAEMMGDANVPEVNFNITWVLPVEPNFTYFVRVHLCDIASLSMN 318
+++ P+ V TA +A+ P N TW L V+PNF Y+V +H +I SL
Sbjct: 215 ISSNNAPYIPPSAVLQTAVTPTNASAP---LNFTWDL-VDPNFEYYVYLHFAEIQSLET- 269
Query: 319 NLVFNLYINDDIAQPSVDLSTLTNGLNVPYYKDFVCNASADSNTLTVSVGPDSVADFTNA 378
F++YIN V Y DF N S +S+ P S +
Sbjct: 270 -REFDIYINGKTVYGDVS-PKYLGTDTGALYLDFPVNVSGGGLL-NISLVPTSGSTL-PP 325
Query: 379 TMNGLEVMKI 388
+N LE+ K+
Sbjct: 326 LLNALEIFKV 335
|
Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. The domain is found on a number of plant receptor kinases. Length = 335 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 186 bits (476), Expect = 9e-54
Identities = 74/199 (37%), Positives = 104/199 (52%), Gaps = 16/199 (8%)
Query: 510 LGVGGFGRVYKGTLDDG-----TKVAVKR-GNPRSEQGIAEFRTEIEMLSKLRHRHLVSL 563
LG G FG VYKGTL +VAVK SEQ I EF E ++ KL H ++V L
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 564 IGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQS 623
+G C E +++V EYM G L +L LS L + ARG+ YL +++
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKN 123
Query: 624 IIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTA---VKGSFGYLDPEYFRRQ 680
IHRD+ N L+ +N V K++DFGLS+ D V ++ ++ PE +
Sbjct: 124 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR----WMAPESLKEG 179
Query: 681 QLTEKSDVYSFGVVLMEVL 699
+ T KSDV+SFGV+L E+
Sbjct: 180 KFTSKSDVWSFGVLLWEIF 198
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 185 bits (473), Expect = 3e-53
Identities = 71/202 (35%), Positives = 102/202 (50%), Gaps = 17/202 (8%)
Query: 510 LGVGGFGRVYKGTLDDG----TKVAVK--RGNPRSEQGIAEFRTEIEMLSKLRHRHLVSL 563
LG G FG VYKG L T+VAVK + + E+ +F E ++ KL H ++V L
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEE-RKDFLKEARVMKKLGHPNVVRL 61
Query: 564 IGYCDERSEMILVYEYMANGPLRSHL-------YGTDLPPLSWKQRLEICIGAARGLHYL 616
+G C E + LV EYM G L +L + LS K L I A+G+ YL
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 617 HTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEY 676
++ +HRD+ N L+ ++ V K++DFGLS+ D T K ++ PE
Sbjct: 122 A---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPES 178
Query: 677 FRRQQLTEKSDVYSFGVVLMEV 698
+ T KSDV+SFGV+L E+
Sbjct: 179 LKDGIFTSKSDVWSFGVLLWEI 200
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 185 bits (471), Expect = 4e-53
Identities = 75/196 (38%), Positives = 103/196 (52%), Gaps = 11/196 (5%)
Query: 510 LGVGGFGRVYKGTLDD-----GTKVAVKR-GNPRSEQGIAEFRTEIEMLSKLRHRHLVSL 563
LG G FG VYKG L +VAVK SEQ I EF E ++ KL H ++V L
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 564 IGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQS 623
+G C E + +V EYM G L S+L P LS L + ARG+ YL +++
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRKNR-PKLSLSDLLSFALQIARGMEYLE---SKN 122
Query: 624 IIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLT 683
IHRD+ N L+ +N V K++DFGLS+ D + K ++ PE + + T
Sbjct: 123 FIHRDLAARNCLVGENLVVKISDFGLSRDLYD-DDYYRKRGGKLPIRWMAPESLKEGKFT 181
Query: 684 EKSDVYSFGVVLMEVL 699
KSDV+SFGV+L E+
Sbjct: 182 SKSDVWSFGVLLWEIF 197
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 183 bits (466), Expect = 2e-52
Identities = 71/197 (36%), Positives = 103/197 (52%), Gaps = 10/197 (5%)
Query: 510 LGVGGFGRVYKGTLDD-----GTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSL 563
LG G FG VYKGTL TKVAVK SE+ EF E ++ KL H ++V L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 564 IGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQS 623
+G C + + +V EYM G L L L+ K L++ + A+G+ YL +++
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHG-EKLTLKDLLQMALQIAKGMEYLE---SKN 122
Query: 624 IIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLT 683
+HRD+ N L+ +N V K++DFGLS+ D K ++ PE + + T
Sbjct: 123 FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFT 182
Query: 684 EKSDVYSFGVVLMEVLC 700
KSDV+SFGV+L E+
Sbjct: 183 SKSDVWSFGVLLWEIFT 199
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 4e-49
Identities = 74/192 (38%), Positives = 99/192 (51%), Gaps = 10/192 (5%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAE-FRTEIEMLSKLRHRHLVSLIGYC 567
LG GGFG VY G KVA+K + E EIE+L KL H ++V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 568 DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHR 627
++ + + LV EY G L+ L + LS + L I + GL YLH + IIHR
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK-ENEGKLSEDEILRILLQILEGLEYLH---SNGIIHR 116
Query: 628 DVKTTNILLD-DNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQ-LTEK 685
D+K NILLD DN K+ADFGLSK + + G+ Y+ PE + +EK
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLT--SDKSLLKTIVGTPAYMAPEVLLGKGYYSEK 174
Query: 686 SDVYSFGVVLME 697
SD++S GV+L E
Sbjct: 175 SDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 3e-45
Identities = 86/266 (32%), Positives = 126/266 (47%), Gaps = 21/266 (7%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVKRGNPRSE--QGIAEFRTEIEMLSKLRHRHLVSLIGY 566
LG G FG VYK G VAVK RSE + R EI +L +L H ++V LI
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 567 CDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIH 626
+++ + LV EY G L +L + PLS + +I + RGL YLH + IIH
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYL--SRGGPLSEDEAKKIALQILRGLEYLH---SNGIIH 121
Query: 627 RDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPE-YFRRQQLTEK 685
RD+K NILLD+N V K+ADFGL+K + ++T V G+ Y+ PE K
Sbjct: 122 RDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV-GTPWYMAPEVLLGGNGYGPK 179
Query: 686 SDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPAS 745
DV+S GV+L E+L +P + + + + + G + +
Sbjct: 180 VDVWSLGVILYELLTGKP-----PFSGENILDQLQLIRRILGPPLEFDEPKWSSG--SEE 232
Query: 746 LKKFGETAEKCLAEHGVDRPSMGDVL 771
K +KCL + RP+ ++L
Sbjct: 233 AKDL---IKKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 1e-44
Identities = 64/197 (32%), Positives = 96/197 (48%), Gaps = 10/197 (5%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAE-FRTEIEMLSKLRHRHLVSLIGY 566
LG G FG+VY G VA+K + + E EI++L KL+H ++V L
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 567 CDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIH 626
++ ++ LV EY G L L LS + L YLH ++ I+H
Sbjct: 66 FEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEARFYLRQILSALEYLH---SKGIVH 120
Query: 627 RDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 686
RD+K NILLD++ K+ADFGL++ LD T G+ Y+ PE + +
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLAR---QLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAV 177
Query: 687 DVYSFGVVLMEVLCTRP 703
D++S GV+L E+L +P
Sbjct: 178 DIWSLGVILYELLTGKP 194
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 5e-41
Identities = 67/205 (32%), Positives = 108/205 (52%), Gaps = 20/205 (9%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVK--RGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIG 565
LLG G FG VY D G +AVK + SE+ + EI +LS L+H ++V G
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 566 -YCDERSEMILVY-EYMANGPLRSHL--YGTDLPPL--SW-KQRLEICIGAARGLHYLHT 618
DE + ++ EY++ G L S L +G P+ + +Q LE GL YLH
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILE-------GLAYLH- 118
Query: 619 GAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFR 678
+ I+HRD+K NIL+D + V K+ADFG +K ++ + +V+G+ ++ PE R
Sbjct: 119 --SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 679 RQQLTEKSDVYSFGVVLMEVLCTRP 703
++ +D++S G ++E+ +P
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGKP 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 72/208 (34%), Positives = 103/208 (49%), Gaps = 22/208 (10%)
Query: 510 LGVGGFGRVYKGTL------DDGTKVAVKR-GNPRSEQGIAEFRTEIEMLSKLRHRHLVS 562
LG G FG+V+ G +D VAVK S +F E E+L+ +H ++V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 563 LIGYCDERSEMILVYEYMANGP----LRSH------LYGTDLP--PLSWKQRLEICIGAA 610
G C E I+V+EYM +G LRSH L D P L+ Q L+I + A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 611 RGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFG 670
G+ YL A+Q +HRD+ T N L+ + V K+ DFG+S+ D V
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR 189
Query: 671 YLDPEYFRRQQLTEKSDVYSFGVVLMEV 698
++ PE ++ T +SDV+SFGVVL E+
Sbjct: 190 WMPPESIMYRKFTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 61/203 (30%), Positives = 97/203 (47%), Gaps = 14/203 (6%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVKRGN--PRSEQGIAEFRTEIEMLSKLRHRHLVSLIG 565
+G G FG+VY DG +K + SE+ + E+++L KL H +++
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66
Query: 566 YCDERSEMILVYEYMANGPLRSHL--YGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQS 623
+E+ ++ +V EY G L + + P +Q L+ + L YLH+ +
Sbjct: 67 SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RK 123
Query: 624 IIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT--HVSTAVKGSFGYLDPEYFRRQQ 681
I+HRD+K NI L N + K+ DFG+SK L T T V G+ YL PE + +
Sbjct: 124 ILHRDIKPQNIFLTSNGLVKLGDFGISKV---LSSTVDLAKTVV-GTPYYLSPELCQNKP 179
Query: 682 LTEKSDVYSFGVVLMEVLCTRPA 704
KSD++S G VL E+ +
Sbjct: 180 YNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 64/191 (33%), Positives = 102/191 (53%), Gaps = 12/191 (6%)
Query: 509 LLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAE-FRTEIEMLSKLRHRHLVSLIGYC 567
+G G FG V G G KVAVK + + A+ F E +++ LRH +LV L+G
Sbjct: 13 TIGKGEFGDVMLGDYR-GQKVAVK--CLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVV 69
Query: 568 DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHR 627
+ + + +V EYMA G L +L ++ Q+L + G+ YL ++ +HR
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHR 126
Query: 628 DVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSD 687
D+ N+L+ ++ VAKV+DFGL+K + Q VK + PE R ++ + KSD
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAKEA-SQGQDSGKLPVK----WTAPEALREKKFSTKSD 181
Query: 688 VYSFGVVLMEV 698
V+SFG++L E+
Sbjct: 182 VWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 65/211 (30%), Positives = 104/211 (49%), Gaps = 23/211 (10%)
Query: 509 LLGVGGFGRVYKG-TLDDGTKVAVKR--GNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIG 565
L+G G FG VYKG L+ G VA+K+ E+ + EI++L L+H ++V IG
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 566 YCDERSEMILVYEYMANGPLRSHL--YGTDLPPLSWKQRLEICIGAA---RGLHYLHTGA 620
+ + ++ EY NG LR + +G P + + +GL YLH
Sbjct: 67 SIETSDSLYIILEYAENGSLRQIIKKFG-PFP------ESLVAVYVYQVLQGLAYLHE-- 117
Query: 621 AQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQ 680
Q +IHRD+K NIL + V K+ADFG++ + + +V G+ ++ PE
Sbjct: 118 -QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAPEVIEMS 174
Query: 681 QLTEKSDVYSFGVVLMEVLCTRPA---LNPV 708
+ SD++S G ++E+L P LNP+
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPPYYDLNPM 205
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 68/200 (34%), Positives = 100/200 (50%), Gaps = 15/200 (7%)
Query: 510 LGVGGFGRVYKGTLD---DGT--KVAVKRGNPRS-EQGIAEFRTEIEMLSKLRHRHLVSL 563
LG G FG+V D D T +VAVK N EQ ++F EIE+L L H ++V
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 564 IGYCDE--RSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAA 621
G C++ + L+ EY+ +G LR +L ++ K+ L +G+ YL +
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGS--- 127
Query: 622 QSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGS--FGYLDPEYFRR 679
Q IHRD+ NIL++ + K++DFGL+K P + S F Y PE R
Sbjct: 128 QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECLRT 186
Query: 680 QQLTEKSDVYSFGVVLMEVL 699
+ + SDV+SFGV L E+
Sbjct: 187 SKFSSASDVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 8e-31
Identities = 60/189 (31%), Positives = 99/189 (52%), Gaps = 5/189 (2%)
Query: 510 LGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDE 569
LG G FG V++G + +VA+K +F+ E++ L +LRH+HL+SL C
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 570 RSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDV 629
+ ++ E M G L + L + L +++ A G+ YL Q+ IHRD+
Sbjct: 74 GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDL 130
Query: 630 KTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 689
NIL+ ++ V KVADFGL++ + ++S+ K + + PE + KSDV+
Sbjct: 131 AARNILVGEDLVCKVADFGLARL--IKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVW 188
Query: 690 SFGVVLMEV 698
SFG++L E+
Sbjct: 189 SFGILLYEM 197
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 1e-30
Identities = 71/192 (36%), Positives = 105/192 (54%), Gaps = 12/192 (6%)
Query: 510 LGVGGFGRVYKGTLDDGTKVAVK--RGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYC 567
+G G FG V+ G + KVA+K R SE+ +F E +++ KL H LV L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE---DFIEEAQVMMKLSHPKLVQLYGVC 68
Query: 568 DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHR 627
ERS + LV+E+M +G L +L S + L +C+ G+ YL + ++IHR
Sbjct: 69 TERSPICLVFEFMEHGCLSDYLR-AQRGKFSQETLLGMCLDVCEGMAYLESS---NVIHR 124
Query: 628 DVKTTNILLDDNFVAKVADFGLSKTGPAL-DQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 686
D+ N L+ +N V KV+DFG+++ L DQ ST K + PE F + + KS
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRF--VLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKS 182
Query: 687 DVYSFGVVLMEV 698
DV+SFGV++ EV
Sbjct: 183 DVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 60/196 (30%), Positives = 97/196 (49%), Gaps = 8/196 (4%)
Query: 503 KFDESLLLGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLV 561
F+ +G GGFG VYK G +VA+K S++ + EI++L K +H ++V
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60
Query: 562 SLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAA 621
G ++ E+ +V E+ + G L+ L T+ L+ Q +C +GL YLH +
Sbjct: 61 KYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQT-LTESQIAYVCKELLKGLEYLH---S 116
Query: 622 QSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQ 681
IIHRD+K NILL + K+ DFGLS + G+ ++ PE +
Sbjct: 117 NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV---GTPYWMAPEVINGKP 173
Query: 682 LTEKSDVYSFGVVLME 697
K+D++S G+ +E
Sbjct: 174 YDYKADIWSLGITAIE 189
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 6e-29
Identities = 66/216 (30%), Positives = 110/216 (50%), Gaps = 19/216 (8%)
Query: 509 LLGVGGFGRVYKGTLDDGTKVAVK--RGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGY 566
+G G FG VYKG L T+VAVK R + +F E E+L + H ++V LIG
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKR-KFLQEAEILKQYDHPNIVKLIGV 60
Query: 567 CDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIH 626
C ++ + +V E + G L + L L+ K+ L++ + AA G+ YL +++ IH
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLE---SKNCIH 116
Query: 627 RDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKG----SFGYLDPEYFRRQQL 682
RD+ N L+ +N V K++DFG+S+ ++ + T G + PE +
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRE----EEGGIYTVSDGLKQIPIKWTAPEALNYGRY 172
Query: 683 TEKSDVYSFGVVLMEVL----CTRPALNPVLPREQV 714
T +SDV+S+G++L E P ++ RE++
Sbjct: 173 TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI 208
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 4e-28
Identities = 77/280 (27%), Positives = 124/280 (44%), Gaps = 32/280 (11%)
Query: 506 ESLLLGVGGFGRVY----KGTLDDGTK--VAVKRGNPRSEQGI-AEFRTEIEMLSKLRHR 558
E LG G FG V+ KG ++G + V VK ++ + +EFR E++M KL H+
Sbjct: 9 EITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHK 68
Query: 559 HLVSLIGYCDERSEMILVYEYMANGPLRSHLYGT-------DLPPLSWKQRLEICIGAAR 611
++V L+G C E ++ EY G L+ L T PPLS KQ++ +C A
Sbjct: 69 NVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIAL 128
Query: 612 GLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGY 671
G+ +L +HRD+ N L+ KV+ LSK + + +
Sbjct: 129 GMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKD-VYNSEYYKLRNALIPLRW 184
Query: 672 LDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQ 731
L PE + + KSDV+SFGV++ EV LP ++ E +L++
Sbjct: 185 LAPEAVQEDDFSTKSDVWSFGVLMWEVFTQG-----ELPFYGLSDEE---------VLNR 230
Query: 732 IMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVL 771
+ L V + + +C A + DRPS +++
Sbjct: 231 LQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELV 270
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 70/192 (36%), Positives = 102/192 (53%), Gaps = 11/192 (5%)
Query: 510 LGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDE 569
LG G FG V+ GT + TKVAVK P + F E +++ KLRH LV L C E
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 570 RSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDV 629
+ +V EYM+ G L L + L Q +++ A G+ YL +++ IHRD+
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDL 129
Query: 630 KTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGS---FGYLDPEYFRRQQLTEKS 686
NIL+ +N V K+ADFGL++ L + TA +G+ + PE + T KS
Sbjct: 130 AARNILVGENLVCKIADFGLAR----LIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKS 185
Query: 687 DVYSFGVVLMEV 698
DV+SFG++L E+
Sbjct: 186 DVWSFGILLTEI 197
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 4e-27
Identities = 67/192 (34%), Positives = 99/192 (51%), Gaps = 12/192 (6%)
Query: 510 LGVGGFGRVYKGTLDDGTKVAVK--RGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYC 567
LG G FG V+ G VA+K R SE +F E +++ KL H +LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED---DFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 568 DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHR 627
++ + +V EYMANG L ++L L + L++C + YL + IHR
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYLR-ERKGKLGTEWLLDMCSDVCEAMEYLES---NGFIHR 124
Query: 628 DVKTTNILLDDNFVAKVADFGLSKTGPALDQTHV-STAVKGSFGYLDPEYFRRQQLTEKS 686
D+ N L+ ++ V KV+DFGL++ LD + S K + PE F + + KS
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGLARY--VLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKS 182
Query: 687 DVYSFGVVLMEV 698
DV+SFGV++ EV
Sbjct: 183 DVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 64/190 (33%), Positives = 97/190 (51%), Gaps = 5/190 (2%)
Query: 510 LGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDE 569
LG G FG V++G ++ T VAVK P + +F E +++ KLRH L+ L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 570 RSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDV 629
+ +V E M G L +L G L Q +++ A G+ YL AQ+ IHRD+
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDL 129
Query: 630 KTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 689
N+L+ +N + KVADFGL++ D K + PE + + KSDV+
Sbjct: 130 AARNVLVGENNICKVADFGLARVIKE-DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVW 188
Query: 690 SFGVVLMEVL 699
SFG++L E++
Sbjct: 189 SFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 70/211 (33%), Positives = 102/211 (48%), Gaps = 26/211 (12%)
Query: 510 LGVGGFGRVYKGTL------DDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSL 563
LG G FG+V+ D VAVK SE +F+ E E+L+ L+H+H+V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 564 IGYCDERSEMILVYEYMANGP----LRSHLYGTD-----------LPPLSWKQRLEICIG 608
G C E +++V+EYM +G LRSH G D L+ Q L I
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSH--GPDAKILAGGEDVAPGQLTLGQMLAIASQ 130
Query: 609 AARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGS 668
A G+ YL A+ +HRD+ T N L+ V K+ DFG+S+ + D V
Sbjct: 131 IASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 187
Query: 669 FGYLDPEYFRRQQLTEKSDVYSFGVVLMEVL 699
++ PE ++ T +SD++SFGVVL E+
Sbjct: 188 IRWMPPESILYRKFTTESDIWSFGVVLWEIF 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 5e-27
Identities = 72/212 (33%), Positives = 111/212 (52%), Gaps = 12/212 (5%)
Query: 509 LLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIA-EFRTEIEMLSKLRHRHLVSLIGYC 567
LLG G FG V+KGTL D T VAVK Q + +F +E +L + H ++V LIG C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 568 DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHR 627
+R + +V E + G S L L KQ ++ + AA G+ YL + ++ IHR
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLES---KNCIHR 117
Query: 628 DVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKG-SFGYLDPEYFRRQQLTEKS 686
D+ N L+ +N V K++DFG+S+ D + S+ +K + PE + + +S
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQED--DGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175
Query: 687 DVYSFGVVLMEV----LCTRPALNPVLPREQV 714
DV+S+G++L E +C P + REQV
Sbjct: 176 DVWSYGILLWETFSLGVCPYPGMTNQQAREQV 207
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 6e-27
Identities = 80/276 (28%), Positives = 114/276 (41%), Gaps = 22/276 (7%)
Query: 509 LLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAE---FRTEIEMLSKLRH-RHLVSLI 564
LG G FG VY D VA+K + E E F EI++L+ L H ++V L
Sbjct: 7 KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 565 GYCDERSEMILVYEYMANGPLRSHL-YGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQS 623
+ + + LV EY+ G L L PLS + L I L YLH+ +
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KG 121
Query: 624 IIHRDVKTTNILLD-DNFVAKVADFGLSK----TGPALDQTHVSTAVKGSFGYLDPEYFR 678
IIHRD+K NILLD D V K+ DFGL+K G + + G+ GY+ PE
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 679 RQQL---TEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDS 735
L + SD++S G+ L E+L P + + + + S
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQT-LKIILELP---TPSLAS 237
Query: 736 NLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVL 771
L K + +K LA+ +R S L
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273
|
Length = 384 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 9e-27
Identities = 70/207 (33%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 510 LGVGGFGRVYKGTL------DDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSL 563
LG G FG+V+ D VAVK S+ +F E E+L+ L+H H+V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 564 IGYCDERSEMILVYEYMANGPLRSHL--YGTDL-------PP--LSWKQRLEICIGAARG 612
G C E +I+V+EYM +G L L +G D P L+ Q L I A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 613 LHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYL 672
+ YL A+Q +HRD+ T N L+ +N + K+ DFG+S+ + D V ++
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 673 DPEYFRRQQLTEKSDVYSFGVVLMEVL 699
PE ++ T +SDV+S GVVL E+
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIF 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 61/195 (31%), Positives = 100/195 (51%), Gaps = 9/195 (4%)
Query: 510 LGVGGFGRVYKGTLDDGTK----VAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLI 564
+G G FG V +G L K VA+K S++ +F TE ++ + H +++ L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 565 GYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSI 624
G + ++++ EYM NG L L D + Q + + G A G+ YL + +
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYL---SEMNY 127
Query: 625 IHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTE 684
+HRD+ NIL++ N V KV+DFGLS+ + T+ + K + PE ++ T
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTS 187
Query: 685 KSDVYSFGVVLMEVL 699
SDV+SFG+V+ EV+
Sbjct: 188 ASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 68/207 (32%), Positives = 102/207 (49%), Gaps = 25/207 (12%)
Query: 509 LLGVGGFGRVYKG-TLDDGTKVAVKR-----GNPRSEQGIAEFRTEIEMLSKLRHRHLVS 562
LLG G FG VY+G LDDG AVK ++ + + EI +LSKL+H ++V
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 563 LIGYCDERSEMILVYEYMANGPLRSHL--YGTDLPP---LSWKQRLEICIGAARGLHYLH 617
+G E + + E + G L L YG+ P L +Q L GL YLH
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL-------GLEYLH 119
Query: 618 TGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYF 677
++ +HRD+K NIL+D N V K+ADFG++K + KGS ++ PE
Sbjct: 120 ---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFA---KSFKGSPYWMAPEVI 173
Query: 678 RRQQL-TEKSDVYSFGVVLMEVLCTRP 703
+Q +D++S G ++E+ +P
Sbjct: 174 AQQGGYGLAADIWSLGCTVLEMATGKP 200
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 66/228 (28%), Positives = 119/228 (52%), Gaps = 27/228 (11%)
Query: 509 LLGVGGFGRVYKGTL------DDGTKVAVK--RGNPRSEQGIAEFRTEIEMLSKL-RHRH 559
LG G FG+V K ++ + VAVK + + +E+ +++ +E+EM+ + +H++
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKN 77
Query: 560 LVSLIGYCDERSEMILVYEYMANGPLRSHL-----------YGTDLPP---LSWKQRLEI 605
+++L+G C + + +V EY A+G LR L PP L+ K +
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 606 CIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAV 665
ARG+ +L A++ IHRD+ N+L+ ++ V K+ADFGL++ +D +T
Sbjct: 138 AYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNG 194
Query: 666 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQ 713
+ ++ PE + T +SDV+SFGV+L E+ + P +P E+
Sbjct: 195 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 72/227 (31%), Positives = 109/227 (48%), Gaps = 32/227 (14%)
Query: 496 EILDATNKFDESLLLGVGGFGRVYKGTL------DDGTKVAVK----RGNPRSEQGIAEF 545
EI + +F E L G G FG+VYKG L T VA+K P+ +Q EF
Sbjct: 1 EIPLSAVRFLEEL--GEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQ---EF 55
Query: 546 RTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHL--------------YG 591
R E E++S L+H ++V L+G C + +++EY+A+G L L
Sbjct: 56 RQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDE 115
Query: 592 TDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSK 651
T L L I I A G+ YL ++ +HRD+ N L+ + K++DFGLS+
Sbjct: 116 TVKSSLDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSR 172
Query: 652 TGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEV 698
+ D V + ++ PE + T +SD++SFGVVL E+
Sbjct: 173 DIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 69/196 (35%), Positives = 96/196 (48%), Gaps = 20/196 (10%)
Query: 510 LGVGGFGRVYKGTLDDGTKVAVK--RGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYC 567
LG G FG V G VA+K + SE EF E +++ KL H LV L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 568 DERSEMILVYEYMANGP----LRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQS 623
++ + +V EYM+NG LR H Q LE+C G+ YL + +
Sbjct: 69 TKQRPIYIVTEYMSNGCLLNYLREHGKR-----FQPSQLLEMCKDVCEGMAYLES---KQ 120
Query: 624 IIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVST-AVKGSFGYLDPEYFRRQQL 682
IHRD+ N L+DD KV+DFGLS+ LD + S+ K + PE +
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDFGLSRY--VLDDEYTSSVGSKFPVRWSPPEVLLYSKF 178
Query: 683 TEKSDVYSFGVVLMEV 698
+ KSDV++FGV++ EV
Sbjct: 179 SSKSDVWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 68/210 (32%), Positives = 102/210 (48%), Gaps = 23/210 (10%)
Query: 510 LGVGGFGRVYKGT------LDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSL 563
LG G FG+V+ D VAVK + +F+ E E+L+ L+H H+V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 564 IGYCDERSEMILVYEYMANGPL----RSH----LYGTDLPPLSWK------QRLEICIGA 609
G C + +I+V+EYM +G L R+H + D P K Q L I
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 610 ARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSF 669
A G+ YL A+Q +HRD+ T N L+ N + K+ DFG+S+ + D V
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 670 GYLDPEYFRRQQLTEKSDVYSFGVVLMEVL 699
++ PE ++ T +SDV+SFGV+L E+
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIF 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 72/223 (32%), Positives = 104/223 (46%), Gaps = 29/223 (13%)
Query: 508 LLLGVGGFGRVYKGT----LDDGT---KVAVK---RGNPRSEQGIAEFRTEIEMLSKLRH 557
LG G FG VY+GT L G+ +VAVK +G E+ EF E ++S H
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK--KEFLKEAHLMSNFNH 58
Query: 558 RHLVSLIGYCDERSEMILVYEYMANGPLRSHLYG-----TDLPPLSWKQRLEICIGAARG 612
++V L+G C ++ E M G L S+L P L+ K+ L+IC+ A+G
Sbjct: 59 PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118
Query: 613 LHYLHTGAAQSIIHRDVKTTNILL-----DDNFVAKVADFGLSKTGPALDQTHVSTAVKG 667
YL IHRD+ N L+ D + V K+ DFGL++ D
Sbjct: 119 CVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL 175
Query: 668 SFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC----TRPALN 706
++ PE + T +SDV+SFGV++ E+L PALN
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN 218
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 63/205 (30%), Positives = 101/205 (49%), Gaps = 18/205 (8%)
Query: 509 LLGVGGFGRVYKG-TLDDGTKVAVKR-----GNPRSEQGIAEFRTEIEMLSKLRHRHLVS 562
LLG G FGRVY +D G ++AVK+ +P +++ + EI++L L+H +V
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 563 LIGYCDERSEMILVYEYMANGPLRSHL--YGTDLPPLSWKQRLEICIGAARGLHYLHTGA 620
G + + + EYM G ++ L YG ++ K +I G+ YLH+
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL----EGVEYLHS-- 122
Query: 621 AQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPA--LDQTHVSTAVKGSFGYLDPEYFR 678
I+HRD+K NIL D K+ DFG SK T + + V G+ ++ PE
Sbjct: 123 -NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-VTGTPYWMSPEVIS 180
Query: 679 RQQLTEKSDVYSFGVVLMEVLCTRP 703
+ K+DV+S G ++E+L +P
Sbjct: 181 GEGYGRKADVWSVGCTVVEMLTEKP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 63/234 (26%), Positives = 98/234 (41%), Gaps = 32/234 (13%)
Query: 510 LGVGGFGRVYKGTLD-DGTKVAVKR----GNPRSEQGIAEFRTEIEMLSKLRHRHLVSLI 564
LG G G VYK G A+K+ G+ + + E++ L ++V
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLL---RELKTLRSCESPYVVKCY 65
Query: 565 GYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSI 624
G + E+ +V EYM G L L + + I +GL YLHT I
Sbjct: 66 GAFYKEGEISIVLEYMDGGSLADLLK--KVGKIPEPVLAYIARQILKGLDYLHTKR--HI 121
Query: 625 IHRDVKTTNILLDDNFVAKVADFGLSK---TGPALDQTHVSTAVKGSFGYLDPEYFRRQQ 681
IHRD+K +N+L++ K+ADFG+SK T V T Y+ PE + +
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVT-----YMSPERIQGES 176
Query: 682 LTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDS 735
+ +D++S G+ L+E + P LP Q + E ++ I D
Sbjct: 177 YSYAADIWSLGLTLLECALGK---FPFLPPGQPSFFE---------LMQAICDG 218
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 69/205 (33%), Positives = 109/205 (53%), Gaps = 15/205 (7%)
Query: 509 LLGVGGFGRVYKGTLDDG----TKVAVKRGNPRSE-QGIAEFRTEIEMLSKLRHRHLVSL 563
++G G FG VY GTL D AVK N ++ + + +F E ++ H +++SL
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 564 IGYC--DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAA 621
+G C E S ++ V YM +G LR+ + P + K + + A+G+ YL A+
Sbjct: 62 LGICLPSEGSPLV-VLPYMKHGDLRNFIRSETHNP-TVKDLIGFGLQVAKGMEYL---AS 116
Query: 622 QSIIHRDVKTTNILLDDNFVAKVADFGLSKT--GPALDQTHVSTAVKGSFGYLDPEYFRR 679
+ +HRD+ N +LD++F KVADFGL++ H T K ++ E +
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT 176
Query: 680 QQLTEKSDVYSFGVVLMEVLCTRPA 704
Q+ T KSDV+SFGV+L E++ TR A
Sbjct: 177 QKFTTKSDVWSFGVLLWELM-TRGA 200
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 74/222 (33%), Positives = 110/222 (49%), Gaps = 22/222 (9%)
Query: 500 ATNKFDESLL--LGVGGFGRVYKGTLDDGTKVAVK-RGNPRSEQGIAEFRTEIEMLSKLR 556
A N + LL +G G FG V G G KVAVK N + Q F E ++++LR
Sbjct: 2 ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLR 57
Query: 557 HRHLVSLIGY-CDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHY 615
H +LV L+G +E+ + +V EYMA G L +L L L+ + + Y
Sbjct: 58 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 117
Query: 616 LHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPE 675
L A + +HRD+ N+L+ ++ VAKV+DFGL+K + T K + PE
Sbjct: 118 LE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPE 169
Query: 676 YFRRQQLTEKSDVYSFGVVLMEVLC------TRPALNPVLPR 711
R ++ + KSDV+SFG++L E+ R L V+PR
Sbjct: 170 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR 211
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 67/216 (31%), Positives = 103/216 (47%), Gaps = 30/216 (13%)
Query: 510 LGVGGFGRVYKGTL------DDGTKVAVKR-GNPRSEQGIAEFRTEIEMLSKLRHRHLVS 562
+G G FGRV++ + T VAVK S A+F+ E ++++ H ++V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 563 LIGYCDERSEMILVYEYMANGPLRSHL--------------------YGTDLPPLSWKQR 602
L+G C M L++EYMA G L L G + PLS ++
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 603 LEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVS 662
L I A G+ YL + + +HRD+ T N L+ +N V K+ADFGLS+ + D S
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 663 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEV 698
++ PE + T +SDV+++GVVL E+
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 35/213 (16%)
Query: 510 LGVGGFGRVYKG-TLDDGTKVAVK-----RGNPRSEQGIAEFRTEIEMLSKLRHRHLVSL 563
+G G FG+VY LD G +AVK +P++ + IA+ E+++L L+H +LV
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIAD---EMKVLELLKHPNLVKY 64
Query: 564 IGYCDERSEMILVYEYMANGPLRSHL-YGTDLPPLSWKQRLEICIGA-----ARGLHYLH 617
G R ++ + EY + G L L +G L E I GL YLH
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLEELLEHGRILD--------EHVIRVYTLQLLEGLAYLH 116
Query: 618 TGAAQSIIHRDVKTTNILLDDNFVAKVADFG----LSKTGPALDQTHVSTAVKGSFGYLD 673
+ I+HRD+K NI LD N V K+ DFG L + + S A G+ Y+
Sbjct: 117 S---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLA--GTPAYMA 171
Query: 674 PEYFRRQQLTEK---SDVYSFGVVLMEVLCTRP 703
PE + +D++S G V++E+ +
Sbjct: 172 PEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 63/196 (32%), Positives = 92/196 (46%), Gaps = 12/196 (6%)
Query: 510 LGVGGFGRVYKGT--LDDGT--KVAVKRGNPRSEQ-GIAEFRTEIEMLSKLRHRHLVSLI 564
LG G FG V KG + G +VAVK G EF E ++++L H +V LI
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 565 GYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSI 624
G C ++LV E GPL Y + E+ A G+ YL + +
Sbjct: 63 GVCKGEP-LMLVMELAPLGPL--LKYLKKRREIPVSDLKELAHQVAMGMAYLES---KHF 116
Query: 625 IHRDVKTTNILLDDNFVAKVADFGLSK-TGPALDQTHVSTAVKGSFGYLDPEYFRRQQLT 683
+HRD+ N+LL + AK++DFG+S+ G D +TA + + PE + +
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFS 176
Query: 684 EKSDVYSFGVVLMEVL 699
KSDV+S+GV L E
Sbjct: 177 SKSDVWSYGVTLWEAF 192
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 3e-23
Identities = 68/192 (35%), Positives = 102/192 (53%), Gaps = 12/192 (6%)
Query: 510 LGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDE 569
LG G FG V+ GT + T+VA+K P + A F E +++ KLRH LV L E
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 570 RSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDV 629
+ +V EYM+ G L L G L Q +++ A G+ Y+ + +HRD+
Sbjct: 73 EP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDL 128
Query: 630 KTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGS---FGYLDPEYFRRQQLTEKS 686
+ NIL+ +N V KVADFGL++ L + + TA +G+ + PE + T KS
Sbjct: 129 RAANILVGENLVCKVADFGLAR----LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 687 DVYSFGVVLMEV 698
DV+SFG++L E+
Sbjct: 185 DVWSFGILLTEL 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 3e-23
Identities = 74/213 (34%), Positives = 109/213 (51%), Gaps = 18/213 (8%)
Query: 510 LGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDE 569
LG G FG V+ GT + TKVAVK P + + F E +++ KLRH LV L E
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES-FLEEAQIMKKLRHDKLVQLYAVVSE 72
Query: 570 RSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDV 629
+ +V EYM+ G L L + L +++ A G+ Y+ + IHRD+
Sbjct: 73 EP-IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDL 128
Query: 630 KTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGS---FGYLDPEYFRRQQLTEKS 686
++ NIL+ D V K+ADFGL++ L + + TA +G+ + PE + T KS
Sbjct: 129 RSANILVGDGLVCKIADFGLAR----LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 687 DVYSFGVVLMEVLCTR-----PALNPVLPREQV 714
DV+SFG++L E L T+ P +N EQV
Sbjct: 185 DVWSFGILLTE-LVTKGRVPYPGMNNREVLEQV 216
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 5e-23
Identities = 65/229 (28%), Positives = 119/229 (51%), Gaps = 27/229 (11%)
Query: 510 LGVGGFGRVY--------KGTLDDGTKVAVKR-GNPRSEQGIAEFRTEIEMLSKL-RHRH 559
LG G FG+V K + VAVK + +E+ +++ +E+EM+ + +H++
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 560 LVSLIGYCDERSEMILVYEYMANGPLRSHL---------YGTDL-----PPLSWKQRLEI 605
+++L+G C + + ++ EY + G LR +L Y D+ +++K +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 606 CIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAV 665
ARG+ YL A+Q IHRD+ N+L+ +N V K+ADFGL++ +D +T
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 666 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQV 714
+ ++ PE + T +SDV+SFGV++ E+ + P +P E++
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 6e-23
Identities = 72/215 (33%), Positives = 106/215 (49%), Gaps = 30/215 (13%)
Query: 509 LLGVGGFGRVYKGTL--DDGT--KVAVKR----GNPRSEQGIAEFRTEIEMLSKLRHRHL 560
+LG G FG V +G L DDG+ KVAVK + SE I EF +E + H ++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSE--IEEFLSEAACMKDFDHPNV 63
Query: 561 VSLIGYCDERSEM------ILVYEYMANGPLRSHLYGTDLPPLSWK---QRL-EICIGAA 610
+ LIG C E S + +++ +M +G L S L + L L K Q L + + A
Sbjct: 64 MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIA 123
Query: 611 RGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKT---GPALDQTHVSTAVKG 667
G+ YL ++ IHRD+ N +L ++ VADFGLSK G Q ++ K
Sbjct: 124 LGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA---KM 177
Query: 668 SFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTR 702
++ E + T KSDV++FGV + E+ TR
Sbjct: 178 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIA-TR 211
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 8e-23
Identities = 68/210 (32%), Positives = 99/210 (47%), Gaps = 36/210 (17%)
Query: 509 LLGVGGFGRVYKGTLD-----DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSL 563
LG G FG V D G VAVK+ + + + +F EIE+L L+H ++V
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 564 IGYCDE--RSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLE----------ICIGAAR 611
G C R + LV EY+ G LR +L ++RL+ IC +
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYLQKH-------RERLDHRKLLLYASQIC----K 119
Query: 612 GLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGS--- 668
G+ YL ++ +HRD+ T NIL++ K+ DFGL+K P D+ + G
Sbjct: 120 GMEYL---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP-QDKEYYKVREPGESPI 175
Query: 669 FGYLDPEYFRRQQLTEKSDVYSFGVVLMEV 698
F Y PE + + SDV+SFGVVL E+
Sbjct: 176 FWYA-PESLTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 1e-22
Identities = 69/193 (35%), Positives = 102/193 (52%), Gaps = 12/193 (6%)
Query: 510 LGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDE 569
LG G FG V+ GT + TKVA+K P + A F E +++ KLRH LV L E
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA-FLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 570 RSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDV 629
+ +V E+M G L L D L Q +++ A G+ Y+ + IHRD+
Sbjct: 73 EP-IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDL 128
Query: 630 KTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGS---FGYLDPEYFRRQQLTEKS 686
+ NIL+ DN V K+ADFGL++ L + + TA +G+ + PE + T KS
Sbjct: 129 RAANILVGDNLVCKIADFGLAR----LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 687 DVYSFGVVLMEVL 699
DV+SFG++L E++
Sbjct: 185 DVWSFGILLTELV 197
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 1e-22
Identities = 68/195 (34%), Positives = 99/195 (50%), Gaps = 18/195 (9%)
Query: 510 LGVGGFGRVYKGTLDDGTKVAVK--RGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYC 567
LG G FG V+ G KVA+K SE+ +F E +++ KL H LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE---DFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 568 DERSEMILVYEYMANGPLRSHL---YGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSI 624
++ + +V E+M NG L ++L G LS L +C G+ YL S
Sbjct: 69 TQQKPLYIVTEFMENGCLLNYLRQRQGK----LSKDMLLSMCQDVCEGMEYLER---NSF 121
Query: 625 IHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTA-VKGSFGYLDPEYFRRQQLT 683
IHRD+ N L+ V KV+DFG+++ LD + S++ K + PE F + +
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRY--VLDDEYTSSSGAKFPVKWSPPEVFNFSKYS 179
Query: 684 EKSDVYSFGVVLMEV 698
KSDV+SFGV++ EV
Sbjct: 180 SKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 2e-22
Identities = 68/206 (33%), Positives = 111/206 (53%), Gaps = 14/206 (6%)
Query: 510 LGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDE 569
+G G FG V +G G KVAVK N + + F E +++KL H++LV L+G
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70
Query: 570 RSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDV 629
+ +V E M+ G L + L +S Q L+ + A G+ YL + + ++HRD+
Sbjct: 71 NG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDL 126
Query: 630 KTTNILLDDNFVAKVADFGLSKTGP-ALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDV 688
NIL+ ++ VAKV+DFGL++ G +D + + VK + PE + ++ + KSDV
Sbjct: 127 AARNILVSEDGVAKVSDFGLARVGSMGVDNSKL--PVK----WTAPEALKHKKFSSKSDV 180
Query: 689 YSFGVVLMEVLCTRPALNPVLPREQV 714
+S+GV+L EV A P + ++V
Sbjct: 181 WSYGVLLWEVFSYGRAPYPKMSLKEV 206
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 2e-22
Identities = 73/230 (31%), Positives = 106/230 (46%), Gaps = 29/230 (12%)
Query: 510 LGVGGFGRV----YKGTLDD-GTKVAVK---RGNPRSEQGIAEFRTEIEMLSKLRHRHLV 561
LG G FG+V Y D G VAVK R +Q + ++ EI +L L H ++V
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIV 69
Query: 562 SLIGYCDERSEMI--LVYEYMANGPLRSHLYGTDLPPLSWKQRL----EICIGAARGLHY 615
G C E+ L+ EY+ G LR +L L + Q L +IC G+ Y
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKL---NLAQLLLFAQQIC----EGMAY 122
Query: 616 LHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH-VSTAVKGSFGYLDP 674
LH +Q IHRD+ N+LLD++ + K+ DFGL+K P + + V +
Sbjct: 123 LH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAV 179
Query: 675 EYFRRQQLTEKSDVYSFGVVLMEVL--CTRPALNPVLPREQVNIAEWAMT 722
E + + + SDV+SFGV L E+L C P E + + MT
Sbjct: 180 ECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMT 229
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 2e-22
Identities = 68/229 (29%), Positives = 120/229 (52%), Gaps = 27/229 (11%)
Query: 510 LGVGGFGRVY--------KGTLDDGTKVAVKR-GNPRSEQGIAEFRTEIEMLSKL-RHRH 559
LG G FG+V K + TKVAVK + +E+ +++ +E+EM+ + +H++
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 560 LVSLIGYCDERSEMILVYEYMANGPLRSHL-----------YGTDLPP---LSWKQRLEI 605
+++L+G C + + ++ EY + G LR +L Y P LS+K +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 606 CIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAV 665
ARG+ YL A++ IHRD+ N+L+ ++ V K+ADFGL++ +D +T
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 666 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQV 714
+ ++ PE + T +SDV+SFGV+L E+ + P +P E++
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 251
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 2e-22
Identities = 61/199 (30%), Positives = 104/199 (52%), Gaps = 14/199 (7%)
Query: 509 LLGVGGFGRVYKGTLDDGTK----VAVKRGNP-RSEQGIAEFRTEIEMLSKLRHRHLVSL 563
++G G FG V++G L + VA+K P +E+ +F +E ++ + H +++ L
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 564 IGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQS 623
G + +++ EYM NG L +L D S Q + + G A G+ YL + +
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYL---SDMN 127
Query: 624 IIHRDVKTTNILLDDNFVAKVADFGLSKT---GPALDQTHVSTAVKGSFGYLDPEYFRRQ 680
+HRD+ NIL++ N KV+DFGLS+ P + T+ ++ K + PE +
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP--EGTYTTSGGKIPIRWTAPEAIAYR 185
Query: 681 QLTEKSDVYSFGVVLMEVL 699
+ T SDV+SFG+V+ EV+
Sbjct: 186 KFTSASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 2e-22
Identities = 62/197 (31%), Positives = 93/197 (47%), Gaps = 13/197 (6%)
Query: 510 LGVGGFGRVYKGTL-DDGTKVAVK----RGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLI 564
+G G FG V+K D A+K R E+ E E +L+KL +++
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRRER--EEAIDEARVLAKLDSSYIIRYY 65
Query: 565 GYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSI 624
++ ++ +V EY NG L L PL Q I GL +LH+ + I
Sbjct: 66 ESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS---KKI 122
Query: 625 IHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTE 684
+HRD+K+ N+ LD K+ D G++K D T+ + + G+ YL PE + E
Sbjct: 123 LHRDIKSLNLFLDAYDNVKIGDLGVAKL--LSDNTNFANTIVGTPYYLSPELCEDKPYNE 180
Query: 685 KSDVYSFGVVLMEVLCT 701
KSDV++ GVVL E CT
Sbjct: 181 KSDVWALGVVLYE-CCT 196
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 4e-22
Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 14/203 (6%)
Query: 499 DATNKFDESLLLGVGGFGRVYKGT-LDDGTKVAVKR---GNPRSEQGIAEFRTEIEMLSK 554
D + +G G G VYK T G +VA+K+ E I EI ++
Sbjct: 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII----NEILIMKD 71
Query: 555 LRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLH 614
+H ++V E+ +V EYM G L + + ++ Q +C +GL
Sbjct: 72 CKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVR-MNEPQIAYVCREVLQGLE 130
Query: 615 YLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDP 674
YLH +Q++IHRD+K+ NILL + K+ADFG + S V G+ ++ P
Sbjct: 131 YLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAP 185
Query: 675 EYFRRQQLTEKSDVYSFGVVLME 697
E +R+ K D++S G++ +E
Sbjct: 186 EVIKRKDYGPKVDIWSLGIMCIE 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.2 bits (243), Expect = 4e-22
Identities = 54/155 (34%), Positives = 80/155 (51%), Gaps = 24/155 (15%)
Query: 510 LGVGGFGRVYKG-TLDDGTKVAVKRGNPRSEQGIAEF-RT---EIEMLSKLRHRHLVSLI 564
+G G +G+VYK G VA+K+ R E F T EI++L KLRH ++V L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKK--IRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 565 GYC--DERSEMILVYEYMA---NGPLRSHLYGTDLPPL-SW-KQRLEICIGAARGLHYLH 617
+ + +V+EYM G L S + + KQ LE GL YLH
Sbjct: 65 EIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLE-------GLQYLH 117
Query: 618 TGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKT 652
+ I+HRD+K +NIL++++ V K+ADFGL++
Sbjct: 118 S---NGILHRDIKGSNILINNDGVLKLADFGLARP 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 4e-22
Identities = 73/209 (34%), Positives = 99/209 (47%), Gaps = 28/209 (13%)
Query: 510 LGVGGFGRVYKGTL----DDGTK--VAVK-RGNPRSEQGIAEFRTEIEMLSKLRHRHLVS 562
LG G FG VY+G D + VAVK SEQ ++F E ++SK H+++V
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 563 LIGYCDERSEMILVYEYMANGPLRSHLY----GTDLP-PLSWKQRLEICIGAARGLHYLH 617
LIG ER ++ E MA G L+S L + P L+ K L A+G YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 618 TGAAQSIIHRDVKTTNILLDD---NFVAKVADFGLSKTGPALDQTHVSTAVKGS-----F 669
IHRD+ N LL VAK+ADFG+++ D S KG
Sbjct: 134 E---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR-----DIYRASYYRKGGRAMLPI 185
Query: 670 GYLDPEYFRRQQLTEKSDVYSFGVVLMEV 698
++ PE F T K+DV+SFGV+L E+
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 6e-22
Identities = 62/206 (30%), Positives = 91/206 (44%), Gaps = 27/206 (13%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVK---RGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIG 565
LG G FG+V D G A+K + + + TE +LS++ H +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 566 YCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAAR--------GLHYLH 617
++ LV EY G L SHL + AR L YLH
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLS----------KEGRFSEERARFYAAEIVLALEYLH 110
Query: 618 TGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYF 677
+ II+RD+K NILLD + K+ DFGL+K + + + +T G+ YL PE
Sbjct: 111 ---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSS-EGSRTNTFC-GTPEYLAPEVL 165
Query: 678 RRQQLTEKSDVYSFGVVLMEVLCTRP 703
+ + D +S GV+L E+L +P
Sbjct: 166 LGKGYGKAVDWWSLGVLLYEMLTGKP 191
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 6e-22
Identities = 66/212 (31%), Positives = 100/212 (47%), Gaps = 23/212 (10%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVKR----GNPRSEQG--IAEFRTEIEMLSKLRHRHLV 561
LG G F Y+ + GT +AVK+ N SEQ + R EI ++++L H H++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 562 SLIGYCDERSEMILVYEYMANGPLRSHL--YGTDLPPLSWKQRLEICIGAARGLHYLHTG 619
++G E S L E+MA G + L YG + ++ RGL YLH
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLL----RGLSYLHE- 121
Query: 620 AAQSIIHRDVKTTNILLDDN-FVAKVADFG----LSKTGPALDQTHVSTAVKGSFGYLDP 674
IIHRDVK N+L+D ++ADFG L+ G + + G+ ++ P
Sbjct: 122 --NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE--FQGQLLGTIAFMAP 177
Query: 675 EYFRRQQLTEKSDVYSFGVVLMEVLCTRPALN 706
E R +Q DV+S G V++E+ +P N
Sbjct: 178 EVLRGEQYGRSCDVWSVGCVIIEMATAKPPWN 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 7e-22
Identities = 67/229 (29%), Positives = 120/229 (52%), Gaps = 27/229 (11%)
Query: 510 LGVGGFGRVY--------KGTLDDGTKVAVKR-GNPRSEQGIAEFRTEIEMLSKL-RHRH 559
LG G FG+V K + VAVK + +++ +++ +E+EM+ + +H++
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 560 LVSLIGYCDERSEMILVYEYMANGPLRSHL---------YGTD---LP--PLSWKQRLEI 605
+++L+G C + + ++ EY + G LR +L Y D LP L++K +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 606 CIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAV 665
ARG+ YL A+Q IHRD+ N+L+ ++ V K+ADFGL++ +D +T
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 666 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQV 714
+ ++ PE + T +SDV+SFGV+L E+ + P +P E++
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 245
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 8e-22
Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 510 LGVGGFGRVYKGTLDD------GTKVAVKRGNPRSEQG-IAEFRTEIEMLSKLRHRHLVS 562
LG G FG VY+G T+VA+K N + EF E ++ + H+V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 563 LIGYCDERSEMILVYEYMANGPLRSHLYGT--------DLPPLSWKQRLEICIGAARGLH 614
L+G ++V E MA G L+S+L L P + ++ +++ A G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 615 YLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYL-- 672
YL AA+ +HRD+ N ++ ++ K+ DFG+++ D KG G L
Sbjct: 134 YL---AAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR-----DIYETDYYRKGGKGLLPV 185
Query: 673 ---DPEYFRRQQLTEKSDVYSFGVVLMEVL 699
PE + T KSDV+SFGVVL E+
Sbjct: 186 RWMAPESLKDGVFTTKSDVWSFGVVLWEMA 215
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 9e-22
Identities = 59/195 (30%), Positives = 95/195 (48%), Gaps = 9/195 (4%)
Query: 504 FDESLLLGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVS 562
FD LG G +G VYK + G VA+K E+ + E EI +L + ++V
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKV--VPVEEDLQEIIKEISILKQCDSPYIVK 62
Query: 563 LIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQ 622
G + +++ +V EY G + + T+ L+ ++ I +GL YLH +
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLH---SN 118
Query: 623 SIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQL 682
IHRD+K NILL++ AK+ADFG+S G D V G+ ++ PE +
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVS--GQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 176
Query: 683 TEKSDVYSFGVVLME 697
K+D++S G+ +E
Sbjct: 177 NNKADIWSLGITAIE 191
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 1e-21
Identities = 69/221 (31%), Positives = 111/221 (50%), Gaps = 37/221 (16%)
Query: 503 KFDESLLLGVGGFGRVYKGTLD-DGTKV--AVKRGNP-RSEQGIAEFRTEIEMLSKL-RH 557
KF++ ++G G FG+V + + DG K+ A+K SE +F E+E+L KL H
Sbjct: 5 KFED--VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHH 62
Query: 558 RHLVSLIGYCDERSEMILVYEYMANGPL-----RSHLYGTD---------LPPLSWKQRL 603
++++L+G C+ R + + EY G L +S + TD L+ +Q L
Sbjct: 63 PNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122
Query: 604 EICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVST 663
+ A G+ YL + + IHRD+ N+L+ +N +K+ADFGLS+
Sbjct: 123 QFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGE--------EV 171
Query: 664 AVKGSFGYLDPEYFRRQQL-----TEKSDVYSFGVVLMEVL 699
VK + G L + + L T KSDV+SFGV+L E++
Sbjct: 172 YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 65/199 (32%), Positives = 93/199 (46%), Gaps = 18/199 (9%)
Query: 511 GVGGFGRVYKGTLDDGTKV-AVKRGNPR---SEQGIAEFRTEIEMLSKLRHRHLVSL-IG 565
G G FG+V D K+ A+K N + + + E +L +L H LV+L
Sbjct: 9 GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYS 68
Query: 566 YCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQ-RLEIC-IGAARGLHYLHTGAAQS 623
+ DE M LV + + G LR HL + S +Q + IC I A L YLH+ +
Sbjct: 69 FQDE-ENMYLVVDLLLGGDLRYHL--SQKVKFSEEQVKFWICEIVLA--LEYLHS---KG 120
Query: 624 IIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLT 683
IIHRD+K NILLD+ + DF ++ T T+ G+ GY+ PE RQ +
Sbjct: 121 IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTPGYMAPEVLCRQGYS 177
Query: 684 EKSDVYSFGVVLMEVLCTR 702
D +S GV E L +
Sbjct: 178 VAVDWWSLGVTAYECLRGK 196
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 2e-21
Identities = 67/214 (31%), Positives = 108/214 (50%), Gaps = 32/214 (14%)
Query: 509 LLGVGGFGRVYKG-TLDDGTKVAVK----------RGNPRSEQGIAEFRTEIEMLSKLRH 557
L+G G +GRVY + G +AVK R + R + + R+EIE L L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 558 RHLVSLIGYCDERSEMIL--VYEYMANGPLRSHL--YGTDLPPLS---WKQRLEICIGAA 610
++V +G+ E +E L EY+ G + S L YG L +Q LE
Sbjct: 68 LNIVQYLGF--ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLE------ 119
Query: 611 RGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFG 670
GL YLH+ + I+HRD+K N+L+D + + K++DFG+SK + + +++GS
Sbjct: 120 -GLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVF 175
Query: 671 YLDPE--YFRRQQLTEKSDVYSFGVVLMEVLCTR 702
++ PE + Q + K D++S G V++E+ R
Sbjct: 176 WMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-21
Identities = 57/196 (29%), Positives = 83/196 (42%), Gaps = 10/196 (5%)
Query: 509 LLGVGGFGRVYKGTLDDGT----KVAVKRGNPRSEQGI-AEFRTEIEMLSKLRHRHLVSL 563
LG G FG V +G VAVK I +F E ++ L H +L+ L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 564 IGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQS 623
G +++V E G L L L + + A G+ YL + +
Sbjct: 62 YGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES---KR 117
Query: 624 IIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTA-VKGSFGYLDPEYFRRQQL 682
IHRD+ NILL + K+ DFGL + P + +V +K F + PE R +
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTF 177
Query: 683 TEKSDVYSFGVVLMEV 698
+ SDV+ FGV L E+
Sbjct: 178 SHASDVWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-21
Identities = 56/190 (29%), Positives = 95/190 (50%), Gaps = 5/190 (2%)
Query: 510 LGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDE 569
LG G FG V+ G ++ TKVAVK P + + F E ++ L+H LV L +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 570 RSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDV 629
+ ++ EYMA G L L + + + ++ A G+ Y+ ++ IHRD+
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDL 129
Query: 630 KTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 689
+ N+L+ ++ + K+ADFGL++ ++ K + PE T KSDV+
Sbjct: 130 RAANVLVSESLMCKIADFGLARVIED-NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 188
Query: 690 SFGVVLMEVL 699
SFG++L E++
Sbjct: 189 SFGILLYEIV 198
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 4e-21
Identities = 62/229 (27%), Positives = 117/229 (51%), Gaps = 27/229 (11%)
Query: 510 LGVGGFGRVYKGTL--------DDGTKVAVKR-GNPRSEQGIAEFRTEIEMLSKL-RHRH 559
LG G FG+V + D VAVK + +++ +A+ +E+E++ + +H++
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 560 LVSLIGYCDERSEMILVYEYMANGPLRSHL---------YGTDLP-----PLSWKQRLEI 605
+++L+G C + + ++ EY A G LR L Y D+ LS+K +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 606 CIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAV 665
ARG+ YL ++ IHRD+ N+L+ ++ V K+ADFGL++ +D ++
Sbjct: 140 AYQVARGMEYL---ESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 666 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQV 714
+ ++ PE + T +SDV+SFG+++ E+ + P +P E++
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL 245
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 5e-21
Identities = 71/215 (33%), Positives = 110/215 (51%), Gaps = 35/215 (16%)
Query: 509 LLGVGGFGRVYKGTL-DDGTKV--AVKR-GNPRSEQGIAEFRTEIEMLSKL-RHRHLVSL 563
++G G FG+V K + DG ++ A+KR S+ +F E+E+L KL H ++++L
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 564 IGYCDERSEMILVYEYMANGPL-----RSHLYGTD---------LPPLSWKQRLEICIGA 609
+G C+ R + L EY +G L +S + TD LS +Q L
Sbjct: 74 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 610 ARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSF 669
ARG+ YL + + IHRD+ NIL+ +N+VAK+ADFGLS+ VK +
Sbjct: 134 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ--------EVYVKKTM 182
Query: 670 GYLDPEYFRRQQL-----TEKSDVYSFGVVLMEVL 699
G L + + L T SDV+S+GV+L E++
Sbjct: 183 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 217
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 9e-21
Identities = 67/234 (28%), Positives = 104/234 (44%), Gaps = 33/234 (14%)
Query: 510 LGVGGFGRVY------------KGTLDDGTK-----VAVKRGNP-RSEQGIAEFRTEIEM 551
LG G FG V+ K ++ VAVK P S+ +F E+++
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 552 LSKLRHRHLVSLIGYCDERSEMILVYEYMANGP----LRSHLYGTD-----LPPLSWKQR 602
LS+L ++ L+G C + ++ EYM NG L+ H+ T LS+
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 603 LEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVS 662
L + A G+ YL + + +HRD+ T N L+ N+ K+ADFG+S+ + D V
Sbjct: 133 LYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQ 189
Query: 663 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEV--LCTRPALNPVLPREQV 714
++ E + T KSDV++FGV L E+ LC L +QV
Sbjct: 190 GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE-HLTDQQV 242
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 1e-20
Identities = 59/193 (30%), Positives = 98/193 (50%), Gaps = 12/193 (6%)
Query: 510 LGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDE 569
LG G FG V+ G + TKVA+K S F E ++ +L+H LV L
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVV-T 71
Query: 570 RSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDV 629
+ + ++ EYM NG L L + L+ + +++ A G+ ++ ++ IHRD+
Sbjct: 72 QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDL 128
Query: 630 KTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGS---FGYLDPEYFRRQQLTEKS 686
+ NIL+ + K+ADFGL++ L + + TA +G+ + PE T KS
Sbjct: 129 RAANILVSETLCCKIADFGLAR----LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 184
Query: 687 DVYSFGVVLMEVL 699
DV+SFG++L E++
Sbjct: 185 DVWSFGILLTEIV 197
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 2e-20
Identities = 56/201 (27%), Positives = 98/201 (48%), Gaps = 21/201 (10%)
Query: 510 LGVGGFGRVYKGT---LDDGTK--VAVKR-GNPRSEQGIAEFRTEIEMLSKLRHRHLVSL 563
LG G FG VYKG + K VA+K S + E E +++ + H H+V L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 564 IGYCDERSEMILVYEYMANGPLRSHL--YGTDLPP---LSWKQRLEICIGAARGLHYLHT 618
+G C S++ L+ + M G L ++ + ++ L+W C+ A+G+ YL
Sbjct: 75 LGIC-LSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKGMSYLEE 127
Query: 619 GAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFR 678
+ ++HRD+ N+L+ K+ DFGL+K ++ + + K ++ E
Sbjct: 128 ---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184
Query: 679 RQQLTEKSDVYSFGVVLMEVL 699
+ T KSDV+S+GV + E++
Sbjct: 185 HRIYTHKSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 2e-20
Identities = 59/201 (29%), Positives = 91/201 (45%), Gaps = 21/201 (10%)
Query: 509 LLGVGGFGRVYKGTL----DDGTKVAVKRGNPRSEQGIAE-FRTEIEMLSKLRHRHLVSL 563
+G G FG VY+G ++ VAVK + + E F E ++ + H H+V L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 564 IGYCDERSEMILVYEYMANGPLRSHL--YGTDLPPLSW-KQRLEICIGAARGLHYLHTGA 620
IG E + + +V E G LRS+L L S ++ L YL +
Sbjct: 73 IGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLS----TALAYLES-- 125
Query: 621 AQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSF--GYLDPEYFR 678
+ +HRD+ N+L+ K+ DFGLS+ L+ A KG ++ PE
Sbjct: 126 -KRFVHRDIAARNVLVSSPDCVKLGDFGLSR---YLEDESYYKASKGKLPIKWMAPESIN 181
Query: 679 RQQLTEKSDVYSFGVVLMEVL 699
++ T SDV+ FGV + E+L
Sbjct: 182 FRRFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 58/228 (25%), Positives = 94/228 (41%), Gaps = 43/228 (18%)
Query: 503 KFDESLLLGVGGFGRVYKGT-LDDGTKVAVKRGNPRS------EQGIAEFRTEIEMLSKL 555
++ +G G FG V K DG + K + + +Q ++E +L +L
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVN----ILREL 56
Query: 556 RHRHLVSLIGYCD-----ERSEMILVYEYMANGPLRS---HLYGTDLP---PLSWKQRLE 604
+H ++V Y D + +V EY G L W+ +
Sbjct: 57 KHPNIV---RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQ 113
Query: 605 ICIGAARGLHYLHTG--AAQSIIHRDVKTTNILLDDNFVAKVADFGLSK---TGPALDQT 659
+ + L+ H +++HRD+K NI LD N K+ DFGL+K + +T
Sbjct: 114 LLLA----LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT 169
Query: 660 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNP 707
+V T Y+ PE EKSD++S G ++ E LC AL+P
Sbjct: 170 YVGTPY-----YMSPEQLNHMSYDEKSDIWSLGCLIYE-LC---ALSP 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 3e-20
Identities = 58/193 (30%), Positives = 95/193 (49%), Gaps = 12/193 (6%)
Query: 510 LGVGGFGRVYKGTLDD-GTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCD 568
LG G +G VY+G VAVK + + + EF E ++ +++H +LV L+G C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 569 ERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRD 628
++ E+M G L +L + ++ L + + + YL ++ IHRD
Sbjct: 73 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 129
Query: 629 VKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGS---FGYLDPEYFRRQQLTEK 685
+ N L+ +N + KVADFGLS+ L TA G+ + PE + + K
Sbjct: 130 LAARNCLVGENHLVKVADFGLSR----LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 185
Query: 686 SDVYSFGVVLMEV 698
SDV++FGV+L E+
Sbjct: 186 SDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 3e-20
Identities = 62/210 (29%), Positives = 105/210 (50%), Gaps = 19/210 (9%)
Query: 510 LGVGGFGRVYKG-TLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIG--Y 566
LG G FG+VYK + G A K SE+ + +F EI++LS+ +H ++V L +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 567 CDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIH 626
+ + +++ E+ G L S + + L+ Q +C L++LH + +IH
Sbjct: 73 YENKLWILI--EFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLH---SHKVIH 126
Query: 627 RDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEY-----FRRQQ 681
RD+K NILL + K+ADFG+S + Q T + G+ ++ PE F+
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR-DTFI-GTPYWMAPEVVACETFKDNP 184
Query: 682 LTEKSDVYSFGVVLMEVLCTRP---ALNPV 708
K+D++S G+ L+E+ P LNP+
Sbjct: 185 YDYKADIWSLGITLIELAQMEPPHHELNPM 214
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (228), Expect = 3e-20
Identities = 53/154 (34%), Positives = 77/154 (50%), Gaps = 24/154 (15%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVKR-GNPRSEQGIAEFRT---EIEMLSKLRHRHLVSLI 564
LG G +G VYK G VA+K+ E+GI T EI +L +L+H ++V L+
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGI--PSTALREISLLKELKHPNIVKLL 64
Query: 565 GYCDERSEMILVYEYMANGPLRSHL--YGTDLPP---LSW-KQRLEICIGAARGLHYLHT 618
++ LV+EY L+ +L L P S Q L RGL Y H
Sbjct: 65 DVIHTERKLYLVFEYCDMD-LKKYLDKRPGPLSPNLIKSIMYQLL-------RGLAYCH- 115
Query: 619 GAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKT 652
+ I+HRD+K NIL++ + V K+ADFGL++
Sbjct: 116 --SHRILHRDLKPQNILINRDGVLKLADFGLARA 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 4e-20
Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 30/212 (14%)
Query: 509 LLGVGGFGRVYK-GTLDDGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVS--- 562
LG G +G VYK L D A+K + S++ + EI +L+ + H +++S
Sbjct: 7 KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKE 66
Query: 563 --LIGYCDERSEMILVYEYMANGPL-----RSHLYGTDLPP-LSWKQRLEICIGAARGLH 614
L G +++ +V EY G L + +P W+ +++ RGL
Sbjct: 67 AFLDG-----NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL----RGLQ 117
Query: 615 YLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDP 674
LH Q I+HRD+K+ NILL N + K+ D G+SK L + T + G+ Y+ P
Sbjct: 118 ALH---EQKILHRDLKSANILLVANDLVKIGDLGISK---VLKKNMAKTQI-GTPHYMAP 170
Query: 675 EYFRRQQLTEKSDVYSFGVVLMEVLCTRPALN 706
E ++ + + KSD++S G +L E+ P
Sbjct: 171 EVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 6e-20
Identities = 54/218 (24%), Positives = 90/218 (41%), Gaps = 28/218 (12%)
Query: 509 LLGVGGFGRVYKGTL-DDGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKL-RHRHLVSL 563
++G G F V + + A+K + R E+ + + E E+L++L H ++ L
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67
Query: 564 IGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQS 623
+ + V EY NG L ++ L K L YLH ++
Sbjct: 68 YYTFQDEENLYFVLEYAPNGELLQYI--RKYGSLDEKCTRFYAAEILLALEYLH---SKG 122
Query: 624 IIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD--------------QTHVSTAVKGSF 669
IIHRD+K NILLD + K+ DFG +K Q + SF
Sbjct: 123 IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASF 182
Query: 670 -G---YLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRP 703
G Y+ PE + + SD+++ G ++ ++L +P
Sbjct: 183 VGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKP 220
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 8e-20
Identities = 63/206 (30%), Positives = 103/206 (50%), Gaps = 18/206 (8%)
Query: 509 LLGVGGFGRVYKG-TLDDGTKVAVKR-----GNPRSEQGIAEFRTEIEMLSKLRHRHLVS 562
LLG G FGRVY +D G ++A K+ +P + + ++ EI++L L+H +V
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 563 LIGYCDERSE--MILVYEYMANGPLRSHL--YGTDLPPLSWKQRLEICIGAARGLHYLHT 618
G +R+E + + EYM G ++ L YG ++ K +I G+ YLH
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQIL----EGMSYLH- 123
Query: 619 GAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVST-AVKGSFGYLDPEYF 677
+ I+HRD+K NIL D K+ DFG SK + + +V G+ ++ PE
Sbjct: 124 --SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI 181
Query: 678 RRQQLTEKSDVYSFGVVLMEVLCTRP 703
+ K+DV+S G ++E+L +P
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 56/201 (27%), Positives = 90/201 (44%), Gaps = 17/201 (8%)
Query: 510 LGVGGFGRVYKG-TLDDGTKVAVKRGNPRSEQGIAEFRT--EIEMLSKLRHRHLVSLIGY 566
+G G +G VYK G VA+K+ R E EI++L +L H +++ L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 567 CDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIH 626
+ ++ LV+E+M L L +GL + H + I+H
Sbjct: 67 FRHKGDLYLVFEFMDTDLY--KLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILH 121
Query: 627 RDVKTTNILLDDNFVAKVADFGLSKT--GPALDQTH-VSTAVKGSFGYLDPE-YFRRQQL 682
RD+K N+L++ V K+ADFGL+++ P TH V T Y PE +
Sbjct: 122 RDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAPELLLGDKGY 176
Query: 683 TEKSDVYSFGVVLMEVLCTRP 703
+ D++S G + E+L RP
Sbjct: 177 STPVDIWSVGCIFAELLSRRP 197
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 2e-19
Identities = 98/401 (24%), Positives = 162/401 (40%), Gaps = 60/401 (14%)
Query: 395 LDGLSSVEGLLPDKPSNKNKIG-IIVGSVVGAVAAVALIGVCYCWLLARKSKTPQQGHPW 453
L G + GL P K K + +GA +AL+ + ++ R +
Sbjct: 607 LCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNN--------- 657
Query: 454 LPLPLYGNSQTMTKMSTTSQKSGTASCISLASSNLGRLFMFQEILDATNKFDESLLLGVG 513
++ + GT + S + + +IL + E ++ G
Sbjct: 658 ------------LELKRVENEDGTWE-LQFFDSKVSKSITINDILSSLK---EENVISRG 701
Query: 514 GFGRVYKG-TLDDGTKVAVKR---GNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDE 569
G YKG ++ +G + VK N IA+ KL+H ++V LIG C
Sbjct: 702 KKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMG-------KLQHPNIVKLIGLCRS 754
Query: 570 RSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDV 629
L++EY+ L L LSW++R +I IG A+ L +LH + +++ ++
Sbjct: 755 EKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNL 809
Query: 630 KTTNILLDDNFVAKVADFGLSKTGP-ALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDV 688
I++D + LS G D ++ Y+ PE + +TEKSD+
Sbjct: 810 SPEKIIIDGKDEPHLR---LSLPGLLCTDTKCFISS-----AYVAPETRETKDITEKSDI 861
Query: 689 YSFGVVLMEVLCTRPALNPVLPREQVN--IAEWAMTWQKKGMLDQIMDSNLVGK--VNPA 744
Y FG++L+E+L + +P V+ I EWA LD +D ++ G VN
Sbjct: 862 YGFGLILIELLTGK---SPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQN 918
Query: 745 SLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLEETSS 785
+ + A C A RP DVL LE A + +SS
Sbjct: 919 EIVEVMNLALHCTATDPTARPCANDVLKTLESASR--SSSS 957
|
Length = 968 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 3e-19
Identities = 61/201 (30%), Positives = 104/201 (51%), Gaps = 16/201 (7%)
Query: 509 LLGVGGFGRVYKGTLDDGTK----VAVKR-GNPRSEQGIAEFRTEIEMLSKLRHRHLVSL 563
++G G FG V +G L K VA+K + +E+ +F +E ++ + H +++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 564 IGYCDERSEMILVYEYMANGPLRSHLYGTD--LPPLSWKQRLEICIGAARGLHYLHTGAA 621
G + ++++ E+M NG L S L D + Q + + G A G+ YL +
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVI---QLVGMLRGIAAGMKYL---SE 124
Query: 622 QSIIHRDVKTTNILLDDNFVAKVADFGLSK--TGPALDQTHVST-AVKGSFGYLDPEYFR 678
+ +HRD+ NIL++ N V KV+DFGLS+ D T+ S+ K + PE
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184
Query: 679 RQQLTEKSDVYSFGVVLMEVL 699
++ T SDV+S+G+V+ EV+
Sbjct: 185 YRKFTSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 3e-19
Identities = 71/215 (33%), Positives = 110/215 (51%), Gaps = 35/215 (16%)
Query: 509 LLGVGGFGRVYKGTLD-DGTKV--AVKR-GNPRSEQGIAEFRTEIEMLSKL-RHRHLVSL 563
++G G FG+V K + DG ++ A+KR S+ +F E+E+L KL H ++++L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 564 IGYCDERSEMILVYEYMANGPL-----RSHLYGTD---------LPPLSWKQRLEICIGA 609
+G C+ R + L EY +G L +S + TD LS +Q L
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 610 ARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSF 669
ARG+ YL + + IHRD+ NIL+ +N+VAK+ADFGLS+ VK +
Sbjct: 122 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ--------EVYVKKTM 170
Query: 670 GYLDPEYFRRQQL-----TEKSDVYSFGVVLMEVL 699
G L + + L T SDV+S+GV+L E++
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 205
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 5e-19
Identities = 60/201 (29%), Positives = 89/201 (44%), Gaps = 28/201 (13%)
Query: 510 LGVGGFGRVYKG-TLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCD 568
+G G +G VYK + G VA+K + EI ML + RH ++V+ G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 569 ERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRD 628
R ++ +V EY G L +Y PLS Q +C +GL YLH IHRD
Sbjct: 71 RRDKLWIVMEYCGGGSL-QDIYQVTRGPLSELQIAYVCRETLKGLAYLHE---TGKIHRD 126
Query: 629 VKTTNILLDDNFVAKVADFGLS---KTGPALDQTHVST---------AVKGSFGYLDPEY 676
+K NILL ++ K+ADFG+S A ++ + T AV+ GY
Sbjct: 127 IKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGY----- 181
Query: 677 FRRQQLTEKSDVYSFGVVLME 697
K D+++ G+ +E
Sbjct: 182 ------DGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 88.0 bits (219), Expect = 5e-19
Identities = 68/219 (31%), Positives = 102/219 (46%), Gaps = 44/219 (20%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVK--RGNPRSEQ--GIAEFRT---EIEMLSKLRHRHL 560
LG G + VYK + G VA+K + R E GI T EI++L +L+H ++
Sbjct: 7 KLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGIN--FTALREIKLLQELKHPNI 64
Query: 561 VSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAA---------- 610
+ L+ +S + LV+E+M TDL + K + I + A
Sbjct: 65 IGLLDVFGHKSNINLVFEFME----------TDLEKV-IKDK-SIVLTPADIKSYMLMTL 112
Query: 611 RGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKT--GPALDQTH-VSTAVKG 667
RGL YLH + I+HRD+K N+L+ + V K+ADFGL+++ P TH V T
Sbjct: 113 RGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRW-- 167
Query: 668 SFGYLDPE-YFRRQQLTEKSDVYSFGVVLMEVLCTRPAL 705
Y PE F + D++S G + E+L P L
Sbjct: 168 ---YRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFL 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 7e-19
Identities = 82/286 (28%), Positives = 124/286 (43%), Gaps = 38/286 (13%)
Query: 502 NKFDESLLLGVGGFGRVYKGTLDDGTKV-AVK----RGNPRSEQGIAEFRTEIEMLSKLR 556
K E LG G G V K L + + A+K NP ++ I R E+E+ +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQI--LR-ELEINKSCK 57
Query: 557 HRHLVSLIG-YCDERSEMI-LVYEYMANGPLRSHLYGTDLPP---LSWKQRLEICIGAAR 611
++V G + DE S I + EY G L S +Y + K +I +
Sbjct: 58 SPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLGKIAESVLK 116
Query: 612 GLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLS-KTGPALDQTHVSTAVKGSFG 670
GL YLH+ + IIHRD+K +NILL K+ DFG+S + +L T T SF
Sbjct: 117 GLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGT----SF- 168
Query: 671 YLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTR---PA--LNPVLPREQVNIAEWAMTWQK 725
Y+ PE + + + SDV+S G+ L+EV R P P+ P E +++
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIE-------LLSYIV 221
Query: 726 KGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVL 771
++ D G K F ++CL + RP+ D+L
Sbjct: 222 NMPNPELKDEPGNGIKWSEEFKDF---IKQCLEKDPTRRPTPWDML 264
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 10/205 (4%)
Query: 496 EILDATNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKL 555
EI + K ++ L G G FG V+ T + TKVAVK P S + F E ++ L
Sbjct: 2 EIPRESLKLEKKL--GAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTL 58
Query: 556 RHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHY 615
+H LV L + + ++ E+MA G L L + + ++ A G+ +
Sbjct: 59 QHDKLVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 117
Query: 616 LHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVS-TAVKGSFGYLDP 674
+ ++ IHRD++ NIL+ + V K+ADFGL++ D + + K + P
Sbjct: 118 IEQ---RNYIHRDLRAANILVSASLVCKIADFGLARV--IEDNEYTAREGAKFPIKWTAP 172
Query: 675 EYFRRQQLTEKSDVYSFGVVLMEVL 699
E T KSDV+SFG++LME++
Sbjct: 173 EAINFGSFTIKSDVWSFGILLMEIV 197
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 1e-18
Identities = 70/227 (30%), Positives = 107/227 (47%), Gaps = 32/227 (14%)
Query: 510 LGVGGFGRVYKGTLDD------GTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVS 562
LG G FG VY+G D T+VAVK N S + EF E ++ H+V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 563 LIGYCDERSEMILVYEYMANGPLRSHLYG--------TDLPPLSWKQRLEICIGAARGLH 614
L+G + ++V E MA+G L+S+L PP + ++ +++ A G+
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 615 YLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFG---- 670
YL+ A+ +HRD+ N ++ +F K+ DFG+++ D KG G
Sbjct: 134 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR-----DIYETDYYRKGGKGLLPV 185
Query: 671 -YLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPV--LPREQV 714
++ PE + T SD++SFGVVL E+ T A P L EQV
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEI--TSLAEQPYQGLSNEQV 230
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 63/210 (30%), Positives = 98/210 (46%), Gaps = 27/210 (12%)
Query: 513 GGFGRVY----KGTLDDGTKVAVK---RGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIG 565
G +GRV+ K T G A+K + + + + + TE ++LS+ + ++V L
Sbjct: 4 GAYGRVFLAKKKST---GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 566 YCDERSEMILVYEYMANGPLRS--HLYGTDLPPLSWKQRL-EICIGAARGLHYLHTGAAQ 622
+ + LV EY+ G L S G+ L + + EI + L YLH +
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGS-LDEDVARIYIAEIVLA----LEYLH---SN 112
Query: 623 SIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVK------GSFGYLDPEY 676
IIHRD+K NIL+D N K+ DFGLSK G Q +++ K G+ Y+ PE
Sbjct: 113 GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172
Query: 677 FRRQQLTEKSDVYSFGVVLMEVLCTRPALN 706
Q ++ D +S G +L E L P +
Sbjct: 173 ILGQGHSKTVDWWSLGCILYEFLVGIPPFH 202
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 32/211 (15%)
Query: 510 LGVGGFGRVY----KGTLDDG--TKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVS 562
LG G FG VY KG + D T+VA+K N S + EF E ++ + H+V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 563 LIGYCDERSEMILVYEYMANGPLRSHLY----------GTDLPPLSWKQRLEICIGAARG 612
L+G + +++ E M G L+S+L P L K+ +++ A G
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSL--KKMIQMAGEIADG 131
Query: 613 LHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFG-- 670
+ YL+ A +HRD+ N ++ ++F K+ DFG+++ D KG G
Sbjct: 132 MAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-----DIYETDYYRKGGKGLL 183
Query: 671 ---YLDPEYFRRQQLTEKSDVYSFGVVLMEV 698
++ PE + T SDV+SFGVVL E+
Sbjct: 184 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-18
Identities = 64/207 (30%), Positives = 99/207 (47%), Gaps = 20/207 (9%)
Query: 509 LLGVGGFGRVYKG-TLDDGTKVAVKR-----GNPRSEQGIAEFRTEIEMLSKLRHRHLVS 562
LLG G FGRVY D G ++AVK+ +P + + + EI++L L H +V
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 563 LIGYCDERSEMIL--VYEYMANGPLRSHL--YGTDLPPLSWKQRLEICIGAARGLHYLHT 618
G + E L E+M G ++ L YG ++ K +I G+ YLH+
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQIL----EGVSYLHS 124
Query: 619 GAAQSIIHRDVKTTNILLDDNFVAKVADFGLSK--TGPALDQTHVSTAVKGSFGYLDPEY 676
I+HRD+K NIL D K+ DFG SK L T + + V G+ ++ PE
Sbjct: 125 NM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-VTGTPYWMSPEV 180
Query: 677 FRRQQLTEKSDVYSFGVVLMEVLCTRP 703
+ K+D++S G ++E+L +P
Sbjct: 181 ISGEGYGRKADIWSVGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-18
Identities = 64/226 (28%), Positives = 98/226 (43%), Gaps = 46/226 (20%)
Query: 510 LGVGGFGRVYKGT------LDDGTKVAVKRGNPRSEQGIAEFR---TEIEMLSKLRHRHL 560
LG G FG+V K T T VAVK + +E R +E +L ++ H H+
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASS--SELRDLLSEFNLLKQVNHPHV 65
Query: 561 VSLIGYCDERSEMILVYEYMANGPLRSHL----------------------YGTDLPPLS 598
+ L G C + ++L+ EY G LRS L D L+
Sbjct: 66 IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 599 WKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQ 658
+ +RG+ YL A ++HRD+ N+L+ + K++DFGLS+ D
Sbjct: 126 MGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSR-----DV 177
Query: 659 THVSTAVKGSFG-----YLDPEYFRRQQLTEKSDVYSFGVVLMEVL 699
+ VK S G ++ E T +SDV+SFGV+L E++
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 223
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-18
Identities = 64/213 (30%), Positives = 105/213 (49%), Gaps = 35/213 (16%)
Query: 509 LLGVGGFGRVYKG-TLDDGTKVAVKR---------GNPRSEQGIAEFRTEIEMLSKLRHR 558
L+G G FG VY G G +AVK+ R + EI +L +L+H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 559 HLVSLIGYCDERSEMILVYEYMANGPLRSHL--YGTDLPPLSW---KQRLEICIGAARGL 613
++V +G + + + EY+ G + + L YG L +Q L +GL
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL-------KGL 119
Query: 614 HYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTA-------VK 666
+YLH + IIHRD+K NIL+D+ K++DFG+SK L+ +ST ++
Sbjct: 120 NYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKK---LEANSLSTKTNGARPSLQ 173
Query: 667 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVL 699
GS ++ PE ++ T K+D++S G +++E+L
Sbjct: 174 GSVFWMAPEVVKQTSYTRKADIWSLGCLVVEML 206
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 2e-18
Identities = 66/203 (32%), Positives = 105/203 (51%), Gaps = 21/203 (10%)
Query: 510 LGVGGFGRV----YKGTLDD-GTKVAVKRGNPRS-EQGIAEFRTEIEMLSKLRHRHLVSL 563
LG G FG+V Y D+ G +VAVK P S IA+ + EIE+L L H ++V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 564 IGYCDER--SEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAA 621
G C E + + L+ E++ +G L+ +L + ++ KQ+L+ + +G+ YL +
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNKNKINLKQQLKYAVQICKGMDYL---GS 127
Query: 622 QSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGS-----FGYLDPEY 676
+ +HRD+ N+L++ K+ DFGL+K A++ VK F Y PE
Sbjct: 128 RQYVHRDLAARNVLVESEHQVKIGDFGLTK---AIETDKEYYTVKDDLDSPVFWYA-PEC 183
Query: 677 FRRQQLTEKSDVYSFGVVLMEVL 699
+ + SDV+SFGV L E+L
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 76/276 (27%), Positives = 118/276 (42%), Gaps = 47/276 (17%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVKRGN-PRSEQGIAEFRTEIEMLSKLRHRHLVSLIGY 566
+G G FG VYK VA+K + +E I + + EI+ LS+ R ++ G
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67
Query: 567 CDERSEMILVYEYMANGPLRSHL-YGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSII 625
+ S++ ++ EY G L G L I GL YLH + I
Sbjct: 68 FLKGSKLWIIMEYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLH---EEGKI 120
Query: 626 HRDVKTTNILLDDNFVAKVADFG----LSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQ 681
HRD+K NILL + K+ADFG L+ T + +T V F ++ PE ++
Sbjct: 121 HRDIKAANILLSEEGDVKLADFGVSGQLTST-----MSKRNTFVGTPF-WMAPEVIKQSG 174
Query: 682 LTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKV 741
EK+D++S G+ +E+ P L+ + P M + + L+ K
Sbjct: 175 YDEKADIWSLGITAIELAKGEPPLSDLHP----------M----RVLF-------LIPKN 213
Query: 742 NPASL------KKFGETAEKCLAEHGVDRPSMGDVL 771
NP SL K F + CL + +RPS ++L
Sbjct: 214 NPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELL 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-18
Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 24/211 (11%)
Query: 510 LGVGGFGRVYKGTL-----DDGTKVAVKR-GNPRSEQGIAEFRTEIEMLSKLRHRHLVSL 563
LG FG++YKG L D VA+K + + Q EF+ E ++++L H ++V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 564 IGYCDERSEMILVYEYMANGPLRSHLY---------------GTDLPPLSWKQRLEICIG 608
+G + + +++EY+ G L L GT L L I I
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 609 AARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGS 668
A G+ YL ++ +H+D+ NIL+ + K++D GLS+ + D V
Sbjct: 133 IAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 669 FGYLDPEYFRRQQLTEKSDVYSFGVVLMEVL 699
++ PE + + SD++SFGVVL E+
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 3e-18
Identities = 62/196 (31%), Positives = 101/196 (51%), Gaps = 12/196 (6%)
Query: 510 LGVGGFGRVYKGTLDDGTK---VAVKRGNPRSEQGIA-EFRTEIEMLSKLRHRHLVSLIG 565
LG G FG V KG K VA+K +E+ + E E E++ +L + ++V +IG
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 566 YCDERSEMILVYEYMANGPLRSHLYGT-DLPPLSWKQRLEICIGAARGLHYLHTGAAQSI 624
C+ + M LV E + GPL L G D +S +E+ + G+ YL ++
Sbjct: 63 VCEAEALM-LVMEMASGGPLNKFLSGKKDEITVS--NVVELMHQVSMGMKYLE---GKNF 116
Query: 625 IHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVS-TAVKGSFGYLDPEYFRRQQLT 683
+HRD+ N+LL + AK++DFGLSK A D + + +A K + PE ++ +
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176
Query: 684 EKSDVYSFGVVLMEVL 699
+SDV+S+G+ + E
Sbjct: 177 SRSDVWSYGITMWEAF 192
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 5e-18
Identities = 60/199 (30%), Positives = 100/199 (50%), Gaps = 14/199 (7%)
Query: 509 LLGVGGFGRVYKGTLDDGTK----VAVKRGNP-RSEQGIAEFRTEIEMLSKLRHRHLVSL 563
++G G FG V G L K VA+K +E+ +F +E ++ + H +++ L
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 564 IGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQS 623
G + +++V EYM NG L + L D + Q + + G A G+ YL +
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYL---SDMG 126
Query: 624 IIHRDVKTTNILLDDNFVAKVADFGLSKT---GPALDQTHVSTAVKGSFGYLDPEYFRRQ 680
+HRD+ NIL++ N V KV+DFGLS+ P + + + K + PE +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP--EAAYTTRGGKIPIRWTAPEAIAYR 184
Query: 681 QLTEKSDVYSFGVVLMEVL 699
+ T SDV+S+G+V+ EV+
Sbjct: 185 KFTSASDVWSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 8e-18
Identities = 56/199 (28%), Positives = 100/199 (50%), Gaps = 17/199 (8%)
Query: 529 VAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRS 587
VAVK ++ +F EI+++S+L++ +++ L+G C + ++ EYM NG L
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106
Query: 588 HL----------YGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLD 637
L + ++P +S L + + A G+ YL A+ + +HRD+ T N L+
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVG 163
Query: 638 DNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLME 697
+++ K+ADFG+S+ + D + ++ E + T SDV++FGV L E
Sbjct: 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWE 223
Query: 698 V--LCTRPALNPVLPREQV 714
+ LC + +L EQV
Sbjct: 224 MFTLCKEQPYS-LLSDEQV 241
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 14/210 (6%)
Query: 510 LGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGI-AEFRTEIEMLSKLRHRHLVSLIGYC 567
+G G FG V+ G L D T VAVK + A+F E +L + H ++V LIG C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 568 DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHR 627
++ + +V E + G + L T+ P L K+ +++ AA G+ YL + + IHR
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLR-TEGPRLKVKELIQMVENAAAGMEYLES---KHCIHR 118
Query: 628 DVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKG----SFGYLDPEYFRRQQLT 683
D+ N L+ + V K++DFG+S+ ++ V + G + PE + +
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSRE----EEDGVYASTGGMKQIPVKWTAPEALNYGRYS 174
Query: 684 EKSDVYSFGVVLMEVLCTRPALNPVLPREQ 713
+SDV+SFG++L E L +Q
Sbjct: 175 SESDVWSFGILLWEAFSLGAVPYANLSNQQ 204
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 59/199 (29%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVKR-GNPRSEQGIAE--FRTEIEMLSKLRHRHLVSLIG 565
+G G G V+K + G VA+K+ R E GI R EI+ L +H ++V L+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALR-EIKALQACQHPYVVKLLD 66
Query: 566 YCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSII 625
S +LV EYM + L L + PL Q +G+ Y+H A I+
Sbjct: 67 VFPHGSGFVLVMEYMPSD-LSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMH---ANGIM 121
Query: 626 HRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPE-YFRRQQLTE 684
HRD+K N+L+ + V K+ADFGL++ + S V + Y PE + ++
Sbjct: 122 HRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPELLYGARKYDP 180
Query: 685 KSDVYSFGVVLMEVLCTRP 703
D+++ G + E+L P
Sbjct: 181 GVDLWAVGCIFAELLNGSP 199
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 21/202 (10%)
Query: 509 LLGVGGFGRVYKGT-LDDGTK----VAVKRGNPRS-EQGIAEFRTEIEMLSKLRHRHLVS 562
LLG G FG V+KG + +G VA+K RS Q E + + L H ++V
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 563 LIGYCDERSEMILVYEYMANGPLRSHL--YGTDLPP---LSWKQRLEICIGAARGLHYLH 617
L+G C + + LV + G L H+ + L P L+W C+ A+G++YL
Sbjct: 74 LLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW------CVQIAKGMYYLE 126
Query: 618 TGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYF 677
++HR++ NILL + + ++ADFG++ D+ + + K ++ E
Sbjct: 127 E---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 678 RRQQLTEKSDVYSFGVVLMEVL 699
+ T +SDV+S+GV + E++
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMM 205
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 55/214 (25%), Positives = 104/214 (48%), Gaps = 19/214 (8%)
Query: 509 LLGVGGFGRVYKGTLDDGTKVAVKR------GNPRSEQGIAEFRTEIEMLSKLRHRHLVS 562
+LG G +G VY G + G +AVK+ +E+ + + E+++L L+H ++V
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 563 LIGYCDERSEMILVYEYMANGPLRSHL--YGTDLPPLSWKQRLEICIGAARGLHYLHTGA 620
+G C + + + + E++ G + S L +G P+ K +I G A YLH
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA----YLHN-- 120
Query: 621 AQSIIHRDVKTTNILLDDNFVAKVADFGLSK----TGPALDQTHVSTAVKGSFGYLDPEY 676
++HRD+K N++L N + K+ DFG ++ G +++ ++ G+ ++ PE
Sbjct: 121 -NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 677 FRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLP 710
KSD++S G + E+ +P L +
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPPLASMDR 213
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 50/168 (29%), Positives = 73/168 (43%), Gaps = 26/168 (15%)
Query: 499 DATNKFDESLLLGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKL-R 556
D T F+ ++G G +G+VYK G VA+K + ++ E + E +L K
Sbjct: 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSN 61
Query: 557 HRHLVSLIG------YCDERSEMILVYEYMANGPLRSHLYGTDLPP--LSWKQRLE---- 604
H ++ + G ++ LV E G + TDL +RL+
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSV------TDLVKGLRKKGKRLKEEWI 115
Query: 605 --ICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLS 650
I RGL YLH +IHRD+K NILL N K+ DFG+S
Sbjct: 116 AYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 3e-17
Identities = 66/224 (29%), Positives = 99/224 (44%), Gaps = 40/224 (17%)
Query: 510 LGVGGFGRVYKG-TLDDGTKVAVKRGNPRSEQG---IAEFRTEIEMLSKLRHRHLVSLI- 564
LG G FG VYK + G VA+K+ +E+ I R EI++L KL+H ++V LI
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKLKHPNVVPLID 74
Query: 565 -------GYCDERSEMILVYEYMA---NGPL---RSHLYGTDLPPLSWKQRLEICIGAAR 611
+R + +V YM +G L L + + Q LE
Sbjct: 75 MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIK-CYMLQLLE------- 126
Query: 612 GLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSK--TGPALDQTHVSTAVKGSF 669
G++YLH I+HRD+K NIL+D+ + K+ADFGL++ GP + +
Sbjct: 127 GINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKY 183
Query: 670 G-------YLDPEY-FRRQQLTEKSDVYSFGVVLMEVLCTRPAL 705
Y PE ++ T D++ G V E+ RP L
Sbjct: 184 TNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPIL 227
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 4e-17
Identities = 62/202 (30%), Positives = 101/202 (50%), Gaps = 21/202 (10%)
Query: 510 LGVGGFGRVYKGTL------DDGTKVAVKRGNPRSEQGIAE-FRTEIEMLSKL-RHRHLV 561
LG G FG+V + T D KVAVK P + E +E++++S L H ++V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 562 SLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAA 621
+L+G C ++++ EY G L + L L+ + L A+G+ +L A+
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL---AS 159
Query: 622 QSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVST-AVKGS----FGYLDPEY 676
++ IHRD+ N+LL + K+ DFGL A D + S VKG+ ++ PE
Sbjct: 160 KNCIHRDLAARNVLLTHGKIVKICDFGL-----ARDIMNDSNYVVKGNARLPVKWMAPES 214
Query: 677 FRRQQLTEKSDVYSFGVVLMEV 698
T +SDV+S+G++L E+
Sbjct: 215 IFNCVYTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-17
Identities = 73/283 (25%), Positives = 119/283 (42%), Gaps = 48/283 (16%)
Query: 506 ESLLLGVGGFGRVYKG-TLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLI 564
E ++LG G +G VY L ++A+K R + + EI + S L+HR++V +
Sbjct: 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYL 71
Query: 565 GYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSW---------KQRLEICIGAARGLHY 615
G E + E + G L S L + PL KQ LE GL Y
Sbjct: 72 GSDSENGFFKIFMEQVPGGSL-SALLRSKWGPLKDNEQTIIFYTKQILE-------GLKY 123
Query: 616 LHTGAAQSIIHRDVKTTNILLDD-NFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDP 674
LH I+HRD+K N+L++ + V K++DFG SK ++ + G+ Y+ P
Sbjct: 124 LHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--CTETFTGTLQYMAP 178
Query: 675 EYFRRQQ--LTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQI 732
E + +D++S G ++E+ +P P ++ + AM K GM
Sbjct: 179 EVIDKGPRGYGAPADIWSLGCTIVEMATGKP------PFIELGEPQAAMF--KVGMF--- 227
Query: 733 MDSNLVGKVNPASLKKFGETAE----KCLAEHGVDRPSMGDVL 771
K++P + A+ +C R S D+L
Sbjct: 228 -------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLL 263
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 5e-17
Identities = 53/201 (26%), Positives = 92/201 (45%), Gaps = 18/201 (8%)
Query: 510 LGVGGFGRVYKGTLDDGTKV-AVKRGNPR---SEQGIAEFRTEIEMLSKLRHRHLVSLIG 565
LG GGFG V + K+ A K+ + + +G E ++L K+ R +VSL
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 566 YCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRL----EICIGAARGLHYLHTGAA 621
+ + ++ LV M G L+ H+Y P + + +I G L +LH
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICG----LEHLHQ--- 113
Query: 622 QSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQ 681
+ I++RD+K N+LLDD+ +++D GL+ + G+ GY+ PE + +
Sbjct: 114 RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMAPEVLQGEV 170
Query: 682 LTEKSDVYSFGVVLMEVLCTR 702
D ++ G L E++ R
Sbjct: 171 YDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 5e-17
Identities = 54/197 (27%), Positives = 93/197 (47%), Gaps = 10/197 (5%)
Query: 510 LGVGGFGR--VYKGTLDDGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIG 565
LG G FG +Y+ T +D + V K N SE+ + EI +LS L+H ++++
Sbjct: 8 LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 566 YCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSII 625
+ + + +++ EY G L + + L + Y+H I+
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK---AGIL 123
Query: 626 HRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEK 685
HRD+KT NI L + K+ DFG+SK + ++ V G+ Y+ PE + + K
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAETVVGTPYYMSPELCQGVKYNFK 181
Query: 686 SDVYSFGVVLMEVLCTR 702
SD+++ G VL E+L +
Sbjct: 182 SDIWALGCVLYELLTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 6e-17
Identities = 57/208 (27%), Positives = 91/208 (43%), Gaps = 25/208 (12%)
Query: 503 KFDESLLLGVGGFGRVYKG-TLDDGTKVAVKRGN-PRSEQGIAEFRTEIEMLSKLRHRHL 560
+ E + GVG VY L + KVA+KR + + + + E R E++ +S+ H ++
Sbjct: 4 ELIEVI--GVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNV 61
Query: 561 VSLIGYCDERSEMILVYEYMANGPLR---SHLYGTDLPPLSWKQRLEICIGAA-----RG 612
V E+ LV Y++ G L Y E I +G
Sbjct: 62 VKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLD-------EAIIATVLKEVLKG 114
Query: 613 LHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKT--GPALDQTHVSTAVKGSFG 670
L YLH+ IHRD+K NILL ++ K+ADFG+S + V G+
Sbjct: 115 LEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPC 171
Query: 671 YLDPEYFRRQQ-LTEKSDVYSFGVVLME 697
++ PE + K+D++SFG+ +E
Sbjct: 172 WMAPEVMEQVHGYDFKADIWSFGITAIE 199
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 7e-17
Identities = 56/189 (29%), Positives = 94/189 (49%), Gaps = 21/189 (11%)
Query: 529 VAVKRGNP-RSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRS 587
VAVK P ++ +F E+++LS+L+ +++ L+G C + + ++ EYM NG L
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 588 HLY----------GTD-------LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVK 630
L G D LP +S+ L + + A G+ YL ++ + +HRD+
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLA 165
Query: 631 TTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYS 690
T N L+ +N K+ADFG+S+ A D + ++ E + T SDV++
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWA 225
Query: 691 FGVVLMEVL 699
FGV L E+L
Sbjct: 226 FGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 8e-17
Identities = 64/229 (27%), Positives = 108/229 (47%), Gaps = 43/229 (18%)
Query: 493 MFQEILDATNKFDESLLLGVGGFGRVYKGT-LDDGTKVAVKR-GNPRSEQGIAE--FRTE 548
+F + + TN++ + +G+G FG V G VA+K+ P S +A+ +R E
Sbjct: 1 IFGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-E 59
Query: 549 IEMLSKLRHRHLVSLIG-YCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLE--- 604
+++L LRH +++SL + ++ V E L GTDL L + LE
Sbjct: 60 LKLLKHLRHENIISLSDIFISPLEDIYFVTE----------LLGTDLHRLLTSRPLEKQF 109
Query: 605 ---ICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHV 661
RGL Y+H+ ++HRD+K +NIL+++N K+ DFGL++ Q
Sbjct: 110 IQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI-----QDPQ 161
Query: 662 STAVKGSFGYLDPEYFRR-------QQLTEKSDVYSFGVVLMEVLCTRP 703
T GY+ Y+R Q+ + D++S G + E+L +P
Sbjct: 162 MT------GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKP 204
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 2e-16
Identities = 56/195 (28%), Positives = 87/195 (44%), Gaps = 19/195 (9%)
Query: 524 DDGTKVAVK---RGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLI--GYCDERSEMILVYE 578
G +VA+K P E A FR E + ++L H ++V+L+ G + V+E
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFE 59
Query: 579 YMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILL-- 636
Y+ LR L P RL + L L Q I+HRD+K NI++
Sbjct: 60 YVPGRTLREVLAADGALPAGETGRL-----MLQVLDALACAHNQGIVHRDLKPQNIMVSQ 114
Query: 637 -DDNFVAKVADFGLSKTGPALDQTHVSTA-----VKGSFGYLDPEYFRRQQLTEKSDVYS 690
AKV DFG+ P + V+T V G+ Y PE R + +T SD+Y+
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYA 174
Query: 691 FGVVLMEVLCTRPAL 705
+G++ +E L + +
Sbjct: 175 WGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 16/206 (7%)
Query: 503 KFDESLLLGVGGFGRVY--KGTLDDGTKVAVKRGN----PRSEQGIAEFRTEIEMLSKLR 556
+++ +G G FG++Y K D +K + P E+ + + E+ +L+K++
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDS-EHCVIKEIDLTKMPVKEKEAS--KKEVILLAKMK 57
Query: 557 HRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYL 616
H ++V+ E + +V EY G L + S Q L + + GL ++
Sbjct: 58 HPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHI 117
Query: 617 HTGAAQSIIHRDVKTTNILLDDN-FVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPE 675
H + I+HRD+K+ NI L N VAK+ DFG+++ D ++ G+ YL PE
Sbjct: 118 HD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELAYTCVGTPYYLSPE 172
Query: 676 YFRRQQLTEKSDVYSFGVVLMEVLCT 701
+ + K+D++S G VL E LCT
Sbjct: 173 ICQNRPYNNKTDIWSLGCVLYE-LCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 62/208 (29%), Positives = 102/208 (49%), Gaps = 15/208 (7%)
Query: 510 LGVGGFGRVYKG-TLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCD 568
LG G FG+VYK + G A K +SE+ + ++ EIE+L+ H ++V L+G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 569 ERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRD 628
++ ++ E+ G + + + D L+ Q IC L YLH+ IIHRD
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHS---MKIIHRD 135
Query: 629 VKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTE---- 684
+K N+LL + K+ADFG+S Q S G+ ++ PE + + +
Sbjct: 136 LKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI--GTPYWMAPEVVMCETMKDTPYD 193
Query: 685 -KSDVYSFGVVLMEVLCTRPA---LNPV 708
K+D++S G+ L+E+ P LNP+
Sbjct: 194 YKADIWSLGITLIEMAQIEPPHHELNPM 221
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 4e-16
Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 20/207 (9%)
Query: 509 LLGVGGFGRVYKG-TLDDGTKVAVKR-----GNPRSEQGIAEFRTEIEMLSKLRHRHLVS 562
LLG G FG VY D G ++AVK+ + + + + EI++L LRH +V
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 563 LIGYC---DERSEMILVYEYMANGPLRSHL--YGTDLPPLSWKQRLEICIGAARGLHYLH 617
G C E ++ + EYM G ++ L YG ++ + +I +G+ YLH
Sbjct: 69 YYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQIL----QGVSYLH 123
Query: 618 TGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVS-TAVKGSFGYLDPEY 676
+ I+HRD+K NIL D K+ DFG SK + + +V G+ ++ PE
Sbjct: 124 ---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEV 180
Query: 677 FRRQQLTEKSDVYSFGVVLMEVLCTRP 703
+ K+DV+S ++E+L +P
Sbjct: 181 ISGEGYGRKADVWSVACTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 5e-16
Identities = 67/206 (32%), Positives = 97/206 (47%), Gaps = 22/206 (10%)
Query: 510 LGVGGFGRVYKGTL---DDGTKVAVKRGN----PRSEQGIAEFRTEIEMLSKLRHRHLVS 562
LG G FG V +G L D KVAVK RSE + +F +E + + H +++
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSE--MEDFLSEAVCMKEFDHPNVMR 64
Query: 563 LIGYCDERSEM------ILVYEYMANGPLRSHLYGT---DLPPLSWKQRL-EICIGAARG 612
LIG C + E +++ +M +G L S L + D P Q L + A G
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 613 LHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYL 672
+ YL + +S IHRD+ N +L++N VADFGLSK D K ++
Sbjct: 125 MEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWI 181
Query: 673 DPEYFRRQQLTEKSDVYSFGVVLMEV 698
E + T KSDV+SFGV + E+
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 5e-16
Identities = 62/207 (29%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 509 LLGVGGFGRVYKGTL--DDGT--KVAVK--RGNPRSEQGIAEFRTEIEMLSKLRHRHLVS 562
+LG G FG V + L +DG+ KVAVK + + S I EF E + + H +++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 563 LIGYCDERSEM------ILVYEYMANGPLRSHLY----GTDLPPLSWKQRLEICIGAARG 612
LIG +++ +M +G L + L G + L + + I A G
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 613 LHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYL 672
+ YL ++++ IHRD+ N +L++N VADFGLSK + D A K +L
Sbjct: 126 MEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182
Query: 673 DPEYFRRQQLTEKSDVYSFGVVLMEVL 699
E T SDV++FGV + E++
Sbjct: 183 ALESLADNVYTTHSDVWAFGVTMWEIM 209
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 8e-16
Identities = 74/288 (25%), Positives = 134/288 (46%), Gaps = 39/288 (13%)
Query: 510 LGVGGFGRVYKGTLDDGTK--VAVKRGN-PRSEQGIAEFRTEIEMLSKLRHRHLVSLIGY 566
+G G FG V+KG +D+ T+ VA+K + +E I + + EI +LS+ ++ G
Sbjct: 12 IGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 567 CDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIH 626
+ +++ ++ EY+ G S L + PL Q I +GL YLH+ + IH
Sbjct: 71 YLKDTKLWIIMEYLGGG---SALDLLEPGPLDETQIATILREILKGLDYLHS---EKKIH 124
Query: 627 RDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 686
RD+K N+LL ++ K+ADFG++ G D G+ ++ PE ++ K+
Sbjct: 125 RDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKA 182
Query: 687 DVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASL 746
D++S G+ +E+ P + + P + + L+ K NP +L
Sbjct: 183 DIWSLGITAIELAKGEPPHSELHPMKVL---------------------FLIPKNNPPTL 221
Query: 747 -----KKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLEETSSALME 789
K E E CL + RP+ ++L + ++ ++ + +S L E
Sbjct: 222 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH-KFIVRFAKKTSYLTE 268
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 3e-15
Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 15/201 (7%)
Query: 510 LGVGGFGRVY------KGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSL 563
LG GGFG V G L K+ KR R +G E +L+K+ R +VSL
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKR--KGYEGAMVEKRILAKVHSRFIVSL 58
Query: 564 IGYCDERSEMILVYEYMANGPLRSHLYGTDL--PPLSWKQRLEICIGAARGLHYLHTGAA 621
++++ LV M G LR H+Y D P + GL +LH
Sbjct: 59 AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ--- 115
Query: 622 QSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQ 681
+ II+RD+K N+LLD++ +++D GL+ D + G+ G++ PE + ++
Sbjct: 116 RRIIYRDLKPENVLLDNDGNVRISDLGLAVE--LKDGQSKTKGYAGTPGFMAPELLQGEE 173
Query: 682 LTEKSDVYSFGVVLMEVLCTR 702
D ++ GV L E++ R
Sbjct: 174 YDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-15
Identities = 62/206 (30%), Positives = 99/206 (48%), Gaps = 22/206 (10%)
Query: 504 FDESLLLGVGGFGRV------YKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRH 557
F + +LG GGFG V G + K+ KR R + +A E ++L K+
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNS 59
Query: 558 RHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRL----EICIGAARGL 613
R +VSL + + + LV M G L+ H+Y + + EIC G L
Sbjct: 60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG----L 115
Query: 614 HYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLD 673
LH + I++RD+K NILLDD+ +++D GL+ P QT + V G+ GY+
Sbjct: 116 EDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE-GQT-IKGRV-GTVGYMA 169
Query: 674 PEYFRRQQLTEKSDVYSFGVVLMEVL 699
PE + ++ T D ++ G +L E++
Sbjct: 170 PEVVKNERYTFSPDWWALGCLLYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-15
Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 503 KFDESLLLGVGGFGRVY--KGTLDDGTKVAVKR----GNPRSEQGIAEFRTEIEMLSKLR 556
K+++ ++G G FG V+ + D V +K+ + E+ A+ E ++L L
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQ--NECQVLKLLS 57
Query: 557 HRHLVSLIGYCD---ERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGL 613
H ++I Y + E +++V EY G L ++ L L + L
Sbjct: 58 HP---NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLAL 114
Query: 614 HYLHTGAAQSIIHRDVKTTNILLDDN-FVAKVADFGLSKTGPALDQTHVSTAVKGSFGYL 672
H++HT + I+HRD+KT NILLD + V K+ DFG+SK L + V G+ Y+
Sbjct: 115 HHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKI---LSSKSKAYTVVGTPCYI 168
Query: 673 DPEYFRRQQLTEKSDVYSFGVVLMEVL 699
PE + +KSD+++ G VL E+
Sbjct: 169 SPELCEGKPYNQKSDIWALGCVLYELA 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 56/174 (32%), Positives = 85/174 (48%), Gaps = 43/174 (24%)
Query: 504 FDESLLLGVGGFGRVYKGT-LDDGTKVAVKRGN-PRSEQGI--AEFRTEIEMLSKLR--- 556
++E +G G +G VYK L+ G VA+K+ P SE+GI + R EI +L +L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR-EIALLKQLESFE 59
Query: 557 HRHLVSLIGYC----DERSEMI-LVYE--------YMANGPLRSHLYGTDLPP-----LS 598
H ++V L+ C +R + LV+E Y++ P LPP L
Sbjct: 60 HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCP------KPGLPPETIKDLM 113
Query: 599 WKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKT 652
Q L RG+ +LH+ I+HRD+K NIL+ + K+ADFGL++
Sbjct: 114 R-QLL-------RGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARI 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 23/211 (10%)
Query: 510 LGVGGFGRVYKG-TLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCD 568
+G G +G VYK ++ G A+K + A + EI M+ +H ++V+ G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 569 ERSEMILVYEYMANGPLRS--HLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIH 626
R ++ + E+ G L+ H+ G PLS Q + +GL+YLH+ + +H
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYHVTG----PLSESQIAYVSRETLQGLYYLHS---KGKMH 129
Query: 627 RDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSF----GYLDPEYF---RR 679
RD+K NILL DN K+ADFG+S Q + A + SF ++ PE R+
Sbjct: 130 RDIKGANILLTDNGHVKLADFGVSA------QITATIAKRKSFIGTPYWMAPEVAAVERK 183
Query: 680 QQLTEKSDVYSFGVVLMEVLCTRPALNPVLP 710
+ D+++ G+ +E+ +P + + P
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPMFDLHP 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 4e-15
Identities = 76/276 (27%), Positives = 113/276 (40%), Gaps = 47/276 (17%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFR---TEIEMLSKLRHRHLVSLIG 565
+G G FG VY + VA+K+ + +Q +++ E+ L +LRH + + G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 566 YCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSII 625
LV EY S + PL + IC GA +GL YLH+ I
Sbjct: 83 CYLREHTAWLVMEYCLGSA--SDILEVHKKPLQEVEIAAICHGALQGLAYLHS---HERI 137
Query: 626 HRDVKTTNILLDDNFVAKVADFG-LSKTGPALDQTHVSTAVKGSFGYLDPEY---FRRQQ 681
HRD+K NILL + K+ADFG S PA + V T ++ PE Q
Sbjct: 138 HRDIKAGNILLTEPGTVKLADFGSASLVSPA--NSFVGTPY-----WMAPEVILAMDEGQ 190
Query: 682 LTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKV 741
K DV+S G+ +E+ +P P +N AM+ L I +
Sbjct: 191 YDGKVDVWSLGITCIELAERKP------PLFNMN----AMS-----ALYHIAQN------ 229
Query: 742 NPASLKK------FGETAEKCLAEHGVDRPSMGDVL 771
+ +L F + CL + DRPS ++L
Sbjct: 230 DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELL 265
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 22/206 (10%)
Query: 504 FDESLLLGVGGFGRV------YKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRH 557
F + +LG GGFG V G + ++ KR R + +A E ++L K+
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA--LNEKQILEKVNS 59
Query: 558 RHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRL----EICIGAARGL 613
+ +V+L + + + LV M G L+ H+Y P ++ L EI G L
Sbjct: 60 QFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCG----L 115
Query: 614 HYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLD 673
LH ++ ++RD+K NILLDD +++D GL+ P + G+ GY+
Sbjct: 116 EDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV---GTVGYMA 169
Query: 674 PEYFRRQQLTEKSDVYSFGVVLMEVL 699
PE Q+ T D + G ++ E++
Sbjct: 170 PEVLNNQRYTLSPDYWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 4e-15
Identities = 59/268 (22%), Positives = 118/268 (44%), Gaps = 34/268 (12%)
Query: 517 RVYKGTLDDGTKVAV---KRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGY----CDE 569
+YKG ++ +V + K+ + + I EI+ L ++ +++ + G+ D+
Sbjct: 35 SIYKGIFNN-KEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93
Query: 570 RSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDV 629
+ L+ EY G LR L LS+K +L++ I +GL+ L+ + ++++
Sbjct: 94 LPRLSLILEYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNL 149
Query: 630 KTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRR--QQLTEKSD 687
+ + L+ +N+ K+ GL K + +V+ V Y + + T K D
Sbjct: 150 TSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV-----YFSYKMLNDIFSEYTIKDD 204
Query: 688 VYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLK 747
+YS GVVL E+ + +P E + K + D I++ N K+
Sbjct: 205 IYSLGVVLWEIFTGK------IPFENLTT---------KEIYDLIINKNNSLKLPLDCPL 249
Query: 748 KFGETAEKCLAEHGVDRPSMGDVLWNLE 775
+ E C + + RP++ ++L+NL
Sbjct: 250 EIKCIVEACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 5e-15
Identities = 49/168 (29%), Positives = 78/168 (46%), Gaps = 44/168 (26%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVKR-GNPRSEQGIAEFRT--EIEMLSKLRHRHLVSLI 564
+G G +G V G KVA+K+ N + A+ R EI++L LRH +++ L+
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAK-RILREIKLLRHLRHENIIGLL 65
Query: 565 -----GYCDERSEMILVYEYMANGPLRSHLYGTDL-------PPLSWK-------QRLEI 605
++ +++ +V E M TDL PL+ Q L
Sbjct: 66 DILRPPSPEDFNDVYIVTELM----------ETDLHKVIKSPQPLTDDHIQYFLYQIL-- 113
Query: 606 CIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTG 653
RGL YLH+ ++IHRD+K +NIL++ N K+ DFGL++
Sbjct: 114 -----RGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGV 153
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 7e-15
Identities = 58/203 (28%), Positives = 104/203 (51%), Gaps = 23/203 (11%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKV----AVKRGNPRS-EQGIAEFRTEIEMLSKLRHRHLVS 562
+LG G FG VYKG + +G V A+K N + + EF E +++ + H HLV
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 563 LIGYCDERSEMILVYEYMANGPLRSHLY------GTDLPPLSWKQRLEICIGAARGLHYL 616
L+G C + + LV + M +G L +++ G+ L L+W C+ A+G+ YL
Sbjct: 74 LLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLL-LNW------CVQIAKGMMYL 125
Query: 617 HTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEY 676
+ ++HRD+ N+L+ K+ DFGL++ ++ + + K ++ E
Sbjct: 126 EE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 182
Query: 677 FRRQQLTEKSDVYSFGVVLMEVL 699
++ T +SDV+S+GV + E++
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 63/201 (31%), Positives = 91/201 (45%), Gaps = 18/201 (8%)
Query: 510 LGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFR--------TEIEMLSKLRHRHLV 561
LG G FG VY + D VA +R E + E E ++LSKL H +V
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 562 SLIGYCDERSEMILVYEYMANGPLRSHL--YGTDLPPLSWKQRLEICIGAARGLHYLHTG 619
ER ++ EY L L LS Q E I G+HY+H
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ- 124
Query: 620 AAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRR 679
+ I+HRD+K NI L +N + K+ DFG+S+ + ++T G+ Y+ PE +
Sbjct: 125 --RRILHRDLKAKNIFLKNNLL-KIGDFGVSRL--LMGSCDLATTFTGTPYYMSPEALKH 179
Query: 680 QQLTEKSDVYSFGVVLMEVLC 700
Q KSD++S G +L E+ C
Sbjct: 180 QGYDSKSDIWSLGCILYEMCC 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 61/208 (29%), Positives = 102/208 (49%), Gaps = 15/208 (7%)
Query: 510 LGVGGFGRVYKG-TLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCD 568
LG G FG+VYK + G A K + +SE+ + ++ EI++L+ H ++V L+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 569 ERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRD 628
+ + ++ E+ A G + + + + PL+ Q +C L+YLH IIHRD
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHE---NKIIHRD 128
Query: 629 VKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYF-----RRQQLT 683
+K NIL + K+ADFG+S Q S G+ ++ PE + +
Sbjct: 129 LKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI--GTPYWMAPEVVMCETSKDRPYD 186
Query: 684 EKSDVYSFGVVLMEVLCTRPA---LNPV 708
K+DV+S G+ L+E+ P LNP+
Sbjct: 187 YKADVWSLGITLIEMAQIEPPHHELNPM 214
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 50/157 (31%), Positives = 80/157 (50%), Gaps = 14/157 (8%)
Query: 502 NKFDESLLLGVGGFGRVYK-GTLDDGTKVAVKRGNPRSEQG----IAEFRTEIEMLSKLR 556
K++ L+G G +G V K + G VA+K+ + IA R EI ML +LR
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIA-MR-EIRMLKQLR 58
Query: 557 HRHLVSLIGYCDERSEMILVYEYMANGPLRS-HLYGTDLPPLSWKQRLEICIGAARGLHY 615
H +LV+LI + + LV+E++ + L Y L ++ L + RG+ +
Sbjct: 59 HENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQIL---RGIEF 115
Query: 616 LHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKT 652
H+ +IIHRD+K NIL+ + V K+ DFG ++T
Sbjct: 116 CHS---HNIIHRDIKPENILVSQSGVVKLCDFGFART 149
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 1e-14
Identities = 63/211 (29%), Positives = 96/211 (45%), Gaps = 40/211 (18%)
Query: 510 LGVGGFGRV----YKGTLDDGTKVAVKRGNPRSEQGIAEFR------TEIEMLSKLRHRH 559
LG G FGRV +KG+ G A+K S+ I + + E +L +RH
Sbjct: 9 LGTGSFGRVMLVRHKGS---GKYYALKI---LSKAKIVKLKQVEHVLNEKRILQSIRHPF 62
Query: 560 LVSLIG-YCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAAR---GLHY 615
LV+L G + D+ + + LV EY+ G L SHL + P AA+ L Y
Sbjct: 63 LVNLYGSFQDDSN-LYLVMEYVPGGELFSHLRKSGRFPEPV-----ARFYAAQVVLALEY 116
Query: 616 LHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVK---GSFGYL 672
LH+ I++RD+K N+LLD + K+ DFG +K V G+ YL
Sbjct: 117 LHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAK--------RVKGRTYTLCGTPEYL 165
Query: 673 DPEYFRRQQLTEKSDVYSFGVVLMEVLCTRP 703
PE + + D ++ G+++ E+L P
Sbjct: 166 APEIILSKGYGKAVDWWALGILIYEMLAGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 72/270 (26%), Positives = 121/270 (44%), Gaps = 38/270 (14%)
Query: 510 LGVGGFGRVYKGTLDDGTK--VAVKRGN-PRSEQGIAEFRTEIEMLSKLRHRHLVSLIGY 566
+G G FG VYKG +D+ TK VA+K + +E I + + EI +LS+ ++ G
Sbjct: 12 IGKGSFGEVYKG-IDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGS 70
Query: 567 CDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIH 626
+ +++ ++ EY+ G S L PL I +GL YLH+ + IH
Sbjct: 71 YLKGTKLWIIMEYLGGG---SALDLLKPGPLEETYIATILREILKGLDYLHS---ERKIH 124
Query: 627 RDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 686
RD+K N+LL + K+ADFG++ G D G+ ++ PE ++ K+
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKA 182
Query: 687 DVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASL 746
D++S G+ +E+ P + + P + L+ K +P +L
Sbjct: 183 DIWSLGITAIELAKGEPPNSDLHPMRVL---------------------FLIPKNSPPTL 221
Query: 747 -----KKFGETAEKCLAEHGVDRPSMGDVL 771
K F E E CL + RP+ ++L
Sbjct: 222 EGQYSKPFKEFVEACLNKDPRFRPTAKELL 251
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 52/199 (26%), Positives = 96/199 (48%), Gaps = 17/199 (8%)
Query: 510 LGVGGFGR-VYKGTLDDGTKVAVK-----RGNPRSEQGIAEFRTEIEMLSKLRHRHLVSL 563
+G G FG+ + + +DG + +K + +P+ + E R E+ +LS ++H ++V
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKERE---ESRKEVAVLSNMKHPNIVQY 64
Query: 564 IGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQS 623
+E + +V +Y G L + Q L+ + L ++H +
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD---RK 121
Query: 624 IIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT-HVSTAVKGSFGYLDPEYFRRQQL 682
I+HRD+K+ NI L + K+ DFG+++ L+ T ++ G+ YL PE +
Sbjct: 122 ILHRDIKSQNIFLTKDGTIKLGDFGIARV---LNSTVELARTCIGTPYYLSPEICENRPY 178
Query: 683 TEKSDVYSFGVVLMEVLCT 701
KSD+++ G VL E +CT
Sbjct: 179 NNKSDIWALGCVLYE-MCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 37/212 (17%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVKR------GNPRSEQGIAEFRTEIEMLSKLRHRHLVS 562
+G G F VYK L DG VA+K+ + ++ Q + EI++L +L H +++
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK---EIDLLKQLDHPNVIK 66
Query: 563 LIGYCDERSEMILVYEYMANGPLRSHLY------GTDLP-PLSWKQRLEICIGAARGLHY 615
+ E +E+ +V E G L S + +P WK +++C L +
Sbjct: 67 YLASFIENNELNIVLELADAGDL-SRMIKHFKKQKRLIPERTIWKYFVQLC----SALEH 121
Query: 616 LHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGL-----SKTGPALDQTHVSTAVKGSFG 670
+H+ + I+HRD+K N+ + V K+ D GL SKT A + V T
Sbjct: 122 MHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA--HSLVGTPY----- 171
Query: 671 YLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTR 702
Y+ PE KSD++S G +L E+ +
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQ 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 62/225 (27%), Positives = 106/225 (47%), Gaps = 26/225 (11%)
Query: 496 EILDATNKFDESLLLGVGGFGRVYKGTL------DDGTKVAVKRGNPRSEQGI-AEFRTE 548
EI +T +F E L G FG+VYKG L + VA+K ++E + EF+ E
Sbjct: 1 EINLSTVRFMEEL--GEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 549 IEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHL--------YGTDLPPLSWK 600
M S+L+H ++V L+G + + +++ Y ++ L L G+ + K
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 601 QRLE------ICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGP 654
LE I A G+ +L ++ ++H+D+ T N+L+ D K++D GL +
Sbjct: 119 STLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175
Query: 655 ALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVL 699
A D + ++ PE + + SD++S+GVVL EV
Sbjct: 176 AADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 63/198 (31%), Positives = 92/198 (46%), Gaps = 20/198 (10%)
Query: 510 LGVGGFGRVYKG---TLDDGTKVAVK--RGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLI 564
LG G FG V KG VAVK + + E E ++ +L + ++V +I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 565 GYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSI 624
G C+ S M LV E GPL L ++ K E+ + G+ YL +
Sbjct: 63 GICEAESWM-LVMELAELGPLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEE---TNF 116
Query: 625 IHRDVKTTNILLDDNFVAKVADFGLSKTGPALD-----QTHVSTAVKGSFGYLDPEYFRR 679
+HRD+ N+LL AK++DFGLSK A + +TH VK + PE
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVK----WYAPECMNY 172
Query: 680 QQLTEKSDVYSFGVVLME 697
+ + KSDV+SFGV++ E
Sbjct: 173 YKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 22/228 (9%)
Query: 513 GGFGRVYKGTLDDGT-----KVAVKR-GNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGY 566
G FGR++ G L D +V VK + SE + E +L L H++++ ++
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76
Query: 567 CDERSEMILV-YEYMANGPLRSHLYGTDLPP------LSWKQRLEICIGAARGLHYLHTG 619
C E E V Y YM G L+ L L LS +Q + + I A G+ YLH
Sbjct: 77 CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK- 135
Query: 620 AAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRR 679
+ +IH+D+ N ++D+ K+ D LS+ +D + ++ E
Sbjct: 136 --RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVN 193
Query: 680 QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKG 727
++ + SDV+SFGV+L E L T P +++ E A + K G
Sbjct: 194 KEYSSASDVWSFGVLLWE-LMTLGQ----TPYVEIDPFEMA-AYLKDG 235
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 4e-14
Identities = 63/213 (29%), Positives = 102/213 (47%), Gaps = 34/213 (15%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRT--EIEMLSKLRHRHLVSLI- 564
+G G +G V T G KVA+K+ +P Q + RT EI++L + +H +++ ++
Sbjct: 12 YIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQ-RTLREIKILRRFKHENIIGILD 70
Query: 565 ----GYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRL---EIC-----IGAARG 612
+ +++ +V E M TDL L Q L I I RG
Sbjct: 71 IIRPPSFESFNDVYIVQELME----------TDLYKLIKTQHLSNDHIQYFLYQI--LRG 118
Query: 613 LHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSK-TGPALDQTHVSTAVKGSFGY 671
L Y+H + +++HRD+K +N+LL+ N K+ DFGL++ P D T T + Y
Sbjct: 119 LKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWY 175
Query: 672 LDPEYFRRQQLTEKS-DVYSFGVVLMEVLCTRP 703
PE + K+ D++S G +L E+L RP
Sbjct: 176 RAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRP 208
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 5e-14
Identities = 59/197 (29%), Positives = 88/197 (44%), Gaps = 21/197 (10%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFR---TEIEMLSKLRHRHLVSLIG 565
LG G G V K G +AVK R E A + E+++L K ++V G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKT--IRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 566 YCDERSEMILVYEYMANGPL----RSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAA 621
++ + EYM G L + L +I + +GL YLH
Sbjct: 67 AFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLHE--K 119
Query: 622 QSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQ 681
IIHRDVK +NIL++ K+ DFG+S L + T V G+ Y+ PE +
Sbjct: 120 HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQ---LVNSLAKTFV-GTSSYMAPERIQGND 175
Query: 682 LTEKSDVYSFGVVLMEV 698
+ KSD++S G+ L+E+
Sbjct: 176 YSVKSDIWSLGLSLIEL 192
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 5e-14
Identities = 55/200 (27%), Positives = 87/200 (43%), Gaps = 12/200 (6%)
Query: 509 LLGVGGFGRV----YKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKL-RHRHLVSL 563
+LG G FG+V KGT + +K+ + + TE +L+ +H L L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 564 IGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQS 623
+ + V EY+ G L H+ + + I GL +LH +
Sbjct: 62 HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEI--VLGLQFLHE---RG 116
Query: 624 IIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLT 683
II+RD+K N+LLD K+ADFG+ K G T ++ G+ Y+ PE Q
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAPEILSYQPYG 174
Query: 684 EKSDVYSFGVVLMEVLCTRP 703
D ++ GV+L E+L +
Sbjct: 175 PAVDWWALGVLLYEMLAGQS 194
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 6e-14
Identities = 68/270 (25%), Positives = 120/270 (44%), Gaps = 38/270 (14%)
Query: 510 LGVGGFGRVYKGTLDDGTK--VAVKRGN-PRSEQGIAEFRTEIEMLSKLRHRHLVSLIGY 566
+G G FG V+KG +D+ T+ VA+K + +E I + + EI +LS+ ++ G
Sbjct: 12 IGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 567 CDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIH 626
+ +++ ++ EY+ G L P Q + +GL YLH+ + IH
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHS---EKKIH 124
Query: 627 RDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 686
RD+K N+LL + K+ADFG++ G D G+ ++ PE ++ K+
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKA 182
Query: 687 DVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASL 746
D++S G+ +E+ P + + P + L+ K NP +L
Sbjct: 183 DIWSLGITAIELAKGEPPNSDMHPMRVL---------------------FLIPKNNPPTL 221
Query: 747 -----KKFGETAEKCLAEHGVDRPSMGDVL 771
K F E + CL + RP+ ++L
Sbjct: 222 TGEFSKPFKEFIDACLNKDPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 7e-14
Identities = 45/165 (27%), Positives = 82/165 (49%), Gaps = 12/165 (7%)
Query: 544 EFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHL---------YGTDL 594
+F EI+++S+L+ +++ L+ C + ++ EYM NG L L D+
Sbjct: 65 DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124
Query: 595 PPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGP 654
+S+ + + A G+ YL ++ + +HRD+ T N L+ N+ K+ADFG+S+
Sbjct: 125 VTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 655 ALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVL 699
+ D + ++ E + T SDV++FGV L E+L
Sbjct: 182 SGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 7e-14
Identities = 63/206 (30%), Positives = 98/206 (47%), Gaps = 27/206 (13%)
Query: 510 LGVGGFGRVYK-GTLDDGTKVAVKRGNPRSE----QGIAEFRTEIEMLSKLRHRHLVSLI 564
+G G +G V+K + G VA+K+ + + IA R EI ML +L+H +LV+LI
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIA-LR-EIRMLKQLKHPNLVNLI 66
Query: 565 GYCDERSEMILVYEYMAN---GPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAA 621
+ ++ LV+EY + L + G +P K+ I + +++ H
Sbjct: 67 EVFRRKRKLHLVFEYCDHTVLNELEKNPRG--VPEHLIKK---IIWQTLQAVNFCH---K 118
Query: 622 QSIIHRDVKTTNILLDDNFVAKVADFGLSK--TGPALDQT-HVSTAVKGSFGYLDPEYF- 677
+ IHRDVK NIL+ K+ DFG ++ TGP D T +V+T Y PE
Sbjct: 119 HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRAPELLV 173
Query: 678 RRQQLTEKSDVYSFGVVLMEVLCTRP 703
Q DV++ G V E+L +P
Sbjct: 174 GDTQYGPPVDVWAIGCVFAELLTGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 69/225 (30%), Positives = 108/225 (48%), Gaps = 32/225 (14%)
Query: 502 NKFDESLLLGVGGFGRVYKGT-LDDGTKVAVKR---GNPRSEQGIAEFRTEIEMLSKLRH 557
+KFD +G G +G+VYK D G VA+K+ N + I R EI++L +L H
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQLNH 65
Query: 558 RHLVSL-------IGYCDERSE---MILVYEYMAN---GPLRSHL--YGTDLPPLSWKQR 602
R++V+L D + + LV+EYM + G L S L + D KQ
Sbjct: 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQL 125
Query: 603 LEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVS 662
LE GL+Y H ++ +HRD+K +NILL++ K+ADFGL++ + + +
Sbjct: 126 LE-------GLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYT 175
Query: 663 TAVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLMEVLCTRPALN 706
V + Y PE ++ DV+S G +L E+ +P
Sbjct: 176 NKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQ 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 1e-13
Identities = 64/198 (32%), Positives = 90/198 (45%), Gaps = 17/198 (8%)
Query: 510 LGVGGFGRV----YKGTLDDGTKVAVKRGNPRSEQGIAEFRTE---IEMLSKLRHRHLVS 562
LG G FG+V YK T + A+K+G+ + + E E + RH LV+
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 563 LIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQ 622
L + V EY A G L H++ TD+ C+ GL YLH
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHIH-TDVFSEPRAVFYAACV--VLGLQYLHE---N 120
Query: 623 SIIHRDVKTTNILLD-DNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQ 681
I++RD+K N+LLD + FV K+ADFGL K G ST G+ +L PE
Sbjct: 121 KIVYRDLKLDNLLLDTEGFV-KIADFGLCKEGMGFGDR-TSTFC-GTPEFLAPEVLTETS 177
Query: 682 LTEKSDVYSFGVVLMEVL 699
T D + GV++ E+L
Sbjct: 178 YTRAVDWWGLGVLIYEML 195
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 65/203 (32%), Positives = 93/203 (45%), Gaps = 22/203 (10%)
Query: 510 LGVGGFGRVYKGTL-DDGTKVAVKRGNPRS--EQGIAE-FRTEIEMLSKLRHRHLVSLI- 564
LGVGGFGRV + A+K R E G E +E E+L + H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 565 GYCDERSEMILVY---EYMANGPLRSHLYGTDLPPLSWKQRLEI-CIGAARGLHYLHTGA 620
+ D++ +Y EY G L + L L + R I C+ A YLH
Sbjct: 61 TFKDKKY----IYMLMEYCLGGELWTILRDRGLFD-EYTARFYIACVVLA--FEYLH--- 110
Query: 621 AQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQ 680
+ II+RD+K N+LLD N K+ DFG +K + +T T G+ Y+ PE +
Sbjct: 111 NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW--TFC-GTPEYVAPEIILNK 167
Query: 681 QLTEKSDVYSFGVVLMEVLCTRP 703
D +S G++L E+L RP
Sbjct: 168 GYDFSVDYWSLGILLYELLTGRP 190
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 55/199 (27%), Positives = 90/199 (45%), Gaps = 16/199 (8%)
Query: 509 LLGVGGFGRVYKGTLDDGTK----VAVK--RGNPRSEQGIAEFRTEIEMLSKLRHRHLVS 562
+LG G FG + +G L +K VA+ R +Q F E L + H ++V
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRG-FLAEALTLGQFDHSNIVR 70
Query: 563 LIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQ 622
L G + M++V EYM+NG L S L + L Q + + G A G+ YL +
Sbjct: 71 LEGVITRGNTMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYL---SEM 126
Query: 623 SIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYL--DPEYFRRQ 680
+H+ + +L++ + V K++ F + T + G L PE +
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYH 183
Query: 681 QLTEKSDVYSFGVVLMEVL 699
+ SDV+SFG+V+ EV+
Sbjct: 184 HFSSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 67/206 (32%), Positives = 98/206 (47%), Gaps = 21/206 (10%)
Query: 510 LGVGGFGRVYKG-TLDDGTKVAVKRGNPRSEQG---IAEFRTEIEMLSKLRHRHLVSL-- 563
+G G +G VY+ G VA+K+ +E+ I+ R EI +L LRH ++V L
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHPNIVELKE 73
Query: 564 --IGYCDERSEMILVYEYMANGPLRSHLYGTDLP-PLSWKQRLEICIGAARGLHYLHTGA 620
+G + LV EY L S L ++P P S Q + + RGL YLH
Sbjct: 74 VVVG--KHLDSIFLVMEYCEQD-LASLLD--NMPTPFSESQVKCLMLQLLRGLQYLHE-- 126
Query: 621 AQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPE-YFRR 679
IIHRD+K +N+LL D K+ADFGL++T + V + Y PE
Sbjct: 127 -NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV--TLWYRAPELLLGC 183
Query: 680 QQLTEKSDVYSFGVVLMEVLCTRPAL 705
T D+++ G +L E+L +P L
Sbjct: 184 TTYTTAIDMWAVGCILAELLAHKPLL 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 65/220 (29%), Positives = 96/220 (43%), Gaps = 23/220 (10%)
Query: 510 LGVGGFGRVYKGTL---------DDGTKVAVKRGNPRSEQGIAE-FRTEIEMLSKLRHRH 559
LG G F +YKG L G +V+V S+ + F ++S+L H+H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 560 LVSLIGYCDERSEMILVYEYMANGPLRSHLY-GTDLPPLSWKQRLEICIGAARGLHYLHT 618
LV L G C R E I+V EY+ GPL L+ + L WK L++ A LHYL
Sbjct: 63 LVKLYGVC-VRDENIMVEEYVKFGPLDVFLHREKNNVSLHWK--LDVAKQLASALHYLED 119
Query: 619 GAAQSIIHRDVKTTNILL--DDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEY 676
+ ++H +V NIL+ V LS G + V+ ++ PE
Sbjct: 120 ---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERI-PWIAPEC 175
Query: 677 FRRQQ--LTEKSDVYSFGVVLMEVLCTRPA-LNPVLPREQ 713
R Q LT +D +SFG L+E+ L+ + E+
Sbjct: 176 IRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK 215
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 3e-13
Identities = 58/216 (26%), Positives = 106/216 (49%), Gaps = 11/216 (5%)
Query: 490 RLFMFQEILDATNKFDESLLLGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRTE 548
+L I D K+ +G G G V+ + G +VA+K+ N + + E
Sbjct: 7 KLRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINE 66
Query: 549 IEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIG 608
I ++ +L++ ++V+ + E+ +V EY+A G L + T + Q +C
Sbjct: 67 ILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRE 123
Query: 609 AARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGL-SKTGPALDQTHVSTAVKG 667
+ L +LH A +IHRD+K+ N+LL + K+ DFG ++ P +Q+ ST V G
Sbjct: 124 CLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-G 177
Query: 668 SFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRP 703
+ ++ PE R+ K D++S G++ +E++ P
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 53/160 (33%), Positives = 79/160 (49%), Gaps = 12/160 (7%)
Query: 496 EILDATNKFDESLL--LGVGGFGRVYKG-TLDDGTKVAVKRGNPRSEQGIAEFRTEIEML 552
+IL + D L+ +G G +G VYK L G AVK + + EI M+
Sbjct: 1 DILRRNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMV 60
Query: 553 SKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRS--HLYGTDLPPLSWKQRLEICIGAA 610
+ +H ++V+ G R ++ + EY G L+ H+ G PLS Q +C
Sbjct: 61 KECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTG----PLSELQIAYVCRETL 116
Query: 611 RGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLS 650
+GL YLH+ +HRD+K NILL DN K+ADFG++
Sbjct: 117 QGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVA 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 5e-13
Identities = 62/222 (27%), Positives = 108/222 (48%), Gaps = 19/222 (8%)
Query: 488 LGRLFMFQEILDATNKFDESLLLGVGGFGRVYKGT-LDDGTKVAVKRGN----PRSEQGI 542
L +L + D K+ +G G G VY + G +VA+K+ N P+ E I
Sbjct: 5 LEKLRTIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELII 64
Query: 543 AEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQR 602
EI ++ + +H ++V+ + E+ +V EY+A G L + T + Q
Sbjct: 65 ----NEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE---GQI 117
Query: 603 LEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGL-SKTGPALDQTHV 661
+C + L +LH + +IHRD+K+ NILL + K+ DFG ++ P +Q+
Sbjct: 118 AAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKR 172
Query: 662 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRP 703
ST V G+ ++ PE R+ K D++S G++ +E++ P
Sbjct: 173 STMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 5e-13
Identities = 61/210 (29%), Positives = 94/210 (44%), Gaps = 31/210 (14%)
Query: 510 LGVGGFGRVYKG----TLDDG----TKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLV 561
LG G F +++KG D G T+V +K + F M+S+L H+HLV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 562 SLIGYCDERSEMILVYEYMANGPLRSHL-YGTDLPPLSWKQRLEICIGAARGLHYLHTGA 620
G C E I+V EY+ G L ++L +L +SWK LE+ A LH+L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK--LEVAKQLAWALHFLED-- 118
Query: 621 AQSIIHRDVKTTNILL----DDN-----FVAKVADFGLSKTGPALDQTHVSTAVKGSFGY 671
+ + H +V N+LL D F+ K++D G+S T + + +
Sbjct: 119 -KGLTHGNVCAKNVLLIREEDRKTGNPPFI-KLSDPGISITVLPKE------ILLERIPW 170
Query: 672 LDPEYFRR-QQLTEKSDVYSFGVVLMEVLC 700
+ PE Q L+ +D +SFG L E+
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFS 200
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 5e-13
Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 19/206 (9%)
Query: 510 LGVGGFGRVYKGTL----DDGTKVAVKRGN----PRSEQGIAEFRTEIEMLSKLRHRHLV 561
+G G +G V +L DG + +K+ N R E+ AE E ++LS+L+H ++V
Sbjct: 8 VGKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAE--QEAQLLSQLKHPNIV 62
Query: 562 SLI-GYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGA 620
+ + E + +V + G L L L Q +E + A L YLH
Sbjct: 63 AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE-- 120
Query: 621 AQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQ 680
+ I+HRD+KT N+ L + KV D G+++ +Q +++ + G+ Y+ PE F +
Sbjct: 121 -KHILHRDLKTQNVFLTRTNIIKVGDLGIARV--LENQCDMASTLIGTPYYMSPELFSNK 177
Query: 681 QLTEKSDVYSFGVVLMEVLCTRPALN 706
KSDV++ G + E+ + A N
Sbjct: 178 PYNYKSDVWALGCCVYEMATLKHAFN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 6e-13
Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 22/206 (10%)
Query: 504 FDESLLLGVGGFGRV------YKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRH 557
F +LG GGFG V G + K+ KR R + +A E ++L K+
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNS 59
Query: 558 RHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRL----EICIGAARGL 613
R +VSL + + + LV M G L+ H+Y P ++ + EI G L
Sbjct: 60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCG----L 115
Query: 614 HYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLD 673
LH + I++RD+K NILLDD +++D GL+ P + + V G+ GY+
Sbjct: 116 EDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIP--EGETIRGRV-GTVGYMA 169
Query: 674 PEYFRRQQLTEKSDVYSFGVVLMEVL 699
PE + ++ T D + G ++ E++
Sbjct: 170 PEVVKNERYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 6e-13
Identities = 59/247 (23%), Positives = 103/247 (41%), Gaps = 56/247 (22%)
Query: 502 NKFDESLLLGVGGFGRVYKG-TLDDGTKVAVK-----RGNPRSEQGIAEFRTEIEMLSKL 555
NK++ ++G G +G V K G VA+K + ++ E+++L +L
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALR---EVKVLRQL 57
Query: 556 RHRHLVSLIGYCDERSEMILVYEYMANGPLRS-HLYGTDLPP-----LSWKQRLEICIGA 609
RH ++V+L + + LV+EY+ L LPP W Q L
Sbjct: 58 RHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIW-QLL------ 110
Query: 610 ARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSF 669
+ + Y H + +IIHRD+K NIL+ ++ V K+ DFG ++ A + ++
Sbjct: 111 -QAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD------ 160
Query: 670 GYLDPEYFRRQQLTEKS-------DVYSFGVVLMEVLCTRP----------------ALN 706
Y+ ++R +L DV++ G ++ E+L P L
Sbjct: 161 -YVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLG 219
Query: 707 PVLPREQ 713
P+ P Q
Sbjct: 220 PLPPSHQ 226
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 7e-13
Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 28/205 (13%)
Query: 509 LLGVGGFGR--VYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGY 566
++G G FGR + + D + P+S + + R E +L+K++H ++V+
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 567 CDERSEMILVYEYMANGPL-------RSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTG 619
+ + +V EY G L R L+ D L W +++C+G + ++H
Sbjct: 67 FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTI-LQW--FVQMCLG----VQHIHE- 118
Query: 620 AAQSIIHRDVKTTNILLDDNFVAKVADFGLSK--TGP-ALDQTHVSTAVKGSFGYLDPEY 676
+ ++HRD+K+ NI L N K+ DFG ++ T P A T+V T Y+ PE
Sbjct: 119 --KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPY-----YVPPEI 171
Query: 677 FRRQQLTEKSDVYSFGVVLMEVLCT 701
+ KSD++S G +L E LCT
Sbjct: 172 WENMPYNNKSDIWSLGCILYE-LCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 7e-13
Identities = 58/212 (27%), Positives = 108/212 (50%), Gaps = 18/212 (8%)
Query: 497 ILDATNKFDESLLLGVGGFGRVYKGT-LDDGTK----VAVKR----GNPRSEQGIAEFRT 547
IL T +F + +LG G FG VYKG + +G K VA+K +P++ + I +
Sbjct: 3 ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD--- 58
Query: 548 EIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICI 607
E +++ + + H+ L+G C S + L+ + M G L ++ + + L C+
Sbjct: 59 EAYVMASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCV 116
Query: 608 GAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKG 667
A+G++YL + ++HRD+ N+L+ K+ DFGL+K A ++ + + K
Sbjct: 117 QIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKV 173
Query: 668 SFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVL 699
++ E + T +SDV+S+GV + E++
Sbjct: 174 PIKWMALESILHRIYTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 8e-13
Identities = 57/206 (27%), Positives = 92/206 (44%), Gaps = 22/206 (10%)
Query: 504 FDESLLLGVGGFGRV------YKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRH 557
F +LG GGFG V G + K+ KR R + +A E +L K+
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNS 59
Query: 558 RHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRL----EICIGAARGL 613
R +VSL + + + LV M G L+ H+Y P ++ + E+C G L
Sbjct: 60 RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCG----L 115
Query: 614 HYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLD 673
L + I++RD+K NILLDD +++D GL+ P + G+ GY+
Sbjct: 116 EDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIP---EGETVRGRVGTVGYMA 169
Query: 674 PEYFRRQQLTEKSDVYSFGVVLMEVL 699
PE ++ T D + G ++ E++
Sbjct: 170 PEVINNEKYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 8e-13
Identities = 63/229 (27%), Positives = 91/229 (39%), Gaps = 50/229 (21%)
Query: 509 LLGVGGFGRVYKGTL----DDGTKVAVKRGNP----RSEQGIAEFRTEIEMLSKLRHRHL 560
++G G FG V+ L D G A+K + Q IA R E ++L+ +
Sbjct: 8 VIGRGAFGEVW---LVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADADSPWI 63
Query: 561 VSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRL--EICIGAARGLHYLHT 618
V L + + LV EYM G L + L D+ P + E+ A L +H
Sbjct: 64 VKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELV--LA--LDSVHK 119
Query: 619 GAAQSIIHRDVKTTNILLDDNFVAKVADFGLSK--------------------------T 652
IHRD+K NIL+D + K+ADFGL K
Sbjct: 120 ---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVR 176
Query: 653 GPALDQTHV--STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVL 699
Q V ++ V G+ Y+ PE R + D +S GV+L E+L
Sbjct: 177 RRDHKQRRVRANSTV-GTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 9e-13
Identities = 49/171 (28%), Positives = 80/171 (46%), Gaps = 28/171 (16%)
Query: 499 DATNKFDESLLLGVGGFGRVYKG-TLDDGTKVAVKR---GNPRSEQGIAEFRTEIEMLSK 554
D +K+++ +G G FG V+K VA+K+ N + I R EI++L
Sbjct: 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR-EIKILQL 67
Query: 555 LRHRHLVSLIGYCDE--------RSEMILVYEYMAN---GPLRSHLYGTDLPPLS--WKQ 601
L+H ++V+LI C + LV+E+ + G L + L + K
Sbjct: 68 LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKM 127
Query: 602 RLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKT 652
L GL+Y+H I+HRD+K NIL+ + + K+ADFGL++
Sbjct: 128 LLN-------GLYYIHR---NKILHRDMKAANILITKDGILKLADFGLARA 168
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 9e-13
Identities = 69/255 (27%), Positives = 110/255 (43%), Gaps = 45/255 (17%)
Query: 507 SLLLGVGGFGRV-YKGTLDDGTKVAVKRGNPR--SEQGIAEFRTEIEML------SKLR- 556
S +LG G G V + DG AVK + SE + E+ L S ++
Sbjct: 37 SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKC 96
Query: 557 HRHLVSLIGYCDERSE-----MILVYEYMANGPLRSHLYG---TDLPPLSWKQRLEICIG 608
H D R+ + LV +Y G LR + T+ + L + I
Sbjct: 97 HEDFA----KKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGL-LFIQ 151
Query: 609 AARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGS 668
+H++H+ + +IHRD+K+ NILL N + K+ DFG SK A V G+
Sbjct: 152 VLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGT 208
Query: 669 FGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGM 728
Y+ PE +RR+ ++K+D++S GV+L E+L + P + N+ E
Sbjct: 209 PYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR------PFDGENMEE---------- 252
Query: 729 LDQIMDSNLVGKVNP 743
+M L G+ +P
Sbjct: 253 ---VMHKTLAGRYDP 264
|
Length = 496 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 9e-13
Identities = 59/217 (27%), Positives = 88/217 (40%), Gaps = 49/217 (22%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRT--------EIEMLSKL-RHRH 559
LG G FG VY + G VA+K+ +F + E++ L KL H +
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 560 LVSLIGYCDERSEMILVYEYMANGPLRSHLYGT----DLPPLSWKQRLEICIGAARGLHY 615
+V L E E+ V+EYM +LY P S I +GL +
Sbjct: 60 IVKLKEVFRENDELYFVFEYMEG-----NLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114
Query: 616 LHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSK--------TGPALDQTHVSTAVKG 667
+H HRD+K N+L+ V K+ADFGL++ T +VST
Sbjct: 115 IHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYT------DYVSTR--- 162
Query: 668 SFGYLDPEYFRRQQL-TEKSDVYSFGVVLMEVLCTRP 703
Y PE R + D+++ G ++ E+ RP
Sbjct: 163 --WYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRP 197
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 79/294 (26%), Positives = 129/294 (43%), Gaps = 50/294 (17%)
Query: 499 DATNKFDESLLLGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKL-R 556
D F+ ++G G +G+VYKG + G A+K + +E E + EI ML K
Sbjct: 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TEDEEEEIKLEINMLKKYSH 71
Query: 557 HRHLVSLIGYCDERS------EMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAA 610
HR++ + G ++S ++ LV E+ G + + T L IC
Sbjct: 72 HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREIL 131
Query: 611 RGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT--HVSTAVKGS 668
RGL +LH A +IHRD+K N+LL +N K+ DFG+S LD+T +T + G+
Sbjct: 132 RGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ---LDRTVGRRNTFI-GT 184
Query: 669 FGYLDPEYFRRQQLTE-----KSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTW 723
++ PE + + +SD++S G+ +E+ P L + P +
Sbjct: 185 PYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL--------- 235
Query: 724 QKKGMLDQIMDSNLVGKVNPASL------KKFGETAEKCLAEHGVDRPSMGDVL 771
L+ + P L KKF + E CL ++ + RPS +L
Sbjct: 236 ------------FLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLL 277
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 69/224 (30%), Positives = 99/224 (44%), Gaps = 21/224 (9%)
Query: 510 LGVGGFGRVYKG-TLDDGTKVAVKRGNPRSEQGIAEFR---TEIEMLSKLRHRHLVSLIG 565
+G GG+G+V+ D G VA+KR + E R TE ++L+ + LV L+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 566 YCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQ-RLEIC--IGAARGLHYLHTGAAQ 622
+ + L EY+ G R+ L +L LS R + A LH L
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLL--NNLGVLSEDHARFYMAEMFEAVDALHEL------ 120
Query: 623 SIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQL 682
IHRD+K N L+D + K+ DFGLSK + +V GS Y+ PE R +
Sbjct: 121 GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY-----ANSVVGSPDYMAPEVLRGKGY 175
Query: 683 TEKSDVYSFGVVLMEVLCTRPALNPVLPREQ-VNIAEWAMTWQK 725
D +S G +L E LC P + P E N+ W T Q+
Sbjct: 176 DFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQR 219
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 55/210 (26%), Positives = 99/210 (47%), Gaps = 17/210 (8%)
Query: 499 DATNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRH 557
D D + +G G G V T G +VAVK+ + R +Q E+ ++ H
Sbjct: 19 DPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHH 78
Query: 558 RHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLH 617
++V + E+ +V E++ G L + T + + +Q +C+ R L YLH
Sbjct: 79 ENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRM---NEEQIATVCLSVLRALSYLH 135
Query: 618 TGAAQSIIHRDVKTTNILLDDNFVAKVADFG----LSKTGPALDQTHVSTAVKGSFGYLD 673
Q +IHRD+K+ +ILL + K++DFG +SK P ++ G+ ++
Sbjct: 136 N---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK------RKSLVGTPYWMA 186
Query: 674 PEYFRRQQLTEKSDVYSFGVVLMEVLCTRP 703
PE R + D++S G++++E++ P
Sbjct: 187 PEVISRLPYGTEVDIWSLGIMVIEMIDGEP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 2e-12
Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 30/208 (14%)
Query: 510 LGVGGFGRVYKGTLDDGT--KVAVKRGNPRSEQGIAEFRT--EIEMLSKLRHRHLVSLIG 565
+G G +G+V D T KVA+K+ + + I RT E+ +L + H +++ L+
Sbjct: 23 VGSGAYGQVCS-AFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLD 81
Query: 566 -YC--DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRL---EICIGA---ARGLHYL 616
+ + VY L +HL G DL + Q+L I RGL Y+
Sbjct: 82 VFTPASSLEDFQDVY-------LVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYI 134
Query: 617 HTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPE- 675
H+ IIHRD+K +NI ++++ K+ DFGL++ +V+T Y PE
Sbjct: 135 HSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEI 186
Query: 676 YFRRQQLTEKSDVYSFGVVLMEVLCTRP 703
+ D++S G ++ E+L +
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLTGKT 214
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 2e-12
Identities = 51/172 (29%), Positives = 82/172 (47%), Gaps = 35/172 (20%)
Query: 503 KFDESLLLGVGGFGRVYKG---TLDDGTKVAVK--RGNPRSEQGI--AEFRTEIEMLSKL 555
K++ +G G +GRVYK DG + A+K +G+ GI + R EI +L +L
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACR-EIALLREL 59
Query: 556 RHRHLVSLIGYCDERSEMI--LVYEYMANGPL------RSHLYGTDLPPLSWK----QRL 603
+H ++VSL+ E ++ L+++Y A L +PP K Q L
Sbjct: 60 KHENVVSLVEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQIL 118
Query: 604 EICIGAARGLHYLHTGAAQSIIHRDVKTTNILL----DDNFVAKVADFGLSK 651
G+HYLH + ++HRD+K NIL+ + V K+ D GL++
Sbjct: 119 N-------GVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 510 LGVGGFGRVYKG-TLDDGTKVAVKRGN-PRSEQG--IAEFRTEIEMLSKLR---HRHLVS 562
+GVG +G VYK G VA+K +E G ++ R E+ +L +L H ++V
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVR-EVALLKRLEAFDHPNIVR 66
Query: 563 LIGYC-----DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLH 617
L+ C D +++ LV+E++ + LR++L P L + ++ RGL +LH
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH 125
Query: 618 TGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVS-TAVKGSFGYLDPEY 676
I+HRD+K NIL+ K+ADFGL++ + ++ T V + Y PE
Sbjct: 126 A---NCIVHRDLKPENILVTSGGQVKLADFGLAR----IYSCQMALTPVVVTLWYRAPEV 178
Query: 677 FRRQQLTEKSDVYSFGVVLMEVLCTRP 703
+ D++S G + E+ +P
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEMFRRKP 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 54/219 (24%), Positives = 92/219 (42%), Gaps = 32/219 (14%)
Query: 509 LLGVGGFGRVYKGTLDDG------------TKVAVKRGNPRSEQGIAEFRTEIEMLSK-L 555
LG G FG VYK + A + ++ I + +E+ ++ + L
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 556 RHRHLVSLIGYCDERSEMILVYEYMANGPLRSHL------YGTDLPPLSWKQRLEICIGA 609
RH ++V E + +V + + PL H W +++ +
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA- 125
Query: 610 ARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSF 669
L YLH + I+HRD+ NI+L ++ + DFGL+K T+V G+
Sbjct: 126 ---LRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQK---QPESKLTSVVGTI 177
Query: 670 GYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPV 708
Y PE + + EK+DV++FG +L + +CT L P
Sbjct: 178 LYSCPEIVKNEPYGEKADVWAFGCILYQ-MCT---LQPP 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 2e-12
Identities = 76/289 (26%), Positives = 122/289 (42%), Gaps = 50/289 (17%)
Query: 499 DATNKFDESLLLGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKL-R 556
D F+ L+G G +G+VYKG + G A+K + ++ E + EI ML K
Sbjct: 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSH 61
Query: 557 HRHLVSLIGYCDERS------EMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAA 610
HR++ + G +++ ++ LV E+ G + + T L + IC
Sbjct: 62 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 121
Query: 611 RGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT-HVSTAVKGSF 669
RGL +LH +IHRD+K N+LL +N K+ DFG+S LD+T G+
Sbjct: 122 RGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ---LDRTVGRRNTFIGTP 175
Query: 670 GYLDPEYFRRQQLTE-----KSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQ 724
++ PE + + KSD++S G+ +E+ P L + P
Sbjct: 176 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-------------- 221
Query: 725 KKGMLDQIMDSNLVGKVNPASL-------KKFGETAEKCLAEHGVDRPS 766
M + + NPA KKF E CL ++ RP+
Sbjct: 222 --------MRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPT 262
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 43/155 (27%), Positives = 78/155 (50%), Gaps = 14/155 (9%)
Query: 548 EIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLR--SHLYGTDLPPLSWKQRLEI 605
E++++ + R ++VS G + + + E+M G L G P+ + +I
Sbjct: 53 ELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGG----PIPVEILGKI 108
Query: 606 CIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLS-KTGPALDQTHVSTA 664
+ GL YL+ I+HRD+K +NIL++ K+ DFG+S + ++ T V T+
Sbjct: 109 AVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTS 166
Query: 665 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVL 699
Y+ PE + + T KSDV+S G+ ++E+
Sbjct: 167 T-----YMSPERIQGGKYTVKSDVWSLGISIIELA 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 3e-12
Identities = 60/206 (29%), Positives = 93/206 (45%), Gaps = 21/206 (10%)
Query: 509 LLGVGGFGRVYKGTLDDGT--------KVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHL 560
+LG GG+G+V++ G KV K R+++ A + E +L ++H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 561 VSLIGYCDERSEMILVYEYMANGPLRSHLY--GTDLPPLSWKQRLEICIGAARGLHYLHT 618
V LI ++ L+ EY++ G L HL G + + EI + L +LH
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLA----LEHLHQ 118
Query: 619 GAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQ-THVSTAVKGSFGYLDPEYF 677
Q II+RD+K NILLD K+ DFGL K TH G+ Y+ PE
Sbjct: 119 ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC---GTIEYMAPEIL 172
Query: 678 RRQQLTEKSDVYSFGVVLMEVLCTRP 703
R + D +S G ++ ++L P
Sbjct: 173 MRSGHGKAVDWWSLGALMYDMLTGAP 198
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 48/185 (25%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 526 GTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPL 585
G +VAVK+ + R +Q E+ ++ +H ++V + E+ +V E++ G L
Sbjct: 44 GRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103
Query: 586 RSHLYGTDL---PPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVA 642
TD+ ++ +Q +C+ + L +LH AQ +IHRD+K+ +ILL +
Sbjct: 104 ------TDIVTHTRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRV 154
Query: 643 KVADFG----LSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEV 698
K++DFG +SK P ++ G+ ++ PE R + D++S G++++E+
Sbjct: 155 KLSDFGFCAQVSKEVPR------RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEM 208
Query: 699 LCTRP 703
+ P
Sbjct: 209 VDGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 60/207 (28%), Positives = 92/207 (44%), Gaps = 29/207 (14%)
Query: 510 LGVGGFGRVY----KGTLDDGTKVAVK---RGNPRSEQGIAEF-RTEIEMLSKLRHR-HL 560
LG G +G+V+ G D G A+K + + AE RTE ++L +R L
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 561 VSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIG----AARGLHYL 616
V+L +++ L+ +Y+ G L +HLY + S + + I A LH L
Sbjct: 68 VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES---EVRVYIAEIVLALDHLHQL 124
Query: 617 HTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSK--TGPALDQTHVSTAVKGSFGYLDP 674
II+RD+K NILLD + DFGLSK ++ + + G+ Y+ P
Sbjct: 125 ------GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY---SFCGTIEYMAP 175
Query: 675 EYFRRQQLTEKS--DVYSFGVVLMEVL 699
E R D +S GV+ E+L
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELL 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 6e-12
Identities = 62/199 (31%), Positives = 92/199 (46%), Gaps = 18/199 (9%)
Query: 509 LLGVGGFGRVY----KGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLS-KLRHRHLVSL 563
+LG G FG+V+ KGT A+K+ + + E +LS H L L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 564 IGYCDERSEMILVYEYMANGPLRSHL---YGTDLPPLSWKQRLEICIGAARGLHYLHTGA 620
+ + V EY+ G L H+ + DLP ++ IC GL +LH+
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIIC-----GLQFLHS-- 114
Query: 621 AQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQ 680
+ I++RD+K NILLD + K+ADFG+ K L T G+ Y+ PE Q
Sbjct: 115 -KGIVYRDLKLDNILLDTDGHIKIADFGMCKEN-MLGDAKTCTFC-GTPDYIAPEILLGQ 171
Query: 681 QLTEKSDVYSFGVVLMEVL 699
+ D +SFGV+L E+L
Sbjct: 172 KYNTSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 7e-12
Identities = 54/202 (26%), Positives = 93/202 (46%), Gaps = 20/202 (9%)
Query: 510 LGVGGFGRV------YKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSL 563
LG GGFG V G + K+ KR +S + +A EI L K+ +V+L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNL 58
Query: 564 IGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQS 623
+ ++ + LV M G L+ H+Y L ++ + G+ +LH+
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MD 115
Query: 624 IIHRDVKTTNILLDDNFVAKVADFGLS---KTGPALDQTHVSTAVKGSFGYLDPEYFRRQ 680
I++RD+K N+LLDD +++D GL+ K G + Q G+ GY+ PE + +
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQR------AGTNGYMAPEILKEE 169
Query: 681 QLTEKSDVYSFGVVLMEVLCTR 702
+ D ++ G + E++ R
Sbjct: 170 PYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 8e-12
Identities = 59/206 (28%), Positives = 102/206 (49%), Gaps = 25/206 (12%)
Query: 510 LGVGGFGRVYKG-TLDDGTKVAVKRGNPRSE-QGIAEFRT-EIEMLSKLRHRHLVSLIGY 566
+G G +G VYKG G VA+K+ SE +G+ EI +L +L+H ++V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 567 CDERSEMILVYEYMANGPLRSHL----YGTDLPPLSWKQRL-EICIGAARGLHYLHTGAA 621
+ S + L++E+++ L+ +L G + K L +I +G+ + H +
Sbjct: 68 LMQESRLYLIFEFLSMD-LKKYLDSLPKGQYMDAELVKSYLYQI----LQGILFCH---S 119
Query: 622 QSIIHRDVKTTNILLDDNFVAKVADFGLSKTG--PALDQTH-VSTAVKGSFGYLDPEYFR 678
+ ++HRD+K N+L+D+ V K+ADFGL++ P TH V T Y PE
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVT-----LWYRAPEVLL 174
Query: 679 -RQQLTEKSDVYSFGVVLMEVLCTRP 703
+ + D++S G + E+ +P
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMATKKP 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 8e-12
Identities = 65/226 (28%), Positives = 104/226 (46%), Gaps = 36/226 (15%)
Query: 510 LGVGGFGRVYKGTLD--DGTKVAVKRGNPRSEQGIAE----FRTEIEMLSKLRHRHLVSL 563
+G G FG V+ T D DG +VA+K+ P Q + FR E++ML +H +++S
Sbjct: 8 IGYGAFGVVWSVT-DPRDGKRVALKK-MPNVFQNLVSCKRVFR-ELKMLCFFKHDNVLSA 64
Query: 564 I-----GYCDERSEMILVYEYMANGPLRSHLYGTDL-------PPLSWKQRLEICIGAAR 611
+ + D E+ +V E M +DL PLS R
Sbjct: 65 LDILQPPHIDPFEEIYVVTELMQ----------SDLHKIIVSPQPLSSDHVKVFLYQILR 114
Query: 612 GLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGY 671
GL YLH+ I+HRD+K N+L++ N V K+ DFGL++ + H++ V + Y
Sbjct: 115 GLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-Y 170
Query: 672 LDPEYFR-RQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNI 716
PE + T D++S G + E+L R P +Q+++
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDL 216
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 63/204 (30%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 510 LGVGGFGRVYKGTLDDGTK-VAVKRGNPRSEQGIAEFR---TEIEMLSKLRHRHLVSLIG 565
+G G FG VY T + VAVK+ + +Q +++ E++ L +L+H + + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 566 YCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSII 625
+ LV EY S L PL + I GA +GL YLH+ ++I
Sbjct: 89 CYLKEHTAWLVMEYCLGSA--SDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMI 143
Query: 626 HRDVKTTNILLDDNFVAKVADFG-LSKTGPALDQTHVSTAVKGSFGYLDPEY---FRRQQ 681
HRD+K NILL + K+ADFG SK+ PA + G+ ++ PE Q
Sbjct: 144 HRDIKAGNILLTEPGQVKLADFGSASKSSPA-------NSFVGTPYWMAPEVILAMDEGQ 196
Query: 682 LTEKSDVYSFGVVLMEVLCTRPAL 705
K DV+S G+ +E+ +P L
Sbjct: 197 YDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 1e-11
Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 11/207 (5%)
Query: 499 DATNKFDESLLLGVGGFGRVYKG-TLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRH 557
D K+ +G G G VY + G +VA+K+ N + + EI ++ + ++
Sbjct: 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKN 75
Query: 558 RHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLH 617
++V+ + E+ +V EY+A G L + T + Q +C + L +LH
Sbjct: 76 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLH 132
Query: 618 TGAAQSIIHRDVKTTNILLDDNFVAKVADFGL-SKTGPALDQTHVSTAVKGSFGYLDPEY 676
+ +IHRD+K+ NILL + K+ DFG ++ P +Q+ ST V G+ ++ PE
Sbjct: 133 S---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYWMAPEV 186
Query: 677 FRRQQLTEKSDVYSFGVVLMEVLCTRP 703
R+ K D++S G++ +E++ P
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 51/206 (24%), Positives = 97/206 (47%), Gaps = 9/206 (4%)
Query: 499 DATNKFDESLLLGVGGFGRVYKGTL-DDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRH 557
D D + +G G G V T+ G VAVK+ + R +Q E+ ++ +H
Sbjct: 17 DPRTYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH 76
Query: 558 RHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLH 617
++V + E+ +V E++ G L + T + + +Q +C+ + L LH
Sbjct: 77 ENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRM---NEEQIAAVCLAVLKALSVLH 133
Query: 618 TGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYF 677
AQ +IHRD+K+ +ILL + K++DFG + ++ G+ ++ PE
Sbjct: 134 ---AQGVIHRDIKSDSILLTHDGRVKLSDFGF--CAQVSKEVPRRKSLVGTPYWMAPELI 188
Query: 678 RRQQLTEKSDVYSFGVVLMEVLCTRP 703
R + D++S G++++E++ P
Sbjct: 189 SRLPYGPEVDIWSLGIMVIEMVDGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 73/288 (25%), Positives = 118/288 (40%), Gaps = 37/288 (12%)
Query: 510 LGVGGFGRVYKG-TLDDGTKVAVKRGNPRSEQGIAEFR---TEIEMLSKLRHRHLVSLIG 565
+G G FG VY + + VA+K+ + +Q +++ E+ L KLRH + + G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 566 YCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSII 625
LV EY S L PL + + GA +GL YLH+ ++I
Sbjct: 83 CYLREHTAWLVMEYCLGSA--SDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMI 137
Query: 626 HRDVKTTNILLDDNFVAKVADFG-LSKTGPALDQTHVSTAVKGSFGYLDPEY---FRRQQ 681
HRDVK NILL + + K+ DFG S PA G+ ++ PE Q
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDFGSASIMAPA-------NXFVGTPYWMAPEVILAMDEGQ 190
Query: 682 LTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKV 741
K DV+S G+ +E+ +P L N+ + + + S +
Sbjct: 191 YDGKVDVWSLGITCIELAERKPPL--------FNMNAMSALYHIAQNESPALQSGHWSE- 241
Query: 742 NPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLEETSSALME 789
+ F + CL + DRP+ +VL + + E + +M+
Sbjct: 242 ---YFRNF---VDSCLQKIPQDRPT-SEVLLKHRF-VLRERPPTVIMD 281
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 35/90 (38%), Positives = 54/90 (60%), Gaps = 5/90 (5%)
Query: 610 ARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSF 669
A L +LH+ II+RD+K NILLD+ K+ DFGLSK ++D + + G+
Sbjct: 108 ALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE--SIDHEKKAYSFCGTV 162
Query: 670 GYLDPEYFRRQQLTEKSDVYSFGVVLMEVL 699
Y+ PE R+ T+ +D +SFGV++ E+L
Sbjct: 163 EYMAPEVVNRRGHTQSADWWSFGVLMFEML 192
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 2e-11
Identities = 59/211 (27%), Positives = 87/211 (41%), Gaps = 37/211 (17%)
Query: 509 LLGVGGFGRVY----KGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLI 564
LLG G FG+V K + +K+ ++ +A TE +L RH L SL
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 565 GYCDERSEMILVYEYMANGPL-------------RSHLYGTDLPPLSWKQRLEICIGAAR 611
+ + V EY+ G L R+ YG ++
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEI---------------VS 106
Query: 612 GLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGY 671
L YLH+G I++RD+K N++LD + K+ DFGL K G D + T G+ Y
Sbjct: 107 ALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEG-ITDAATMKTFC-GTPEY 161
Query: 672 LDPEYFRRQQLTEKSDVYSFGVVLMEVLCTR 702
L PE D + GVV+ E++C R
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 4e-11
Identities = 50/174 (28%), Positives = 81/174 (46%), Gaps = 19/174 (10%)
Query: 548 EIEMLSKLRHRHLVSLIG--YCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEI 605
E+++L + ++V G Y D E+ + E+M G L L P + ++ I
Sbjct: 49 ELKVLHECNSPYIVGFYGAFYSD--GEISICMEHMDGGSLDQVLKKAGRIPENILGKISI 106
Query: 606 CIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTA- 664
+ RGL YL I+HRDVK +NIL++ K+ DFG+S Q S A
Sbjct: 107 AV--LRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS------GQLIDSMAN 156
Query: 665 -VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIA 717
G+ Y+ PE + T +SD++S G+ L+E+ R P+ P + +
Sbjct: 157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR---YPIPPPDAKELE 207
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 53/199 (26%), Positives = 95/199 (47%), Gaps = 19/199 (9%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVKR---GNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIG 565
+G G F VY+ T L DG VA+K+ + + A+ EI++L +L H +++
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 566 YCDERSEMILVYEYMANGPL----RSHLYGTDLPP--LSWKQRLEICIGAARGLHYLHTG 619
E +E+ +V E G L + L P WK +++C L ++H+
Sbjct: 70 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC----SALEHMHS- 124
Query: 620 AAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRR 679
+ ++HRD+K N+ + V K+ D GL + + +T + ++ G+ Y+ PE
Sbjct: 125 --RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERIHE 180
Query: 680 QQLTEKSDVYSFGVVLMEV 698
KSD++S G +L E+
Sbjct: 181 NGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 4e-11
Identities = 59/243 (24%), Positives = 101/243 (41%), Gaps = 33/243 (13%)
Query: 513 GGFGRVY----KGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYC- 567
G FG VY + T D +K+ + ++ + + E ++ V+ + Y
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66
Query: 568 DERSEMILVYEYMANGPLRSHLYGTDLPPLSW-KQRL-EICIGAARGLHYLHTGAAQSII 625
+ + LV EY+ G S + P W KQ + E+ +G + LH + II
Sbjct: 67 QSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLG----VEDLH---QRGII 119
Query: 626 HRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEK 685
HRD+K N+L+D K+ DFGLS+ G + G+ YL PE +
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYLAPETILGVGDDKM 173
Query: 686 SDVYSFGVVLMEVLCTRPALNPVLPREQV--NIAEWAMTWQK----------KGMLDQIM 733
SD +S G V+ E L P + P + V NI + W + ++++++
Sbjct: 174 SDWWSLGCVIFEFLFGYPPFHAETP-DAVFDNILSRRINWPEEVKEFCSPEAVDLINRLL 232
Query: 734 DSN 736
+
Sbjct: 233 CMD 235
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 5e-11
Identities = 59/210 (28%), Positives = 90/210 (42%), Gaps = 42/210 (20%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRTEIEM---LSKLRHR--HLVS 562
+G G G+VYK G +AVK+ R+ G E I M + H ++V
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQ-MRRT--GNKEENKRILMDLDVVLKSHDCPYIVK 78
Query: 563 LIGYCDERSEMILVYEYMA----------NGPLRSHLYGTDLPPLSWKQRLEICIGAARG 612
GY S++ + E M+ GP+ + G ++ + +
Sbjct: 79 CYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILG------------KMTVAIVKA 126
Query: 613 LHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD-QTHVSTAVKGSFGY 671
LHYL +IHRDVK +NILLD + K+ DFG+S G +D + +A G Y
Sbjct: 127 LHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGIS--GRLVDSKAKTRSA--GCAAY 180
Query: 672 LDPEYFRRQQLTEK----SDVYSFGVVLME 697
+ PE K +DV+S G+ L+E
Sbjct: 181 MAPERIDPPDPNPKYDIRADVWSLGISLVE 210
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 57/213 (26%), Positives = 94/213 (44%), Gaps = 46/213 (21%)
Query: 509 LLGVGGFGRVYKGTLDDGTKV-AVKRGNPRSEQGIAEFRTEIEMLSK------LRHRHLV 561
+LG G FG+V L + A+K + + + + E M+ + H L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIK--ALKKDVVLEDDDVECTMVERRVLALAWEHPFLT 59
Query: 562 SLIGYCDERSE--MILVYEYMANGPL-------------RSHLYGTDLPPLSWKQRLEIC 606
L +C +++ + V EY+ G L R+ Y ++ IC
Sbjct: 60 HL--FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEI----------IC 107
Query: 607 IGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVK 666
GL +LH + II+RD+K N+LLD + K+ADFG+ K + ++
Sbjct: 108 -----GLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFC 157
Query: 667 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVL 699
G+ Y+ PE + Q+ E D +SFGV+L E+L
Sbjct: 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 27/205 (13%)
Query: 509 LLGVGGFGRVYKGT-LDDGTK----VAVK--RGNPRSEQGIAEFRTEIEMLSKLRHRHLV 561
+LG G FG VYKG + DG VA+K R N S + E E +++ + ++
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVC 72
Query: 562 SLIGYCDERSEMILVYEYMANGPL-------RSHLYGTDLPPLSWKQRLEICIGAARGLH 614
L+G C S + LV + M G L + + DL L+W C+ A+G+
Sbjct: 73 RLLGIC-LTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDL--LNW------CVQIAKGMS 123
Query: 615 YLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDP 674
YL ++HRD+ N+L+ K+ DFGL++ + + + K ++
Sbjct: 124 YLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMAL 180
Query: 675 EYFRRQQLTEKSDVYSFGVVLMEVL 699
E ++ T +SDV+S+GV + E++
Sbjct: 181 ESILHRRFTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 8e-11
Identities = 43/165 (26%), Positives = 78/165 (47%), Gaps = 34/165 (20%)
Query: 503 KFDESLLLGVGGFGRVYKG-TLDDGTKVAVKRGNPRSE-QGIAEFRT-EIEMLSKLRHRH 559
K+++ +G G +G V+K + VA+KR + +G+ EI +L +L+H++
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 560 LVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAA--------- 610
+V L ++ LV+EY DL K+ + C G
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYCDQ----------DL-----KKYFDSCNGDIDPEIVKSFM 105
Query: 611 ----RGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSK 651
+GL + H + +++HRD+K N+L++ N K+ADFGL++
Sbjct: 106 FQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 9e-11
Identities = 53/202 (26%), Positives = 97/202 (48%), Gaps = 11/202 (5%)
Query: 510 LGVGGFGRVYKG-TLDDGTKVAVK--RGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGY 566
+G G +G VYK G VA+K R + +E + EI +L +L H ++V L+
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 567 CDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIH 626
+++ LV+E++ + L+ + + L + +GL + H + ++H
Sbjct: 68 IHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 123
Query: 627 RDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQL-TEK 685
RD+K N+L++ K+ADFGL++ +T+ V + Y PE + +
Sbjct: 124 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGCKYYSTA 181
Query: 686 SDVYSFGVVLMEVLCTRPALNP 707
D++S G + E++ TR AL P
Sbjct: 182 VDIWSLGCIFAEMV-TRRALFP 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 1e-10
Identities = 55/207 (26%), Positives = 102/207 (49%), Gaps = 11/207 (5%)
Query: 499 DATNKFDESLLLGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRH 557
D K+ +G G G VY + G +VA+++ N + + EI ++ + ++
Sbjct: 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN 76
Query: 558 RHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLH 617
++V+ + E+ +V EY+A G L + T + Q +C + L +LH
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH 133
Query: 618 TGAAQSIIHRDVKTTNILLDDNFVAKVADFGL-SKTGPALDQTHVSTAVKGSFGYLDPEY 676
+ +IHRD+K+ NILL + K+ DFG ++ P +Q+ ST V G+ ++ PE
Sbjct: 134 S---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYWMAPEV 187
Query: 677 FRRQQLTEKSDVYSFGVVLMEVLCTRP 703
R+ K D++S G++ +E++ P
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 62/198 (31%), Positives = 88/198 (44%), Gaps = 18/198 (9%)
Query: 510 LGVGGFGRVY--KGTLDD---GTKVAVKRG-NPRSEQG--IAEFRTEIEMLSKLRHRHLV 561
+G G FG+V K D KV K+ + EQ +AE +L ++H LV
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNV---LLKNVKHPFLV 59
Query: 562 SLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAA 621
L ++ V +Y+ G L HL P + I +A G YLH+
Sbjct: 60 GLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALG--YLHS--- 114
Query: 622 QSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQ 681
+II+RD+K NILLD + DFGL K G +T ++ G+ YL PE R+Q
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLAPEVLRKQP 172
Query: 682 LTEKSDVYSFGVVLMEVL 699
D + G VL E+L
Sbjct: 173 YDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 1e-10
Identities = 60/222 (27%), Positives = 102/222 (45%), Gaps = 41/222 (18%)
Query: 502 NKFDESLLLGVGGFGRVYKGT-LDDGTKVAVKRGNPRSE-QG--IAEFRTEIEMLSKLRH 557
N+ +E G +G VY+ G VA+K+ E +G I R EI +L KL+H
Sbjct: 11 NRIEE------GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKLQH 63
Query: 558 RHLVSLIGYCDERSEMI---------LVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIG 608
++V++ E++ +V EY+ + L+S L T P + + +
Sbjct: 64 PNIVTV-------KEVVVGSNLDKIYMVMEYVEH-DLKS-LMETMKQPFLQSEVKCLMLQ 114
Query: 609 AARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKT--GPALDQTH-VSTAV 665
G+ +LH I+HRD+KT+N+LL++ + K+ DFGL++ P T V T
Sbjct: 115 LLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVT-- 169
Query: 666 KGSFGYLDPE-YFRRQQLTEKSDVYSFGVVLMEVLCTRPALN 706
Y PE ++ + D++S G + E+L +P
Sbjct: 170 ---LWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFP 208
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 47/182 (25%), Positives = 91/182 (50%), Gaps = 16/182 (8%)
Query: 526 GTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPL 585
G +VAVK + R +Q E+ ++ +H+++V + E+ ++ E++ G L
Sbjct: 46 GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105
Query: 586 RSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVA 645
+ T L + +Q +C + L YLH +Q +IHRD+K+ +ILL + K++
Sbjct: 106 TDIVSQTRL---NEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLS 159
Query: 646 DFG----LSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCT 701
DFG +SK P ++ G+ ++ PE R + D++S G++++E++
Sbjct: 160 DFGFCAQISKDVPK------RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDG 213
Query: 702 RP 703
P
Sbjct: 214 EP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 1e-10
Identities = 67/232 (28%), Positives = 103/232 (44%), Gaps = 23/232 (9%)
Query: 482 SLASSNLGRLFMFQEILDATNKFDESLLLGVGGFGRVY-KGTLDDGTKVAVKRGNPRSEQ 540
SL + LF F+E D F + +G G FG VY + VA+K+ + +Q
Sbjct: 8 SLKDPEIAELF-FKE--DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ 64
Query: 541 GIAEFR---TEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPL 597
+++ E++ L +++H + + G LV EY S L PL
Sbjct: 65 SNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSA--SDLLEVHKKPL 122
Query: 598 SWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFG-LSKTGPAL 656
+ I GA +GL YLH+ ++IHRD+K NILL + K+ADFG S PA
Sbjct: 123 QEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178
Query: 657 DQTHVSTAVKGSFGYLDPEY---FRRQQLTEKSDVYSFGVVLMEVLCTRPAL 705
+ G+ ++ PE Q K DV+S G+ +E+ +P L
Sbjct: 179 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 54/206 (26%), Positives = 99/206 (48%), Gaps = 19/206 (9%)
Query: 510 LGVGGFGRVYKG-TLDDGTK-VAVKRGNPRSEQGIAEFRT--EIEMLSKLR---HRHLVS 562
+G G +G+V+K L +G + VA+KR ++ + T E+ +L L H ++V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 563 LIGYC-----DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLH 617
L C D +++ LV+E++ + L ++L P + + ++ RGL +LH
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 618 TGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYF 677
+ ++HRD+K NIL+ + K+ADFGL++ T+V + Y PE
Sbjct: 128 S---HRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYRAPEVL 181
Query: 678 RRQQLTEKSDVYSFGVVLMEVLCTRP 703
+ D++S G + E+ +P
Sbjct: 182 LQSSYATPVDLWSVGCIFAEMFRRKP 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 47/218 (21%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRT--EIEMLSKLRHRHLVSLIGY 566
+G G +G V + KVA+K+ + I RT EI++L L H +++++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 567 C-----DERSEMILVYEYMANGPLRSHLYGTDL-------PPLSWKQRLEICIGAARGLH 614
+ +++ +VYE M TDL LS RGL
Sbjct: 73 MPPPHREAFNDVYIVYELM----------DTDLHQIIRSSQTLSDDHCQYFLYQLLRGLK 122
Query: 615 YLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSF--GYL 672
Y+H+ +++HRD+K +N+LL+ N K+ DFGL++T T+ KG F Y+
Sbjct: 123 YIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLART----------TSEKGDFMTEYV 169
Query: 673 DPEYFRRQQL-------TEKSDVYSFGVVLMEVLCTRP 703
++R +L T DV+S G + E+L +P
Sbjct: 170 VTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKP 207
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 45/150 (30%), Positives = 80/150 (53%), Gaps = 17/150 (11%)
Query: 510 LGVGGFGRVYKG-TLDDGTKVAVKRGNPRSE-QGI--AEFRTEIEMLSKLRHRHLVSLIG 565
+G G +G VYK G VA+K+ +E +G+ R EI +L +L H ++V L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR-EISLLKELNHPNIVRLLD 65
Query: 566 YCDERSEMILVYEYMANGPLRSHL---YGTDLPPLSWKQRL-EICIGAARGLHYLHTGAA 621
+++ LV+E++ + L+ ++ T L P K L ++ +G+ Y H+
Sbjct: 66 VVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLL----QGIAYCHS--- 117
Query: 622 QSIIHRDVKTTNILLDDNFVAKVADFGLSK 651
++HRD+K N+L+D K+ADFGL++
Sbjct: 118 HRVLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 41/113 (36%), Positives = 56/113 (49%), Gaps = 19/113 (16%)
Query: 611 RGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD---QTHVSTAVKG 667
+ L+YL IIHRDVK +NILLD N K+ DFG+S G +D +T + G
Sbjct: 118 KALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGIS--GQLVDSIAKTRDA----G 169
Query: 668 SFGYLDPEY---FRRQQLTEKSDVYSFGVVLMEVLCTR---PALNPVLPREQV 714
Y+ PE R +SDV+S G+ L EV + P N V +Q+
Sbjct: 170 CRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVF--DQL 220
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 59/214 (27%), Positives = 87/214 (40%), Gaps = 43/214 (20%)
Query: 509 LLGVGGFGRVY----KGTLDDGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLRHRHLV 561
LLG G FG+V K T G A+K ++ +A TE +L RH L
Sbjct: 2 LLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 58
Query: 562 SLIGYCDERSEMILVYEYMANGPL-------------RSHLYGTDLPPLSWKQRLEICIG 608
+L + V EY G L R+ YG ++
Sbjct: 59 ALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEI-------------- 104
Query: 609 AARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGS 668
L YLH+ + +++RD+K N++LD + K+ DFGL K G + D + T G+
Sbjct: 105 -VSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-DGATMKTFC-GT 158
Query: 669 FGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTR 702
YL PE D + GVV+ E++C R
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-10
Identities = 54/199 (27%), Positives = 96/199 (48%), Gaps = 36/199 (18%)
Query: 533 RGNPRSEQGIAEF------------RTEIEMLSKLRHRHLVSLIGYCDERSE--MILVYE 578
RG+ E+ +A+F R+E+ L+ H +V + D +S+ ++L+ E
Sbjct: 88 RGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVK--HFDDFKSDDKLLLIME 145
Query: 579 YMANGPLRSHLYGTDLPPLSWKQRL---------EICIGAARGLHYLHTGAAQSIIHRDV 629
Y + G L + KQRL E+ + + + L ++ ++HRD+
Sbjct: 146 YGSGGDLNKQI----------KQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDL 195
Query: 630 KTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 689
K+ NI L + K+ DFG SK V+++ G+ YL PE + R++ ++K+D++
Sbjct: 196 KSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMW 255
Query: 690 SFGVVLMEVLCT-RPALNP 707
S GV+L E+L RP P
Sbjct: 256 SLGVILYELLTLHRPFKGP 274
|
Length = 478 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 73/237 (30%), Positives = 109/237 (45%), Gaps = 32/237 (13%)
Query: 494 FQEILDATNKFDESLLLGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRTEIEML 552
+ + D T+ ++ +G G +G+VYK T DG+ AVK +P S+ E E +L
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNIL 72
Query: 553 SKL-RHRHLVSLIG--YCDER---SEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLE-- 604
L H ++V G Y ++ ++ LV E G + + G L QRL+
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGL----LICGQRLDEA 128
Query: 605 ----ICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH 660
I GA GL +LH IIHRDVK NILL K+ DFG+S L T
Sbjct: 129 MISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ---LTSTR 182
Query: 661 V--STAVKGSFGYLDPEYFRRQQLTEKS-----DVYSFGVVLMEVLCTRPALNPVLP 710
+ +T+V F ++ PE +Q + S DV+S G+ +E+ P L + P
Sbjct: 183 LRRNTSVGTPF-WMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP 238
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 3e-10
Identities = 39/104 (37%), Positives = 53/104 (50%), Gaps = 6/104 (5%)
Query: 596 PLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPA 655
PL Q L I GL YLH AQ IIHRDVKT NI ++D + D G ++ P
Sbjct: 153 PLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQF-PV 208
Query: 656 LDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVL 699
+ + A G+ PE R + K+D++S G+VL E+L
Sbjct: 209 VAPAFLGLA--GTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 34/99 (34%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 604 EICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVST 663
+I + + L YLH+ S+IHRDVK +N+L++ N K+ DFG+S G +D T
Sbjct: 107 KIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGIS--GYLVDSV-AKT 161
Query: 664 AVKGSFGYLDPEYF----RRQQLTEKSDVYSFGVVLMEV 698
G Y+ PE ++ KSDV+S G+ ++E+
Sbjct: 162 IDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIEL 200
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 4e-10
Identities = 59/208 (28%), Positives = 93/208 (44%), Gaps = 28/208 (13%)
Query: 510 LGVGGFGRVYKG-TLDDGTKVAVKRGNPRSEQGI--AEFRTEIEMLSKLRHRHLVSLIGY 566
LG G + VYKG + +G VA+K + ++E+G+ R E +L L+H ++V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR-EASLLKGLKHANIVLLHDI 71
Query: 567 CDERSEMILVYEY--------MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHT 618
+ + V+EY M P H Y L RGL Y+H
Sbjct: 72 IHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRL----------FMFQLLRGLAYIH- 120
Query: 619 GAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFR 678
Q I+HRD+K N+L+ K+ADFGL++ QT+ S V + Y P+
Sbjct: 121 --GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLL 176
Query: 679 -RQQLTEKSDVYSFGVVLMEVLCTRPAL 705
+ D++ G + +E+L +PA
Sbjct: 177 GATDYSSALDIWGAGCIFIEMLQGQPAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 51/202 (25%), Positives = 96/202 (47%), Gaps = 25/202 (12%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVKR------GNPRSEQGIAEFRTEIEMLSKLRHRHLVS 562
+G G F VY+ T L D VA+K+ + ++ Q + EI++L +L H +++
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVK---EIDLLKQLNHPNVIK 66
Query: 563 LIGYCDERSEMILVYEYMANGPLRSHLY----GTDLPP--LSWKQRLEICIGAARGLHYL 616
+ E +E+ +V E G L + L P WK +++C + ++
Sbjct: 67 YLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLC----SAVEHM 122
Query: 617 HTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEY 676
H+ + ++HRD+K N+ + V K+ D GL + + +T + ++ G+ Y+ PE
Sbjct: 123 HS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPER 177
Query: 677 FRRQQLTEKSDVYSFGVVLMEV 698
KSD++S G +L E+
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 5e-10
Identities = 63/205 (30%), Positives = 93/205 (45%), Gaps = 22/205 (10%)
Query: 509 LLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS-----EQG--IAEFRTEIEMLSKLRHRHL 560
++G G FG+V DG+ AVK ++ EQ +AE +L L+H L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNV---LLKNLKHPFL 58
Query: 561 VSLIGYCDERSEMILVYEYMANGPLRSHLYGTD--LPPLSWKQRLEICIGAARGLHYLHT 618
V L ++ V +Y+ G L HL L P + E+ A + YLH+
Sbjct: 59 VGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEV----ASAIGYLHS 114
Query: 619 GAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFR 678
+II+RD+K NILLD + DFGL K G ++T ++ G+ YL PE R
Sbjct: 115 ---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYLAPEVLR 169
Query: 679 RQQLTEKSDVYSFGVVLMEVLCTRP 703
++ D + G VL E+L P
Sbjct: 170 KEPYDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 5e-10
Identities = 69/270 (25%), Positives = 115/270 (42%), Gaps = 73/270 (27%)
Query: 454 LPLPLYGNSQTMTKMSTTSQKSGTASCISLASSNLGRLFMFQEILDATNKFDESLLLGVG 513
+PLPL S + + S++S SG+A + + S L R+ N+ +G G
Sbjct: 43 VPLPLPPPSSSSSS-SSSSSASGSAPSAAKSLSELERV----------NR------IGSG 85
Query: 514 GFGRVYK----------------GTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRH 557
G VYK G +D + + R EIE+L + H
Sbjct: 86 AGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICR--------------EIEILRDVNH 131
Query: 558 RHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTD--LPPLSWKQRLEICIGAARGLHY 615
++V D E+ ++ E+M G L + L ++ +Q L G+ Y
Sbjct: 132 PNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVA-RQILS-------GIAY 183
Query: 616 LHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH--VSTAVKGSFGYLD 673
LH + I+HRD+K +N+L++ K+ADFG+S+ L QT +++V G+ Y+
Sbjct: 184 LHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRI---LAQTMDPCNSSV-GTIAYMS 236
Query: 674 PEYFRRQQLTE------KSDVYSFGVVLME 697
PE L D++S GV ++E
Sbjct: 237 PERI-NTDLNHGAYDGYAGDIWSLGVSILE 265
|
Length = 353 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 5e-10
Identities = 58/211 (27%), Positives = 85/211 (40%), Gaps = 37/211 (17%)
Query: 509 LLGVGGFGRVY----KGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLI 564
LLG G FG+V K T +K+ ++ +A TE +L RH L +L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61
Query: 565 GYCDERSEMILVYEYMANGPLRSHL-------------YGTDLPPLSWKQRLEICIGAAR 611
+ V EY G L HL YG ++ + A
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI------------VSA-- 107
Query: 612 GLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGY 671
L YLH+ +++RD+K N++LD + K+ DFGL K G + T G+ Y
Sbjct: 108 -LGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEY 161
Query: 672 LDPEYFRRQQLTEKSDVYSFGVVLMEVLCTR 702
L PE D + GVV+ E++C R
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 63/203 (31%), Positives = 90/203 (44%), Gaps = 18/203 (8%)
Query: 509 LLGVGGFGRVY--KGTLDD---GTKVAVKRG--NPRSEQGIAEFRTEIEMLSKLRHRHLV 561
++G G FG+V K LD KV K+ N + ++ I R +L ++H LV
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNV--LLKNVKHPFLV 59
Query: 562 SLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGA-ARGLHYLHTGA 620
L ++ V +++ G L HL P + R A L YLH+
Sbjct: 60 GLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFP---EPRARFYAAEIASALGYLHS-- 114
Query: 621 AQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQ 680
+I++RD+K NILLD + DFGL K G A T +T G+ YL PE R+Q
Sbjct: 115 -INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGTPEYLAPEVIRKQ 171
Query: 681 QLTEKSDVYSFGVVLMEVLCTRP 703
D + G VL E+L P
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 6e-10
Identities = 63/211 (29%), Positives = 93/211 (44%), Gaps = 24/211 (11%)
Query: 499 DATNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRT---EIEMLSKL 555
D DE LG G +G VYK L T V + R E ++F E+++L K
Sbjct: 1 DEIEVLDE---LGKGNYGSVYK-VLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKA 56
Query: 556 RHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLY--GTDLPPLSWKQRLEICIGAARGL 613
++V G + + EYM G L LY G + I +GL
Sbjct: 57 VSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGL 115
Query: 614 HYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPA-LDQTHVSTAVKGSFGYL 672
+L +IIHRDVK TN+L++ N K+ DFG+S A L +T++ G Y+
Sbjct: 116 KFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYM 168
Query: 673 DPEYFR------RQQLTEKSDVYSFGVVLME 697
PE + T +SDV+S G+ ++E
Sbjct: 169 APERIKSGGPNQNPTYTVQSDVWSLGLSILE 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 6e-10
Identities = 60/202 (29%), Positives = 98/202 (48%), Gaps = 22/202 (10%)
Query: 510 LGVGGFGRV----YKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLI 564
LG G FGRV +KGT + K KR + +Q + E +L +L H +V+++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQ-VQHVAQEKSILMELSHPFIVNMM 84
Query: 565 -GYCDERSEMILVYEYMANGPLRSHLYGTDLPP--LSWKQRLEICIGAARGLHYLHTGAA 621
+ DE + + E++ G L +HL P ++ E+ + YLH+
Sbjct: 85 CSFQDEN-RVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLA----FEYLHS--- 136
Query: 622 QSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQ 681
+ II+RD+K N+LLD+ KV DFG +K P D+T + G+ YL PE + +
Sbjct: 137 KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP--DRTF---TLCGTPEYLAPEVIQSKG 191
Query: 682 LTEKSDVYSFGVVLMEVLCTRP 703
+ D ++ GV+L E + P
Sbjct: 192 HGKAVDWWTMGVLLYEFIAGYP 213
|
Length = 329 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 7e-10
Identities = 46/165 (27%), Positives = 80/165 (48%), Gaps = 8/165 (4%)
Query: 548 EIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICI 607
E+++L + ++V G E+ + E+M G L L P ++ I +
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV 112
Query: 608 GAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKG 667
RGL YL I+HRDVK +NIL++ K+ DFG+S G +D ++ + G
Sbjct: 113 --LRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVG 164
Query: 668 SFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPRE 712
+ Y+ PE + + +SD++S G+ L+E+ R + P +E
Sbjct: 165 TRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE 209
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 8e-10
Identities = 54/230 (23%), Positives = 96/230 (41%), Gaps = 50/230 (21%)
Query: 510 LGVGGFGRVYKG-TLDDGTKVAVKR--------GNPRSEQGIAE----FRT--EIEMLSK 554
LG G +G+V K G VA+K+ + Q + F T E++++++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 555 LRHRHLVSLIG-YCDERSEMILVYEYMANGPLRSHLYGTDLPPL-SWKQRLEI----CI- 607
++H +++ L+ Y E + LV + MA +DL + K RL CI
Sbjct: 77 IKHENIMGLVDVYV-EGDFINLVMDIMA----------SDLKKVVDRKIRLTESQVKCIL 125
Query: 608 -GAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSK-------TGPALDQT 659
GL+ LH +HRD+ NI ++ + K+ADFGL++ +
Sbjct: 126 LQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDE 182
Query: 660 HVS-----TAVKGSFGYLDPE-YFRRQQLTEKSDVYSFGVVLMEVLCTRP 703
+ T+ + Y PE ++ D++S G + E+L +P
Sbjct: 183 TMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232
|
Length = 335 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 8e-10
Identities = 60/230 (26%), Positives = 90/230 (39%), Gaps = 39/230 (16%)
Query: 510 LGVGGFGRVYKGTLDDGTKVA---VKR----GNPRSEQGIAEFRTEIEMLSKLRHRHLVS 562
+G G FG+V G G A VK P EQ F E++ +L H +++
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPD-EQ--LLFLQEVQPYRELNHPNVLQ 59
Query: 563 LIGYCDERSEMILVYEYMANGPL-------RSHLYGTDLPPLSWKQRLEICIGAARGLHY 615
+G C E +LV E+ G L R + + + E+ G LH
Sbjct: 60 CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLL-WLHQ 118
Query: 616 LHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFG--YLD 673
IH D+ N L + K+ D+GL+ D + T + +L
Sbjct: 119 AD------FIHSDLALRNCQLTADLSVKIGDYGLALEQYPED--YYITKDCHAVPLRWLA 170
Query: 674 PEYF--RRQQL-----TEKSDVYSFGVVLMEV--LCTRPALNPVLPREQV 714
PE R Q L T+KS+++S GV + E+ +P P L EQV
Sbjct: 171 PELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPY--PDLSDEQV 218
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 9e-10
Identities = 45/162 (27%), Positives = 76/162 (46%), Gaps = 11/162 (6%)
Query: 560 LVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQ--RLEICIGAARGLHYLH 617
LV L S + LV EY+ G L H+ P + EICI L++LH
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIA----LNFLH 113
Query: 618 TGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYF 677
+ II+RD+K N+LLD + K+ D+G+ K G L ++ G+ Y+ PE
Sbjct: 114 E---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEG--LGPGDTTSTFCGTPNYIAPEIL 168
Query: 678 RRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEW 719
R ++ D ++ GV++ E++ R + + +N ++
Sbjct: 169 RGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDY 210
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 1e-09
Identities = 64/219 (29%), Positives = 104/219 (47%), Gaps = 47/219 (21%)
Query: 510 LGVGGFGRVYKGTLDDGTK--VAVKR-----GNPRSEQGIAEFRT--EIEMLSKLR-HRH 559
LG G +G V+K +D TK VA+K+ N Q RT EI L +L H +
Sbjct: 15 LGKGAYGIVWKA-IDRRTKEVVALKKIFDAFRNATDAQ-----RTFREIMFLQELGDHPN 68
Query: 560 LVSLIGY--CDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLE------ICIGAAR 611
+V L+ + ++ LV+EYM TDL + LE I +
Sbjct: 69 IVKLLNVIKAENDKDIYLVFEYME----------TDLHAVIRANILEDVHKRYIMYQLLK 118
Query: 612 GLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGY 671
L Y+H+G ++IHRD+K +NILL+ + K+ADFGL+++ L++ + + Y
Sbjct: 119 ALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLT---DY 172
Query: 672 LDPEYFRRQQLTEKSDVYSFGV-------VLMEVLCTRP 703
+ ++R ++ S Y+ GV +L E+L +P
Sbjct: 173 VATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKP 211
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 57/211 (27%), Positives = 86/211 (40%), Gaps = 36/211 (17%)
Query: 509 LLGVGGFGRVY----KGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLI 564
LLG G FG+V K T +K+ ++ +A TE +L RH L +L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 565 GYCDERSEMILVYEYMANGPL-------------RSHLYGTDLPPLSWKQRLEICIGAAR 611
+ V EY G L R+ YG ++
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI---------------VS 106
Query: 612 GLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGY 671
L YLH + +++++RD+K N++LD + K+ DFGL K G D + T G+ Y
Sbjct: 107 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK-DGATMKTFC-GTPEY 162
Query: 672 LDPEYFRRQQLTEKSDVYSFGVVLMEVLCTR 702
L PE D + GVV+ E++C R
Sbjct: 163 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 55/204 (26%), Positives = 96/204 (47%), Gaps = 22/204 (10%)
Query: 510 LGVGGFGRVYKG-TLDDGTKVAVKRGNPRSEQGIAEFRT-EIEMLSKLRHRHLVSLIGYC 567
LG G + VYKG G VA+K + +E+G EI ++ +L+H ++V L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 568 DERSEMILVYEYMANGPLR---SHLYGTDLPPLSWK----QRLEICIGAARGLHYLHTGA 620
++++LV+EYM + +H L P + K Q L +G+ + H
Sbjct: 68 HTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLL-------KGIAFCHE-- 118
Query: 621 AQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQ 680
++HRD+K N+L++ K+ADFGL++ T + V + Y P+
Sbjct: 119 -NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAPDVLLGS 175
Query: 681 QLTEKS-DVYSFGVVLMEVLCTRP 703
+ S D++S G ++ E++ RP
Sbjct: 176 RTYSTSIDIWSVGCIMAEMITGRP 199
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 40/212 (18%)
Query: 510 LGVGGFGRVYKG--TLDDGTKVAVKRGNPRSEQG--IAEFRTEIEMLSKLRHRHLVSLIG 565
LG G + VYKG L D VA+K E+G R E+ +L L+H ++V+L
Sbjct: 14 LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71
Query: 566 YCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEIC-------------IGAARG 612
+ LV+EY+ DL KQ L+ C RG
Sbjct: 72 IIHTEKSLTLVFEYLDK----------DL-----KQYLDDCGNSINMHNVKLFLFQLLRG 116
Query: 613 LHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYL 672
L+Y H + ++HRD+K N+L+++ K+ADFGL++ +T+ + V + Y
Sbjct: 117 LNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYR 171
Query: 673 DPE-YFRRQQLTEKSDVYSFGVVLMEVLCTRP 703
P+ + + D++ G + E+ RP
Sbjct: 172 PPDILLGSTDYSTQIDMWGVGCIFYEMSTGRP 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 58/199 (29%), Positives = 81/199 (40%), Gaps = 14/199 (7%)
Query: 510 LGVGGFGRVYKGTL---DDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGY 566
L G G V+ T + KV VK G EI++L + HR +++LI
Sbjct: 100 LTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPG-----REIDILKTISHRAIINLIHA 154
Query: 567 CDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIH 626
+S + +V M Y PL +Q + I L YLH + IIH
Sbjct: 155 YRWKSTVCMV---MPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLH---GRGIIH 208
Query: 627 RDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 686
RDVKT NI LD+ A + DFG + A T G+ PE K+
Sbjct: 209 RDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKT 268
Query: 687 DVYSFGVVLMEVLCTRPAL 705
D++S G+VL E+ L
Sbjct: 269 DIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 66/264 (25%), Positives = 103/264 (39%), Gaps = 68/264 (25%)
Query: 510 LGVGGFGRVYKG-TLDDGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLR-HRHLVSLI 564
+G G F V K + G A+K EQ + R EI+ L +L H +++ LI
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-VNNLR-EIQALRRLSPHPNILRLI 64
Query: 565 GYCDERS-----------EMILVYEYMANGPLRSHLYGTDLPPLSWKQRL-EICIGAARG 612
+R +M L YE + R LP K + ++ +
Sbjct: 65 EVLFDRKTGRLALVFELMDMNL-YELIKG---RKRP----LPEKRVKSYMYQLL----KS 112
Query: 613 LHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYL 672
L ++H I HRD+K NIL+ D+ + K+ADFG + + T + Y
Sbjct: 113 LDHMH---RNGIFHRDIKPENILIKDD-ILKLADFGSCRG---IYSKPPYTEYISTRWYR 165
Query: 673 DPE------YFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKK 726
PE Y+ K D+++ G V E+L +L P+ P
Sbjct: 166 APECLLTDGYY-----GPKMDIWAVGCVFFEIL----SLFPLFP--------------GT 202
Query: 727 GMLDQIMD-SNLVGKVNPASLKKF 749
LDQI +++G + LKKF
Sbjct: 203 NELDQIAKIHDVLGTPDAEVLKKF 226
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 76/327 (23%), Positives = 132/327 (40%), Gaps = 46/327 (14%)
Query: 509 LLGVGGFGRVYKGTL-DDGTKVAVK---RGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLI 564
+LG G FG+V L + G AVK + + + TE +LS R+ ++ +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 565 GYCDERSE-MILVYEYMANGPLRSHLYGTDLPPLSWKQRLE---ICIGAAR---GLHYLH 617
C + + + V E++ G L H+ + +R + AA L +LH
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKS--------RRFDEARARFYAAEITSALMFLH 113
Query: 618 TGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYF 677
+ II+RD+K N+LLD K+ADFG+ K G + ++ G+ Y+ PE
Sbjct: 114 D---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG--IFNGKTTSTFCGTPDYIAPEIL 168
Query: 678 RRQQLTEKSDVYSFGVVLMEVLC--------TRPALNPVLPREQVNIAEWAMTWQKKGML 729
+ D ++ GV+L E+LC L + ++V W ++ +L
Sbjct: 169 QEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTW-LSQDAVDIL 227
Query: 730 DQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDR-PSMGDVLWNLEYALQLEETSSALM 788
M NP + G E + R P ++ W Q+E +
Sbjct: 228 KAFM------TKNPT--MRLGSLTLG--GEEAILRHPFFKELDWEKLNRRQIEPPFRPRI 277
Query: 789 EPEDNSTNHIP-CIQLTP-LEPFDNSV 813
+ ++ +N P I+ P L P + S+
Sbjct: 278 KSREDVSNFDPDFIKEDPVLTPIEESL 304
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 50/217 (23%), Positives = 90/217 (41%), Gaps = 40/217 (18%)
Query: 504 FDESLLLGVGGFGRVYKGT-LDDGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLRHRH 559
+ +G G FGRV+ A+K + E +L ++ H
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62
Query: 560 LVSLIGYCDERSEMILVYEYMANGPLRSHL-------------YGTDLPPLSWKQRLEIC 606
++ L ++ + ++ EY+ G L S+L Y +++ +C
Sbjct: 63 IIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEI----------VC 112
Query: 607 IGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVK 666
L YLH+ + I++RD+K NILLD K+ DFG +K D+T +
Sbjct: 113 -----ALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKK--LRDRTW---TLC 159
Query: 667 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRP 703
G+ YL PE + + + D ++ G+++ E+L P
Sbjct: 160 GTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 47/166 (28%), Positives = 82/166 (49%), Gaps = 10/166 (6%)
Query: 548 EIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRL-EIC 606
E+++L + ++V G E+ + E+M G L L P +Q L ++
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP---EQILGKVS 109
Query: 607 IGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVK 666
I +GL YL I+HRDVK +NIL++ K+ DFG+S G +D ++ +
Sbjct: 110 IAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFV 163
Query: 667 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPRE 712
G+ Y+ PE + + +SD++S G+ L+E+ R + P +E
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE 209
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 22/201 (10%)
Query: 509 LLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSK------LRHRHLV 561
+LG G FG+V L G AVK + + + + E M+ K + L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKA--LKKDVVLIDDDVECTMVEKRVLALAWENPFLT 59
Query: 562 SLIGYCDERSEMILVYEYMANGPLRSHLYGT---DLPPLSWKQRLEICIGAARGLHYLHT 618
L + + V E++ G L H+ DL ++ +C GL +LH+
Sbjct: 60 HLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVC-----GLQFLHS 114
Query: 619 GAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFR 678
+ II+RD+K N++LD + K+ADFG+ K D ++ G+ Y+ PE +
Sbjct: 115 ---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDYIAPEILQ 169
Query: 679 RQQLTEKSDVYSFGVVLMEVL 699
+ T D +SFGV+L E+L
Sbjct: 170 GLKYTFSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 67/276 (24%), Positives = 102/276 (36%), Gaps = 109/276 (39%)
Query: 510 LGVGGFGRVYKGTLDDGTK------VAVK---RGNPRSEQGIAEFRTEIEMLSKL-RHRH 559
LG G FG+V + + K VAVK G SE TE+++L + H +
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEY--KALMTELKILIHIGHHLN 72
Query: 560 LVSLIGYCDERS-EMILVYEYMANGPLRSHL----------------YGTDLPPLSWKQR 602
+V+L+G C + ++++ EY G L ++L KQR
Sbjct: 73 VVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQR 132
Query: 603 LE-----------------------------------------IC--IGAARGLHYLHTG 619
L+ I ARG+ +L
Sbjct: 133 LDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL--- 189
Query: 620 AAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRR 679
A++ IHRD+ NILL +N V K+ DFGL++ Y DP+Y R+
Sbjct: 190 ASRKCIHRDLAARNILLSENNVVKICDFGLARD-----------------IYKDPDYVRK 232
Query: 680 -----------------QQLTEKSDVYSFGVVLMEV 698
+ T +SDV+SFGV+L E+
Sbjct: 233 GDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEI 268
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 39/110 (35%), Positives = 59/110 (53%), Gaps = 11/110 (10%)
Query: 594 LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTG 653
PL+ + + ARG+ +L A++ IHRD+ NILL +N V K+ DFGL++
Sbjct: 168 KSPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARD- 223
Query: 654 PALDQTHVSTAVKGS----FGYLDPEYFRRQQLTEKSDVYSFGVVLMEVL 699
D +V KGS ++ PE + T +SDV+SFGV+L E+
Sbjct: 224 IYKDPDYVR---KGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIF 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 4e-09
Identities = 33/94 (35%), Positives = 52/94 (55%), Gaps = 5/94 (5%)
Query: 610 ARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSF 669
A GL +LH+ + II+RD+K N++LD K+ADFG+ K +T + G+
Sbjct: 111 AIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT--TRTFCGTP 165
Query: 670 GYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRP 703
Y+ PE Q + D ++FGV+L E+L +P
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQP 199
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 4e-09
Identities = 44/145 (30%), Positives = 72/145 (49%), Gaps = 13/145 (8%)
Query: 513 GGFGRVYKGTLDDGTKV----AVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCD 568
G FG+VY G + +K+ VK+ + ++ + + + E + L+ + +V L
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74
Query: 569 ERSEMILVYEYMANGPLRS--HLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIH 626
+ + LV EY+ G ++S H+YG ++ K E A L YLH IIH
Sbjct: 75 SANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISE----VALALDYLHR---HGIIH 127
Query: 627 RDVKTTNILLDDNFVAKVADFGLSK 651
RD+K N+L+ + K+ DFGLSK
Sbjct: 128 RDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 4e-09
Identities = 61/213 (28%), Positives = 95/213 (44%), Gaps = 33/213 (15%)
Query: 504 FDESLLLGVGGFGRVYKGTLDDGTKV-AVKRGNP-----RSEQGIAEFRTEIEMLSKLRH 557
FD ++G G FG V +V A+K + RS+ A F E ++++
Sbjct: 45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDS--AFFWEERDIMAHANS 102
Query: 558 RHLVSL-IGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQ--RLEICIGAARGLH 614
+V L + D++ + +V EYM G L + + D+P W + E+ + A +H
Sbjct: 103 EWIVQLHYAFQDDKY-LYMVMEYMPGGDLVNLMSNYDIPE-KWARFYTAEVVL-ALDAIH 159
Query: 615 YLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFG----LSKTGPALDQTHVSTAVKGSFG 670
+ IHRDVK N+LLD + K+ADFG + G TAV G+
Sbjct: 160 SM------GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG----MVRCDTAV-GTPD 208
Query: 671 YLDPEYFRRQ----QLTEKSDVYSFGVVLMEVL 699
Y+ PE + Q + D +S GV L E+L
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 5e-09
Identities = 49/158 (31%), Positives = 74/158 (46%), Gaps = 35/158 (22%)
Query: 510 LGVGGFGRVYKG-TLDDGTKVAVKRGNPRSEQGIAEFRT--EIEMLSKLRHRHLVSLIGY 566
LG G + VYKG + G VA+K E+G A F E +L L+H ++V+L
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHDI 71
Query: 567 CDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAA-------------RGL 613
+ + LV+EY+ TDL KQ ++ C G RGL
Sbjct: 72 IHTKKTLTLVFEYLD----------TDL-----KQYMDDCGGGLSMHNVRLFLFQLLRGL 116
Query: 614 HYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSK 651
Y H + ++HRD+K N+L+ + K+ADFGL++
Sbjct: 117 AYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 6e-09
Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 27/207 (13%)
Query: 510 LGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQ---GIAEFRT-EIEMLSKLRHRHLVSL-- 563
+G G +G VYK D T + R EQ G+ EI +L +++H ++V L
Sbjct: 10 IGEGTYGVVYKAR-DRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 564 IGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRL--EICIGAARGLHYLHTGAA 621
+ + ++R + LV+EY+ + L+ H+ + P + RL RG+ Y H+
Sbjct: 69 VVHSEKR--LYLVFEYL-DLDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHS--- 120
Query: 622 QSIIHRDVKTTNILLDDNFVA-KVADFGLSKTG--PALDQTH-VSTAVKGSFGYLDPE-Y 676
++HRD+K N+L+D A K+ADFGL++ P TH V T Y PE
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVT-----LWYRAPEIL 175
Query: 677 FRRQQLTEKSDVYSFGVVLMEVLCTRP 703
+ + D++S G + E++ +P
Sbjct: 176 LGSRHYSTPVDIWSVGCIFAEMVNQKP 202
|
Length = 294 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 6e-09
Identities = 42/132 (31%), Positives = 62/132 (46%), Gaps = 10/132 (7%)
Query: 571 SEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGA-ARGLHYLHTGAAQSIIHRDV 629
S++ LV +YM+ G L HL + R + I L +LH I++RD+
Sbjct: 69 SDLYLVTDYMSGGELFWHLQKEGRFS---EDRAKFYIAELVLALEHLHK---YDIVYRDL 122
Query: 630 KTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQ-LTEKSDV 688
K NILLD + DFGLSK L + G+ YL PE ++ T+ D
Sbjct: 123 KPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDF 180
Query: 689 YSFGVVLMEVLC 700
+S GV++ E+ C
Sbjct: 181 WSLGVLVFEMCC 192
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 6e-09
Identities = 60/226 (26%), Positives = 99/226 (43%), Gaps = 42/226 (18%)
Query: 510 LGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQG--IAEFRTEIEMLSKLRHRHLVSLIGY 566
LG G + V+KG VA+K E+G R E+ +L L+H ++V+L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLHDI 71
Query: 567 CDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEIC-------------IGAARGL 613
+ LV+EY+ + DL KQ L+ C RGL
Sbjct: 72 IHTERCLTLVFEYLDS----------DL-----KQYLDNCGNLMSMHNVKIFMFQLLRGL 116
Query: 614 HYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLD 673
Y H + I+HRD+K N+L+++ K+ADFGL++ +T+ + V + Y
Sbjct: 117 SYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRP 171
Query: 674 PEYFRRQQLTEKS---DVYSFGVVLMEVLCTRPALNPVLPREQVNI 716
P+ TE S D++ G +L E+ RP +E++++
Sbjct: 172 PDVLLGS--TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHL 215
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 6e-09
Identities = 58/224 (25%), Positives = 101/224 (45%), Gaps = 36/224 (16%)
Query: 497 ILDATNKFDESLLLGVGGFGRVYKGTLD--DGTKVAVKR-GNP-RSEQGIAEFRTEIEML 552
I + +++ + +G G +G V LD G KVA+K+ P +SE E+ +L
Sbjct: 10 IWEVPDRYRDLKQVGSGAYGTVCS-ALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLL 68
Query: 553 SKLRHRHLVSLIGY------CDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLE-- 604
++H +++ L+ D + LV +M GTDL L ++L
Sbjct: 69 KHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM----------GTDLGKLMKHEKLSED 118
Query: 605 ----ICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH 660
+ +GL Y+H A IIHRD+K N+ ++++ K+ DFGL++ + +
Sbjct: 119 RIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGY 175
Query: 661 VSTAVKGSFGYLDPEY-FRRQQLTEKSDVYSFGVVLMEVLCTRP 703
V T Y PE T+ D++S G ++ E+L +P
Sbjct: 176 VVTR-----WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKP 214
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 9e-09
Identities = 53/205 (25%), Positives = 89/205 (43%), Gaps = 12/205 (5%)
Query: 509 LLGVGGFGRVYKGTLDDGTKV----AVKRGNPRSEQGIAEFRTEIEMLSKL-RHRHLVSL 563
++G G + +V L ++ VK+ ++ I +TE + + H LV L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 564 IGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQS 623
S + V EY+ G L H+ P + I A L+YLH +
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA--LNYLHE---RG 116
Query: 624 IIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLT 683
II+RD+K N+LLD K+ D+G+ K G L ++ G+ Y+ PE R +
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG--LRPGDTTSTFCGTPNYIAPEILRGEDYG 174
Query: 684 EKSDVYSFGVVLMEVLCTRPALNPV 708
D ++ GV++ E++ R + V
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIV 199
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 509 LLGVGGFGRVY---KGTLDDGTKV----AVKRGNPRSEQGIAEF-RTEIEMLSKLRHR-H 559
+LG G +G+V+ K + D K+ +K+ + E RTE ++L +R
Sbjct: 7 VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66
Query: 560 LVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGA-ARGLHYLHT 618
LV+L +++ L+ +Y+ G L +HL + +Q ++I G L +LH
Sbjct: 67 LVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK---EQEVQIYSGEIVLALEHLHK 123
Query: 619 GAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFR 678
II+RD+K NILLD N + DFGLSK D+ + + G+ Y+ P+ R
Sbjct: 124 ---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE-DEVERAYSFCGTIEYMAPDIVR 179
Query: 679 RQQLTEKS--DVYSFGVVLMEVL 699
D +S GV++ E+L
Sbjct: 180 GGDGGHDKAVDWWSMGVLMYELL 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 32/209 (15%)
Query: 509 LLGVGGFGRVY---KGTLDD-----GTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHR-H 559
+LG G +G+V+ K T D KV K + + + RTE +L +R
Sbjct: 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66
Query: 560 LVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAAR-------- 611
LV+L +++ L+ +Y++ G + +HLY QR R
Sbjct: 67 LVTLHYAFQTEAKLHLILDYVSGGEMFTHLY----------QRDNFSEDEVRFYSGEIIL 116
Query: 612 GLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGY 671
L +LH I++RD+K NILLD + DFGLSK + ++ + + G+ Y
Sbjct: 117 ALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS-EEKERTYSFCGTIEY 172
Query: 672 LDPEYFRRQQLTEKS-DVYSFGVVLMEVL 699
+ PE R + K+ D +S G+++ E+L
Sbjct: 173 MAPEIIRGKGGHGKAVDWWSLGILIFELL 201
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 65/252 (25%), Positives = 102/252 (40%), Gaps = 59/252 (23%)
Query: 509 LLGVGGFGRVY----KGTLDDGTKVAV-KRGNPRSEQGIAEFRTEIEMLS-KLRHRHLVS 562
+LG G FG+V KGT D+ + V K+ + + TE +L+ +H L +
Sbjct: 2 VLGKGSFGKVMLAELKGT-DEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 563 LIGYCDERSEMILVYEYMANGPL-------------RSHLYGTDLPPLSWKQRLEICIGA 609
L + + V EY+ G L RS Y ++
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEV--------------- 105
Query: 610 ARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSF 669
L +LH +I+RD+K NILLD K+ADFG+ K G T +T G+
Sbjct: 106 TLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTP 160
Query: 670 GYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRP------------------ALNPV-LP 710
Y+ PE + + D ++ GV++ E++ +P L PV L
Sbjct: 161 DYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLS 220
Query: 711 REQVNIAEWAMT 722
+E V+I + MT
Sbjct: 221 KEAVSILKAFMT 232
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 55/194 (28%), Positives = 88/194 (45%), Gaps = 21/194 (10%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVK----RGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLI 564
LG G G VYK L +AVK ++ I +E+E+L K +++
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIM---SELEILYKCDSPYIIGFY 65
Query: 565 GYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSI 624
G + + + E+M G L +Y + + I + +GL YL + I
Sbjct: 66 GAFFVENRISICTEFMDGGSL--DVYRKIPEHVLGR----IAVAVVKGLTYLW---SLKI 116
Query: 625 IHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTE 684
+HRDVK +N+L++ K+ DFG+S L + T V G+ Y+ PE +Q
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQ---LVNSIAKTYV-GTNAYMAPERISGEQYGI 172
Query: 685 KSDVYSFGVVLMEV 698
SDV+S G+ ME+
Sbjct: 173 HSDVWSLGISFMEL 186
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 51/209 (24%), Positives = 93/209 (44%), Gaps = 30/209 (14%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQG-IAEFRTEIEMLSKLRHRHLVSLIGY 566
L+G G +G VY+G + G VA+K N + +++ + E+ +LS+LR ++ Y
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 567 CD---ERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAA-----RGLHYLHT 618
+ + ++ EY G +R+ + P++ E I L Y+H
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLMKAG---PIA-----EKYISVIIREVLVALKYIHK 119
Query: 619 GAAQSIIHRDVKTTNILLDDNFVAKVADFGLS---KTGPALDQTHVSTAVKGSFGYLDPE 675
+IHRD+K NIL+ + K+ DFG++ + T V T ++ PE
Sbjct: 120 ---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPY-----WMAPE 171
Query: 676 YFRR-QQLTEKSDVYSFGVVLMEVLCTRP 703
+ K+D++S G+ + E+ P
Sbjct: 172 VITEGKYYDTKADIWSLGITIYEMATGNP 200
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 54/206 (26%), Positives = 93/206 (45%), Gaps = 11/206 (5%)
Query: 502 NKFDESLLLGVGGFGRVYKGTLDDGTK-VAVKRGNPRSEQGIAEFRT--EIEMLSKLRHR 558
NKF+ ++G G +G V K + + VA+K+ E + T E++ML L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 559 HLVSLIGYCDERSEMILVYEYMANGPLRS-HLYGTDLPPLSWKQRLEICIGAARGLHYLH 617
++V L R ++ LV+EY+ L +PP + + I A +H+ H
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKA---IHWCH 117
Query: 618 TGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYF 677
I+HRD+K N+L+ N V K+ DFG ++ + + V + Y PE
Sbjct: 118 K---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRW-YRSPELL 173
Query: 678 RRQQLTEKSDVYSFGVVLMEVLCTRP 703
+ D++S G +L E+ +P
Sbjct: 174 LGAPYGKAVDMWSVGCILGELSDGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 2e-08
Identities = 39/112 (34%), Positives = 59/112 (52%), Gaps = 11/112 (9%)
Query: 591 GTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLS 650
D PL L A+G+ +L A+++ IHRDV N+LL D VAK+ DFGL+
Sbjct: 203 TEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLA 259
Query: 651 KTGPALDQTHVSTAVKGS----FGYLDPEYFRRQQLTEKSDVYSFGVVLMEV 698
+ D +V VKG+ ++ PE T +SDV+S+G++L E+
Sbjct: 260 RD-IMNDSNYV---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 307
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 53/200 (26%), Positives = 96/200 (48%), Gaps = 16/200 (8%)
Query: 510 LGVGGFGRVYKG--TLDDGTKVAVKRGNPRSEQG--IAEFRTEIEMLSKLRHRHLVSLIG 565
LG G + V+KG L + VA+K E+G R E+ +L L+H ++V+L
Sbjct: 14 LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71
Query: 566 YCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICI-GAARGLHYLHTGAAQSI 624
+ LV+EY+ + L+ Y D + ++I + RGL Y H + +
Sbjct: 72 IVHTDKSLTLVFEYL-DKDLKQ--YMDDCGNIMSMHNVKIFLYQILRGLAYCHR---RKV 125
Query: 625 IHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFR-RQQLT 683
+HRD+K N+L+++ K+ADFGL++ +T+ + V + Y P+ + +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSSEYS 183
Query: 684 EKSDVYSFGVVLMEVLCTRP 703
+ D++ G + E+ RP
Sbjct: 184 TQIDMWGVGCIFFEMASGRP 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 54/210 (25%), Positives = 98/210 (46%), Gaps = 36/210 (17%)
Query: 510 LGVGGFGRVYKG-TLDDGTKVAVKRGNPRSEQGIAEFRT--EIEMLSKLRHRHLVSLIG- 565
+G G +G V G +VAVK+ + + I RT E+ +L ++H +++ L+
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 566 YCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLE------ICIGAARGLHYLHTG 619
+ RS E + L +HL G DL + Q+L + RGL Y+H+
Sbjct: 85 FTPARS-----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 139
Query: 620 AAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRR 679
IIHRD+K +N+ ++++ K+ DFGL++ H + GY+ ++R
Sbjct: 140 ---DIIHRDLKPSNLAVNEDCELKILDFGLAR--------HTDDEMT---GYVATRWYRA 185
Query: 680 QQL-------TEKSDVYSFGVVLMEVLCTR 702
++ + D++S G ++ E+L R
Sbjct: 186 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 33/91 (36%), Positives = 52/91 (57%), Gaps = 5/91 (5%)
Query: 610 ARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTA-VKGS 668
A+G+ +L A++ IHRD+ NILL +N V K+ DFGL++ D +V +
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARD-IYKDPDYVRKGDARLP 244
Query: 669 FGYLDPEYFRRQQLTEKSDVYSFGVVLMEVL 699
++ PE + T +SDV+SFGV+L E+
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 275
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 3e-08
Identities = 59/199 (29%), Positives = 93/199 (46%), Gaps = 22/199 (11%)
Query: 510 LGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQG--IAEFRTEIEMLSKLRHRHLVSLIGY 566
LG G + VYKG +G VA+K + E+G R E +L L+H ++V L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIVLLHDI 71
Query: 567 CDERSEMILVYEYMANGP---LRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQS 623
+ + LV+EY+ + H G L P + K L RGL Y+H +
Sbjct: 72 IHTKETLTLVFEYVHTDLCQYMDKHPGG--LHPENVKLFL---FQLLRGLSYIHQ---RY 123
Query: 624 IIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLT 683
I+HRD+K N+L+ D K+ADFGL++ T+ + V + Y P+ T
Sbjct: 124 ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--TLWYRPPDVLLGS--T 179
Query: 684 EKS---DVYSFGVVLMEVL 699
E S D++ G + +E++
Sbjct: 180 EYSTCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 18/213 (8%)
Query: 510 LGVGGFGRVYKGTLDDGT--KVAVKRGNPRS---EQGIAEFRTEIEMLSKLRHRHLVSLI 564
LG G FGRV T + VA+KR ++ + +E ++L+ + H V+L
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97
Query: 565 GYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSI 624
G + S + LV E++ G + L P C AA+ + + +I
Sbjct: 98 GSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVG-----CFYAAQIVLIFEYLQSLNI 152
Query: 625 IHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTE 684
++RD+K N+LLD + K+ DFG +K + T T + G+ Y+ PE +
Sbjct: 153 VYRDLKPENLLLDKDGFIKMTDFGFAK----VVDTRTYT-LCGTPEYIAPEILLNVGHGK 207
Query: 685 KSDVYSFGVVLMEVLCTRP---ALNPVLPREQV 714
+D ++ G+ + E+L P A P+L +++
Sbjct: 208 AADWWTLGIFIYEILVGCPPFYANEPLLIYQKI 240
|
Length = 340 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 69/243 (28%), Positives = 102/243 (41%), Gaps = 35/243 (14%)
Query: 509 LLGVGGFGRVY--KGTLDD---GTKVAVKRG--NPRSEQGIAEFRTEIEMLSKLRHRHLV 561
++G G FG+V + ++ KV K+ + E+ I R +L ++H LV
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNV--LLKNVKHPFLV 59
Query: 562 SLIGYCDERSEMILVYEYMANGPLRSHLYGTD--LPPLSWKQRLEICIGAARGLHYLHTG 619
L ++ V +Y+ G L HL L P + EI A L YLH+
Sbjct: 60 GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEI----ASALGYLHS- 114
Query: 620 AAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRR 679
+I++RD+K NILLD + DFGL K ++ ++ G+ YL PE +
Sbjct: 115 --LNIVYRDLKPENILLDSQGHIVLTDFGLCKEN--IEHNGTTSTFCGTPEYLAPEVLHK 170
Query: 680 QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVG 739
Q D + G VL E+L P P R N AE M D I++ L
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYGLP---PFYSR---NTAE---------MYDNILNKPLQL 215
Query: 740 KVN 742
K N
Sbjct: 216 KPN 218
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-08
Identities = 48/171 (28%), Positives = 82/171 (47%), Gaps = 29/171 (16%)
Query: 510 LGVGGFGRVYKG-TLDDGTKVAVKRGNPRS-EQGI--AEFRTEIEMLSKLRHR-HLVSLI 564
+G G +G+VYK + G VA+K+ E+GI R EI +L L ++V L+
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR-EISLLQMLSESIYIVRLL 67
Query: 565 G--YCDE---RSEMILVYEYMANGPLRSHL------YGTDLPPLSWKQRL-EICIGAARG 612
+ +E + + LV+EY+ + L+ + G LP + K + ++ G A
Sbjct: 68 DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA-- 124
Query: 613 LHYLHTGAAQSIIHRDVKTTNILLDDN-FVAKVADFGLSK--TGPALDQTH 660
+ H ++HRD+K N+L+D + K+AD GL + + P TH
Sbjct: 125 --HCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH 170
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-08
Identities = 42/133 (31%), Positives = 63/133 (47%), Gaps = 11/133 (8%)
Query: 573 MILVYEYMANGPLRSHL--YGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVK 630
+ V EY+ G L + G P + EI IG L +LH+ + II+RD+K
Sbjct: 76 LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIG----LFFLHS---KGIIYRDLK 128
Query: 631 TTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYS 690
N++LD K+ADFG+ K D T G+ Y+ PE Q + D ++
Sbjct: 129 LDNVMLDSEGHIKIADFGMCKEN-MWDGVTTKTFC-GTPDYIAPEIIAYQPYGKSVDWWA 186
Query: 691 FGVVLMEVLCTRP 703
FGV+L E+L +
Sbjct: 187 FGVLLYEMLAGQA 199
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 6e-08
Identities = 58/207 (28%), Positives = 89/207 (42%), Gaps = 21/207 (10%)
Query: 504 FDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSE----QGIAEFRTEIEMLSKLRHRH 559
+D ++G G FG V KV + + E A F E ++++
Sbjct: 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 560 LVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTG 619
+V L + + +V EYM G L + + D+P K + A +H
Sbjct: 105 VVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIH----- 159
Query: 620 AAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT---HVSTAVKGSFGYLDPEY 676
+ +IHRDVK N+LLD + K+ADFG T +D+T TAV G+ Y+ PE
Sbjct: 160 -SMGLIHRDVKPDNMLLDKHGHLKLADFG---TCMKMDETGMVRCDTAV-GTPDYISPEV 214
Query: 677 FRRQ----QLTEKSDVYSFGVVLMEVL 699
+ Q + D +S GV L E+L
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 7e-08
Identities = 41/157 (26%), Positives = 68/157 (43%), Gaps = 29/157 (18%)
Query: 557 HRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQR-----------LEI 605
H LV L S + V E+++ G L H+ +QR EI
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQ---------RQRKLPEEHARFYSAEI 105
Query: 606 CIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAV 665
+ L++LH II+RD+K N+LLD K+ D+G+ K G + ++
Sbjct: 106 SLA----LNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG--IRPGDTTSTF 156
Query: 666 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTR 702
G+ Y+ PE R + D ++ GV++ E++ R
Sbjct: 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 9e-08
Identities = 58/240 (24%), Positives = 102/240 (42%), Gaps = 55/240 (22%)
Query: 510 LGVGGFGRVYKGTLDD-GTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLV------- 561
LG G G V+ D +VAVK+ Q + EI+++ +L H ++V
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 562 -------SLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLE------ICIG 608
+G E + + +V EYM TDL + + L
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYME----------TDLANVLEQGPLSEEHARLFMYQ 122
Query: 609 AARGLHYLHTGAAQSIIHRDVKTTNILLD-DNFVAKVADFGLSKTGPALDQTHVSTAVKG 667
RGL Y+H+ +++HRD+K N+ ++ ++ V K+ DFGL++ +D H S
Sbjct: 123 LLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARI---VDP-HYSHK--- 172
Query: 668 SFGYLD----PEYFRRQQL-------TEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNI 716
GYL +++R +L T+ D+++ G + E+L +P EQ+ +
Sbjct: 173 --GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQL 230
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 25/208 (12%)
Query: 510 LGVGGFGRVYKGTLDDG---TKVAVKRGNPRSEQGIAE---FRTEIEMLSKLRHRHLVSL 563
+G G FG+V G ++ G +V VK R + E F E + L+H +L+
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKE--LRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 564 IGYCDERSEMILVYEYMANGPLRSHLYGTDL-----PPLSWKQRLEICIGAARGLHYLHT 618
+G C E + +LV E+ G L+ +L P + QR+ I A GL +LH
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEI--ALGLLHLHK 118
Query: 619 GAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFR 678
+ IH D+ N LL + K+ D+GLS D + ++ PE
Sbjct: 119 ---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVD 175
Query: 679 RQQ-------LTEKSDVYSFGVVLMEVL 699
T++S+V+S GV + E+
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 70/244 (28%), Positives = 108/244 (44%), Gaps = 36/244 (14%)
Query: 489 GRLFMFQEILDATNKFDESLLLGVGGFGRVYK-GTLDDGTKVAVKRGNPRSEQGIAEFRT 547
G+ +F D ++ ++ +G G +G+V+K +G+K AVK +P + E
Sbjct: 5 GKTIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEA 63
Query: 548 EIEMLSKLR-HRHLVSLIGYCDERS-----EMILVYEYMANGPLRSHLYGTDLPP--LSW 599
E +L L H ++V G ++ ++ LV E G + TDL L
Sbjct: 64 EYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSV------TDLVKGFLKR 117
Query: 600 KQRLE------ICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTG 653
+R+E I A GL +LH IHRDVK NILL K+ DFG+S
Sbjct: 118 GERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQ- 173
Query: 654 PALDQTHV--STAVKGSFGYLDPEYFR-RQQL----TEKSDVYSFGVVLMEVLCTRPALN 706
L T + +T+V F ++ PE QQL + DV+S G+ +E+ P L
Sbjct: 174 --LTSTRLRRNTSVGTPF-WMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLA 230
Query: 707 PVLP 710
+ P
Sbjct: 231 DLHP 234
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 40/136 (29%), Positives = 65/136 (47%), Gaps = 11/136 (8%)
Query: 573 MILVYEYMANGPLRSHL--YGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVK 630
+ V EY+ G L H+ G P + EI +G L +LH + II+RD+K
Sbjct: 76 LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVG----LFFLHR---RGIIYRDLK 128
Query: 631 TTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYS 690
N++LD K+ADFG+ K + + G+ Y+ PE Q + D ++
Sbjct: 129 LDNVMLDSEGHIKIADFGMCKE--HMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWA 186
Query: 691 FGVVLMEVLCTRPALN 706
+GV+L E+L +P +
Sbjct: 187 YGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-07
Identities = 39/139 (28%), Positives = 63/139 (45%), Gaps = 13/139 (9%)
Query: 577 YEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILL 636
Y A R + P LS+ + A G+ +L A+++ +HRD+ N+L+
Sbjct: 216 YLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLI 272
Query: 637 DDNFVAKVADFGLSKTGPALDQTHVSTAV-KGS----FGYLDPEYFRRQQLTEKSDVYSF 691
+ + K+ DFGL++ D S + KGS ++ PE T SDV+SF
Sbjct: 273 CEGKLVKICDFGLAR-----DIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSF 327
Query: 692 GVVLMEVLCTRPALNPVLP 710
G++L E+ P LP
Sbjct: 328 GILLWEIFTLGGTPYPELP 346
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 52/236 (22%), Positives = 105/236 (44%), Gaps = 56/236 (23%)
Query: 497 ILDATNKFDESLLLGVGGFGRVYKGTLDDGT--KVAVKR-GNPRSEQGIAEFRT--EIEM 551
+ + K E++ G G +G V +D + KVA+K+ + +A+ RT E+++
Sbjct: 2 DVGSRYKPIENI--GSGAYGVVCSA-IDTRSGKKVAIKKIPHAFDVPTLAK-RTLRELKI 57
Query: 552 LSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLY------GTDL-------PPLS 598
L +H +++++ +++ G +Y +DL PL+
Sbjct: 58 LRHFKHDNIIAI-------RDIL-----RPPGADFKDVYVVMDLMESDLHHIIHSDQPLT 105
Query: 599 WK-------QRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSK 651
+ Q L RGL Y+H + ++IHRD+K +N+L++++ ++ DFG+++
Sbjct: 106 EEHIRYFLYQLL-------RGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMAR 155
Query: 652 ---TGPALDQTHVSTAVKGSFGYLDPE-YFRRQQLTEKSDVYSFGVVLMEVLCTRP 703
+ P + + T + Y PE + T D++S G + E+L R
Sbjct: 156 GLSSSP-TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQ 210
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 59/239 (24%), Positives = 94/239 (39%), Gaps = 44/239 (18%)
Query: 510 LGVGGFGRVYKGTLDDGTKVA------VKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSL 563
+G G FG+V + T VA +K EQ EF + + L+H +++
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQN--EFLQQGDPYRILQHPNILQC 60
Query: 564 IGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWK---------QRLEICIGAARGLH 614
+G C E +LV+EY G L+S+L W QR+ I A G+
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQ-----WHRRNSQLLLLQRMACEIAA--GVT 113
Query: 615 YLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDP 674
++H + +H D+ N L + KV D+G+ + D +L P
Sbjct: 114 HMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAP 170
Query: 675 EYFRRQQ-------LTEKSDVYSFGVVLMEV----------LCTRPALNPVLPREQVNI 716
E T+ S+V++ GV L E+ L R LN V+ +QV +
Sbjct: 171 ELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKL 229
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 43/212 (20%)
Query: 509 LLGVGGFGRVYK-GTLDDGTKVAVK---RGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLI 564
++G GGFG VY D G A+K + + +QG E L+ L R ++SL+
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG--------ETLA-LNERIMLSLV 51
Query: 565 GYCD------------ERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARG 612
D ++ + + M G L HL + S K+ G
Sbjct: 52 STGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV--FSEKEMRFYATEIILG 109
Query: 613 LHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGL----SKTGPALDQTHVSTAVKGS 668
L ++H + +++RD+K NILLD++ +++D GL SK P H S G+
Sbjct: 110 LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-----HASV---GT 158
Query: 669 FGYLDPEYFRRQQLTEKS-DVYSFGVVLMEVL 699
GY+ PE ++ + S D +S G +L ++L
Sbjct: 159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 6e-07
Identities = 61/238 (25%), Positives = 88/238 (36%), Gaps = 66/238 (27%)
Query: 509 LLGVGGFGRVY----KGTLDDGTKVAVK-----RGNPRSEQGIAEFRTEIEMLSKLRHRH 559
LLG G GRV+ KGT G A+K R++ + TE E+L+ L H
Sbjct: 8 LLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNK--VKRVLTEQEILATLDHPF 62
Query: 560 LVSLIGYCDERSEM--ILVYEYMANGPLRSHLYGTDLPPLSWKQRLE-ICIGAAR----- 611
L +L Y ++E LV +Y G L L +Q + + AR
Sbjct: 63 LPTL--YASFQTETYLCLVMDYCPGGELFRLLQ---------RQPGKCLSEEVARFYAAE 111
Query: 612 ---GLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGS 668
L YLH I++RD+K NILL ++ ++DF LSK KGS
Sbjct: 112 VLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGS 168
Query: 669 FG---------------------------YLDPEYFRRQQLTEKSDVYSFGVVLMEVL 699
Y+ PE D ++ G++L E+L
Sbjct: 169 RRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEML 226
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 7e-07
Identities = 67/313 (21%), Positives = 121/313 (38%), Gaps = 71/313 (22%)
Query: 510 LGVGGFGRV-YKGTLDDGTKVAVK---RGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIG 565
LG+G FG V +D A+K + + + +A + E ++L++ + +V L
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 566 YCDERSEMILVYEYMANGPLRSHLYGTDLPP--LSWKQRLEICIGAARGLHYLHTGAAQS 623
++ + V +Y+ G + S L ++ P L+ E+ + A +H +
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTL-AIESVHKM------G 121
Query: 624 IIHRDVKTTNILLDDNFVAKVADFGL---------------------------------- 649
IHRD+K NIL+D + K+ DFGL
Sbjct: 122 FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVS 181
Query: 650 -SKTGPAL----------DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEV 698
+ G L Q ++ ++ G+ Y+ PE R+ T+ D +S GV+L E+
Sbjct: 182 NCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM 241
Query: 699 LCTRPA-LNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCL 757
L +P L P Q+ + W T + K++P ++ + C
Sbjct: 242 LVGQPPFLAPTPTETQLKVINWENTLHIPPQV----------KLSPEAVDLITKLC--CS 289
Query: 758 AEHGVDRPSMGDV 770
AE + R D+
Sbjct: 290 AEERLGRNGADDI 302
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 7e-07
Identities = 63/220 (28%), Positives = 97/220 (44%), Gaps = 45/220 (20%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRT--EIEMLSKLRHRHLVS--- 562
++G G +G V G KVA+K+ N E R EI++L LRH +V
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 563 --LIGYCDERSEMILVYEYMANGPLRSHLY-----GTDLPPLSWK----QRLEICIGAAR 611
L E ++ +V+E M S L+ DL P + Q L R
Sbjct: 67 IMLPPSRREFKDIYVVFELM-----ESDLHQVIKANDDLTPEHHQFFLYQLL-------R 114
Query: 612 GLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGY 671
L Y+HT ++ HRD+K NIL + + K+ DFGL++ A + T TA+ + Y
Sbjct: 115 ALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLAR--VAFNDT--PTAIFWT-DY 166
Query: 672 LDPEYFRRQQL--------TEKSDVYSFGVVLMEVLCTRP 703
+ ++R +L T D++S G + EVL +P
Sbjct: 167 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 206
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 58/202 (28%), Positives = 92/202 (45%), Gaps = 18/202 (8%)
Query: 509 LLGVGGFGRVYKGTLDDGTKV-AVKRGNPRSEQGIAE---FRTEIEMLSKLRHRHLVSLI 564
++G G FG V L + KV A+K N AE FR E ++L ++ + +L
Sbjct: 8 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLH 67
Query: 565 GYCDERSEMILVYEYMANGPLRSHL--YGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQ 622
+ + + LV +Y G L + L + LP + L + A +H LH
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH----- 122
Query: 623 SIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFR---- 678
+HRD+K NIL+D N ++ADFG S D T S+ G+ Y+ PE +
Sbjct: 123 -YVHRDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVAVGTPDYISPEILQAMED 180
Query: 679 -RQQLTEKSDVYSFGVVLMEVL 699
+ + + D +S GV + E+L
Sbjct: 181 GKGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 53/214 (24%), Positives = 87/214 (40%), Gaps = 21/214 (9%)
Query: 502 NKFDESLLLGVGGFGRVY----KGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRH 557
FD L+G G FG V K T D +K+ +++ ++ F E ++LS
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 558 RHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLP---PLSWKQRLEICIGAARGLH 614
+ L ++ + LV EY G L S L + ++ E+ + +H
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLA----IH 116
Query: 615 YLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDP 674
+H +HRD+K N+L+D K+ADFG S ++ S G+ Y+ P
Sbjct: 117 SVHQ---MGYVHRDIKPENVLIDRTGHIKLADFG-SAARLTANKMVNSKLPVGTPDYIAP 172
Query: 675 EYFRRQQLTEKS------DVYSFGVVLMEVLCTR 702
E K D +S GV+ E++ R
Sbjct: 173 EVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 33/95 (34%), Positives = 52/95 (54%), Gaps = 13/95 (13%)
Query: 610 ARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAV-KGS 668
ARG+ +L A+++ +HRD+ N+LL + K+ DFGL++ D H S V KGS
Sbjct: 247 ARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLAR-----DIMHDSNYVSKGS 298
Query: 669 ----FGYLDPEYFRRQQLTEKSDVYSFGVVLMEVL 699
++ PE T SDV+S+G++L E+
Sbjct: 299 TFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIF 333
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 1e-06
Identities = 52/225 (23%), Positives = 87/225 (38%), Gaps = 42/225 (18%)
Query: 509 LLGVGGFGRVYKGTLDD---GTKVAVKR------GNPRSEQGIAEFRTEIEMLSKLRHRH 559
L+G GG G VY D +VA+K+ NP ++ F E ++ + L H
Sbjct: 9 LIGKGGMGEVYLAY--DPVCSRRVALKKIREDLSENPLLKK---RFLREAKIAADLIHPG 63
Query: 560 LVSLIGYCDERSEMILVYEYMANGPLRSHLYGT----DLP-PL----SWKQRLEICIGAA 610
+V + C + + Y+ L+S L L L S L I
Sbjct: 64 IVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC 123
Query: 611 RGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFG--LSKTGPALDQTHVSTAVKGS 668
+ Y+H+ + ++HRD+K NILL + D+G + K D + +
Sbjct: 124 ATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 669 F--------------GYLDPEYFRRQQLTEKSDVYSFGVVLMEVL 699
Y+ PE +E +D+Y+ GV+L ++L
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 2e-06
Identities = 34/105 (32%), Positives = 57/105 (54%), Gaps = 11/105 (10%)
Query: 610 ARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGS- 668
A+G+ +L A+++ IHRD+ NILL + K+ DFGL++ D +V VKG+
Sbjct: 224 AKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARD-IRNDSNYV---VKGNA 276
Query: 669 ---FGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLP 710
++ PE T +SDV+S+G++L E+ + P +P
Sbjct: 277 RLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMP 321
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 54/218 (24%), Positives = 92/218 (42%), Gaps = 28/218 (12%)
Query: 502 NKFDESLLLGVGGFGRVY----KGTLDDGTKVAVKRGNPRS---EQGIAEFRTEIEMLSK 554
F+ L+ G +G VY K T + A+K+ N ++ I + E ++L+
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETR---QRFAMKKINKQNLILRNQIQQVFVERDILTF 57
Query: 555 LRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLH 614
+ +VS+ + + + +V EY+ G + L ++ L L
Sbjct: 58 AENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLL--KNIGALPVDMARMYFAETVLALE 115
Query: 615 YLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTG-----PALDQTHVSTAVK--- 666
YLH I+HRD+K N+L+ K+ DFGLSK G L + H+ +
Sbjct: 116 YLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFL 172
Query: 667 -----GSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVL 699
G+ Y+ PE RQ + D ++ G++L E L
Sbjct: 173 DKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 47/214 (21%)
Query: 509 LLGVGGFGRVYK-GTLDDGTKVAVK---RGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLI 564
++G GGFG VY D G A+K + + +QG E L+ L R ++SL+
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG--------ETLA-LNERIMLSLV 51
Query: 565 GYCD------------ERSEMILVYEYMANGPLRSHL--YGTDLPPLSWKQRLEICIGAA 610
D ++ + + M G L HL +G S +
Sbjct: 52 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV----FSEAEMRFYAAEII 107
Query: 611 RGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGL----SKTGPALDQTHVSTAVK 666
GL ++H + +++RD+K NILLD++ +++D GL SK P H S
Sbjct: 108 LGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-----HASV--- 156
Query: 667 GSFGYLDPEYFRRQQLTEKS-DVYSFGVVLMEVL 699
G+ GY+ PE ++ + S D +S G +L ++L
Sbjct: 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 66/257 (25%), Positives = 113/257 (43%), Gaps = 39/257 (15%)
Query: 528 KVAVKRGNPRSEQGIA-EFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLR 586
+V +K +P S + IA F ++S++ H HL + G C SE I+V E++ +GPL
Sbjct: 46 RVVLKVLDP-SHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLD 104
Query: 587 SHLYGTDLP-PLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVA--- 642
L P++WK + + A L YL ++++H +V NILL +A
Sbjct: 105 VCLRKEKGRVPVAWK--ITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLAEGT 159
Query: 643 ----KVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLME 697
K++D G+S T AL + + ++ PE L+ +D +SFG L+E
Sbjct: 160 SPFIKLSDPGVSFT--ALSREERVERIP----WIAPECVPGGNSLSTAADKWSFGTTLLE 213
Query: 698 VLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCL 757
+ + +P ++ +E ++KK L + S K+ +CL
Sbjct: 214 I-----CFDGEVPLKERTPSEKERFYEKKHRLPE------------PSCKELATLISQCL 256
Query: 758 AEHGVDRPSMGDVLWNL 774
RPS +L +L
Sbjct: 257 TYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 31/213 (14%)
Query: 510 LGVGGFGRV----YKGTLDDGTKVAVKRGNPRSEQGIAEFRT--EIEMLSKLR-HRHLVS 562
LG G +G V T + VA+K+ + I R E+++L R H+++
Sbjct: 8 LGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITC 66
Query: 563 LIGYCDERSEMILVYEYMANGP-LRSHLYGTDL-------PPLSWKQRLEICIGAARGLH 614
L +M +V+ N L L DL PL+ GL
Sbjct: 67 LY-------DMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLK 119
Query: 615 YLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSK---TGPALDQTHVSTAVKGSFGY 671
Y+H+ +++HRD+K N+L++ + K+ DFGL++ P + ++ V + Y
Sbjct: 120 YIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV-ATRWY 175
Query: 672 LDPEYFRRQQLTEKS-DVYSFGVVLMEVLCTRP 703
PE Q K+ DV+S G +L E+L +P
Sbjct: 176 RAPEIMLSFQSYTKAIDVWSVGCILAELLGRKP 208
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 3e-06
Identities = 52/207 (25%), Positives = 94/207 (45%), Gaps = 36/207 (17%)
Query: 510 LGVGGFGRVYKGTLDDGT--KVAVKRGNPRSEQGIAEFRT--EIEMLSKLRHRHLVSLIG 565
+G G +G V D KVAVK+ + + I RT E+ +L ++H +++ L+
Sbjct: 23 VGSGAYGSVCSA-YDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLD 81
Query: 566 Y------CDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLE------ICIGAARGL 613
+ +E+ LV ++L G DL + Q+L + RGL
Sbjct: 82 VFTPATSIENFNEVYLV----------TNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGL 131
Query: 614 HYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLD 673
Y+H+ IIHRD+K +N+ ++++ ++ DFGL++ +V+T Y
Sbjct: 132 KYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WYRA 183
Query: 674 PE-YFRRQQLTEKSDVYSFGVVLMEVL 699
PE + D++S G ++ E+L
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELL 210
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 4e-06
Identities = 34/148 (22%), Positives = 58/148 (39%), Gaps = 14/148 (9%)
Query: 509 LLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVS--LIGY 566
LL G RVY D +K R + A+ E+ +L L + L ++
Sbjct: 5 LLKGGLTNRVYLLGTKDE-DYVLKINPSREKG--ADREREVAILQLLARKGLPVPKVLAS 61
Query: 567 CDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIH 626
+ L+ E++ G L +S +++ +I A L LH + H
Sbjct: 62 GESDGWSYLLMEWIE---------GETLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCH 112
Query: 627 RDVKTTNILLDDNFVAKVADFGLSKTGP 654
D+ NIL+DD + + D+ + GP
Sbjct: 113 GDLHPGNILVDDGKILGIIDWEYAGYGP 140
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 5e-06
Identities = 51/184 (27%), Positives = 88/184 (47%), Gaps = 23/184 (12%)
Query: 526 GTKVAVKR-GNPRSEQGIAE--FRTEIEMLSKLRHRHLVSLIGY------CDERSEMILV 576
G VAVK+ P Q A+ +R E+ +L + H++++SL+ +E ++ LV
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLV 104
Query: 577 YEYM-ANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNIL 635
E M AN H+ D +S+ +C G+ +LH+ IIHRD+K +NI+
Sbjct: 105 MELMDANLCQVIHM-ELDHERMSYLLYQMLC-----GIKHLHSAG---IIHRDLKPSNIV 155
Query: 636 LDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL 695
+ + K+ DFGL++T + T + Y PE E D++S G ++
Sbjct: 156 VKSDCTLKILDFGLARTACT---NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 212
Query: 696 MEVL 699
E++
Sbjct: 213 GELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 5e-06
Identities = 42/139 (30%), Positives = 62/139 (44%), Gaps = 12/139 (8%)
Query: 565 GYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSI 624
+ D+R + +V EYM G L + + D+P + + A +H +
Sbjct: 111 AFQDDRY-LYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIH------SMGF 163
Query: 625 IHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQ---- 680
IHRDVK N+LLD + K+ADFG TAV G+ Y+ PE + Q
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDG 222
Query: 681 QLTEKSDVYSFGVVLMEVL 699
+ D +S GV L E+L
Sbjct: 223 YYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 6e-06
Identities = 56/264 (21%), Positives = 100/264 (37%), Gaps = 57/264 (21%)
Query: 510 LGVGGFGRV-YKGTLDDGTKVAVKRGNPRS---EQGIAEFRTEIEMLSKLRHRHLVSLIG 565
LG+G FG V +D A+K + +A + E ++L++ + +V L
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68
Query: 566 YCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQ-RLEICIGAARGLHYLHTGAAQSI 624
++ + V +Y+ G + S L + P + + A +H +
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM------GF 122
Query: 625 IHRDVKTTNILLDDNFVAKVADFGLS------------KTGPALDQTH------------ 660
IHRD+K NIL+D + K+ DFGL ++G + Q
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 661 ---------------------VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVL 699
++ ++ G+ Y+ PE R T+ D +S GV+L E+L
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 700 CTRPALNPVLPRE-QVNIAEWAMT 722
+P P E Q+ + W +
Sbjct: 243 VGQPPFLAQTPLETQMKVINWQTS 266
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 8e-06
Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 24/210 (11%)
Query: 504 FDESLLLGVGGFGRVYKGTLDDGTKV-AVKRGNP-----RSEQGIAEFRTEIEMLSKLRH 557
F+ ++G G FG V + + +V A+K N R+E A FR E ++L
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAE--TACFREERDVLVNGDR 60
Query: 558 RHLVSL-IGYCDERSEMILVYEYMANGPLRSHL--YGTDLPPLSWKQRLEICIGAARGLH 614
R + +L + DE + + LV +Y G L + L + LP + L + A +H
Sbjct: 61 RWITNLHYAFQDENN-LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH 119
Query: 615 YLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDP 674
L +HRD+K N+LLD N ++ADFG S D T S G+ Y+ P
Sbjct: 120 QLG------YVHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYISP 172
Query: 675 EYFR-----RQQLTEKSDVYSFGVVLMEVL 699
E + + + + D +S GV + E+L
Sbjct: 173 EILQAMEDGKGRYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 8e-06
Identities = 50/197 (25%), Positives = 82/197 (41%), Gaps = 27/197 (13%)
Query: 513 GGFGRVYKGTLDDGTKVAVKRGN--PRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDER 570
+ K T VAVK+ N S++ + + EI +L+H +++ +
Sbjct: 13 LMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD 71
Query: 571 SEMILVYEYMANGP----LRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIH 626
SE+ +V MA G L++H + LP L+ I L Y+H+ + IH
Sbjct: 72 SELYVVSPLMAYGSCEDLLKTH-FPEGLPELAIAF---ILKDVLNALDYIHS---KGFIH 124
Query: 627 RDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGS-------FGYLDPEYFRR 679
R VK ++ILL + ++ GL + + V +L PE +
Sbjct: 125 RSVKASHILLSGDGKVVLS--GLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQ- 181
Query: 680 QQL---TEKSDVYSFGV 693
Q L EKSD+YS G+
Sbjct: 182 QNLQGYNEKSDIYSVGI 198
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 52/189 (27%), Positives = 84/189 (44%), Gaps = 26/189 (13%)
Query: 526 GTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANG 583
GT V V+ + +E+ + + E+ + RH ++++ S + ++ +MA G
Sbjct: 25 GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84
Query: 584 PLRSHLYGTDLPP-LSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVA 642
L T P +S I GA RGL+YLH IHR++K ++IL+ + +
Sbjct: 85 SAN-SLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGY---IHRNIKASHILISGDGLV 140
Query: 643 KVADFGLS----------KTGPALDQTHVSTAVKGSFGYLDPEYFRRQQL---TEKSDVY 689
++ GLS K D ST+V +L PE RQ L KSD+Y
Sbjct: 141 SLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSV---LPWLSPELL-RQDLYGYNVKSDIY 194
Query: 690 SFGVVLMEV 698
S G+ E+
Sbjct: 195 SVGITACEL 203
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 1e-05
Identities = 52/202 (25%), Positives = 93/202 (46%), Gaps = 26/202 (12%)
Query: 510 LGVGGFGRV---YKGTLDDGTKVAVKR-GNPRSEQGIAE--FRTEIEMLSKLRHRHLVSL 563
+G G G V Y LD VA+K+ P Q A+ +R E+ ++ + H++++SL
Sbjct: 25 IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 81
Query: 564 IGY------CDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLH 617
+ +E ++ LV E M + D +S+ +C G+ +LH
Sbjct: 82 LNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLH 136
Query: 618 TGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYF 677
+ IIHRD+K +NI++ + K+ DFGL++T + + T + Y PE
Sbjct: 137 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVI 190
Query: 678 RRQQLTEKSDVYSFGVVLMEVL 699
E D++S G ++ E++
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 58/212 (27%), Positives = 93/212 (43%), Gaps = 35/212 (16%)
Query: 510 LGVGGFGRVYKGTL-------DDGT------KVAVKRGNPRSEQGIAEFRTEIEMLSKLR 556
LG G ++Y G L DDG KV +K +P F M+ ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 557 HRHLVSLIGYCDERSEMILVYEYMANGPLRSHLY-GTDLPPLSWKQRLEICIGAARGLHY 615
H+H+V L G C E I+V E++ GPL ++ +D+ WK ++ A L Y
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWK--FKVAKQLASALSY 120
Query: 616 LHTGAAQSIIHRDVKTTNILLD----DN----FVAKVADFGLSKTGPALDQTHVSTAVKG 667
L + ++H +V T NILL D F+ K++D G+ T L + +
Sbjct: 121 LED---KDLVHGNVCTKNILLAREGIDGECGPFI-KLSDPGIPIT--VLSRQECVERIP- 173
Query: 668 SFGYLDPEYFR-RQQLTEKSDVYSFGVVLMEV 698
++ PE + L+ +D +SFG L E+
Sbjct: 174 ---WIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 53/218 (24%), Positives = 96/218 (44%), Gaps = 28/218 (12%)
Query: 506 ESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRT-EIEMLSKLRHRHLVSL- 563
E +G G +G VYK DG GI+ EI +L +L+H +++SL
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQ 64
Query: 564 ---IGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAAR--------G 612
+ + D + + L+++Y + H+ + K+ +++ G + G
Sbjct: 65 KVFLSHADRK--VWLLFDYAEHDLW--HIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 120
Query: 613 LHYLHTGAAQSIIHRDVKTTNILL----DDNFVAKVADFGLSK--TGPALDQTHVSTAVK 666
+HYLH A ++HRD+K NIL+ + K+AD G ++ P + V
Sbjct: 121 IHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177
Query: 667 GSFGYLDPEYFR-RQQLTEKSDVYSFGVVLMEVLCTRP 703
+F Y PE + T+ D+++ G + E+L + P
Sbjct: 178 -TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 47/177 (26%), Positives = 68/177 (38%), Gaps = 27/177 (15%)
Query: 529 VAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSH 588
V +K G G A TE +L + H ++ L G L+
Sbjct: 120 VVIKAGQ---RGGTA---TEAHILRAINHPSIIQLKGTFTYNKFTCLILPR--------- 164
Query: 589 LYGTDLPP-LSWKQRLEICIGAA------RGLHYLHTGAAQSIIHRDVKTTNILLDDNFV 641
Y TDL L+ K+ + IC A R + YLH IIHRD+K NI ++
Sbjct: 165 -YKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGD 220
Query: 642 AKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEV 698
+ DFG + P + G+ PE R D++S G+VL E+
Sbjct: 221 VCLGDFG-AACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEM 276
|
Length = 391 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 65/268 (24%), Positives = 100/268 (37%), Gaps = 57/268 (21%)
Query: 466 TKMSTTSQKSGTASCISLASSNLGRLFMFQEILDATNKFDESLLLGVGGFGRVYKGTLDD 525
+ + A + LA + L E L D+ L G FG+++ L
Sbjct: 118 SHLDFDEAPPDAAGPVPLAQAKLKH---DDEFLAHFRVIDD---LPAGAFGKIFICALRA 171
Query: 526 GTKVAVKR--------GNPRSEQGIAEF-----------RTEIEMLSKLRHRHLVSLIGY 566
T+ A R G P+ E+ IA+ EI L +L H +++ +
Sbjct: 172 STEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKI--- 228
Query: 567 CDERSEMILVYE---YMANG----PLRSHLYGTDLP----PLSWKQRLEICIGAARGLHY 615
E IL E YM L S +Y PL + R I + Y
Sbjct: 229 -----EEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTR-AIMKQLLCAVEY 282
Query: 616 LHTGAAQSIIHRDVKTTNILLDDNFVAKVADFG----LSKTGPALDQTHVSTAVKGSFGY 671
+H + +IHRD+K NI L+ + + DFG K A D V T S
Sbjct: 283 IHD---KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNS--- 336
Query: 672 LDPEYFRRQQLTEKSDVYSFGVVLMEVL 699
PE E +D++S G++L+++L
Sbjct: 337 --PEILAGDGYCEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 4e-05
Identities = 53/202 (26%), Positives = 91/202 (45%), Gaps = 25/202 (12%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVKR-GNPRSEQGIAE--FRTEIEMLSKLRHRHLVSLI 564
+G G +G V G KVA+K+ P + A+ +R E+ +L ++H +++ L+
Sbjct: 22 QVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQHENVIGLL 80
Query: 565 GY------CDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHT 618
DE + LV YM ++ L PLS + + GL Y+H
Sbjct: 81 DVFTSAVSGDEFQDFYLVMPYM-----QTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIH- 134
Query: 619 GAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEY-F 677
+ IIHRD+K N+ ++++ K+ DFGL++ A +V T Y PE
Sbjct: 135 --SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEVIL 187
Query: 678 RRQQLTEKSDVYSFGVVLMEVL 699
+ D++S G ++ E+L
Sbjct: 188 NWMHYNQTVDIWSVGCIMAEML 209
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 4e-05
Identities = 27/91 (29%), Positives = 46/91 (50%), Gaps = 10/91 (10%)
Query: 612 GLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPA--LDQTHVSTAVKGSF 669
G+ +LH+ IIHRD+K +NI++ + K+ DFGL++T + +V T
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---- 190
Query: 670 GYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC 700
Y PE E D++S G ++ E++
Sbjct: 191 -YRAPEVILGMGYKENVDIWSVGCIMGEMIK 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 4e-05
Identities = 56/250 (22%), Positives = 101/250 (40%), Gaps = 46/250 (18%)
Query: 502 NKFDESLLLGVGGFGRV-YKGTLDDGTKVAVK---RGNPRSEQGIAEFRTEIEMLSKLRH 557
+ F+ ++G G FG V D G A+K + + ++ +A R E ++L +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 558 RHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTD-LPPLSWKQRLEICIGAARGLHYL 616
+V + ++ + L+ E++ G + + L D L + + + + A +H L
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120
Query: 617 HTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTG----------------PALD--- 657
IHRD+K N+LLD K++DFGL TG P D
Sbjct: 121 ------GFIHRDIKPDNLLLDAKGHVKLSDFGLC-TGLKKAHRTEFYRNLTHNPPSDFSF 173
Query: 658 ---------------QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTR 702
+ ++ + G+ Y+ PE F + + D +S GV++ E+L
Sbjct: 174 QNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233
Query: 703 PALNPVLPRE 712
P P+E
Sbjct: 234 PPFCSETPQE 243
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 5e-05
Identities = 52/208 (25%), Positives = 84/208 (40%), Gaps = 31/208 (14%)
Query: 510 LGVGGFGRVYKGTLDDGTKV----AVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIG 565
+G G FG+V + D ++ +++ + S + E +L+++ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 566 YCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAAR----------GLHY 615
++ LV ++ G L HL QR E +R L
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHL-----------QR-EGRFDLSRARFYTAELLCALEN 108
Query: 616 LHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPE 675
LH ++I+RD+K NILLD + DFGL K D + G+ YL PE
Sbjct: 109 LHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK--TNTFCGTPEYLAPE 163
Query: 676 YFRRQQLTEKSDVYSFGVVLMEVLCTRP 703
T+ D ++ GV+L E+L P
Sbjct: 164 LLLGHGYTKAVDWWTLGVLLYEMLTGLP 191
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 6e-05
Identities = 27/89 (30%), Positives = 47/89 (52%), Gaps = 6/89 (6%)
Query: 612 GLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGY 671
G+ +LH + IIHRD+K +NI++ + K+ DFGL++T A ++ V + Y
Sbjct: 130 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRY-Y 183
Query: 672 LDPEYFRRQQLTEKSDVYSFGVVLMEVLC 700
PE E D++S G ++ E++
Sbjct: 184 RAPEVILGMGYKENVDIWSVGCIMGEMIR 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 7e-05
Identities = 59/275 (21%), Positives = 110/275 (40%), Gaps = 60/275 (21%)
Query: 456 LPLYGNSQTMTKMSTTSQKSGTASCISLASSNLGRLFMFQEILDATNKFDESLLLGVGGF 515
+ + S + + +++ R + ++G G F
Sbjct: 28 FEMNDKKLDEEERSHNNNAGEDEDEEKMIDNDINR--------SPNKSYKLGNIIGNGSF 79
Query: 516 GRVYKGT-LDDGTKVAVKR--GNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGY----CD 568
G VY+ +D KVA+K+ +P+ + E+ ++ L H +++ L Y C
Sbjct: 80 GVVYEAICIDTSEKVAIKKVLQDPQYKN------RELLIMKNLNHINIIFLKDYYYTECF 133
Query: 569 ERSE----MILVYEYMANGPLRSHLY-------GTDLPPLSWK-QRLEICIGAARGLHYL 616
+++E + +V E++ P H Y LP K ++C R L Y+
Sbjct: 134 KKNEKNIFLNVVMEFI---PQTVHKYMKHYARNNHALPLFLVKLYSYQLC----RALAYI 186
Query: 617 HTGAAQSIIHRDVKTTNILLDDN-FVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPE 675
H+ + I HRD+K N+L+D N K+ DFG +K A + S Y+
Sbjct: 187 HS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKN---------LLAGQRSVSYICSR 234
Query: 676 YFRRQQL-------TEKSDVYSFGVVLMEVLCTRP 703
++R +L T D++S G ++ E++ P
Sbjct: 235 FYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYP 269
|
Length = 440 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 9e-05
Identities = 51/214 (23%), Positives = 93/214 (43%), Gaps = 20/214 (9%)
Query: 506 ESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRT-EIEMLSKLRHRHLVSL- 563
E +G G +G VYK DG GI+ EI +L +L+H ++++L
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQ 64
Query: 564 ---IGYCDERSEMILVY-EYMANGPLRSHLYG-TDLPPLSWKQRL--EICIGAARGLHYL 616
+ + D + ++ Y E+ ++ H + P+ + + + G+HYL
Sbjct: 65 KVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124
Query: 617 HTGAAQSIIHRDVKTTNILL----DDNFVAKVADFGLSK--TGPALDQTHVSTAVKGSFG 670
H A ++HRD+K NIL+ + K+AD G ++ P + V +F
Sbjct: 125 H---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFW 180
Query: 671 YLDPEYFR-RQQLTEKSDVYSFGVVLMEVLCTRP 703
Y PE + T+ D+++ G + E+L + P
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 55/204 (26%), Positives = 90/204 (44%), Gaps = 22/204 (10%)
Query: 509 LLGVGGFGRVYKGTLDDGTKV-AVKRGNP-----RSEQGIAEFRTEIEMLSKLRHRHLVS 562
++G G FG V + ++ A+K N R+E A FR E +L + + +
Sbjct: 8 VIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAET--ACFREERNVLVNGDCQWITT 65
Query: 563 LIGYCDERSEMILVYEYMANGPLRSHL--YGTDLPPLSWKQRLEICIGAARGLHYLHTGA 620
L + + + LV +Y G L + L + LP + + + A +H LH
Sbjct: 66 LHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH--- 122
Query: 621 AQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQ 680
+HRD+K N+LLD N ++ADFG S D T S+ G+ Y+ PE +
Sbjct: 123 ---YVHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPEILQAM 178
Query: 681 Q-----LTEKSDVYSFGVVLMEVL 699
+ + D +S GV + E+L
Sbjct: 179 EDGMGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 1e-04
Identities = 26/94 (27%), Positives = 37/94 (39%), Gaps = 16/94 (17%)
Query: 612 GLHYLHTGAAQSIIHRDVKTTNILLDDNFV-AKVADFGLSK---TGPALDQTHVSTAVKG 667
L+ LH +IIH D+K N+L D + D+GL K T D T
Sbjct: 121 ALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGTLD------ 171
Query: 668 SFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCT 701
Y PE + D ++ GV+ E+L
Sbjct: 172 ---YFSPEKIKGHNYDVSFDWWAVGVLTYELLTG 202
|
Length = 267 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 55/263 (20%), Positives = 102/263 (38%), Gaps = 53/263 (20%)
Query: 504 FDESLLLGVGGFGRVYKGTLDDGTKV----AVKRGNPRSEQGIAEFRTEIEMLSKLRHRH 559
F+ ++G G FG V D V +++ + ++ + R E ++L +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 560 LVSLIGYCDERSEMILVYEYMANGPLRSHLYGTD-LPPLSWKQRLEICIGAARGLHYLHT 618
+V + ++ + L+ E++ G + + L D L + + + A +H L
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL-- 120
Query: 619 GAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH------------------ 660
IHRD+K N+LLD K++DFGL TG L + H
Sbjct: 121 ----GFIHRDIKPDNLLLDSKGHVKLSDFGLC-TG--LKKAHRTEFYRNLNHSLPSDFTF 173
Query: 661 ------------------VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTR 702
++ + G+ Y+ PE F + + D +S GV++ E+L
Sbjct: 174 QNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233
Query: 703 PALNPVLPREQVNIAEWAMTWQK 725
P P+E + M W++
Sbjct: 234 PPFCSETPQETY---KKVMNWKE 253
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 48/186 (25%), Positives = 76/186 (40%), Gaps = 23/186 (12%)
Query: 559 HLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIG--AARGLHYL 616
++V L Y + LV ++ G L SH+ + E C+ AA + L
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI-------SKFLNIPEECVKRWAAEMVVAL 98
Query: 617 HTGAAQSIIHRDVKTTNILLDDNFVAKVADFG-LSKTGPALDQTHVSTAVKGSFGYLDPE 675
+ I+ RD+ NILLDD ++ F S+ + D V Y PE
Sbjct: 99 DALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YCAPE 152
Query: 676 YFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLP-----REQVNIAEWAMTWQKKGMLD 730
+ TE D +S G +L E+L T L P +NI EW ++ + + +L
Sbjct: 153 VGGISEETEACDWWSLGAILFELL-TGKTLVECHPSGINTHTTLNIPEW-VSEEARSLLQ 210
Query: 731 QIMDSN 736
Q++ N
Sbjct: 211 QLLQFN 216
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 29/104 (27%), Positives = 42/104 (40%), Gaps = 18/104 (17%)
Query: 596 PLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPA 655
PL+ ++ +C+ L LH R K+ NILL + + K+ KT
Sbjct: 13 PLNEEEIWAVCLQCLGALRELH---------RQAKSGNILLTWDGLLKLDGSVAFKTPEQ 63
Query: 656 LDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVL 699
A PE + Q TEK+D+YS G+ L E L
Sbjct: 64 SRPDPYFMA---------PEVIQGQSYTEKADIYSLGITLYEAL 98
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-04
Identities = 41/164 (25%), Positives = 58/164 (35%), Gaps = 48/164 (29%)
Query: 510 LGVGGFGRVYKGTLDD-----GTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLI 564
LG G FG VYK +L + K +K+ E G E I M ++R S
Sbjct: 140 LGEGAFGVVYKASLVNKQSKKEGKYVLKKAT---EYGAVE----IWMNERVRRACPNSCA 192
Query: 565 GYC---------DERSEMILVYEYMANGPL-------------RSHLYG--TDLPPLSWK 600
+ + E LV+ Y L +L G DLP +
Sbjct: 193 DFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLER 252
Query: 601 QRLEI------CIGAARGLHYLHTGAAQSIIHRDVKTTNILLDD 638
+ I + A GLH + I+HRDVK NI+ +
Sbjct: 253 ENKIIQTIMRQILFALDGLH------STGIVHRDVKPQNIIFSE 290
|
Length = 566 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 51/173 (29%), Positives = 79/173 (45%), Gaps = 33/173 (19%)
Query: 506 ESL-LLGVGGFGRV----YKGTLDDGTKVAVKRGNP----RSEQGIAEFRTEIEMLSKLR 556
ES+ ++G G FG V K D G A+K+ EQ +A R E ++L++
Sbjct: 4 ESIKVIGRGAFGEVRLVQKK---DTGHIYAMKKLRKSEMLEKEQ-VAHVRAERDILAEAD 59
Query: 557 HRHLVSLIGYC---DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQ-RLEI--CIGAA 610
+ +V L Y DE + L+ EY+ G + + L D + ++ R I I A
Sbjct: 60 NPWVVKL--YYSFQDENY-LYLIMEYLPGGDMMTLLMKKDT--FTEEETRFYIAETILAI 114
Query: 611 RGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVST 663
+H L IHRD+K N+LLD K++DFGL L ++H +
Sbjct: 115 DSIHKL------GYIHRDIKPDNLLLDAKGHIKLSDFGLCT---GLKKSHRTE 158
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|221187 pfam11721, Malectin, Di-glucose binding within endoplasmic reticulum | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 31/159 (19%), Positives = 60/159 (37%), Gaps = 20/159 (12%)
Query: 212 TVYRLNMGGPLITAQNDTLGRTWENDETYLHVNSSAVNVSVRPSAIRYTASVTAETAPNW 271
V +N GGP T D+ G T+E D + + + V + ++S+ T P
Sbjct: 1 VVLAINCGGPEHT---DSDGITYEADT---YFTGGSADYYVSDT--NGSSSIAGTTDPE- 51
Query: 272 VYATAEMMGDANVPEVNFNITWVLPVEPNFTYFVRVHLCDI--ASLSMNNLVFNLYINDD 329
+Y T + ++ +P N Y V +H +I + VF++Y+
Sbjct: 52 LYQTERYSPS--------SFSYYIPCLENGNYTVILHFAEIYFGEDGLGRRVFDVYVQGK 103
Query: 330 IAQPSVDLSTLTNGLNVPYYKDFVCNASADSNTLTVSVG 368
+ D+ G +K+++ + TL +
Sbjct: 104 LVLKDFDIVAEAGGKGKTAHKEYI-PVTVTDGTLEIHFY 141
|
Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan. Length = 164 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 4e-04
Identities = 44/185 (23%), Positives = 76/185 (41%), Gaps = 28/185 (15%)
Query: 232 RTWENDETYLHVNSSAVNVSVRPSAIRYTASVTAETAPNWVYATAEMMGDANVPEVNFNI 291
R W +T+ + A++ AS P +Y +A ++ P++++
Sbjct: 218 RFWNRMQTFGSGSDQAISTENVIK----KASNAPNFYPESLYQSA-LVSTDTQPDLSYT- 271
Query: 292 TWVLPVEPNFTYFVRVHLCDIAS--LSMNNLVFNLYINDDIAQPSVDLSTLTNGLNVPYY 349
+ V+PN Y V +H +I + + VF++ IN D A VD+ ++ Y
Sbjct: 272 ---MDVDPNRNYSVWLHFAEIDNSITAEGKRVFDVLINGDTAFKDVDIVKMSGER----Y 324
Query: 350 KDFVCNAS--ADSNTLTVSVGPDSVADFTNATMNGLEVMKI--------SNEARSLDGLS 399
V N + TLT+ + P T+A +N +EV +I E +L L
Sbjct: 325 TALVLNKTVAVSGRTLTIVLQP---KKGTHAIINAIEVFEIITAESKTLLEEVSALQTLK 381
Query: 400 SVEGL 404
S GL
Sbjct: 382 SSLGL 386
|
Length = 623 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 5e-04
Identities = 57/247 (23%), Positives = 96/247 (38%), Gaps = 60/247 (24%)
Query: 509 LLGVGGFGRV-YKGTLDDGTKVAVK---RGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLI 564
++G G FG V D G A+K + + +A + E ++L++ +VSL
Sbjct: 8 VIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLY 67
Query: 565 GYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWK-QRLEI--CIGAARGLHYLHTGAA 621
+ + L+ E++ G L + L D S R + C+ A +H L
Sbjct: 68 YSFQDAQYLYLIMEFLPGGDLMTMLIKYDT--FSEDVTRFYMAECVLAIEAVHKL----- 120
Query: 622 QSIIHRDVKTTNILLDDNFVAKVADFGLS---------------------------KTGP 654
IHRD+K NIL+D K++DFGLS +
Sbjct: 121 -GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSV 179
Query: 655 ALDQTHVSTAVK------------------GSFGYLDPEYFRRQQLTEKSDVYSFGVVLM 696
A+D +++ + K G+ Y+ PE F +Q ++ D +S G ++
Sbjct: 180 AVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMF 239
Query: 697 EVLCTRP 703
E L P
Sbjct: 240 ECLIGWP 246
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.002
Identities = 27/88 (30%), Positives = 47/88 (53%), Gaps = 8/88 (9%)
Query: 510 LGVGGFGRVYKGTL------DDGTKVAVKRGNPRSEQGIAE-FRTEIEMLSKL-RHRHLV 561
LG G FG+V + T D+ +VAVK + E +E+++LS L +H+++V
Sbjct: 46 LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIV 105
Query: 562 SLIGYCDERSEMILVYEYMANGPLRSHL 589
+L+G C ++++ EY G L + L
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFL 133
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.003
Identities = 58/259 (22%), Positives = 95/259 (36%), Gaps = 57/259 (22%)
Query: 510 LGVGGFGRVYKGTLDDGTKV-AVK---RGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIG 565
+G+G FG V D + A+K + + A + E ++L++ + +V L
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68
Query: 566 YCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSII 625
++ + V +Y+ G + S L + R I + +H I
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLA-RFYIA-ELTCAIESVHK---MGFI 123
Query: 626 HRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVST---------------------- 663
HRD+K NIL+D + K+ DFGL TG TH S
Sbjct: 124 HRDIKPDNILIDRDGHIKLTDFGLC-TG--FRWTHDSKYYQKGDHHRQDSMEPSEEWSEI 180
Query: 664 ----------------------AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCT 701
++ G+ Y+ PE R T+ D +S GV+L E+L
Sbjct: 181 DRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 240
Query: 702 RPALNPVLPRE-QVNIAEW 719
+P P E Q+ + W
Sbjct: 241 QPPFLADTPAETQLKVINW 259
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.003
Identities = 33/115 (28%), Positives = 49/115 (42%), Gaps = 6/115 (5%)
Query: 586 RSHLY---GTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVA 642
RS LY G L PL Q + + Y+H + IIHRD+KT N+L++
Sbjct: 243 RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDI 299
Query: 643 KVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLME 697
+ DFG + T + G+ PE T D++S G+V+ E
Sbjct: 300 CLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 845 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PF12819 | 347 | Malectin_like: Carbohydrate-binding protein of the | 100.0 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.98 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.98 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.98 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.98 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.82 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.78 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.77 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.74 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.74 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.73 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.69 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.69 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.68 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.68 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.67 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.66 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.65 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.65 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.6 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.55 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.53 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.48 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.43 | |
| PF11721 | 174 | Malectin: Di-glucose binding within endoplasmic re | 99.32 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.32 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.31 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.24 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.21 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.2 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.19 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.15 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.11 | |
| PF11721 | 174 | Malectin: Di-glucose binding within endoplasmic re | 99.11 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.1 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.07 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.99 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.95 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.85 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.83 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.72 | |
| PF12819 | 347 | Malectin_like: Carbohydrate-binding protein of the | 98.71 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.64 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.6 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.53 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.52 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.42 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.42 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.32 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.3 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.18 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.12 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.02 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.0 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.96 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.85 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.7 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.7 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.7 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.62 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.57 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.55 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.54 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.47 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.43 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.38 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.26 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.23 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.94 | |
| PLN02236 | 344 | choline kinase | 96.82 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.78 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.67 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.59 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.54 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.26 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.05 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.98 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.54 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.46 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.46 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.41 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.29 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.17 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.13 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.04 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.98 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-57 Score=497.35 Aligned_cols=292 Identities=52% Similarity=0.847 Sum_probs=261.0
Q ss_pred cCccccHHHHHHHhcCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEE
Q 003139 488 LGRLFMFQEILDATNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYC 567 (845)
Q Consensus 488 ~~~~~~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 567 (845)
..+.|++.||..||++|...++||+|+||.||+|.+++|+.||||++.....+..++|.+|++++.+++|||||+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 46789999999999999999999999999999999999999999988776543146699999999999999999999999
Q ss_pred ecCC-cEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEe
Q 003139 568 DERS-EMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVAD 646 (845)
Q Consensus 568 ~~~~-~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~D 646 (845)
.+.+ +.+||||||++|+|.++|+.....+|+|.+|++||.++|+||+|||+.+.++||||||||+|||||+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9999 599999999999999999876543899999999999999999999999888999999999999999999999999
Q ss_pred ccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhc
Q 003139 647 FGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKK 726 (845)
Q Consensus 647 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 726 (845)
||+|+..+.. .....+...||.+|+|||++..+..+.|+|||||||+|+||+||+++.+...+.....+++|++...++
T Consensus 221 FGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 221 FGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE 299 (361)
T ss_pred ccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence 9999875431 222221118999999999999999999999999999999999999999877666677799999999999
Q ss_pred CchhhhhccccC-CCCCH-HHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhh
Q 003139 727 GMLDQIMDSNLV-GKVNP-ASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQL 780 (845)
Q Consensus 727 ~~~~~~~d~~l~-~~~~~-~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~ 780 (845)
+.+.+++|+.+. +.... .+..++.+++.+|++.+|.+||+|.+|+++|+.+...
T Consensus 300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 999999999997 55554 6888999999999999999999999999999665443
|
|
| >PF12819 Malectin_like: Carbohydrate-binding protein of the ER; InterPro: IPR024788 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan [] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-56 Score=488.41 Aligned_cols=322 Identities=34% Similarity=0.581 Sum_probs=252.8
Q ss_pred EecCCCccc----c-cCCceeecCCCCcccccccCCccccc--CCCCCCCcccceeEeec--ccceEEEeecc--cceEE
Q 003139 38 IACGSSQKV----T-FQARTYVPDTEHSSLSMKSGNSTTAS--SNSSAPSPIYQSARIFS--AAAFYKFEIEH--KGRHW 106 (845)
Q Consensus 38 i~CG~~~~~----~-~~~~~~v~D~~~~~~~~~~~~~~~~~--~~~~~~~~~~~t~R~F~--~~~cY~~~~~~--~g~~~ 106 (845)
||||++.+. | .+||+|++|.+|.+. |..+.++.. ...+...++|+|||+|+ +++||+||+.+ ++|||
T Consensus 1 IdCG~~~~~s~y~D~~tg~~~~~D~~~~~~--g~~~~i~~~~~~~~~~~~~~y~taR~F~~g~r~cY~l~~~~~~~~~yl 78 (347)
T PF12819_consen 1 IDCGSSSNSSSYVDDSTGRTWVSDDDFIDT--GKSGNISSQPDSSSSDSSPPYQTARIFPEGSRNCYTLPVTPPGGGKYL 78 (347)
T ss_pred CcCCCCCCCcccccCCCCcEEeCCCCcccC--CCccccccccCCcCCccccccceEEEcCCCCccEEEeeccCCCCceEE
Confidence 899977443 3 379999999999876 776666322 33567788999999995 88999999984 45999
Q ss_pred EEEEeecCCCCCcC----CccceEEEEeCcEEEeecccccccCCCcceEEEEEeec-CCceEEEEeeCCCCc-ceeeeeE
Q 003139 107 VRLYFYTLPGSNQH----LNSASFTVATDKFVLLSNFTFKNYNSSFMFKEYAINVN-SDALTLTFIPSNNSV-AFVNAIE 180 (845)
Q Consensus 107 vR~~f~~~~~~~~~----~~~~~f~v~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~-~~~~~vc~~~~~~~~-pfi~~iE 180 (845)
||+||+|++|++.+ .+++.|++..+.....+. ...+....++++||++.+. ++.++|||+|+++|+ |||||||
T Consensus 79 iRl~F~~gnyd~~~fs~~~~~~~FdL~~~~n~~~tV-~~~~~~~~~~~~E~ii~v~~~~~l~vclv~~~~g~~pFIsaiE 157 (347)
T PF12819_consen 79 IRLHFYYGNYDGLNFSVSSSPPTFDLLLGFNFWSTV-NLSNSPSSPVVKEFIINVTWSDTLSVCLVPTGSGTFPFISAIE 157 (347)
T ss_pred EEEEeccccccccccccccCCcceEEEECCceeEEE-EecCCCcceEEEEEEEEEcCCCcEEEEEEeCCCCCCCceeEEE
Confidence 99999999999764 246779887765443221 1112223579999999999 799999999999877 9999999
Q ss_pred EEecCCCcccccccccCCCCccCCccccceeEEEEeecCCCc--cCCCCCcCCccccCC---CCceeeCCCCceeeccCc
Q 003139 181 VVSVPDAIFPDQALALEPSASFSGLSDLGFETVYRLNMGGPL--ITAQNDTLGRTWEND---ETYLHVNSSAVNVSVRPS 255 (845)
Q Consensus 181 ~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~r~n~g~~~--i~~~~D~~~R~W~~~---~~~~~~~~~~~~~~~~~~ 255 (845)
||+||+++|++.. ...+.+|++++|+||||.. ||||+|+|||+|.+. ..|....+. .
T Consensus 158 l~~lp~~ly~~~~----------~~~s~~L~~~~R~n~G~~~~~iryp~D~~dR~W~~~~~~~~~~~ist~--------~ 219 (347)
T PF12819_consen 158 LRPLPDSLYPDTD----------ANSSQALETVYRLNVGGSSSFIRYPDDTYDRIWQPYSSSPGWSNISTT--------S 219 (347)
T ss_pred EEECCccceeccc----------cCCCceeEEEEeecCCCcccccCCCCCcceeeccccccCccccccccc--------e
Confidence 9999999996431 2467899999999999998 999999999999964 234332221 2
Q ss_pred eeeeeccCCcccChHHHHHHhhhccCCCCccceeeEEEEeecCCCCceEEEEEccCcccc--ccceEEEEEEecccccCC
Q 003139 256 AIRYTASVTAETAPNWVYATAEMMGDANVPEVNFNITWVLPVEPNFTYFVRVHLCDIASL--SMNNLVFNLYINDDIAQP 333 (845)
Q Consensus 256 ~~~~~~~~~~~~~P~~Vy~ta~~~~~~~~~~~~~~ltw~~~~~~~~~y~vrlhf~ei~s~--~~~~r~F~i~in~~~~~~ 333 (845)
.+......+.+.||..||+||+++++.+. .++++|.+ ++++..|+||||||||+.. ..++|+|+|+|||+.+..
T Consensus 220 ~i~~~~~~~~~~~P~~V~~TA~~~~~~s~---~~nltw~~-~~~~~~y~v~lHFaEi~~~~~~~~~R~F~IyiN~~~~~~ 295 (347)
T PF12819_consen 220 NININSSNNPYDAPSAVYQTARTPSNSSD---PLNLTWSF-VDPGFSYYVRLHFAEIQSLSPNNNQREFDIYINGQTAYS 295 (347)
T ss_pred eeecccCCccCcChHHHHHhhhccccccc---ceEEEecc-CCCCccEEEEEEEeecccccCCCCeEEEEEEECCeEccC
Confidence 23322345678999999999999988762 48899999 9999999999999999873 445799999999998875
Q ss_pred Ccchhh-hcCCccceeeeeeeeeecCCCCeeEEEecCCcccccchhccccceeeec
Q 003139 334 SVDLST-LTNGLNVPYYKDFVCNASADSNTLTVSVGPDSVADFTNATMNGLEVMKI 388 (845)
Q Consensus 334 ~~~~~~-~~~~~~~~~~~d~~~~~~~~~~~l~v~~~P~~~~~~~~a~lngle~~~i 388 (845)
++.. ..+....++|.|+.+..+. .+.+.|++.|...+.. +++|||+|+|+|
T Consensus 296 --~~~~~~~~~~~~~~~~d~~~~~~~-~~~~~isL~~t~~S~l-ppiLNalEIy~v 347 (347)
T PF12819_consen 296 --DVSPPYLGADTVPYYSDYVVNVPD-SGFLNISLGPTPDSTL-PPILNALEIYKV 347 (347)
T ss_pred --ccCcccccCcceEeecceEEEecC-CCEEEEEEEeCCCCCc-CceeEeeeeEeC
Confidence 5554 4566677889999887653 3478889999877644 999999999986
|
This entry represents a malectin-like domain found in a number of plant receptor kinases. |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-53 Score=496.73 Aligned_cols=329 Identities=22% Similarity=0.300 Sum_probs=263.1
Q ss_pred ccCCCceEEEecCCCcccc--cCCceeecCCCCcccccccCCcccccCCCCCCCcccceeEeecc----cceEEEeeccc
Q 003139 29 AFTPVDNYLIACGSSQKVT--FQARTYVPDTEHSSLSMKSGNSTTASSNSSAPSPIYQSARIFSA----AAFYKFEIEHK 102 (845)
Q Consensus 29 ~~~~~~~~~i~CG~~~~~~--~~~~~~v~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~R~F~~----~~cY~~~~~~~ 102 (845)
+.+++++|+||||++++.+ .+||+|++|..|.. |.... .. ....+.+.|+|||+|+. ++||+||++++
T Consensus 19 ~~~~~~~~~I~CGs~~~~~~d~~~~~w~~D~~~~~---~~~~~--~~-~~~~~~~~~~t~R~F~~~~g~~~cY~~~~~~~ 92 (623)
T PLN03150 19 ASPEPFTMRISCGARVNVRTAPTNTLWYKDFAYTG---GIPAN--AT-RPSFIAPPLKTLRYFPLSDGPENCYNINRVPK 92 (623)
T ss_pred ccCCCccEEEeCCCCCCcccCCCCCEEcCCccccc---Ccccc--cc-CcccccchhhccccCCcccccccceEeeecCC
Confidence 3448889999999887653 68999999966632 11111 11 12355678999999953 88999999999
Q ss_pred ceEEEEEEeecCCCCCcCCccceEEEEeCc---EEEeecccccccCCCcceEEEEEeecCCceEEEEeeCCCCcceeeee
Q 003139 103 GRHWVRLYFYTLPGSNQHLNSASFTVATDK---FVLLSNFTFKNYNSSFMFKEYAINVNSDALTLTFIPSNNSVAFVNAI 179 (845)
Q Consensus 103 g~~~vR~~f~~~~~~~~~~~~~~f~v~~~~---~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~vc~~~~~~~~pfi~~i 179 (845)
|+||||+||+|++|++.+ +++.|+|.+++ +.++.+|+.. +..+++||++.++++.++|||+|+++++||||+|
T Consensus 93 g~ylVRl~F~~~~y~~~~-~~~~Fdv~~~~~~~~tv~~~~~~~---~~~v~~E~i~~~~~~~l~vcf~~~~~~~pFIs~i 168 (623)
T PLN03150 93 GHYSVRVFFGLVAEPNFD-SEPLFDVSVEGTQISSLKSGWSSH---DEQVFAEALVFLTDGSASICFHSTGHGDPAILSI 168 (623)
T ss_pred CcEEEEEEeecCCcCCCC-CCCceEEEECcEEEEEEecCcccC---CCcEEEEEEEEecCCcEEEEEecCCCCCCceeEE
Confidence 999999999999999998 78899999999 6677777532 4568999999999999999999999999999999
Q ss_pred EEEecCCCcccccccccCCCCccCCccccceeEEEEeecCCC----ccCCCCCcC--CccccCCCCceeeCCCCceeecc
Q 003139 180 EVVSVPDAIFPDQALALEPSASFSGLSDLGFETVYRLNMGGP----LITAQNDTL--GRTWENDETYLHVNSSAVNVSVR 253 (845)
Q Consensus 180 E~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~r~n~g~~----~i~~~~D~~--~R~W~~~~~~~~~~~~~~~~~~~ 253 (845)
|||+||+++|... +. .....+|+++||+||||+ .++||+|++ ||+|.+|.+|... ...+++.
T Consensus 169 Ev~~l~~~~y~~~-----~~----~~~~~~L~~~~R~n~G~~~~~~~~d~~~D~~~~dR~W~~d~~~~~~--~~~~~st- 236 (623)
T PLN03150 169 EILQVDDKAYNFG-----PS----WGQGVILRTAKRLSCGAGKSKFDEDYSGDHWGGDRFWNRMQTFGSG--SDQAIST- 236 (623)
T ss_pred EEEEcCccccccc-----cc----ccCceEEEEEEEEEecCcccccccCCCCCcccCccccCcCcccCCC--ccccccc-
Confidence 9999999999422 10 112567999999999986 478999998 9999999887622 1222322
Q ss_pred CceeeeeccCCcccChHHHHHHhhhccCCCCccceeeEEEEeecCCCCceEEEEEccCccc--cccceEEEEEEeccccc
Q 003139 254 PSAIRYTASVTAETAPNWVYATAEMMGDANVPEVNFNITWVLPVEPNFTYFVRVHLCDIAS--LSMNNLVFNLYINDDIA 331 (845)
Q Consensus 254 ~~~~~~~~~~~~~~~P~~Vy~ta~~~~~~~~~~~~~~ltw~~~~~~~~~y~vrlhf~ei~s--~~~~~r~F~i~in~~~~ 331 (845)
...|.+. +.+.+.+|+.||+||+.+.+.. .+++|.++++++..|+||||||||+. ...++|+|+|++||+.+
T Consensus 237 ~~~I~~~-~~~~~~~P~~VyqTA~~~~~~~-----~~lty~~~v~~~~~Y~VrLhFaEi~~~~~~~~~R~F~V~ing~~~ 310 (623)
T PLN03150 237 ENVIKKA-SNAPNFYPESLYQSALVSTDTQ-----PDLSYTMDVDPNRNYSVWLHFAEIDNSITAEGKRVFDVLINGDTA 310 (623)
T ss_pred ccccccc-cCCCccChHHHhhhhccccCCC-----CceEEEeecCCCCCEEEEEEEEeccCccCCCceEEEEEEECCEEe
Confidence 3445544 3467789999999999887632 36899999999999999999999974 35578999999999999
Q ss_pred CCCcchhhhcCCccceeeeeeeeeecCCCCeeEEEecCCcccccchhccccceeeeccC
Q 003139 332 QPSVDLSTLTNGLNVPYYKDFVCNASADSNTLTVSVGPDSVADFTNATMNGLEVMKISN 390 (845)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~l~v~~~P~~~~~~~~a~lngle~~~i~~ 390 (845)
..++++...+++...++++++.+... .+.+.|+++|... .++++|++|+|++..
T Consensus 311 ~~~~di~~~~g~~~~~~~~~~~v~~~--~g~l~isl~p~~~---s~pilNaiEI~~~~~ 364 (623)
T PLN03150 311 FKDVDIVKMSGERYTALVLNKTVAVS--GRTLTIVLQPKKG---THAIINAIEVFEIIT 364 (623)
T ss_pred ecccChhhhcCCcccceEEEeEEeec--CCeEEEEEeeCCC---Ccceeeeeeeeeccc
Confidence 88999988887777788888876654 3679999999753 358999999999974
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-47 Score=411.31 Aligned_cols=254 Identities=35% Similarity=0.558 Sum_probs=214.4
Q ss_pred ceeeeeeceEEEEEEEEcCCcEEEEEEcCCCC--hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCC-cEEEEEEeccCC
Q 003139 507 SLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRS--EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERS-EMILVYEYMANG 583 (845)
Q Consensus 507 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~Ey~~~g 583 (845)
.+.||+|+||+||+|.+++...||||++.... ....++|.+|+.+|.+++|||||+++|+|.+.. .+++|||||++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 34599999999999999844449999987653 223679999999999999999999999999887 799999999999
Q ss_pred CccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCc-eeeccCCCCcEEECCCC-ceEEEeccccCCCCCCCCccc
Q 003139 584 PLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQS-IIHRDVKTTNILLDDNF-VAKVADFGLSKTGPALDQTHV 661 (845)
Q Consensus 584 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-ivHrDik~~NILl~~~~-~~kl~DFGla~~~~~~~~~~~ 661 (845)
+|.++|+......+++..+++|+.|||+||+|||+ .+ ||||||||+||||+.++ ++||+|||+++...... ..
T Consensus 126 sL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~ 200 (362)
T KOG0192|consen 126 SLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TS 200 (362)
T ss_pred cHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecccc--cc
Confidence 99999987555789999999999999999999999 66 99999999999999997 99999999998743211 33
Q ss_pred ccccccCCCcCChhhhc--cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCC
Q 003139 662 STAVKGSFGYLDPEYFR--RQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVG 739 (845)
Q Consensus 662 ~~~~~gt~~y~aPE~~~--~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 739 (845)
.+...||+.|||||+++ ..+|+.|+|||||||+||||+||+.||..... .+ . ...+.......
T Consensus 201 ~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~--~------------~~~v~~~~~Rp 265 (362)
T KOG0192|consen 201 MTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQ--V------------ASAVVVGGLRP 265 (362)
T ss_pred ccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HH--H------------HHHHHhcCCCC
Confidence 44578999999999999 67999999999999999999999999976554 21 1 11222223334
Q ss_pred CCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhh
Q 003139 740 KVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQL 780 (845)
Q Consensus 740 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~ 780 (845)
.++..++..+..++.+||+.||.+||++.+++..|+.+...
T Consensus 266 ~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~ 306 (362)
T KOG0192|consen 266 PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH 306 (362)
T ss_pred CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence 44555788899999999999999999999999999988663
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=400.16 Aligned_cols=253 Identities=31% Similarity=0.445 Sum_probs=214.6
Q ss_pred cceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEeccCCCc
Q 003139 506 ESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPL 585 (845)
Q Consensus 506 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 585 (845)
..+.||+|.||.||.|.++....||+|.+..... ..++|.+|+++|++|+|+|||+|+|+|..++.++||||||+.|+|
T Consensus 210 l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsL 288 (468)
T KOG0197|consen 210 LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSL 288 (468)
T ss_pred HHHHhcCCccceEEEEEEcCCCcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcH
Confidence 3557999999999999999777999998876532 347899999999999999999999999998899999999999999
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCccccccc
Q 003139 586 RSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAV 665 (845)
Q Consensus 586 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 665 (845)
.++|.......+...+.+.++.|||+||+||++ +++|||||.++||||+++..+||+||||||...+ +........
T Consensus 289 l~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d-~~Y~~~~~~ 364 (468)
T KOG0197|consen 289 LDYLRTREGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGD-DEYTASEGG 364 (468)
T ss_pred HHHhhhcCCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCC-CceeecCCC
Confidence 999987667789999999999999999999999 9999999999999999999999999999995332 334344555
Q ss_pred ccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCCHH
Q 003139 666 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPA 744 (845)
Q Consensus 666 ~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 744 (845)
.-.+.|.|||.+..+.++.|||||||||+||||+| |+.|+...... +.+ +.++...+-..|..
T Consensus 365 kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~------ev~----------~~le~GyRlp~P~~ 428 (468)
T KOG0197|consen 365 KFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE------EVL----------ELLERGYRLPRPEG 428 (468)
T ss_pred CCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH------HHH----------HHHhccCcCCCCCC
Confidence 66789999999999999999999999999999998 55555433222 111 22233333345677
Q ss_pred HHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 003139 745 SLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779 (845)
Q Consensus 745 ~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~ 779 (845)
++..+.+++..||+.+|++|||++.+...|+....
T Consensus 429 CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 429 CPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred CCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 89999999999999999999999999999887654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-45 Score=377.36 Aligned_cols=251 Identities=27% Similarity=0.372 Sum_probs=209.8
Q ss_pred cceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCC-cEEEEEEeccC
Q 003139 506 ESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERS-EMILVYEYMAN 582 (845)
Q Consensus 506 ~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~Ey~~~ 582 (845)
..+.||+|..|+|||++++ +++.+|+|.+... .....+++.+|++++++.+||+||.++|.|.... +..|+||||.+
T Consensus 83 ~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDg 162 (364)
T KOG0581|consen 83 RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDG 162 (364)
T ss_pred hhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCC
Confidence 3557999999999999987 6788999988543 4556688999999999999999999999999988 59999999999
Q ss_pred CCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcccc
Q 003139 583 GPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVS 662 (845)
Q Consensus 583 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 662 (845)
|||+..+... +.+++..+-+|+.+|++||.|||+ .++||||||||+||||+..|++||||||.++..... ..
T Consensus 163 GSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~a 234 (364)
T KOG0581|consen 163 GSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----IA 234 (364)
T ss_pred CCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----hc
Confidence 9999998543 579999999999999999999996 389999999999999999999999999999874332 55
Q ss_pred cccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCC
Q 003139 663 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVN 742 (845)
Q Consensus 663 ~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 742 (845)
....||..|||||.+.+..|+.++||||||+.++|+.+|+-|+....+. .....+ .+..+++... ...+
T Consensus 235 ~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~-~~~~~~---------Ll~~Iv~~pp-P~lP 303 (364)
T KOG0581|consen 235 NTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP-YLDIFE---------LLCAIVDEPP-PRLP 303 (364)
T ss_pred ccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC-CCCHHH---------HHHHHhcCCC-CCCC
Confidence 6789999999999999999999999999999999999999998764211 111111 2233333211 1223
Q ss_pred H-HHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 743 P-ASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 743 ~-~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
. .+..++..++..||++||.+||++.+++++-.
T Consensus 304 ~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpf 337 (364)
T KOG0581|consen 304 EGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPF 337 (364)
T ss_pred cccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHH
Confidence 3 37788999999999999999999999987743
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-45 Score=411.66 Aligned_cols=257 Identities=32% Similarity=0.476 Sum_probs=217.4
Q ss_pred CcceeeeeeceEEEEEEEEc------CCcEEEEEEcCCCChH-hHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 505 DESLLLGVGGFGRVYKGTLD------DGTKVAVKRGNPRSEQ-GIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 505 ~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
...+.||+|+||+||+|+.. +.+.||||.++..... ..++|++|+++|+.++|||||+|+|+|.+++.+++|+
T Consensus 489 ~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvF 568 (774)
T KOG1026|consen 489 VFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVF 568 (774)
T ss_pred eehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEE
Confidence 34457999999999999854 3457999998877554 7889999999999999999999999999999999999
Q ss_pred EeccCCCccccccCC--------C----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEE
Q 003139 578 EYMANGPLRSHLYGT--------D----LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVA 645 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~--------~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~ 645 (845)
|||..|+|.++|... . ..+|+-.+.+.||.|||.||+||-+ +.+|||||..+|+||.++..+||+
T Consensus 569 EYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l~VKIs 645 (774)
T KOG1026|consen 569 EYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENLVVKIS 645 (774)
T ss_pred EecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CcccccchhhhhceeccceEEEec
Confidence 999999999999632 1 2348999999999999999999998 999999999999999999999999
Q ss_pred eccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHh
Q 003139 646 DFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQ 724 (845)
Q Consensus 646 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~ 724 (845)
||||+|.....+.........-.++|||||.+..++||.+||||||||+|||+++ |+.|+......+ +.+++
T Consensus 646 DfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E-------VIe~i 718 (774)
T KOG1026|consen 646 DFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE-------VIECI 718 (774)
T ss_pred ccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-------HHHHH
Confidence 9999997655444443334445789999999999999999999999999999997 888887654433 22333
Q ss_pred hcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhh
Q 003139 725 KKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQL 780 (845)
Q Consensus 725 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~ 780 (845)
+++ ++ -..+..++.++.+|+..||+.+|.+||+++||-..|+...+.
T Consensus 719 ~~g--------~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 719 RAG--------QL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred HcC--------Cc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 333 33 346778999999999999999999999999999999877553
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=398.89 Aligned_cols=263 Identities=24% Similarity=0.384 Sum_probs=223.6
Q ss_pred CCcceeeeeeceEEEEEEEEcC----CcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEE
Q 003139 504 FDESLLLGVGGFGRVYKGTLDD----GTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYE 578 (845)
Q Consensus 504 f~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 578 (845)
..+.++||.|.||+|++|+++- ...||||.++.. .+++..+|+.|..||.++.||||++|.|+.......+||.|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 3466789999999999999862 356999998876 46677899999999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCC
Q 003139 579 YMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQ 658 (845)
Q Consensus 579 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~ 658 (845)
||+||+|+.+|+.++ +++++.++..++++||.||+||-+ .++|||||.++|||++.+..+|++||||+|...+...
T Consensus 711 yMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~ 786 (996)
T KOG0196|consen 711 YMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 786 (996)
T ss_pred hhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeeccceEEEeccccceeecccCCC
Confidence 999999999999877 569999999999999999999998 9999999999999999999999999999997654322
Q ss_pred cc-cccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccc
Q 003139 659 TH-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSN 736 (845)
Q Consensus 659 ~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (845)
.. ....-+-.++|.|||.+..+++|.+||||||||+|||.++ |.+|+.....++- .+.++..
T Consensus 787 ~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdV----------------IkaIe~g 850 (996)
T KOG0196|consen 787 AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV----------------IKAIEQG 850 (996)
T ss_pred ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHH----------------HHHHHhc
Confidence 22 2223444679999999999999999999999999999875 8888866544331 1222333
Q ss_pred cCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhhhccccc
Q 003139 737 LVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLEETSSA 786 (845)
Q Consensus 737 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~~~~~~ 786 (845)
.+-..+.+++..|.+|++.||++|-.+||.+.+|+..|+++...+.....
T Consensus 851 yRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~ 900 (996)
T KOG0196|consen 851 YRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKT 900 (996)
T ss_pred cCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhcc
Confidence 44456789999999999999999999999999999999998876665443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=372.31 Aligned_cols=203 Identities=31% Similarity=0.496 Sum_probs=183.0
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
..+|...+.||+|+|+.||+|+++ ++..||||.+... ..+..+.+..|+++|+.++|||||.|++++..++.++|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 356777788999999999999986 6889999998766 5667778899999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCC------CceEEEeccccC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDN------FVAKVADFGLSK 651 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~------~~~kl~DFGla~ 651 (845)
|||.+|+|.++++.. +.+++.....++.|+|.||++||+ ++||||||||+||||+.. -.+||+|||+||
T Consensus 89 EyC~gGDLs~yi~~~--~~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRR--GRLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 999999999999655 479999999999999999999999 999999999999999864 468999999999
Q ss_pred CCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCc
Q 003139 652 TGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPR 711 (845)
Q Consensus 652 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~ 711 (845)
... ........+|++-|||||+++.++|+.|+|+||.|+|||||++|+.||+.....
T Consensus 164 ~L~---~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~ 220 (429)
T KOG0595|consen 164 FLQ---PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK 220 (429)
T ss_pred hCC---chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH
Confidence 854 445556789999999999999999999999999999999999999999765443
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=386.09 Aligned_cols=251 Identities=26% Similarity=0.429 Sum_probs=214.1
Q ss_pred cCCCcceeeeeeceEEEEEEEE-cCCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTL-DDGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
..|...++||+|||+.+|+++. ..|+.||+|.+... .....+...+||++.++|+|||||++++++++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4688889999999999999997 78999999987653 3455678899999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
|+|++++|..++. ...++++.+++.+++||+.||.|||+ ++|+|||||..|+||+++.++||+|||||.....
T Consensus 98 ELC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~-- 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY-- 170 (592)
T ss_pred EecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecC--
Confidence 9999999999985 55689999999999999999999999 9999999999999999999999999999987543
Q ss_pred CcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcccc
Q 003139 658 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNL 737 (845)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (845)
........+||+.|.|||++.+...+..+||||+|||||-||+|++||+...-.+ .+..+.....
T Consensus 171 ~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke---------------ty~~Ik~~~Y 235 (592)
T KOG0575|consen 171 DGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE---------------TYNKIKLNEY 235 (592)
T ss_pred cccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH---------------HHHHHHhcCc
Confidence 2234567899999999999999999999999999999999999999997542221 1111111111
Q ss_pred CCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003139 738 VGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEY 776 (845)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~ 776 (845)
.+|........+|+.++|+.+|.+|||+++|+.+--.
T Consensus 236 --~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff 272 (592)
T KOG0575|consen 236 --SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFF 272 (592)
T ss_pred --ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence 1334555677899999999999999999999876443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=363.90 Aligned_cols=252 Identities=26% Similarity=0.374 Sum_probs=204.4
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChH-------hHHHHHHHHHHHHhCCCCCcceEEEEEecCCcE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQ-------GIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEM 573 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 573 (845)
+.|...+.||+|+||.|-+|..+ +|+.||||+++...-. ......+|+++|++++|||||++.++++..+..
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~ 251 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS 251 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence 45677889999999999999854 7999999987654211 123357999999999999999999999999999
Q ss_pred EEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCC---CceEEEecccc
Q 003139 574 ILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDN---FVAKVADFGLS 650 (845)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~---~~~kl~DFGla 650 (845)
|||||||+||.|.+.+-.++ .+.+..-..+++|++.|+.|||+ +||+||||||+||||..+ ..+||+|||+|
T Consensus 252 YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 252 YMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred EEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEecccchh
Confidence 99999999999999986554 46666778899999999999999 999999999999999765 88999999999
Q ss_pred CCCCCCCCcccccccccCCCcCChhhhccCCC---CchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcC
Q 003139 651 KTGPALDQTHVSTAVKGSFGYLDPEYFRRQQL---TEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKG 727 (845)
Q Consensus 651 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 727 (845)
+... ........+||+.|.|||++.++.. ..|+|+||+|||||-+|+|.+||....... .+.
T Consensus 327 K~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~---------- 391 (475)
T KOG0615|consen 327 KVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLK---------- 391 (475)
T ss_pred hccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHH----------
Confidence 9843 4455667899999999999986543 348899999999999999999997654322 111
Q ss_pred chhhhhccccCC--CCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 728 MLDQIMDSNLVG--KVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 728 ~~~~~~d~~l~~--~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
+++...+... ....+..++..+++.+||..||++||++.|++++-+
T Consensus 392 --eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW 439 (475)
T KOG0615|consen 392 --EQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPW 439 (475)
T ss_pred --HHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChh
Confidence 1222222211 122456788899999999999999999999987754
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=350.18 Aligned_cols=256 Identities=24% Similarity=0.338 Sum_probs=208.0
Q ss_pred CCCcceeeeeeceEEEEEEEE-cCCcEEEEEEcCC--CChHhHHHHHHHHHHHHhCCCCCcceEEEE-EecCCc-EEEEE
Q 003139 503 KFDESLLLGVGGFGRVYKGTL-DDGTKVAVKRGNP--RSEQGIAEFRTEIEMLSKLRHRHLVSLIGY-CDERSE-MILVY 577 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~-~~~~~~-~~lV~ 577 (845)
+|.+.+.||+|.||+|||+.. .+|..+|.|.+.- .+.+..++...|+.+|++|+|||||+++++ +.+..+ ++|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 356677899999999999984 5899999998763 356667889999999999999999999984 445555 89999
Q ss_pred EeccCCCccccccC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-ceeeccCCCCcEEECCCCceEEEeccccCCCC
Q 003139 578 EYMANGPLRSHLYG--TDLPPLSWKQRLEICIGAARGLHYLHTGAAQ-SIIHRDVKTTNILLDDNFVAKVADFGLSKTGP 654 (845)
Q Consensus 578 Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDik~~NILl~~~~~~kl~DFGla~~~~ 654 (845)
|||..|+|...+.. +....++++.+++++.|+++||.++|..... .|+||||||.||+|+.+|.+||+||||++...
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 99999999998853 3445789999999999999999999984432 38999999999999999999999999999854
Q ss_pred CCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhc
Q 003139 655 ALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMD 734 (845)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (845)
. ........+|||.||+||.+.+.+|+.||||||+||++|||..-++||.+. ++.+.. +.++.+...
T Consensus 180 s--~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~-~KI~qgd~~---- 246 (375)
T KOG0591|consen 180 S--KTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLC-KKIEQGDYP---- 246 (375)
T ss_pred c--hhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHH-HHHHcCCCC----
Confidence 3 344456789999999999999999999999999999999999999999764 222211 112222111
Q ss_pred cccCCCCC-HHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003139 735 SNLVGKVN-PASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEY 776 (845)
Q Consensus 735 ~~l~~~~~-~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~ 776 (845)
.++ .-....+.+|+..|+..||++||+...+++.+..
T Consensus 247 -----~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 247 -----PLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred -----CCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 122 3456789999999999999999997666666654
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=357.54 Aligned_cols=242 Identities=26% Similarity=0.376 Sum_probs=202.8
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILV 576 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 576 (845)
.+.|+..++||+|+||+||.++.+ +++.+|+|.+++. .....+....|..+|.+++||.||+|+..+++.+.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 357899999999999999999865 6888999987664 234567788999999999999999999999999999999
Q ss_pred EEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCC
Q 003139 577 YEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPAL 656 (845)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~ 656 (845)
+||+.||.|..+|... +.+++..+.-++.+|+.||.|||+ ++||||||||+|||||++|+++|+||||++....
T Consensus 104 ld~~~GGeLf~hL~~e--g~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~- 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQRE--GRFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK- 177 (357)
T ss_pred EeccCCccHHHHHHhc--CCcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhccc-
Confidence 9999999999999544 578999999999999999999999 9999999999999999999999999999986432
Q ss_pred CCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccc
Q 003139 657 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSN 736 (845)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (845)
........+||+.|||||++.+..|+..+|+||+|+++|||++|.+||......+ +. +.+...+
T Consensus 178 -~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~------~~---------~~I~~~k 241 (357)
T KOG0598|consen 178 -DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK------MY---------DKILKGK 241 (357)
T ss_pred -CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH------HH---------HHHhcCc
Confidence 2333456899999999999999999999999999999999999999997643221 21 1222211
Q ss_pred cCCCCCHHHHHHHHHHHHHhhhhCCCCCC
Q 003139 737 LVGKVNPASLKKFGETAEKCLAEHGVDRP 765 (845)
Q Consensus 737 l~~~~~~~~~~~l~~l~~~cl~~~p~~RP 765 (845)
+. ..+.-......+++.+.|+.+|++|.
T Consensus 242 ~~-~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 242 LP-LPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred CC-CCCccCCHHHHHHHHHHhccCHHHhc
Confidence 11 12222456778999999999999996
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=356.03 Aligned_cols=264 Identities=28% Similarity=0.444 Sum_probs=217.6
Q ss_pred cCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHh-HHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEec
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQG-IAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYM 580 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 580 (845)
....+.++||+|-||+|.++....+.+||||+++....+. ..+|.+|+++|.+++||||++|+|+|..++.+++|+|||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 4556677899999999999999988999999998876544 589999999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcc
Q 003139 581 ANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH 660 (845)
Q Consensus 581 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 660 (845)
++|+|.++|..+..+.+.-....+||.|||.||+||.+ .++|||||.++|||+|.++++||+|||++|....-+..+
T Consensus 618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~ 694 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR 694 (807)
T ss_pred hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccccCCcee
Confidence 99999999987755555667788899999999999998 999999999999999999999999999999765545555
Q ss_pred cccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHH--cCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccC
Q 003139 661 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVL--CTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLV 738 (845)
Q Consensus 661 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ell--tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 738 (845)
.....+-.++|||||.+..+++|.+||||+||+.|||++ |..+|+.....++ .++-...+...+.....
T Consensus 695 vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vven~~~~~~~~~~~~~------ 765 (807)
T KOG1094|consen 695 VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVENAGEFFRDQGRQVV------ 765 (807)
T ss_pred eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHHhhhhhcCCCCccee------
Confidence 555667789999999999999999999999999999986 5667775432221 22212222222111111
Q ss_pred CCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 003139 739 GKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYA 777 (845)
Q Consensus 739 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~ 777 (845)
...++.++..+.+++++||..+-++||+++++...|++.
T Consensus 766 l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 766 LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 123566788899999999999999999999999888753
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=367.04 Aligned_cols=262 Identities=27% Similarity=0.472 Sum_probs=214.7
Q ss_pred HHhcCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEE
Q 003139 499 DATNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILV 576 (845)
Q Consensus 499 ~at~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 576 (845)
.-.+.+.....||+|.||+||+|+|.+ .||||.++.. +.+..+.|++|+..+++-||.||+-++|||...+. .||
T Consensus 389 Ip~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIi 465 (678)
T KOG0193|consen 389 IPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AII 465 (678)
T ss_pred cCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eee
Confidence 334556677789999999999999973 5899987654 56678999999999999999999999999988776 999
Q ss_pred EEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCC
Q 003139 577 YEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPAL 656 (845)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~ 656 (845)
..+|+|.+|+.+|+..+ ..++..+.+.|+.|||+|+.|||. ++|||||||+.||+|.+++.|||+||||+......
T Consensus 466 TqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w 541 (678)
T KOG0193|consen 466 TQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRW 541 (678)
T ss_pred ehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccceeeeeee
Confidence 99999999999998665 578999999999999999999998 99999999999999999999999999999754333
Q ss_pred CCcccccccccCCCcCChhhhcc---CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhh
Q 003139 657 DQTHVSTAVKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIM 733 (845)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (845)
..........|...|||||+++. .+|+..+||||||+|+|||+||..|+. ....+++. .+...|.+. .
T Consensus 542 ~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIi------fmVGrG~l~--p 612 (678)
T KOG0193|consen 542 SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQII------FMVGRGYLM--P 612 (678)
T ss_pred ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheE------EEecccccC--c
Confidence 33333345568889999999975 478999999999999999999999997 44433321 122222111 1
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 003139 734 DSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779 (845)
Q Consensus 734 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~ 779 (845)
| + ......+++++.+|+..||..++++||.+.+|+..|+.++.
T Consensus 613 d--~-s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 613 D--L-SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred c--c-hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 1 1 12335678889999999999999999999999998887765
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=392.74 Aligned_cols=261 Identities=30% Similarity=0.447 Sum_probs=215.0
Q ss_pred CCCcceeeeeeceEEEEEEEEc--CCc----EEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEE
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD--DGT----KVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMIL 575 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~--~g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 575 (845)
+.+..+.||+|+||.||+|... +|. .||||.+... +.+...+|++|..+|++++|||||+++|+|.+....++
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i 772 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI 772 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence 4455678999999999999865 233 4899988765 56778899999999999999999999999999999999
Q ss_pred EEEeccCCCccccccCCC-----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEecccc
Q 003139 576 VYEYMANGPLRSHLYGTD-----LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLS 650 (845)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla 650 (845)
++|||++|+|..+|++.+ ...|+..+++.++.|||+|+.||++ +++|||||.++|+||+....+||+|||||
T Consensus 773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccchh
Confidence 999999999999998652 3468999999999999999999999 99999999999999999999999999999
Q ss_pred CCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCch
Q 003139 651 KTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGML 729 (845)
Q Consensus 651 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 729 (845)
|.....+.........-..+|||||.++.+.+|.|+|||||||+|||++| |..|+......+- .....+.+
T Consensus 850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v------~~~~~~gg-- 921 (1025)
T KOG1095|consen 850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV------LLDVLEGG-- 921 (1025)
T ss_pred HhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH------HHHHHhCC--
Confidence 95443333322222344678999999999999999999999999999998 5666654433221 11112222
Q ss_pred hhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhhhc
Q 003139 730 DQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLEE 782 (845)
Q Consensus 730 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~~ 782 (845)
+| +.+..++.++.+++..||+.+|++||++.++++.++.+.+-..
T Consensus 922 ------RL--~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 922 ------RL--DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred ------cc--CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 22 3567889999999999999999999999999999888766433
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=367.37 Aligned_cols=261 Identities=25% Similarity=0.393 Sum_probs=205.9
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc------CCcEEEEEEcCCCC-hHhHHHHHHHHHHHHhC-CCCCcceEEEEEecC-C
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD------DGTKVAVKRGNPRS-EQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDER-S 571 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~-~ 571 (845)
.++|++.+.||+|+||.||+|.+. .+..||+|++.... ....+.+.+|++++.++ +||||++++++|... .
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 357888899999999999999742 34679999886543 34456789999999999 899999999998764 4
Q ss_pred cEEEEEEeccCCCccccccCCC----------------------------------------------------------
Q 003139 572 EMILVYEYMANGPLRSHLYGTD---------------------------------------------------------- 593 (845)
Q Consensus 572 ~~~lV~Ey~~~gsL~~~l~~~~---------------------------------------------------------- 593 (845)
..++||||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 6899999999999998885421
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcccccccccCCCc
Q 003139 594 --LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGY 671 (845)
Q Consensus 594 --~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y 671 (845)
..++++.+++.++.||++||+|||+ .+|+||||||+|||+++++.+||+|||+++...............++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 1358899999999999999999998 89999999999999999999999999999864321111122234567889
Q ss_pred CChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCCHHHHHHHH
Q 003139 672 LDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFG 750 (845)
Q Consensus 672 ~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 750 (845)
+|||++.+..++.++|||||||+||||++ |+.||......+. .. .....+.. ...+......+.
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-----~~-~~~~~~~~---------~~~~~~~~~~l~ 307 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-----FC-QRLKDGTR---------MRAPENATPEIY 307 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-----HH-HHHhcCCC---------CCCCCCCCHHHH
Confidence 99999999999999999999999999997 9999865432211 11 11111110 112234456788
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 003139 751 ETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779 (845)
Q Consensus 751 ~l~~~cl~~~p~~RPs~~~vl~~L~~~~~ 779 (845)
+++.+||+.+|.+||++.++++.|+.+++
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=363.43 Aligned_cols=248 Identities=31% Similarity=0.508 Sum_probs=208.3
Q ss_pred ccHHHHHHHhcCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Q 003139 492 FMFQEILDATNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERS 571 (845)
Q Consensus 492 ~~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 571 (845)
..|++|.+ .+-||+|+.|.||+|+++ ++.||||+++... ..+|+-|++|+||||+.+.|+|....
T Consensus 121 iPFe~IsE-------LeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsP 185 (904)
T KOG4721|consen 121 IPFEEISE-------LEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSP 185 (904)
T ss_pred CCHHHhhh-------hhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCc
Confidence 44566543 446999999999999998 6889999876332 35888999999999999999999999
Q ss_pred cEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccC
Q 003139 572 EMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSK 651 (845)
Q Consensus 572 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~ 651 (845)
.+|||||||+.|.|...|... .+++-.....+.++||.||.|||. +.|||||||+-||||..+..+||+|||.++
T Consensus 186 cyCIiMEfCa~GqL~~VLka~--~~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~ 260 (904)
T KOG4721|consen 186 CYCIIMEFCAQGQLYEVLKAG--RPITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSK 260 (904)
T ss_pred eeEEeeeccccccHHHHHhcc--CccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchH
Confidence 999999999999999999544 478888899999999999999999 999999999999999999999999999998
Q ss_pred CCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhh
Q 003139 652 TGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQ 731 (845)
Q Consensus 652 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (845)
.... ......+.||..|||||++++.+.++|+|||||||||||||||..|+.......- -|.
T Consensus 261 e~~~---~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI----IwG----------- 322 (904)
T KOG4721|consen 261 ELSD---KSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI----IWG----------- 322 (904)
T ss_pred hhhh---hhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee----EEe-----------
Confidence 7432 2344578999999999999999999999999999999999999999864332110 011
Q ss_pred hhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 003139 732 IMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYA 777 (845)
Q Consensus 732 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~ 777 (845)
+=...|.-..+..+++.|.-|+++||+..|..||++++++.+|+-+
T Consensus 323 VGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 323 VGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred ccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 1112233345677889999999999999999999999999998755
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=339.84 Aligned_cols=265 Identities=24% Similarity=0.311 Sum_probs=206.2
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCCh-H-hHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSE-Q-GIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYE 578 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 578 (845)
++|+..-++|+|+||.|||++++ +|+.||||++....+ . -.+-.++|+++|++++|+|+|.|+.+|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 35666778999999999999987 699999999865433 3 33456899999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCC
Q 003139 579 YMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQ 658 (845)
Q Consensus 579 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~ 658 (845)
||+..-|.++-+. ...++.+.+.+++.|+++|+.|+|+ +++|||||||+||||+.++.+||||||+||.... .
T Consensus 82 ~~dhTvL~eLe~~--p~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--p 154 (396)
T KOG0593|consen 82 YCDHTVLHELERY--PNGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSA--P 154 (396)
T ss_pred ecchHHHHHHHhc--cCCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcC--C
Confidence 9987555544322 2357889999999999999999999 9999999999999999999999999999998654 3
Q ss_pred cccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHH--------HHhh-cCc
Q 003139 659 THVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAM--------TWQK-KGM 728 (845)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~--------~~~~-~~~ 728 (845)
....+..+.|.+|+|||.+-+ .+|...+||||.||++.||++|.+.|.+....++..++.... ..+. ++.
T Consensus 155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~ 234 (396)
T KOG0593|consen 155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF 234 (396)
T ss_pred cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence 344566788999999999887 799999999999999999999999998766555433222110 0011 111
Q ss_pred -----hhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 729 -----LDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 729 -----~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
+.+.-++.-....-+....-+.+++..|++.||.+|++-++++.+
T Consensus 235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 111111111111123345578899999999999999999998754
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=353.89 Aligned_cols=258 Identities=27% Similarity=0.401 Sum_probs=207.1
Q ss_pred CCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCC--cEEEEEEe
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERS--EMILVYEY 579 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~Ey 579 (845)
++...+.||+|+||.||++... +|...|||.....+....+.+.+|+.+|.+++|||||+.+|.....+ .+++.|||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 3455668999999999999976 48999999876654334677899999999999999999999854444 68999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECC-CCceEEEeccccCCCCC-CC
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDD-NFVAKVADFGLSKTGPA-LD 657 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~-~~~~kl~DFGla~~~~~-~~ 657 (845)
+++|+|.+++..... .|++..+..+.+||++||+|||+ ++||||||||+||||+. ++.+||+|||+++.... ..
T Consensus 98 ~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 98 APGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred cCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 999999999976654 79999999999999999999998 99999999999999999 79999999999986442 11
Q ss_pred CcccccccccCCCcCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccc
Q 003139 658 QTHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSN 736 (845)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (845)
.........||+.|||||++..+ ....++||||+||+++||+||++||... ....++......+ .
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~---------~ 239 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGRE---------D 239 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhcc---------C
Confidence 12233467899999999999964 3345999999999999999999998653 1111121111111 1
Q ss_pred cCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhh
Q 003139 737 LVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYAL 778 (845)
Q Consensus 737 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~ 778 (845)
....++........+++.+|++.+|++|||+.+++++.--..
T Consensus 240 ~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 240 SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 122455667778889999999999999999999998765433
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=367.41 Aligned_cols=257 Identities=30% Similarity=0.464 Sum_probs=211.2
Q ss_pred CcceeeeeeceEEEEEEEEcC--C--cE-EEEEEcCC---CChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEE
Q 003139 505 DESLLLGVGGFGRVYKGTLDD--G--TK-VAVKRGNP---RSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILV 576 (845)
Q Consensus 505 ~~~~~LG~G~fg~Vy~~~~~~--g--~~-vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 576 (845)
...++||+|+||+||+|++.. + .. ||||.... ......++|++|.++|++++|||||+++|++.....+++|
T Consensus 160 ~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~iv 239 (474)
T KOG0194|consen 160 ELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLV 239 (474)
T ss_pred cccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEE
Confidence 344689999999999999763 2 23 89998774 3577789999999999999999999999999999999999
Q ss_pred EEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCC
Q 003139 577 YEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPAL 656 (845)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~ 656 (845)
||+|+||+|.++|.... ..++..++++++.++|+||+|||+ +++|||||.++|+|++.++.+||+||||++.....
T Consensus 240 mEl~~gGsL~~~L~k~~-~~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~ 315 (474)
T KOG0194|consen 240 MELCNGGSLDDYLKKNK-KSLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQY 315 (474)
T ss_pred EEecCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccccccCCcce
Confidence 99999999999997654 269999999999999999999999 99999999999999999999999999999875421
Q ss_pred CCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcc
Q 003139 657 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDS 735 (845)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (845)
... .....-...|+|||.+....|+.++|||||||++||+++ |..|+.+....+ + ..++...
T Consensus 316 ~~~--~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~---v------------~~kI~~~ 378 (474)
T KOG0194|consen 316 VMK--KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE---V------------KAKIVKN 378 (474)
T ss_pred eec--cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH---H------------HHHHHhc
Confidence 111 112245679999999999999999999999999999998 777776543321 1 1112122
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhhhc
Q 003139 736 NLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLEE 782 (845)
Q Consensus 736 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~~ 782 (845)
......+...+..+..+..+||..+|++||+|.++.+.|+.+.....
T Consensus 379 ~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 379 GYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred CccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 22233445667788889999999999999999999999998866444
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=355.28 Aligned_cols=262 Identities=24% Similarity=0.311 Sum_probs=208.1
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHH--HHHHHHHHhCC-CCCcceEEEEEecCC-cEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEF--RTEIEMLSKLR-HRHLVSLIGYCDERS-EMILV 576 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~--~~E~~~l~~l~-H~niv~l~g~~~~~~-~~~lV 576 (845)
++|...+.||.|.||.||+|+.. .|..||||+++..-.. +++. ++|+..|++|. |||||+|.+++.+.+ .+++|
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 46777789999999999999854 7889999998765433 3333 57999999998 999999999998877 99999
Q ss_pred EEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCC
Q 003139 577 YEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPAL 656 (845)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~ 656 (845)
||||+ .+|.+++... ...+++..+..|+.||++||+|+|. +|+.|||+||+|||+..+..+||+||||||...
T Consensus 89 fE~Md-~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~-- 161 (538)
T KOG0661|consen 89 FEFMD-CNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVR-- 161 (538)
T ss_pred HHhhh-hhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEecccccccccc--
Confidence 99995 5899988766 5789999999999999999999999 999999999999999999999999999999743
Q ss_pred CCcccccccccCCCcCChhhh-ccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcC--------
Q 003139 657 DQTHVSTAVKGSFGYLDPEYF-RRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKG-------- 727 (845)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~-~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~-------- 727 (845)
.....+..+.|.+|+|||++ +.+.|+.+.|+|++|||++|+.+-++.|.+..+.++..-+- ...+..
T Consensus 162 -SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc---~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 162 -SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKIC---EVLGTPDKDSWPEG 237 (538)
T ss_pred -cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHH---HHhCCCccccchhH
Confidence 33345667889999999976 56789999999999999999999999998766555432111 111100
Q ss_pred -chhhhhcccc-------CCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 728 -MLDQIMDSNL-------VGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 728 -~~~~~~d~~l-------~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
.+...+.=.+ ....-+....+..+++.+|++.||.+|||+.+.+++--
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pf 293 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPF 293 (538)
T ss_pred HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcc
Confidence 0111111000 01112336778899999999999999999999987743
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=348.53 Aligned_cols=248 Identities=22% Similarity=0.331 Sum_probs=201.9
Q ss_pred ceeeeeeceEEEEEEEEcCCcEEEEEEcCCCCh---HhHHHHHHHHHHHHhCCCCCcceEEEEEec----CCcEEEEEEe
Q 003139 507 SLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSE---QGIAEFRTEIEMLSKLRHRHLVSLIGYCDE----RSEMILVYEY 579 (845)
Q Consensus 507 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~Ey 579 (845)
...||+|++|.||+|.++ |+.||||++..... ...+.|.+|+++|++++||||++++|++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEEC-CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 357999999999999984 88999998865432 225778899999999999999999999866 4578999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCc
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT 659 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~ 659 (845)
+++|+|.+++... ..++|...++++.|++.||.|||+ ..+++||||||+|||+++++.+||+|||+++.....
T Consensus 104 ~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~--- 176 (283)
T PHA02988 104 CTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP--- 176 (283)
T ss_pred CCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc---
Confidence 9999999999654 478999999999999999999997 247889999999999999999999999999763321
Q ss_pred ccccccccCCCcCChhhhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcccc
Q 003139 660 HVSTAVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNL 737 (845)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (845)
.....|+..|+|||++.+ ..++.++|||||||++|||++|+.||......+ +....... ..
T Consensus 177 --~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~------~~~~i~~~---------~~ 239 (283)
T PHA02988 177 --PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE------IYDLIINK---------NN 239 (283)
T ss_pred --cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhc---------CC
Confidence 123457889999999976 789999999999999999999999997543221 11111111 11
Q ss_pred CCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 003139 738 VGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779 (845)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~ 779 (845)
....+..++..+.+++.+||+.||++|||+.++++.|+...+
T Consensus 240 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 240 SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 112233456789999999999999999999999999987654
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=353.49 Aligned_cols=254 Identities=24% Similarity=0.329 Sum_probs=213.1
Q ss_pred HHhcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcE
Q 003139 499 DATNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERSEM 573 (845)
Q Consensus 499 ~at~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 573 (845)
...++|...+.||+|+|++|++|+.. .+..+|||++.+. .++..+-...|-++|.+| .||.|++|+--+.+...+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 34467888899999999999999854 6889999987653 222334456789999999 899999999999999999
Q ss_pred EEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCC
Q 003139 574 ILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTG 653 (845)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~ 653 (845)
|+|+||+++|+|.++|+. .+.|++.....++.+|+.||+|||+ +|||||||||+|||||+|+++||+|||.|+..
T Consensus 150 YFvLe~A~nGdll~~i~K--~Gsfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKK--YGSFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEEEecCCCcHHHHHHH--hCcchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccccC
Confidence 999999999999999954 4689999999999999999999999 99999999999999999999999999999975
Q ss_pred CCCCCc---------ccc--cccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHH
Q 003139 654 PALDQT---------HVS--TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMT 722 (845)
Q Consensus 654 ~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~ 722 (845)
...... ... ..++||..|.+||++..+..+..+|+|+||||||+|+.|.+||....+.-
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl---------- 294 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL---------- 294 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH----------
Confidence 543221 112 45899999999999999999999999999999999999999997654321
Q ss_pred HhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003139 723 WQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNL 774 (845)
Q Consensus 723 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L 774 (845)
..++|++- .-++++..++...+|+.+.|..||.+|+|.++|.++.
T Consensus 295 -----iFqkI~~l--~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 295 -----IFQKIQAL--DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred -----HHHHHHHh--cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 23344432 2346677778899999999999999999998887663
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=351.22 Aligned_cols=262 Identities=26% Similarity=0.320 Sum_probs=205.8
Q ss_pred cCCCcceeeeeeceEEEEEEEE-cCCcEEEEEEcCCCC--hHhHHHHHHHHHHHHhCCCCCcceEEEEEecC--CcEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTL-DDGTKVAVKRGNPRS--EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDER--SEMILV 576 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV 576 (845)
..|+..++||+|.||.||||+. .+|+.||+|++.... +....-..+||.+|++|.||||++|.+...+. ..+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 3466677899999999999984 579999999876554 33344567899999999999999999998776 689999
Q ss_pred EEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCC
Q 003139 577 YEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPAL 656 (845)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~ 656 (845)
+|||++ +|..++... .-.++..++..++.|++.||+|+|. .+|+|||||.+|||||.+|.+||+|||||++...
T Consensus 197 FeYMdh-DL~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~- 270 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP- 270 (560)
T ss_pred Eecccc-hhhhhhcCC-CcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeeccC-
Confidence 999975 777777543 3479999999999999999999999 9999999999999999999999999999997554
Q ss_pred CCcccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcC--------
Q 003139 657 DQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKG-------- 727 (845)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~-------- 727 (845)
......+..+-|.+|+|||.+.+ ..|+.++|+||.||||.||+.|++.|.+..+.++...+- ++....
T Consensus 271 ~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIf---klcGSP~e~~W~~~ 347 (560)
T KOG0600|consen 271 SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIF---KLCGSPTEDYWPVS 347 (560)
T ss_pred CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHH---HHhCCCChhccccc
Confidence 33334667788999999999887 589999999999999999999999998877666543321 111110
Q ss_pred chh--hhhcc------ccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 728 MLD--QIMDS------NLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 728 ~~~--~~~d~------~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.+. ..+.+ ++.+ .-...+....+|+..+|..||.+|.|+.++++.
T Consensus 348 kLP~~~~~kp~~~y~r~l~E-~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLRE-TFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred cCCcccccCCCCcccchHHH-HhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 000 00000 0100 011234556789999999999999999998765
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=361.81 Aligned_cols=258 Identities=24% Similarity=0.381 Sum_probs=204.0
Q ss_pred cCCCcceeeeeeceEEEEEEEE------cCCcEEEEEEcCCCC-hHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTL------DDGTKVAVKRGNPRS-EQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERSEM 573 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 573 (845)
++|+..+.||+|+||.||+|++ +.+..||||++.... ....+.+.+|++++..+ +||||++++++|.+.+..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 4677888999999999999974 235679999886542 34456788999999999 899999999999999999
Q ss_pred EEEEEeccCCCccccccCCC------------------------------------------------------------
Q 003139 574 ILVYEYMANGPLRSHLYGTD------------------------------------------------------------ 593 (845)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~------------------------------------------------------------ 593 (845)
++||||+++|+|.+++....
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 99999999999988875321
Q ss_pred -------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcc
Q 003139 594 -------------LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH 660 (845)
Q Consensus 594 -------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 660 (845)
...++|..+++++.||++||+|||+ ++|+||||||+|||+++++.+||+|||+++.........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 1257899999999999999999998 899999999999999999999999999997643322212
Q ss_pred cccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCC
Q 003139 661 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVG 739 (845)
Q Consensus 661 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 739 (845)
......++..|+|||++.+..++.++|||||||++|||++ |..||....... .... ...++ ...
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~----~~~~~---------~~~ 336 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYK----MIKEG---------YRM 336 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHH----HHHhC---------ccC
Confidence 2223345678999999999999999999999999999998 788875432211 1111 11111 111
Q ss_pred CCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 003139 740 KVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYA 777 (845)
Q Consensus 740 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~ 777 (845)
..+...+..+.+++.+||+.+|++||++.+|++.|++.
T Consensus 337 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 337 LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 11222346788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=324.90 Aligned_cols=236 Identities=26% Similarity=0.371 Sum_probs=204.3
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC---hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS---EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
.+|+..+.||.|+||.|.+++.+ +|.-+|+|.++... .++.+...+|..+|+.+.||++++|.+-|.+.+.++|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 35778889999999999999976 68889999887653 445667789999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
||++||.|..+|+.. ++++.....-++.||+.||+|||+ .+|++|||||+|||||++|.+||+|||+|+....
T Consensus 124 eyv~GGElFS~Lrk~--~rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~-- 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKS--GRFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG-- 196 (355)
T ss_pred eccCCccHHHHHHhc--CCCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecC--
Confidence 999999999999654 579999999999999999999999 9999999999999999999999999999987432
Q ss_pred CcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcccc
Q 003139 658 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNL 737 (845)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (845)
.....+||+.|+|||.+..+.+..++|.|||||++|||+.|.+||....+.. ..++|+...+
T Consensus 197 ---rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~---------------iY~KI~~~~v 258 (355)
T KOG0616|consen 197 ---RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ---------------IYEKILEGKV 258 (355)
T ss_pred ---cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH---------------HHHHHHhCcc
Confidence 2457899999999999999999999999999999999999999998765421 2334444443
Q ss_pred CCCCCHHHHHHHHHHHHHhhhhCCCCC
Q 003139 738 VGKVNPASLKKFGETAEKCLAEHGVDR 764 (845)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~cl~~~p~~R 764 (845)
. ++.-....+.+|+...|+.|-.+|
T Consensus 259 ~--fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 K--FPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred c--CCcccCHHHHHHHHHHHhhhhHhh
Confidence 2 555566778889999999988888
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=343.81 Aligned_cols=250 Identities=35% Similarity=0.537 Sum_probs=198.2
Q ss_pred cceeeeeeceEEEEEEEEc-----CCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 506 ESLLLGVGGFGRVYKGTLD-----DGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 506 ~~~~LG~G~fg~Vy~~~~~-----~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
..+.||.|.||.||+|.+. .+..|+||.+... .....++|.+|++.+++++||||++++|+|...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3568999999999999987 2567999998654 445578999999999999999999999999988889999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCc
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT 659 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~ 659 (845)
+++|+|.++|.......+++.++++|+.|+++||.|||+ .+++|+||+++|||+++++.+||+|||+++........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred ccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc
Confidence 999999999987756789999999999999999999999 89999999999999999999999999999875322222
Q ss_pred ccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccC
Q 003139 660 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLV 738 (845)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 738 (845)
.......+...|+|||.+....++.++||||||+++|||++ |+.|+..... .++.... .++. .
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~------~~~~~~~-~~~~---------~ 223 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN------EEIIEKL-KQGQ---------R 223 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH------HHHHHHH-HTTE---------E
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc------ccccccc-cccc---------c
Confidence 23334556778999999999999999999999999999999 6777654321 1122221 1111 1
Q ss_pred CCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003139 739 GKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNL 774 (845)
Q Consensus 739 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L 774 (845)
...+..++..+.+++.+||+.+|++||++.++++.|
T Consensus 224 ~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 112334567788999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=347.51 Aligned_cols=262 Identities=27% Similarity=0.408 Sum_probs=203.6
Q ss_pred cCCCcceeeeeeceEEEEEEEEcC-----------------CcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLDD-----------------GTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSL 563 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~~-----------------g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l 563 (845)
++|...+.||+|+||.||++.+++ +..||+|.+... ......+|.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 467788899999999999997542 336999987764 34456789999999999999999999
Q ss_pred EEEEecCCcEEEEEEeccCCCccccccCCC-----------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceee
Q 003139 564 IGYCDERSEMILVYEYMANGPLRSHLYGTD-----------------LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIH 626 (845)
Q Consensus 564 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~-----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH 626 (845)
++++.+.+..++||||+++|+|.+++.... ...++|.++++++.|++.||+|||+ .+|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCccc
Confidence 999999999999999999999998874321 1357899999999999999999999 89999
Q ss_pred ccCCCCcEEECCCCceEEEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcC--CCC
Q 003139 627 RDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCT--RPA 704 (845)
Q Consensus 627 rDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg--~~p 704 (845)
|||||+|||+++++.+||+|||+++...............++..|+|||++..+.++.++||||||+++|||+++ ..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 999999999999999999999999764332222222334567899999999999999999999999999999874 456
Q ss_pred CCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 705 LNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 705 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
+...... ....++......... ......++.++..+.+++.+||+.+|++|||+.+|.+.|+
T Consensus 242 ~~~~~~~---~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTDE---QVIENAGEFFRDQGR------QVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCHH---HHHHHHHHHhhhccc------cccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 6543221 122222221111100 0001122345678899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=352.34 Aligned_cols=247 Identities=28% Similarity=0.434 Sum_probs=212.2
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYE 578 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 578 (845)
++|...+.||+|.||.||||+.+ +.+.||+|.+.+. .+++++.+.+|++++++++|||||.++++++...++++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46777788999999999999866 6788999977653 56678889999999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCC
Q 003139 579 YMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQ 658 (845)
Q Consensus 579 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~ 658 (845)
|+.+ +|..+|... +.++++.+..|+.++..||.|||+ .+|+|||+||+||||++++.+|++|||+||.... .
T Consensus 82 ~a~g-~L~~il~~d--~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTILEQD--GKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--N 153 (808)
T ss_pred hhhh-hHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhccc--C
Confidence 9976 999999654 479999999999999999999999 9999999999999999999999999999997543 5
Q ss_pred cccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccC
Q 003139 659 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLV 738 (845)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 738 (845)
....+.++||+-|||||...+++|+..+|.||+|||+|||++|++||.... +.+.+.....+ + .
T Consensus 154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv~~I~~d--------~-v- 217 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLVKSILKD--------P-V- 217 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHHHHHhcC--------C-C-
Confidence 566778999999999999999999999999999999999999999996421 22222221111 1 1
Q ss_pred CCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 739 GKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 739 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
..+......+..++...|.+||.+|.+-.+++.+
T Consensus 218 -~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 218 -KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred -CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 2345667889999999999999999999998765
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=353.67 Aligned_cols=250 Identities=26% Similarity=0.406 Sum_probs=210.3
Q ss_pred cCCCcceeeeeeceEEEEEEEE-cCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEec
Q 003139 502 NKFDESLLLGVGGFGRVYKGTL-DDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYM 580 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 580 (845)
..|.....||+|+.|.||.++- .+++.||||++........+-+.+|+.+|+..+|+|||+++..+..+++++.|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 4566677899999999999974 468899999998777666677889999999999999999999998889999999999
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcc
Q 003139 581 ANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH 660 (845)
Q Consensus 581 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 660 (845)
++|+|.+.+... .+++.++..||+++++||+|||. ++|+|||||.+|||++.++.+||+|||++....... .
T Consensus 353 ~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~--~ 424 (550)
T KOG0578|consen 353 EGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ--S 424 (550)
T ss_pred CCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeecccccc--C
Confidence 999999998544 48999999999999999999999 999999999999999999999999999997654322 2
Q ss_pred cccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCC
Q 003139 661 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGK 740 (845)
Q Consensus 661 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 740 (845)
.....+||+.|||||+.....|..|.||||||++++||+-|.+||-...+-... |.. ..+|. +.+ .
T Consensus 425 KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAl----yLI--a~ng~------P~l--k 490 (550)
T KOG0578|consen 425 KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL----YLI--ATNGT------PKL--K 490 (550)
T ss_pred ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHH----HHH--hhcCC------CCc--C
Confidence 345788999999999999999999999999999999999999999653332211 111 11111 111 2
Q ss_pred CCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 741 VNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 741 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.+......|.+++.+||+.|+++||++.|+|++
T Consensus 491 ~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 491 NPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 334566789999999999999999999999876
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=396.12 Aligned_cols=268 Identities=29% Similarity=0.461 Sum_probs=222.5
Q ss_pred ccHHHHHHHhcCCCcceeeeeeceEEEEEEEE-cCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Q 003139 492 FMFQEILDATNKFDESLLLGVGGFGRVYKGTL-DDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDER 570 (845)
Q Consensus 492 ~~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 570 (845)
+.++++. ..|...+.||+|+||.||+|+. .++..||||++...... ...|++.+++++|||||+++|+|.+.
T Consensus 683 ~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~ 755 (968)
T PLN00113 683 ITINDIL---SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSE 755 (968)
T ss_pred hhHHHHH---hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcC
Confidence 4455544 4567788999999999999997 47899999988654322 23468899999999999999999999
Q ss_pred CcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEecccc
Q 003139 571 SEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLS 650 (845)
Q Consensus 571 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla 650 (845)
+..++||||+++|+|.++++ .++|.++.+|+.|+|+||+|||+.+.++|+||||||+||+++.++.+++. ||..
T Consensus 756 ~~~~lv~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~ 829 (968)
T PLN00113 756 KGAYLIHEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLP 829 (968)
T ss_pred CCCEEEEeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccc
Confidence 99999999999999999984 38999999999999999999997666899999999999999999988886 6665
Q ss_pred CCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchh
Q 003139 651 KTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLD 730 (845)
Q Consensus 651 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (845)
..... .....+|..|||||++.+..++.|+|||||||++|||++|+.|++.... ....+.+|+..........
T Consensus 830 ~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~ 902 (968)
T PLN00113 830 GLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLD 902 (968)
T ss_pred ccccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchh
Confidence 43211 1223678999999999999999999999999999999999999864332 3456788888777666677
Q ss_pred hhhccccCCC--CCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 003139 731 QIMDSNLVGK--VNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779 (845)
Q Consensus 731 ~~~d~~l~~~--~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~ 779 (845)
.++|+.+... .+.....++.+++.+||+.+|++||+|+||++.|+.+.+
T Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 903 MWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred heeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 7778776543 345677788999999999999999999999999998755
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=359.38 Aligned_cols=259 Identities=25% Similarity=0.389 Sum_probs=204.9
Q ss_pred cCCCcceeeeeeceEEEEEEEEc------CCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD------DGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERSEM 573 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 573 (845)
++|+..+.||+|+||.||+|+.. ++..||+|++... .....+.+.+|+++++.+ +|+||++++++|.+.+..
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 46888889999999999998742 2357999998654 334456788999999999 899999999999999999
Q ss_pred EEEEEeccCCCccccccCCC------------------------------------------------------------
Q 003139 574 ILVYEYMANGPLRSHLYGTD------------------------------------------------------------ 593 (845)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~------------------------------------------------------------ 593 (845)
++||||+++|+|.+++....
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 99999999999998874321
Q ss_pred --------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCccccccc
Q 003139 594 --------LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAV 665 (845)
Q Consensus 594 --------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 665 (845)
..++++.++++|+.||++||+|||+ ++|+||||||+|||+++++.+||+|||+++..............
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 1257889999999999999999998 99999999999999999999999999999764322111122233
Q ss_pred ccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCCHH
Q 003139 666 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPA 744 (845)
Q Consensus 666 ~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 744 (845)
.++..|||||++.+..++.++|||||||++|||++ |+.||........ . ..... .......+..
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~--~----~~~~~---------~~~~~~~~~~ 339 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK--F----YKMVK---------RGYQMSRPDF 339 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH--H----HHHHH---------cccCccCCCC
Confidence 45678999999999999999999999999999997 9999865432111 0 01111 1111111222
Q ss_pred HHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhh
Q 003139 745 SLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYAL 778 (845)
Q Consensus 745 ~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~ 778 (845)
.+..+.+++.+||+.+|.+||++.+|++.|++++
T Consensus 340 ~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 340 APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 3567889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=335.89 Aligned_cols=262 Identities=25% Similarity=0.344 Sum_probs=210.7
Q ss_pred cCCCcceeeeeeceEEEEEEEE-cCCcEEEEEEcCCCC-hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 502 NKFDESLLLGVGGFGRVYKGTL-DDGTKVAVKRGNPRS-EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
+.|+....||.|..+.||+|+. ..++.||||+++... ....+.+++|+..|+.++||||++.+..|..+.++|+||.|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 5688888999999999999985 467999999987653 34468899999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCC-
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQ- 658 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~- 658 (845)
|.+||+.+.+...-...+++..+..|++++++||.|||+ +|.||||||+.||||+++|.+||+|||.+-.......
T Consensus 106 Ma~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R 182 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDR 182 (516)
T ss_pred hcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeecccCce
Confidence 999999999976544569999999999999999999999 9999999999999999999999999999765333221
Q ss_pred cccc-cccccCCCcCChhhhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcc
Q 003139 659 THVS-TAVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDS 735 (845)
Q Consensus 659 ~~~~-~~~~gt~~y~aPE~~~~--~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (845)
.... ....||+.|||||+++. ..|+.|+||||||+...||.+|..||....+-+.. ....... .....-.
T Consensus 183 ~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL-----l~tLqn~--pp~~~t~ 255 (516)
T KOG0582|consen 183 QVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL-----LLTLQND--PPTLLTS 255 (516)
T ss_pred eeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH-----HHHhcCC--CCCcccc
Confidence 1112 56789999999999654 57999999999999999999999999866553311 1111111 1100011
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 736 NLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 736 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.+..+......+.+.+++..||++||.+|||++++++.
T Consensus 256 ~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 256 GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 11122223455689999999999999999999998765
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=335.22 Aligned_cols=270 Identities=27% Similarity=0.384 Sum_probs=201.7
Q ss_pred cceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHh--CCCCCcceEEEEEecCC----cEEEEEEe
Q 003139 506 ESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSK--LRHRHLVSLIGYCDERS----EMILVYEY 579 (845)
Q Consensus 506 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~~----~~~lV~Ey 579 (845)
...+||+|+||.||||.++ ++.||||++.. +..+.|++|-++.+. ++|+||++++++-.... +++||+||
T Consensus 214 l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~f 289 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEF 289 (534)
T ss_pred hHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeee
Confidence 3447999999999999997 59999999764 455678888888875 58999999999876555 89999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC------CCceeeccCCCCcEEECCCCceEEEeccccCCC
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGA------AQSIIHRDVKTTNILLDDNFVAKVADFGLSKTG 653 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~ 653 (845)
.++|+|.++|..+ .++|....+|+..+++||+|||++. .++|+|||||++||||.+|+.+.|+|||||...
T Consensus 290 h~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~ 366 (534)
T KOG3653|consen 290 HPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRL 366 (534)
T ss_pred ccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEe
Confidence 9999999999654 6999999999999999999999753 467999999999999999999999999999875
Q ss_pred CCCCCcccccccccCCCcCChhhhccCC-CC-----chhHHHHHHHHHHHHHcCCCCCCCCC-CcccccHHHHHHHHhhc
Q 003139 654 PALDQTHVSTAVKGSFGYLDPEYFRRQQ-LT-----EKSDVYSFGVVLMEVLCTRPALNPVL-PREQVNIAEWAMTWQKK 726 (845)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-----~ksDV~S~Gvvl~Elltg~~p~~~~~-~~~~~~l~~~~~~~~~~ 726 (845)
............+||.+|||||++.+.- +. .+.||||+|.|||||++....++... +.-+.....-+.....-
T Consensus 367 ~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~ 446 (534)
T KOG3653|consen 367 EPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTL 446 (534)
T ss_pred cCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCH
Confidence 5433334444689999999999997642 22 37999999999999999876553211 11111110000000000
Q ss_pred Cchhh-hhccccCCCCC-----HHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhhhc
Q 003139 727 GMLDQ-IMDSNLVGKVN-----PASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLEE 782 (845)
Q Consensus 727 ~~~~~-~~d~~l~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~~ 782 (845)
+.+++ ++..+.+..++ -.-+..+.+.+..||..||+.|.|+.=|.+.+.++..+.+
T Consensus 447 e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 447 EEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred HHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 00000 01111111111 1346678999999999999999999999998887765554
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=344.21 Aligned_cols=251 Identities=24% Similarity=0.347 Sum_probs=203.1
Q ss_pred CCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC---hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 504 FDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS---EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 504 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
|+..+.||+|+||.||+|... +|+.+|+|.+.... ......+.+|++++++++|+||+++.+++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 677889999999999999864 78999999876432 23345678999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCc
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT 659 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~ 659 (845)
+++|+|..++.......+++..++.++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.... .
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~---~ 155 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE---G 155 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC---C
Confidence 999999988765444578999999999999999999999 9999999999999999999999999999976332 1
Q ss_pred ccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCC
Q 003139 660 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVG 739 (845)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 739 (845)
.......||..|+|||++.+..++.++|||||||++|||++|+.||......... ... .. .+... ..
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~--~~~-~~--------~~~~~--~~ 222 (285)
T cd05631 156 ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR--EEV-DR--------RVKED--QE 222 (285)
T ss_pred CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH--HHH-HH--------Hhhcc--cc
Confidence 1223457899999999999999999999999999999999999999754332111 000 00 00000 11
Q ss_pred CCCHHHHHHHHHHHHHhhhhCCCCCCC-----HHHHHHH
Q 003139 740 KVNPASLKKFGETAEKCLAEHGVDRPS-----MGDVLWN 773 (845)
Q Consensus 740 ~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~~vl~~ 773 (845)
.++......+.+++.+||+.+|.+||+ +++++++
T Consensus 223 ~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 223 EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 233344567889999999999999997 7887765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=337.89 Aligned_cols=255 Identities=22% Similarity=0.358 Sum_probs=205.9
Q ss_pred cCCCcceeeeeeceEEEEEEEEc----CCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD----DGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILV 576 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 576 (845)
++|++.+.||+|+||.||+|.++ .+..+|+|.+... +....+.|.+|+.++++++||||++++|++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46788889999999999999864 3568999987765 334456799999999999999999999999999999999
Q ss_pred EEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCC
Q 003139 577 YEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPAL 656 (845)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~ 656 (845)
|||+++|+|.+++.... ..++|.+++.++.|++.||+|||+ .+++||||||+|||+++++.+|++|||.+.....
T Consensus 85 ~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~- 159 (266)
T cd05064 85 TEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS- 159 (266)
T ss_pred EEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCcccccccc-
Confidence 99999999999986542 478999999999999999999998 8999999999999999999999999998765321
Q ss_pred CCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcc
Q 003139 657 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDS 735 (845)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (845)
..........++..|+|||.+.+..++.++|||||||++|||++ |+.||......+ + .. ...++
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~---~~-~~~~~-------- 224 (266)
T cd05064 160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---V---IK-AVEDG-------- 224 (266)
T ss_pred cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---H---HH-HHHCC--------
Confidence 11111112345678999999999999999999999999999875 999986543221 1 11 11111
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 003139 736 NLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYA 777 (845)
Q Consensus 736 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~ 777 (845)
.....+..++..+.+++.+||+.+|.+||++.+|++.|+..
T Consensus 225 -~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 225 -FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 11122344567889999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=350.27 Aligned_cols=252 Identities=26% Similarity=0.380 Sum_probs=208.4
Q ss_pred HhcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC----Ch-HhHHHHHHHHHHHHhCC-CCCcceEEEEEecCCc
Q 003139 500 ATNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR----SE-QGIAEFRTEIEMLSKLR-HRHLVSLIGYCDERSE 572 (845)
Q Consensus 500 at~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~ 572 (845)
..++|...+.||+|.||.|++|... +++.||+|.++.. .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 4567888999999999999999865 6899999976553 12 23445668999999999 9999999999999999
Q ss_pred EEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCC-CceEEEeccccC
Q 003139 573 MILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDN-FVAKVADFGLSK 651 (845)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~-~~~kl~DFGla~ 651 (845)
.++||||+.+|+|.+++.. .+++.+.+..+++.|++.|++|||+ ++|+||||||+|||+|.+ +++||+|||++.
T Consensus 95 ~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred EEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 9999999999999999976 4678999999999999999999999 999999999999999999 999999999998
Q ss_pred CCCCCCCcccccccccCCCcCChhhhccCC-CC-chhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCch
Q 003139 652 TGPALDQTHVSTAVKGSFGYLDPEYFRRQQ-LT-EKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGML 729 (845)
Q Consensus 652 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 729 (845)
... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+...... ...
T Consensus 170 ~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~------l~~-------- 233 (370)
T KOG0583|consen 170 ISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN------LYR-------- 233 (370)
T ss_pred ccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH------HHH--------
Confidence 753 2334456789999999999999977 86 78999999999999999999997632111 111
Q ss_pred hhhhccccCCCCCHHH-HHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 730 DQIMDSNLVGKVNPAS-LKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 730 ~~~~d~~l~~~~~~~~-~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
.+..... .++... ...+..++.+|+..+|.+|+++.+|+..=+
T Consensus 234 -ki~~~~~--~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w 277 (370)
T KOG0583|consen 234 -KIRKGEF--KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPW 277 (370)
T ss_pred -HHhcCCc--cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChh
Confidence 1111111 123333 677889999999999999999999994433
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=339.60 Aligned_cols=255 Identities=29% Similarity=0.452 Sum_probs=207.2
Q ss_pred CCCcceeeeeeceEEEEEEEEcC-C-----cEEEEEEcCCCC-hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEE
Q 003139 503 KFDESLLLGVGGFGRVYKGTLDD-G-----TKVAVKRGNPRS-EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMIL 575 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~~-g-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 575 (845)
+|+..+.||+|+||.||+|.... + ..+++|.+.... ....++|.+|++++.+++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 57778899999999999998643 2 569999876543 3445679999999999999999999999999999999
Q ss_pred EEEeccCCCccccccCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCc
Q 003139 576 VYEYMANGPLRSHLYGTD--------------LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFV 641 (845)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~ 641 (845)
+|||+++++|.+++.... ...+++.+++.++.|++.||+|||+ .+++||||||+||++++++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCCc
Confidence 999999999999886431 1468899999999999999999999 89999999999999999999
Q ss_pred eEEEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHH
Q 003139 642 AKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWA 720 (845)
Q Consensus 642 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~ 720 (845)
+||+|||+++.....+.........++..|+|||.+.+..++.++|||||||++|||++ |+.||......+ +..+
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~---~~~~- 238 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE---VIEM- 238 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH-
Confidence 99999999976433222222334456788999999999999999999999999999998 999986543221 1111
Q ss_pred HHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003139 721 MTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEY 776 (845)
Q Consensus 721 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~ 776 (845)
... ......+..++..+.+++.+||+.+|.+||++.+|++.|+.
T Consensus 239 ---i~~---------~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 239 ---IRS---------RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ---HHc---------CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 111 11112334566789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=315.47 Aligned_cols=262 Identities=24% Similarity=0.310 Sum_probs=207.7
Q ss_pred CCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHh--HHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQG--IAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
+|...+.||+|.||.||+|+.. +|+.||||++......+ ....++|++.|+.++|+||+.|++++...+.+.||+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 4666778999999999999854 79999999987654321 34578999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCc
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT 659 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~ 659 (845)
|+ .+|...++.+. ..++-.++..++.++++||+|||+ +.|+||||||.|+||+++|.+||+|||+|+.....+..
T Consensus 83 m~-tdLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 83 MP-TDLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred cc-ccHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 96 58888886554 578899999999999999999999 89999999999999999999999999999986654433
Q ss_pred ccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCc----------
Q 003139 660 HVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGM---------- 728 (845)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~---------- 728 (845)
. +..+-|..|+|||.+.+ ++|+..+|+||.|||+.||+-|.+.|.+...-++...+- ....-..
T Consensus 158 ~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If---~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 158 Q--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIF---RALGTPTPDQWPEMTSL 232 (318)
T ss_pred c--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHH---HHcCCCCcccCcccccc
Confidence 3 33477899999998876 689999999999999999999999887766555433211 1111100
Q ss_pred -----hhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 729 -----LDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 729 -----~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
+...-.+.+. ..-+.......+++..++..||.+|++++|++++=-
T Consensus 233 pdY~~~~~~P~~~~~-~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~y 283 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLN-NLFPAASSDALDLLSKMLTYNPKKRITASQALKHPY 283 (318)
T ss_pred ccHHHHhcCCCCccc-cccccccHHHHHHHHhhhccCchhcccHHHHhcchh
Confidence 0101111111 122345566689999999999999999999987643
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=333.38 Aligned_cols=254 Identities=25% Similarity=0.362 Sum_probs=207.8
Q ss_pred CCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEecc
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMA 581 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 581 (845)
+|...+.||+|+||.||+|... .++.+++|..... ....+++.+|++++++++|+||++++++|...+..++||||++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 4677789999999999999875 5788999987644 3345789999999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCccc
Q 003139 582 NGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHV 661 (845)
Q Consensus 582 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 661 (845)
+++|.+++.......+++..++.++.|+++||+|||+ .+++||||||+|||+++++.+||+|||+++...... ...
T Consensus 86 ~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~-~~~ 161 (263)
T cd05052 86 YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTA 161 (263)
T ss_pred CCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccce-eec
Confidence 9999999876555679999999999999999999998 899999999999999999999999999997643211 111
Q ss_pred ccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCC
Q 003139 662 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGK 740 (845)
Q Consensus 662 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 740 (845)
.....++..|+|||.+.+..++.++|||||||++|||++ |..|+...... ++... .. ......
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~------~~~~~-~~---------~~~~~~ 225 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------QVYEL-LE---------KGYRME 225 (263)
T ss_pred cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHH-HH---------CCCCCC
Confidence 112334668999999999999999999999999999998 88887643221 11111 11 111122
Q ss_pred CCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 003139 741 VNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYA 777 (845)
Q Consensus 741 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~ 777 (845)
.+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 226 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 226 RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 3344567899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=342.51 Aligned_cols=259 Identities=24% Similarity=0.362 Sum_probs=206.2
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCc----EEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGT----KVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMIL 575 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 575 (845)
.+|+..+.||+|+||.||+|++. +++ .||+|.+... .....++|.+|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 45888999999999999999864 343 3899988654 345567899999999999999999999999764 5789
Q ss_pred EEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCC
Q 003139 576 VYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPA 655 (845)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~ 655 (845)
|+||+++|+|.+++.... ..+++..+++++.||++||+|||+ .+|+||||||+|||+++++.+||+|||+++....
T Consensus 86 v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccccC
Confidence 999999999999986543 468999999999999999999998 8999999999999999999999999999986543
Q ss_pred CCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhc
Q 003139 656 LDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMD 734 (845)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (845)
...........++..|+|||++.+..++.++|||||||++|||++ |+.|+......+ +. .....
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~---~~----~~~~~-------- 226 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---IS----SILEK-------- 226 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HH----HHHhC--------
Confidence 222222223344678999999999999999999999999999997 999886432211 11 11111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhhh
Q 003139 735 SNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLE 781 (845)
Q Consensus 735 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~ 781 (845)
......+..+...+.+++.+||+.+|.+||++.+++..|..+...+
T Consensus 227 -~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 227 -GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred -CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 1111122334567889999999999999999999999988775543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=353.28 Aligned_cols=260 Identities=24% Similarity=0.342 Sum_probs=206.3
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc------CCcEEEEEEcCCCC-hHhHHHHHHHHHHHHhCC-CCCcceEEEEEecCCc
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD------DGTKVAVKRGNPRS-EQGIAEFRTEIEMLSKLR-HRHLVSLIGYCDERSE 572 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~ 572 (845)
.++|.+.++||+|+||.||+|+.. .+..||||++.... ....+.|.+|+++++++. ||||++++++|.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 457888889999999999999853 13469999986543 344567999999999996 9999999999999999
Q ss_pred EEEEEEeccCCCccccccCCC-----------------------------------------------------------
Q 003139 573 MILVYEYMANGPLRSHLYGTD----------------------------------------------------------- 593 (845)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~----------------------------------------------------------- 593 (845)
.+|||||+++|+|.++|+...
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 999999999999988875321
Q ss_pred -----------------------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECC
Q 003139 594 -----------------------------------LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDD 638 (845)
Q Consensus 594 -----------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~ 638 (845)
...+++.++++++.|+++||+|||+ .+|+||||||+|||+++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEeC
Confidence 1247889999999999999999998 89999999999999999
Q ss_pred CCceEEEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHH
Q 003139 639 NFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIA 717 (845)
Q Consensus 639 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~ 717 (845)
++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.||........
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~---- 348 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST---- 348 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH----
Confidence 99999999999976432222122223456788999999999999999999999999999997 8888864322111
Q ss_pred HHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhh
Q 003139 718 EWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYAL 778 (845)
Q Consensus 718 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~ 778 (845)
.......+ .....+...+..+.+++.+||+.+|++||++.+|.+.|+.+.
T Consensus 349 --~~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 349 --FYNKIKSG---------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred --HHHHHhcC---------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 01111111 111122345677899999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=333.54 Aligned_cols=254 Identities=24% Similarity=0.414 Sum_probs=207.9
Q ss_pred cCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEecc
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMA 581 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 581 (845)
++|+..+.||+|+||.||+|...+++.+++|.+.... ...+.+.+|+.++++++|+||+++++.+.+.+..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 4678888999999999999998888899999876543 335788999999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCccc
Q 003139 582 NGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHV 661 (845)
Q Consensus 582 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 661 (845)
+++|.+++.......+++.+++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++...... ...
T Consensus 85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~ 160 (261)
T cd05072 85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE-YTA 160 (261)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCc-eec
Confidence 9999999976555678999999999999999999998 899999999999999999999999999998643211 111
Q ss_pred ccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCC
Q 003139 662 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGK 740 (845)
Q Consensus 662 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 740 (845)
.....++..|+|||++....++.++|||||||++|||++ |+.||......+ ...+ ...+. ...
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~----~~~~~---------~~~ 224 (261)
T cd05072 161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMSA----LQRGY---------RMP 224 (261)
T ss_pred cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHHH----HHcCC---------CCC
Confidence 223345678999999999999999999999999999998 888885432211 1111 11110 001
Q ss_pred CCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003139 741 VNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEY 776 (845)
Q Consensus 741 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~ 776 (845)
.....+..+.+++.+|+..+|++||+++++++.|+.
T Consensus 225 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 225 RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 112345678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=346.88 Aligned_cols=257 Identities=25% Similarity=0.408 Sum_probs=217.9
Q ss_pred cCCCcceeeeeeceEEEEEEEEcC-CcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEec
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLDD-GTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYM 580 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 580 (845)
.+..-.++||-|-||.||.|.|+. .-.||||.++... -..++|+.|..+|+.++|||+|+|+|+|..+..+|||.|||
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM 345 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM 345 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence 344556689999999999999974 4579999887543 45789999999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcc
Q 003139 581 ANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH 660 (845)
Q Consensus 581 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 660 (845)
.+|+|.++|++.++..++-..++.++.||+.||+||.. +++|||||.++|+|+.++..+||+||||+|++.. +...
T Consensus 346 ~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg-DTYT 421 (1157)
T KOG4278|consen 346 CYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTG-DTYT 421 (1157)
T ss_pred cCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhcC-Ccee
Confidence 99999999998888888889999999999999999998 9999999999999999999999999999998654 2322
Q ss_pred cccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcC-CCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCC
Q 003139 661 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCT-RPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVG 739 (845)
Q Consensus 661 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 739 (845)
.....+-.+.|.|||.+....++.|+|||+|||+||||.|- -.|+.+ +++.+ +..+++...+-
T Consensus 422 AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG------idlSq----------VY~LLEkgyRM 485 (1157)
T KOG4278|consen 422 AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG------IDLSQ----------VYGLLEKGYRM 485 (1157)
T ss_pred cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC------ccHHH----------HHHHHhccccc
Confidence 33345567899999999999999999999999999999984 444432 22221 22333333444
Q ss_pred CCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 003139 740 KVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779 (845)
Q Consensus 740 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~ 779 (845)
+-++.|+.++.+|++.||+.+|.+||++.|+-+.+|....
T Consensus 486 ~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 486 DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 5678899999999999999999999999999999998765
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=336.44 Aligned_cols=259 Identities=27% Similarity=0.412 Sum_probs=210.3
Q ss_pred cCCCcceeeeeeceEEEEEEEEc------CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD------DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMIL 575 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 575 (845)
++|...+.||+|+||.||+|+.. ++..+++|..........+.+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 34667789999999999999743 345689999877766666789999999999999999999999999999999
Q ss_pred EEEeccCCCccccccCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCc
Q 003139 576 VYEYMANGPLRSHLYGTD--------------LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFV 641 (845)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~ 641 (845)
||||+++++|.+++.... ...++|..+++++.|++.||+|||+ ++|+||||||+|||+++++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCc
Confidence 999999999999986432 2358999999999999999999998 99999999999999999999
Q ss_pred eEEEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHH
Q 003139 642 AKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWA 720 (845)
Q Consensus 642 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~ 720 (845)
+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ..
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~--- 235 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---VI--- 235 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HH---
Confidence 99999999976433222222334456788999999999999999999999999999998 999886543221 11
Q ss_pred HHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 003139 721 MTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779 (845)
Q Consensus 721 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~ 779 (845)
.....+.. ...+..++..+.+++.+||+.+|.+||++.+|+++|+.+..
T Consensus 236 -~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 236 -ECITQGRV---------LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred -HHHhCCCC---------CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 11111111 11223345678999999999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=345.66 Aligned_cols=260 Identities=26% Similarity=0.392 Sum_probs=204.9
Q ss_pred cCCCcceeeeeeceEEEEEEEEc------CCcEEEEEEcCCCC-hHhHHHHHHHHHHHHhC-CCCCcceEEEEEec-CCc
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD------DGTKVAVKRGNPRS-EQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDE-RSE 572 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~-~~~ 572 (845)
++|++.+.||+|+||.||+|... .++.||+|++.... ....+.+.+|++++.++ +|+||++++++|.. +..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 46888899999999999999642 24689999876542 34456788999999999 89999999998864 456
Q ss_pred EEEEEEeccCCCccccccCCC-----------------------------------------------------------
Q 003139 573 MILVYEYMANGPLRSHLYGTD----------------------------------------------------------- 593 (845)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~----------------------------------------------------------- 593 (845)
.+++|||+++++|.+++....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 889999999999988874321
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcccccccccCCCcCC
Q 003139 594 LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLD 673 (845)
Q Consensus 594 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~a 673 (845)
..+++|..+.+++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++...............++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 1368999999999999999999998 8999999999999999999999999999986432221112223456778999
Q ss_pred hhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHH
Q 003139 674 PEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGET 752 (845)
Q Consensus 674 PE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l 752 (845)
||++.+..++.++|||||||+|+||++ |+.||......+. ......++. ....+......+.++
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~------~~~~~~~~~---------~~~~~~~~~~~~~~l 308 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE------FCRRLKEGT---------RMRAPEYATPEIYSI 308 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH------HHHHHhccC---------CCCCCccCCHHHHHH
Confidence 999999999999999999999999998 9998865332211 111111111 111223345678999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 003139 753 AEKCLAEHGVDRPSMGDVLWNLEYALQ 779 (845)
Q Consensus 753 ~~~cl~~~p~~RPs~~~vl~~L~~~~~ 779 (845)
+.+||+.+|++||++.+++++|+.+++
T Consensus 309 ~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 309 MLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=332.82 Aligned_cols=255 Identities=27% Similarity=0.432 Sum_probs=212.4
Q ss_pred hcCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEec
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYM 580 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 580 (845)
..+|+..+.||+|+||.||+|...++..+++|.+.........++..|+.+++.++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 35677888999999999999998888999999987766656778999999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcc
Q 003139 581 ANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH 660 (845)
Q Consensus 581 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 660 (845)
++++|.+++.......+++.+++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||++...... ..
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~--~~ 159 (261)
T cd05148 85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKED--VY 159 (261)
T ss_pred ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCc--cc
Confidence 99999999977656679999999999999999999998 89999999999999999999999999999764321 11
Q ss_pred cccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCC
Q 003139 661 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVG 739 (845)
Q Consensus 661 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 739 (845)
......++..|+|||.+.++.++.++||||||++++||++ |+.||......+ .... +. .....
T Consensus 160 ~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~---~~~~------------~~-~~~~~ 223 (261)
T cd05148 160 LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE---VYDQ------------IT-AGYRM 223 (261)
T ss_pred cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHH------------HH-hCCcC
Confidence 1223345678999999999999999999999999999998 888886433211 1111 11 11111
Q ss_pred CCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003139 740 KVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEY 776 (845)
Q Consensus 740 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~ 776 (845)
..+..++..+.+++.+||+.+|.+|||+.++++.|+.
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 224 PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 2234456778899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=344.14 Aligned_cols=264 Identities=23% Similarity=0.297 Sum_probs=206.4
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
++|+..+.||+|+||.||+++.. +|..+|+|.+... .....+++.+|++++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 67888999999999999999976 6788999987654 334457899999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCc
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT 659 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~ 659 (845)
+++++|.+++... ..+++..+..++.|++.||.|||+ ..+|+||||||+|||+++++.+||+|||+++....
T Consensus 85 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~---- 156 (331)
T cd06649 85 MDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---- 156 (331)
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCcccccccc----
Confidence 9999999998543 368999999999999999999997 24699999999999999999999999999875322
Q ss_pred ccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhc-------------
Q 003139 660 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKK------------- 726 (845)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~------------- 726 (845)
.......|+..|+|||++.+..++.++|||||||++|||++|+.||......+ +..........
T Consensus 157 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 233 (331)
T cd06649 157 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEGEPHSISPRP 233 (331)
T ss_pred cccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccCCccccCccc
Confidence 11234568999999999999999999999999999999999999996432211 10000000000
Q ss_pred -----------------Cchhhhhc----cccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003139 727 -----------------GMLDQIMD----SNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEY 776 (845)
Q Consensus 727 -----------------~~~~~~~d----~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~ 776 (845)
....++.+ ..............+.+++.+||+.||++|||+.+++++...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~ 304 (331)
T cd06649 234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFI 304 (331)
T ss_pred ccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHH
Confidence 00000011 000000112345678999999999999999999999987543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=331.12 Aligned_cols=255 Identities=29% Similarity=0.446 Sum_probs=207.3
Q ss_pred hcCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEec
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYM 580 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 580 (845)
.++|+..+.||+|++|.||+|...+++.||+|.+.... ...+++.+|++++++++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 35688889999999999999998778889999876543 23467899999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcc
Q 003139 581 ANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH 660 (845)
Q Consensus 581 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 660 (845)
++++|.+++.......++|.++.+++.|++.||.|||+ .+++||||||+||++++++.+||+|||+++...... ..
T Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~ 159 (261)
T cd05068 84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI-YE 159 (261)
T ss_pred cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc-cc
Confidence 99999999976554578999999999999999999998 899999999999999999999999999997643211 11
Q ss_pred cccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCC
Q 003139 661 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVG 739 (845)
Q Consensus 661 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 739 (845)
.......+..|+|||++.+..++.++||||||++++||++ |+.||....... + ...... ....
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~----~~~~~~---------~~~~ 223 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE---V----LQQVDQ---------GYRM 223 (261)
T ss_pred ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH---H----HHHHHc---------CCCC
Confidence 1112223457999999999999999999999999999999 888886432211 0 011111 1111
Q ss_pred CCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003139 740 KVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEY 776 (845)
Q Consensus 740 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~ 776 (845)
..+...+..+.+++.+|++.+|.+||++.++++.|+.
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 1223455778999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=329.86 Aligned_cols=251 Identities=29% Similarity=0.422 Sum_probs=202.5
Q ss_pred cCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEecc
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMA 581 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 581 (845)
++|+..+.||+|+||.||++.++++..+|+|...... ...++|.+|++++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 4577788999999999999999888889999876432 234678999999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCccc
Q 003139 582 NGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHV 661 (845)
Q Consensus 582 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 661 (845)
+|+|.+++.... ..++|..++.++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++..... ....
T Consensus 83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~-~~~~ 157 (256)
T cd05114 83 NGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD-EYTS 157 (256)
T ss_pred CCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCC-ceec
Confidence 999999886543 368999999999999999999998 89999999999999999999999999998764321 1111
Q ss_pred ccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCC
Q 003139 662 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGK 740 (845)
Q Consensus 662 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 740 (845)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ . .... .++. .. .
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~---~---~~~i-~~~~--~~-------~ 221 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE---V---VEMI-SRGF--RL-------Y 221 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH---H---HHHH-HCCC--CC-------C
Confidence 223345668999999998899999999999999999999 888886433211 1 1111 1110 00 0
Q ss_pred CCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003139 741 VNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNL 774 (845)
Q Consensus 741 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L 774 (845)
.+...+..+.+++.+||+.+|.+||++.++++.|
T Consensus 222 ~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 222 RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1122345788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=339.42 Aligned_cols=253 Identities=21% Similarity=0.317 Sum_probs=205.9
Q ss_pred HhcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC---hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEE
Q 003139 500 ATNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS---EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMIL 575 (845)
Q Consensus 500 at~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 575 (845)
..++|+..+.||+|+||.||+++-+ +|..+|+|++++.. ..+.+..+.|-.+|....+|+||+|+..+.+.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4578999999999999999999865 69999999988753 3456778899999999999999999999999999999
Q ss_pred EEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCC
Q 003139 576 VYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPA 655 (845)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~ 655 (845)
||||+|||++..+|.. ...|++.....++.+++.||+-||+ .|+|||||||+|+|||..|++||+||||+.-...
T Consensus 219 iMEylPGGD~mTLL~~--~~~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMR--KDTLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred EEEecCCccHHHHHHh--cCcCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchhhh
Confidence 9999999999999954 4579999999999999999999999 9999999999999999999999999999842100
Q ss_pred ----------------------CCCc-----------------------ccccccccCCCcCChhhhccCCCCchhHHHH
Q 003139 656 ----------------------LDQT-----------------------HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYS 690 (845)
Q Consensus 656 ----------------------~~~~-----------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S 690 (845)
.+.. ......+|||.|||||++.+..|+..+|+||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 0000 0012357999999999999999999999999
Q ss_pred HHHHHHHHHcCCCCCCCCCCccc-ccHHHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCC---
Q 003139 691 FGVVLMEVLCTRPALNPVLPREQ-VNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPS--- 766 (845)
Q Consensus 691 ~Gvvl~Elltg~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs--- 766 (845)
+||||||||.|-+||....+.+. ..+..|...+.. ........+..++|.+|+. ||++|..
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~f--------------P~~~~~s~eA~DLI~rll~-d~~~RLG~~G 438 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKF--------------PEEVDLSDEAKDLITRLLC-DPENRLGSKG 438 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccC--------------CCcCcccHHHHHHHHHHhc-CHHHhcCccc
Confidence 99999999999999988776552 233344322111 1112233667799999998 9999975
Q ss_pred HHHHHH
Q 003139 767 MGDVLW 772 (845)
Q Consensus 767 ~~~vl~ 772 (845)
++||-+
T Consensus 439 ~~EIK~ 444 (550)
T KOG0605|consen 439 AEEIKK 444 (550)
T ss_pred HHHHhc
Confidence 444443
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=330.22 Aligned_cols=256 Identities=25% Similarity=0.410 Sum_probs=207.6
Q ss_pred cCCCcceeeeeeceEEEEEEEEcC----CcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLDD----GTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILV 576 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 576 (845)
++|+..+.||+|+||.||+|.+.. ...+++|..... ......+|.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568888999999999999998752 357899987654 344457899999999999999999999999999999999
Q ss_pred EEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCC
Q 003139 577 YEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPAL 656 (845)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~ 656 (845)
|||+++++|.+++.... ..+++.++++++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.....
T Consensus 84 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 84 TEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999986543 478999999999999999999998 99999999999999999999999999999875422
Q ss_pred CCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcc
Q 003139 657 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDS 735 (845)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (845)
..........++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ +.. ...++
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---~~~----~~~~~-------- 224 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---VIK----AVEDG-------- 224 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---HHH----HHHcC--------
Confidence 22222223345678999999999999999999999999999998 988885432111 111 11111
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 003139 736 NLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYA 777 (845)
Q Consensus 736 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~ 777 (845)
.....+...+..+.+++.+|++.+|++||++.+|+++|+.+
T Consensus 225 -~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 225 -YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01112234456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=346.25 Aligned_cols=242 Identities=24% Similarity=0.314 Sum_probs=198.4
Q ss_pred eeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEeccCC
Q 003139 508 LLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANG 583 (845)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 583 (845)
+.||+|+||.||+++.. +|+.+|+|.+... .......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999875 6889999987643 2334567889999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCccccc
Q 003139 584 PLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVST 663 (845)
Q Consensus 584 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 663 (845)
+|.+++... ..+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.... ......
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~--~~~~~~ 153 (323)
T cd05571 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS--DGATMK 153 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc--CCCccc
Confidence 999888543 478999999999999999999999 8999999999999999999999999999875322 112233
Q ss_pred ccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCCH
Q 003139 664 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNP 743 (845)
Q Consensus 664 ~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 743 (845)
...||+.|+|||++.+..++.++|||||||++|||++|+.||....... +.. .+.... ..++.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~~~------------~~~~~~--~~~p~ 216 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFE------------LILMEE--IRFPR 216 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH---HHH------------HHHcCC--CCCCC
Confidence 4679999999999999999999999999999999999999996432111 110 011111 12233
Q ss_pred HHHHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 003139 744 ASLKKFGETAEKCLAEHGVDRP-----SMGDVLWN 773 (845)
Q Consensus 744 ~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~~ 773 (845)
.....+.+++.+||+.||++|| ++.+++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 4556788999999999999999 78888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=348.28 Aligned_cols=248 Identities=24% Similarity=0.303 Sum_probs=208.1
Q ss_pred CCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEE
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYE 578 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 578 (845)
-|+..+.||+|+-|.|-+|++. +|+.+|||.+... +......+.+|+-+|+.+.|||+++|++++++..++|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 3556678999999999999975 7999999987655 22334567789999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCC
Q 003139 579 YMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQ 658 (845)
Q Consensus 579 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~ 658 (845)
|+++|.|.++|..+ +++.+.+..++++||+.|+.|+|. .+|+||||||+|+|||..+++||+|||+|.+.. .
T Consensus 93 yv~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~---~ 164 (786)
T KOG0588|consen 93 YVPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEV---P 164 (786)
T ss_pred ecCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeeccc---C
Confidence 99999999999544 589999999999999999999999 999999999999999999999999999997622 2
Q ss_pred cccccccccCCCcCChhhhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcccc
Q 003139 659 THVSTAVKGSFGYLDPEYFRRQQLT-EKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNL 737 (845)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (845)
......-+|++.|.+||++++.+|. .++||||+|||||.||+|+.||++..-+. .. ...+.|.
T Consensus 165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~------LL-lKV~~G~--------- 228 (786)
T KOG0588|consen 165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRV------LL-LKVQRGV--------- 228 (786)
T ss_pred CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHH------HH-HHHHcCc---------
Confidence 2334467899999999999999985 79999999999999999999998533211 11 1112221
Q ss_pred CCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 738 VGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
-+.+..+..+.++|+.+|+..||+.|.|++||+++-.
T Consensus 229 -f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 229 -FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred -ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence 1234566778899999999999999999999998754
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=334.75 Aligned_cols=259 Identities=28% Similarity=0.419 Sum_probs=209.1
Q ss_pred cCCCcceeeeeeceEEEEEEEEc------CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD------DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMIL 575 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 575 (845)
++|.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 46788889999999999999752 345689998877776677889999999999999999999999999999999
Q ss_pred EEEeccCCCccccccCCC-----------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEE
Q 003139 576 VYEYMANGPLRSHLYGTD-----------LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKV 644 (845)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl 644 (845)
||||+++++|.+++.... ...+++.+++.++.|++.||+|||+ .+++||||||+|||+++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEEe
Confidence 999999999998885321 2358999999999999999999998 89999999999999999999999
Q ss_pred EeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHH
Q 003139 645 ADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTW 723 (845)
Q Consensus 645 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~ 723 (845)
+|||+++...............++..|+|||.+.+..++.++|||||||+++||++ |++||......+ . . ..
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~---~-~~ 234 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---V---I-EC 234 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---H---H-HH
Confidence 99999976432222222223445778999999999999999999999999999998 888885443211 1 1 11
Q ss_pred hhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 003139 724 QKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779 (845)
Q Consensus 724 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~ 779 (845)
...+.. ...+...+..+.+++.+||+.+|.+||++.++++.|+.+.+
T Consensus 235 i~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 235 ITQGRV---------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred HHcCCc---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 111111 01122344578999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=340.91 Aligned_cols=247 Identities=23% Similarity=0.262 Sum_probs=202.8
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC---hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS---EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
++|+..+.||+|+||.||+|... +|+.+|+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36788899999999999999976 68899999875432 234567889999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
||+++|+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~-- 153 (291)
T cd05612 81 EYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-- 153 (291)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccC--
Confidence 999999999998543 468999999999999999999999 9999999999999999999999999999976432
Q ss_pred CcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcccc
Q 003139 658 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNL 737 (845)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (845)
......|++.|+|||.+.+..++.++|||||||++|||++|+.||......+ ... .+.....
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~------~~~---------~i~~~~~ 215 (291)
T cd05612 154 ---RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG------IYE---------KILAGKL 215 (291)
T ss_pred ---CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHH---------HHHhCCc
Confidence 1223568999999999999999999999999999999999999986543211 111 1111111
Q ss_pred CCCCCHHHHHHHHHHHHHhhhhCCCCCCC-----HHHHHHHHH
Q 003139 738 VGKVNPASLKKFGETAEKCLAEHGVDRPS-----MGDVLWNLE 775 (845)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~~vl~~L~ 775 (845)
.++......+.+++.+||+.||.+||+ +.+++++-.
T Consensus 216 --~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~ 256 (291)
T cd05612 216 --EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRW 256 (291)
T ss_pred --CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCcc
Confidence 122333567889999999999999995 888776643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=358.84 Aligned_cols=252 Identities=23% Similarity=0.308 Sum_probs=205.6
Q ss_pred CCCcceeeeeeceEEEEEEEEc-C-CcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEec
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-D-GTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYM 580 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 580 (845)
.|...+.||+|+||.||+|... + ++.||+|............+.+|+.+++.++||||+++++++...+..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3778889999999999999854 3 6778899876666666677889999999999999999999999999999999999
Q ss_pred cCCCccccccCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCC
Q 003139 581 ANGPLRSHLYGT--DLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQ 658 (845)
Q Consensus 581 ~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~ 658 (845)
++|+|.++|... ...++++.++..++.|++.||+|||+ ++|+||||||+||||++++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999887542 34578999999999999999999998 8999999999999999999999999999986433222
Q ss_pred cccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccC
Q 003139 659 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLV 738 (845)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 738 (845)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...... +... .++....
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~------~~~~---------~~~~~~~- 288 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR------EIMQ---------QVLYGKY- 288 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHH---------HHHhCCC-
Confidence 22334567999999999999999999999999999999999999998643221 1111 1111111
Q ss_pred CCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 739 GKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 739 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
...+......+.+++.+||+.+|++||++.+++..
T Consensus 289 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 289 DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 01223345678899999999999999999998753
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=334.90 Aligned_cols=255 Identities=28% Similarity=0.441 Sum_probs=206.4
Q ss_pred cCCCcceeeeeeceEEEEEEEEcC------CcEEEEEEcCCCChH-hHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLDD------GTKVAVKRGNPRSEQ-GIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMI 574 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 574 (845)
++|...+.||+|+||.||+|...+ +..+|+|.+...... ..++|.+|++++++++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457777899999999999998643 468999988765443 5678999999999999999999999999999999
Q ss_pred EEEEeccCCCccccccCCC------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCce
Q 003139 575 LVYEYMANGPLRSHLYGTD------------LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVA 642 (845)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~ 642 (845)
+||||+++++|.+++.... ...+++.++..++.|++.||+|||+ ++++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCeE
Confidence 9999999999999986432 2458899999999999999999998 899999999999999999999
Q ss_pred EEEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHH
Q 003139 643 KVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAM 721 (845)
Q Consensus 643 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~ 721 (845)
||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |+.||......+ ....
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~~~~-- 236 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---VIEC-- 236 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHH--
Confidence 9999999975432222222233445788999999999999999999999999999998 999886433221 1111
Q ss_pred HHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 722 TWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 722 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
...+. ....+...+..+.+++.+||+.+|++||++.||++.|+
T Consensus 237 --~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 237 --ITQGR---------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred --HHcCC---------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 11111 11122345677899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=346.59 Aligned_cols=254 Identities=26% Similarity=0.343 Sum_probs=205.3
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
++|++.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|++++.+++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46888999999999999999976 5889999987643 2234567889999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
||+++|+|.+++... ..+++.++..++.|++.||.|||+ .+|+||||||+|||+++++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 999999999998543 468999999999999999999999 9999999999999999999999999999976332
Q ss_pred CcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcccc
Q 003139 658 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNL 737 (845)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (845)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ...... . ..+....
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~---~~i~~~--~----~~~~~~~ 221 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW---ENLKYW--K----ETLQRPV 221 (333)
T ss_pred ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHH---HHHHhc--c----ccccCCC
Confidence 234567899999999999999999999999999999999999999754332211 000000 0 0010000
Q ss_pred CCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003139 738 VGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNL 774 (845)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L 774 (845)
...........+.+++.+||..+|.+||++.+++++-
T Consensus 222 ~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~ 258 (333)
T cd05600 222 YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHP 258 (333)
T ss_pred CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCc
Confidence 0001123456788999999999999999999998763
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=333.13 Aligned_cols=257 Identities=26% Similarity=0.385 Sum_probs=204.3
Q ss_pred HhcCCCcceeeeeeceEEEEEEEEc------CCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Q 003139 500 ATNKFDESLLLGVGGFGRVYKGTLD------DGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSE 572 (845)
Q Consensus 500 at~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 572 (845)
.+++|+..+.||+|+||.||+|.+. .+..+|+|+.... ......+|.+|+.+++.++||||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3567889999999999999999753 2467999987643 33445678999999999999999999999999999
Q ss_pred EEEEEEeccCCCccccccCCC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEE
Q 003139 573 MILVYEYMANGPLRSHLYGTD--------LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKV 644 (845)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl 644 (845)
.++||||+++++|.+++.... ...+++..++.++.|++.||+|||+ .+++||||||+|||+++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEE
Confidence 999999999999999885421 2346899999999999999999998 89999999999999999999999
Q ss_pred EeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHH
Q 003139 645 ADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTW 723 (845)
Q Consensus 645 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~ 723 (845)
+|||+++...............++..|+|||++.++.++.++|||||||++|||++ |..||......+ .....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~------~~~~~ 234 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ------VLRFV 234 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHHH
Confidence 99999875432222121222345778999999999999999999999999999999 677875432211 11111
Q ss_pred hhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 724 QKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 724 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
.++. . ...+...+..+.+++.+|++.+|++||++.|+++.|+
T Consensus 235 -~~~~--------~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 235 -MEGG--------L-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred -HcCC--------c-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 1111 0 1122344567899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=330.72 Aligned_cols=260 Identities=27% Similarity=0.375 Sum_probs=209.1
Q ss_pred HhcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCCh--------------HhHHHHHHHHHHHHhCCCCCcceEE
Q 003139 500 ATNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSE--------------QGIAEFRTEIEMLSKLRHRHLVSLI 564 (845)
Q Consensus 500 at~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~H~niv~l~ 564 (845)
.-++|++.+.||+|.||.|-+|+.. +++.||||.+.+... ..++...+|+.+|++++|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 3478899999999999999999865 789999998654311 1235788999999999999999999
Q ss_pred EEEecC--CcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCce
Q 003139 565 GYCDER--SEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVA 642 (845)
Q Consensus 565 g~~~~~--~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~ 642 (845)
.+..+. +.+|||+|||..|.+...- .....|+..+.+++++++..||+|||. ++||||||||+|+||+++|++
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p--~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCP--PDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCC--CCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCCCcE
Confidence 998664 5799999999998876543 222339999999999999999999999 999999999999999999999
Q ss_pred EEEeccccCCCCCC---CCcccccccccCCCcCChhhhccCC----CCchhHHHHHHHHHHHHHcCCCCCCCCCCccccc
Q 003139 643 KVADFGLSKTGPAL---DQTHVSTAVKGSFGYLDPEYFRRQQ----LTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVN 715 (845)
Q Consensus 643 kl~DFGla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~ 715 (845)
||+|||.+...+.. +.........||+.|+|||...++. .+.+.||||+||.||.|+.|+.||......+
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~--- 326 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE--- 326 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH---
Confidence 99999999754221 1111123478999999999987632 3568999999999999999999997543322
Q ss_pred HHHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 003139 716 IAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779 (845)
Q Consensus 716 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~ 779 (845)
..++|+...+.-...+++.+.+.+|++++|.+||++|.+..+|..+..-...
T Consensus 327 ------------l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 327 ------------LFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred ------------HHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 2345555555544456678899999999999999999999999887765443
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=311.51 Aligned_cols=250 Identities=27% Similarity=0.390 Sum_probs=213.3
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC---hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS---EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
++|++.+.||+|.||.||.|+.+ ++-.||+|.+.... .+..+++.+|+++-+.|+||||+++++|+.+....||++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 46889999999999999999966 67789999875432 223467889999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
||.++|+|...|.+....+++......++.|+|.||.|+|. +++|||||||+|+|++..+..||+|||.+...+
T Consensus 102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--- 175 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--- 175 (281)
T ss_pred EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecC---
Confidence 99999999999987777789999999999999999999998 999999999999999999999999999987632
Q ss_pred CcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcccc
Q 003139 658 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNL 737 (845)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (845)
.......+||..|++||...+...+.++|+|++|++.+|++.|.+||......+ ...++...++
T Consensus 176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e---------------tYkrI~k~~~ 239 (281)
T KOG0580|consen 176 -SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE---------------TYKRIRKVDL 239 (281)
T ss_pred -CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH---------------HHHHHHHccc
Confidence 233456899999999999999999999999999999999999999997544211 2223332222
Q ss_pred CCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 738 VGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
.++........+++.+|+..+|.+|.+..|++++-.
T Consensus 240 --~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpw 275 (281)
T KOG0580|consen 240 --KFPSTISGGAADLISRLLVKNPIERLALTEVMDHPW 275 (281)
T ss_pred --cCCcccChhHHHHHHHHhccCccccccHHHHhhhHH
Confidence 234556677889999999999999999999987643
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=346.29 Aligned_cols=245 Identities=24% Similarity=0.355 Sum_probs=201.4
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
++|+..+.||+|+||.||+|+.. +++.+|+|.+... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 46788889999999999999976 6889999987543 2234567889999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
||+++|+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+||||++++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~- 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR- 171 (329)
T ss_pred cCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-
Confidence 999999999998643 468899999999999999999999 99999999999999999999999999999764321
Q ss_pred CcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcccc
Q 003139 658 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNL 737 (845)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (845)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .. ..+....+
T Consensus 172 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~------~~---------~~i~~~~~ 232 (329)
T PTZ00263 172 ----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR------IY---------EKILAGRL 232 (329)
T ss_pred ----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH------HH---------HHHhcCCc
Confidence 123578999999999999999999999999999999999999996533211 00 11111111
Q ss_pred CCCCCHHHHHHHHHHHHHhhhhCCCCCCC-----HHHHHHH
Q 003139 738 VGKVNPASLKKFGETAEKCLAEHGVDRPS-----MGDVLWN 773 (845)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~~vl~~ 773 (845)
.++......+.+++.+||+.||.+||+ +.+++.+
T Consensus 233 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 233 --KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred --CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 122234456889999999999999997 6777655
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=335.62 Aligned_cols=258 Identities=22% Similarity=0.368 Sum_probs=207.0
Q ss_pred cCCCcceeeeeeceEEEEEEEEc------CCcEEEEEEcCCCC-hHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD------DGTKVAVKRGNPRS-EQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERSEM 573 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 573 (845)
++|...+.||+|+||.||++... .+..+|+|++.... ....+.+.+|+++++++ +|+||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 46888889999999999999742 34579999876543 34456789999999999 799999999999999999
Q ss_pred EEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCC
Q 003139 574 ILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTG 653 (845)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~ 653 (845)
++||||+++|+|.+++.......+++.+++.++.|++.||+|||+ ++|+|+||||+|||+++++.+||+|||+++..
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~ 191 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLARDI 191 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCcccccc
Confidence 999999999999999875544458999999999999999999998 89999999999999999999999999999764
Q ss_pred CCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhh
Q 003139 654 PALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQI 732 (845)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (845)
.............++..|+|||.+.+..++.++|||||||++|||++ |+.||......+. .. . .
T Consensus 192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~~----~---------~ 256 (302)
T cd05055 192 MNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--FY----K---------L 256 (302)
T ss_pred cCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--HH----H---------H
Confidence 33222112223345778999999999999999999999999999998 8988864432211 10 1 1
Q ss_pred hccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 003139 733 MDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYA 777 (845)
Q Consensus 733 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~ 777 (845)
.+.......+......+.+++.+|++.+|++||++.++++.|+.+
T Consensus 257 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 257 IKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 111111111223356789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=336.90 Aligned_cols=266 Identities=20% Similarity=0.228 Sum_probs=202.5
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYE 578 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 578 (845)
++|++.+.||+|+||.||+++.+ +++.+|+|++... .....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46888999999999999999986 5788999987643 23345678899999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCC
Q 003139 579 YMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQ 658 (845)
Q Consensus 579 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~ 658 (845)
|++++.|..+... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++..... .
T Consensus 81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~ 154 (287)
T cd07848 81 YVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG-S 154 (287)
T ss_pred cCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCccccccc-c
Confidence 9998877655422 2468999999999999999999998 89999999999999999999999999999864321 1
Q ss_pred cccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHH---------HHHHhhcCch
Q 003139 659 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEW---------AMTWQKKGML 729 (845)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~---------~~~~~~~~~~ 729 (845)
........|+..|+|||++.+..++.++|||||||++|||++|++||......+....... ..........
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07848 155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF 234 (287)
T ss_pred cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence 1122345689999999999999999999999999999999999999975433221110000 0000000000
Q ss_pred hhhhccccCC------CCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 730 DQIMDSNLVG------KVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 730 ~~~~d~~l~~------~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.....+.... .........+.+++.+||+.||++|||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000000 0111234568999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=332.24 Aligned_cols=254 Identities=26% Similarity=0.419 Sum_probs=203.6
Q ss_pred CCCcceeeeeeceEEEEEEEE-----cCCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEE
Q 003139 503 KFDESLLLGVGGFGRVYKGTL-----DDGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILV 576 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 576 (845)
.|+..+.||+|+||.||+|.+ ..+..+++|.+... ..+..++|.+|++++++++||||+++++++......++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 85 (283)
T cd05090 6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCML 85 (283)
T ss_pred hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEE
Confidence 467778999999999999984 24578999988643 344557899999999999999999999999999999999
Q ss_pred EEeccCCCccccccCCC---------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCc
Q 003139 577 YEYMANGPLRSHLYGTD---------------LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFV 641 (845)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~ 641 (845)
|||+++++|.+++.... ...+++.+++.++.|++.||+|||+ ++++||||||+|||+++++.
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 86 FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCCc
Confidence 99999999999884221 2358899999999999999999998 89999999999999999999
Q ss_pred eEEEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHH
Q 003139 642 AKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWA 720 (845)
Q Consensus 642 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~ 720 (845)
+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||......+ +
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~---~---- 235 (283)
T cd05090 163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE---V---- 235 (283)
T ss_pred EEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---H----
Confidence 99999999976433222222334446778999999998899999999999999999998 888886432211 1
Q ss_pred HHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 721 MTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 721 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
........ ....+...+..+.+++.+|++.+|++||++.+|++.|.
T Consensus 236 ~~~~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05090 236 IEMVRKRQ---------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281 (283)
T ss_pred HHHHHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence 11111111 11122344567889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=339.10 Aligned_cols=257 Identities=28% Similarity=0.418 Sum_probs=214.0
Q ss_pred CCcceeeeeeceEEEEEEEEcC---Cc--EEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 504 FDESLLLGVGGFGRVYKGTLDD---GT--KVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 504 f~~~~~LG~G~fg~Vy~~~~~~---g~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
....++||+|-||.||+|...+ |+ .||||..+.. ..+..+.|+.|..+|++++||||++|+|+|.+ ...+|||
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wivm 469 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVM 469 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEE
Confidence 3445689999999999998542 33 4888977663 45567899999999999999999999999976 5789999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
|.++.|.|+.+|..++ ..|+......++.||+.+|.|||+ ..+|||||..+|||+.+.-.+||+||||+|...+.
T Consensus 470 EL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~- 544 (974)
T KOG4257|consen 470 ELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD- 544 (974)
T ss_pred ecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhhhcccc-
Confidence 9999999999997554 578999999999999999999999 99999999999999999999999999999986642
Q ss_pred CcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccc
Q 003139 658 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSN 736 (845)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (845)
.....+...-.+.|||||.+.-+++|.+||||.|||++||++. |..||.+....+-. . .++..
T Consensus 545 ~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI---------------~-~iEnG 608 (974)
T KOG4257|consen 545 AYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI---------------G-HIENG 608 (974)
T ss_pred chhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE---------------E-EecCC
Confidence 2333345566789999999999999999999999999999875 88999765433311 1 11122
Q ss_pred cCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhhhc
Q 003139 737 LVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLEE 782 (845)
Q Consensus 737 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~~ 782 (845)
-+-..++.|+..+..+..+||..+|.+||.+.++...|..+++.+.
T Consensus 609 eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek 654 (974)
T KOG4257|consen 609 ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEK 654 (974)
T ss_pred CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhh
Confidence 2234678899999999999999999999999999999999887443
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=335.68 Aligned_cols=259 Identities=26% Similarity=0.456 Sum_probs=208.1
Q ss_pred hcCCCcceeeeeeceEEEEEEEEcC------CcEEEEEEcCCC-ChHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCc
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLDD------GTKVAVKRGNPR-SEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERSE 572 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 572 (845)
.++|+..+.||+|+||.||++...+ ...+|+|..... ..+...++.+|++++.++ +|+||+++++++...+.
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 4568888899999999999998642 357899987653 344557789999999999 89999999999999999
Q ss_pred EEEEEEeccCCCccccccC--------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECC
Q 003139 573 MILVYEYMANGPLRSHLYG--------------TDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDD 638 (845)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~--------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~ 638 (845)
.+++|||+++|+|..++.. .....+++..+++++.|++.||+|||+ .+|+||||||+|||+++
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVTE 167 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEcC
Confidence 9999999999999998853 223568999999999999999999998 89999999999999999
Q ss_pred CCceEEEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHH
Q 003139 639 NFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIA 717 (845)
Q Consensus 639 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~ 717 (845)
++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+......+.
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---- 243 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL---- 243 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH----
Confidence 99999999999986543222222223345678999999999999999999999999999998 8888754322110
Q ss_pred HHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhh
Q 003139 718 EWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYAL 778 (845)
Q Consensus 718 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~ 778 (845)
.. .+........+......+.+++.+|++.+|++|||+.++++.|+.++
T Consensus 244 ---~~---------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 244 ---FK---------LLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ---HH---------HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 01 11111111223345567889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=331.85 Aligned_cols=258 Identities=25% Similarity=0.388 Sum_probs=205.6
Q ss_pred CCCcceeeeeeceEEEEEEEEc------CCcEEEEEEcCCCC-hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEE
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD------DGTKVAVKRGNPRS-EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMIL 575 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 575 (845)
+|+..+.||+|+||.||+|... ....+++|...... ....+++.+|+.+++.++||||+++++.|...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4667789999999999999853 23468888776543 3456789999999999999999999999999999999
Q ss_pred EEEeccCCCccccccCC----------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCc
Q 003139 576 VYEYMANGPLRSHLYGT----------------------DLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTN 633 (845)
Q Consensus 576 V~Ey~~~gsL~~~l~~~----------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~N 633 (845)
|+||+++++|.+++... ...++++.+++.++.|++.||+|||+ .+++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhhe
Confidence 99999999999887532 12358899999999999999999998 999999999999
Q ss_pred EEECCCCceEEEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcc
Q 003139 634 ILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPRE 712 (845)
Q Consensus 634 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~ 712 (845)
||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |+.||....+.+
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999976432222111223345678999999999999999999999999999998 998886543221
Q ss_pred cccHHHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 003139 713 QVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779 (845)
Q Consensus 713 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~ 779 (845)
+. ....+ ......+......+.+++.+|++.+|++||++.++++.|+++..
T Consensus 238 ---~~----~~~~~---------~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 238 ---LF----NLLKT---------GYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred ---HH----HHHhC---------CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 11 11111 11112233445678899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=330.39 Aligned_cols=257 Identities=25% Similarity=0.379 Sum_probs=203.3
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCc----EEEEEEcCCCC-hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGT----KVAVKRGNPRS-EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMIL 575 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 575 (845)
++|+..+.||+|+||.||+|.+. +++ .+++|...... ....+++..|+..+++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 35677789999999999999874 344 47888775443 3445678889999999999999999999864 56789
Q ss_pred EEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCC
Q 003139 576 VYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPA 655 (845)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~ 655 (845)
++||+++|+|.+++.... ..++|..++.++.|++.||+|||+ .+++||||||+|||+++++.+||+|||+++....
T Consensus 86 i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 999999999999996543 468999999999999999999998 8999999999999999999999999999986433
Q ss_pred CCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhc
Q 003139 656 LDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMD 734 (845)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (845)
...........++..|+|||.+.++.++.++|||||||++|||++ |+.||......+ +.++ ..++.
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~~~----~~~~~------ 228 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---VPDL----LEKGE------ 228 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH----HHCCC------
Confidence 222222334567789999999999999999999999999999998 998886543221 1111 11111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 003139 735 SNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779 (845)
Q Consensus 735 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~ 779 (845)
....+..+...+.+++.+|+..+|++||++.|+++.|+.+.+
T Consensus 229 ---~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 229 ---RLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred ---cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 001112234567889999999999999999999999888654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=327.49 Aligned_cols=251 Identities=30% Similarity=0.411 Sum_probs=202.4
Q ss_pred CCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEeccC
Q 003139 503 KFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMAN 582 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 582 (845)
+|...+.||+|+||.||+|...++..+|+|.+.... ...++|.+|+.++++++||||+++++++.+....++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 467778999999999999998777779999876443 2346789999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcccc
Q 003139 583 GPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVS 662 (845)
Q Consensus 583 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 662 (845)
|+|.+++.... ..+++.++++++.|++.||+|||+ .+++|+||||+|||+++++.+||+|||+++..... .....
T Consensus 84 ~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~-~~~~~ 158 (256)
T cd05113 84 GCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD-EYTSS 158 (256)
T ss_pred CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCC-ceeec
Confidence 99999986543 368999999999999999999998 89999999999999999999999999998764321 11112
Q ss_pred cccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCC
Q 003139 663 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKV 741 (845)
Q Consensus 663 ~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 741 (845)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ... .. ..+. ....
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~---~~-~~~~---------~~~~ 222 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---TVE---KV-SQGL---------RLYR 222 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHH---HH-hcCC---------CCCC
Confidence 23345678999999998899999999999999999998 998886433211 111 11 1110 0011
Q ss_pred CHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 742 NPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 742 ~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
+......+.+++.+||+.+|.+||++.++++.|+
T Consensus 223 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 223 PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 1223567899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=343.14 Aligned_cols=240 Identities=27% Similarity=0.365 Sum_probs=206.4
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcEEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERSEMIL 575 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 575 (845)
-++|...++||+|.||+|+++.++ +++.+|||.+++. ..++.+..+.|.+++... +||.|++|+..+...+++++
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 457899999999999999999987 6788999987765 355677888899998887 59999999999999999999
Q ss_pred EEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCC
Q 003139 576 VYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPA 655 (845)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~ 655 (845)
||||+.||++..+.+ ...+++....-++..|+.||+|||+ ++|||||||.+|||||.+|.+||+||||++....
T Consensus 447 vmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred EEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccccCC
Confidence 999999999655543 2469999999999999999999999 9999999999999999999999999999997543
Q ss_pred CCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcc
Q 003139 656 LDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDS 735 (845)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (845)
.......++||+.|||||++.++.|+.++|+|||||+|||||.|..||.+..+.+ +.|.
T Consensus 521 --~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee-------------------~Fds 579 (694)
T KOG0694|consen 521 --QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE-------------------VFDS 579 (694)
T ss_pred --CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH-------------------HHHH
Confidence 2334567999999999999999999999999999999999999999997654332 2333
Q ss_pred ccCC--CCCHHHHHHHHHHHHHhhhhCCCCCCCH
Q 003139 736 NLVG--KVNPASLKKFGETAEKCLAEHGVDRPSM 767 (845)
Q Consensus 736 ~l~~--~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 767 (845)
.+.. .++.....+.+.|+.+++.++|++|..+
T Consensus 580 I~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 580 IVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 3322 2456677889999999999999999877
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=341.74 Aligned_cols=240 Identities=22% Similarity=0.264 Sum_probs=195.6
Q ss_pred eeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEeccCCCc
Q 003139 510 LGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPL 585 (845)
Q Consensus 510 LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 585 (845)
||+|+||.||+|+.. +++.+|+|++... .....+.+..|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999976 5788999987542 344556788999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCccccccc
Q 003139 586 RSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAV 665 (845)
Q Consensus 586 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 665 (845)
.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.... ........
T Consensus 81 ~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~~~ 153 (312)
T cd05585 81 FHHLQRE--GRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK--DDDKTNTF 153 (312)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCcc--CCCccccc
Confidence 9998543 468999999999999999999998 9999999999999999999999999999975322 11223456
Q ss_pred ccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCCHHH
Q 003139 666 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPAS 745 (845)
Q Consensus 666 ~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 745 (845)
.||+.|+|||++.+..++.++|||||||++|||++|+.||...... +.... +..... .++...
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~------~~~~~---------~~~~~~--~~~~~~ 216 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN------EMYRK---------ILQEPL--RFPDGF 216 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH------HHHHH---------HHcCCC--CCCCcC
Confidence 7999999999999999999999999999999999999999643211 11111 111111 123345
Q ss_pred HHHHHHHHHHhhhhCCCCCCC---HHHHHHH
Q 003139 746 LKKFGETAEKCLAEHGVDRPS---MGDVLWN 773 (845)
Q Consensus 746 ~~~l~~l~~~cl~~~p~~RPs---~~~vl~~ 773 (845)
...+.+++.+||+.+|++||+ +.+++.+
T Consensus 217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 567889999999999999986 4555443
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=330.52 Aligned_cols=256 Identities=28% Similarity=0.366 Sum_probs=203.3
Q ss_pred hcCCCcceeeeeeceEEEEEEEEcC------CcEEEEEEcCCCC-hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLDD------GTKVAVKRGNPRS-EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEM 573 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 573 (845)
+++|...+.||+|++|.||+|.+.+ +..+++|...... ......|.+|+.++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4678888999999999999998753 5678999876443 44456799999999999999999999999999999
Q ss_pred EEEEEeccCCCccccccCCC-----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCC---ceEEE
Q 003139 574 ILVYEYMANGPLRSHLYGTD-----LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNF---VAKVA 645 (845)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~---~~kl~ 645 (845)
++||||+++++|.+++.... ...++|.++++++.||+.||+|||+ .+++||||||+|||++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEec
Confidence 99999999999999886542 1358999999999999999999998 8999999999999998654 69999
Q ss_pred eccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHh
Q 003139 646 DFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQ 724 (845)
Q Consensus 646 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~ 724 (845)
|||+++................+..|+|||++.+..++.++|||||||++|||++ |+.||......+ ...
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~------~~~--- 232 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE------VME--- 232 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------HHH---
Confidence 9999986422111111112233567999999999999999999999999999997 888886433221 111
Q ss_pred hcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 725 KKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 725 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
.+........+...+..+.+++.+|++.+|++||++.+|++.|+
T Consensus 233 -------~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 233 -------FVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred -------HHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11111111223445678899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=351.02 Aligned_cols=261 Identities=23% Similarity=0.304 Sum_probs=215.6
Q ss_pred hcCCCcceeeeeeceEEEEEEEEcCC-cEEEEEEcCCCChHhHHHHHHHHHHHHhCC-CCCcceEEEEE-e---c---CC
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLDDG-TKVAVKRGNPRSEQGIAEFRTEIEMLSKLR-HRHLVSLIGYC-D---E---RS 571 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~~g-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~-~---~---~~ 571 (845)
..+.++.+.|.+|||+.||.|....+ ..+|+|++...++..++...+|+++|++|+ |||||.+++.. . . .-
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 35677888999999999999998765 999999988889999999999999999997 99999999933 1 1 24
Q ss_pred cEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccC
Q 003139 572 EMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSK 651 (845)
Q Consensus 572 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~ 651 (845)
+.+|+||||++|.|-+++.......|++.++++|+.|+++|+.+||. +..+|||||||-+||||+.++..||||||.|.
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 78999999999999999976655569999999999999999999998 55789999999999999999999999999986
Q ss_pred CCCCCCCccc-------ccccccCCCcCChhhh---ccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHH
Q 003139 652 TGPALDQTHV-------STAVKGSFGYLDPEYF---RRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAM 721 (845)
Q Consensus 652 ~~~~~~~~~~-------~~~~~gt~~y~aPE~~---~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~ 721 (845)
.....-.... .....-|+-|+|||.+ ++..+++|+|||+|||+||-|+....||+....
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----------- 263 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----------- 263 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-----------
Confidence 4322111110 0122358899999976 578999999999999999999999999975421
Q ss_pred HHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhhh
Q 003139 722 TWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLE 781 (845)
Q Consensus 722 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~ 781 (845)
..|++....-...+.....|..||..||+.+|++||++-+|+..+-.++..+
T Consensus 264 --------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 264 --------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred --------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 1233333333334678899999999999999999999999999988876543
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=335.51 Aligned_cols=261 Identities=24% Similarity=0.316 Sum_probs=196.5
Q ss_pred cCCCcceeeeeeceEEEEEEEEc--CCcEEEEEEcCCCC--hHhHHHHHHHHHHHHhC---CCCCcceEEEEEe-----c
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD--DGTKVAVKRGNPRS--EQGIAEFRTEIEMLSKL---RHRHLVSLIGYCD-----E 569 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~--~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~-----~ 569 (845)
++|+..+.||+|+||.||+|+.. +++.+|+|++.... ......+.+|+++++++ +||||++++++|. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888899999999999999863 46789999765432 22234566777777665 6999999999985 3
Q ss_pred CCcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccc
Q 003139 570 RSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGL 649 (845)
Q Consensus 570 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGl 649 (845)
....++||||++ ++|.+++.......+++.++..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 456899999996 689888866555568999999999999999999999 9999999999999999999999999999
Q ss_pred cCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcC--
Q 003139 650 SKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKG-- 727 (845)
Q Consensus 650 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~-- 727 (845)
++.... ........|++.|+|||.+.+..++.++|||||||++|||++|++||......+.. ..........
T Consensus 157 ~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~---~~i~~~~~~~~~ 230 (290)
T cd07862 157 ARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL---GKILDVIGLPGE 230 (290)
T ss_pred eEeccC---CcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHH---HHHHHHhCCCCh
Confidence 976332 12234556899999999999999999999999999999999999999765432211 1111100000
Q ss_pred -c-------hhhhhccccC---CCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 003139 728 -M-------LDQIMDSNLV---GKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLW 772 (845)
Q Consensus 728 -~-------~~~~~d~~l~---~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~ 772 (845)
. .......... ....+.....+.+++.+||+.+|++||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0 0000000000 0011234466789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=342.01 Aligned_cols=242 Identities=24% Similarity=0.330 Sum_probs=197.7
Q ss_pred eeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEeccCC
Q 003139 508 LLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANG 583 (845)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 583 (845)
+.||+|+||.||+++.. +|+.||+|.+... .......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36999999999999865 6899999987643 2344567888999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCccccc
Q 003139 584 PLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVST 663 (845)
Q Consensus 584 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 663 (845)
+|..++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++.... ......
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~ 153 (323)
T cd05595 81 ELFFHLSRE--RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMK 153 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccC--CCCccc
Confidence 998888543 468999999999999999999998 8999999999999999999999999999875322 111223
Q ss_pred ccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCCH
Q 003139 664 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNP 743 (845)
Q Consensus 664 ~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 743 (845)
...||+.|+|||++.++.++.++|||||||++|||++|+.||......+. ...+..... .++.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~---------------~~~~~~~~~--~~p~ 216 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL---------------FELILMEEI--RFPR 216 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH---------------HHHHhcCCC--CCCC
Confidence 45789999999999999999999999999999999999999864332110 001111111 1233
Q ss_pred HHHHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 003139 744 ASLKKFGETAEKCLAEHGVDRP-----SMGDVLWN 773 (845)
Q Consensus 744 ~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~~ 773 (845)
.....+.+++.+||+.+|++|| ++.+++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 4456788999999999999998 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=326.33 Aligned_cols=254 Identities=29% Similarity=0.401 Sum_probs=198.9
Q ss_pred CcceeeeeeceEEEEEEEEcC-Cc--EEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecC------CcE
Q 003139 505 DESLLLGVGGFGRVYKGTLDD-GT--KVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDER------SEM 573 (845)
Q Consensus 505 ~~~~~LG~G~fg~Vy~~~~~~-g~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~ 573 (845)
.+.+.||+|+||.||+|.+.+ ++ .+|+|..... +....+.|.+|++++++++|+||++++++|... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456789999999999999764 33 5899977643 455577899999999999999999999988432 256
Q ss_pred EEEEEeccCCCccccccCC----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccc
Q 003139 574 ILVYEYMANGPLRSHLYGT----DLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGL 649 (845)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGl 649 (845)
++++||+++|+|.+++... ....+++..++.++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCc
Confidence 8999999999998877421 23458999999999999999999998 8999999999999999999999999999
Q ss_pred cCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCc
Q 003139 650 SKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGM 728 (845)
Q Consensus 650 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~ 728 (845)
++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ .. ....++.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------~~-~~~~~~~ 231 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE------IY-DYLRQGN 231 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH------HH-HHHHcCC
Confidence 986433221111223345678999999999999999999999999999999 788875432211 11 1111111
Q ss_pred hhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 003139 729 LDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYA 777 (845)
Q Consensus 729 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~ 777 (845)
. ...+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 232 ~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 R---------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred C---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 012234456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=324.17 Aligned_cols=247 Identities=26% Similarity=0.411 Sum_probs=197.9
Q ss_pred eeeeeceEEEEEEEEc-CCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEeccCCCcc
Q 003139 509 LLGVGGFGRVYKGTLD-DGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLR 586 (845)
Q Consensus 509 ~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 586 (845)
.||+|+||.||+|+.. +++.+|+|..... .......|.+|++++++++||||++++++|......++||||+++++|.
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 81 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 81 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence 6899999999999875 6889999986543 3445678999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcccccccc
Q 003139 587 SHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVK 666 (845)
Q Consensus 587 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 666 (845)
+++... ...+++.+++.++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++...............
T Consensus 82 ~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 82 TFLRTE-GPRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 998643 3468999999999999999999998 899999999999999999999999999987533211111111112
Q ss_pred cCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCCHHH
Q 003139 667 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPAS 745 (845)
Q Consensus 667 gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 745 (845)
.+..|+|||.+.++.++.++||||||+++|||++ |..|+....... ... .++.......+...
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-------~~~---------~~~~~~~~~~~~~~ 221 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-------TRE---------AIEQGVRLPCPELC 221 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-------HHH---------HHHcCCCCCCcccC
Confidence 3457999999999999999999999999999998 888775432211 011 11111111223344
Q ss_pred HHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 746 LKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 746 ~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
+..+.+++.+|++.+|++||++.+++++|+
T Consensus 222 ~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 222 PDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=326.01 Aligned_cols=253 Identities=28% Similarity=0.407 Sum_probs=204.4
Q ss_pred cCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEecc
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMA 581 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 581 (845)
++|++.+.||+|+||.||+|...++..+|+|.+..... ..++|.+|+.++++++|+|++++++++. ....++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 35777889999999999999988888899998775433 2467899999999999999999999885 456899999999
Q ss_pred CCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCccc
Q 003139 582 NGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHV 661 (845)
Q Consensus 582 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 661 (845)
+++|.+++.+.....+++.+++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||++....... ...
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~-~~~ 159 (260)
T cd05070 84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE-YTA 159 (260)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCcc-ccc
Confidence 9999999976555678999999999999999999999 899999999999999999999999999997643211 111
Q ss_pred ccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCC
Q 003139 662 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGK 740 (845)
Q Consensus 662 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 740 (845)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ . ..... ......
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~---~~~~~----------~~~~~~ 223 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---V---LEQVE----------RGYRMP 223 (260)
T ss_pred ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---H---HHHHH----------cCCCCC
Confidence 122345678999999998999999999999999999999 888886432211 1 11111 111112
Q ss_pred CCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003139 741 VNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEY 776 (845)
Q Consensus 741 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~ 776 (845)
.+...+..+.+++.+|++.+|.+|||+.++.+.|++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 224 CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 233455679999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=334.39 Aligned_cols=261 Identities=27% Similarity=0.422 Sum_probs=207.9
Q ss_pred cCCCcceeeeeeceEEEEEEEEc--------CCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCC
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD--------DGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERS 571 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~--------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 571 (845)
++|.+.+.||+|+||.||+++.. .+..+|+|.+... ......++..|+++++++ +||||++++++|.+.+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 46888899999999999999753 2346999988754 344567788999999999 7999999999999999
Q ss_pred cEEEEEEeccCCCccccccCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEEC
Q 003139 572 EMILVYEYMANGPLRSHLYGTD--------------LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLD 637 (845)
Q Consensus 572 ~~~lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~ 637 (845)
..++||||+++|+|.+++.... ...++|.++++++.|++.||+|||+ .+++||||||+|||++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEEc
Confidence 9999999999999999986432 1358999999999999999999998 8999999999999999
Q ss_pred CCCceEEEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccH
Q 003139 638 DNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNI 716 (845)
Q Consensus 638 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l 716 (845)
+++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.||.....
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~------ 248 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------ 248 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH------
Confidence 999999999999876432221111222334568999999999999999999999999999998 7788754321
Q ss_pred HHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhhh
Q 003139 717 AEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLE 781 (845)
Q Consensus 717 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~ 781 (845)
.+..... .. ......+......+.+++.+|++.+|.+||++.+|++.|+.+++..
T Consensus 249 ~~~~~~~-~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 249 EELFKLL-KE---------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred HHHHHHH-Hc---------CCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 1111111 11 1111223345568889999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=333.52 Aligned_cols=262 Identities=26% Similarity=0.433 Sum_probs=209.2
Q ss_pred cCCCcceeeeeeceEEEEEEEEc--------CCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCC
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD--------DGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERS 571 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~--------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 571 (845)
.+|.+.+.||+|+||.||+|+.. ++..+++|..... .....+++.+|+.+++.+ +||||+++++++....
T Consensus 15 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 94 (304)
T cd05101 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 94 (304)
T ss_pred HHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCC
Confidence 46777889999999999999742 2457899987643 345567899999999999 8999999999999999
Q ss_pred cEEEEEEeccCCCccccccCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEEC
Q 003139 572 EMILVYEYMANGPLRSHLYGTD--------------LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLD 637 (845)
Q Consensus 572 ~~~lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~ 637 (845)
..++||||+++|+|.+++.... ...++|.+++.++.|+++||+|||+ ++++||||||+|||++
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nili~ 171 (304)
T cd05101 95 PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVLVT 171 (304)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEEEc
Confidence 9999999999999999986431 2358899999999999999999998 8999999999999999
Q ss_pred CCCceEEEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccH
Q 003139 638 DNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNI 716 (845)
Q Consensus 638 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l 716 (845)
+++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+.....
T Consensus 172 ~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------ 245 (304)
T cd05101 172 ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV------ 245 (304)
T ss_pred CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH------
Confidence 999999999999986543222222233445678999999999999999999999999999998 7777754321
Q ss_pred HHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhhhc
Q 003139 717 AEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLEE 782 (845)
Q Consensus 717 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~~ 782 (845)
.++.... ..+. ....+..++..+.+++.+||+.+|.+||++.++++.|+.++.+..
T Consensus 246 ~~~~~~~-~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~ 301 (304)
T cd05101 246 EELFKLL-KEGH---------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT 301 (304)
T ss_pred HHHHHHH-HcCC---------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence 1121111 1110 111223456778899999999999999999999999999877644
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=341.40 Aligned_cols=242 Identities=25% Similarity=0.321 Sum_probs=198.3
Q ss_pred eeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEeccCC
Q 003139 508 LLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANG 583 (845)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 583 (845)
+.||+|+||.||++... +|+.+|+|++... ......++.+|+++++.++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999865 6889999987643 2345567889999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCccccc
Q 003139 584 PLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVST 663 (845)
Q Consensus 584 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 663 (845)
+|..++... ..+++.++..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++.... ......
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~ 153 (328)
T cd05593 81 ELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT--DAATMK 153 (328)
T ss_pred CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCC--cccccc
Confidence 998888543 468999999999999999999998 9999999999999999999999999999875322 111223
Q ss_pred ccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCCH
Q 003139 664 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNP 743 (845)
Q Consensus 664 ~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 743 (845)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .... +.... ..++.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~------~~~~---------~~~~~--~~~p~ 216 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------LFEL---------ILMED--IKFPR 216 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH------HHHH---------hccCC--ccCCC
Confidence 4579999999999999999999999999999999999999996532211 1111 00000 11233
Q ss_pred HHHHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 003139 744 ASLKKFGETAEKCLAEHGVDRP-----SMGDVLWN 773 (845)
Q Consensus 744 ~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~~ 773 (845)
.....+.+++.+||+.+|++|| ++.+++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 4456788999999999999997 89998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=328.36 Aligned_cols=260 Identities=25% Similarity=0.368 Sum_probs=209.0
Q ss_pred hcCCCcceeeeeeceEEEEEEEEcC-----CcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEec-CCcE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLDD-----GTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDE-RSEM 573 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~~-----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~ 573 (845)
.++|...++||+|+||.||+|.+.+ +..|++|++... .....+.+.+|+.++++++|+||+++++++.+ ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4578888899999999999999765 678999987654 34556788999999999999999999999866 5678
Q ss_pred EEEEEeccCCCccccccCCCC------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEec
Q 003139 574 ILVYEYMANGPLRSHLYGTDL------PPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADF 647 (845)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DF 647 (845)
++++||+++++|.+++..... ..+++.+++.++.|++.||+|||+ .+++||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECCC
Confidence 999999999999999865322 468999999999999999999998 89999999999999999999999999
Q ss_pred cccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhc
Q 003139 648 GLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKK 726 (845)
Q Consensus 648 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~ 726 (845)
|+++...............++..|+|||++.+..++.++||||||+++||+++ |+.||....+.+ +..+. ...
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~---~~~ 235 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAYL---KDG 235 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHHH---HcC
Confidence 99986433222222233456778999999999999999999999999999999 999986543211 11111 111
Q ss_pred CchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 003139 727 GMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779 (845)
Q Consensus 727 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~ 779 (845)
. .......++..+.+++.+||+.+|++||++.++++.|+.+.+
T Consensus 236 ~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 236 Y----------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred C----------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0 001122345678899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=327.81 Aligned_cols=272 Identities=22% Similarity=0.285 Sum_probs=211.3
Q ss_pred HHHHhcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcC--CCChHhHHHHHHHHHHHHhCCCCCcceEEEEEec----
Q 003139 497 ILDATNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGN--PRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDE---- 569 (845)
Q Consensus 497 l~~at~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~---- 569 (845)
..+....|...+.||+|+||.|+++... +|+.||||++. -.+....++-.+|+++|+.++|+||+.+.+.+..
T Consensus 17 ~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~ 96 (359)
T KOG0660|consen 17 LFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRD 96 (359)
T ss_pred EEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccc
Confidence 3344556666778999999999999865 78999999987 3455667888999999999999999999998854
Q ss_pred -CCcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEecc
Q 003139 570 -RSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFG 648 (845)
Q Consensus 570 -~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFG 648 (845)
-+..|+|+|+| ..+|.+.++.. ..|+......++.|+++||.|+|+ .+|+||||||+|+|++.+...||+|||
T Consensus 97 ~f~DvYiV~elM-etDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFG 170 (359)
T KOG0660|consen 97 KFNDVYLVFELM-ETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFG 170 (359)
T ss_pred ccceeEEehhHH-hhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEecccc
Confidence 45789999999 56888888543 359999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCCCcccccccccCCCcCChhhhc-cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHH------
Q 003139 649 LSKTGPALDQTHVSTAVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAM------ 721 (845)
Q Consensus 649 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~------ 721 (845)
+||...........+..+.|..|+|||.+. ...||.+.||||.|||+.||++|++.|.+....++..+..-..
T Consensus 171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e 250 (359)
T KOG0660|consen 171 LARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEE 250 (359)
T ss_pred ceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHH
Confidence 999865432334446778899999999764 5789999999999999999999999998766555543322111
Q ss_pred --HHhhcCchhhhhccccC-C-----CCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003139 722 --TWQKKGMLDQIMDSNLV-G-----KVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNL 774 (845)
Q Consensus 722 --~~~~~~~~~~~~d~~l~-~-----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L 774 (845)
...........+..... . ..-+......++++.+||..||.+|+|++|.+++-
T Consensus 251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hP 311 (359)
T KOG0660|consen 251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHP 311 (359)
T ss_pred HHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence 11111111111111110 0 01123445677999999999999999999988763
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=333.87 Aligned_cols=262 Identities=21% Similarity=0.299 Sum_probs=199.7
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC-hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS-EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
++|...+.||+|+||.||+|..+ +++.||+|.+.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888899999999999999876 68899999876432 22345678999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCc
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT 659 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~ 659 (845)
++ ++|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++..... .
T Consensus 85 ~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~--~ 157 (288)
T cd07871 85 LD-SDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVP--T 157 (288)
T ss_pred CC-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCC--C
Confidence 97 48888875432 357899999999999999999998 99999999999999999999999999999753321 1
Q ss_pred ccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhc------------
Q 003139 660 HVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKK------------ 726 (845)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~------------ 726 (845)
.......+++.|+|||.+.+ ..++.++||||+||++|||++|++||......+.... .......
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07871 158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHL---IFRLLGTPTEETWPGITSN 234 (288)
T ss_pred ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhCCCChHHhhccccc
Confidence 12234567899999998875 5689999999999999999999999976543322111 1111000
Q ss_pred CchhhhhccccCCC----CCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 727 GMLDQIMDSNLVGK----VNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 727 ~~~~~~~d~~l~~~----~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
........+..... ..+.....+.+++.+||+.||.+|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000010110000 011234567899999999999999999999753
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=330.57 Aligned_cols=265 Identities=26% Similarity=0.401 Sum_probs=205.2
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-----CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEec--CCcEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-----DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDE--RSEMI 574 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~ 574 (845)
+.|+..+.||+|+||.||++..+ ++..|++|++........+.|.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46778889999999999999743 578899999887777777889999999999999999999998754 34689
Q ss_pred EEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCC
Q 003139 575 LVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGP 654 (845)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~ 654 (845)
+|+||+++++|.+++... ...++|..++.++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++...
T Consensus 84 lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 999999999999998643 2468999999999999999999998 899999999999999999999999999998654
Q ss_pred CCCCccc-ccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcC------
Q 003139 655 ALDQTHV-STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKG------ 727 (845)
Q Consensus 655 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~------ 727 (845)
....... .....++..|+|||.+.+..++.++|||||||+++||++|..++...... +........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~ 232 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE-------FMRMMGNDKQGQMIV 232 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh-------hhhhcccccccccch
Confidence 3221111 11222345699999999999999999999999999999988765322110 000000000
Q ss_pred -chhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 003139 728 -MLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYA 777 (845)
Q Consensus 728 -~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~ 777 (845)
.+.+.+........+...+..+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 233 YHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 01111111111112334567799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=308.26 Aligned_cols=264 Identities=23% Similarity=0.316 Sum_probs=212.6
Q ss_pred hcCCCcceeeeeeceEEEEEEE-EcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecC-----CcEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDER-----SEMI 574 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~ 574 (845)
.++|.+.+.||+|||+-||+++ ..++..+|+|++...+.++.+..++|++.-++++|||++++++++..+ .+.|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 4678999999999999999998 457889999999888888889999999999999999999999887433 3589
Q ss_pred EEEEeccCCCccccccCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCC
Q 003139 575 LVYEYMANGPLRSHLYGT--DLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKT 652 (845)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~ 652 (845)
|+++|...|+|.+.+... +...+++.+.++|+.+|++||++||+.. .++.||||||.|||+.+.+.++|.|||.+..
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccc
Confidence 999999999999988643 3447999999999999999999999832 4699999999999999999999999999875
Q ss_pred CCCCCCc-------ccccccccCCCcCChhhhc---cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHH
Q 003139 653 GPALDQT-------HVSTAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMT 722 (845)
Q Consensus 653 ~~~~~~~-------~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~ 722 (845)
.+-.-.. +.......|..|+|||.+. +...++++|||||||+||+|+.|..||+......+.
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS-------- 250 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS-------- 250 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe--------
Confidence 3321111 1112346789999999885 557899999999999999999999999765442211
Q ss_pred HhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhh
Q 003139 723 WQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYAL 778 (845)
Q Consensus 723 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~ 778 (845)
....+....+...-.....+.+.+++.+|++.||.+||++.+++..++.+.
T Consensus 251 -----laLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 251 -----LALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred -----EEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 011111222222222336788999999999999999999999999988753
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=325.23 Aligned_cols=250 Identities=28% Similarity=0.398 Sum_probs=201.3
Q ss_pred CCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEeccC
Q 003139 503 KFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMAN 582 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 582 (845)
+|++.+.||+|+||.||+|.++++..+|+|....... ..++|.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 4677789999999999999988777899998764322 335788999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcccc
Q 003139 583 GPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVS 662 (845)
Q Consensus 583 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 662 (845)
++|.+++.... ..++|..+++++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++..... .....
T Consensus 84 ~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~-~~~~~ 158 (256)
T cd05059 84 GCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD-QYTSS 158 (256)
T ss_pred CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceecccc-ccccc
Confidence 99999986543 368999999999999999999999 89999999999999999999999999999764321 11111
Q ss_pred cccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCC
Q 003139 663 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKV 741 (845)
Q Consensus 663 ~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 741 (845)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ . ... ... ......
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~---~~~-~~~---------~~~~~~ 222 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---V---VES-VSA---------GYRLYR 222 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---H---HHH-HHc---------CCcCCC
Confidence 12234567999999999999999999999999999999 788886432211 1 111 111 111112
Q ss_pred CHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003139 742 NPASLKKFGETAEKCLAEHGVDRPSMGDVLWNL 774 (845)
Q Consensus 742 ~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L 774 (845)
+...+..+.+++.+||+.+|++||++.++++.|
T Consensus 223 ~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 223 PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 234567899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=338.87 Aligned_cols=263 Identities=22% Similarity=0.303 Sum_probs=204.0
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
++|+..+.||+|+||.||++... ++..+|+|.+... .....+++.+|++++++++||||++++++|.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence 67888999999999999999976 6788999987654 334456789999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCc
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT 659 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~ 659 (845)
+++|+|.+++... ..+++..+..++.|++.||.|||+ ..+|+||||||+|||+++++.+||+|||+++....
T Consensus 85 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~---- 156 (333)
T cd06650 85 MDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---- 156 (333)
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh----
Confidence 9999999998643 468899999999999999999997 24799999999999999999999999999875322
Q ss_pred ccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhc-------------
Q 003139 660 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKK------------- 726 (845)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~------------- 726 (845)
.......|+..|+|||++.+..++.++|||||||++|||++|+.||......+.. .........
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 233 (333)
T cd06650 157 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE---LMFGCPVEGDPAESETSPRPRP 233 (333)
T ss_pred hccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHH---HHhcCcccCCccccccCcccCC
Confidence 1123456899999999999999999999999999999999999998653321110 000000000
Q ss_pred ---------------CchhhhhccccCCC---C-CHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 727 ---------------GMLDQIMDSNLVGK---V-NPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 727 ---------------~~~~~~~d~~l~~~---~-~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
.....+.+...... . .......+.+++.+||+.||++||++.|++++-.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~ 301 (333)
T cd06650 234 PGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAF 301 (333)
T ss_pred ccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHH
Confidence 00000111000000 0 0123456889999999999999999999987643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=344.51 Aligned_cols=259 Identities=25% Similarity=0.368 Sum_probs=205.0
Q ss_pred cCCCcceeeeeeceEEEEEEEEc------CCcEEEEEEcCCCC-hHhHHHHHHHHHHHHhCC-CCCcceEEEEEecCCcE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD------DGTKVAVKRGNPRS-EQGIAEFRTEIEMLSKLR-HRHLVSLIGYCDERSEM 573 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~ 573 (845)
++|...+.||+|+||.||+|++. .+..||+|++.... ....+.+.+|+++|.++. ||||++++++|...+..
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 45667789999999999999864 23579999987542 333457899999999997 99999999999999999
Q ss_pred EEEEEeccCCCccccccCCC------------------------------------------------------------
Q 003139 574 ILVYEYMANGPLRSHLYGTD------------------------------------------------------------ 593 (845)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~------------------------------------------------------------ 593 (845)
++|+||+++|+|.++++...
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 99999999999998885421
Q ss_pred ------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEEC
Q 003139 594 ------------------------------------LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLD 637 (845)
Q Consensus 594 ------------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~ 637 (845)
...++|..+++++.|++.||+|||+ .+++||||||+|||++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~NiLl~ 273 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLIC 273 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceEEEe
Confidence 1247888899999999999999998 8999999999999999
Q ss_pred CCCceEEEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccH
Q 003139 638 DNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNI 716 (845)
Q Consensus 638 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l 716 (845)
+++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.||......+.
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~--- 350 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ--- 350 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH---
Confidence 999999999999976332111111223456788999999999999999999999999999998 8888754322111
Q ss_pred HHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhh
Q 003139 717 AEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYAL 778 (845)
Q Consensus 717 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~ 778 (845)
.......+ .....+......+.+++.+||+.+|.+||++++|++.|+.++
T Consensus 351 ---~~~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 351 ---FYNAIKRG---------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred ---HHHHHHcC---------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11111111 111123344578899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=324.82 Aligned_cols=254 Identities=29% Similarity=0.434 Sum_probs=204.9
Q ss_pred cCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEecc
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMA 581 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 581 (845)
++|++.+.||+|+||.||+|++.+...+++|+...... ..++|.+|++++++++|+||+++++.+.+ ...++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence 46888899999999999999987777899998875332 34678999999999999999999998754 56899999999
Q ss_pred CCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCccc
Q 003139 582 NGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHV 661 (845)
Q Consensus 582 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 661 (845)
+|+|.+++.......+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++....... ..
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-~~ 159 (262)
T cd05071 84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TA 159 (262)
T ss_pred CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeecccccc-cc
Confidence 9999999976544568999999999999999999998 8999999999999999999999999999976432111 11
Q ss_pred ccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCC
Q 003139 662 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGK 740 (845)
Q Consensus 662 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 740 (845)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||......+. ......+ ....
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~-------~~~~~~~---------~~~~ 223 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-------LDQVERG---------YRMP 223 (262)
T ss_pred ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH-------HHHHhcC---------CCCC
Confidence 223446678999999999999999999999999999999 7778754332110 0111110 0111
Q ss_pred CCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 003139 741 VNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYA 777 (845)
Q Consensus 741 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~ 777 (845)
.....+..+.+++.+|++.+|++||++.++++.|+..
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 224 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 2344567889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=342.32 Aligned_cols=247 Identities=23% Similarity=0.334 Sum_probs=194.6
Q ss_pred CCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEecc
Q 003139 504 FDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMA 581 (845)
Q Consensus 504 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 581 (845)
|+..+.||+|+||.||+|+.. +++.||+|.+... .....+.+.+|++++++++|+||+++++++.+.+..++||||++
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 155 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence 445668999999999999875 6899999987644 33445678999999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCccc
Q 003139 582 NGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHV 661 (845)
Q Consensus 582 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 661 (845)
+|+|.... .+++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++..... ...
T Consensus 156 ~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~ 224 (353)
T PLN00034 156 GGSLEGTH------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT--MDP 224 (353)
T ss_pred CCcccccc------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceecccc--ccc
Confidence 99987543 35677888999999999999998 89999999999999999999999999999764321 111
Q ss_pred ccccccCCCcCChhhhcc-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccc
Q 003139 662 STAVKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSN 736 (845)
Q Consensus 662 ~~~~~gt~~y~aPE~~~~-----~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (845)
.....||..|+|||.+.. ...+.++|||||||++|||++|+.||......+ |...... +. ..
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~------~~~~~~~------~~-~~ 291 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD------WASLMCA------IC-MS 291 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc------HHHHHHH------Hh-cc
Confidence 234578999999998743 234569999999999999999999997322211 1111100 00 00
Q ss_pred cCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003139 737 LVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNL 774 (845)
Q Consensus 737 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L 774 (845)
.....+......+.+++.+||+.+|++||++.|++++-
T Consensus 292 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp 329 (353)
T PLN00034 292 QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHP 329 (353)
T ss_pred CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 01112234556789999999999999999999998763
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=333.45 Aligned_cols=248 Identities=26% Similarity=0.394 Sum_probs=208.1
Q ss_pred CCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEec
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYM 580 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 580 (845)
.|....+||+|.||.||||... .++.||+|.+... .+...++..+|+.++.+++|+||.+.+|.+..+..++++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 4556678999999999999865 6888999998765 4556788999999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcc
Q 003139 581 ANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH 660 (845)
Q Consensus 581 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 660 (845)
.+|++.+.|... ..+++..+.-|+++++.||.|||. ++.+|||||+.|||+..+|.+||+|||++-.... ...
T Consensus 94 ~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~--~~~ 166 (467)
T KOG0201|consen 94 GGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTN--TVK 166 (467)
T ss_pred cCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeec--hhh
Confidence 999999999543 345888888999999999999999 9999999999999999999999999999976443 222
Q ss_pred cccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCC
Q 003139 661 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGK 740 (845)
Q Consensus 661 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 740 (845)
....++||+.|||||+++...|+.|+||||||++.+||.+|.+|+....+..-.- .+.+-.-|.+.+
T Consensus 167 rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf------------lIpk~~PP~L~~- 233 (467)
T KOG0201|consen 167 RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF------------LIPKSAPPRLDG- 233 (467)
T ss_pred ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE------------eccCCCCCcccc-
Confidence 2367899999999999998899999999999999999999999997766532211 111111223322
Q ss_pred CCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 741 VNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 741 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.....+.+++..||.++|+.||++.+++++
T Consensus 234 ---~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 234 ---DFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ---ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 455678999999999999999999998865
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=331.18 Aligned_cols=258 Identities=26% Similarity=0.418 Sum_probs=205.2
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCc--EEEEEEcCCC-ChHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGT--KVAVKRGNPR-SEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERSEMILV 576 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 576 (845)
++|+..+.||+|+||.||+|... ++. .+++|.+... .....+.|.+|++++.++ +||||+++++++.+.+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 46788889999999999999875 333 4688877643 344567899999999999 799999999999999999999
Q ss_pred EEeccCCCccccccCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCce
Q 003139 577 YEYMANGPLRSHLYGTD--------------LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVA 642 (845)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~ 642 (845)
+||+++++|.+++.... ...+++..++.++.|++.||+|||+ .+|+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeE
Confidence 99999999999885421 1358899999999999999999998 999999999999999999999
Q ss_pred EEEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHH
Q 003139 643 KVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAM 721 (845)
Q Consensus 643 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~ 721 (845)
||+|||++..... .........+..|+|||++.+..++.++|||||||++|||++ |+.||......+ ...
T Consensus 159 kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~------~~~ 229 (297)
T cd05089 159 KIADFGLSRGEEV---YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE------LYE 229 (297)
T ss_pred EECCcCCCccccc---eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH------HHH
Confidence 9999999864221 111111223557999999999999999999999999999997 999986543221 111
Q ss_pred HHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhhh
Q 003139 722 TWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLE 781 (845)
Q Consensus 722 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~ 781 (845)
.. ........+......+.+++.+||+.+|.+||++.++++.|+.+++..
T Consensus 230 ~~----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 230 KL----------PQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred HH----------hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 11 111111223345567889999999999999999999999999887644
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=326.00 Aligned_cols=255 Identities=29% Similarity=0.408 Sum_probs=202.0
Q ss_pred CCcceeeeeeceEEEEEEEEcC----CcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCc-----
Q 003139 504 FDESLLLGVGGFGRVYKGTLDD----GTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSE----- 572 (845)
Q Consensus 504 f~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----- 572 (845)
|++.+.||+|+||.||+|.+.. +..+|+|++... .....+++.+|++.++.++||||+++++++.+.+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567789999999999998652 367999987643 34556789999999999999999999999866554
Q ss_pred -EEEEEEeccCCCccccccCC----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEec
Q 003139 573 -MILVYEYMANGPLRSHLYGT----DLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADF 647 (845)
Q Consensus 573 -~~lV~Ey~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DF 647 (845)
.++|+||+++|+|..++... ....+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCc
Confidence 79999999999999887432 23468999999999999999999998 89999999999999999999999999
Q ss_pred cccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhc
Q 003139 648 GLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKK 726 (845)
Q Consensus 648 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~ 726 (845)
|+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||......+ +.++. ..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~~~~~----~~ 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IYDYL----RH 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----Hc
Confidence 99986433222111222335678999999999999999999999999999999 888875432211 11111 11
Q ss_pred CchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 003139 727 GMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYA 777 (845)
Q Consensus 727 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~ 777 (845)
.. ....+......+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 231 --------~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 --------GN-RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred --------CC-CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11 1112334567889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=323.84 Aligned_cols=264 Identities=24% Similarity=0.396 Sum_probs=201.7
Q ss_pred cCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHH--hCCCCCcceEEEEEecC----CcEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLS--KLRHRHLVSLIGYCDER----SEMIL 575 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~--~l~H~niv~l~g~~~~~----~~~~l 575 (845)
++....+.||+|.||+||+|.++ |+.||||++...++. .+.+|.++.+ .|+|+||+.+++.-..+ .+++|
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE~---SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL 286 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDER---SWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL 286 (513)
T ss_pred heeEEEEEecCccccceeecccc-CCceEEEEecccchh---hhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence 45566778999999999999998 899999999876654 3445555554 57999999999886433 37899
Q ss_pred EEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-----CCCceeeccCCCCcEEECCCCceEEEecccc
Q 003139 576 VYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTG-----AAQSIIHRDVKTTNILLDDNFVAKVADFGLS 650 (845)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivHrDik~~NILl~~~~~~kl~DFGla 650 (845)
|.+|.++|||.++|.. ..++-...++++..+|.||++||-+ ..+.|.|||||+.|||+.+++.+.|+|+|||
T Consensus 287 vTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA 363 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 363 (513)
T ss_pred eeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence 9999999999999954 4689999999999999999999952 4577999999999999999999999999999
Q ss_pred CCCCCCCC--cccccccccCCCcCChhhhccC----CC--CchhHHHHHHHHHHHHHcC----------CCCCCCCCCcc
Q 003139 651 KTGPALDQ--THVSTAVKGSFGYLDPEYFRRQ----QL--TEKSDVYSFGVVLMEVLCT----------RPALNPVLPRE 712 (845)
Q Consensus 651 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~----~~--s~ksDV~S~Gvvl~Elltg----------~~p~~~~~~~~ 712 (845)
-....... .......+||.+|||||++... .+ -..+||||||+|+||+... +.||.+..+.+
T Consensus 364 v~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~D 443 (513)
T KOG2052|consen 364 VRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSD 443 (513)
T ss_pred EEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCC
Confidence 76433211 2234467899999999998653 22 2469999999999999753 25555443332
Q ss_pred cccHHHHHHHHhhcCchhhhhccccCCCC-----CHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhhhc
Q 003139 713 QVNIAEWAMTWQKKGMLDQIMDSNLVGKV-----NPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLEE 782 (845)
Q Consensus 713 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~~ 782 (845)
.. . +++.+-+...++...+ ..+.+..+.++++.||..+|.-|.|+-.+-+.|.++.+.++
T Consensus 444 Ps-~---------eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~~e 508 (513)
T KOG2052|consen 444 PS-F---------EEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNSDE 508 (513)
T ss_pred CC-H---------HHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcChh
Confidence 11 1 0111122223333332 24578889999999999999999999999999888765443
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=342.86 Aligned_cols=245 Identities=22% Similarity=0.308 Sum_probs=200.7
Q ss_pred cCCCcceeeeeeceEEEEEEEEcC--CcEEEEEEcCCC---ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLDD--GTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILV 576 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~~--g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 576 (845)
++|+..+.||+|+||.||+|.+++ +..+|+|++... .....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 468888999999999999998653 367999987532 233456788999999999999999999999999999999
Q ss_pred EEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCC
Q 003139 577 YEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPAL 656 (845)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~ 656 (845)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 110 ~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~- 183 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT- 183 (340)
T ss_pred EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecCC-
Confidence 9999999999998644 468999999999999999999999 9999999999999999999999999999976322
Q ss_pred CCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccc
Q 003139 657 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSN 736 (845)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (845)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....+.. .. ..+.+..
T Consensus 184 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-------~~--------~~i~~~~ 244 (340)
T PTZ00426 184 ----RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL-------IY--------QKILEGI 244 (340)
T ss_pred ----CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH-------HH--------HHHhcCC
Confidence 1234578999999999999999999999999999999999999997533211 01 1111111
Q ss_pred cCCCCCHHHHHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 003139 737 LVGKVNPASLKKFGETAEKCLAEHGVDRP-----SMGDVLWN 773 (845)
Q Consensus 737 l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~~ 773 (845)
. .++......+.+++.+|++.+|++|+ ++++++++
T Consensus 245 ~--~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 245 I--YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred C--CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 1 12333445678999999999999995 78887765
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=340.55 Aligned_cols=262 Identities=23% Similarity=0.303 Sum_probs=197.6
Q ss_pred CCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecC-----CcEE
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDER-----SEMI 574 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~ 574 (845)
+|+..+.||+|+||.||+|+.. +|+.||+|++... ......++.+|++++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4778889999999999999865 6899999987642 233446788999999999999999999988543 2479
Q ss_pred EEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCC
Q 003139 575 LVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGP 654 (845)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~ 654 (845)
+||||++ ++|.+++... ..+++..+..++.|+++||+|||+ .+|+||||||+|||+++++.+||+|||+++...
T Consensus 81 lv~e~~~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELME-SDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecCC-CCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 9999995 6888887543 468999999999999999999999 899999999999999999999999999997532
Q ss_pred CCCC-cccccccccCCCcCChhhhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhh------
Q 003139 655 ALDQ-THVSTAVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQK------ 725 (845)
Q Consensus 655 ~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~------ 725 (845)
.... ........||..|+|||++.+ ..++.++|||||||++|||++|++||......... .+......
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~---~~~~~~~~~~~~~~ 231 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL---DLITDLLGTPSPET 231 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHH---HHHHHHhCCCCHHH
Confidence 2111 112234578999999999876 68899999999999999999999999654322211 11111000
Q ss_pred -----cCchhhhhcc---ccCCC---CCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 726 -----KGMLDQIMDS---NLVGK---VNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 726 -----~~~~~~~~d~---~l~~~---~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.....+.++. ..... ..+.....+.+++.+||+.+|++||+++|++++
T Consensus 232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0001111110 00000 001234567899999999999999999999876
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=355.28 Aligned_cols=256 Identities=26% Similarity=0.330 Sum_probs=206.5
Q ss_pred HHhcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCC----
Q 003139 499 DATNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERS---- 571 (845)
Q Consensus 499 ~at~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~---- 571 (845)
...++|.+.+.||+|+||.||+|+.. +|+.||||++... +......+.+|+.++..++|+|++++.+.+....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 34568999999999999999999864 7899999987543 4556678899999999999999999987764322
Q ss_pred ----cEEEEEEeccCCCccccccCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEE
Q 003139 572 ----EMILVYEYMANGPLRSHLYGT--DLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVA 645 (845)
Q Consensus 572 ----~~~lV~Ey~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~ 645 (845)
..++||||+++|+|.+++... ....+++..+..++.|++.||+|||+ .+|+||||||+||||++++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEEE
Confidence 368999999999999988643 23578999999999999999999999 999999999999999999999999
Q ss_pred eccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhh
Q 003139 646 DFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQK 725 (845)
Q Consensus 646 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~ 725 (845)
|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.....
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~------~~~~~~~-- 257 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM------EEVMHKT-- 257 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHH--
Confidence 99999864432222333456799999999999999999999999999999999999999964321 1111111
Q ss_pred cCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 726 KGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 726 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
+... ....+......+.+++.+||+.+|.+||++.+++.+
T Consensus 258 -------~~~~-~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 258 -------LAGR-YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred -------hcCC-CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1111 111334456778999999999999999999999864
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=329.66 Aligned_cols=254 Identities=24% Similarity=0.334 Sum_probs=202.9
Q ss_pred CCcceeeeeeceEEEEEEEEc------CCcEEEEEEcCCCCh-HhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEE
Q 003139 504 FDESLLLGVGGFGRVYKGTLD------DGTKVAVKRGNPRSE-QGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILV 576 (845)
Q Consensus 504 f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 576 (845)
|+..+.||+|+||.||+|... .++.||+|++..... ...+.|.+|+.++.+++||||+++++++.+.+..+++
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~ 86 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI 86 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence 555668999999999999864 246799999875543 3356788999999999999999999999999999999
Q ss_pred EEeccCCCccccccCC--------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCce
Q 003139 577 YEYMANGPLRSHLYGT--------------DLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVA 642 (845)
Q Consensus 577 ~Ey~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~ 642 (845)
+||+++++|.+++... ....+++..+++++.|++.||+|||+ ++|+||||||+|||+++++.+
T Consensus 87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05091 87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLNV 163 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCCce
Confidence 9999999999887421 12358899999999999999999998 899999999999999999999
Q ss_pred EEEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHH
Q 003139 643 KVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAM 721 (845)
Q Consensus 643 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~ 721 (845)
||+|||+++...............+++.|+|||.+.++.++.++|||||||++|||++ |..|+...... ++..
T Consensus 164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~~~ 237 (283)
T cd05091 164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ------DVIE 237 (283)
T ss_pred EecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH------HHHH
Confidence 9999999886433222222234456789999999998899999999999999999998 77777543221 1111
Q ss_pred HHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003139 722 TWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEY 776 (845)
Q Consensus 722 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~ 776 (845)
. +.+.. ....+.+++..+.+++.+|++.+|++||++.+|+..|+.
T Consensus 238 ~---------i~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 238 M---------IRNRQ-VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred H---------HHcCC-cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1 11111 112234566778999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=338.58 Aligned_cols=203 Identities=22% Similarity=0.371 Sum_probs=175.1
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC---hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS---EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
++|+..+.||+|+||.||++... +++.+|+|++.... ......+..|++++.+++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 36888999999999999999865 58899999876432 234467888999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
||+++|+|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 81 EFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred cCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 999999999998643 478999999999999999999998 999999999999999999999999999987532111
Q ss_pred C---------------------------------cccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCC
Q 003139 658 Q---------------------------------THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPA 704 (845)
Q Consensus 658 ~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p 704 (845)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 0 0011235799999999999999999999999999999999999999
Q ss_pred CCCCC
Q 003139 705 LNPVL 709 (845)
Q Consensus 705 ~~~~~ 709 (845)
|....
T Consensus 236 f~~~~ 240 (363)
T cd05628 236 FCSET 240 (363)
T ss_pred CCCCC
Confidence 97543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=323.87 Aligned_cols=256 Identities=26% Similarity=0.424 Sum_probs=205.6
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCc---EEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGT---KVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILV 576 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 576 (845)
++|+..+.||+|+||.||+|+.. +++ .+++|+.... .....+++.+|++++++++|+|++++.+++.+.+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 46778889999999999999875 333 6899987655 344567899999999999999999999999999999999
Q ss_pred EEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCC
Q 003139 577 YEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPAL 656 (845)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~ 656 (845)
|||+++++|.+++.... ..+++.+++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++.....
T Consensus 85 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 85 TEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999986543 578999999999999999999998 89999999999999999999999999999764322
Q ss_pred CCcc-cccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhc
Q 003139 657 DQTH-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMD 734 (845)
Q Consensus 657 ~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (845)
.... .......+..|+|||++..+.++.++|||||||++|||++ |+.||...... ++..... .+
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~------~~~~~i~-~~------- 226 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH------EVMKAIN-DG------- 226 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH------HHHHHHh-cC-------
Confidence 1111 1112233567999999999999999999999999999997 99998643321 1111111 11
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 003139 735 SNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYA 777 (845)
Q Consensus 735 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~ 777 (845)
.........+..+.+++.+|++.+|++||++.+|++.|+++
T Consensus 227 --~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 --FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred --CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11111223456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=324.06 Aligned_cols=253 Identities=26% Similarity=0.385 Sum_probs=206.0
Q ss_pred cCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEecc
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMA 581 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 581 (845)
+.|+..+.||+|+||.||+|..++++.+|+|.+..... ..++|.+|++++++++|+|++++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYME 83 (260)
T ss_pred HHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCC
Confidence 46788889999999999999988899999998765432 3467899999999999999999999874 467899999999
Q ss_pred CCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCccc
Q 003139 582 NGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHV 661 (845)
Q Consensus 582 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 661 (845)
+++|.+++.......+++.+++.++.|++.||+|||+ .+++||||||+||++++++.++|+|||+++..... ....
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~-~~~~ 159 (260)
T cd05067 84 NGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDN-EYTA 159 (260)
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCC-Cccc
Confidence 9999999876655679999999999999999999998 89999999999999999999999999999764321 1111
Q ss_pred ccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCC
Q 003139 662 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGK 740 (845)
Q Consensus 662 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 740 (845)
.....++..|+|||++....++.++||||||++++||++ |+.||......+ ..... .. .....
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~-~~---------~~~~~ 223 (260)
T cd05067 160 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE------VIQNL-ER---------GYRMP 223 (260)
T ss_pred ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH------HHHHH-Hc---------CCCCC
Confidence 223445678999999999999999999999999999999 999986543211 11111 11 11111
Q ss_pred CCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003139 741 VNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEY 776 (845)
Q Consensus 741 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~ 776 (845)
.+...+..+.+++.+|+..+|++||++++++..|+.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 224 RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 223345679999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=323.19 Aligned_cols=258 Identities=20% Similarity=0.297 Sum_probs=208.0
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCC---CChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNP---RSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
++|++.+.||+|+||.||+|+.. +++.+|+|.+.. .......++.+|+++++.++||||+++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 46888899999999999999965 688999997643 23445567899999999999999999999999999999999
Q ss_pred EeccCCCccccccCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCC
Q 003139 578 EYMANGPLRSHLYGT--DLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPA 655 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~ 655 (845)
||+++++|.+++... ....+++..++.++.|+++||+|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999999887532 23468899999999999999999998 9999999999999999999999999999876432
Q ss_pred CCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcc
Q 003139 656 LDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDS 735 (845)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (845)
.. .......++..|+|||.+.+..++.++|+||||+++|||++|+.|+..... ...++.......
T Consensus 159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~~~~~~~~~~~~--------- 223 (267)
T cd08228 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLFSLCQKIEQC--------- 223 (267)
T ss_pred hh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc----cHHHHHHHHhcC---------
Confidence 11 112235688899999999998999999999999999999999999854321 111222111110
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 003139 736 NLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYA 777 (845)
Q Consensus 736 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~ 777 (845)
.............+.+++.+||+.+|++||++.+|++.++++
T Consensus 224 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 224 DYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 011111234557789999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=325.91 Aligned_cols=259 Identities=24% Similarity=0.349 Sum_probs=204.9
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCc----EEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGT----KVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMIL 575 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 575 (845)
.+|+..+.||+|+||.||+|++. +|+ .||+|..... .....+++.+|+.+++.++|+||++++++|.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 46778889999999999999854 444 4799987654 34456788999999999999999999999975 45789
Q ss_pred EEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCC
Q 003139 576 VYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPA 655 (845)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~ 655 (845)
++||+++|+|.+++.... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++....
T Consensus 86 ~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 86 VTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 999999999999986543 468999999999999999999998 9999999999999999999999999999986443
Q ss_pred CCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhc
Q 003139 656 LDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMD 734 (845)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (845)
...........++..|+|||.+.+..++.++|||||||++|||++ |..||...... .+..+.. .+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~----~~------- 227 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR---EIPDLLE----KG------- 227 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHH----CC-------
Confidence 222111222345678999999999999999999999999999998 88888643221 1111111 11
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhhh
Q 003139 735 SNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLE 781 (845)
Q Consensus 735 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~ 781 (845)
.....+......+.+++.+||+.+|++||++.++++.|+.+.+.+
T Consensus 228 --~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 228 --ERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred --CcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 111122334567889999999999999999999999988775543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=321.73 Aligned_cols=250 Identities=26% Similarity=0.366 Sum_probs=206.1
Q ss_pred CCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
+|...+.||+|++|.||+|... +++.+++|.+... .....+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 3677789999999999999975 6889999986533 455667899999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCc
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT 659 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~ 659 (845)
+++++|.+++.......+++.++.+++.|++.||.|||+ .+++||||||+||++++++.+||+|||+++..... .
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~--~ 155 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN--T 155 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCc--c
Confidence 999999999976545679999999999999999999998 89999999999999999999999999998764321 1
Q ss_pred ccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCC
Q 003139 660 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVG 739 (845)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 739 (845)
.......|++.|+|||++.+..++.++||||||++++||++|+.||......+ .......+. ..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~---------~~ 219 (256)
T cd08529 156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA-------LILKIIRGV---------FP 219 (256)
T ss_pred chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCC---------CC
Confidence 12234567889999999999999999999999999999999999986443111 111111111 11
Q ss_pred CCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 740 KVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 740 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
..+......+.+++.+||+.+|++||++.++++.
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 220 PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1223455678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=327.54 Aligned_cols=255 Identities=28% Similarity=0.420 Sum_probs=204.9
Q ss_pred cCCCcceeeeeeceEEEEEEEEc------CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD------DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMIL 575 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 575 (845)
.+|...+.||+|+||.||++... ++..+++|..........+.|.+|++++++++|+||+++++++.+....++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 35666778999999999999742 356789998887777777899999999999999999999999999999999
Q ss_pred EEEeccCCCccccccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCce
Q 003139 576 VYEYMANGPLRSHLYGTD-------------LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVA 642 (845)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~ 642 (845)
||||+++++|.+++.... ...+++.+++.++.|++.||+|||+ .+++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCE
Confidence 999999999999886432 1358999999999999999999998 999999999999999999999
Q ss_pred EEEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHH
Q 003139 643 KVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAM 721 (845)
Q Consensus 643 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~ 721 (845)
||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |++||......+. ..
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~------~~ 235 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA------IE 235 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH------HH
Confidence 9999999875432221122223345678999999999999999999999999999998 8888854322211 11
Q ss_pred HHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 722 TWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 722 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
. +... .....+..++..+.+++.+||+.+|.+||++.+|++.|+
T Consensus 236 ~---------~~~~-~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 236 C---------ITQG-RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred H---------HHcC-ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 1 1110 001122334567889999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=321.48 Aligned_cols=253 Identities=30% Similarity=0.434 Sum_probs=203.6
Q ss_pred cCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEecc
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMA 581 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 581 (845)
++|.....||+|++|.||+|.+.++..+++|+..... ...+.+.+|++++++++|+|++++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 3477788999999999999998877789999876443 23467889999999999999999999885 456899999999
Q ss_pred CCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCccc
Q 003139 582 NGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHV 661 (845)
Q Consensus 582 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 661 (845)
+++|.+++.......++|..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++...... ...
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~-~~~ 159 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE-YTA 159 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCc-ccc
Confidence 9999999976555568999999999999999999998 899999999999999999999999999997643211 111
Q ss_pred ccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCC
Q 003139 662 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGK 740 (845)
Q Consensus 662 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 740 (845)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ...+ ...+ ....
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~----~~~~---------~~~~ 223 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VLEQ----VERG---------YRMP 223 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HHcC---------CCCC
Confidence 223346678999999999999999999999999999999 888886533211 1111 1111 0111
Q ss_pred CCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003139 741 VNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEY 776 (845)
Q Consensus 741 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~ 776 (845)
.+...+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 233456788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=320.92 Aligned_cols=249 Identities=28% Similarity=0.467 Sum_probs=206.5
Q ss_pred cCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEecc
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMA 581 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 581 (845)
++|+..+.||+|+||.||+|... |+.+++|....... ..+++.+|+.++++++|+||+++++++.+....++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 46778889999999999999876 78999999876544 56789999999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCccc
Q 003139 582 NGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHV 661 (845)
Q Consensus 582 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 661 (845)
+++|.+++.......+++..+..++.|++.||.|||+ .+++||||||+||++++++.+||+|||+++.....
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~----- 155 (256)
T cd05039 84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG----- 155 (256)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccc-----
Confidence 9999999876555579999999999999999999998 99999999999999999999999999999864221
Q ss_pred ccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCC
Q 003139 662 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGK 740 (845)
Q Consensus 662 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 740 (845)
......+..|+|||++..+.++.++||||||++++||++ |+.||......+ + ......+ ....
T Consensus 156 ~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~----~~~~~~~---------~~~~ 219 (256)
T cd05039 156 QDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---V----VPHVEKG---------YRME 219 (256)
T ss_pred cccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---H----HHHHhcC---------CCCC
Confidence 112334668999999998899999999999999999997 988885432111 1 1111111 1111
Q ss_pred CCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003139 741 VNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEY 776 (845)
Q Consensus 741 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~ 776 (845)
.+...+..+.+++.+||..+|++||++.+++++|+.
T Consensus 220 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 220 APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 223445778899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=327.87 Aligned_cols=267 Identities=25% Similarity=0.360 Sum_probs=204.7
Q ss_pred CcceeeeeeceEEEEEEEE-----cCCcEEEEEEcCCCC-hHhHHHHHHHHHHHHhCCCCCcceEEEEEecC--CcEEEE
Q 003139 505 DESLLLGVGGFGRVYKGTL-----DDGTKVAVKRGNPRS-EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDER--SEMILV 576 (845)
Q Consensus 505 ~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV 576 (845)
...+.||+|+||.||++.. .+++.+|+|...... ....+.|.+|++++++++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 7778999999999988653 357789999876543 34457789999999999999999999998653 458899
Q ss_pred EEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCC
Q 003139 577 YEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPAL 656 (845)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~ 656 (845)
|||+++++|.+++... .+++.+++.++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.....
T Consensus 87 ~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 87 MEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred ecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 9999999999998543 58999999999999999999998 89999999999999999999999999999864432
Q ss_pred CCc-ccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcc
Q 003139 657 DQT-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDS 735 (845)
Q Consensus 657 ~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (845)
... .......++..|+|||.+.+..++.++||||||++++||++|+.|+....... .....+.........+.+.++.
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIELLER 239 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhhhhhc
Confidence 111 11122345667999999998999999999999999999999999875432110 0111111000011112222222
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhh
Q 003139 736 NLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYAL 778 (845)
Q Consensus 736 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~ 778 (845)
......+...+..+.+++.+||+.+|++||+++++++.|+.+.
T Consensus 240 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 240 GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 2222234455678999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=327.53 Aligned_cols=259 Identities=25% Similarity=0.389 Sum_probs=204.9
Q ss_pred HhcCCCcceeeeeeceEEEEEEEEc------CCcEEEEEEcCCCC-hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Q 003139 500 ATNKFDESLLLGVGGFGRVYKGTLD------DGTKVAVKRGNPRS-EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSE 572 (845)
Q Consensus 500 at~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 572 (845)
..++|++.+.||+|+||.||+|..+ .+..||+|.+.... .....++.+|+.++++++||||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3567889999999999999999754 24479999876443 3344578899999999999999999999999999
Q ss_pred EEEEEEeccCCCccccccCCC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEE
Q 003139 573 MILVYEYMANGPLRSHLYGTD--------LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKV 644 (845)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl 644 (845)
.++||||+++|+|.+++.... ...+++..+++++.|++.||.|||+ ++|+||||||+|||+++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEE
Confidence 999999999999999986421 2456788899999999999999998 99999999999999999999999
Q ss_pred EeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHH
Q 003139 645 ADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTW 723 (845)
Q Consensus 645 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~ 723 (845)
+|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||...... ++..
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~------~~~~-- 232 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE------QVLK-- 232 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHH--
Confidence 99999986433222222222345678999999999999999999999999999998 67777543221 1111
Q ss_pred hhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 003139 724 QKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYA 777 (845)
Q Consensus 724 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~ 777 (845)
.+.+... ...+...+..+.+++.+|++.+|++||++.++++.|+..
T Consensus 233 -------~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 233 -------FVMDGGY-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred -------HHHcCCC-CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 1111111 112233456899999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=330.30 Aligned_cols=259 Identities=29% Similarity=0.455 Sum_probs=204.7
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCc--EEEEEEcCCC-ChHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGT--KVAVKRGNPR-SEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERSEMILV 576 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 576 (845)
++|+..+.||+|+||.||+|.++ ++. .+++|+.... .....+++.+|++++.++ +|+||+++++++.+.+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 46788889999999999999875 444 4577776543 345567889999999999 899999999999999999999
Q ss_pred EEeccCCCccccccCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCce
Q 003139 577 YEYMANGPLRSHLYGTD--------------LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVA 642 (845)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~ 642 (845)
|||+++++|.+++.... ...+++.+++.++.|++.||+|||+ .+++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCcE
Confidence 99999999999886432 2358899999999999999999998 999999999999999999999
Q ss_pred EEEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHH
Q 003139 643 KVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAM 721 (845)
Q Consensus 643 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~ 721 (845)
||+|||+++.... ........++..|+|||++.+..++.++|||||||+++||++ |..||......+ ...
T Consensus 164 kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~ 234 (303)
T cd05088 164 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LYE 234 (303)
T ss_pred EeCccccCcccch---hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH------HHH
Confidence 9999999864211 111112234567999999998889999999999999999998 999886433211 111
Q ss_pred HHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhhhc
Q 003139 722 TWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLEE 782 (845)
Q Consensus 722 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~~ 782 (845)
.. .. ......+...+..+.+++.+|++.+|++||++.+++++|+.+++...
T Consensus 235 ~~-~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 235 KL-PQ---------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred HH-hc---------CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 11 10 01111122344578899999999999999999999999998766544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=330.50 Aligned_cols=262 Identities=24% Similarity=0.388 Sum_probs=202.3
Q ss_pred cCCCcceeeeeeceEEEEEEEEcC---------------CcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLDD---------------GTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIG 565 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~~---------------g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g 565 (845)
++|+..+.||+|+||.||++...+ ...||+|..... .....+.|.+|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 468888899999999999987542 224899988654 3445567999999999999999999999
Q ss_pred EEecCCcEEEEEEeccCCCccccccCCC----------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEE
Q 003139 566 YCDERSEMILVYEYMANGPLRSHLYGTD----------LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNIL 635 (845)
Q Consensus 566 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIL 635 (845)
++...+..++||||+++++|.+++.... ...++|..++.++.|+++||+|||+ .+++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhEE
Confidence 9999999999999999999999885421 1247899999999999999999998 89999999999999
Q ss_pred ECCCCceEEEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc--CCCCCCCCCCccc
Q 003139 636 LDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC--TRPALNPVLPREQ 713 (845)
Q Consensus 636 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt--g~~p~~~~~~~~~ 713 (845)
+++++.+||+|||+++...............++..|+|||.+.++.++.++|||||||+++||++ |..||......+
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~- 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ- 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH-
Confidence 99999999999999976432222222233445778999999999999999999999999999998 455665432211
Q ss_pred ccHHHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 714 VNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 714 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
............ ........++..+..+.+++.+|++.+|++||++.+|++.|+
T Consensus 241 --~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 --VIENTGEFFRNQ------GRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred --HHHHHHHhhhhc------cccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 111111111100 000011122334568999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=329.81 Aligned_cols=252 Identities=24% Similarity=0.331 Sum_probs=203.3
Q ss_pred CCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC---hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEE
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS---EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYE 578 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 578 (845)
+|+..++||+|+||.||++... +++.||+|++.... ......+.+|++++++++||||+++++.+.+++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 3777889999999999999865 68899999876432 2233567889999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCC
Q 003139 579 YMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQ 658 (845)
Q Consensus 579 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~ 658 (845)
|+++|+|.+++.......+++..+..++.|++.||+|||+ .+|+||||||+||++++++.++|+|||+++....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~--- 154 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE--- 154 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCC---
Confidence 9999999988865544579999999999999999999999 8999999999999999999999999999876432
Q ss_pred cccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccC
Q 003139 659 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLV 738 (845)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 738 (845)
........|+..|+|||++.+..++.++|||||||++|||++|+.||........ .+........ ..
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~---~~~~~~~~~~----------~~ 221 (285)
T cd05605 155 GETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK---REEVERRVKE----------DQ 221 (285)
T ss_pred CCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH---HHHHHHHhhh----------cc
Confidence 1112345689999999999999999999999999999999999999975332211 0111110000 01
Q ss_pred CCCCHHHHHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 003139 739 GKVNPASLKKFGETAEKCLAEHGVDRP-----SMGDVLWN 773 (845)
Q Consensus 739 ~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~~ 773 (845)
..++......+.+++.+||+.||.+|| ++++++++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 123344566788999999999999999 77787665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=344.39 Aligned_cols=252 Identities=25% Similarity=0.318 Sum_probs=204.9
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC---hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS---EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
++|.+.+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36888999999999999999976 68999999876431 234567889999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
||+++++|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999999998654 578999999999999999999999 999999999999999999999999999997643322
Q ss_pred ---------------------------CcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Q 003139 658 ---------------------------QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLP 710 (845)
Q Consensus 658 ---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~ 710 (845)
.........||+.|+|||.+.+..++.++|||||||+||||++|+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 01122345689999999999999999999999999999999999999975432
Q ss_pred cccccHHHHHHHHhhcCchhhhhc--cccCCCCCHHHHHHHHHHHHHhhhhCCCCCCC-HHHHHHHH
Q 003139 711 REQVNIAEWAMTWQKKGMLDQIMD--SNLVGKVNPASLKKFGETAEKCLAEHGVDRPS-MGDVLWNL 774 (845)
Q Consensus 711 ~~~~~l~~~~~~~~~~~~~~~~~d--~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-~~~vl~~L 774 (845)
.+. .. .+.. ..+...........+.+++.+|+. +|.+||+ +.+++++.
T Consensus 236 ~~~------~~---------~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp 286 (350)
T cd05573 236 QET------YN---------KIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP 286 (350)
T ss_pred HHH------HH---------HHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence 211 11 1111 111111112245678899999997 9999999 99998763
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=318.62 Aligned_cols=246 Identities=28% Similarity=0.439 Sum_probs=199.7
Q ss_pred eeeeeceEEEEEEEEcCCcEEEEEEcCCCC-hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEeccCCCccc
Q 003139 509 LLGVGGFGRVYKGTLDDGTKVAVKRGNPRS-EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRS 587 (845)
Q Consensus 509 ~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~ 587 (845)
+||+|+||.||+|...+++.+|+|...... ......|.+|++++++++||||++++++|...+..++||||+++++|.+
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence 689999999999998888999999877654 3344578999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCccccccccc
Q 003139 588 HLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKG 667 (845)
Q Consensus 588 ~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 667 (845)
++.... ..+++.++++++.|++.||.|||+ ++++||||||+||++++++.+||+|||+++..... .........+
T Consensus 82 ~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~ 156 (250)
T cd05085 82 FLRKKK-DELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDG-IYSSSGLKQI 156 (250)
T ss_pred HHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceecccc-ccccCCCCCC
Confidence 886443 468999999999999999999998 89999999999999999999999999998753221 1111112234
Q ss_pred CCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCCHHHH
Q 003139 668 SFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASL 746 (845)
Q Consensus 668 t~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 746 (845)
+..|+|||++.+..++.++||||||+++|||++ |..||....... .......+ .....+...+
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~-------~~~~~~~~---------~~~~~~~~~~ 220 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ-------AREQVEKG---------YRMSCPQKCP 220 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHHHcC---------CCCCCCCCCC
Confidence 678999999999999999999999999999998 888886432211 11111111 1112233456
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 747 KKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 747 ~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
..+.+++.+|++.+|++||++.++++.|.
T Consensus 221 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 221 DDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 78899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=337.75 Aligned_cols=242 Identities=26% Similarity=0.385 Sum_probs=196.5
Q ss_pred eeeeeeceEEEEEEEE----cCCcEEEEEEcCCC----ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 508 LLLGVGGFGRVYKGTL----DDGTKVAVKRGNPR----SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 508 ~~LG~G~fg~Vy~~~~----~~g~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
+.||+|+||.||+++. ..++.+|+|.+... .......+.+|++++++++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999985 25788999987542 223345678899999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCc
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT 659 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~ 659 (845)
+++++|.+++... ..+.+..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.... ..
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~ 154 (323)
T cd05584 82 LSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH--EG 154 (323)
T ss_pred CCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc--CC
Confidence 9999999988543 468889999999999999999999 9999999999999999999999999999875322 12
Q ss_pred ccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCC
Q 003139 660 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVG 739 (845)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 739 (845)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....... . +..+.....
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~------~---------~~~~~~~~~-- 217 (323)
T cd05584 155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK------T---------IDKILKGKL-- 217 (323)
T ss_pred CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH------H---------HHHHHcCCC--
Confidence 22334578999999999999999999999999999999999999996533211 1 111111111
Q ss_pred CCCHHHHHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 003139 740 KVNPASLKKFGETAEKCLAEHGVDRP-----SMGDVLWN 773 (845)
Q Consensus 740 ~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~~ 773 (845)
.++......+.+++.+||+.+|++|| ++.+++++
T Consensus 218 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 218 NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 23334456788999999999999999 78887664
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=342.39 Aligned_cols=254 Identities=22% Similarity=0.301 Sum_probs=197.7
Q ss_pred CCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEE
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYE 578 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 578 (845)
.|...+.||+|+||.||+|+.. +++.+|+|++... .....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788889999999999999865 6789999987643 23445678999999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCC
Q 003139 579 YMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQ 658 (845)
Q Consensus 579 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~ 658 (845)
|+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||||+.++.+||+|||+++.......
T Consensus 82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 82 YIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred cCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 99999999998643 468899999999999999999998 9999999999999999999999999999753210000
Q ss_pred ---------------------------------------------cccccccccCCCcCChhhhccCCCCchhHHHHHHH
Q 003139 659 ---------------------------------------------THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGV 693 (845)
Q Consensus 659 ---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gv 693 (845)
........||+.|+|||.+.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 00112357999999999999999999999999999
Q ss_pred HHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHH--hhhhCCCCCCCHHHHH
Q 003139 694 VLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEK--CLAEHGVDRPSMGDVL 771 (845)
Q Consensus 694 vl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~--cl~~~p~~RPs~~~vl 771 (845)
++|||++|+.||......+.. ...... ...+...........+.+++.+ |+..++..||++.+++
T Consensus 237 il~elltG~~Pf~~~~~~~~~------~~i~~~-------~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l 303 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTETQ------LKVINW-------ENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIK 303 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHHH------HHHHcc-------ccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHh
Confidence 999999999999754332210 000000 0001000111234556677776 5566777799999998
Q ss_pred HHH
Q 003139 772 WNL 774 (845)
Q Consensus 772 ~~L 774 (845)
.+-
T Consensus 304 ~hp 306 (381)
T cd05626 304 AHP 306 (381)
T ss_pred cCc
Confidence 763
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=338.09 Aligned_cols=251 Identities=24% Similarity=0.342 Sum_probs=214.0
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCc-EEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSE-MILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-~~lV~ 577 (845)
++|...+++|+|+||.++..+++ ++..+++|++... +....+...+|+.++++++|||||.+.+.+.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 45777889999999999999876 5778999976544 44455578899999999999999999999998888 99999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
+|++||+|.+.+...+...++++++.+++.|++.|+.|||+ ..|+|||||+.||+++++..+||+|||+|+......
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 99999999999987776789999999999999999999998 999999999999999999999999999999855422
Q ss_pred CcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcccc
Q 003139 658 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNL 737 (845)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (845)
.......||+.||.||.+.+.+|..|+|||||||++|||++-+++|....... .+ .+++...
T Consensus 161 --~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~------Li---------~ki~~~~- 222 (426)
T KOG0589|consen 161 --SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE------LI---------LKINRGL- 222 (426)
T ss_pred --hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH------HH---------HHHhhcc-
Confidence 24567889999999999999999999999999999999999999997543221 11 1222211
Q ss_pred CCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 738 VGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
....+......+..++..|++.+|+.||++.+++.+
T Consensus 223 ~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 223 YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 223455667889999999999999999999999877
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=337.55 Aligned_cols=260 Identities=24% Similarity=0.370 Sum_probs=202.4
Q ss_pred cCCCcceeeeeeceEEEEEEEE------cCCcEEEEEEcCCCC-hHhHHHHHHHHHHHHhC-CCCCcceEEEEEec-CCc
Q 003139 502 NKFDESLLLGVGGFGRVYKGTL------DDGTKVAVKRGNPRS-EQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDE-RSE 572 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~-~~~ 572 (845)
++|+..+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++.++ +|+||++++++|.. +..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 4688889999999999999973 246789999886543 34456788999999999 68999999998865 456
Q ss_pred EEEEEEeccCCCccccccCCC-----------------------------------------------------------
Q 003139 573 MILVYEYMANGPLRSHLYGTD----------------------------------------------------------- 593 (845)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~----------------------------------------------------------- 593 (845)
.++||||+++|+|.+++....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 789999999999998875321
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCccccccccc
Q 003139 594 ------LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKG 667 (845)
Q Consensus 594 ------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 667 (845)
...++|.++++++.|+++||+|||+ .+|+||||||+|||+++++.+||+|||+++...............+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 1247889999999999999999998 9999999999999999999999999999976432211111223345
Q ss_pred CCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCCHHHH
Q 003139 668 SFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASL 746 (845)
Q Consensus 668 t~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 746 (845)
+..|+|||.+.+..++.++||||||+++|||++ |..|+......+. ......++.. ...+....
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~------~~~~~~~~~~---------~~~~~~~~ 308 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKEGTR---------MRAPDYTT 308 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH------HHHHHhccCC---------CCCCCCCC
Confidence 678999999999999999999999999999997 8888754322111 1111111110 11111233
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 003139 747 KKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779 (845)
Q Consensus 747 ~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~ 779 (845)
..+.+++.+||+.+|++||++.+|+++|+.+++
T Consensus 309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 568899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=320.99 Aligned_cols=246 Identities=27% Similarity=0.367 Sum_probs=197.2
Q ss_pred eeeeeceEEEEEEEEc---CCcEEEEEEcCCCC--hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEeccCC
Q 003139 509 LLGVGGFGRVYKGTLD---DGTKVAVKRGNPRS--EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANG 583 (845)
Q Consensus 509 ~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 583 (845)
.||+|+||.||+|.++ ++..+|+|++.... ....+++.+|+.++++++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999753 57789999876443 345678999999999999999999999985 45679999999999
Q ss_pred CccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcc-cc
Q 003139 584 PLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH-VS 662 (845)
Q Consensus 584 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~ 662 (845)
+|.+++... ..+++..+++++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++......... ..
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 81 PLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 999998543 468999999999999999999998 899999999999999999999999999997643322111 11
Q ss_pred cccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCC
Q 003139 663 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKV 741 (845)
Q Consensus 663 ~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 741 (845)
....++..|+|||.+....++.++|||||||++|||++ |+.||......+ +... .+++ .....
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~~~~-i~~~---------~~~~~ 219 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE------VTQM-IESG---------ERMEC 219 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHH-HHCC---------CCCCC
Confidence 22234578999999988899999999999999999998 999986543221 1111 1111 11123
Q ss_pred CHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003139 742 NPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEY 776 (845)
Q Consensus 742 ~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~ 776 (845)
+...+..+.+++.+||+.+|++||++.+|.+.|+.
T Consensus 220 ~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 220 PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 34456778999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=326.78 Aligned_cols=248 Identities=22% Similarity=0.326 Sum_probs=196.5
Q ss_pred eeeeceEEEEEEEEc-CCcEEEEEEcCCCC---hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEeccCCCc
Q 003139 510 LGVGGFGRVYKGTLD-DGTKVAVKRGNPRS---EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPL 585 (845)
Q Consensus 510 LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 585 (845)
||+|+||.||++..+ +|+.+|+|++.... ....+.+..|++++++++||||+++.+++.++...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999875 68999999875421 12234556799999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCccccccc
Q 003139 586 RSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAV 665 (845)
Q Consensus 586 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 665 (845)
..++.......+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||++..... .......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~---~~~~~~~ 154 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD---GKTITQR 154 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCC---Cceeecc
Confidence 988866555578999999999999999999998 9999999999999999999999999999876432 1122345
Q ss_pred ccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCCHHH
Q 003139 666 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPAS 745 (845)
Q Consensus 666 ~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 745 (845)
.|+..|+|||++.+..++.++|||||||++|||++|+.||....... ...+.... .....+. ......
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~--~~~~~~~~---------~~~~~~~-~~~~~~ 222 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV--AKEELKRR---------TLEDEVK-FEHQNF 222 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh--hHHHHHHH---------hhccccc-cccccC
Confidence 68999999999999999999999999999999999999986433211 11111111 1111110 011234
Q ss_pred HHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 746 LKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 746 ~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
...+.+++.+||+.+|++||++.|+++.+.
T Consensus 223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 223 TEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred CHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 556889999999999999999987764443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=335.73 Aligned_cols=237 Identities=25% Similarity=0.338 Sum_probs=189.0
Q ss_pred eeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC---hHhHHHHHHHHH-HHHhCCCCCcceEEEEEecCCcEEEEEEeccC
Q 003139 508 LLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS---EQGIAEFRTEIE-MLSKLRHRHLVSLIGYCDERSEMILVYEYMAN 582 (845)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 582 (845)
++||+|+||.||+|+.. +++.+|+|.+.... .....++..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999975 68899999875432 223345555654 57889999999999999999999999999999
Q ss_pred CCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcccc
Q 003139 583 GPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVS 662 (845)
Q Consensus 583 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 662 (845)
|+|..++... ..+++.++..++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+++.... .....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~ 153 (321)
T cd05603 81 GELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE--PEETT 153 (321)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCC--CCCcc
Confidence 9998887543 468889999999999999999998 8999999999999999999999999999875322 12223
Q ss_pred cccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCC
Q 003139 663 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVN 742 (845)
Q Consensus 663 ~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 742 (845)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .... .+....+ ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~---------~i~~~~~--~~~ 216 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS------QMYD---------NILHKPL--QLP 216 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH------HHHH---------HHhcCCC--CCC
Confidence 3457899999999999999999999999999999999999999653211 1111 1111111 123
Q ss_pred HHHHHHHHHHHHHhhhhCCCCCCCHH
Q 003139 743 PASLKKFGETAEKCLAEHGVDRPSMG 768 (845)
Q Consensus 743 ~~~~~~l~~l~~~cl~~~p~~RPs~~ 768 (845)
......+.+++.+||+.+|.+||+..
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 217 GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 34456788999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=335.43 Aligned_cols=249 Identities=21% Similarity=0.328 Sum_probs=198.9
Q ss_pred eeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcEEEEEEeccC
Q 003139 508 LLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERSEMILVYEYMAN 582 (845)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 582 (845)
++||+|+||.||+++.. +++.||+|.+... .....+.+..|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36999999999999876 6889999987643 233456688999999998 799999999999999999999999999
Q ss_pred CCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcccc
Q 003139 583 GPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVS 662 (845)
Q Consensus 583 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 662 (845)
|+|..++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++.... .....
T Consensus 81 g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~--~~~~~ 153 (329)
T cd05588 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR--PGDTT 153 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCcccccccc--CCCcc
Confidence 9998887543 479999999999999999999998 9999999999999999999999999999875221 11223
Q ss_pred cccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcc--cccHHHHHHHHhhcCchhhhhccccCCC
Q 003139 663 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPRE--QVNIAEWAMTWQKKGMLDQIMDSNLVGK 740 (845)
Q Consensus 663 ~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 740 (845)
....||..|+|||++.+..++.++|||||||++|||++|+.||+.....+ .....++......++ .. .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--------~~--~ 223 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK--------QI--R 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC--------CC--C
Confidence 34678999999999999999999999999999999999999996432221 112222332222211 11 1
Q ss_pred CCHHHHHHHHHHHHHhhhhCCCCCCC------HHHHHHH
Q 003139 741 VNPASLKKFGETAEKCLAEHGVDRPS------MGDVLWN 773 (845)
Q Consensus 741 ~~~~~~~~l~~l~~~cl~~~p~~RPs------~~~vl~~ 773 (845)
.+......+.+++.+||+.+|.+||+ +.+++++
T Consensus 224 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 224 IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 23344567889999999999999997 5666644
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=322.48 Aligned_cols=258 Identities=21% Similarity=0.300 Sum_probs=207.4
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
++|+..+.||+|+||.||+|... ++..++||.+... .....+++.+|+++++.++|+||+++++++.+.+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 35777789999999999999964 7899999976542 3344568899999999999999999999999999999999
Q ss_pred EeccCCCccccccC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCC
Q 003139 578 EYMANGPLRSHLYG--TDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPA 655 (845)
Q Consensus 578 Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~ 655 (845)
||+++++|.+++.. .....+++.++..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999998853 223568999999999999999999998 9999999999999999999999999999876432
Q ss_pred CCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcc
Q 003139 656 LDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDS 735 (845)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (845)
.. .......++..|+|||.+.+..++.++||||||+++|||++|..||...... ...+... +.....+
T Consensus 159 ~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~------~~~~~~~ 226 (267)
T cd08229 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKK------IEQCDYP 226 (267)
T ss_pred CC--cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhhh------hhcCCCC
Confidence 11 1122456888999999999999999999999999999999999998643221 1111111 0011111
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 003139 736 NLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYA 777 (845)
Q Consensus 736 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~ 777 (845)
. .........+.+++.+||+.+|++||||.+|++.+++.
T Consensus 227 ~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 227 P---LPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred C---CCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 1 11234567899999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=325.17 Aligned_cols=255 Identities=26% Similarity=0.408 Sum_probs=205.3
Q ss_pred cCCCcceeeeeeceEEEEEEEEcC------CcEEEEEEcCCCC-hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLDD------GTKVAVKRGNPRS-EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMI 574 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 574 (845)
++|...+.||+|+||.||+|...+ +..+++|...... .....++.+|+.+++.++|+||+++++++......+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 567888899999999999998652 3679999876543 344567899999999999999999999999999999
Q ss_pred EEEEeccCCCccccccCCC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEe
Q 003139 575 LVYEYMANGPLRSHLYGTD--------LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVAD 646 (845)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~D 646 (845)
+||||+++|+|.+++.... ...++|..++.++.|++.||.|||+ .+++||||||+|||+++++.+||+|
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEECC
Confidence 9999999999999886421 2357899999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhh
Q 003139 647 FGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQK 725 (845)
Q Consensus 647 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~ 725 (845)
||+++...............++..|+|||.+.++.++.++|||||||++|||++ |+.||......+ +..+. .
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~~----~ 235 (277)
T cd05032 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---VLKFV----I 235 (277)
T ss_pred cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---HHHHH----h
Confidence 999976433222222233456788999999998899999999999999999998 888885433211 11111 1
Q ss_pred cCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 726 KGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 726 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
.+. ....+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 236 ~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 236 DGG---------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred cCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 111 11123334678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=320.24 Aligned_cols=248 Identities=28% Similarity=0.436 Sum_probs=202.0
Q ss_pred cCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEe-cCCcEEEEEEec
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCD-ERSEMILVYEYM 580 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~-~~~~~~lV~Ey~ 580 (845)
.+|...+.||+|+||.||++... |..+++|...... ..+.|.+|+.++++++|+|++++++++. +.+..++|+||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46778889999999999999876 7889999876443 3467899999999999999999999764 556789999999
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcc
Q 003139 581 ANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH 660 (845)
Q Consensus 581 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 660 (845)
++++|.+++.......+++..+++++.|++.||+|||+ ++++||||||+||++++++.+||+|||+++.....
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~---- 155 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---- 155 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceecccc----
Confidence 99999999876555568999999999999999999998 89999999999999999999999999998753221
Q ss_pred cccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCC
Q 003139 661 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVG 739 (845)
Q Consensus 661 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 739 (845)
.....++..|+|||++.+..++.++|||||||++|||++ |+.|+.... ..+..... ..+ ...
T Consensus 156 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~------~~~~~~~~-~~~---------~~~ 218 (256)
T cd05082 156 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP------LKDVVPRV-EKG---------YKM 218 (256)
T ss_pred -CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHH-hcC---------CCC
Confidence 122344568999999999999999999999999999997 888875322 11111111 111 111
Q ss_pred CCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003139 740 KVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEY 776 (845)
Q Consensus 740 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~ 776 (845)
..+..++..+.+++.+|++.+|++|||+.++++.|+.
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 219 DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 2233456788899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=335.05 Aligned_cols=245 Identities=25% Similarity=0.348 Sum_probs=194.8
Q ss_pred CCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHH---HhCCCCCcceEEEEEecCCcEEEE
Q 003139 504 FDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEML---SKLRHRHLVSLIGYCDERSEMILV 576 (845)
Q Consensus 504 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l---~~l~H~niv~l~g~~~~~~~~~lV 576 (845)
|++.+.||+|+||.||+|... +++.||||.+... .....+.+..|++++ +.++||||+++++++.+.+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 566789999999999999875 6889999987643 223345666676655 566899999999999999999999
Q ss_pred EEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCC
Q 003139 577 YEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPAL 656 (845)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~ 656 (845)
|||+++++|..++.. ..+++.++..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.....
T Consensus 81 ~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 81 MEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 999999999888753 368999999999999999999998 99999999999999999999999999998753221
Q ss_pred CCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccc
Q 003139 657 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSN 736 (845)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (845)
........|++.|+|||.+.+..++.++|||||||++|||++|+.||......+ .... +....
T Consensus 155 --~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~------~~~~---------i~~~~ 217 (324)
T cd05589 155 --GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE------VFDS---------IVNDE 217 (324)
T ss_pred --CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH------HHHH---------HHhCC
Confidence 122234678999999999999999999999999999999999999996543211 1111 11111
Q ss_pred cCCCCCHHHHHHHHHHHHHhhhhCCCCCCC-----HHHHHHH
Q 003139 737 LVGKVNPASLKKFGETAEKCLAEHGVDRPS-----MGDVLWN 773 (845)
Q Consensus 737 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~~vl~~ 773 (845)
. ..+......+.+++.+||+.+|.+||+ +.+++++
T Consensus 218 ~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 218 V--RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred C--CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 1 123334567889999999999999994 5555543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=343.31 Aligned_cols=253 Identities=21% Similarity=0.302 Sum_probs=199.9
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
++|+..+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46888999999999999999976 6889999987643 2334567889999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
||+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 81 EYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 999999999998643 468999999999999999999999 999999999999999999999999999986532111
Q ss_pred Cc------------------------------------ccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcC
Q 003139 658 QT------------------------------------HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCT 701 (845)
Q Consensus 658 ~~------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg 701 (845)
.. .......||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 00 001124699999999999999999999999999999999999
Q ss_pred CCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCC---HHHHHHH
Q 003139 702 RPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPS---MGDVLWN 773 (845)
Q Consensus 702 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs---~~~vl~~ 773 (845)
+.||......+. ....... ...+...........+.+++.+|+. +|.+|++ +.+++++
T Consensus 236 ~~Pf~~~~~~~~------~~~i~~~-------~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 236 YPPFCSDNPQET------YRKIINW-------KETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCCHHHH------HHHHHcC-------CCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 999975432211 0110000 0001000111234567788899986 9999998 8888765
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=329.68 Aligned_cols=259 Identities=24% Similarity=0.440 Sum_probs=205.4
Q ss_pred cCCCcceeeeeeceEEEEEEEEc--------CCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCC
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD--------DGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERS 571 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~--------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 571 (845)
.+|.+.+.||+|+||.||+++.. ....+|+|..... ......++.+|+++++++ +||||++++++|.+.+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 46778889999999999999742 2446899987654 345567889999999999 6999999999999999
Q ss_pred cEEEEEEeccCCCccccccCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEEC
Q 003139 572 EMILVYEYMANGPLRSHLYGTD--------------LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLD 637 (845)
Q Consensus 572 ~~~lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~ 637 (845)
..++||||+++|+|.+++.... ...++|.++++++.|++.||+|||+ .+++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEEc
Confidence 9999999999999999885421 2458999999999999999999998 9999999999999999
Q ss_pred CCCceEEEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccH
Q 003139 638 DNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNI 716 (845)
Q Consensus 638 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l 716 (845)
+++.+||+|||+++...............++..|+|||.+.++.++.++||||||+++|||++ |+.||......+ +
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~ 245 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE---L 245 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH---H
Confidence 999999999999986433221111122234567999999999999999999999999999999 888875432211 1
Q ss_pred HHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 003139 717 AEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779 (845)
Q Consensus 717 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~ 779 (845)
. .....+. ....+..++..+.+++.+|++.+|++||++.++++.|+.+..
T Consensus 246 ~----~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 246 F----KLLREGH---------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred H----HHHHcCC---------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 1 1111110 111233445678899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=322.39 Aligned_cols=255 Identities=24% Similarity=0.390 Sum_probs=204.2
Q ss_pred CCCcceeeeeeceEEEEEEEEcC-C---cEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 503 KFDESLLLGVGGFGRVYKGTLDD-G---TKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~~-g---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
.|+..+.||+|+||.||+|.+.. + ..|++|..... .....++|..|+.++++++||||+++.+++.+....++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46678899999999999998752 3 36999988754 4555678999999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
||+++++|.+++... ...+++.+++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++......
T Consensus 85 e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 85 EFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred ecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 999999999998654 3468999999999999999999998 999999999999999999999999999987643221
Q ss_pred Cccccc-ccc--cCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhh
Q 003139 658 QTHVST-AVK--GSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIM 733 (845)
Q Consensus 658 ~~~~~~-~~~--gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (845)
...... ... .+..|+|||.+.+..++.++|||||||++|||++ |+.||...... ....+.. .
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i~----~------- 226 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAIE----Q------- 226 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHHH----c-------
Confidence 111111 111 2457999999999999999999999999999886 99988654322 1111111 0
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 003139 734 DSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYA 777 (845)
Q Consensus 734 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~ 777 (845)
......+.+++..+.+++.+||+.+|.+||++.+|+..|+.+
T Consensus 227 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 227 --DYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred --CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 001112234566788999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=335.00 Aligned_cols=249 Identities=22% Similarity=0.333 Sum_probs=197.4
Q ss_pred eeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcEEEEEEeccC
Q 003139 508 LLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERSEMILVYEYMAN 582 (845)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 582 (845)
++||+|+||.||+|+.. +++.+|+|.+... .....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36999999999999976 5788999987643 334456678899988877 799999999999999999999999999
Q ss_pred CCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcccc
Q 003139 583 GPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVS 662 (845)
Q Consensus 583 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 662 (845)
|+|..++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.... .....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~--~~~~~ 153 (329)
T cd05618 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--PGDTT 153 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccC--CCCcc
Confidence 9998887543 468999999999999999999999 8999999999999999999999999999875322 11122
Q ss_pred cccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcc--cccHHHHHHHHhhcCchhhhhccccCCC
Q 003139 663 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPRE--QVNIAEWAMTWQKKGMLDQIMDSNLVGK 740 (845)
Q Consensus 663 ~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 740 (845)
....||..|+|||++.+..++.++|||||||++|||++|+.||....... ......+......... ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----------~~ 223 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----------IR 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC----------CC
Confidence 34678999999999999999999999999999999999999996422211 1112222222221111 12
Q ss_pred CCHHHHHHHHHHHHHhhhhCCCCCCC------HHHHHHH
Q 003139 741 VNPASLKKFGETAEKCLAEHGVDRPS------MGDVLWN 773 (845)
Q Consensus 741 ~~~~~~~~l~~l~~~cl~~~p~~RPs------~~~vl~~ 773 (845)
++......+.+++.+||+.||++||+ +.+++++
T Consensus 224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 224 IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 33445567889999999999999998 4566543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=320.28 Aligned_cols=255 Identities=30% Similarity=0.460 Sum_probs=207.8
Q ss_pred hcCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEec
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYM 580 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 580 (845)
.++|.+.+.||+|+||.||+|..++++.+++|.+.... ...+++.+|++++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 35788889999999999999998888889999877543 23467899999999999999999999999989999999999
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcc
Q 003139 581 ANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH 660 (845)
Q Consensus 581 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 660 (845)
++++|.+++.......+++.+++.++.|++.||+|||+ .+++|+||||+||++++++.+||+|||+++.... ....
T Consensus 84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~-~~~~ 159 (261)
T cd05034 84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIED-DEYT 159 (261)
T ss_pred CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccc-hhhh
Confidence 99999999977655679999999999999999999998 8999999999999999999999999999876432 1111
Q ss_pred cccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCC
Q 003139 661 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVG 739 (845)
Q Consensus 661 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 739 (845)
......++..|+|||.+.+..++.++||||||++++||++ |+.||......+ . .... .. ....
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~---~~~~-~~---------~~~~ 223 (261)
T cd05034 160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE---V---LEQV-ER---------GYRM 223 (261)
T ss_pred hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---H---HHHH-Hc---------CCCC
Confidence 1122334568999999999999999999999999999998 998885432211 1 1111 00 0111
Q ss_pred CCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003139 740 KVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEY 776 (845)
Q Consensus 740 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~ 776 (845)
..+...+..+.+++.+|++.+|++||++.++++.|+.
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 1223345678999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=331.21 Aligned_cols=261 Identities=25% Similarity=0.424 Sum_probs=206.5
Q ss_pred cCCCcceeeeeeceEEEEEEEEc--------CCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCC
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD--------DGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERS 571 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~--------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 571 (845)
.+|.+.+.||+|+||.||++... .+..+|+|..... .....+++.+|+++++++ +||||++++++|.+.+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 35778889999999999999742 1236899987643 344567899999999999 7999999999999999
Q ss_pred cEEEEEEeccCCCccccccCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEEC
Q 003139 572 EMILVYEYMANGPLRSHLYGTD--------------LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLD 637 (845)
Q Consensus 572 ~~~lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~ 637 (845)
..++++||+++|+|.+++.... ...++|.+++.++.|++.||+|||+ ++++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEc
Confidence 9999999999999999886421 2358999999999999999999998 9999999999999999
Q ss_pred CCCceEEEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccH
Q 003139 638 DNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNI 716 (845)
Q Consensus 638 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l 716 (845)
+++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------ 242 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV------ 242 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH------
Confidence 999999999999976433221111222334567999999999999999999999999999998 7787754321
Q ss_pred HHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhhh
Q 003139 717 AEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLE 781 (845)
Q Consensus 717 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~ 781 (845)
.++..... .+ .....+......+.+++.+|++.+|++||++.++++.|+.+....
T Consensus 243 ~~~~~~~~-~~---------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 243 EELFKLLK-EG---------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred HHHHHHHH-cC---------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 11111111 11 111122344567889999999999999999999999999886533
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=336.56 Aligned_cols=253 Identities=22% Similarity=0.250 Sum_probs=201.8
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
++|+..+.||+|+||.||+++.. +|+.+|+|++... .....+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36888899999999999999875 6889999987643 2234567889999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
||+++|+|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.... .
T Consensus 81 e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~-~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTA-N 155 (330)
T ss_pred CCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCC-C
Confidence 999999999998654 2478999999999999999999999 9999999999999999999999999999976432 1
Q ss_pred CcccccccccCCCcCChhhhc------cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhh
Q 003139 658 QTHVSTAVKGSFGYLDPEYFR------RQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQ 731 (845)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~------~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (845)
.........||+.|+|||++. ...++.++|||||||++|||++|+.||......+ ..........
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------~~~~i~~~~~--- 226 (330)
T cd05601 156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK------TYNNIMNFQR--- 226 (330)
T ss_pred CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH------HHHHHHcCCC---
Confidence 122233457899999999986 4567899999999999999999999996543221 1111111000
Q ss_pred hhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 732 IMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 732 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.+.....+.....+.+++..|++ +|.+||++.+++.+
T Consensus 227 ----~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 227 ----FLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred ----ccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 01001112345678899999997 99999999998754
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=327.10 Aligned_cols=264 Identities=22% Similarity=0.274 Sum_probs=198.3
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCCh-HhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSE-QGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYE 578 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 578 (845)
.++|+..+.||+|+||.||+|+.. +++.+|+|.+..... .....+.+|++++++++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 367888999999999999999976 688999998764432 223467889999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCC
Q 003139 579 YMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQ 658 (845)
Q Consensus 579 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~ 658 (845)
|++ ++|.+++... ...+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++.... .
T Consensus 84 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~ 156 (303)
T cd07869 84 YVH-TDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSV--P 156 (303)
T ss_pred CCC-cCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccC--C
Confidence 995 6777777543 3468899999999999999999999 9999999999999999999999999999875322 1
Q ss_pred cccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCch--------
Q 003139 659 THVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGML-------- 729 (845)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~-------- 729 (845)
........+++.|+|||.+.+ ..++.++||||+||++|||++|+.||........ ..............
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 234 (303)
T cd07869 157 SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD--QLERIFLVLGTPNEDTWPGVHS 234 (303)
T ss_pred CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhCCCChhhccchhh
Confidence 122234568899999999865 4689999999999999999999999975432111 11111110000000
Q ss_pred -hhhhccccCCCCCH---------HHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 730 -DQIMDSNLVGKVNP---------ASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 730 -~~~~d~~l~~~~~~---------~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
............+. .....+.+++.+||+.||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 00000000000000 112457799999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=318.50 Aligned_cols=248 Identities=26% Similarity=0.401 Sum_probs=197.6
Q ss_pred eeeeeceEEEEEEEEc---CCcEEEEEEcCCCC-hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEeccCCC
Q 003139 509 LLGVGGFGRVYKGTLD---DGTKVAVKRGNPRS-EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGP 584 (845)
Q Consensus 509 ~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 584 (845)
.||+|+||.||+|.+. .+..||+|...... ....++|.+|++++++++||||++++++|. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999864 35569999876653 344567999999999999999999999985 457899999999999
Q ss_pred ccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcc-ccc
Q 003139 585 LRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH-VST 663 (845)
Q Consensus 585 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~~ 663 (845)
|.+++... ...+++.++++++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++......... ...
T Consensus 81 L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 81 LNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred HHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 99998643 3478999999999999999999998 899999999999999999999999999997533221111 112
Q ss_pred ccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCC
Q 003139 664 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVN 742 (845)
Q Consensus 664 ~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 742 (845)
...++..|+|||.+.++.++.++|||||||++|||++ |+.||......+ +.. ....+ .....+
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~-~~~~~---------~~~~~~ 220 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE------VMS-FIEQG---------KRLDCP 220 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH------HHH-HHHCC---------CCCCCC
Confidence 2234578999999998899999999999999999996 999986543221 111 11111 111233
Q ss_pred HHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 003139 743 PASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYA 777 (845)
Q Consensus 743 ~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~ 777 (845)
..++..+.+++.+||+.+|++||++.+|.+.|+..
T Consensus 221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 44567888999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=321.19 Aligned_cols=248 Identities=30% Similarity=0.470 Sum_probs=196.7
Q ss_pred eeeeeceEEEEEEEEcC-Cc--EEEEEEcCCC-ChHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcEEEEEEeccCC
Q 003139 509 LLGVGGFGRVYKGTLDD-GT--KVAVKRGNPR-SEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERSEMILVYEYMANG 583 (845)
Q Consensus 509 ~LG~G~fg~Vy~~~~~~-g~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~g 583 (845)
+||+|+||.||+|.+.+ +. .+++|..... .....+.+.+|++++.++ +||||+++++++...+..++||||+++|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 68999999999999753 43 4688887643 345567889999999999 7999999999999999999999999999
Q ss_pred CccccccCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccc
Q 003139 584 PLRSHLYGTD--------------LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGL 649 (845)
Q Consensus 584 sL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGl 649 (845)
+|.+++.... ...+++.++++++.|++.||+|||+ .+++||||||+|||+++++.+||+|||+
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCCC
Confidence 9999886432 2358899999999999999999998 8999999999999999999999999999
Q ss_pred cCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCc
Q 003139 650 SKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGM 728 (845)
Q Consensus 650 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~ 728 (845)
++.... .........+..|+|||++....++.++|||||||+++||++ |+.||......+ ......
T Consensus 159 ~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~------~~~~~~---- 225 (270)
T cd05047 159 SRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LYEKLP---- 225 (270)
T ss_pred ccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH------HHHHHh----
Confidence 864211 111112233567999999999999999999999999999997 999885432211 111111
Q ss_pred hhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhh
Q 003139 729 LDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYAL 778 (845)
Q Consensus 729 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~ 778 (845)
.......+......+.+++.+|++.+|.+||++.++++.|+.++
T Consensus 226 ------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 226 ------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred ------CCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 11111122234467889999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=340.98 Aligned_cols=254 Identities=20% Similarity=0.259 Sum_probs=198.0
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
++|+..+.||+|+||.||++... +++.||+|++... .....+.+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 36888899999999999999865 6889999987543 2334567889999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
||+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 81 EFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 999999999998543 468899999999999999999999 999999999999999999999999999996321100
Q ss_pred Cc---------------------------------------------ccccccccCCCcCChhhhccCCCCchhHHHHHH
Q 003139 658 QT---------------------------------------------HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFG 692 (845)
Q Consensus 658 ~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~G 692 (845)
.. .......||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 00 000124699999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCC---CCHHH
Q 003139 693 VVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDR---PSMGD 769 (845)
Q Consensus 693 vvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~R---Ps~~~ 769 (845)
|++|||++|+.||......+. ........ ..+.-.........+.+++.+|+. +|.+| +++.+
T Consensus 236 vil~elltG~~Pf~~~~~~~~------~~~i~~~~-------~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~ 301 (377)
T cd05629 236 AIMFECLIGWPPFCSENSHET------YRKIINWR-------ETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHE 301 (377)
T ss_pred hhhhhhhcCCCCCCCCCHHHH------HHHHHccC-------CccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHH
Confidence 999999999999965432211 00000000 000000011234567889999997 67765 59999
Q ss_pred HHHHH
Q 003139 770 VLWNL 774 (845)
Q Consensus 770 vl~~L 774 (845)
++++-
T Consensus 302 ~l~hp 306 (377)
T cd05629 302 IKSHP 306 (377)
T ss_pred HhcCC
Confidence 88763
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=327.62 Aligned_cols=263 Identities=27% Similarity=0.402 Sum_probs=205.7
Q ss_pred hcCCCcceeeeeeceEEEEEEEEcC-----------------CcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcce
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLDD-----------------GTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVS 562 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~~-----------------g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~ 562 (845)
.++|+..+.||+|+||.||+|...+ +..+|+|.+... .....+++.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3568888999999999999998642 245899987654 3445678999999999999999999
Q ss_pred EEEEEecCCcEEEEEEeccCCCccccccCCC---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCc
Q 003139 563 LIGYCDERSEMILVYEYMANGPLRSHLYGTD---------LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTN 633 (845)
Q Consensus 563 l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~N 633 (845)
+++++..++..++|+||+++++|.+++.... ...+++..++.++.|++.||+|||+ .+|+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhc
Confidence 9999999999999999999999999986432 1368999999999999999999998 899999999999
Q ss_pred EEECCCCceEEEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc--CCCCCCCCCCc
Q 003139 634 ILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC--TRPALNPVLPR 711 (845)
Q Consensus 634 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt--g~~p~~~~~~~ 711 (845)
|++++++.++|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999976433222222334556789999999998899999999999999999998 56666432211
Q ss_pred ccccHHHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 712 EQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 712 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
.............. .......+...+..+.+++.+|++.+|++||++.+|++.|+
T Consensus 241 ---~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 ---QVIENAGHFFRDDG------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred ---HHHHHHHhcccccc------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 11112211111111 01111122334567999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=339.06 Aligned_cols=261 Identities=21% Similarity=0.207 Sum_probs=198.4
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
.++|...+.||+|+||.||++... .++.||+|+.. .+.+.+|++++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 357999999999999999999865 68899999743 23567899999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCc
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT 659 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~ 659 (845)
+. ++|..++... ..+++.+++.|+.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...... .
T Consensus 165 ~~-~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~ 237 (391)
T PHA03212 165 YK-TDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-A 237 (391)
T ss_pred CC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-c
Confidence 95 6888877543 468999999999999999999999 899999999999999999999999999997532211 1
Q ss_pred ccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccc----cHHHHHHHHhhc---------
Q 003139 660 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQV----NIAEWAMTWQKK--------- 726 (845)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~----~l~~~~~~~~~~--------- 726 (845)
.......||+.|+|||++.+..++.++|||||||++|||++|+.|+......... ............
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA 317 (391)
T ss_pred cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence 2223467999999999999999999999999999999999999876543211100 000000000000
Q ss_pred -Cchhhhh----cc-ccC-CCC-----CHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003139 727 -GMLDQIM----DS-NLV-GKV-----NPASLKKFGETAEKCLAEHGVDRPSMGDVLWNL 774 (845)
Q Consensus 727 -~~~~~~~----d~-~l~-~~~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L 774 (845)
..+.... .. ... ... ....+..+.+++.+||+.||++|||+.|++++-
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp 377 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFA 377 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcCh
Confidence 0000000 00 000 000 013456788999999999999999999998653
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=337.70 Aligned_cols=243 Identities=24% Similarity=0.305 Sum_probs=196.9
Q ss_pred eeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEeccCC
Q 003139 508 LLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANG 583 (845)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 583 (845)
+.||+|+||.||++... +|+.+|+|.+... ......++..|++++..++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999865 6889999987643 2334567788999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCccccc
Q 003139 584 PLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVST 663 (845)
Q Consensus 584 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 663 (845)
+|..++... ..+++.++..++.||+.||+|||+ ..+|+||||||+|||+++++.+||+|||+++.... ......
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~ 154 (325)
T cd05594 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMK 154 (325)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCC--CCcccc
Confidence 999888543 468999999999999999999995 26899999999999999999999999999875321 111223
Q ss_pred ccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCCH
Q 003139 664 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNP 743 (845)
Q Consensus 664 ~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 743 (845)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ... +.... ..++.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~------~~~---------i~~~~--~~~p~ 217 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL------FEL---------ILMEE--IRFPR 217 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH------HHH---------HhcCC--CCCCC
Confidence 45699999999999999999999999999999999999999965332110 000 00000 11223
Q ss_pred HHHHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 003139 744 ASLKKFGETAEKCLAEHGVDRP-----SMGDVLWN 773 (845)
Q Consensus 744 ~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~~ 773 (845)
.....+.+++.+||+.||++|+ ++.+++++
T Consensus 218 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 218 TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 3456788999999999999996 89998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=324.99 Aligned_cols=254 Identities=28% Similarity=0.411 Sum_probs=201.1
Q ss_pred HHhcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhC-CCCCcceEEEEEecC------
Q 003139 499 DATNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDER------ 570 (845)
Q Consensus 499 ~at~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~------ 570 (845)
++++.|+..+.||+|+||.||+|... +++.+|+|+..... ....++.+|+.++.++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 45677888889999999999999875 57889999876443 3346788999999998 799999999998643
Q ss_pred CcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEecccc
Q 003139 571 SEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLS 650 (845)
Q Consensus 571 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla 650 (845)
...++||||+++++|.+++.......+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence 458999999999999999876555678999999999999999999999 89999999999999999999999999998
Q ss_pred CCCCCCCCcccccccccCCCcCChhhhc-----cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhh
Q 003139 651 KTGPALDQTHVSTAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQK 725 (845)
Q Consensus 651 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~ 725 (845)
+..... ........|+..|+|||++. +..++.++|||||||++|||++|+.||........ +. ...
T Consensus 159 ~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~-----~~--~~~ 229 (272)
T cd06637 159 AQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-----LF--LIP 229 (272)
T ss_pred eecccc--cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH-----HH--HHh
Confidence 753321 11223456889999999986 34688899999999999999999999864332111 00 000
Q ss_pred cCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 726 KGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 726 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
... ...+ .....+..+.+++.+||..+|.+||++.+++++
T Consensus 230 ~~~-----~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 230 RNP-----APRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred cCC-----CCCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 000 0111 112344578899999999999999999998753
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=334.40 Aligned_cols=252 Identities=23% Similarity=0.292 Sum_probs=198.9
Q ss_pred CCCcceeeeeeceEEEEEEEEc----CCcEEEEEEcCCC----ChHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcE
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD----DGTKVAVKRGNPR----SEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERSEM 573 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 573 (845)
+|++.+.||+|+||.||+++.. +++.+|+|.+... .....+.+..|++++.++ +|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4778889999999999998753 5788999987532 223346688899999999 599999999999999999
Q ss_pred EEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCC
Q 003139 574 ILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTG 653 (845)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~ 653 (845)
++||||+++|+|.+++... ..+++.++..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 9999999999999988543 468999999999999999999998 89999999999999999999999999999753
Q ss_pred CCCCCcccccccccCCCcCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhh
Q 003139 654 PALDQTHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQI 732 (845)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (845)
... .........||..|+|||++.+. .++.++|||||||++|||++|+.||........ ..........
T Consensus 156 ~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~~~~~~~~~~------- 225 (332)
T cd05614 156 LSE-EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT--QSEVSRRILK------- 225 (332)
T ss_pred ccc-CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC--HHHHHHHHhc-------
Confidence 321 11222346799999999999865 478999999999999999999999964332211 1111111110
Q ss_pred hccccCCCCCHHHHHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 003139 733 MDSNLVGKVNPASLKKFGETAEKCLAEHGVDRP-----SMGDVLWN 773 (845)
Q Consensus 733 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~~ 773 (845)
.++ .++......+.+++.+||+.||++|| ++++++++
T Consensus 226 ~~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 226 CDP----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCC----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 011 12334456788999999999999999 67777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=335.35 Aligned_cols=242 Identities=21% Similarity=0.314 Sum_probs=195.5
Q ss_pred eeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcEEEEEEeccC
Q 003139 508 LLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERSEMILVYEYMAN 582 (845)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 582 (845)
++||+|+||.||+|+.. +++.+|+|.+... .....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999876 5789999987643 234456678899999876 799999999999999999999999999
Q ss_pred CCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcccc
Q 003139 583 GPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVS 662 (845)
Q Consensus 583 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 662 (845)
|+|..++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++.... .....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~ 153 (321)
T cd05591 81 GDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL--NGVTT 153 (321)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceeccc--CCccc
Confidence 9999888543 468999999999999999999999 8999999999999999999999999999875322 12223
Q ss_pred cccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCC
Q 003139 663 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVN 742 (845)
Q Consensus 663 ~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 742 (845)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .... +..... ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~------~~~~---------i~~~~~--~~p 216 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD------LFES---------ILHDDV--LYP 216 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH------HHHH---------HHcCCC--CCC
Confidence 34678999999999999999999999999999999999999997543221 1111 111111 122
Q ss_pred HHHHHHHHHHHHHhhhhCCCCCC-------CHHHHHHH
Q 003139 743 PASLKKFGETAEKCLAEHGVDRP-------SMGDVLWN 773 (845)
Q Consensus 743 ~~~~~~l~~l~~~cl~~~p~~RP-------s~~~vl~~ 773 (845)
......+.+++.+||+.+|++|| ++.+++++
T Consensus 217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 23346788999999999999999 77777654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=325.10 Aligned_cols=256 Identities=29% Similarity=0.435 Sum_probs=204.3
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc------CCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD------DGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEM 573 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 573 (845)
.++|+..+.||+|+||.||+|... ++..+|+|.+... .....++|.+|+.++++++||||++++++|.++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 457888899999999999999864 3578999987654 344557799999999999999999999999999999
Q ss_pred EEEEEeccCCCccccccCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCc
Q 003139 574 ILVYEYMANGPLRSHLYGTD--------------------LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTN 633 (845)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~--------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~N 633 (845)
++||||+++|+|.+++.... ...+++.+++.++.|++.||+|||+ .+++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhh
Confidence 99999999999999885321 2357899999999999999999998 899999999999
Q ss_pred EEECCCCceEEEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcc
Q 003139 634 ILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPRE 712 (845)
Q Consensus 634 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~ 712 (845)
||+++++.+||+|||+++................+..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~- 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE- 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 9999999999999999875332211111222344667999999999999999999999999999997 77787543221
Q ss_pred cccHHHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 713 QVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 713 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
++... ...+. .. ..+...+..+.+++.+||+.+|.+||++.|+++.|+
T Consensus 240 -----~~~~~-~~~~~--------~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 240 -----EVIYY-VRDGN--------VL-SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred -----HHHHH-HhcCC--------CC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 11111 11111 11 112334567899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=319.45 Aligned_cols=248 Identities=26% Similarity=0.386 Sum_probs=201.0
Q ss_pred eeeeeceEEEEEEEEcC--C--cEEEEEEcCCCCh-HhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEeccCC
Q 003139 509 LLGVGGFGRVYKGTLDD--G--TKVAVKRGNPRSE-QGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANG 583 (845)
Q Consensus 509 ~LG~G~fg~Vy~~~~~~--g--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 583 (845)
.||+|++|.||+|.+.+ + ..+|+|.+..... ...++|.+|++++++++||||+++++++.+ ...++|+||++++
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~ 80 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLG 80 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCC
Confidence 68999999999998753 3 3689999877655 667889999999999999999999999988 8899999999999
Q ss_pred CccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCc-ccc
Q 003139 584 PLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT-HVS 662 (845)
Q Consensus 584 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~ 662 (845)
+|.+++.......++|..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++........ ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 81 SLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred cHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence 99999876543578999999999999999999998 89999999999999999999999999999865432211 112
Q ss_pred cccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCC
Q 003139 663 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKV 741 (845)
Q Consensus 663 ~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 741 (845)
....++..|+|||.+.+..++.++|||||||++|||++ |+.||......+ ......... .....
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~~~~~~~~~---------~~~~~ 222 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ------ILKKIDKEG---------ERLER 222 (257)
T ss_pred cCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHhcC---------CcCCC
Confidence 23457789999999999999999999999999999998 999986432221 111111100 00112
Q ss_pred CHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 742 NPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 742 ~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
+...+..+.+++.+|++.+|++||++.++++.|.
T Consensus 223 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 223 PEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 2334567899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=356.49 Aligned_cols=262 Identities=23% Similarity=0.306 Sum_probs=206.9
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
++|+..++||+|+||.||+|... +|+.||+|++... .....++|.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57888999999999999999875 5889999987643 2334567999999999999999999999999999999999
Q ss_pred EeccCCCccccccCC---------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEecc
Q 003139 578 EYMANGPLRSHLYGT---------DLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFG 648 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~---------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFG 648 (845)
||+++|+|.+++... ....+++..+++++.||++||+|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecC
Confidence 999999999887531 12356788899999999999999999 899999999999999999999999999
Q ss_pred ccCCCCCCCC----------------cccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcc
Q 003139 649 LSKTGPALDQ----------------THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPRE 712 (845)
Q Consensus 649 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~ 712 (845)
+++....... ........||+.|||||.+.+..++.++|||||||++|||++|+.||......+
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9976421110 001123569999999999999999999999999999999999999996532211
Q ss_pred cccHHHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCC-CHHHHHHHHHHhhhh
Q 003139 713 QVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRP-SMGDVLWNLEYALQL 780 (845)
Q Consensus 713 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~~vl~~L~~~~~~ 780 (845)
.. + . ..+.++... ......+..+.+++.+|++.+|++|| +++++++.|+..++.
T Consensus 239 i~----~------~---~~i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 239 IS----Y------R---DVILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred hh----h------h---hhccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 00 0 0 001111000 01123456788999999999999995 678888888877653
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=325.53 Aligned_cols=246 Identities=24% Similarity=0.361 Sum_probs=196.2
Q ss_pred eeeeceEEEEEEEEc-CCcEEEEEEcCCCC---hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEeccCCCc
Q 003139 510 LGVGGFGRVYKGTLD-DGTKVAVKRGNPRS---EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPL 585 (845)
Q Consensus 510 LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 585 (845)
||+|+||.||++... +|+.+|+|++.... ....+.+..|++++++++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999865 68899999876432 23346778899999999999999999999999999999999999999
Q ss_pred cccccCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCccccc
Q 003139 586 RSHLYGT--DLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVST 663 (845)
Q Consensus 586 ~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 663 (845)
..++... ....+++..++.++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++...... ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~--~~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--SKTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC--cccc
Confidence 8877432 33568999999999999999999999 899999999999999999999999999997543211 1223
Q ss_pred ccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCCH
Q 003139 664 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNP 743 (845)
Q Consensus 664 ~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 743 (845)
...||+.|+|||.+.+..++.++|||||||++|||++|+.||........ ..... ..+..... ..+.
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~---------~~~~~~~~--~~~~ 222 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELK---------QRILNDSV--TYPD 222 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HHHHH---------HhhcccCC--CCcc
Confidence 45789999999999999999999999999999999999999965332111 00000 11111111 1233
Q ss_pred HHHHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 003139 744 ASLKKFGETAEKCLAEHGVDRP-----SMGDVLWN 773 (845)
Q Consensus 744 ~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~~ 773 (845)
..+..+.+++.+||+.+|++|| ++++++++
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 4566788999999999999999 66676654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=320.19 Aligned_cols=252 Identities=25% Similarity=0.383 Sum_probs=203.7
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC-----hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS-----EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMIL 575 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 575 (845)
++|...+.||+|++|.||++... +++.+++|.+.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46888899999999999999864 68899999765331 2234678899999999999999999999999999999
Q ss_pred EEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCC
Q 003139 576 VYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPA 655 (845)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~ 655 (845)
|+||+++++|.+++... ..+++..+.+++.|++.||.|||+ .+|+||||||+||++++++.+||+|||+++....
T Consensus 82 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 99999999999988543 468899999999999999999998 8999999999999999999999999999875432
Q ss_pred CCCcc-cccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhc
Q 003139 656 LDQTH-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMD 734 (845)
Q Consensus 656 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (845)
..... ......++..|+|||.+.+..++.++||||||+++|||++|+.||......+. . .....
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~------------~~~~~ 221 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA---I------------FKIAT 221 (263)
T ss_pred cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH---H------------HHHhc
Confidence 11111 11334578899999999999999999999999999999999999864322110 0 01111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 735 SNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 735 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.......+......+.+++.+||..+|.+||++.+++++
T Consensus 222 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 222 QPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred cCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 111122334456678899999999999999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=318.39 Aligned_cols=257 Identities=21% Similarity=0.320 Sum_probs=209.0
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCC---CChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNP---RSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
++|+..+.||+|+||.||+|... +|+.+++|.+.. ......+.+.+|++++++++|+|++++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999987 789999997653 23344678999999999999999999999999999999999
Q ss_pred EeccCCCccccccCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCC
Q 003139 578 EYMANGPLRSHLYGT--DLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPA 655 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~ 655 (845)
||+++++|.+++... ....+++.+++.++.|++.||.|||+ .+|+||||||+||++++++.++|+|||+++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999888542 23568999999999999999999998 9999999999999999999999999999875332
Q ss_pred CCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcc
Q 003139 656 LDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDS 735 (845)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (845)
. ........++..|+|||.+.+..++.++|||||||++|||++|+.||.... ..+.++..... .+
T Consensus 159 ~--~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~-~~-------- 223 (267)
T cd08224 159 K--TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLCKKIE-KC-------- 223 (267)
T ss_pred C--CcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC----ccHHHHHhhhh-cC--------
Confidence 1 111233467889999999999999999999999999999999999985432 11211111111 11
Q ss_pred ccCCCCC-HHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 003139 736 NLVGKVN-PASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYA 777 (845)
Q Consensus 736 ~l~~~~~-~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~ 777 (845)
.....+ ......+.+++.+||..+|++||++.+|+++|+.+
T Consensus 224 -~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 224 -DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred -CCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 111112 24556788999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=334.73 Aligned_cols=237 Identities=23% Similarity=0.331 Sum_probs=192.4
Q ss_pred eeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcEEEEEEeccC
Q 003139 508 LLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERSEMILVYEYMAN 582 (845)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 582 (845)
+.||+|+||.||+|+.+ +++.||+|.+... .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999976 5789999987643 233456778899999876 699999999999999999999999999
Q ss_pred CCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcccc
Q 003139 583 GPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVS 662 (845)
Q Consensus 583 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 662 (845)
|+|..++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++.... .....
T Consensus 81 g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~--~~~~~ 153 (320)
T cd05590 81 GDLMFHIQKS--RRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF--NGKTT 153 (320)
T ss_pred chHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc--CCCcc
Confidence 9999888543 468999999999999999999998 9999999999999999999999999999875321 11223
Q ss_pred cccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCC
Q 003139 663 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVN 742 (845)
Q Consensus 663 ~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 742 (845)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .... +..... ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------~~~~---------i~~~~~--~~~ 216 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD------LFEA---------ILNDEV--VYP 216 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH------HHHH---------HhcCCC--CCC
Confidence 34679999999999999999999999999999999999999996543211 1111 111111 122
Q ss_pred HHHHHHHHHHHHHhhhhCCCCCCCHH
Q 003139 743 PASLKKFGETAEKCLAEHGVDRPSMG 768 (845)
Q Consensus 743 ~~~~~~l~~l~~~cl~~~p~~RPs~~ 768 (845)
......+.+++.+||+.||++||++.
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 217 TWLSQDAVDILKAFMTKNPTMRLGSL 242 (320)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCC
Confidence 23456788999999999999999983
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=333.98 Aligned_cols=241 Identities=24% Similarity=0.348 Sum_probs=195.2
Q ss_pred CCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhCCCC-CcceEEEEEecCCcEEEEE
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLRHR-HLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lV~ 577 (845)
+|+..+.||+|+||.||+|+.. +++.||+|.+... .....+.+..|.+++..++|+ +|+++.+++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4778889999999999999876 5778999987643 234456788899999999765 6888999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
||+++|+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~-- 153 (324)
T cd05587 81 EYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF-- 153 (324)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCC--
Confidence 999999999888543 468999999999999999999999 8999999999999999999999999999874221
Q ss_pred CcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcccc
Q 003139 658 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNL 737 (845)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (845)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||......+ + ...+.+..
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~------------~~~i~~~~- 217 (324)
T cd05587 154 GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---L------------FQSIMEHN- 217 (324)
T ss_pred CCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---H------------HHHHHcCC-
Confidence 1122334578999999999999999999999999999999999999996543211 1 11111111
Q ss_pred CCCCCHHHHHHHHHHHHHhhhhCCCCCCCH
Q 003139 738 VGKVNPASLKKFGETAEKCLAEHGVDRPSM 767 (845)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 767 (845)
..++......+.+++.+||+.+|.+|++.
T Consensus 218 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 218 -VSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred -CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 12233445678899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=333.21 Aligned_cols=237 Identities=27% Similarity=0.377 Sum_probs=190.3
Q ss_pred eeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC---hHhHHHHHHHHH-HHHhCCCCCcceEEEEEecCCcEEEEEEeccC
Q 003139 508 LLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS---EQGIAEFRTEIE-MLSKLRHRHLVSLIGYCDERSEMILVYEYMAN 582 (845)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 582 (845)
+.||+|+||.||+|+.. +|+.||+|++.... ....+++..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999975 68999999876432 223345555555 45789999999999999999999999999999
Q ss_pred CCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcccc
Q 003139 583 GPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVS 662 (845)
Q Consensus 583 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 662 (845)
|+|..++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++.... .....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~ 153 (323)
T cd05575 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE--HSKTT 153 (323)
T ss_pred CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCccccc--CCCcc
Confidence 9999888543 468999999999999999999998 8999999999999999999999999999875322 12223
Q ss_pred cccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCC
Q 003139 663 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVN 742 (845)
Q Consensus 663 ~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 742 (845)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... +... .+....+ ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~------~~~~---------~i~~~~~--~~~ 216 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA------EMYD---------NILNKPL--RLK 216 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH------HHHH---------HHHcCCC--CCC
Confidence 4567899999999999999999999999999999999999999653221 1111 1111111 122
Q ss_pred HHHHHHHHHHHHHhhhhCCCCCCCHH
Q 003139 743 PASLKKFGETAEKCLAEHGVDRPSMG 768 (845)
Q Consensus 743 ~~~~~~l~~l~~~cl~~~p~~RPs~~ 768 (845)
+.....+.+++.+||+.+|.+||++.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 217 PNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 33456788999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=333.34 Aligned_cols=241 Identities=23% Similarity=0.332 Sum_probs=195.1
Q ss_pred CCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcEEEEE
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 577 (845)
+|+..+.||+|+||.||+|+.. +++.+|+|.+... .....+.+..|..++..+ +|++|+++.+++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778889999999999999876 5788999987643 223345677788888877 5899999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
||+++|+|.+++... ..+++.+++.++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~-- 153 (323)
T cd05616 81 EYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW-- 153 (323)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCC--
Confidence 999999999888543 468999999999999999999998 8999999999999999999999999999975321
Q ss_pred CcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcccc
Q 003139 658 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNL 737 (845)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (845)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||......+ + ...+.+...
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~---~------------~~~i~~~~~ 218 (323)
T cd05616 154 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---L------------FQSIMEHNV 218 (323)
T ss_pred CCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH---H------------HHHHHhCCC
Confidence 1122335678999999999999999999999999999999999999996543211 1 111111111
Q ss_pred CCCCCHHHHHHHHHHHHHhhhhCCCCCCCH
Q 003139 738 VGKVNPASLKKFGETAEKCLAEHGVDRPSM 767 (845)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 767 (845)
.++......+.+++.+|++.+|.+|++.
T Consensus 219 --~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 --AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred --CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 1233455678899999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=341.73 Aligned_cols=253 Identities=23% Similarity=0.258 Sum_probs=201.6
Q ss_pred HhcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEE
Q 003139 500 ATNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMIL 575 (845)
Q Consensus 500 at~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 575 (845)
..++|+..+.||+|+||.||+++.. +++.+|+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3467899999999999999999876 6889999987532 22334567889999999999999999999999999999
Q ss_pred EEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCC
Q 003139 576 VYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPA 655 (845)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~ 655 (845)
||||+++|+|.+++... .++...+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++....
T Consensus 121 v~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999999988543 47888899999999999999999 9999999999999999999999999999976432
Q ss_pred CCCcccccccccCCCcCChhhhccC----CCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhh
Q 003139 656 LDQTHVSTAVKGSFGYLDPEYFRRQ----QLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQ 731 (845)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (845)
. .........||+.|+|||.+.+. .++.++|||||||++|||++|+.||....... ....
T Consensus 195 ~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---------------~~~~ 258 (370)
T cd05596 195 N-GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG---------------TYSK 258 (370)
T ss_pred C-CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH---------------HHHH
Confidence 1 11122345799999999998653 47899999999999999999999997543211 0111
Q ss_pred hhccc--cCCCCCHHHHHHHHHHHHHhhhhCCCC--CCCHHHHHHHH
Q 003139 732 IMDSN--LVGKVNPASLKKFGETAEKCLAEHGVD--RPSMGDVLWNL 774 (845)
Q Consensus 732 ~~d~~--l~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~~vl~~L 774 (845)
+++.. +.-.........+.+++.+||+.+|.+ ||++.+++++-
T Consensus 259 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 259 IMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred HHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 11111 110111234567889999999999987 99999998763
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=311.84 Aligned_cols=266 Identities=23% Similarity=0.279 Sum_probs=202.6
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHh--HHHHHHHHHHHHhCCCCCcceEEEEEe--cCCcEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQG--IAEFRTEIEMLSKLRHRHLVSLIGYCD--ERSEMILV 576 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~~~lV 576 (845)
++|+..+.|++|.||.||+|+.+ +++.||+|+++...+.. --.-++||.+|.+++|||||.+-.+.. +-+.+|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 34677788999999999999975 68899999987654221 113478999999999999999988774 44579999
Q ss_pred EEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCC
Q 003139 577 YEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPAL 656 (845)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~ 656 (845)
||||+. +|..++.... +++...++..+..|+++|++|||. ..|+|||||++|+|++..|.+||+||||||.....
T Consensus 156 Me~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred HHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 999975 7888886554 589999999999999999999999 88999999999999999999999999999985532
Q ss_pred CCcccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhh---
Q 003139 657 DQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQI--- 732 (845)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~--- 732 (845)
....+..+-|.+|+|||.+.+ ..|+...|+||+|||+.||+++++.|.+....++.+.+--......+.....+
T Consensus 231 --~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~l 308 (419)
T KOG0663|consen 231 --LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL 308 (419)
T ss_pred --cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence 233567788999999998876 57999999999999999999999999876655543322111000000000000
Q ss_pred -----------hccccCCCCCHH-HHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003139 733 -----------MDSNLVGKVNPA-SLKKFGETAEKCLAEHGVDRPSMGDVLWNL 774 (845)
Q Consensus 733 -----------~d~~l~~~~~~~-~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L 774 (845)
.-..+...+.-. ..+.-.+++...+..||.+|-|++|.+++=
T Consensus 309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~ 362 (419)
T KOG0663|consen 309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHE 362 (419)
T ss_pred chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccc
Confidence 001111112111 235566889999999999999999988663
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=317.44 Aligned_cols=249 Identities=32% Similarity=0.475 Sum_probs=204.8
Q ss_pred eeeeeeceEEEEEEEEcC----CcEEEEEEcCCCChH-hHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEeccC
Q 003139 508 LLLGVGGFGRVYKGTLDD----GTKVAVKRGNPRSEQ-GIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMAN 582 (845)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 582 (845)
+.||+|+||.||+|.... +..+++|.+...... ..+++.+|++++..++|+|++++++++.+....++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 369999999999999764 778999988765433 367899999999999999999999999999999999999999
Q ss_pred CCccccccCCC-------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCC
Q 003139 583 GPLRSHLYGTD-------LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPA 655 (845)
Q Consensus 583 gsL~~~l~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~ 655 (845)
++|.+++.... ...+++.++.+++.|+++||+|||+ .+++||||||+||++++++.+||+|||.++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999986542 3679999999999999999999998 9999999999999999999999999999987554
Q ss_pred CCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhc
Q 003139 656 LDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMD 734 (845)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (845)
...........++..|+|||.+....++.++||||+|++++||++ |+.||......+ .... ...+
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~-~~~~------- 223 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE------VLEY-LRKG------- 223 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH------HHHH-HHcC-------
Confidence 332223345567889999999998899999999999999999999 588886542211 1111 1111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 735 SNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 735 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
.....+...+..+.+++.+|++.+|++||++.+++++|+
T Consensus 224 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 224 --YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred --CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 111223344678899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=317.60 Aligned_cols=253 Identities=25% Similarity=0.406 Sum_probs=205.5
Q ss_pred cCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEecc
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMA 581 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 581 (845)
++|+..+.||+|+||.||+|...++..+++|..... ....+.|.+|++++++++|+||+++.+.+.+ ...+++|||++
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA 83 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence 567888999999999999999877888999987654 3345788999999999999999999999887 77899999999
Q ss_pred CCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCccc
Q 003139 582 NGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHV 661 (845)
Q Consensus 582 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 661 (845)
+++|.+++.......+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++...... ...
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-~~~ 159 (260)
T cd05073 84 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YTA 159 (260)
T ss_pred CCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCC-ccc
Confidence 9999999976555678999999999999999999998 899999999999999999999999999997543211 111
Q ss_pred ccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCC
Q 003139 662 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGK 740 (845)
Q Consensus 662 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 740 (845)
.....++..|+|||++....++.++|+|||||+++||++ |+.||....... +..+ ...+ ....
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~----~~~~---------~~~~ 223 (260)
T cd05073 160 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIRA----LERG---------YRMP 223 (260)
T ss_pred ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---HHHH----HhCC---------CCCC
Confidence 223345678999999999899999999999999999999 888886432211 1111 1111 1111
Q ss_pred CCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003139 741 VNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEY 776 (845)
Q Consensus 741 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~ 776 (845)
.....+..+.+++.+|++.+|++||++.++++.|+.
T Consensus 224 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 224 RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 223445678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=332.00 Aligned_cols=244 Identities=21% Similarity=0.333 Sum_probs=196.2
Q ss_pred eeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcEEEEEEeccC
Q 003139 508 LLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERSEMILVYEYMAN 582 (845)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 582 (845)
++||+|+||.||+|+.. +++.+|+|.+... .....+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999875 5788999987653 234456788999999888 699999999999999999999999999
Q ss_pred CCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcccc
Q 003139 583 GPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVS 662 (845)
Q Consensus 583 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 662 (845)
|+|..++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++.... .....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~ 153 (327)
T cd05617 81 GDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG--PGDTT 153 (327)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccC--CCCce
Confidence 9998887543 469999999999999999999999 8999999999999999999999999999875221 11223
Q ss_pred cccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCC
Q 003139 663 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVN 742 (845)
Q Consensus 663 ~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 742 (845)
....||+.|+|||++.+..++.++|||||||+||||++|+.||............++......... . .++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--------~--~~p 223 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP--------I--RIP 223 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC--------C--CCC
Confidence 346799999999999999999999999999999999999999975443333222233322222111 1 123
Q ss_pred HHHHHHHHHHHHHhhhhCCCCCCCHH
Q 003139 743 PASLKKFGETAEKCLAEHGVDRPSMG 768 (845)
Q Consensus 743 ~~~~~~l~~l~~~cl~~~p~~RPs~~ 768 (845)
......+.+++.+||+.||++||++.
T Consensus 224 ~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 224 RFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 33456778999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=321.36 Aligned_cols=254 Identities=25% Similarity=0.362 Sum_probs=202.2
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEec
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYM 580 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 580 (845)
++|+..+.||+|+||.||+|+.. +++.+|+|+.........+.+.+|+.++++++||||+++++++...+..++|+||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 46888899999999999999964 68889999887555455567889999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcc
Q 003139 581 ANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH 660 (845)
Q Consensus 581 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 660 (845)
++++|.+++... .++++.++..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++..... ..
T Consensus 89 ~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~--~~ 161 (267)
T cd06646 89 GGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT--IA 161 (267)
T ss_pred CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeeccc--cc
Confidence 999999988543 468999999999999999999998 89999999999999999999999999999764321 11
Q ss_pred cccccccCCCcCChhhhc---cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcccc
Q 003139 661 VSTAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNL 737 (845)
Q Consensus 661 ~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (845)
......|+..|+|||.+. ...++.++|||||||++|||++|+.|+....+.+... . .... ....+..
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~------~-~~~~---~~~~~~~ 231 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF------L-MSKS---NFQPPKL 231 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe------e-eecC---CCCCCCC
Confidence 122356888999999884 4557889999999999999999999985433221100 0 0000 0000111
Q ss_pred CCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003139 738 VGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNL 774 (845)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L 774 (845)
. ........+.+++.+||+.+|++||+++++++.|
T Consensus 232 ~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 232 K--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred c--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0 1123456788999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=318.68 Aligned_cols=247 Identities=25% Similarity=0.397 Sum_probs=208.8
Q ss_pred cCCCcceeeeeeceEEEEEEEE-cCCcEEEEEEcCC---CChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTL-DDGTKVAVKRGNP---RSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
.+|++.+.||+|.||.|-+|.. ..|+.||||.+.. .+++++-.+++|+++|+.|+||||++++.+|+..+.+.|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 4677777899999999999985 5799999997654 35677778899999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
||..+|.|.+++. ..+.|++.+...+++||..|+.|+|. ++++|||||.+|||||+|+++||+||||+-.. .
T Consensus 133 EYaS~GeLYDYiS--er~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly---~ 204 (668)
T KOG0611|consen 133 EYASGGELYDYIS--ERGSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLY---A 204 (668)
T ss_pred EecCCccHHHHHH--HhccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhh---c
Confidence 9999999999995 44689999999999999999999998 99999999999999999999999999999763 3
Q ss_pred CcccccccccCCCcCChhhhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccc
Q 003139 658 QTHVSTAVKGSFGYLDPEYFRRQQLT-EKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSN 736 (845)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (845)
+......++|++-|.+||...+.+|. +.+|-||+||+||.|+.|..||++.... .+ +++ +..|..
T Consensus 205 ~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk---~l---vrQ-Is~GaY------- 270 (668)
T KOG0611|consen 205 DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK---RL---VRQ-ISRGAY------- 270 (668)
T ss_pred cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH---HH---HHH-hhcccc-------
Confidence 44556688999999999999999985 7899999999999999999999764321 11 111 111111
Q ss_pred cCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003139 737 LVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNL 774 (845)
Q Consensus 737 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L 774 (845)
..+..+....-|++|||..+|+.|-|+.+|..+-
T Consensus 271 ----rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 271 ----REPETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred ----cCCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 1234455667889999999999999999997654
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=318.77 Aligned_cols=256 Identities=25% Similarity=0.401 Sum_probs=204.6
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-C---CcEEEEEEcCCCC-hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-D---GTKVAVKRGNPRS-EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILV 576 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~---g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 576 (845)
++|++.+.||+|+||.||+|.+. + +..+|+|.+.... ....+.|.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46778889999999999999864 2 3368999876543 34457899999999999999999999999999999999
Q ss_pred EEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCC
Q 003139 577 YEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPAL 656 (845)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~ 656 (845)
|||+++++|.+++.... ..+++.+++.++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 84 TEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999986543 468999999999999999999998 99999999999999999999999999999864332
Q ss_pred CCcc-cccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhc
Q 003139 657 DQTH-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMD 734 (845)
Q Consensus 657 ~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (845)
.... ......++..|+|||++.++.++.++||||||++++|+++ |+.||......+ ..... .++
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~~~----~~~------- 225 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIKAI----EEG------- 225 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHHHH----hCC-------
Confidence 1111 1112233568999999999999999999999999999886 999886543221 11111 111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 003139 735 SNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYA 777 (845)
Q Consensus 735 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~ 777 (845)
.....+...+..+.+++.+|++.+|.+||+|.++++.|+.+
T Consensus 226 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 226 --YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred --CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 00111233456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=331.49 Aligned_cols=240 Identities=25% Similarity=0.347 Sum_probs=191.6
Q ss_pred eeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcEEEEEEeccC
Q 003139 508 LLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERSEMILVYEYMAN 582 (845)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 582 (845)
+.||+|+||.||+|+.. +++.||+|.+... .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999976 5788999987643 223345566677777654 899999999999999999999999999
Q ss_pred CCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcccc
Q 003139 583 GPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVS 662 (845)
Q Consensus 583 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 662 (845)
|+|..++... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~--~~~~ 153 (316)
T cd05592 81 GDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG--EGKA 153 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCC--CCcc
Confidence 9999888543 468999999999999999999999 99999999999999999999999999999753221 1223
Q ss_pred cccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCC
Q 003139 663 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVN 742 (845)
Q Consensus 663 ~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 742 (845)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .... +... ...++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~------~~~~---------i~~~--~~~~~ 216 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE------LFDS---------ILND--RPHFP 216 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH------HHHH---------HHcC--CCCCC
Confidence 45678999999999999999999999999999999999999997543211 1111 1100 11123
Q ss_pred HHHHHHHHHHHHHhhhhCCCCCCCHH-HHH
Q 003139 743 PASLKKFGETAEKCLAEHGVDRPSMG-DVL 771 (845)
Q Consensus 743 ~~~~~~l~~l~~~cl~~~p~~RPs~~-~vl 771 (845)
......+.+++.+||+.+|.+||++. +++
T Consensus 217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 217 RWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 33456778999999999999999875 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=324.84 Aligned_cols=253 Identities=23% Similarity=0.336 Sum_probs=202.4
Q ss_pred CCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC---hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 504 FDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS---EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 504 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
|+..+.||+|+||.||++... +++.+|+|++.... ....+.+.+|+.++++++|+|++++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999876 68899999875432 22345678899999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCc
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT 659 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~ 659 (845)
+++++|.+++.......+++.+++.++.|++.||.|||+ .+|+||||||+||++++++.++|+|||++......
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~--- 155 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG--- 155 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC---
Confidence 999999998865554579999999999999999999998 99999999999999999999999999998753321
Q ss_pred ccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCC
Q 003139 660 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVG 739 (845)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 739 (845)
.......|+..|+|||++.+..++.++|||||||++|||++|+.||.......... . ...... .. ..
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~--~-~~~~~~-----~~-----~~ 222 (285)
T cd05630 156 QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE--E-VERLVK-----EV-----QE 222 (285)
T ss_pred ccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHH--H-HHhhhh-----hh-----hh
Confidence 11223468999999999999999999999999999999999999997543211100 0 000000 00 01
Q ss_pred CCCHHHHHHHHHHHHHhhhhCCCCCCC-----HHHHHHHHH
Q 003139 740 KVNPASLKKFGETAEKCLAEHGVDRPS-----MGDVLWNLE 775 (845)
Q Consensus 740 ~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~~vl~~L~ 775 (845)
..+......+.+++.+||+.+|++||+ +.|++++-.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~ 263 (285)
T cd05630 223 EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPL 263 (285)
T ss_pred hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChh
Confidence 122334456889999999999999999 888887533
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=320.37 Aligned_cols=252 Identities=23% Similarity=0.330 Sum_probs=193.1
Q ss_pred eeeeeceEEEEEEEEcC---CcEEEEEEcCCCC-hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEeccCCC
Q 003139 509 LLGVGGFGRVYKGTLDD---GTKVAVKRGNPRS-EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGP 584 (845)
Q Consensus 509 ~LG~G~fg~Vy~~~~~~---g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 584 (845)
.||+|+||.||+|...+ +..+++|++.... ......|.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 58999999999998653 3578999876543 3444678999999999999999999999999999999999999999
Q ss_pred ccccccCCC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCccc
Q 003139 585 LRSHLYGTD---LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHV 661 (845)
Q Consensus 585 L~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 661 (845)
|.+++.... ...+++..++.++.|+++||+|||+ .+++||||||+||+++.++.+||+|||+++..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 999986432 2356788889999999999999998 8999999999999999999999999999975332221122
Q ss_pred ccccccCCCcCChhhhccC-------CCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhh
Q 003139 662 STAVKGSFGYLDPEYFRRQ-------QLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIM 733 (845)
Q Consensus 662 ~~~~~gt~~y~aPE~~~~~-------~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (845)
.....++..|+|||++.+. .++.++||||||+++|||++ |+.||......+. ... ...+....+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~~~----~~~~~~~~~~ 231 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---LTY----TVREQQLKLP 231 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---HHH----HhhcccCCCC
Confidence 2344577889999998642 35789999999999999996 9999865332211 111 0011111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 734 DSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 734 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
++.+ .......+.+++..|+ .+|++||++.||++.|+
T Consensus 232 ~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 232 KPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 2221 1223456778999998 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=318.92 Aligned_cols=257 Identities=23% Similarity=0.368 Sum_probs=205.3
Q ss_pred HHHHhcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEE
Q 003139 497 ILDATNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMIL 575 (845)
Q Consensus 497 l~~at~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 575 (845)
++.+++++.....||+|+||.||+|+.. ++..+++|..........+.+.+|++++++++|+||+++++++..++..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 4456777777889999999999999865 577899998877776777889999999999999999999999999999999
Q ss_pred EEEeccCCCccccccCCCCCCC--CHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECC-CCceEEEeccccCC
Q 003139 576 VYEYMANGPLRSHLYGTDLPPL--SWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDD-NFVAKVADFGLSKT 652 (845)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~-~~~~kl~DFGla~~ 652 (845)
|+||+++++|.+++.... ..+ ++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||++..
T Consensus 83 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 83 FMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 999999999999986532 234 788899999999999999998 89999999999999986 67999999999875
Q ss_pred CCCCCCcccccccccCCCcCChhhhccC--CCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchh
Q 003139 653 GPALDQTHVSTAVKGSFGYLDPEYFRRQ--QLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLD 730 (845)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (845)
..... .......++..|+|||++.+. .++.++||||||+++|||++|+.|+....... ...|.....
T Consensus 159 ~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~---~~~~~~~~~------ 227 (268)
T cd06624 159 LAGIN--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ---AAMFKVGMF------ 227 (268)
T ss_pred cccCC--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh---hhHhhhhhh------
Confidence 43211 112234578999999998764 37899999999999999999999986432111 111110000
Q ss_pred hhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 731 QIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 731 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.....++......+.+++.+||+.+|.+||++.+++++
T Consensus 228 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 228 -----KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred -----ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 01112334455678899999999999999999998764
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=316.28 Aligned_cols=250 Identities=20% Similarity=0.318 Sum_probs=204.4
Q ss_pred CCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCC-CChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEec
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNP-RSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYM 580 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 580 (845)
+|+..+.||+|+||.||++... +++.+++|.+.. ......+.+.+|+.++++++|+||+++++.+.+.+..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4677889999999999999875 688999998653 33445678889999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcc
Q 003139 581 ANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH 660 (845)
Q Consensus 581 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 660 (845)
++++|.+++.......+++..++.++.|++.||.|||+ ++|+|+||||+||++++++.++|+|||+++..... ..
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~--~~ 155 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP--GA 155 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccc--cc
Confidence 99999998865555568999999999999999999998 99999999999999999999999999998764321 12
Q ss_pred cccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCC
Q 003139 661 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGK 740 (845)
Q Consensus 661 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 740 (845)
......|+..|+|||++.+..++.++|+||||+++|||++|+.||....... ...... .+.. ..
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~~~~~~-~~~~---------~~ 219 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN------LILKVC-QGSY---------KP 219 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH------HHHHHh-cCCC---------CC
Confidence 2234568889999999999999999999999999999999999986432211 111111 1111 11
Q ss_pred CCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 741 VNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 741 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.+......+.+++.+||+.+|++||++.+++..
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 223345678899999999999999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=341.50 Aligned_cols=252 Identities=22% Similarity=0.283 Sum_probs=195.2
Q ss_pred CCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC---hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEE
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS---EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYE 578 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 578 (845)
.|+..+.||+|+||.||+|+.. +++.+|+|++.... ....+.+.+|++++++++|+||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5788899999999999999865 67889999876432 3345678899999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC-
Q 003139 579 YMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD- 657 (845)
Q Consensus 579 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~- 657 (845)
|+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 82 YIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 99999999988543 468889999999999999999999 899999999999999999999999999975321000
Q ss_pred --------------------------------------------CcccccccccCCCcCChhhhccCCCCchhHHHHHHH
Q 003139 658 --------------------------------------------QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGV 693 (845)
Q Consensus 658 --------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gv 693 (845)
.........||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 000112356899999999999999999999999999
Q ss_pred HHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCC---HHHH
Q 003139 694 VLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPS---MGDV 770 (845)
Q Consensus 694 vl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs---~~~v 770 (845)
+||||++|++||....+.+. ....... ...+...........+.+++.+++ .+|++|++ +.++
T Consensus 237 il~elltG~~Pf~~~~~~~~------~~~i~~~-------~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei 302 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPLET------QMKVINW-------QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEI 302 (382)
T ss_pred HHHHHHhCCCCCCCCCHHHH------HHHHHcc-------CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHH
Confidence 99999999999975433211 0010000 001110111223445667777765 49999987 7776
Q ss_pred HHH
Q 003139 771 LWN 773 (845)
Q Consensus 771 l~~ 773 (845)
+++
T Consensus 303 ~~h 305 (382)
T cd05625 303 KAH 305 (382)
T ss_pred hcC
Confidence 654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=320.90 Aligned_cols=257 Identities=24% Similarity=0.288 Sum_probs=195.9
Q ss_pred CCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCC-----cEEEE
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERS-----EMILV 576 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~lV 576 (845)
.|...+++|+|.||.||+|++. .++.||||+.-..... --.|+++|+++.|||||+|+-++.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4666789999999999999976 5689999986544321 136999999999999999998884322 34689
Q ss_pred EEeccCCCccccccC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCC-CceEEEeccccCCC
Q 003139 577 YEYMANGPLRSHLYG--TDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDN-FVAKVADFGLSKTG 653 (845)
Q Consensus 577 ~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~-~~~kl~DFGla~~~ 653 (845)
|||||. +|.+.++. .....++...+.-+..||++||.|||+ .+|+||||||+|+|+|.+ |.+||||||.|+..
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999975 78887763 123567788888899999999999999 999999999999999965 99999999999975
Q ss_pred CCCCCcccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchh--
Q 003139 654 PALDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLD-- 730 (845)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~-- 730 (845)
.. .........|..|+|||.+.+ ..|+.+.||||.|||+.||+-|++.|.+....++... ..++.+-...+
T Consensus 177 ~~---~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~e---Iik~lG~Pt~e~I 250 (364)
T KOG0658|consen 177 VK---GEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVE---IIKVLGTPTREDI 250 (364)
T ss_pred cc---CCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHH---HHHHhCCCCHHHH
Confidence 43 222344567889999998876 5899999999999999999999999987655544322 11222111111
Q ss_pred --------hhhccccCCC-----CCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 731 --------QIMDSNLVGK-----VNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 731 --------~~~d~~l~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
+...+.+... +......+..+++.++++.+|.+|.++.|++.+
T Consensus 251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 1111122111 234456778899999999999999999999866
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=339.12 Aligned_cols=256 Identities=22% Similarity=0.245 Sum_probs=200.7
Q ss_pred HHHHhcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Q 003139 497 ILDATNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSE 572 (845)
Q Consensus 497 l~~at~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 572 (845)
+....++|+..+.||+|+||.||+++.. +++.+|+|.+... .....+.+.+|+.+++.++||||+++++++.+++.
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 3344578999999999999999999976 5788999987532 22334568899999999999999999999999999
Q ss_pred EEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCC
Q 003139 573 MILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKT 652 (845)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~ 652 (845)
.++||||+++|+|.+++... .+++..+..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++.
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEeccccee
Confidence 99999999999999988543 57889999999999999999999 9999999999999999999999999999976
Q ss_pred CCCCCCcccccccccCCCcCChhhhccC----CCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCc
Q 003139 653 GPALDQTHVSTAVKGSFGYLDPEYFRRQ----QLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGM 728 (845)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 728 (845)
..... ........||+.|+|||++.+. .++.++||||+||+||||++|+.||......+ .
T Consensus 192 ~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~---------------~ 255 (370)
T cd05621 192 MDETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG---------------T 255 (370)
T ss_pred cccCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH---------------H
Confidence 43211 1122356799999999998764 37899999999999999999999996543211 1
Q ss_pred hhhhhccccCCCCC--HHHHHHHHHHHHHhhhhCCC--CCCCHHHHHHHH
Q 003139 729 LDQIMDSNLVGKVN--PASLKKFGETAEKCLAEHGV--DRPSMGDVLWNL 774 (845)
Q Consensus 729 ~~~~~d~~l~~~~~--~~~~~~l~~l~~~cl~~~p~--~RPs~~~vl~~L 774 (845)
...+++......++ ......+.+++.+|+..++. .||++.+++++-
T Consensus 256 ~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp 305 (370)
T cd05621 256 YSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHP 305 (370)
T ss_pred HHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCc
Confidence 11222211111111 23356677888999975554 388999988763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=333.77 Aligned_cols=241 Identities=27% Similarity=0.357 Sum_probs=191.7
Q ss_pred eeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHH-HHHhCCCCCcceEEEEEecCCcEEEEEEeccC
Q 003139 508 LLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIE-MLSKLRHRHLVSLIGYCDERSEMILVYEYMAN 582 (845)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 582 (845)
+.||+|+||.||+|+.. +|+.+|+|++... .....+++..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 36999999999999865 6899999987543 2233455666665 46779999999999999999999999999999
Q ss_pred CCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcccc
Q 003139 583 GPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVS 662 (845)
Q Consensus 583 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 662 (845)
|+|..++... ..+++.++..++.||++||+|||+ .+|+||||||+|||+++++.+||+|||+++.... .....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~ 153 (325)
T cd05604 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSDTT 153 (325)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCC--CCCCc
Confidence 9998888543 478999999999999999999998 9999999999999999999999999999875321 12223
Q ss_pred cccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCC
Q 003139 663 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVN 742 (845)
Q Consensus 663 ~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 742 (845)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ... .++...+ ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~------~~~---------~~~~~~~--~~~ 216 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE------MYD---------NILHKPL--VLR 216 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH------HHH---------HHHcCCc--cCC
Confidence 45678999999999999999999999999999999999999996533211 111 1111111 112
Q ss_pred HHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 003139 743 PASLKKFGETAEKCLAEHGVDRPSMGDVLW 772 (845)
Q Consensus 743 ~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~ 772 (845)
+.....+.+++.+|++.+|.+||++++.++
T Consensus 217 ~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~ 246 (325)
T cd05604 217 PGASLTAWSILEELLEKDRQRRLGAKEDFL 246 (325)
T ss_pred CCCCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence 234566789999999999999998864433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=336.61 Aligned_cols=262 Identities=24% Similarity=0.332 Sum_probs=200.3
Q ss_pred CCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCC-----cEE
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERS-----EMI 574 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 574 (845)
+|+..+.||+|+||.||++... +|+.||+|++... .....+++.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778889999999999999864 7899999987643 3344577889999999999999999999998776 789
Q ss_pred EEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCC
Q 003139 575 LVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGP 654 (845)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~ 654 (845)
+|+||+. ++|.+.+... ..+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++...
T Consensus 81 lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 9999996 5777776433 468999999999999999999999 899999999999999999999999999997643
Q ss_pred CCCCcccccccccCCCcCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchh---
Q 003139 655 ALDQTHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLD--- 730 (845)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~--- 730 (845)
.. .........++..|+|||.+.+. .++.++|||||||++|||++|+.||....+.+..... ..........
T Consensus 155 ~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i---~~~~g~~~~~~~~ 230 (372)
T cd07853 155 PD-ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLI---TDLLGTPSLEAMR 230 (372)
T ss_pred cC-ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHH---HHHcCCCCHHHHH
Confidence 21 12222344678899999998874 5799999999999999999999999765443221111 0100000000
Q ss_pred --------hhhccccC-------CCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003139 731 --------QIMDSNLV-------GKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNL 774 (845)
Q Consensus 731 --------~~~d~~l~-------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L 774 (845)
.+...... ..........+.+++.+||+.||++|||+.|++++-
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 289 (372)
T cd07853 231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHP 289 (372)
T ss_pred HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCH
Confidence 00000000 011122356788999999999999999999998764
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=319.12 Aligned_cols=257 Identities=24% Similarity=0.375 Sum_probs=205.6
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCc----EEEEEEcCCCC-hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGT----KVAVKRGNPRS-EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMIL 575 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 575 (845)
.+|+..+.||+|+||.||+|.+. +|. .+++|...... .....++.+|+.++++++||||++++++|.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 45677889999999999999865 333 58999876553 4456789999999999999999999999987 78999
Q ss_pred EEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCC
Q 003139 576 VYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPA 655 (845)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~ 655 (845)
|+||+++|+|.+++.... ..+++..++.++.|++.||+|||+ .+++||||||+|||+++++.+||+|||+++....
T Consensus 86 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 999999999999986543 358999999999999999999998 9999999999999999999999999999986543
Q ss_pred CCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhc
Q 003139 656 LDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMD 734 (845)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (845)
...........++..|+|||.+....++.++||||||+++|||++ |+.||......+ +..... .+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~-~~------- 227 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE------IPDLLE-KG------- 227 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH------HHHHHh-CC-------
Confidence 222211222334568999999998899999999999999999998 999986543211 111111 11
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 003139 735 SNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779 (845)
Q Consensus 735 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~ 779 (845)
.....+..+...+.+++.+||..+|.+||++.++++.|+.+.+
T Consensus 228 --~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 228 --ERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred --CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0111222344578899999999999999999999999998755
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=323.87 Aligned_cols=262 Identities=23% Similarity=0.357 Sum_probs=202.1
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-----------------CCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-----------------DGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSL 563 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-----------------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l 563 (845)
++|+..+.||+|+||.||++... ++..+|+|..... .....++|.+|++++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46888889999999999998532 2346899988654 34456789999999999999999999
Q ss_pred EEEEecCCcEEEEEEeccCCCccccccCCC---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcE
Q 003139 564 IGYCDERSEMILVYEYMANGPLRSHLYGTD---------LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNI 634 (845)
Q Consensus 564 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NI 634 (845)
++++...+..++||||+++++|.+++.... ...+++.+++.++.|++.||+|||+ .+++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheE
Confidence 999999999999999999999999886432 1247889999999999999999998 8999999999999
Q ss_pred EECCCCceEEEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc--CCCCCCCCCCcc
Q 003139 635 LLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC--TRPALNPVLPRE 712 (845)
Q Consensus 635 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt--g~~p~~~~~~~~ 712 (845)
|+++++.+||+|||+++...............++..|++||....+.++.++|||||||++|||++ |..||......+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999976432221111222344678999999988899999999999999999998 667775432221
Q ss_pred cccHHHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 713 QVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 713 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
.............. ......+..++..+.+++.+||+.+|.+||++.+|++.|+
T Consensus 242 ---~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 242 ---VIENTGEFFRDQGR------QVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred ---HHHHHHHHHhhccc------cccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 11111111111000 0001112334578899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=331.51 Aligned_cols=242 Identities=24% Similarity=0.337 Sum_probs=195.7
Q ss_pred eeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcEEEEEEeccC
Q 003139 508 LLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERSEMILVYEYMAN 582 (845)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 582 (845)
+.||+|+||.||+|... +++.+|+|.+... .....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999876 5788999987643 233456678899999888 799999999999999999999999999
Q ss_pred CCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcccc
Q 003139 583 GPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVS 662 (845)
Q Consensus 583 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 662 (845)
|+|..++... ..+++.++..++.|++.||.|||+ .+|+||||||+|||+++++.+||+|||+++.... .....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~~~~ 153 (318)
T cd05570 81 GDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL--GGVTT 153 (318)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCc--CCCcc
Confidence 9999888543 469999999999999999999998 9999999999999999999999999999875221 11122
Q ss_pred cccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCC
Q 003139 663 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVN 742 (845)
Q Consensus 663 ~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 742 (845)
....|+..|+|||++.+..++.++|||||||++|||++|+.||......+ .... +..... .++
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~------~~~~---------i~~~~~--~~~ 216 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE------LFQS---------ILEDEV--RYP 216 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH------HHHH---------HHcCCC--CCC
Confidence 34568999999999999999999999999999999999999996433211 1111 111111 122
Q ss_pred HHHHHHHHHHHHHhhhhCCCCCCCH-----HHHHHH
Q 003139 743 PASLKKFGETAEKCLAEHGVDRPSM-----GDVLWN 773 (845)
Q Consensus 743 ~~~~~~l~~l~~~cl~~~p~~RPs~-----~~vl~~ 773 (845)
......+.+++.+||+.+|.+||++ .+++++
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 3345678899999999999999999 776643
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=314.23 Aligned_cols=247 Identities=28% Similarity=0.436 Sum_probs=199.7
Q ss_pred eeeeeceEEEEEEEEcCCcEEEEEEcCCCCh-HhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEeccCCCccc
Q 003139 509 LLGVGGFGRVYKGTLDDGTKVAVKRGNPRSE-QGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRS 587 (845)
Q Consensus 509 ~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~ 587 (845)
+||+|+||.||++...+++.+++|+...... ...+.+.+|++++++++|+||+++++++.+....++||||+++++|.+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~ 81 (251)
T cd05041 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLT 81 (251)
T ss_pred ccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHH
Confidence 6999999999999987789999998765433 356789999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCccccccccc
Q 003139 588 HLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKG 667 (845)
Q Consensus 588 ~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 667 (845)
++.... ..+++..++.++.+++.||+|||+ ++++||||||+|||+++++.+||+|||+++................
T Consensus 82 ~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 82 FLRKKK-NRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 986543 368899999999999999999998 8999999999999999999999999999976432111111112233
Q ss_pred CCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCCHHHH
Q 003139 668 SFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASL 746 (845)
Q Consensus 668 t~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 746 (845)
+..|+|||.+.++.++.++||||||++++||++ |..||....... ... .++.......+...+
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~---~~~-------------~~~~~~~~~~~~~~~ 221 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ---TRE-------------RIESGYRMPAPQLCP 221 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH---HHH-------------HHhcCCCCCCCccCC
Confidence 567999999998999999999999999999999 777775433211 000 011111111233456
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 747 KKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 747 ~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
..+.+++.+|+..+|.+||++.|+++.|+
T Consensus 222 ~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 222 EEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 68999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=335.02 Aligned_cols=250 Identities=25% Similarity=0.372 Sum_probs=209.6
Q ss_pred cceeeeeeceEEEEEEEEc--CCc--EEEEEEcCCCChH-hHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEec
Q 003139 506 ESLLLGVGGFGRVYKGTLD--DGT--KVAVKRGNPRSEQ-GIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYM 580 (845)
Q Consensus 506 ~~~~LG~G~fg~Vy~~~~~--~g~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 580 (845)
..++||+|.||.|++|.|. +|+ .||||.+...... ...+|++|+.+|.+|+|+|+++|+|+..+ ....||+|.+
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 3457999999999999986 344 5899998876544 67899999999999999999999999987 7889999999
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcc
Q 003139 581 ANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH 660 (845)
Q Consensus 581 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 660 (845)
+.|+|.+.|++.....|-...+..++.|||.||.||.. +++|||||..+|+||-....+||+||||.|.....++.+
T Consensus 193 plGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y 269 (1039)
T KOG0199|consen 193 PLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY 269 (1039)
T ss_pred ccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCCCcce
Confidence 99999999988666788889999999999999999998 999999999999999999999999999999866544433
Q ss_pred c-ccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCC-CCCCCCCCcccccHHHHHHHHhhcCchhhhhccccC
Q 003139 661 V-STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTR-PALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLV 738 (845)
Q Consensus 661 ~-~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~-~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 738 (845)
. ....+-.+.|+|||.++.+.++.+||||+|||.||||+++. .||-+..... +.+.+|....
T Consensus 270 vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q----------------IL~~iD~~er 333 (1039)
T KOG0199|consen 270 VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ----------------ILKNIDAGER 333 (1039)
T ss_pred EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH----------------HHHhcccccc
Confidence 3 23445677899999999999999999999999999999854 5664433211 2233343333
Q ss_pred CCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 739 GKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 739 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
-..++.|++.+.++++.||..+|++||++.+|.+.+-
T Consensus 334 LpRPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 334 LPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred CCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 3456789999999999999999999999999985543
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=319.67 Aligned_cols=250 Identities=23% Similarity=0.295 Sum_probs=199.6
Q ss_pred CCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEec
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYM 580 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 580 (845)
+|+..++||+|+||.||+|... +++.+|+|..... .....+++.+|++++++++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 5677889999999999999864 6888999987543 3445567999999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcc
Q 003139 581 ANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH 660 (845)
Q Consensus 581 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 660 (845)
++++|..+. .+++..+..++.|++.||+|||+ .+|+|+||||+|||++.++.+||+|||++..... .
T Consensus 82 ~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~----~ 148 (279)
T cd06619 82 DGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN----S 148 (279)
T ss_pred CCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc----c
Confidence 999986542 47888999999999999999999 9999999999999999999999999999975322 1
Q ss_pred cccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCccccc-HHHHHHHHhhcCchhhhhccccCC
Q 003139 661 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVN-IAEWAMTWQKKGMLDQIMDSNLVG 739 (845)
Q Consensus 661 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~-l~~~~~~~~~~~~~~~~~d~~l~~ 739 (845)
......|+..|+|||++.+..++.++||||||+++|||++|+.||.......... ...+.. .+.+.....
T Consensus 149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~---------~~~~~~~~~ 219 (279)
T cd06619 149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQ---------CIVDEDPPV 219 (279)
T ss_pred cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHH---------HHhccCCCC
Confidence 2234578899999999999999999999999999999999999986533222111 111111 111111111
Q ss_pred CCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003139 740 KVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNL 774 (845)
Q Consensus 740 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L 774 (845)
.........+.+++.+|++.+|++||++++++++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~ 254 (279)
T cd06619 220 LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHP 254 (279)
T ss_pred CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence 11122345688999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=324.16 Aligned_cols=250 Identities=22% Similarity=0.335 Sum_probs=204.6
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEec
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYM 580 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 580 (845)
.+|+..+.||+|+||.||+|... +++.+++|.+........+.+.+|+++++.++|+||+++++.+......++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 57888889999999999999864 68899999887665555678899999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcc
Q 003139 581 ANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH 660 (845)
Q Consensus 581 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 660 (845)
++++|.+++.. ..+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 100 ~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~--~ 171 (296)
T cd06654 100 AGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--S 171 (296)
T ss_pred CCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhccccc--c
Confidence 99999998853 358999999999999999999998 899999999999999999999999999987533211 1
Q ss_pred cccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCC
Q 003139 661 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGK 740 (845)
Q Consensus 661 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 740 (845)
......+++.|+|||.+.+..++.++|||||||++|||++|+.||....+... + ......+ .....
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~-----~-~~~~~~~--------~~~~~ 237 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-----L-YLIATNG--------TPELQ 237 (296)
T ss_pred ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh-----H-HHHhcCC--------CCCCC
Confidence 12334688899999999998999999999999999999999999965432211 1 1110100 00001
Q ss_pred CCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 741 VNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 741 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.+......+.+++.+||..+|++||++.++++.
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 123445678899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=321.13 Aligned_cols=251 Identities=24% Similarity=0.359 Sum_probs=200.8
Q ss_pred CCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC---hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 504 FDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS---EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 504 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
|+..+.||+|+||+||+|... +++.+|+|.+.... ....+.+.+|++++++++|+|++++.+.+..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566788999999999999875 68899999876432 22345678899999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCc
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT 659 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~ 659 (845)
+++++|.+++.......+++..+..++.|++.||.|||+ .+|+||||||+||++++++.+||+|||++......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~--- 155 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG--- 155 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCC---
Confidence 999999988865555579999999999999999999998 89999999999999999999999999998653321
Q ss_pred ccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCC
Q 003139 660 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVG 739 (845)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 739 (845)
.......|+..|+|||.+.+..++.++|+|||||++|||++|+.||........ ...+.. .+.+.. .
T Consensus 156 ~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~--~~~~~~---------~~~~~~--~ 222 (285)
T cd05632 156 ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK--REEVDR---------RVLETE--E 222 (285)
T ss_pred CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHH---------hhhccc--c
Confidence 112345689999999999999999999999999999999999999975432211 111100 011100 1
Q ss_pred CCCHHHHHHHHHHHHHhhhhCCCCCCC-----HHHHHHH
Q 003139 740 KVNPASLKKFGETAEKCLAEHGVDRPS-----MGDVLWN 773 (845)
Q Consensus 740 ~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~~vl~~ 773 (845)
.+.......+.+++.+|++.+|++||+ +.+++.+
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 122344567789999999999999999 5566554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=340.84 Aligned_cols=253 Identities=21% Similarity=0.268 Sum_probs=197.3
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC---hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS---EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
++|++.+.||+|+||.||+++.. +++.+|+|.+.... ....+.+.+|++++++++|+||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36888999999999999999865 68899999875432 223466889999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 81 E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 81 DYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 999999999998543 468889999999999999999999 999999999999999999999999999975211000
Q ss_pred -----------------------------------------CcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHH
Q 003139 658 -----------------------------------------QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLM 696 (845)
Q Consensus 658 -----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ 696 (845)
.........||+.|||||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 000112357999999999999999999999999999999
Q ss_pred HHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCC---CHHHHHHH
Q 003139 697 EVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRP---SMGDVLWN 773 (845)
Q Consensus 697 Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP---s~~~vl~~ 773 (845)
||++|+.||....+.+. ........ ..+...........+.+++.+|+ .+|.+|+ ++.+++++
T Consensus 236 ell~G~~Pf~~~~~~~~------~~~i~~~~-------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 236 EMLVGQPPFLADTPAET------QLKVINWE-------TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred ehhhCCCCCCCCCHHHH------HHHHhccC-------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 99999999975443221 11100000 00000011123455667777766 5999999 88888766
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=334.25 Aligned_cols=238 Identities=24% Similarity=0.315 Sum_probs=193.3
Q ss_pred eeeeeeceEEEEEEEE----cCCcEEEEEEcCCCC--hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEecc
Q 003139 508 LLLGVGGFGRVYKGTL----DDGTKVAVKRGNPRS--EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMA 581 (845)
Q Consensus 508 ~~LG~G~fg~Vy~~~~----~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 581 (845)
+.||+|+||.||+++. .+|+.+|+|++.... ......+..|++++++++||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 4799999999999875 357899999876432 2234567789999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCccc
Q 003139 582 NGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHV 661 (845)
Q Consensus 582 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 661 (845)
+|+|.+++... ..+++..+..++.|+++||+|||+ .+|+||||||+|||+++++.+||+|||+++..... ...
T Consensus 82 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~--~~~ 154 (318)
T cd05582 82 GGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--EKK 154 (318)
T ss_pred CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC--CCc
Confidence 99999988543 468999999999999999999999 99999999999999999999999999999763321 122
Q ss_pred ccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCC
Q 003139 662 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKV 741 (845)
Q Consensus 662 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 741 (845)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||......+ ... .+.... ..+
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~------~~~---------~i~~~~--~~~ 217 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE------TMT---------MILKAK--LGM 217 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH------HHH---------HHHcCC--CCC
Confidence 234678999999999999999999999999999999999999996532211 111 111111 112
Q ss_pred CHHHHHHHHHHHHHhhhhCCCCCCCHHH
Q 003139 742 NPASLKKFGETAEKCLAEHGVDRPSMGD 769 (845)
Q Consensus 742 ~~~~~~~l~~l~~~cl~~~p~~RPs~~~ 769 (845)
+......+.+++.+||+.+|++||++.+
T Consensus 218 p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 PQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 3344567889999999999999999555
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=329.38 Aligned_cols=241 Identities=24% Similarity=0.337 Sum_probs=192.3
Q ss_pred eeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC---hHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcEEEEEEeccC
Q 003139 508 LLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS---EQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERSEMILVYEYMAN 582 (845)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 582 (845)
+.||+|+||.||+|... +++.||+|.+.... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999976 57889999876431 23345667788888764 899999999999999999999999999
Q ss_pred CCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcccc
Q 003139 583 GPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVS 662 (845)
Q Consensus 583 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 662 (845)
|+|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.... .....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~ 153 (316)
T cd05619 81 GDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENML--GDAKT 153 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCC--CCCce
Confidence 9999988543 468999999999999999999998 8999999999999999999999999999875221 11122
Q ss_pred cccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCC
Q 003139 663 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVN 742 (845)
Q Consensus 663 ~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 742 (845)
....||..|+|||++.+..++.++|||||||++|||++|+.||......+ +.. . .... .+ .++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~~---~-i~~~------~~----~~~ 216 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE---LFQ---S-IRMD------NP----CYP 216 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH---HHH---H-HHhC------CC----CCC
Confidence 34578999999999999999999999999999999999999996543211 111 1 0000 01 122
Q ss_pred HHHHHHHHHHHHHhhhhCCCCCCCHH-HHHH
Q 003139 743 PASLKKFGETAEKCLAEHGVDRPSMG-DVLW 772 (845)
Q Consensus 743 ~~~~~~l~~l~~~cl~~~p~~RPs~~-~vl~ 772 (845)
......+.+++.+||+.+|++||++. ++++
T Consensus 217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 217 RWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 23445678999999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=314.67 Aligned_cols=248 Identities=27% Similarity=0.376 Sum_probs=197.4
Q ss_pred eeeeeeceEEEEEEEEcC----CcEEEEEEcCCCCh-HhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEeccC
Q 003139 508 LLLGVGGFGRVYKGTLDD----GTKVAVKRGNPRSE-QGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMAN 582 (845)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 582 (845)
+.||+|+||.||+|+... +..+|+|....... ...+++.+|+++++++.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 369999999999997542 26799998775543 34578999999999999999999999876 4568999999999
Q ss_pred CCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcc-c
Q 003139 583 GPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH-V 661 (845)
Q Consensus 583 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~-~ 661 (845)
|+|.+++.... .+++..++.++.|++.||+|||+ .+++||||||+|||+++++.+||+|||+++......... .
T Consensus 80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~ 154 (257)
T cd05060 80 GPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154 (257)
T ss_pred CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence 99999996543 78999999999999999999998 899999999999999999999999999998643222111 1
Q ss_pred ccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCC
Q 003139 662 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGK 740 (845)
Q Consensus 662 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 740 (845)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .+..+.. ... ...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~~~~~----~~~---------~~~ 218 (257)
T cd05060 155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVIAMLE----SGE---------RLP 218 (257)
T ss_pred ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHH----cCC---------cCC
Confidence 112234567999999999999999999999999999998 99998654321 1111111 110 011
Q ss_pred CCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 003139 741 VNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYA 777 (845)
Q Consensus 741 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~ 777 (845)
.+...+..+.+++.+||..+|++||++.++++.|+..
T Consensus 219 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 219 RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 2234456788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=314.92 Aligned_cols=251 Identities=27% Similarity=0.419 Sum_probs=195.1
Q ss_pred eeeeeeceEEEEEEEEc----CCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEe-cCCcEEEEEEecc
Q 003139 508 LLLGVGGFGRVYKGTLD----DGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCD-ERSEMILVYEYMA 581 (845)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~-~~~~~~lV~Ey~~ 581 (845)
+.||+|+||.||+|.+. ++..+|+|+.... .....+.+.+|+.+++.++||||++++++|. .++..++|+||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 36899999999999864 2356999987543 3455678899999999999999999999875 4556899999999
Q ss_pred CCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCC--c
Q 003139 582 NGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQ--T 659 (845)
Q Consensus 582 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~--~ 659 (845)
+|+|.+++.... ..+++..++.++.|++.||+|||+ .+++||||||+|||+++++.+||+|||+++....... .
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 81 HGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 999999986442 357888899999999999999998 8999999999999999999999999999975332111 1
Q ss_pred ccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCC-CCCCCCCCcccccHHHHHHHHhhcCchhhhhccccC
Q 003139 660 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTR-PALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLV 738 (845)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~-~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 738 (845)
.......++..|+|||.+.+..++.++|||||||++|||++|+ +|+..... .+......... .
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~------~~~~~~~~~~~----------~ 220 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS------FDITVYLLQGR----------R 220 (262)
T ss_pred cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHhcCC----------C
Confidence 1112345677899999999999999999999999999999964 55543221 11111111110 0
Q ss_pred CCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhh
Q 003139 739 GKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYAL 778 (845)
Q Consensus 739 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~ 778 (845)
...+...+..+.+++.+||+.+|++||++.++++.|+.+.
T Consensus 221 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 221 LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 0112223567889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=329.16 Aligned_cols=240 Identities=23% Similarity=0.325 Sum_probs=192.3
Q ss_pred eeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC---hHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcEEEEEEeccC
Q 003139 508 LLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS---EQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERSEMILVYEYMAN 582 (845)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 582 (845)
+.||+|+||.||+|+.. +|+.||+|.+.... ....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36999999999999976 68899999876431 23345667788888764 899999999999999999999999999
Q ss_pred CCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcccc
Q 003139 583 GPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVS 662 (845)
Q Consensus 583 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 662 (845)
|+|..++... ..+++.++..++.|+++||+|||+ ++|+||||||+|||+++++.+||+|||+++.... .....
T Consensus 81 g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~ 153 (316)
T cd05620 81 GDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF--GDNRA 153 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeeccc--CCCce
Confidence 9999888543 468999999999999999999999 9999999999999999999999999999874221 11223
Q ss_pred cccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCC
Q 003139 663 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVN 742 (845)
Q Consensus 663 ~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 742 (845)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ + ... ...+ . ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~---~---~~~-~~~~------~----~~~~ 216 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE---L---FES-IRVD------T----PHYP 216 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---H---HHH-HHhC------C----CCCC
Confidence 45678999999999999999999999999999999999999996543211 1 111 1100 0 1122
Q ss_pred HHHHHHHHHHHHHhhhhCCCCCCCHH-HHH
Q 003139 743 PASLKKFGETAEKCLAEHGVDRPSMG-DVL 771 (845)
Q Consensus 743 ~~~~~~l~~l~~~cl~~~p~~RPs~~-~vl 771 (845)
......+.+++.+||+.||++||++. +++
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 217 RWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 23456788999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=329.60 Aligned_cols=242 Identities=24% Similarity=0.355 Sum_probs=195.0
Q ss_pred CCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhCC-CCCcceEEEEEecCCcEEEEE
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLR-HRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 577 (845)
+|+..+.||+|+||.||+|... +|+.||+|++... .....+.+..|.+++..+. |++|+++.+++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677889999999999999865 6889999987643 2334566788999998885 577888999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
||+++|+|.+++... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++....
T Consensus 81 Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~-- 153 (323)
T cd05615 81 EYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV-- 153 (323)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCC--
Confidence 999999999988543 469999999999999999999998 8999999999999999999999999999875322
Q ss_pred CcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcccc
Q 003139 658 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNL 737 (845)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (845)
.........||+.|+|||++.++.++.++|||||||++|||++|+.||....... + ...+.....
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~------------~~~i~~~~~ 218 (323)
T cd05615 154 DGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE---L------------FQSIMEHNV 218 (323)
T ss_pred CCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH---H------------HHHHHhCCC
Confidence 1112234568999999999999999999999999999999999999997543211 1 111111111
Q ss_pred CCCCCHHHHHHHHHHHHHhhhhCCCCCCCHH
Q 003139 738 VGKVNPASLKKFGETAEKCLAEHGVDRPSMG 768 (845)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ 768 (845)
..+......+.+++.+||+.+|.+|++..
T Consensus 219 --~~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 219 --SYPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred --CCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 12334456788999999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=325.15 Aligned_cols=264 Identities=24% Similarity=0.318 Sum_probs=204.4
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
++|++.+.||+|+||.||++... ++..+++|..... .....+++.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888999999999999999876 5788899987644 344456788999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCc
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT 659 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~ 659 (845)
+++++|.+++... ..+++..+..++.|+++||.|||+ ..+++||||||+|||+++++.+||+|||+++....
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---- 152 (308)
T cd06615 81 MDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---- 152 (308)
T ss_pred cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccc----
Confidence 9999999998644 468999999999999999999997 25899999999999999999999999999875322
Q ss_pred ccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcC------------
Q 003139 660 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKG------------ 727 (845)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~------------ 727 (845)
.......++..|+|||.+.+..++.++||||||+++|||++|+.||....... ...+........
T Consensus 153 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
T cd06615 153 SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE---LEAMFGRPVSEGEAKESHRPVSGH 229 (308)
T ss_pred cccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh---HHHhhcCccccccccCCcccccCC
Confidence 11234568899999999988889999999999999999999999986433211 111000000000
Q ss_pred --------chhhhhccccC---CCCC-HHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003139 728 --------MLDQIMDSNLV---GKVN-PASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEY 776 (845)
Q Consensus 728 --------~~~~~~d~~l~---~~~~-~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~ 776 (845)
...+..+.... ...+ ......+.+++.+||+.+|++||++.+++++...
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~ 290 (308)
T cd06615 230 PPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI 290 (308)
T ss_pred CCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 00000000000 0011 1234568899999999999999999999887554
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=322.92 Aligned_cols=260 Identities=25% Similarity=0.401 Sum_probs=203.4
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCc----EEEEEEcCCCC-hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGT----KVAVKRGNPRS-EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMIL 575 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 575 (845)
++|+..+.||+|+||.||+|.+. +|. .+|+|...... .....++.+|+.++++++||||++++|+|... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 45777889999999999999864 444 47888876543 33345789999999999999999999999754 5779
Q ss_pred EEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCC
Q 003139 576 VYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPA 655 (845)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~ 655 (845)
++||+++|+|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++....
T Consensus 86 v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 86 VTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred eehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccccC
Confidence 99999999999998644 2368999999999999999999998 8999999999999999999999999999986433
Q ss_pred CCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhc
Q 003139 656 LDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMD 734 (845)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (845)
...........++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ..++. ..+.
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---~~~~~----~~~~------ 228 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---IPDLL----EKGE------ 228 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----HCCC------
Confidence 222212223445678999999999999999999999999999997 888885432111 11111 1110
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhhhc
Q 003139 735 SNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLEE 782 (845)
Q Consensus 735 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~~ 782 (845)
....+..+...+.+++.+||..+|++||++.++++.|+.+...+.
T Consensus 229 ---~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (303)
T cd05110 229 ---RLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ 273 (303)
T ss_pred ---CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence 011122344578899999999999999999999999998755433
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=316.58 Aligned_cols=256 Identities=25% Similarity=0.347 Sum_probs=204.6
Q ss_pred cCCCcceeeeeeceEEEEEEEEcC----CcEEEEEEcCCCC-hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLDD----GTKVAVKRGNPRS-EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILV 576 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 576 (845)
++|...+.||+|+||.||+|...+ ...+++|...... .+..+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 457778899999999999998643 2468999876554 5566789999999999999999999999875 567899
Q ss_pred EEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCC
Q 003139 577 YEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPAL 656 (845)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~ 656 (845)
|||+++|+|.+++.... ..+++..++.++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 85 MELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 99999999999986532 368999999999999999999998 89999999999999999999999999999764332
Q ss_pred CCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcc
Q 003139 657 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDS 735 (845)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (845)
.........++..|+|||.+....++.++||||||++++||++ |+.||......+ ...+ . ..+.
T Consensus 161 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~~---~-~~~~------- 225 (270)
T cd05056 161 -SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND---VIGR---I-ENGE------- 225 (270)
T ss_pred -cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHH---H-HcCC-------
Confidence 1111223334568999999998899999999999999999986 999986543221 1111 1 1110
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 003139 736 NLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779 (845)
Q Consensus 736 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~ 779 (845)
....+..++..+.+++.+|+..+|.+||++.++++.|+.+..
T Consensus 226 --~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 226 --RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred --cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 001223455678999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=320.31 Aligned_cols=251 Identities=26% Similarity=0.391 Sum_probs=201.7
Q ss_pred CCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEeccC
Q 003139 504 FDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMAN 582 (845)
Q Consensus 504 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 582 (845)
|++.+.||+|+||.||+|... ++..+++|..........+.+.+|+++++.++|||++++++++...+..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 455668999999999999976 4778899988777777778899999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcccc
Q 003139 583 GPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVS 662 (845)
Q Consensus 583 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 662 (845)
++|..++... ..++++..+..++.|+++||+|||+ .+++||||||+|||++.++.+||+|||+++.... .....
T Consensus 87 ~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~--~~~~~ 160 (282)
T cd06643 87 GAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--TIQRR 160 (282)
T ss_pred CcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEccccccccccc--ccccc
Confidence 9998887543 3479999999999999999999999 8999999999999999999999999999875332 11122
Q ss_pred cccccCCCcCChhhhc-----cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcccc
Q 003139 663 TAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNL 737 (845)
Q Consensus 663 ~~~~gt~~y~aPE~~~-----~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (845)
....++..|+|||++. +..++.++|||||||++|||++|++||......+. ....... . .+.+
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~------~~~~~~~-~-----~~~~ 228 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV------LLKIAKS-E-----PPTL 228 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH------HHHHhhc-C-----CCCC
Confidence 3456889999999984 45678899999999999999999999865332111 1111000 0 0011
Q ss_pred CCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003139 738 VGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNL 774 (845)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L 774 (845)
..+......+.+++.+||+.+|.+||++.+++++-
T Consensus 229 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 229 --AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred --CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 11223456788999999999999999999987653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=321.16 Aligned_cols=270 Identities=27% Similarity=0.400 Sum_probs=206.2
Q ss_pred CCCcceeeeeeceEEEEEEEEc-----CCcEEEEEEcCCCChH-hHHHHHHHHHHHHhCCCCCcceEEEEEec--CCcEE
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-----DGTKVAVKRGNPRSEQ-GIAEFRTEIEMLSKLRHRHLVSLIGYCDE--RSEMI 574 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-----~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~ 574 (845)
.|+..+.||+|+||.||+|++. .+..+|+|.+...... ..++|.+|++++++++|+||+++++++.. ....+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 4666788999999999999864 3678999988765443 56789999999999999999999999977 56789
Q ss_pred EEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCC
Q 003139 575 LVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGP 654 (845)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~ 654 (845)
+||||+++++|.+++.... ..+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++....
T Consensus 85 lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred EEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 9999999999999996543 369999999999999999999998 899999999999999999999999999998754
Q ss_pred CCCCcc-cccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhh
Q 003139 655 ALDQTH-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIM 733 (845)
Q Consensus 655 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (845)
...... ......++..|+|||.+.+..++.++||||||++++||++|+.|+............. .........+.+.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 239 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI-AQGQMIVTRLLELL 239 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc-ccccccHHHHHHHH
Confidence 221111 1112344567999999998999999999999999999999998875432211000000 00000000011111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 003139 734 DSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYA 777 (845)
Q Consensus 734 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~ 777 (845)
........+..++..+.+++.+||+.+|++||++.||+++|+.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 240 KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11111122234457799999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=314.03 Aligned_cols=250 Identities=26% Similarity=0.390 Sum_probs=204.3
Q ss_pred cCCCcceeeeeeceEEEEEEEEcC-CcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEec
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLDD-GTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYM 580 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 580 (845)
++|+..+.||+|+||.||+|...+ ++.+++|.+..... .+++.+|++++++++|+||+++++++.+....++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 568888899999999999999874 78999998765433 678999999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcc
Q 003139 581 ANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH 660 (845)
Q Consensus 581 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 660 (845)
++++|.+++.... ..+++..+..++.|++.||.|||+ .+++||||+|+||++++++.+||+|||++....... .
T Consensus 81 ~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~--~ 154 (256)
T cd06612 81 GAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM--A 154 (256)
T ss_pred CCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCc--c
Confidence 9999999985433 578999999999999999999998 899999999999999999999999999987643321 1
Q ss_pred cccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCC
Q 003139 661 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGK 740 (845)
Q Consensus 661 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 740 (845)
......++..|+|||.+.+..++.++||||||+++|||++|+.|+....+..... .... ...+. ..
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~-------~~~~-----~~~~~--~~ 220 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF-------MIPN-----KPPPT--LS 220 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh-------hhcc-----CCCCC--CC
Confidence 2233457889999999999999999999999999999999999987543322110 0000 00000 11
Q ss_pred CCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 741 VNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 741 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.+......+.+++.+|++.+|++||++.+++++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred chhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 123345678999999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=323.27 Aligned_cols=261 Identities=25% Similarity=0.329 Sum_probs=194.6
Q ss_pred CCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC--hHhHHHHHHHHHHHHhC---CCCCcceEEEEEec-----CC
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS--EQGIAEFRTEIEMLSKL---RHRHLVSLIGYCDE-----RS 571 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~-----~~ 571 (845)
+|+..+.||+|+||.||+|... +++.+|+|.+.... ......+.+|+++++++ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778889999999999999876 68899999876432 11223455677777665 79999999998854 34
Q ss_pred cEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccC
Q 003139 572 EMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSK 651 (845)
Q Consensus 572 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~ 651 (845)
..++||||++ ++|.+++.......+++.++..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCccc
Confidence 5799999997 588888866555568999999999999999999999 899999999999999999999999999997
Q ss_pred CCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhh
Q 003139 652 TGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQ 731 (845)
Q Consensus 652 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (845)
.... ........|+..|+|||++.+..++.++|||||||++|||++|++||......+. +.... ..........
T Consensus 157 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~--~~~~~-~~~~~~~~~~ 230 (288)
T cd07863 157 IYSC---QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ--LGKIF-DLIGLPPEDD 230 (288)
T ss_pred cccC---cccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH--HHHHH-HHhCCCChhh
Confidence 6432 1222345678999999999999999999999999999999999999865432211 11100 0000000000
Q ss_pred ----------hhcccc---CCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 732 ----------IMDSNL---VGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 732 ----------~~d~~l---~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
...+.. .....+.....+.+++.+||+.||++||++.|++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000 001112345678899999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=321.22 Aligned_cols=262 Identities=26% Similarity=0.421 Sum_probs=204.2
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-----CCcEEEEEEcCCCC-hHhHHHHHHHHHHHHhCCCCCcceEEEEEecC--CcE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-----DGTKVAVKRGNPRS-EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDER--SEM 573 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-----~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 573 (845)
..|.+.+.||+|+||.||+++++ ++..+|+|.+.... ....+.+.+|++++++++|||++++.+++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 34677889999999999999742 47789999987553 44557899999999999999999999999775 568
Q ss_pred EEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCC
Q 003139 574 ILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTG 653 (845)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~ 653 (845)
++||||+++++|.+++.... ..++|.+++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++..
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCcccccc
Confidence 99999999999999985432 368999999999999999999998 99999999999999999999999999999864
Q ss_pred CCCCCc-ccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCc---------ccccHHHHHHHH
Q 003139 654 PALDQT-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPR---------EQVNIAEWAMTW 723 (845)
Q Consensus 654 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~---------~~~~l~~~~~~~ 723 (845)
...... .......++..|+|||++.+..++.++||||||+++|||++++.|....... .+.....+.. .
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 238 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR-V 238 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH-H
Confidence 322111 1122345677899999999989999999999999999999988654321100 0111111111 1
Q ss_pred hhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 003139 724 QKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYA 777 (845)
Q Consensus 724 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~ 777 (845)
...+ .....+...+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 239 ~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 LEEG---------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHcC---------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1111 11112234567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=313.90 Aligned_cols=251 Identities=31% Similarity=0.463 Sum_probs=201.7
Q ss_pred cCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEecc
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMA 581 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 581 (845)
.+|+..+.||+|+||.||+|.+.++..+++|.+..... ...+|.+|++++++++|||++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 35777889999999999999987788899998764432 23578899999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCccc
Q 003139 582 NGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHV 661 (845)
Q Consensus 582 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 661 (845)
+++|.+++.... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++..... ....
T Consensus 83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~-~~~~ 157 (256)
T cd05112 83 HGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD-QYTS 157 (256)
T ss_pred CCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccC-cccc
Confidence 999999886443 468999999999999999999998 89999999999999999999999999998753321 1111
Q ss_pred ccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCC
Q 003139 662 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGK 740 (845)
Q Consensus 662 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 740 (845)
.....++.+|+|||.+.++.++.++||||||+++|||++ |+.||......+ ..... .++ ....
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------~~~~~-~~~--~~~~------- 221 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE------VVETI-NAG--FRLY------- 221 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH------HHHHH-hCC--CCCC-------
Confidence 223335678999999998999999999999999999998 888886433211 11111 110 0001
Q ss_pred CCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003139 741 VNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNL 774 (845)
Q Consensus 741 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L 774 (845)
.+...+..+.+++.+||+.+|++||++.++++.|
T Consensus 222 ~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 222 KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 1122346788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=318.58 Aligned_cols=248 Identities=29% Similarity=0.444 Sum_probs=197.3
Q ss_pred eeeeeceEEEEEEEEcC-------CcEEEEEEcCCCC-hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEec
Q 003139 509 LLGVGGFGRVYKGTLDD-------GTKVAVKRGNPRS-EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYM 580 (845)
Q Consensus 509 ~LG~G~fg~Vy~~~~~~-------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 580 (845)
.||+|+||.||+|+..+ ++.+++|...... .....+|.+|+++++.++||||++++++|...+..++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 68999999999998642 2578999765433 344678899999999999999999999999999999999999
Q ss_pred cCCCccccccCC-----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCC-----ceEEEecccc
Q 003139 581 ANGPLRSHLYGT-----DLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNF-----VAKVADFGLS 650 (845)
Q Consensus 581 ~~gsL~~~l~~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~-----~~kl~DFGla 650 (845)
++++|.+++... ....++|.+++.++.|++.||+|||+ .+++|+||||+||+++.+. .+||+|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999998643 22348899999999999999999998 8999999999999999877 8999999999
Q ss_pred CCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCch
Q 003139 651 KTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGML 729 (845)
Q Consensus 651 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 729 (845)
+...............++..|+|||++.++.++.++|||||||++|||++ |+.||......+ . .... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~---~~~~-~~--- 228 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---V---LQHV-TA--- 228 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---H---HHHH-hc---
Confidence 75432222122223345678999999999999999999999999999998 998885432211 1 1111 11
Q ss_pred hhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 730 DQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 730 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
......+...+..+.+++.+||+.+|.+||++.+|++.|+
T Consensus 229 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 229 ------GGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred ------CCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 0111123345677889999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=316.52 Aligned_cols=238 Identities=24% Similarity=0.376 Sum_probs=189.3
Q ss_pred eeeeeceEEEEEEEEcC-------------CcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEE
Q 003139 509 LLGVGGFGRVYKGTLDD-------------GTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMIL 575 (845)
Q Consensus 509 ~LG~G~fg~Vy~~~~~~-------------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 575 (845)
.||+|+||.||+|++.. ...+++|.+..........|.+|+.++++++||||+++++++......++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l 81 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence 68999999999998542 22588998776655566788999999999999999999999999999999
Q ss_pred EEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCc-------eEEEecc
Q 003139 576 VYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFV-------AKVADFG 648 (845)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~-------~kl~DFG 648 (845)
||||+++|+|..++... ...+++..+++++.|+++||+|||+ .+|+||||||+|||++.++. +|++|||
T Consensus 82 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 82 VEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 99999999999887543 3468999999999999999999998 99999999999999987664 8999999
Q ss_pred ccCCCCCCCCcccccccccCCCcCChhhhc-cCCCCchhHHHHHHHHHHHHH-cCCCCCCCCCCcccccHHHHHHHHhhc
Q 003139 649 LSKTGPALDQTHVSTAVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLMEVL-CTRPALNPVLPREQVNIAEWAMTWQKK 726 (845)
Q Consensus 649 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDV~S~Gvvl~Ell-tg~~p~~~~~~~~~~~l~~~~~~~~~~ 726 (845)
++..... .....++..|+|||.+. +..++.++|||||||++|||+ .|+.|+......+. . ....
T Consensus 158 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~------~-~~~~- 223 (262)
T cd05077 158 IPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK------E-RFYE- 223 (262)
T ss_pred CCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH------H-HHHh-
Confidence 9865321 12345778899999887 567899999999999999998 57777653221110 0 0000
Q ss_pred CchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003139 727 GMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNL 774 (845)
Q Consensus 727 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L 774 (845)
.... ........+.+++.+||+.+|.+||++.+|++.|
T Consensus 224 --------~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 224 --------GQCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred --------cCcc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 0000 1112245688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=316.30 Aligned_cols=251 Identities=21% Similarity=0.308 Sum_probs=190.0
Q ss_pred eeeeeceEEEEEEEEcC---CcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEeccCCC
Q 003139 509 LLGVGGFGRVYKGTLDD---GTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGP 584 (845)
Q Consensus 509 ~LG~G~fg~Vy~~~~~~---g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 584 (845)
.||+|+||.||+|...+ ...+++|.+... .......|.+|++.++.++|+||+++++.|.+....++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 346888876544 33445678999999999999999999999999999999999999999
Q ss_pred ccccccCCC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCccc
Q 003139 585 LRSHLYGTD---LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHV 661 (845)
Q Consensus 585 L~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 661 (845)
|.+++.... ....++...+.++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 999986542 2335688889999999999999999 8999999999999999999999999999875332111111
Q ss_pred ccccccCCCcCChhhhcc-------CCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhh
Q 003139 662 STAVKGSFGYLDPEYFRR-------QQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIM 733 (845)
Q Consensus 662 ~~~~~gt~~y~aPE~~~~-------~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (845)
.....++..|+|||++.. ..++.++|||||||++|||++ |+.||......+ . ........ ...+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~---~~~~~~~~-~~~~~ 231 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ---V---LKQVVREQ-DIKLP 231 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH---H---HHHHhhcc-CccCC
Confidence 223345678999998753 457889999999999999999 677775432211 0 11111111 11111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003139 734 DSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNL 774 (845)
Q Consensus 734 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L 774 (845)
++ ..+......+.+++..|+ .+|++||++.+|++.|
T Consensus 232 ~~----~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 232 KP----QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred CC----cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 11 122344566778888888 5999999999999886
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=317.17 Aligned_cols=255 Identities=29% Similarity=0.430 Sum_probs=203.3
Q ss_pred cCCCcceeeeeeceEEEEEEEEc------CCcEEEEEEcCCCChH-hHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD------DGTKVAVKRGNPRSEQ-GIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMI 574 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 574 (845)
++|+....||+|+||.||+|+.+ +.+.+++|........ ..+++.+|++++++++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 46788889999999999999864 2456899987665443 5678999999999999999999999999999999
Q ss_pred EEEEeccCCCccccccCCC-------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEec
Q 003139 575 LVYEYMANGPLRSHLYGTD-------LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADF 647 (845)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DF 647 (845)
+||||+++|+|.+++.... ...+++..++.++.|++.||+|||+ .+|+||||||+|||+++++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999986543 1268999999999999999999998 89999999999999999999999999
Q ss_pred cccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhc
Q 003139 648 GLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKK 726 (845)
Q Consensus 648 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~ 726 (845)
|+++..... .........++..|+|||.+.+...+.++||||||++++||++ |..||....... .... ...
T Consensus 162 ~~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~------~~~~-~~~ 233 (275)
T cd05046 162 SLSKDVYNS-EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE------VLNR-LQA 233 (275)
T ss_pred ccccccCcc-cccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH------HHHH-HHc
Confidence 998753221 1111223356778999999998889999999999999999999 777775322111 1111 111
Q ss_pred CchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 727 GMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 727 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
+. +....+...+..+.+++.+||+.+|++||++.+++..|.
T Consensus 234 ~~--------~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 GK--------LELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CC--------cCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 11 111122345568899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=341.95 Aligned_cols=261 Identities=21% Similarity=0.249 Sum_probs=193.7
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecC--------C
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDER--------S 571 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--------~ 571 (845)
.++|...+.||+|+||.||+|... +++.||||++.... ....+|+.+|++++||||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 457999999999999999999875 68899999875432 2234799999999999999999876322 2
Q ss_pred cEEEEEEeccCCCccccccC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCC-ceEEEecc
Q 003139 572 EMILVYEYMANGPLRSHLYG--TDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNF-VAKVADFG 648 (845)
Q Consensus 572 ~~~lV~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~-~~kl~DFG 648 (845)
.+++||||+++ +|.+++.. .....+++..+..++.||+.||+|||+ .+|+||||||+||||+.++ .+||+|||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 46799999975 66665532 234578999999999999999999999 9999999999999999664 79999999
Q ss_pred ccCCCCCCCCcccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcC
Q 003139 649 LSKTGPALDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKG 727 (845)
Q Consensus 649 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 727 (845)
+++..... .......||+.|+|||++.+ ..++.++|||||||+||||++|++||......+.. .. ........
T Consensus 217 la~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~--~~-i~~~~~~p 290 (440)
T PTZ00036 217 SAKNLLAG---QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQL--VR-IIQVLGTP 290 (440)
T ss_pred cchhccCC---CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH--HH-HHHHhCCC
Confidence 99864321 12234568999999999876 46899999999999999999999999765433221 11 11111110
Q ss_pred chhhh---------------hccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 728 MLDQI---------------MDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 728 ~~~~~---------------~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
....+ ....+...++...+..+.+++.+||+.+|.+|||+.|++++-.
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~ 353 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPF 353 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChh
Confidence 00000 0000111122234467889999999999999999999987643
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=325.96 Aligned_cols=267 Identities=20% Similarity=0.283 Sum_probs=199.5
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC-hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS-EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
++|...+.||+|+||.||+|+.. +++.+|+|++.... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 46888889999999999999876 67889999876443 22334678899999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCc
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT 659 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~ 659 (845)
+++ +|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++..... .
T Consensus 86 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~ 158 (309)
T cd07872 86 LDK-DLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVP--T 158 (309)
T ss_pred CCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCC--c
Confidence 975 7877775432 458899999999999999999998 99999999999999999999999999999753221 1
Q ss_pred ccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHH---------HHhhcCch
Q 003139 660 HVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAM---------TWQKKGML 729 (845)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~---------~~~~~~~~ 729 (845)
.......++..|+|||.+.+ ..++.++|||||||++|||++|++||......+......... ........
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 11223467889999998865 568999999999999999999999997554332211111000 00000000
Q ss_pred hhhhccccCC----CCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 730 DQIMDSNLVG----KVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 730 ~~~~d~~l~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
...-.+.... ...+.....+.+++.+||+.||.+|||+.|++++-.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 288 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAY 288 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChh
Confidence 0000000000 011223456789999999999999999999987543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=313.03 Aligned_cols=251 Identities=24% Similarity=0.320 Sum_probs=205.9
Q ss_pred CCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
+|+..+.||.|+||.||.++.. +++.+++|++... +....+++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4778889999999999998854 6888999986543 355567889999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCc
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT 659 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~ 659 (845)
+++++|.+++.......+++.++..++.|+++||+|||+ .+++||||||+||++++++.+||+|||+++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~-- 155 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY-- 155 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEccccc--
Confidence 999999999976545678999999999999999999998 899999999999999999999999999997643322
Q ss_pred ccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCC
Q 003139 660 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVG 739 (845)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 739 (845)
.......++..|+|||.+.+..++.++||||||+++|||++|+.||......+ ...... .... .
T Consensus 156 ~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~~~~~~---------~~~~-~ 219 (256)
T cd08221 156 SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN------LVVKIV---------QGNY-T 219 (256)
T ss_pred ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHH---------cCCC-C
Confidence 12234568899999999998889999999999999999999999986433211 111111 1111 1
Q ss_pred CCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003139 740 KVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNL 774 (845)
Q Consensus 740 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L 774 (845)
.........+.+++.+||+.+|++||++.++++++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 11234456788999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=330.58 Aligned_cols=241 Identities=25% Similarity=0.337 Sum_probs=190.6
Q ss_pred eeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC---hHhHHHHHHHHH-HHHhCCCCCcceEEEEEecCCcEEEEEEeccC
Q 003139 508 LLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS---EQGIAEFRTEIE-MLSKLRHRHLVSLIGYCDERSEMILVYEYMAN 582 (845)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 582 (845)
+.||+|+||.||+|+.. +++.+|+|.+.... .....++..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999976 57789999875432 222334444544 56788999999999999999999999999999
Q ss_pred CCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcccc
Q 003139 583 GPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVS 662 (845)
Q Consensus 583 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 662 (845)
|+|.+++... ..+++.....++.||++||+|||+ .+|+||||||+|||+++++.+||+|||+++.... .....
T Consensus 81 ~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~--~~~~~ 153 (325)
T cd05602 81 GELFYHLQRE--RCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE--HNGTT 153 (325)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCccccc--CCCCc
Confidence 9999988543 467888899999999999999999 9999999999999999999999999999975322 12223
Q ss_pred cccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCC
Q 003139 663 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVN 742 (845)
Q Consensus 663 ~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 742 (845)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .... +....+ ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~---------i~~~~~--~~~ 216 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE------MYDN---------ILNKPL--QLK 216 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH------HHHH---------HHhCCc--CCC
Confidence 45679999999999999999999999999999999999999996533211 1111 111111 122
Q ss_pred HHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 003139 743 PASLKKFGETAEKCLAEHGVDRPSMGDVLW 772 (845)
Q Consensus 743 ~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~ 772 (845)
+.....+.+++.+|++.+|.+||++.+.+.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 217 PNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 344567889999999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=338.10 Aligned_cols=254 Identities=25% Similarity=0.378 Sum_probs=212.7
Q ss_pred CcceeeeeeceEEEEEEEEc-CCc----EEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEE
Q 003139 505 DESLLLGVGGFGRVYKGTLD-DGT----KVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYE 578 (845)
Q Consensus 505 ~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 578 (845)
...++||+|+||+||||.+- .|+ +||+|.+... +.+...+++.|...|.+++||||++|+|+|.... +.||.+
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 44668999999999999863 443 5888876554 4556789999999999999999999999997765 889999
Q ss_pred eccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCC
Q 003139 579 YMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQ 658 (845)
Q Consensus 579 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~ 658 (845)
|||.|+|.++++..+ ..+--+..+.|+.|||+||.|||+ ++++||||.++|||+.+...+||.|||+++.......
T Consensus 778 ~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred hcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 999999999997653 578889999999999999999998 9999999999999999999999999999998776555
Q ss_pred cccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcccc
Q 003139 659 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNL 737 (845)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (845)
.......+-.+.|||-|.++...++.++|||||||.+||++| |..|++.....+ +.++++...
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e----------------I~dlle~ge 917 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE----------------IPDLLEKGE 917 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH----------------hhHHHhccc
Confidence 555555566788999999999999999999999999999997 788887654433 222222222
Q ss_pred CCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 003139 738 VGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779 (845)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~ 779 (845)
+-..++.+...+..++.+||..|+..||+++++...+.....
T Consensus 918 RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 918 RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 234567788889999999999999999999999888766543
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=336.02 Aligned_cols=262 Identities=23% Similarity=0.223 Sum_probs=196.5
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
...|.+.+.||+|+||.||++.+. .++.||||.... ..+.+|+++|++++|+||+++++++...+..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 346888999999999999999976 578899996432 3457899999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCc
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT 659 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~ 659 (845)
+. ++|..++... ...++|.+++.|+.|+++||+|||+ .+|+||||||+||||+.++.+||+|||+++........
T Consensus 242 ~~-~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 242 YR-SDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred cC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 94 7888887543 2479999999999999999999998 89999999999999999999999999999764332222
Q ss_pred ccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCc-cc----ccHHHHHHHHhhc-Cch----
Q 003139 660 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPR-EQ----VNIAEWAMTWQKK-GML---- 729 (845)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~-~~----~~l~~~~~~~~~~-~~~---- 729 (845)
.......||..|+|||++.+..++.++|||||||+||||++|..++...... .. ..+...+...... ...
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 2233467999999999999999999999999999999999988665332111 10 1111111110000 000
Q ss_pred ----h-hhhc---cccCCCCC-------HHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 730 ----D-QIMD---SNLVGKVN-------PASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 730 ----~-~~~d---~~l~~~~~-------~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
. .... ........ ......+.+++.+||+.||.+|||+.|++++
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0 0000 00000000 0122367889999999999999999999876
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=319.29 Aligned_cols=238 Identities=26% Similarity=0.393 Sum_probs=188.7
Q ss_pred eeeeeceEEEEEEEEcC-------------------------CcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceE
Q 003139 509 LLGVGGFGRVYKGTLDD-------------------------GTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSL 563 (845)
Q Consensus 509 ~LG~G~fg~Vy~~~~~~-------------------------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 563 (845)
+||+|+||.||+|.+.. ...|++|.+.........+|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997521 13488898876555556788999999999999999999
Q ss_pred EEEEecCCcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCC---
Q 003139 564 IGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNF--- 640 (845)
Q Consensus 564 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~--- 640 (845)
+++|.+....++||||+++|+|..++... ...+++..+++++.|+++||+|||+ .+|+||||||+|||+++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCccc
Confidence 99999999999999999999999888643 3468999999999999999999998 8999999999999997643
Q ss_pred ----ceEEEeccccCCCCCCCCcccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHH-cCCCCCCCCCCcccc
Q 003139 641 ----VAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVL-CTRPALNPVLPREQV 714 (845)
Q Consensus 641 ----~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Ell-tg~~p~~~~~~~~~~ 714 (845)
.+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.|+....+.+.
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~- 230 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK- 230 (274)
T ss_pred CccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH-
Confidence 4899999998643211 12346788999998875 56899999999999999995 78888865433221
Q ss_pred cHHHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003139 715 NIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNL 774 (845)
Q Consensus 715 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L 774 (845)
..+ ... .. ..+......+.+++.+||+.+|++||++.+|++.|
T Consensus 231 --~~~----~~~---------~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 231 --ERF----YEK---------KH--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred --HHH----HHh---------cc--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 010 000 00 01112234688999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=314.57 Aligned_cols=251 Identities=23% Similarity=0.418 Sum_probs=201.6
Q ss_pred CCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCC------hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEE
Q 003139 503 KFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRS------EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILV 576 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 576 (845)
+|...+.||+|+||.||+|...+++.+|+|.+.... ....+.+.+|++++++++|+||++++++|.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 366778999999999999998889999999765431 23346688999999999999999999999999999999
Q ss_pred EEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCC
Q 003139 577 YEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPAL 656 (845)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~ 656 (845)
+||+++++|.+++... .++++..+..++.|++.||+|||+ .+|+|+||||+||++++++.+||+|||+++.....
T Consensus 81 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 81 MEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 9999999999998543 468899999999999999999998 89999999999999999999999999998753211
Q ss_pred C----CcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhh
Q 003139 657 D----QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQI 732 (845)
Q Consensus 657 ~----~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (845)
. .........++..|+|||++.+..++.++||||||++++||++|+.||......+. ........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-----~~~~~~~~------ 224 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA-----MFYIGAHR------ 224 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH-----HHHhhhcc------
Confidence 1 11122345688999999999999999999999999999999999999964322111 00000000
Q ss_pred hccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 003139 733 MDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLW 772 (845)
Q Consensus 733 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~ 772 (845)
......+......+.+++.+||+.+|.+||++.+++.
T Consensus 225 ---~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 225 ---GLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ---CCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0111223345567889999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=335.48 Aligned_cols=253 Identities=21% Similarity=0.308 Sum_probs=196.6
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
++|+..+.||+|+||.||++... +++.+|+|.+... .....+.+..|+.++.+++|+||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36788899999999999999876 6889999987542 2334567888999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
||+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||||+.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 81 EFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred eCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 999999999998543 468999999999999999999998 999999999999999999999999999987432110
Q ss_pred C---------------------------------cccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCC
Q 003139 658 Q---------------------------------THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPA 704 (845)
Q Consensus 658 ~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p 704 (845)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 0 0011235799999999999999999999999999999999999999
Q ss_pred CCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCC---HHHHHHH
Q 003139 705 LNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPS---MGDVLWN 773 (845)
Q Consensus 705 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs---~~~vl~~ 773 (845)
|....+.+. ....... ...+.-.........+.+++.+|+. +|.+|++ +.+++++
T Consensus 236 f~~~~~~~~------~~~i~~~-------~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 236 FCSETPQET------YRKVMNW-------KETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCCHHHH------HHHHHcC-------CCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 975443221 1111000 0000000001134567778888764 9999985 5665544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=315.56 Aligned_cols=253 Identities=30% Similarity=0.470 Sum_probs=200.6
Q ss_pred CCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHH--HHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEec
Q 003139 504 FDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIA--EFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYM 580 (845)
Q Consensus 504 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 580 (845)
|+..+.||+|+||.||+++.. +++.+|+|........... ....|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 456789999999999999987 4668999998776544332 3456999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcc
Q 003139 581 ANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH 660 (845)
Q Consensus 581 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 660 (845)
++++|.+++. ....+++.+++.++.|+++||++||+ .+++|+||||+||++++++.++|+|||.+.... ....
T Consensus 81 ~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~~ 153 (260)
T PF00069_consen 81 PGGSLQDYLQ--KNKPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENNE 153 (260)
T ss_dssp TTEBHHHHHH--HHSSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEEST--STTS
T ss_pred cccccccccc--cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc--cccc
Confidence 9999999996 33468999999999999999999999 899999999999999999999999999987531 2222
Q ss_pred cccccccCCCcCChhhhc-cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCC
Q 003139 661 VSTAVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVG 739 (845)
Q Consensus 661 ~~~~~~gt~~y~aPE~~~-~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 739 (845)
......++..|+|||++. +..++.++||||+|++++||++|+.|+........... ....... .......
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~---~~~~~~~----~~~~~~~-- 224 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEI---IEKILKR----PLPSSSQ-- 224 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHH---HHHHHHT----HHHHHTT--
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhh---hhhcccc----ccccccc--
Confidence 344567889999999998 88999999999999999999999999875411111111 1110000 0000000
Q ss_pred CCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 740 KVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 740 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
........+.+++.+||+.+|++||++.+++++
T Consensus 225 -~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 225 -QSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp -SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred -ccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 001113789999999999999999999999753
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=312.07 Aligned_cols=262 Identities=24% Similarity=0.308 Sum_probs=199.6
Q ss_pred CCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChH--hHHHHHHHHHHHHhCCCCC-cceEEEEEecCC------c
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQ--GIAEFRTEIEMLSKLRHRH-LVSLIGYCDERS------E 572 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~------~ 572 (845)
.|+..++||+|+||.||+|+.. +|+.||+|++....++ .-....+|+.++++++|+| |++|.+++...+ .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 3444557999999999999965 7899999987765432 2234578999999999999 999999998777 7
Q ss_pred EEEEEEeccCCCccccccCCCC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEecccc
Q 003139 573 MILVYEYMANGPLRSHLYGTDL--PPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLS 650 (845)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla 650 (845)
+++|+||+ ..+|..++..... ..++-..+..+..|+++||+|||+ ++|+||||||+||||+++|.+||+|||+|
T Consensus 92 l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccchH
Confidence 89999999 4688888865432 356778899999999999999999 99999999999999999999999999999
Q ss_pred CCCCCCCCcccccccccCCCcCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCc-
Q 003139 651 KTGPALDQTHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGM- 728 (845)
Q Consensus 651 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~- 728 (845)
+...- .....+...+|..|+|||++.+. .|+...||||+|||+.||+++++.|.+..+.++... +........
T Consensus 168 ra~~i--p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~---If~~lGtP~e 242 (323)
T KOG0594|consen 168 RAFSI--PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFR---IFRLLGTPNE 242 (323)
T ss_pred HHhcC--CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHH---HHHHcCCCCc
Confidence 96432 22224567889999999999876 799999999999999999999999887665433211 111111000
Q ss_pred -----hhhhhccc----------cCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 729 -----LDQIMDSN----------LVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 729 -----~~~~~d~~----------l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
+..+.+-. .....-+.......+++.+||+.+|.+|.|+..++++
T Consensus 243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 00000000 0000001112467899999999999999999998876
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=311.64 Aligned_cols=250 Identities=25% Similarity=0.373 Sum_probs=202.6
Q ss_pred CCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEec-CCcEEEEEE
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDE-RSEMILVYE 578 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~E 578 (845)
+|+..+.||+|++|.||+++.. +++.+++|++... .....+.+.+|++++++++|+|++++++.+.. ....++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4778889999999999999875 5788999987543 34456678899999999999999999998764 446789999
Q ss_pred eccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCC
Q 003139 579 YMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQ 658 (845)
Q Consensus 579 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~ 658 (845)
|+++++|.+++.......+++.++.+++.|++.||++||+ .+++||||||+||++++++.++|+|||+++.... .
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~--~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN--Q 155 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecc--c
Confidence 9999999999876555578999999999999999999998 8999999999999999999999999999976432 1
Q ss_pred cccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccC
Q 003139 659 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLV 738 (845)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 738 (845)
........+++.|+|||++.+..++.++||||||++++||++|+.||..... ..+..... .+.+
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~------~~~~~~~~-~~~~--------- 219 (257)
T cd08223 156 CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM------NSLVYRII-EGKL--------- 219 (257)
T ss_pred CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHH-hcCC---------
Confidence 1223345688999999999999999999999999999999999998864321 11111111 1111
Q ss_pred CCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 739 GKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 739 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
...+......+.+++.+|++.+|++||++.+++++
T Consensus 220 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 220 PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11233455678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=319.78 Aligned_cols=259 Identities=22% Similarity=0.305 Sum_probs=206.2
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
++|+..+.||+|+||.||++... +|+.+|+|..... .....+++.+|+++++.++||||+++++++...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 45677788999999999999865 6888999976543 234467899999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCc
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT 659 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~ 659 (845)
+++++|.+++... +.+++..+..++.+++.||.|||+ .++++||||||+||++++++.++|+|||++.....
T Consensus 85 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~---- 156 (284)
T cd06620 85 MDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN---- 156 (284)
T ss_pred CCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhh----
Confidence 9999999888543 468999999999999999999996 25799999999999999999999999999865321
Q ss_pred ccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCccc-----ccHHHHHHHHhhcCchhhhhc
Q 003139 660 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQ-----VNIAEWAMTWQKKGMLDQIMD 734 (845)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~-----~~l~~~~~~~~~~~~~~~~~d 734 (845)
.......|+..|+|||++.+..++.++|||||||++|||++|+.||......+. ..+.++... +..
T Consensus 157 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~ 227 (284)
T cd06620 157 SIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQ---------IVQ 227 (284)
T ss_pred hccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHH---------Hhh
Confidence 112245689999999999888999999999999999999999999975443211 111122211 111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 003139 735 SNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYA 777 (845)
Q Consensus 735 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~ 777 (845)
...........+..+.+++.+|++.+|++||++.|++++...+
T Consensus 228 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~ 270 (284)
T cd06620 228 EPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI 270 (284)
T ss_pred ccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence 1110001122556788999999999999999999999876543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=334.09 Aligned_cols=260 Identities=22% Similarity=0.235 Sum_probs=202.4
Q ss_pred HHHHHHHhcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhCCCCCcceEEEEEec
Q 003139 494 FQEILDATNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDE 569 (845)
Q Consensus 494 ~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 569 (845)
..++....++|+..+.||+|+||.||+++.. +++.+|+|.+... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 3344455688999999999999999999976 6788999987532 22334567889999999999999999999999
Q ss_pred CCcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccc
Q 003139 570 RSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGL 649 (845)
Q Consensus 570 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGl 649 (845)
.+..++||||+++|+|.+++... .++...+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 99999999999999999988543 47888899999999999999999 9999999999999999999999999999
Q ss_pred cCCCCCCCCcccccccccCCCcCChhhhccC----CCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhh
Q 003139 650 SKTGPALDQTHVSTAVKGSFGYLDPEYFRRQ----QLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQK 725 (845)
Q Consensus 650 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~ 725 (845)
++..... .........||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ..
T Consensus 189 a~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~----- 256 (371)
T cd05622 189 CMKMNKE-GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------TY----- 256 (371)
T ss_pred eeEcCcC-CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH------HH-----
Confidence 9764321 11122356799999999998754 37899999999999999999999997533211 11
Q ss_pred cCchhhhhccc--cCCCCCHHHHHHHHHHHHHhhhhCCCC--CCCHHHHHHHHH
Q 003139 726 KGMLDQIMDSN--LVGKVNPASLKKFGETAEKCLAEHGVD--RPSMGDVLWNLE 775 (845)
Q Consensus 726 ~~~~~~~~d~~--l~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~~vl~~L~ 775 (845)
..++... +...........+.+++.+|+...+.+ ||++.+++++..
T Consensus 257 ----~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~ 306 (371)
T cd05622 257 ----SKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 306 (371)
T ss_pred ----HHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence 1111110 100111234567888999999844433 788988887653
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=298.93 Aligned_cols=256 Identities=25% Similarity=0.333 Sum_probs=206.4
Q ss_pred HHHhcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC--------hHhHHHHHHHHHHHHhC-CCCCcceEEEEE
Q 003139 498 LDATNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS--------EQGIAEFRTEIEMLSKL-RHRHLVSLIGYC 567 (845)
Q Consensus 498 ~~at~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~H~niv~l~g~~ 567 (845)
....++|...++||.|..+.|-+..++ +|...|+|++.... ..-.+.-++|+.+|+++ .||+|+++.+++
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 345567888889999999999888765 67889998764321 12234557899999998 699999999999
Q ss_pred ecCCcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEec
Q 003139 568 DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADF 647 (845)
Q Consensus 568 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DF 647 (845)
+....+++|+|.|+.|.|.++|.+ .-.+++++..+|++|+..|++|||. .+||||||||+|||+|++.++||+||
T Consensus 93 es~sF~FlVFdl~prGELFDyLts--~VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTS--KVTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhh--heeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEecc
Confidence 999999999999999999999954 4579999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCCCCcccccccccCCCcCChhhhcc------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHH
Q 003139 648 GLSKTGPALDQTHVSTAVKGSFGYLDPEYFRR------QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAM 721 (845)
Q Consensus 648 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~ 721 (845)
|++.... ........+||++|+|||.++- ..|+..+|+|++|||||.|+.|.+||... .+..
T Consensus 168 GFa~~l~---~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR---kQml------ 235 (411)
T KOG0599|consen 168 GFACQLE---PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR---KQML------ 235 (411)
T ss_pred ceeeccC---CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH---HHHH------
Confidence 9998743 3344567899999999998852 35788999999999999999999999531 1111
Q ss_pred HHhhcCchhhhhccccC--CCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003139 722 TWQKKGMLDQIMDSNLV--GKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEY 776 (845)
Q Consensus 722 ~~~~~~~~~~~~d~~l~--~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~ 776 (845)
++.-++..... .....+......+++.+||+.||.+|.|.+|++++-..
T Consensus 236 ------MLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff 286 (411)
T KOG0599|consen 236 ------MLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFF 286 (411)
T ss_pred ------HHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHH
Confidence 12222222221 11223556778899999999999999999999977543
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=310.98 Aligned_cols=253 Identities=26% Similarity=0.300 Sum_probs=212.2
Q ss_pred CCCcceeeeeeceEEEEEEEEcC-CcEEEEEEcCCCC---hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEE
Q 003139 503 KFDESLLLGVGGFGRVYKGTLDD-GTKVAVKRGNPRS---EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYE 578 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 578 (845)
.|+..+.||.|.-|+||++.+++ +..+|+|.+.+.. .+...+...|-+||+.+.||.+..|++.++..+..|+|||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 45667789999999999999874 5789999987653 4455677889999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCC---
Q 003139 579 YMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPA--- 655 (845)
Q Consensus 579 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~--- 655 (845)
||+||+|..+++.+....+++..+.-++.+|+.||+|||- .|||.|||||+||||-++|++.|+||.|+.....
T Consensus 158 yCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt 234 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT 234 (459)
T ss_pred cCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence 9999999999988878889999999999999999999998 9999999999999999999999999999743110
Q ss_pred ------------------------------CCC---------------------cccccccccCCCcCChhhhccCCCCc
Q 003139 656 ------------------------------LDQ---------------------THVSTAVKGSFGYLDPEYFRRQQLTE 684 (845)
Q Consensus 656 ------------------------------~~~---------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ 684 (845)
... ...+...+||-.|+|||++++...+.
T Consensus 235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs 314 (459)
T KOG0610|consen 235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS 314 (459)
T ss_pred eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence 000 01123467999999999999999999
Q ss_pred hhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCC
Q 003139 685 KSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDR 764 (845)
Q Consensus 685 ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~R 764 (845)
++|+|+|||+|||||.|+.||-+....+ .+..++-..+.-...+.....+.+||++.|.+||.+|
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG~~~~~---------------Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kR 379 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKGSNNKE---------------TLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKR 379 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCCCCchh---------------hHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhh
Confidence 9999999999999999999997765443 3445555444433344667889999999999999999
Q ss_pred CC----HHHHHHH
Q 003139 765 PS----MGDVLWN 773 (845)
Q Consensus 765 Ps----~~~vl~~ 773 (845)
.. +.||-++
T Consensus 380 lg~~rGA~eIK~H 392 (459)
T KOG0610|consen 380 LGSKRGAAEIKRH 392 (459)
T ss_pred hccccchHHhhcC
Confidence 88 6666443
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=313.22 Aligned_cols=247 Identities=30% Similarity=0.439 Sum_probs=200.2
Q ss_pred cCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEecc
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMA 581 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 581 (845)
++|.+.+.||+|+||.||++.. .++.+|+|...... ..+.+.+|+.++++++|||++++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 3577888999999999999975 47889999876433 346789999999999999999999998664 4799999999
Q ss_pred CCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCccc
Q 003139 582 NGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHV 661 (845)
Q Consensus 582 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 661 (845)
+++|.+++.......+++..+++++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----- 153 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----- 153 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceecccc-----
Confidence 9999999976555578999999999999999999998 99999999999999999999999999998753221
Q ss_pred ccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCC
Q 003139 662 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGK 740 (845)
Q Consensus 662 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 740 (845)
......+..|+|||.+.+..++.++||||||+++|||++ |+.||......+ +... ...+ ....
T Consensus 154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------~~~~-~~~~---------~~~~ 217 (254)
T cd05083 154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE------VKEC-VEKG---------YRME 217 (254)
T ss_pred CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH------HHHH-HhCC---------CCCC
Confidence 112234567999999998999999999999999999997 898886443211 1111 1111 1111
Q ss_pred CCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003139 741 VNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEY 776 (845)
Q Consensus 741 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~ 776 (845)
.+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 223455778899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=316.13 Aligned_cols=247 Identities=27% Similarity=0.375 Sum_probs=203.1
Q ss_pred CCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC-hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEec
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS-EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYM 580 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 580 (845)
+|+..+.||.|++|.||+|+.. +++.+++|...... ......+.+|++++++++|+|++++++++.+....++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 5777789999999999999976 68899999876543 445577899999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcc
Q 003139 581 ANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH 660 (845)
Q Consensus 581 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 660 (845)
++++|.+++... ++++..+..++.|++.||.|||+ .+++||||+|+||++++++.++|+|||+++...... .
T Consensus 82 ~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~ 153 (274)
T cd06609 82 GGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--S 153 (274)
T ss_pred CCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecccc--c
Confidence 999999998643 78999999999999999999998 899999999999999999999999999997644321 1
Q ss_pred cccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCC
Q 003139 661 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGK 740 (845)
Q Consensus 661 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 740 (845)
......++..|+|||.+.+..++.++||||||+++|||++|+.||....+.+ .... .... ..+.
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~------~~~~-~~~~-----~~~~---- 217 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR------VLFL-IPKN-----NPPS---- 217 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH------HHHH-hhhc-----CCCC----
Confidence 2234567889999999999899999999999999999999999986543211 1100 1111 0111
Q ss_pred CCHH-HHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 741 VNPA-SLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 741 ~~~~-~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.... .+..+.+++.+||..+|++||++++++++
T Consensus 218 ~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 218 LEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred CcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1111 45678899999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=332.65 Aligned_cols=264 Identities=25% Similarity=0.236 Sum_probs=200.4
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc---CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD---DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
..+|.+.+.||+|+||.||++... .+..|++|.+... +.+.+|++++++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 357999999999999999999754 3567999987643 23467999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
|++. ++|.+++. ....+++.+++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 166 e~~~-~~l~~~l~--~~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 166 PKYK-CDLFTYVD--RSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred hhcC-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 9995 67888873 33579999999999999999999999 899999999999999999999999999997644322
Q ss_pred CcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchh-------
Q 003139 658 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLD------- 730 (845)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~------- 730 (845)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||.............-+....+.....
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 319 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST 319 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence 2222335679999999999999999999999999999999999999997644322111000011111000000
Q ss_pred ---h-h--hccccCCC--CC-----HHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 731 ---Q-I--MDSNLVGK--VN-----PASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 731 ---~-~--~d~~l~~~--~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
+ + ........ .+ ......+.+++.+||+.+|++||++.|++.+-.
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~ 377 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPL 377 (392)
T ss_pred hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCch
Confidence 0 0 00000000 00 112356788999999999999999999987743
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=320.01 Aligned_cols=251 Identities=22% Similarity=0.329 Sum_probs=204.9
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
.++|...+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 367888999999999999999864 7899999988765555567788999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCc
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT 659 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~ 659 (845)
+++++|.+++.. ..+++.+++.++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++.......
T Consensus 98 ~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~-- 169 (297)
T cd06656 98 LAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-- 169 (297)
T ss_pred cCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCc--
Confidence 999999998853 358899999999999999999998 899999999999999999999999999987533211
Q ss_pred ccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCC
Q 003139 660 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVG 739 (845)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 739 (845)
.......+++.|+|||.+.+..++.++|||||||++|||++|+.||....+...... .... .....
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~------~~~~--------~~~~~ 235 (297)
T cd06656 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATN--------GTPEL 235 (297)
T ss_pred cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee------eccC--------CCCCC
Confidence 112345688899999999999999999999999999999999999965433221100 0000 00000
Q ss_pred CCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 740 KVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 740 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
..+......+.+++.+||+.+|++||++.+++++
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1123345667899999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=320.43 Aligned_cols=252 Identities=23% Similarity=0.357 Sum_probs=205.2
Q ss_pred cCCCcceeeeeeceEEEEEEEE-cCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEec
Q 003139 502 NKFDESLLLGVGGFGRVYKGTL-DDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYM 580 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 580 (845)
.+|+..+.||.|++|.||+|.. .+++.+++|.+........+.+.+|+++++.++|||++++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4688888999999999999986 468999999887655555678899999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcc
Q 003139 581 ANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH 660 (845)
Q Consensus 581 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 660 (845)
++++|..++.. ..+++.+++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||++....... .
T Consensus 99 ~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~--~ 170 (296)
T cd06655 99 AGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ--S 170 (296)
T ss_pred CCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhccccc--c
Confidence 99999998853 358999999999999999999999 899999999999999999999999999987543211 1
Q ss_pred cccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCC
Q 003139 661 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGK 740 (845)
Q Consensus 661 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 740 (845)
......++..|+|||.+.+..++.++|||||||++|||++|+.||......... ....... . +.+ .
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~------~~~~~~~-~-----~~~--~ 236 (296)
T cd06655 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YLIATNG-T-----PEL--Q 236 (296)
T ss_pred cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHhcC-C-----ccc--C
Confidence 123456888999999999999999999999999999999999998654332211 0000000 0 000 1
Q ss_pred CCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 741 VNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 741 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
.+......+.+++.+||..+|.+||++.+++++=.
T Consensus 237 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~ 271 (296)
T cd06655 237 NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPF 271 (296)
T ss_pred CcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence 12334557889999999999999999999986633
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=312.98 Aligned_cols=251 Identities=25% Similarity=0.384 Sum_probs=196.9
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC-----ChHhHHHHHHHHHHHHhCCCCCcceEEEEEec--CCcE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR-----SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDE--RSEM 573 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~ 573 (845)
.+|+..+.||+|+||.||+|... ++..+++|++... ..+..+.+.+|++++++++||||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888899999999999999875 5889999986532 23345678899999999999999999998865 3567
Q ss_pred EEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCC
Q 003139 574 ILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTG 653 (845)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~ 653 (845)
++++||+++++|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 8999999999999998543 358999999999999999999998 89999999999999999999999999998754
Q ss_pred CCCCC-cccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhh
Q 003139 654 PALDQ-THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQI 732 (845)
Q Consensus 654 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (845)
..... ........++..|+|||.+.+..++.++|||||||++|||++|+.||......+ .... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~------~~~~---------~ 221 (266)
T cd06651 157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA------AIFK---------I 221 (266)
T ss_pred ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH------HHHH---------H
Confidence 32111 111223457889999999999999999999999999999999999986432211 0111 1
Q ss_pred hccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 733 MDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 733 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
........++......+.+++ +||..+|++||+++||+++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 222 ATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred hcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 100111122333445566666 7888999999999999753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=317.27 Aligned_cols=248 Identities=26% Similarity=0.377 Sum_probs=201.6
Q ss_pred CCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEecc
Q 003139 504 FDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMA 581 (845)
Q Consensus 504 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 581 (845)
|+..+.||+|+||.||+|.+. +++.||+|..... .....+.+.+|++++++++||||+++++++......++||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 445567999999999999865 5788999987643 34456788999999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCccc
Q 003139 582 NGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHV 661 (845)
Q Consensus 582 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 661 (845)
+++|.+++.. ..+++..+..++.|+++||.|||+ .+++|+||+|+||++++++.+||+|||+++..... ...
T Consensus 86 ~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~--~~~ 157 (277)
T cd06642 86 GGSALDLLKP---GPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT--QIK 157 (277)
T ss_pred CCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCc--chh
Confidence 9999998853 368999999999999999999998 89999999999999999999999999999764321 112
Q ss_pred ccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCC
Q 003139 662 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKV 741 (845)
Q Consensus 662 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 741 (845)
.....++..|+|||++.+..++.++|||||||++|||++|+.|+....+... ... ... ......
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~------~~~-~~~---------~~~~~~ 221 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV------LFL-IPK---------NSPPTL 221 (277)
T ss_pred hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH------Hhh-hhc---------CCCCCC
Confidence 2234678899999999999999999999999999999999999864332211 000 011 111112
Q ss_pred CHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 742 NPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 742 ~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
....+..+.+++.+||+.+|++||++.+++++-.
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06642 222 EGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKF 255 (277)
T ss_pred CcccCHHHHHHHHHHccCCcccCcCHHHHHHhHH
Confidence 2344567889999999999999999999998643
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=318.51 Aligned_cols=252 Identities=27% Similarity=0.390 Sum_probs=203.0
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEec
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYM 580 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 580 (845)
+.|++.+.||+|+||.||+|... +++.+++|.....+....+++.+|++++++++|+|++++++.+...+..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 45777889999999999999976 58899999988777777888999999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcc
Q 003139 581 ANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH 660 (845)
Q Consensus 581 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 660 (845)
++++|..++.+.. ..+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++..... ...
T Consensus 92 ~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~--~~~ 165 (292)
T cd06644 92 PGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK--TLQ 165 (292)
T ss_pred CCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceeccc--ccc
Confidence 9999988775433 468999999999999999999998 8999999999999999999999999999865322 111
Q ss_pred cccccccCCCcCChhhhc-----cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcc
Q 003139 661 VSTAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDS 735 (845)
Q Consensus 661 ~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (845)
......++..|+|||++. ...++.++|||||||++|||++|++|+......+ ....... .. .+
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~~~~~~~-~~-----~~ 233 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLLKIAK-SE-----PP 233 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH------HHHHHhc-CC-----Cc
Confidence 223456788999999884 3457889999999999999999999986433211 1111110 00 01
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 736 NLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 736 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.+ ..+......+.+++.+||+.+|++||++.+++++
T Consensus 234 ~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 234 TL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred cC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 11 1123345578899999999999999999999764
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=324.83 Aligned_cols=255 Identities=20% Similarity=0.220 Sum_probs=196.8
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
++|+..+.||+|+||.||+++.. +++.+|+|.+... .....+.+.+|..++..++|+||+++.+++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999976 5788999987542 2233456888999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 155 (331)
T cd05624 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD- 155 (331)
T ss_pred eCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCC-
Confidence 9999999999996532 468999999999999999999998 99999999999999999999999999999764321
Q ss_pred CcccccccccCCCcCChhhhcc-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhh
Q 003139 658 QTHVSTAVKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQI 732 (845)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (845)
.........||+.|+|||++.+ +.++.++|||||||+||||++|+.||......+ ........... .
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------~~~~i~~~~~~--~ 227 (331)
T cd05624 156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHEER--F 227 (331)
T ss_pred CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH------HHHHHHcCCCc--c
Confidence 1112234569999999999875 568899999999999999999999996533211 11111110000 0
Q ss_pred hccccCCCCCHHHHHHHHHHHHHhhhhCCCC--CCCHHHHHHH
Q 003139 733 MDSNLVGKVNPASLKKFGETAEKCLAEHGVD--RPSMGDVLWN 773 (845)
Q Consensus 733 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~~vl~~ 773 (845)
.+ ..........+.+++.+|+...+++ |+++++++++
T Consensus 228 ---~~-p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 228 ---QF-PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred ---cC-CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 00 0011223567888899988865543 4688888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=313.26 Aligned_cols=249 Identities=26% Similarity=0.409 Sum_probs=200.1
Q ss_pred CCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCCh---------HhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcE
Q 003139 504 FDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSE---------QGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEM 573 (845)
Q Consensus 504 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 573 (845)
|.....||+|++|.||+|... +++.+++|.+..... +..+.+.+|++++++++||||+++++++.+.+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 566779999999999999865 578899997654321 2235788999999999999999999999999999
Q ss_pred EEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCC
Q 003139 574 ILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTG 653 (845)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~ 653 (845)
++|+||+++++|.+++... ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++..
T Consensus 82 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred EEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 9999999999999998543 468999999999999999999998 89999999999999999999999999999764
Q ss_pred CCCCC----cccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCch
Q 003139 654 PALDQ----THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGML 729 (845)
Q Consensus 654 ~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 729 (845)
..... ........|+..|+|||.+.+..++.++||||||+++|||++|+.||........ +
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---------------~ 221 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA---------------I 221 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH---------------H
Confidence 32111 1111234578899999999999999999999999999999999999964321110 0
Q ss_pred hhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 730 DQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 730 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
..+.. ......+...+..+.+++.+||+.+|.+||++.++++.
T Consensus 222 ~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 222 FKIGE-NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred HHHhc-cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 01111 11112334456778899999999999999999998763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=313.80 Aligned_cols=253 Identities=23% Similarity=0.384 Sum_probs=201.5
Q ss_pred CCCcceeeeeeceEEEEEEEEcC--CcEEEEEEcCCC----------ChHhHHHHHHHHHHHHh-CCCCCcceEEEEEec
Q 003139 503 KFDESLLLGVGGFGRVYKGTLDD--GTKVAVKRGNPR----------SEQGIAEFRTEIEMLSK-LRHRHLVSLIGYCDE 569 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~~--g~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~ 569 (845)
.|+..+.||+|+||.||+|.... ++.+|+|.+... ......++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 36777889999999999999764 678999976432 23445678889998875 799999999999999
Q ss_pred CCcEEEEEEeccCCCccccccC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEec
Q 003139 570 RSEMILVYEYMANGPLRSHLYG--TDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADF 647 (845)
Q Consensus 570 ~~~~~lV~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DF 647 (845)
.+..++||||+++++|.+++.. .....+++..+++++.|++.||.|||+ ..+++|+||||+|||+++++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence 9999999999999999988743 233568999999999999999999995 267999999999999999999999999
Q ss_pred cccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcC
Q 003139 648 GLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKG 727 (845)
Q Consensus 648 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 727 (845)
|++....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||...... ......
T Consensus 159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~------~~~~~~---- 225 (269)
T cd08528 159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML------SLATKI---- 225 (269)
T ss_pred cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH------HHHHHH----
Confidence 9997643211 234556889999999999989999999999999999999999998543211 111111
Q ss_pred chhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 728 MLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 728 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
.+..............+.+++.+||+.+|++||++.|+..+++
T Consensus 226 -----~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 226 -----VEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred -----hhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 1111110011134467889999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=316.53 Aligned_cols=239 Identities=25% Similarity=0.369 Sum_probs=190.7
Q ss_pred eeeeeceEEEEEEEEcC--------CcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEec
Q 003139 509 LLGVGGFGRVYKGTLDD--------GTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYM 580 (845)
Q Consensus 509 ~LG~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 580 (845)
.||+|+||.||+|.... ...+++|..........+++.+|+.++++++|||++++++++..++..++||||+
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV 81 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence 68999999999998642 2348888876655556678999999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCc--------eEEEeccccCC
Q 003139 581 ANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFV--------AKVADFGLSKT 652 (845)
Q Consensus 581 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~--------~kl~DFGla~~ 652 (845)
++|+|..++.... ..+++..+++++.|++.||+|||+ .+|+||||||+|||++.++. ++++|||++..
T Consensus 82 ~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 82 KFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9999999986543 368999999999999999999998 99999999999999987765 69999998865
Q ss_pred CCCCCCcccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCC-CCCCCCCCcccccHHHHHHHHhhcCchh
Q 003139 653 GPALDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTR-PALNPVLPREQVNIAEWAMTWQKKGMLD 730 (845)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~-~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (845)
... .....++..|+|||++.+ +.++.++||||||+++|||++|. .|+....... ...
T Consensus 158 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~------~~~--------- 216 (258)
T cd05078 158 VLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK------KLQ--------- 216 (258)
T ss_pred cCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH------HHH---------
Confidence 321 123457889999999986 45899999999999999999995 4443222111 000
Q ss_pred hhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 731 QIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 731 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
+... ....+......+.+++.+||+.+|++||+++++++.|+
T Consensus 217 -~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 217 -FYED--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -HHHc--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0000 01122333467889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=315.64 Aligned_cols=253 Identities=25% Similarity=0.367 Sum_probs=200.9
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEec
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYM 580 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 580 (845)
++|...+.||+|+||.||+|+.. +++.+|+|.+..........+.+|+.+++.++||||+++++.+...+..++|+||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 45667778999999999999865 68899999877665555667889999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcc
Q 003139 581 ANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH 660 (845)
Q Consensus 581 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 660 (845)
++++|.+++... ..+++.+++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++..... ...
T Consensus 89 ~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~--~~~ 161 (267)
T cd06645 89 GGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITA--TIA 161 (267)
T ss_pred CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccC--ccc
Confidence 999999988543 468999999999999999999999 8999999999999999999999999999865322 111
Q ss_pred cccccccCCCcCChhhhc---cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcccc
Q 003139 661 VSTAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNL 737 (845)
Q Consensus 661 ~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (845)
......|+..|+|||++. .+.++.++|||||||++|||++|+.|+....+.... ...... . ...+..
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~------~~~~~~-~---~~~~~~ 231 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL------FLMTKS-N---FQPPKL 231 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH------Hhhhcc-C---CCCCcc
Confidence 223456899999999974 456889999999999999999999998644322211 000000 0 000111
Q ss_pred CCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 738 VGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.. .......+.+++.+|++.+|++||++++++++
T Consensus 232 ~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 232 KD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred cc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 00 11234568899999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=327.07 Aligned_cols=264 Identities=21% Similarity=0.278 Sum_probs=197.6
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCC------
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERS------ 571 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 571 (845)
.++|...+.||+|+||.||++... +|+.+|+|++... .....+++.+|+.+++.++||||+++++++...+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 468999999999999999999865 6889999987643 3344567889999999999999999999985443
Q ss_pred cEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccC
Q 003139 572 EMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSK 651 (845)
Q Consensus 572 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~ 651 (845)
..++||||+++ +|...+. ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 100 ~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIH----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171 (359)
T ss_pred eeEEEEeCCCc-CHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence 57999999965 5655553 247889999999999999999999 999999999999999999999999999997
Q ss_pred CCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCccccc---------HHHH---
Q 003139 652 TGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVN---------IAEW--- 719 (845)
Q Consensus 652 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~---------l~~~--- 719 (845)
.... ........||..|+|||.+.+..++.++|||||||++|||++|+.||......+... ..++
T Consensus 172 ~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (359)
T cd07876 172 TACT---NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR 248 (359)
T ss_pred cccc---CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHH
Confidence 5321 222334578999999999999999999999999999999999999997543221100 0000
Q ss_pred ----HHHHhhcC------chhhhhccccC---CCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 720 ----AMTWQKKG------MLDQIMDSNLV---GKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 720 ----~~~~~~~~------~~~~~~d~~l~---~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
........ ...+....... ..........+.+++.+||+.||++|||+.|++++-.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 317 (359)
T cd07876 249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPY 317 (359)
T ss_pred HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCch
Confidence 00000000 00000000000 0011112456889999999999999999999987643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=318.51 Aligned_cols=264 Identities=25% Similarity=0.358 Sum_probs=205.3
Q ss_pred cccHHHHHHHhcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhC-CCCCcceEEEEEe
Q 003139 491 LFMFQEILDATNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCD 568 (845)
Q Consensus 491 ~~~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~ 568 (845)
.+.+..+..+.++|+..+.||+|+||.||+++.. +++.+++|....... ..+++.+|+.+++++ +||||+++++++.
T Consensus 7 ~~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 85 (286)
T cd06638 7 TIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYY 85 (286)
T ss_pred eEEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence 3555667778899999999999999999999875 578899998764322 235678899999999 6999999999884
Q ss_pred -----cCCcEEEEEEeccCCCccccccC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCc
Q 003139 569 -----ERSEMILVYEYMANGPLRSHLYG--TDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFV 641 (845)
Q Consensus 569 -----~~~~~~lV~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~ 641 (845)
.++..++||||+++++|.+++.. .....+++..+..++.|+++||.|||+ .+|+||||||+||++++++.
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~ 162 (286)
T cd06638 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGG 162 (286)
T ss_pred ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCC
Confidence 34568999999999999988753 233568999999999999999999998 89999999999999999999
Q ss_pred eEEEeccccCCCCCCCCcccccccccCCCcCChhhhcc-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccH
Q 003139 642 AKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNI 716 (845)
Q Consensus 642 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l 716 (845)
+||+|||+++..... ........|+..|+|||++.. ..++.++|||||||++|||++|+.|+.........
T Consensus 163 ~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~-- 238 (286)
T cd06638 163 VKLVDFGVSAQLTST--RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL-- 238 (286)
T ss_pred EEEccCCceeecccC--CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH--
Confidence 999999998764321 112234568999999998853 45789999999999999999999998654322110
Q ss_pred HHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003139 717 AEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNL 774 (845)
Q Consensus 717 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L 774 (845)
. . ..... .+.+ ..+......+.+++.+||+.+|++||++.|+++.+
T Consensus 239 ---~-~-~~~~~-----~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 239 ---F-K-IPRNP-----PPTL--HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred ---h-h-ccccC-----CCcc--cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 0 0 00000 0000 01112345688999999999999999999998764
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=325.17 Aligned_cols=255 Identities=22% Similarity=0.228 Sum_probs=196.0
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
++|++.+.||+|+||.||+++.. +++.+|+|.+... .....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 36888999999999999999976 5889999987532 2234566889999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
||+++|+|.+++... ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~- 155 (331)
T cd05597 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD- 155 (331)
T ss_pred ecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCC-
Confidence 999999999998543 3468999999999999999999999 99999999999999999999999999998653321
Q ss_pred CcccccccccCCCcCChhhhcc-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhh
Q 003139 658 QTHVSTAVKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQI 732 (845)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (845)
.........||+.|+|||++.. +.++.++|||||||++|||++|+.||......+ .............+
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~------~~~~i~~~~~~~~~ 229 (331)
T cd05597 156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHKEHFQF 229 (331)
T ss_pred CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH------HHHHHHcCCCcccC
Confidence 1112233568999999999863 467889999999999999999999996532211 11111111000000
Q ss_pred hccccCCCCCHHHHHHHHHHHHHhhhh--CCCCCCCHHHHHHH
Q 003139 733 MDSNLVGKVNPASLKKFGETAEKCLAE--HGVDRPSMGDVLWN 773 (845)
Q Consensus 733 ~d~~l~~~~~~~~~~~l~~l~~~cl~~--~p~~RPs~~~vl~~ 773 (845)
..........+.+++.+|+.. ++..||++.+++++
T Consensus 230 ------~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 230 ------PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred ------CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 001122455677788887654 33447899998877
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=311.17 Aligned_cols=250 Identities=23% Similarity=0.360 Sum_probs=204.5
Q ss_pred CCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
+|+..+.||+|+||.+|++... +|+.+++|++... .....+++.+|++++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4778889999999999999865 6889999987542 344557889999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCc
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT 659 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~ 659 (845)
+++++|.+++.......+++.++++++.|++.||.|||+ .+++|+||+|+|||+++++.++|+|||++...... .
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~--~ 155 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST--V 155 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc--h
Confidence 999999998865544568999999999999999999998 89999999999999999999999999999764321 1
Q ss_pred ccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCC
Q 003139 660 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVG 739 (845)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 739 (845)
.......|+..|+|||++.++.++.++|+|||||+++||++|+.|+...... +........ . ..
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~~~~---------~-~~ 219 (256)
T cd08218 156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK------NLVLKIIRG---------S-YP 219 (256)
T ss_pred hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH------HHHHHHhcC---------C-CC
Confidence 1122345788999999999999999999999999999999999998643211 111111111 0 01
Q ss_pred CCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 740 KVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 740 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
..+......+.+++.+||+.+|.+||++.+|+++
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1223445678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=317.12 Aligned_cols=260 Identities=27% Similarity=0.383 Sum_probs=205.6
Q ss_pred ccHHHHHHHhcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhC-CCCCcceEEEEEec
Q 003139 492 FMFQEILDATNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDE 569 (845)
Q Consensus 492 ~~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 569 (845)
.++.++....+.|+..+.||+|+||.||+|... +++.+|+|...... ....++..|+.++.++ +|+||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 355666677789999999999999999999975 67889999875443 3446788999999998 69999999999843
Q ss_pred ------CCcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceE
Q 003139 570 ------RSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAK 643 (845)
Q Consensus 570 ------~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~k 643 (845)
....+++|||+++|+|.+++.......+++..+..++.|++.||.|||+ .+|+||||||+||++++++.++
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEE
Confidence 4578999999999999999876555568899999999999999999998 8999999999999999999999
Q ss_pred EEeccccCCCCCCCCcccccccccCCCcCChhhhc-----cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHH
Q 003139 644 VADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAE 718 (845)
Q Consensus 644 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~ 718 (845)
|+|||+++..... ........|+..|+|||.+. ...++.++|||||||++|||++|+.||....+.+...
T Consensus 162 l~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~--- 236 (282)
T cd06636 162 LVDFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF--- 236 (282)
T ss_pred EeeCcchhhhhcc--ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh---
Confidence 9999998753211 11123456889999999886 3568889999999999999999999986543221110
Q ss_pred HHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 003139 719 WAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLW 772 (845)
Q Consensus 719 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~ 772 (845)
.+.............+..+.+++.+||+.+|.+||++.|+++
T Consensus 237 ------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 237 ------------LIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ------------hHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 000011111112234567899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=310.16 Aligned_cols=248 Identities=27% Similarity=0.405 Sum_probs=202.2
Q ss_pred CCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC-----hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEE
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS-----EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILV 576 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 576 (845)
+|+..+.||+|++|.||+|... +++.+++|.+.... .+..+.+.+|++++++++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3666788999999999999976 78999999765432 34567899999999999999999999999999999999
Q ss_pred EEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCC
Q 003139 577 YEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPAL 656 (845)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~ 656 (845)
+||+++++|.+++... .++++..+..++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 81 LELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 9999999999998543 468999999999999999999998 89999999999999999999999999998764321
Q ss_pred CCcccccccccCCCcCChhhhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcc
Q 003139 657 DQTHVSTAVKGSFGYLDPEYFRRQQ-LTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDS 735 (845)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (845)
. ......++..|++||.+.... ++.++|+||||+++|||++|+.||......+ ..........
T Consensus 156 ~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~------~~~~~~~~~~------- 219 (258)
T cd06632 156 S---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA------AVFKIGRSKE------- 219 (258)
T ss_pred c---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH------HHHHHHhccc-------
Confidence 1 223456888999999988776 8999999999999999999999986543211 1111111000
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 736 NLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 736 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
....+......+.+++.+||+.+|.+||++.+++..
T Consensus 220 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 220 --LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred --CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 112233445678899999999999999999998753
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=312.89 Aligned_cols=249 Identities=24% Similarity=0.381 Sum_probs=205.3
Q ss_pred CCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEec
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYM 580 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 580 (845)
.|+..+.||+|+||.||+|... +++.+|+|..... .....+.+.+|++++++++|+||+++++++.+....++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4566778999999999999975 5788999987643 3455678999999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcc
Q 003139 581 ANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH 660 (845)
Q Consensus 581 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 660 (845)
++++|.+++.. .++++.++..++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++....... .
T Consensus 85 ~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~ 156 (277)
T cd06640 85 GGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--I 156 (277)
T ss_pred CCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCc--c
Confidence 99999998853 368899999999999999999998 899999999999999999999999999997643211 1
Q ss_pred cccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCC
Q 003139 661 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGK 740 (845)
Q Consensus 661 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 740 (845)
......++..|+|||++.+..++.++|||||||++|||++|+.|+....+.... . .........
T Consensus 157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~------~----------~~~~~~~~~ 220 (277)
T cd06640 157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL------F----------LIPKNNPPT 220 (277)
T ss_pred ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh------h----------hhhcCCCCC
Confidence 223346788999999999989999999999999999999999998654332111 0 001111122
Q ss_pred CCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 741 VNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 741 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
.....+..+.+++.+||+.+|++||++.++++.-.
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06640 221 LTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKF 255 (277)
T ss_pred CchhhhHHHHHHHHHHcccCcccCcCHHHHHhChH
Confidence 34456778999999999999999999999987743
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=326.68 Aligned_cols=193 Identities=27% Similarity=0.342 Sum_probs=165.6
Q ss_pred HhcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEE
Q 003139 500 ATNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYE 578 (845)
Q Consensus 500 at~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 578 (845)
...+|.+.+.||+|+||.||+|+.. +++.||+|..... ....|+.++++++|+||+++++++.+....++|+|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 3467999999999999999999976 5678999975432 23569999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCC
Q 003139 579 YMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQ 658 (845)
Q Consensus 579 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~ 658 (845)
|+. ++|.+++... ...++|.+++.|+.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++....
T Consensus 138 ~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~--- 209 (357)
T PHA03209 138 HYS-SDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV--- 209 (357)
T ss_pred ccC-CcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCcccccccc---
Confidence 994 6888887543 3579999999999999999999999 8999999999999999999999999999975221
Q ss_pred cccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 003139 659 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALN 706 (845)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~ 706 (845)
........||..|+|||++.+..++.++|||||||++|||+++..++.
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 210 APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 112234568999999999999999999999999999999998765553
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=313.01 Aligned_cols=255 Identities=29% Similarity=0.406 Sum_probs=199.1
Q ss_pred CCcceeeeeeceEEEEEEEEc----CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCC------
Q 003139 504 FDESLLLGVGGFGRVYKGTLD----DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERS------ 571 (845)
Q Consensus 504 f~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 571 (845)
|.+.+.||+|+||.||+|.+. .++.+|+|.+... .....+++.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456678999999999999864 3678999987653 3455678999999999999999999999885432
Q ss_pred cEEEEEEeccCCCccccccCC----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEec
Q 003139 572 EMILVYEYMANGPLRSHLYGT----DLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADF 647 (845)
Q Consensus 572 ~~~lV~Ey~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DF 647 (845)
..++++||+++|+|.+++... +...+++..+++++.|++.||+|||+ .+|+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcc
Confidence 247899999999998876432 22357899999999999999999998 89999999999999999999999999
Q ss_pred cccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhc
Q 003139 648 GLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKK 726 (845)
Q Consensus 648 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~ 726 (845)
|+++...............++..|++||.+....++.++||||||+++|||++ |++||...... .+..+.. ..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~~~~~~---~~ 231 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EIYNYLI---KG 231 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HHHHHHH---cC
Confidence 99986432221112223345678999999999999999999999999999999 88887543221 1111111 11
Q ss_pred CchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 003139 727 GMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYA 777 (845)
Q Consensus 727 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~ 777 (845)
.. + ..+......+.+++.+|++.+|++||++.++++.|+.+
T Consensus 232 ~~--------~--~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 NR--------L--KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred Cc--------C--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 0 11233456899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=320.54 Aligned_cols=264 Identities=22% Similarity=0.310 Sum_probs=199.8
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC-hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS-EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
++|...+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46788889999999999999876 57889999876432 22335677899999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCc
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT 659 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~ 659 (845)
++ ++|.+++... ...+++..+..++.|+++||+|||+ .+|+||||||+|||+++++.+||+|||+++......
T Consensus 86 ~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-- 158 (301)
T cd07873 86 LD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-- 158 (301)
T ss_pred cc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC--
Confidence 97 5888887543 2468899999999999999999998 999999999999999999999999999997532211
Q ss_pred ccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhh---cCchhhhhc-
Q 003139 660 HVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQK---KGMLDQIMD- 734 (845)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~---~~~~~~~~d- 734 (845)
.......+++.|+|||.+.+ ..++.++|||||||++|||++|++||......+.. ........ ......+++
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 235 (301)
T cd07873 159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQL---HFIFRILGTPTEETWPGILSN 235 (301)
T ss_pred CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHcCCCChhhchhhhcc
Confidence 11223456889999998865 45789999999999999999999999754332211 11111000 000011110
Q ss_pred --------cccCC----CCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 735 --------SNLVG----KVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 735 --------~~l~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
+.... ...+.....+.+++.+||+.||.+|||+.|++++-.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~ 288 (301)
T cd07873 236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPY 288 (301)
T ss_pred ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 00000 011233456789999999999999999999987533
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=310.35 Aligned_cols=237 Identities=28% Similarity=0.433 Sum_probs=189.0
Q ss_pred eeeeeceEEEEEEEEcCCc-----------EEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 509 LLGVGGFGRVYKGTLDDGT-----------KVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 509 ~LG~G~fg~Vy~~~~~~g~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
.||+|+||.||+|.+.+.. .+++|........ ...|.+|+.++++++||||+++++++.. ...++||
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 6899999999999986432 4777876544333 6788999999999999999999999988 7889999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCC-------ceEEEecccc
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNF-------VAKVADFGLS 650 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~-------~~kl~DFGla 650 (845)
||+++|+|.+++.... ..+++..++.++.|++.||+|||+ ++|+||||||+|||++.++ .+||+|||++
T Consensus 80 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 80 EYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 9999999999986543 268999999999999999999998 9999999999999999887 7999999998
Q ss_pred CCCCCCCCcccccccccCCCcCChhhhccC--CCCchhHHHHHHHHHHHHHcC-CCCCCCCCCcccccHHHHHHHHhhcC
Q 003139 651 KTGPALDQTHVSTAVKGSFGYLDPEYFRRQ--QLTEKSDVYSFGVVLMEVLCT-RPALNPVLPREQVNIAEWAMTWQKKG 727 (845)
Q Consensus 651 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDV~S~Gvvl~Elltg-~~p~~~~~~~~~~~l~~~~~~~~~~~ 727 (845)
+.... .....++..|+|||++.+. .++.++||||||+++|||++| ..|+......+ +.....
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~------~~~~~~--- 220 (259)
T cd05037 156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE------KERFYQ--- 220 (259)
T ss_pred ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh------HHHHHh---
Confidence 76332 1233466789999999876 789999999999999999995 66665432211 111110
Q ss_pred chhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 728 MLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 728 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
+... .+......+.+++.+||..+|.+||++.++++.|+
T Consensus 221 ------~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 ------DQHR---LPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred ------cCCC---CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0000 11111267889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=325.31 Aligned_cols=245 Identities=27% Similarity=0.442 Sum_probs=204.9
Q ss_pred eeeeeceEEEEEEEEcC-CcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEeccCCCccc
Q 003139 509 LLGVGGFGRVYKGTLDD-GTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRS 587 (845)
Q Consensus 509 ~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~ 587 (845)
+||+|.||+||.|+..+ ...+|||.+........+-+..|+.+-++++|+|||+.+|.|.+++.+-|.||-+|||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 69999999999999764 45689999888777777888999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCC--CHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEEC-CCCceEEEeccccCCCCCCCCcccccc
Q 003139 588 HLYGTDLPPL--SWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLD-DNFVAKVADFGLSKTGPALDQTHVSTA 664 (845)
Q Consensus 588 ~l~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~ 664 (845)
+|+.+ -+++ ++.+.-.+.+||++||.|||+ +.|||||||-+||||+ -.|.+||+|||.++.....+. ....
T Consensus 662 LLrsk-WGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP--~TET 735 (1226)
T KOG4279|consen 662 LLRSK-WGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP--CTET 735 (1226)
T ss_pred HHHhc-cCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccCCc--cccc
Confidence 99754 3566 777888899999999999999 9999999999999997 678999999999987554332 2346
Q ss_pred cccCCCcCChhhhccC--CCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCC
Q 003139 665 VKGSFGYLDPEYFRRQ--QLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVN 742 (845)
Q Consensus 665 ~~gt~~y~aPE~~~~~--~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 742 (845)
+.||.-|||||++..+ .|..++|||||||.+.||.|||+||........ .+.+-|... ....++
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--------AMFkVGmyK------vHP~iP 801 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--------AMFKVGMYK------VHPPIP 801 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--------hhhhhccee------cCCCCc
Confidence 7899999999999765 588999999999999999999999964432221 112222211 123466
Q ss_pred HHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 743 PASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 743 ~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.+...+...++++|+.++|.+||++.++++.
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 7788889999999999999999999998764
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=321.93 Aligned_cols=259 Identities=21% Similarity=0.274 Sum_probs=196.1
Q ss_pred ceeeeee--ceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEecc
Q 003139 507 SLLLGVG--GFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMA 581 (845)
Q Consensus 507 ~~~LG~G--~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 581 (845)
..+||+| +|++||++..+ +|+.||+|++... .....+.+.+|+++++.++||||+++++++..++..++||||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 4579999 78999999875 7899999988654 23344567789999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCc--
Q 003139 582 NGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT-- 659 (845)
Q Consensus 582 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~-- 659 (845)
+|+|.+++.......+++..+++++.|++.||+|||+ .+|+||||||+|||++.++.++++||+...........
T Consensus 83 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred CCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 9999999865544568999999999999999999998 89999999999999999999999999875432111110
Q ss_pred ---ccccccccCCCcCChhhhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhc
Q 003139 660 ---HVSTAVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMD 734 (845)
Q Consensus 660 ---~~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (845)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||........ .... . .+......+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~----~-~~~~~~~~~ 232 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEK----L-NGTVPCLLD 232 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHHH----h-cCCcccccc
Confidence 01122346778999999976 4689999999999999999999999965332110 0000 0 000000000
Q ss_pred -------------------ccc-----------------CCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 735 -------------------SNL-----------------VGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 735 -------------------~~l-----------------~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
... ...........+.+++.+||+.||++|||+.+++++-.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~ 309 (327)
T cd08227 233 TTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF 309 (327)
T ss_pred ccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChh
Confidence 000 00111233467889999999999999999999987543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=308.96 Aligned_cols=250 Identities=33% Similarity=0.495 Sum_probs=201.2
Q ss_pred CcceeeeeeceEEEEEEEEcC-----CcEEEEEEcCCCChH-hHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEE
Q 003139 505 DESLLLGVGGFGRVYKGTLDD-----GTKVAVKRGNPRSEQ-GIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYE 578 (845)
Q Consensus 505 ~~~~~LG~G~fg~Vy~~~~~~-----g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 578 (845)
.+.+.||.|+||.||++...+ +..+|+|........ ..+.+..|++++.+++|+||+++++++.+.+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 456789999999999999763 378999998765433 56789999999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCC
Q 003139 579 YMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQ 658 (845)
Q Consensus 579 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~ 658 (845)
|+++++|.+++.......+++.++..++.|++.||+|||+ .+++||||||+||++++++.++|+|||+++.......
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 82 YMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred ccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 9999999999865543338999999999999999999998 8999999999999999999999999999976443211
Q ss_pred cccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcccc
Q 003139 659 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNL 737 (845)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (845)
.. .....++..|+|||.+.+..++.++||||+|++++||++ |++|+...... ...... ..+.
T Consensus 159 ~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~------~~~~~~-~~~~--------- 221 (258)
T smart00219 159 YK-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE------EVLEYL-KKGY--------- 221 (258)
T ss_pred cc-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHH-hcCC---------
Confidence 11 112346789999999988899999999999999999998 77777542211 111111 1111
Q ss_pred CCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003139 738 VGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNL 774 (845)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L 774 (845)
....+...+..+.+++.+|+..+|++|||+.++++.|
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 222 RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 1112233566789999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=327.88 Aligned_cols=264 Identities=20% Similarity=0.274 Sum_probs=198.1
Q ss_pred HhcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecC------
Q 003139 500 ATNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDER------ 570 (845)
Q Consensus 500 at~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 570 (845)
..++|+..+.||+|+||.||++... .++.+|+|++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4568999999999999999999865 5889999987653 334456788999999999999999999988543
Q ss_pred CcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEecccc
Q 003139 571 SEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLS 650 (845)
Q Consensus 571 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla 650 (845)
...++||||+++ +|.+.+. ..+++..+..++.|+++||+|||+ .+|+||||||+||||++++.+||+|||++
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCccc
Confidence 357999999965 5666553 248899999999999999999998 99999999999999999999999999999
Q ss_pred CCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccH---------HHH--
Q 003139 651 KTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNI---------AEW-- 719 (845)
Q Consensus 651 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l---------~~~-- 719 (845)
+.... ........||..|+|||++.+..++.++|||||||++|||++|+.||......+.... .++
T Consensus 167 ~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (355)
T cd07874 167 RTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_pred ccCCC---ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 76322 2223345789999999999999999999999999999999999999965432111000 000
Q ss_pred -----HHHHhhcC-chh-----hhhccccC---CCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003139 720 -----AMTWQKKG-MLD-----QIMDSNLV---GKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNL 774 (845)
Q Consensus 720 -----~~~~~~~~-~~~-----~~~d~~l~---~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L 774 (845)
.....+.. ... ......+. ..........+.+++.+||+.||++|||+.|++++-
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp 312 (355)
T cd07874 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHP 312 (355)
T ss_pred hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCc
Confidence 00000000 000 00000000 001122345688999999999999999999998763
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=310.33 Aligned_cols=253 Identities=28% Similarity=0.396 Sum_probs=205.3
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEec
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYM 580 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 580 (845)
++|+..+.||+|+||.||+|... +++.+++|..........+.+.+|++++++++||||+++++++.+....+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 56888899999999999999875 57889999877665556788999999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcc
Q 003139 581 ANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH 660 (845)
Q Consensus 581 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 660 (845)
++++|.+++... ...+++.++..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||++...... ..
T Consensus 83 ~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~--~~ 156 (262)
T cd06613 83 GGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT--IA 156 (262)
T ss_pred CCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhh--hh
Confidence 999999988543 2468999999999999999999998 89999999999999999999999999998753321 11
Q ss_pred cccccccCCCcCChhhhccC---CCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcccc
Q 003139 661 VSTAVKGSFGYLDPEYFRRQ---QLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNL 737 (845)
Q Consensus 661 ~~~~~~gt~~y~aPE~~~~~---~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (845)
......++..|+|||.+... .++.++||||||+++|||++|+.|+......+... . ..... ...+.+
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~------~-~~~~~---~~~~~~ 226 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF------L-ISKSN---FPPPKL 226 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH------H-HHhcc---CCCccc
Confidence 22345678899999999776 88999999999999999999999986543222110 0 00000 000111
Q ss_pred CCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 003139 738 VGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLW 772 (845)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~ 772 (845)
......+..+.+++.+||+.+|.+||++.+|+.
T Consensus 227 --~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 227 --KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred --cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 122345677899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=309.62 Aligned_cols=249 Identities=24% Similarity=0.344 Sum_probs=203.2
Q ss_pred CCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
+|+..+.||+|+||.||++... +++.+++|++... +....+.+.+|++++++++|||++++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4778889999999999999864 6788999987543 344567899999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCC-CceEEEeccccCCCCCCCC
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDN-FVAKVADFGLSKTGPALDQ 658 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~-~~~kl~DFGla~~~~~~~~ 658 (845)
+++++|.+++.......+++..+.+++.|++.||+|||+ ++++||||||+||+++++ +.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~-- 155 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK-- 155 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC--
Confidence 999999999976555568999999999999999999998 899999999999999854 46899999999764321
Q ss_pred cccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccC
Q 003139 659 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLV 738 (845)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 738 (845)
.......++..|+|||.+.+..++.++||||||+++|||++|+.||....... .+...... ..
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~------~~~~~~~~----------~~ 218 (256)
T cd08220 156 -SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA------LVLKIMSG----------TF 218 (256)
T ss_pred -ccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH------HHHHHHhc----------CC
Confidence 11223567889999999999899999999999999999999999986533211 11111110 01
Q ss_pred CCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 739 GKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 739 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
...+......+.+++.+||+.+|.+|||+.|++++
T Consensus 219 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 219 APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11223345678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=312.49 Aligned_cols=255 Identities=24% Similarity=0.388 Sum_probs=200.3
Q ss_pred CCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC----------hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS----------EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERS 571 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 571 (845)
+|...+.||+|+||.||+|... +|+.+|+|.+.... ....+.+.+|++++++++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 3566779999999999999865 68899999764321 112356788999999999999999999999999
Q ss_pred cEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccC
Q 003139 572 EMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSK 651 (845)
Q Consensus 572 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~ 651 (845)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++||||+|+||++++++.+||+|||+++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence 999999999999999998654 478999999999999999999998 899999999999999999999999999997
Q ss_pred CCCCCCCcccccccccCCCcCChhhhccCC--CCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCch
Q 003139 652 TGPALDQTHVSTAVKGSFGYLDPEYFRRQQ--LTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGML 729 (845)
Q Consensus 652 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 729 (845)
...............++..|+|||.+.... ++.++||||||+++|||++|+.|+......+ ......... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~~-~ 229 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA------AMFKLGNKR-S 229 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH------HHHHhhccc-c
Confidence 643322222233456889999999987654 8999999999999999999999985322111 011111000 0
Q ss_pred hhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 730 DQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 730 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.........+.....+.+++.+||+.+|.+||++.+|+++
T Consensus 230 ----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 230 ----APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ----CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 0111111223446788899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=311.97 Aligned_cols=252 Identities=21% Similarity=0.303 Sum_probs=190.5
Q ss_pred eeeeeceEEEEEEEEcCC---cEEEEEEcCCCC-hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEeccCCC
Q 003139 509 LLGVGGFGRVYKGTLDDG---TKVAVKRGNPRS-EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGP 584 (845)
Q Consensus 509 ~LG~G~fg~Vy~~~~~~g---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 584 (845)
.||+|+||.||+|...++ ..+++|.+.... ....+.|.+|+.+++.++||||+++++.|.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999975433 346677665433 4456789999999999999999999999999999999999999999
Q ss_pred ccccccCCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcccc
Q 003139 585 LRSHLYGTD--LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVS 662 (845)
Q Consensus 585 L~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 662 (845)
|.+++.... ...+++..+..++.|+++||+|||+ .+++||||||+|||++.++.+||+|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999986542 2356777888999999999999998 89999999999999999999999999998643221111222
Q ss_pred cccccCCCcCChhhhcc-------CCCCchhHHHHHHHHHHHHHcC-CCCCCCCCCcccccHHHHHHHHhhcCchhhhhc
Q 003139 663 TAVKGSFGYLDPEYFRR-------QQLTEKSDVYSFGVVLMEVLCT-RPALNPVLPREQVNIAEWAMTWQKKGMLDQIMD 734 (845)
Q Consensus 663 ~~~~gt~~y~aPE~~~~-------~~~s~ksDV~S~Gvvl~Elltg-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (845)
....++..|+|||++.. ..++.++|||||||++|||+++ ..|+...... +.......+ ....+.+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~~~~~~~~~-~~~~~~~ 231 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR------EVLNHVIKD-QQVKLFK 231 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHhh-cccccCC
Confidence 34567889999998753 3457899999999999999974 5666433221 112221111 1122233
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 735 SNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 735 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
+.+. ......+.+++..|| .+|++||++++|++.|.
T Consensus 232 ~~~~----~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 PQLE----LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CccC----CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 3322 224456788899999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=315.73 Aligned_cols=263 Identities=22% Similarity=0.269 Sum_probs=197.4
Q ss_pred CCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC--hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS--EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
+|+..+.||+|++|.||+|+.. +++.+|+|++.... ....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4677889999999999999975 68899999875432 22346788999999999999999999999999999999999
Q ss_pred ccCCCccccccCCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCC
Q 003139 580 MANGPLRSHLYGTD-LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQ 658 (845)
Q Consensus 580 ~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~ 658 (845)
++ ++|.+++.... ...+++.++..++.|++.||+|||+ .+++||||||+|||+++++.+||+|||+++.....
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 154 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP-- 154 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCC--
Confidence 97 68888775432 3578999999999999999999998 89999999999999999999999999998753221
Q ss_pred cccccccccCCCcCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHh-------h-cCch
Q 003139 659 THVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQ-------K-KGML 729 (845)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~-------~-~~~~ 729 (845)
........+++.|+|||.+.+. .++.++|||||||+++||++|++||........ +........ . ...+
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd07861 155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ--LFRIFRILGTPTEDVWPGVTSL 232 (285)
T ss_pred cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChhhhhcchhh
Confidence 1112234568899999988754 578999999999999999999999875432111 000000000 0 0000
Q ss_pred ---hhhhccccC---CCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 730 ---DQIMDSNLV---GKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 730 ---~~~~d~~l~---~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
....+.... .........++.+++.+||+.||.+|||+.+|+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 233 PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000000 00111234567899999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=325.38 Aligned_cols=255 Identities=21% Similarity=0.244 Sum_probs=196.3
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
++|+..+.||+|+||.||+++.+ +++.+|+|.+... .....+.+.+|+.++..++|+||+++.+++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36888899999999999999976 4678999987532 2233456888999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
||+++|+|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.... .
T Consensus 81 ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~-~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME-D 155 (332)
T ss_pred eccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheeccc-C
Confidence 999999999999653 2468999999999999999999999 9999999999999999999999999999875322 1
Q ss_pred CcccccccccCCCcCChhhhc-----cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhh
Q 003139 658 QTHVSTAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQI 732 (845)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (845)
.........||+.|+|||++. ...++.++|||||||++|||++|+.||......+ .......... ..
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~------~~~~i~~~~~--~~ 227 (332)
T cd05623 156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHKE--RF 227 (332)
T ss_pred CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH------HHHHHhCCCc--cc
Confidence 122223457999999999986 3568899999999999999999999996533211 1111111100 00
Q ss_pred hccccCCCCCHHHHHHHHHHHHHhhhh--CCCCCCCHHHHHHH
Q 003139 733 MDSNLVGKVNPASLKKFGETAEKCLAE--HGVDRPSMGDVLWN 773 (845)
Q Consensus 733 ~d~~l~~~~~~~~~~~l~~l~~~cl~~--~p~~RPs~~~vl~~ 773 (845)
.. ..........+.+++.+|+.. ++..|+++.+++++
T Consensus 228 ---~~-p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 228 ---QF-PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ---cC-CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00 011123456677888887754 34447899998877
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=309.80 Aligned_cols=251 Identities=24% Similarity=0.365 Sum_probs=198.3
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC-----ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecC--CcE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR-----SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDER--SEM 573 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 573 (845)
.+|+..++||+|+||.||+|... +|..|++|.+... .....+.+.+|++++++++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888899999999999999875 5889999976422 233456888999999999999999999988653 467
Q ss_pred EEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCC
Q 003139 574 ILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTG 653 (845)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~ 653 (845)
++||||+++++|.+++... ..+++...++++.|++.||+|||+ .+++|+||||+||++++++.+||+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 8999999999999988543 358899999999999999999998 89999999999999999999999999999754
Q ss_pred CCCCCc-ccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhh
Q 003139 654 PALDQT-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQI 732 (845)
Q Consensus 654 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (845)
...... .......++..|+|||.+.+..++.++|||||||++|||++|+.||........ . .+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~---------~~~ 221 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA------I---------FKI 221 (265)
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH------H---------HHH
Confidence 321111 112234588899999999988999999999999999999999999864321110 0 011
Q ss_pred hccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 733 MDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 733 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.........+......+.+++.+|+. +|++||++++++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 222 ATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred hcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 11111122344556678889999985 99999999998754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=316.40 Aligned_cols=252 Identities=26% Similarity=0.397 Sum_probs=204.5
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEec
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYM 580 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 580 (845)
++|++.+.||+|+||.||+|... +++.+++|..........+.|..|++++++++||||+++++.+.+....++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 45777888999999999999975 68899999987777777788999999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcc
Q 003139 581 ANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH 660 (845)
Q Consensus 581 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 660 (845)
++++|.+++.... ..+++.++..++.|++.||.|||+ .+|+|+||||+||+++.++.++|+|||++...... ..
T Consensus 85 ~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~--~~ 158 (280)
T cd06611 85 DGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST--LQ 158 (280)
T ss_pred CCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhccc--cc
Confidence 9999999886433 468999999999999999999999 89999999999999999999999999998653321 11
Q ss_pred cccccccCCCcCChhhhc-----cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcc
Q 003139 661 VSTAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDS 735 (845)
Q Consensus 661 ~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (845)
......++..|+|||.+. ...++.++||||||+++|||++|+.||......+ ..... ..+.. +
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~------~~~~~-~~~~~-----~ 226 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR------VLLKI-LKSEP-----P 226 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH------HHHHH-hcCCC-----C
Confidence 223456889999999875 3457889999999999999999999986543211 11111 11100 0
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 736 NLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 736 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.+ ..+......+.+++.+||+.+|.+||++.++++.
T Consensus 227 ~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 227 TL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred Cc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 11 1123345678899999999999999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=327.15 Aligned_cols=263 Identities=20% Similarity=0.275 Sum_probs=197.5
Q ss_pred HhcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecC------
Q 003139 500 ATNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDER------ 570 (845)
Q Consensus 500 at~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 570 (845)
..++|...+.||+|+||.||++... .++.+|||++... .....+++.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3468999999999999999999865 5788999987643 334456788999999999999999999987543
Q ss_pred CcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEecccc
Q 003139 571 SEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLS 650 (845)
Q Consensus 571 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla 650 (845)
...++||||+++ +|.+.+. ..+++.++..++.|+++||+|||+ ++|+||||||+|||+++++.+||+|||++
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH----hcCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 357999999965 6666653 247899999999999999999998 89999999999999999999999999999
Q ss_pred CCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHH---------HHHH
Q 003139 651 KTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIA---------EWAM 721 (845)
Q Consensus 651 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~---------~~~~ 721 (845)
+.... ........+|..|+|||++.+..++.++|||||||++|||++|+.||......+..... ++..
T Consensus 174 ~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (364)
T cd07875 174 RTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 250 (364)
T ss_pred cccCC---CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 76322 22233457899999999999999999999999999999999999999654322110000 0000
Q ss_pred -------HHhhcC-c-----hhhhhcccc---CCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 722 -------TWQKKG-M-----LDQIMDSNL---VGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 722 -------~~~~~~-~-----~~~~~d~~l---~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
...... . ..++....+ ...........+.+++.+|++.||.+|||+.+++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000 0 000000000 000111123567899999999999999999999876
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=338.73 Aligned_cols=268 Identities=21% Similarity=0.250 Sum_probs=196.8
Q ss_pred HHHHHhcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCC------CCcceEEEEEe
Q 003139 496 EILDATNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRH------RHLVSLIGYCD 568 (845)
Q Consensus 496 el~~at~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H------~niv~l~g~~~ 568 (845)
++...+++|++.++||+|+||.||+|... .++.||||++.... ...+++..|++++.+++| .+++++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34445788999999999999999999875 57889999886432 233456677777777754 45888999886
Q ss_pred cC-CcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCC-------
Q 003139 569 ER-SEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNF------- 640 (845)
Q Consensus 569 ~~-~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~------- 640 (845)
.. ...++|||++ +++|.+++... ..+++.++..|+.||+.||+|||+ ..+||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCccccccc
Confidence 54 5789999988 77888887543 479999999999999999999996 24899999999999998765
Q ss_pred ---------ceEEEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCc
Q 003139 641 ---------VAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPR 711 (845)
Q Consensus 641 ---------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~ 711 (845)
.+||+|||++.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 351 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL 351 (467)
T ss_pred ccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 49999999886421 2234567999999999999999999999999999999999999999765433
Q ss_pred ccccHH---------HHHHHHhhcCchhhhhccc--cCCCC---------------CHHHHHHHHHHHHHhhhhCCCCCC
Q 003139 712 EQVNIA---------EWAMTWQKKGMLDQIMDSN--LVGKV---------------NPASLKKFGETAEKCLAEHGVDRP 765 (845)
Q Consensus 712 ~~~~l~---------~~~~~~~~~~~~~~~~d~~--l~~~~---------------~~~~~~~l~~l~~~cl~~~p~~RP 765 (845)
+...+. .|...+..+ ...++.+.. +.... .......+.+|+.+||+.||++||
T Consensus 352 ~~~~~i~~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ 430 (467)
T PTZ00284 352 EHLHLMEKTLGRLPSEWAGRCGTE-EARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL 430 (467)
T ss_pred HHHHHHHHHcCCCCHHHHhhccch-hHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC
Confidence 222111 111110000 000010000 00000 001134678999999999999999
Q ss_pred CHHHHHHHHH
Q 003139 766 SMGDVLWNLE 775 (845)
Q Consensus 766 s~~~vl~~L~ 775 (845)
|++|++++-.
T Consensus 431 ta~e~L~Hp~ 440 (467)
T PTZ00284 431 NARQMTTHPY 440 (467)
T ss_pred CHHHHhcCcc
Confidence 9999997643
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=315.92 Aligned_cols=262 Identities=27% Similarity=0.356 Sum_probs=204.9
Q ss_pred ccHHHHHHHhcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhC-CCCCcceEEEEEec
Q 003139 492 FMFQEILDATNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDE 569 (845)
Q Consensus 492 ~~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 569 (845)
+.+.++..++++|+..+.||+|+||.||++... +++.+|+|....... ..+++.+|+.++.++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 455666777899999999999999999999875 688999998764422 235677899999998 89999999999865
Q ss_pred C-----CcEEEEEEeccCCCccccccCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCce
Q 003139 570 R-----SEMILVYEYMANGPLRSHLYGT--DLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVA 642 (845)
Q Consensus 570 ~-----~~~~lV~Ey~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~ 642 (845)
. +..++|+||+++++|.+++... ....+++..++.++.|++.||+|||+ .+++||||||+||++++++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCE
Confidence 3 3589999999999999987532 33568999999999999999999998 899999999999999999999
Q ss_pred EEEeccccCCCCCCCCcccccccccCCCcCChhhhccC-----CCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHH
Q 003139 643 KVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQ-----QLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIA 717 (845)
Q Consensus 643 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~ 717 (845)
||+|||+++...... .......|+..|+|||.+... .++.++|||||||++|||++|+.||......+. +.
T Consensus 168 kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~--~~ 243 (291)
T cd06639 168 KLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT--LF 243 (291)
T ss_pred EEeecccchhccccc--ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH--HH
Confidence 999999987643211 112334678899999998654 368999999999999999999999865432211 11
Q ss_pred HHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 718 EWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 718 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.. .++....+. .+......+.+++.+||+.+|++||++.+++++
T Consensus 244 ----~~-~~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 244 ----KI-PRNPPPTLL-------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred ----HH-hcCCCCCCC-------cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 10 011111110 122344568899999999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=317.64 Aligned_cols=253 Identities=24% Similarity=0.301 Sum_probs=203.2
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCCh---HhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSE---QGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
++|+..+.||+|++|.||+|... +++.+|+|.+..... ...+.+..|++++++++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36788889999999999999976 489999998765432 35567899999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
||+++++|.+++.......+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 99999999999875555679999999999999999999998 899999999999999999999999999986532211
Q ss_pred Cc---------------------------ccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Q 003139 658 QT---------------------------HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLP 710 (845)
Q Consensus 658 ~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~ 710 (845)
.. .......|+..|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 00 011134678899999999999999999999999999999999999864432
Q ss_pred cccccHHHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCC----HHHHHH
Q 003139 711 REQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPS----MGDVLW 772 (845)
Q Consensus 711 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs----~~~vl~ 772 (845)
... ..++.+..............+.+++.+||+.+|++||+ +.+++.
T Consensus 238 ~~~---------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 238 DET---------------FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HHH---------------HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 211 11112211111111225678999999999999999999 555554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=314.31 Aligned_cols=253 Identities=26% Similarity=0.359 Sum_probs=202.2
Q ss_pred CCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEec
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYM 580 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 580 (845)
+|+..+.||+|+||.||++... .++.+|+|.+... .....+++.+|++++++++|+||+++++.+...+..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5677889999999999999976 6889999987643 4445678999999999999999999999999999999999999
Q ss_pred cCCCccccccCCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCc
Q 003139 581 ANGPLRSHLYGTD-LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT 659 (845)
Q Consensus 581 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~ 659 (845)
++++|..++.... ...+++..+..++.|++.||.|||+ ..+|+||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---- 155 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA---- 155 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC----
Confidence 9999998886431 3478999999999999999999996 25899999999999999999999999999875322
Q ss_pred ccccccccCCCcCChhhhccC------CCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhh
Q 003139 660 HVSTAVKGSFGYLDPEYFRRQ------QLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIM 733 (845)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~~------~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (845)
.......++..|+|||.+.+. .++.++|||||||++|||++|+.||........ .. .+..+.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~------~~------~~~~~~ 223 (286)
T cd06622 156 SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI------FA------QLSAIV 223 (286)
T ss_pred CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH------HH------HHHHHh
Confidence 112234578899999998654 358899999999999999999999864322110 00 011111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003139 734 DSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNL 774 (845)
Q Consensus 734 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L 774 (845)
+.. ....+......+.+++.+||+.+|++||++.+++..-
T Consensus 224 ~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~ 263 (286)
T cd06622 224 DGD-PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHP 263 (286)
T ss_pred hcC-CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcCh
Confidence 111 1123344667888999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=305.71 Aligned_cols=248 Identities=25% Similarity=0.382 Sum_probs=209.1
Q ss_pred CCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEeccC
Q 003139 504 FDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMAN 582 (845)
Q Consensus 504 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 582 (845)
|++..+||+|.||.|||+.++ .|+.+|+|++...+ +++++.+|+.+|.+...|++|+++|.+.....+++|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 455668999999999999976 69999999976543 568899999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcccc
Q 003139 583 GPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVS 662 (845)
Q Consensus 583 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 662 (845)
|++.+.++.. ..+|++.++..|++..++||+|||. ..-||||||+.||||+-+|.+||+|||.|.... +.....
T Consensus 113 GSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLT--DTMAKR 186 (502)
T KOG0574|consen 113 GSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLT--DTMAKR 186 (502)
T ss_pred CcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhh--hhHHhh
Confidence 9999998754 4689999999999999999999998 888999999999999999999999999997533 233334
Q ss_pred cccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCC
Q 003139 663 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVN 742 (845)
Q Consensus 663 ~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 742 (845)
..+.||+.|||||++..-.|..++||||+|+...||.-|++|+....+-...-+ +. -.|...-..+
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM-------IP-------T~PPPTF~KP 252 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM-------IP-------TKPPPTFKKP 252 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe-------cc-------CCCCCCCCCh
Confidence 567899999999999999999999999999999999999999977655332110 00 0111112234
Q ss_pred HHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 743 PASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 743 ~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
......+.++++.||-++|++|-|+.+++++
T Consensus 253 E~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 253 EEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred HhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 5667889999999999999999999987764
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=318.09 Aligned_cols=196 Identities=24% Similarity=0.354 Sum_probs=158.7
Q ss_pred ceeeeeeceEEEEEEEEc---CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEec--CCcEEEEEEecc
Q 003139 507 SLLLGVGGFGRVYKGTLD---DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDE--RSEMILVYEYMA 581 (845)
Q Consensus 507 ~~~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~Ey~~ 581 (845)
.++||+|+||.||+|+.. +++.+|+|.+..... ...+.+|++++++++||||+++++++.. ....++||||++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 357999999999999865 457899998764422 2456789999999999999999998854 456889999995
Q ss_pred CCCccccccCC-------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEE----CCCCceEEEecccc
Q 003139 582 NGPLRSHLYGT-------DLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILL----DDNFVAKVADFGLS 650 (845)
Q Consensus 582 ~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl----~~~~~~kl~DFGla 650 (845)
++|.+++... ....+++..+..++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 4776665321 12358899999999999999999998 899999999999999 46679999999999
Q ss_pred CCCCCCCC-cccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 003139 651 KTGPALDQ-THVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPV 708 (845)
Q Consensus 651 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~ 708 (845)
+....... ........||+.|+|||++.+ ..++.++||||+||++|||++|++||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 86432111 112234678999999999876 46899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=316.46 Aligned_cols=256 Identities=23% Similarity=0.296 Sum_probs=202.1
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC---hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS---EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
++|+..+.||+|+||.||++... .++.|++|.+.... ....+.+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888899999999999999976 57889999876543 234567889999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
||+++++|.+++... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 81 EYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 999999999998544 468999999999999999999998 899999999999999999999999999987421100
Q ss_pred -------------CcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHh
Q 003139 658 -------------QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQ 724 (845)
Q Consensus 658 -------------~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~ 724 (845)
.........++..|+|||.+.+..++.++|+||||+++|||++|+.||...... ++.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~------~~~~~~~ 229 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------ELFGQVI 229 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHH
Confidence 001112345788999999999889999999999999999999999998643221 1111111
Q ss_pred hcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003139 725 KKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEY 776 (845)
Q Consensus 725 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~ 776 (845)
.. . ...+. .....+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 230 ~~-~---~~~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 230 SD-D---IEWPE----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred hc-c---cCCCC----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 11 0 00011 111345668899999999999999997666666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=307.70 Aligned_cols=253 Identities=23% Similarity=0.327 Sum_probs=203.1
Q ss_pred CCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEec--CCcEEEEE
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDE--RSEMILVY 577 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~ 577 (845)
+|+..+.||+|+||.||++... +++.+++|.+... .....+++.+|++++++++|+||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4677889999999999999865 6788999987532 44556788999999999999999999998753 45679999
Q ss_pred EeccCCCccccccCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCceeeccCCCCcEEECCCCceEEEeccccCCC
Q 003139 578 EYMANGPLRSHLYGT--DLPPLSWKQRLEICIGAARGLHYLHTGA--AQSIIHRDVKTTNILLDDNFVAKVADFGLSKTG 653 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~ 653 (845)
||+++++|.+++... ...++++..++.++.|++.||+|||..+ ..+++|+||||+||++++++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999988542 2457999999999999999999999321 389999999999999999999999999999864
Q ss_pred CCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhh
Q 003139 654 PALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIM 733 (845)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (845)
.... .......++..|+|||.+.+..++.++||||||++++||++|+.|+...... ..... ...+
T Consensus 161 ~~~~--~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~-~~~~------ 225 (265)
T cd08217 161 GHDS--SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL------QLASK-IKEG------ 225 (265)
T ss_pred cCCc--ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH------HHHHH-HhcC------
Confidence 4321 1123456889999999999999999999999999999999999998754311 11111 1111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 734 DSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 734 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.....+......+.+++.+|++.+|++||++.+|+++
T Consensus 226 ---~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 226 ---KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ---CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1122344556788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=307.50 Aligned_cols=257 Identities=24% Similarity=0.360 Sum_probs=206.1
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC-hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS-EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
++|+..+.||.|+||.||+|... ++..+++|++.... ....+.+.+|+++++.++|+|++++++.+...+..++|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888899999999999999865 67889999876432 33567899999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCC
Q 003139 580 MANGPLRSHLYGTDL-PPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQ 658 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~ 658 (845)
+++++|.+++..... ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999865432 568999999999999999999998 9999999999999999999999999999876443222
Q ss_pred c--ccccccccCCCcCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcc
Q 003139 659 T--HVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDS 735 (845)
Q Consensus 659 ~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (845)
. .......|+..|+|||++... .++.++|||||||++|||++|+.||......+. ... .... ..+
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~----~~~~------~~~ 225 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--LML----TLQN------DPP 225 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--HHH----HhcC------CCC
Confidence 2 122345688999999998877 789999999999999999999999965433211 111 0111 011
Q ss_pred ccCCCC-CHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 736 NLVGKV-NPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 736 ~l~~~~-~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.+.... ....+..+.+++.+|++.+|++||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 111111 12455778899999999999999999999864
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=311.01 Aligned_cols=262 Identities=23% Similarity=0.262 Sum_probs=200.0
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC--hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS--EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYE 578 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 578 (845)
++|+..+.||+|+||.||+|+.. +|+.+|+|++.... ....+.+.+|++++++++|+|++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 36788889999999999999976 58899999865432 2234568899999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCC
Q 003139 579 YMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQ 658 (845)
Q Consensus 579 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~ 658 (845)
|++++.|..++... ..+++..++.++.|++.||+|||+ ++++||||||+||++++++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 81 YCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred ccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 99999888776433 368999999999999999999999 9999999999999999999999999999976433221
Q ss_pred cccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhc-----------
Q 003139 659 THVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKK----------- 726 (845)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~----------- 726 (845)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+... .+ ......
T Consensus 156 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~--~~-~~~~~~~~~~~~~~~~~ 230 (286)
T cd07847 156 --DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLY--LI-RKTLGDLIPRHQQIFST 230 (286)
T ss_pred --cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHH--HH-HHHhCCCChHHhhhccc
Confidence 1223457789999999876 568899999999999999999999997544322110 00 000000
Q ss_pred -CchhhhhccccCCCC-----CHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 727 -GMLDQIMDSNLVGKV-----NPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 727 -~~~~~~~d~~l~~~~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
........+...... .+.....+.+++.+||+.+|++||++.+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 231 NQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 000000000000000 01234678899999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=345.42 Aligned_cols=254 Identities=21% Similarity=0.333 Sum_probs=197.9
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEec--CCcEEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDE--RSEMIL 575 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~l 575 (845)
.++|.+.+.||+|+||.||+++.. .++.+|+|.+... .......|..|+.++++++|||||++++++.+ ...++|
T Consensus 12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI 91 (1021)
T PTZ00266 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI 91 (1021)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence 467899999999999999999976 5678889976543 34456788999999999999999999998744 456899
Q ss_pred EEEeccCCCccccccCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcC----CCceeeccCCCCcEEECC-----------
Q 003139 576 VYEYMANGPLRSHLYGT--DLPPLSWKQRLEICIGAARGLHYLHTGA----AQSIIHRDVKTTNILLDD----------- 638 (845)
Q Consensus 576 V~Ey~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~----~~~ivHrDik~~NILl~~----------- 638 (845)
||||+++|+|.++|... ....+++..++.|+.||+.||+|||+.. ..+||||||||+||||+.
T Consensus 92 VMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~ 171 (1021)
T PTZ00266 92 LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ 171 (1021)
T ss_pred EEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence 99999999999988642 2357999999999999999999999732 145999999999999964
Q ss_pred ------CCceEEEeccccCCCCCCCCcccccccccCCCcCChhhhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Q 003139 639 ------NFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLMEVLCTRPALNPVLP 710 (845)
Q Consensus 639 ------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~ 710 (845)
...+||+|||+++.... ........||+.|+|||++.+ ..++.++||||||||||||++|+.||.....
T Consensus 172 ~~n~ng~~iVKLsDFGlAr~l~~---~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~ 248 (1021)
T PTZ00266 172 ANNLNGRPIAKIGDFGLSKNIGI---ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN 248 (1021)
T ss_pred ccccCCCCceEEccCCccccccc---cccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 33589999999976432 122234578999999999864 4689999999999999999999999964322
Q ss_pred cccccHHHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 711 REQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 711 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.. ..... ...+ +.+ ........+.+|+..||+.+|.+||++.+++..
T Consensus 249 ~~-----qli~~-lk~~-------p~l---pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 249 FS-----QLISE-LKRG-------PDL---PIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred HH-----HHHHH-HhcC-------CCC---CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 11 11111 1111 001 012234678899999999999999999999854
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=322.65 Aligned_cols=245 Identities=27% Similarity=0.391 Sum_probs=200.8
Q ss_pred CCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEE
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYE 578 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 578 (845)
.|...+.||+|.||.||.|+.. +.+.||||++.-. +...+.++++|+..|.+++|||++.+-|++......+||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 3555667999999999999864 6788999998654 34456789999999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCC
Q 003139 579 YMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQ 658 (845)
Q Consensus 579 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~ 658 (845)
|| -||-.++|.-.+ .+|-..++.-|+.+.+.||+|||+ ++.||||||+.||||.+.|.+||+|||.|.+...
T Consensus 107 YC-lGSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P--- 178 (948)
T KOG0577|consen 107 YC-LGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP--- 178 (948)
T ss_pred HH-hccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCc---
Confidence 99 567777774332 478899999999999999999999 9999999999999999999999999999876432
Q ss_pred cccccccccCCCcCChhhhc---cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcc
Q 003139 659 THVSTAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDS 735 (845)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (845)
...++|||.|||||++. .++|+-|+||||+|+...||.-.++|......-.. + .....++ .|
T Consensus 179 ---AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA--L----YHIAQNe------sP 243 (948)
T KOG0577|consen 179 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--L----YHIAQNE------SP 243 (948)
T ss_pred ---hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH--H----HHHHhcC------CC
Confidence 35689999999999874 57999999999999999999999999865443221 0 0101110 11
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 736 NLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 736 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.+ ...+....|..++..||++-|.+|||.++++.+
T Consensus 244 tL---qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 244 TL---QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CC---CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 22 135677889999999999999999999886543
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=310.87 Aligned_cols=255 Identities=27% Similarity=0.406 Sum_probs=201.2
Q ss_pred HHhcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCC-----
Q 003139 499 DATNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERS----- 571 (845)
Q Consensus 499 ~at~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~----- 571 (845)
.++++|+..+.||+|++|.||+|... +++.+++|.+..... ..+++.+|+++++++ +|+||+++++++.+..
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 35688999999999999999999975 578899998765443 346789999999999 6999999999996644
Q ss_pred -cEEEEEEeccCCCccccccCCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEecc
Q 003139 572 -EMILVYEYMANGPLRSHLYGTD--LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFG 648 (845)
Q Consensus 572 -~~~lV~Ey~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFG 648 (845)
..++||||+++++|.+++.... ...+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCc
Confidence 4899999999999999886432 4578999999999999999999998 899999999999999999999999999
Q ss_pred ccCCCCCCCCcccccccccCCCcCChhhhcc-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHH
Q 003139 649 LSKTGPALDQTHVSTAVKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTW 723 (845)
Q Consensus 649 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~ 723 (845)
++...... ........|+..|+|||.+.. ..++.++|||||||+|+||++|+.||........ + ..
T Consensus 159 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~----~~- 229 (275)
T cd06608 159 VSAQLDST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA--L----FK- 229 (275)
T ss_pred cceecccc--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH--H----HH-
Confidence 98753321 112234568889999998753 3578899999999999999999999964322110 0 00
Q ss_pred hhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 724 QKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 724 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
...... +.+ ..+......+.+++.+||..||++|||+.+++++
T Consensus 230 ~~~~~~-----~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 230 IPRNPP-----PTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred hhccCC-----CCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 001100 011 1122355678899999999999999999999763
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=307.88 Aligned_cols=254 Identities=26% Similarity=0.430 Sum_probs=202.8
Q ss_pred CCCcceeeeeeceEEEEEEEE-cCCcEEEEEEcCCCC------hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEE
Q 003139 503 KFDESLLLGVGGFGRVYKGTL-DDGTKVAVKRGNPRS------EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMIL 575 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 575 (845)
+|+..+.||+|++|.||+|.. .+++.+|+|.+.... ....+++.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 467778999999999999986 468899999875432 2245788999999999999999999999999999999
Q ss_pred EEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCC-ceEEEeccccCCCC
Q 003139 576 VYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNF-VAKVADFGLSKTGP 654 (845)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~-~~kl~DFGla~~~~ 654 (845)
|+||+++++|.+++... .++++..+..++.|++.||+|||+ .+++|+||||+||+++.++ .+||+|||++....
T Consensus 81 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 99999999999998543 478999999999999999999999 8999999999999998775 69999999987643
Q ss_pred CCCC--cccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhh
Q 003139 655 ALDQ--THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQI 732 (845)
Q Consensus 655 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (845)
.... ........++..|+|||.+.+..++.++||||+|++++||++|+.||......... .... +.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~---~~~~---------~~ 223 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL---ALIF---------KI 223 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH---HHHH---------HH
Confidence 3211 11122346788999999999889999999999999999999999998643322111 1110 11
Q ss_pred hccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 733 MDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 733 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.........+......+.+++.+|++.+|.+||++.++++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 224 ASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred hccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 11111123444566788999999999999999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=313.05 Aligned_cols=263 Identities=22% Similarity=0.271 Sum_probs=201.9
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYE 578 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 578 (845)
++|+..+.||+|+||.||+|... +++.|++|++... .....+.+.+|++++++++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888899999999999999976 5789999987643 23345778999999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCC
Q 003139 579 YMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQ 658 (845)
Q Consensus 579 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~ 658 (845)
|++++.|..++.. ...+++.++..++.|++.||+|||+ .+++||||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 81 YVERTLLELLEAS--PGGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred cCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 9998777665533 2458999999999999999999998 8999999999999999999999999999986543222
Q ss_pred cccccccccCCCcCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhh------------
Q 003139 659 THVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQK------------ 725 (845)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~------------ 725 (845)
.......++..|+|||++.+. .++.++||||||+++|||++|++||......+.. ........
T Consensus 156 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07833 156 -SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQL---YLIQKCLGPLPPSHQELFSS 231 (288)
T ss_pred -ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCCHHHhhhccc
Confidence 122345678899999999888 8899999999999999999999998654322111 00000000
Q ss_pred cCchh-----hhhcccc-CCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 726 KGMLD-----QIMDSNL-VGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 726 ~~~~~-----~~~d~~l-~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
..... ...++.. ....+...+..+.+++.+||..+|++||++++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00000 0000000 001122236779999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=306.73 Aligned_cols=247 Identities=26% Similarity=0.384 Sum_probs=201.6
Q ss_pred CCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEec
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYM 580 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 580 (845)
-|+..+.||+|+||.||+|... +++.+|+|..... .....+.+.+|++++++++||||+++++++.++...++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3667778999999999999865 6789999986543 2344578899999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcc
Q 003139 581 ANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH 660 (845)
Q Consensus 581 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 660 (845)
++++|.+++.. ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+++..... ..
T Consensus 85 ~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~--~~ 156 (277)
T cd06641 85 GGGSALDLLEP---GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT--QI 156 (277)
T ss_pred CCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccc--hh
Confidence 99999998853 368999999999999999999998 99999999999999999999999999998754321 11
Q ss_pred cccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCC
Q 003139 661 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGK 740 (845)
Q Consensus 661 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 740 (845)
......++..|+|||.+.+..++.++|||||||++|||++|+.|+....... +.... ... ....
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~------~~~~~-~~~---------~~~~ 220 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK------VLFLI-PKN---------NPPT 220 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH------HHHHH-hcC---------CCCC
Confidence 1223467889999999998899999999999999999999999986432211 11111 110 0111
Q ss_pred CCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 741 VNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 741 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.....+..+.+++.+|++.+|.+||++.+++++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 221 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 223445678899999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=314.69 Aligned_cols=195 Identities=24% Similarity=0.360 Sum_probs=158.3
Q ss_pred eeeeeeceEEEEEEEEc---CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEe--cCCcEEEEEEeccC
Q 003139 508 LLLGVGGFGRVYKGTLD---DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCD--ERSEMILVYEYMAN 582 (845)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~~~lV~Ey~~~ 582 (845)
..||+|+||.||+|+.. ++..+|+|.+..... ...+.+|++++++++||||+++++++. .....++|+||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 57999999999999865 346799998765432 246788999999999999999999884 35678999999964
Q ss_pred CCccccccC-------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEE----CCCCceEEEeccccC
Q 003139 583 GPLRSHLYG-------TDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILL----DDNFVAKVADFGLSK 651 (845)
Q Consensus 583 gsL~~~l~~-------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl----~~~~~~kl~DFGla~ 651 (845)
+|.+++.. .....+++..+..++.|++.||+|||+ .+|+||||||+|||+ ++++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 66665532 122358899999999999999999998 899999999999999 567899999999998
Q ss_pred CCCCCCC-cccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 003139 652 TGPALDQ-THVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPV 708 (845)
Q Consensus 652 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~ 708 (845)
....... ........||..|+|||.+.+ ..++.++|||||||++|||++|++||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 6432211 112234568999999999876 45899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=317.95 Aligned_cols=252 Identities=23% Similarity=0.339 Sum_probs=207.0
Q ss_pred cCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcC--CCChHhHHHHHHHHHHHHhCC-CCCcceEEEEEecCCcEEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGN--PRSEQGIAEFRTEIEMLSKLR-HRHLVSLIGYCDERSEMILVYE 578 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 578 (845)
..|++.++||+||.+.||++...+.+.+|+|++. ..+.+.+.-|.+|++.|.+|+ |.+||+|++|-..++.+|||||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 4678888999999999999998888889998754 346777889999999999995 9999999999999999999999
Q ss_pred eccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCC
Q 003139 579 YMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQ 658 (845)
Q Consensus 579 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~ 658 (845)
|= .-+|..+|.+.......| .+..+..|++.++.++|+ ++|||.||||.|+|+-+ |.+||+|||+|........
T Consensus 441 ~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 441 CG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred cc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEEe-eeEEeeeechhcccCcccc
Confidence 76 568999998776555667 778899999999999999 99999999999999986 5999999999987665444
Q ss_pred cccccccccCCCcCChhhhccC-----------CCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcC
Q 003139 659 THVSTAVKGSFGYLDPEYFRRQ-----------QLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKG 727 (845)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~-----------~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 727 (845)
.-.....+||+.||+||.+... +.+.++||||+|||||+|+.|++||.... ..|.
T Consensus 515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-------n~~a------- 580 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-------NQIA------- 580 (677)
T ss_pred ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-------HHHH-------
Confidence 4455578999999999998532 25679999999999999999999995321 1122
Q ss_pred chhhhhccccCCCCCH-HHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 728 MLDQIMDSNLVGKVNP-ASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 728 ~~~~~~d~~l~~~~~~-~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.+..+.|+.-.-+++. ....+++++++.||+.||.+||+..+++++
T Consensus 581 Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 581 KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 4566777754333331 112338999999999999999999999865
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=314.85 Aligned_cols=265 Identities=26% Similarity=0.342 Sum_probs=199.9
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC--hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS--EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYE 578 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 578 (845)
++|+..+.||+|+||.||+|..+ +++.+|+|+..... ....+.+.+|+++++.++||||+++++++...+..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36778889999999999999986 58899999865432 2234678899999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCC
Q 003139 579 YMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQ 658 (845)
Q Consensus 579 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~ 658 (845)
|+++++|..+.... ..++|.+++.++.|+++||+|||+ .+++||||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~- 154 (286)
T cd07846 81 FVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 154 (286)
T ss_pred cCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence 99999988876433 358999999999999999999998 899999999999999999999999999987643211
Q ss_pred cccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccc-cHHHHHH-------HHhhcCc-
Q 003139 659 THVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQV-NIAEWAM-------TWQKKGM- 728 (845)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~-~l~~~~~-------~~~~~~~- 728 (845)
.......++..|+|||++.+ ..++.++||||||+++|||++|++||......+.. .+..+.. .......
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07846 155 -EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL 233 (286)
T ss_pred -cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchH
Confidence 22233557889999999875 45788999999999999999999988643321110 0000000 0000000
Q ss_pred hhhhhccccC-----CCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 729 LDQIMDSNLV-----GKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 729 ~~~~~d~~l~-----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
...+..+... ....+..+..+.+++.+||+.+|++||++.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0000000000 00112345678999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=309.69 Aligned_cols=252 Identities=23% Similarity=0.323 Sum_probs=193.9
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC-hHhHHHHHHHHHH-HHhCCCCCcceEEEEEecCCcEEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS-EQGIAEFRTEIEM-LSKLRHRHLVSLIGYCDERSEMILVYE 578 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lV~E 578 (845)
++|++.+.||+|+||.||+|+.. +|+.||+|++.... .....++..|+.. ++.++||||+++++++...+..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36788889999999999999976 68999999876542 2333456666665 566789999999999999999999999
Q ss_pred eccCCCccccccCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-ceeeccCCCCcEEECCCCceEEEeccccCCCCC
Q 003139 579 YMANGPLRSHLYGT--DLPPLSWKQRLEICIGAARGLHYLHTGAAQ-SIIHRDVKTTNILLDDNFVAKVADFGLSKTGPA 655 (845)
Q Consensus 579 y~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~ 655 (845)
|++ |+|.+++... ....+++..++.++.|++.||+|||+ + +++||||||+|||+++++.+||+|||+++....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 6787776432 23578999999999999999999998 5 899999999999999999999999999876322
Q ss_pred CCCcccccccccCCCcCChhhhcc----CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhh
Q 003139 656 LDQTHVSTAVKGSFGYLDPEYFRR----QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQ 731 (845)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (845)
........++..|+|||.+.+ ..++.++|+|||||++|||++|+.||...... ... . ..
T Consensus 157 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~-~---------~~ 219 (283)
T cd06617 157 ---SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP----FQQ-L---------KQ 219 (283)
T ss_pred ---ccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC----HHH-H---------HH
Confidence 112233467889999998864 45789999999999999999999998532211 000 0 01
Q ss_pred hhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003139 732 IMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNL 774 (845)
Q Consensus 732 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L 774 (845)
..............+..+.+++.+||..+|++||++.++++.-
T Consensus 220 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 262 (283)
T cd06617 220 VVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHP 262 (283)
T ss_pred HHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 1111000001123456788999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=314.47 Aligned_cols=245 Identities=22% Similarity=0.349 Sum_probs=199.1
Q ss_pred ceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEeccCCCc
Q 003139 507 SLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPL 585 (845)
Q Consensus 507 ~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 585 (845)
...||+|+||.||++... ++..+|+|++........+.+.+|+.++++++|+||+++++.+...+..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 346999999999999875 6889999998766666677899999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCccccccc
Q 003139 586 RSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAV 665 (845)
Q Consensus 586 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 665 (845)
.+++.. ..+++.++..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++....... ......
T Consensus 107 ~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~ 178 (292)
T cd06658 107 TDIVTH---TRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--PKRKSL 178 (292)
T ss_pred HHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc--ccCcee
Confidence 998743 358999999999999999999999 899999999999999999999999999987533211 112335
Q ss_pred ccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCCHHH
Q 003139 666 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPAS 745 (845)
Q Consensus 666 ~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 745 (845)
.|+..|+|||.+.+..++.++||||||++++||++|+.||......+.. .. +...+.+.+.. ....
T Consensus 179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~-------~~-----~~~~~~~~~~~--~~~~ 244 (292)
T cd06658 179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAM-------RR-----IRDNLPPRVKD--SHKV 244 (292)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HH-----HHhcCCCcccc--cccc
Confidence 6889999999999889999999999999999999999998643321110 00 01111111111 1123
Q ss_pred HHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 746 LKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 746 ~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
...+.+++.+|+..+|.+|||+.++++.
T Consensus 245 ~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 245 SSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 4568889999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=324.12 Aligned_cols=240 Identities=23% Similarity=0.281 Sum_probs=187.1
Q ss_pred eeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhC---CCCCcceEEEEEecCCcEEEEEEeccC
Q 003139 510 LGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKL---RHRHLVSLIGYCDERSEMILVYEYMAN 582 (845)
Q Consensus 510 LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~~~lV~Ey~~~ 582 (845)
||+|+||.||+|+.. +++.||+|++... .......+..|..++.+. +||||+++++++.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999875 6899999987542 122334556677777665 699999999999999999999999999
Q ss_pred CCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcccc
Q 003139 583 GPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVS 662 (845)
Q Consensus 583 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 662 (845)
|+|..++... ..+++..+..++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++.... .....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~--~~~~~ 153 (330)
T cd05586 81 GELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLT--DNKTT 153 (330)
T ss_pred ChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCC--CCCCc
Confidence 9999888543 468999999999999999999999 8999999999999999999999999999875322 11223
Q ss_pred cccccCCCcCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCC
Q 003139 663 TAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKV 741 (845)
Q Consensus 663 ~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 741 (845)
....||..|+|||++.+. .++.++|||||||++|||++|+.||......+ .... ...+. ..+ .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~------~~~~-i~~~~------~~~---~ 217 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ------MYRN-IAFGK------VRF---P 217 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH------HHHH-HHcCC------CCC---C
Confidence 356799999999998764 48999999999999999999999986532211 1111 11110 011 0
Q ss_pred CHHHHHHHHHHHHHhhhhCCCCCCC----HHHHHH
Q 003139 742 NPASLKKFGETAEKCLAEHGVDRPS----MGDVLW 772 (845)
Q Consensus 742 ~~~~~~~l~~l~~~cl~~~p~~RPs----~~~vl~ 772 (845)
.......+.+++.+||+.+|.+||+ +.++++
T Consensus 218 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 218 KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 1123456789999999999999984 555554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=311.66 Aligned_cols=251 Identities=23% Similarity=0.340 Sum_probs=204.9
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEec
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYM 580 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 580 (845)
++|...+.||+|+||.||++... +++.+++|.+........+.+.+|+.++++++|||++++++.+...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 57888889999999999999864 67889999886555555678899999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcc
Q 003139 581 ANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH 660 (845)
Q Consensus 581 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 660 (845)
++++|.+++... .+++.++..++.|++.||.|||+ .+++||||||+||++++++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-- 170 (293)
T cd06647 99 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 170 (293)
T ss_pred CCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--
Confidence 999999998543 57899999999999999999998 8999999999999999999999999999865432211
Q ss_pred cccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCC
Q 003139 661 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGK 740 (845)
Q Consensus 661 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 740 (845)
......+++.|+|||.+.+..++.++||||||+++|||++|+.||......+.... .... ......
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~------~~~~--------~~~~~~ 236 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATN--------GTPELQ 236 (293)
T ss_pred ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee------hhcC--------CCCCCC
Confidence 12334688899999999988999999999999999999999999965433221100 0000 000011
Q ss_pred CCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003139 741 VNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNL 774 (845)
Q Consensus 741 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L 774 (845)
.+......+.+++.+||+.+|++||++.+++.+-
T Consensus 237 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~ 270 (293)
T cd06647 237 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHP 270 (293)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 1223456788999999999999999999998774
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=312.33 Aligned_cols=262 Identities=21% Similarity=0.299 Sum_probs=198.5
Q ss_pred CCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC--hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS--EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
+|+..+.||+|++|.||+|+.. +|+.+++|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778889999999999999875 68899999876432 22345788999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCc
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT 659 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~ 659 (845)
++ ++|.+++.......+++..+..++.|++.||+|||+ .+++||||+|+||++++++.+||+|||+++......
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~-- 154 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-- 154 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc--
Confidence 95 688888876555679999999999999999999998 899999999999999999999999999987543211
Q ss_pred ccccccccCCCcCChhhhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhc------------
Q 003139 660 HVSTAVKGSFGYLDPEYFRRQQ-LTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKK------------ 726 (845)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~~~-~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~------------ 726 (845)
.......++..|+|||.+.+.. ++.++||||||+++|||+||+.||......+ .+..........
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhhhhHHH
Confidence 1122345678999999887644 6899999999999999999999986543211 111111000000
Q ss_pred ---CchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 727 ---GMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 727 ---~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
..........+ ....+.....+.+++.+|++.||.+||++++++.+
T Consensus 233 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 233 DYKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 00000000000 00011234567899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=305.74 Aligned_cols=250 Identities=23% Similarity=0.391 Sum_probs=202.6
Q ss_pred CCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
+|+..+.||+|+||.||+|... +|..+|+|.+... .....+.+.+|++++++++|+||+++++.+.+....++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4777889999999999999976 5788999987543 223456788999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCC-ceEEEeccccCCCCCCCC
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNF-VAKVADFGLSKTGPALDQ 658 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~-~~kl~DFGla~~~~~~~~ 658 (845)
+++++|.+++.......+++..++.++.|++.||.|||+ .+++|+||||+||++++++ .+||+|||.+..... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~--~ 155 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND--S 155 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccC--C
Confidence 999999999876554568999999999999999999998 8999999999999999875 569999999876432 1
Q ss_pred cccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccC
Q 003139 659 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLV 738 (845)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 738 (845)
........|++.|+|||++.+..++.++||||||++++||++|+.|+..... .++....... ..
T Consensus 156 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~---------~~- 219 (257)
T cd08225 156 MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------HQLVLKICQG---------YF- 219 (257)
T ss_pred cccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHhcc---------cC-
Confidence 1122234588899999999988999999999999999999999999854321 2222221111 11
Q ss_pred CCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 739 GKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 739 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
....+.....+.+++.+|++.+|++||++.+++++
T Consensus 220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 220 APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11223345678899999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=310.33 Aligned_cols=262 Identities=23% Similarity=0.277 Sum_probs=202.0
Q ss_pred CCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC--hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS--EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
+|+..+.||+|+||.||+|+.. +|+.+++|++.... ....+.+.+|+.++++++||||+++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4677889999999999999975 68899999876543 33457889999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCc
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT 659 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~ 659 (845)
+ +++|.+++.... ..+++.+++.++.|+++||+|||+ .+++|+||||+||++++++.++|+|||+++.......
T Consensus 81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (286)
T cd07832 81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP- 154 (286)
T ss_pred c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-
Confidence 9 999999886443 569999999999999999999998 8999999999999999999999999999986443221
Q ss_pred ccccccccCCCcCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCch---------
Q 003139 660 HVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGML--------- 729 (845)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~--------- 729 (845)
.......++..|+|||.+.+. .++.++||||+|++++||++|+++|......+ ...+..........
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE---QLAIVFRTLGTPNEETWPGLTSL 231 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH---HHHHHHHHcCCCChHHHhhccCc
Confidence 122345688999999988654 46899999999999999999988775433211 11111111110000
Q ss_pred ---hhhhcccc----CCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 730 ---DQIMDSNL----VGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 730 ---~~~~d~~l----~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
..+..+.. .....++....+.+++.+|++.+|++||++++++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000 001112345788999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=304.56 Aligned_cols=252 Identities=25% Similarity=0.366 Sum_probs=200.9
Q ss_pred CCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCCh--HhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSE--QGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
+|+..+.||+|+||.||+|... +++.+++|.+..... ...+++.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4677889999999999999865 688999998765433 4678899999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCc
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT 659 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~ 659 (845)
+++++|.+++... ..+++..+..++.|+++||+|||+ .+++|+||+|+||++++++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 81 CSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 9999999998643 358899999999999999999998 89999999999999999999999999999764432221
Q ss_pred cc--ccccccCCCcCChhhhccCC---CCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhc
Q 003139 660 HV--STAVKGSFGYLDPEYFRRQQ---LTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMD 734 (845)
Q Consensus 660 ~~--~~~~~gt~~y~aPE~~~~~~---~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (845)
.. .....++..|+|||++.+.. ++.++||||||++++||++|+.||....... ........ +. .
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-----~~~~~~~~-~~-----~ 224 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-----QIMFHVGA-GH-----K 224 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-----HHHHHHhc-CC-----C
Confidence 11 12356788999999998766 8999999999999999999999996432111 01110000 00 0
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 003139 735 SNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLW 772 (845)
Q Consensus 735 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~ 772 (845)
+.+ .........+.+++.+||+.+|.+||++.+++.
T Consensus 225 ~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 225 PPI--PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCC--CcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 001 011123567789999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=305.52 Aligned_cols=260 Identities=25% Similarity=0.307 Sum_probs=202.8
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC-hHhHHHHHHHHHHHHhCCCCCcceEEEEEecC--CcEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS-EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDER--SEMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 577 (845)
++|+..+.||.|++|.||++... +++.+|+|.+.... ....+++.+|++++++++||||++++++|.+. +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 35778889999999999999975 57889999876442 34557789999999999999999999998543 4689999
Q ss_pred EeccCCCccccccC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCC
Q 003139 578 EYMANGPLRSHLYG--TDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPA 655 (845)
Q Consensus 578 Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~ 655 (845)
||+++++|.+++.. .....+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999887643 233568999999999999999999998 9999999999999999999999999999875322
Q ss_pred CCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCc--ccccHHHHHHHHhhcCchhhhh
Q 003139 656 LDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPR--EQVNIAEWAMTWQKKGMLDQIM 733 (845)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~--~~~~l~~~~~~~~~~~~~~~~~ 733 (845)
. ......++..|+|||.+.+..++.++||||||+++|||++|+.||...... ....+..|... .....+.
T Consensus 158 ~----~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~ 229 (287)
T cd06621 158 S----LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN----MPNPELK 229 (287)
T ss_pred c----ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc----CCchhhc
Confidence 1 112345788999999999999999999999999999999999999754321 11112222111 0111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 734 DSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 734 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
+ .. .........+.+++.+||+.+|.+|||+.|+++.-.
T Consensus 230 ~-~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~ 268 (287)
T cd06621 230 D-EP--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPW 268 (287)
T ss_pred c-CC--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcc
Confidence 0 00 011234567899999999999999999999987643
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=311.48 Aligned_cols=263 Identities=22% Similarity=0.300 Sum_probs=196.2
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCCh-HhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSE-QGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
++|+..+.||+|++|.||+|..+ +++.||+|.+..... .....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 56888889999999999999976 688999998764322 2234567899999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCc
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT 659 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~ 659 (845)
++ ++|.+++.... ..+++..+..++.|++.||.|||+ .+|+||||||+||++++++.+||+|||+++..... .
T Consensus 85 ~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--~ 157 (291)
T cd07844 85 LD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVP--S 157 (291)
T ss_pred CC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCC--C
Confidence 97 48988876443 368999999999999999999998 89999999999999999999999999998753221 1
Q ss_pred ccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhc---Cchhhhh--
Q 003139 660 HVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKK---GMLDQIM-- 733 (845)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~~~~-- 733 (845)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ ........... .....+.
T Consensus 158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED--QLHKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHhcCCCChhhhhhhhhc
Confidence 11223346788999999875 5689999999999999999999999865431111 00000000000 0000000
Q ss_pred ------------ccccCCCCC-HHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 734 ------------DSNLVGKVN-PASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 734 ------------d~~l~~~~~-~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
...+..... ......+.+++.+||+.+|++||++.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 000000000 0112567899999999999999999998753
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=296.89 Aligned_cols=251 Identities=24% Similarity=0.318 Sum_probs=200.2
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYE 578 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 578 (845)
++|++.+.||+|.|+.||+..+. .|+.+|+|.++.. +..+.+++.+|+++-+.|+||||++|..-..+....+||+|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 44566668999999999998754 7899998876543 34467888999999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEEC---CCCceEEEeccccCCCCC
Q 003139 579 YMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLD---DNFVAKVADFGLSKTGPA 655 (845)
Q Consensus 579 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~---~~~~~kl~DFGla~~~~~ 655 (845)
+|.|++|..-+-.. .-.++...-..+.||+++|.|+|. ++|||||+||+|+||- ..--+||+|||+|....
T Consensus 91 ~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~- 164 (355)
T KOG0033|consen 91 LVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN- 164 (355)
T ss_pred cccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEeC-
Confidence 99999997665433 346777788899999999999999 9999999999999995 34468999999998743
Q ss_pred CCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcc
Q 003139 656 LDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDS 735 (845)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (845)
.........||++|||||+++..+|+..+|||+.|||||-||.|++||.+... ..+-+ .+..+.. -+++
T Consensus 165 --~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~---~rlye----~I~~g~y--d~~~ 233 (355)
T KOG0033|consen 165 --DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRLYE----QIKAGAY--DYPS 233 (355)
T ss_pred --CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH---HHHHH----HHhcccc--CCCC
Confidence 44455678899999999999999999999999999999999999999975321 11111 1111111 0111
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 736 NLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 736 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
..-+...+...+|+++||..||.+|.|+.|.+.+
T Consensus 234 ----~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 234 ----PEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred ----cccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 1223445667899999999999999999997654
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=323.03 Aligned_cols=262 Identities=20% Similarity=0.263 Sum_probs=197.6
Q ss_pred HHHHhcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC--hHhHHHHHHHHHHHHhCCCCCcceEEEEEecC---
Q 003139 497 ILDATNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS--EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDER--- 570 (845)
Q Consensus 497 l~~at~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--- 570 (845)
..+..++|...+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++...
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 10 VWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI 89 (343)
T ss_pred HhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence 3345678999999999999999999864 67899999876532 23346678999999999999999999887533
Q ss_pred ---CcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEec
Q 003139 571 ---SEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADF 647 (845)
Q Consensus 571 ---~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DF 647 (845)
...++++|++ +++|.+++.. ..+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+||
T Consensus 90 ~~~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 90 ENFNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred cccCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCC
Confidence 4578999988 7888877642 368999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCCCcccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhc
Q 003139 648 GLSKTGPALDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKK 726 (845)
Q Consensus 648 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 726 (845)
|+++.... ......||..|+|||++.+ ..++.++|||||||++|||++|+.||......+. +..+. .....
T Consensus 163 g~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~-~~~~~ 234 (343)
T cd07878 163 GLARQADD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ--LKRIM-EVVGT 234 (343)
T ss_pred ccceecCC-----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--HHHHH-HHhCC
Confidence 99976332 1234568999999999876 5789999999999999999999999865332111 11110 00000
Q ss_pred -----------CchhhhhccccCCCC-------CHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003139 727 -----------GMLDQIMDSNLVGKV-------NPASLKKFGETAEKCLAEHGVDRPSMGDVLWNL 774 (845)
Q Consensus 727 -----------~~~~~~~d~~l~~~~-------~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L 774 (845)
......+. .+.... .......+.+++.+|++.||.+|||+.|++++-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp 299 (343)
T cd07878 235 PSPEVLKKISSEHARKYIQ-SLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHP 299 (343)
T ss_pred CCHHHHHhcchhhHHHHhh-ccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 00000000 000000 011234577999999999999999999998763
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=314.60 Aligned_cols=246 Identities=22% Similarity=0.329 Sum_probs=198.9
Q ss_pred ceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEeccCCCc
Q 003139 507 SLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPL 585 (845)
Q Consensus 507 ~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 585 (845)
...||+|+||.||++... +++.+|+|.+........+.+.+|+.++..++||||+++++++..++..++|+||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 447999999999999865 6889999988655555567788999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCccccccc
Q 003139 586 RSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAV 665 (845)
Q Consensus 586 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 665 (845)
..++.. ..+++.+++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||++...... .......
T Consensus 106 ~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~--~~~~~~~ 177 (297)
T cd06659 106 TDIVSQ---TRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD--VPKRKSL 177 (297)
T ss_pred HHHHhh---cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhcccc--cccccce
Confidence 987743 358999999999999999999998 89999999999999999999999999998753321 1112345
Q ss_pred ccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCCHHH
Q 003139 666 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPAS 745 (845)
Q Consensus 666 ~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 745 (845)
.|+..|+|||++.+..++.++|||||||+++||++|+.||......+. ... ..... .+.. ......
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~~~-~~~~~-----~~~~--~~~~~~ 243 (297)
T cd06659 178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA------MKR-LRDSP-----PPKL--KNAHKI 243 (297)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHH-HhccC-----CCCc--cccCCC
Confidence 688999999999998999999999999999999999999864332211 011 11100 0000 111233
Q ss_pred HHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003139 746 LKKFGETAEKCLAEHGVDRPSMGDVLWNL 774 (845)
Q Consensus 746 ~~~l~~l~~~cl~~~p~~RPs~~~vl~~L 774 (845)
...+.+++.+|++.+|.+||++.+++++-
T Consensus 244 ~~~l~~~i~~~l~~~P~~Rps~~~ll~~~ 272 (297)
T cd06659 244 SPVLRDFLERMLTREPQERATAQELLDHP 272 (297)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhhCh
Confidence 45688999999999999999999998863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=301.32 Aligned_cols=252 Identities=27% Similarity=0.409 Sum_probs=207.0
Q ss_pred CCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC--hHhHHHHHHHHHHHHhCCCCCcceEEEEEecC--CcEEEEE
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS--EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDER--SEMILVY 577 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 577 (845)
+|+..+.||+|++|.||+|... +++.+++|...... ....+.+.+|++++++++|+||+++++.+.+. ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3677789999999999999987 68899999876554 35678899999999999999999999999888 8899999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
||+++++|.+++.... .+++.++..++.|+++||+|||+ .+++|+||+|+||++++++.+||+|||.+.......
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 9999999999986543 79999999999999999999999 899999999999999999999999999997644322
Q ss_pred CcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcccc
Q 003139 658 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNL 737 (845)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (845)
.........++..|+|||.+.+...+.++||||||++++||++|+.||....... .-.. .+.....
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~---------~~~~~~~ 221 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM-----AALY---------KIGSSGE 221 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-----HHHH---------hccccCC
Confidence 2111334568889999999998889999999999999999999999987544111 1011 1111111
Q ss_pred CCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 738 VGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
....+......+.+++.+|++.+|.+||++.+++.+
T Consensus 222 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 222 PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 222344456789999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=307.02 Aligned_cols=248 Identities=25% Similarity=0.388 Sum_probs=199.6
Q ss_pred CCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCC---CCCcceEEEEEecCCcEEEEE
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLR---HRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~ 577 (845)
.|+..+.||+|+||.||+|... +++.+++|.+... .....+++.+|++++++++ |||++++++++.++...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4667778999999999999974 6889999987644 3445677889999999997 999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
||+++++|.+++... .+++..++.++.|++.||.|||+ .+|+||||+|+||++++++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 82 EYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred ecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 999999999988542 68999999999999999999998 899999999999999999999999999987644322
Q ss_pred CcccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccc
Q 003139 658 QTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSN 736 (845)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (845)
.......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||........ ... ... ...+.
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~------~~~-~~~-----~~~~~ 221 (277)
T cd06917 156 --SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA------MML-IPK-----SKPPR 221 (277)
T ss_pred --cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh------hhc-ccc-----CCCCC
Confidence 11234468889999998875 4578999999999999999999999965432211 100 000 00111
Q ss_pred cCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 737 LVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 737 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
+.. ...+..+.+++.+||+.+|++||++.+++.+
T Consensus 222 ~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 222 LED---NGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 111 1245678899999999999999999999875
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=310.13 Aligned_cols=261 Identities=23% Similarity=0.305 Sum_probs=198.9
Q ss_pred CCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCCh-----HhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEE
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSE-----QGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILV 576 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 576 (845)
+|+..+.||+|+||.||+|... +|+.|++|++..... .....+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4677789999999999999975 688999998765432 2345677899999999999999999999999999999
Q ss_pred EEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCC
Q 003139 577 YEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPAL 656 (845)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~ 656 (845)
|||+ +++|.+++.... ..+++..+++++.||++||.|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 9999 999999986543 479999999999999999999999 89999999999999999999999999999764332
Q ss_pred CCcccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcC--------
Q 003139 657 DQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKG-------- 727 (845)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~-------- 727 (845)
.. ......++..|+|||.+.+ ..++.++|||||||+++||++|.++|......+. +.... ......
T Consensus 156 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~ 230 (298)
T cd07841 156 NR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ--LGKIF-EALGTPTEENWPGV 230 (298)
T ss_pred Cc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH--HHHHH-HHcCCCchhhhhhc
Confidence 11 1223356788999998865 5679999999999999999999887764332211 10000 000000
Q ss_pred -chhhhhccccCCC-----CCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 728 -MLDQIMDSNLVGK-----VNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 728 -~~~~~~d~~l~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.+........... ........+.+++.+||+.+|++||++.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000000000 112335678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=312.18 Aligned_cols=248 Identities=28% Similarity=0.381 Sum_probs=197.7
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
+.|+..+.||+|+||.||+|+.. +++.|++|++... .....+++.+|+++++.++||||+++.++|.+.+..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45778889999999999999875 6889999987533 2344567899999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
||++ |+|.+++... ...+++..+..++.|++.||.|||+ .+|+||||+|+||++++++.+||+|||++.....
T Consensus 95 e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~-- 167 (307)
T cd06607 95 EYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSP-- 167 (307)
T ss_pred HhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCC--
Confidence 9996 5776666433 2468999999999999999999998 8999999999999999999999999999876332
Q ss_pred CcccccccccCCCcCChhhhc---cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhc
Q 003139 658 QTHVSTAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMD 734 (845)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (845)
.....++..|+|||.+. .+.++.++||||||+++|||++|++|+....... ......... .
T Consensus 168 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~------~~~~~~~~~------~ 231 (307)
T cd06607 168 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQND------S 231 (307)
T ss_pred ----CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH------HHHHHhcCC------C
Confidence 12345788999999874 4678999999999999999999999986432211 011100000 0
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 735 SNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 735 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
+.+ ........+.+++.+||+.+|++||++.+++.+..
T Consensus 232 ~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 269 (307)
T cd06607 232 PTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRF 269 (307)
T ss_pred CCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 011 12235567899999999999999999999987644
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=306.10 Aligned_cols=253 Identities=26% Similarity=0.349 Sum_probs=203.6
Q ss_pred CCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC-hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEec
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS-EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYM 580 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 580 (845)
+|+..+.||+|++|.||++... +++.+++|++.... ....+++.+|++++++++||||+++++.+...+..++|+||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5667778999999999999976 68899999876553 345578899999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcc
Q 003139 581 ANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH 660 (845)
Q Consensus 581 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 660 (845)
++++|.+++.... ..+++..+.+++.|++.||+|||+ ..+++||||||+||++++++.+||+|||++......
T Consensus 82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~---- 154 (265)
T cd06605 82 DGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS---- 154 (265)
T ss_pred CCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH----
Confidence 9999999986543 578999999999999999999996 478999999999999999999999999998653211
Q ss_pred cccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCC
Q 003139 661 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGK 740 (845)
Q Consensus 661 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 740 (845)
......++..|+|||.+.+..++.++||||||++++||++|+.|+....... ....+..... ..... ..
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~---------~~~~~-~~ 223 (265)
T cd06605 155 LAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYI---------VNEPP-PR 223 (265)
T ss_pred HhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHH---------hcCCC-CC
Confidence 1112668889999999999999999999999999999999999986543211 1111111111 11110 01
Q ss_pred CCHH-HHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 741 VNPA-SLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 741 ~~~~-~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.+.. ....+.+++.+||..+|++||++.+++.+
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 224 LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 1122 56678899999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=308.37 Aligned_cols=248 Identities=21% Similarity=0.353 Sum_probs=201.0
Q ss_pred CCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEeccC
Q 003139 504 FDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMAN 582 (845)
Q Consensus 504 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 582 (845)
|...+.||+|++|.||++... +++.+++|+.........+.+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 444568999999999999864 6889999987665555567789999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcccc
Q 003139 583 GPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVS 662 (845)
Q Consensus 583 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 662 (845)
++|.+++.. .++++.++..++.|++.||+|||+ ++++||||+|+||++++++.++|+|||++...... ....
T Consensus 101 ~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~--~~~~ 172 (285)
T cd06648 101 GALTDIVTH---TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE--VPRR 172 (285)
T ss_pred CCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccC--Cccc
Confidence 999998865 468999999999999999999998 89999999999999999999999999988753321 1112
Q ss_pred cccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCC
Q 003139 663 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVN 742 (845)
Q Consensus 663 ~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 742 (845)
....|+..|+|||.+.+..++.++|||||||+++||++|+.||....+. ....... .+. .+.+. ..
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~------~~~~~~~-~~~-----~~~~~--~~ 238 (285)
T cd06648 173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL------QAMKRIR-DNL-----PPKLK--NL 238 (285)
T ss_pred ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH------HHHHHHH-hcC-----CCCCc--cc
Confidence 2346889999999999989999999999999999999999998643221 1111111 110 01111 11
Q ss_pred HHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 743 PASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 743 ~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
......+.+++.+||+.+|++||++.+++++
T Consensus 239 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 239 HKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred ccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 2245678999999999999999999998854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=302.26 Aligned_cols=253 Identities=25% Similarity=0.363 Sum_probs=207.4
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCCh-HhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSE-QGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
++|+..+.||+|++|.||+|+.. +++.+++|++..... ...+++.+|++.+.+++|+|++++++++...+..++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 35778889999999999999987 589999998776544 4567899999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCc
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT 659 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~ 659 (845)
+++++|.+++... ..+++..+++++.|+++||+|||+ ..+++||||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~--~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~-- 154 (264)
T cd06623 81 MDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL-- 154 (264)
T ss_pred cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhc--cCCCccCCCCHHHEEECCCCCEEEccCccceecccCC--
Confidence 9999999998644 578999999999999999999996 2789999999999999999999999999987643211
Q ss_pred ccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCC
Q 003139 660 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVG 739 (845)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 739 (845)
.......++..|+|||.+.+..++.++||||||+++|||++|+.|+..........+..+ +..... .
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~------------~~~~~~-~ 221 (264)
T cd06623 155 DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA------------ICDGPP-P 221 (264)
T ss_pred CcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHH------------HhcCCC-C
Confidence 112245678899999999999999999999999999999999999865442111111111 111111 1
Q ss_pred CCCHH-HHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 740 KVNPA-SLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 740 ~~~~~-~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
..+.. .+..+.+++.+||..+|++||++.++++.
T Consensus 222 ~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 222 SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 12233 56789999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=316.38 Aligned_cols=249 Identities=24% Similarity=0.323 Sum_probs=211.0
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCCh---HhHHHHHHHHHHHHhCC-CCCcceEEEEEecCCcEEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSE---QGIAEFRTEIEMLSKLR-HRHLVSLIGYCDERSEMIL 575 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~l 575 (845)
...|+..+.||.|.||.||+++.+ +|+.+|+|.+..... ...+.+.+|+++|+++. |||||.+.+.+++....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 456777789999999999999977 499999998765433 34568899999999998 9999999999999999999
Q ss_pred EEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCC----CceEEEeccccC
Q 003139 576 VYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDN----FVAKVADFGLSK 651 (845)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~----~~~kl~DFGla~ 651 (845)
|||++.||.|.+.+... .+++.....++.|++.+++|||+ .+|+||||||+|+|+... +.+|++|||++.
T Consensus 114 vmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred EEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 99999999999998655 39999999999999999999999 999999999999999633 579999999998
Q ss_pred CCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhh
Q 003139 652 TGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQ 731 (845)
Q Consensus 652 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (845)
.... .......+||+.|+|||++....|+..+||||.||++|.|++|.+||......+.. ..
T Consensus 188 ~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~---------------~~ 249 (382)
T KOG0032|consen 188 FIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIF---------------LA 249 (382)
T ss_pred EccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHH---------------HH
Confidence 7443 44556789999999999999999999999999999999999999999765433211 12
Q ss_pred hhcc--ccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 732 IMDS--NLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 732 ~~d~--~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
+... .......+.......+++..|+..||.+|+|+.+++++
T Consensus 250 i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 250 ILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred HHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 2221 22233445667888999999999999999999999986
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=298.55 Aligned_cols=249 Identities=28% Similarity=0.452 Sum_probs=204.5
Q ss_pred CCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEeccC
Q 003139 504 FDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMAN 582 (845)
Q Consensus 504 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 582 (845)
|+..+.||+|++|.||++... +++.+++|+.........+++.+|++++++++|+|++++++++......++++||+++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 81 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG 81 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence 667789999999999999986 6889999998776655678899999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcccc
Q 003139 583 GPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVS 662 (845)
Q Consensus 583 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 662 (845)
++|.+++.... ..+++..+..++.|++.||.|||+ .+++||||+|+||++++++.++|+|||.+........ .
T Consensus 82 ~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~ 154 (253)
T cd05122 82 GSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R 154 (253)
T ss_pred CcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence 99999886543 478999999999999999999998 9999999999999999999999999999876443211 2
Q ss_pred cccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCC
Q 003139 663 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVN 742 (845)
Q Consensus 663 ~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 742 (845)
....++..|+|||.+.+..++.++||||||++++||++|+.|+......+. ...... ....... ..
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~-~~~~~~~-------~~ 220 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA------LFKIAT-NGPPGLR-------NP 220 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH------HHHHHh-cCCCCcC-------cc
Confidence 345688899999999988899999999999999999999999865322111 100000 0000000 01
Q ss_pred HHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 743 PASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 743 ~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
......+.+++.+||+.+|.+|||+.+++++
T Consensus 221 ~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 221 EKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred cccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1125678999999999999999999998753
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=308.95 Aligned_cols=256 Identities=27% Similarity=0.381 Sum_probs=207.1
Q ss_pred HHhcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 499 DATNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 499 ~at~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
+.++.|+..+.||+|++|.||+|.++ +++.+++|.+..... ..+.+.+|++++++++|+|++++++.+......++|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 34566777889999999999999987 688999998876544 5677899999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
||+++++|.+++.... ..+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||++.......
T Consensus 95 e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 95 EYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred eccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 9999999999997543 479999999999999999999998 999999999999999999999999999986533211
Q ss_pred CcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcccc
Q 003139 658 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNL 737 (845)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (845)
.......++..|++||.+.+..++.++|||||||++|||++|+.|+....+... ....... ....
T Consensus 171 --~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~------~~~~~~~-~~~~------ 235 (286)
T cd06614 171 --SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA------LFLITTK-GIPP------ 235 (286)
T ss_pred --hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhc-CCCC------
Confidence 112334578899999999988999999999999999999999999864332211 1110010 0000
Q ss_pred CCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 738 VGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
.......+..+.+++.+|++.+|.+||++.+++++..
T Consensus 236 -~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 272 (286)
T cd06614 236 -LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPF 272 (286)
T ss_pred -CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChH
Confidence 0111224567889999999999999999999987544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=323.49 Aligned_cols=263 Identities=24% Similarity=0.285 Sum_probs=206.7
Q ss_pred CCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCC-C-----CCcceEEEEEecCCcEEE
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLR-H-----RHLVSLIGYCDERSEMIL 575 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-----~niv~l~g~~~~~~~~~l 575 (845)
+|++.+.||+|.||.|-||... +++.||||+++... ....+-..|+.+|..|+ | -|+|++++++..++++||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 7889999999999999999855 68999999987553 34566688999999997 3 489999999999999999
Q ss_pred EEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECC--CCceEEEeccccCCC
Q 003139 576 VYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDD--NFVAKVADFGLSKTG 653 (845)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~--~~~~kl~DFGla~~~ 653 (845)
|+|.+ .-+|.++|..++...++...+..|+.||+.||..||+ .+|||+||||+||||.+ ...+||+|||.+...
T Consensus 266 VfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 99999 5699999998888889999999999999999999998 99999999999999974 348999999999873
Q ss_pred CCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHH--------HHHH---
Q 003139 654 PALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAE--------WAMT--- 722 (845)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~--------~~~~--- 722 (845)
.. ... ....+..|+|||++.+.+|+.+.||||||||+.||++|.+.|.+..+.++..... |...
T Consensus 342 ~q----~vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~ 416 (586)
T KOG0667|consen 342 SQ----RVY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAK 416 (586)
T ss_pred CC----cce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 32 112 4456778999999999999999999999999999999998888766655432211 1100
Q ss_pred ----Hhhc--Cchh-----------------h----hhccc-cC-------CCCCHHHHHHHHHHHHHhhhhCCCCCCCH
Q 003139 723 ----WQKK--GMLD-----------------Q----IMDSN-LV-------GKVNPASLKKFGETAEKCLAEHGVDRPSM 767 (845)
Q Consensus 723 ----~~~~--~~~~-----------------~----~~d~~-l~-------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 767 (845)
.... +... . ..+.. .. ..........+++++.+|+..||.+|+|.
T Consensus 417 ~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp 496 (586)
T KOG0667|consen 417 KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP 496 (586)
T ss_pred ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH
Confidence 0000 0000 0 00000 00 00112345778999999999999999999
Q ss_pred HHHHHHHH
Q 003139 768 GDVLWNLE 775 (845)
Q Consensus 768 ~~vl~~L~ 775 (845)
.+++++-.
T Consensus 497 ~qal~Hpf 504 (586)
T KOG0667|consen 497 AQALNHPF 504 (586)
T ss_pred HHHhcCcc
Confidence 99987643
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=311.12 Aligned_cols=250 Identities=26% Similarity=0.370 Sum_probs=199.0
Q ss_pred CCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 504 FDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 504 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
|+..+.||+|+||.||+|+.. +++.+|+|++... .....+++.+|++++++++|||++++++++.+....++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 667778999999999999965 6889999987533 334456788999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCc
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT 659 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~ 659 (845)
++ |+|.+.+... ..+++|.++..++.|++.||.|||+ .+|+||||+|+||+++.++.+||+|||++.....
T Consensus 107 ~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---- 177 (317)
T cd06635 107 CL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---- 177 (317)
T ss_pred CC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCC----
Confidence 96 5777766433 3468999999999999999999998 8999999999999999999999999999865322
Q ss_pred ccccccccCCCcCChhhhc---cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccc
Q 003139 660 HVSTAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSN 736 (845)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (845)
.....++..|+|||++. .+.++.++|||||||++|||++|+.||........ ... +....
T Consensus 178 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~------~~~---------~~~~~ 240 (317)
T cd06635 178 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYH---------IAQNE 240 (317)
T ss_pred --cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH------HHH---------HHhcc
Confidence 12346788999999874 46789999999999999999999999864321110 111 11111
Q ss_pred cCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 003139 737 LVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779 (845)
Q Consensus 737 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~ 779 (845)
............+.+++.+||+.+|.+||++.++++.+.....
T Consensus 241 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 241 SPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred CCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 1111122345678899999999999999999999988765443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=309.18 Aligned_cols=245 Identities=25% Similarity=0.352 Sum_probs=201.1
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
++|+..+.||+|+||.||++... +++.+|+|.+... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36788889999999999999976 5889999987543 2334567889999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
||+++++|.+++... ..+++..+..++.|++.||+|||+ .+++||||+|+|||+++++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 999999999998544 478999999999999999999999 99999999999999999999999999999764321
Q ss_pred CcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcccc
Q 003139 658 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNL 737 (845)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (845)
.....+++.|+|||.+.+...+.++||||||++++||++|+.||......+ .. ..+....
T Consensus 155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~--------~~~~~~~- 214 (290)
T cd05580 155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ-------IY--------EKILEGK- 214 (290)
T ss_pred ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-------HH--------HHHhcCC-
Confidence 234568899999999998889999999999999999999999986433111 00 1111111
Q ss_pred CCCCCHHHHHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 003139 738 VGKVNPASLKKFGETAEKCLAEHGVDRP-----SMGDVLWN 773 (845)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~~ 773 (845)
..++......+.+++.+||..+|.+|| +++|++++
T Consensus 215 -~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 215 -VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred -ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 112333456788999999999999998 66666543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=306.61 Aligned_cols=246 Identities=24% Similarity=0.350 Sum_probs=204.8
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILV 576 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 576 (845)
.+.|..-++||+||||+||-+..+ +|+-+|.|++.+. ..++....++|-.+|.+++.+.||.|-..++..+.+|||
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 356888899999999999998865 6888999876544 233445678999999999999999999999999999999
Q ss_pred EEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCC
Q 003139 577 YEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPAL 656 (845)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~ 656 (845)
+..|.||+|.-||.+...+.++++..+-++.+|+.||++||. .+||.|||||+|||||+.|+++|+|+|||...+.
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~- 339 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE- 339 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecCC-
Confidence 999999999999988877889999999999999999999999 9999999999999999999999999999987443
Q ss_pred CCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccc
Q 003139 657 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSN 736 (845)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (845)
.......+||.+|||||++.++.|+...|.||+||+||||+.|+.||........ | +-+|.+
T Consensus 340 --g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk-----~-----------eEvdrr 401 (591)
T KOG0986|consen 340 --GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK-----R-----------EEVDRR 401 (591)
T ss_pred --CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh-----H-----------HHHHHH
Confidence 2334456899999999999999999999999999999999999999954322111 0 011111
Q ss_pred c---CCCCCHHHHHHHHHHHHHhhhhCCCCCCCHH
Q 003139 737 L---VGKVNPASLKKFGETAEKCLAEHGVDRPSMG 768 (845)
Q Consensus 737 l---~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ 768 (845)
. ..+++....++...+....|++||++|..-+
T Consensus 402 ~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 402 TLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred HhcchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 1 1234455667778888889999999997654
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=310.45 Aligned_cols=262 Identities=21% Similarity=0.269 Sum_probs=196.2
Q ss_pred CCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC--hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS--EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
+|+..+.||+|+||.||+|+.. +|+.+++|++.... ....+.+.+|++++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4777889999999999999975 68899999875432 22335678899999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCc
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT 659 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~ 659 (845)
++ ++|.+++... ...+++..++.++.||++||.|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-- 153 (284)
T cd07839 81 CD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-- 153 (284)
T ss_pred CC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC--
Confidence 97 5777776543 3468999999999999999999998 899999999999999999999999999997533211
Q ss_pred ccccccccCCCcCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCc------hhhh
Q 003139 660 HVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGM------LDQI 732 (845)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~------~~~~ 732 (845)
.......++..|+|||.+.+. .++.++|||||||++|||++|+.|+......+. ............. +...
T Consensus 154 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 154 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH--HHHHHHHHhCCCChHHhHHhhhc
Confidence 112234578899999998765 479999999999999999999988654332111 0000000000000 0000
Q ss_pred hccccC---------CCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 733 MDSNLV---------GKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 733 ~d~~l~---------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.+.... .+..+.....+.+++.+||+.+|.+|||+.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 010000 01112345678899999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=306.92 Aligned_cols=266 Identities=24% Similarity=0.288 Sum_probs=196.6
Q ss_pred HhcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCCh-HhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 500 ATNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSE-QGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 500 at~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
++++|...+.||+|+||.||+|... +|+.+++|.+..... .....+.+|++++++++|+||+++.+++.++...++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4577889999999999999999865 688999998764432 22346788999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
||++ ++|.+++.... ..+.+.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 83 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 83 EYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred eccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 9996 67766654332 467889999999999999999998 899999999999999999999999999997633211
Q ss_pred CcccccccccCCCcCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHH----------Hhh-
Q 003139 658 QTHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMT----------WQK- 725 (845)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~----------~~~- 725 (845)
.......++..|+|||.+.+. .++.++|||||||++|||++|+.||.............|... ...
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07870 158 --QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL 235 (291)
T ss_pred --CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhc
Confidence 112334578899999998764 578999999999999999999999975433211100001000 000
Q ss_pred cCchhhhhccccCCCC-----CHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 003139 726 KGMLDQIMDSNLVGKV-----NPASLKKFGETAEKCLAEHGVDRPSMGDVLW 772 (845)
Q Consensus 726 ~~~~~~~~d~~l~~~~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~ 772 (845)
................ .......+.+++.+|++.+|.+|||+.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000000000000 0012456789999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=294.77 Aligned_cols=265 Identities=23% Similarity=0.297 Sum_probs=216.0
Q ss_pred HHHHHHHhcCCCcceeeeeeceEEEEEEEEcC------CcEEEEEEcCC-CChHhHHHHHHHHHHHHhCCCCCcceEEEE
Q 003139 494 FQEILDATNKFDESLLLGVGGFGRVYKGTLDD------GTKVAVKRGNP-RSEQGIAEFRTEIEMLSKLRHRHLVSLIGY 566 (845)
Q Consensus 494 ~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~ 566 (845)
.+++.-...+++...++-+|.||.||.|.|++ .+.|.+|.++. .++-+...++.|.-++..+.|||+.++.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 34555566778888889999999999997653 34567776544 466677889999999999999999999999
Q ss_pred Eec-CCcEEEEEEeccCCCccccccC-----C-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCC
Q 003139 567 CDE-RSEMILVYEYMANGPLRSHLYG-----T-DLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDN 639 (845)
Q Consensus 567 ~~~-~~~~~lV~Ey~~~gsL~~~l~~-----~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~ 639 (845)
+.+ ....+.+|.++.-|+|..+|.. . ..+.++-.+...++.|++.|++|||. +++||.||.++|++||+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhh
Confidence 955 4567889999999999999972 2 23457778889999999999999999 999999999999999999
Q ss_pred CceEEEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHH
Q 003139 640 FVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAE 718 (845)
Q Consensus 640 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~ 718 (845)
.++||+|=.++|..-..+......+......||+||.+.+..|+.++|||||||+||||+| |+.|+....+.|.
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm----- 507 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM----- 507 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH-----
Confidence 9999999999997665555555556667789999999999999999999999999999997 7777765555442
Q ss_pred HHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 003139 719 WAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYA 777 (845)
Q Consensus 719 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~ 777 (845)
..+.++| .+-..+-.++.++..++.-||...|++||++++++.-|.+.
T Consensus 508 --~~ylkdG---------yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 508 --EHYLKDG---------YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred --HHHHhcc---------ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 1222222 11123557888999999999999999999999999988653
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=309.51 Aligned_cols=254 Identities=24% Similarity=0.295 Sum_probs=195.5
Q ss_pred CCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC-hHhHHHHHHHHHHHHhCC-CCCcceEEEEEecCCcEEEEEEec
Q 003139 504 FDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS-EQGIAEFRTEIEMLSKLR-HRHLVSLIGYCDERSEMILVYEYM 580 (845)
Q Consensus 504 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~ 580 (845)
|.....||+|+||.||++... +++.+|+|++.... ......+.+|+.++.++. |+||+++++++...+..+++|||+
T Consensus 6 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~ 85 (288)
T cd06616 6 LKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELM 85 (288)
T ss_pred hHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecc
Confidence 445568999999999999875 58899999876542 344567889999999996 999999999999999999999998
Q ss_pred cCCCcccc---ccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 581 ANGPLRSH---LYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 581 ~~gsL~~~---l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
+. +|.++ +.......+++..+.+++.|++.||+|||+ ..+++||||||+||++++++.+||+|||+++....
T Consensus 86 ~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~-- 160 (288)
T cd06616 86 DI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD-- 160 (288)
T ss_pred cC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc--
Confidence 64 54443 222334579999999999999999999997 25899999999999999999999999999875322
Q ss_pred CcccccccccCCCcCChhhhccC---CCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhc
Q 003139 658 QTHVSTAVKGSFGYLDPEYFRRQ---QLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMD 734 (845)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (845)
........|+..|+|||.+.+. .++.++|||||||++|||++|+.||.... ...+-....... ..
T Consensus 161 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~------~~ 228 (288)
T cd06616 161 -SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVKG------DP 228 (288)
T ss_pred -CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcCC------CC
Confidence 1112334678899999999776 68999999999999999999999986432 111111111100 01
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003139 735 SNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNL 774 (845)
Q Consensus 735 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L 774 (845)
+.+...........+.+++.+||+.+|++||++.+|+..-
T Consensus 229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~ 268 (288)
T cd06616 229 PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHP 268 (288)
T ss_pred CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 1222222234567889999999999999999999998763
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=309.20 Aligned_cols=267 Identities=22% Similarity=0.274 Sum_probs=196.7
Q ss_pred CCCcceeeeeeceEEEEEEEEc---CCcEEEEEEcCCCC---hHhHHHHHHHHHHHHhCCCCCcceEEEEEecC--CcEE
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD---DGTKVAVKRGNPRS---EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDER--SEMI 574 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 574 (845)
+|+..+.||+|+||.||+|... +++.+|+|.+.... ....+.+.+|+.++++++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4777889999999999999975 37899999877632 33346678899999999999999999999888 7899
Q ss_pred EEEEeccCCCccccccCC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECC----CCceEEEec
Q 003139 575 LVYEYMANGPLRSHLYGT---DLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDD----NFVAKVADF 647 (845)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~----~~~~kl~DF 647 (845)
+||||+++ +|.+++... ....+++..+..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 566555322 22368999999999999999999998 89999999999999999 999999999
Q ss_pred cccCCCCCCCC-cccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCccc-------ccHHH
Q 003139 648 GLSKTGPALDQ-THVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQ-------VNIAE 718 (845)
Q Consensus 648 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~-------~~l~~ 718 (845)
|+++....... ........++..|+|||.+.+ ..++.++|||||||+++||++|++||........ ..+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99986433222 112234567889999998876 4589999999999999999999999975443220 01111
Q ss_pred HHHHHhh-----------cCchhhhhccccCCCCC---------H--HHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 719 WAMTWQK-----------KGMLDQIMDSNLVGKVN---------P--ASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 719 ~~~~~~~-----------~~~~~~~~d~~l~~~~~---------~--~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
....+.. ........+.......+ . .....+.+++.+||+.+|++|||+.|++++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 1110000 00000000000000111 0 233568899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=307.05 Aligned_cols=262 Identities=24% Similarity=0.301 Sum_probs=197.9
Q ss_pred CCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC--hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEec
Q 003139 504 FDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS--EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYM 580 (845)
Q Consensus 504 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 580 (845)
|+..+.||+|++|.||+|... +|+.+++|++.... ....+.+.+|++++++++|||++++++++.+.+..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 566778999999999999875 78999999876442 223467889999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcc
Q 003139 581 ANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH 660 (845)
Q Consensus 581 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 660 (845)
+ ++|.+++.......+++..+++++.|+++||+|||+ ++++||||+|+||++++++.++|+|||+++...... .
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~ 154 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV--R 154 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc--c
Confidence 5 689988865544578999999999999999999998 899999999999999999999999999997533211 1
Q ss_pred cccccccCCCcCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcC--------chhh
Q 003139 661 VSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKG--------MLDQ 731 (845)
Q Consensus 661 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~--------~~~~ 731 (845)
......++..|+|||++.+. .++.++||||||+++|||++|++||........ +........... .+.+
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChHHhhhhhhchh
Confidence 12233568899999988664 579999999999999999999999865432111 111110000000 0000
Q ss_pred hhcc------ccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 732 IMDS------NLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 732 ~~d~------~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.... .......+.....+.+++.+|++.+|.+||+++|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000 00001112334678899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=299.72 Aligned_cols=250 Identities=24% Similarity=0.351 Sum_probs=199.6
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC-----ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecC--CcE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR-----SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDER--SEM 573 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 573 (845)
.+|+..+.||+|+||.||+|... +++.+++|..... ..+..+.+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888899999999999999865 6889999976421 234557889999999999999999999998654 458
Q ss_pred EEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCC
Q 003139 574 ILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTG 653 (845)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~ 653 (845)
++|+||+++++|.+++... ..+++..+.+++.|++.||.|||+ .+++|+||||+||++++++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 8999999999999988543 358899999999999999999998 89999999999999999999999999999764
Q ss_pred CCCCC-cccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhh
Q 003139 654 PALDQ-THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQI 732 (845)
Q Consensus 654 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (845)
..... ........++..|+|||.+.+..++.++|||||||+++||++|+.||......+. +.++
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---------------~~~~ 221 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA---------------IFKI 221 (264)
T ss_pred ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH---------------HHHH
Confidence 32111 1112235688999999999998899999999999999999999999864321110 1111
Q ss_pred hccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 003139 733 MDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLW 772 (845)
Q Consensus 733 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~ 772 (845)
.........+......+.+++.+|++ +|..||+..+++.
T Consensus 222 ~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 222 ATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 11111223445566789999999999 5799999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=307.97 Aligned_cols=265 Identities=23% Similarity=0.292 Sum_probs=198.3
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC--hHhHHHHHHHHHHHHhCCCCCcceEEEEEecC--CcEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS--EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDER--SEMILV 576 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV 576 (845)
++|+..+.||+|+||.||+|... +++.+++|.+.... ......+.+|++++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46777889999999999999976 58889999876432 22234677899999999999999999998777 889999
Q ss_pred EEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCC
Q 003139 577 YEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPAL 656 (845)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~ 656 (845)
|||++ ++|.+++.... ..+++.+++.++.|++.||+|||+ .+++||||||+|||+++++.+||+|||+++.....
T Consensus 85 ~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 85 MEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred ehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 99997 58888875433 368999999999999999999998 89999999999999999999999999999864332
Q ss_pred CCcccccccccCCCcCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccH-H---------HHHHH---
Q 003139 657 DQTHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNI-A---------EWAMT--- 722 (845)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l-~---------~~~~~--- 722 (845)
. .......++..|+|||.+.+. .++.++|+||||+++|||++|++||......+.... . .|...
T Consensus 160 ~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (293)
T cd07843 160 L--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL 237 (293)
T ss_pred c--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence 1 112334578899999998764 468999999999999999999999875432211000 0 01000
Q ss_pred -HhhcCchhhhhccccCCCCCHH-HHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 723 -WQKKGMLDQIMDSNLVGKVNPA-SLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 723 -~~~~~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
..............+...++.. ....+.+++.+||+.+|++||++.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000000001111111112222 35678899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=304.36 Aligned_cols=247 Identities=25% Similarity=0.296 Sum_probs=203.1
Q ss_pred CCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEE
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYE 578 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 578 (845)
+|+..+.||.|+||.||+|... +++.+++|.+... .....+.+.+|++++++++||||+++++.+.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778889999999999999976 5889999987643 23456789999999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCC
Q 003139 579 YMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQ 658 (845)
Q Consensus 579 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~ 658 (845)
|+++++|.+++... .++++.++..++.|+++||.|||+ ++++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 99999999998544 578999999999999999999998 899999999999999999999999999987643211
Q ss_pred cccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccC
Q 003139 659 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLV 738 (845)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 738 (845)
......|+..|+|||.+.+..++.++|+||||+++|||++|+.|+....... ..+....... ..
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~----------~~ 218 (258)
T cd05578 155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRAKQET----------AD 218 (258)
T ss_pred --cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHHHhcc----------cc
Confidence 2234567889999999998889999999999999999999999987544321 1111111110 11
Q ss_pred CCCCHHHHHHHHHHHHHhhhhCCCCCCCH--HHHH
Q 003139 739 GKVNPASLKKFGETAEKCLAEHGVDRPSM--GDVL 771 (845)
Q Consensus 739 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~--~~vl 771 (845)
...+...+..+.+++.+||+.+|.+||++ +|++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 22334456788899999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=300.86 Aligned_cols=242 Identities=25% Similarity=0.305 Sum_probs=196.9
Q ss_pred eeeeceEEEEEEEEc-CCcEEEEEEcCCCC---hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEeccCCCc
Q 003139 510 LGVGGFGRVYKGTLD-DGTKVAVKRGNPRS---EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPL 585 (845)
Q Consensus 510 LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 585 (845)
||.|++|.||+++.. +++.+++|.+.... ....+.+.+|++++++++||||+++++.+.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999976 48899999875432 23456789999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCccccccc
Q 003139 586 RSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAV 665 (845)
Q Consensus 586 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 665 (845)
.+++... ..+++..+..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||+++...... .....
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~ 152 (262)
T cd05572 81 WTILRDR--GLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTF 152 (262)
T ss_pred HHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccc
Confidence 9999654 358999999999999999999998 999999999999999999999999999998643321 22334
Q ss_pred ccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCCHHH
Q 003139 666 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPAS 745 (845)
Q Consensus 666 ~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 745 (845)
.++..|++||.+.+..++.++|+||||+++|||++|+.||....... .+.. ..+.+.......+...
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~---------~~~~~~~~~~~~~~~~ 219 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----MEIY---------NDILKGNGKLEFPNYI 219 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HHHH---------HHHhccCCCCCCCccc
Confidence 67889999999998899999999999999999999999997544211 1111 1122111122233344
Q ss_pred HHHHHHHHHHhhhhCCCCCCC-----HHHHHH
Q 003139 746 LKKFGETAEKCLAEHGVDRPS-----MGDVLW 772 (845)
Q Consensus 746 ~~~l~~l~~~cl~~~p~~RPs-----~~~vl~ 772 (845)
...+.+++.+||+.+|++||+ +.|+++
T Consensus 220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 678899999999999999999 666654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=307.05 Aligned_cols=263 Identities=21% Similarity=0.268 Sum_probs=194.7
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC--hHhHHHHHHHHHHHHhCC-CCCcceEEEEEecCCc-----
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS--EQGIAEFRTEIEMLSKLR-HRHLVSLIGYCDERSE----- 572 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~----- 572 (845)
++|+..+.||+|+||.||+|... +++.||+|+..... ......+.+|+.++++++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36888899999999999999975 68899999865432 223467888999999995 6999999999876665
Q ss_pred EEEEEEeccCCCccccccCCC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECC-CCceEEEecc
Q 003139 573 MILVYEYMANGPLRSHLYGTD---LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDD-NFVAKVADFG 648 (845)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~-~~~~kl~DFG 648 (845)
.++||||+++ +|.+++.... ...+++..++.++.||+.||+|||+ .+|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999985 7888775432 3468999999999999999999998 89999999999999998 8999999999
Q ss_pred ccCCCCCCCCcccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcC
Q 003139 649 LSKTGPALDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKG 727 (845)
Q Consensus 649 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 727 (845)
+++..... ........+++.|+|||++.+ ..++.++||||||+++|||++|+.||......+. +.... ......
T Consensus 157 ~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~--~~~~~-~~~~~~ 231 (295)
T cd07837 157 LGRAFSIP--VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ--LLHIF-KLLGTP 231 (295)
T ss_pred cceecCCC--ccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH--HHHHH-HHhCCC
Confidence 98753221 111123356788999998865 4679999999999999999999999865332211 00000 000000
Q ss_pred chh---hhhc-------c----ccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 728 MLD---QIMD-------S----NLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 728 ~~~---~~~d-------~----~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
... ...+ + .......+.....+.+++.+||+.+|.+||++.|++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000 0000 0 00000112345678899999999999999999998754
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=303.29 Aligned_cols=246 Identities=23% Similarity=0.350 Sum_probs=208.9
Q ss_pred CCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC--hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS--EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
-|+..+.||+|.|..|-+|++- .|+.||||.+.+.. ......+.+|++.|+.++|||||+|+.+......+|||.|.
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 4566668999999999999854 79999999987654 33456788999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEE-CCCCceEEEeccccCCCCCCCC
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILL-DDNFVAKVADFGLSKTGPALDQ 658 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl-~~~~~~kl~DFGla~~~~~~~~ 658 (845)
=.+|+|.+++.+.+ ..+.+....+++.||..|+.|+|+ ..+|||||||+||.+ .+-|-+||.|||++-.. ..
T Consensus 99 GD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf---~P 171 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF---QP 171 (864)
T ss_pred cCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccC---CC
Confidence 99999999997664 358899999999999999999999 999999999999866 57789999999998542 23
Q ss_pred cccccccccCCCcCChhhhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcccc
Q 003139 659 THVSTAVKGSFGYLDPEYFRRQQLT-EKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNL 737 (845)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (845)
....+..+|+..|-|||.+.+..|+ +++||||+|||||-|+||++||+.....+ .+..|+|-..
T Consensus 172 G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE---------------TLTmImDCKY 236 (864)
T KOG4717|consen 172 GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE---------------TLTMIMDCKY 236 (864)
T ss_pred cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh---------------hhhhhhcccc
Confidence 3344567899999999999998886 68999999999999999999997544433 4555666443
Q ss_pred CCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 003139 738 VGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLW 772 (845)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~ 772 (845)
..+.-...++.+||..||..||.+|.+.++|+.
T Consensus 237 --tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 237 --TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred --cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 356667888999999999999999999999763
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=302.70 Aligned_cols=261 Identities=21% Similarity=0.301 Sum_probs=198.0
Q ss_pred CCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCCh-HhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEec
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSE-QGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYM 580 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 580 (845)
+|+..+.||.|++|.||+|+.. +|+.+|+|++..... ...+.+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4778889999999999999976 688999998765432 23456788999999999999999999999999999999999
Q ss_pred cCCCccccccCCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCc
Q 003139 581 ANGPLRSHLYGTD-LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT 659 (845)
Q Consensus 581 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~ 659 (845)
++ +|.+++.... ...+++..+.+++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++..... .
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~--~ 154 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP--V 154 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC--c
Confidence 85 8888775432 3468999999999999999999998 89999999999999999999999999999753221 1
Q ss_pred ccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhh---cCchhhhhc-
Q 003139 660 HVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQK---KGMLDQIMD- 734 (845)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~---~~~~~~~~d- 734 (845)
.......++..|++||.+.+ ..++.++|||||||++|||++|+.||......+... . ...... ......+.+
T Consensus 155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~--~-~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07836 155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLL--K-IFRIMGTPTESTWPGISQL 231 (284)
T ss_pred cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHH--H-HHHHhCCCChhhHHHHhcC
Confidence 11223456889999998866 457899999999999999999999987544322110 0 000000 000000000
Q ss_pred cccC-----------CCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 003139 735 SNLV-----------GKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLW 772 (845)
Q Consensus 735 ~~l~-----------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~ 772 (845)
+.+. ....+.....+.+++.+|++.+|.+||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000 0111233567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=328.57 Aligned_cols=271 Identities=19% Similarity=0.215 Sum_probs=189.7
Q ss_pred HhcCCCcceeeeeeceEEEEEEEEcC--CcEEEEE------------------EcCCCChHhHHHHHHHHHHHHhCCCCC
Q 003139 500 ATNKFDESLLLGVGGFGRVYKGTLDD--GTKVAVK------------------RGNPRSEQGIAEFRTEIEMLSKLRHRH 559 (845)
Q Consensus 500 at~~f~~~~~LG~G~fg~Vy~~~~~~--g~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~H~n 559 (845)
..++|++.+.||+|+||.||++.++. +...+.| +.. ........+.+|+++|++++|||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 35789999999999999999987542 2222222 111 12233456889999999999999
Q ss_pred cceEEEEEecCCcEEEEEEeccCCCccccccCCC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEE
Q 003139 560 LVSLIGYCDERSEMILVYEYMANGPLRSHLYGTD---LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILL 636 (845)
Q Consensus 560 iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl 636 (845)
|+++++++.+.+..++|+|++. ++|.+++.... .......+...|+.|++.||+|||+ ++|+||||||+||||
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEE
Confidence 9999999999999999999985 56666654321 1233456778899999999999998 899999999999999
Q ss_pred CCCCceEEEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCC-CCCCCccccc
Q 003139 637 DDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPAL-NPVLPREQVN 715 (845)
Q Consensus 637 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~-~~~~~~~~~~ 715 (845)
+.++.+||+|||+++..... .........||..|+|||++.+..++.++|||||||+||||++|+.++ ..........
T Consensus 301 ~~~~~vkL~DFGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKE-REAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred CCCCCEEEEeCCCceecCcc-cccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 99999999999999764321 122233467999999999999999999999999999999999998543 3222111111
Q ss_pred HHHHHHHHh--hcC------chhhhhccccCC----CCC-----HHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003139 716 IAEWAMTWQ--KKG------MLDQIMDSNLVG----KVN-----PASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEY 776 (845)
Q Consensus 716 l~~~~~~~~--~~~------~~~~~~d~~l~~----~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~ 776 (845)
+.+...... .++ .+.+.++..... .++ ......+.+++.+||+.||.+|||+.|++.+-..
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f 457 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLF 457 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhh
Confidence 111111000 000 000000000000 000 0123456788999999999999999999876443
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=303.59 Aligned_cols=243 Identities=22% Similarity=0.291 Sum_probs=188.5
Q ss_pred eeeeeceEEEEEEEEc-CCcEEEEEEcCCCC---hHhHHHHHHHHHHHH---hCCCCCcceEEEEEecCCcEEEEEEecc
Q 003139 509 LLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS---EQGIAEFRTEIEMLS---KLRHRHLVSLIGYCDERSEMILVYEYMA 581 (845)
Q Consensus 509 ~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~---~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 581 (845)
+||+|+||.||++... +++.+|+|.+.... ......+.+|..++. ..+|||++.+.+++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999875 58899999765431 122233445544443 3479999999999999999999999999
Q ss_pred CCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCccc
Q 003139 582 NGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHV 661 (845)
Q Consensus 582 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 661 (845)
+++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||++...... .
T Consensus 81 ~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~----~ 151 (279)
T cd05633 81 GGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----K 151 (279)
T ss_pred CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceecccc----C
Confidence 99999888543 469999999999999999999998 89999999999999999999999999998653221 1
Q ss_pred ccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCC
Q 003139 662 STAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGK 740 (845)
Q Consensus 662 ~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 740 (845)
.....|+..|+|||.+.+ ..++.++|||||||+++||++|+.||.......... ..... ......
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~----~~~~~----------~~~~~~ 217 (279)
T cd05633 152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMT----------LTVNVE 217 (279)
T ss_pred ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH----HHHHh----------hcCCcC
Confidence 223468999999999864 568999999999999999999999996543222111 11100 011112
Q ss_pred CCHHHHHHHHHHHHHhhhhCCCCCC-----CHHHHHHHH
Q 003139 741 VNPASLKKFGETAEKCLAEHGVDRP-----SMGDVLWNL 774 (845)
Q Consensus 741 ~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~~L 774 (845)
.+......+.+++.+||+.+|.+|| ++++++++.
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~ 256 (279)
T cd05633 218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHV 256 (279)
T ss_pred CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence 3344567788999999999999999 598887764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=304.98 Aligned_cols=261 Identities=25% Similarity=0.328 Sum_probs=197.6
Q ss_pred CCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC--hHhHHHHHHHHHHHHhCCCCCcceEEEEEecC--CcEEEEEE
Q 003139 504 FDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS--EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDER--SEMILVYE 578 (845)
Q Consensus 504 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~E 578 (845)
|+..+.||+|++|.||+|+.. +++.+++|++.... ....+.+.+|++++++++|+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 566778999999999999976 57899999887552 33446788999999999999999999999887 89999999
Q ss_pred eccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCC
Q 003139 579 YMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQ 658 (845)
Q Consensus 579 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~ 658 (845)
|+++ +|.+++.... ..+++.+++.++.|+++||+|||+ .+++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 81 YMDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred cccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 9974 8888875442 478999999999999999999998 8999999999999999999999999999976443221
Q ss_pred cccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCc---hhhh--
Q 003139 659 THVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGM---LDQI-- 732 (845)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~~-- 732 (845)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......... ........... ...+
T Consensus 156 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07840 156 -ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQL---EKIFELCGSPTDENWPGVSK 231 (287)
T ss_pred -ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCchhhcccccc
Confidence 12233456788999998765 46899999999999999999999998654432211 11111000000 0000
Q ss_pred ------------hccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 733 ------------MDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 733 ------------~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
....+...+...+...+.+++.+||+.+|++||++.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00000000111125678899999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=296.96 Aligned_cols=250 Identities=26% Similarity=0.416 Sum_probs=205.8
Q ss_pred CCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC--hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS--EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
+|+..+.||+|+||.||++... +++.+++|++.... ....+++.+|++++++++|+|++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4677889999999999999976 68899999876543 35567889999999999999999999999999999999999
Q ss_pred ccCCCccccccCCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 580 MANGPLRSHLYGTD--LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 580 ~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
+++++|.+++.... ...+++.++..++.+++.||.|||+ .+++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999886542 3679999999999999999999999 899999999999999999999999999997643321
Q ss_pred CcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcccc
Q 003139 658 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNL 737 (845)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (845)
.......|++.|+|||.+.+..++.++||||+|++++||++|+.|+...... +..... ... .
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~---------~~~-~ 219 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL------ELALKI---------LKG-Q 219 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH------HHHHHH---------hcC-C
Confidence 1223456788999999999999999999999999999999999998643311 111111 111 1
Q ss_pred CCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 738 VGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
....+......+.+++.+||..+|++||++.++++.
T Consensus 220 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 220 YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 112333456778999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=316.50 Aligned_cols=245 Identities=26% Similarity=0.421 Sum_probs=200.8
Q ss_pred eeeeeceEEEEEEEEcC-CcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEeccCCCccc
Q 003139 509 LLGVGGFGRVYKGTLDD-GTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRS 587 (845)
Q Consensus 509 ~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~ 587 (845)
.||.|+||.||||..++ +-..|.|.+...+...+++|+-|+++|+...||+||+|++.++..+.++|+.|||.||-...
T Consensus 39 ELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDa 118 (1187)
T KOG0579|consen 39 ELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDA 118 (1187)
T ss_pred hhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhH
Confidence 58999999999998774 34457788888899999999999999999999999999999999999999999999999888
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCccccccccc
Q 003139 588 HLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKG 667 (845)
Q Consensus 588 ~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 667 (845)
.+..-. ..|+..++.-+|+|++.||.|||+ ++|||||||+.|||++-+|.++|+|||.+.... ........+.|
T Consensus 119 imlEL~-r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~qkRDsFIG 192 (1187)
T KOG0579|consen 119 IMLELG-RVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STRQKRDSFIG 192 (1187)
T ss_pred HHHHhc-cccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccch--hHHhhhccccC
Confidence 775443 479999999999999999999999 999999999999999999999999999985422 11222346789
Q ss_pred CCCcCChhhh-----ccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCC
Q 003139 668 SFGYLDPEYF-----RRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVN 742 (845)
Q Consensus 668 t~~y~aPE~~-----~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 742 (845)
|+.|||||+. ...+|+.++||||||+.|.||..+.+|.....+.. +.-.+.+... |.|. .+
T Consensus 193 TPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR-------VllKiaKSeP-----PTLl--qP 258 (1187)
T KOG0579|consen 193 TPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-------VLLKIAKSEP-----PTLL--QP 258 (1187)
T ss_pred CcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH-------HHHHHhhcCC-----Cccc--Cc
Confidence 9999999976 46799999999999999999999999875443321 0000111110 1111 23
Q ss_pred HHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 743 PASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 743 ~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
......|.+++.+||.+||+.||++.+++++
T Consensus 259 S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 259 SHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred chhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 4566789999999999999999999998754
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=301.55 Aligned_cols=258 Identities=23% Similarity=0.237 Sum_probs=193.3
Q ss_pred CCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC-hHhHHHHHHHHHHHHhCC-CCCcceEEEEEecC--CcEEEEEE
Q 003139 504 FDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS-EQGIAEFRTEIEMLSKLR-HRHLVSLIGYCDER--SEMILVYE 578 (845)
Q Consensus 504 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lV~E 578 (845)
|+..+.||+|+||.||+|... +++.+|+|+..... ........+|+.++.++. |+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 456778999999999999865 68899999876532 222234457899999885 99999999999887 88999999
Q ss_pred eccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCC
Q 003139 579 YMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQ 658 (845)
Q Consensus 579 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~ 658 (845)
|++ ++|.+++.... ..++|.+++.++.|++.||+|||+ .+++||||||+||++++ +.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~-- 152 (282)
T cd07831 81 LMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK-- 152 (282)
T ss_pred cCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccC--
Confidence 997 57877775432 478999999999999999999999 89999999999999999 99999999999764321
Q ss_pred cccccccccCCCcCChhhhc-cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcC----------
Q 003139 659 THVSTAVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKG---------- 727 (845)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~---------- 727 (845)
.......++..|+|||.+. ++.++.++|||||||++|||++|++||......+ ...+........
T Consensus 153 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07831 153 -PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKFRK 228 (282)
T ss_pred -CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhhcc
Confidence 1122345788999999765 4567899999999999999999999996543322 112221111110
Q ss_pred -chhhhhccccCC----CCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 728 -MLDQIMDSNLVG----KVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 728 -~~~~~~d~~l~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.......+.... ...+..+..+.+++.+||+.+|++||++.++++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 000000000000 0112346789999999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=305.45 Aligned_cols=262 Identities=20% Similarity=0.280 Sum_probs=197.0
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC--hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS--EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYE 578 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 578 (845)
++|+..+.||+|++|.||+|+.. +|+.+++|++.... ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888899999999999999976 68899999875432 2334678899999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECC-CCceEEEeccccCCCCCCC
Q 003139 579 YMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDD-NFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 579 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~-~~~~kl~DFGla~~~~~~~ 657 (845)
|++ ++|.+++.......+++..+..++.||+.||+|||+ ++++||||||+||++++ ++.+||+|||+++.....
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~- 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP- 156 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCC-
Confidence 996 578777754444456888899999999999999998 89999999999999985 567999999999753321
Q ss_pred CcccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhh---
Q 003139 658 QTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIM--- 733 (845)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~--- 733 (845)
........+++.|+|||++.+ ..++.++|||||||++|||++|++||......+.. .. ........ .....
T Consensus 157 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~--~~-~~~~~~~~-~~~~~~~~ 231 (294)
T PLN00009 157 -VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDEL--FK-IFRILGTP-NEETWPGV 231 (294)
T ss_pred -ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--HH-HHHHhCCC-Chhhcccc
Confidence 111233457889999999876 46799999999999999999999998654322110 00 00000000 00000
Q ss_pred -------c--cccCC----CCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 734 -------D--SNLVG----KVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 734 -------d--~~l~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
. +.... ...+.....+.+++.+|++.+|++||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 00000 0112334568899999999999999999999864
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=302.60 Aligned_cols=244 Identities=24% Similarity=0.359 Sum_probs=194.2
Q ss_pred eeeeceEEEEEEEEc-CCcEEEEEEcCCCC---hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEeccCCCc
Q 003139 510 LGVGGFGRVYKGTLD-DGTKVAVKRGNPRS---EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPL 585 (845)
Q Consensus 510 LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 585 (845)
||+|+||+||++... +|+.+++|.+.... ....+.+..|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999865 68899999875432 22345678899999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCccccccc
Q 003139 586 RSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAV 665 (845)
Q Consensus 586 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 665 (845)
.+++.......+++.+++.++.|++.||.|||+ .+++||||+|+||++++++.+||+|||+++.... .......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~ 154 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGR 154 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccccc
Confidence 999876554579999999999999999999998 8999999999999999999999999999876432 1122334
Q ss_pred ccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCCHHH
Q 003139 666 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPAS 745 (845)
Q Consensus 666 ~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 745 (845)
.++..|+|||.+.++.++.++|||||||+++||++|+.||......... .. . .... .. .....+...
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~-~----~~~~----~~--~~~~~~~~~ 221 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK--EE-L----KRRT----LE--MAVEYPDKF 221 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH--HH-H----Hhcc----cc--ccccCCccC
Confidence 6788999999999888999999999999999999999998654321110 00 0 0000 00 011122334
Q ss_pred HHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 003139 746 LKKFGETAEKCLAEHGVDRP-----SMGDVLW 772 (845)
Q Consensus 746 ~~~l~~l~~~cl~~~p~~RP-----s~~~vl~ 772 (845)
...+.+++.+||+.+|.+|| ++.+++.
T Consensus 222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 56788999999999999999 5555654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=300.75 Aligned_cols=244 Identities=26% Similarity=0.333 Sum_probs=196.4
Q ss_pred eeeeceEEEEEEEEc-CCcEEEEEEcCCCCh---HhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEeccCCCc
Q 003139 510 LGVGGFGRVYKGTLD-DGTKVAVKRGNPRSE---QGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPL 585 (845)
Q Consensus 510 LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 585 (845)
||+|+||.||+++.. +|+.+++|.+..... ...+.+.+|++++++++||||+++++.+..+...++|+||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999987 489999998765433 4567889999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCC------c
Q 003139 586 RSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQ------T 659 (845)
Q Consensus 586 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~------~ 659 (845)
.+++... ..+++..+..++.|++.||+|||+ .+++||||+|+||++++++.+||+|||++........ .
T Consensus 81 ~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENV--GSLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 9998643 378999999999999999999998 8999999999999999999999999999876432211 1
Q ss_pred ccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCC
Q 003139 660 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVG 739 (845)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 739 (845)
.......++..|+|||.+.....+.++||||||++++||++|+.||......+ ..... .....
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~~~---------~~~~~-- 218 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE------IFQNI---------LNGKI-- 218 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH------HHHHH---------hcCCc--
Confidence 12234567889999999998889999999999999999999999986543211 11111 11011
Q ss_pred CCCHH--HHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 740 KVNPA--SLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 740 ~~~~~--~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
..+.. ....+.+++.+|++.+|.+||++.++.+.|+
T Consensus 219 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 219 EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 01111 2577889999999999999999966555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=331.77 Aligned_cols=259 Identities=27% Similarity=0.430 Sum_probs=206.4
Q ss_pred cCCCcceeeeeeceEEEEEEEEc----C----CcEEEEEEcCCC-ChHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCC
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD----D----GTKVAVKRGNPR-SEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERS 571 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~----~----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 571 (845)
++..+.+.||+|.||.|++|... . ...||||.+... ...+.+.+..|+++|+.+ +|+||+.++|+|.+.+
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 33445558999999999999854 1 346999987754 345678899999999998 6999999999999999
Q ss_pred cEEEEEEeccCCCccccccCCC------------C--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEEC
Q 003139 572 EMILVYEYMANGPLRSHLYGTD------------L--PPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLD 637 (845)
Q Consensus 572 ~~~lV~Ey~~~gsL~~~l~~~~------------~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~ 637 (845)
..++|+||++.|+|.++|+.++ . ..|+..+++.++.|||.|++||++ .++|||||.++||||.
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARNVLIT 452 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhhEEec
Confidence 9999999999999999997654 0 138899999999999999999998 8999999999999999
Q ss_pred CCCceEEEeccccCCCCCCCCcccccccc--cCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccc
Q 003139 638 DNFVAKVADFGLSKTGPALDQTHVSTAVK--GSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQV 714 (845)
Q Consensus 638 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~ 714 (845)
++..+||+|||+||.....+.... ..-. -...|||||.+....|+.|+|||||||+||||++ |..|+......+
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~-~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~-- 529 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRT-KSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE-- 529 (609)
T ss_pred CCCEEEEccccceeccCCCCceEe-cCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH--
Confidence 999999999999996544222221 1112 3557999999999999999999999999999998 455654322111
Q ss_pred cHHHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 003139 715 NIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779 (845)
Q Consensus 715 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~ 779 (845)
++ .++.++|. +-+.+..+..++.++++.||+.+|++||++.++++.++..++
T Consensus 530 ~l----~~~l~~G~---------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 530 EL----LEFLKEGN---------RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred HH----HHHHhcCC---------CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 11 11222221 223445567889999999999999999999999999998643
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=294.32 Aligned_cols=247 Identities=26% Similarity=0.427 Sum_probs=203.4
Q ss_pred CCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCCh--HhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSE--QGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
+|+..+.||+|++|.||+++.. +++.+++|....... ...+.+.+|++++++++|+|++++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4677889999999999999876 578899998766543 5667899999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCc
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT 659 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~ 659 (845)
+++++|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (254)
T cd06627 81 AENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK- 154 (254)
T ss_pred CCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc-
Confidence 9999999988544 579999999999999999999998 8999999999999999999999999999986443221
Q ss_pred ccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCC
Q 003139 660 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVG 739 (845)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 739 (845)
......++..|+|||.+.+..++.++||||+|++++||++|+.|+....... ..|.. .. ....
T Consensus 155 -~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~----~~~~~--~~----------~~~~ 217 (254)
T cd06627 155 -DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA----ALFRI--VQ----------DDHP 217 (254)
T ss_pred -cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH----HHHHH--hc----------cCCC
Confidence 1234567889999999988889999999999999999999999986432111 01110 00 0111
Q ss_pred CCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 003139 740 KVNPASLKKFGETAEKCLAEHGVDRPSMGDVLW 772 (845)
Q Consensus 740 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~ 772 (845)
..+......+.+++.+||..+|++||++.+++.
T Consensus 218 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 218 PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 223344678889999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=307.48 Aligned_cols=267 Identities=21% Similarity=0.302 Sum_probs=194.2
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC--hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCC-------
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS--EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERS------- 571 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------- 571 (845)
++|+..+.||+|+||.||+|+.. +++.+|+|++.... ......+.+|++++++++||||++++++|...+
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 56888999999999999999976 68899999865432 222345678999999999999999999986654
Q ss_pred -cEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEecccc
Q 003139 572 -EMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLS 650 (845)
Q Consensus 572 -~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla 650 (845)
..++||||++ ++|.+.+.... ..+++.+++.++.|++.||+|||+ ++++|+||||+||++++++.+||+|||++
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 3599999996 47777775432 468999999999999999999998 89999999999999999999999999999
Q ss_pred CCCCCCCCc--ccccccccCCCcCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcC
Q 003139 651 KTGPALDQT--HVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKG 727 (845)
Q Consensus 651 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 727 (845)
......... .......++..|+|||.+.+. .++.++||||||++++||++|++||.....................+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 764332211 112234578889999988764 47899999999999999999999987544332211111110000000
Q ss_pred chh-----hhhcc-ccCCCC---------CHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 728 MLD-----QIMDS-NLVGKV---------NPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 728 ~~~-----~~~d~-~l~~~~---------~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
... ...+. .+.... .......+.+++.+||+.+|.+||++.+++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 000 00000 000000 00112456789999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=301.16 Aligned_cols=261 Identities=25% Similarity=0.304 Sum_probs=195.5
Q ss_pred CCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC--hHhHHHHHHHHHHHHhC---CCCCcceEEEEEecCCc-----
Q 003139 504 FDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS--EQGIAEFRTEIEMLSKL---RHRHLVSLIGYCDERSE----- 572 (845)
Q Consensus 504 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~----- 572 (845)
|++.+.||+|+||.||+|+.+ +++.+|+|++.... ......+.+|+.+++++ .|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 566789999999999999987 48999999876432 22234566788777666 59999999999987776
Q ss_pred EEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCC
Q 003139 573 MILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKT 652 (845)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~ 652 (845)
.+++|||++ ++|.+++.......+++..++.++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||++..
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 999999997 578888765444469999999999999999999999 8999999999999999999999999999876
Q ss_pred CCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCch---
Q 003139 653 GPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGML--- 729 (845)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~--- 729 (845)
.... .......++..|+|||.+.+..++.++|||||||++|||++|++||......+. +..+..........
T Consensus 157 ~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 231 (287)
T cd07838 157 YSFE---MALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ--LDKIFDVIGLPSEEEWP 231 (287)
T ss_pred ccCC---cccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH--HHHHHHHcCCCChHhcC
Confidence 4321 112234578899999999999999999999999999999999998865432221 11111100000000
Q ss_pred ------hhhhccccC---CCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 730 ------DQIMDSNLV---GKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 730 ------~~~~d~~l~---~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
......... ....+.....+.+++.+||+.+|.+||++.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 000000000 01112345678899999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=313.42 Aligned_cols=263 Identities=24% Similarity=0.337 Sum_probs=196.8
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC-hHhHHHHHHHHHHHHhCCCCCcceEEEEEecC-----CcE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS-EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDER-----SEM 573 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~ 573 (845)
.++|++.+.||+|+||.||+|+.. +|+.||+|++.... ......+.+|+.++++++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 467899999999999999999865 68999999886432 33456788999999999999999999987544 357
Q ss_pred EEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCC
Q 003139 574 ILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTG 653 (845)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~ 653 (845)
++|+||++ ++|..++.. ..+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 84 YIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred EEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceeec
Confidence 99999996 477766633 368999999999999999999999 89999999999999999999999999999764
Q ss_pred CCCCC-cccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcC---c
Q 003139 654 PALDQ-THVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKG---M 728 (845)
Q Consensus 654 ~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~---~ 728 (845)
..... ........|+..|+|||.+.+ ..++.++|||||||++|||++|+.||........ ..+........ .
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~---~~~~~~~~~~~~~~~ 233 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ---LNLILGVLGTPSQED 233 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCCHHH
Confidence 32111 111233568899999998754 5689999999999999999999999965322111 11111111110 0
Q ss_pred hhhhhcccc---------CCC-----CCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 729 LDQIMDSNL---------VGK-----VNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 729 ~~~~~d~~l---------~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
...+.+... ... ..+.....+.+++.+||+.+|++||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111110000 000 011234568899999999999999999999877
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=296.68 Aligned_cols=248 Identities=25% Similarity=0.354 Sum_probs=203.8
Q ss_pred CCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
+|++.+.||+|+||.||+++.. +++.+++|++... ......++.+|++++++++|+||+++.+++.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4677889999999999999865 6789999987643 344566788999999999999999999999999999999999
Q ss_pred ccCCCccccccCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 580 MANGPLRSHLYGT--DLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 580 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
+++++|.+++... ....+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999988542 23568999999999999999999998 89999999999999999999999999999874432
Q ss_pred CcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcccc
Q 003139 658 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNL 737 (845)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (845)
......++..|++||.+.+..++.++|+||||+++|||++|+.||......+ +. . .... ..
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~---~-~~~~---------~~ 217 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD---LR---Y-KVQR---------GK 217 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH---H-HHhc---------CC
Confidence 2223457889999999999999999999999999999999999986543211 10 0 1111 11
Q ss_pred CCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 738 VGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
....+......+.+++.+|++.+|++||++.++++.
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 218 YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 122334556778999999999999999999999764
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=305.71 Aligned_cols=264 Identities=25% Similarity=0.313 Sum_probs=197.2
Q ss_pred HhcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC--hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCC-----
Q 003139 500 ATNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS--EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERS----- 571 (845)
Q Consensus 500 at~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----- 571 (845)
..++|++.+.||+|+||.||+|... +|+.+++|++.... ......+.+|++++++++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 4567888999999999999999986 58899999876432 223356778999999999999999999987654
Q ss_pred -----cEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEe
Q 003139 572 -----EMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVAD 646 (845)
Q Consensus 572 -----~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~D 646 (845)
..++|+||+++ +|...+... ...+++.++..++.|++.||+|||+ .+|+||||||+||++++++.+||+|
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEeCc
Confidence 78999999976 666666433 3478999999999999999999999 8999999999999999999999999
Q ss_pred ccccCCCCCCCCcccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhh
Q 003139 647 FGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQK 725 (845)
Q Consensus 647 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~ 725 (845)
||+++....... .......++..|+|||.+.+ ..++.++|||||||+++||++|++||......+.. . .......
T Consensus 160 fg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~--~-~~~~~~~ 235 (302)
T cd07864 160 FGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQL--E-LISRLCG 235 (302)
T ss_pred ccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHH--H-HHHHHhC
Confidence 999976433221 12223346778999998865 45789999999999999999999998653322111 1 1111111
Q ss_pred cCch---hhhh--------cc------ccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 726 KGML---DQIM--------DS------NLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 726 ~~~~---~~~~--------d~------~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.... ..+. +. ... ......+..+.+++.+||+.+|.+||++.+++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLR-EEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CCChhhcccccccccccccccccccccchh-hhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000 0000 00 000 0011235678999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=310.51 Aligned_cols=263 Identities=21% Similarity=0.289 Sum_probs=198.2
Q ss_pred HhcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecC------
Q 003139 500 ATNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDER------ 570 (845)
Q Consensus 500 at~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 570 (845)
..++|+..+.||+|+||.||+|... +|+.+|+|++... .....+++.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3477999999999999999999865 6899999987542 334456788899999999999999999988543
Q ss_pred CcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEecccc
Q 003139 571 SEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLS 650 (845)
Q Consensus 571 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla 650 (845)
...++||||++ ++|.+.+.. .+++.++..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence 35799999995 577777642 28899999999999999999998 89999999999999999999999999999
Q ss_pred CCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCccccc-H--------HHHHH
Q 003139 651 KTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVN-I--------AEWAM 721 (845)
Q Consensus 651 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~-l--------~~~~~ 721 (845)
+.... ........++..|+|||.+.+..++.++|||||||+++||++|+.||.......... + .++..
T Consensus 166 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (353)
T cd07850 166 RTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS 242 (353)
T ss_pred eeCCC---CCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 76432 112234467889999999999999999999999999999999999986543211100 0 00000
Q ss_pred H-------Hhhc------CchhhhhccccC----CCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 722 T-------WQKK------GMLDQIMDSNLV----GKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 722 ~-------~~~~------~~~~~~~d~~l~----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
. .... ....++....+. ..........+.+++.+||+.||++||++.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 0000 000111111000 00112345678899999999999999999999865
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=302.56 Aligned_cols=258 Identities=16% Similarity=0.198 Sum_probs=183.6
Q ss_pred cCCCcceeeeeeceEEEEEEEEcC----CcEEEEEEcCCCChHhH-----------HHHHHHHHHHHhCCCCCcceEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLDD----GTKVAVKRGNPRSEQGI-----------AEFRTEIEMLSKLRHRHLVSLIGY 566 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~H~niv~l~g~ 566 (845)
++|.+.++||+|+||.||+|...+ +..+++|.......... .....+...+..+.|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 578889999999999999999764 34566665332221110 112234445566789999999997
Q ss_pred EecCC----cEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCce
Q 003139 567 CDERS----EMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVA 642 (845)
Q Consensus 567 ~~~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~ 642 (845)
+.... ..++++|++. .++.+.+.. ....++..+..|+.|+++||+|||+ .+|+||||||+|||++.++.+
T Consensus 92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLV-ENTKEIFKR--IKCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred eeEecCCceEEEEEEehhc-cCHHHHHHh--hccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCcE
Confidence 75443 3467777663 355554432 2346788899999999999999998 899999999999999999999
Q ss_pred EEEeccccCCCCCCCC-----cccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHH
Q 003139 643 KVADFGLSKTGPALDQ-----THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIA 717 (845)
Q Consensus 643 kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~ 717 (845)
||+|||+++....... ........||+.|+|||++.+..++.++|||||||+|+||++|+.||......... .
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~--~ 243 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL--I 243 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH--H
Confidence 9999999976432111 11122346999999999999999999999999999999999999999765322211 1
Q ss_pred HHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003139 718 EWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNL 774 (845)
Q Consensus 718 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L 774 (845)
.-. ..+.+..+....+ ..+..+..+.+++..|++.+|++||++.++++.|
T Consensus 244 ~~~----~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 244 HAA----KCDFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHh----HHHHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 000 0001111111111 1123457788999999999999999999998876
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=313.33 Aligned_cols=266 Identities=25% Similarity=0.330 Sum_probs=198.3
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhC-CCCCcceEEEEEecC--CcEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDER--SEMI 574 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~--~~~~ 574 (845)
.++|+..+.||+|+||.||+|... +|+.+|+|++... .......+.+|+.+++++ +||||++++++|... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 456788889999999999999976 5788999987542 334456678899999999 999999999998543 4689
Q ss_pred EEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCC
Q 003139 575 LVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGP 654 (845)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~ 654 (845)
+||||++ ++|..++... .++|..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++...
T Consensus 86 lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158 (337)
T ss_pred EEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence 9999997 5888887543 68899999999999999999998 899999999999999999999999999998643
Q ss_pred CCCCc---ccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHH--------H
Q 003139 655 ALDQT---HVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAM--------T 722 (845)
Q Consensus 655 ~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~--------~ 722 (845)
..... .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||......+......... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE 238 (337)
T ss_pred cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 32211 12234568899999998765 567899999999999999999999986543322110000000 0
Q ss_pred HhhcCchhhhhccccC------CCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 723 WQKKGMLDQIMDSNLV------GKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 723 ~~~~~~~~~~~d~~l~------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.........+++.... ....+.....+.+++.+||+.+|.+||++.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000001111110000 01112245678999999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=317.65 Aligned_cols=242 Identities=26% Similarity=0.431 Sum_probs=190.2
Q ss_pred eeeeeceEEEEEEEEc-CCcEEE---EEEcC-CCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCc--EEEEEEecc
Q 003139 509 LLGVGGFGRVYKGTLD-DGTKVA---VKRGN-PRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSE--MILVYEYMA 581 (845)
Q Consensus 509 ~LG~G~fg~Vy~~~~~-~g~~va---vK~~~-~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~--~~lV~Ey~~ 581 (845)
+||+|+|-+||||... +|..|| ||.-+ ..+....++|..|+.+|+.|+||||++++.++.+... +-+|.|.|.
T Consensus 47 vLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~T 126 (632)
T KOG0584|consen 47 VLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFT 126 (632)
T ss_pred hcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeeccc
Confidence 6999999999999875 465555 33211 2355667899999999999999999999998866554 789999999
Q ss_pred CCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECC-CCceEEEeccccCCCCCCCCcc
Q 003139 582 NGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDD-NFVAKVADFGLSKTGPALDQTH 660 (845)
Q Consensus 582 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~-~~~~kl~DFGla~~~~~~~~~~ 660 (845)
.|+|+.|+... ..++.+.+..||+||++||.|||+.. ++|||||||-+||+|+. -|.+||+|+|||..... .
T Consensus 127 SGtLr~Y~kk~--~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~---s- 199 (632)
T KOG0584|consen 127 SGTLREYRKKH--RRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK---S- 199 (632)
T ss_pred CCcHHHHHHHh--ccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc---c-
Confidence 99999999544 46889999999999999999999844 78999999999999985 58999999999987332 2
Q ss_pred cccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCC
Q 003139 661 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGK 740 (845)
Q Consensus 661 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 740 (845)
....+.|||.|||||.+. ..|++.+||||||++|+||+|+.-|+..-. +.++ +.+....|.....+.
T Consensus 200 ~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~-----n~AQ-IYKKV~SGiKP~sl~------ 266 (632)
T KOG0584|consen 200 HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT-----NPAQ-IYKKVTSGIKPAALS------ 266 (632)
T ss_pred ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC-----CHHH-HHHHHHcCCCHHHhh------
Confidence 234588999999999988 789999999999999999999999885322 2221 112222222111111
Q ss_pred CCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 741 VNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 741 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.-...++.++|.+||.. ..+|||+.|+|..
T Consensus 267 --kV~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 267 --KVKDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred --ccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 11134678999999999 9999999999865
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=302.89 Aligned_cols=260 Identities=22% Similarity=0.287 Sum_probs=200.0
Q ss_pred CCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCCh--HhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEec
Q 003139 504 FDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSE--QGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYM 580 (845)
Q Consensus 504 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 580 (845)
|+..+.||+|++|.||++... +++.+++|++..... .....+.+|++++++++|+||+++++++..+...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456678999999999999875 688999998765432 34567889999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcc
Q 003139 581 ANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH 660 (845)
Q Consensus 581 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 660 (845)
++ +|.+++.... ..+++.+++.++.|++.||.|||+ .+|+|+||||+||++++++.+||+|||.+....... .
T Consensus 81 ~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~ 153 (283)
T cd05118 81 DT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--R 153 (283)
T ss_pred CC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--c
Confidence 75 8887775533 579999999999999999999998 899999999999999999999999999997644322 1
Q ss_pred cccccccCCCcCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcC---chhhhh---
Q 003139 661 VSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKG---MLDQIM--- 733 (845)
Q Consensus 661 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~~~~--- 733 (845)
......++..|+|||.+.+. .++.++||||||+++|||++|+.||......+.. .-........ ....+.
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQL---FKIFRTLGTPDPEVWPKFTSLA 230 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHcCCCchHhcccchhhh
Confidence 22334577889999998876 7899999999999999999999998654332211 0000000000 000000
Q ss_pred --------cccc--CCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 734 --------DSNL--VGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 734 --------d~~l--~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
+... .....+.....+.+++.+||+.+|.+||++++++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000 001123456789999999999999999999999753
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=304.38 Aligned_cols=253 Identities=24% Similarity=0.349 Sum_probs=195.0
Q ss_pred cCCCcceeeeeeceEEEEEEEEcC-CcEEEEEEcCCCC-hHhHHHHHHHHHHHHhCC-CCCcceEEEEEecCCcEEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLDD-GTKVAVKRGNPRS-EQGIAEFRTEIEMLSKLR-HRHLVSLIGYCDERSEMILVYE 578 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 578 (845)
++|+..+.||+|+||.||+|..++ ++.+|||.+.... .....++..|+.++.+.+ |+||++++++|.+....++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 457788899999999999999874 8899999876542 334566777888777775 9999999999999999999999
Q ss_pred eccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCC
Q 003139 579 YMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQ 658 (845)
Q Consensus 579 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~ 658 (845)
|++ ++|.+++... ...+++..+..++.|+++||+|||+ .++|+||||+|+||++++++.+||+|||++.....
T Consensus 95 ~~~-~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~--- 167 (296)
T cd06618 95 LMS-TCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD--- 167 (296)
T ss_pred ccC-cCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccC---
Confidence 985 4666655432 2478999999999999999999996 25899999999999999999999999999875322
Q ss_pred cccccccccCCCcCChhhhccCC----CCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhc
Q 003139 659 THVSTAVKGSFGYLDPEYFRRQQ----LTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMD 734 (845)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (845)
........++..|+|||.+.+.. ++.++||||||+++|||++|+.||....... +... .+++
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~~---------~~~~ 233 (296)
T cd06618 168 SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-----EVLT---------KILQ 233 (296)
T ss_pred CCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-----HHHH---------HHhc
Confidence 11122345778999999987554 8899999999999999999999985422110 1111 1111
Q ss_pred cccCC-CCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 735 SNLVG-KVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 735 ~~l~~-~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
..... .........+.+++.+||+.+|.+||++.+++++..
T Consensus 234 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 275 (296)
T cd06618 234 EEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275 (296)
T ss_pred CCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 11100 011134567899999999999999999999987744
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=306.46 Aligned_cols=265 Identities=27% Similarity=0.309 Sum_probs=196.5
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC--hHhHHHHHHHHHHHHhCCCCCcceEEEEEecC--CcEEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS--EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDER--SEMIL 575 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 575 (845)
.++|+..+.||+|+||.||+|... +|+.||+|++.... ......+.+|++++++++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 357888999999999999999975 68999999875432 22223567899999999999999999998654 56899
Q ss_pred EEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCC
Q 003139 576 VYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPA 655 (845)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~ 655 (845)
||||++ ++|.+++.... ..+++.++..++.|+++||+|||+ .+++||||||+||++++++.+||+|||+++....
T Consensus 86 v~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 86 VMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 999996 47887775432 578999999999999999999999 8999999999999999999999999999976433
Q ss_pred CCCcccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCc---hhh
Q 003139 656 LDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGM---LDQ 731 (845)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~ 731 (845)
.. .......++..|+|||.+.+ ..++.++|||||||++|||++|++||......+... -......... ...
T Consensus 161 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~---~~~~~~~~~~~~~~~~ 235 (309)
T cd07845 161 PA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLD---LIIQLLGTPNESIWPG 235 (309)
T ss_pred cc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHhcCCCChhhchh
Confidence 21 11223345788999999865 567999999999999999999999997544322111 0011000000 000
Q ss_pred hhc------cccCCC----C---CHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 732 IMD------SNLVGK----V---NPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 732 ~~d------~~l~~~----~---~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
+.+ -.+... . .......+.+++.+|++.||++|||+.+++.+-.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~ 292 (309)
T cd07845 236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSY 292 (309)
T ss_pred hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 000 000000 0 0113456789999999999999999999986533
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=302.43 Aligned_cols=244 Identities=21% Similarity=0.348 Sum_probs=198.0
Q ss_pred eeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEeccCCCcc
Q 003139 508 LLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLR 586 (845)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 586 (845)
..||+|+||.||++... +++.+|+|++........+.+.+|+.++++++|+|++++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 46999999999999875 68899999887666566678999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcccccccc
Q 003139 587 SHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVK 666 (845)
Q Consensus 587 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 666 (845)
+++.. ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||++...... ........
T Consensus 106 ~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~--~~~~~~~~ 177 (292)
T cd06657 106 DIVTH---TRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKSLV 177 (292)
T ss_pred HHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceecccc--cccccccc
Confidence 88743 358999999999999999999999 89999999999999999999999999998754321 11123456
Q ss_pred cCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCCHHHH
Q 003139 667 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASL 746 (845)
Q Consensus 667 gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 746 (845)
|+..|+|||.+.+..++.++|+||||+++|||++|+.||......+. .. .... ...+.+. ......
T Consensus 178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~---~~----~~~~-----~~~~~~~--~~~~~~ 243 (292)
T cd06657 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---MK----MIRD-----NLPPKLK--NLHKVS 243 (292)
T ss_pred cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HH----HHHh-----hCCcccC--CcccCC
Confidence 88999999999888899999999999999999999999864322111 00 0000 0111110 112234
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 747 KKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 747 ~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
..+.+++.+||+.+|.+||++.+++.+
T Consensus 244 ~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 244 PSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred HHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 567889999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=306.51 Aligned_cols=263 Identities=22% Similarity=0.310 Sum_probs=196.3
Q ss_pred eeeee--ceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEeccCC
Q 003139 509 LLGVG--GFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANG 583 (845)
Q Consensus 509 ~LG~G--~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 583 (845)
.||+| +||.||+++.. +|+.||+|..... .....+.+.+|+.+++.++||||+++++++..++..++|+||++++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 89999999875 7899999987643 3445578899999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcc---
Q 003139 584 PLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH--- 660 (845)
Q Consensus 584 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~--- 660 (845)
+|.+++.......+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+|++||+.+..........
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 99998876544568999999999999999999998 899999999999999999999999998653321111100
Q ss_pred --cccccccCCCcCChhhhccC--CCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHH--------------
Q 003139 661 --VSTAVKGSFGYLDPEYFRRQ--QLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMT-------------- 722 (845)
Q Consensus 661 --~~~~~~gt~~y~aPE~~~~~--~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~-------------- 722 (845)
......++..|+|||++.+. .++.++|||||||+++||++|+.||........ +......
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDITTFPCE 239 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCccccccchh
Confidence 01112345679999999764 578999999999999999999999965432211 0000000
Q ss_pred --H-------hh---------cCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003139 723 --W-------QK---------KGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEY 776 (845)
Q Consensus 723 --~-------~~---------~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~ 776 (845)
. .. ......+.+..+...........+.+++.+||+.+|++|||+.+++++-..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~ 311 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFF 311 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHH
Confidence 0 00 000001111111112233456788999999999999999999999877554
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=314.89 Aligned_cols=267 Identities=26% Similarity=0.367 Sum_probs=207.2
Q ss_pred ceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC-hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCC------cEEEEEE
Q 003139 507 SLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS-EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERS------EMILVYE 578 (845)
Q Consensus 507 ~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~~lV~E 578 (845)
.+.||+|+||.||+|+++ .|+.||||.++... ....+...+|+++|++++|+|||++.+.-++.. ...+|||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 347999999999999965 79999999887643 344567789999999999999999998865543 6789999
Q ss_pred eccCCCccccccCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEEC----CCCceEEEeccccCCC
Q 003139 579 YMANGPLRSHLYGT-DLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLD----DNFVAKVADFGLSKTG 653 (845)
Q Consensus 579 y~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~----~~~~~kl~DFGla~~~ 653 (845)
||.+|+|+..|... +...|++.+.+.++.+++.||.|||+ ++|+||||||.||++- ..-.-||+|||.||..
T Consensus 98 yC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel 174 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL 174 (732)
T ss_pred ecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence 99999999999765 34579999999999999999999998 9999999999999993 3335799999999984
Q ss_pred CCCCCcccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhh
Q 003139 654 PALDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQI 732 (845)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (845)
+ +........||..|++||.+.. +.|+..+|.|||||++||..||..||.+........-..|.....+...+.-.
T Consensus 175 ~---d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~ 251 (732)
T KOG4250|consen 175 D---DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIG 251 (732)
T ss_pred C---CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEe
Confidence 4 4446778999999999999985 88999999999999999999999999765544322222333222221111111
Q ss_pred hccccCC------------CCCHHHHHHHHHHHHHhhhhCCCCCC--CHHHHHHHHHHhhh
Q 003139 733 MDSNLVG------------KVNPASLKKFGETAEKCLAEHGVDRP--SMGDVLWNLEYALQ 779 (845)
Q Consensus 733 ~d~~l~~------------~~~~~~~~~l~~l~~~cl~~~p~~RP--s~~~vl~~L~~~~~ 779 (845)
.++...+ ...+.....+-..+..++..+|++|- ...+.-..+..+++
T Consensus 252 ~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 252 AQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred eecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 1222221 12345566677788888999999998 66666666666654
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=295.26 Aligned_cols=249 Identities=19% Similarity=0.228 Sum_probs=192.9
Q ss_pred HHHHHHhcCCCcceee--eeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhC-CCCCcceEEEEEecC
Q 003139 495 QEILDATNKFDESLLL--GVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDER 570 (845)
Q Consensus 495 ~el~~at~~f~~~~~L--G~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 570 (845)
.++....++|+..+.+ |+|+||.||++..+ ++..+++|.......... |+.....+ +|||++++++++...
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecC
Confidence 4445555677776666 99999999999865 678899998654321111 22222222 799999999999999
Q ss_pred CcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCC-ceEEEeccc
Q 003139 571 SEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNF-VAKVADFGL 649 (845)
Q Consensus 571 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~-~~kl~DFGl 649 (845)
+..++||||+++++|.+++... ..++|.++..++.|+++||.|||+ .+++||||||+||+++.++ .++|+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~ 156 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGL 156 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence 9999999999999999998654 379999999999999999999999 8999999999999999988 999999999
Q ss_pred cCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCch
Q 003139 650 SKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGML 729 (845)
Q Consensus 650 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 729 (845)
++.... .....++..|+|||++.+..++.++||||||++++||++|+.||..... +......|....
T Consensus 157 ~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~------ 223 (267)
T PHA03390 157 CKIIGT------PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED-EELDLESLLKRQ------ 223 (267)
T ss_pred ceecCC------CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc-chhhHHHHHHhh------
Confidence 875332 1234678899999999999999999999999999999999999974322 222222222211
Q ss_pred hhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCC-HHHHHH
Q 003139 730 DQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPS-MGDVLW 772 (845)
Q Consensus 730 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-~~~vl~ 772 (845)
.... .........+.+++.+||+.+|.+||+ ++++++
T Consensus 224 ----~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 224 ----QKKL--PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ----cccC--CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0000 112245567889999999999999996 688874
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=302.74 Aligned_cols=249 Identities=27% Similarity=0.350 Sum_probs=196.7
Q ss_pred CCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCC---CChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEE
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNP---RSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYE 578 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 578 (845)
.|+..+.||+|+||.||+|+.. +++.+++|.... ......+++.+|+++++.++|+|++++++++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3556678999999999999975 578899998653 233445678899999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCC
Q 003139 579 YMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQ 658 (845)
Q Consensus 579 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~ 658 (845)
|+. |+|.+.+.... .++++.++..++.|++.||.|||+ .+++||||||+|||+++++.+||+|||++.....
T Consensus 96 ~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~--- 167 (308)
T cd06634 96 YCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--- 167 (308)
T ss_pred ccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecC---
Confidence 996 67777664332 468999999999999999999998 8999999999999999999999999999875322
Q ss_pred cccccccccCCCcCChhhhc---cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcc
Q 003139 659 THVSTAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDS 735 (845)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (845)
.....++..|+|||.+. ...++.++|||||||++|||++|+.|+......+ ........ .
T Consensus 168 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~-~------- 230 (308)
T cd06634 168 ---ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQN-E------- 230 (308)
T ss_pred ---cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH------HHHHHhhc-C-------
Confidence 12345788999999974 3568899999999999999999999985432211 11111111 0
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 003139 736 NLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYA 777 (845)
Q Consensus 736 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~ 777 (845)
............+.+++.+||+.+|++||++.+++......
T Consensus 231 -~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~ 271 (308)
T cd06634 231 -SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271 (308)
T ss_pred -CCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccc
Confidence 00111224556788999999999999999999998775433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=311.65 Aligned_cols=262 Identities=23% Similarity=0.310 Sum_probs=198.3
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecC-----Cc
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDER-----SE 572 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 572 (845)
.++|...+.||+|+||.||+|+.. +++.||+|++... ......++.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457888999999999999999865 6889999987643 233345678899999999999999999988544 35
Q ss_pred EEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCC
Q 003139 573 MILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKT 652 (845)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~ 652 (845)
.++|+||+. ++|.+++... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 899999995 6888887543 469999999999999999999998 8999999999999999999999999999986
Q ss_pred CCCCCCcccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHh-------
Q 003139 653 GPALDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQ------- 724 (845)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~------- 724 (845)
..... .......++..|+|||.+.. ..++.++|||||||++|||++|++||......+.. .......
T Consensus 158 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~ 232 (337)
T cd07858 158 TSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQL---KLITELLGSPSEED 232 (337)
T ss_pred cCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHH---HHHHHHhCCCChHH
Confidence 43211 22234467889999998865 56899999999999999999999998653221110 0000000
Q ss_pred ----hcCchhhhhccccC------CCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 725 ----KKGMLDQIMDSNLV------GKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 725 ----~~~~~~~~~d~~l~------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
......+.++.... ....+.....+.+++.+||+.+|++||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 233 LGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 00001111100000 00112345678899999999999999999999987
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=304.60 Aligned_cols=261 Identities=22% Similarity=0.212 Sum_probs=194.5
Q ss_pred eeeeeceEEEEEEEEcCCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEeccCCCcc
Q 003139 509 LLGVGGFGRVYKGTLDDGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLR 586 (845)
Q Consensus 509 ~LG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 586 (845)
.+|.|+++.||++.. +++.+|+|++... .....+.+.+|++++++++|+||+++++++.+.+..+++|||+++|+|.
T Consensus 9 ~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 87 (314)
T cd08216 9 CFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE 87 (314)
T ss_pred hhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHH
Confidence 345556666666655 5899999987644 4556678999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCC-----ccc
Q 003139 587 SHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQ-----THV 661 (845)
Q Consensus 587 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~-----~~~ 661 (845)
+++.......+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||.+........ ...
T Consensus 88 ~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~ 164 (314)
T cd08216 88 DLLKTHFPEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF 164 (314)
T ss_pred HHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccc
Confidence 99876544568999999999999999999998 8999999999999999999999999999865332111 111
Q ss_pred ccccccCCCcCChhhhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHH----hhcC-------c
Q 003139 662 STAVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTW----QKKG-------M 728 (845)
Q Consensus 662 ~~~~~gt~~y~aPE~~~~--~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~----~~~~-------~ 728 (845)
.....++..|+|||.+.. ..++.++|||||||++|||++|+.||........ +.+..... .... .
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 242 (314)
T cd08216 165 PKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTYPLYEDS 242 (314)
T ss_pred cccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCchhhhcCC
Confidence 223456788999999876 4588999999999999999999999975432211 11100000 0000 0
Q ss_pred hhh----hhcccc----CCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 729 LDQ----IMDSNL----VGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 729 ~~~----~~d~~l----~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
... ..++.. ...........+.+++.+||+.+|++|||+.+++++-.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~ 297 (314)
T cd08216 243 MSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF 297 (314)
T ss_pred cCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCch
Confidence 000 000000 00112334567889999999999999999999987644
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=295.42 Aligned_cols=242 Identities=22% Similarity=0.270 Sum_probs=188.8
Q ss_pred eeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC---hHhHHHHHHHHHHH-HhCCCCCcceEEEEEecCCcEEEEEEeccC
Q 003139 508 LLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS---EQGIAEFRTEIEML-SKLRHRHLVSLIGYCDERSEMILVYEYMAN 582 (845)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l-~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 582 (845)
+.||+|+||.||+|... +|+.+|+|...... ......+..|..++ ...+|+|++++++++.+++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999875 68899999876543 22233445555544 455899999999999999999999999999
Q ss_pred CCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcccc
Q 003139 583 GPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVS 662 (845)
Q Consensus 583 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 662 (845)
++|.+++... ..+++..+..++.|++.||.|||+ .+++||||+|+||++++++.+||+|||+++.... .
T Consensus 82 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~ 150 (260)
T cd05611 82 GDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------N 150 (260)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc------c
Confidence 9999998543 468899999999999999999999 8999999999999999999999999999875322 2
Q ss_pred cccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCC
Q 003139 663 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVN 742 (845)
Q Consensus 663 ~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 742 (845)
....++..|+|||.+.+..++.++||||||++++||++|..||......+ .... ...+.. .......
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~-~~~~~~------~~~~~~~ 217 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA------VFDN-ILSRRI------NWPEEVK 217 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH------HHHH-HHhccc------CCCCccc
Confidence 23457889999999998889999999999999999999999996433211 1111 011000 0011112
Q ss_pred HHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 743 PASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 743 ~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
..++..+.+++.+||+.+|++||++.++.+.
T Consensus 218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~ 248 (260)
T cd05611 218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEI 248 (260)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCCCcHHHH
Confidence 2345778999999999999999977655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=311.56 Aligned_cols=266 Identities=18% Similarity=0.273 Sum_probs=200.9
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC--hHhHHHHHHHHHHHHhCCCCCcceEEEEEe----cCCcE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS--EQGIAEFRTEIEMLSKLRHRHLVSLIGYCD----ERSEM 573 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~----~~~~~ 573 (845)
..+|+..+.||+|+||.||+|... +|+.|++|++.... ....+.+.+|+.++++++||||+++.+++. .....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 367888899999999999999865 68999999876542 234567788999999999999999998875 33568
Q ss_pred EEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCC
Q 003139 574 ILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTG 653 (845)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~ 653 (845)
++||||+. ++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 99999995 6898888543 458999999999999999999998 89999999999999999999999999999764
Q ss_pred CCCCC--cccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhh-----
Q 003139 654 PALDQ--THVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQK----- 725 (845)
Q Consensus 654 ~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~----- 725 (845)
..... ........++..|+|||.+.+ ..++.++|||||||++|||++|+.||......... ........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~---~~~~~~~g~~~~~ 234 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQL---KLILSVLGSPSEE 234 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHH---HHHHHHhCCChhH
Confidence 32221 111234568889999999865 56899999999999999999999999654332211 11111000
Q ss_pred ------cCchhhhhccc-cCCC-----CCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 726 ------KGMLDQIMDSN-LVGK-----VNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 726 ------~~~~~~~~d~~-l~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
...+.+..+.. .... ..+.....+.+++.+||+.+|++||++.+++.+-.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~ 296 (334)
T cd07855 235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPF 296 (334)
T ss_pred hhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChh
Confidence 00111111100 0000 11234677899999999999999999999987644
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=300.92 Aligned_cols=244 Identities=27% Similarity=0.376 Sum_probs=193.6
Q ss_pred CCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 504 FDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 504 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
|...+.||+|+||.||+|+.. +|+.+++|++... .....+++.+|++++++++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 455567999999999999875 6889999987543 334456788999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCc
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT 659 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~ 659 (845)
+. |+|.+++... ..++++.+++.++.|++.||.|||+ .+++||||||+||++++++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---- 173 (313)
T cd06633 103 CL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---- 173 (313)
T ss_pred CC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence 96 5777666433 3468999999999999999999998 8999999999999999999999999999864221
Q ss_pred ccccccccCCCcCChhhhc---cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccc
Q 003139 660 HVSTAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSN 736 (845)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (845)
.....|+..|+|||++. ...++.++|||||||++|||++|++|+....... .........
T Consensus 174 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~------~~~~~~~~~--------- 236 (313)
T cd06633 174 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQND--------- 236 (313)
T ss_pred --CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHHhcC---------
Confidence 12356788999999984 4678999999999999999999999986543211 111111110
Q ss_pred cCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 737 LVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 737 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
............+.+++.+||+.+|.+||++.+++..
T Consensus 237 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 237 SPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011112234568899999999999999999999865
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=287.73 Aligned_cols=240 Identities=26% Similarity=0.332 Sum_probs=199.6
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
++|+..++||+|.||+|-+++-+ .|+.+|+|++++. ...+...-+.|-++|+..+||.+..|-..+...+.+|+||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 56888899999999999999855 7889999987764 3445566788999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
||..||.|.-+|... ..+++....-+-..|..||.|||+ .+||.||||.+|.|||++|++||+||||++....
T Consensus 248 eyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~-- 320 (516)
T KOG0690|consen 248 EYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK-- 320 (516)
T ss_pred EEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhccc--
Confidence 999999999998543 468888888899999999999999 9999999999999999999999999999986432
Q ss_pred CcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcccc
Q 003139 658 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNL 737 (845)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (845)
........+||+.|+|||++....|..++|.|.+||+||||+|||.||.......-..+ ++-..+
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeL---------------Il~ed~ 385 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFEL---------------ILMEDL 385 (516)
T ss_pred ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHH---------------HHhhhc
Confidence 33345678999999999999999999999999999999999999999975433221111 111111
Q ss_pred CCCCCHHHHHHHHHHHHHhhhhCCCCCC
Q 003139 738 VGKVNPASLKKFGETAEKCLAEHGVDRP 765 (845)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~cl~~~p~~RP 765 (845)
.++.....+...|+...|.+||.+|.
T Consensus 386 --kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 386 --KFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred --cCCccCCHHHHHHHHHHhhcChHhhc
Confidence 24444555667788889999999995
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=299.66 Aligned_cols=263 Identities=24% Similarity=0.327 Sum_probs=196.9
Q ss_pred CCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCCh-HhHHHHHHHHHHHHhCC-CCCcceEEEEEecCCcEEEEEEec
Q 003139 504 FDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSE-QGIAEFRTEIEMLSKLR-HRHLVSLIGYCDERSEMILVYEYM 580 (845)
Q Consensus 504 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~ 580 (845)
|+..+.||+|++|.||+|+.. +++.+++|++..... .......+|+..+++++ |+|++++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 456778999999999999976 578899998765422 22234457999999999 999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcc
Q 003139 581 ANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH 660 (845)
Q Consensus 581 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 660 (845)
+|+|.+++.......+++.+++.++.|++.+|.|||+ .+++|+||+|+||++++++.++|+|||+++.... ..
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~---~~ 153 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRS---RP 153 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccC---CC
Confidence 8899988866554578999999999999999999998 8999999999999999999999999999976332 11
Q ss_pred cccccccCCCcCChhhhc-cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCccccc----------HHHHHHHHhhcCch
Q 003139 661 VSTAVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVN----------IAEWAMTWQKKGML 729 (845)
Q Consensus 661 ~~~~~~gt~~y~aPE~~~-~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~----------l~~~~~~~~~~~~~ 729 (845)
......++..|+|||.+. ...++.++|+||||++++||++|++||......+... -..|..........
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07830 154 PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233 (283)
T ss_pred CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence 123345788999999875 4568999999999999999999999986543322110 00011110000000
Q ss_pred hhhhcccc---CCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 730 DQIMDSNL---VGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 730 ~~~~d~~l---~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
...+.... .....+.....+.+++.+||+.+|++||++.|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00000000 000111124678899999999999999999998754
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=296.06 Aligned_cols=242 Identities=21% Similarity=0.284 Sum_probs=187.6
Q ss_pred eeeeeceEEEEEEEEc-CCcEEEEEEcCCCC---hHhHHHHHHHHH---HHHhCCCCCcceEEEEEecCCcEEEEEEecc
Q 003139 509 LLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS---EQGIAEFRTEIE---MLSKLRHRHLVSLIGYCDERSEMILVYEYMA 581 (845)
Q Consensus 509 ~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~---~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 581 (845)
+||+|+||.||++... +++.||+|.+.... ......+..|.. .++...||||+++.+++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999865 58899999875432 122223444443 4445679999999999999999999999999
Q ss_pred CCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCccc
Q 003139 582 NGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHV 661 (845)
Q Consensus 582 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 661 (845)
+++|..++... ..+++.++..++.|+++||+|||+ .+|+||||||+||++++++.+||+|||+++..... .
T Consensus 81 g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~----~ 151 (278)
T cd05606 81 GGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----K 151 (278)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc----C
Confidence 99999888543 479999999999999999999998 89999999999999999999999999998753221 1
Q ss_pred ccccccCCCcCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCC
Q 003139 662 STAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGK 740 (845)
Q Consensus 662 ~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 740 (845)
.....|+..|+|||.+.++ .++.++||||+||+++||++|+.||........... ..... ..+ ..
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~------~~~----~~ 217 (278)
T cd05606 152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTL------TMA----VE 217 (278)
T ss_pred CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH----HHHhh------ccC----CC
Confidence 2234689999999998754 689999999999999999999999975432221110 00000 001 11
Q ss_pred CCHHHHHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 003139 741 VNPASLKKFGETAEKCLAEHGVDRP-----SMGDVLWN 773 (845)
Q Consensus 741 ~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~~ 773 (845)
.+......+.+++.+|+..+|.+|| ++.+++++
T Consensus 218 ~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 218 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 2233456788999999999999999 89898754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=308.65 Aligned_cols=260 Identities=22% Similarity=0.303 Sum_probs=193.0
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecC------C
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDER------S 571 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~ 571 (845)
.++|...+.||+|+||.||+|+.. +|+.+|+|++... .......+.+|++++++++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478999999999999999999865 6899999987643 223345688999999999999999999998654 3
Q ss_pred cEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccC
Q 003139 572 EMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSK 651 (845)
Q Consensus 572 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~ 651 (845)
..++|+||+.. +|..++ ...+++..+..++.|+++||+|||+ .+++||||||+|||+++++.+||+|||+++
T Consensus 94 ~~~lv~e~~~~-~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred eEEEEeccccc-CHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 46999999964 666554 2358999999999999999999998 899999999999999999999999999987
Q ss_pred CCCCCCCcccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHH--------HH
Q 003139 652 TGPALDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWA--------MT 722 (845)
Q Consensus 652 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~--------~~ 722 (845)
.... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||............... ..
T Consensus 166 ~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07879 166 HADA-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ 240 (342)
T ss_pred CCCC-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 6322 1223467889999999876 56899999999999999999999999754321111000000 00
Q ss_pred HhhcCchhhhhcc--cc-CCCC---CHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 723 WQKKGMLDQIMDS--NL-VGKV---NPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 723 ~~~~~~~~~~~d~--~l-~~~~---~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
...........+. .. .... .+.....+.+++.+||+.+|++||++.+++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred HhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000000000 00 0000 01234567899999999999999999999865
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=307.95 Aligned_cols=274 Identities=20% Similarity=0.270 Sum_probs=204.5
Q ss_pred ccccHHHHHHHhcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEE
Q 003139 490 RLFMFQEILDATNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGY 566 (845)
Q Consensus 490 ~~~~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~ 566 (845)
+.....++...+++|...+.||+|+||.||+|... +++.||+|++... .....+.+.+|++++++++||||+++.++
T Consensus 5 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~ 84 (345)
T cd07877 5 RQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84 (345)
T ss_pred hhhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeee
Confidence 45566788889999999999999999999999864 6889999987643 23335678899999999999999999998
Q ss_pred EecC------CcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCC
Q 003139 567 CDER------SEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNF 640 (845)
Q Consensus 567 ~~~~------~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~ 640 (845)
+... ...++++|++ +++|.+++.. ..+++..+..++.|+++||+|||+ .+|+||||||+||++++++
T Consensus 85 ~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~ 157 (345)
T cd07877 85 FTPARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDC 157 (345)
T ss_pred eeecccccccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCC
Confidence 8543 3468888887 7888887743 358999999999999999999999 8999999999999999999
Q ss_pred ceEEEeccccCCCCCCCCcccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHH-H
Q 003139 641 VAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIA-E 718 (845)
Q Consensus 641 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~-~ 718 (845)
.+||+|||+++.... ......++..|+|||.+.+ ..++.++|||||||+++||++|+.||............ .
T Consensus 158 ~~kl~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 232 (345)
T cd07877 158 ELKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 232 (345)
T ss_pred CEEEecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 999999999876322 1234567889999999876 57889999999999999999999998643322111000 0
Q ss_pred H-------HHHHhhcCchhhh---hccccCCC---CCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 719 W-------AMTWQKKGMLDQI---MDSNLVGK---VNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 719 ~-------~~~~~~~~~~~~~---~d~~l~~~---~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
+ ............. ++...... ........+.+++.+|++.+|.+||++.+++.+-.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 302 (345)
T cd07877 233 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 302 (345)
T ss_pred HhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChh
Confidence 0 0000000000000 00000000 00112456789999999999999999999987743
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=298.98 Aligned_cols=249 Identities=24% Similarity=0.357 Sum_probs=203.0
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhCC-CCCcceEEEEEecCCcEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLR-HRHLVSLIGYCDERSEMILV 576 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV 576 (845)
++|...+.||+|+||.||+|+.. +|+.+++|..... .....+.+..|++++++++ |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36788889999999999999976 6899999987642 2344567889999999998 99999999999999999999
Q ss_pred EEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCC
Q 003139 577 YEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPAL 656 (845)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~ 656 (845)
|||+++++|.+++... ..+++..++.|+.|++.||.|||+ .+++|+||||+||++++++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 81 LEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 9999999999998644 479999999999999999999998 89999999999999999999999999998764322
Q ss_pred CCc------------------ccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHH
Q 003139 657 DQT------------------HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAE 718 (845)
Q Consensus 657 ~~~------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~ 718 (845)
... .......++..|+|||.+....++.++||||||++++||++|+.|+....... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~-- 230 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL---T-- 230 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH---H--
Confidence 210 11223457889999999998889999999999999999999999986443111 0
Q ss_pred HHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCH----HHHHH
Q 003139 719 WAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSM----GDVLW 772 (845)
Q Consensus 719 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~----~~vl~ 772 (845)
...+.+ ....++...+..+.+++.+||+.+|.+||++ +++++
T Consensus 231 ----------~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 231 ----------FQKILK--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred ----------HHHHHh--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 111111 1112334446778999999999999999999 77654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=295.59 Aligned_cols=255 Identities=24% Similarity=0.266 Sum_probs=199.3
Q ss_pred CCCcceeeeeeceEEEEEEEEc----CCcEEEEEEcCCCC----hHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcE
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD----DGTKVAVKRGNPRS----EQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERSEM 573 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 573 (845)
+|+..+.||+|++|.||+++.. +++.+|+|.+.... ....+.+.+|++++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 3667789999999999999743 56789999875432 23346788999999999 599999999999999999
Q ss_pred EEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCC
Q 003139 574 ILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTG 653 (845)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~ 653 (845)
++||||+++|+|.+++... ..+++..+..++.|+++||+|||+ .+++||||||+||+++.++.++|+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 9999999999999988543 468999999999999999999998 89999999999999999999999999998764
Q ss_pred CCCCCcccccccccCCCcCChhhhccCC--CCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhh
Q 003139 654 PALDQTHVSTAVKGSFGYLDPEYFRRQQ--LTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQ 731 (845)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (845)
... .........|+..|+|||.+.+.. .+.++||||||++++||++|+.||...... ....++....
T Consensus 156 ~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--~~~~~~~~~~-------- 224 (288)
T cd05583 156 LAE-EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ--NSQSEISRRI-------- 224 (288)
T ss_pred ccc-cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc--chHHHHHHHH--------
Confidence 322 111122356889999999987665 789999999999999999999998532211 1111111111
Q ss_pred hhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003139 732 IMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEY 776 (845)
Q Consensus 732 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~ 776 (845)
... ....+......+.+++.+||+.+|++|||+.++.+.|+.
T Consensus 225 -~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 225 -LKS--KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred -Hcc--CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 110 111233345678899999999999999999888776553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=306.49 Aligned_cols=263 Identities=24% Similarity=0.322 Sum_probs=202.1
Q ss_pred CCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC--hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCC-----cEE
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS--EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERS-----EMI 574 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 574 (845)
+|+..+.||+|++|.||+|+.. .++.+++|++.... ....+.+.+|+++++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4777889999999999999976 48899999876543 344578899999999999999999999997765 789
Q ss_pred EEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCC
Q 003139 575 LVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGP 654 (845)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~ 654 (845)
+||||++ ++|.+++... .++++..++.++.|++.||+|||+ .+|+||||||+|||+++++.++|+|||++....
T Consensus 81 lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELME-TDLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchh-hhHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 9999997 5788887543 379999999999999999999999 899999999999999999999999999998644
Q ss_pred CCCC-cccccccccCCCcCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhh-------
Q 003139 655 ALDQ-THVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQK------- 725 (845)
Q Consensus 655 ~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~------- 725 (845)
.... ........++..|+|||.+.+. .++.++||||||++++||++|++||......+.. ........
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~ 231 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQL---NLIVEVLGTPSEEDL 231 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHH---HHHHHhcCCCChhHh
Confidence 3211 0112344678899999999887 8999999999999999999999999755432211 00100000
Q ss_pred ----cCchhhhhcc-ccC-----CCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003139 726 ----KGMLDQIMDS-NLV-----GKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNL 774 (845)
Q Consensus 726 ----~~~~~~~~d~-~l~-----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L 774 (845)
.......+.. ... ....+.....+.+++.+||+.+|++||++.+++.+-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 290 (330)
T cd07834 232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHP 290 (330)
T ss_pred hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCc
Confidence 0000111110 000 001122456788999999999999999999998763
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=296.83 Aligned_cols=252 Identities=23% Similarity=0.290 Sum_probs=196.3
Q ss_pred CCCcceeeeeeceEEEEEEEE----cCCcEEEEEEcCCCC----hHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcE
Q 003139 503 KFDESLLLGVGGFGRVYKGTL----DDGTKVAVKRGNPRS----EQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERSEM 573 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 573 (845)
+|+..+.||+|+||.||+++. .+|..+|+|++.... ....+.+.+|++++.++ +|+||+++.+++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 367788999999999999986 368899999876432 22346788899999999 599999999999999999
Q ss_pred EEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCC
Q 003139 574 ILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTG 653 (845)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~ 653 (845)
++||||+++++|.+++... ..+++..+..++.|+++||.|||+ .+++||||||+|||+++++.+||+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 81 HLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 9999999999999998644 468899999999999999999998 99999999999999999999999999999764
Q ss_pred CCCCCcccccccccCCCcCChhhhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhh
Q 003139 654 PALDQTHVSTAVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQ 731 (845)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (845)
.. ..........|+..|+|||.+.. ..++.++||||||+++|||++|+.|+...... .....+.......
T Consensus 156 ~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~----- 227 (290)
T cd05613 156 HE-DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRRILKS----- 227 (290)
T ss_pred cc-ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHHhhcc-----
Confidence 32 11112224568899999999875 34788999999999999999999998643221 1111111111110
Q ss_pred hhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 003139 732 IMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRP-----SMGDVLWN 773 (845)
Q Consensus 732 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~~ 773 (845)
....+......+.+++.+|++.+|++|| +..+++.+
T Consensus 228 ------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 228 ------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred ------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 0112334556788999999999999997 56666543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=303.76 Aligned_cols=248 Identities=25% Similarity=0.338 Sum_probs=207.7
Q ss_pred HhcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC--hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEE
Q 003139 500 ATNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS--EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILV 576 (845)
Q Consensus 500 at~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 576 (845)
..+.|.+.+.||+|.|+.|.+|++. .+..||+|.+++.. ....+.+.+|+++|+.++|||||+++.+......+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 3567888999999999999999975 68999999887653 33445688999999999999999999999999999999
Q ss_pred EEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCC
Q 003139 577 YEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPAL 656 (845)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~ 656 (845)
|||+.+|.+.++|.... .+.......+..|+.++++|||+ +.|+|||||++||||+.+.++||+|||++...
T Consensus 134 ~eya~~ge~~~yl~~~g--r~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~--- 205 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHG--RMKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFF--- 205 (596)
T ss_pred EEeccCchhHHHHHhcc--cchhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceee---
Confidence 99999999999996553 56668888999999999999999 99999999999999999999999999999763
Q ss_pred CCcccccccccCCCcCChhhhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcc
Q 003139 657 DQTHVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDS 735 (845)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (845)
+........+|++.|.|||++.+.++ .+++|+||+|++||-|++|..||++..-.+ +-++
T Consensus 206 ~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~-------------------Lr~r 266 (596)
T KOG0586|consen 206 DYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE-------------------LRPR 266 (596)
T ss_pred cccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc-------------------ccch
Confidence 34445567899999999999998776 589999999999999999999998643322 1112
Q ss_pred ccCCC--CCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003139 736 NLVGK--VNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNL 774 (845)
Q Consensus 736 ~l~~~--~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L 774 (845)
.+.+. ++.-....+.++++++|..+|.+|++++++.+.-
T Consensus 267 vl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~ 307 (596)
T KOG0586|consen 267 VLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDR 307 (596)
T ss_pred heeeeecccceeechhHHHHHHhhccCccccCCHHHhhhhc
Confidence 22222 2333445677899999999999999999987653
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=300.98 Aligned_cols=266 Identities=24% Similarity=0.312 Sum_probs=199.7
Q ss_pred HHHHHhcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEec-CC
Q 003139 496 EILDATNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDE-RS 571 (845)
Q Consensus 496 el~~at~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~ 571 (845)
++...+++|+..+.||+|+||.||++... +++.+|+|++... .....+.+..|++++++++||||+++.+++.. ..
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 34557789999999999999999999865 7889999986532 22344678899999999999999999998865 56
Q ss_pred cEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccC
Q 003139 572 EMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSK 651 (845)
Q Consensus 572 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~ 651 (845)
..++|+||+ +++|..++.. .++++.....++.|+++||+|||+ .+|+||||||+|||+++++.+||+|||+++
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred cEEEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 789999998 5688887743 357888899999999999999999 899999999999999999999999999987
Q ss_pred CCCCCCCcccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCccccc-H--------HHHHH
Q 003139 652 TGPALDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVN-I--------AEWAM 721 (845)
Q Consensus 652 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~-l--------~~~~~ 721 (845)
.... ......++..|+|||.+.+ ..++.++||||||++++||++|++||.......... + .+|..
T Consensus 157 ~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (328)
T cd07856 157 IQDP-----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN 231 (328)
T ss_pred ccCC-----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 5322 1123456788999998766 578999999999999999999999986543211100 0 01111
Q ss_pred HHhhcCchhhhhccccCCCCC-----HHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 722 TWQKKGMLDQIMDSNLVGKVN-----PASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 722 ~~~~~~~~~~~~d~~l~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
..........+.........+ +.....+.+++.+||+.+|++||++.+++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 111111111111101111111 1234678899999999999999999998755
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=291.73 Aligned_cols=249 Identities=26% Similarity=0.362 Sum_probs=194.4
Q ss_pred CCCcceeeeeeceEEEEEEEEcC-CcEEEEEEcCC-----CChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEE
Q 003139 503 KFDESLLLGVGGFGRVYKGTLDD-GTKVAVKRGNP-----RSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILV 576 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~-----~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 576 (845)
+|.+.+.||+|+||.||+++... +..+++|.... .......++..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47778899999999999998653 34444444332 1223344677899999999999999999999999999999
Q ss_pred EEeccCCCccccccC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCC
Q 003139 577 YEYMANGPLRSHLYG--TDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGP 654 (845)
Q Consensus 577 ~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~ 654 (845)
|||+++++|.+++.. .....+++.+++.++.|++.||.|||+ .+++|+||||+||++++ +.+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999988753 234579999999999999999999998 99999999999999986 469999999987643
Q ss_pred CCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhc
Q 003139 655 ALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMD 734 (845)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (845)
.. ........|+..|+|||.+.+..++.++|+||||+++|||++|+.|+..... ....... ..
T Consensus 157 ~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~~~---------~~ 219 (260)
T cd08222 157 GS--CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVVLRI---------VE 219 (260)
T ss_pred CC--cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHH---------Hc
Confidence 21 1222345678899999999888899999999999999999999999853221 1111111 11
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 735 SNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 735 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
......+......+.+++.+||+.+|++||++.++++.
T Consensus 220 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 220 -GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred -CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 01112234556788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=299.59 Aligned_cols=268 Identities=25% Similarity=0.291 Sum_probs=193.8
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC--hHhHHHHHHHHHHHHhCCCCCcceEEEEEecC-------
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS--EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDER------- 570 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------- 570 (845)
.++|+..+.||+|+||.||+|... +++.+++|++.... ......+.+|++++++++|+||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 467899999999999999999976 68899999865432 22234667899999999999999999987443
Q ss_pred -CcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccc
Q 003139 571 -SEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGL 649 (845)
Q Consensus 571 -~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGl 649 (845)
...++|+||+++ +|...+... ...+++.++..++.|+++||+|||+ .+|+||||||+||++++++.+||+|||+
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCcc
Confidence 346999999964 666666433 3469999999999999999999998 8999999999999999999999999999
Q ss_pred cCCCCCCCCc---------ccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHH
Q 003139 650 SKTGPALDQT---------HVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEW 719 (845)
Q Consensus 650 a~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~ 719 (845)
++........ ...+...+++.|+|||.+.+ ..++.++|||||||+++||++|++||..............
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9753321111 11233467888999998765 4589999999999999999999999865443221111000
Q ss_pred HHHHhhc------CchhhhhccccCCCCC-------HHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 720 AMTWQKK------GMLDQIMDSNLVGKVN-------PASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 720 ~~~~~~~------~~~~~~~d~~l~~~~~-------~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
....... ..+....+.......+ ......+.+++.+||+.+|++|||+.+++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 0000000 0000000000000011 1123568899999999999999999998753
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=301.58 Aligned_cols=264 Identities=20% Similarity=0.246 Sum_probs=194.6
Q ss_pred CCC-cceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHh--------------HHHHHHHHHHHHhCCCCCcceEEEE
Q 003139 503 KFD-ESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQG--------------IAEFRTEIEMLSKLRHRHLVSLIGY 566 (845)
Q Consensus 503 ~f~-~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~H~niv~l~g~ 566 (845)
+|. ..+.||+|+||.||+|... +++.||+|+........ ...+.+|++++++++|+||++++++
T Consensus 9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (335)
T PTZ00024 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV 88 (335)
T ss_pred chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence 443 3457999999999999865 68899999865432111 1257789999999999999999999
Q ss_pred EecCCcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEe
Q 003139 567 CDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVAD 646 (845)
Q Consensus 567 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~D 646 (845)
+...+..++||||++ |+|.+++.. ...+++.....++.|++.||+|||+ .+++||||||+||+++.++.+||+|
T Consensus 89 ~~~~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~d 162 (335)
T PTZ00024 89 YVEGDFINLVMDIMA-SDLKKVVDR--KIRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIAD 162 (335)
T ss_pred EecCCcEEEEEeccc-cCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEECC
Confidence 999999999999996 688888853 3468999999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCC------------CcccccccccCCCcCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCccc
Q 003139 647 FGLSKTGPALD------------QTHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQ 713 (845)
Q Consensus 647 FGla~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~ 713 (845)
||+++...... .........++..|+|||.+.+. .++.++|||||||++|||++|++||......+.
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~ 242 (335)
T PTZ00024 163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ 242 (335)
T ss_pred ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99987543100 01111233467889999998764 479999999999999999999999875433221
Q ss_pred ccHHHHHHHHhhcCchhhhhc-----------ccc---CCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 714 VNIAEWAMTWQKKGMLDQIMD-----------SNL---VGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 714 ~~l~~~~~~~~~~~~~~~~~d-----------~~l---~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
...............+.+ ... ...........+.+++.+||+.+|++||++.|++.+-.
T Consensus 243 ---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~ 315 (335)
T PTZ00024 243 ---LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEY 315 (335)
T ss_pred ---HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcc
Confidence 111111111100000000 000 00011123466889999999999999999999986543
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=300.22 Aligned_cols=264 Identities=22% Similarity=0.262 Sum_probs=192.5
Q ss_pred CCCcceeeeeeceEEEEEEEEc-C--CcEEEEEEcCCC--ChHhHHHHHHHHHHHHhC-CCCCcceEEEEEecC----Cc
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-D--GTKVAVKRGNPR--SEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDER----SE 572 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~--g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~----~~ 572 (845)
+|+..+.||+|+||.||++... . +..+|+|++... .....+.+.+|+++++++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4677889999999999999975 3 678999987643 223356788999999999 599999999875332 45
Q ss_pred EEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCC
Q 003139 573 MILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKT 652 (845)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~ 652 (845)
.++++||++ ++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 788899885 6888887543 468999999999999999999998 8999999999999999999999999999975
Q ss_pred CCCCCCc--ccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccH---------HHHH
Q 003139 653 GPALDQT--HVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNI---------AEWA 720 (845)
Q Consensus 653 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l---------~~~~ 720 (845)
....... .......|+..|+|||.+.+ ..++.++|||||||+++||++|++||......+.... .++.
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL 234 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 4321111 11233568899999998765 5689999999999999999999999865432111000 0000
Q ss_pred HHHhhcCchhhhhc---ccc---CCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 721 MTWQKKGMLDQIMD---SNL---VGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 721 ~~~~~~~~~~~~~d---~~l---~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
...... ....... ... .....+.....+.+++.+|++.+|++||++.+++..
T Consensus 235 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 235 SRIGSP-KAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred Hhhhhh-hHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000 0000000 000 000111234678899999999999999999998755
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=293.47 Aligned_cols=259 Identities=26% Similarity=0.318 Sum_probs=198.2
Q ss_pred CCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC--hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEec
Q 003139 504 FDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS--EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYM 580 (845)
Q Consensus 504 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 580 (845)
|+..+.||+|++|.||+|+.. +++.+++|...... ....+.+..|++++++++|+|++++++++.+.+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 445668999999999999976 58999999877653 333467889999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcc
Q 003139 581 ANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH 660 (845)
Q Consensus 581 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 660 (845)
+ ++|.+++.... ..+++..+++++.|+++||+|||+ .+|+||||+|+||++++++.+||+|||+++.......
T Consensus 81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 153 (282)
T cd07829 81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-- 153 (282)
T ss_pred C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--
Confidence 7 58999886543 469999999999999999999999 8999999999999999999999999999976432211
Q ss_pred cccccccCCCcCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhc-------------
Q 003139 661 VSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKK------------- 726 (845)
Q Consensus 661 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~------------- 726 (845)
......++..|+|||.+.+. .++.++||||||++++||++|++||......+. ..........
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ---LFKIFQILGTPTEESWPGVTKLP 230 (282)
T ss_pred ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH---HHHHHHHhCCCcHHHHHhhcccc
Confidence 12234457789999998776 889999999999999999999998865432111 1111110000
Q ss_pred ---CchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 727 ---GMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 727 ---~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
........... ....+.....+.+++.+||+.+|++||++.+++..
T Consensus 231 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 231 DYKPTFPKFPPKDL-EKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccccccCccch-HHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 00000000000 00111235678999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=301.57 Aligned_cols=264 Identities=22% Similarity=0.329 Sum_probs=198.3
Q ss_pred HHHHhcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCC--
Q 003139 497 ILDATNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERS-- 571 (845)
Q Consensus 497 l~~at~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-- 571 (845)
+....++|+..+.||+|+||.||+|... +|+.||+|+.... .....+.+.+|++++++++||||+++++++....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 4445678999999999999999999865 6899999987543 2334567889999999999999999999986543
Q ss_pred ----cEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEec
Q 003139 572 ----EMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADF 647 (845)
Q Consensus 572 ----~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DF 647 (845)
..++||||+ +++|.+++.. ..+++..++.++.|+++||+|||+ .+|+||||||+||++++++.+||+||
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeec
Confidence 458999999 7788887743 368999999999999999999998 89999999999999999999999999
Q ss_pred cccCCCCCCCCcccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccc-c--------HH
Q 003139 648 GLSKTGPALDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQV-N--------IA 717 (845)
Q Consensus 648 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~-~--------l~ 717 (845)
|+++.... ......++..|+|||.+.+ ..++.++|+||||++++||++|+.||......... . ..
T Consensus 163 g~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07880 163 GLARQTDS-----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK 237 (343)
T ss_pred cccccccc-----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 99976322 1223467889999999876 46899999999999999999999998754321100 0 00
Q ss_pred HHHHHHhhcCchhhhhcc--ccC----CCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 718 EWAMTWQKKGMLDQIMDS--NLV----GKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 718 ~~~~~~~~~~~~~~~~d~--~l~----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
+|....... ........ ... ....+.....+.+++.+|++.+|.+||++.+++.+
T Consensus 238 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 238 EFVQKLQSE-DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred HHHHhhcch-hHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 011000000 00000000 000 00112334568899999999999999999999854
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-33 Score=276.07 Aligned_cols=245 Identities=23% Similarity=0.366 Sum_probs=195.0
Q ss_pred cceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCC-CCCcceEEEEEecCCcEEEEEEeccC
Q 003139 506 ESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLR-HRHLVSLIGYCDERSEMILVYEYMAN 582 (845)
Q Consensus 506 ~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~ 582 (845)
....||+|..|.|++.+++ .|..+|||.+... +.++.++++..+.++.+-+ .|.||+.+||+..+...++.||.|.
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs- 174 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS- 174 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-
Confidence 3446999999999999976 5889999987654 5566788899999888776 8999999999999999999999983
Q ss_pred CCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcccc
Q 003139 583 GPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVS 662 (845)
Q Consensus 583 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 662 (845)
..+..+|. .-.+++++.-+-++...+.+||.||.+ .++|+|||+||+|||+|+.|++|+||||++-..- +....
T Consensus 175 ~C~ekLlk-rik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlv---dSkAh 248 (391)
T KOG0983|consen 175 TCAEKLLK-RIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV---DSKAH 248 (391)
T ss_pred HHHHHHHH-HhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceee---ccccc
Confidence 33444443 234568888888999999999999987 6899999999999999999999999999986532 33344
Q ss_pred cccccCCCcCChhhhc---cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhc---cc
Q 003139 663 TAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMD---SN 736 (845)
Q Consensus 663 ~~~~gt~~y~aPE~~~---~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d---~~ 736 (845)
+...|.+.|||||.+. ..+|+.++||||||+.|+||.||+.|+..-...-+ .+..+++ |.
T Consensus 249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe--------------~ltkvln~ePP~ 314 (391)
T KOG0983|consen 249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE--------------VLTKVLNEEPPL 314 (391)
T ss_pred ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH--------------HHHHHHhcCCCC
Confidence 5667899999999885 34788999999999999999999999875332111 1222222 22
Q ss_pred cCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 737 LVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 737 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
|.+ .......+++++..||++|+.+||...+++++
T Consensus 315 L~~--~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 315 LPG--HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CCc--ccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 221 12356789999999999999999999998765
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=304.59 Aligned_cols=265 Identities=21% Similarity=0.301 Sum_probs=194.8
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecC----------
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDER---------- 570 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~---------- 570 (845)
++|...+.||.|+||.||+|... +|+.|++|++........+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 67888999999999999999875 6889999987766556667889999999999999999999776443
Q ss_pred ----CcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEEC-CCCceEEE
Q 003139 571 ----SEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLD-DNFVAKVA 645 (845)
Q Consensus 571 ----~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~-~~~~~kl~ 645 (845)
...++||||++ ++|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++ +++.+||+
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEEEC
Confidence 35789999997 588877743 358899999999999999999998 8999999999999997 56688999
Q ss_pred eccccCCCCCCCC-cccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHH--
Q 003139 646 DFGLSKTGPALDQ-THVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAM-- 721 (845)
Q Consensus 646 DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~-- 721 (845)
|||+++....... ........++..|+|||.+.. ..++.++|||||||++|||++|+.||....+.+.........
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 9999975322111 111123357889999998754 568899999999999999999999997544322110000000
Q ss_pred ------HHhhcCchhhhhccccCCC-----CCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 722 ------TWQKKGMLDQIMDSNLVGK-----VNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 722 ------~~~~~~~~~~~~d~~l~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
..........+.+...... ..+.....+.+++.+||+.+|++||++.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 0000000000000000000 011234568899999999999999999999865
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-34 Score=331.30 Aligned_cols=252 Identities=26% Similarity=0.340 Sum_probs=199.7
Q ss_pred hcCCCcceeeeeeceEEEEEEEE-cCCcEEEEEEcCC--CChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTL-DDGTKVAVKRGNP--RSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
+-++.....||.|.||.||-|.. ++|+..|+|.+.. ......+...+|+.++..++|||+|+.+|+-.++++.+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 44566677899999999999984 5799999996543 33455667889999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
|||++|+|.+.+.... -+++.....+..|++.|+.|||+ ++||||||||.||||+.+|.+|++|||.|.......
T Consensus 1314 EyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred HHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecCch
Confidence 9999999999985432 35555666788899999999999 999999999999999999999999999997644321
Q ss_pred C--cccccccccCCCcCChhhhccC---CCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHH-HhhcCchhh
Q 003139 658 Q--THVSTAVKGSFGYLDPEYFRRQ---QLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMT-WQKKGMLDQ 731 (845)
Q Consensus 658 ~--~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~-~~~~~~~~~ 731 (845)
+ ........||+.|||||++.+. .-..+.||||+|||++||+||++||..... +|+.- ....|.
T Consensus 1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-------e~aIMy~V~~gh--- 1458 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-------EWAIMYHVAAGH--- 1458 (1509)
T ss_pred hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-------hhHHHhHHhccC---
Confidence 1 1223467899999999999763 345789999999999999999999964322 24321 111111
Q ss_pred hhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 732 IMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 732 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
..++|.....+-.+++.+||+.||++|.++.|+++.
T Consensus 1459 ------~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1459 ------KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ------CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 123455566677889999999999999888876654
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=320.19 Aligned_cols=253 Identities=27% Similarity=0.402 Sum_probs=188.1
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEec---------
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDE--------- 569 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--------- 569 (845)
-++|++..+||+||||.|||++.+ ||+.+|||++... +........+|+..+++|+|||||+++....+
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 456788889999999999999987 8999999997655 44556678899999999999999997621100
Q ss_pred ---------------------------------------------------------------------C----------
Q 003139 570 ---------------------------------------------------------------------R---------- 570 (845)
Q Consensus 570 ---------------------------------------------------------------------~---------- 570 (845)
+
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence 0
Q ss_pred -------------------------------CcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 003139 571 -------------------------------SEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTG 619 (845)
Q Consensus 571 -------------------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~ 619 (845)
..+||-||||+...|+++++.+.... .-...++++++|++||.|+|+
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH~- 715 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIHD- 715 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHHh-
Confidence 12578899999888888876553221 356778999999999999999
Q ss_pred CCCceeeccCCCCcEEECCCCceEEEeccccCCCC----C------------CCCcccccccccCCCcCChhhhccC---
Q 003139 620 AAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGP----A------------LDQTHVSTAVKGSFGYLDPEYFRRQ--- 680 (845)
Q Consensus 620 ~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~----~------------~~~~~~~~~~~gt~~y~aPE~~~~~--- 680 (845)
.+||||||||.||+||++..+||+|||+|.... . .......+...||.-|+|||++.+.
T Consensus 716 --~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~ 793 (1351)
T KOG1035|consen 716 --QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN 793 (1351)
T ss_pred --CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence 999999999999999999999999999997611 0 0111234677899999999999764
Q ss_pred CCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhC
Q 003139 681 QLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEH 760 (845)
Q Consensus 681 ~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~ 760 (845)
+|+.|+|+||+|||++||+. ||....++.. +....+++.+..- ..+.......=..+++++++.|
T Consensus 794 ~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~------iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~hd 858 (1351)
T KOG1035|consen 794 KYNSKIDMYSLGIVLFEMLY---PFGTSMERAS------ILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLLSHD 858 (1351)
T ss_pred cccchhhhHHHHHHHHHHhc---cCCchHHHHH------HHHhcccCCCCCC------cccccccchHHHHHHHHHhcCC
Confidence 59999999999999999974 3543222110 0011112222111 1122333445568999999999
Q ss_pred CCCCCCHHHHHH
Q 003139 761 GVDRPSMGDVLW 772 (845)
Q Consensus 761 p~~RPs~~~vl~ 772 (845)
|.+|||+.|++.
T Consensus 859 P~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 859 PSKRPTATELLN 870 (1351)
T ss_pred CccCCCHHHHhh
Confidence 999999999874
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.3e-32 Score=284.75 Aligned_cols=236 Identities=27% Similarity=0.340 Sum_probs=193.4
Q ss_pred eeeeceEEEEEEEEc-CCcEEEEEEcCCCC---hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEeccCCCc
Q 003139 510 LGVGGFGRVYKGTLD-DGTKVAVKRGNPRS---EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPL 585 (845)
Q Consensus 510 LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 585 (845)
||+|+||.||++... +++.+++|.+.... ....+.+..|++++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999976 58899999876542 23566889999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCccccccc
Q 003139 586 RSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAV 665 (845)
Q Consensus 586 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 665 (845)
.+++... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~ 153 (250)
T cd05123 81 FSHLSKE--GRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTF 153 (250)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCC
Confidence 9998544 368999999999999999999998 999999999999999999999999999987643211 123345
Q ss_pred ccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCCHHH
Q 003139 666 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPAS 745 (845)
Q Consensus 666 ~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 745 (845)
.++..|++||.+.+...+.++|+||||+++|||++|+.||...... .... .+.... ..++...
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~------~~~~---------~~~~~~--~~~~~~~ 216 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK------EIYE---------KILKDP--LRFPEFL 216 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH------HHHH---------HHhcCC--CCCCCCC
Confidence 6788999999999888999999999999999999999998543221 1111 111111 1233334
Q ss_pred HHHHHHHHHHhhhhCCCCCCCHHH
Q 003139 746 LKKFGETAEKCLAEHGVDRPSMGD 769 (845)
Q Consensus 746 ~~~l~~l~~~cl~~~p~~RPs~~~ 769 (845)
+..+.+++.+|+..+|++||++.+
T Consensus 217 ~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 217 SPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CHHHHHHHHHHhcCCHhhCCCccc
Confidence 677889999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.6e-32 Score=299.24 Aligned_cols=262 Identities=22% Similarity=0.297 Sum_probs=198.1
Q ss_pred HHhcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCc---
Q 003139 499 DATNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSE--- 572 (845)
Q Consensus 499 ~at~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~--- 572 (845)
+..++|+..+.||+|++|.||+|+.. +++.+|+|++... +....+.+.+|+.++++++|+|++++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 44678999999999999999999976 5788999987643 23344677889999999999999999988765554
Q ss_pred ---EEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccc
Q 003139 573 ---MILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGL 649 (845)
Q Consensus 573 ---~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGl 649 (845)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+ .+|+||||||+||++++++.+||+|||+
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEccccc
Confidence 89999999 6789888753 468999999999999999999998 8999999999999999999999999999
Q ss_pred cCCCCCCCCcccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCccccc-H--------HHH
Q 003139 650 SKTGPALDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVN-I--------AEW 719 (845)
Q Consensus 650 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~-l--------~~~ 719 (845)
+..... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+... + ..+
T Consensus 165 ~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 239 (343)
T cd07851 165 ARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL 239 (343)
T ss_pred cccccc-----cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence 976332 1233467889999999865 468899999999999999999999996543221100 0 000
Q ss_pred HHHHhhcCchhhhhccccCC------CCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 720 AMTWQKKGMLDQIMDSNLVG------KVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 720 ~~~~~~~~~~~~~~d~~l~~------~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
...... ......+...... .........+.+++.+||+.+|++|||+.+|+++
T Consensus 240 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 240 LQKISS-ESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred Hhhccc-hhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 000000 0000111100000 0011235678899999999999999999998765
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=317.65 Aligned_cols=145 Identities=28% Similarity=0.390 Sum_probs=130.9
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
++|.+.+.||+|+||.||+|... +++.||+|++... .....+.+..|+.+++.++||||+++++++......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888899999999999999976 6889999987643 2344577889999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSK 651 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~ 651 (845)
||+++++|.+++... ..+++..++.|+.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999998543 368899999999999999999998 899999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-32 Score=275.49 Aligned_cols=264 Identities=23% Similarity=0.373 Sum_probs=203.5
Q ss_pred HHHHHHHhcCCCcceeeeeeceEEEEEEE-EcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCC-CCCcceEEEEEecCC
Q 003139 494 FQEILDATNKFDESLLLGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLR-HRHLVSLIGYCDERS 571 (845)
Q Consensus 494 ~~el~~at~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~ 571 (845)
++++...|+. +||+|+|+.|--++ +.+|..+|||++.+.......+..+|++++.+.+ |+||++|+.|++++.
T Consensus 75 F~d~YkLt~e-----~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~ 149 (463)
T KOG0607|consen 75 FEDMYKLTSE-----LLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT 149 (463)
T ss_pred HHHHHHhHHH-----HhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence 4555555543 79999999999887 5689999999998887777788999999999985 999999999999999
Q ss_pred cEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCC---ceEEEecc
Q 003139 572 EMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNF---VAKVADFG 648 (845)
Q Consensus 572 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~---~~kl~DFG 648 (845)
.+|||||-|.||+|..++.+. ..+++.+..++.++|+.||.+||. ++|.||||||+|||..+.. -+||+||.
T Consensus 150 ~FYLVfEKm~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDfD 224 (463)
T KOG0607|consen 150 RFYLVFEKMRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDFD 224 (463)
T ss_pred eEEEEEecccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeeccc
Confidence 999999999999999999655 479999999999999999999999 9999999999999997654 57999999
Q ss_pred ccCCCCCCCC-----cccccccccCCCcCChhhhc-----cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHH
Q 003139 649 LSKTGPALDQ-----THVSTAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAE 718 (845)
Q Consensus 649 la~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~ 718 (845)
|+.-...... .......+|+..|||||+.. ...|+.+.|.||+|||||-||+|.+||.+.-..+. .
T Consensus 225 LgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC----G 300 (463)
T KOG0607|consen 225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC----G 300 (463)
T ss_pred cccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC----C
Confidence 9753211111 11123567899999999763 34688999999999999999999999987655331 1
Q ss_pred HHHH----HhhcCchhhhhccccCCCCCH----HHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 719 WAMT----WQKKGMLDQIMDSNLVGKVNP----ASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 719 ~~~~----~~~~~~~~~~~d~~l~~~~~~----~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
|-+. ..++...+.|-+... +++. .+..+..+++...+..++.+|.++.+++.+
T Consensus 301 WdrGe~Cr~CQ~~LFesIQEGkY--eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 301 WDRGEVCRVCQNKLFESIQEGKY--EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred ccCCCccHHHHHHHHHHHhccCC--cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 2110 011111122222111 2332 245566778888899999999999998874
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-32 Score=273.87 Aligned_cols=251 Identities=24% Similarity=0.328 Sum_probs=199.9
Q ss_pred hcCCCcc-eeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhC-CCCCcceEEEEEe----cCCcE
Q 003139 501 TNKFDES-LLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCD----ERSEM 573 (845)
Q Consensus 501 t~~f~~~-~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~----~~~~~ 573 (845)
|++|.+. ++||-|-.|.|-.+..+ +|+.+|+|.+... ...++|+++--.. .|||||++++++. ....+
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 3445443 46999999999998876 7889999987643 3456788876665 6999999999874 45678
Q ss_pred EEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEEC---CCCceEEEecccc
Q 003139 574 ILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLD---DNFVAKVADFGLS 650 (845)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~---~~~~~kl~DFGla 650 (845)
++|||.|+||.|...+.+.....++++++-+|..||+.|+.|||+ .+|.||||||+|+|.. .|-.+||+|||+|
T Consensus 135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEecccccc
Confidence 899999999999999988877889999999999999999999999 9999999999999996 4568999999999
Q ss_pred CCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchh
Q 003139 651 KTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLD 730 (845)
Q Consensus 651 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (845)
+... ........+-|+.|.|||++...+|+...|+||+||++|-||||-+||....... + ..|.-.
T Consensus 212 K~t~---~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a---i--------spgMk~ 277 (400)
T KOG0604|consen 212 KETQ---EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---I--------SPGMKR 277 (400)
T ss_pred cccC---CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc---C--------ChhHHh
Confidence 8732 2334456788999999999999999999999999999999999999997654321 1 111111
Q ss_pred hhhccccCCCCC----HHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 731 QIMDSNLVGKVN----PASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 731 ~~~d~~l~~~~~----~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
+|..... +++ ....+...++++..|..+|.+|.|+.+++.+-.
T Consensus 278 rI~~gqy--~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpw 324 (400)
T KOG0604|consen 278 RIRTGQY--EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPW 324 (400)
T ss_pred HhhccCc--cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCch
Confidence 1111111 122 345677888999999999999999999986643
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-32 Score=313.50 Aligned_cols=258 Identities=24% Similarity=0.268 Sum_probs=208.9
Q ss_pred HHHHHHHhcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhCCCCCcceEEEEEec
Q 003139 494 FQEILDATNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDE 569 (845)
Q Consensus 494 ~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 569 (845)
..++.-...+|++.++||+|+||.|..++++ .++.+|.|++++. .......|..|-.+|..-..+-|++|.-.+.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 3445555678999999999999999999986 5788999988763 34455779999999999999999999999999
Q ss_pred CCcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccc
Q 003139 570 RSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGL 649 (845)
Q Consensus 570 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGl 649 (845)
...+|+|||||+||+|-.++.... +++......++..|..||.-||+ .|+|||||||+|||||..|++||+|||.
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADFGs 221 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADFGS 221 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccchh
Confidence 999999999999999999995544 78888899999999999999999 9999999999999999999999999999
Q ss_pred cCCCCCCCCcccccccccCCCcCChhhhcc-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHh
Q 003139 650 SKTGPALDQTHVSTAVKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQ 724 (845)
Q Consensus 650 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~ 724 (845)
+-.+.. +....+...+|||.|.+||++.. +.|...+|+||+||++|||+.|..||.... +++
T Consensus 222 Clkm~~-dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads------lve------ 288 (1317)
T KOG0612|consen 222 CLKMDA-DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS------LVE------ 288 (1317)
T ss_pred HHhcCC-CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH------HHH------
Confidence 866443 34445667899999999999852 678999999999999999999999996432 221
Q ss_pred hcCchhhhhccccCCCCC--HHHHHHHHHHHHHhhhhCCCCCCC---HHHHHHH
Q 003139 725 KKGMLDQIMDSNLVGKVN--PASLKKFGETAEKCLAEHGVDRPS---MGDVLWN 773 (845)
Q Consensus 725 ~~~~~~~~~d~~l~~~~~--~~~~~~l~~l~~~cl~~~p~~RPs---~~~vl~~ 773 (845)
...+|++-.-.-.+| .+..+...+||.+.+ -+|+.|.. ++++..+
T Consensus 289 ---TY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 289 ---TYGKIMNHKESLSFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNH 338 (1317)
T ss_pred ---HHHHHhchhhhcCCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHHhC
Confidence 223334332112233 345677778887766 47777877 7777654
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=278.88 Aligned_cols=221 Identities=19% Similarity=0.149 Sum_probs=177.8
Q ss_pred eceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEeccCCCccccccC
Q 003139 513 GGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYG 591 (845)
Q Consensus 513 G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~ 591 (845)
|.+|.||++... +++.+|+|++...+ .+..|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999875 68899999986543 234455566667899999999999999999999999999999998854
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcccccccccCCCc
Q 003139 592 TDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGY 671 (845)
Q Consensus 592 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y 671 (845)
. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++++|||++...... .....++..|
T Consensus 79 ~--~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y 148 (237)
T cd05576 79 F--LNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMY 148 (237)
T ss_pred h--cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCccc
Confidence 3 368999999999999999999998 89999999999999999999999999987653221 1233456789
Q ss_pred CChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHH
Q 003139 672 LDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGE 751 (845)
Q Consensus 672 ~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 751 (845)
+|||.+.++.++.++||||+|++++||++|+.|+........ .......+......+.+
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~ 207 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN---------------------THTTLNIPEWVSEEARS 207 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc---------------------cccccCCcccCCHHHHH
Confidence 999999888899999999999999999999987643211000 00000122334567889
Q ss_pred HHHHhhhhCCCCCCCHHH
Q 003139 752 TAEKCLAEHGVDRPSMGD 769 (845)
Q Consensus 752 l~~~cl~~~p~~RPs~~~ 769 (845)
++.+|++.||++||++.+
T Consensus 208 li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 208 LLQQLLQFNPTERLGAGV 225 (237)
T ss_pred HHHHHccCCHHHhcCCCc
Confidence 999999999999999744
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-32 Score=281.19 Aligned_cols=241 Identities=25% Similarity=0.356 Sum_probs=199.5
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERSEMILV 576 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 576 (845)
.+|....+||+|+||.|.+|.-+ ..+.+|||+++.. ..++.+--+.|-++|+.. +-|.+++|..++..-+.+|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 36888899999999999999866 3567999987654 223344456788888876 578999999999999999999
Q ss_pred EEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCC
Q 003139 577 YEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPAL 656 (845)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~ 656 (845)
|||+.||+|-.++.+- +.+.+....-++.+||-||-+||+ ++||.||||.+|||||.+|++||+|||+++..-.
T Consensus 429 MEyvnGGDLMyhiQQ~--GkFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~- 502 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQV--GKFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF- 502 (683)
T ss_pred EEEecCchhhhHHHHh--cccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeeccccccccc-
Confidence 9999999999888543 467788889999999999999999 9999999999999999999999999999986332
Q ss_pred CCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccc
Q 003139 657 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSN 736 (845)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (845)
........+||+.|+|||.+..++|...+|.|||||+||||+.|++||++..+.+ ....+++..
T Consensus 503 -~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e---------------lF~aI~ehn 566 (683)
T KOG0696|consen 503 -DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---------------LFQAIMEHN 566 (683)
T ss_pred -CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH---------------HHHHHHHcc
Confidence 2334557899999999999999999999999999999999999999998754332 233444443
Q ss_pred cCCCCCHHHHHHHHHHHHHhhhhCCCCCCC
Q 003139 737 LVGKVNPASLKKFGETAEKCLAEHGVDRPS 766 (845)
Q Consensus 737 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs 766 (845)
. .++.....+...+....+.++|.+|..
T Consensus 567 v--syPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 567 V--SYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred C--cCcccccHHHHHHHHHHhhcCCccccC
Confidence 3 356667778888999999999999953
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=270.35 Aligned_cols=204 Identities=24% Similarity=0.372 Sum_probs=166.7
Q ss_pred HhcCCCcceeeeeeceEEEEEEEEcC-----CcEEEEEEcCCCChH-h-HHHHHHHHHHHHhCCCCCcceEEEEEec-CC
Q 003139 500 ATNKFDESLLLGVGGFGRVYKGTLDD-----GTKVAVKRGNPRSEQ-G-IAEFRTEIEMLSKLRHRHLVSLIGYCDE-RS 571 (845)
Q Consensus 500 at~~f~~~~~LG~G~fg~Vy~~~~~~-----g~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~ 571 (845)
.-..|+....||+|.||.||||.-.+ ...+|+|+++..... + -....+|+.+++.++||||+.|..++.+ +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 34568888899999999999996432 236899988765321 1 2456789999999999999999998866 78
Q ss_pred cEEEEEEeccCCCccccccC---CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCC----CceEE
Q 003139 572 EMILVYEYMANGPLRSHLYG---TDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDN----FVAKV 644 (845)
Q Consensus 572 ~~~lV~Ey~~~gsL~~~l~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~----~~~kl 644 (845)
..+|++||.+. +|.+.++- .+...++-..+..|+.||+.|+.|||+ +=|+||||||.||||..+ |.+||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEe
Confidence 89999999976 56665542 233578889999999999999999998 779999999999999877 99999
Q ss_pred EeccccCCCCCCCCcc-cccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 003139 645 ADFGLSKTGPALDQTH-VSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNP 707 (845)
Q Consensus 645 ~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~ 707 (845)
+|||++|+....-... ....++-|+.|+|||.+.+ +.||.+.|||+.|||+.||++-.+.|..
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 9999999854433322 3446778999999998876 5799999999999999999999888764
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=272.07 Aligned_cols=237 Identities=27% Similarity=0.331 Sum_probs=193.4
Q ss_pred ceEEEEEEEEc-CCcEEEEEEcCCCChHh-HHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEeccCCCccccccC
Q 003139 514 GFGRVYKGTLD-DGTKVAVKRGNPRSEQG-IAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYG 591 (845)
Q Consensus 514 ~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~ 591 (845)
+||.||+|+.. +|+.+++|+........ .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999987 48999999987665544 68899999999999999999999999999999999999999999999865
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcccccccccCCCc
Q 003139 592 TDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGY 671 (845)
Q Consensus 592 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y 671 (845)
.. .+++..++.++.+++++|.|||+ .+++|+||+|+||++++++.++|+|||.+....... ......++..|
T Consensus 81 ~~--~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~ 152 (244)
T smart00220 81 RG--RLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEY 152 (244)
T ss_pred cc--CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCC
Confidence 43 38999999999999999999999 899999999999999999999999999997644321 23345678899
Q ss_pred CChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCC-HHHHHHHH
Q 003139 672 LDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVN-PASLKKFG 750 (845)
Q Consensus 672 ~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~-~~~~~~l~ 750 (845)
++||.+.+..++.++||||||++++||++|+.|+......+ .+.++ ..++ ....... ......+.
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~--~~~~~----~~~~--------~~~~~~~~~~~~~~~~ 218 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL--ELFKK----IGKP--------KPPFPPPEWKISPEAK 218 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHH----Hhcc--------CCCCccccccCCHHHH
Confidence 99999998899999999999999999999999986531111 11111 1111 0000000 11556889
Q ss_pred HHHHHhhhhCCCCCCCHHHHHH
Q 003139 751 ETAEKCLAEHGVDRPSMGDVLW 772 (845)
Q Consensus 751 ~l~~~cl~~~p~~RPs~~~vl~ 772 (845)
+++.+|+..+|++||++.++++
T Consensus 219 ~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 219 DLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHccCCchhccCHHHHhh
Confidence 9999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-32 Score=286.35 Aligned_cols=245 Identities=23% Similarity=0.320 Sum_probs=198.3
Q ss_pred ceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEeccCC
Q 003139 507 SLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANG 583 (845)
Q Consensus 507 ~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 583 (845)
.+.||+|-||+||-|+++ +|+.||||.+.+. ..++..++++|+.+|.+++||.||.|...|+..+..+.|||-+. |
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-G 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-c
Confidence 358999999999999976 7999999987654 33445788999999999999999999999999999999999994 5
Q ss_pred CccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECC---CCceEEEeccccCCCCCCCCcc
Q 003139 584 PLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDD---NFVAKVADFGLSKTGPALDQTH 660 (845)
Q Consensus 584 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~---~~~~kl~DFGla~~~~~~~~~~ 660 (845)
+..+.+...+.+.|+......++.||+.||.|||. ++|+|+||||+||||.+ --++||||||+||+.. ...
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg---Eks 721 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIG---EKS 721 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecc---hhh
Confidence 55555555666789999888999999999999998 99999999999999964 3489999999999844 444
Q ss_pred cccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCC
Q 003139 661 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGK 740 (845)
Q Consensus 661 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 740 (845)
....++||+.|+|||+++.+.|...-|+||.|||+|--|+|--||+.... +.+.. ++. .-+.-+ .
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd-----IndQI----QNA--aFMyPp----~ 786 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED-----INDQI----QNA--AFMYPP----N 786 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc-----hhHHh----hcc--ccccCC----C
Confidence 55678999999999999999999999999999999999999999964322 11111 110 001111 1
Q ss_pred CCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 741 VNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 741 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
...++....++++...|+..-++|-+...-+.+
T Consensus 787 PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 787 PWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred chhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 224455667899999999999999998876543
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=296.63 Aligned_cols=261 Identities=26% Similarity=0.377 Sum_probs=211.0
Q ss_pred cHHHHHHHhcCCCcceeeeeeceEEEEEEEE-cCCcEEEEEEcCCCChHhHHHHHHHHHHHHhC-CCCCcceEEEEEe--
Q 003139 493 MFQEILDATNKFDESLLLGVGGFGRVYKGTL-DDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCD-- 568 (845)
Q Consensus 493 ~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~-- 568 (845)
.++.+.+-+..|++.+.||.|.+|.||+++. ++++..|+|++...... -++...|.++++.+ .|||++.++|++.
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 3444455677889999999999999999985 47899999987765432 35677899999988 6999999999984
Q ss_pred ---cCCcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEE
Q 003139 569 ---ERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVA 645 (845)
Q Consensus 569 ---~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~ 645 (845)
.+++++||||||.+||.-+++.+.....+.|..+..|++.+++||.+||. ..++|||||-.||||+.++.+||+
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEe
Confidence 35689999999999999999987777789999999999999999999998 999999999999999999999999
Q ss_pred eccccCCCCCCCCcccccccccCCCcCChhhhcc-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHH
Q 003139 646 DFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWA 720 (845)
Q Consensus 646 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~ 720 (845)
|||++..... .-.......||+.|||||++.- ..|+.++|+||+|++..||--|.+|+.+..+....
T Consensus 166 DFGvSaQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL------ 237 (953)
T KOG0587|consen 166 DFGVSAQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL------ 237 (953)
T ss_pred eeeeeeeeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh------
Confidence 9999876322 1222345679999999999853 35778999999999999999999999766553211
Q ss_pred HHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 721 MTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 721 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
..+.. .|...-.-+.....+|.+++..||.+|-++||++.+++++
T Consensus 238 -F~IpR-------NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 238 -FLIPR-------NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred -ccCCC-------CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 00000 1222222345677899999999999999999999998754
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=289.54 Aligned_cols=243 Identities=21% Similarity=0.260 Sum_probs=196.3
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcEEEEEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERSEMILVYE 578 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 578 (845)
+..|.....+|.|+|+.|-++... +++..++|++.... .+-.+|+.++... +||||+++.+.+.+..+.++|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 566777778999999999998865 67889999987652 2234577666665 79999999999999999999999
Q ss_pred eccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEE-CCCCceEEEeccccCCCCCCC
Q 003139 579 YMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILL-DDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 579 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl-~~~~~~kl~DFGla~~~~~~~ 657 (845)
.+.++-|.+.+.... ... .++..|+.+|+.++.|||+ +++|||||||+|||+ ++.++++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~~~~--~~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKP--EFC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred hccccHHHHHHHhcc--hhH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 999998887775443 223 7788899999999999999 999999999999999 69999999999999875432
Q ss_pred CcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcccc
Q 003139 658 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNL 737 (845)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (845)
....+-|..|.|||++....|++++|+||||++|||||+|+.||....... ++.....
T Consensus 470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~------------------ei~~~i~ 527 (612)
T KOG0603|consen 470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI------------------EIHTRIQ 527 (612)
T ss_pred ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH------------------HHHHhhc
Confidence 234466889999999999999999999999999999999999997543321 1111111
Q ss_pred CCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003139 738 VGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEY 776 (845)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~ 776 (845)
.+++.........+|+.+||+.+|.+||+|.++..+-..
T Consensus 528 ~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 528 MPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred CCccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 223335566778899999999999999999999876443
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-32 Score=267.77 Aligned_cols=250 Identities=25% Similarity=0.269 Sum_probs=193.2
Q ss_pred ceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC-hHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcEEEEEEeccCC
Q 003139 507 SLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS-EQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERSEMILVYEYMANG 583 (845)
Q Consensus 507 ~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~g 583 (845)
...||.|+||+|+|-.++ .|+..|||++.... +.+.++++.|.+...+- +.||||+++|.+..++..++.||.|. -
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~ 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-I 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-h
Confidence 346999999999999876 78999999987654 46678899999887766 68999999999999999999999994 4
Q ss_pred Ccccc---ccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcc
Q 003139 584 PLRSH---LYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH 660 (845)
Q Consensus 584 sL~~~---l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 660 (845)
||..+ .+......+++.-+-.|.....+||.||.+ ...|||||+||+|||||..|.+||||||++-. .....
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGq---Lv~Si 222 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQ---LVDSI 222 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHh---HHHHH
Confidence 55433 233334568888888888999999999987 57899999999999999999999999999865 23344
Q ss_pred cccccccCCCcCChhhhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccC
Q 003139 661 VSTAVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLV 738 (845)
Q Consensus 661 ~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 738 (845)
..+...|...|||||.+.. ..|+.+|||||+|+.|+|+.||+-|+..-. ++.+.+........ |.+.
T Consensus 223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~-----svfeql~~Vv~gdp------p~l~ 291 (361)
T KOG1006|consen 223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD-----SVFEQLCQVVIGDP------PILL 291 (361)
T ss_pred HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH-----HHHHHHHHHHcCCC------Ceec
Confidence 4556778889999998853 458999999999999999999998875321 12222222221111 1111
Q ss_pred CC-CCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 739 GK-VNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 739 ~~-~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.. ........+..++..|+.+|-.+||...++.++
T Consensus 292 ~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 292 FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred CcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 11 112355678899999999999999999998765
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-32 Score=268.09 Aligned_cols=269 Identities=24% Similarity=0.341 Sum_probs=196.7
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC--hHhHHHHHHHHHHHHhCCCCCcceEEEEEec--------C
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS--EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDE--------R 570 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--------~ 570 (845)
+.|+...+||+|.||+||+|+.+ .|+.||+|+.--.+ +..-...++|+++|..++|+|++.++..|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 34455568999999999999866 57788998643322 2222455789999999999999999998843 3
Q ss_pred CcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEecccc
Q 003139 571 SEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLS 650 (845)
Q Consensus 571 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla 650 (845)
..+++||.+|+. +|..+|... ...++..++.++..++..||.|+|. ..|+|||+|+.|+||+.++.+||+|||++
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeeccccc
Confidence 358999999975 677777433 3578999999999999999999999 89999999999999999999999999999
Q ss_pred CCCCCCCC--cccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhh--
Q 003139 651 KTGPALDQ--THVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQK-- 725 (845)
Q Consensus 651 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~-- 725 (845)
|....... ....+..+-|..|++||.+.+ +.|+++.|||.-||||.||.++.+.+.......+..++...-.-..
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 76433222 112345667999999998775 6899999999999999999999998887665555443332211111
Q ss_pred ------cCchhhhhccc-c-CCCCC--HHHH------HHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 726 ------KGMLDQIMDSN-L-VGKVN--PASL------KKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 726 ------~~~~~~~~d~~-l-~~~~~--~~~~------~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
+-.+.+-+... + .+... ++.. ....+++.+++..||.+|+++.+++.+.-
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~ 317 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDF 317 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhh
Confidence 11111111100 1 01100 1111 24668999999999999999999886643
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=276.13 Aligned_cols=265 Identities=20% Similarity=0.253 Sum_probs=205.3
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCC-C-C----CcceEEEEEecCCcE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLR-H-R----HLVSLIGYCDERSEM 573 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-~----niv~l~g~~~~~~~~ 573 (845)
+++|.+..++|+|.||.|-+...+ .+..||||+++... ...+..+-|++++.++. + | -+|++.+|++-.++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 788999999999999999998755 46889999876543 23355677999999993 2 2 377888999999999
Q ss_pred EEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEEC----------------
Q 003139 574 ILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLD---------------- 637 (845)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~---------------- 637 (845)
|||+|.+ |-|+.++|..++..+++..++..|+.|+++++++||+ .+++|-||||+|||+.
T Consensus 167 Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEeccCCccce
Confidence 9999999 6699999998888899999999999999999999999 9999999999999993
Q ss_pred ----CCCceEEEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCccc
Q 003139 638 ----DNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQ 713 (845)
Q Consensus 638 ----~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~ 713 (845)
++..+||+|||-|..... ....++.|..|+|||++.+-.++..+||||+||||.|+.+|...|+.....++
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~e-----~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EH 317 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDHE-----HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEH 317 (415)
T ss_pred eccCCCcceEEEecCCcceecc-----CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence 134689999999986222 22567889999999999999999999999999999999999999877664443
Q ss_pred ccHHHHH--------------HHHhhcCch-----------hhhhccccC----CCCCHHHHHHHHHHHHHhhhhCCCCC
Q 003139 714 VNIAEWA--------------MTWQKKGML-----------DQIMDSNLV----GKVNPASLKKFGETAEKCLAEHGVDR 764 (845)
Q Consensus 714 ~~l~~~~--------------~~~~~~~~~-----------~~~~d~~l~----~~~~~~~~~~l~~l~~~cl~~~p~~R 764 (845)
..+-+-+ .+....+.+ ..+.++... -.....+...|.+|+++||..||.+|
T Consensus 318 LaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~R 397 (415)
T KOG0671|consen 318 LAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARR 397 (415)
T ss_pred HHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccc
Confidence 2221111 111111111 111111000 01123456779999999999999999
Q ss_pred CCHHHHHHHHH
Q 003139 765 PSMGDVLWNLE 775 (845)
Q Consensus 765 Ps~~~vl~~L~ 775 (845)
+|+.|++++--
T Consensus 398 iTl~EAL~HpF 408 (415)
T KOG0671|consen 398 ITLREALSHPF 408 (415)
T ss_pred ccHHHHhcCHH
Confidence 99999987643
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-30 Score=299.45 Aligned_cols=260 Identities=20% Similarity=0.261 Sum_probs=169.6
Q ss_pred HhcCCCcceeeeeeceEEEEEEEEc-C----CcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEE------Ee
Q 003139 500 ATNKFDESLLLGVGGFGRVYKGTLD-D----GTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGY------CD 568 (845)
Q Consensus 500 at~~f~~~~~LG~G~fg~Vy~~~~~-~----g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~------~~ 568 (845)
..++|...+.||+|+||.||+|++. + +..||+|++...... +.+..| .+....+.++..++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4578999999999999999999976 4 688999987643322 111111 1222223333222211 34
Q ss_pred cCCcEEEEEEeccCCCccccccCCCCC------------------CCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCC
Q 003139 569 ERSEMILVYEYMANGPLRSHLYGTDLP------------------PLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVK 630 (845)
Q Consensus 569 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~------------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik 630 (845)
...+.++||||+++++|.+++...... ......+..|+.|++.||+|||+ ++|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCC
Confidence 667899999999999999888643210 11233456799999999999998 899999999
Q ss_pred CCcEEECC-CCceEEEeccccCCCCCCCCcccccccccCCCcCChhhhccC----------------------CCCchhH
Q 003139 631 TTNILLDD-NFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQ----------------------QLTEKSD 687 (845)
Q Consensus 631 ~~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~ksD 687 (845)
|+|||+++ ++.+||+|||+++.... ..........+++.|||||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~-~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRV-GINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccc-ccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999985 68999999999975432 222233456789999999966422 2345679
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCC-------cccccHHHHHHHHhhcCchhhhhccccCC--CCCHHHHHHHHHHHHHhhh
Q 003139 688 VYSFGVVLMEVLCTRPALNPVLP-------REQVNIAEWAMTWQKKGMLDQIMDSNLVG--KVNPASLKKFGETAEKCLA 758 (845)
Q Consensus 688 V~S~Gvvl~Elltg~~p~~~~~~-------~~~~~l~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~~l~~l~~~cl~ 758 (845)
||||||+||||+++..+.+.... ....++..|....... ..+.+.. +..........+|+.+||+
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHcc
Confidence 99999999999997655432100 0011112221111000 0000000 0000112234589999999
Q ss_pred hCCCCCCCHHHHHHH
Q 003139 759 EHGVDRPSMGDVLWN 773 (845)
Q Consensus 759 ~~p~~RPs~~~vl~~ 773 (845)
.||++|||+.+++++
T Consensus 436 ~dP~kR~ta~e~L~H 450 (566)
T PLN03225 436 FKGRQRISAKAALAH 450 (566)
T ss_pred CCcccCCCHHHHhCC
Confidence 999999999999876
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-30 Score=291.23 Aligned_cols=259 Identities=22% Similarity=0.260 Sum_probs=182.5
Q ss_pred hcCCCcceeeeeeceEEEEEEEE-----------------cCCcEEEEEEcCCCChHhHHHH--------------HHHH
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTL-----------------DDGTKVAVKRGNPRSEQGIAEF--------------RTEI 549 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~-----------------~~g~~vavK~~~~~~~~~~~~~--------------~~E~ 549 (845)
.++|++.++||+|+||.||+|.+ ..++.||||++........++| ..|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 56899999999999999999964 2356799999865543333333 3477
Q ss_pred HHHHhCCCCCc-----ceEEEEEec--------CCcEEEEEEeccCCCccccccCCC----------------------C
Q 003139 550 EMLSKLRHRHL-----VSLIGYCDE--------RSEMILVYEYMANGPLRSHLYGTD----------------------L 594 (845)
Q Consensus 550 ~~l~~l~H~ni-----v~l~g~~~~--------~~~~~lV~Ey~~~gsL~~~l~~~~----------------------~ 594 (845)
.++.+++|.++ ++++++|.. .+..+|||||+++++|.++|+... .
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77788876654 678888753 356899999999999999886421 1
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcccccccccCCCcCCh
Q 003139 595 PPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDP 674 (845)
Q Consensus 595 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 674 (845)
..++|..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++..... .........+++.|+||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~-~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTG-INFNPLYGMLDPRYSPP 379 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccC-CccCccccCCCcceeCh
Confidence 235788899999999999999998 89999999999999999999999999999753221 11111223347899999
Q ss_pred hhhccCCC----------------------CchhHHHHHHHHHHHHHcCCC-CCCCCCCcc------cccHHHHHHHHhh
Q 003139 675 EYFRRQQL----------------------TEKSDVYSFGVVLMEVLCTRP-ALNPVLPRE------QVNIAEWAMTWQK 725 (845)
Q Consensus 675 E~~~~~~~----------------------s~ksDV~S~Gvvl~Elltg~~-p~~~~~~~~------~~~l~~~~~~~~~ 725 (845)
|.+..... ..+.||||+||+++||++|.. |+....... ..++..|.. ..
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~--~~ 457 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM--YK 457 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh--hc
Confidence 98754321 234799999999999999985 553221111 111222221 11
Q ss_pred cCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCC---CCCCCHHHHHHH
Q 003139 726 KGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHG---VDRPSMGDVLWN 773 (845)
Q Consensus 726 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p---~~RPs~~~vl~~ 773 (845)
... ..-...........+++.++|..+| .+|+|+.|++++
T Consensus 458 ~~~--------~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 458 GQK--------YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred ccC--------CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 110 0001112334667789999999766 689999999875
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-31 Score=244.44 Aligned_cols=264 Identities=22% Similarity=0.263 Sum_probs=192.4
Q ss_pred CCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC--hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS--EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
+|+..++||+|.||+||||+.. .++.||+|+..... +.--...++|+.+++.++|+|||++++....++.+-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4555678999999999999965 67899999765432 22235678999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCc
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT 659 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~ 659 (845)
|. .+|..+...- .+.++.+....++.|+++||.++|+ +++.||||||+|.||+.+|+.|++|||++|...-.-
T Consensus 83 cd-qdlkkyfdsl-ng~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipv-- 155 (292)
T KOG0662|consen 83 CD-QDLKKYFDSL-NGDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV-- 155 (292)
T ss_pred hh-HHHHHHHHhc-CCcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCce--
Confidence 94 4677766433 3578999999999999999999999 999999999999999999999999999998643211
Q ss_pred ccccccccCCCcCChhhhccC-CCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCc---hhhhhc
Q 003139 660 HVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGM---LDQIMD 734 (845)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~~~d 734 (845)
.-....+-|..|++|.++.+. -|+...|+||-|||+.|+.. |++.|.+....++..-+-|......++. +.++-|
T Consensus 156 rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpd 235 (292)
T KOG0662|consen 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD 235 (292)
T ss_pred EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCC
Confidence 112345678999999998775 57899999999999999986 5555544333332222222211111111 122222
Q ss_pred cccCCCCC---------HHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 735 SNLVGKVN---------PASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 735 ~~l~~~~~---------~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
-....-++ +.....=.+++.+.+.-+|.+|.++++.++.
T Consensus 236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 11111111 2222334567778888899999999887654
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-31 Score=278.07 Aligned_cols=250 Identities=21% Similarity=0.267 Sum_probs=206.1
Q ss_pred CCcceeeeeeceEEEEEEEEcCCc-EEEEEEcCC---CChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 504 FDESLLLGVGGFGRVYKGTLDDGT-KVAVKRGNP---RSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 504 f~~~~~LG~G~fg~Vy~~~~~~g~-~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
++....||-||||.|=+++.+... .+|+|.+++ .+.++.+....|-++|.+.+.|.||+|+--+.+.+..|++||-
T Consensus 422 l~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEa 501 (732)
T KOG0614|consen 422 LKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEA 501 (732)
T ss_pred hhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHh
Confidence 344557999999999999876433 367775543 3455667888999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCc
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT 659 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~ 659 (845)
|-||.|-..|+. ++.++......++..+.+|++|||. ++||.|||||+|.|||.+|-+||.|||+|+... ..
T Consensus 502 ClGGElWTiLrd--Rg~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~---~g 573 (732)
T KOG0614|consen 502 CLGGELWTILRD--RGSFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG---SG 573 (732)
T ss_pred hcCchhhhhhhh--cCCcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhc---cC
Confidence 999999999954 4578889999999999999999999 999999999999999999999999999998743 33
Q ss_pred ccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCC
Q 003139 660 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVG 739 (845)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 739 (845)
.....++||+.|.|||.+.++..+.++|.||+|++++|||+|++||....+...-+ .++...-.-
T Consensus 574 ~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn---------------~ILkGid~i 638 (732)
T KOG0614|consen 574 RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYN---------------LILKGIDKI 638 (732)
T ss_pred CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHH---------------HHHhhhhhh
Confidence 44567899999999999999999999999999999999999999998765533211 112212222
Q ss_pred CCCHHHHHHHHHHHHHhhhhCCCCCCC-----HHHHHHHHHH
Q 003139 740 KVNPASLKKFGETAEKCLAEHGVDRPS-----MGDVLWNLEY 776 (845)
Q Consensus 740 ~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~~vl~~L~~ 776 (845)
+++..+.+...+++++.+..+|.+|.. +.||.++-+.
T Consensus 639 ~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf 680 (732)
T KOG0614|consen 639 EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWF 680 (732)
T ss_pred hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhh
Confidence 456667778889999999999999976 6677666554
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-30 Score=272.64 Aligned_cols=255 Identities=27% Similarity=0.344 Sum_probs=194.3
Q ss_pred CCCcceeeeeeceEEEEEEEE-cCCcEEEEEEcCCC-------ChHhHHHHHHHHHHHHhCCCCCcceEEEEE-ecCCcE
Q 003139 503 KFDESLLLGVGGFGRVYKGTL-DDGTKVAVKRGNPR-------SEQGIAEFRTEIEMLSKLRHRHLVSLIGYC-DERSEM 573 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~H~niv~l~g~~-~~~~~~ 573 (845)
+|-..++||+|||++||||.. ...+-||||+.... .+...+...+|.++-+.|.||.||++++|+ .+...+
T Consensus 464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF 543 (775)
T KOG1151|consen 464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF 543 (775)
T ss_pred HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence 344556799999999999984 45677899974322 122245567899999999999999999998 456678
Q ss_pred EEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEEC---CCCceEEEecccc
Q 003139 574 ILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLD---DNFVAKVADFGLS 650 (845)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~---~~~~~kl~DFGla 650 (845)
|-|.|||+|.+|.-+|...+ .+++++...|+.||+.||.||.+ -..+|||-||||.||||. .-|.+||+||||+
T Consensus 544 CTVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 544 CTVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred eeeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 99999999999999996554 68999999999999999999987 447899999999999995 4589999999999
Q ss_pred CCCCCCCCc-----ccccccccCCCcCChhhhcc----CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHH
Q 003139 651 KTGPALDQT-----HVSTAVKGSFGYLDPEYFRR----QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAM 721 (845)
Q Consensus 651 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~----~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~ 721 (845)
+++...... .......||.+|++||.+-- -+.+.|+||||.|||+|..+.|+.||........ +
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd--I----- 693 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD--I----- 693 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH--H-----
Confidence 987653332 23445789999999998743 3578999999999999999999999975443221 1
Q ss_pred HHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHH
Q 003139 722 TWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVL 771 (845)
Q Consensus 722 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl 771 (845)
.++..+.+.-+ ..-...+....+...++++||+..-++|....++.
T Consensus 694 --LqeNTIlkAtE--VqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 694 --LQENTILKATE--VQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred --Hhhhchhccee--ccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 11111111111 11112244556778899999999999998776653
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=253.91 Aligned_cols=247 Identities=22% Similarity=0.354 Sum_probs=199.7
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERSEMILV 576 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 576 (845)
++|+..++||+|.|.+|..+++. ..+.+|+|.+++. ..+.++-.+.|-.+..+. +||.+|-|..++..+..+++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 57889999999999999999976 5678899876543 334455567788888776 799999999999999999999
Q ss_pred EEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCC
Q 003139 577 YEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPAL 656 (845)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~ 656 (845)
.||+++|+|--++.. +..|+++....+...|+.||.|||+ .+||.||||.+|||||..|++||+|+|+++....
T Consensus 330 ieyv~ggdlmfhmqr--qrklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l~- 403 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQR--QRKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG- 403 (593)
T ss_pred EEEecCcceeeehhh--hhcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCCC-
Confidence 999999999877743 3479999999999999999999999 9999999999999999999999999999987433
Q ss_pred CCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCc-ccccHHHHHHHHhhcCchhhhhcc
Q 003139 657 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPR-EQVNIAEWAMTWQKKGMLDQIMDS 735 (845)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~-~~~~l~~~~~~~~~~~~~~~~~d~ 735 (845)
........+||+.|.|||.+++..|...+|.|++||+|+||+.||.||+-.... .+.+..++.-+. +++.
T Consensus 404 -~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv--------ilek 474 (593)
T KOG0695|consen 404 -PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV--------ILEK 474 (593)
T ss_pred -CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH--------Hhhh
Confidence 334456789999999999999999999999999999999999999999743321 122233333222 2222
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhhhCCCCCC
Q 003139 736 NLVGKVNPASLKKFGETAEKCLAEHGVDRP 765 (845)
Q Consensus 736 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP 765 (845)
.+ .++.....+...+++.-|.+||.+|.
T Consensus 475 qi--riprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 475 QI--RIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred cc--cccceeehhhHHHHHHhhcCCcHHhc
Confidence 22 24455556677888999999999984
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=273.97 Aligned_cols=214 Identities=26% Similarity=0.386 Sum_probs=176.8
Q ss_pred hcCCCcceeeeeeceEEEEEEEE-cCCcEEEEEEcCCCC---hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTL-DDGTKVAVKRGNPRS---EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILV 576 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 576 (845)
..-|-.++.||-|+||+|.++.. ++...+|.|.+.+.+ ..+......|-.||....++-||+|+-.+.+++.+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 44577788899999999999974 456678999876553 34456678899999999999999999999999999999
Q ss_pred EEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCC
Q 003139 577 YEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPAL 656 (845)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~ 656 (845)
|||++||++-.+|... +-+.+.....++.++..|+++.|. .|+|||||||+|||||.+|++||+||||+.-....
T Consensus 708 MdYIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred EeccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccccccceec
Confidence 9999999998888544 457778888889999999999998 99999999999999999999999999998311000
Q ss_pred ---------C-------------------------------CcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHH
Q 003139 657 ---------D-------------------------------QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLM 696 (845)
Q Consensus 657 ---------~-------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ 696 (845)
+ ........+||+.|+|||++....++..+|.||.||||+
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 0 000112457999999999999999999999999999999
Q ss_pred HHHcCCCCCCCCCCcc-cccHHHH
Q 003139 697 EVLCTRPALNPVLPRE-QVNIAEW 719 (845)
Q Consensus 697 Elltg~~p~~~~~~~~-~~~l~~~ 719 (845)
||+.|++||....+.+ +..+..|
T Consensus 863 em~~g~~pf~~~tp~~tq~kv~nw 886 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGETQYKVINW 886 (1034)
T ss_pred HHhhCCCCccCCCCCcceeeeeeh
Confidence 9999999998776655 3334444
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-30 Score=286.23 Aligned_cols=245 Identities=27% Similarity=0.372 Sum_probs=187.9
Q ss_pred CCcceeeeeeceEE-EEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcEEEEEEecc
Q 003139 504 FDESLLLGVGGFGR-VYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERSEMILVYEYMA 581 (845)
Q Consensus 504 f~~~~~LG~G~fg~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~ 581 (845)
|...+++|.|+-|+ ||+|..+ |+.||||++-... .+-..+|+..|+.- .|||||++++.-.+.+..||..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 44445789999875 8999997 7899999976443 23456899999988 6999999999989999999999999
Q ss_pred CCCccccccCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECC-----CCceEEEeccccCCCC
Q 003139 582 NGPLRSHLYGT--DLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDD-----NFVAKVADFGLSKTGP 654 (845)
Q Consensus 582 ~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~-----~~~~kl~DFGla~~~~ 654 (845)
..+|.+++... +.....-...+.++.|+++||++||+ .+||||||||+||||+. ..+++|+|||+++...
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 56999999763 21112224557889999999999999 99999999999999975 3589999999998755
Q ss_pred CCCCc-ccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcC-CCCCCCCCCcccccHHHHHHHHhhcCchhhh
Q 003139 655 ALDQT-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCT-RPALNPVLPREQVNIAEWAMTWQKKGMLDQI 732 (845)
Q Consensus 655 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (845)
..... .......||-||+|||++....-+.++||||+|||+|..++| ..||.....++...+ ..+..+..+
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl-------~~~~~L~~L 735 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANIL-------TGNYTLVHL 735 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhh-------cCccceeee
Confidence 42211 123467799999999999999889999999999999999987 788876554432211 000011100
Q ss_pred hccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 003139 733 MDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLW 772 (845)
Q Consensus 733 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~ 772 (845)
+...++ ...+||.+|+..+|..||++.+|+.
T Consensus 736 -------~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 736 -------EPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred -------ccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 011122 6779999999999999999999974
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-30 Score=253.54 Aligned_cols=264 Identities=25% Similarity=0.343 Sum_probs=200.1
Q ss_pred CcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecC-----CcEEEE
Q 003139 505 DESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDER-----SEMILV 576 (845)
Q Consensus 505 ~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~lV 576 (845)
+..+.||-|+||.||.++.. +|+.|++|++... +-...+.+.+|+++|.-++|.|++..++..... +++|.|
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 34568999999999999865 7999999987653 233457888999999999999999999877543 367889
Q ss_pred EEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCC
Q 003139 577 YEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPAL 656 (845)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~ 656 (845)
.|.| ..+|...+... +.|+-..+.-++.||++||+|||+ .+|.||||||.|.|+++|...||+|||++|.-..
T Consensus 136 TELm-QSDLHKIIVSP--Q~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~- 208 (449)
T KOG0664|consen 136 TELM-QSDLHKIIVSP--QALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ- 208 (449)
T ss_pred HHHH-HhhhhheeccC--CCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccch-
Confidence 9998 46788877543 578888999999999999999999 9999999999999999999999999999997443
Q ss_pred CCcccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHH--------HHHhhcC
Q 003139 657 DQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWA--------MTWQKKG 727 (845)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~--------~~~~~~~ 727 (845)
++....+..+-|..|+|||.+++ +.|+.+.||||.|||+.||+..|..|....+.++.+++.-. ++..-+|
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence 33444456677889999999987 57999999999999999999999888877777665443211 1111122
Q ss_pred chhhhhccccCCC-------CC--HHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 728 MLDQIMDSNLVGK-------VN--PASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 728 ~~~~~~d~~l~~~-------~~--~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
.-..++....... +. ...-.+-..+..+++..+|++|.+..+.+..+.
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 2222222221110 11 112233456777888999999999888876653
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.6e-29 Score=236.39 Aligned_cols=195 Identities=26% Similarity=0.341 Sum_probs=162.5
Q ss_pred ceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcEEEEEEeccCC
Q 003139 507 SLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERSEMILVYEYMANG 583 (845)
Q Consensus 507 ~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~g 583 (845)
...||+|++|.|-+-++. +|+..|+|++... +.+..++.++|+++..+. ..|.+|.++|........++.||.|. -
T Consensus 51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~-t 129 (282)
T KOG0984|consen 51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD-T 129 (282)
T ss_pred hhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh-h
Confidence 346999999999888865 7999999987654 455667888999988776 69999999999999999999999994 5
Q ss_pred CccccccC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCccc
Q 003139 584 PLRSHLYG--TDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHV 661 (845)
Q Consensus 584 sL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 661 (845)
||..+-.+ .....+++.-+-+|+..+.+||.|||+ ...+||||+||+||||+.+|++||||||++-... +.-.
T Consensus 130 Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~---dSiA 204 (282)
T KOG0984|consen 130 SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLV---DSIA 204 (282)
T ss_pred hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeeh---hhhH
Confidence 77655432 234578888899999999999999998 5789999999999999999999999999986532 2223
Q ss_pred ccccccCCCcCChhhhcc----CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 003139 662 STAVKGSFGYLDPEYFRR----QQLTEKSDVYSFGVVLMEVLCTRPALNP 707 (845)
Q Consensus 662 ~~~~~gt~~y~aPE~~~~----~~~s~ksDV~S~Gvvl~Elltg~~p~~~ 707 (845)
.+-..|...|||||.+.. ..|+.|+||||+|+.+.||.+++.|++.
T Consensus 205 kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 205 KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 344568889999998753 4789999999999999999999999864
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=240.38 Aligned_cols=210 Identities=38% Similarity=0.576 Sum_probs=183.3
Q ss_pred eeeeceEEEEEEEEcC-CcEEEEEEcCCCChH-hHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEeccCCCccc
Q 003139 510 LGVGGFGRVYKGTLDD-GTKVAVKRGNPRSEQ-GIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRS 587 (845)
Q Consensus 510 LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~ 587 (845)
||+|.+|.||++...+ ++.+++|+....... ..+.+.+|++.++.++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999864 889999998766443 45678999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECC-CCceEEEeccccCCCCCCCCcccccccc
Q 003139 588 HLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDD-NFVAKVADFGLSKTGPALDQTHVSTAVK 666 (845)
Q Consensus 588 ~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~ 666 (845)
++.... ..+++..+..++.+++++|++||+ .+++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~ 154 (215)
T cd00180 81 LLKENE-GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIV 154 (215)
T ss_pred HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhccc
Confidence 986442 468999999999999999999999 89999999999999999 89999999999976433211 123355
Q ss_pred cCCCcCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCCHHH
Q 003139 667 GSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPAS 745 (845)
Q Consensus 667 gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 745 (845)
+...|++||.+... ..+.+.|+|++|++++||
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------- 187 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------- 187 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence 77889999999887 889999999999999998
Q ss_pred HHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 746 LKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 746 ~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
..+.+++.+|++.+|.+||++.++++.
T Consensus 188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 467799999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=237.19 Aligned_cols=199 Identities=33% Similarity=0.449 Sum_probs=172.5
Q ss_pred CCcceeeeeeceEEEEEEEEcC-CcEEEEEEcCCCChH-hHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEecc
Q 003139 504 FDESLLLGVGGFGRVYKGTLDD-GTKVAVKRGNPRSEQ-GIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMA 581 (845)
Q Consensus 504 f~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 581 (845)
|+..+.||+|++|.||++...+ ++.+++|........ ..+.+.+|++.+.+++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4566789999999999999875 889999998766544 67889999999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCccc
Q 003139 582 NGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHV 661 (845)
Q Consensus 582 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 661 (845)
+++|.+++..... .+++..+..++.+++.+|.+||+ .+++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~-~~~ 155 (225)
T smart00221 81 GGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL-AAL 155 (225)
T ss_pred CCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc-ccc
Confidence 9999999865431 28999999999999999999998 899999999999999999999999999997644321 012
Q ss_pred ccccccCCCcCChhhh-ccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 003139 662 STAVKGSFGYLDPEYF-RRQQLTEKSDVYSFGVVLMEVLCTRPALNP 707 (845)
Q Consensus 662 ~~~~~gt~~y~aPE~~-~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~ 707 (845)
.....++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 2345677889999998 777888899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.3e-28 Score=244.25 Aligned_cols=254 Identities=22% Similarity=0.300 Sum_probs=191.1
Q ss_pred CCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecC------CcE
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDER------SEM 573 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~ 573 (845)
+|...+.+|.|.- .|..+... .++.||+|+.... .....++..+|..++..+.|+|+++++.++... .+.
T Consensus 18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~ 96 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV 96 (369)
T ss_pred eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence 4555567888887 56555433 5789999976543 334456778999999999999999999998543 467
Q ss_pred EEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCC
Q 003139 574 ILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTG 653 (845)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~ 653 (845)
|+|||+| ..+|.+.+. -.++-+++..|..|++.|++|||+ .+|+||||||+||++..+..+||.|||+|+..
T Consensus 97 y~v~e~m-~~nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 97 YLVMELM-DANLCQVIL----MELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred HHHHHhh-hhHHHHHHH----HhcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhhccc
Confidence 9999999 568888775 347778899999999999999999 99999999999999999999999999999873
Q ss_pred CCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcC------
Q 003139 654 PALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKG------ 727 (845)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~------ 727 (845)
. ..-..+....|..|.|||++.+..+.+.+||||.||++.||++|+-.|.+.. .+-+|..-...-|
T Consensus 169 ~---~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d-----~idQ~~ki~~~lgtpd~~F 240 (369)
T KOG0665|consen 169 D---TDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD-----HIDQWNKIIEQLGTPDPSF 240 (369)
T ss_pred C---cccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch-----HHHHHHHHHHHhcCCCHHH
Confidence 2 2235567788999999999999889999999999999999999998776432 2223322111000
Q ss_pred ---------------------chhhhh-ccccCC--CCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 728 ---------------------MLDQIM-DSNLVG--KVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 728 ---------------------~~~~~~-d~~l~~--~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
...+.+ |..... +.++.......+++.+||..+|++|-+.++++.+
T Consensus 241 ~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 241 MKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 001111 111111 1112234567789999999999999999998765
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-27 Score=254.06 Aligned_cols=196 Identities=21% Similarity=0.371 Sum_probs=165.0
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC--------hHhHHHHHHHHHHHHhCC---CCCcceEEEEEec
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS--------EQGIAEFRTEIEMLSKLR---HRHLVSLIGYCDE 569 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~ 569 (845)
..|...+.||+|+||.|+.+.++ +...|+||.+.+.. ...+-..-.|+.+|..++ |+||+++++++++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 35778889999999999999987 45678888765432 111223456999999997 9999999999999
Q ss_pred CCcEEEEEEecc-CCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEecc
Q 003139 570 RSEMILVYEYMA-NGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFG 648 (845)
Q Consensus 570 ~~~~~lV~Ey~~-~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFG 648 (845)
++..||+||-.. +-+|.+++.- .+.+++.+..-|.+||+.|+++||+ ++|||||||-+||.++.+|.+||+|||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~--kp~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEF--KPRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhc--cCccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEeecc
Confidence 999999999764 4477777743 4579999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCCCcccccccccCCCcCChhhhccCCC-CchhHHHHHHHHHHHHHcCCCCCC
Q 003139 649 LSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLMEVLCTRPALN 706 (845)
Q Consensus 649 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~S~Gvvl~Elltg~~p~~ 706 (845)
.|.. ........++||.+|.|||++.+.+| ...-|||++|++||.++....|+.
T Consensus 716 saa~----~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 716 SAAY----TKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred chhh----hcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9865 23344556889999999999999887 456899999999999998888875
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.7e-27 Score=225.34 Aligned_cols=260 Identities=18% Similarity=0.286 Sum_probs=193.6
Q ss_pred hcCCCcceeeeeeceEEEEEEEE-cCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCC-CCCcceEEEEEecC--CcEEEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTL-DDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLR-HRHLVSLIGYCDER--SEMILV 576 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lV 576 (845)
.++|++.+.+|+|.+++||.|.. .+.++++||.+++... +.+.+|+.+|..|+ ||||++|++...+. ....||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk---kKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK---KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH---HHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 45678888999999999999984 4688999999887643 56778999999997 99999999998654 457899
Q ss_pred EEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEEC-CCCceEEEeccccCCCCC
Q 003139 577 YEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLD-DNFVAKVADFGLSKTGPA 655 (845)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~-~~~~~kl~DFGla~~~~~ 655 (845)
+||+.+.+...+- +.|+...+...+.++++||.|+|+ .||+|||+||.|++|| +...++|+|.|||.....
T Consensus 114 FE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 9999887766543 467888899999999999999999 9999999999999999 456899999999987543
Q ss_pred CCCcccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHH--------HHhhc
Q 003139 656 LDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAM--------TWQKK 726 (845)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~--------~~~~~ 726 (845)
... ....+.+..|.-||.+-. +.|+..-|+|||||+|.+|+..+.||.......+ .++..+. ....+
T Consensus 186 ~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~D-QLVkIakVLGt~el~~Yl~K 261 (338)
T KOG0668|consen 186 GKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVKIAKVLGTDELYAYLNK 261 (338)
T ss_pred Cce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHH-HHHHHHHHhChHHHHHHHHH
Confidence 221 223345667889998864 6789999999999999999999999865443321 1222211 11111
Q ss_pred ------CchhhhhccccCCC-------CCHH-HHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 727 ------GMLDQIMDSNLVGK-------VNPA-SLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 727 ------~~~~~~~d~~l~~~-------~~~~-~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
.....++....... .+.. ...+.++++.+.|..|-.+|||+.|.+.+--
T Consensus 262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~Hpy 324 (338)
T KOG0668|consen 262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPY 324 (338)
T ss_pred HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCch
Confidence 11122222111111 0111 2356779999999999999999999887643
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-25 Score=239.79 Aligned_cols=132 Identities=26% Similarity=0.368 Sum_probs=112.4
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCC-----C---CCcceEEEEEe---
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLR-----H---RHLVSLIGYCD--- 568 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H---~niv~l~g~~~--- 568 (845)
.++|...++||.|.|++||++... +.+.||+|+.+.. +...+..+.||++|++++ | ..||+|++.|.
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 368889999999999999999754 5677999987533 334466788999999984 2 47999999984
Q ss_pred -cCCcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEE
Q 003139 569 -ERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILL 636 (845)
Q Consensus 569 -~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl 636 (845)
.+.+.|||+|++ |.+|..+|.......++...+.+|++||+.||.|||.+ .+|||-||||+||||
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLL 221 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeee
Confidence 456899999999 77888888877778899999999999999999999984 589999999999999
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.1e-27 Score=259.36 Aligned_cols=253 Identities=26% Similarity=0.387 Sum_probs=203.7
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
..+|+....+|+|.+|.|||++.. .++..|+|.++........-..+|+-+++..+||||+.++|-+.....+++.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 356778889999999999999865 6889999988776666667778899999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCc
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT 659 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~ 659 (845)
|.+|+|++.-+.. +++++.++..+++..++||+|||+ .+-+|||||-.|||+++.+.+|++|||.+-.... .-
T Consensus 94 cgggslQdiy~~T--gplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqita--ti 166 (829)
T KOG0576|consen 94 CGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITA--TI 166 (829)
T ss_pred cCCCcccceeeec--ccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhh--hh
Confidence 9999999987544 589999999999999999999999 8999999999999999999999999999854322 12
Q ss_pred ccccccccCCCcCChhhh---ccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccc
Q 003139 660 HVSTAVKGSFGYLDPEYF---RRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSN 736 (845)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~---~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (845)
.......||+.|||||+. +.+.|..++|||+.|+...|+---++|.....+.... .+.. ....++.
T Consensus 167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l-------~LmT----kS~~qpp 235 (829)
T KOG0576|consen 167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRAL-------FLMT----KSGFQPP 235 (829)
T ss_pred hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHH-------HHhh----ccCCCCC
Confidence 223567899999999975 4678999999999999999997777776544332211 1111 1112222
Q ss_pred cCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 003139 737 LVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLW 772 (845)
Q Consensus 737 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~ 772 (845)
-..+ .......|-++++.|+-++|++||+++.+++
T Consensus 236 ~lkD-k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 236 TLKD-KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred cccC-CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 1111 1234567889999999999999999988664
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.4e-26 Score=226.08 Aligned_cols=250 Identities=20% Similarity=0.294 Sum_probs=181.2
Q ss_pred hcCCCcceeeeeeceEEEEEEEEcC-CcEEEEEEcCCCChHhHHHHHHHHHHHHhC-CCCCcceEEEE-EecCCcEEEEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLDD-GTKVAVKRGNPRSEQGIAEFRTEIEMLSKL-RHRHLVSLIGY-CDERSEMILVY 577 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~-~~~~~~~~lV~ 577 (845)
.+.|++.+.||+|.||.+.++.++. .+.+++|-+. ......++|.+|..---.| .|.||+.-++. ++..+..++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp-~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVP-RPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccC-cchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 3568888999999999999999884 5667788654 3344568899998755555 58999987764 46667788999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEEC--CCCceEEEeccccCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLD--DNFVAKVADFGLSKTGPA 655 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~--~~~~~kl~DFGla~~~~~ 655 (845)
||+|.|+|..-+... .+.+....+++.|++.||.|+|+ .++||||||.+||||- +..++||||||+.+....
T Consensus 102 E~aP~gdL~snv~~~---GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAA---GIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred ccCccchhhhhcCcc---cccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 999999999887543 46677788999999999999999 9999999999999993 455999999999875322
Q ss_pred CCCcccccccccCCCcCChhhhccC-----CCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchh
Q 003139 656 LDQTHVSTAVKGSFGYLDPEYFRRQ-----QLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLD 730 (845)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (845)
.......+..|.+||..... ...+.+|||.||++++.++||+.||..... .+....+| ..+.++...
T Consensus 176 -----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~-~d~~Y~~~--~~w~~rk~~ 247 (378)
T KOG1345|consen 176 -----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI-MDKPYWEW--EQWLKRKNP 247 (378)
T ss_pred -----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc-cCchHHHH--HHHhcccCc
Confidence 12234456679999977532 346789999999999999999999974322 22233333 333333222
Q ss_pred hhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHH
Q 003139 731 QIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVL 771 (845)
Q Consensus 731 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl 771 (845)
.+ |+. + ....+++.++-++-+..++++|=-..++.
T Consensus 248 ~~--P~~---F-~~fs~~a~r~Fkk~lt~~~~drcki~~~k 282 (378)
T KOG1345|consen 248 AL--PKK---F-NPFSEKALRLFKKSLTPRFKDRCKIWTAK 282 (378)
T ss_pred cC--chh---h-cccCHHHHHHHHHhcCCcccccchhHHHH
Confidence 21 111 1 12234556677788889999984444433
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.9e-26 Score=242.38 Aligned_cols=264 Identities=22% Similarity=0.245 Sum_probs=197.7
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCC------CCCcceEEEEEecCCcE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLR------HRHLVSLIGYCDERSEM 573 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------H~niv~l~g~~~~~~~~ 573 (845)
.++|.+.-..|+|-|++|..|... .|+.||||++... +.-.+.=+.|+++|++|. -.|+++|+-.|...+++
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHL 509 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHL 509 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhccee
Confidence 478888888999999999999865 5789999998754 333345578999999995 35889999999999999
Q ss_pred EEEEEeccCCCccccccCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCC-CceEEEeccccC
Q 003139 574 ILVYEYMANGPLRSHLYGT-DLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDN-FVAKVADFGLSK 651 (845)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~-~~~kl~DFGla~ 651 (845)
|||+|-+ ..+|++.|..- ..-.|..+.+..++.|+.-||..|.. .+|+|.||||.|||+++. ..+||||||.|.
T Consensus 510 ClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~ 585 (752)
T KOG0670|consen 510 CLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNESKNILKLCDFGSAS 585 (752)
T ss_pred EEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEeccCcceeeeccCcccc
Confidence 9999987 56888888643 23458889999999999999999998 899999999999999864 578999999997
Q ss_pred CCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHH-----HHHhhc
Q 003139 652 TGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWA-----MTWQKK 726 (845)
Q Consensus 652 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~-----~~~~~~ 726 (845)
.... .. .+...-+..|.|||.+.+-+|+...|+||.||.||||.||+..|.+........+..-+ .+++.+
T Consensus 586 ~~~e---ne-itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRK 661 (752)
T KOG0670|consen 586 FASE---NE-ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRK 661 (752)
T ss_pred cccc---cc-ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhh
Confidence 6332 22 22333456799999999999999999999999999999999888765433322111111 011111
Q ss_pred Cc-hhhhhcc--------------------------------ccCC--CCC---HHHHHHHHHHHHHhhhhCCCCCCCHH
Q 003139 727 GM-LDQIMDS--------------------------------NLVG--KVN---PASLKKFGETAEKCLAEHGVDRPSMG 768 (845)
Q Consensus 727 ~~-~~~~~d~--------------------------------~l~~--~~~---~~~~~~l~~l~~~cl~~~p~~RPs~~ 768 (845)
+. ..+-+|. .|.+ .++ +.....|.+|+..|+..||++|.|..
T Consensus 662 gqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~n 741 (752)
T KOG0670|consen 662 GQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVN 741 (752)
T ss_pred cchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHH
Confidence 10 1111111 1111 122 33556788899999999999999999
Q ss_pred HHHHH
Q 003139 769 DVLWN 773 (845)
Q Consensus 769 ~vl~~ 773 (845)
+.|++
T Consensus 742 qAL~H 746 (752)
T KOG0670|consen 742 QALKH 746 (752)
T ss_pred HHhcC
Confidence 88764
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-25 Score=275.28 Aligned_cols=197 Identities=18% Similarity=0.205 Sum_probs=139.7
Q ss_pred hCCC-CCcceEEEEE-------ecCCcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcee
Q 003139 554 KLRH-RHLVSLIGYC-------DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSII 625 (845)
Q Consensus 554 ~l~H-~niv~l~g~~-------~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv 625 (845)
.++| +||++++++| .+...+++++||+ +++|.++|... ...+++.+++.++.||++||+|||+ ++|+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~gIv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHS---QGIV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHh---CCee
Confidence 4556 6888888887 2334678889988 66999999643 3469999999999999999999998 9999
Q ss_pred eccCCCCcEEECCC-------------------CceEEEeccccCCCCCCCC--------------cccccccccCCCcC
Q 003139 626 HRDVKTTNILLDDN-------------------FVAKVADFGLSKTGPALDQ--------------THVSTAVKGSFGYL 672 (845)
Q Consensus 626 HrDik~~NILl~~~-------------------~~~kl~DFGla~~~~~~~~--------------~~~~~~~~gt~~y~ 672 (845)
||||||+||||+.. +.+||+|||+++....... ........||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 99999999999654 4556666666653211000 00011235788999
Q ss_pred ChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHH
Q 003139 673 DPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGET 752 (845)
Q Consensus 673 aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l 752 (845)
|||++.+..++.++|||||||+||||++|.+|+.... . ...... ...+.+.. .........+
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~----~----~~~~~~-----~~~~~~~~-----~~~~~~~~~~ 244 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS----R----TMSSLR-----HRVLPPQI-----LLNWPKEASF 244 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH----H----HHHHHH-----HhhcChhh-----hhcCHHHHHH
Confidence 9999999999999999999999999999987753211 0 000000 00111111 1112345678
Q ss_pred HHHhhhhCCCCCCCHHHHHHH
Q 003139 753 AEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 753 ~~~cl~~~p~~RPs~~~vl~~ 773 (845)
+.+||+.+|.+||+|.|++++
T Consensus 245 ~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 245 CLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHhCCCChhhCcChHHHhhc
Confidence 889999999999999999753
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.1e-25 Score=231.74 Aligned_cols=266 Identities=23% Similarity=0.310 Sum_probs=196.2
Q ss_pred HHHHhcCCCcceeeeeeceEEEEEEEEc----CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCC-CCCcceEEEEEecCC
Q 003139 497 ILDATNKFDESLLLGVGGFGRVYKGTLD----DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLR-HRHLVSLIGYCDERS 571 (845)
Q Consensus 497 l~~at~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~ 571 (845)
+....+.|...++||+|.|+.||++++. ....||+|.+...+.. ....+|+++|..+. +.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 3444567888999999999999999854 3567999998776544 46889999999994 999999999999999
Q ss_pred cEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEEC-CCCceEEEecccc
Q 003139 572 EMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLD-DNFVAKVADFGLS 650 (845)
Q Consensus 572 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~-~~~~~kl~DFGla 650 (845)
..++|+||++.....+++. .++..++...++.+..||.++|. .|||||||||+|+|.+ .-+.-.|.|||||
T Consensus 109 ~v~ivlp~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred eeEEEecccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhH
Confidence 9999999999988888773 46788999999999999999999 9999999999999998 4567899999999
Q ss_pred CCC-----------------CC-CC------------------------CcccccccccCCCcCChhhhcc-CCCCchhH
Q 003139 651 KTG-----------------PA-LD------------------------QTHVSTAVKGSFGYLDPEYFRR-QQLTEKSD 687 (845)
Q Consensus 651 ~~~-----------------~~-~~------------------------~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksD 687 (845)
... .. .. .........||+||+|||++.. ...+.++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 610 00 00 0000113458999999998865 56799999
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHH-----------Hhhc------Cc---hhhhh---ccc--------
Q 003139 688 VYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMT-----------WQKK------GM---LDQIM---DSN-------- 736 (845)
Q Consensus 688 V~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~-----------~~~~------~~---~~~~~---d~~-------- 736 (845)
|||.|||++-+++++.||...... ...+.+.+.- ..+. .. +.+.. +..
T Consensus 261 iws~GVI~Lslls~~~PFf~a~dd-~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~ 339 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKAKDD-ADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS 339 (418)
T ss_pred eeeccceeehhhccccccccCccc-cchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence 999999999999999998643322 1122222110 0000 00 00000 000
Q ss_pred ----cCCCC-CHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 737 ----LVGKV-NPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 737 ----l~~~~-~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
..... ....+..+.+++.+|+..||.+|-|++|.+++
T Consensus 340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 00001 11123468899999999999999999998865
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.6e-24 Score=213.38 Aligned_cols=168 Identities=21% Similarity=0.200 Sum_probs=125.9
Q ss_pred CCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcccc
Q 003139 583 GPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVS 662 (845)
Q Consensus 583 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 662 (845)
|+|.+++... ...++|.+++.|+.|+++||+|||+ .+ ||+|||+++++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~------ 62 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPE------ 62 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeeccc------
Confidence 6888888643 3469999999999999999999998 44 999999999999999 9998764321
Q ss_pred cccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCC
Q 003139 663 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVN 742 (845)
Q Consensus 663 ~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 742 (845)
...||+.|||||++.+..++.++|||||||++|||++|+.||........ .+..+....... ++. .....
T Consensus 63 -~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~~-------~~~-~~~~~ 132 (176)
T smart00750 63 -QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA-ILEILLNGMPAD-------DPR-DRSNL 132 (176)
T ss_pred -cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH-HHHHHHHHhccC-------Ccc-ccccH
Confidence 12588999999999999999999999999999999999999864322111 111111111000 000 00111
Q ss_pred HHHHH--HHHHHHHHhhhhCCCCCCCHHHHHHHHHHhh
Q 003139 743 PASLK--KFGETAEKCLAEHGVDRPSMGDVLWNLEYAL 778 (845)
Q Consensus 743 ~~~~~--~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~ 778 (845)
..... .+.+++.+||+.+|.+||++.++++++....
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 22233 6899999999999999999999999987653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.6e-25 Score=216.51 Aligned_cols=245 Identities=20% Similarity=0.343 Sum_probs=195.3
Q ss_pred eeeeeceEEEEEEEEcCCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEeccCCCcc
Q 003139 509 LLGVGGFGRVYKGTLDDGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLR 586 (845)
Q Consensus 509 ~LG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 586 (845)
+|.+...|+.|+|+++ |..+++|++... ....-++|..|.-.|+.+.||||+.++|.|.....+.++..|||.|+|.
T Consensus 197 kl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsly 275 (448)
T KOG0195|consen 197 KLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLY 275 (448)
T ss_pred hhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHH
Confidence 6888999999999998 556667765433 2333468999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcccccccc
Q 003139 587 SHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVK 666 (845)
Q Consensus 587 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 666 (845)
..|++......+-.+..+++.++|+|++|||+-. +-|.---|.+..|+||++..++|+- +-.++ ........
T Consensus 276 nvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarism-ad~kf------sfqe~gr~ 347 (448)
T KOG0195|consen 276 NVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISM-ADTKF------SFQEVGRA 347 (448)
T ss_pred HHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheec-cccee------eeeccccc
Confidence 9999877667788899999999999999999832 3344447999999999999998852 11111 00111223
Q ss_pred cCCCcCChhhhccCCCC---chhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCCH
Q 003139 667 GSFGYLDPEYFRRQQLT---EKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNP 743 (845)
Q Consensus 667 gt~~y~aPE~~~~~~~s---~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 743 (845)
-.+.||+||.+..++-+ .++|+|||.++||||.|...||....+-+. -.++.-..+...+++
T Consensus 348 y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec---------------gmkialeglrv~ipp 412 (448)
T KOG0195|consen 348 YSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC---------------GMKIALEGLRVHIPP 412 (448)
T ss_pred cCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh---------------hhhhhhccccccCCC
Confidence 46789999999876643 579999999999999999999977655442 112233445567888
Q ss_pred HHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 003139 744 ASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYA 777 (845)
Q Consensus 744 ~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~ 777 (845)
.....+.+++.-|+..||.+||.+..|+-.||+.
T Consensus 413 gis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 413 GISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred CccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 8899999999999999999999999999999875
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=221.79 Aligned_cols=165 Identities=22% Similarity=0.187 Sum_probs=128.8
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc--CCcEEEEEEcCCC-----ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD--DGTKVAVKRGNPR-----SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEM 573 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~--~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 573 (845)
-++|...+.||+|+||.||+|.++ +++.+|||+.... .....+.|.+|+++|++++|+|+++.+.. .+..
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~ 93 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKD 93 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCc
Confidence 467888999999999999999875 5777899986533 22345678999999999999999964432 2468
Q ss_pred EEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccC-CCCcEEECCCCceEEEeccccCC
Q 003139 574 ILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDV-KTTNILLDDNFVAKVADFGLSKT 652 (845)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDi-k~~NILl~~~~~~kl~DFGla~~ 652 (845)
++||||+++++|... . . .. ...++.|++++|.|||+ ++|+|||| ||+|||++.++.+||+|||+|+.
T Consensus 94 ~LVmE~~~G~~L~~~-~-~----~~---~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 94 GLVRGWTEGVPLHLA-R-P----HG---DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQLASV 161 (365)
T ss_pred EEEEEccCCCCHHHh-C-c----cc---hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence 999999999999632 1 1 11 14678899999999999 99999999 99999999999999999999986
Q ss_pred CCCCCCcc------cccccccCCCcCChhhhccC
Q 003139 653 GPALDQTH------VSTAVKGSFGYLDPEYFRRQ 680 (845)
Q Consensus 653 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~ 680 (845)
........ ..+...+++.|+|||.+...
T Consensus 162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 44322111 11456788999999998643
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.6e-21 Score=213.78 Aligned_cols=263 Identities=19% Similarity=0.229 Sum_probs=196.2
Q ss_pred CCCcceeeeeeceEEEEEEEEcCC--cEEEEEEcCCCChHhHHHHHHHHHHHHhCCC----CCcceEEEEE-ecCCcEEE
Q 003139 503 KFDESLLLGVGGFGRVYKGTLDDG--TKVAVKRGNPRSEQGIAEFRTEIEMLSKLRH----RHLVSLIGYC-DERSEMIL 575 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~~g--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H----~niv~l~g~~-~~~~~~~l 575 (845)
+|.+.+.||+|+||.||++..... ..+|+|............+..|..++..+.+ +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 788999999999999999997643 4688886554432222267788998988873 5888999888 57778999
Q ss_pred EEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCC-----CceEEEecccc
Q 003139 576 VYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDN-----FVAKVADFGLS 650 (845)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~-----~~~kl~DFGla 650 (845)
||+.+ |.+|.++........++..+.++|+.|++.+|++||+ .+++||||||.|+++... ..+.|.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99988 8899997755445689999999999999999999999 999999999999999854 46999999999
Q ss_pred C--CCCCCCC-----ccc-ccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHH
Q 003139 651 K--TGPALDQ-----THV-STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMT 722 (845)
Q Consensus 651 ~--~~~~~~~-----~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~ 722 (845)
+ ....... ... .....||..|++++...+...+.+.|+||++.++.|++.|..||.......... .
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~--~---- 248 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKS--K---- 248 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHH--H----
Confidence 8 3211111 111 234569999999999999999999999999999999999999986544322110 0
Q ss_pred HhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhhh
Q 003139 723 WQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLE 781 (845)
Q Consensus 723 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~ 781 (845)
..+......... .....+..+.++...+-..+..++|....+...|+....-.
T Consensus 249 -~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 249 -FEKDPRKLLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred -HHHHhhhhcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 000011111111 11223345556666666689999999999999988765533
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.9e-20 Score=200.12 Aligned_cols=261 Identities=30% Similarity=0.392 Sum_probs=196.0
Q ss_pred CCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChH---hHHHHHHHHHHHHhCCCC-CcceEEEEEecCCcEEEEEEe
Q 003139 504 FDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQ---GIAEFRTEIEMLSKLRHR-HLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 504 f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lV~Ey 579 (845)
|...+.||.|+||.||++... ..+++|.+...... ....|.+|+.++..+.|+ +++++.+.+......++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 556778999999999999887 77888987654322 467899999999999988 799999999777778999999
Q ss_pred ccCCCccccccCCCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCC-ceEEEeccccCCCCCCC
Q 003139 580 MANGPLRSHLYGTDL-PPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNF-VAKVADFGLSKTGPALD 657 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~-~~kl~DFGla~~~~~~~ 657 (845)
+.+++|.+++..... ..+.......++.|++.+++|+|+ .+++||||||+||+++... .++++|||+++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999966643321 268889999999999999999999 8899999999999999988 79999999997533322
Q ss_pred Ccc----cccccccCCCcCChhhhcc---CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchh
Q 003139 658 QTH----VSTAVKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLD 730 (845)
Q Consensus 658 ~~~----~~~~~~gt~~y~aPE~~~~---~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (845)
... ......|+..|+|||.+.+ ...+...|+||+|++++++++|..|+...... ................
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP 233 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc
Confidence 211 3456789999999999987 68899999999999999999999996543321 0001111111111100
Q ss_pred hhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 731 QIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 731 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.................+.+++..|+..+|..|.++.+....
T Consensus 234 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 -SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred -ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000001223578899999999999999999887765
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.6e-21 Score=186.53 Aligned_cols=258 Identities=18% Similarity=0.233 Sum_probs=198.7
Q ss_pred hcCCCcceeeeeeceEEEEEEE-EcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCC-CCcceEEEEEecCCcEEEEEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRH-RHLVSLIGYCDERSEMILVYE 578 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E 578 (845)
.++|...+.||+|+||.+|.|. ..+|+.||||.-.... ...++.-|.++...|+| ..|..+..|..++..-.+|||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 3678999999999999999998 4589999999855432 22456789999999976 467777777888889999999
Q ss_pred eccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECC---CCceEEEeccccCCCCC
Q 003139 579 YMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDD---NFVAKVADFGLSKTGPA 655 (845)
Q Consensus 579 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~---~~~~kl~DFGla~~~~~ 655 (845)
.+ |.||.+++.-.+ ..++.++++-++-|++.-++|+|. +++|||||||+|.|..- ...+.++|||||+...+
T Consensus 92 LL-GPsLEdLfnfC~-R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCS-RRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred cc-CccHHHHHHHHh-hhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 98 789988774332 468999999999999999999999 99999999999999973 35789999999986443
Q ss_pred CCC-----cccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchh
Q 003139 656 LDQ-----THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLD 730 (845)
Q Consensus 656 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (845)
... ........||..|.+-....+...+.+.|+=|+|.+|..+..|..||.+..+...... .+
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QK------------yE 234 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQK------------YE 234 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHH------------HH
Confidence 222 1223467899999999988888889999999999999999999999987765432211 11
Q ss_pred hhhccccC---CCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 003139 731 QIMDSNLV---GKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYA 777 (845)
Q Consensus 731 ~~~d~~l~---~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~ 777 (845)
++.+..+. ...-...+.++.-.+.-|-...-++-|...-+.+...-+
T Consensus 235 kI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriL 284 (341)
T KOG1163|consen 235 KISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRIL 284 (341)
T ss_pred HHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHH
Confidence 22221111 111233466777888889888889999887766655443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.7e-20 Score=191.58 Aligned_cols=261 Identities=17% Similarity=0.208 Sum_probs=196.9
Q ss_pred CCCcceeeeeeceEEEEEEEE-cCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCC-CCCcceEEEEEecCCcEEEEEEec
Q 003139 503 KFDESLLLGVGGFGRVYKGTL-DDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLR-HRHLVSLIGYCDERSEMILVYEYM 580 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~ 580 (845)
.|.+.++||+|.||.++.|+. -+++.||||.-...++. -++..|.+..+.|. .++|...+-+-.++.+-.||+|.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A--PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA--PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCCc--chHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 588889999999999999983 47899999975444432 45667888888884 689999988888888999999998
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECC-----CCceEEEeccccCCCCC
Q 003139 581 ANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDD-----NFVAKVADFGLSKTGPA 655 (845)
Q Consensus 581 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~-----~~~~kl~DFGla~~~~~ 655 (845)
|-||+++..-. ...++.++++.||.|++.-++|+|+ +.+|.|||||+|+||.. ...+.|+|||+|+...+
T Consensus 107 -GPSLEDLFD~C-gR~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 107 -GPSLEDLFDLC-GRRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred -CcCHHHHHHHh-cCcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 78998876433 3479999999999999999999999 99999999999999963 34789999999987554
Q ss_pred CCCc-----ccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchh
Q 003139 656 LDQT-----HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLD 730 (845)
Q Consensus 656 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (845)
.... .......||.+||+-....++..+.+.|+=|+|-+++..|.|..||.+........--+-+....+.-.+.
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~ 261 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIE 261 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHH
Confidence 3322 22456789999999999999999999999999999999999999998765543211101000001111122
Q ss_pred hhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 003139 731 QIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779 (845)
Q Consensus 731 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~ 779 (845)
+++ ...+.++..-+.-.-..+-++-|..+-+...+..++.
T Consensus 262 ~Lc---------~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvld 301 (449)
T KOG1165|consen 262 VLC---------EGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLD 301 (449)
T ss_pred HHH---------hcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 222 2344555565555566777788888777766666543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.2e-21 Score=225.95 Aligned_cols=255 Identities=21% Similarity=0.225 Sum_probs=187.0
Q ss_pred cceeeeeeceEEEEEEEEc-CCcEEEEEEcC-----CCChH-hHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEE
Q 003139 506 ESLLLGVGGFGRVYKGTLD-DGTKVAVKRGN-----PRSEQ-GIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYE 578 (845)
Q Consensus 506 ~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~-----~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 578 (845)
...++|.|++|.|+..... .....+.|... ..+.. ....+..|+.+-..++|+|++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 3458999999977776643 33334444321 11221 22236678888888999999888877777666666699
Q ss_pred eccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCC
Q 003139 579 YMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQ 658 (845)
Q Consensus 579 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~ 658 (845)
|+++ +|..++... ..++-.++..+..|+..|++|||+ .+|.|||||++|+++..++.+||+|||.+........
T Consensus 402 ~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred cccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 9999 999888543 468888999999999999999999 9999999999999999999999999999875433333
Q ss_pred c--ccccccccCCCcCChhhhccCCCCc-hhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcc
Q 003139 659 T--HVSTAVKGSFGYLDPEYFRRQQLTE-KSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDS 735 (845)
Q Consensus 659 ~--~~~~~~~gt~~y~aPE~~~~~~~s~-ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (845)
. ......+|+..|+|||++.+.+|.+ ..||||.|+++..|++|+.||......++.. ..... ..+.-..
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-----~~~~~---~~~~~~~ 547 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-----KTNNY---SDQRNIF 547 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----hhhcc---ccccccc
Confidence 3 5567889999999999999999976 5899999999999999999986543332210 00000 0000000
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003139 736 NLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNL 774 (845)
Q Consensus 736 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L 774 (845)
.-...+....+.+...++.++|+.+|.+|-|+.+|++.=
T Consensus 548 ~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~ 586 (601)
T KOG0590|consen 548 EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDE 586 (601)
T ss_pred cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhCh
Confidence 000112244567788899999999999999999998653
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.3e-20 Score=206.20 Aligned_cols=218 Identities=24% Similarity=0.340 Sum_probs=164.5
Q ss_pred HHhCCCCCcceEEEEEecCCcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCC
Q 003139 552 LSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKT 631 (845)
Q Consensus 552 l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~ 631 (845)
|+.+.|.|+.+++|.|.++...+.|.+||..|+|.+.+... ...++|.-...+++++++||+|||. ++-..|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHN--SPIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhc--Ccceeeeeecc
Confidence 45789999999999999999999999999999999999763 4579999999999999999999998 23339999999
Q ss_pred CcEEECCCCceEEEeccccCCCCCCCCcccccccccCCCcCChhhhccC-------CCCchhHHHHHHHHHHHHHcCCCC
Q 003139 632 TNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQ-------QLTEKSDVYSFGVVLMEVLCTRPA 704 (845)
Q Consensus 632 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~s~ksDV~S~Gvvl~Elltg~~p 704 (845)
+|+++|..+.+||+|||+.................-..-|.|||.++.. ..+.+.||||||++++|+++.+.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 9999999999999999998775431112222223344579999998763 257789999999999999999999
Q ss_pred CCCCCCccc-ccHHHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 003139 705 LNPVLPREQ-VNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779 (845)
Q Consensus 705 ~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~ 779 (845)
|+.....+. ..++.++.. .-.....|.+... .+....+..++.+||..+|++||++++|...++....
T Consensus 158 ~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cccccccCChHHHHHHHHh-----cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 976433322 223332222 0011111111100 1334478899999999999999999999887776544
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.8e-20 Score=183.31 Aligned_cols=137 Identities=18% Similarity=0.164 Sum_probs=107.2
Q ss_pred eeeeeeceEEEEEEEEcCCcEEEEEEcCCCChH--h-------HHH-----------------HHHHHHHHHhCCCCCcc
Q 003139 508 LLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQ--G-------IAE-----------------FRTEIEMLSKLRHRHLV 561 (845)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--~-------~~~-----------------~~~E~~~l~~l~H~niv 561 (845)
..||+|+||.||+|...+|+.||||.+...... . ... ...|++.+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 479999999999999888999999987543210 0 112 23499999999888764
Q ss_pred eEEEEEecCCcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCceeeccCCCCcEEECCCC
Q 003139 562 SLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYL-HTGAAQSIIHRDVKTTNILLDDNF 640 (845)
Q Consensus 562 ~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivHrDik~~NILl~~~~ 640 (845)
....+.. ...+|||||+++++|...+.. ...+++.+.++++.|++.+|.|| |+ .+|+||||||+|||++ ++
T Consensus 83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~-~~ 154 (190)
T cd05147 83 CPEPILL--KSHVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYH-DG 154 (190)
T ss_pred CCcEEEe--cCCEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEE-CC
Confidence 4333322 234899999998877654322 24688999999999999999999 66 8999999999999998 47
Q ss_pred ceEEEeccccCC
Q 003139 641 VAKVADFGLSKT 652 (845)
Q Consensus 641 ~~kl~DFGla~~ 652 (845)
.++|+|||+|..
T Consensus 155 ~v~LiDFG~a~~ 166 (190)
T cd05147 155 KLYIIDVSQSVE 166 (190)
T ss_pred cEEEEEcccccc
Confidence 899999999975
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.5e-20 Score=186.75 Aligned_cols=170 Identities=15% Similarity=0.147 Sum_probs=133.4
Q ss_pred hcCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCC---hHhHHH------HHHHHHHHHhCCCCCcceEEEEEecC-
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRS---EQGIAE------FRTEIEMLSKLRHRHLVSLIGYCDER- 570 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~---~~~~~~------~~~E~~~l~~l~H~niv~l~g~~~~~- 570 (845)
.++|...++||.|+||.||+... ++..+|+|.+.+.. +..... +.+|++.+.+++|++|..+..++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 58999999999999999999765 57789999886542 222233 57899999999999999998885432
Q ss_pred -------CcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceE
Q 003139 571 -------SEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAK 643 (845)
Q Consensus 571 -------~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~k 643 (845)
+..+|||||++|.+|.++. .++. ....+++.+|..||+ .+++||||||+||++++++ ++
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~------~~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~g-i~ 174 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMP------EISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKNG-LR 174 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhh------hccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCCC-EE
Confidence 3589999999999998763 1222 346699999999999 9999999999999999988 99
Q ss_pred EEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHH
Q 003139 644 VADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVL 699 (845)
Q Consensus 644 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ell 699 (845)
|+|||..+.... .... ..+...+.+..++|+|+||+.+.-+.
T Consensus 175 liDfg~~~~~~e--~~a~------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 175 IIDLSGKRCTAQ--RKAK------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEECCCcccccc--hhhH------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999998865321 1100 11445556778999999999988763
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.9e-20 Score=216.24 Aligned_cols=249 Identities=20% Similarity=0.217 Sum_probs=180.0
Q ss_pred CCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCC-hHhHHHHHHHHHH--HHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 503 KFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRS-EQGIAEFRTEIEM--LSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
++...+.||++.|=+|.+|++++|. |+||.+-+.. .-.++.|.++++- ...++|||.+++.-+-......|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5666778999999999999999887 8888765443 3345555554443 4556899999998887777778899899
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCC-CC
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPAL-DQ 658 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~-~~ 658 (845)
.. -+|.+.|. .++-|...+...|+.|++.||..+|. .+|+|||||.+||||++-.-+.|+||.--+...-. +.
T Consensus 103 vk-hnLyDRlS--TRPFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 103 VK-HNLYDRLS--TRPFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred Hh-hhhhhhhc--cchHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 85 47888883 34567888899999999999999999 99999999999999999999999999877643221 11
Q ss_pred ccccc----ccccCCCcCChhhhcc----------CC-CCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHH
Q 003139 659 THVST----AVKGSFGYLDPEYFRR----------QQ-LTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMT 722 (845)
Q Consensus 659 ~~~~~----~~~gt~~y~aPE~~~~----------~~-~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~ 722 (845)
....+ .-..-.+|.|||.+-. .. .+++.||||+||++.||++ |+++|+. .+....
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L---------SQL~aY 247 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL---------SQLLAY 247 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH---------HHHHhH
Confidence 11111 1222347999998743 12 6789999999999999987 5777642 111111
Q ss_pred Hhh-cCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 723 WQK-KGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 723 ~~~-~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
... ....+..+.. + +...++++++.|++.||.+|.++++.++.-.
T Consensus 248 r~~~~~~~e~~Le~-----I---ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 248 RSGNADDPEQLLEK-----I---EDVSLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred hccCccCHHHHHHh-----C---cCccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 111 1111111111 1 1125778999999999999999999998844
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.6e-18 Score=171.19 Aligned_cols=186 Identities=18% Similarity=0.113 Sum_probs=140.4
Q ss_pred CcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCCh----HhHHHHHHHHHHHHhCC-CCCcceEEEEEecCCcEEEEEEe
Q 003139 505 DESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSE----QGIAEFRTEIEMLSKLR-HRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 505 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
.+...|++|+||+||.+.- .+.+++.+.+..... .....|.+|+++|++++ |+++.+++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3456899999999997765 577888777654432 11235789999999995 5889999987 457999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccC-CCCcEEECCCCceEEEeccccCCCCCCCC
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDV-KTTNILLDDNFVAKVADFGLSKTGPALDQ 658 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDi-k~~NILl~~~~~~kl~DFGla~~~~~~~~ 658 (845)
++|.+|...+.. ....++.|++++|+++|+ .+|+|||| ||+|||+++++.++|+|||+|........
T Consensus 80 I~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 80 LAGAAMYQRPPR---------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred ecCccHHhhhhh---------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 999888654311 124578899999999999 99999999 79999999999999999999985432211
Q ss_pred c----c------c-ccccccCCCcCChhhhccC-CCC-chhHHHHHHHHHHHHHcCCCCCCC
Q 003139 659 T----H------V-STAVKGSFGYLDPEYFRRQ-QLT-EKSDVYSFGVVLMEVLCTRPALNP 707 (845)
Q Consensus 659 ~----~------~-~~~~~gt~~y~aPE~~~~~-~~s-~ksDV~S~Gvvl~Elltg~~p~~~ 707 (845)
- . . ......++.|++|+..+-- ..+ ...+.++-|.-+|.++|++.+...
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0 0 0 1122368889999865432 333 678999999999999999987654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=2e-18 Score=174.35 Aligned_cols=141 Identities=18% Similarity=0.151 Sum_probs=110.7
Q ss_pred ceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChH--------------------------hHHHHHHHHHHHHhCCCCCc
Q 003139 507 SLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQ--------------------------GIAEFRTEIEMLSKLRHRHL 560 (845)
Q Consensus 507 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~H~ni 560 (845)
...||+|++|.||+|...+|+.||||........ ....+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 3579999999999999878999999987654210 01224578999999999988
Q ss_pred ceEEEEEecCCcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCC
Q 003139 561 VSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNF 640 (845)
Q Consensus 561 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~ 640 (845)
.....+... ..+|||||++++++...... ...++..+..+++.|++.+|.+||+ ..+|+||||||+|||++ ++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~--~~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~-~~ 154 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK--DVPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh--hccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE-CC
Confidence 555444333 24899999998865443211 2357788999999999999999996 36999999999999999 78
Q ss_pred ceEEEeccccCCCC
Q 003139 641 VAKVADFGLSKTGP 654 (845)
Q Consensus 641 ~~kl~DFGla~~~~ 654 (845)
.++|+|||+++...
T Consensus 155 ~~~liDFG~a~~~~ 168 (190)
T cd05145 155 KPYIIDVSQAVELD 168 (190)
T ss_pred CEEEEEcccceecC
Confidence 99999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.4e-18 Score=178.49 Aligned_cols=231 Identities=19% Similarity=0.271 Sum_probs=149.6
Q ss_pred CCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCC---CChHhHHHHHHHHHHHHhCCC----------CCcceEEEEEe-
Q 003139 504 FDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNP---RSEQGIAEFRTEIEMLSKLRH----------RHLVSLIGYCD- 568 (845)
Q Consensus 504 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H----------~niv~l~g~~~- 568 (845)
+.....||.|+++.||.+++. +|+.+|+|.... ......+++.+|.-....+.+ -.++..++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 344568999999999999987 589999996432 233456777777766666433 12222222221
Q ss_pred --------cC---C-----cEEEEEEeccCCCccccccC---C--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeec
Q 003139 569 --------ER---S-----EMILVYEYMANGPLRSHLYG---T--DLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHR 627 (845)
Q Consensus 569 --------~~---~-----~~~lV~Ey~~~gsL~~~l~~---~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHr 627 (845)
.. . ..+++|+-+ .++|.+++.. . ....+....++.+..|+++.+++||+ .+++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEec
Confidence 11 1 236778877 5678776531 1 11234456677888999999999999 999999
Q ss_pred cCCCCcEEECCCCceEEEeccccCCCCCCCCcccccccccCCCcCChhhhcc--------CCCCchhHHHHHHHHHHHHH
Q 003139 628 DVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRR--------QQLTEKSDVYSFGVVLMEVL 699 (845)
Q Consensus 628 Dik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~ksDV~S~Gvvl~Ell 699 (845)
||||+|++++++|.++|+||+....... . ... ...+..|.+||.... -.++.+.|.|++|+++|.|.
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~---~-~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGT---R-YRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTE---E-EEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCc---e-eec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 9999999999999999999998765221 1 111 344578999997643 25789999999999999999
Q ss_pred cCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCC
Q 003139 700 CTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDR 764 (845)
Q Consensus 700 tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~R 764 (845)
||+.||+...+..... | ...... +.++.+..|+..+|+.+|++|
T Consensus 245 C~~lPf~~~~~~~~~~---~-----------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADPE---W-----------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTSG---G-----------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCcccccc---c-----------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999997653322110 0 112334 778889999999999999988
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=6.6e-19 Score=195.33 Aligned_cols=224 Identities=22% Similarity=0.272 Sum_probs=177.3
Q ss_pred eeeeceEEEEEEE----EcCCcEEEEEEcCCCChH--hHHHHHHHHHHHHhCC-CCCcceEEEEEecCCcEEEEEEeccC
Q 003139 510 LGVGGFGRVYKGT----LDDGTKVAVKRGNPRSEQ--GIAEFRTEIEMLSKLR-HRHLVSLIGYCDERSEMILVYEYMAN 582 (845)
Q Consensus 510 LG~G~fg~Vy~~~----~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~ 582 (845)
+|+|.||.|+++. .+.|..+|.|........ .......|..++...+ ||.+|++...+..+...+++.+|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 6899999999764 334667787765543211 1114556888888887 99999999999999999999999999
Q ss_pred CCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcccc
Q 003139 583 GPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVS 662 (845)
Q Consensus 583 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 662 (845)
|.|...+.+. ..++..........++-+++++|+ .+|+|||+|++||+++.+|++++.|||+++..-...
T Consensus 82 g~lft~l~~~--~~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~----- 151 (612)
T KOG0603|consen 82 GDLFTRLSKE--VMFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK----- 151 (612)
T ss_pred chhhhccccC--CchHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhh-----
Confidence 9998888543 456777777888899999999998 999999999999999999999999999998633211
Q ss_pred cccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCC
Q 003139 663 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVN 742 (845)
Q Consensus 663 ~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 742 (845)
..+||..|||||++. ....++|.||||++++||++|-.||.. + .+..|+...+ ..+
T Consensus 152 -~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~---------------~~~~Il~~~~--~~p 207 (612)
T KOG0603|consen 152 -IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----D---------------TMKRILKAEL--EMP 207 (612)
T ss_pred -hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----H---------------HHHHHhhhcc--CCc
Confidence 118999999999998 667899999999999999999999864 1 1222222111 245
Q ss_pred HHHHHHHHHHHHHhhhhCCCCCCCH
Q 003139 743 PASLKKFGETAEKCLAEHGVDRPSM 767 (845)
Q Consensus 743 ~~~~~~l~~l~~~cl~~~p~~RPs~ 767 (845)
.........++..++..+|..|...
T Consensus 208 ~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 208 RELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred hhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 6667778888899999999999765
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.2e-17 Score=197.81 Aligned_cols=199 Identities=23% Similarity=0.225 Sum_probs=159.4
Q ss_pred HHHHhcCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCC---CCCcceEEEEEecCCcE
Q 003139 497 ILDATNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLR---HRHLVSLIGYCDERSEM 573 (845)
Q Consensus 497 l~~at~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~ 573 (845)
+......|.+.+.||+|+||.||+|...+|+.||+|.-++.+. -+|.--.+++.+|+ -+-|..+...+.-.+.-
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 3344567888899999999999999988899999998766542 12333344455555 12333333444556778
Q ss_pred EEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEEC-------CCCceEEEe
Q 003139 574 ILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLD-------DNFVAKVAD 646 (845)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~-------~~~~~kl~D 646 (845)
+||+||.+.|+|.+++. ..+.++|.-++.++.|+++-+++||. .+|||+||||+|.||. ++..++|+|
T Consensus 770 ~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred eeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEEEe
Confidence 99999999999999996 44579999999999999999999999 9999999999999994 345789999
Q ss_pred ccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCC
Q 003139 647 FGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRP 703 (845)
Q Consensus 647 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~ 703 (845)
||.+..+....+........+|-.+--+|...+++++...|.|.++-+++-||.|+.
T Consensus 845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 999865444334445567788999999999999999999999999999999999983
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.4e-17 Score=167.60 Aligned_cols=135 Identities=19% Similarity=0.226 Sum_probs=106.4
Q ss_pred CcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhC-----CCCCcceEEEEEecCC---c-EE
Q 003139 505 DESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKL-----RHRHLVSLIGYCDERS---E-MI 574 (845)
Q Consensus 505 ~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~g~~~~~~---~-~~ 574 (845)
...++||+|+||.||. +. ++.. +||+.........+++.+|+++++++ .||||++++|++.+.. . ..
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 4456899999999996 43 4444 79987665444567899999999999 5799999999997763 3 33
Q ss_pred EEEEe--ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHH-HHHhhcCCCceeeccCCCCcEEECC----CCceEEEec
Q 003139 575 LVYEY--MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGL-HYLHTGAAQSIIHRDVKTTNILLDD----NFVAKVADF 647 (845)
Q Consensus 575 lV~Ey--~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~ivHrDik~~NILl~~----~~~~kl~DF 647 (845)
+|+|| +++|+|.+++.+. .+++. ..++.|++.++ +|||+ ++|+||||||+|||++. +..++|+||
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 78999 6689999999542 35544 35678888888 99999 99999999999999974 348999995
Q ss_pred ccc
Q 003139 648 GLS 650 (845)
Q Consensus 648 Gla 650 (845)
+.+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 544
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.1e-16 Score=164.40 Aligned_cols=134 Identities=26% Similarity=0.397 Sum_probs=114.0
Q ss_pred eeeeeeceEEEEEEEEcCCcEEEEEEcCCCCh--------HhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 508 LLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSE--------QGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
+.||+|++|.||+|.. .|..+++|+...... .....+.+|++++..++|+++.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4799999999999987 577899997553321 1124678899999999999998888888777889999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCC
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKT 652 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~ 652 (845)
+++++|.+++... .+ ++..++.+++.+|.+||+ .+++|||++|.|||++ ++.++|+|||+++.
T Consensus 81 ~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN-----GM-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999988432 22 888999999999999999 9999999999999999 78999999999865
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.69 E-value=2e-16 Score=164.71 Aligned_cols=140 Identities=17% Similarity=0.149 Sum_probs=110.2
Q ss_pred CCCcceeeeeeceEEEEEEE--EcCCcEEEEEEcCCCChH------------------------hHHHHHHHHHHHHhCC
Q 003139 503 KFDESLLLGVGGFGRVYKGT--LDDGTKVAVKRGNPRSEQ------------------------GIAEFRTEIEMLSKLR 556 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~--~~~g~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 556 (845)
-|.+.+.||+|+||.||+|. ..+|+.||+|........ ....+..|++.+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 46777899999999999998 458999999986543210 1123568999999997
Q ss_pred CCC--cceEEEEEecCCcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCc-eeeccCCCCc
Q 003139 557 HRH--LVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQS-IIHRDVKTTN 633 (845)
Q Consensus 557 H~n--iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-ivHrDik~~N 633 (845)
+.+ +.+++++ ...++||||+++++|...+... ..+...+...++.|++.+|++||+ .+ |+||||||+|
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~N 179 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEYN 179 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChhh
Confidence 633 4445543 2358999999998887765322 345666778999999999999999 88 9999999999
Q ss_pred EEECCCCceEEEeccccCC
Q 003139 634 ILLDDNFVAKVADFGLSKT 652 (845)
Q Consensus 634 ILl~~~~~~kl~DFGla~~ 652 (845)
|+++ ++.++|+|||.+..
T Consensus 180 Ili~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred EEEE-CCCEEEEEChhhhc
Confidence 9999 88999999999875
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.5e-16 Score=160.17 Aligned_cols=143 Identities=20% Similarity=0.171 Sum_probs=112.4
Q ss_pred HHHHHHhcCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCCh----------------------HhHHHHHHHHHHH
Q 003139 495 QEILDATNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSE----------------------QGIAEFRTEIEML 552 (845)
Q Consensus 495 ~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~----------------------~~~~~~~~E~~~l 552 (845)
+++......|...+.||+|+||.||++...+|+.+|||+...... .....+..|..++
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 444444445777889999999999999988899999997543220 0112366789999
Q ss_pred HhCCCC--CcceEEEEEecCCcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCC
Q 003139 553 SKLRHR--HLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVK 630 (845)
Q Consensus 553 ~~l~H~--niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik 630 (845)
.++.|+ .+.+.++. ...++||||+++++|...... .....++.+++.++.++|+ .+|+|||||
T Consensus 88 ~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~ 152 (198)
T cd05144 88 KALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYK---HGIIHGDLS 152 (198)
T ss_pred HHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHH---CCCCcCCCC
Confidence 999887 44555543 355899999999998775421 3456789999999999999 999999999
Q ss_pred CCcEEECCCCceEEEeccccCC
Q 003139 631 TTNILLDDNFVAKVADFGLSKT 652 (845)
Q Consensus 631 ~~NILl~~~~~~kl~DFGla~~ 652 (845)
|+||++++++.++|+|||++..
T Consensus 153 p~Nill~~~~~~~liDfg~~~~ 174 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVS 174 (198)
T ss_pred cccEEEcCCCcEEEEECCcccc
Confidence 9999999999999999999965
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.4e-16 Score=160.49 Aligned_cols=130 Identities=27% Similarity=0.394 Sum_probs=107.6
Q ss_pred eeeeeceEEEEEEEEcCCcEEEEEEcCCCC--------hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEec
Q 003139 509 LLGVGGFGRVYKGTLDDGTKVAVKRGNPRS--------EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYM 580 (845)
Q Consensus 509 ~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 580 (845)
+||+|+||.||+|.+. |..+++|...... ....+++.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 4899999999999864 7889999754321 112356788999999999988766666666677789999999
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCC
Q 003139 581 ANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKT 652 (845)
Q Consensus 581 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~ 652 (845)
++++|.+++.... ..++.+++++|.+||+ .+++|||++|+||+++ ++.++++|||+++.
T Consensus 80 ~g~~l~~~~~~~~---------~~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN---------DELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH---------HHHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998774321 1889999999999999 9999999999999999 78999999999876
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.2e-16 Score=184.83 Aligned_cols=136 Identities=23% Similarity=0.284 Sum_probs=112.0
Q ss_pred cCCCcceeeeeeceEEEEEEEEcCCcEEEEEE-cCCC-C------hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLDDGTKVAVKR-GNPR-S------EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEM 573 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~-~~~~-~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 573 (845)
..|...+.||+|+||.||+|.+.+.. +++|+ .... . ....+++.+|++++.+++|++++....++......
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 34456778999999999999876443 44443 2111 1 12235688999999999999999988888887888
Q ss_pred EEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCC
Q 003139 574 ILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKT 652 (845)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~ 652 (845)
++||||+++++|.+++. ...+++.+++++|.|||+ .+++||||||+|||+ +++.++|+|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999998873 467899999999999999 999999999999999 577999999999976
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.2e-16 Score=162.91 Aligned_cols=197 Identities=19% Similarity=0.192 Sum_probs=138.9
Q ss_pred CCCCcceEEEEEec---------------------------CCcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHH
Q 003139 556 RHRHLVSLIGYCDE---------------------------RSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIG 608 (845)
Q Consensus 556 ~H~niv~l~g~~~~---------------------------~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ 608 (845)
+|||||++.+++.+ ...+|+||...+ -+|+++|... ..+.....-|+.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~---~~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR---HRSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC---CCchHHHHHHHHH
Confidence 69999998876532 235789998774 4899888644 3566777789999
Q ss_pred HHHHHHHHhhcCCCceeeccCCCCcEEEC--CCC--ceEEEeccccCCCCCC--CCc--ccccccccCCCcCChhhhccC
Q 003139 609 AARGLHYLHTGAAQSIIHRDVKTTNILLD--DNF--VAKVADFGLSKTGPAL--DQT--HVSTAVKGSFGYLDPEYFRRQ 680 (845)
Q Consensus 609 ia~gL~yLH~~~~~~ivHrDik~~NILl~--~~~--~~kl~DFGla~~~~~~--~~~--~~~~~~~gt~~y~aPE~~~~~ 680 (845)
+++|+.|||. ++|.|||+|++||||. +|. ...|+|||++-..... .-. ...-...|...-||||+....
T Consensus 350 lLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 350 LLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 9999999999 9999999999999993 333 5789999998542221 111 112234577789999988643
Q ss_pred C------CCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHH
Q 003139 681 Q------LTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAE 754 (845)
Q Consensus 681 ~------~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~ 754 (845)
+ --.|+|.|+.|-+.||++..+.||...... ..+... +++ .-....+..++..+.+++.
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-~L~~r~-----Yqe---------~qLPalp~~vpp~~rqlV~ 491 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-LLDTRT-----YQE---------SQLPALPSRVPPVARQLVF 491 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccchh-eechhh-----hhh---------hhCCCCcccCChHHHHHHH
Confidence 2 235899999999999999999999752111 111111 111 1112344566777889999
Q ss_pred HhhhhCCCCCCCHHHHHHHH
Q 003139 755 KCLAEHGVDRPSMGDVLWNL 774 (845)
Q Consensus 755 ~cl~~~p~~RPs~~~vl~~L 774 (845)
..|+.||.+|++..-....|
T Consensus 492 ~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 492 DLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHhcCCccccCCccHHHhHH
Confidence 99999999999876544333
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.65 E-value=3.6e-17 Score=178.37 Aligned_cols=172 Identities=25% Similarity=0.341 Sum_probs=127.9
Q ss_pred CcEEEEEEeccCCCccccccCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccc
Q 003139 571 SEMILVYEYMANGPLRSHLYGT-DLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGL 649 (845)
Q Consensus 571 ~~~~lV~Ey~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGl 649 (845)
..+++.|++|...+|.++|... .....+|...+.++.|++.|++| ++.+|||+||.||+...+..+||.|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhh
Confidence 3578999999999999999744 34567899999999999999999 5789999999999999999999999999
Q ss_pred cCCCCCCC----CcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHh
Q 003139 650 SKTGPALD----QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQ 724 (845)
Q Consensus 650 a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~ 724 (845)
........ .....+...||..||+||.+.+++|+.|+||||||+||+||+. =...++.
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er----------------- 465 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER----------------- 465 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH-----------------
Confidence 86544322 1223456789999999999999999999999999999999987 2221110
Q ss_pred hcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCH
Q 003139 725 KKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSM 767 (845)
Q Consensus 725 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 767 (845)
.+.+.++-|..+...+..+.+ .=..++.+++.+.|.+||++
T Consensus 466 -~~t~~d~r~g~ip~~~~~d~p-~e~~ll~~lls~~p~~RP~~ 506 (516)
T KOG1033|consen 466 -IATLTDIRDGIIPPEFLQDYP-EEYTLLQQLLSPSPEERPSA 506 (516)
T ss_pred -HHhhhhhhcCCCChHHhhcCc-HHHHHHHHhcCCCcccCchH
Confidence 011111111111111111111 22478899999999999944
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.6e-16 Score=184.32 Aligned_cols=211 Identities=25% Similarity=0.317 Sum_probs=146.6
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
...|+.+++|..|++|.||..+++ ..+.+|.|. ++.+- +.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l-----ilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL-----ILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcc-cccch-----hhhc--cccccCCccee------------------
Confidence 367889999999999999999887 456788843 32211 0100 22233344433
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCC-
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQ- 658 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~- 658 (845)
|+-...+... ++++... +.+++|||+ .+|+|||+||+|.||..-|++|++|||+++.......
T Consensus 136 ---gDc~tllk~~--g~lPvdm--------vla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 ---GDCATLLKNI--GPLPVDM--------VLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred ---chhhhhcccC--CCCcchh--------hHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 4444444322 2333322 788999999 9999999999999999999999999999975322110
Q ss_pred ------------cccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhc
Q 003139 659 ------------THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKK 726 (845)
Q Consensus 659 ------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 726 (845)
.-....++||+.|.|||++..+.|...+|+|++|+|+||.+-|+.||.+..+++-.. ..+.
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg------~vis- 272 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG------QVIS- 272 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHh------hhhh-
Confidence 112245689999999999999999999999999999999999999998775544211 0000
Q ss_pred CchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCH
Q 003139 727 GMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSM 767 (845)
Q Consensus 727 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 767 (845)
|.....+-....+.+..+++.+.|+.+|..|--.
T Consensus 273 -------d~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt 306 (1205)
T KOG0606|consen 273 -------DDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGT 306 (1205)
T ss_pred -------hhccccccCcCCCHHHHHHHHHHHHhChHhhccc
Confidence 0111111233445677889999999999999543
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.1e-14 Score=140.28 Aligned_cols=134 Identities=22% Similarity=0.229 Sum_probs=115.6
Q ss_pred ceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCC--CCcceEEEEEecCCcEEEEEEeccCCC
Q 003139 507 SLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRH--RHLVSLIGYCDERSEMILVYEYMANGP 584 (845)
Q Consensus 507 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~Ey~~~gs 584 (845)
.+.||+|.++.||++...+ ..+++|....... ..++..|+.++..++| .++.+++++....+..++++||++++.
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 4579999999999999864 7899998765543 4678899999999976 599999999988889999999999887
Q ss_pred ccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCC
Q 003139 585 LRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKT 652 (845)
Q Consensus 585 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~ 652 (845)
+..+ ++.....++.+++++|++||.....+++|+||+|+||++++.+.+++.|||.++.
T Consensus 80 ~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 80 LDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 7654 5677788999999999999984445799999999999999999999999999875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.7e-14 Score=143.69 Aligned_cols=136 Identities=20% Similarity=0.211 Sum_probs=98.0
Q ss_pred ceeeeeeceEEEEEEEEcCCcEEEEEEcCCCCh--HhHHHH----------------------HHHHHHHHhCCCCC--c
Q 003139 507 SLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSE--QGIAEF----------------------RTEIEMLSKLRHRH--L 560 (845)
Q Consensus 507 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~--~~~~~~----------------------~~E~~~l~~l~H~n--i 560 (845)
.+.||+|+||.||+|...+|+.||||....... .....+ ..|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 357999999999999988899999997654321 111111 34666666664432 4
Q ss_pred ceEEEEEecCCcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCC
Q 003139 561 VSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNF 640 (845)
Q Consensus 561 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~ 640 (845)
.+.++. ...++||||++++.+........ ... .+...++.+++.++.++|. .++|+||||||+||+++ ++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~--~~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV--RLL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD-DG 151 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh--hhc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE-CC
Confidence 444443 24689999999965432211111 011 5678899999999999996 37899999999999999 88
Q ss_pred ceEEEeccccCC
Q 003139 641 VAKVADFGLSKT 652 (845)
Q Consensus 641 ~~kl~DFGla~~ 652 (845)
.++|+|||.+..
T Consensus 152 ~~~liDfg~a~~ 163 (187)
T cd05119 152 KVYIIDVPQAVE 163 (187)
T ss_pred cEEEEECccccc
Confidence 999999999975
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.53 E-value=6.5e-14 Score=146.22 Aligned_cols=135 Identities=19% Similarity=0.188 Sum_probs=105.7
Q ss_pred ceeee-eeceEEEEEEEEcCCcEEEEEEcCCCC-------------hHhHHHHHHHHHHHHhCCCCCc--ceEEEEEecC
Q 003139 507 SLLLG-VGGFGRVYKGTLDDGTKVAVKRGNPRS-------------EQGIAEFRTEIEMLSKLRHRHL--VSLIGYCDER 570 (845)
Q Consensus 507 ~~~LG-~G~fg~Vy~~~~~~g~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~H~ni--v~l~g~~~~~ 570 (845)
...|| .||.|+||++... +..++||+..... ......+.+|++++.+++|+++ ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 34788 8999999999886 6788998764321 1223567889999999998875 6777775433
Q ss_pred Cc----EEEEEEeccC-CCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEE
Q 003139 571 SE----MILVYEYMAN-GPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVA 645 (845)
Q Consensus 571 ~~----~~lV~Ey~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~ 645 (845)
.. .++|+|++++ .+|.+++... +++.. .+.+++.+|.+||+ .+|+||||||.|||++.++.++|+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEEEE
Confidence 22 3599999997 6888887432 34443 36789999999999 999999999999999998999999
Q ss_pred eccccCC
Q 003139 646 DFGLSKT 652 (845)
Q Consensus 646 DFGla~~ 652 (845)
|||.++.
T Consensus 185 Dfg~~~~ 191 (239)
T PRK01723 185 DFDRGEL 191 (239)
T ss_pred ECCCccc
Confidence 9999876
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.48 E-value=4e-15 Score=173.72 Aligned_cols=256 Identities=23% Similarity=0.279 Sum_probs=188.8
Q ss_pred CCCcceeeeeeceEEEEEEEEcC--CcEEEEEEcCCCC--hHhHHHHHHHHHHHHhCC-CCCcceEEEEEecCCcEEEEE
Q 003139 503 KFDESLLLGVGGFGRVYKGTLDD--GTKVAVKRGNPRS--EQGIAEFRTEIEMLSKLR-HRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~~--g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 577 (845)
.|...+.||+|.|+.|-...... ...+++|.+.... ....+....|..+-..+. |+|++.+++...+.+..++..
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 34555569999999998876532 3456777655443 333445556888777886 999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHh-hcCCCceeeccCCCCcEEECCCC-ceEEEeccccCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLH-TGAAQSIIHRDVKTTNILLDDNF-VAKVADFGLSKTGPA 655 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivHrDik~~NILl~~~~-~~kl~DFGla~~~~~ 655 (845)
||..++++...+........+....-....|+..++.|+| . .++.||||||+|.+++..+ ..+++|||+|.....
T Consensus 101 ~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred CcccccccccccccCCccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 9999999998884333324555667789999999999999 6 8999999999999999999 999999999976554
Q ss_pred -CCCccccccccc-CCCcCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhh
Q 003139 656 -LDQTHVSTAVKG-SFGYLDPEYFRRQ-QLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQI 732 (845)
Q Consensus 656 -~~~~~~~~~~~g-t~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (845)
..........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++......+ ....|.... +
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-~~~~~~~~~---~----- 248 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-RYSSWKSNK---G----- 248 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-cceeecccc---c-----
Confidence 333444455677 9999999998874 557789999999999999999999875443331 111221111 0
Q ss_pred hccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 733 MDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 733 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
................+..+++..+|..|.+.+++...
T Consensus 249 ---~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 249 ---RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred ---ccccCccccCChhhhhcccccccCCchhcccccccccc
Confidence 00011122334455677888888999999999887543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.43 E-value=5.9e-13 Score=150.97 Aligned_cols=143 Identities=27% Similarity=0.307 Sum_probs=102.4
Q ss_pred CCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHH---------------------------------------
Q 003139 503 KFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIA--------------------------------------- 543 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~--------------------------------------- 543 (845)
.|+. +.||+|++|.||+|++++|+.||||...+...+..+
T Consensus 119 ~fd~-~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~E 197 (437)
T TIGR01982 119 EFEE-KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRE 197 (437)
T ss_pred hCCC-cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHH
Confidence 4443 579999999999999999999999987765322110
Q ss_pred -HHHHHHHHHHhCC----CCCcceEEEEE-ecCCcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHH-HHHHH
Q 003139 544 -EFRTEIEMLSKLR----HRHLVSLIGYC-DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAAR-GLHYL 616 (845)
Q Consensus 544 -~~~~E~~~l~~l~----H~niv~l~g~~-~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~-gL~yL 616 (845)
+|.+|.+.+.+++ |.+-+.+-..+ ...+..+|||||++|++|.+.+..... .. .+.+++.++++ .+..+
T Consensus 198 ldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~~l~ql 273 (437)
T TIGR01982 198 LDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARSFLNQV 273 (437)
T ss_pred HCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHHHHHHH
Confidence 2445666555552 33223322222 334567999999999999887643211 12 34567777666 46788
Q ss_pred hhcCCCceeeccCCCCcEEECCCCceEEEeccccCCC
Q 003139 617 HTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTG 653 (845)
Q Consensus 617 H~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~ 653 (845)
|. .+++|+|+||.||++++++.++++|||++...
T Consensus 274 ~~---~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 274 LR---DGFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred Hh---CCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 88 89999999999999999999999999998764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan | Back alignment and domain information |
|---|
Probab=99.32 E-value=3.7e-12 Score=125.88 Aligned_cols=144 Identities=19% Similarity=0.236 Sum_probs=91.2
Q ss_pred EEEecCCCcccccCCceeecCCCCcccccc--cC-------CcccccCCCCCCCcccceeEeecccceEEEeecccceEE
Q 003139 36 YLIACGSSQKVTFQARTYVPDTEHSSLSMK--SG-------NSTTASSNSSAPSPIYQSARIFSAAAFYKFEIEHKGRHW 106 (845)
Q Consensus 36 ~~i~CG~~~~~~~~~~~~v~D~~~~~~~~~--~~-------~~~~~~~~~~~~~~~~~t~R~F~~~~cY~~~~~~~g~~~ 106 (845)
+.||||++.+++..|++|.+|..|.....+ .+ ............+++|+|.|+=.....|.+|+.++|.|.
T Consensus 3 ~~IN~Gg~~~~~~~g~~w~~D~~~~~g~~~y~~~~~~~~~~~~~~~~i~~t~d~~Lyqt~R~g~~~f~Y~ip~~~~G~Y~ 82 (174)
T PF11721_consen 3 LRINAGGPAYTDSSGIVWEADQYYTGGSWGYYVSSDNNGSTSSTNSSIPGTTDDPLYQTERYGPSSFSYDIPVVPNGTYT 82 (174)
T ss_dssp EEEEETSSSEEETTTEEE-SSSSSTTSS-----------SSTTS--TTS-HHHHHTTT-----SSSEEEEEE--S-EEEE
T ss_pred EEEECCCCcccCCCCCEEcCCCCCCCCCcccccccccccccccccccccCCCchhhhHhhcCCCCceEEEEecCCCcEEE
Confidence 689999998878899999999988443220 00 011111222233577999999656789999988999999
Q ss_pred EEEEeecCCCCC----cCCccceEEEEeCcEEEeecccccccC-C--CcceEEE-EEeecCCceEEEEee----------
Q 003139 107 VRLYFYTLPGSN----QHLNSASFTVATDKFVLLSNFTFKNYN-S--SFMFKEY-AINVNSDALTLTFIP---------- 168 (845)
Q Consensus 107 vR~~f~~~~~~~----~~~~~~~f~v~~~~~~~~~~~~~~~~~-~--~~~~~e~-~~~~~~~~~~vc~~~---------- 168 (845)
|||||--..+.. .....-.|+|.++|-+++.+|...... + .+...+| .+.+.++.|.|+|..
T Consensus 83 V~L~FaE~~~~~~~~~~~~G~RvFdV~v~g~~vl~~~Di~~~~G~~~~~~~~~~~~v~v~dg~L~i~f~~~~~~~~~i~~ 162 (174)
T PF11721_consen 83 VRLHFAELYFGASGGASGPGQRVFDVYVNGETVLKNFDIYAEAGGFNKAAVRRFFNVTVTDGTLNIQFVWAGKGTLCIPF 162 (174)
T ss_dssp EEEEEE-SSS--------SSSS-EEEEETTEEEEEEE-HHHHHSSSS---EEEEEEEEEETTEEETTEEEE--SEEEEEE
T ss_pred EEEEeccccccccccccCCCceEEEEEecceEEEeccCHHHHcCCCceEEEEEEEEEEEeCCcEEEEEEecCCCcEEeec
Confidence 999999776665 455677899999999999999443222 2 2477777 788888999999996
Q ss_pred -CCCCcceeeee
Q 003139 169 -SNNSVAFVNAI 179 (845)
Q Consensus 169 -~~~~~pfi~~i 179 (845)
...+.|.||||
T Consensus 163 ~~~~~~p~IsaI 174 (174)
T PF11721_consen 163 IGSYGNPLISAI 174 (174)
T ss_dssp ESSSSSSSEEEE
T ss_pred cccCCCcEEeeC
Confidence 34466888887
|
It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A. |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.32 E-value=1e-11 Score=147.21 Aligned_cols=151 Identities=19% Similarity=0.275 Sum_probs=111.6
Q ss_pred EEEecCCCcc---ccc----C--CceeecCCCCccc---ccccCCcccccCCCC--CCCcccceeEeecc---cceEEEe
Q 003139 36 YLIACGSSQK---VTF----Q--ARTYVPDTEHSSL---SMKSGNSTTASSNSS--APSPIYQSARIFSA---AAFYKFE 98 (845)
Q Consensus 36 ~~i~CG~~~~---~~~----~--~~~~v~D~~~~~~---~~~~~~~~~~~~~~~--~~~~~~~t~R~F~~---~~cY~~~ 98 (845)
|.||||+... .+. . +|.|.+|..|... ...+...+......+ .|..+|+|||.+.. ...|.|+
T Consensus 194 ~R~n~G~~~~~~~~d~~~D~~~~dR~W~~d~~~~~~~~~~~st~~~I~~~~~~~~~~P~~VyqTA~~~~~~~~~lty~~~ 273 (623)
T PLN03150 194 KRLSCGAGKSKFDEDYSGDHWGGDRFWNRMQTFGSGSDQAISTENVIKKASNAPNFYPESLYQSALVSTDTQPDLSYTMD 273 (623)
T ss_pred EEEEecCcccccccCCCCCcccCccccCcCcccCCCcccccccccccccccCCCccChHHHhhhhccccCCCCceEEEee
Confidence 6899997532 111 2 7999999876322 111222221111122 24557999999964 4599999
Q ss_pred ecccceEEEEEEeecCCCCCcCCccceEEEEeCcEEEeecccccc---cCCCcceEEEEEeecCCceEEEEeeCCCCcce
Q 003139 99 IEHKGRHWVRLYFYTLPGSNQHLNSASFTVATDKFVLLSNFTFKN---YNSSFMFKEYAINVNSDALTLTFIPSNNSVAF 175 (845)
Q Consensus 99 ~~~~g~~~vR~~f~~~~~~~~~~~~~~f~v~~~~~~~~~~~~~~~---~~~~~~~~e~~~~~~~~~~~vc~~~~~~~~pf 175 (845)
+.++|+|+|||||+.............|+|.++|..+..+|.... ....+++++|.++++++.+.|+|+++..+.||
T Consensus 274 v~~~~~Y~VrLhFaEi~~~~~~~~~R~F~V~ing~~~~~~~di~~~~g~~~~~~~~~~~v~~~~g~l~isl~p~~~s~pi 353 (623)
T PLN03150 274 VDPNRNYSVWLHFAEIDNSITAEGKRVFDVLINGDTAFKDVDIVKMSGERYTALVLNKTVAVSGRTLTIVLQPKKGTHAI 353 (623)
T ss_pred cCCCCCEEEEEEEEeccCccCCCceEEEEEEECCEEeecccChhhhcCCcccceEEEeEEeecCCeEEEEEeeCCCCcce
Confidence 988899999999999976665667789999999999988874322 12357888999999988899999999877899
Q ss_pred eeeeEEEecCC
Q 003139 176 VNAIEVVSVPD 186 (845)
Q Consensus 176 i~~iE~~~~~~ 186 (845)
||||||+.+-.
T Consensus 354 lNaiEI~~~~~ 364 (623)
T PLN03150 354 INAIEVFEIIT 364 (623)
T ss_pred eeeeeeeeccc
Confidence 99999999876
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.31 E-value=6e-13 Score=136.64 Aligned_cols=204 Identities=23% Similarity=0.364 Sum_probs=139.5
Q ss_pred HHHHhCCCCCcceEEEEEec-----CCcEEEEEEeccCCCccccccCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 003139 550 EMLSKLRHRHLVSLIGYCDE-----RSEMILVYEYMANGPLRSHLYGT--DLPPLSWKQRLEICIGAARGLHYLHTGAAQ 622 (845)
Q Consensus 550 ~~l~~l~H~niv~l~g~~~~-----~~~~~lV~Ey~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 622 (845)
.-|-++-|.|||++..|..+ ..+..++.|||+.|+|..+|+.. ....+..+...+++.||..||.|||+ |.+
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCC
Confidence 34556679999999998754 34578999999999999999754 23456777778999999999999998 679
Q ss_pred ceeeccCCCCcEEECCCCceEEEeccccCCCCCCC--CcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc
Q 003139 623 SIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD--QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC 700 (845)
Q Consensus 623 ~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt 700 (845)
+|+|+++..+-|++..++-+||.----....+... .........+-++|.+||+-.....+.++|||+||...+||--
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 99999999999999999988884321111100000 0111122346789999999888888999999999999999987
Q ss_pred CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 701 TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 701 g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
+..--........ .+..+...+ .+.. -..-..++.+|++..|..||+|++++.+
T Consensus 278 lEiq~tnseS~~~-----------~ee~ia~~i----~~le----n~lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 278 LEIQSTNSESKVE-----------VEENIANVI----IGLE----NGLQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred heeccCCCcceee-----------hhhhhhhhe----eecc----CccccCcCcccccCCCCCCcchhhhhcC
Confidence 7632111110000 000011100 0000 0111356789999999999999997654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.24 E-value=4.1e-11 Score=118.41 Aligned_cols=130 Identities=18% Similarity=0.121 Sum_probs=96.8
Q ss_pred eeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcce-EEEEEecCCcEEEEEEeccCCCcc
Q 003139 508 LLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVS-LIGYCDERSEMILVYEYMANGPLR 586 (845)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~-l~g~~~~~~~~~lV~Ey~~~gsL~ 586 (845)
+.|+.|.++.||+++.. +..+++|....... ....+..|++++..+.+.++++ ++++. ....++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 46889999999999876 77899998654432 1234678999999987666554 44443 23458999999998876
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCceeeccCCCCcEEECCCCceEEEeccccCC
Q 003139 587 SHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGA--AQSIIHRDVKTTNILLDDNFVAKVADFGLSKT 652 (845)
Q Consensus 587 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDik~~NILl~~~~~~kl~DFGla~~ 652 (845)
... .....++.+++++|+.||... ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 80 ~~~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TED----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 531 111346789999999999832 22369999999999999 66899999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.1e-11 Score=138.47 Aligned_cols=247 Identities=20% Similarity=0.177 Sum_probs=174.6
Q ss_pred CCCcceeeee--eceEEEEEEEE--c-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcEE
Q 003139 503 KFDESLLLGV--GGFGRVYKGTL--D-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERSEMI 574 (845)
Q Consensus 503 ~f~~~~~LG~--G~fg~Vy~~~~--~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 574 (845)
.|...+.+|. |.+|.||++.. . ++..+|+|+-+.. ..+....=.+|+...+++ .|+|.++........+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4566678999 99999999987 3 6788999973322 223333335677777777 4999999888889999999
Q ss_pred EEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHH----HHHHHhhcCCCceeeccCCCCcEEECCC-CceEEEeccc
Q 003139 575 LVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAAR----GLHYLHTGAAQSIIHRDVKTTNILLDDN-FVAKVADFGL 649 (845)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~ivHrDik~~NILl~~~-~~~kl~DFGl 649 (845)
+-.|++ +.+|..+.+... ..++......+..+..+ ||.++|. .+++|-|+||.||++.++ ...+++|||+
T Consensus 195 iqtE~~-~~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred eeeccc-cchhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecCCcce
Confidence 999998 478887775432 23555666677777777 9999998 999999999999999999 8999999999
Q ss_pred cCCCCCCCCcc---cccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhc
Q 003139 650 SKTGPALDQTH---VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKK 726 (845)
Q Consensus 650 a~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 726 (845)
.......+... ......|...|++||..++ -++.++|+|++|.+++|..++-.......... |.. .+.
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~------W~~--~r~ 340 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSS------WSQ--LRQ 340 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCC------ccc--ccc
Confidence 87654422111 1223357778999998754 67899999999999999998876543321111 110 011
Q ss_pred CchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHH
Q 003139 727 GMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVL 771 (845)
Q Consensus 727 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl 771 (845)
.. +..++-.....++...+..+++.+|..|++.+.+.
T Consensus 341 -----~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 341 -----GY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred -----cc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 00 01111112233445588899999999999887764
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.3e-10 Score=128.91 Aligned_cols=165 Identities=18% Similarity=0.244 Sum_probs=125.6
Q ss_pred cCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEeccCCCccccccCCCCCCCCHHHHH
Q 003139 524 DDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRL 603 (845)
Q Consensus 524 ~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~ 603 (845)
.++.+|.|...+..+....+...+-++.|+.+|||||++++...+..+.+|||.|.+ ..|..++.+ +......
T Consensus 35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~-----l~~~~v~ 107 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE-----LGKEEVC 107 (690)
T ss_pred ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH-----hHHHHHH
Confidence 367788877766655544455677889999999999999999999999999999988 356666532 3355666
Q ss_pred HHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCC
Q 003139 604 EICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLT 683 (845)
Q Consensus 604 ~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s 683 (845)
..+.||+.||.+||+ ..+++|++|..+.|+++..|+.||++|.++........ ......--..|..|+.+....
T Consensus 108 ~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~-- 181 (690)
T KOG1243|consen 108 LGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE-- 181 (690)
T ss_pred HHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--
Confidence 788999999999996 47899999999999999999999999999865333221 111112223467777543322
Q ss_pred chhHHHHHHHHHHHHHcC
Q 003139 684 EKSDVYSFGVVLMEVLCT 701 (845)
Q Consensus 684 ~ksDV~S~Gvvl~Elltg 701 (845)
-..|.|-||++++|++.|
T Consensus 182 ~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cchhhhhHHHHHHHHhCc
Confidence 457999999999999999
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.19 E-value=6.1e-11 Score=136.04 Aligned_cols=146 Identities=19% Similarity=0.150 Sum_probs=93.8
Q ss_pred hcCCCcceeeeeeceEEEEEEEEcC-CcEEEEEEcCCCChHh----------------------------------HH--
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLDD-GTKVAVKRGNPRSEQG----------------------------------IA-- 543 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~----------------------------------~~-- 543 (845)
-..|+. +.||+|++|.||+|++++ |+.||||...+.-.+. .+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345666 689999999999999987 9999999887552111 01
Q ss_pred ----HHHHHHHHHHhCC----CCCcceEEEEEe-cCCcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHH-HH
Q 003139 544 ----EFRTEIEMLSKLR----HRHLVSLIGYCD-ERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAAR-GL 613 (845)
Q Consensus 544 ----~~~~E~~~l~~l~----H~niv~l~g~~~-~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~-gL 613 (845)
+|.+|...+.+++ +.+.+.+=.++. -..+.+|||||++|++|.+.-.-.. ...+. ..++...++ -+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~-~g~d~---~~la~~~v~~~~ 273 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRA-AGTDM---KLLAERGVEVFF 273 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHh-cCCCH---HHHHHHHHHHHH
Confidence 2344554444442 333333323332 2456789999999999976421111 11121 122222221 12
Q ss_pred HHHhhcCCCceeeccCCCCcEEECCCC----ceEEEeccccCCCC
Q 003139 614 HYLHTGAAQSIIHRDVKTTNILLDDNF----VAKVADFGLSKTGP 654 (845)
Q Consensus 614 ~yLH~~~~~~ivHrDik~~NILl~~~~----~~kl~DFGla~~~~ 654 (845)
..++. .+++|+|+||.||+++.++ ++++.|||++....
T Consensus 274 ~Qif~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 274 TQVFR---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred HHHHh---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 23334 7899999999999999888 99999999987643
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.15 E-value=5.4e-10 Score=115.39 Aligned_cols=142 Identities=23% Similarity=0.319 Sum_probs=113.5
Q ss_pred eeeeeeceEEEEEEEEcCCcEEEEEEcCCCCh-HhHHHHHHHHHHHHhCCCC--CcceEEEEEecCC---cEEEEEEecc
Q 003139 508 LLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSE-QGIAEFRTEIEMLSKLRHR--HLVSLIGYCDERS---EMILVYEYMA 581 (845)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~--niv~l~g~~~~~~---~~~lV~Ey~~ 581 (845)
+.|+.|..+.||++...+|+.+++|....... ....++..|.++++.+++. ++.+++.++.+.. ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 46899999999999987778999998654322 2345788999999999764 4677888876643 5689999999
Q ss_pred CCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----------------------------------------
Q 003139 582 NGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGA----------------------------------------- 620 (845)
Q Consensus 582 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----------------------------------------- 620 (845)
+.+|...+.. ..++..++..++.++++.|..||+..
T Consensus 84 G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 84 GRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 9988876632 35788888899999999999999521
Q ss_pred ------------CCceeeccCCCCcEEECC--CCceEEEeccccCC
Q 003139 621 ------------AQSIIHRDVKTTNILLDD--NFVAKVADFGLSKT 652 (845)
Q Consensus 621 ------------~~~ivHrDik~~NILl~~--~~~~kl~DFGla~~ 652 (845)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 66789999998875
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=5e-10 Score=108.00 Aligned_cols=130 Identities=26% Similarity=0.353 Sum_probs=104.6
Q ss_pred eeeeeceEEEEEEEEcCCcEEEEEEcCCCC--hH------hHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEec
Q 003139 509 LLGVGGFGRVYKGTLDDGTKVAVKRGNPRS--EQ------GIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYM 580 (845)
Q Consensus 509 ~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~--~~------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 580 (845)
++++|+-+.+|.+.+. |..+++|.-.++. .. ..++-.+|.+++.+++--.|.-.+=+..+.....|+|||+
T Consensus 3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 5789999999999875 4557777433321 11 1245678999999998777777777777888899999999
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCC
Q 003139 581 ANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKT 652 (845)
Q Consensus 581 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~ 652 (845)
+|..|.+.+... +..++..+-+-+.-||. .+|+|+||.++||++..+. +.++||||+..
T Consensus 82 ~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA---------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc---------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999999888533 36788888888999999 9999999999999999774 99999999976
|
|
| >PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan | Back alignment and domain information |
|---|
Probab=99.11 E-value=4.1e-11 Score=118.44 Aligned_cols=142 Identities=27% Similarity=0.410 Sum_probs=82.9
Q ss_pred EEEeecCCCccCCCCCcCCccccCCCCceeeCCCCceeec-cCceeeeeccCCcccChHHHHHHhhhccCCCCccceeeE
Q 003139 213 VYRLNMGGPLITAQNDTLGRTWENDETYLHVNSSAVNVSV-RPSAIRYTASVTAETAPNWVYATAEMMGDANVPEVNFNI 291 (845)
Q Consensus 213 ~~r~n~g~~~i~~~~D~~~R~W~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~P~~Vy~ta~~~~~~~~~~~~~~l 291 (845)
++||||||+.. .|.....|++|..+...... ..... ++.........-.+..++.+|+|+|.... ++
T Consensus 2 ~~~IN~Gg~~~---~~~~g~~w~~D~~~~~g~~~-y~~~~~~~~~~~~~~~~i~~t~d~~Lyqt~R~g~~--------~f 69 (174)
T PF11721_consen 2 VLRINAGGPAY---TDSSGIVWEADQYYTGGSWG-YYVSSDNNGSTSSTNSSIPGTTDDPLYQTERYGPS--------SF 69 (174)
T ss_dssp EEEEEETSSSE---EETTTEEE-SSSSSTTSS------------SSTTS--TTS-HHHHHTTT-----SS--------SE
T ss_pred EEEEECCCCcc---cCCCCCEEcCCCCCCCCCcc-cccccccccccccccccccCCCchhhhHhhcCCCC--------ce
Confidence 68999999865 78899999999877532220 00000 00000000112245667899999998422 38
Q ss_pred EEEeecCCCCceEEEEEccCccccc------cceEEEEEEecccccCCCcchhhhcCCccceeeeee-eeeecCCCCeeE
Q 003139 292 TWVLPVEPNFTYFVRVHLCDIASLS------MNNLVFNLYINDDIAQPSVDLSTLTNGLNVPYYKDF-VCNASADSNTLT 364 (845)
Q Consensus 292 tw~~~~~~~~~y~vrlhf~ei~s~~------~~~r~F~i~in~~~~~~~~~~~~~~~~~~~~~~~d~-~~~~~~~~~~l~ 364 (845)
+|.+|+.++..|.|+|||+|+.... .++|+|+|++||+.+..++|+...+++...+..+.+ .+++ ..+.|.
T Consensus 70 ~Y~ip~~~~G~Y~V~L~FaE~~~~~~~~~~~~G~RvFdV~v~g~~vl~~~Di~~~~G~~~~~~~~~~~~v~v--~dg~L~ 147 (174)
T PF11721_consen 70 SYDIPVVPNGTYTVRLHFAELYFGASGGASGPGQRVFDVYVNGETVLKNFDIYAEAGGFNKAAVRRFFNVTV--TDGTLN 147 (174)
T ss_dssp EEEEE--S-EEEEEEEEEE-SSS--------SSSS-EEEEETTEEEEEEE-HHHHHSSSS---EEEEEEEEE--ETTEEE
T ss_pred EEEEecCCCcEEEEEEEeccccccccccccCCCceEEEEEecceEEEeccCHHHHcCCCceEEEEEEEEEEE--eCCcEE
Confidence 9999988889999999999998776 888999999999999999999999987664444444 3333 234555
Q ss_pred EEec
Q 003139 365 VSVG 368 (845)
Q Consensus 365 v~~~ 368 (845)
|+..
T Consensus 148 i~f~ 151 (174)
T PF11721_consen 148 IQFV 151 (174)
T ss_dssp TTEE
T ss_pred EEEE
Confidence 5444
|
It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=9.6e-10 Score=105.33 Aligned_cols=143 Identities=21% Similarity=0.237 Sum_probs=110.3
Q ss_pred cceeeeeeceEEEEEEEEcCCcEEEEEEcCCCC--------hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 506 ESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRS--------EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 506 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
...+|-+|+-+.|+++.+. |+..+||.-..+. .-..++..+|.+.+.+++--.|....-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4568999999999999987 7888888533221 112456788999999988767766666677777789999
Q ss_pred EeccC-CCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCC---ceEEEeccccCC
Q 003139 578 EYMAN-GPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNF---VAKVADFGLSKT 652 (845)
Q Consensus 578 Ey~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~---~~kl~DFGla~~ 652 (845)
||+++ .++.+++......+........++..|-+.+.-||. .+|||+||..+||+|..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99976 477787765443343444447899999999999999 9999999999999996543 458999999865
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.6e-09 Score=108.50 Aligned_cols=133 Identities=14% Similarity=0.136 Sum_probs=96.5
Q ss_pred eeeeeceEEEEEEEEcC-------CcEEEEEEcCCCC----------------------hHhHHHH----HHHHHHHHhC
Q 003139 509 LLGVGGFGRVYKGTLDD-------GTKVAVKRGNPRS----------------------EQGIAEF----RTEIEMLSKL 555 (845)
Q Consensus 509 ~LG~G~fg~Vy~~~~~~-------g~~vavK~~~~~~----------------------~~~~~~~----~~E~~~l~~l 555 (845)
.||.|.-+.||.|.-.+ +..+|||..+... ....+.+ .+|.+.|+++
T Consensus 4 ~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~rl 83 (197)
T cd05146 4 CISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKRM 83 (197)
T ss_pred ccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 68999999999997543 4789999532210 0112223 3799999998
Q ss_pred CC--CCcceEEEEEecCCcEEEEEEeccCCCccc-cccCCCCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCceeeccCCC
Q 003139 556 RH--RHLVSLIGYCDERSEMILVYEYMANGPLRS-HLYGTDLPPLSWKQRLEICIGAARGLHYL-HTGAAQSIIHRDVKT 631 (845)
Q Consensus 556 ~H--~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~-~l~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivHrDik~ 631 (845)
.. -++.+++++ ...+|||||+.+..+.. .|.. ..++..+..++..+++.+|..| |+ .++|||||++
T Consensus 84 ~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGDLs~ 153 (197)
T cd05146 84 QKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHADLSE 153 (197)
T ss_pred HHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHh---CCeecCCCCH
Confidence 54 466666754 56799999997654432 1211 1344556778889999999999 77 8999999999
Q ss_pred CcEEECCCCceEEEeccccCC
Q 003139 632 TNILLDDNFVAKVADFGLSKT 652 (845)
Q Consensus 632 ~NILl~~~~~~kl~DFGla~~ 652 (845)
.|||+++ +.+.|+|||.+..
T Consensus 154 ~NIL~~~-~~v~iIDF~qav~ 173 (197)
T cd05146 154 YNMLWHD-GKVWFIDVSQSVE 173 (197)
T ss_pred HHEEEEC-CcEEEEECCCcee
Confidence 9999974 6899999998865
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.99 E-value=2.6e-10 Score=127.66 Aligned_cols=249 Identities=18% Similarity=0.185 Sum_probs=174.5
Q ss_pred HHhcCCCcceeeeeeceEEEEEEEEc--CCcEEEEEEcCCCChHhHHHH--HHHHHHHHhC-CCCCcceEEEEEecCCcE
Q 003139 499 DATNKFDESLLLGVGGFGRVYKGTLD--DGTKVAVKRGNPRSEQGIAEF--RTEIEMLSKL-RHRHLVSLIGYCDERSEM 573 (845)
Q Consensus 499 ~at~~f~~~~~LG~G~fg~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~--~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 573 (845)
..+.+|.+...||.|.|+.|++...+ ++..+++|...........+. ..|+-+...+ .|.+++.....+.+....
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 34567888899999999999998754 577899997665433322221 3466655555 588888876666666677
Q ss_pred EEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCC-CceEEEeccccCC
Q 003139 574 ILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDN-FVAKVADFGLSKT 652 (845)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~-~~~kl~DFGla~~ 652 (845)
++--||++++++...+ .-...++...++++..|++.++.++|+ +.++|+|+||+||++..+ +..++.|||++..
T Consensus 342 ~ip~e~~~~~s~~l~~--~~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRS--VTSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred cCchhhhcCcchhhhh--HHHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhccccccccc
Confidence 7999999999887665 222356778889999999999999998 999999999999999876 8899999999864
Q ss_pred CCCCCCcccccccccCCCcC--ChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchh
Q 003139 653 GPALDQTHVSTAVKGSFGYL--DPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLD 730 (845)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (845)
.... .......-+++ +|+......+-.+.|++|||.-+.|.+++...-.... +|.. +..+.+
T Consensus 417 ~~~~-----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--------~~~~--i~~~~~- 480 (524)
T KOG0601|consen 417 LAFS-----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV--------QSLT--IRSGDT- 480 (524)
T ss_pred ccee-----cccccccccccccchhhccccccccccccccccccccccccCcccCcccc--------ccee--eecccc-
Confidence 2111 11112223344 5556667788899999999999999999875332111 1110 011100
Q ss_pred hhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 003139 731 QIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYA 777 (845)
Q Consensus 731 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~ 777 (845)
++ . +.....+..++..++..++..||.+.++..+.+..
T Consensus 481 ----p~----~-~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 481 ----PN----L-PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred ----cC----C-CchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 01 1 22225677888889999999999998887666543
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.95 E-value=1.2e-08 Score=111.66 Aligned_cols=167 Identities=17% Similarity=0.246 Sum_probs=125.6
Q ss_pred eEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEe----cCCcEEEEEEeccC-CCcccc
Q 003139 515 FGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCD----ERSEMILVYEYMAN-GPLRSH 588 (845)
Q Consensus 515 fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~----~~~~~~lV~Ey~~~-gsL~~~ 588 (845)
-.+.||+... +|..+++||+.....+....-..-+++++++.|.|+|++..++. .+..+++||+|.|+ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 3578999865 89999999984433333323345688999999999999998875 34568999999986 466554
Q ss_pred ccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCC
Q 003139 589 LYGT-------------DLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPA 655 (845)
Q Consensus 589 l~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~ 655 (845)
-... .....++..++.++.|+..||.++|+ .|+..+-|.+++||++.+.+++|+..|.......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 3321 12346778899999999999999999 8999999999999999999999998887755322
Q ss_pred CCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCC
Q 003139 656 LDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRP 703 (845)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~ 703 (845)
+. . |-+.. -.+-|.=.||.+++-|.||+.
T Consensus 446 -d~-------------~--~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 446 -DP-------------T--EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred -CC-------------C--cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 11 0 11111 236799999999999999974
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.9e-08 Score=104.93 Aligned_cols=140 Identities=14% Similarity=0.095 Sum_probs=102.4
Q ss_pred eeeeeceEEEEEEEEcCCcEEEEEEcCCCChH-hHH----------HHHHHHHHHHhCCCCC--cceEEEEEec-----C
Q 003139 509 LLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQ-GIA----------EFRTEIEMLSKLRHRH--LVSLIGYCDE-----R 570 (845)
Q Consensus 509 ~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~-~~~----------~~~~E~~~l~~l~H~n--iv~l~g~~~~-----~ 570 (845)
.+-+-....|.+..+. |+.+.||+....... ..+ .+.+|...+.++...+ ..+++++... .
T Consensus 29 ~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 4544444557777664 788999976544321 122 3778999998885433 3455666543 2
Q ss_pred CcEEEEEEeccCC-CccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECC-------CCce
Q 003139 571 SEMILVYEYMANG-PLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDD-------NFVA 642 (845)
Q Consensus 571 ~~~~lV~Ey~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~-------~~~~ 642 (845)
..-+||+|++++. +|.+++......+.+...+..++.+++..+.-||+ .+|+|+|++++|||++. +..+
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCCceE
Confidence 3578999999886 78888743222345667778999999999999999 99999999999999975 5789
Q ss_pred EEEeccccCC
Q 003139 643 KVADFGLSKT 652 (845)
Q Consensus 643 kl~DFGla~~ 652 (845)
.++||+.++.
T Consensus 185 ~LIDl~r~~~ 194 (268)
T PRK15123 185 SVIDLHRAQI 194 (268)
T ss_pred EEEECCcccc
Confidence 9999998864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.83 E-value=6.2e-10 Score=130.45 Aligned_cols=247 Identities=21% Similarity=0.259 Sum_probs=164.3
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcC---CCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGN---PRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~---~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
..|.+.+-+-+|.++.++.++-. .|...+.|... .......+..+.+-.++-.-+||-++....-+.......||+
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~ 883 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG 883 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence 34555556778899988876533 23222332211 111112233333444444445666665554455667889999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCC-
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPAL- 656 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~- 656 (845)
+|..+++|...|+... ..+..-....+..+...++|||. ..+.|||++|.|+|+..++..+++|||+.......
T Consensus 884 ~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~ 958 (1205)
T KOG0606|consen 884 HYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIP 958 (1205)
T ss_pred HHhccCCchhhhhcCC--CcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCcccccccccccc
Confidence 9999999999886543 45555556667778889999998 66999999999999999999999999843221000
Q ss_pred --------------------------C--CcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 003139 657 --------------------------D--QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPV 708 (845)
Q Consensus 657 --------------------------~--~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~ 708 (845)
. .........||+.|.+||.+.+......+|+|++|++++|.++|.+||+..
T Consensus 959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence 0 001123457899999999999999999999999999999999999999765
Q ss_pred CCcccccHHHHHHHHhhcCchhhhhccccC-CCCCHHHHHHHHHHHHHhhhhCCCCCCCHH
Q 003139 709 LPREQVNIAEWAMTWQKKGMLDQIMDSNLV-GKVNPASLKKFGETAEKCLAEHGVDRPSMG 768 (845)
Q Consensus 709 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ 768 (845)
.+.... +.++...+. ..-+........+++...+..+|.+|-.|.
T Consensus 1039 tpq~~f---------------~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1039 TPQQIF---------------ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred chhhhh---------------hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 543311 111111110 011223445566778888889999997765
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.72 E-value=6.6e-08 Score=96.47 Aligned_cols=124 Identities=26% Similarity=0.290 Sum_probs=83.0
Q ss_pred EEEEEEEcCCcEEEEEEcCCCC--------------------------hHhHHHHHHHHHHHHhCCCC--CcceEEEEEe
Q 003139 517 RVYKGTLDDGTKVAVKRGNPRS--------------------------EQGIAEFRTEIEMLSKLRHR--HLVSLIGYCD 568 (845)
Q Consensus 517 ~Vy~~~~~~g~~vavK~~~~~~--------------------------~~~~~~~~~E~~~l~~l~H~--niv~l~g~~~ 568 (845)
.||.|...+|..+|||...... ........+|.+.|.++..- ++.+++++-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899998889999999533210 01123467899999999876 455666442
Q ss_pred cCCcEEEEEEecc--CCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCceeeccCCCCcEEECCCCceEEE
Q 003139 569 ERSEMILVYEYMA--NGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYL-HTGAAQSIIHRDVKTTNILLDDNFVAKVA 645 (845)
Q Consensus 569 ~~~~~~lV~Ey~~--~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivHrDik~~NILl~~~~~~kl~ 645 (845)
..+|||||++ +..+..+.. . .++......++.+++..+..+ |. .+|+|+||.+.|||++++ .+.|+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~-~---~~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKD-V---DLSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHH-C---GGGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEEE-
T ss_pred ---CCEEEEEecCCCccchhhHHh-c---cccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEEEE
Confidence 4589999998 555544332 1 122445677888888866664 66 899999999999999988 99999
Q ss_pred eccccCC
Q 003139 646 DFGLSKT 652 (845)
Q Consensus 646 DFGla~~ 652 (845)
|||.+..
T Consensus 149 Df~qav~ 155 (188)
T PF01163_consen 149 DFGQAVD 155 (188)
T ss_dssp -GTTEEE
T ss_pred ecCccee
Confidence 9998865
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF12819 Malectin_like: Carbohydrate-binding protein of the ER; InterPro: IPR024788 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan [] | Back alignment and domain information |
|---|
Probab=98.71 E-value=6.6e-08 Score=106.56 Aligned_cols=147 Identities=22% Similarity=0.335 Sum_probs=101.7
Q ss_pred eEEEecCCCc----c-cccCCceeecC---CCCcccccccCCccc---ccCCCCCCCcccceeEeeccc-----ceEEEe
Q 003139 35 NYLIACGSSQ----K-VTFQARTYVPD---TEHSSLSMKSGNSTT---ASSNSSAPSPIYQSARIFSAA-----AFYKFE 98 (845)
Q Consensus 35 ~~~i~CG~~~----~-~~~~~~~~v~D---~~~~~~~~~~~~~~~---~~~~~~~~~~~~~t~R~F~~~-----~cY~~~ 98 (845)
.+++|||+.. + .|.-+|+|.+. ...... .+...+. ....-..|..+|+|||.-+.. ..|.+
T Consensus 180 ~~R~n~G~~~~~iryp~D~~dR~W~~~~~~~~~~~i--st~~~i~~~~~~~~~~~P~~V~~TA~~~~~~s~~~nltw~~- 256 (347)
T PF12819_consen 180 VYRLNVGGSSSFIRYPDDTYDRIWQPYSSSPGWSNI--STTSNININSSNNPYDAPSAVYQTARTPSNSSDPLNLTWSF- 256 (347)
T ss_pred EEeecCCCcccccCCCCCcceeeccccccCcccccc--ccceeeecccCCccCcChHHHHHhhhcccccccceEEEecc-
Confidence 4689999764 1 22358999963 222222 2222221 223445566779999988433 27777
Q ss_pred ecccceEEEEEEeecCCCCCcCCccceEEEEeCcEEEeecccccc--cCCCcceEEEEEeecC-CceEEEEeeCCCC--c
Q 003139 99 IEHKGRHWVRLYFYTLPGSNQHLNSASFTVATDKFVLLSNFTFKN--YNSSFMFKEYAINVNS-DALTLTFIPSNNS--V 173 (845)
Q Consensus 99 ~~~~g~~~vR~~f~~~~~~~~~~~~~~f~v~~~~~~~~~~~~~~~--~~~~~~~~e~~~~~~~-~~~~vc~~~~~~~--~ 173 (845)
+..+-.|+|||||+-......+...-.|+|.+||......++... ....+++..|.+.+++ ..+.|+|.+++.+ -
T Consensus 257 ~~~~~~y~v~lHFaEi~~~~~~~~~R~F~IyiN~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~isL~~t~~S~lp 336 (347)
T PF12819_consen 257 VDPGFSYYVRLHFAEIQSLSPNNNQREFDIYINGQTAYSDVSPPYLGADTVPYYSDYVVNVPDSGFLNISLGPTPDSTLP 336 (347)
T ss_pred CCCCccEEEEEEEeecccccCCCCeEEEEEEECCeEccCccCcccccCcceEeecceEEEecCCCEEEEEEEeCCCCCcC
Confidence 666668999999998887655666788999999998876665422 2233457788888875 4799999999776 5
Q ss_pred ceeeeeEEEec
Q 003139 174 AFVNAIEVVSV 184 (845)
Q Consensus 174 pfi~~iE~~~~ 184 (845)
|+|||+|++.+
T Consensus 337 piLNalEIy~v 347 (347)
T PF12819_consen 337 PILNALEIYKV 347 (347)
T ss_pred ceeEeeeeEeC
Confidence 99999999864
|
This entry represents a malectin-like domain found in a number of plant receptor kinases. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.64 E-value=1e-06 Score=94.36 Aligned_cols=256 Identities=14% Similarity=0.158 Sum_probs=158.0
Q ss_pred ceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhC-CCCCcceEEEEE------ecCC-cEEEEEE
Q 003139 507 SLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKL-RHRHLVSLIGYC------DERS-EMILVYE 578 (845)
Q Consensus 507 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~------~~~~-~~~lV~E 578 (845)
.+.||+|+.+.+|-.--- +. .+.|+..........+ .++.|... .||-+-.-+.|= -+++ ..-++|.
T Consensus 16 gr~LgqGgea~ly~l~e~-~d-~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 16 GRPLGQGGEADLYTLGEV-RD-QVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CccccCCccceeeecchh-hc-hhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 446999999999964211 11 2344433322222122 23334443 566544323321 1222 3667888
Q ss_pred eccCCC-cccccc----CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCC
Q 003139 579 YMANGP-LRSHLY----GTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTG 653 (845)
Q Consensus 579 y~~~gs-L~~~l~----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~ 653 (845)
.+++.. +..++. ....+..+|.-.+++++.+|.+.+-||+ .|.+-+|+.++|+|+.+++.+.|.|=..-...
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccceeec
Confidence 877642 222221 1234568999999999999999999999 89999999999999999999999986554432
Q ss_pred CCCCCcccccccccCCCcCChhhhc-----cCCCCchhHHHHHHHHHHHHHcC-CCCCCCCCCcccc--cHH-HHHHHHh
Q 003139 654 PALDQTHVSTAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLMEVLCT-RPALNPVLPREQV--NIA-EWAMTWQ 724 (845)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~S~Gvvl~Elltg-~~p~~~~~~~~~~--~l~-~~~~~~~ 724 (845)
.........+|...|.+||.-. +..-+...|-|.+||+++|+|.| +.||.+....... .+. ..+
T Consensus 168 ---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia---- 240 (637)
T COG4248 168 ---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIA---- 240 (637)
T ss_pred ---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhh----
Confidence 2223334567889999999754 34557789999999999999987 8888754322110 000 000
Q ss_pred hcCchhhhhcccc-----CCCCC-HHHHHHHHHHHHHhhhhC--CCCCCCHHHHHHHHHHhh
Q 003139 725 KKGMLDQIMDSNL-----VGKVN-PASLKKFGETAEKCLAEH--GVDRPSMGDVLWNLEYAL 778 (845)
Q Consensus 725 ~~~~~~~~~d~~l-----~~~~~-~~~~~~l~~l~~~cl~~~--p~~RPs~~~vl~~L~~~~ 778 (845)
.+.....-|... -..++ .-.+..+..+-.+|+... +.-||+++.++..|..+.
T Consensus 241 -~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~ 301 (637)
T COG4248 241 -HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALR 301 (637)
T ss_pred -cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHH
Confidence 011111111110 01122 234466777788888743 568999999998887654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.60 E-value=3.8e-07 Score=93.43 Aligned_cols=133 Identities=24% Similarity=0.213 Sum_probs=95.8
Q ss_pred cceeeeeeceEEEEEEEEcCCcEEEEEEcCCC--------------------C--hHhHHHHHHHHHHHHhCCCC--Ccc
Q 003139 506 ESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPR--------------------S--EQGIAEFRTEIEMLSKLRHR--HLV 561 (845)
Q Consensus 506 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~--------------------~--~~~~~~~~~E~~~l~~l~H~--niv 561 (845)
+...||.|.-+.||.|....|.++|||..... + .-......+|.++|.+|... .+.
T Consensus 95 iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP 174 (304)
T COG0478 95 IGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVP 174 (304)
T ss_pred hccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCC
Confidence 44589999999999999999999999942211 0 01123457899999999765 777
Q ss_pred eEEEEEecCCcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCc
Q 003139 562 SLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFV 641 (845)
Q Consensus 562 ~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~ 641 (845)
+.+++ +...+||||+++-.|...- ++-...-.|+..|++-+.-+-. .|+||+|+.+-||+++++|.
T Consensus 175 ~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 175 KPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVTEDGD 240 (304)
T ss_pred Ccccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEecCCC
Confidence 77754 5678999999987666542 1222233344444444443334 78999999999999999999
Q ss_pred eEEEeccccCC
Q 003139 642 AKVADFGLSKT 652 (845)
Q Consensus 642 ~kl~DFGla~~ 652 (845)
+.++||--+..
T Consensus 241 ~~vIDwPQ~v~ 251 (304)
T COG0478 241 IVVIDWPQAVP 251 (304)
T ss_pred EEEEeCccccc
Confidence 99999976654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.53 E-value=2.9e-08 Score=112.82 Aligned_cols=151 Identities=19% Similarity=0.278 Sum_probs=103.0
Q ss_pred HHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC-------CcccccccccCCCcCChhhhc
Q 003139 606 CIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD-------QTHVSTAVKGSFGYLDPEYFR 678 (845)
Q Consensus 606 ~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~-------~~~~~~~~~gt~~y~aPE~~~ 678 (845)
+.+++.||.|+|. ..++||++|.|++|.++.++..||+.|+.+....... +.....-......|.|||++.
T Consensus 105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 3445599999998 5789999999999999999999999999886533211 111111223456799999999
Q ss_pred cCCCCchhHHHHHHHHHHHHHcCCCC-CCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhh
Q 003139 679 RQQLTEKSDVYSFGVVLMEVLCTRPA-LNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCL 757 (845)
Q Consensus 679 ~~~~s~ksDV~S~Gvvl~Elltg~~p-~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl 757 (845)
+...+.++|+||+||+++-+..|+.+ +....... .+. ...-.+..-........+.++.+-+.+.+
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~-----~~~--------~~~~~~~~~~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLL-----SYS--------FSRNLLNAGAFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcc-----hhh--------hhhcccccccccccccCcHHHHHHHHHHh
Confidence 98899999999999999999955443 32211110 000 00001111111223456777888889999
Q ss_pred hhCCCCCCCHHHHH
Q 003139 758 AEHGVDRPSMGDVL 771 (845)
Q Consensus 758 ~~~p~~RPs~~~vl 771 (845)
..++..||++.++.
T Consensus 250 ~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLL 263 (700)
T ss_pred cCCcccCcchhhhh
Confidence 99999999877754
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.52 E-value=1.1e-06 Score=88.14 Aligned_cols=138 Identities=19% Similarity=0.188 Sum_probs=105.3
Q ss_pred eeeeceEEEEEEEEcCCcEEEEEEcCCC---C---hHhHHHHHHHHHHHHhCCCC--CcceEEEEEe-c----CCcEEEE
Q 003139 510 LGVGGFGRVYKGTLDDGTKVAVKRGNPR---S---EQGIAEFRTEIEMLSKLRHR--HLVSLIGYCD-E----RSEMILV 576 (845)
Q Consensus 510 LG~G~fg~Vy~~~~~~g~~vavK~~~~~---~---~~~~~~~~~E~~~l~~l~H~--niv~l~g~~~-~----~~~~~lV 576 (845)
-|.||-+.|++-.+. |+.+-+|+.... + +.....|.+|+..|.++... .+.+.+ ++. . .-.-+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 467899999998776 557999975521 1 23456799999999998532 345555 332 1 1246899
Q ss_pred EEeccC-CCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCc--eEEEeccccCC
Q 003139 577 YEYMAN-GPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFV--AKVADFGLSKT 652 (845)
Q Consensus 577 ~Ey~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~--~kl~DFGla~~ 652 (845)
+|-+++ -+|.+++.+....+.+...+..++.++++.+.-||+ .++.|+|+.+.|||++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997764 578888765555567888889999999999999999 99999999999999986666 99999987764
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.42 E-value=1.4e-06 Score=99.66 Aligned_cols=145 Identities=19% Similarity=0.270 Sum_probs=95.7
Q ss_pred cCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhH------------------------------H--------
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGI------------------------------A-------- 543 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~------------------------------~-------- 543 (845)
.+|+. ..|+.++-|.||+|++++|+.||||...+.-.+.. +
T Consensus 126 ~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ 204 (517)
T COG0661 126 SEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE 204 (517)
T ss_pred HHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence 34543 47999999999999999999999998766432211 1
Q ss_pred --HHHHHHHHHHhCC-----CCCcceEEEEEecCCcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHH-HHH
Q 003139 544 --EFRTEIEMLSKLR-----HRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARG-LHY 615 (845)
Q Consensus 544 --~~~~E~~~l~~l~-----H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~g-L~y 615 (845)
++..|...+.+++ .+++.-.-=|.+-.+...|+|||++|-.+.+...-.. ..++-+. |+..++++ +..
T Consensus 205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~---ia~~~~~~f~~q 280 (517)
T COG0661 205 ELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKE---LAELLVRAFLRQ 280 (517)
T ss_pred HhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHH---HHHHHHHHHHHH
Confidence 1344555554442 2333222222233567899999999999988743222 3345333 33333332 223
Q ss_pred HhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCC
Q 003139 616 LHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGP 654 (845)
Q Consensus 616 LH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~ 654 (845)
+-. .+++|.|.+|.||+++.++++.+.|||+.....
T Consensus 281 ~~~---dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 281 LLR---DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred HHh---cCccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 322 689999999999999999999999999987643
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.42 E-value=1.2e-06 Score=89.43 Aligned_cols=105 Identities=26% Similarity=0.295 Sum_probs=84.0
Q ss_pred HHHHHHHHHHHhCCC--CCcceEEEEEecCC----cEEEEEEeccCC-CccccccCCCCCCCCHHHHHHHHHHHHHHHHH
Q 003139 543 AEFRTEIEMLSKLRH--RHLVSLIGYCDERS----EMILVYEYMANG-PLRSHLYGTDLPPLSWKQRLEICIGAARGLHY 615 (845)
Q Consensus 543 ~~~~~E~~~l~~l~H--~niv~l~g~~~~~~----~~~lV~Ey~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~y 615 (845)
....+|.+.+.+++. -...+.+++..... .-+||+|++++. +|.+++.... .++......++.++++.+.-
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~--~~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE--QLDPSQRRELLRALARLIAK 133 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc--ccchhhHHHHHHHHHHHHHH
Confidence 457788888888753 34566777765532 358999999884 7888885432 25666788999999999999
Q ss_pred HhhcCCCceeeccCCCCcEEECCCC---ceEEEeccccCC
Q 003139 616 LHTGAAQSIIHRDVKTTNILLDDNF---VAKVADFGLSKT 652 (845)
Q Consensus 616 LH~~~~~~ivHrDik~~NILl~~~~---~~kl~DFGla~~ 652 (845)
||+ .+|+|+|+++.|||++.+. .+.++||+-++.
T Consensus 134 lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 134 LHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999 9999999999999999887 899999998875
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.32 E-value=8.2e-06 Score=84.52 Aligned_cols=133 Identities=18% Similarity=0.160 Sum_probs=86.9
Q ss_pred eeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCc--ceEEEEEecCCcEEEEEEeccCCC-
Q 003139 508 LLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHL--VSLIGYCDERSEMILVYEYMANGP- 584 (845)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~g~~~~~~~~~lV~Ey~~~gs- 584 (845)
..||+|..+.||+. .|..+++|...... ......+|.+++..+..-.+ .+.++++...+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 36899999999984 24567888866533 22456789999999865444 667888877778889999998863
Q ss_pred ccccccCCCCCCCCHHHHHHHHHHHHHHHHHHh---------------------------------------h-cCCCce
Q 003139 585 LRSHLYGTDLPPLSWKQRLEICIGAARGLHYLH---------------------------------------T-GAAQSI 624 (845)
Q Consensus 585 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH---------------------------------------~-~~~~~i 624 (845)
+...+. .+......++.++++.+.-|| . .....+
T Consensus 82 ~~~~~~------~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~ 155 (226)
T TIGR02172 82 FSRIIS------DNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTC 155 (226)
T ss_pred hhhhhc------CCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCce
Confidence 221111 011111122222222222222 1 112457
Q ss_pred eeccCCCCcEEECCCCceEEEeccccCC
Q 003139 625 IHRDVKTTNILLDDNFVAKVADFGLSKT 652 (845)
Q Consensus 625 vHrDik~~NILl~~~~~~kl~DFGla~~ 652 (845)
+|+|+.|.||++++++ +.|+||+.+..
T Consensus 156 ~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 156 LHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred EecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 8999999999999888 99999998865
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.30 E-value=6.2e-06 Score=83.14 Aligned_cols=137 Identities=17% Similarity=0.173 Sum_probs=93.4
Q ss_pred hcCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHH---------HHHHHHHHhCCCCC---cceEEEEE-
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEF---------RTEIEMLSKLRHRH---LVSLIGYC- 567 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l~H~n---iv~l~g~~- 567 (845)
.++|...+++-......|.+-..+ |..+++|..........+.| .+++..+.+++... ...++.++
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 467888888888777777777665 78899998766543322222 33444444443322 22322222
Q ss_pred ----ecCCcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceE
Q 003139 568 ----DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAK 643 (845)
Q Consensus 568 ----~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~k 643 (845)
.-....+|||||++|..|.++.. ++. .++..+..++.-||+ .|+.|+|++|.|++++++ .++
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~-~i~ 174 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNN-GIR 174 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECC-cEE
Confidence 22345679999999988877641 222 355667788999999 999999999999999965 599
Q ss_pred EEeccccCC
Q 003139 644 VADFGLSKT 652 (845)
Q Consensus 644 l~DFGla~~ 652 (845)
+.||+..+.
T Consensus 175 iID~~~k~~ 183 (229)
T PF06176_consen 175 IIDTQGKRM 183 (229)
T ss_pred EEECccccc
Confidence 999987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.18 E-value=5.2e-05 Score=76.00 Aligned_cols=103 Identities=23% Similarity=0.300 Sum_probs=82.9
Q ss_pred HHHHHHHHhCCC-CCcceEEEEEecCCcEEEEEEeccCCCccccccC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCc
Q 003139 546 RTEIEMLSKLRH-RHLVSLIGYCDERSEMILVYEYMANGPLRSHLYG-TDLPPLSWKQRLEICIGAARGLHYLHTGAAQS 623 (845)
Q Consensus 546 ~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 623 (845)
..|.-+|..+++ +++.+++|+|-. ++|.||.+.+++...-.. .....-+|..|.+|+.++++.+++|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 358888999976 699999999943 789999987766422000 11124689999999999999999999866666
Q ss_pred eeeccCCCCcEEECCCCceEEEeccccCC
Q 003139 624 IIHRDVKTTNILLDDNFVAKVADFGLSKT 652 (845)
Q Consensus 624 ivHrDik~~NILl~~~~~~kl~DFGla~~ 652 (845)
+...|++++|+-+++++++|++|...+..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 88899999999999999999999987754
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.12 E-value=2.6e-05 Score=80.92 Aligned_cols=143 Identities=22% Similarity=0.243 Sum_probs=86.4
Q ss_pred ceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCC--CcceEEEEEec---CCcEEEEEEecc
Q 003139 507 SLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHR--HLVSLIGYCDE---RSEMILVYEYMA 581 (845)
Q Consensus 507 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~~~~---~~~~~lV~Ey~~ 581 (845)
.+.|+.|..+.||+....+ ..+++|..... .....+..|..++..+... .+.+++.++.. ....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3578999999999999886 68999986544 4556778899998888543 34567765532 334689999999
Q ss_pred CCCccc----------------cc---cCC--CCCCCCHHH---------HHHH------------HHHHHH-HHHHHhh
Q 003139 582 NGPLRS----------------HL---YGT--DLPPLSWKQ---------RLEI------------CIGAAR-GLHYLHT 618 (845)
Q Consensus 582 ~gsL~~----------------~l---~~~--~~~~l~~~~---------~~~i------------~~~ia~-gL~yLH~ 618 (845)
+..+.. .+ +.. ....+.+.. .... ...+.+ .++.+++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 987776 11 111 111111111 0000 111222 3333332
Q ss_pred ----cCCCceeeccCCCCcEEEC-CCCceEEEeccccCC
Q 003139 619 ----GAAQSIIHRDVKTTNILLD-DNFVAKVADFGLSKT 652 (845)
Q Consensus 619 ----~~~~~ivHrDik~~NILl~-~~~~~kl~DFGla~~ 652 (845)
.....++|+|+.++|||++ +++.+.|.||+.+..
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2346799999999999999 666778999987754
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.02 E-value=0.00015 Score=73.99 Aligned_cols=151 Identities=20% Similarity=0.207 Sum_probs=98.3
Q ss_pred ccHHHHHHHhcCCCcceee---eeeceEEEEEEEEcCCcEEEEEEcCCCChHhH------------------------HH
Q 003139 492 FMFQEILDATNKFDESLLL---GVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGI------------------------AE 544 (845)
Q Consensus 492 ~~~~el~~at~~f~~~~~L---G~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~------------------------~~ 544 (845)
.++..|.....+..+..+. .+|.-+.||+|.-.++..+|||+......... .-
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 4455555555555555554 46777899999888899999997554321110 11
Q ss_pred HHHHHHHHHhCC--CCCcceEEEEEecCCcEEEEEEeccCCCcc-ccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 003139 545 FRTEIEMLSKLR--HRHLVSLIGYCDERSEMILVYEYMANGPLR-SHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAA 621 (845)
Q Consensus 545 ~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~-~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 621 (845)
..+|..-|.++. +=.+.+.+++. +-.|||||+....+. -.|.. .++...+...+..++++.+.-|-. .
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD---v~~e~~e~~~~~~~~v~~~~~l~~--~ 185 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD---VPLELEEAEGLYEDVVEYMRRLYK--E 185 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc---CCcCchhHHHHHHHHHHHHHHHHH--h
Confidence 245777777663 34445555543 348999999654211 11111 122233566677777777777754 3
Q ss_pred CceeeccCCCCcEEECCCCceEEEeccccCC
Q 003139 622 QSIIHRDVKTTNILLDDNFVAKVADFGLSKT 652 (845)
Q Consensus 622 ~~ivHrDik~~NILl~~~~~~kl~DFGla~~ 652 (845)
.++||+||..-|||+. ++.+.|+|+|-|..
T Consensus 186 a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~ 215 (268)
T COG1718 186 AGLVHGDLSEYNILVH-DGEPYIIDVSQAVT 215 (268)
T ss_pred cCcccccchhhheEEE-CCeEEEEECccccc
Confidence 6899999999999999 78999999998865
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.00 E-value=6.5e-05 Score=78.92 Aligned_cols=139 Identities=18% Similarity=0.174 Sum_probs=85.8
Q ss_pred eeeece-EEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCC-CCCcceEEEEEecCCcEEEEEEeccCCCccc
Q 003139 510 LGVGGF-GRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLR-HRHLVSLIGYCDERSEMILVYEYMANGPLRS 587 (845)
Q Consensus 510 LG~G~f-g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~ 587 (845)
|-.|.. ..||+...+ +..+++|+..... ..+..+|+++++.+. +--+.+++++....+..++|||+++|.+|..
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 444555 789998765 4788889875543 345667999888884 4445577887776667899999999987764
Q ss_pred cc-------------------cCCCC--CCCC--HHHHHHHHHH--------------------HHHHHHHHhh----cC
Q 003139 588 HL-------------------YGTDL--PPLS--WKQRLEICIG--------------------AARGLHYLHT----GA 620 (845)
Q Consensus 588 ~l-------------------~~~~~--~~l~--~~~~~~i~~~--------------------ia~gL~yLH~----~~ 620 (845)
.. +.... .++. +...+..... +...++.|-. ..
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 32 11100 0111 0011100000 1111122211 11
Q ss_pred CCceeeccCCCCcEEECCCCceEEEeccccCC
Q 003139 621 AQSIIHRDVKTTNILLDDNFVAKVADFGLSKT 652 (845)
Q Consensus 621 ~~~ivHrDik~~NILl~~~~~~kl~DFGla~~ 652 (845)
...++|+|+.|.|||++++....|+||+.+..
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 24589999999999999987889999998765
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.96 E-value=5.1e-05 Score=86.78 Aligned_cols=145 Identities=21% Similarity=0.225 Sum_probs=91.5
Q ss_pred CCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhH-------------------------------H------HH
Q 003139 503 KFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGI-------------------------------A------EF 545 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~-------------------------------~------~~ 545 (845)
.|+. +.||.-..|.||+|++++|+.||||...+.-++.. + +|
T Consensus 163 ~f~~-~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF 241 (538)
T KOG1235|consen 163 EFDE-EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDF 241 (538)
T ss_pred hcCc-chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcch
Confidence 4443 37999999999999999999999998665422210 1 14
Q ss_pred HHHHHHHHhC----CCCCcce---EEEEE-ecCCcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 003139 546 RTEIEMLSKL----RHRHLVS---LIGYC-DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLH 617 (845)
Q Consensus 546 ~~E~~~l~~l----~H~niv~---l~g~~-~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH 617 (845)
.+|.+-..++ +|-++.. .=.++ .-.....|+||||+|..+.+...-. ...++-.. |+..+.++.. +
T Consensus 242 ~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~-~~gi~~~~---i~~~l~~~~~--~ 315 (538)
T KOG1235|consen 242 TKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAID-KRGISPHD---ILNKLVEAYL--E 315 (538)
T ss_pred HHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHH-HcCCCHHH---HHHHHHHHHH--H
Confidence 4444443333 3555111 11111 2335789999999999887764211 12344443 3333333322 1
Q ss_pred hcCCCceeeccCCCCcEEECC----CCceEEEeccccCCCC
Q 003139 618 TGAAQSIIHRDVKTTNILLDD----NFVAKVADFGLSKTGP 654 (845)
Q Consensus 618 ~~~~~~ivHrDik~~NILl~~----~~~~kl~DFGla~~~~ 654 (845)
.-...|++|+|-+|.||+++. ++++.+-|||+.....
T Consensus 316 qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 316 QIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred HHHhcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 111268999999999999984 6799999999987643
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.93 E-value=0.00014 Score=89.84 Aligned_cols=148 Identities=17% Similarity=0.280 Sum_probs=93.0
Q ss_pred ceeeeeeceEEEEEEEEcCC---cEEEEEEcCCCC-hHhHHHHHHHHHHHHhCC-CCCc--ceEEEEEecC---CcEEEE
Q 003139 507 SLLLGVGGFGRVYKGTLDDG---TKVAVKRGNPRS-EQGIAEFRTEIEMLSKLR-HRHL--VSLIGYCDER---SEMILV 576 (845)
Q Consensus 507 ~~~LG~G~fg~Vy~~~~~~g---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~ni--v~l~g~~~~~---~~~~lV 576 (845)
...++.|.+..+|+....++ ..+++|+..... ......+.+|.++|+.+. |.++ .+++++|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 45688999999999887654 367888754432 122356789999999995 6665 7788888764 467899
Q ss_pred EEeccCCCcccc-----------------------ccCCCC---------CCCCHH--HHHHHH---------------H
Q 003139 577 YEYMANGPLRSH-----------------------LYGTDL---------PPLSWK--QRLEIC---------------I 607 (845)
Q Consensus 577 ~Ey~~~gsL~~~-----------------------l~~~~~---------~~l~~~--~~~~i~---------------~ 607 (845)
|||+++..+.+. ||.-.. .+..+. ++..+. -
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 999998654321 111100 011110 111111 1
Q ss_pred HHHHHHHHHhhcCC--------CceeeccCCCCcEEECCC-C-ceEEEeccccCCCC
Q 003139 608 GAARGLHYLHTGAA--------QSIIHRDVKTTNILLDDN-F-VAKVADFGLSKTGP 654 (845)
Q Consensus 608 ~ia~gL~yLH~~~~--------~~ivHrDik~~NILl~~~-~-~~kl~DFGla~~~~ 654 (845)
.+.+.+++|....+ ..+||+|+++.|||++.+ . ..-|.|++++....
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd 259 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN 259 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence 12334556643211 359999999999999853 3 35799999987643
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.85 E-value=2e-06 Score=96.81 Aligned_cols=182 Identities=19% Similarity=0.135 Sum_probs=130.2
Q ss_pred ceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCC-cceEEEEEecCCcEEEEEEeccCC-C
Q 003139 507 SLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRH-LVSLIGYCDERSEMILVYEYMANG-P 584 (845)
Q Consensus 507 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~Ey~~~g-s 584 (845)
.+-+++|++++++|.+-.-.+....+.+... ....-++++|.+++||| .+..++-++.+...+++++++..+ +
T Consensus 247 fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs 321 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRS 321 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcc
Confidence 3347899999999987432333334443322 34456899999999999 667777777777889999999877 2
Q ss_pred ccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcccccc
Q 003139 585 LRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTA 664 (845)
Q Consensus 585 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 664 (845)
-..... .....+...+...+++.-++++++||+ ..=+|+| ||+..+ ...|..||+....... ......
T Consensus 322 ~~~~~~-~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~---~~~~~t 389 (829)
T KOG0576|consen 322 SALEMT-VSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTR---TMKPRT 389 (829)
T ss_pred ccccCC-hhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCc---cccccc
Confidence 222111 111234445566778888899999998 3358988 777766 5889999999876433 223456
Q ss_pred cccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCC
Q 003139 665 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPAL 705 (845)
Q Consensus 665 ~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~ 705 (845)
..+++.++|||+.....+..+.|+|+.|+--.+|--|-+|-
T Consensus 390 ~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 390 AIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred CCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 77899999999999999999999999999777776666553
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00035 Score=73.02 Aligned_cols=139 Identities=19% Similarity=0.244 Sum_probs=78.2
Q ss_pred eeeeeeceE-EEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCC---CcceEEEEEecC---CcEEEEEEec
Q 003139 508 LLLGVGGFG-RVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHR---HLVSLIGYCDER---SEMILVYEYM 580 (845)
Q Consensus 508 ~~LG~G~fg-~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~~~---~~~~lV~Ey~ 580 (845)
+.|+.|+.. .||+. +..+++|..... ....++..|.+++..+... -+.+.++.+... ...+++||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 357777766 58875 245777765432 2235788899999888532 344445444332 2348899999
Q ss_pred cCCCccccc------------------cCCCCC--CC-------------CHHHHH--HHH-------HHHHHH-HHH-H
Q 003139 581 ANGPLRSHL------------------YGTDLP--PL-------------SWKQRL--EIC-------IGAARG-LHY-L 616 (845)
Q Consensus 581 ~~gsL~~~l------------------~~~~~~--~l-------------~~~~~~--~i~-------~~ia~g-L~y-L 616 (845)
+|.++.... |.-... +. .|.... .+. .+.... ++. +
T Consensus 77 ~G~~l~~~~~~~~~~l~~~la~~l~~LH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 156 (235)
T cd05155 77 EGETATAAALSDPSEFAEDLADFLAALRQIDPSGGPPAGRHNFLRGGDLAVRDAETREAIEALEGVIDVDAARALWEAAL 156 (235)
T ss_pred cCCCCCccccCCHHHHHHHHHHHHHHHhCCCcccCCccCCccccCCCChhHhhHHHHHHHHHcccccChHHHHHHHHHHh
Confidence 998875431 111000 00 121110 000 011111 111 1
Q ss_pred hh--cCCCceeeccCCCCcEEECCCCceEEEeccccCC
Q 003139 617 HT--GAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKT 652 (845)
Q Consensus 617 H~--~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~ 652 (845)
+. .....++|+|+.+.|||++++...-|.||+.+..
T Consensus 157 ~~~~~~~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 157 RAPWWGPPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred cccccCCceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 11 1234589999999999999776667999998865
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00083 Score=72.73 Aligned_cols=79 Identities=11% Similarity=0.062 Sum_probs=57.7
Q ss_pred CCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCC---CCcceEEEEEecC---CcEEEEE
Q 003139 504 FDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRH---RHLVSLIGYCDER---SEMILVY 577 (845)
Q Consensus 504 f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~g~~~~~---~~~~lV~ 577 (845)
....+.||.|..+.||+....++ .+++|..+... ....|..|.+.|+.+.. -.+.+++++|... +..+|||
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQG-NPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred hheeeecCCccceeEEEEEcCCC-CEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 34455799999999999876655 46666643211 22578889999998853 3678889888543 6689999
Q ss_pred EeccCCCc
Q 003139 578 EYMANGPL 585 (845)
Q Consensus 578 Ey~~~gsL 585 (845)
|+++++++
T Consensus 93 E~i~G~~~ 100 (297)
T PRK10593 93 ERLRGVSV 100 (297)
T ss_pred eccCCEec
Confidence 99998765
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00051 Score=69.24 Aligned_cols=129 Identities=22% Similarity=0.286 Sum_probs=89.6
Q ss_pred cceeeeeeceEEEEEEEEcCCcEEEEEEcCCCC----------------hHhHHHHHHHHHHHHhCC------CCCcceE
Q 003139 506 ESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRS----------------EQGIAEFRTEIEMLSKLR------HRHLVSL 563 (845)
Q Consensus 506 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------H~niv~l 563 (845)
....||+|+.-.||. +.+....+||...... ....+++.+|+.....+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 345899999999987 4455667888766554 223456667776666655 8899999
Q ss_pred EEEEecCCcEEEEEEeccCC------CccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEEC
Q 003139 564 IGYCDERSEMILVYEYMANG------PLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLD 637 (845)
Q Consensus 564 ~g~~~~~~~~~lV~Ey~~~g------sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~ 637 (845)
+|+.+...-.-+|+|.+.+. +|.+++... .++. +..+.+. +-.+||-+ .+|+.+||+|+||++.
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~~~~~L~---~f~~~l~~---~~Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-ELRQALD---EFKRYLLD---HHIVIRDLNPHNIVVQ 152 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC---CccH-HHHHHHH---HHHHHHHH---cCCeecCCCcccEEEE
Confidence 99999999999999987642 455555322 3444 3333333 34556666 7899999999999996
Q ss_pred CC---C-ceEEEe
Q 003139 638 DN---F-VAKVAD 646 (845)
Q Consensus 638 ~~---~-~~kl~D 646 (845)
.+ . .+.|+|
T Consensus 153 ~~~~~~~~lvlID 165 (199)
T PF10707_consen 153 RRDSGEFRLVLID 165 (199)
T ss_pred ecCCCceEEEEEe
Confidence 32 2 567776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00069 Score=70.64 Aligned_cols=140 Identities=16% Similarity=0.204 Sum_probs=82.2
Q ss_pred eeeeeeceEEEEEEEEcC--CcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcce-EEEEEecCCcEEEEEEeccCCC
Q 003139 508 LLLGVGGFGRVYKGTLDD--GTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVS-LIGYCDERSEMILVYEYMANGP 584 (845)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~--g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~-l~g~~~~~~~~~lV~Ey~~~gs 584 (845)
+.|..|-...+|+....+ +..+++|......... -+-.+|+.++..+...++++ +++.+. -.+||||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~-~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI-IDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce-ecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 457778888999998764 6788899765432221 22246888888886544444 443332 248999999877
Q ss_pred cccc-----------------ccCCC--C-------CCC-CHHHHHHHHH----------------------HHHHHHHH
Q 003139 585 LRSH-----------------LYGTD--L-------PPL-SWKQRLEICI----------------------GAARGLHY 615 (845)
Q Consensus 585 L~~~-----------------l~~~~--~-------~~l-~~~~~~~i~~----------------------~ia~gL~y 615 (845)
+... +|... . ... -|..+..+.. .+..-+..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 6321 11111 0 011 1222212111 11111111
Q ss_pred ----Hhh-cCCCceeeccCCCCcEEECC-CCceEEEeccccCC
Q 003139 616 ----LHT-GAAQSIIHRDVKTTNILLDD-NFVAKVADFGLSKT 652 (845)
Q Consensus 616 ----LH~-~~~~~ivHrDik~~NILl~~-~~~~kl~DFGla~~ 652 (845)
+.. .....++|+|+.+.|||+++ +..+.|+||..|..
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 111 12356999999999999998 57899999998865
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00021 Score=86.25 Aligned_cols=199 Identities=21% Similarity=0.210 Sum_probs=137.0
Q ss_pred HHHHHHHHHHHhCCCCCcceEEEEEecCCcEE----EEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 003139 543 AEFRTEIEMLSKLRHRHLVSLIGYCDERSEMI----LVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHT 618 (845)
Q Consensus 543 ~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~----lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~ 618 (845)
....-|++.+.++.|+|++.+.+|-.+....- +..|++..-++...+... ..++....+.+..++.+||.|+|+
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v--~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV--GSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc--cccCHHHHHHHHHHHhhhHHHHHH
Confidence 34445788888999999999999986554333 445778777777777433 467888888999999999999998
Q ss_pred cCCCceeeccCCCC---cEEECCCCceEEE--eccccCCCCCCCCcccccccccCCCcCChhhhccCCCCc--hhHHHHH
Q 003139 619 GAAQSIIHRDVKTT---NILLDDNFVAKVA--DFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTE--KSDVYSF 691 (845)
Q Consensus 619 ~~~~~ivHrDik~~---NILl~~~~~~kl~--DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~--ksDV~S~ 691 (845)
....|.-+..+ +--.+..+...++ ||+..+..+..... .....+..+.+||......++. +.|+|++
T Consensus 305 ---~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 305 ---LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred ---hccceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHH
Confidence 45555555444 4445666777777 88888765443222 2223445678888877665544 4799999
Q ss_pred HHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHH
Q 003139 692 GVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVL 771 (845)
Q Consensus 692 Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl 771 (845)
|.++..+..|..+-.... ....+++. .....+.....+|+..++++|++..+++
T Consensus 379 gll~~~~~~~~~i~~~~~------------------~~~~~l~~--------~~~~~~~d~~~~~~~~~~~~Rl~~~~ll 432 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDISEKSA------------------VPVSLLDV--------LSTSELLDALPKCLDEDSEERLSALELL 432 (1351)
T ss_pred HHHHhhhhhcCccccccc------------------chhhhhcc--------ccchhhhhhhhhhcchhhhhccchhhhh
Confidence 999999998875432211 11111111 1111456778899999999999999998
Q ss_pred HHHH
Q 003139 772 WNLE 775 (845)
Q Consensus 772 ~~L~ 775 (845)
.+.-
T Consensus 433 ~~~f 436 (1351)
T KOG1035|consen 433 THPF 436 (1351)
T ss_pred hchh
Confidence 7643
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00057 Score=72.41 Aligned_cols=137 Identities=18% Similarity=0.181 Sum_probs=80.0
Q ss_pred eeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcc-eEEEEEecCCcEEEEEEeccCCCcccc
Q 003139 510 LGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLV-SLIGYCDERSEMILVYEYMANGPLRSH 588 (845)
Q Consensus 510 LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~Ey~~~gsL~~~ 588 (845)
+..|-...+|+... ++..+++|..........-+..+|.++++.+....++ ++++.+. -.+||||++|..+...
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 45677788998874 4678888875443222111346788999988654443 3444432 3689999998776532
Q ss_pred -----------------ccCCC--CCCCCHHHHH-HHHHH---------HHHHHHHHhh-----cCCCceeeccCCCCcE
Q 003139 589 -----------------LYGTD--LPPLSWKQRL-EICIG---------AARGLHYLHT-----GAAQSIIHRDVKTTNI 634 (845)
Q Consensus 589 -----------------l~~~~--~~~l~~~~~~-~i~~~---------ia~gL~yLH~-----~~~~~ivHrDik~~NI 634 (845)
||... ..+++...++ ....+ +.+.++.+-. .....++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 11111 1122222111 11111 1111222211 1124589999999999
Q ss_pred EECCCCceEEEeccccCC
Q 003139 635 LLDDNFVAKVADFGLSKT 652 (845)
Q Consensus 635 Ll~~~~~~kl~DFGla~~ 652 (845)
++++++ ++|+||+.+..
T Consensus 159 l~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEeCCC-CEEEeccccCc
Confidence 999876 78999998865
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00048 Score=66.64 Aligned_cols=128 Identities=23% Similarity=0.268 Sum_probs=86.9
Q ss_pred cceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEeccCCCc
Q 003139 506 ESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPL 585 (845)
Q Consensus 506 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 585 (845)
..+.|++|.+|.||+|.+. |..+|+|.....+. ...+..|.++|..+.-.++.+=+-.+ ++-.+.|||+.|-+|
T Consensus 26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~y---g~~~i~me~i~G~~L 99 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFY---GEDFIRMEYIDGRPL 99 (201)
T ss_pred hhhhhhcccccEEEEeecc-CceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEe---chhhhhhhhhcCcch
Confidence 3457999999999999998 55888887655443 36788899999999877776544333 223455999988787
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCC-C-CcEEECCCCceEEEeccccCC
Q 003139 586 RSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVK-T-TNILLDDNFVAKVADFGLSKT 652 (845)
Q Consensus 586 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik-~-~NILl~~~~~~kl~DFGla~~ 652 (845)
.+.-... +-++++. +++.---|.. .+|-|+.|. | .||++.+ ..+.|+||.-|..
T Consensus 100 ~~~~~~~-----~rk~l~~----vlE~a~~LD~---~GI~H~El~~~~k~vlv~~-~~~~iIDFd~At~ 155 (201)
T COG2112 100 GKLEIGG-----DRKHLLR----VLEKAYKLDR---LGIEHGELSRPWKNVLVND-RDVYIIDFDSATF 155 (201)
T ss_pred hhhhhcc-----cHHHHHH----HHHHHHHHHH---hccchhhhcCCceeEEecC-CcEEEEEccchhh
Confidence 7654221 2233333 3333333443 688888886 4 4555554 4999999998874
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.0011 Score=66.31 Aligned_cols=125 Identities=28% Similarity=0.371 Sum_probs=90.7
Q ss_pred cCCCcceeeeeece-EEEEEEEEcCCcEEEEEEcCC---CC---------h---------HhHHHHHHHHHHHHhCC---
Q 003139 502 NKFDESLLLGVGGF-GRVYKGTLDDGTKVAVKRGNP---RS---------E---------QGIAEFRTEIEMLSKLR--- 556 (845)
Q Consensus 502 ~~f~~~~~LG~G~f-g~Vy~~~~~~g~~vavK~~~~---~~---------~---------~~~~~~~~E~~~l~~l~--- 556 (845)
..++..+.||.|.- |.|||++.. |+.+|+|.+.. .. . .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67888889999999 999999987 78999998211 10 0 12245888999888885
Q ss_pred CCCc--ceEEEEEecC------------------CcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 003139 557 HRHL--VSLIGYCDER------------------SEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYL 616 (845)
Q Consensus 557 H~ni--v~l~g~~~~~------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yL 616 (845)
+.++ |+.+||..-. ....||.||++... .+. .+-+.+|.+-|..+
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~----~~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQ----IRDIPQMLRDLKIL 180 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccc----hhHHHHHHHHHHHH
Confidence 4566 8999987221 12357788775432 122 33456677778889
Q ss_pred hhcCCCceeeccCCCCcEEECCCCceEEEecccc
Q 003139 617 HTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLS 650 (845)
Q Consensus 617 H~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla 650 (845)
|. .+|+-+|+++.|.. .-||+|||.+
T Consensus 181 ~k---~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HK---LGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HH---CCeeeccCcccccc-----CCEEEecccC
Confidence 98 99999999999985 5689999864
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.0017 Score=70.27 Aligned_cols=142 Identities=21% Similarity=0.184 Sum_probs=87.1
Q ss_pred ceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCC--cceEEEE------EecCCcEEEEEE
Q 003139 507 SLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRH--LVSLIGY------CDERSEMILVYE 578 (845)
Q Consensus 507 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~------~~~~~~~~lV~E 578 (845)
.+.|..|....+|+....+ ..+++|+..... .++...|++++..+++.+ +.+++.. ....+..++|+|
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEKVS---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCCCC---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 4567778778999987654 468888876422 345666888888775433 4454432 123345689999
Q ss_pred eccCCCcccc--------------ccC--C--C-----CCCCCHHHHHH----------HHHHHHHHHHHHhh----cCC
Q 003139 579 YMANGPLRSH--------------LYG--T--D-----LPPLSWKQRLE----------ICIGAARGLHYLHT----GAA 621 (845)
Q Consensus 579 y~~~gsL~~~--------------l~~--~--~-----~~~l~~~~~~~----------i~~~ia~gL~yLH~----~~~ 621 (845)
|++|..+... +|. . . .....|..... ....+...+.++.+ ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 9998776431 010 0 0 01123332210 11123334445442 234
Q ss_pred CceeeccCCCCcEEECCCCceEEEeccccCC
Q 003139 622 QSIIHRDVKTTNILLDDNFVAKVADFGLSKT 652 (845)
Q Consensus 622 ~~ivHrDik~~NILl~~~~~~kl~DFGla~~ 652 (845)
.+++|+|+.|.|||++++....|.||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 5799999999999999987789999998754
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0053 Score=68.62 Aligned_cols=75 Identities=21% Similarity=0.272 Sum_probs=53.6
Q ss_pred eeeeeeceEEEEEEEEcCC-cEEEEEEcCCC------C-hHhHHHHHHHHHHHHhCC---CCCcceEEEEEecCCcEEEE
Q 003139 508 LLLGVGGFGRVYKGTLDDG-TKVAVKRGNPR------S-EQGIAEFRTEIEMLSKLR---HRHLVSLIGYCDERSEMILV 576 (845)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~g-~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV 576 (845)
+.||.|.+..||++...+| +.++||.-.+. + ....+++..|.+.|..+. ..++.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 3689999999999998877 48999974321 1 223566778888888763 2456667766 34567899
Q ss_pred EEeccCCC
Q 003139 577 YEYMANGP 584 (845)
Q Consensus 577 ~Ey~~~gs 584 (845)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.002 Score=70.02 Aligned_cols=140 Identities=24% Similarity=0.313 Sum_probs=84.6
Q ss_pred eeeeeeceEEEEEEEEcC-------CcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcc-eEEEEEecCCcEEEEEEe
Q 003139 508 LLLGVGGFGRVYKGTLDD-------GTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLV-SLIGYCDERSEMILVYEY 579 (845)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~-------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~Ey 579 (845)
+.|..|-...+|+....+ ++.+++|....... ...+..+|.+++..+...++. ++++++.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 356667777899988765 47889998654432 223456788888888544444 45555532 368999
Q ss_pred ccCCCcccc-----------------ccCCCCC---------CCCHHHHHH--------------------------HHH
Q 003139 580 MANGPLRSH-----------------LYGTDLP---------PLSWKQRLE--------------------------ICI 607 (845)
Q Consensus 580 ~~~gsL~~~-----------------l~~~~~~---------~l~~~~~~~--------------------------i~~ 607 (845)
++|..+... +|..... +.-|..+.+ +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 998876531 1111110 111111111 111
Q ss_pred HHHHHHHHHhh------cCCCceeeccCCCCcEEECCC----CceEEEeccccCC
Q 003139 608 GAARGLHYLHT------GAAQSIIHRDVKTTNILLDDN----FVAKVADFGLSKT 652 (845)
Q Consensus 608 ~ia~gL~yLH~------~~~~~ivHrDik~~NILl~~~----~~~kl~DFGla~~ 652 (845)
.+.+-++.|.. .....++|+|+.+.|||++++ +.++++||..|..
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 22223334432 234678999999999999985 8899999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0061 Score=66.76 Aligned_cols=141 Identities=14% Similarity=0.184 Sum_probs=78.5
Q ss_pred eeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCC--cceEEE------EEecCCcEEEEEEe
Q 003139 508 LLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRH--LVSLIG------YCDERSEMILVYEY 579 (845)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g------~~~~~~~~~lV~Ey 579 (845)
+.|+.|....+|+....+| .+++|+...... ++...|++++..|...+ +.+.+. +....+..++++||
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFERLTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEeccCCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 4566777789999887655 688887652222 23334555555543222 333332 12234567899999
Q ss_pred ccCCCcccc--------------ccCC--C-------CCCCCH-HHHHHHH------------HH-HHHHHHHHhhc---
Q 003139 580 MANGPLRSH--------------LYGT--D-------LPPLSW-KQRLEIC------------IG-AARGLHYLHTG--- 619 (845)
Q Consensus 580 ~~~gsL~~~--------------l~~~--~-------~~~l~~-~~~~~i~------------~~-ia~gL~yLH~~--- 619 (845)
++|..+... +|.. . ...+.| .+...-. .+ +...++.+...
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 998765321 1110 0 011222 2221111 11 11122333211
Q ss_pred -CCCceeeccCCCCcEEECCCCceEEEeccccCC
Q 003139 620 -AAQSIIHRDVKTTNILLDDNFVAKVADFGLSKT 652 (845)
Q Consensus 620 -~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~ 652 (845)
...++||+|+++.|||++++...-|+||+.+..
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 346899999999999999776668999998865
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.012 Score=63.99 Aligned_cols=143 Identities=18% Similarity=0.183 Sum_probs=84.0
Q ss_pred ceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCC--cceEEEEE------ecCCcEEEEEE
Q 003139 507 SLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRH--LVSLIGYC------DERSEMILVYE 578 (845)
Q Consensus 507 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~------~~~~~~~lV~E 578 (845)
.+.++.|....+|+...++| .+++|+...... .++...|.+++..|.... +.+++... ...+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 34566777789999876655 577887654321 234455677777664322 34444321 22456789999
Q ss_pred eccCCCcccc--------------ccC--CC--C------CCCCHHHHHH------------HHHHHHHHHHHHhh----
Q 003139 579 YMANGPLRSH--------------LYG--TD--L------PPLSWKQRLE------------ICIGAARGLHYLHT---- 618 (845)
Q Consensus 579 y~~~gsL~~~--------------l~~--~~--~------~~l~~~~~~~------------i~~~ia~gL~yLH~---- 618 (845)
|++|..+... +|. .. . ..-.|..... ....+.+.++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 9998665321 111 00 0 0112221111 11123345555542
Q ss_pred cCCCceeeccCCCCcEEECCCCceEEEeccccCC
Q 003139 619 GAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKT 652 (845)
Q Consensus 619 ~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~ 652 (845)
....+++|+|+++.||++++++...|.||+.+..
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 2357899999999999999987778999998754
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.0097 Score=65.86 Aligned_cols=139 Identities=18% Similarity=0.217 Sum_probs=83.3
Q ss_pred eeeeeceEEEEEEEEcC-----CcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcc-eEEEEEecCCcEEEEEEeccC
Q 003139 509 LLGVGGFGRVYKGTLDD-----GTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLV-SLIGYCDERSEMILVYEYMAN 582 (845)
Q Consensus 509 ~LG~G~fg~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~Ey~~~ 582 (845)
.|-.|-.-.+|+....+ ++.+++|...........+ .+|..+++.+...++. ++++.+.. + .|+||+++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi~g 117 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFIHA 117 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEECC-c---eEEEeeCC
Confidence 34456777899987542 3678899876554333333 6789999888655554 45555433 2 58999988
Q ss_pred CCcccc-----------------ccCCCC----CCCCHHHHHHHHHHH-----------------HHHHHHHh----h-c
Q 003139 583 GPLRSH-----------------LYGTDL----PPLSWKQRLEICIGA-----------------ARGLHYLH----T-G 619 (845)
Q Consensus 583 gsL~~~-----------------l~~~~~----~~l~~~~~~~i~~~i-----------------a~gL~yLH----~-~ 619 (845)
.+|... +|+... ....|.++.++..++ ...+..|. . .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 776421 122110 112233333333221 11122222 1 1
Q ss_pred CCCceeeccCCCCcEEECC-CCceEEEeccccCC
Q 003139 620 AAQSIIHRDVKTTNILLDD-NFVAKVADFGLSKT 652 (845)
Q Consensus 620 ~~~~ivHrDik~~NILl~~-~~~~kl~DFGla~~ 652 (845)
....++|+|+++.|||+++ ++.++++||..+..
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 2346899999999999986 47899999998864
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.0023 Score=67.52 Aligned_cols=134 Identities=19% Similarity=0.144 Sum_probs=92.0
Q ss_pred CCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCC--------------------ChHhH--HHHHHHHHHHHhCCC--CC
Q 003139 504 FDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPR--------------------SEQGI--AEFRTEIEMLSKLRH--RH 559 (845)
Q Consensus 504 f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~--------------------~~~~~--~~~~~E~~~l~~l~H--~n 559 (845)
+...+.||-|.-+.||.+...+|++.++|..... +...+ -...+|...|+.|.. --
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 4556789999999999999999999998832111 00011 124568888888853 23
Q ss_pred cceEEEEEecCCcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCC
Q 003139 560 LVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDN 639 (845)
Q Consensus 560 iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~ 639 (845)
+.+.+++ +..++|||++.+-.|...-+-. +..++.. .+..-+.-|-. +|+||+|..-=||+++++
T Consensus 174 VPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~-----d~~~ly~---~lm~~Iv~la~---~GlIHgDFNEFNimv~dd 238 (465)
T KOG2268|consen 174 VPKPIDH----NRHCVVMELVDGYPLRQVRHVE-----DPPTLYD---DLMGLIVRLAN---HGLIHGDFNEFNIMVKDD 238 (465)
T ss_pred CCCcccc----cceeeHHHhhcccceeeeeecC-----ChHHHHH---HHHHHHHHHHH---cCceecccchheeEEecC
Confidence 4445543 4678999999998887764322 2233332 22223444444 899999999999999999
Q ss_pred CceEEEeccccCC
Q 003139 640 FVAKVADFGLSKT 652 (845)
Q Consensus 640 ~~~kl~DFGla~~ 652 (845)
..++++||--+..
T Consensus 239 ~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 239 DKIVVIDFPQMVS 251 (465)
T ss_pred CCEEEeechHhhc
Confidence 9999999976644
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.029 Score=60.64 Aligned_cols=131 Identities=18% Similarity=0.263 Sum_probs=82.1
Q ss_pred EEEEEEEcCCcEEEEEEcC-CCChHhHHHHHHHHHHHHhCCC--CCcceEEEEEecCC--cEEEEEEeccCCCccccccC
Q 003139 517 RVYKGTLDDGTKVAVKRGN-PRSEQGIAEFRTEIEMLSKLRH--RHLVSLIGYCDERS--EMILVYEYMANGPLRSHLYG 591 (845)
Q Consensus 517 ~Vy~~~~~~g~~vavK~~~-~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~--~~~lV~Ey~~~gsL~~~l~~ 591 (845)
.+|..... ++.+++++-. ...........+|.++|+.+.- --+-..+++|.++. ..+.||+|++|..+...+..
T Consensus 40 ~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~ 118 (321)
T COG3173 40 DTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPP 118 (321)
T ss_pred ceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCc
Confidence 34444433 7778888321 1223334555678888887753 23445677786665 77999999998655544422
Q ss_pred CCCCCCCHHHHHHHH-HHHHHHHHHHhh--------------------------------------------------c-
Q 003139 592 TDLPPLSWKQRLEIC-IGAARGLHYLHT--------------------------------------------------G- 619 (845)
Q Consensus 592 ~~~~~l~~~~~~~i~-~~ia~gL~yLH~--------------------------------------------------~- 619 (845)
... . .+++ ..+++.|.-||+ .
T Consensus 119 ~~~---~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~ 191 (321)
T COG3173 119 ESL---G----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANR 191 (321)
T ss_pred ccc---h----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcC
Confidence 111 0 1111 244444555552 1
Q ss_pred ----CCCceeeccCCCCcEEECCCCceEEEeccccCCCCC
Q 003139 620 ----AAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPA 655 (845)
Q Consensus 620 ----~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~ 655 (845)
....++|+|+++.||+++.+..+-|.||+++.....
T Consensus 192 p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 192 PPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred CCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 134699999999999999988899999999987443
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.59 E-value=0.031 Score=59.79 Aligned_cols=137 Identities=15% Similarity=0.070 Sum_probs=75.5
Q ss_pred eeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCC--CC-cceEEEEEecCCcEEEEEEeccCCCcc
Q 003139 510 LGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRH--RH-LVSLIGYCDERSEMILVYEYMANGPLR 586 (845)
Q Consensus 510 LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~n-iv~l~g~~~~~~~~~lV~Ey~~~gsL~ 586 (845)
.++|--..|+.....+|..+++|.-. .........+|.++|+.++. +- +.+++..+ .-+++|++++|..+.
T Consensus 19 ~~~g~~~~v~~i~~~~g~~~VlR~p~--~~~~~~~l~rE~~vL~~L~~~l~vpvP~~~~~~----~~~~~y~~i~G~p~~ 92 (276)
T cd05152 19 NESGLDFQVVFAKDTDGVPWVLRIPR--RPDVSERAAAEKRVLALVRKHLPVQVPDWRVHT----PELIAYPKLPGVPAA 92 (276)
T ss_pred cCCcceeEEEEEEcCCCCeEEEEecC--CHHHHHHHHHHHHHHHHHHhcCCCCCCceeeec----CceEEEeccCCCccc
Confidence 34444456666544568889999864 22334567889999998853 21 12222222 235678888776553
Q ss_pred ccccCCCC---CCCCHHHHHHHHHHHHHHHHHHhh---------------------------------------------
Q 003139 587 SHLYGTDL---PPLSWKQRLEICIGAARGLHYLHT--------------------------------------------- 618 (845)
Q Consensus 587 ~~l~~~~~---~~l~~~~~~~i~~~ia~gL~yLH~--------------------------------------------- 618 (845)
..-..... ..........++.++++.|.-||+
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~la~~la~~La~LH~i~~~~~~~~g~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~~~~ 172 (276)
T cd05152 93 TIDPEIGEYVWNFDHKNPPEVFIESLAKALAELHSIPQDEAEAAGIPVETPEEVRQTMADRMDRVKEEFGVSEALWNRWQ 172 (276)
T ss_pred ccCcccccceecccCCCcCHHHHHHHHHHHHHHhCCChhhccccCCCCCCHHHHHHHHHHHHHHHHHhcCCCHHHHHHHH
Confidence 21000000 000001112233344444444441
Q ss_pred ---------cCCCceeeccCCCCcEEECCCCc-eEEEeccccCC
Q 003139 619 ---------GAAQSIIHRDVKTTNILLDDNFV-AKVADFGLSKT 652 (845)
Q Consensus 619 ---------~~~~~ivHrDik~~NILl~~~~~-~kl~DFGla~~ 652 (845)
.....++|+|+++.|||+++++. .-|.||+.+..
T Consensus 173 ~~L~~~~~~~~~~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 173 AWLDDDSYWPRHTVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred HHHhhcCCCCCCCeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 01234899999999999997554 56999999876
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.00041 Score=85.36 Aligned_cols=162 Identities=15% Similarity=0.023 Sum_probs=115.3
Q ss_pred HHHHHHHHHHHHhCCCCCcceEEEEE--ecCCcEEEEEEeccCCCccccccCC--CCCCCCHHHHHHHHHHHHHHHHHHh
Q 003139 542 IAEFRTEIEMLSKLRHRHLVSLIGYC--DERSEMILVYEYMANGPLRSHLYGT--DLPPLSWKQRLEICIGAARGLHYLH 617 (845)
Q Consensus 542 ~~~~~~E~~~l~~l~H~niv~l~g~~--~~~~~~~lV~Ey~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH 617 (845)
.+-.+.|...+++..|+++.....-. .+..+.+.+++|+..|.+.+.|-+. +.++++..-+...-.+......-+|
T Consensus 1273 kemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~l 1352 (2724)
T KOG1826|consen 1273 KEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVIL 1352 (2724)
T ss_pred HHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhh
Confidence 34445566666777899877655444 2345678999999999998887543 2334444444433334355555555
Q ss_pred hc--CCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHH
Q 003139 618 TG--AAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL 695 (845)
Q Consensus 618 ~~--~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl 695 (845)
.. ...--+|+++|+-|.+|..+.++|++++|+.++..+ .........+++-|+.|+....-.++.++|+|..|+.+
T Consensus 1353 s~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~l 1430 (2724)
T KOG1826|consen 1353 SLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSL 1430 (2724)
T ss_pred hcccCCccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHH
Confidence 42 224479999999999999999999999999984221 22223345677889999999999999999999999999
Q ss_pred HHHHcCCCCC
Q 003139 696 MEVLCTRPAL 705 (845)
Q Consensus 696 ~Elltg~~p~ 705 (845)
++.-.|..+|
T Consensus 1431 y~rs~~n~~f 1440 (2724)
T KOG1826|consen 1431 YLRSDGNAYF 1440 (2724)
T ss_pred HHHhcccHHH
Confidence 9988777654
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.26 E-value=0.026 Score=60.54 Aligned_cols=141 Identities=22% Similarity=0.277 Sum_probs=73.5
Q ss_pred CCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCC---CCCcceEEEEEecCCcEEEEEEec
Q 003139 504 FDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLR---HRHLVSLIGYCDERSEMILVYEYM 580 (845)
Q Consensus 504 f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~Ey~ 580 (845)
.+..+.|+.|....+|+.. .+++.+.||.-. ......|..|.+-|+.|. --.+.+.+++....+..+||+||+
T Consensus 19 i~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp --EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 3445568889999999987 567889999855 233356788888888883 446778899887777789999999
Q ss_pred cCCCcc-----------ccccC-CCCC-------------------CCCHHH-----HHHHHHHHH--------------
Q 003139 581 ANGPLR-----------SHLYG-TDLP-------------------PLSWKQ-----RLEICIGAA-------------- 610 (845)
Q Consensus 581 ~~gsL~-----------~~l~~-~~~~-------------------~l~~~~-----~~~i~~~ia-------------- 610 (845)
+.+... ..||. ...+ .-+|.+ |+.-..+.+
T Consensus 95 ~~~~~~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~~~l~ 174 (288)
T PF03881_consen 95 EMGSPSPPDWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAELERLV 174 (288)
T ss_dssp ------CCHHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHHHHHH
T ss_pred cCCCCCchhHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHHHHHH
Confidence 877111 01122 1100 123432 222111111
Q ss_pred HHH-HHHhhc-CCCceeeccCCCCcEEECCCCceEEEecc
Q 003139 611 RGL-HYLHTG-AAQSIIHRDVKTTNILLDDNFVAKVADFG 648 (845)
Q Consensus 611 ~gL-~yLH~~-~~~~ivHrDik~~NILl~~~~~~kl~DFG 648 (845)
+.+ ..|+.. ..+.++|+||.+.|++.+.++.+.|.|=.
T Consensus 175 ~~~~~~l~~~~~~PsLlHGDLW~GN~~~~~~g~p~l~DPa 214 (288)
T PF03881_consen 175 ERLPSLLPGREPKPSLLHGDLWSGNVGFDADGEPVLFDPA 214 (288)
T ss_dssp HHHHHCCTTS----EEE-SS-SGGGEEEETTE-EEE-S--
T ss_pred HHHHHHhcCCCCCceeeEcCccccceeecCCCCceeeccc
Confidence 111 122211 23569999999999999999889998854
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.05 E-value=0.088 Score=57.38 Aligned_cols=32 Identities=13% Similarity=0.236 Sum_probs=29.0
Q ss_pred CCceeeccCCCCcEEECCCCceEEEeccccCC
Q 003139 621 AQSIIHRDVKTTNILLDDNFVAKVADFGLSKT 652 (845)
Q Consensus 621 ~~~ivHrDik~~NILl~~~~~~kl~DFGla~~ 652 (845)
..+++|+|+.++|||+++++.+.++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 45799999999999999999999999998865
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.98 E-value=0.044 Score=60.33 Aligned_cols=139 Identities=17% Similarity=0.250 Sum_probs=80.4
Q ss_pred eeeeeceEEEEEEEEcC----CcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcc-eEEEEEecCCcEEEEEEeccCC
Q 003139 509 LLGVGGFGRVYKGTLDD----GTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLV-SLIGYCDERSEMILVYEYMANG 583 (845)
Q Consensus 509 ~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~Ey~~~g 583 (845)
.|..|-...+|+....+ +..+++|.........+. -.+|..+++.+..-++- ++++++. .+ +|.+|+++.
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~Id-R~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g~ 95 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVID-RERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINAR 95 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEec-hHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcCC
Confidence 34446667888887543 237888876554332222 25788899888766664 4565553 22 589999877
Q ss_pred Ccccc-----------------ccCCCC----CCCCHHHHHHHHHHH----------------------HHHHHHHhh--
Q 003139 584 PLRSH-----------------LYGTDL----PPLSWKQRLEICIGA----------------------ARGLHYLHT-- 618 (845)
Q Consensus 584 sL~~~-----------------l~~~~~----~~l~~~~~~~i~~~i----------------------a~gL~yLH~-- 618 (845)
.|... ||.... .+--|..+.++..++ ..-+..+..
T Consensus 96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~ 175 (330)
T PLN02421 96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT 175 (330)
T ss_pred CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence 66321 111110 011233333322221 111222111
Q ss_pred ---cCCCceeeccCCCCcEEECC-CCceEEEeccccCC
Q 003139 619 ---GAAQSIIHRDVKTTNILLDD-NFVAKVADFGLSKT 652 (845)
Q Consensus 619 ---~~~~~ivHrDik~~NILl~~-~~~~kl~DFGla~~ 652 (845)
..+.-++|+|+.+.|||+++ ++.++++||..|..
T Consensus 176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11234799999999999974 57899999998854
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.54 E-value=0.03 Score=57.34 Aligned_cols=31 Identities=26% Similarity=0.384 Sum_probs=21.9
Q ss_pred CceeeccCCCCcEEE-CCCCceEEEeccccCC
Q 003139 622 QSIIHRDVKTTNILL-DDNFVAKVADFGLSKT 652 (845)
Q Consensus 622 ~~ivHrDik~~NILl-~~~~~~kl~DFGla~~ 652 (845)
.-++|+||.+.|||+ +.++.++++||..|..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 457899999999999 8899999999998754
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.46 E-value=0.086 Score=57.87 Aligned_cols=73 Identities=22% Similarity=0.212 Sum_probs=47.2
Q ss_pred eeeeeceEEEEEEEEcCC-cEEEEEEcCC-------CChHhHHHHHHHHHHHHhCC--CCCcceEEEEEecCCcEEEEEE
Q 003139 509 LLGVGGFGRVYKGTLDDG-TKVAVKRGNP-------RSEQGIAEFRTEIEMLSKLR--HRHLVSLIGYCDERSEMILVYE 578 (845)
Q Consensus 509 ~LG~G~fg~Vy~~~~~~g-~~vavK~~~~-------~~~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~E 578 (845)
.||.|...-||++...+| +.++||.-.+ .-+-..++..-|.+.|+... -|..++-+- +.+.+...+|||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy-~~D~e~~~~vME 80 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIF-HFDTEMAVTVME 80 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEE-EEccccceehHh
Confidence 478999999999998754 5899995321 11333455566777776653 344444332 234556679999
Q ss_pred eccC
Q 003139 579 YMAN 582 (845)
Q Consensus 579 y~~~ 582 (845)
+++.
T Consensus 81 dL~~ 84 (370)
T TIGR01767 81 DLSH 84 (370)
T ss_pred hCcc
Confidence 9865
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.46 E-value=0.048 Score=58.85 Aligned_cols=110 Identities=20% Similarity=0.210 Sum_probs=73.1
Q ss_pred cCCcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEecc
Q 003139 569 ERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFG 648 (845)
Q Consensus 569 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFG 648 (845)
+....|++|++. +++|... .-..|.+.+.|+.+.+.-+.-|.. ..++-|||+.-.||||+ +|++-|+||-
T Consensus 297 e~~y~yl~~kdh-gt~is~i------k~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDfk 366 (488)
T COG5072 297 ETLYLYLHFKDH-GTPISII------KADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDFK 366 (488)
T ss_pred CceEEEEEEecC-Cceeeee------ecccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEee
Confidence 334456777765 4555432 235789999999998888887765 46789999999999999 9999999999
Q ss_pred ccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHH
Q 003139 649 LSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLM 696 (845)
Q Consensus 649 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ 696 (845)
++|.... +.... -...-.|-.+.+. -+.+=|||-+--.|.
T Consensus 367 lsRl~~~--q~~is-----y~rldhp~lF~G~-dd~QFeIYrlMr~l~ 406 (488)
T COG5072 367 LSRLSYS--QGIIS-----YNRLDHPDLFNGV-DDYQFEIYRLMRRLL 406 (488)
T ss_pred eeecccC--Cceee-----ccccCchhhhcCc-cceeeeHHHHHHHHh
Confidence 9996322 11111 1122344445533 366667776544443
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.41 E-value=0.21 Score=55.92 Aligned_cols=73 Identities=15% Similarity=0.162 Sum_probs=49.5
Q ss_pred ceeeeeeceEEEEEEEEcCCcEEEEEEcCCC----Ch---HhHHHHHHHHHHHHhCC---CCCcceEEEEEecCCcEEEE
Q 003139 507 SLLLGVGGFGRVYKGTLDDGTKVAVKRGNPR----SE---QGIAEFRTEIEMLSKLR---HRHLVSLIGYCDERSEMILV 576 (845)
Q Consensus 507 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~----~~---~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV 576 (845)
.+.||.|....||+.... +..++||+-.+. +. ....+-..|.+.|+.+. ..++.+++.+|. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 346899999999998764 557999975421 11 12334445566666553 357788888887 446889
Q ss_pred EEeccC
Q 003139 577 YEYMAN 582 (845)
Q Consensus 577 ~Ey~~~ 582 (845)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.29 E-value=0.01 Score=66.43 Aligned_cols=47 Identities=19% Similarity=0.325 Sum_probs=36.3
Q ss_pred HHHHHHHHHHhCCCCCcceEEEEEecCC-cEEEEEEeccCCCccccccC
Q 003139 544 EFRTEIEMLSKLRHRHLVSLIGYCDERS-EMILVYEYMANGPLRSHLYG 591 (845)
Q Consensus 544 ~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~Ey~~~gsL~~~l~~ 591 (845)
+.+-...+++.+.|+|+.+.+.+..... ...+|+|++ +.||.+.+..
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~ 75 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKT 75 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHh
Confidence 4456677889999999999998875543 367889998 6788887743
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.17 E-value=0.21 Score=63.30 Aligned_cols=141 Identities=22% Similarity=0.304 Sum_probs=79.5
Q ss_pred eeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCC--CCC--cceEEE--------EEec-CC--c
Q 003139 508 LLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLR--HRH--LVSLIG--------YCDE-RS--E 572 (845)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--H~n--iv~l~g--------~~~~-~~--~ 572 (845)
+.|+ |..-.+|+....+|..+++|+.+..... .....|.+.|..|. ++. +.+++- .... .+ .
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~~--~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSEPR--VESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCccch--hHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 3454 4457789988888889999998765322 23334555555442 122 222221 1111 22 4
Q ss_pred EEEEEEeccCCCcccccc---------------------CC----CCCCCCHHH-----------------HHHHHHHHH
Q 003139 573 MILVYEYMANGPLRSHLY---------------------GT----DLPPLSWKQ-----------------RLEICIGAA 610 (845)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~---------------------~~----~~~~l~~~~-----------------~~~i~~~ia 610 (845)
.+-+++|++|..|.+... .- ....+.|.. ...++.++.
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 567899999987754110 00 012234432 112222333
Q ss_pred HHHH-----HHhhcCCCceeeccCCCCcEEECCCC--ceE-EEeccccCC
Q 003139 611 RGLH-----YLHTGAAQSIIHRDVKTTNILLDDNF--VAK-VADFGLSKT 652 (845)
Q Consensus 611 ~gL~-----yLH~~~~~~ivHrDik~~NILl~~~~--~~k-l~DFGla~~ 652 (845)
...+ .| .....++||+|+.+.|||++.+. ++. |+|||-+..
T Consensus 188 ~~~~~~v~p~l-~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 188 ARFERNVAPRL-AALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHH-hcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 2222 12 22456799999999999999775 454 999998865
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.13 E-value=0.41 Score=52.36 Aligned_cols=139 Identities=23% Similarity=0.280 Sum_probs=82.1
Q ss_pred eeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCC---cce---EEE----EEecCCcEEEEEEe
Q 003139 510 LGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRH---LVS---LIG----YCDERSEMILVYEY 579 (845)
Q Consensus 510 LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n---iv~---l~g----~~~~~~~~~lV~Ey 579 (845)
|.+ .-..+|+....+|.. ++|..... ....+...|++.|..+.-.+ -++ +=| ........+-|++|
T Consensus 34 l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~ 109 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY 109 (331)
T ss_pred ccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence 444 556789988877766 88877665 22345556777777663221 122 112 11222477889999
Q ss_pred ccCCCccc-cc--------------c--CCC--------CCCCCHHH-------------HHHHHHHHHHHHHHHhh---
Q 003139 580 MANGPLRS-HL--------------Y--GTD--------LPPLSWKQ-------------RLEICIGAARGLHYLHT--- 618 (845)
Q Consensus 580 ~~~gsL~~-~l--------------~--~~~--------~~~l~~~~-------------~~~i~~~ia~gL~yLH~--- 618 (845)
++|..+.. .. + ..+ .....|.. ......++...+..+.+
T Consensus 110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~ 189 (331)
T COG2334 110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP 189 (331)
T ss_pred cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence 99988883 11 0 000 11234431 01133334444444443
Q ss_pred -cCCCc---eeeccCCCCcEEECCCCc-eEEEeccccCC
Q 003139 619 -GAAQS---IIHRDVKTTNILLDDNFV-AKVADFGLSKT 652 (845)
Q Consensus 619 -~~~~~---ivHrDik~~NILl~~~~~-~kl~DFGla~~ 652 (845)
..... +||+|+.|.|||++.+.. +.+.||+-+..
T Consensus 190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred hhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 12223 999999999999998875 89999998764
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.04 E-value=0.65 Score=50.99 Aligned_cols=137 Identities=15% Similarity=0.134 Sum_probs=76.0
Q ss_pred eceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCC--CcceEE---E--EEecCCcEEEEEEeccCCCc
Q 003139 513 GGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHR--HLVSLI---G--YCDERSEMILVYEYMANGPL 585 (845)
Q Consensus 513 G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~---g--~~~~~~~~~lV~Ey~~~gsL 585 (845)
+.-..||+...++|..+++|...... ....+...|++.+..|... .++..+ | +..-++..+.|+++++|...
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP 114 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence 45578999988888889999865332 2234556677777766321 122222 1 12224567889999988654
Q ss_pred cc--------------cccC--C--C---CCCCCHHHH-----H-----------------HHHHHHHHHHHH-Hhh-cC
Q 003139 586 RS--------------HLYG--T--D---LPPLSWKQR-----L-----------------EICIGAARGLHY-LHT-GA 620 (845)
Q Consensus 586 ~~--------------~l~~--~--~---~~~l~~~~~-----~-----------------~i~~~ia~gL~y-LH~-~~ 620 (845)
.. .||. . . ...+++... . +++.++..-++- +.. ..
T Consensus 115 ~~~~~~~~~~lG~~LarlH~~~~~~~~~~r~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 194 (325)
T PRK11768 115 ELDNLDQLEWVGRFLGRIHQVGAKRPFEHRPTLDLQEYGIEPRDWLLASDLIPSDLRPAYLAAADQLLAAVEACWARGDV 194 (325)
T ss_pred CCCCHHHHHHHHHHHHHHHhhccCCCCCCCCcCCHHHHHHHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 22 1111 1 0 112221111 0 111111111111 111 13
Q ss_pred CCceeeccCCCCcEEECCCCceEEEeccccCC
Q 003139 621 AQSIIHRDVKTTNILLDDNFVAKVADFGLSKT 652 (845)
Q Consensus 621 ~~~ivHrDik~~NILl~~~~~~kl~DFGla~~ 652 (845)
..++||+|+.+.|||++ + .+.|.||+-+..
T Consensus 195 ~~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~ 224 (325)
T PRK11768 195 RLLRLHGDCHPGNILWR-D-GPHFVDLDDARM 224 (325)
T ss_pred CccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence 45789999999999996 4 578999998865
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.98 E-value=0.38 Score=52.25 Aligned_cols=31 Identities=32% Similarity=0.404 Sum_probs=26.7
Q ss_pred CCceeeccCCCCcEEECCCCceEEEeccccCC
Q 003139 621 AQSIIHRDVKTTNILLDDNFVAKVADFGLSKT 652 (845)
Q Consensus 621 ~~~ivHrDik~~NILl~~~~~~kl~DFGla~~ 652 (845)
..+++|+|+.+.||+++. +.+.|.||+.+..
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 367999999999999998 5789999997654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 845 | ||||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-105 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-104 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-52 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-51 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-41 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-41 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-40 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-38 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-26 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-25 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-24 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-24 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-23 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-22 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-22 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-22 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-22 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-22 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-22 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-22 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-22 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-22 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-22 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-22 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-22 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-22 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-22 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-22 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-22 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-22 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-22 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-22 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-22 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-22 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-22 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-22 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-22 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-22 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-22 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-21 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-21 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-21 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-21 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-21 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-21 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-21 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-21 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-21 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-21 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-21 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-21 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-21 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-21 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 8e-21 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-20 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-20 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-20 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-20 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-20 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-20 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-20 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-20 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-20 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-20 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-20 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-20 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-20 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-20 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-20 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-20 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-20 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-20 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-20 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-20 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-20 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-20 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-20 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-20 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-20 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-20 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-20 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-20 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-20 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 8e-20 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 8e-20 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 8e-20 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-20 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 9e-20 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-20 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 9e-20 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-19 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-19 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-19 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-19 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-19 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-19 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-19 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-19 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-19 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 7e-19 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 8e-19 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-18 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-18 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-18 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-18 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-18 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-18 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-18 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-18 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-18 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-18 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-18 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-18 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-18 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-18 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-18 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-18 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-17 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-17 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-17 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-17 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-17 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-17 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-17 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-17 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-17 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-17 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-17 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-17 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-17 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-17 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-17 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-17 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 8e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 8e-17 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 8e-17 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-16 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-16 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-16 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-16 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-16 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-16 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-16 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-16 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-16 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-16 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-16 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-16 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-16 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-16 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-16 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-16 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-16 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 7e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-16 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 8e-16 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 9e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-15 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-15 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-15 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 6e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-15 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 8e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 9e-15 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 9e-15 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-14 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-14 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-14 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-14 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-14 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-14 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-14 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-14 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-14 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-14 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-14 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-14 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-14 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-14 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 7e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 8e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 8e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 8e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 9e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-13 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-13 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 7e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 9e-13 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-12 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-12 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 7e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 7e-12 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 8e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 9e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 6e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 7e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 7e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 7e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 8e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 8e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 8e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 8e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 8e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 9e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-10 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 7e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 7e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 8e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 8e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 9e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 9e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 9e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-09 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-09 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-09 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-09 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 7e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 7e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 8e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 8e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 8e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 8e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 8e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 8e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 8e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 8e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 9e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 9e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 9e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 9e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-08 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-08 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-08 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-08 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-08 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-08 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-08 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-08 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-08 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-08 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-08 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-08 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-08 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-08 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-08 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-08 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-08 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-08 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-08 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-08 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-08 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-08 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-08 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-08 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-08 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-08 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-08 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-08 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 6e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-08 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 7e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 7e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 8e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 8e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 9e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 9e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 9e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-07 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-07 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-07 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-07 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-07 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-07 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-07 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-07 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-07 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-07 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-07 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-07 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-07 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-07 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-07 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-07 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-07 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-07 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-07 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-07 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-07 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-07 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-07 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-07 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-07 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-07 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-07 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-07 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-07 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-07 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 7e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 7e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 8e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 8e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 8e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 8e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-06 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 6e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 6e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 6e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 6e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 6e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 6e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 6e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 7e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 7e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 8e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 8e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 9e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 9e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-05 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-05 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-05 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 5e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 6e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 6e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 6e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 6e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 6e-05 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 6e-05 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-05 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 7e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-05 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 7e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 7e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 8e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 8e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 8e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 9e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 9e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-04 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-04 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-04 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-04 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-04 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-04 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-04 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 4e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-04 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 5e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-04 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 5e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 6e-04 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 7e-04 |
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 583 bits (1504), Expect = 0.0
Identities = 198/322 (61%), Positives = 237/322 (73%), Gaps = 9/322 (2%)
Query: 468 MSTTSQKSGTASCISLASSNL----GRLFMFQEILDATNKFDESLLLGVGGFGRVYKGTL 523
M + K+ + +L+SS L ++ +ATN FD L+G G FG+VYKG L
Sbjct: 1 MGSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL 60
Query: 524 DDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANG 583
DG KVA+KR P S QGI EF TEIE LS RH HLVSLIG+CDER+EMIL+Y+YM NG
Sbjct: 61 RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENG 120
Query: 584 PLRSHLYGTDLP--PLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFV 641
L+ HLYG+DLP +SW+QRLEICIGAARGLHYLHT A IIHRDVK+ NILLD+NFV
Sbjct: 121 NLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFV 177
Query: 642 AKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCT 701
K+ DFG+SK G LDQTH+ST VKG+ GY+DPEYF + +LTEKSDVYSFGVVL EVLC
Sbjct: 178 PKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCA 237
Query: 702 RPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHG 761
R A+ LPRE VN+AEWA+ G L+QI+D NL K+ P SL+KFG+TA KCLA
Sbjct: 238 RSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSS 297
Query: 762 VDRPSMGDVLWNLEYALQLEET 783
DRPSMGDVLW LEYAL+L+E+
Sbjct: 298 EDRPSMGDVLWKLEYALRLQES 319
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 400 bits (1029), Expect = e-134
Identities = 105/308 (34%), Positives = 169/308 (54%), Gaps = 21/308 (6%)
Query: 481 ISLASSNLGRLFMFQEILDATNKFDESL------LLGVGGFGRVYKGTLDDGTKVAVKR- 533
+ ++ + F F E+ + TN FDE +G GGFG VYKG ++ T VAVK+
Sbjct: 5 LEVSDTRF-HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKL 62
Query: 534 ---GNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLY 590
+ +E+ +F EI++++K +H +LV L+G+ + ++ LVY YM NG L L
Sbjct: 63 AAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLS 122
Query: 591 GTD-LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGL 649
D PPLSW R +I GAA G+++LH IHRD+K+ NILLD+ F AK++DFGL
Sbjct: 123 CLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGL 179
Query: 650 SKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVL 709
++ QT +++ + G+ Y+ PE R ++T KSD+YSFGVVL+E++ PA++
Sbjct: 180 ARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDE-- 236
Query: 710 PREQVNIAEWAMT-WQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMG 768
RE + + ++ ++ +D + + S++ A +CL E RP +
Sbjct: 237 HREPQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIK 295
Query: 769 DVLWNLEY 776
V L+
Sbjct: 296 KVQQLLQE 303
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 386 bits (995), Expect = e-128
Identities = 117/292 (40%), Positives = 170/292 (58%), Gaps = 6/292 (2%)
Query: 489 GRLFMFQEILDATNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGI-AEFRT 547
+ F +E+ A++ F +LG GGFG+VYKG L DGT VAVKR QG +F+T
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76
Query: 548 EIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGT--DLPPLSWKQRLEI 605
E+EM+S HR+L+ L G+C +E +LVY YMANG + S L PPL W +R I
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 606 CIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAV 665
+G+ARGL YLH IIHRDVK NILLD+ F A V DFGL+K THV+TAV
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY-KDTHVTTAV 195
Query: 666 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQ--VNIAEWAMTW 723
+G+ G++ PEY + +EK+DV+ +GV+L+E++ + A + V + +W
Sbjct: 196 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255
Query: 724 QKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775
K+ L+ ++D +L G +++ + A C ++RP M +V+ LE
Sbjct: 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 262 bits (671), Expect = 6e-81
Identities = 72/316 (22%), Positives = 120/316 (37%), Gaps = 35/316 (11%)
Query: 485 SSNLGRLFMFQEILDATNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAE 544
SS + + + + + G FG V+K L VAVK + +Q +
Sbjct: 9 SSGVD--LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQS-WQ 64
Query: 545 FRTEIEMLSKLRHRHLVSLIGYCDE----RSEMILVYEYMANGPLRSHLYGTDLPPLSWK 600
E+ L ++H +++ IG ++ L+ + G L L +SW
Sbjct: 65 NEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA---NVVSWN 121
Query: 601 QRLEICIGAARGLHYLHTGAAQS-------IIHRDVKTTNILLDDNFVAKVADFGLSKTG 653
+ I ARGL YLH I HRD+K+ N+LL +N A +ADFGL+
Sbjct: 122 ELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF 181
Query: 654 PALDQTHVSTAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLMEVLCTRPALNPV 708
A + G+ Y+ PE ++ + D+Y+ G+VL E+ A +
Sbjct: 182 EAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241
Query: 709 LPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNP---------ASLKKFGETAEKCLAE 759
+ + E + L+ + + + K P A + ET E+C
Sbjct: 242 VDEYMLPFEEE---IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDH 298
Query: 760 HGVDRPSMGDVLWNLE 775
R S G V +
Sbjct: 299 DAEARLSAGCVGERIT 314
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 226 bits (577), Expect = 1e-67
Identities = 85/324 (26%), Positives = 140/324 (43%), Gaps = 37/324 (11%)
Query: 510 LGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDE 569
+G G FG V K VA+K+ SE F E+ LS++ H ++V L G C
Sbjct: 16 VGRGAFGVVCKAKWR-AKDVAIKQ--IESESERKAFIVELRQLSRVNHPNIVKLYGAC-- 70
Query: 570 RSEMILVYEYMANGPLRSHLYGTD-LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRD 628
+ + LV EY G L + L+G + LP + + C+ ++G+ YLH+ +++IHRD
Sbjct: 71 LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130
Query: 629 VKTTNILLDDNF-VAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSD 687
+K N+LL V K+ DFG + D T KGS ++ PE F +EK D
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSEKCD 185
Query: 688 VYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQ-KKGMLDQIMDSNLVGKVNPASL 746
V+S+G++L EV+ R P +++ + + W G ++ + P +
Sbjct: 186 VFSWGIILWEVITRR------KPFDEIGGPAFRIMWAVHNGTRPPLIKN------LPKPI 233
Query: 747 KKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLEETSSALMEPEDNSTNHIPCIQLTPL 806
+ +C ++ RPSM +++ + L EP H L P
Sbjct: 234 ESL---MTRCWSKDPSQRPSMEEIVKIMT---HLMRYFPGADEPLQYPCQH----SLPPG 283
Query: 807 EPFDNSVSMI--DVRNSGTDDDGE 828
E + + + D GE
Sbjct: 284 EDGRVEPYVDFAEFYRLWSVDHGE 307
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 6e-65
Identities = 76/270 (28%), Positives = 126/270 (46%), Gaps = 24/270 (8%)
Query: 510 LGVGGFGRVYKGTLDDGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYC 567
+G G FG V++ G+ VAVK + + + EF E+ ++ +LRH ++V +G
Sbjct: 45 IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 568 DERSEMILVYEYMANGPLRSHLYGTDL-PPLSWKQRLEICIGAARGLHYLHTGAAQSIIH 626
+ + +V EY++ G L L+ + L ++RL + A+G++YLH I+H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVH 162
Query: 627 RDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 686
R++K+ N+L+D + KV DFGLS+ S + G+ ++ PE R + EKS
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKS 220
Query: 687 DVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASL 746
DVYSFGV+L E+ + P +N A+ K +I P +L
Sbjct: 221 DVYSFGVILWELATLQ------QPWGNLNPAQVVAAVGFKCKRLEI----------PRNL 264
Query: 747 -KKFGETAEKCLAEHGVDRPSMGDVLWNLE 775
+ E C RPS ++ L
Sbjct: 265 NPQVAAIIEGCWTNEPWKRPSFATIMDLLR 294
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 9e-65
Identities = 71/341 (20%), Positives = 124/341 (36%), Gaps = 43/341 (12%)
Query: 492 FMFQEILDATNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEM 551
E + L+G G +G VYKG+LD VAVK + + Q + I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFANRQNFINEK-NIYR 60
Query: 552 LSKLRHRHLVSLIGYC-----DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEIC 606
+ + H ++ I D R E +LV EY NG L +L W +
Sbjct: 61 VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL---HTSDWVSSCRLA 117
Query: 607 IGAARGLHYLHTGAAQS------IIHRDVKTTNILLDDNFVAKVADFGLSKT------GP 654
RGL YLHT + I HRD+ + N+L+ ++ ++DFGLS
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVR 177
Query: 655 ALDQTHVSTAVKGSFGYLDPEYFR-------RQQLTEKSDVYSFGVVLMEVLCTRPALNP 707
++ + + + G+ Y+ PE + ++ D+Y+ G++ E+ L P
Sbjct: 178 PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237
Query: 708 VLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGK-----------VNPASLKKFGETAEKC 756
+ +A D M + + N +++ ET E C
Sbjct: 238 GESVPEYQMAFQTEVGNHPTFED--MQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDC 295
Query: 757 LAEHGVDRPSMGDVLWNLEYALQLEETSSALMEPEDNSTNH 797
+ R + + L + + + P + +H
Sbjct: 296 WDQDAEARLTAQXAEERMA-ELMMIWERNKSVSPTAHHHHH 335
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 1e-61
Identities = 78/279 (27%), Positives = 132/279 (47%), Gaps = 37/279 (13%)
Query: 510 LGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIA----EFRTEIEMLSKLRHRHLVSLIG 565
+G+GGFG+VY+ G +VAVK ++ I+ R E ++ + L+H ++++L G
Sbjct: 15 IGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 566 YCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSII 625
C + + LV E+ GPL L G +P + + ARG++YLH A II
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVLSGKRIP---PDILVNWAVQIARGMNYLHDEAIVPII 130
Query: 626 HRDVKTTNILLD--------DNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYF 677
HRD+K++NIL+ N + K+ DFGL++ +T +A G++ ++ PE
Sbjct: 131 HRDLKSSNILILQKVENGDLSNKILKITDFGLARE---WHRTTKMSAA-GAYAWMAPEVI 186
Query: 678 RRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNL 737
R ++ SDV+S+GV+L E+L +P ++ A + I
Sbjct: 187 RASMFSKGSDVWSYGVLLWELLTGE------VPFRGIDGLAVAYGVAMNKLALPI----- 235
Query: 738 VGKVNPASL-KKFGETAEKCLAEHGVDRPSMGDVLWNLE 775
P++ + F + E C RPS ++L L
Sbjct: 236 -----PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLT 269
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 6e-61
Identities = 51/273 (18%), Positives = 106/273 (38%), Gaps = 31/273 (11%)
Query: 510 LGVGGFGRVYKGTLDDGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYC 567
L G ++KG G + VK R S + +F E L H +++ ++G C
Sbjct: 18 LNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 568 DE--RSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSII 625
L+ +M G L + L+ + Q ++ + ARG+ +LHT I
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT-LEPLIP 135
Query: 626 HRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQL--- 682
+ + ++++D++ A+++ + + S + ++ PE +++
Sbjct: 136 RHALNSRSVMIDEDMTARISMADVKFS-------FQSPGRMYAPAWVAPEALQKKPEDTN 188
Query: 683 TEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVN 742
+D++SF V+L E++ +P ++ E M +G+ I
Sbjct: 189 RRSADMWSFAVLLWELVTRE------VPFADLSNMEIGMKVALEGLRPTIPPGI------ 236
Query: 743 PASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775
+ K + C+ E RP ++ LE
Sbjct: 237 SPHVSKL---MKICMNEDPAKRPKFDMIVPILE 266
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 8e-61
Identities = 82/271 (30%), Positives = 134/271 (49%), Gaps = 23/271 (8%)
Query: 510 LGVGGFGRVYKGTLDDGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYC 567
+G G FG VYKG VAVK N + Q + F+ E+ +L K RH +++ +GY
Sbjct: 32 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 568 DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHR 627
++ +V ++ L HL+ ++ K+ ++I ARG+ YLH A+SIIHR
Sbjct: 90 TA-PQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLH---AKSIIHR 144
Query: 628 DVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQL---TE 684
D+K+ NI L ++ K+ DFGL+ +H + GS ++ PE R Q +
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 685 KSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPA 744
+SDVY+FG+VL E++ + LP +N + + +G L D + V P
Sbjct: 205 QSDVYAFGIVLYELMTGQ------LPYSNINNRDQIIEMVGRGSLSP--DLSKVRSNCPK 256
Query: 745 SLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775
+K+ +CL + +RPS +L +E
Sbjct: 257 RMKRL---MAECLKKKRDERPSFPRILAEIE 284
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 4e-60
Identities = 63/300 (21%), Positives = 114/300 (38%), Gaps = 41/300 (13%)
Query: 510 LGVGGFGRVYKGTLDDGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYC 567
+G G FG+VY G +VA++ + +E + F+ E+ + RH ++V +G C
Sbjct: 41 IGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 568 DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHR 627
+ ++ L S + L + +I +G+ YLH A+ I+H+
Sbjct: 99 MSPPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLH---AKGILHK 154
Query: 628 DVKTTNILLDDNFVAKVADFGLSK---TGPALDQTHVSTAVKGSFGYLDPEYFRRQQL-- 682
D+K+ N+ D+ V + DFGL A + G +L PE R+
Sbjct: 155 DLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDT 213
Query: 683 -------TEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQ-KKGMLDQIMD 734
++ SDV++ G + E+ P + A+ WQ GM +
Sbjct: 214 EEDKLPFSKHSDVFALGTIWYELHARE------WPFKTQPAE--AIIWQMGTGMKPNLSQ 265
Query: 735 SNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLEETSSALMEPEDNS 794
+ + C A +RP+ ++ LE +L + + L P
Sbjct: 266 IGM-----GKEISDI---LLFCWAFEQEERPTFTKLMDMLE---KLPKRNRRLSHPGHFW 314
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 3e-59
Identities = 63/206 (30%), Positives = 100/206 (48%), Gaps = 24/206 (11%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVKR-------GNPRSEQGIAEFRTEIEMLSKLRHRHLV 561
+G GGFG V+KG + D + VA+K G + EF+ E+ ++S L H ++V
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 562 SLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAA 621
L G +V E++ G L L P+ W +L + + A G+ Y+
Sbjct: 87 KLYGLMHN--PPRMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQN-QN 142
Query: 622 QSIIHRDVKTTNILLD-----DNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEY 676
I+HRD+++ NI L AKVADFGLS+ H + + G+F ++ PE
Sbjct: 143 PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWMAPET 197
Query: 677 FRRQQL--TEKSDVYSFGVVLMEVLC 700
++ TEK+D YSF ++L +L
Sbjct: 198 IGAEEESYTEKADTYSFAMILYTILT 223
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 4e-59
Identities = 75/297 (25%), Positives = 118/297 (39%), Gaps = 34/297 (11%)
Query: 510 LGVGGFGRVYKGTL-DDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCD 568
LG G FG+ K T + G + +K E+ F E++++ L H +++ IG
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 569 ERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRD 628
+ + + EY+ G LR + D W QR+ A G+ YLH + +IIHRD
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLH---SMNIIHRD 133
Query: 629 VKTTNILLDDNFVAKVADFGLSK------------TGPALDQTHVSTAVKGSFGYLDPEY 676
+ + N L+ +N VADFGL++ V G+ ++ PE
Sbjct: 134 LNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM 193
Query: 677 FRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSN 736
+ EK DV+SFG+VL E++ A LPR ++ +G LD+ N
Sbjct: 194 INGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPR-TMDFGL-----NVRGFLDRYCPPN 247
Query: 737 LVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLEETSSALMEPEDN 793
P S +C RPS + LE L + +
Sbjct: 248 C-----PPSFFPI---TVRCCDLDPEKRPSFVKLEHWLE---TLRMHLAGHLPLGPQ 293
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 4e-56
Identities = 75/339 (22%), Positives = 130/339 (38%), Gaps = 46/339 (13%)
Query: 463 QTMTKMSTTSQKSGTASCISLASSNLGRLFMFQEILDATNKFDESLLLGVGGFGRVYKGT 522
+++ + SQ SG+ S + L Q + + + +G G +G V+ G
Sbjct: 9 ESLRDLIEQSQSSGSGSGLPLLV---------QRTIAKQIQMVK--QIGKGRYGEVWMGK 57
Query: 523 LDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYC----DERSEMILVYE 578
G KVAVK E TEI +RH +++ I +++ L+ +
Sbjct: 58 WR-GEKVAVKVFFTTEEAS-WFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITD 115
Query: 579 YMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQS-----IIHRDVKTTN 633
Y NG L +L L K L++ + GL +LHT + I HRD+K+ N
Sbjct: 116 YHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKN 172
Query: 634 ILLDDNFVAKVADFGLSKTGPALDQTH--VSTAVKGSFGYLDPE------YFRRQQLTEK 685
IL+ N +AD GL+ + G+ Y+ PE Q
Sbjct: 173 ILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIM 232
Query: 686 SDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNP-- 743
+D+YSFG++L E + R ++ Q+ + + + + + K+ P
Sbjct: 233 ADMYSFGLILWE-VARRCVSGGIVEEYQL---PYHDLVPSDPSYEDMREIVCIKKLRPSF 288
Query: 744 -------ASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775
L++ G+ +C A + R + V L
Sbjct: 289 PNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 5e-53
Identities = 62/295 (21%), Positives = 113/295 (38%), Gaps = 39/295 (13%)
Query: 509 LLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEM--LSKLRHRHLVSLIGY 566
+G G +G V++G+ G VAVK + R E+ + E E+ LRH +++ I
Sbjct: 15 CVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEK---SWFRETELYNTVMLRHENILGFIAS 70
Query: 567 C----DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQ 622
+++ L+ Y G L +L L L I + A GL +LH
Sbjct: 71 DMTSRHSSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 623 S-----IIHRDVKTTNILLDDNFVAKVADFGLS--KTGPALDQTHVSTAVKGSFGYLDPE 675
+ I HRD+K+ NIL+ N +AD GL+ + + G+ Y+ PE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 676 ------YFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGML 729
++ D+++FG+VL E + R N ++ + +
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWE-VARRMVSNGIVEDYKPPFYDVV---PNDPSF 243
Query: 730 DQIMDSNLVGKVNP---------ASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775
+ + V + P +L + ++C ++ R + + L
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 3e-52
Identities = 71/346 (20%), Positives = 129/346 (37%), Gaps = 38/346 (10%)
Query: 452 PWLPLPLYGNSQTMTKMSTTSQKSGTASCISLASSNLGRLFMFQEILDATNKFDESLLLG 511
P L P T+ + SG+ S + L Q + T E +G
Sbjct: 3 PSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLV---------QRTIARTIVLQE--SIG 51
Query: 512 VGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYC---- 567
G FG V++G G +VAVK + R E+ EI LRH +++ I
Sbjct: 52 KGRFGEVWRGKWR-GEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADNKDN 109
Query: 568 DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQS---- 623
+++ LV +Y +G L +L ++ + +++ + A GL +LH +
Sbjct: 110 GTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP 166
Query: 624 -IIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH--VSTAVKGSFGYLDPE----- 675
I HRD+K+ NIL+ N +AD GL+ + T G+ Y+ PE
Sbjct: 167 AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDS 226
Query: 676 -YFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMD 734
+ + +++D+Y+ G+V E+ + + M + +
Sbjct: 227 INMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCE 286
Query: 735 SNL-----VGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775
L + +L+ + +C +G R + + L
Sbjct: 287 QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 9e-45
Identities = 59/194 (30%), Positives = 94/194 (48%), Gaps = 10/194 (5%)
Query: 510 LGVGGFGRVYKGTL-DDGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYC 567
+G G FG V+ G L D T VAVK A+F E +L + H ++V LIG C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 568 DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHR 627
++ + +V E + G + L T+ L K L++ AA G+ YL ++ IHR
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFL-RTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHR 237
Query: 628 DVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGY--LDPEYFRRQQLTEK 685
D+ N L+ + V K++DFG+S+ D + ++ PE + + +
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSRE--EADGVYAASGGLRQVPVKWTAPEALNYGRYSSE 295
Query: 686 SDVYSFGVVLMEVL 699
SDV+SFG++L E
Sbjct: 296 SDVWSFGILLWETF 309
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 6e-42
Identities = 62/200 (31%), Positives = 93/200 (46%), Gaps = 26/200 (13%)
Query: 510 LGVGGFGRVYKGTLDDGTKVAVK--RGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYC 567
LG G FG V+ G + TKVAVK + S F E ++ +L+H+ LV L
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLVRLYAVV 77
Query: 568 DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHR 627
+ I + EYM NG L L L+ + L++ A G+ ++ ++ IHR
Sbjct: 78 TQEPIYI-ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI---EERNYIHR 133
Query: 628 DVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVS--------TAVKGSFGYLDPEYFRR 679
D++ NIL+ D K+ADFGL++ + T TA PE
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA---------PEAINY 184
Query: 680 QQLTEKSDVYSFGVVLMEVL 699
T KSDV+SFG++L E++
Sbjct: 185 GTFTIKSDVWSFGILLTEIV 204
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 9e-42
Identities = 65/190 (34%), Positives = 95/190 (50%), Gaps = 6/190 (3%)
Query: 510 LGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDE 569
LG G FG V+ GT + T+VA+K P + F E +++ KLRH LV L E
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 570 RSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDV 629
I V EYM+ G L L G L Q +++ A G+ Y+ + +HRD+
Sbjct: 251 EPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDL 306
Query: 630 KTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 689
+ NIL+ +N V KVADFGL++ ++ K + PE + T KSDV+
Sbjct: 307 RAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 690 SFGVVLMEVL 699
SFG++L E+
Sbjct: 366 SFGILLTELT 375
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-41
Identities = 63/230 (27%), Positives = 104/230 (45%), Gaps = 23/230 (10%)
Query: 510 LGVGGFGRVYKGTLD-----DGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSL 563
LG G FG+V D G +VAVK P IA+ + EIE+L L H ++V
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 564 IGYC--DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAA 621
G C D + + L+ E++ +G L+ +L ++ KQ+L+ + +G+ YL +
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYL---GS 144
Query: 622 QSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTA-----VKGSFGYLDPEY 676
+ +HRD+ N+L++ K+ DFGL+K + + V + PE
Sbjct: 145 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF----WYAPEC 200
Query: 677 FRRQQLTEKSDVYSFGVVLMEV--LCTRPALNPVLPREQVNIAEWAMTWQ 724
+ + SDV+SFGV L E+ C + L + + MT
Sbjct: 201 LMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVT 250
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 2e-41
Identities = 50/196 (25%), Positives = 92/196 (46%), Gaps = 11/196 (5%)
Query: 510 LGVGGFGRVYKGTLDDG-----TKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSL 563
LG G FG VYKG VA+K S + E E +++ + + H+ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 564 IGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQS 623
+G C + + + + M G L ++ + + L C+ A+G++YL +
Sbjct: 83 LGICLTSTVQL-ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYL---EDRR 137
Query: 624 IIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLT 683
++HRD+ N+L+ K+ DFGL+K A ++ + + K ++ E + T
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 684 EKSDVYSFGVVLMEVL 699
+SDV+S+GV + E++
Sbjct: 198 HQSDVWSYGVTVWELM 213
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 3e-41
Identities = 60/229 (26%), Positives = 89/229 (38%), Gaps = 22/229 (9%)
Query: 510 LGVGGFGRVYKGTLD-----DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLI 564
LG G FG V D G VAVK+ +F+ EI++L L +V
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 565 GYCDERSE--MILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQ 622
G + LV EY+ +G LR L L + L +G+ YL ++
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLG---SR 146
Query: 623 SIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTA-----VKGSFGYLDPEYF 677
+HRD+ NIL++ K+ADFGL+K P +V + + PE
Sbjct: 147 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF----WYAPESL 202
Query: 678 RRQQLTEKSDVYSFGVVLMEV--LCTRPALNPVLPREQVNIAEWAMTWQ 724
+ +SDV+SFGVVL E+ C + +
Sbjct: 203 SDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALS 251
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 4e-41
Identities = 59/192 (30%), Positives = 91/192 (47%), Gaps = 10/192 (5%)
Query: 510 LGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDE 569
LG G FG V+ T + TKVAVK P S F E ++ L+H LV L +
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHAVVTK 254
Query: 570 RSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDV 629
I + E+MA G L L + + ++ A G+ ++ ++ IHRD+
Sbjct: 255 EPIYI-ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIHRDL 310
Query: 630 KTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGY--LDPEYFRRQQLTEKSD 687
+ NIL+ + V K+ADFGL++ ++ + F PE T KSD
Sbjct: 311 RAANILVSASLVCKIADFGLAR---VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 367
Query: 688 VYSFGVVLMEVL 699
V+SFG++LME++
Sbjct: 368 VWSFGILLMEIV 379
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 5e-41
Identities = 68/197 (34%), Positives = 103/197 (52%), Gaps = 20/197 (10%)
Query: 510 LGVGGFGRVYKGTLDDGTKVAVK--RGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYC 567
+G G FG V+ G + KVA+K R SE+ +F E E++ KL H LV L G C
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 568 DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHR 627
E++ + LV E+M +G L +L + + L +C+ G+ YL +IHR
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYL---EEACVIHR 128
Query: 628 DVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTA-----VKGSFGYLDPEYFRRQQL 682
D+ N L+ +N V KV+DFG+++ LD + S+ VK + PE F +
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRF--VLDDQYTSSTGTKFPVK----WASPEVFSFSRY 182
Query: 683 TEKSDVYSFGVVLMEVL 699
+ KSDV+SFGV++ EV
Sbjct: 183 SSKSDVWSFGVLMWEVF 199
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 6e-41
Identities = 61/191 (31%), Positives = 96/191 (50%), Gaps = 12/191 (6%)
Query: 510 LGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYC-D 568
+G G FG V G G KVAVK + F E ++++LRH +LV L+G +
Sbjct: 29 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 569 ERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRD 628
E+ + +V EYMA G L +L L L+ + + YL + +HRD
Sbjct: 86 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRD 142
Query: 629 VKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDV 688
+ N+L+ ++ VAKV+DFGL+K + + K + PE R ++ + KSDV
Sbjct: 143 LAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDV 197
Query: 689 YSFGVVLMEVL 699
+SFG++L E+
Sbjct: 198 WSFGILLWEIY 208
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 7e-41
Identities = 65/190 (34%), Positives = 95/190 (50%), Gaps = 6/190 (3%)
Query: 510 LGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDE 569
LG G FG V+ GT + T+VA+K P + F E +++ KLRH LV L E
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 333
Query: 570 RSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDV 629
I V EYM+ G L L G L Q +++ A G+ Y+ + +HRD+
Sbjct: 334 EPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDL 389
Query: 630 KTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 689
+ NIL+ +N V KVADFGL++ ++ K + PE + T KSDV+
Sbjct: 390 RAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 448
Query: 690 SFGVVLMEVL 699
SFG++L E+
Sbjct: 449 SFGILLTELT 458
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 1e-40
Identities = 56/193 (29%), Positives = 92/193 (47%), Gaps = 10/193 (5%)
Query: 510 LGVGGFGRVYKGTL-DDGTKVAVK--RGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGY 566
LG G +G VY+G VAVK + + + EF E ++ +++H +LV L+G
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLLGV 284
Query: 567 CDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIH 626
C ++ E+M G L +L + +S L + + + YL ++ IH
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIH 341
Query: 627 RDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 686
R++ N L+ +N + KVADFGLS+ D K + PE + + KS
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKS 400
Query: 687 DVYSFGVVLMEVL 699
DV++FGV+L E+
Sbjct: 401 DVWAFGVLLWEIA 413
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-40
Identities = 54/211 (25%), Positives = 88/211 (41%), Gaps = 29/211 (13%)
Query: 510 LGVGGFGRVYKGTLDDG----TKVAVK--RGNPRSEQGIAEFRTEIEMLSKLRHRHLVSL 563
LG G FG V + L KVAVK + + + I EF E + + H H+ L
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 564 IGYC------DERSEMILVYEYMANGPLRSHL----YGTDLPPLSWKQRLEICIGAARGL 613
+G +++ +M +G L + L G + L + + + A G+
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 614 HYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYL- 672
YL ++++ IHRD+ N +L ++ VADFGLS+ +G L
Sbjct: 151 EYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR-----KIYSGDYYRQGCASKLP 202
Query: 673 ----DPEYFRRQQLTEKSDVYSFGVVLMEVL 699
E T SDV++FGV + E++
Sbjct: 203 VKWLALESLADNLYTVHSDVWAFGVTMWEIM 233
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 52/198 (26%), Positives = 77/198 (38%), Gaps = 13/198 (6%)
Query: 510 LGVGGFGRVYKGTL----DDGTKVAVK---RGNPRSEQGIAEFRTEIEMLSKLRHRHLVS 562
LG G FG V +G VAVK + + +F E+ + L HR+L+
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 563 LIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQ 622
L G + V E G L L + A G+ YL ++
Sbjct: 86 LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYL---ESK 140
Query: 623 SIIHRDVKTTNILLDDNFVAKVADFGLSKT-GPALDQTHVSTAVKGSFGYLDPEYFRRQQ 681
IHRD+ N+LL + K+ DFGL + D + K F + PE + +
Sbjct: 141 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 200
Query: 682 LTEKSDVYSFGVVLMEVL 699
+ SD + FGV L E+
Sbjct: 201 FSHASDTWMFGVTLWEMF 218
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-40
Identities = 66/197 (33%), Positives = 97/197 (49%), Gaps = 20/197 (10%)
Query: 510 LGVGGFGRVYKGTLDDGTKVAVK--RGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYC 567
LG G FG V G VAVK + SE EF E + + KL H LV G C
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED---EFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 568 DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHR 627
+ + +V EY++NG L ++L L Q LE+C G+ +L + IHR
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFL---ESHQFIHR 128
Query: 628 DVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTA-----VKGSFGYLDPEYFRRQQL 682
D+ N L+D + KV+DFG+++ LD +VS+ VK + PE F +
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRY--VLDDQYVSSVGTKFPVK----WSAPEVFHYFKY 182
Query: 683 TEKSDVYSFGVVLMEVL 699
+ KSDV++FG+++ EV
Sbjct: 183 SSKSDVWAFGILMWEVF 199
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 62/201 (30%), Positives = 99/201 (49%), Gaps = 18/201 (8%)
Query: 510 LGVGGFGRVYKGTLDDG----TKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLI 564
+G G FG VY GTL D AVK N +++F TE ++ H +++SL+
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 565 GYC-DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQS 623
G C ++V YM +G LR+ + + K + + A+G+ YL A++
Sbjct: 93 GICLRSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYL---ASKK 148
Query: 624 IIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYL-----DPEYFR 678
+HRD+ N +LD+ F KVADFGL++ + + + L E +
Sbjct: 149 FVHRDLAARNCMLDEKFTVKVADFGLARD---MYDKEYYSVHNKTGAKLPVKWMALESLQ 205
Query: 679 RQQLTEKSDVYSFGVVLMEVL 699
Q+ T KSDV+SFGV+L E++
Sbjct: 206 TQKFTTKSDVWSFGVLLWELM 226
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-40
Identities = 61/191 (31%), Positives = 94/191 (49%), Gaps = 12/191 (6%)
Query: 510 LGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDE 569
+G G FG V G G KVAVK + F E ++++LRH +LV L+G E
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 570 RSEMI-LVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRD 628
+ +V EYMA G L +L L L+ + + YL + +HRD
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRD 314
Query: 629 VKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDV 688
+ N+L+ ++ VAKV+DFGL+K + + K + PE R ++ + KSDV
Sbjct: 315 LAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDV 369
Query: 689 YSFGVVLMEVL 699
+SFG++L E+
Sbjct: 370 WSFGILLWEIY 380
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-40
Identities = 62/202 (30%), Positives = 95/202 (47%), Gaps = 30/202 (14%)
Query: 510 LGVGGFGRVYKGTLDDGTKVAVK--RGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYC 567
LG G FG V G VA+K + SE EF E +++ L H LV L G C
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 568 DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHR 627
++ + ++ EYMANG L ++L +Q LE+C + YL ++ +HR
Sbjct: 89 TKQRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYL---ESKQFLHR 144
Query: 628 DVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVS----------TAVKGSFGYLDPEYF 677
D+ N L++D V KV+DFGLS+ LD + S + PE
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRY--VLDDEYTSSVGSKFPVRWSP---------PEVL 193
Query: 678 RRQQLTEKSDVYSFGVVLMEVL 699
+ + KSD+++FGV++ E+
Sbjct: 194 MYSKFSSKSDIWAFGVLMWEIY 215
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-40
Identities = 55/209 (26%), Positives = 89/209 (42%), Gaps = 31/209 (14%)
Query: 510 LGVGGFGRVYKGTL--------DDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLV 561
LG G F +++KG T+V +K + F M+SKL H+HLV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 562 SLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAA 621
G C E ILV E++ G L ++L ++ +LE+ A +H+L
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFL---EE 131
Query: 622 QSIIHRDVKTTNILLD--------DNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLD 673
++IH +V NILL + K++D G+S T L + + + ++
Sbjct: 132 NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT--VLPKDILQERIP----WVP 185
Query: 674 PE---YFRRQQLTEKSDVYSFGVVLMEVL 699
PE + L +D +SFG L E+
Sbjct: 186 PECIENPKN--LNLATDKWSFGTTLWEIC 212
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-40
Identities = 67/221 (30%), Positives = 97/221 (43%), Gaps = 35/221 (15%)
Query: 510 LGVGGFGRVYKGTL------DDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSL 563
LG G FG+V+ D VAVK + +F+ E E+L+ L+H H+V
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 564 IGYCDERSEMILVYEYMANGPLRSHL--------------YGTDLPPLSWKQRLEICIGA 609
G C + +I+V+EYM +G L L L Q L I
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 610 ARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSF 669
A G+ YL A+Q +HRD+ T N L+ N + K+ DFG+S+ D G
Sbjct: 143 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR-----DVYSTDYYRVGGH 194
Query: 670 GYL-----DPEYFRRQQLTEKSDVYSFGVVLMEV--LCTRP 703
L PE ++ T +SDV+SFGV+L E+ +P
Sbjct: 195 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 3e-40
Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 18/201 (8%)
Query: 510 LGVGGFGRVYKGTLDDG----TKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLI 564
+G G FG VY G D + A+K + Q + F E ++ L H ++++LI
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 565 GYCDERSEMIL-VYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQS 623
G + + YM +G L + + K + + ARG+ YL A Q
Sbjct: 89 GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYL---AEQK 144
Query: 624 IIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYL-----DPEYFR 678
+HRD+ N +LD++F KVADFGL++ + + + L E +
Sbjct: 145 FVHRDLAARNCMLDESFTVKVADFGLARD---ILDREYYSVQQHRHARLPVKWTALESLQ 201
Query: 679 RQQLTEKSDVYSFGVVLMEVL 699
+ T KSDV+SFGV+L E+L
Sbjct: 202 TYRFTTKSDVWSFGVLLWELL 222
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-40
Identities = 68/220 (30%), Positives = 98/220 (44%), Gaps = 34/220 (15%)
Query: 510 LGVGGFGRVYKGTLDDG------TKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSL 563
LG G FG+V+ + VAVK SE +F+ E E+L+ L+H+H+V
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 564 IGYCDERSEMILVYEYMANGPLRSHL-------------YGTDLPPLSWKQRLEICIGAA 610
G C E +++V+EYM +G L L PL Q L + A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 611 RGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFG 670
G+ YL A +HRD+ T N L+ V K+ DFG+S+ + D G
Sbjct: 169 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR-----VGGRT 220
Query: 671 YL-----DPEYFRRQQLTEKSDVYSFGVVLMEV--LCTRP 703
L PE ++ T +SDV+SFGVVL E+ +P
Sbjct: 221 MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-40
Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 30/211 (14%)
Query: 510 LGVGGFGRVYKGTLDDG----TKVAVK--RGNPRSEQGIAEFRTEIEMLSKLRHRHLVSL 563
LG G FG V +G L KVAVK + + S++ I EF +E + H +++ L
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 564 IGYC------DERSEMILVYEYMANGPLRSHL----YGTDLPPLSWKQRLEICIGAARGL 613
+G C M+++ +M G L ++L T + + L+ + A G+
Sbjct: 102 LGVCIEMSSQGIPKPMVIL-PFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160
Query: 614 HYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYL- 672
YL + ++ +HRD+ N +L D+ VADFGLSK +G +
Sbjct: 161 EYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK-----KIYSGDYYRQGRIAKMP 212
Query: 673 ----DPEYFRRQQLTEKSDVYSFGVVLMEVL 699
E + T KSDV++FGV + E+
Sbjct: 213 VKWIAIESLADRVYTSKSDVWAFGVTMWEIA 243
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 3e-40
Identities = 65/209 (31%), Positives = 98/209 (46%), Gaps = 17/209 (8%)
Query: 504 FDESLL-----LGVGGFGRVYKGTLD-----DGTKVAVKRGNPRSEQGIAEFRTEIEMLS 553
F+E L LG G FG V D G VAVK+ +E+ + +F EIE+L
Sbjct: 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 66
Query: 554 KLRHRHLVSLIGYCDERSE--MILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAAR 611
L+H ++V G C + L+ EY+ G LR +L + + L+ +
Sbjct: 67 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICK 125
Query: 612 GLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPA-LDQTHVSTAVKGSFG 670
G+ YL + IHRD+ T NIL+++ K+ DFGL+K P + V +
Sbjct: 126 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF 182
Query: 671 YLDPEYFRRQQLTEKSDVYSFGVVLMEVL 699
+ PE + + SDV+SFGVVL E+
Sbjct: 183 WYAPESLTESKFSVASDVWSFGVVLYELF 211
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 4e-40
Identities = 53/197 (26%), Positives = 84/197 (42%), Gaps = 15/197 (7%)
Query: 510 LGVGGFGRVYKGTL----DDGTKVAVKRGNP-RSEQGIAEFRTEIEMLSKLRHRHLVSLI 564
LG G FG VY+G + VAVK + +F +E ++ L H H+V LI
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 565 GYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSI 624
G +E I + E G L +L L + + + + YL + +
Sbjct: 80 GIIEEEPTWI-IMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYL---ESINC 134
Query: 625 IHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSF--GYLDPEYFRRQQL 682
+HRD+ NIL+ K+ DFGLS+ ++ A ++ PE ++
Sbjct: 135 VHRDIAVRNILVASPECVKLGDFGLSR---YIEDEDYYKASVTRLPIKWMSPESINFRRF 191
Query: 683 TEKSDVYSFGVVLMEVL 699
T SDV+ F V + E+L
Sbjct: 192 TTASDVWMFAVCMWEIL 208
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 7e-40
Identities = 65/209 (31%), Positives = 98/209 (46%), Gaps = 17/209 (8%)
Query: 504 FDESLL-----LGVGGFGRVYKGTLD-----DGTKVAVKRGNPRSEQGIAEFRTEIEMLS 553
F+E L LG G FG V D G VAVK+ +E+ + +F EIE+L
Sbjct: 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 97
Query: 554 KLRHRHLVSLIGYCDERSE--MILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAAR 611
L+H ++V G C + L+ EY+ G LR +L + + L+ +
Sbjct: 98 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICK 156
Query: 612 GLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPA-LDQTHVSTAVKGSFG 670
G+ YL + IHRD+ T NIL+++ K+ DFGL+K P + V +
Sbjct: 157 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF 213
Query: 671 YLDPEYFRRQQLTEKSDVYSFGVVLMEVL 699
+ PE + + SDV+SFGVVL E+
Sbjct: 214 WYAPESLTESKFSVASDVWSFGVVLYELF 242
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 8e-40
Identities = 68/281 (24%), Positives = 121/281 (43%), Gaps = 30/281 (10%)
Query: 442 RKSKTPQQGHPWLPLPLYGNSQTMTKMSTTSQKSGTASCISLASSNLGRLFM-------F 494
R++ P ++ ++ST+ K + + +N + +
Sbjct: 17 RRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELV 76
Query: 495 QEILDATNKFDESLL-----LGVGGFGRVYKGTLDDG----TKVAVKRGNPR-SEQGIAE 544
Q + ++ +G G FG VY GTL D AVK N +++
Sbjct: 77 QAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ 136
Query: 545 FRTEIEMLSKLRHRHLVSLIGYC-DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRL 603
F TE ++ H +++SL+G C ++V YM +G LR+ + + K +
Sbjct: 137 FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLI 195
Query: 604 EICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVST 663
+ A+G+ +L A++ +HRD+ N +LD+ F KVADFGL++ + +
Sbjct: 196 GFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARD---MYDKEFDS 249
Query: 664 AVKGSFGYL-----DPEYFRRQQLTEKSDVYSFGVVLMEVL 699
+ L E + Q+ T KSDV+SFGV+L E++
Sbjct: 250 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 290
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 9e-40
Identities = 67/214 (31%), Positives = 100/214 (46%), Gaps = 35/214 (16%)
Query: 509 LLGVGGFGRVYKGTLDDG---TKVAVKRGNPR-SEQGIAEFRTEIEMLSKL-RHRHLVSL 563
++G G FG+V K + A+KR S+ +F E+E+L KL H ++++L
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 564 IGYCDERSEMILVYEYMANGPLRSHL--------------YGTDLPPLSWKQRLEICIGA 609
+G C+ R + L EY +G L L + LS +Q L
Sbjct: 92 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151
Query: 610 ARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSF 669
ARG+ YL + + IHRD+ NIL+ +N+VAK+ADFGLS+ VK +
Sbjct: 152 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ--------EVYVKKTM 200
Query: 670 GYL-----DPEYFRRQQLTEKSDVYSFGVVLMEV 698
G L E T SDV+S+GV+L E+
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 234
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-39
Identities = 52/197 (26%), Positives = 87/197 (44%), Gaps = 13/197 (6%)
Query: 510 LGVGGFGRVYKGTLDDG-----TKVAVK--RGNPRSEQGIAEFRTEIEMLSKLRHRHLVS 562
LG G FG V+KG V +K Q + + L H H+V
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVR 79
Query: 563 LIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQ 622
L+G C S + V +Y+ G L H+ L + L + A+G++YL
Sbjct: 80 LLGLCPGSSLQL-VTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYL---EEH 134
Query: 623 SIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQL 682
++HR++ N+LL +VADFG++ P D+ + + K ++ E +
Sbjct: 135 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKY 194
Query: 683 TEKSDVYSFGVVLMEVL 699
T +SDV+S+GV + E++
Sbjct: 195 THQSDVWSYGVTVWELM 211
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-39
Identities = 49/196 (25%), Positives = 92/196 (46%), Gaps = 11/196 (5%)
Query: 510 LGVGGFGRVYKGTLDDG-----TKVAVKRGNPRS-EQGIAEFRTEIEMLSKLRHRHLVSL 563
LG G FG VYKG VA+K + + E E +++ + + H+ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 564 IGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQS 623
+G C + + + + M G L ++ + + L C+ A+G++YL +
Sbjct: 83 LGICLTSTVQL-ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYL---EDRR 137
Query: 624 IIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLT 683
++HRD+ N+L+ K+ DFGL+K A ++ + + K ++ E + T
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 684 EKSDVYSFGVVLMEVL 699
+SDV+S+GV + E++
Sbjct: 198 HQSDVWSYGVTVWELM 213
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-39
Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 28/204 (13%)
Query: 510 LGVGGFGRVYKGTL---DDGTKVAVKRGNP-RSEQGIAEFRTEIEMLSKLRHRHLVSLIG 565
LG G FG V +G VA+K + E E +++ +L + ++V LIG
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 566 YCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSII 625
C + M+ V E GPL L G + E+ + G+ YL ++ +
Sbjct: 78 VCQAEALML-VMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYL---EEKNFV 132
Query: 626 HRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVS----------TAVKGSFGYLDPE 675
HRD+ N+LL + AK++DFGLSK A D + + A PE
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA---------PE 183
Query: 676 YFRRQQLTEKSDVYSFGVVLMEVL 699
++ + +SDV+S+GV + E L
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEAL 207
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-39
Identities = 56/197 (28%), Positives = 86/197 (43%), Gaps = 15/197 (7%)
Query: 510 LGVGGFGRVYKGTLDDG----TKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLI 564
+G G FG V++G VA+K S+ +F E + + H H+V LI
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 565 GYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSI 624
G E I + E G LRS L L + + L YL ++
Sbjct: 83 GVITENPVWI-IMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYL---ESKRF 137
Query: 625 IHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSF--GYLDPEYFRRQQL 682
+HRD+ N+L+ N K+ DFGLS+ ++ + A KG ++ PE ++
Sbjct: 138 VHRDIAARNVLVSSNDCVKLGDFGLSR---YMEDSTYYKASKGKLPIKWMAPESINFRRF 194
Query: 683 TEKSDVYSFGVVLMEVL 699
T SDV+ FGV + E+L
Sbjct: 195 TSASDVWMFGVCMWEIL 211
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-39
Identities = 60/200 (30%), Positives = 91/200 (45%), Gaps = 20/200 (10%)
Query: 510 LGVGGFGRVYKGTL---DDGTKVAVK--RGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLI 564
LG G FG V KG VAVK + E E ++ +L + ++V +I
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 565 GYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSI 624
G C+ S M+ V E GPL +L + K +E+ + G+ YL +
Sbjct: 85 GICEAESWML-VMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYL---EESNF 138
Query: 625 IHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTA-----VKGSFGYLDPEYFRR 679
+HRD+ N+LL AK++DFGLSK A + + + VK + PE
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK----WYAPECINY 194
Query: 680 QQLTEKSDVYSFGVVLMEVL 699
+ + KSDV+SFGV++ E
Sbjct: 195 YKFSSKSDVWSFGVLMWEAF 214
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-39
Identities = 58/198 (29%), Positives = 96/198 (48%), Gaps = 20/198 (10%)
Query: 510 LGVGGFGRVYKGTL-DDGTKVAVK--RGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGY 566
LG G +G VY+G VAVK + + + EF E ++ +++H +LV L+G
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLLGV 77
Query: 567 CDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIH 626
C ++ E+M G L +L + +S L + + + YL ++ IH
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIH 134
Query: 627 RDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTA-----VKGSFGYLDPEYFRRQQ 681
RD+ N L+ +N + KVADFGLS+ T+ + A +K + PE +
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKFPIK----WTAPESLAYNK 188
Query: 682 LTEKSDVYSFGVVLMEVL 699
+ KSDV++FGV+L E+
Sbjct: 189 FSIKSDVWAFGVLLWEIA 206
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-39
Identities = 71/224 (31%), Positives = 101/224 (45%), Gaps = 17/224 (7%)
Query: 510 LGVGGFGRVYKGTLDD-----GTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSL 563
LG G FG+V D G VAVK Q + ++ EI++L L H H++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 564 IGYCDERSE--MILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAA 621
G C++ + LV EY+ G LR +L + Q L G+ YLH A
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYLPR---HSIGLAQLLLFAQQICEGMAYLH---A 152
Query: 622 QSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPA-LDQTHVSTAVKGSFGYLDPEYFRRQ 680
Q IHRD+ N+LLD++ + K+ DFGL+K P + V + PE +
Sbjct: 153 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY 212
Query: 681 QLTEKSDVYSFGVVLMEV--LCTRPALNPVLPREQVNIAEWAMT 722
+ SDV+SFGV L E+ C P E + IA+ MT
Sbjct: 213 KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMT 256
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 4e-39
Identities = 62/210 (29%), Positives = 95/210 (45%), Gaps = 28/210 (13%)
Query: 510 LGVGGFGRVYKGTLDDG------TKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVS 562
LG G FG VY+G T+VA+K N S + EF E ++ + H+V
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 563 LIGYCDERSEMILVYEYMANGPLRSHL--------YGTDLPPLSWKQRLEICIGAARGLH 614
L+G + +++ E M G L+S+L L P S + +++ A G+
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 615 YLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYL-- 672
YL A +HRD+ N ++ ++F K+ DFG+++ D KG G L
Sbjct: 153 YL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-----DIYETDYYRKGGKGLLPV 204
Query: 673 ---DPEYFRRQQLTEKSDVYSFGVVLMEVL 699
PE + T SDV+SFGVVL E+
Sbjct: 205 RWMSPESLKDGVFTTYSDVWSFGVVLWEIA 234
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-38
Identities = 61/218 (27%), Positives = 107/218 (49%), Gaps = 37/218 (16%)
Query: 510 LGVGGFGRVYKGTL--------DDGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKL-RHRH 559
LG G FG+V + VAVK +E+ +++ +E+EM+ + +H++
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 560 LVSLIGYCDERSEMILVYEYMANGPLRSHL--------------YGTDLPPLSWKQRLEI 605
+++L+G C + + ++ EY + G LR +L +++K +
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 606 CIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAV 665
ARG+ YL A+Q IHRD+ N+L+ +N V K+ADFGL++ D ++
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-----DINNIDYYK 214
Query: 666 KGSFGYL-----DPEYFRRQQLTEKSDVYSFGVVLMEV 698
K + G L PE + T +SDV+SFGV++ E+
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-38
Identities = 54/222 (24%), Positives = 92/222 (41%), Gaps = 36/222 (16%)
Query: 510 LGVGGFGRVYKGTLDDG------TKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVS 562
LG FG+VYKG L VA+K + EFR E + ++L+H ++V
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 563 LIGYCDERSEMILVYEYMANGPLRSHL--------------YGTDLPPLSWKQRLEICIG 608
L+G + + +++ Y ++G L L T L + +
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 609 AARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGS 668
A G+ YL ++ ++H+D+ T N+L+ D K++D GL + +
Sbjct: 137 IAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR-----EVYAADYYKLLG 188
Query: 669 FGYL-----DPEYFRRQQLTEKSDVYSFGVVLMEV--LCTRP 703
L PE + + SD++S+GVVL EV +P
Sbjct: 189 NSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-38
Identities = 60/196 (30%), Positives = 93/196 (47%), Gaps = 10/196 (5%)
Query: 510 LGVGGFGRVYKGTL----DDGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLI 564
+G G G V G L VA+K +E+ +F +E ++ + H +++ L
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 565 GYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSI 624
G ++V EYM NG L + L D + Q + + G G+ YL +
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYL---SDLGY 172
Query: 625 IHRDVKTTNILLDDNFVAKVADFGLSKT-GPALDQTHVSTAVKGSFGYLDPEYFRRQQLT 683
+HRD+ N+L+D N V KV+DFGLS+ D + +T K + PE + +
Sbjct: 173 VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFS 232
Query: 684 EKSDVYSFGVVLMEVL 699
SDV+SFGVV+ EVL
Sbjct: 233 SASDVWSFGVVMWEVL 248
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-38
Identities = 68/216 (31%), Positives = 93/216 (43%), Gaps = 30/216 (13%)
Query: 510 LGVGGFGRVYKGTL------DDGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVS 562
LG G FG VY+G + +VAVK SEQ +F E ++SK H+++V
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 563 LIGYCDERSEMILVYEYMANGPLRSHL-----YGTDLPPLSWKQRLEICIGAARGLHYLH 617
IG + ++ E MA G L+S L + L+ L + A G YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL- 156
Query: 618 TGAAQSIIHRDVKTTNILLD---DNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYL-- 672
IHRD+ N LL VAK+ DFG+++ D S KG L
Sbjct: 157 --EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAMLPV 209
Query: 673 ---DPEYFRRQQLTEKSDVYSFGVVLMEV--LCTRP 703
PE F T K+D +SFGV+L E+ L P
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-38
Identities = 56/197 (28%), Positives = 86/197 (43%), Gaps = 15/197 (7%)
Query: 510 LGVGGFGRVYKGTLDDG----TKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLI 564
+G G FG V++G VA+K S+ +F E + + H H+V LI
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 565 GYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSI 624
G E I + E G LRS L L + + L YL ++
Sbjct: 458 GVITENPVWI-IMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYL---ESKRF 512
Query: 625 IHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSF--GYLDPEYFRRQQL 682
+HRD+ N+L+ N K+ DFGLS+ ++ + A KG ++ PE ++
Sbjct: 513 VHRDIAARNVLVSSNDCVKLGDFGLSR---YMEDSTYYKASKGKLPIKWMAPESINFRRF 569
Query: 683 TEKSDVYSFGVVLMEVL 699
T SDV+ FGV + E+L
Sbjct: 570 TSASDVWMFGVCMWEIL 586
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-38
Identities = 61/218 (27%), Positives = 107/218 (49%), Gaps = 37/218 (16%)
Query: 510 LGVGGFGRVYKGTL--------DDGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKL-RHRH 559
LG G FG+V + VAVK +E+ +++ +E+EM+ + +H++
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 560 LVSLIGYCDERSEMILVYEYMANGPLRSHL--------------YGTDLPPLSWKQRLEI 605
+++L+G C + + ++ EY + G LR +L +++K +
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 606 CIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAV 665
ARG+ YL A+Q IHRD+ N+L+ +N V K+ADFGL++ D ++
Sbjct: 209 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-----DINNIDYYK 260
Query: 666 KGSFGYL-----DPEYFRRQQLTEKSDVYSFGVVLMEV 698
K + G L PE + T +SDV+SFGV++ E+
Sbjct: 261 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 298
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-38
Identities = 64/206 (31%), Positives = 97/206 (47%), Gaps = 29/206 (14%)
Query: 510 LGVGGFGRVYKGTL-----DDGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSL 563
+G G FG VYKG L VA+K +E+ +F E ++ + H +++ L
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 564 IGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQS 623
G + M+++ EYM NG L L D S Q + + G A G+ YL A +
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYL---ANMN 167
Query: 624 IIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVS----------TAVKGSFGYLD 673
+HRD+ NIL++ N V KV+DFGLS+ + + TA
Sbjct: 168 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA--------- 218
Query: 674 PEYFRRQQLTEKSDVYSFGVVLMEVL 699
PE ++ T SDV+SFG+V+ EV+
Sbjct: 219 PEAISYRKFTSASDVWSFGIVMWEVM 244
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-38
Identities = 62/223 (27%), Positives = 94/223 (42%), Gaps = 42/223 (18%)
Query: 510 LGVGGFGRVYKGTLDDG------TKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVS 562
LG G FG+V K T T VAVK S + + +E +L ++ H H++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 563 LIGYCDERSEMILVYEYMANGPLRSHL----------------------YGTDLPPLSWK 600
L G C + ++L+ EY G LR L D L+
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 601 QRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH 660
+ ++G+ YL A ++HRD+ NIL+ + K++DFGLS+ D
Sbjct: 151 DLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR-----DVYE 202
Query: 661 VSTAVKGSFGYL-----DPEYFRRQQLTEKSDVYSFGVVLMEV 698
+ VK S G + E T +SDV+SFGV+L E+
Sbjct: 203 EDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 5e-38
Identities = 59/196 (30%), Positives = 95/196 (48%), Gaps = 10/196 (5%)
Query: 510 LGVGGFGRVYKGTL----DDGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLI 564
+G G FG V G L VA+K +E+ +F E ++ + H +++ L
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 565 GYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSI 624
G + +++V EYM NG L S L D + Q + + G A G+ YL +
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYL---SDMGY 168
Query: 625 IHRDVKTTNILLDDNFVAKVADFGLSKT-GPALDQTHVSTAVKGSFGYLDPEYFRRQQLT 683
+HRD+ NIL++ N V KV+DFGL + + + + K + PE ++ T
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 684 EKSDVYSFGVVLMEVL 699
SDV+S+G+VL EV+
Sbjct: 229 SASDVWSYGIVLWEVM 244
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 5e-38
Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 33/214 (15%)
Query: 510 LGVGGFGRVYKGTL------DDGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKL-RHRHLV 561
LG G FG+V + T D KVAVK +E++++S L +H ++V
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 562 SLIGYCDERSEMILVYEYMANGPLRSHL------------YGTDLPPLSWKQRLEICIGA 609
+L+G C ++++ EY G L + L + S + L
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173
Query: 610 ARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSF 669
A+G+ +L A+++ IHRDV N+LL + VAK+ DFGL++ D + S +
Sbjct: 174 AQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-----DIMNDSNYIVKGN 225
Query: 670 GYL-----DPEYFRRQQLTEKSDVYSFGVVLMEV 698
L PE T +SDV+S+G++L E+
Sbjct: 226 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 259
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 6e-38
Identities = 67/216 (31%), Positives = 92/216 (42%), Gaps = 30/216 (13%)
Query: 510 LGVGGFGRVYKGTL------DDGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVS 562
LG G FG VY+G + +VAVK SEQ +F E ++SK H+++V
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 563 LIGYCDERSEMILVYEYMANGPLRSHL-----YGTDLPPLSWKQRLEICIGAARGLHYLH 617
IG + ++ E MA G L+S L + L+ L + A G YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL- 197
Query: 618 TGAAQSIIHRDVKTTNILLD---DNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYL-- 672
IHRD+ N LL VAK+ DFG+++ D KG L
Sbjct: 198 --EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRAGYYRKGGCAMLPV 250
Query: 673 ---DPEYFRRQQLTEKSDVYSFGVVLMEV--LCTRP 703
PE F T K+D +SFGV+L E+ L P
Sbjct: 251 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-37
Identities = 61/218 (27%), Positives = 93/218 (42%), Gaps = 37/218 (16%)
Query: 510 LGVGGFGRVYKGTL------DDGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKL-RHRHLV 561
LG G FG+V + T D VAVK P +E+++LS L H ++V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 562 SLIGYCDERSEMILVYEYMANGPLRSHL----------------YGTDLPPLSWKQRLEI 605
+L+G C +++ EY G L + L D L + L
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 606 CIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAV 665
A+G+ +L A+++ IHRD+ NILL + K+ DFGL++ D + S V
Sbjct: 151 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR-----DIKNDSNYV 202
Query: 666 KGSFGYL-----DPEYFRRQQLTEKSDVYSFGVVLMEV 698
L PE T +SDV+S+G+ L E+
Sbjct: 203 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 240
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-37
Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 510 LGVGGFGRVYKGTL------DDGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKL-RHRHLV 561
LG G FG+V + VAVK + +E+++L + H ++V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 562 SLIGYC-DERSEMILVYEYMANGPLRSHL--------------YGTDLPPLSWKQRLEIC 606
+L+G C ++++ E+ G L ++L L+ + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 607 IGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVK 666
A+G+ +L A++ IHRD+ NILL + V K+ DFGL++ D V+
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-----DIYKDPDYVR 206
Query: 667 GSFGYL-----DPEYFRRQQLTEKSDVYSFGVVLMEV 698
L PE + T +SDV+SFGV+L E+
Sbjct: 207 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-37
Identities = 59/223 (26%), Positives = 96/223 (43%), Gaps = 42/223 (18%)
Query: 510 LGVGGFGRVYKGTL------DDGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKL-RHRHLV 561
LG G FG+V T +VAVK + +E++M+++L H ++V
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 562 SLIGYCDERSEMILVYEYMANGPLRSHL---------------------YGTDLPPLSWK 600
+L+G C + L++EY G L ++L DL L+++
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 601 QRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH 660
L A+G+ +L +S +HRD+ N+L+ V K+ DFGL++ D
Sbjct: 173 DLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR-----DIMS 224
Query: 661 VSTAVKGSFGYL-----DPEYFRRQQLTEKSDVYSFGVVLMEV 698
S V L PE T KSDV+S+G++L E+
Sbjct: 225 DSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI 267
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-37
Identities = 65/218 (29%), Positives = 108/218 (49%), Gaps = 37/218 (16%)
Query: 510 LGVGGFGRVYKGTL--------DDGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKL-RHRH 559
LG G FG+V + TKVAVK +E+ +++ +E+EM+ + +H++
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 560 LVSLIGYCDERSEMILVYEYMANGPLRSHL--------------YGTDLPPLSWKQRLEI 605
+++L+G C + + ++ EY + G LR +L LS K +
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 606 CIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAV 665
ARG+ YL A++ IHRD+ N+L+ ++ V K+ADFGL++ D H+
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYK 248
Query: 666 KGSFGYL-----DPEYFRRQQLTEKSDVYSFGVVLMEV 698
K + G L PE + T +SDV+SFGV+L E+
Sbjct: 249 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 286
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 6e-37
Identities = 64/224 (28%), Positives = 98/224 (43%), Gaps = 42/224 (18%)
Query: 510 LGVGGFGRVYKGTLDDG------TKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVS 562
+G G FGRV++ T VAVK S A+F+ E ++++ + ++V
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 563 LIGYCDERSEMILVYEYMANGPLRSHL----------------------YGTDLPPLSWK 600
L+G C M L++EYMA G L L PPLS
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 601 QRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH 660
++L I A G+ YL + + +HRD+ T N L+ +N V K+ADFGLS+ +
Sbjct: 175 EQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR-----NIYS 226
Query: 661 VSTAVKGSFGYL-----DPEYFRRQQLTEKSDVYSFGVVLMEVL 699
+ PE + T +SDV+++GVVL E+
Sbjct: 227 ADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 6e-37
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 18/209 (8%)
Query: 503 KFDESLLLGVGGFGRVYKGT-LDDGTKVAVK--RGNPRSEQGIAEFRTEIEMLSKLRHRH 559
KFD +G G F VYKG + +VA + ++ F+ E EML L+H +
Sbjct: 29 KFDI--EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 86
Query: 560 LVSLIGY----CDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHY 615
+V + ++LV E M +G L+++L + K C +GL +
Sbjct: 87 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGLQF 144
Query: 616 LHTGAAQSIIHRDVKTTNILLD-DNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDP 674
LHT IIHRD+K NI + K+ D GL+ L + + AV G+ ++ P
Sbjct: 145 LHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT----LKRASFAKAVIGTPEFMAP 199
Query: 675 EYFRRQQLTEKSDVYSFGVVLMEVLCTRP 703
E + ++ E DVY+FG+ ++E+ +
Sbjct: 200 EMY-EEKYDESVDVYAFGMCMLEMATSEY 227
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 8e-37
Identities = 53/244 (21%), Positives = 96/244 (39%), Gaps = 16/244 (6%)
Query: 468 MSTTSQKSGTASCISLASSNLGRLFMFQEILDATNKFDESLLLGVGGFGRVYKGT-LDDG 526
M SQ R M L F +G G F VY+ L DG
Sbjct: 1 MDEQSQGMQGPPVPQFQPQKALRPDMGYNTLA---NFRIEKKIGRGQFSEVYRAACLLDG 57
Query: 527 TKVAVKR---GNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANG 583
VA+K+ + + A+ EI++L +L H +++ E +E+ +V E G
Sbjct: 58 VPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAG 117
Query: 584 PLRSHL--YGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFV 641
L + + + + + + L ++H ++ ++HRD+K N+ + V
Sbjct: 118 DLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGV 174
Query: 642 AKVADFGLSKTGPALDQTH-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC 700
K+ D GL + + ++ G+ Y+ PE KSD++S G +L E+
Sbjct: 175 VKLGDLGLGR---FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA 231
Query: 701 TRPA 704
+
Sbjct: 232 LQSP 235
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-36
Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 18/199 (9%)
Query: 510 LGVGGFGRVYKGTL---DDGTKVAVKRGNP-RSEQGIAEFRTEIEMLSKLRHRHLVSLIG 565
LG G FG V +G VA+K + E E +++ +L + ++V LIG
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 566 YCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSII 625
C + M+ V E GPL L G + E+ + G+ YL ++ +
Sbjct: 404 VCQAEALML-VMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYL---EEKNFV 458
Query: 626 HRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTA-----VKGSFGYLDPEYFRRQ 680
HR++ N+LL + AK++DFGLSK A D + + + +K + PE +
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK----WYAPECINFR 514
Query: 681 QLTEKSDVYSFGVVLMEVL 699
+ + +SDV+S+GV + E L
Sbjct: 515 KFSSRSDVWSYGVTMWEAL 533
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 66/303 (21%), Positives = 106/303 (34%), Gaps = 45/303 (14%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYC 567
LG GGF V L DG A+KR +Q E + E +M H +++ L+ YC
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 568 DERS----EMILVYEYMANGPLRSHL--YGTDLPPLSWKQRLEICIGAARGLHYLHTGAA 621
E L+ + G L + + L+ Q L + +G RGL +H
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--- 152
Query: 622 QSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVS-------TAVKGSFGYLDP 674
+ HRD+K TNILL D + D G + A + + Y P
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 675 EYF---RRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQ 731
E F + E++DV+S G VL + P + V QK +
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYA-MMFG-----EGPYDMVF--------QKGDSVAL 258
Query: 732 IMDSNLVGKVNPASLKKFGETAE----KCLAEHGVDRPSMGDVL---WNLEYALQLEETS 784
+ +++ + + RP + +L L+ + T+
Sbjct: 259 A----VQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQHTT 314
Query: 785 SAL 787
L
Sbjct: 315 QIL 317
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-36
Identities = 52/216 (24%), Positives = 89/216 (41%), Gaps = 34/216 (15%)
Query: 509 LLGVGGFGRVYKGTLDDGTKVAVKRGN--PRSEQGIAEFRTEIEMLSKLRH--RHLVSLI 564
+G GG +V++ + A+K N Q + +R EI L+KL+ ++ L
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 565 GYCDERSEMILVYEYMANGPLRSHL--YGTDLPPLS----WKQRLEICIGAARGLHYLHT 618
Y + +V E N L S L + + P WK LE +H +H
Sbjct: 95 DYEITDQYIYMVMEC-GNIDLNSWLKKKKS-IDPWERKSYWKNMLE-------AVHTIH- 144
Query: 619 GAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPE--- 675
I+H D+K N L+ D + K+ DFG++ + V + G+ Y+ PE
Sbjct: 145 --QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 201
Query: 676 --------YFRRQQLTEKSDVYSFGVVLMEVLCTRP 703
+ +++ KSDV+S G +L + +
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 237
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 5e-36
Identities = 52/216 (24%), Positives = 89/216 (41%), Gaps = 34/216 (15%)
Query: 509 LLGVGGFGRVYKGTLDDGTKVAVKRGN--PRSEQGIAEFRTEIEMLSKLRH--RHLVSLI 564
+G GG +V++ + A+K N Q + +R EI L+KL+ ++ L
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 565 GYCDERSEMILVYEYMANGPLRSHL--YGTDLPPLS----WKQRLEICIGAARGLHYLHT 618
Y + +V E N L S L + + P WK LE +H +H
Sbjct: 76 DYEITDQYIYMVMEC-GNIDLNSWLKKKKS-IDPWERKSYWKNMLE-------AVHTIH- 125
Query: 619 GAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPE--- 675
I+H D+K N L+ D + K+ DFG++ + V + G+ Y+ PE
Sbjct: 126 --QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 182
Query: 676 --------YFRRQQLTEKSDVYSFGVVLMEVLCTRP 703
+ +++ KSDV+S G +L + +
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 218
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 6e-36
Identities = 51/207 (24%), Positives = 95/207 (45%), Gaps = 10/207 (4%)
Query: 502 NKFDESLLLGVGGFGRVYKGT-LDDGTKVAVK--RGNPRSEQGIAEFRTEIEMLSKLRHR 558
K+ +G G FG+ +DG + +K + S + E R E+ +L+ ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 559 HLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHT 618
++V +E + +V +Y G L + Q L+ + L ++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 619 GAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT-HVSTAVKGSFGYLDPEYF 677
+ I+HRD+K+ NI L + ++ DFG+++ L+ T ++ A G+ YL PE
Sbjct: 144 ---RKILHRDIKSQNIFLTKDGTVQLGDFGIARV---LNSTVELARACIGTPYYLSPEIC 197
Query: 678 RRQQLTEKSDVYSFGVVLMEVLCTRPA 704
+ KSD+++ G VL E+ + A
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 9e-36
Identities = 71/307 (23%), Positives = 119/307 (38%), Gaps = 55/307 (17%)
Query: 502 NKFDESLLLGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHL 560
F E L+G GGFG+V+K DG +KR +E + E++ L+KL H ++
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNI 66
Query: 561 VSLIGYCDERSEMI----------------LVYEYMANGPLRSHLYGTDLPPLSWKQRLE 604
V G D + E+ G L + L LE
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 605 ICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTA 664
+ +G+ Y+H+ + +I+RD+K +NI L D K+ DFGL +L T
Sbjct: 127 LFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVT---SLKNDGKRTR 180
Query: 665 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQ 724
KG+ Y+ PE Q ++ D+Y+ G++L E+L E +
Sbjct: 181 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT-----AFETSKF------FT 229
Query: 725 K--KGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVL---WNLEYALQ 779
G++ I D + K L++ DRP+ ++L + + +
Sbjct: 230 DLRDGIISDIFDKKEKTLLQ------------KLLSKKPEDRPNTSEILRTLTVWKKSPE 277
Query: 780 LEETSSA 786
E +A
Sbjct: 278 KNERHTA 284
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-35
Identities = 52/216 (24%), Positives = 89/216 (41%), Gaps = 34/216 (15%)
Query: 509 LLGVGGFGRVYKGTLDDGTKVAVKRGN--PRSEQGIAEFRTEIEMLSKLRH--RHLVSLI 564
+G GG +V++ + A+K N Q + +R EI L+KL+ ++ L
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 565 GYCDERSEMILVYEYMANGPLRSHL--YGTDLPPLS----WKQRLEICIGAARGLHYLHT 618
Y + +V E N L S L + + P WK LE +H +H
Sbjct: 123 DYEITDQYIYMVMEC-GNIDLNSWLKKKKS-IDPWERKSYWKNMLE-------AVHTIH- 172
Query: 619 GAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPE--- 675
I+H D+K N L+ D + K+ DFG++ + V + G+ Y+ PE
Sbjct: 173 --QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIK 229
Query: 676 --------YFRRQQLTEKSDVYSFGVVLMEVLCTRP 703
+ +++ KSDV+S G +L + +
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 265
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 57/208 (27%), Positives = 82/208 (39%), Gaps = 19/208 (9%)
Query: 503 KFDESLLLGVGGFGRVYKGT-LDDGTKVAVKRGN--PRSEQGIAEFRTEIEMLSKL-RHR 558
F LG G +G V+K +DG AVKR R + A E+ K+ +H
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 559 HLVSLIGYCDERSEMILVYEYMANGPLRSHL--YGTDLP-PLSWKQRLEICIGAARGLHY 615
V L +E + L E L+ H +G LP W + L +
Sbjct: 118 CCVRLEQAWEEGGILYLQTEL-CGPSLQQHCEAWGASLPEAQVWGYLRDTL----LALAH 172
Query: 616 LHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPE 675
LH+ Q ++H DVK NI L K+ DFGL L +G Y+ PE
Sbjct: 173 LHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLV---ELGTAGAGEVQEGDPRYMAPE 226
Query: 676 YFRRQQLTEKSDVYSFGVVLMEVLCTRP 703
+ +DV+S G+ ++EV C
Sbjct: 227 LL-QGSYGTAADVFSLGLTILEVACNME 253
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 6e-35
Identities = 52/206 (25%), Positives = 87/206 (42%), Gaps = 13/206 (6%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVKRGN--PRSEQGIAEFRTEIEMLSKLRHRHLVSLIG 565
+G G +GR K DG + K + +E +E+ +L +L+H ++V
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 566 -YCDERSEMI-LVYEYMANGPLRSHL--YGTDLPPLSWKQRLEICIGAARGLHYLHT--G 619
D + + +V EY G L S + + L + L + L H
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 620 AAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT-HVSTAVKGSFGYLDPEYFR 678
+++HRD+K N+ LD K+ DFGL++ L+ + G+ Y+ PE
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR---ILNHDTSFAKTFVGTPYYMSPEQMN 189
Query: 679 RQQLTEKSDVYSFGVVLMEVLCTRPA 704
R EKSD++S G +L E+ P
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 52/224 (23%), Positives = 87/224 (38%), Gaps = 28/224 (12%)
Query: 502 NKFDESLLLGVGGFGRVYKGT-LDDGTKVAVKRGN-PRSEQGIAEFRTEIEMLSKLRHRH 559
F+ LG GGFG V++ D A+KR P E + E++ L+KL H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 560 LVSLIGYCDERSEMI------------LVYEYMANGPLRSHL-YGTDLPPLSWKQRLEIC 606
+V E++ + + L+ + + L I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 607 IGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSK----------TGPAL 656
+ A + +LH ++ ++HRD+K +NI + V KV DFGL +
Sbjct: 125 LQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 657 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC 700
T G+ Y+ PE + K D++S G++L E+L
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 56/231 (24%), Positives = 102/231 (44%), Gaps = 40/231 (17%)
Query: 501 TNKFDESLLLGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRH 559
+ F+E +LG G FG+V K D A+K+ +E+ ++ +E+ +L+ L H++
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQY 63
Query: 560 LVSLIG-YCDERSEMI------------LVYEYMANGPLRSHL--YGTDLPP-LSWKQRL 603
+V + + R+ + + EY NG L + + W+
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 604 EICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSK------------ 651
+I L Y+H +Q IIHRD+K NI +D++ K+ DFGL+K
Sbjct: 124 QIL----EALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 652 -TGPALDQTHVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLMEVLC 700
++++A+ G+ Y+ E EK D+YS G++ E++
Sbjct: 177 SQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 6e-33
Identities = 67/245 (27%), Positives = 104/245 (42%), Gaps = 42/245 (17%)
Query: 509 LLGVGGFGRVYKGT---LDDGTKVAVKRGNP---RSEQGIAEFRTEIEMLSKLRHRHLVS 562
LG GG VY L+ KVA+K E+ + F E+ S+L H+++VS
Sbjct: 18 KLGGGGMSTVYLAEDTILN--IKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 563 LIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQ 622
+I +E LV EY+ L ++ PLS + G+ + H
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYI--ESHGPLSVDTAINFTNQILDGIKHAH---DM 130
Query: 623 SIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHV--STAVKGSFGYLDPEYFRRQ 680
I+HRD+K NIL+D N K+ DFG++K AL +T + + V G+ Y PE + +
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAK---ALSETSLTQTNHVLGTVQYFSPEQAKGE 187
Query: 681 QLTEKSDVYSFGVVLMEVLCTRP------------------------ALNPVLPREQVNI 716
E +D+YS G+VL E+L P + +P+ N+
Sbjct: 188 ATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNV 247
Query: 717 AEWAM 721
A
Sbjct: 248 ILRAT 252
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 7e-33
Identities = 49/201 (24%), Positives = 81/201 (40%), Gaps = 14/201 (6%)
Query: 509 LLGVGGFGRVYKGT---LDDGTKVAVKRGNP---RSEQGIAEFRTEIEMLSKLRHRHLVS 562
L+G GG G VY+ + VA+K + + E +L+ H+V
Sbjct: 41 LVGRGGMGDVYEAEDTVRER--IVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 563 LIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQ 622
+ + + ++ + + L + L PL+ + + I L H A
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAML--RRQGPLAPPRAVAIVRQIGSALDAAH---AA 153
Query: 623 SIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQL 682
HRDVK NIL+ + A + DFG++ T + V G+ Y+ PE F
Sbjct: 154 GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYMAPERFSESHA 212
Query: 683 TEKSDVYSFGVVLMEVLCTRP 703
T ++D+Y+ VL E L P
Sbjct: 213 TYRADIYALTCVLYECLTGSP 233
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 26/208 (12%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYC 567
+LG G +G VY G L + ++A+K R + EI + L+H+++V +G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 568 DERSEMILVYEYMANGPLRSHLYGTDLPPLSW---------KQRLEICIGAARGLHYLHT 618
E + + E + G L + L + PL KQ LE GL YLH
Sbjct: 89 SENGFIKIFMEQVPGGSLSA-LLRSKWGPLKDNEQTIGFYTKQILE-------GLKYLH- 139
Query: 619 GAAQSIIHRDVKTTNILLD-DNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYF 677
I+HRD+K N+L++ + V K++DFG SK ++ + G+ Y+ PE
Sbjct: 140 --DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEII 195
Query: 678 RRQQL--TEKSDVYSFGVVLMEVLCTRP 703
+ + +D++S G ++E+ +P
Sbjct: 196 DKGPRGYGKAADIWSLGCTIIEMATGKP 223
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-32
Identities = 69/247 (27%), Positives = 107/247 (43%), Gaps = 29/247 (11%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVK----RGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLI 564
LG GGFG V + D G +VA+K +P++ + EI+++ KL H ++VS
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERW---CLEIQIMKKLNHPNVVSAR 78
Query: 565 GYCDERSEM------ILVYEYMANGPLRSHLYGTD-LPPLSWKQRLEICIGAARGLHYLH 617
D ++ +L EY G LR +L + L + + L YLH
Sbjct: 79 EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 138
Query: 618 TGAAQSIIHRDVKTTNILLD---DNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDP 674
IIHRD+K NI+L + K+ D G +K LDQ + T G+ YL P
Sbjct: 139 ---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE---LDQGELCTEFVGTLQYLAP 192
Query: 675 EYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMD 734
E +++ T D +SFG + E + P LP +W ++K ++
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFR---PFLPNW--QPVQWHGKVREKSNEHIVVY 247
Query: 735 SNLVGKV 741
+L G V
Sbjct: 248 DDLTGAV 254
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-32
Identities = 43/219 (19%), Positives = 89/219 (40%), Gaps = 32/219 (14%)
Query: 510 LGVGGFGRVYKGTLDDGTKVAVK-----------------RGNPRSEQGIAEFRTEIEML 552
L G F ++ D A+K + +F+ E++++
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 553 SKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGA--- 609
+ +++ + ++ G E+ ++YEYM N + + ++ + I +
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 610 ---ARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVK 666
Y+H ++I HRDVK +NIL+D N K++DFG S+ + +
Sbjct: 158 KSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV---DKKIKGSR- 211
Query: 667 GSFGYLDPEYFRRQQLT--EKSDVYSFGVVLMEVLCTRP 703
G++ ++ PE+F + K D++S G+ L +
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVV 250
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 7e-32
Identities = 51/212 (24%), Positives = 88/212 (41%), Gaps = 23/212 (10%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAE-FRTEIEMLSKLRHRHLVSLIGY 566
+LG G V++G G A+K N S + E E+L KL H+++V L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 567 CDERS--EMILVYEYMANGPLRSHLY-GTDLPPLSWKQRLEICIGAARGLHYLHTGAAQS 623
+E + +L+ E+ G L + L ++ L + L + G+++L
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENG 132
Query: 624 IIHRDVKTTNILL----DDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRR 679
I+HR++K NI+ D V K+ DFG ++ L+ ++ G+ YL P+ + R
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE---LEDDEQFVSLYGTEEYLHPDMYER 189
Query: 680 QQL--------TEKSDVYSFGVVLMEVLCTRP 703
L D++S GV
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 1e-31
Identities = 41/205 (20%), Positives = 79/205 (38%), Gaps = 27/205 (13%)
Query: 509 LLGVGGFGRVYKGTLD---DGTKVAVK--RGNPRSEQGIAEFRTEIEMLSKLRHRHLVSL 563
+ GG G +Y D +G V +K + + A E + L+++ H +V +
Sbjct: 87 CIAHGGLGWIYLAL-DRNVNGRPVVLKGLV-HSGDAEAQAMAMAERQFLAEVVHPSIVQI 144
Query: 564 IGYCDERSEMI-----LVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHT 618
+ + +V EY+ L+ L + + + L YLH
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLH- 199
Query: 619 GAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFR 678
+ +++ D+K NI+L + + K+ D G ++ + G+ G+ PE R
Sbjct: 200 --SIGLVYNDLKPENIMLTEEQL-KLIDLGAVS---RINSF---GYLYGTPGFQAPEIVR 250
Query: 679 RQQLTEKSDVYSFGVVLMEVLCTRP 703
T +D+Y+ G L + P
Sbjct: 251 TGP-TVATDIYTVGRTLAALTLDLP 274
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 64/209 (30%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 509 LLGVGGFGRVYKGT---LDDGTKVAVKRGNP---RSEQGIAEFRTEIEMLSKLRHRHLVS 562
+LG GG V+ VAVK R FR E + + L H +V+
Sbjct: 19 ILGFGGMSEVHLARDLRDHR--DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 563 L--IGYCDERSEMI--LVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHT 618
+ G + + + +V EY+ LR + P++ K+ +E+ A + L++ H
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQALNFSH- 133
Query: 619 GAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVST----AVKGSFGYLDP 674
IIHRDVK NI++ KV DFG+++ A+ + S AV G+ YL P
Sbjct: 134 --QNGIIHRDVKPANIMISATNAVKVMDFGIAR---AIADSGNSVTQTAAVIGTAQYLSP 188
Query: 675 EYFRRQQLTEKSDVYSFGVVLMEVLCTRP 703
E R + +SDVYS G VL EVL P
Sbjct: 189 EQARGDSVDARSDVYSLGCVLYEVLTGEP 217
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-30
Identities = 51/212 (24%), Positives = 88/212 (41%), Gaps = 23/212 (10%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAE-FRTEIEMLSKLRHRHLVSLIGY 566
+LG G V++G G A+K N S + E E+L KL H+++V L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 567 CDERS--EMILVYEYMANGPLRSHLYG-TDLPPLSWKQRLEICIGAARGLHYLHTGAAQS 623
+E + +L+ E+ G L + L ++ L + L + G+++L
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENG 132
Query: 624 IIHRDVKTTNILL----DDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRR 679
I+HR++K NI+ D V K+ DFG ++ L+ ++ G+ YL P+ + R
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE---LEDDEQFVSLYGTEEYLHPDMYER 189
Query: 680 QQL--------TEKSDVYSFGVVLMEVLCTRP 703
L D++S GV
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 52/219 (23%), Positives = 85/219 (38%), Gaps = 24/219 (10%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLR-HRHLVSLIGY 566
+L GGF VY+ + G + A+KR E+ E+ + KL H ++V
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 567 CDERSEM-------ILVYEYMANGPLRSHLYGTDLP-PLSWKQRLEICIGAARGLHYLHT 618
E L+ + G L L + PLS L+I R + ++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 619 GAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKT---GPALDQTHVSTAVK-------GS 668
IIHRD+K N+LL + K+ DFG + T P + A+ +
Sbjct: 155 -QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 669 FGYLDPE---YFRRQQLTEKSDVYSFGVVLMEVLCTRPA 704
Y PE + + EK D+++ G +L + +
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 59/212 (27%), Positives = 88/212 (41%), Gaps = 25/212 (11%)
Query: 502 NKFDESLLLGVGGFGRVYKGT-LDDGTKVAVK---RGNPRSEQGIAEFRTEIEMLSKLRH 557
F+ LG G FG VY +A+K + + R E+E+ S LRH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 558 RHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGA------AR 611
+++ L GY + + + L+ EY G + L + + A A
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITELAN 120
Query: 612 GLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGY 671
L Y H ++ +IHRD+K N+LL K+ADFG S P G+ Y
Sbjct: 121 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--SSRRTDLC--GTLDY 173
Query: 672 LDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRP 703
L PE + EK D++S GV+ E L +P
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 205
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-30
Identities = 39/228 (17%), Positives = 71/228 (31%), Gaps = 23/228 (10%)
Query: 496 EILDATNKFDESLLLGVGGFGRVYKGTLDD------GTKVAVKRGNPRSEQGIAEFRTEI 549
E + LLG G F +VY+ T D K +K P + +
Sbjct: 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLM 118
Query: 550 EMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHL---YGTDLPPLSWKQRLEIC 606
E L + ++ +LV E + G L + + T + +
Sbjct: 119 ERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA 178
Query: 607 IGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVA-----------KVADFGLSKTGPA 655
+ + +H IIH D+K N +L + F+ + D G S
Sbjct: 179 MRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL 235
Query: 656 LDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRP 703
+ + TA + G+ E + + D + + +L
Sbjct: 236 FPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTY 283
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 46/230 (20%), Positives = 82/230 (35%), Gaps = 35/230 (15%)
Query: 501 TNKFDESLLLGVGGFGRVYKGT-LDDGTKVAVKRGN--PRSEQGIAEFRTEIEMLSKL-R 556
T +F E +G G FG V+K DG A+KR E+ + L +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 557 HRHLVSLIGYCDERSEMILVYEYMANGPLRSHL--YGTDLPPLSWKQRLEICIGAARGLH 614
H H+V E M++ EY G L + + + ++ + RGL
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 615 YLHTGAAQSIIHRDVKTTNILLDDN-------------------FVAKVADFGLSKTGPA 655
Y+H + S++H D+K +NI + + K+ D G
Sbjct: 130 YIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR--- 183
Query: 656 LDQTHVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLMEVLCTRPA 704
+ V +G +L E + K+D+++ + ++ P
Sbjct: 184 ISSPQV---EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 48/208 (23%), Positives = 84/208 (40%), Gaps = 29/208 (13%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVK---RGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLI 564
LG GGF + ++ + D A K + + EI + L H+H+V
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 565 GYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRL-EICIGAAR--------GLHY 615
G+ ++ + +V E L ++ L E AR G Y
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLEL--------HKRRKALTEP---EARYYLRQIVLGCQY 130
Query: 616 LHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPE 675
LH +IHRD+K N+ L+++ K+ DFGL+ + G+ Y+ PE
Sbjct: 131 LH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GTPNYIAPE 185
Query: 676 YFRRQQLTEKSDVYSFGVVLMEVLCTRP 703
++ + + DV+S G ++ +L +P
Sbjct: 186 VLSKKGHSFEVDVWSIGCIMYTLLVGKP 213
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 7e-30
Identities = 48/208 (23%), Positives = 84/208 (40%), Gaps = 29/208 (13%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVK---RGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLI 564
LG GGF + ++ + D A K + + EI + L H+H+V
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 565 GYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRL-EICIGAAR--------GLHY 615
G+ ++ + +V E L ++ L E AR G Y
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLEL--------HKRRKALTEP---EARYYLRQIVLGCQY 156
Query: 616 LHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPE 675
LH +IHRD+K N+ L+++ K+ DFGL+ + G+ Y+ PE
Sbjct: 157 LH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GTPNYIAPE 211
Query: 676 YFRRQQLTEKSDVYSFGVVLMEVLCTRP 703
++ + + DV+S G ++ +L +P
Sbjct: 212 VLSKKGHSFEVDVWSIGCIMYTLLVGKP 239
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 62/212 (29%), Positives = 91/212 (42%), Gaps = 25/212 (11%)
Query: 502 NKFDESLLLGVGGFGRVYKG-TLDDGTKVAVK---RGNPRSEQGIAEFRTEIEMLSKLRH 557
+ FD LG G FG VY + +A+K + E + R EIE+ S LRH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 558 RHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGA------AR 611
+++ + Y +R + L+ E+ G L L R + A A
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKEL--------QKHGRFDEQRSATFMEELAD 125
Query: 612 GLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGY 671
LHY H + +IHRD+K N+L+ K+ADFG S P+ + T G+ Y
Sbjct: 126 ALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS-LRRR--TMC-GTLDY 178
Query: 672 LDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRP 703
L PE + EK D++ GV+ E L P
Sbjct: 179 LPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMP 210
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 49/205 (23%), Positives = 83/205 (40%), Gaps = 25/205 (12%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVKR---GNPRSEQGIAEFRTEIEMLSKLRHRHLVSLI 564
+G G FG V++ G + AVK+ R E E+ + L +V L
Sbjct: 65 RVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE--------ELVACAGLSSPRIVPLY 116
Query: 565 GYCDERSEMILVYEYMANGPLRSHL--YGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQ 622
G E + + E + G L + G L + L A GL YLH +
Sbjct: 117 GAVREGPWVNIFMELLEGGSLGQLIKQMG----CLPEDRALYYLGQALEGLEYLH---TR 169
Query: 623 SIIHRDVKTTNILLDDN-FVAKVADFGLSK--TGPALDQTHVST-AVKGSFGYLDPEYFR 678
I+H DVK N+LL + A + DFG + L ++ ++ + G+ ++ PE
Sbjct: 170 RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 229
Query: 679 RQQLTEKSDVYSFGVVLMEVLCTRP 703
+ K D++S +++ +L
Sbjct: 230 GKPCDAKVDIWSSCCMMLHMLNGCH 254
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-29
Identities = 72/313 (23%), Positives = 112/313 (35%), Gaps = 52/313 (16%)
Query: 503 KFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKL-RHRHLV 561
F +LG G G + + D VAVKR P E+++L + H +++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFA---DREVQLLRESDEHPNVI 81
Query: 562 SLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAA 621
+R + E A L+ ++ D + + + GL +LH +
Sbjct: 82 RYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLH---S 136
Query: 622 QSIIHRDVKTTNILL-----DDNFVAKVADFGLSK-TGPALDQTHVSTAVKGSFGYLDPE 675
+I+HRD+K NIL+ A ++DFGL K + V G+ G++ PE
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196
Query: 676 YFRR---QQLTEKSDVYSFGVVLMEVLCT-RPALNPVLPREQVNIAEWAMTWQKKGMLDQ 731
+ T D++S G V V+ L R Q NI
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR-QANI--------------- 240
Query: 732 IMDSNLVGKVNPASLKKFGETAE-------KCLAEHGVDRPSMGDVL-----WNLEYALQ 779
L+G + L K +A RPS VL W+LE LQ
Sbjct: 241 -----LLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQ 295
Query: 780 LEETSSALMEPED 792
+ S +E E
Sbjct: 296 FFQDVSDRIEKES 308
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 120 bits (301), Expect = 2e-29
Identities = 31/299 (10%), Positives = 63/299 (21%), Gaps = 52/299 (17%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVK---RGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLI 564
L VG V+ ++ A+K G S + ++L
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 565 GYC--------------------------DERSEMILVYEYMA--NGPLRSHL--YGTDL 594
+ +L+ + L S L
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 595 PPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGP 654
+ R L ++ ++H N+ + + + D
Sbjct: 189 GDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245
Query: 655 ALDQTHVSTAVKGSFGYLDPEYFRRQ--QLTEKSDVYSFGVVLMEVLCTRPALNPVLPRE 712
Y E+ T + + G+ + V C P
Sbjct: 246 TRGPASSVPV-----TYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL---PFGLVT 297
Query: 713 QVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVL 771
W + D + + P +K + L R + +
Sbjct: 298 PGIKGSWKRPSLRVPGTDSLAFGSCTPL--PDFVKTL---IGRFLNFDRRRRLLPLEAM 351
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-29
Identities = 46/200 (23%), Positives = 86/200 (43%), Gaps = 22/200 (11%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCD 568
LG G FG V++ G K N + EI ++++L H L++L +
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 569 ERSEMILVYEYMANGPL------RSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQ 622
++ EM+L+ E+++ G L + +Q E GL ++H
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE-------GLKHMH---EH 168
Query: 623 SIIHRDVKTTNILLDDNFVA--KVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQ 680
SI+H D+K NI+ + + K+ DFGL+ L+ + + + PE R+
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLATK---LNPDEIVKVTTATAEFAAPEIVDRE 225
Query: 681 QLTEKSDVYSFGVVLMEVLC 700
+ +D+++ GV+ +L
Sbjct: 226 PVGFYTDMWAIGVLGYVLLS 245
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 3e-29
Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 16/202 (7%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVK---RGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLI 564
LLG G F VY+ + G +VA+K + + + E+++ +L+H ++ L
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 565 GYCDERSEMILVYEYMANGPLRSHL--YGTDLP-PLSWKQRLEICIGAARGLHYLHTGAA 621
Y ++ + + LV E NG + +L + +I G+ YLH +
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI----ITGMLYLH---S 130
Query: 622 QSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQ 681
I+HRD+ +N+LL N K+ADFGL+ + H + G+ Y+ PE R
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC--GTPNYISPEIATRSA 188
Query: 682 LTEKSDVYSFGVVLMEVLCTRP 703
+SDV+S G + +L RP
Sbjct: 189 HGLESDVWSLGCMFYTLLIGRP 210
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 54/202 (26%), Positives = 88/202 (43%), Gaps = 25/202 (12%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYC 567
+LG G F V+ G A+K + EI +L K++H ++V+L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 568 DERSEMILVYEYMANGPL------RSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAA 621
+ + LV + ++ G L R D + +Q L + YLH
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLV-IQQVLS-------AVKYLH---E 124
Query: 622 QSIIHRDVKTTNILL---DDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFR 678
I+HRD+K N+L ++N + DFGLSK +STA G+ GY+ PE
Sbjct: 125 NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM---EQNGIMSTAC-GTPGYVAPEVLA 180
Query: 679 RQQLTEKSDVYSFGVVLMEVLC 700
++ ++ D +S GV+ +LC
Sbjct: 181 QKPYSKAVDCWSIGVITYILLC 202
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 1e-28
Identities = 52/228 (22%), Positives = 89/228 (39%), Gaps = 37/228 (16%)
Query: 502 NKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKL-RHRHL 560
N +LG G G V G VAVKR EI++L++ H ++
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIA---LMEIKLLTESDDHPNV 71
Query: 561 VSLIGYCDERSEMILVYEYMANGPL-----RSHLYGTDLPPLSWKQRLEICIGAARGLHY 615
+ + + E N L ++ +L + + A G+ +
Sbjct: 72 IRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 616 LHTGAAQSIIHRDVKTTNILLD-------------DNFVAKVADFGLSK---TGPALDQT 659
LH + IIHRD+K NIL+ +N ++DFGL K +G + +T
Sbjct: 131 LH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 660 HVSTAVKGSFGYLDPEYFR-------RQQLTEKSDVYSFGVVLMEVLC 700
+++ G+ G+ PE +++LT D++S G V +L
Sbjct: 188 NLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 19/216 (8%)
Query: 488 LGRLFMFQEILDATNKFDESLLLGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFR 546
L +L + D K+ +G G G VY + G +VA+++ N + +
Sbjct: 6 LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII 65
Query: 547 TEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDL---PPLSWKQRL 603
EI ++ + ++ ++V+ + E+ +V EY+A G L TD+ + Q
Sbjct: 66 NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL------TDVVTETCMDEGQIA 119
Query: 604 EICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHV-- 661
+C + L +LH + +IHRD+K+ NILL + K+ DFG +
Sbjct: 120 AVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ---ITPEQSKR 173
Query: 662 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLME 697
ST V G+ ++ PE R+ K D++S G++ +E
Sbjct: 174 STMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIE 208
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 56/213 (26%), Positives = 99/213 (46%), Gaps = 26/213 (12%)
Query: 498 LDATNKFDESLLLGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLR 556
LD ++ LG G FG+VYK + G A K +SE+ + ++ EIE+L+
Sbjct: 15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCD 74
Query: 557 HRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYL 616
H ++V L+G ++ ++ E+ G + + + L+ Q +C L++L
Sbjct: 75 HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQVVCRQMLEALNFL 133
Query: 617 HTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLS-KTGPALDQ--THVST----AVKGSF 669
H ++ IIHRD+K N+L+ ++ADFG+S K L + + + T A
Sbjct: 134 H---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMA----- 185
Query: 670 GYLDPE-----YFRRQQLTEKSDVYSFGVVLME 697
PE + K+D++S G+ L+E
Sbjct: 186 ----PEVVMCETMKDTPYDYKADIWSLGITLIE 214
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 13/213 (6%)
Query: 488 LGRLFMFQEILDATNKFDESLLLGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFR 546
L +L FD LG G +G VYK + G VA+K+ E + E
Sbjct: 15 LKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV--ESDLQEII 72
Query: 547 TEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEIC 606
EI ++ + H+V G + +++ +V EY G + + L+ + I
Sbjct: 73 KEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIATIL 131
Query: 607 IGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHV--STA 664
+GL YLH IHRD+K NILL+ AK+ADFG++ L T +T
Sbjct: 132 QSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQ---LTDTMAKRNTV 185
Query: 665 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLME 697
+ G+ ++ PE + +D++S G+ +E
Sbjct: 186 I-GTPFWMAPEVIQEIGYNCVADIWSLGITAIE 217
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 19/205 (9%)
Query: 499 DATNKFDESLLLGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRH 557
D D + +G G G V G +VAVK + R +Q E+ ++ +H
Sbjct: 42 DPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH 101
Query: 558 RHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDL---PPLSWKQRLEICIGAARGLH 614
++V + E+ ++ E++ G L TD+ L+ +Q +C + L
Sbjct: 102 FNVVEMYKSYLVGEELWVLMEFLQGGAL------TDIVSQVRLNEEQIATVCEAVLQALA 155
Query: 615 YLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHV--STAVKGSFGYL 672
YLH AQ +IHRD+K+ +ILL + K++DFG + + + V G+ ++
Sbjct: 156 YLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQ---ISKDVPKRKSLV-GTPYWM 208
Query: 673 DPEYFRRQQLTEKSDVYSFGVVLME 697
PE R + D++S G++++E
Sbjct: 209 APEVISRSLYATEVDIWSLGIMVIE 233
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-28
Identities = 31/235 (13%), Positives = 60/235 (25%), Gaps = 44/235 (18%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVK---RGNPRSEQGIAEFRTEIEMLSKLR-------- 556
+LG + T + G V I + + E+ L LR
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 557 --HRHLVSLI----------------GYCDERSEMILVYEYMANGPLRSHL-----YGTD 593
H + D L++ + +
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 594 LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTG 653
L RL++ + R L LH ++H ++ +I+LD + F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 654 PALDQTHVSTAVKGSFGYLDPEYFRRQQ-----LTEKSDVYSFGVVLMEVLCTRP 703
A + + Q +T D ++ G+ + + C
Sbjct: 262 GASAVSPIGRGF-APPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* Length = 174 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 5e-28
Identities = 25/194 (12%), Positives = 57/194 (29%), Gaps = 31/194 (15%)
Query: 208 LGFETVYRLNMGGPLITAQNDTLGRTWENDETYLHVNSSAVNVSVRPSAIRYTASVTAET 267
L + ++ +N GG D G + D V ++ P
Sbjct: 2 LADKVIWAVNAGGESHV---DVHGIHYRKDPLEGRVGRASDYGMKLPILRSNPE------ 52
Query: 268 APNWVYATAEMMGDANVPEVNFNITWVLPVEPNFTYFVRVHLCDIASLSMNNLVFNLYIN 327
+Y T + + +P++ Y + + ++ VF++ +N
Sbjct: 53 -DQVLYQTERYN--------EDSFGYDIPIKEEGEYVLVLKFAEVYFAQSQQKVFDVRVN 103
Query: 328 DDIAQPSVDLSTLTNGLNVPYYKDFVCNASADSNTLTVSVGPDSVA----------DFTN 377
+D+ G + + + S L+V + + N
Sbjct: 104 GHTVVKDLDIFD-RVGHSTAHDEII--PISIKKGKLSVQGEVSTFTGKLSVEFVKGYYDN 160
Query: 378 ATMNGLEVMKISNE 391
+ L +MK + +
Sbjct: 161 PKVCALFIMKGTAD 174
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* Length = 174 | Back alignment and structure |
|---|
Score = 82.7 bits (204), Expect = 2e-18
Identities = 23/167 (13%), Positives = 50/167 (29%), Gaps = 19/167 (11%)
Query: 36 YLIACGSSQKVTFQARTYVPDTEHSSLSMKS--GNSTTASSNSSAPSPIYQSARIFSAAA 93
+ + G V Y D + S G ++ +YQ+ R +
Sbjct: 8 WAVNAGGESHVDVHGIHYRKDPLEGRVGRASDYGMKLPILRSNPEDQVLYQTERYNEDSF 67
Query: 94 FYKFEIEHKGRHWVRLYFYTLPGSNQHLNSASFTVATDKFVLLSNF---------TFKNY 144
Y I+ +G + + L F F V + ++ + T +
Sbjct: 68 GYDIPIKEEGEYVLVLKFA--EVYFAQSQQKVFDVRVNGHTVVKDLDIFDRVGHSTAHDE 125
Query: 145 NSSFMFKEYAINVNSDA------LTLTFIPSNNSVAFVNAIEVVSVP 185
K+ ++V + L++ F+ V A+ ++
Sbjct: 126 IIPISIKKGKLSVQGEVSTFTGKLSVEFVKGYYDNPKVCALFIMKGT 172
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-28
Identities = 52/201 (25%), Positives = 83/201 (41%), Gaps = 16/201 (7%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVK---RGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIG 565
LG G FG V G + AVK + + + E+++L +L H +++ L
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 566 YCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSII 625
+ +++ LV E G L + S I G+ Y+H I+
Sbjct: 94 FFEDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMH---KNKIV 148
Query: 626 HRDVKTTNILL---DDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQL 682
HRD+K N+LL + ++ DFGLS + + G+ Y+ PE
Sbjct: 149 HRDLKPENLLLESKSKDANIRIIDFGLSTH---FEASKKMKDKIGTAYYIAPEVLHG-TY 204
Query: 683 TEKSDVYSFGVVLMEVLCTRP 703
EK DV+S GV+L +L P
Sbjct: 205 DEKCDVWSTGVILYILLSGCP 225
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 42/204 (20%), Positives = 76/204 (37%), Gaps = 25/204 (12%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCD 568
+G G +G V + A K+ + + F+ EIE++ L H +++ L +
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 569 ERSEMILVYEYMANGPL------RSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQ 622
+ +++ LV E G L + I + Y H
Sbjct: 77 DNTDIYLVMELCTGGELFERVVHKRV--------FRESDAARIMKDVLSAVAYCH---KL 125
Query: 623 SIIHRDVKTTNILL---DDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRR 679
++ HRD+K N L + K+ DFGL+ + G+ Y+ P+
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR---FKPGKMMRTKVGTPYYVSPQVLEG 182
Query: 680 QQLTEKSDVYSFGVVLMEVLCTRP 703
+ D +S GV++ +LC P
Sbjct: 183 -LYGPECDEWSAGVMMYVLLCGYP 205
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 49/208 (23%), Positives = 89/208 (42%), Gaps = 31/208 (14%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVK------RGNPRSEQGIAEFRTEIEMLSKLRHRHLVS 562
LG G F V K G + A K R E E+ +L ++ H ++++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 563 LIGYCDERSEMILVYEYMANGPL------RSHLYGTDLPPLSWKQRLEICIGAARGLHYL 616
L + R++++L+ E ++ G L + L + KQ L+ G++YL
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-IKQILD-------GVNYL 131
Query: 617 HTGAAQSIIHRDVKTTNILL----DDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYL 672
H + I H D+K NI+L K+ DFGL+ ++ + G+ ++
Sbjct: 132 H---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE---IEDGVEFKNIFGTPEFV 185
Query: 673 DPEYFRRQQLTEKSDVYSFGVVLMEVLC 700
PE + L ++D++S GV+ +L
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLS 213
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-27
Identities = 53/203 (26%), Positives = 92/203 (45%), Gaps = 24/203 (11%)
Query: 503 KFDESLLLGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLV 561
++ +LG G FG+V+K G K+A K R + E + EI ++++L H +L+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 562 SLIGYCDERSEMILVYEYMANGPL------RSHLYGTDLPPLSWKQRLEICIGAARGLHY 615
L + +++++LV EY+ G L S+ L KQ E G+ +
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICE-------GIRH 202
Query: 616 LHTGAAQSIIHRDVKTTNILL---DDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYL 672
+H I+H D+K NIL D + K+ DFGL++ G+ +L
Sbjct: 203 MHQ---MYILHLDLKPENILCVNRDAKQI-KIIDFGLARR---YKPREKLKVNFGTPEFL 255
Query: 673 DPEYFRRQQLTEKSDVYSFGVVL 695
PE ++ +D++S GV+
Sbjct: 256 APEVVNYDFVSFPTDMWSVGVIA 278
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-27
Identities = 35/241 (14%), Positives = 67/241 (27%), Gaps = 55/241 (22%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVK---RGNPRSEQGIAEFRTEIEMLSKLR-------- 556
+LG + T + G V I + + E+ L LR
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 557 -----------------HRHLVSLIG-YCDERSEMILVYEYMANGPLRSHL-----YGTD 593
+ ++ + D L++ + +
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 594 LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTG 653
L RL++ + R L LH ++H ++ +I+LD + F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 254
Query: 654 PALDQTHVSTAVKGSFGYLDPEYF-----------RRQQLTEKSDVYSFGVVLMEVLCTR 702
+ S G+ PE RR +T D ++ G+V+ + C
Sbjct: 255 ----RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 703 P 703
Sbjct: 311 L 311
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 49/203 (24%), Positives = 92/203 (45%), Gaps = 31/203 (15%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVK------RGNPRSEQGIAEFRTEIEMLSKLRHRHLVS 562
LG G F V K G + A K + R E E+ +L ++RH ++++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 563 LIGYCDERSEMILVYEYMANGPL------RSHLYGTDLPPLSWKQRLEICIGAARGLHYL 616
L + +++++L+ E ++ G L + L + KQ L+ G+HYL
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF-LKQILD-------GVHYL 124
Query: 617 HTGAAQSIIHRDVKTTNILL----DDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYL 672
H+ + I H D+K NI+L N K+ DFG++ ++ + + G+ ++
Sbjct: 125 HS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK---IEAGNEFKNIFGTPEFV 178
Query: 673 DPEYFRRQQLTEKSDVYSFGVVL 695
PE + L ++D++S GV+
Sbjct: 179 APEIVNYEPLGLEADMWSIGVIT 201
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-27
Identities = 52/200 (26%), Positives = 85/200 (42%), Gaps = 15/200 (7%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGY 566
LG G +G V + A+K S ++ E+ +L L H +++ L +
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 567 CDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIH 626
+++ LV E G L + + I G+ YLH +I+H
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLH---KHNIVH 159
Query: 627 RDVKTTNILL---DDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLT 683
RD+K N+LL + + + K+ DFGLS + G+ Y+ PE R+ +
Sbjct: 160 RDLKPENLLLESKEKDALIKIVDFGLSAV---FENQKKMKERLGTAYYIAPEVLRK-KYD 215
Query: 684 EKSDVYSFGVVLMEVLCTRP 703
EK DV+S GV+L +L P
Sbjct: 216 EKCDVWSIGVILFILLAGYP 235
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-27
Identities = 50/208 (24%), Positives = 90/208 (43%), Gaps = 31/208 (14%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVK------RGNPRSEQGIAEFRTEIEMLSKLRHRHLVS 562
LG G F V K G + A K R E E+ +L ++ H ++++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 563 LIGYCDERSEMILVYEYMANGPL------RSHLYGTDLPPLSWKQRLEICIGAARGLHYL 616
L + R++++L+ E ++ G L + L + KQ L+ G++YL
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-IKQILD-------GVNYL 131
Query: 617 HTGAAQSIIHRDVKTTNILL----DDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYL 672
HT + I H D+K NI+L K+ DFGL+ ++ + G+ ++
Sbjct: 132 HT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE---IEDGVEFKNIFGTPEFV 185
Query: 673 DPEYFRRQQLTEKSDVYSFGVVLMEVLC 700
PE + L ++D++S GV+ +L
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLS 213
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 8e-27
Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 499 DATNKFDESLLLGVGGFGRVYKGT-LDDGTKVAVKRGN-PRSEQGIAEFRTEIEMLSKLR 556
D F + +G G FG V+KG VA+K + +E I + + EI +LS+
Sbjct: 19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 78
Query: 557 HRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYL 616
++ G + +++ ++ EY+ G L PL Q I +GL YL
Sbjct: 79 SPYVTKYYGSYLKDTKLWIIMEYLGGGSA-LDLLEPG--PLDETQIATILREILKGLDYL 135
Query: 617 HTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHV--STAVKGSFGYLDP 674
H+ + IHRD+K N+LL ++ K+ADFG++ L T + +T V G+ ++ P
Sbjct: 136 HS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQ---LTDTQIKRNTFV-GTPFWMAP 188
Query: 675 EYFRRQQLTEKSDVYSFGVVLME 697
E ++ K+D++S G+ +E
Sbjct: 189 EVIKQSAYDSKADIWSLGITAIE 211
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 49/203 (24%), Positives = 89/203 (43%), Gaps = 31/203 (15%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVK------RGNPRSEQGIAEFRTEIEMLSKLRHRHLVS 562
LG G F V K G + A K + R + E+ +L +++H ++++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 563 LIGYCDERSEMILVYEYMANGPL------RSHLYGTDLPPLSWKQRLEICIGAARGLHYL 616
L + ++++IL+ E +A G L + L + KQ L G++YL
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF-LKQILN-------GVYYL 130
Query: 617 HTGAAQSIIHRDVKTTNILL----DDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYL 672
H+ I H D+K NI+L K+ DFGL+ +D + + G+ ++
Sbjct: 131 HS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFGNEFKNIFGTPEFV 184
Query: 673 DPEYFRRQQLTEKSDVYSFGVVL 695
PE + L ++D++S GV+
Sbjct: 185 APEIVNYEPLGLEADMWSIGVIT 207
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-26
Identities = 55/211 (26%), Positives = 87/211 (41%), Gaps = 26/211 (12%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVK-------------RGNPRSEQGIAEFRTEIEMLSKL 555
LG G +G V + ++ A+K N E+ E EI +L L
Sbjct: 44 LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 556 RHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHY 615
H +++ L +++ LV E+ G L + I G+ Y
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICY 161
Query: 616 LHTGAAQSIIHRDVKTTNILL---DDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYL 672
LH +I+HRD+K NILL + K+ DFGLS + + G+ Y+
Sbjct: 162 LH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF---FSKDYKLRDRLGTAYYI 215
Query: 673 DPEYFRRQQLTEKSDVYSFGVVLMEVLCTRP 703
PE ++ + EK DV+S GV++ +LC P
Sbjct: 216 APEVLKK-KYNEKCDVWSCGVIMYILLCGYP 245
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 54/206 (26%), Positives = 88/206 (42%), Gaps = 26/206 (12%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGY 566
LG G F V + G + A K N + S + + E + KL+H ++V L
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 567 CDERSEMILVYEYMANGPL------RSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGA 620
E S LV++ + G L R D +Q LE + Y H
Sbjct: 74 IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCI-QQILE-------SIAYCH--- 122
Query: 621 AQSIIHRDVKTTNILL---DDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYF 677
+ I+HR++K N+LL K+ADFGL+ ++ + G+ GYL PE
Sbjct: 123 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE---VNDSEAWHGFAGTPGYLSPEVL 179
Query: 678 RRQQLTEKSDVYSFGVVLMEVLCTRP 703
++ ++ D+++ GV+L +L P
Sbjct: 180 KKDPYSKPVDIWACGVILYILLVGYP 205
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-26
Identities = 62/252 (24%), Positives = 92/252 (36%), Gaps = 44/252 (17%)
Query: 481 ISLASSNLGRLFMFQEILDATNKFDESLL--------LGVGGFGRVYKGT-LDDGTKVAV 531
I+L+ S F +D + + ++L LG G G V KVA+
Sbjct: 106 IALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAI 165
Query: 532 K--------RGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANG 583
+ G+ R TEIE+L KL H ++ + + D +V E M G
Sbjct: 166 RIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGG 224
Query: 584 PL------RSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILL- 636
L L + YLH IIHRD+K N+LL
Sbjct: 225 ELFDKVVGNKRL--------KEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLS 273
Query: 637 --DDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPE---YFRRQQLTEKSDVYSF 691
+++ + K+ DFG SK + + + T G+ YL PE D +S
Sbjct: 274 SQEEDCLIKITDFGHSKI--LGETSLMRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSL 330
Query: 692 GVVLMEVLCTRP 703
GV+L L P
Sbjct: 331 GVILFICLSGYP 342
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 62/214 (28%), Positives = 100/214 (46%), Gaps = 23/214 (10%)
Query: 499 DATNKFDESLLLGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKL-R 556
D F+ L+G G +G+VYKG + G A+K + ++ E + EI ML K
Sbjct: 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSH 79
Query: 557 HRHLVSLIG------YCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAA 610
HR++ + G ++ LV E+ G + + T L + IC
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139
Query: 611 RGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHV--STAVKGS 668
RGL +LH +IHRD+K N+LL +N K+ DFG+S LD+T +T + G+
Sbjct: 140 RGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ---LDRTVGRRNTFI-GT 192
Query: 669 FGYLDPEYFRRQQLTE-----KSDVYSFGVVLME 697
++ PE + + KSD++S G+ +E
Sbjct: 193 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-26
Identities = 45/205 (21%), Positives = 77/205 (37%), Gaps = 16/205 (7%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVK-----RGNPRSEQGIAEFRTEIEMLSKLRHRHLVSL 563
+G G F V + + G + AVK + + + E + L+H H+V L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 564 IGYCDERSEMILVYEYMANGPL--RSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAA 621
+ + +V+E+M L S L Y H
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---D 148
Query: 622 QSIIHRDVKTTNILL---DDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFR 678
+IIHRDVK +LL +++ K+ FG++ V G+ ++ PE +
Sbjct: 149 NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE-SGLVAGGRV-GTPHFMAPEVVK 206
Query: 679 RQQLTEKSDVYSFGVVLMEVLCTRP 703
R+ + DV+ GV+L +L
Sbjct: 207 REPYGKPVDVWGCGVILFILLSGCL 231
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 57/201 (28%), Positives = 89/201 (44%), Gaps = 14/201 (6%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVKRGN-PRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYC 567
LG G FG V+ G + +K N RS+ + + EIE+L L H +++ +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 568 DERSEMILVYEYMANGPL--RSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSII 625
++ M +V E G L R LS E+ L Y H +Q ++
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVV 146
Query: 626 HRDVKTTNILL---DDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQL 682
H+D+K NIL + K+ DFGL++ ST G+ Y+ PE F+R +
Sbjct: 147 HKDLKPENILFQDTSPHSPIKIIDFGLAEL---FKSDEHSTNAAGTALYMAPEVFKR-DV 202
Query: 683 TEKSDVYSFGVVLMEVLCTRP 703
T K D++S GVV+ +L
Sbjct: 203 TFKCDIWSAGVVMYFLLTGCL 223
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-26
Identities = 52/201 (25%), Positives = 87/201 (43%), Gaps = 24/201 (11%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCD 568
LG G FG V++ T G A K E R EI+ +S LRH LV+L +
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 569 ERSEMILVYEYMANGPL-------RSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAA 621
+ +EM+++YE+M+ G L + + + +Q + GL ++H
Sbjct: 225 DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY-MRQVCK-------GLCHMHE--- 273
Query: 622 QSIIHRDVKTTNILLDDNFVA--KVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRR 679
+ +H D+K NI+ K+ DFGL+ LD G+ + PE
Sbjct: 274 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH---LDPKQSVKVTTGTAEFAAPEVAEG 330
Query: 680 QQLTEKSDVYSFGVVLMEVLC 700
+ + +D++S GV+ +L
Sbjct: 331 KPVGYYTDMWSVGVLSYILLS 351
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 60/215 (27%), Positives = 83/215 (38%), Gaps = 36/215 (16%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVK--------RGNPRSEQGIAEFRTEIEMLSKLRHRHL 560
LG G G V KVA+K G+ R TEIE+L KL H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 561 VSLIGYCDERSEMILVYEYMANGPL------RSHLYGTDLPPLSWKQRLEICIGAARGLH 614
+ + + D +V E M G L L + Q L +
Sbjct: 78 IKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLY-FYQMLL-------AVQ 128
Query: 615 YLHTGAAQSIIHRDVKTTNILL---DDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGY 671
YLH IIHRD+K N+LL +++ + K+ DFG SK L +T + + G+ Y
Sbjct: 129 YLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTY 182
Query: 672 LDPE---YFRRQQLTEKSDVYSFGVVLMEVLCTRP 703
L PE D +S GV+L L P
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 217
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-26
Identities = 66/271 (24%), Positives = 98/271 (36%), Gaps = 44/271 (16%)
Query: 444 SKTPQQGHPWLPLPLYGNSQTMTKMST--TSQKSGTASCISLASSNLGRLFMFQEILDAT 501
S H +P N M ++G+ +A D
Sbjct: 2 SYYHHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKD--------DPE 53
Query: 502 NKFDESLLLGVGGFGRVYKGT-LDDGTKVAVKR---GNPRSEQGIAEFRTEIEMLSKLRH 557
F + +G G FG VY + + VA+K+ +S + + E+ L KLRH
Sbjct: 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113
Query: 558 RHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLH 617
+ + G LV EY L PL + + GA +GL YLH
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAVTHGALQGLAYLH 171
Query: 618 TGAAQSIIHRDVKTTNILLDDNFVAKVADFG----LSKTGPALDQTHVST----AVKGSF 669
+ ++IHRDVK NILL + + K+ DFG ++ + V T A
Sbjct: 172 S---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----NSFVGTPYWMA----- 218
Query: 670 GYLDPE---YFRRQQLTEKSDVYSFGVVLME 697
PE Q K DV+S G+ +E
Sbjct: 219 ----PEVILAMDEGQYDGKVDVWSLGITCIE 245
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-26
Identities = 42/199 (21%), Positives = 74/199 (37%), Gaps = 17/199 (8%)
Query: 511 GVGGFGRVYKGT-LDDGTKVAVKRGN--PRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYC 567
G V G V V+R N S + + + E+ + H ++V
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95
Query: 568 DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHR 627
+E+ +V +MA G + + + ++ I G + L Y+H +HR
Sbjct: 96 IADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH---MGYVHR 152
Query: 628 DVKTTNILLDDNFVAKVADFG----LSKTGPALDQTHVSTAVKGSFG---YLDPEYFRRQ 680
VK ++IL+ + ++ + G Q V K S +L PE ++
Sbjct: 153 SVKASHILISVDGKVYLSGLRSNLSMISHGQR--QRVVHDFPKYSVKVLPWLSPEVLQQN 210
Query: 681 QL--TEKSDVYSFGVVLME 697
KSD+YS G+ E
Sbjct: 211 LQGYDAKSDIYSVGITACE 229
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-26
Identities = 68/286 (23%), Positives = 112/286 (39%), Gaps = 36/286 (12%)
Query: 440 LARKSKTPQQGHPWLPLPLYGNSQTMTKMSTTSQKSGTASCISLASSNLGRLFMFQEILD 499
L R+ + N K +Q GT + + L + +
Sbjct: 32 LNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKE 91
Query: 500 ATNKFDESLLLGVGGFGRVYKGT-LDDGTKVAVK--------RGNPRSEQGIAEFRTEIE 550
K+D ++G G V + G + AVK + E+ R E
Sbjct: 92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETH 151
Query: 551 MLSKLR-HRHLVSLIGYCDERSEMILVYEYMANGPL------RSHLYGTDLPPLSWKQRL 603
+L ++ H H+++LI + S M LV++ M G L + L S K+
Sbjct: 152 ILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVAL--------SEKETR 203
Query: 604 EICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVST 663
I + +LH A +I+HRD+K NILLDDN +++DFG S L+
Sbjct: 204 SIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCH---LEPGEKLR 257
Query: 664 AVKGSFGYLDPEYFRRQQL------TEKSDVYSFGVVLMEVLCTRP 703
+ G+ GYL PE + ++ D+++ GV+L +L P
Sbjct: 258 ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSP 303
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-26
Identities = 54/206 (26%), Positives = 88/206 (42%), Gaps = 26/206 (12%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGY 566
LG G F V + G + A K N + S + + E + KL+H ++V L
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 567 CDERSEMILVYEYMANGPL------RSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGA 620
E S LV++ + G L R D +Q LE + Y H
Sbjct: 97 IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCI-QQILE-------SIAYCH--- 145
Query: 621 AQSIIHRDVKTTNILL---DDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYF 677
+ I+HR++K N+LL K+ADFGL+ ++ + G+ GYL PE
Sbjct: 146 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE---VNDSEAWHGFAGTPGYLSPEVL 202
Query: 678 RRQQLTEKSDVYSFGVVLMEVLCTRP 703
++ ++ D+++ GV+L +L P
Sbjct: 203 KKDPYSKPVDIWACGVILYILLVGYP 228
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 8e-26
Identities = 54/201 (26%), Positives = 87/201 (43%), Gaps = 17/201 (8%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVKRGN-PRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYC 567
+G G V KVA+KR N + + + E EI+ +S+ H ++VS
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82
Query: 568 DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLE------ICIGAARGLHYLHTGAA 621
+ E+ LV + ++ G + + L+ I GL YLH
Sbjct: 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---K 139
Query: 622 QSIIHRDVKTTNILLDDNFVAKVADFG----LSKTGPALDQTHVSTAVKGSFGYLDPEYF 677
IHRDVK NILL ++ ++ADFG L+ G T V G+ ++ PE
Sbjct: 140 NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV-GTPCWMAPEVM 198
Query: 678 RRQQL-TEKSDVYSFGVVLME 697
+ + K+D++SFG+ +E
Sbjct: 199 EQVRGYDFKADIWSFGITAIE 219
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 61/206 (29%), Positives = 85/206 (41%), Gaps = 27/206 (13%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQG--IAEFRTEIEMLSKLRHRHLVSLIGY 566
LG G FG V K + AVK N S + + E+E+L KL H +++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 567 CDERSEMILVYEYMANGPL------RSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGA 620
++ S +V E G L R S I G+ Y+H
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKR--------FSEHDAARIIKQVFSGITYMH--- 138
Query: 621 AQSIIHRDVKTTNILL---DDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYF 677
+I+HRD+K NILL + + K+ DFGLS Q G+ Y+ PE
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC---FQQNTKMKDRIGTAYYIAPEVL 195
Query: 678 RRQQLTEKSDVYSFGVVLMEVLCTRP 703
R EK DV+S GV+L +L P
Sbjct: 196 RG-TYDEKCDVWSAGVILYILLSGTP 220
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 62/260 (23%), Positives = 102/260 (39%), Gaps = 31/260 (11%)
Query: 459 YGNSQTMTKMSTTSQKSGTASCISLASSNLGRLFMFQEIL-----DATNKFDESLLLGVG 513
+ +S + + +S + A+ L I ++ F+ LG G
Sbjct: 5 HHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRG 64
Query: 514 GFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSE 572
VY+ A+K + RTEI +L +L H +++ L + +E
Sbjct: 65 ATSIVYRCKQKGTQKPYALKVLKKTVD--KKIVRTEIGVLLRLSHPNIIKLKEIFETPTE 122
Query: 573 MILVYEYMANGPL------RSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIH 626
+ LV E + G L + + D KQ LE + YLH I+H
Sbjct: 123 ISLVLELVTGGELFDRIVEKGYYSERDAADA-VKQILE-------AVAYLH---ENGIVH 171
Query: 627 RDVKTTNILL---DDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLT 683
RD+K N+L + K+ADFGLSK ++ + V G+ GY PE R
Sbjct: 172 RDLKPENLLYATPAPDAPLKIADFGLSKI---VEHQVLMKTVCGTPGYCAPEILRGCAYG 228
Query: 684 EKSDVYSFGVVLMEVLCTRP 703
+ D++S G++ +LC
Sbjct: 229 PEVDMWSVGIITYILLCGFE 248
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-25
Identities = 59/200 (29%), Positives = 84/200 (42%), Gaps = 15/200 (7%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGY 566
LG G FG V K + AVK N + + E+E+L KL H +++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 567 CDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIH 626
++ S +V E G L + S I G+ Y+H +I+H
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMH---KHNIVH 144
Query: 627 RDVKTTNILL---DDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLT 683
RD+K NILL + + K+ DFGLS Q G+ Y+ PE R
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTC---FQQNTKMKDRIGTAYYIAPEVLRG-TYD 200
Query: 684 EKSDVYSFGVVLMEVLCTRP 703
EK DV+S GV+L +L P
Sbjct: 201 EKCDVWSAGVILYILLSGTP 220
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 39/214 (18%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVK-------RGNPRSEQGIAEFRTEIEMLSKLRHRHL 560
LLG G +G+V + + + AVK R P E + + EI++L +LRH+++
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANV---KKEIQLLRRLRHKNV 68
Query: 561 VSL--IGYCDERSEMILVYEYMANGP--LRSHLYGTDLPPLSWKQRLEICIGAAR----- 611
+ L + Y +E+ +M +V EY G + + ++R +C A
Sbjct: 69 IQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVP---------EKRFPVC--QAHGYFCQ 117
Query: 612 ---GLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGS 668
GL YLH +Q I+H+D+K N+LL K++ G+++ +GS
Sbjct: 118 LIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGS 174
Query: 669 FGYLDPEYFRRQQLTE--KSDVYSFGVVLMEVLC 700
+ PE K D++S GV L +
Sbjct: 175 PAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITT 208
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 37/200 (18%), Positives = 79/200 (39%), Gaps = 23/200 (11%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCD 568
LG G FG V++ K + + EI +L+ RHR+++ L +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFE 71
Query: 569 ERSEMILVYEYMANGPL------RSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQ 622
E+++++E+++ + + Q E L +LH +
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE-------ALQFLH---SH 121
Query: 623 SIIHRDVKTTNILL--DDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQ 680
+I H D++ NI+ + K+ +FG ++ L + + Y PE +
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ---LKPGDNFRLLFTAPEYYAPEVHQHD 178
Query: 681 QLTEKSDVYSFGVVLMEVLC 700
++ +D++S G ++ +L
Sbjct: 179 VVSTATDMWSLGTLVYVLLS 198
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 52/217 (23%), Positives = 85/217 (39%), Gaps = 37/217 (17%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVK---------RGNPRSEQGIAEFRTEIEMLSKL-RHR 558
LG G V + + AVK ++ E+++L K+ H
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 559 HLVSLIGYCDERSEMILVYEYMANGPL------RSHLYGTDLPPLSWKQRLEICIGAARG 612
+++ L + + LV++ M G L + L + + + LE
Sbjct: 85 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI-MRALLE-------V 136
Query: 613 LHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYL 672
+ LH +I+HRD+K NILLDD+ K+ DFG S LD V G+ YL
Sbjct: 137 ICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ---LDPGEKLREVCGTPSYL 190
Query: 673 DPE------YFRRQQLTEKSDVYSFGVVLMEVLCTRP 703
PE ++ D++S GV++ +L P
Sbjct: 191 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 227
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 2e-25
Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 12/206 (5%)
Query: 510 LGVGGFGRVYKGTL-DDGTKVAVK--RGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGY 566
LG G G V+K + G +A K + E+++L + ++V G
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGA 99
Query: 567 CDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIH 626
E+ + E+M G L + + + ++ I +GL YL I+H
Sbjct: 100 FYSDGEISICMEHMDGGSL-DQVLKK-AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMH 155
Query: 627 RDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 686
RDVK +NIL++ K+ DFG+S L + ++ V G+ Y+ PE + + +S
Sbjct: 156 RDVKPSNILVNSRGEIKLCDFGVSGQ---LIDSMANSFV-GTRSYMSPERLQGTHYSVQS 211
Query: 687 DVYSFGVVLMEVLCTRPALNPVLPRE 712
D++S G+ L+E+ R + P +E
Sbjct: 212 DIWSMGLSLVEMAVGRYPIPPPDAKE 237
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 51/245 (20%), Positives = 84/245 (34%), Gaps = 55/245 (22%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVK-----RGNPRSEQGIAEFRTEIEMLSKLRHRHLVSL 563
+G G +G V A+K + + + + +TE+ ++ KL H ++ L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 564 IGYCDERSEMILVYEYMANGPL------RSHLYGTDLPPLSWKQRLEICIG--------- 608
++ + LV E G L K ++ C
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 609 ----------------AAR-------GLHYLHTGAAQSIIHRDVKTTNILL--DDNFVAK 643
+ LHYLH Q I HRD+K N L + +F K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIK 210
Query: 644 VADFGLSK---TGPALDQTHVSTAVKGSFGYLDPEYFR--RQQLTEKSDVYSFGVVLMEV 698
+ DFGLSK + ++T G+ ++ PE + K D +S GV+L +
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269
Query: 699 LCTRP 703
L
Sbjct: 270 LMGAV 274
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 53/206 (25%), Positives = 90/206 (43%), Gaps = 34/206 (16%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVK-----RGNPRSEQGIAEFRTEIEMLSKLRHRHLVSL 563
+G G F +V + G +VA+K + NP S Q + E+ ++ L H ++V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKL---FREVRIMKILNHPNIVKL 79
Query: 564 IGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAAR--------GLHY 615
+ + L+ EY + G + +L R++ AR + Y
Sbjct: 80 FEVIETEKTLYLIMEYASGGEVFDYL--------VAHGRMKE--KEARSKFRQIVSAVQY 129
Query: 616 LHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPE 675
H + I+HRD+K N+LLD + K+ADFG S + G+ Y PE
Sbjct: 130 CH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNE--FTVGGKLDAFC-GAPPYAAPE 183
Query: 676 YFRRQQLT-EKSDVYSFGVVLMEVLC 700
F+ ++ + DV+S GV+L ++
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVS 209
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 54/200 (27%), Positives = 86/200 (43%), Gaps = 27/200 (13%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVK--RGNPRSEQGIAEFRTEIEMLSKLRHR-HLVSLIG 565
LG G F V + G + A K + R + AE EI +L + +++L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 566 YCDERSEMILVYEYMANGPLRSHLYGTDLPPLS-------WKQRLEICIGAARGLHYLHT 618
+ SE+IL+ EY A G + S +S KQ LE G++YLH
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILE-------GVYYLHQ 149
Query: 619 GAAQSIIHRDVKTTNILL---DDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPE 675
+I+H D+K NILL K+ DFG+S+ + + G+ YL PE
Sbjct: 150 ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK---IGHACELREIMGTPEYLAPE 203
Query: 676 YFRRQQLTEKSDVYSFGVVL 695
+T +D+++ G++
Sbjct: 204 ILNYDPITTATDMWNIGIIA 223
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-25
Identities = 47/206 (22%), Positives = 80/206 (38%), Gaps = 25/206 (12%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGY 566
LG G F V + + G + A N + S + + E + L+H ++V L
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 567 CDERSEMILVYEYMANGPL------RSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGA 620
E L+++ + G L R + S + + H
Sbjct: 79 ISEEGHHYLIFDLVTGGELFEDIVAREYY--------SEADASHCIQQILEAVLHCHQ-- 128
Query: 621 AQSIIHRDVKTTNILL---DDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYF 677
++HR++K N+LL K+ADFGL+ +Q G+ GYL PE
Sbjct: 129 -MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG-EQQAWFGFA-GTPGYLSPEVL 185
Query: 678 RRQQLTEKSDVYSFGVVLMEVLCTRP 703
R+ + D+++ GV+L +L P
Sbjct: 186 RKDPYGKPVDLWACGVILYILLVGYP 211
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 54/204 (26%), Positives = 86/204 (42%), Gaps = 26/204 (12%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAE-FRTEIEMLSKLRHRHLVSLIGY 566
LG G +G V VAVK + + E + EI + L H ++V G+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 567 CDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAAR--------GLHYLHT 618
E + L EY + G L + + A+ G+ YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRI--------EPDIGMPE--PDAQRFFHQLMAGVVYLH- 122
Query: 619 GAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHV-STAVKGSFGYLDPEYF 677
I HRD+K N+LLD+ K++DFGL+ ++ + + G+ Y+ PE
Sbjct: 123 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELL 179
Query: 678 RRQQLT-EKSDVYSFGVVLMEVLC 700
+R++ E DV+S G+VL +L
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLA 203
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 56/247 (22%), Positives = 89/247 (36%), Gaps = 34/247 (13%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLR-HRHLVSLIGY 566
+LG G RV L + AVK + + E+EML + + HR+++ LI +
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 567 CDERSEMILVYEYMANGPL------RSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGA 620
+E LV+E M G + R H + + + A L +LH
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSHIHKRRHF--------NELEASVVVQDVASALDFLHN-- 129
Query: 621 AQSIIHRDVKTTNILL---DDNFVAKVADFGLSK------TGPALDQTHVSTAVKGSFGY 671
+ I HRD+K NIL + K+ DF L + + T GS Y
Sbjct: 130 -KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-GSAEY 187
Query: 672 LDPEYFRRQQLTEKS-----DVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKK 726
+ PE D++S GV+L +L P + A +
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN 247
Query: 727 GMLDQIM 733
+ + I
Sbjct: 248 MLFESIQ 254
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 54/204 (26%), Positives = 86/204 (42%), Gaps = 26/204 (12%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAE-FRTEIEMLSKLRHRHLVSLIGY 566
LG G +G V VAVK + + E + EI + L H ++V G+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 567 CDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAAR--------GLHYLHT 618
E + L EY + G L + + A+ G+ YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRI--------EPDIGMPE--PDAQRFFHQLMAGVVYLH- 122
Query: 619 GAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHV-STAVKGSFGYLDPEYF 677
I HRD+K N+LLD+ K++DFGL+ ++ + + G+ Y+ PE
Sbjct: 123 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELL 179
Query: 678 RRQQLT-EKSDVYSFGVVLMEVLC 700
+R++ E DV+S G+VL +L
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLA 203
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 66/208 (31%), Positives = 95/208 (45%), Gaps = 35/208 (16%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVK---RGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLI 564
LGVG FG+V G G KVAVK R RS + + + EI+ L RH H++ L
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 565 GYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAAR--------GLHYL 616
++ +V EY++ G L ++ R+E AR + Y
Sbjct: 78 QVISTPTDFFMVMEYVSGGELFDYI--------CKHGRVEE--MEARRLFQQILSAVDYC 127
Query: 617 HTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLS---KTGPALDQTHVSTAVKGSFGYLD 673
H ++HRD+K N+LLD + AK+ADFGLS G L T+ GS Y
Sbjct: 128 H---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR-----TSC-GSPNYAA 178
Query: 674 PEYFRRQQLT-EKSDVYSFGVVLMEVLC 700
PE + + D++S GV+L +LC
Sbjct: 179 PEVISGRLYAGPEVDIWSCGVILYALLC 206
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 50/205 (24%), Positives = 79/205 (38%), Gaps = 27/205 (13%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLR-HRHLVSLIGYC 567
LG G F K AVK + R E + EI L H ++V L
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANT---QKEITALKLCEGHPNIVKLHEVF 75
Query: 568 DERSEMILVYEYMANGPL------RSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAA 621
++ LV E + G L + H S + I + ++H
Sbjct: 76 HDQLHTFLVMELLNGGELFERIKKKKHF--------SETEASYIMRKLVSAVSHMHD--- 124
Query: 622 QSIIHRDVKTTNILL---DDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFR 678
++HRD+K N+L +DN K+ DFG ++ P +Q + T + Y PE
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-LKTPC-FTLHYAAPELLN 182
Query: 679 RQQLTEKSDVYSFGVVLMEVLCTRP 703
+ E D++S GV+L +L +
Sbjct: 183 QNGYDESCDLWSLGVILYTMLSGQV 207
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 108 bits (269), Expect = 5e-24
Identities = 95/557 (17%), Positives = 172/557 (30%), Gaps = 161/557 (28%)
Query: 325 YINDDIAQPSVDLSTLTNGLNVPYYKDFVCNASADSNTLTVSVGPDSVADFTNATMNGLE 384
Y DI D + +F C V D + ++ E
Sbjct: 16 YQYKDILSVFED----------AFVDNFDCK---------------DVQDMPKSILSKEE 50
Query: 385 VMKISNEARSLDGLSSVEGLLPDKPSNKNKIGIIVGSVVGAVAAVALIGVCYCWLLARKS 444
+ I ++ G + L K +V V V + Y +L++
Sbjct: 51 IDHIIMSKDAVSGTLRLFWTLLSKQEE------MVQKFVEEVLRIN-----YKFLMSPIK 99
Query: 445 KTPQQGHPWLPLPLYGNSQTMTKMSTTSQKSGTASCISLASSNLGRLFMFQEILDATNKF 504
+Q P + +Y + ++ +Q A N+ RL + ++ A +
Sbjct: 100 TEQRQ--PSMMTRMY--IEQRDRLYNDNQV--------FAKYNVSRLQPYLKLRQALLEL 147
Query: 505 DES---LLLGVGGFGRVYKGTL------DDGTKVA-------VKRGNPRSEQGIAEFRTE 548
+ L+ GV G G K + + + N S + +
Sbjct: 148 RPAKNVLIDGVLGSG---KTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETV------ 198
Query: 549 IEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIG 608
+EML KL ++ + D + +N LR H S + L +
Sbjct: 199 LEMLQKLLYQIDPNWTSRSD----------HSSNIKLRIH---------SIQAELRRLLK 239
Query: 609 AARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGS 668
+ + L ++ +V+ + F + K L ++T K
Sbjct: 240 SKPYENCL-------LVLLNVQNAKAW--NAF-----NLS-CKI---L----LTTRFKQV 277
Query: 669 FGYLDPEYFRRQQLTEKSDVYSFG---VVLMEVLCTRPALNPVLPRE--QVN------IA 717
+L L S + +L++ L RP LPRE N IA
Sbjct: 278 TDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQD---LPREVLTTNPRRLSIIA 334
Query: 718 E----WAMTWQ-------KKGMLDQIMDSNLVGKVNPASLKK-FGETAEKCLA--EHGVD 763
E TW K L I++S+L + PA +K F L+
Sbjct: 335 ESIRDGLATWDNWKHVNCDK--LTTIIESSL-NVLEPAEYRKMF-----DRLSVFPPSAH 386
Query: 764 RPSMG-DVLW-NLEYA-----LQLEETSSALMEPEDNSTNHIPCIQLTPLEPFDNSVSM- 815
P++ ++W ++ + + S + + ST IP I L +N ++
Sbjct: 387 IPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALH 446
Query: 816 ---IDVRNSGTDDDGED 829
+D N D +D
Sbjct: 447 RSIVDHYNIPKTFDSDD 463
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 55.2 bits (132), Expect = 8e-08
Identities = 94/706 (13%), Positives = 171/706 (24%), Gaps = 227/706 (32%)
Query: 89 FSAAAFYKFEIEH--KGRH---WVRLYFYTLPGSNQHLNSASFTVATDKFV--LLSNFTF 141
+ K EI+H + F+TL L+ V KFV +L
Sbjct: 41 MPKSILSKEEIDHIIMSKDAVSGTLRLFWTL------LSKQEEMV--QKFVEEVLR---- 88
Query: 142 KNYNSSFMFKEYAINVNSDALTLTFIPSNNSVAFVNAIEVVSVPDAIF-------PDQAL 194
NY F+ PS + ++ + + + +F L
Sbjct: 89 INYK--FLMSPIKTEQRQ--------PSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYL 138
Query: 195 ALEPSASFSGLSDLGFETVYRLNMGGPLITAQNDTLGRTWENDETYLHVNSSAVNVSVRP 254
L + L + + G G+TW
Sbjct: 139 KLR--QALLELRPAKNVLID--GVLG---------SGKTW-------------------- 165
Query: 255 SAIRYTASVTAETAPNWVYATAEMMGDANVPEVNFNITWVLPVEPNFTYFVRVHLCDIAS 314
V + + Y M +F I W+ N C+
Sbjct: 166 --------VALDVCLS--YKVQCKM--------DFKIFWL-----NLKN------CNSPE 196
Query: 315 LSMNNLVFNLYIN---------DDIAQPSVDLSTLTNGLNV-----PYYK-----DFVCN 355
+ L L D + + + ++ L PY V N
Sbjct: 197 TVLEMLQ-KLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQN 255
Query: 356 ASA------DSNTLTVSVGPDSVADFTNATMNGLEVMKISN----EARSLDGLSSVEGLL 405
A A L ++ V DF +A + + L
Sbjct: 256 AKAWNAFNLSCKIL-LTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCR 314
Query: 406 PDK-PSNKNKIGIIVGSVVGAVAAVALIGVCYCWLLARKSKTPQQGHPWLPLPLYGNSQT 464
P P +++I W +
Sbjct: 315 PQDLPREVLTTNPR---------RLSIIA-------ESIRDGLAT---WDNWKHVNCDKL 355
Query: 465 MTKMSTTSQKSGTASCISLASSNLGR-----LFMFQEILDATNKFDESLLLGVGGFGRVY 519
T + S +++ R L +F A LL ++
Sbjct: 356 TTIIE---------SSLNVLEPAEYRKMFDRLSVFPP--SA--HIPTILL------SLIW 396
Query: 520 KGTLDDGTKVAVKRGNPRS--EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEM--IL 575
+ V V + + S E+ E I + L + + +
Sbjct: 397 FDVIKSDVMVVVNKLHKYSLVEKQPKESTISI-------PSIYLELKVKLENEYALHRSI 449
Query: 576 VYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYL--HTGAAQSIIHRDVKTTN 633
V Y + DL P Q ++ H + R
Sbjct: 450 VDHY----NIPKTFDSDDLIPPYLDQYF---------YSHIGHHLKNIEHP-ERMTLFRM 495
Query: 634 ILLDDNFV-AKVADFGLSKTGPALDQTHVSTAVKGSFGYLD-----PEYFRRQQLTEKSD 687
+ LD F+ K+ H STA S L+ Y + + +
Sbjct: 496 VFLDFRFLEQKI--------------RHDSTAWNASGSILNTLQQLKFY--KPYICDNDP 539
Query: 688 VYSFGV-VLMEVLCTRPALNPVLPR-EQVNIAEWAMTWQKKGMLDQ 731
Y V +++ L P + L + ++ A+ + + + ++
Sbjct: 540 KYERLVNAILDFL---PKIEENLICSKYTDLLRIALMAEDEAIFEE 582
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.5 bits (125), Expect = 5e-07
Identities = 64/429 (14%), Positives = 128/429 (29%), Gaps = 107/429 (24%)
Query: 23 CHKSCVAFTPVDNYLIACGSSQKV---TFQARTYVPDTEHSSLSMKSGNSTTASSNSSAP 79
K+ VA +Y + C K+ + ++ + L M N ++
Sbjct: 161 SGKTWVALDVCLSYKVQCKMDFKIFWLNLKNC----NSPETVLEMLQKLLYQIDPNWTSR 216
Query: 80 SPIYQSARIFSAAAFYKFEIEHKGRHWVRLYFYTLPGSNQHLNSASFTVATDKFVLLSNF 139
S + K I H + +R S + N LL
Sbjct: 217 SDHSSN---------IKLRI-HSIQAELRRLLK----SKPYENC-----------LL--- 248
Query: 140 TFKNYNSSFMFKEYAINVNSDALTLTFIPSNNSVA-FVNA-----IEVVSVPDAIFPDQA 193
N ++ + A N++ L T V F++A I + + PD+
Sbjct: 249 VLLNVQNAKAWN--AFNLSCKILLTT---RFKQVTDFLSAATTTHISLDHHSMTLTPDEV 303
Query: 194 LALEPSASFSGLS--DLGFETVYRLNMGGPL----ITAQNDTLGRTWENDETYLHVNSSA 247
+L + DL E + P I TW+N + HVN
Sbjct: 304 KSL--LLKYLDCRPQDLPREVL----TTNPRRLSIIAESIRDGLATWDN---WKHVNCDK 354
Query: 248 VNVSVRPSAIRYTASVTAETAPNWVYATAEMMG----DANVPEVNFNITWVLPVEPNFTY 303
+ + I +S+ P + + A++P + ++ W ++
Sbjct: 355 LT-----TIIE--SSLNVLE-PAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIK----S 402
Query: 304 FVRVHLCDIASLSM---NNLVFNLYIND---DIAQPSVDLSTLTNGLNVPYYKDFVCNAS 357
V V + + S+ + I ++ + L + V +Y
Sbjct: 403 DVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSI-VDHYNIPKT--- 458
Query: 358 ADSNTLTVS---------VG--------PDSVADFTNATMNGLEVM--KISNEARSLDGL 398
DS+ L +G P+ + F ++ + KI +++ + +
Sbjct: 459 FDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLD-FRFLEQKIRHDSTAWNAS 517
Query: 399 SSVEGLLPD 407
S+ L
Sbjct: 518 GSILNTLQQ 526
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-24
Identities = 47/212 (22%), Positives = 84/212 (39%), Gaps = 39/212 (18%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVK--------RGNPRSEQGIAEFRTEIEMLSKLRHRHL 560
LG G FG V+ + +V VK + + + EI +LS++ H ++
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 561 VSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAAR--------G 612
+ ++ + + LV E +G L+ + RL+ A
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSG---LDLF--AF--IDRHPRLDE--PLASYIFRQLVSA 142
Query: 613 LHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLS---KTGPALDQTHVSTAVKGSF 669
+ YL + IIHRD+K NI++ ++F K+ DFG + + G T G+
Sbjct: 143 VGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFY-----TFC-GTI 193
Query: 670 GYLDPEYFRRQQLT-EKSDVYSFGVVLMEVLC 700
Y PE + +++S GV L ++
Sbjct: 194 EYCAPEVLMGNPYRGPELEMWSLGVTLYTLVF 225
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 57/232 (24%), Positives = 92/232 (39%), Gaps = 56/232 (24%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVK---------------RGNPRSEQGIAEFRT----- 547
+G G +G V +D T A+K R PR +
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 548 ------EIEMLSKLRHRHLVSLIGYCD--ERSEMILVYEYMANGPLRSHLYGTDLPPLSW 599
EI +L KL H ++V L+ D + +V+E + GP+ ++P
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV------MEVPT--- 130
Query: 600 KQRLEICIGAAR--------GLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSK 651
+ L AR G+ YLH Q IIHRD+K +N+L+ ++ K+ADFG+S
Sbjct: 131 LKPLSE--DQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSN 185
Query: 652 TGPALDQTHVSTAVKGSFGYLDPEYFRRQQLT---EKSDVYSFGVVLMEVLC 700
+S V G+ ++ PE + + DV++ GV L +
Sbjct: 186 E-FKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF 235
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 52/216 (24%), Positives = 87/216 (40%), Gaps = 45/216 (20%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVK---------RGNPRSEQGIAEFRTEIEMLSKLRHR 558
LLG GGFG VY G + D VA+K G + + E+ +L K+
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV---PMEVVLLKKVSSG 106
Query: 559 --HLVSLIGYCDERSEMILVYEYMAN-GPLRSHLYGTDLPPLSWKQRL-EICIGAAR--- 611
++ L+ + + +L+ E L + + + L E AR
Sbjct: 107 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI--------TERGALQE---ELARSFF 155
Query: 612 -----GLHYLHTGAAQSIIHRDVKTTNILLDDNFV-AKVADFGLSKTGPALDQTHVSTAV 665
+ + H ++HRD+K NIL+D N K+ DFG L T +
Sbjct: 156 WQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL---LKDTVYTDFD 209
Query: 666 KGSFGYLDPEYFRRQQLT-EKSDVYSFGVVLMEVLC 700
G+ Y PE+ R + + V+S G++L +++C
Sbjct: 210 -GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC 244
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 47/206 (22%), Positives = 85/206 (41%), Gaps = 29/206 (14%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKL-RHRHLVSLIGYC 567
+GVG + + + AVK + EIE+L + +H ++++L
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP----TEEIEILLRYGQHPNIITLKDVY 85
Query: 568 DERSEMILVYEYMANGPL------RSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAA 621
D+ + +V E M G L + S ++ + + + YLH A
Sbjct: 86 DDGKYVYVVTELMKGGELLDKILRQKFF--------SEREASAVLFTITKTVEYLH---A 134
Query: 622 QSIIHRDVKTTNILL----DDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYF 677
Q ++HRD+K +NIL + ++ DFG +K A + + T + ++ PE
Sbjct: 135 QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA-ENGLLMTPC-YTANFVAPEVL 192
Query: 678 RRQQLTEKSDVYSFGVVLMEVLCTRP 703
RQ D++S GV+L +L
Sbjct: 193 ERQGYDAACDIWSLGVLLYTMLTGYT 218
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 57/216 (26%), Positives = 94/216 (43%), Gaps = 43/216 (19%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVK-------RGNPRSEQGIAEFRTEIEMLSKLR---- 556
LLG GGFG V+ G L D +VA+K G + E+ +L K+
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL-EVALLWKVGAGGG 96
Query: 557 HRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRL-EICIGAAR---- 611
H ++ L+ + + + +LV E L+ D ++ K L E G +R
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPA---QDLF--DY--ITEKGPLGE---GPSRCFFG 146
Query: 612 ----GLHYLHTGAAQSIIHRDVKTTNILLD-DNFVAKVADFGLSKTGPALDQ-THVSTAV 665
+ + H+ + ++HRD+K NIL+D AK+ DFG AL +
Sbjct: 147 QVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSG----ALLHDEPYTDFD 199
Query: 666 KGSFGYLDPEYFRRQQLT-EKSDVYSFGVVLMEVLC 700
G+ Y PE+ R Q + V+S G++L +++C
Sbjct: 200 -GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVC 234
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 63/205 (30%), Positives = 89/205 (43%), Gaps = 30/205 (14%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVK---RGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLI 564
LG G FG+V T KVA+K R + EI L LRH H++ L
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 565 GYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAAR--------GLHYL 616
+++++V EY A G L ++ K+R+ R + Y
Sbjct: 76 DVITTPTDIVMVIEY-AGGELFDYI--------VEKKRMTE--DEGRRFFQQIICAIEYC 124
Query: 617 HTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEY 676
H I+HRD+K N+LLDDN K+ADFGLS D + T+ GS Y PE
Sbjct: 125 H---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT--DGNFLKTSC-GSPNYAAPEV 178
Query: 677 FRRQQLT-EKSDVYSFGVVLMEVLC 700
+ + DV+S G+VL +L
Sbjct: 179 INGKLYAGPEVDVWSCGIVLYVMLV 203
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-23
Identities = 68/208 (32%), Positives = 97/208 (46%), Gaps = 35/208 (16%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVK---RGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLI 564
LGVG FG+V G G KVAVK R RS + + R EI+ L RH H++ L
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 565 GYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAAR--------GLHYL 616
S++ +V EY++ G L ++ RL+ +R G+ Y
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYI--------CKNGRLDE--KESRRLFQQILSGVDYC 132
Query: 617 HTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLS---KTGPALDQTHVSTAVKGSFGYLD 673
H ++HRD+K N+LLD + AK+ADFGLS G L T+ GS Y
Sbjct: 133 H---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR-----TSC-GSPNYAA 183
Query: 674 PEYFRRQQLT-EKSDVYSFGVVLMEVLC 700
PE + + D++S GV+L +LC
Sbjct: 184 PEVISGRLYAGPEVDIWSSGVILYALLC 211
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 8e-23
Identities = 48/204 (23%), Positives = 87/204 (42%), Gaps = 21/204 (10%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKL-RHRHLVSLIGY 566
+LG+G G+V + G K A+K + R E++ + H+V ++
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDV 90
Query: 567 CDERSEMI----LVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQ 622
+ ++ E M G L S + + ++ EI + +LH +
Sbjct: 91 YENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SH 147
Query: 623 SIIHRDVKTTNILL---DDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRR 679
+I HRDVK N+L + + V K+ DFG +K Q + T + Y+ PE
Sbjct: 148 NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE---TTQNALQTPC-YTPYYVAPEVLGP 203
Query: 680 QQLTEKSDVYSFGVVLMEVLCTRP 703
++ + D++S GV++ +LC P
Sbjct: 204 EKYDKSCDMWSLGVIMYILLCGFP 227
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-22
Identities = 56/207 (27%), Positives = 83/207 (40%), Gaps = 35/207 (16%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVK---RGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLI 564
+G G FG VAVK RG E + EI LRH ++V
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN----VQREIINHRSLRHPNIVRFK 82
Query: 565 GYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAAR--------GLHYL 616
+ + ++ EY + G L + R AR G+ Y
Sbjct: 83 EVILTPTHLAIIMEYASGGELYERI--------CNAGRFSE--DEARFFFQQLLSGVSYC 132
Query: 617 HTGAAQSIIHRDVKTTNILLDDNFVA--KVADFGLSKTGPALDQTHVSTAVKGSFGYLDP 674
H + I HRD+K N LLD + K+ DFG SK+ ++ + + V G+ Y+ P
Sbjct: 133 H---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS--SVLHSQPKSTV-GTPAYIAP 186
Query: 675 EYFRRQQLT-EKSDVYSFGVVLMEVLC 700
E RQ+ + +DV+S GV L +L
Sbjct: 187 EVLLRQEYDGKIADVWSCGVTLYVMLV 213
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 50/198 (25%), Positives = 86/198 (43%), Gaps = 14/198 (7%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVKRGNP-RSEQGIAEFRTEIE-MLSKLRHRHLVSLIGY 566
+G G +G V K G +AVKR E+ + +++ ++ ++V G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 567 CDERSEMILVYEYMANGPLR--SHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSI 624
+ + E M+ + ++Y + + +I + + L++L I
Sbjct: 90 LFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE--NLKI 147
Query: 625 IHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPE----YFRRQ 680
IHRD+K +NILLD + K+ DFG+S L + T G Y+ PE RQ
Sbjct: 148 IHRDIKPSNILLDRSGNIKLCDFGISGQ---LVDSIAKTRDAGCRPYMAPERIDPSASRQ 204
Query: 681 QLTEKSDVYSFGVVLMEV 698
+SDV+S G+ L E+
Sbjct: 205 GYDVRSDVWSLGITLYEL 222
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 3e-22
Identities = 36/174 (20%), Positives = 66/174 (37%), Gaps = 14/174 (8%)
Query: 538 SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHL-YGTDLPP 596
S + +I + ++ V + + + + + L+ + L
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160
Query: 597 LSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSK----- 651
L I I A + +LH ++ ++HRD+K +NI + V KV DFGL
Sbjct: 161 REHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217
Query: 652 -----TGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC 700
+ T G+ Y+ PE + K D++S G++L E+L
Sbjct: 218 EEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY 271
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 4e-22
Identities = 47/209 (22%), Positives = 88/209 (42%), Gaps = 15/209 (7%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVKRGNP-RSEQGIAEFRTEIEMLSKL-RHRHLVSLIGY 566
+G G G+V+K G +AVK+ +++ +++++ K ++V G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 567 CDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIH 626
+++ + E M + L P+ + ++ + + L+YL +IH
Sbjct: 93 FITNTDVFIAMELMGTCAEK--LKKRMQGPIPERILGKMTVAIVKALYYLKE--KHGVIH 148
Query: 627 RDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTE-- 684
RDVK +NILLD+ K+ DFG+S L G Y+ PE T+
Sbjct: 149 RDVKPSNILLDERGQIKLCDFGISGR---LVDDKAKDRSAGCAAYMAPERIDPPDPTKPD 205
Query: 685 ---KSDVYSFGVVLMEVLCTRPALNPVLP 710
++DV+S G+ L+E+ +
Sbjct: 206 YDIRADVWSLGISLVELATGQFPYKNCKT 234
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 7e-22
Identities = 46/197 (23%), Positives = 85/197 (43%), Gaps = 13/197 (6%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVKRGNP-RSEQGIAEFRTEIEM-LSKLRHRHLVSLIGY 566
LG G +G V K + G +AVKR + Q ++++ + + V+ G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 567 CDERSEMILVYEYMANGPLRSHLYGTDLP-PLSWKQRLEICIGAARGLHYLHTGAAQSII 625
++ + E M + + D + +I + + L +LH+ S+I
Sbjct: 75 LFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS--KLSVI 132
Query: 626 HRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPE----YFRRQQ 681
HRDVK +N+L++ K+ DFG+S L G Y+ PE ++
Sbjct: 133 HRDVKPSNVLINALGQVKMCDFGISGY---LVDDVAKDIDAGCKPYMAPERINPELNQKG 189
Query: 682 LTEKSDVYSFGVVLMEV 698
+ KSD++S G+ ++E+
Sbjct: 190 YSVKSDIWSLGITMIEL 206
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 9e-22
Identities = 60/216 (27%), Positives = 102/216 (47%), Gaps = 27/216 (12%)
Query: 502 NKFDESLLLGVGGFGRVY----KGTLDDGTKVAVK---RGNPRSEQGIAEFRTEIEMLSK 554
+ F + +LG GGFG V+ K T G A K + + +G E ++L+K
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKAT---GKLYACKKLNKKRLKKRKGYQGAMVEKKILAK 241
Query: 555 LRHRHLVSLIGYCDE-RSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRL------EICI 607
+ R +VSL Y E ++++ LV M G +R H+Y D +++ +I
Sbjct: 242 VHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS 300
Query: 608 GAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKG 667
G L +LH ++II+RD+K N+LLDD+ +++D GL+ A G
Sbjct: 301 G----LEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYA-G 351
Query: 668 SFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRP 703
+ G++ PE ++ D ++ GV L E++ R
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARG 387
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 3e-21
Identities = 28/265 (10%), Positives = 68/265 (25%), Gaps = 56/265 (21%)
Query: 509 LLGVGGFGRVYKGTLDD--GTKVAVK---RGNPRSEQGIAEFRTEIEMLSKLRHRHLVSL 563
G + ++ D +VA+ + + E + LS++ + +
Sbjct: 38 FHGGVPPLQFWQAL-DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 564 IGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQS 623
+ R+ ++V E++ G L+ + P + A H
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPV----GAIRAMQSLAAAADAAH---RAG 149
Query: 624 IIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLT 683
+ + + + + +A +
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYPA----------------------TMPDA-------N 180
Query: 684 EKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLV--GKV 741
+ D+ G L +L R L R + AE + + +
Sbjct: 181 PQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE------------RDTAGQPIEPADI 228
Query: 742 NPASLKKFGETAEKCLAEHGVDRPS 766
+ + A + + G R +
Sbjct: 229 DRDIPFQISAVAARSVQGDGGIRSA 253
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 4e-21
Identities = 63/214 (29%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 502 NKFDESLLLGVGGFGRVY----KGTLDDGTKVAVK---RGNPRSEQGIAEFRTEIEMLSK 554
N F + +LG GGFG V + T G A K + + +G A E ++L K
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRAT---GKMYACKKLEKKRIKKRKGEAMALNEKQILEK 240
Query: 555 LRHRHLVSLIGYCDERSEMI-LVYEYMANGPLRSHLYGTDLPPLSWKQRL----EICIGA 609
+ R +VSL Y E + + LV M G L+ H+Y + + EIC G
Sbjct: 241 VNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCG- 298
Query: 610 ARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSF 669
L LH + I++RD+K NILLDD+ +++D GL+ P V G+
Sbjct: 299 ---LEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK--GRV-GTV 349
Query: 670 GYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRP 703
GY+ PE + ++ T D ++ G +L E++ +
Sbjct: 350 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 383
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 7e-20
Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 26/206 (12%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKL-RHRHLVSLIGYC 567
LG+G G+V + K A+K Q + R E+E+ + + H+V ++
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALK-----MLQDCPKARREVELHWRASQCPHIVRIVDVY 124
Query: 568 DE----RSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQS 623
+ R +++V E + G L S + + ++ EI + YLH+ +
Sbjct: 125 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---IN 181
Query: 624 IIHRDVKTTNILL---DDNFVAKVADFGLSK---TGPALDQTHVSTAVKGSFGYLDPEYF 677
I HRDVK N+L N + K+ DFG +K + +L T T Y+ PE
Sbjct: 182 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL-TTPCYTP-----YYVAPEVL 235
Query: 678 RRQQLTEKSDVYSFGVVLMEVLCTRP 703
++ + D++S GV++ +LC P
Sbjct: 236 GPEKYDKSCDMWSLGVIMYILLCGYP 261
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 9e-20
Identities = 49/166 (29%), Positives = 78/166 (46%), Gaps = 23/166 (13%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRT--EIEMLSKLRHRHLVSLIGY 566
+G G +G V+K D G VA+K+ + + + EI ML +L+H +LV+L+
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 567 CDERSEMILVYEYMANGPLRSHL--YGTDLPPLSWK----QRLEICIGAARGLHYLHTGA 620
+ + LV+EY + + L Y +P K Q L + +++ H
Sbjct: 71 FRRKRRLHLVFEYC-DHTVLHELDRYQRGVPEHLVKSITWQTL-------QAVNFCH--- 119
Query: 621 AQSIIHRDVKTTNILLDDNFVAKVADFGL--SKTGPALDQTH-VST 663
+ IHRDVK NIL+ + V K+ DFG TGP+ V+T
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVAT 165
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 1e-19
Identities = 55/222 (24%), Positives = 96/222 (43%), Gaps = 41/222 (18%)
Query: 502 NKFDESLLLGVGGFGRVYKGTLDDGTKV-AVK---RGNPRSEQGIAEFRTEIEMLSKL-- 555
N F ++G GGFG VY D K+ A+K + + +QG E MLS +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 556 -RHRHLVSLIGYCDE-RSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRL---------- 603
+V + Y ++ + + M G L HL + +
Sbjct: 249 GDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLS---------QHGVFSEADMRFYA 298
Query: 604 -EICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVS 662
EI +G L ++H + +++RD+K NILLD++ +++D GL+ + H
Sbjct: 299 AEIILG----LEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPH-- 348
Query: 663 TAVKGSFGYLDPEYFRRQQLTEKS-DVYSFGVVLMEVLCTRP 703
+V G+ GY+ PE ++ + S D +S G +L ++L
Sbjct: 349 ASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-19
Identities = 57/216 (26%), Positives = 88/216 (40%), Gaps = 43/216 (19%)
Query: 509 LLGVGGFGRVYKGTL-DDGT----KVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSL 563
+G G FG+V D K K+ + + E++++ L H LV+L
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNE-VRNVFKELQIMQGLEHPFLVNL 80
Query: 564 IGYC--DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRL-----------EICIGAA 610
Y DE +M +V + + G LR HL + E+ +
Sbjct: 81 W-YSFQDE-EDMFMVVDLLLGGDLRYHLQ---------QNVHFKEETVKLFICELVMA-- 127
Query: 611 RGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFG 670
L YL Q IIHRD+K NILLD++ + DF ++ P Q T + G+
Sbjct: 128 --LDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---TTMAGTKP 179
Query: 671 YLDPEYFRRQQLTE--KS-DVYSFGVVLMEVLCTRP 703
Y+ PE F ++ + D +S GV E+L R
Sbjct: 180 YMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 49/215 (22%), Positives = 85/215 (39%), Gaps = 31/215 (14%)
Query: 504 FDESLLLGVGGFGRVYKGTL-DDGTKVAVKRGNPRS---EQGIAEFRTEIEMLSKLRHRH 559
F +LG G F V + A+K R E + E +++S+L H
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 560 LVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRL-----------EICIG 608
V L + ++ Y NG L ++ K EI
Sbjct: 92 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---------KIGSFDETCTRFYTAEIVSA 142
Query: 609 AARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGS 668
L YLH + IIHRD+K NILL+++ ++ DFG +K + + + G+
Sbjct: 143 ----LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 195
Query: 669 FGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRP 703
Y+ PE + + SD+++ G ++ +++ P
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 230
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 6e-19
Identities = 44/148 (29%), Positives = 68/148 (45%), Gaps = 12/148 (8%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRT---EIEMLSKLRHRHLVSLIG 565
LG G + VYKG G VA+K SE+G T EI ++ +L+H ++V L
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTP--STAIREISLMKELKHENIVRLYD 70
Query: 566 YCDERSEMILVYEYMAN---GPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQ 622
+++ LV+E+M N + S G L +GL + H
Sbjct: 71 VIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---EN 127
Query: 623 SIIHRDVKTTNILLDDNFVAKVADFGLS 650
I+HRD+K N+L++ K+ DFGL+
Sbjct: 128 KILHRDLKPQNLLINKRGQLKLGDFGLA 155
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 6e-19
Identities = 38/162 (23%), Positives = 67/162 (41%), Gaps = 13/162 (8%)
Query: 542 IAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQ 601
+ + + + R L S+ S + + +++ L+ +
Sbjct: 135 FRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEH 194
Query: 602 RLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHV 661
+ A+G+ +L A++ IHRD+ NILL + V K+ DFGL++ D
Sbjct: 195 LICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-----DIYKD 246
Query: 662 STAVKGSFGYLD-----PEYFRRQQLTEKSDVYSFGVVLMEV 698
V+ L PE + T +SDV+SFGV+L E+
Sbjct: 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 288
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 29/151 (19%), Positives = 56/151 (37%), Gaps = 18/151 (11%)
Query: 510 LGVGGFGRVYKGTL------DDGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKL-RHRHLV 561
LG G FG+V + VAVK + +E+++L + H ++V
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 562 SLIGYC-DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGA 620
+L+G C ++++ E+ G L ++L +R E +G +
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYL---------RSKRNEFVPYKTKGARFRQGKD 140
Query: 621 AQSIIHRDVKTTNILLDDNFVAKVADFGLSK 651
I D+K + + + + F K
Sbjct: 141 YVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 7e-19
Identities = 46/166 (27%), Positives = 80/166 (48%), Gaps = 23/166 (13%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRT--EIEMLSKLRHRHLVSLIGY 566
+G G +G V K D G VA+K+ + + + EI++L +LRH +LV+L+
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 567 CDERSEMILVYEYMANGPLRSHL--YGTDLPPLSWK----QRLEICIGAARGLHYLHTGA 620
C ++ LV+E++ + + L + L + Q + G+ + H
Sbjct: 93 CKKKKRWYLVFEFVDHT-ILDDLELFPNGLDYQVVQKYLFQII-------NGIGFCH--- 141
Query: 621 AQSIIHRDVKTTNILLDDNFVAKVADFGLSKT--GPALDQTH-VST 663
+ +IIHRD+K NIL+ + V K+ DFG ++T P V+T
Sbjct: 142 SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVAT 187
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-18
Identities = 58/236 (24%), Positives = 104/236 (44%), Gaps = 50/236 (21%)
Query: 494 FQEILDATNKFDESLLLGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRT--EIE 550
++ D ++ +G G +G V + +VA+K+ +P Q + RT EI+
Sbjct: 19 RGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ-RTLREIK 77
Query: 551 MLSKLRHRHLVSLI-----GYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLE- 604
+L + RH +++ + ++ ++ +V + M TDL L Q L
Sbjct: 78 ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM----------ETDLYKLLKTQHLSN 127
Query: 605 ---------ICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSK-TGP 654
I RGL Y+H+ +++HRD+K +N+LL+ K+ DFGL++ P
Sbjct: 128 DHICYFLYQIL----RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180
Query: 655 ALDQTHVSTAVKGSFGYLDPEYFR-------RQQLTEKSDVYSFGVVLMEVLCTRP 703
D T T Y+ ++R + T+ D++S G +L E+L RP
Sbjct: 181 DHDHTGFLT------EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 2e-18
Identities = 56/228 (24%), Positives = 81/228 (35%), Gaps = 50/228 (21%)
Query: 504 FDESLLLGVGGFGRVY----KGTLDDGTKVAVKRGN-----PRSEQGIAEFRTEIEMLSK 554
F+ ++G G F V K T G A+K N R E ++ FR E ++L
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQT---GQVYAMKIMNKWDMLKRGE--VSCFREERDVLVN 117
Query: 555 LRHRHLVSLIGYC--DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAAR- 611
R + L + DE + LV EY G L + L + I A
Sbjct: 118 GDRRWITQLH-FAFQDEN-YLYLVMEYYVGGDLLTLL-----------SKFGERIPAEMA 164
Query: 612 ---------GLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVS 662
+ +H +HRD+K NILLD ++ADFG A
Sbjct: 165 RFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSL 221
Query: 663 TAVKGSFGYLDPEYFRRQQLTEKSDVY-------SFGVVLMEVLCTRP 703
AV G+ YL PE + + Y + GV E+ +
Sbjct: 222 VAV-GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQT 268
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 3e-18
Identities = 52/274 (18%), Positives = 108/274 (39%), Gaps = 53/274 (19%)
Query: 501 TNKFDESLLLGVGGFGRVYKGT-LDDGTKVAVKR-GNPRSEQGIAEFRT--EIEMLSKLR 556
++ +G G G V VA+K+ P Q A+ R E+ ++ +
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK-RAYRELVLMKCVN 82
Query: 557 HRHLVSLI------GYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLE------ 604
H++++ L+ +E ++ +V E M +L + + L+
Sbjct: 83 HKNIIGLLNVFTPQKSLEEFQDVYIVMELM----------DANLCQVI-QMELDHERMSY 131
Query: 605 ICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTA 664
+ G+ +LH+ IIHRD+K +NI++ + K+ DFGL++T + + T
Sbjct: 132 LLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMMTP 185
Query: 665 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLP-REQVNIAEWAMTW 723
+ Y PE E D++S G ++ E++ + P + ++
Sbjct: 186 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG----VLFPGTDHID-------- 233
Query: 724 QKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCL 757
+++++ +G P +KK T +
Sbjct: 234 ----QWNKVIE--QLGTPCPEFMKKLQPTVRTYV 261
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 3e-18
Identities = 57/239 (23%), Positives = 101/239 (42%), Gaps = 46/239 (19%)
Query: 493 MFQEIL-DATNKFDESLLLGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRT--E 548
M + I+ + ++ F LLG G +G V T G VA+K+ P + A RT E
Sbjct: 1 MPKRIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFAL-RTLRE 59
Query: 549 IEMLSKLRHRHLVSLI-----GYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRL 603
I++L +H +++++ + +E+ ++ E M TDL + Q L
Sbjct: 60 IKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM----------QTDLHRVISTQML 109
Query: 604 E----------ICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTG 653
R + LH ++IHRD+K +N+L++ N KV DFGL++
Sbjct: 110 SDDHIQYFIYQTL----RAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARII 162
Query: 654 PALDQTHVSTAVKGSF--GYLDPEYFR-------RQQLTEKSDVYSFGVVLMEVLCTRP 703
+ + S ++ ++R + + DV+S G +L E+ RP
Sbjct: 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 4e-18
Identities = 47/152 (30%), Positives = 74/152 (48%), Gaps = 23/152 (15%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRT---EIEMLSKLRHRHLVSLIG 565
LG G + VYKG VA+K E+G T E+ +L L+H ++V+L
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAP--CTAIREVSLLKDLKHANIVTLHD 67
Query: 566 YCDERSEMILVYEYMANGPLRSHL--YGTDLPPLSWK----QRLEICIGAARGLHYLHTG 619
+ LV+EY+ + L+ +L G + + K Q L RGL Y H
Sbjct: 68 IIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQLL-------RGLAYCH-- 117
Query: 620 AAQSIIHRDVKTTNILLDDNFVAKVADFGLSK 651
Q ++HRD+K N+L+++ K+ADFGL++
Sbjct: 118 -RQKVLHRDLKPQNLLINERGELKLADFGLAR 148
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 6e-18
Identities = 51/249 (20%), Positives = 86/249 (34%), Gaps = 67/249 (26%)
Query: 493 MFQEILDATNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKR--GNPRSEQGIAEF----- 545
+ E+ + + + G +G V G +G VA+KR + +
Sbjct: 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFL 72
Query: 546 --RT--EIEMLSKLRHRHLVSLI-----GYCDERSEMILVYEYMANGPLRSHLYGTDL-- 594
R EI +L+ H +++ L ++ LV E M TDL
Sbjct: 73 CKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM----------RTDLAQ 122
Query: 595 ------PPLSWK-------QRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFV 641
+S + L GLH LH ++HRD+ NILL DN
Sbjct: 123 VIHDQRIVISPQHIQYFMYHIL-------LGLHVLHEA---GVVHRDLHPGNILLADNND 172
Query: 642 AKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFR-------RQQLTEKSDVYSFGVV 694
+ DF L++ T Y+ ++R + T+ D++S G V
Sbjct: 173 ITICDFNLARE---DTADANKT------HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCV 223
Query: 695 LMEVLCTRP 703
+ E+ +
Sbjct: 224 MAEMFNRKA 232
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 6e-18
Identities = 41/152 (26%), Positives = 74/152 (48%), Gaps = 19/152 (12%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVKR--------GNPRSEQGIAEFRTEIEMLSKLRHRHL 560
+G G +G VYK G VA+K+ G P + I R EI +L +L H ++
Sbjct: 11 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPST--AI---R-EISLLKELNHPNI 64
Query: 561 VSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGA 620
V L+ +++ LV+E++ + L+ + + L + +GL + H
Sbjct: 65 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH--- 120
Query: 621 AQSIIHRDVKTTNILLDDNFVAKVADFGLSKT 652
+ ++HRD+K N+L++ K+ADFGL++
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARA 152
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-17
Identities = 51/157 (32%), Positives = 79/157 (50%), Gaps = 27/157 (17%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVKR----GNPRSEQGIAEFRT---EIEMLSKLRHRHLV 561
LG G F VYK + VA+K+ ++ GI RT EI++L +L H +++
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGIN--RTALREIKLLQELSHPNII 75
Query: 562 SLIGYCDERSEMILVYEYMANGPLRSHL--YGTDLPPL---SW-KQRLEICIGAARGLHY 615
L+ +S + LV+++M L + L P ++ L +GL Y
Sbjct: 76 GLLDAFGHKSNISLVFDFMETD-LEVIIKDNSLVLTPSHIKAYMLMTL-------QGLEY 127
Query: 616 LHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKT 652
LH I+HRD+K N+LLD+N V K+ADFGL+K+
Sbjct: 128 LH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKS 161
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 1e-17
Identities = 52/224 (23%), Positives = 84/224 (37%), Gaps = 44/224 (19%)
Query: 504 FDESLLLGVGGFGRVY----KGTLDDGTKVAVKRGN-----PRSEQGIAEFRTEIEMLSK 554
F+ ++G G FG V K A+K N R+E A FR E ++L
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNA---DKVFAMKILNKWEMLKRAE--TACFREERDVLVN 130
Query: 555 LRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAAR--- 611
+ + +L + + + LV +Y G L + L + E +
Sbjct: 131 GDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLL-----------SKFEDRLPEEMARF 179
Query: 612 -------GLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTA 664
+ +H +HRD+K NIL+D N ++ADFG S A
Sbjct: 180 YLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA 236
Query: 665 VKGSFGYLDPEYFRRQQLTEKS-----DVYSFGVVLMEVLCTRP 703
V G+ Y+ PE + + + D +S GV + E+L
Sbjct: 237 V-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGET 279
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 51/156 (32%), Positives = 74/156 (47%), Gaps = 31/156 (19%)
Query: 510 LGVGGFGRVYKGTLDDGTKVAVKR--------GNPRSEQGIAEFRTEIEMLSKLRHRHLV 561
+G G +G VYK G VA+KR G P + I R EI +L +L H ++V
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPST--AI---R-EISLLKELHHPNIV 82
Query: 562 SLIGYCDERSEMILVYEYMANGPLRSHL--YGTDLPPLSWK----QRLEICIGAARGLHY 615
SLI + LV+E+M L+ L T L K Q L RG+ +
Sbjct: 83 SLIDVIHSERCLTLVFEFMEKD-LKKVLDENKTGLQDSQIKIYLYQLL-------RGVAH 134
Query: 616 LHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSK 651
H I+HRD+K N+L++ + K+ADFGL++
Sbjct: 135 CH---QHRILHRDLKPQNLLINSDGALKLADFGLAR 167
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-17
Identities = 54/235 (22%), Positives = 101/235 (42%), Gaps = 44/235 (18%)
Query: 490 RLFMFQEILDATNKFDESLLLGVGGFGRVYKGT-LDDGTKVAVKR-GNPRSEQGIAEFRT 547
R + + + + + +G G +G V G KVA+K+ P + A+ R
Sbjct: 13 RQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK-RA 71
Query: 548 --EIEMLSKLRHRHLVSLI------GYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSW 599
E+ +L +RH +++ L+ D+ ++ LV +M GTDL L
Sbjct: 72 YRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM----------GTDLGKLMK 121
Query: 600 KQRLE----------ICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGL 649
++L + +GL Y+H IIHRD+K N+ ++++ K+ DFGL
Sbjct: 122 HEKLGEDRIQFLVYQML----KGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 174
Query: 650 SKTGPALDQTHVSTAVKGSFGYLDPEY-FRRQQLTEKSDVYSFGVVLMEVLCTRP 703
++ + +V T Y PE + T+ D++S G ++ E++ +
Sbjct: 175 ARQADSEMTGYVVTRW-----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 224
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-17
Identities = 58/217 (26%), Positives = 89/217 (41%), Gaps = 33/217 (15%)
Query: 504 FDESLLLGVGGFGRVY----KGTLDDGTKVAVKRGN-----PRSEQGIAEFRTEIEMLSK 554
++ ++G G FG V K T A+K + RS+ A F E ++++
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSD--SAFFWEERDIMAF 125
Query: 555 LRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLP-PLSWKQRL---EICIGAA 610
+V L + + +V EYM G L + + D+P + R E+ +
Sbjct: 126 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWA---RFYTAEVVLA-- 180
Query: 611 RGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFG 670
L +H + IHRDVK N+LLD + K+ADFG TAV G+
Sbjct: 181 --LDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPD 234
Query: 671 YLDPEYFRRQQLTEK----SDVYSFGVVLMEVLCTRP 703
Y+ PE + Q D +S GV L E+L
Sbjct: 235 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 271
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 42/153 (27%), Positives = 78/153 (50%), Gaps = 24/153 (15%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQ-GIAEFRT---EIEMLSKLRHRHLVSLI 564
+G G +G V+K + VA+KR + G+ + EI +L +L+H+++V L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVP--SSALREICLLKELKHKNIVRLH 67
Query: 565 GYCDERSEMILVYEYMANGPLRSHL--YGTDLPPLSWK----QRLEICIGAARGLHYLHT 618
++ LV+E+ + L+ + DL P K Q L +GL + H
Sbjct: 68 DVLHSDKKLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQLL-------KGLGFCH- 118
Query: 619 GAAQSIIHRDVKTTNILLDDNFVAKVADFGLSK 651
+++++HRD+K N+L++ N K+A+FGL++
Sbjct: 119 --SRNVLHRDLKPQNLLINRNGELKLANFGLAR 149
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 3e-17
Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 47/217 (21%)
Query: 510 LGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRT----EIEMLSKLRHRHLVSLIG 565
+G G FG V++ L + +VA+K+ + + + E++++ ++H ++V L
Sbjct: 48 IGNGSFGVVFQAKLVESDEVAIKK--------VLQDKRFKNRELQIMRIVKHPNVVDLKA 99
Query: 566 Y----CDERSEMI--LVYEYMANGP------LRSHL-YGTDLPPLSWK----QRLEICIG 608
+ D++ E+ LV EY+ P R + +P L K Q L
Sbjct: 100 FFYSNGDKKDEVFLNLVLEYV---PETVYRASRHYAKLKQTMPMLLIKLYMYQLL----- 151
Query: 609 AARGLHYLHTGAAQSIIHRDVKTTNILLD-DNFVAKVADFGLSKTGPALDQTHVSTAVKG 667
R L Y+H+ I HRD+K N+LLD + V K+ DFG +K L + +
Sbjct: 152 --RSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAK---ILIAGEPNVSYIC 203
Query: 668 SFGYLDPE-YFRRQQLTEKSDVYSFGVVLMEVLCTRP 703
S Y PE F T D++S G V+ E++ +P
Sbjct: 204 SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQP 240
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 3e-17
Identities = 60/297 (20%), Positives = 122/297 (41%), Gaps = 57/297 (19%)
Query: 482 SLASSNLGRLFMFQEILDAT----NKFDESLLLGVGGFGRVYKGT-LDDGTKVAVKR-GN 535
+++ S + F E+ D+T ++ +G G G V VA+K+
Sbjct: 38 NMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR 97
Query: 536 PRSEQGIAEFRT--EIEMLSKLRHRHLVSLI------GYCDERSEMILVYEYMANGPLRS 587
P Q A+ R E+ ++ + H++++SL+ +E ++ LV E M
Sbjct: 98 PFQNQTHAK-RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM------- 149
Query: 588 HLYGTDLPPLSWKQRLE------ICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFV 641
+L + + L+ + G+ +LH+ IIHRD+K +NI++ +
Sbjct: 150 ---DANLCQVI-QMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCT 202
Query: 642 AKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCT 701
K+ DFGL++T + + T + Y PE E D++S G ++ E++
Sbjct: 203 LKILDFGLART---AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 259
Query: 702 RPALNPVLP-REQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCL 757
+ + P R+ ++ +++++ +G P +KK T +
Sbjct: 260 K----ILFPGRDYID------------QWNKVIE--QLGTPCPEFMKKLQPTVRNYV 298
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-17
Identities = 47/232 (20%), Positives = 92/232 (39%), Gaps = 45/232 (19%)
Query: 493 MFQEILDATNKFDESLLLGVGGFGRVYKGT-LDDGTKVAVKR-GNPRSEQGIAEFRT--E 548
+ + + + +G G +G V G KVA+K+ P + A+ R E
Sbjct: 15 VNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAK-RAYRE 73
Query: 549 IEMLSKLRHRHLVSLI------GYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQR 602
+ +L ++H +++ L+ + LV +M TDL + +
Sbjct: 74 LLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM----------QTDLQKIM-GLK 122
Query: 603 LE----------ICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKT 652
+ +GL Y+H+ ++HRD+K N+ ++++ K+ DFGL++
Sbjct: 123 FSEEKIQYLVYQML----KGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARH 175
Query: 653 GPALDQTHVSTAVKGSFGYLDPE-YFRRQQLTEKSDVYSFGVVLMEVLCTRP 703
A +V T Y PE + D++S G ++ E+L +
Sbjct: 176 ADAEMTGYVVTRW-----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKT 222
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 81.4 bits (202), Expect = 4e-17
Identities = 44/156 (28%), Positives = 75/156 (48%), Gaps = 31/156 (19%)
Query: 510 LGVGGFGRVYKGTLDDGTKVAVKR--------GNPRSEQGIAEFRTEIEMLSKLRHRHLV 561
+G G +G VYK + G A+K+ G P + I R EI +L +L+H ++V
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPST--TI---R-EISILKELKHSNIV 63
Query: 562 SLIGYCDERSEMILVYEYMANGPLRSHL--YGTDLPPLSWK----QRLEICIGAARGLHY 615
L + ++LV+E++ L+ L L ++ K Q L G+ Y
Sbjct: 64 KLYDVIHTKKRLVLVFEHLDQD-LKKLLDVCEGGLESVTAKSFLLQLL-------NGIAY 115
Query: 616 LHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSK 651
H + ++HRD+K N+L++ K+ADFGL++
Sbjct: 116 CH---DRRVLHRDLKPQNLLINREGELKIADFGLAR 148
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 6e-17
Identities = 57/228 (25%), Positives = 92/228 (40%), Gaps = 44/228 (19%)
Query: 501 TNKFDESLLLGVGGFGRVYKGTL-DDGTKVAVKR--GNPRSEQGIAEFRT--EIEMLSKL 555
++F + G G FG V G G VA+K+ +PR R ++ L+ L
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRN-----RELQIMQDLAVL 76
Query: 556 RHRHLVSL--IGYCDERSEM-----ILVYEYMANGP------LRSHLY-GTDLPPLSWK- 600
H ++V L Y + +V EY+ P R++ PP+ K
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV---PDTLHRCCRNYYRRQVAPPPILIKV 133
Query: 601 ---QRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLD-DNFVAKVADFGLSKTGPAL 656
Q + R + LH + + HRD+K N+L++ + K+ DFG +K L
Sbjct: 134 FLFQLI-------RSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAK---KL 182
Query: 657 DQTHVSTAVKGSFGYLDPEY-FRRQQLTEKSDVYSFGVVLMEVLCTRP 703
+ + A S Y PE F Q T D++S G + E++ P
Sbjct: 183 SPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEP 230
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 9e-17
Identities = 55/228 (24%), Positives = 100/228 (43%), Gaps = 36/228 (15%)
Query: 493 MFQEILDATNKFDESLLLGVGGFGRVYKGT-LDDGTKVAVKR-GNPRSEQGIAEFRT--E 548
+ + I + ++ +G G +G V G +VAVK+ P A+ RT E
Sbjct: 20 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK-RTYRE 78
Query: 549 IEMLSKLRHRHLVSLI------GYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQR 602
+ +L ++H +++ L+ +E +++ LV M G DL + Q+
Sbjct: 79 LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM----------GADLNNIVKCQK 128
Query: 603 LE------ICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPAL 656
L + RGL Y+H+ IIHRD+K +N+ ++++ K+ DFGL++
Sbjct: 129 LTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADE 185
Query: 657 DQTHVSTAVKGSFGYLDPE-YFRRQQLTEKSDVYSFGVVLMEVLCTRP 703
+V+T Y PE + D++S G ++ E+L R
Sbjct: 186 MTGYVATRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 1e-16
Identities = 41/212 (19%), Positives = 77/212 (36%), Gaps = 49/212 (23%)
Query: 501 TNKFDESLLLGVGGFGRVYKGT-LDDGTKVAVKR-GNPRSEQGIAEFRT--EIEMLSKLR 556
++++ L+G G +G V + + VA+K+ + + R EI +L++L
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCK-RILREIAILNRLN 110
Query: 557 HRHLVSLI-----GYCDERSEMILVYEYMANGPLRSHLYGTDL-------PPLSWK---- 600
H H+V ++ ++ E+ +V E +D L+
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEIA----------DSDFKKLFRTPVYLTELHIKT 160
Query: 601 ---QRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLS-----KT 652
L G+ Y+H+ I+HRD+K N L++ + KV DFGL+
Sbjct: 161 LLYNLL-------VGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE 210
Query: 653 GPALDQTHVSTAVKGSFGYLDPEYFRRQQLTE 684
+ ++QLT
Sbjct: 211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTG 242
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-16
Identities = 69/264 (26%), Positives = 111/264 (42%), Gaps = 54/264 (20%)
Query: 464 TMTKMSTTSQKSGTASCISLASSNLGRLFMFQEILDATNKFDESLLLGVGGFGRVYKGTL 523
M + K G+ +A+ G + ++ ++G G FG VY+ L
Sbjct: 22 AFGSMKVSRDKDGSKVTTVVATPGQGPDRPQ------EVSYTDTKVIGNGSFGVVYQAKL 75
Query: 524 -DDGTKVAVKRGNPRSEQGIAEFRT----EIEMLSKLRHRHLVSLIGY----CDERSEMI 574
D G VA+K+ + + + E++++ KL H ++V L + +++ E+
Sbjct: 76 CDSGELVAIKK--------VLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127
Query: 575 L--VYEYMANGP------LRSHLY-GTDLPPLSWK----QRLEICIGAARGLHYLHTGAA 621
L V +Y+ P R + LP + K Q R L Y+H+
Sbjct: 128 LNLVLDYV---PETVYRVARHYSRAKQTLPVIYVKLYMYQLF-------RSLAYIHS--- 174
Query: 622 QSIIHRDVKTTNILLD-DNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEY-FRR 679
I HRD+K N+LLD D V K+ DFG +K L + + + S Y PE F
Sbjct: 175 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK---QLVRGEPNVSYICSRYYRAPELIFGA 231
Query: 680 QQLTEKSDVYSFGVVLMEVLCTRP 703
T DV+S G VL E+L +P
Sbjct: 232 TDYTSSIDVWSAGCVLAELLLGQP 255
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 1e-16
Identities = 46/224 (20%), Positives = 87/224 (38%), Gaps = 44/224 (19%)
Query: 484 ASSNLGRLFMFQEILDATNKFDESLLLGVGGFGRVYKGT-LDDGTKVAVKR-GNPRSEQG 541
+S F + + + + L+G G +G VY + VA+K+ +
Sbjct: 8 SSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLI 67
Query: 542 IAEFRT--EIEMLSKLRHRHLVSLI-----GYCDERSEMILVYEYMANGPLRSHLYGTDL 594
+ R EI +L++L+ +++ L + E+ +V E +DL
Sbjct: 68 DCK-RILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA----------DSDL 116
Query: 595 -------PPLSWK-------QRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNF 640
L+ + L G +++H IIHRD+K N LL+ +
Sbjct: 117 KKLFKTPIFLTEEHIKTILYNLL-------LGENFIHES---GIIHRDLKPANCLLNQDC 166
Query: 641 VAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTE 684
KV DFGL++T + T++ ++ + ++QLT
Sbjct: 167 SVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTS 210
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 5e-16
Identities = 49/167 (29%), Positives = 77/167 (46%), Gaps = 21/167 (12%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQ-GIAEF-----RTEIEMLSKLR---HRH 559
+GVG +G VYK G VA+K + G R E+ +L +L H +
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVR-EVALLRRLEAFEHPN 75
Query: 560 LVSLI-----GYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLH 614
+V L+ D ++ LV+E++ LR++L P L + ++ RGL
Sbjct: 76 VVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYLDKAPPPGLPAETIKDLMRQFLRGLD 134
Query: 615 YLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKT-GPALDQTH 660
+LH A I+HRD+K NIL+ K+ADFGL++ + T
Sbjct: 135 FLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP 178
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 8e-16
Identities = 63/241 (26%), Positives = 107/241 (44%), Gaps = 57/241 (23%)
Query: 501 TNKFDESLLLGVGGFGRVYKGT-LDDGTKVAVKR-GNPRSEQGIAEFRT--EIEMLSKLR 556
K++ LG G +G V+K G VAVK+ + A+ RT EI +L++L
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQ-RTFREIMILTELS 66
Query: 557 -HRHLVSL--IGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLE--------- 604
H ++V+L + D ++ LV++YM TDL + LE
Sbjct: 67 GHENIVNLLNVLRADNDRDVYLVFDYM----------ETDLHAVIRANILEPVHKQYVVY 116
Query: 605 -ICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVST 663
+ + + YLH+G ++HRD+K +NILL+ KVADFGLS++ + + +
Sbjct: 117 QLI----KVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169
Query: 664 AVKGSFGYLDPEYFRRQQLTE--------------------KS-DVYSFGVVLMEVLCTR 702
+ + + + + LT+ K D++S G +L E+LC +
Sbjct: 170 PLSINENTENFDD-DQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
Query: 703 P 703
P
Sbjct: 229 P 229
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 48/164 (29%), Positives = 73/164 (44%), Gaps = 42/164 (25%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVKR--------GNPRSEQGIAEFRTEIEMLSKLRHRHL 560
+G G FG V+K G KVA+K+ G P I R EI++L L+H ++
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFP-----ITALR-EIKILQLLKHENV 78
Query: 561 VSLIGYCDERSEMI--------LVYEYMAN---GPLRSHLYGTDLPPLSWK----QRLEI 605
V+LI C ++ LV+++ + G L + K L
Sbjct: 79 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLN- 135
Query: 606 CIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGL 649
GL+Y+H I+HRD+K N+L+ + V K+ADFGL
Sbjct: 136 ------GLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGL 170
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 51/242 (21%), Positives = 100/242 (41%), Gaps = 67/242 (27%)
Query: 501 TNKFDESLLLGVGGFGRVYKGT-LDDGTKVAVKR---GNPRSEQGIAEFRT--EIEMLSK 554
+++ + LG GG G V+ D +VA+K+ +P+S + EI+++ +
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVK-----HALREIKIIRR 64
Query: 555 LRHRHLVSLI--------------GYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWK 600
L H ++V + G E + + +V EYM TDL + +
Sbjct: 65 LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM----------ETDLANVLEQ 114
Query: 601 QRLE----------ICIGAARGLHYLHTGAAQSIIHRDVKTTNILLD-DNFVAKVADFGL 649
L + RGL Y+H+ +++HRD+K N+ ++ ++ V K+ DFGL
Sbjct: 115 GPLLEEHARLFMYQLL----RGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGL 167
Query: 650 SKT-GPALDQTHVSTAVKGSFGYLDPEYFR-------RQQLTEKSDVYSFGVVLMEVLCT 701
++ P + L +++R T+ D+++ G + E+L
Sbjct: 168 ARIMDPHYSHKGHLS------EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 221
Query: 702 RP 703
+
Sbjct: 222 KT 223
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 43/170 (25%), Positives = 69/170 (40%), Gaps = 42/170 (24%)
Query: 506 ESLLLGVGGFGRVYKG---TLDDGTKVAVKR----GNPRSEQGIAEFRTEIEMLSKLRHR 558
E +G G +G VYK D A+K+ G S EI +L +L+H
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR------EIALLRELKHP 78
Query: 559 HLVSLIGYCDERSEMI--LVYEYM---------ANGPLRSHLYGTDLPPLSWK----QRL 603
+++SL ++ L+++Y + +++ LP K Q L
Sbjct: 79 NVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 138
Query: 604 EICIGAARGLHYLHTGAAQSIIHRDVKTTNILL----DDNFVAKVADFGL 649
G+HYLH A ++HRD+K NIL+ + K+AD G
Sbjct: 139 -------DGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGF 178
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 41/152 (26%), Positives = 73/152 (48%), Gaps = 18/152 (11%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQ-GIAEFRT---EIEMLSKLRHRHLVSLI 564
LG G +G VYK VA+KR E+ G+ T E+ +L +L+HR+++ L
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVP--GTAIREVSLLKELQHRNIIELK 99
Query: 565 GYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSI 624
+ L++EY N L+ ++ P +S + G+++ H+ +
Sbjct: 100 SVIHHNHRLHLIFEYAEND-LKKYM--DKNPDVSMRVIKSFLYQLINGVNFCHS---RRC 153
Query: 625 IHRDVKTTNILLDDNFVA-----KVADFGLSK 651
+HRD+K N+LL + + K+ DFGL++
Sbjct: 154 LHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 3e-15
Identities = 56/221 (25%), Positives = 92/221 (41%), Gaps = 51/221 (23%)
Query: 509 LLGVGGFGRVY----KGTLDDGT----KVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHL 560
+LG GG+G+V+ + G KV K R+ + A + E +L +++H +
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 561 VSLIGYC---DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRL-----------EIC 606
V LI Y + + L+ EY++ G L L ++ + EI
Sbjct: 84 VDLI-YAFQTGGK--LYLILEYLSGGELFMQLE---------REGIFMEDTACFYLAEIS 131
Query: 607 IGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVK 666
+ L +LH + II+RD+K NI+L+ K+ DFGL K T
Sbjct: 132 MA----LGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV---T--- 178
Query: 667 GSF-G---YLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRP 703
+F G Y+ PE R D +S G ++ ++L P
Sbjct: 179 HTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAP 219
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 3e-15
Identities = 56/219 (25%), Positives = 96/219 (43%), Gaps = 49/219 (22%)
Query: 509 LLGVGGFGRVY----KGTLDDGTKVAVK--RGNPRSEQGIAEFRTEIEMLSKLRHRHLVS 562
+LG G FG+V+ D A+K + + + E ++L ++ H +V
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 563 LIGYC---DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRL-----------EICIG 608
L Y + + + L+ +++ G L + L K+ + E+ +
Sbjct: 91 LH-YAFQTEGK--LYLILDFLRGGDLFTRLS---------KEVMFTEEDVKFYLAELALA 138
Query: 609 AARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGS 668
L +LH + II+RD+K NILLD+ K+ DFGLSK ++ S
Sbjct: 139 ----LDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK---A---YS 185
Query: 669 F-G---YLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRP 703
F G Y+ PE R+ T+ +D +SFGV++ E+L
Sbjct: 186 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTL 224
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 55/213 (25%), Positives = 82/213 (38%), Gaps = 32/213 (15%)
Query: 504 FDESLLLGVGGFGRVYKGTLDDGT-----KVAVKRGNPRSEQGIAEFRTEIEMLSKLRHR 558
FD LG G FGRV + K+ K+ + +Q I E +L +
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVNFP 101
Query: 559 HLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAAR------- 611
LV L + S + +V EY+A G + SHL R AR
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR--------IGRFSEP--HARFYAAQIV 151
Query: 612 -GLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFG 670
YLH + +I+RD+K N+L+D +V DFG +K T T
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTP-----E 203
Query: 671 YLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRP 703
L PE + + D ++ GV++ E+ P
Sbjct: 204 ALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-15
Identities = 63/221 (28%), Positives = 93/221 (42%), Gaps = 44/221 (19%)
Query: 504 FDESLLLGVGGFGRVY----KGTLDDGTKVAVK---RGNPRSEQGIAEFRTEIEMLSKLR 556
F+ LLG G FG+V K T G A+K + ++ +A TE +L R
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 206
Query: 557 HRHLVSLIGYC---DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRL---------- 603
H L +L Y +R + V EY G L HL ++R+
Sbjct: 207 HPFLTALK-YSFQTHDR--LCFVMEYANGGELFFHLS---------RERVFSEDRARFYG 254
Query: 604 -EICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVS 662
EI L YLH + +++++RD+K N++LD + K+ DFGL K G T
Sbjct: 255 AEIVSA----LDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--M 306
Query: 663 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRP 703
G+ YL PE D + GVV+ E++C R
Sbjct: 307 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 347
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 8e-15
Identities = 61/223 (27%), Positives = 95/223 (42%), Gaps = 52/223 (23%)
Query: 504 FDESLLLGVGGFGRVY----KGTLDDGT----KVAVKRGNPRSEQGIAEFRTEIEMLSKL 555
F LG G FGRV+ + G KV K R +Q + E MLS +
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHN---GRYYAMKVLKKEIVVRLKQ-VEHTNDERLMLSIV 63
Query: 556 RHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRL-----------E 604
H ++ + G + ++ ++ +Y+ G L S L K + E
Sbjct: 64 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR---------KSQRFPNPVAKFYAAE 114
Query: 605 ICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTA 664
+C+ L YLH ++ II+RD+K NILLD N K+ DFG +K P D T+
Sbjct: 115 VCLA----LEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP--DVTY---- 161
Query: 665 VKGSF-G---YLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRP 703
+ G Y+ PE + + D +SFG+++ E+L
Sbjct: 162 ---TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT 201
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 62/299 (20%), Positives = 114/299 (38%), Gaps = 57/299 (19%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVK--RGNPR-SEQGIAEFRTEIEMLSKLR-------- 556
LG G F V+ + + T VA+K RG+ +E EI++L ++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAE----DEIKLLQRVNDADNTKED 81
Query: 557 ---HRHLVSLIGYCDERSE----MILVYEYMANGPLRSHLYG----TDLPPLSWKQRLEI 605
H++ L+ + + + +++V+E L +L + + +I
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVMVFE-----VLGENLLALIKKYEHRGIPLIYVKQI 136
Query: 606 CIGAARGLHYLHTGAAQSIIHRDVKTTNILLDD------NFVAKVADFGLSKTGPALDQT 659
GL Y+H IIH D+K N+L++ K+AD G +
Sbjct: 137 SKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA----CWYDE 190
Query: 660 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEW 719
H + +++ Y PE +D++S ++ E L T L P E +
Sbjct: 191 HYTNSIQTRE-YRSPEVLLGAPWGCGADIWSTACLIFE-LITGDFLFE--PDEGHS---- 242
Query: 720 AMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYAL 778
+ + QI++ L+G++ P+ L + G+ G+ R W LE L
Sbjct: 243 --YTKDDDHIAQIIE--LLGEL-PSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVL 296
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 46/203 (22%), Positives = 82/203 (40%), Gaps = 41/203 (20%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKL-RHRHLVSLIGYC 567
LG+G G+V + K A+K Q + R E+E+ + + H+V ++
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALK-----MLQDCPKARREVELHWRASQCPHIVRIVDVY 80
Query: 568 DE----RSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQS 623
+ R +++V E + G L S + + ++ EI + YLH + +
Sbjct: 81 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SIN 137
Query: 624 IIHRDVKTTNILL---DDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQ 680
I HRDVK N+L N + K+ DFG + E +
Sbjct: 138 IAHRDVKPENLLYTSKRPNAILKLTDFGFA-----------------------KE-TTGE 173
Query: 681 QLTEKSDVYSFGVVLMEVLCTRP 703
+ + D++S GV++ +LC P
Sbjct: 174 KYDKSCDMWSLGVIMYILLCGYP 196
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 48/211 (22%), Positives = 92/211 (43%), Gaps = 38/211 (18%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLR-HRHLVSL--IG 565
LG G + V++ + + KV VK P ++ I R EI++L LR ++++L I
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI--KR-EIKILENLRGGPNIITLADIV 100
Query: 566 YCDERSEMILVYEYMANGPLRSHLYGTDLPPLS-------WKQRLEICIGAARGLHYLHT 618
LV+E++ N + L+ + L + L Y H+
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEIL-------KALDYCHS 148
Query: 619 GAAQSIIHRDVKTTNILLD-DNFVAKVADFGLSKTG-PALDQTH-VSTAVKGSFGYLDPE 675
I+HRDVK N+++D ++ ++ D+GL++ P + V++ + PE
Sbjct: 149 ---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-----FKGPE 200
Query: 676 YFRRQQLTEKS-DVYSFGVVLMEVLCTRPAL 705
Q+ + S D++S G +L ++ +
Sbjct: 201 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 63/219 (28%), Positives = 91/219 (41%), Gaps = 51/219 (23%)
Query: 509 LLGVGGFGRV----YKGTLDDGTKVAVK---RGNPRSEQGIAEFRTEIEMLSKLRHRHLV 561
LLG G FG+V K T G A+K + ++ +A TE +L RH L
Sbjct: 12 LLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 68
Query: 562 SLIGYC---DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRL----------EICIG 608
+L Y +R + V EY G L HL S ++ EI
Sbjct: 69 ALK-YAFQTHDR--LCFVMEYANGGELFFHL--------SRERVFTEERARFYGAEIVSA 117
Query: 609 AARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGS 668
L YLH ++ +++RD+K N++LD + K+ DFGL K G + T +
Sbjct: 118 ----LEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---M---KT 164
Query: 669 F-G---YLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRP 703
F G YL PE D + GVV+ E++C R
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 4e-14
Identities = 48/171 (28%), Positives = 81/171 (47%), Gaps = 29/171 (16%)
Query: 510 LGVGGFGRVYKG--TLDDGTKVAVKR--------GNPRSEQGIAEFRTEIEMLSKLR--- 556
+G G +G+V+K + G VA+KR G P S I R E+ +L L
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLS--TI---R-EVAVLRHLETFE 72
Query: 557 HRHLVSLI-----GYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAAR 611
H ++V L D +++ LV+E++ L ++L P + + ++ R
Sbjct: 73 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPTETIKDMMFQLLR 131
Query: 612 GLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKT-GPALDQTHV 661
GL +LH + ++HRD+K NIL+ + K+ADFGL++ + T V
Sbjct: 132 GLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV 179
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 73.9 bits (181), Expect = 1e-13
Identities = 60/217 (27%), Positives = 91/217 (41%), Gaps = 36/217 (16%)
Query: 504 FDESLLLGVGGFGRV----YKGTLDDGTKVAVK---RGNPRSEQGIAEFRTEIEMLSK-L 555
F+ ++LG G FG+V KGT AVK + + + E +L+
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGT---DELYAVKILKKDVVIQDDDVECTMVEKRVLALPG 399
Query: 556 RHRHLVSLIGYC---DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQ--RLEICIGAA 610
+ L L C +R + V EY+ G L H+ EI IG
Sbjct: 400 KPPFLTQLH-SCFQTMDR--LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG-- 454
Query: 611 RGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSF- 669
L +L ++ II+RD+K N++LD K+ADFG+ K T T +F
Sbjct: 455 --LFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TK---TFC 503
Query: 670 G---YLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRP 703
G Y+ PE Q + D ++FGV+L E+L +
Sbjct: 504 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 540
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 45/254 (17%), Positives = 88/254 (34%), Gaps = 88/254 (34%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRT----EIEMLSKLRHRHLVSLI 564
LG G FG V + ++ G + A+K+ + + E++++ L H +++ L+
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKK--------VLQDPRYKNRELDIMKVLDHVNIIKLV 66
Query: 565 GY--------------------------------------CDERSEMILVYEYMANGPLR 586
Y + + ++ EY+
Sbjct: 67 DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV------ 120
Query: 587 SHLYGTDL-----PPLSWKQRLE----------ICIGAARGLHYLHTGAAQSIIHRDVKT 631
L + + + + R + ++H+ I HRD+K
Sbjct: 121 ----PDTLHKVLKSFIRSGRSIPMNLISIYIYQLF----RAVGFIHS---LGICHRDIKP 169
Query: 632 TNILLD-DNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPE-YFRRQQLTEKSDVY 689
N+L++ + K+ DFG +K L + S A S Y PE + T D++
Sbjct: 170 QNLLVNSKDNTLKLCDFGSAK---KLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLW 226
Query: 690 SFGVVLMEVLCTRP 703
S G V E++ +P
Sbjct: 227 SIGCVFGELILGKP 240
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 4e-13
Identities = 59/220 (26%), Positives = 91/220 (41%), Gaps = 45/220 (20%)
Query: 509 LLGVGGFGRVY----KGTLDDGT----KVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRH- 559
+LG G +G+V+ D G KV K + + RTE ++L +R
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 560 LVSLIGYC---DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRL-----------EI 605
LV+L Y + + +IL +Y+ G L +HL ++ EI
Sbjct: 121 LVTLH-YAFQTETKLHLIL--DYINGGELFTHLS---------QRERFTEHEVQIYVGEI 168
Query: 606 CIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAV 665
+ L +LH II+RD+K NILLD N + DFGLSK A +
Sbjct: 169 VLA----LEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC 221
Query: 666 KGSFGYLDPEYFRRQQL--TEKSDVYSFGVVLMEVLCTRP 703
G+ Y+ P+ R + D +S GV++ E+L
Sbjct: 222 -GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 260
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-12
Identities = 59/212 (27%), Positives = 88/212 (41%), Gaps = 36/212 (16%)
Query: 509 LLGVGGFGRV----YKGTLDDGTKVAVK---RGNPRSEQGIAEFRTEIEMLSK-LRHRHL 560
+LG G FG+V KGT AVK + + + E +L+ + L
Sbjct: 27 VLGKGSFGKVMLSERKGT---DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFL 83
Query: 561 VSLIGYC---DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQ--RLEICIGAARGLHY 615
L C +R + V EY+ G L H+ EI IG L +
Sbjct: 84 TQLH-SCFQTMDR--LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG----LFF 136
Query: 616 LHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSF-G---Y 671
L ++ II+RD+K N++LD K+ADFG+ K T T +F G Y
Sbjct: 137 LQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TK---TFCGTPDY 187
Query: 672 LDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRP 703
+ PE Q + D ++FGV+L E+L +
Sbjct: 188 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 219
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-12
Identities = 59/221 (26%), Positives = 88/221 (39%), Gaps = 54/221 (24%)
Query: 509 LLGVGGFGRVY----KGTLDDGTKVAVK---RGNPRSEQGIAEFRTEIEMLSK-LRHRHL 560
++G G FG+V K AVK + ++ +E +L K ++H L
Sbjct: 45 VIGKGSFGKVLLARHKAE---EVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFL 101
Query: 561 VSLIGYC---DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRL-----------EIC 606
V L + ++ + V +Y+ G L HL ++R EI
Sbjct: 102 VGLH-FSFQTADK--LYFVLDYINGGELFYHLQ---------RERCFLEPRARFYAAEIA 149
Query: 607 IGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVK 666
L YLH + +I++RD+K NILLD + DFGL K + T T
Sbjct: 150 SA----LGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST---T--- 196
Query: 667 GSF-G---YLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRP 703
+F G YL PE +Q D + G VL E+L P
Sbjct: 197 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLP 237
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-12
Identities = 53/206 (25%), Positives = 82/206 (39%), Gaps = 28/206 (13%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVK--RGNPR-SEQGIAEFRTEIEMLSKLRHR------ 558
++G G FG+V K VA+K R R Q EI +L LR +
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA----AEEIRILEHLRKQDKDNTM 159
Query: 559 HLVSLIGYCDERSEMILVYEYMA-NGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLH 617
+++ ++ R+ + + +E ++ N L + S + + L LH
Sbjct: 160 NVIHMLENFTFRNHICMTFELLSMN--LYELIKKNKFQGFSLPLVRKFAHSILQCLDALH 217
Query: 618 TGAAQSIIHRDVKTTNILLDDNFVA--KVADFGLSKTGPALDQTHVSTAVKGSFGYLDPE 675
IIH D+K NILL + KV DFG S + V T ++ F Y PE
Sbjct: 218 K---NRIIHCDLKPENILLKQQGRSGIKVIDFGSS----CYEHQRVYTYIQSRF-YRAPE 269
Query: 676 YFRRQQLTEKSDVYSFGVVLMEVLCT 701
+ D++S G +L E L T
Sbjct: 270 VILGARYGMPIDMWSLGCILAE-LLT 294
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 51/206 (24%), Positives = 82/206 (39%), Gaps = 26/206 (12%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVK--RGNPR-SEQGIAEFRTEIEMLSKLRHR------ 558
L+G G FG+V K + VA+K + Q + E+ +L +
Sbjct: 61 LIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA----QIEVRLLELMNKHDTEMKY 116
Query: 559 HLVSLIGYCDERSEMILVYEYMA-NGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLH 617
++V L + R+ + LV+E ++ N L L T+ +S + L +L
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEMLSYN--LYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA 174
Query: 618 TGAAQSIIHRDVKTTNILL--DDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPE 675
T IIH D+K NILL K+ DFG S + ++ F Y PE
Sbjct: 175 TPELS-IIHCDLKPENILLCNPKRSAIKIVDFGSS----CQLGQRIYQYIQSRF-YRSPE 228
Query: 676 YFRRQQLTEKSDVYSFGVVLMEVLCT 701
D++S G +L+E + T
Sbjct: 229 VLLGMPYDLAIDMWSLGCILVE-MHT 253
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-12
Identities = 59/221 (26%), Positives = 88/221 (39%), Gaps = 54/221 (24%)
Query: 509 LLGVGGFGRV----YKGTLDDGTKVAVK---RGNPRSEQGIAEFRTEIEMLSK-LRHRHL 560
+LG G FG+V +K T A+K + + + E +LS H L
Sbjct: 24 MLGKGSFGKVFLAEFKKT---NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 80
Query: 561 VSLIGYC---DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRL-----------EIC 606
+ E + V EY+ G L H+ EI
Sbjct: 81 THMF-CTFQTKEN--LFFVMEYLNGGDLMYHIQ---------SCHKFDLSRATFYAAEII 128
Query: 607 IGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVK 666
+G L +LH ++ I++RD+K NILLD + K+ADFG+ K D T
Sbjct: 129 LG----LQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TN-- 176
Query: 667 GSF-G---YLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRP 703
+F G Y+ PE Q+ D +SFGV+L E+L +
Sbjct: 177 -TFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS 216
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-12
Identities = 60/256 (23%), Positives = 103/256 (40%), Gaps = 60/256 (23%)
Query: 509 LLGVGGFGRVY----KGTLDDGTKVAVK---RGNPRSEQGIAEFRTEIEMLSK-LRHRHL 560
++G G + +V K T A+K + ++ I +TE + + H L
Sbjct: 16 VIGRGSYAKVLLVRLKKT---DRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFL 72
Query: 561 VSLIGYC---DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRL-----------EIC 606
V L C + R + V EY+ G L H+ +QR EI
Sbjct: 73 VGLH-SCFQTESR--LFFVIEYVNGGDLMFHMQ---------RQRKLPEEHARFYSAEIS 120
Query: 607 IGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVK 666
+ L+YLH + II+RD+K N+LLD K+ D+G+ K G T T+
Sbjct: 121 LA----LNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TS-- 168
Query: 667 GSF-G---YLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMT 722
+F G Y+ PE R + D ++ GV++ E++ R P + V ++
Sbjct: 169 -TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS------PFDIVGSSDNPDQ 221
Query: 723 WQKKGMLDQIMDSNLV 738
+ + I++ +
Sbjct: 222 NTEDYLFQVILEKQIR 237
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 68.0 bits (165), Expect = 3e-12
Identities = 34/199 (17%), Positives = 56/199 (28%), Gaps = 47/199 (23%)
Query: 498 LDATNKFDESLLLGVGGFGRVYKGTLDDGTKVAVK--------RGNPRSEQGIAEFRTEI 549
T K +G G FG V++ D T VA+K N ++ E EI
Sbjct: 16 CLPTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEI 74
Query: 550 EMLSKL---------RHRHLVSLIGYCDER----SEMILVYEYMANG----------PLR 586
+ +L R + L + ++ +++ +
Sbjct: 75 IISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134
Query: 587 SHLY--------GTDL-----PPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTN 633
L+ G DL S I L HRD+ N
Sbjct: 135 DQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHRDLHWGN 192
Query: 634 ILLDDNFVAKVADFGLSKT 652
+LL + K+ K+
Sbjct: 193 VLLKKTSLKKLHYTLNGKS 211
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 3e-12
Identities = 59/256 (23%), Positives = 103/256 (40%), Gaps = 60/256 (23%)
Query: 509 LLGVGGFGRVY----KGTLDDGTKVAVK---RGNPRSEQGIAEFRTEIEMLSK-LRHRHL 560
++G G + +V K T A++ + ++ I +TE + + H L
Sbjct: 59 VIGRGSYAKVLLVRLKKT---DRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFL 115
Query: 561 VSLIGYC---DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRL-----------EIC 606
V L C + R + V EY+ G L H+ +QR EI
Sbjct: 116 VGLH-SCFQTESR--LFFVIEYVNGGDLMFHMQ---------RQRKLPEEHARFYSAEIS 163
Query: 607 IGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVK 666
+ L+YLH + II+RD+K N+LLD K+ D+G+ K G T T+
Sbjct: 164 LA----LNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TS-- 211
Query: 667 GSF-G---YLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMT 722
+F G Y+ PE R + D ++ GV++ E++ R P + V ++
Sbjct: 212 -TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS------PFDIVGSSDNPDQ 264
Query: 723 WQKKGMLDQIMDSNLV 738
+ + I++ +
Sbjct: 265 NTEDYLFQVILEKQIR 280
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 4e-12
Identities = 62/212 (29%), Positives = 90/212 (42%), Gaps = 36/212 (16%)
Query: 509 LLGVGGFGRVY----KGTLDDGTKVAVK---RGNPRSEQGIAEFRTEIEMLSK-LRHRHL 560
+LG G FG+V K T G AVK + + + TE +LS H L
Sbjct: 30 VLGKGSFGKVMLARVKET---GDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFL 86
Query: 561 VSLIGYC---DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQ--RLEICIGAARGLHY 615
L C +R + V E++ G L H+ + + + EI L +
Sbjct: 87 TQLF-CCFQTPDR--LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIIS----ALMF 139
Query: 616 LHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSF-G---Y 671
LH + II+RD+K N+LLD K+ADFG+ K G T TA +F G Y
Sbjct: 140 LH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT---TA---TFCGTPDY 190
Query: 672 LDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRP 703
+ PE + D ++ GV+L E+LC
Sbjct: 191 IAPEILQEMLYGPAVDWWAMGVLLYEMLCGHA 222
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 5e-11
Identities = 57/232 (24%), Positives = 85/232 (36%), Gaps = 58/232 (25%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVK--RGNPR-SEQGIAEFRTEIEMLSKLRHR-----H 559
+G G FGRV +D+ AVK R + + + E ++L K+++ +
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQNDDINNNN 97
Query: 560 LVSLIGYCDERSEMILVYEYMANGPLRSHLY----GTDLPPLSWKQRLEICIGAARGLHY 615
+V G M L++E PL LY + + CI + L+Y
Sbjct: 98 IVKYHGKFMYYDHMCLIFE-----PLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNY 152
Query: 616 LHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHV--STAVK----GSF 669
L S+ H D+K NILLDD + K T Q + ST +K G
Sbjct: 153 LRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA 209
Query: 670 GYLD--------------PE------YFRRQQLTEKSDVYSFGVVLMEVLCT 701
+ PE + SD++SFG VL E L T
Sbjct: 210 TFKSDYHGSIINTRQYRAPEVILNLGW------DVSSDMWSFGCVLAE-LYT 254
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 43/229 (18%), Positives = 79/229 (34%), Gaps = 56/229 (24%)
Query: 509 LLGVGGFGRVYKG--TLDDGTKVAVK--RGNPR-SEQGIAEFRTEIEMLSKLRHR----- 558
LG G FG+V + ++VA+K R + E R EI +L K++ +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA----RLEINVLKKIKEKDKENK 81
Query: 559 -HLVSLIGYCDERSEMILVYEYMANGP-LRSHLYGTDLPPLSWKQRLEICIGAARGLHYL 616
V + + + M + +E + G L + P + L +L
Sbjct: 82 FLCVLMSDWFNFHGHMCIAFELL--GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFL 139
Query: 617 HTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVK----GSFGYL 672
H + H D+K NIL ++ + + S ++ +T+++ GS +
Sbjct: 140 HE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVK----NTSIRVADFGSATFD 192
Query: 673 D--------------PE------YFRRQQLTEKSDVYSFGVVLMEVLCT 701
PE + + DV+S G +L E
Sbjct: 193 HEHHTTIVATRHYRPPEVILELGW------AQPCDVWSIGCILFE-YYR 234
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 8e-10
Identities = 45/230 (19%), Positives = 83/230 (36%), Gaps = 58/230 (25%)
Query: 509 LLGVGGFGRVYKGTLDDGTK---VAVK--RGNPR-SEQGIAEFRTEIEMLSKLRHR---- 558
LG G FG+V + +D VAVK + R E R+EI++L L
Sbjct: 21 TLGEGAFGKVVEC-IDHKAGGRHVAVKIVKNVDRYCEAA----RSEIQVLEHLNTTDPNS 75
Query: 559 --HLVSLIGYCDERSEMILVYEYMANGP-LRSHLYGTDLPPLSWKQRLEICIGAARGLHY 615
V ++ + + + +V+E + G + P ++ + +++
Sbjct: 76 TFRCVQMLEWFEHHGHICIVFELL--GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNF 133
Query: 616 LHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVK----GSFGY 671
LH+ + H D+K NIL + + + + + L + +K GS Y
Sbjct: 134 LHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLI----NPDIKVVDFGSATY 186
Query: 672 LD--------------PE------YFRRQQLTEKSDVYSFGVVLMEVLCT 701
D PE + ++ DV+S G +L+E
Sbjct: 187 DDEHHSTLVSTRHYRAPEVILALGW------SQPCDVWSIGCILIE-YYL 229
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 36/147 (24%), Positives = 65/147 (44%), Gaps = 12/147 (8%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRH-RHLVSLIGYC 567
+G G FG +Y GT + G +VA+K +++ E ++ ++ + ++
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI--ESKIYKMMQGGVGIPTIRWCG 74
Query: 568 DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHR 627
E ++V E + GP L+ S K L + + Y+H +++ IHR
Sbjct: 75 AEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHR 129
Query: 628 DVKTTNILL---DDNFVAKVADFGLSK 651
DVK N L+ + + DFGL+K
Sbjct: 130 DVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 29/165 (17%), Positives = 56/165 (33%), Gaps = 28/165 (16%)
Query: 510 LGVGGFGRVYKGT---------LDDGTKVAVK----RGNPRSEQGIAEFRTEIEMLSKLR 556
G +Y+ K ++K G +EQ + + ++K +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 557 HRHLVSLIG-----YC--DERSEMILVYEYMANGP-LRSHLYGTDLPPLSWKQRLEICIG 608
+ L+ + LV + G L+S L + LS + L++
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVACR 167
Query: 609 AARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKV--ADFGLSK 651
L +LH +H +V NI +D ++V A +G +
Sbjct: 168 LLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 5e-08
Identities = 35/150 (23%), Positives = 61/150 (40%), Gaps = 16/150 (10%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRH-RHLVSLIGYC 567
+G G FG +++GT L + +VA+K RS+ E L + ++ +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD--EYRTYKLLAGCTGIPNVYYFG 75
Query: 568 DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHR 627
E +LV + + GP L S K + +H +S+++R
Sbjct: 76 QEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYR 130
Query: 628 DVKTTNILL------DDNFVAKVADFGLSK 651
D+K N L+ + N + V DFG+ K
Sbjct: 131 DIKPDNFLIGRPNSKNANMIY-VVDFGMVK 159
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 54.6 bits (131), Expect = 8e-08
Identities = 37/147 (25%), Positives = 68/147 (46%), Gaps = 12/147 (8%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLR-HRHLVSLIGYC 567
+G G FG +Y GT + +VA+K N +++ + E ++ L+ + ++ +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY--ESKIYRILQGGTGIPNVRWFG 72
Query: 568 DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHR 627
E +LV + + GP L+ LS K L + + ++H+ +S +HR
Sbjct: 73 VEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS---KSFLHR 127
Query: 628 DVKTTNILLDDNFVAK---VADFGLSK 651
D+K N L+ A + DFGL+K
Sbjct: 128 DIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 38/153 (24%), Positives = 58/153 (37%), Gaps = 22/153 (14%)
Query: 510 LGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRH-RHLVSLIGYC 567
+G G FG + G L VA+K +S E +L + + +
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL--EYRFYKQLGSGDGIPQVYYFG 74
Query: 568 DERSEMILVYEYMANGP----LRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQS 623
+V E + GP L T S K L I I + Y+H+ ++
Sbjct: 75 PCGKYNAMVLELL--GPSLEDLFDLCDRT----FSLKTVLMIAIQLISRMEYVHS---KN 125
Query: 624 IIHRDVKTTNILL--DDNFVAKVA---DFGLSK 651
+I+RDVK N L+ N +V DF L+K
Sbjct: 126 LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 31/166 (18%), Positives = 60/166 (36%), Gaps = 28/166 (16%)
Query: 509 LLGVGGFGRVYKGTLDDGT------KVAVKRGNPRSEQGIAEFRT-----EIEMLSKLRH 557
+G GGFG +Y ++ VK + E + + E + K
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 558 RHLVSLIG----------YCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICI 607
+ +G + +S ++ + G +Y + S K L++ +
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQLSL 159
Query: 608 GAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKV--ADFGLSK 651
L Y+H +H D+K +N+LL+ +V D+GL+
Sbjct: 160 RILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 38/171 (22%), Positives = 57/171 (33%), Gaps = 41/171 (23%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVA---VKRGNPRSEQGIAEFRTEI-----EMLSKLRHRH 559
+G GGFG +Y + K A VK + +E + + + K R
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 560 LVSLIG-----YC-----DERSEMILVYEYMANGPLRSHLYGTDL-------PPLSWKQR 602
+ +G RS +V E G DL
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVME----------RLGIDLQKISGQNGTFKKSTV 153
Query: 603 LEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKV--ADFGLSK 651
L++ I L Y+H +H D+K N+LL +V AD+GLS
Sbjct: 154 LQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 48/264 (18%), Positives = 72/264 (27%), Gaps = 87/264 (32%)
Query: 510 LGVGGFGRVYKG-TLDDGTKVAVK--RGNPRSEQGIAEFRTEIEMLSKLR--------HR 558
LG G F V+ + VA+K + + EI +L +R
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTE---TALDEIRLLKSVRNSDPNDPNRE 101
Query: 559 HLVSLIGYCDERSE----MILVYEYMANGPLRSHLYGTDLPPLSWKQRL------EICIG 608
+V L+ + +V+E L HL S Q L +I
Sbjct: 102 MVVQLLDDFKISGVNGTHICMVFE-----VLGHHLL--KWIIKSNYQGLPLPCVKKIIQQ 154
Query: 609 AARGLHYLHTGAAQSIIHRDVKTTNILL-------------------------------- 636
+GL YLHT IIH D+K NILL
Sbjct: 155 VLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212
Query: 637 -----------------DDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRR 679
+ K+AD G + + T Y E
Sbjct: 213 APATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIG 267
Query: 680 QQLTEKSDVYSFGVVLMEVLCTRP 703
+D++S + E+
Sbjct: 268 SGYNTPADIWSTACMAFELATGDY 291
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 845 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 2jwp_A | 174 | Malectin, MGC80075; sugar binding, sugar binding p | 99.86 | |
| 2jwp_A | 174 | Malectin, MGC80075; sugar binding, sugar binding p | 99.79 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.75 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.59 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.19 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.11 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.95 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.85 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.54 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.48 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.32 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.24 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.21 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.21 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.84 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.75 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.49 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.42 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.25 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.22 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.09 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.95 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.89 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.86 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.84 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.81 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.69 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.93 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.45 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.29 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.81 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 92.83 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 92.53 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.54 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 90.94 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 90.34 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 80.25 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=466.01 Aligned_cols=260 Identities=29% Similarity=0.425 Sum_probs=211.7
Q ss_pred cCCCcceeeeeeceEEEEEEEEc------CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD------DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMIL 575 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 575 (845)
++|...+.||+|+||.||+|+++ +++.||||+++..+....++|.+|+++|++++|||||+++|+|.+.+.++|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45667788999999999999864 478899999988888888999999999999999999999999999999999
Q ss_pred EEEeccCCCccccccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCce
Q 003139 576 VYEYMANGPLRSHLYGTD-------------LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVA 642 (845)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~ 642 (845)
|||||++|+|.++|+... ..+++|.++++|+.|||+||+|||+ ++||||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcE
Confidence 999999999999986532 2469999999999999999999999 899999999999999999999
Q ss_pred EEEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHH
Q 003139 643 KVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAM 721 (845)
Q Consensus 643 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~ 721 (845)
||+|||+++.....+.........||+.|||||++.+..++.++|||||||+||||+| |+.||......+ +.
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~---- 270 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE---AI---- 270 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH---HH----
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH---HH----
Confidence 9999999987544333344456789999999999999999999999999999999999 899997543221 11
Q ss_pred HHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhh
Q 003139 722 TWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQL 780 (845)
Q Consensus 722 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~ 780 (845)
....++. ....+..++..+.+|+.+||+.||++||||.||+++|+.+.+.
T Consensus 271 ~~i~~g~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 271 DCITQGR---------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHHHHTC---------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHcCC---------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 1111111 1123455667899999999999999999999999999988664
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-54 Score=462.31 Aligned_cols=259 Identities=28% Similarity=0.418 Sum_probs=217.1
Q ss_pred cCCCcceeeeeeceEEEEEEEEc------CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD------DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMIL 575 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 575 (845)
++|...+.||+|+||.||+|++. +++.||||+++..+.+..++|.+|+++|++++|||||+++|+|.+.+..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 45777889999999999999864 467899999988888888999999999999999999999999999999999
Q ss_pred EEEeccCCCccccccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEE
Q 003139 576 VYEYMANGPLRSHLYGT-----------DLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKV 644 (845)
Q Consensus 576 V~Ey~~~gsL~~~l~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl 644 (845)
|||||++|+|.++|+.. ....++|.++++|+.|||+||+|||+ ++||||||||+||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEE
Confidence 99999999999999643 23579999999999999999999999 99999999999999999999999
Q ss_pred EeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHH
Q 003139 645 ADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTW 723 (845)
Q Consensus 645 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~ 723 (845)
+|||+|+.....+.........||+.|||||++.++.++.++|||||||+||||+| |+.||......+ + . ..
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~---~---~-~~ 242 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---V---I-EC 242 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---H---H-HH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---H---H-HH
Confidence 99999986443233333345679999999999999999999999999999999998 899997543221 1 1 11
Q ss_pred hhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 003139 724 QKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779 (845)
Q Consensus 724 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~ 779 (845)
..++. ....+..++..+.+++.+||+.||++||||++|++.|+.+.+
T Consensus 243 i~~~~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 243 ITQGR---------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp HHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHcCC---------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11111 112345567789999999999999999999999999988754
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-53 Score=459.68 Aligned_cols=256 Identities=24% Similarity=0.340 Sum_probs=212.3
Q ss_pred CCCcceeeeeeceEEEEEEEEc------CCcEEEEEEcCCCC-hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEE
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD------DGTKVAVKRGNPRS-EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMIL 575 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 575 (845)
+++..+.||+|+||.||+|++. +++.||||++.... ....++|.+|+.+|++++|||||+++|+|.+.+..+|
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 3455678999999999999873 46789999987543 3446789999999999999999999999999999999
Q ss_pred EEEeccCCCccccccCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCc
Q 003139 576 VYEYMANGPLRSHLYGTD--------------LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFV 641 (845)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~ 641 (845)
|||||++|+|.++|.... ...++|.++++|+.|||+||+|||+ ++||||||||+||||++++.
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCCCC
Confidence 999999999999996432 2469999999999999999999999 89999999999999999999
Q ss_pred eEEEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHH
Q 003139 642 AKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWA 720 (845)
Q Consensus 642 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~ 720 (845)
+||+|||+++.....+.........||+.|||||++.++.++.++|||||||+||||+| |+.||......+ +..
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~---~~~-- 258 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---VVE-- 258 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH---HHH--
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH---HHH--
Confidence 99999999986543333334456789999999999999999999999999999999998 899987543221 111
Q ss_pred HHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 003139 721 MTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYA 777 (845)
Q Consensus 721 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~ 777 (845)
...++ .....+..++..+.+++.+||+.||++||||.||++.|+..
T Consensus 259 --~i~~~---------~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 259 --MIRNR---------QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp --HHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred --HHHcC---------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11111 11224456677899999999999999999999999999854
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-52 Score=450.44 Aligned_cols=259 Identities=27% Similarity=0.478 Sum_probs=207.5
Q ss_pred cCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
+++...+.||+|+||.||+|++++ .||||.++.. +.+..++|.+|+++|++++|||||+++|+|.+ +.++|||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 567788899999999999999763 5899987643 45667899999999999999999999999865 568999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCc
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT 659 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~ 659 (845)
|++|+|.++|+..+ .+++|.++++|+.|||+||+|||+ ++||||||||+||||++++.+||+|||+|+........
T Consensus 113 ~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 113 CEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp CSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred CCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 99999999997543 479999999999999999999999 89999999999999999999999999999875443333
Q ss_pred ccccccccCCCcCChhhhcc---CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccc
Q 003139 660 HVSTAVKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSN 736 (845)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~---~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (845)
.......||+.|||||++.+ ++|+.++|||||||+||||+||+.||....... ........+. ..+.
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~------~~~~~~~~~~----~~p~ 258 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD------QIIFMVGRGY----ASPD 258 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHTTC----CCCC
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH------HHHHHHhcCC----CCCC
Confidence 34456789999999999964 468999999999999999999999997543322 1111111111 1111
Q ss_pred cCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhh
Q 003139 737 LVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYAL 778 (845)
Q Consensus 737 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~ 778 (845)
+ ...+..++..+.+++.+||+.+|++||||.||++.|+.+.
T Consensus 259 ~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 259 L-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299 (307)
T ss_dssp S-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred c-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 1 2234556778999999999999999999999999998653
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=448.58 Aligned_cols=252 Identities=23% Similarity=0.363 Sum_probs=207.5
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYE 578 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 578 (845)
++|++.+.||+|+||.||+|+.. +|+.||||++... .....+.|.+|+++|++++|||||++++++.+.+.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 57999999999999999999975 6899999987543 45567889999999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCC
Q 003139 579 YMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQ 658 (845)
Q Consensus 579 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~ 658 (845)
||++|+|.++|...+...+++.+++.|+.||+.||+|||+ ++||||||||+||||++++.+||+|||+|+.... .
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~ 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--T 178 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCH--H
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecC--C
Confidence 9999999999976666678999999999999999999999 9999999999999999999999999999987432 1
Q ss_pred cccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccC
Q 003139 659 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLV 738 (845)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 738 (845)
....+..+||+.|||||++.+..|+.++|||||||+||||++|+.||...... +.... ++....
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~------~~~~~---------i~~~~~- 242 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK------NLVLK---------IISGSF- 242 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHH---------HHHTCC-
T ss_pred cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHH---------HHcCCC-
Confidence 22334578999999999999999999999999999999999999999754321 11111 111111
Q ss_pred CCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003139 739 GKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNL 774 (845)
Q Consensus 739 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L 774 (845)
...+......+.+++.+||+.||++|||+.|++++-
T Consensus 243 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp 278 (350)
T 4b9d_A 243 PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKG 278 (350)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSH
T ss_pred CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence 112334556788999999999999999999998753
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-51 Score=447.41 Aligned_cols=263 Identities=24% Similarity=0.352 Sum_probs=217.1
Q ss_pred HhcCCCcceeeeeeceEEEEEEEEcC------CcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCC-CCcceEEEEEec-C
Q 003139 500 ATNKFDESLLLGVGGFGRVYKGTLDD------GTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRH-RHLVSLIGYCDE-R 570 (845)
Q Consensus 500 at~~f~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~-~ 570 (845)
..++|+..+.||+|+||.||+|++.. ++.||||++... .....++|.+|+++|++++| ||||+++|+|.+ .
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~ 141 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 141 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence 35688999999999999999998652 357999998765 34556789999999999965 899999999966 4
Q ss_pred CcEEEEEEeccCCCccccccCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEE
Q 003139 571 SEMILVYEYMANGPLRSHLYGTD--------------LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILL 636 (845)
Q Consensus 571 ~~~~lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl 636 (845)
+.++||||||++|+|.++|+... ...++|.+++.|+.|||+||+|||+ ++||||||||+||||
T Consensus 142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~~NILl 218 (353)
T 4ase_A 142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILL 218 (353)
T ss_dssp SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCccceee
Confidence 57899999999999999996431 2458999999999999999999999 999999999999999
Q ss_pred CCCCceEEEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCccccc
Q 003139 637 DDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVN 715 (845)
Q Consensus 637 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~ 715 (845)
++++.+||+|||+|+...............||+.|||||++.++.|+.++|||||||+||||+| |+.||......+.
T Consensus 219 ~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~-- 296 (353)
T 4ase_A 219 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-- 296 (353)
T ss_dssp CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH--
T ss_pred CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH--
Confidence 9999999999999987544333334456789999999999999999999999999999999998 8999976443221
Q ss_pred HHHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhh
Q 003139 716 IAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQL 780 (845)
Q Consensus 716 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~ 780 (845)
......++ .....+..++..+.+++.+||+.||++|||+.||+++|+.+++.
T Consensus 297 ----~~~~i~~g---------~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 297 ----FCRRLKEG---------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp ----HHHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----HHHHHHcC---------CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 11112221 11223445567889999999999999999999999999998764
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=437.25 Aligned_cols=256 Identities=21% Similarity=0.226 Sum_probs=210.0
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEec
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYM 580 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 580 (845)
+.|...+.||+|+||.||+|++. +|+.||||+++.... +.+|+.+|++++|||||++++++.+.+.++||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 46778889999999999999976 689999999864321 246999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCC-ceEEEeccccCCCCCCCCc
Q 003139 581 ANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNF-VAKVADFGLSKTGPALDQT 659 (845)
Q Consensus 581 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~-~~kl~DFGla~~~~~~~~~ 659 (845)
++|+|.++|... +.+++.++..++.||+.||+|||+ ++||||||||+||||+.++ ++||+|||+|+........
T Consensus 133 ~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 133 EGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp TTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred CCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 999999999643 479999999999999999999998 9999999999999999987 6999999999864432111
Q ss_pred ---ccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccc
Q 003139 660 ---HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSN 736 (845)
Q Consensus 660 ---~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (845)
......+||+.|||||++.++.++.++|||||||+||||++|++||......+.. ..+....
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---------------~~i~~~~ 272 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC---------------LKIASEP 272 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH---------------HHHHHSC
T ss_pred cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH---------------HHHHcCC
Confidence 1123467999999999999999999999999999999999999999765433211 1111110
Q ss_pred -cCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhhhc
Q 003139 737 -LVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLEE 782 (845)
Q Consensus 737 -l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~~ 782 (845)
...++++.++..+.+++.+||+.||.+|||+.|++++|..+++...
T Consensus 273 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 273 PPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp CGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred CCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 0112345566788999999999999999999999999998876443
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-50 Score=438.03 Aligned_cols=250 Identities=22% Similarity=0.357 Sum_probs=209.3
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEec
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYM 580 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 580 (845)
..|+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+.+.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 46888999999999999999976 68999999986554444567889999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcc
Q 003139 581 ANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH 660 (845)
Q Consensus 581 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 660 (845)
++|+|.+++.. ..+++.++..|+.||+.||+|||+ ++||||||||+||||++++.+||+|||+|+.... ...
T Consensus 154 ~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~~~ 225 (346)
T 4fih_A 154 EGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVP 225 (346)
T ss_dssp TTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--SSC
T ss_pred CCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCC--CCC
Confidence 99999999864 369999999999999999999999 9999999999999999999999999999986432 222
Q ss_pred cccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCC
Q 003139 661 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGK 740 (845)
Q Consensus 661 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 740 (845)
.....+||+.|||||++.+..|+.++|||||||+||||++|++||......+. . ....++ ..+.+ .
T Consensus 226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~------~-~~i~~~-----~~~~~--~ 291 (346)
T 4fih_A 226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA------M-KMIRDN-----LPPRL--K 291 (346)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------H-HHHHHS-----SCCCC--S
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH------H-HHHHcC-----CCCCC--C
Confidence 34567899999999999999999999999999999999999999975432211 1 111111 11111 1
Q ss_pred CCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 741 VNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 741 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
........+.+++.+||+.||++|||+.|++++
T Consensus 292 ~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 292 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 223456678899999999999999999998765
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-50 Score=427.64 Aligned_cols=245 Identities=26% Similarity=0.432 Sum_probs=197.6
Q ss_pred CcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEec----CCcEEEEE
Q 003139 505 DESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDE----RSEMILVY 577 (845)
Q Consensus 505 ~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~ 577 (845)
+..+.||+|+||.||+|.+. +++.||+|++... .....+.|.+|+++|++++|||||++++++.+ .+.++|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 44567999999999999976 6889999987543 45566789999999999999999999999864 34589999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCc--eeeccCCCCcEEEC-CCCceEEEeccccCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQS--IIHRDVKTTNILLD-DNFVAKVADFGLSKTGP 654 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDik~~NILl~-~~~~~kl~DFGla~~~~ 654 (845)
|||++|+|.++|... ..+++..+..|+.||+.||+|||+ ++ |+||||||+||||+ +++.+||+|||+|+...
T Consensus 109 Ey~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 999999999999643 479999999999999999999998 66 99999999999998 47999999999998632
Q ss_pred CCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhc
Q 003139 655 ALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMD 734 (845)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (845)
.......+||+.|||||++.+ +|+.++|||||||+||||+||+.||....... . .......+....
T Consensus 184 ----~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~-----~-~~~~i~~~~~~~--- 249 (290)
T 3fpq_A 184 ----ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-----Q-IYRRVTSGVKPA--- 249 (290)
T ss_dssp ----TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-----H-HHHHHTTTCCCG---
T ss_pred ----CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH-----H-HHHHHHcCCCCC---
Confidence 223446789999999998865 69999999999999999999999996433221 1 111111111110
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 735 SNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 735 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.++......+.+++.+||+.||++|||+.|++++
T Consensus 250 -----~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 250 -----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1112233568899999999999999999999764
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=436.43 Aligned_cols=269 Identities=23% Similarity=0.322 Sum_probs=200.5
Q ss_pred CCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCC----cEEEEEE
Q 003139 503 KFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERS----EMILVYE 578 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lV~E 578 (845)
++...+.||+|+||.||+|+++ |+.||||++...... ...+..|+..+.+++|||||+++|+|.+.+ +++||||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 4566789999999999999985 899999998654322 122345666667899999999999997654 5899999
Q ss_pred eccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----CCceeeccCCCCcEEECCCCceEEEeccccCCC
Q 003139 579 YMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGA-----AQSIIHRDVKTTNILLDDNFVAKVADFGLSKTG 653 (845)
Q Consensus 579 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~ 653 (845)
||++|+|.++|+.. +++|.++++|+.|+++||+|||+.+ .++||||||||+||||++++.+||+|||+|+..
T Consensus 82 y~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 82 YHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp CCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred CCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence 99999999999653 5899999999999999999999731 248999999999999999999999999999864
Q ss_pred CCCCCc--ccccccccCCCcCChhhhccC------CCCchhHHHHHHHHHHHHHcCCCCCCCCCCccc---------ccH
Q 003139 654 PALDQT--HVSTAVKGSFGYLDPEYFRRQ------QLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQ---------VNI 716 (845)
Q Consensus 654 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~---------~~l 716 (845)
...... .......||+.|||||++.+. +++.++|||||||+||||+||++|+......+. ...
T Consensus 159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~ 238 (303)
T 3hmm_A 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence 332221 122346799999999999764 467899999999999999999987753322110 111
Q ss_pred HHHHHHHhhcCchhhhhccccCCC-CCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhhh
Q 003139 717 AEWAMTWQKKGMLDQIMDSNLVGK-VNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLE 781 (845)
Q Consensus 717 ~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~ 781 (845)
..+ ..... .+.+++.+... ...+.+..+.+++.+||+.||++||||.||++.|+++.+.+
T Consensus 239 ~~~-~~~~~----~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~ 299 (303)
T 3hmm_A 239 EEM-RKVVC----EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp HHH-HHHHT----TSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHH-HHHHh----cccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence 111 11111 11112222111 12346678999999999999999999999999999876543
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-50 Score=431.66 Aligned_cols=250 Identities=21% Similarity=0.299 Sum_probs=210.1
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
++|++.+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|+++|++++|||||++++++.+.+.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46999999999999999999975 7899999987643 2234577899999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
|||++|+|.++|... +.+++.++..++.||+.||+|||+ ++|+||||||+||||++++.+||+|||+|+......
T Consensus 112 Ey~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp CCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 999999999999643 479999999999999999999999 999999999999999999999999999998754433
Q ss_pred CcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcccc
Q 003139 658 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNL 737 (845)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (845)
........+||+.|||||++.++.|+.++||||+||+||||++|+.||......+ .. ..++....
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~------~~---------~~i~~~~~ 251 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL------IF---------AKIIKLEY 251 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HH---------HHHHHTCC
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH------HH---------HHHHcCCC
Confidence 3334456789999999999999999999999999999999999999997533211 11 11111111
Q ss_pred CCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 738 VGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.++......+.+++.+||+.||++|||++|++..
T Consensus 252 --~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 252 --DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp --CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred --CCCcccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence 2334445678899999999999999999987543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-49 Score=439.24 Aligned_cols=251 Identities=22% Similarity=0.358 Sum_probs=210.3
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
.+.|+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+.+.+||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 356999999999999999999976 6899999998766555566789999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCc
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT 659 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~ 659 (845)
|++|+|.+++... .+++.++..|+.||+.||+|||+ ++||||||||+||||+.++.+||+|||+|+.... ..
T Consensus 230 ~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~--~~ 301 (423)
T 4fie_A 230 LEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EV 301 (423)
T ss_dssp CTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCS--SC
T ss_pred CCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCC--CC
Confidence 9999999998543 59999999999999999999999 9999999999999999999999999999986432 22
Q ss_pred ccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCC
Q 003139 660 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVG 739 (845)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 739 (845)
......+||+.|||||++.+..|+.++|||||||+||||++|++||......+. . .....+ ..+.+
T Consensus 302 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~------~-~~i~~~-----~~~~~-- 367 (423)
T 4fie_A 302 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA------M-KMIRDN-----LPPRL-- 367 (423)
T ss_dssp CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------H-HHHHHS-----CCCCC--
T ss_pred ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH------H-HHHHcC-----CCCCC--
Confidence 234567899999999999999999999999999999999999999965432211 1 111111 11111
Q ss_pred CCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 740 KVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 740 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.........+.+|+.+||+.||++|||+.|++++
T Consensus 368 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 368 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1123345678899999999999999999998765
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=414.59 Aligned_cols=248 Identities=25% Similarity=0.353 Sum_probs=193.8
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
++|++.+.||+|+||.||+|+.. +|+.||+|++... .....+.+.+|+++|++++|||||++++++.+.+..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999975 6899999987543 2334567999999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
||+ +|+|.+++... .++++.++..++.||+.||+|||+ ++|+||||||+||||++++.+||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~-- 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD-- 164 (275)
T ss_dssp ECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred eCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCC--
Confidence 999 68999988654 479999999999999999999999 9999999999999999999999999999986432
Q ss_pred CcccccccccCCCcCChhhhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccc
Q 003139 658 QTHVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSN 736 (845)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (845)
.......+||+.|||||++.+..+ +.++||||+||+||||+||+.||...... ..... ..++ .
T Consensus 165 -~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~------~~~~~-i~~~--------~ 228 (275)
T 3hyh_A 165 -GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP------VLFKN-ISNG--------V 228 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHH-HHHT--------C
T ss_pred -CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH------HHHHH-HHcC--------C
Confidence 223345789999999999998876 58999999999999999999999653211 11111 1111 1
Q ss_pred cCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 737 LVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 737 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
. .++......+.+++.+||+.||++|||++|++++-.
T Consensus 229 ~--~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw 265 (275)
T 3hyh_A 229 Y--TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDW 265 (275)
T ss_dssp C--CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHH
T ss_pred C--CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCcc
Confidence 1 123344567889999999999999999999988644
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-49 Score=422.49 Aligned_cols=242 Identities=23% Similarity=0.302 Sum_probs=195.1
Q ss_pred cCCCcceeeeeeceEEEEEEEEc----CCcEEEEEEcCCCC--hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD----DGTKVAVKRGNPRS--EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMIL 575 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 575 (845)
++|++.+.||+|+||.||+|+.. .++.||+|.+.... .....++.+|+++|++++|||||++++++.+.+..+|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46899999999999999999863 46789999876432 2233468899999999999999999999999999999
Q ss_pred EEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCC
Q 003139 576 VYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPA 655 (845)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~ 655 (845)
|||||++|+|.++|... ..+++.++..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+|+....
T Consensus 104 vmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 99999999999999643 479999999999999999999999 9999999999999999999999999999986432
Q ss_pred CCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcc
Q 003139 656 LDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDS 735 (845)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (845)
........+||+.|||||++.++.++.++||||+||+||||+||+.||......+ ... .+...
T Consensus 179 --~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~------~~~---------~i~~~ 241 (304)
T 3ubd_A 179 --HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE------TMT---------MILKA 241 (304)
T ss_dssp ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHH---------HHHHC
T ss_pred --CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH------HHH---------HHHcC
Confidence 2223345789999999999999999999999999999999999999997543221 111 11111
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCH
Q 003139 736 NLVGKVNPASLKKFGETAEKCLAEHGVDRPSM 767 (845)
Q Consensus 736 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 767 (845)
.. .++......+.+++.+||+.||++|||+
T Consensus 242 ~~--~~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 242 KL--GMPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp CC--CCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred CC--CCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 11 2334456678899999999999999984
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-47 Score=414.50 Aligned_cols=290 Identities=65% Similarity=1.092 Sum_probs=258.2
Q ss_pred ccccHHHHHHHhcCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEec
Q 003139 490 RLFMFQEILDATNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDE 569 (845)
Q Consensus 490 ~~~~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 569 (845)
..+.+.++..++++|+..+.||+|+||.||+|++++|+.||+|+.........+++.+|++++++++||||+++++++.+
T Consensus 27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 106 (321)
T 2qkw_B 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE 106 (321)
T ss_dssp ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred eeecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 34555667778899999999999999999999988899999999887777777899999999999999999999999999
Q ss_pred CCcEEEEEEeccCCCccccccCCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEec
Q 003139 570 RSEMILVYEYMANGPLRSHLYGTD--LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADF 647 (845)
Q Consensus 570 ~~~~~lV~Ey~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DF 647 (845)
.+..++||||+++|+|.+++.... ...++|.+++.++.|+++||+|||+ ++|+||||||+|||+++++.+||+||
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Df 183 (321)
T 2qkw_B 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDF 183 (321)
T ss_dssp TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCC
T ss_pred CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeec
Confidence 999999999999999999997553 2359999999999999999999999 89999999999999999999999999
Q ss_pred cccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcC
Q 003139 648 GLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKG 727 (845)
Q Consensus 648 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 727 (845)
|+++...............||+.|+|||.+.+..++.++||||||+++|||++|+.||....+.+......|.......+
T Consensus 184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 263 (321)
T 2qkw_B 184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG 263 (321)
T ss_dssp TTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTT
T ss_pred ccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccc
Confidence 99986443333333455678999999999999999999999999999999999999998877777778888888777777
Q ss_pred chhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhhhc
Q 003139 728 MLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLEE 782 (845)
Q Consensus 728 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~~ 782 (845)
.+..++++.+.....+..+..+.+++.+||+.||++|||+.|+++.|+.++++++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~ 318 (321)
T 2qkw_B 264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318 (321)
T ss_dssp CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence 8888888888778888999999999999999999999999999999999987655
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=409.04 Aligned_cols=248 Identities=23% Similarity=0.361 Sum_probs=188.6
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCC--------
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERS-------- 571 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-------- 571 (845)
++|++.+.||+|+||.||+|+.. +|+.||||++... .....+++.+|+++|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 35888999999999999999976 7899999987643 3445678999999999999999999999986544
Q ss_pred ----cEEEEEEeccCCCccccccCCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEe
Q 003139 572 ----EMILVYEYMANGPLRSHLYGTD-LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVAD 646 (845)
Q Consensus 572 ----~~~lV~Ey~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~D 646 (845)
.+++|||||++|+|.+++.... ....++..++.|+.||+.||+|||+ ++|+||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEcc
Confidence 3799999999999999997543 2345677889999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCCCCc----------ccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccH
Q 003139 647 FGLSKTGPALDQT----------HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNI 716 (845)
Q Consensus 647 FGla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l 716 (845)
||+|+........ ...+..+||+.|||||++.+..|+.++|||||||+||||++ ||.... + .
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~--~---~ 233 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM--E---R 233 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH--H---H
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc--H---H
Confidence 9999874432111 11234679999999999999999999999999999999996 553210 0 0
Q ss_pred HHHHHHHhhcCchhhhhccccCCCCC---HHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 717 AEWAMTWQKKGMLDQIMDSNLVGKVN---PASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 717 ~~~~~~~~~~~~~~~~~d~~l~~~~~---~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.... ..+.+ ...+ ......+.+++.+||+.||++|||+.|++++
T Consensus 234 ~~~~---------~~~~~----~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 234 VRTL---------TDVRN----LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHHH---------HHHHT----TCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHH---------HHHhc----CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0000 01111 1122 2233456789999999999999999998764
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=406.91 Aligned_cols=263 Identities=20% Similarity=0.293 Sum_probs=203.2
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEec------CCc
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDE------RSE 572 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~~ 572 (845)
++|++.+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|+++|++++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999975 7999999998654 34456788999999999999999999999753 367
Q ss_pred EEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCC
Q 003139 573 MILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKT 652 (845)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~ 652 (845)
+|||||||+ |+|.+++... ..+++.++..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+.
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecceeee
Confidence 899999995 6799988543 579999999999999999999999 9999999999999999999999999999986
Q ss_pred CCCC--CCcccccccccCCCcCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcC--
Q 003139 653 GPAL--DQTHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKG-- 727 (845)
Q Consensus 653 ~~~~--~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~-- 727 (845)
.... .........+||+.|||||++.+. .++.++||||+||++|||++|++||.+....+.... ........
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~---I~~~~g~p~~ 284 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQL---IMMVLGTPSP 284 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHH---HHHHHCCCCG
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHH---HHHhcCCCCh
Confidence 4321 122234567899999999998875 569999999999999999999999976543322111 11111100
Q ss_pred ---------chhhhhccccC-CCC-----CHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 728 ---------MLDQIMDSNLV-GKV-----NPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 728 ---------~~~~~~d~~l~-~~~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.....+..... ... .+.....+.+|+.+||+.||++|||+.|++++
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000000000 000 11234567899999999999999999998765
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=394.36 Aligned_cols=287 Identities=40% Similarity=0.699 Sum_probs=248.0
Q ss_pred ccccHHHHHHHhcCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCCh-HhHHHHHHHHHHHHhCCCCCcceEEEEEe
Q 003139 490 RLFMFQEILDATNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSE-QGIAEFRTEIEMLSKLRHRHLVSLIGYCD 568 (845)
Q Consensus 490 ~~~~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 568 (845)
+.+++.++...+++|...+.||+|+||.||+|+..+|+.||||++..... .....+.+|++++++++||||++++++|.
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 56889999999999999999999999999999988899999999876532 22346899999999999999999999999
Q ss_pred cCCcEEEEEEeccCCCccccccCCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEe
Q 003139 569 ERSEMILVYEYMANGPLRSHLYGTD--LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVAD 646 (845)
Q Consensus 569 ~~~~~~lV~Ey~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~D 646 (845)
+.+..++||||+++|+|.+++.... ...++|..+..|+.|++.||+|||+.+..+|+||||||+|||+++++.+||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D 177 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 177 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence 9999999999999999999997643 34599999999999999999999993233999999999999999999999999
Q ss_pred ccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC--CCcccccHHHHHHHHh
Q 003139 647 FGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPV--LPREQVNIAEWAMTWQ 724 (845)
Q Consensus 647 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~--~~~~~~~l~~~~~~~~ 724 (845)
||+++.... ..........||+.|+|||.+.+..++.++||||||+++|||++|+.||... .......+.+|.....
T Consensus 178 fg~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (326)
T 3uim_A 178 FGLAKLMDY-KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256 (326)
T ss_dssp CSSCEECCS-SSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred CccccccCc-ccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence 999986443 2233344566999999999999999999999999999999999999999632 1223456677887777
Q ss_pred hcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 003139 725 KKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYA 777 (845)
Q Consensus 725 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~ 777 (845)
....+..+.+..+...........+.+++.+||+.+|.+|||+.+|+++|+..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 77888888888888888899999999999999999999999999999999863
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=393.89 Aligned_cols=201 Identities=22% Similarity=0.351 Sum_probs=171.2
Q ss_pred HHhcCCCcceeeeeeceEEEEEEEEc----CCcEEEEEEcCCCChHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcE
Q 003139 499 DATNKFDESLLLGVGGFGRVYKGTLD----DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERSEM 573 (845)
Q Consensus 499 ~at~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 573 (845)
...++|++.+.||+|+||.||+|+.+ .++.||+|++..... ..++.+|+++|+++ +||||+++++++.+.+..
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 44678999999999999999999864 467899998865543 35678999999998 699999999999999999
Q ss_pred EEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCC-CceEEEeccccCC
Q 003139 574 ILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDN-FVAKVADFGLSKT 652 (845)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~-~~~kl~DFGla~~ 652 (845)
++||||+++|+|.+++. .+++.++..++.|++.||+|||+ ++|+||||||+||||+.+ +.+||+|||+|+.
T Consensus 96 ~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 99999999999999882 58999999999999999999999 999999999999999876 7999999999975
Q ss_pred CCCCCC--------------------------cccccccccCCCcCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCC
Q 003139 653 GPALDQ--------------------------THVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLMEVLCTRPAL 705 (845)
Q Consensus 653 ~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~Elltg~~p~ 705 (845)
...... ....+..+||+.|||||++.+. .++.++||||+||++|||++|+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 332110 1112345799999999999875 5899999999999999999999999
Q ss_pred CCCC
Q 003139 706 NPVL 709 (845)
Q Consensus 706 ~~~~ 709 (845)
....
T Consensus 248 ~~~~ 251 (361)
T 4f9c_A 248 YKAS 251 (361)
T ss_dssp SCCS
T ss_pred CCCC
Confidence 6543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=416.24 Aligned_cols=252 Identities=23% Similarity=0.296 Sum_probs=210.4
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEec
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYM 580 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 580 (845)
++|++.+.||+|+||.||+|+.+ +|+.||+|++........+.+.+|+++|++++|||||++++++.+.+.++||||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 57999999999999999999976 78999999987777777788999999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCC--CceEEEeccccCCCCCCCC
Q 003139 581 ANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDN--FVAKVADFGLSKTGPALDQ 658 (845)
Q Consensus 581 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~--~~~kl~DFGla~~~~~~~~ 658 (845)
++|+|.++|... ...+++.++..++.||+.||+|||+ ++|+||||||+||||+.+ +.+||+|||+|+....
T Consensus 237 ~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~--- 309 (573)
T 3uto_A 237 SGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP--- 309 (573)
T ss_dssp CCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT---
T ss_pred CCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccC---
Confidence 999999988543 3479999999999999999999999 999999999999999854 8999999999987432
Q ss_pred cccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccC
Q 003139 659 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLV 738 (845)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 738 (845)
.......+||+.|||||++.+..|+.++||||+||+||||++|++||......+. ... ..... ..+.
T Consensus 310 ~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~------~~~-i~~~~------~~~~ 376 (573)
T 3uto_A 310 KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET------LRN-VKSCD------WNMD 376 (573)
T ss_dssp TSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHH-HHTTC------CCCC
T ss_pred CCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH------HHH-HHhCC------CCCC
Confidence 2233456899999999999999999999999999999999999999975432221 111 11100 0111
Q ss_pred CCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 739 GKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 739 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
..........+.+|+.+||+.||.+|||+.|++++
T Consensus 377 ~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 377 DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11112345678899999999999999999999874
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=410.09 Aligned_cols=249 Identities=21% Similarity=0.289 Sum_probs=200.8
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC------ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR------SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMI 574 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~------~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 574 (845)
++|++.++||+|+||.||+|+.. +|+.||+|++... ......+...++.+++.++|||||++++++.+.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 56899999999999999999976 6899999987532 1222233344567777889999999999999999999
Q ss_pred EEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCC
Q 003139 575 LVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGP 654 (845)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~ 654 (845)
||||||+||+|..+|... +.+++..+..++.||+.||+|||+ ++||||||||+||||+.+|.+||+|||+|+...
T Consensus 269 lVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 999999999999999653 479999999999999999999999 999999999999999999999999999998643
Q ss_pred CCCCcccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhh
Q 003139 655 ALDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIM 733 (845)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (845)
. ......+||+.|||||++.+ ..|+.++||||+||+||||++|++||..........+ . ..+.
T Consensus 344 ~----~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i---~---------~~i~ 407 (689)
T 3v5w_A 344 K----KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI---D---------RMTL 407 (689)
T ss_dssp S----CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHH---H---------HHHH
T ss_pred C----CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---H---------Hhhc
Confidence 2 12345689999999999974 5799999999999999999999999965332221111 1 1111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCC-----HHHHHHH
Q 003139 734 DSNLVGKVNPASLKKFGETAEKCLAEHGVDRPS-----MGDVLWN 773 (845)
Q Consensus 734 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~~vl~~ 773 (845)
... ..++......+.+++.+||+.||.+|++ +.||+++
T Consensus 408 ~~~--~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 408 TMA--VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp HCC--CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred CCC--CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 111 1233445667889999999999999998 6777654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=386.16 Aligned_cols=262 Identities=26% Similarity=0.433 Sum_probs=216.9
Q ss_pred cCCCcceeeeeeceEEEEEEEEc--------CCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCC
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD--------DGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERS 571 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~--------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 571 (845)
++|...+.||+|+||.||+|++. ++..||||++... .....+++.+|+++++++ +||||++++++|.+.+
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 160 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 160 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence 57888899999999999999863 3457999998765 345567899999999999 8999999999999999
Q ss_pred cEEEEEEeccCCCccccccCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEEC
Q 003139 572 EMILVYEYMANGPLRSHLYGTD--------------LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLD 637 (845)
Q Consensus 572 ~~~lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~ 637 (845)
..++||||+++|+|.+++.... ...+++.+++.++.||++||+|||+ ++|+||||||+||||+
T Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~ 237 (370)
T 2psq_A 161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVT 237 (370)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEC
T ss_pred CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEEC
Confidence 9999999999999999986542 2358999999999999999999999 8999999999999999
Q ss_pred CCCceEEEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccH
Q 003139 638 DNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNI 716 (845)
Q Consensus 638 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l 716 (845)
.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+ +
T Consensus 238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~---~ 314 (370)
T 2psq_A 238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---L 314 (370)
T ss_dssp TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---H
T ss_pred CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---H
Confidence 999999999999986443332233344567889999999999999999999999999999999 999986543222 1
Q ss_pred HHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhhhc
Q 003139 717 AEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLEE 782 (845)
Q Consensus 717 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~~ 782 (845)
.. .... ......+..+...+.+++.+||+.+|.+||++.|+++.|+.++.+..
T Consensus 315 ~~----~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~ 367 (370)
T 2psq_A 315 FK----LLKE---------GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 367 (370)
T ss_dssp HH----HHHT---------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HH----HHhc---------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 11 1111 11122344556788999999999999999999999999999887544
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=367.72 Aligned_cols=281 Identities=36% Similarity=0.645 Sum_probs=233.5
Q ss_pred ccccHHHHHHHhcCCCcc------eeeeeeceEEEEEEEEcCCcEEEEEEcCCC----ChHhHHHHHHHHHHHHhCCCCC
Q 003139 490 RLFMFQEILDATNKFDES------LLLGVGGFGRVYKGTLDDGTKVAVKRGNPR----SEQGIAEFRTEIEMLSKLRHRH 559 (845)
Q Consensus 490 ~~~~~~el~~at~~f~~~------~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~H~n 559 (845)
..|++.++..++++|... +.||+|+||.||+|.. +++.+|+|++... .....+.+.+|++++++++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 568999999999999988 8999999999999987 4889999987643 2345678999999999999999
Q ss_pred cceEEEEEecCCcEEEEEEeccCCCccccccCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECC
Q 003139 560 LVSLIGYCDERSEMILVYEYMANGPLRSHLYGT-DLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDD 638 (845)
Q Consensus 560 iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~ 638 (845)
|+++++++.+.+..++||||+++++|.+++... ...+++|..++.++.|++.||+|||+ .+|+||||||+|||+++
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDE 168 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECT
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEEcC
Confidence 999999999999999999999999999998643 23579999999999999999999999 89999999999999999
Q ss_pred CCceEEEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHH
Q 003139 639 NFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAE 718 (845)
Q Consensus 639 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~ 718 (845)
++.+||+|||+++...............||+.|+|||.+.+ .++.++||||||+++|||++|++||........ +..
T Consensus 169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~ 245 (307)
T 2nru_A 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--LLD 245 (307)
T ss_dssp TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--TTH
T ss_pred CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH--HHH
Confidence 99999999999986543333333445679999999998865 589999999999999999999999976543322 222
Q ss_pred HHHHHhh-cCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhh
Q 003139 719 WAMTWQK-KGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYAL 778 (845)
Q Consensus 719 ~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~ 778 (845)
+...... ...+...+++.+ ...+......+.+++.+||+.+|.+||++.++++.|+.+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 246 IKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 2222222 233455555544 3456778889999999999999999999999999999864
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=375.24 Aligned_cols=261 Identities=27% Similarity=0.370 Sum_probs=215.9
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEec
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYM 580 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 580 (845)
++|...+.||+|+||.||+|.+. +++.||+|++........+.|.+|++++++++||||+++++++.+.+..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 56788899999999999999976 68999999988777888889999999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcc
Q 003139 581 ANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH 660 (845)
Q Consensus 581 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 660 (845)
++|+|.+++... ...+++.+++.++.|+++||+|||+ .+|+||||||+|||+++++.+||+|||+++.........
T Consensus 90 ~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 90 KGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp TTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred CCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 999999999654 3469999999999999999999999 899999999999999999999999999997643221110
Q ss_pred ------------cccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCc
Q 003139 661 ------------VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGM 728 (845)
Q Consensus 661 ------------~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 728 (845)
......||+.|+|||.+.+..++.++||||||+++|||++|..|+........... ..
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~----------~~ 235 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG----------LN 235 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS----------BC
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh----------hh
Confidence 11145799999999999999999999999999999999999998875443321100 01
Q ss_pred hhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhh
Q 003139 729 LDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQL 780 (845)
Q Consensus 729 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~ 780 (845)
.....+.. .+..++..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 236 ~~~~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 236 VRGFLDRY----CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp HHHHHHHT----CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhcccccc----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 11111111 1233445688999999999999999999999999987653
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=373.63 Aligned_cols=259 Identities=27% Similarity=0.447 Sum_probs=206.2
Q ss_pred hcCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYE 578 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 578 (845)
.++|++.+.||+|+||.||+|+.. |+.||||++... .....++|.+|++++++++||||+++++++.+.+..++|||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 467888999999999999999874 889999987654 34556789999999999999999999999999999999999
Q ss_pred eccCCCccccccCCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCc--eeeccCCCCcEEECCCCceEEEeccccCCCCC
Q 003139 579 YMANGPLRSHLYGTD-LPPLSWKQRLEICIGAARGLHYLHTGAAQS--IIHRDVKTTNILLDDNFVAKVADFGLSKTGPA 655 (845)
Q Consensus 579 y~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDik~~NILl~~~~~~kl~DFGla~~~~~ 655 (845)
|+++|+|.+++.... ...+++..++.++.|+++||+|||+ .+ |+||||||+|||+++++.+||+|||+++....
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 191 (309)
T 3p86_A 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191 (309)
T ss_dssp CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence 999999999996543 1248999999999999999999998 77 99999999999999999999999999976332
Q ss_pred CCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcc
Q 003139 656 LDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDS 735 (845)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (845)
.........||+.|+|||.+.+..++.++|||||||++|||++|+.||......+. .... ...
T Consensus 192 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~------~~~~---------~~~ 254 (309)
T 3p86_A 192 --TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV------VAAV---------GFK 254 (309)
T ss_dssp ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH------HHHH---------HHS
T ss_pred --cccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHH---------Hhc
Confidence 11223456799999999999999999999999999999999999999975432211 1111 001
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhh
Q 003139 736 NLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQL 780 (845)
Q Consensus 736 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~ 780 (845)
......+......+.+++.+||+.+|.+|||+.++++.|+.+++.
T Consensus 255 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 255 CKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 111223445567789999999999999999999999999988653
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=382.55 Aligned_cols=262 Identities=24% Similarity=0.375 Sum_probs=204.7
Q ss_pred cCCCcceeeeeeceEEEEEEEEc----CCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD----DGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILV 576 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 576 (845)
++|+..+.||+|+||.||+|++. ++..||||++... .....++|.+|++++++++||||++++++|.+.+..++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 57889999999999999999875 5678999998764 455667899999999999999999999999999999999
Q ss_pred EEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCC
Q 003139 577 YEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPAL 656 (845)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~ 656 (845)
|||+++|+|.+++... ...+++.+++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 125 ~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 125 TEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp EECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 9999999999999654 3469999999999999999999999 89999999999999999999999999999864432
Q ss_pred CCc-ccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhc
Q 003139 657 DQT-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMD 734 (845)
Q Consensus 657 ~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (845)
... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||......+ ... .++
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~------~~~----------~i~ 264 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD------VIK----------AVD 264 (373)
T ss_dssp -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH------HHH----------HHH
T ss_pred CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH------HHH----------HHH
Confidence 111 11223345778999999999999999999999999999998 999986543211 111 111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhhhcc
Q 003139 735 SNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLEET 783 (845)
Q Consensus 735 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~~~ 783 (845)
.......+..++..+.+++.+||+.+|.+||++.+|++.|+.+++....
T Consensus 265 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~~ 313 (373)
T 2qol_A 265 EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGS 313 (373)
T ss_dssp TTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGGG
T ss_pred cCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCccc
Confidence 1111223345567889999999999999999999999999998765443
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=374.23 Aligned_cols=261 Identities=25% Similarity=0.387 Sum_probs=213.2
Q ss_pred cCCCcceeeeeeceEEEEEEEEc----CCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD----DGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILV 576 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 576 (845)
++|.+.+.||+|+||.||+|.+. .+..||||++... .....++|.+|++++++++||||+++++++.+.+..++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 56888899999999999999975 3456999998765 455667899999999999999999999999999999999
Q ss_pred EEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCC
Q 003139 577 YEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPAL 656 (845)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~ 656 (845)
|||+++|+|.+++.... ..+++.+++.|+.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 129 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 204 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204 (325)
T ss_dssp EECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred eeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence 99999999999996443 479999999999999999999999 99999999999999999999999999999864432
Q ss_pred CC-cccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhc
Q 003139 657 DQ-THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMD 734 (845)
Q Consensus 657 ~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (845)
.. ........+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+ .... ..
T Consensus 205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~------~~~~-~~--------- 268 (325)
T 3kul_A 205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD------VISS-VE--------- 268 (325)
T ss_dssp --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH------HHHH-HH---------
T ss_pred ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH------HHHH-HH---------
Confidence 21 122234456788999999999999999999999999999999 999986543221 1111 11
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhhhc
Q 003139 735 SNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLEE 782 (845)
Q Consensus 735 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~~ 782 (845)
.......+..++..+.+++.+||+.+|++||++.+|++.|+.+++..+
T Consensus 269 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 269 EGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred cCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 111122334556788999999999999999999999999999876544
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=376.95 Aligned_cols=269 Identities=25% Similarity=0.348 Sum_probs=210.2
Q ss_pred hcCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCC----cEEEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERS----EMILV 576 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lV 576 (845)
.++|+..+.||+|+||.||+|++. ++.||||++.... .....+..|+.++++++||||+++++++.+.. ..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 357888999999999999999886 7899999986543 33455667999999999999999999997744 47999
Q ss_pred EEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC----------ceeeccCCCCcEEECCCCceEEEe
Q 003139 577 YEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQ----------SIIHRDVKTTNILLDDNFVAKVAD 646 (845)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~----------~ivHrDik~~NILl~~~~~~kl~D 646 (845)
|||+++|+|.+++... .++|.+++.++.|+++||+|||+ . +|+||||||+|||+++++.+||+|
T Consensus 101 ~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 101 TAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp EECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred EecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence 9999999999999653 59999999999999999999998 6 999999999999999999999999
Q ss_pred ccccCCCCCCCCcccccccccCCCcCChhhhcc-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHH
Q 003139 647 FGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAM 721 (845)
Q Consensus 647 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~ 721 (845)
||+++...............||+.|+|||++.+ ..++.++|||||||++|||++|+.||...............
T Consensus 175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~- 253 (322)
T 3soc_A 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI- 253 (322)
T ss_dssp CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH-
T ss_pred CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh-
Confidence 999976443233323345679999999999986 35567899999999999999999999765443222111110
Q ss_pred HHhhcCchhhh----hccccCCCC-----CHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhh
Q 003139 722 TWQKKGMLDQI----MDSNLVGKV-----NPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQL 780 (845)
Q Consensus 722 ~~~~~~~~~~~----~d~~l~~~~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~ 780 (845)
........+ ......... ....+..+.+++.+||+.||++|||+.+|++.|+.+.+.
T Consensus 254 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 254 --GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp --CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --ccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 000011111 111111111 124567799999999999999999999999999988764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=384.06 Aligned_cols=259 Identities=25% Similarity=0.374 Sum_probs=212.0
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYE 578 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 578 (845)
.++|...+.||+|+||.||+|++. +++.||||.+... .....++|.+|+++|++++||||++++++|.+.+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 356788899999999999999986 7899999998754 34455678999999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCC
Q 003139 579 YMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQ 658 (845)
Q Consensus 579 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~ 658 (845)
|+++|+|.+++... ...+++.+++.++.|+++||+|||+ .+|+||||||+|||+++++.+||+|||+++.......
T Consensus 193 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 193 LVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp CCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred cCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence 99999999998643 2368999999999999999999999 8999999999999999999999999999986332111
Q ss_pred cccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcccc
Q 003139 659 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNL 737 (845)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (845)
........+++.|+|||.+.++.++.++|||||||++|||++ |+.||......+ .......+ .
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~---------~ 332 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-------TREFVEKG---------G 332 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH-------HHHHHHTT---------C
T ss_pred eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcC---------C
Confidence 111122345778999999999999999999999999999998 998886543211 11111111 1
Q ss_pred CCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 003139 738 VGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779 (845)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~ 779 (845)
....+..++..+.+++.+||+.+|++|||+.++++.|+.+.+
T Consensus 333 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 333 RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 112334456778899999999999999999999999998764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=379.88 Aligned_cols=270 Identities=23% Similarity=0.320 Sum_probs=217.3
Q ss_pred cHHHHHHHhcCCCcceeeeeeceEEEEEEEEc------CCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhC-CCCCcceEE
Q 003139 493 MFQEILDATNKFDESLLLGVGGFGRVYKGTLD------DGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKL-RHRHLVSLI 564 (845)
Q Consensus 493 ~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~ 564 (845)
...+..-..++|...+.||+|+||.||+|++. +++.||||++... .....+.+.+|++++.++ +||||++++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 34444445688999999999999999999842 4578999998764 445567899999999999 799999999
Q ss_pred EEEecCC-cEEEEEEeccCCCccccccCCCC-------------------------------------------------
Q 003139 565 GYCDERS-EMILVYEYMANGPLRSHLYGTDL------------------------------------------------- 594 (845)
Q Consensus 565 g~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~------------------------------------------------- 594 (845)
++|.+.+ ..++||||+++|+|.+++.....
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 9997755 48999999999999999865431
Q ss_pred ---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCc
Q 003139 595 ---------------PPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT 659 (845)
Q Consensus 595 ---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~ 659 (845)
..+++..++.++.|+++||+|||+ .+|+||||||+||||+.++.+||+|||+++........
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 249 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence 128999999999999999999999 89999999999999999999999999999865433333
Q ss_pred ccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccC
Q 003139 660 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLV 738 (845)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 738 (845)
.......||+.|+|||++.+..++.++|||||||++|||++ |+.||......+. ....... ...
T Consensus 250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~------~~~~~~~---------~~~ 314 (359)
T 3vhe_A 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKE---------GTR 314 (359)
T ss_dssp EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH------HHHHHHH---------TCC
T ss_pred hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH------HHHHHHc---------CCC
Confidence 33455678999999999999999999999999999999998 9999965443221 1111111 111
Q ss_pred CCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhh
Q 003139 739 GKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQL 780 (845)
Q Consensus 739 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~ 780 (845)
...+......+.+++.+||+.+|.+|||+.+++++|+.+++.
T Consensus 315 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 315 MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 122334456788999999999999999999999999988753
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=366.61 Aligned_cols=251 Identities=23% Similarity=0.336 Sum_probs=208.8
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
.++|+..+.||+|+||.||+|... +|+.||+|++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 468999999999999999999864 7899999987655444567789999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCc
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT 659 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~ 659 (845)
+++|+|.+++... .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..... .
T Consensus 99 ~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~ 170 (297)
T 3fxz_A 99 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--Q 170 (297)
T ss_dssp CTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCST--T
T ss_pred CCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc--c
Confidence 9999999998643 58999999999999999999999 89999999999999999999999999998764321 1
Q ss_pred ccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCC
Q 003139 660 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVG 739 (845)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 739 (845)
.......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ .......+ ....
T Consensus 171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~~~~~~--------~~~~ 236 (297)
T 3fxz_A 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNG--------TPEL 236 (297)
T ss_dssp CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHHC--------SCCC
T ss_pred cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhCC--------CCCC
Confidence 223456799999999999999999999999999999999999999965432211 11111111 0011
Q ss_pred CCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 740 KVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 740 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
..+......+.+++.+||+.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 237 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1234456678899999999999999999999865
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=378.59 Aligned_cols=264 Identities=26% Similarity=0.411 Sum_probs=217.5
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc--------CCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhC-CCCCcceEEEEEecC
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD--------DGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDER 570 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~--------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 570 (845)
.++|...+.||+|+||.||+|+.. .+..||||++... .....+++.+|+++++++ +||||++++++|.+.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 357888899999999999999863 2357999988654 455668899999999999 999999999999999
Q ss_pred CcEEEEEEeccCCCccccccCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEE
Q 003139 571 SEMILVYEYMANGPLRSHLYGTD--------------LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILL 636 (845)
Q Consensus 571 ~~~~lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl 636 (845)
+..++||||+++|+|.+++.... ...+++.+++.|+.|++.||+|||+ .+|+||||||+||||
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEEE
Confidence 99999999999999999986543 2469999999999999999999999 899999999999999
Q ss_pred CCCCceEEEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCccccc
Q 003139 637 DDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVN 715 (845)
Q Consensus 637 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~ 715 (845)
++++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~--- 301 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--- 301 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---
Confidence 9999999999999986544333333445567889999999999999999999999999999999 999886543211
Q ss_pred HHHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhhhcc
Q 003139 716 IAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLEET 783 (845)
Q Consensus 716 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~~~ 783 (845)
.. ..... ......+..+...+.+++.+||+.+|++||++.+|++.|+.++.....
T Consensus 302 ---~~-~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 356 (382)
T 3tt0_A 302 ---LF-KLLKE---------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN 356 (382)
T ss_dssp ---HH-HHHHT---------TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred ---HH-HHHHc---------CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 11 11111 111222344566789999999999999999999999999998875543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=360.11 Aligned_cols=256 Identities=29% Similarity=0.408 Sum_probs=212.2
Q ss_pred cCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEecc
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMA 581 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 581 (845)
++|+..+.||+|+||.||+|++.+++.||+|++..... ..+++.+|++++++++||||+++++++.+.+..++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 56888899999999999999998889999999875432 24678999999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCccc
Q 003139 582 NGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHV 661 (845)
Q Consensus 582 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 661 (845)
+++|.+++.... ..+++..++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++.... .....
T Consensus 89 ~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~-~~~~~ 163 (269)
T 4hcu_A 89 HGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTS 163 (269)
T ss_dssp TCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC-HHHHS
T ss_pred CCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEeccccccccccc-ccccc
Confidence 999999996543 468999999999999999999999 9999999999999999999999999999986432 11222
Q ss_pred ccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCC
Q 003139 662 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGK 740 (845)
Q Consensus 662 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 740 (845)
.....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ..... .. .....
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~------~~~~~-~~---------~~~~~ 227 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE------VVEDI-ST---------GFRLY 227 (269)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHH-HT---------TCCCC
T ss_pred ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH------HHHHH-hc---------CccCC
Confidence 334556788999999999999999999999999999999 899986533211 11111 11 11111
Q ss_pred CCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 003139 741 VNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779 (845)
Q Consensus 741 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~ 779 (845)
.+......+.+++.+||+.+|++||++.+++++|+.+.+
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 228 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 223345678899999999999999999999999998765
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=371.48 Aligned_cols=260 Identities=23% Similarity=0.373 Sum_probs=206.1
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCc----EEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGT----KVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMIL 575 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 575 (845)
++|+..+.||+|+||.||+|++. +++ +||+|.+... .....++|.+|++++++++||||++++++|.+. ..++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEE
Confidence 56888899999999999999964 344 3688887543 334567899999999999999999999999875 4889
Q ss_pred EEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCC
Q 003139 576 VYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPA 655 (845)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~ 655 (845)
|+||+++|+|.+++.... ..+++..++.|+.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 94 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred EEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 999999999999987543 469999999999999999999999 8999999999999999999999999999986443
Q ss_pred CCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhc
Q 003139 656 LDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMD 734 (845)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (845)
...........+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+ + ...+.
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~-------------~~~~~ 233 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---I-------------SSILE 233 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---H-------------HHHHH
T ss_pred CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---H-------------HHHHH
Confidence 333333345567889999999999999999999999999999999 999997543322 1 11111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhhhc
Q 003139 735 SNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLEE 782 (845)
Q Consensus 735 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~~ 782 (845)
.......+..+...+.+++.+||+.+|++||++.+++++|+.+.....
T Consensus 234 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~ 281 (327)
T 3poz_A 234 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 281 (327)
T ss_dssp TTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSHH
T ss_pred cCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhhh
Confidence 111222344556778999999999999999999999999998876443
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=367.06 Aligned_cols=263 Identities=21% Similarity=0.308 Sum_probs=216.6
Q ss_pred ccccHHHHHHHhcC----------CCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCC
Q 003139 490 RLFMFQEILDATNK----------FDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHR 558 (845)
Q Consensus 490 ~~~~~~el~~at~~----------f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ 558 (845)
..++++++..+++. |+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45788888888765 667789999999999999986 7999999998766666677899999999999999
Q ss_pred CcceEEEEEecCCcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECC
Q 003139 559 HLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDD 638 (845)
Q Consensus 559 niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~ 638 (845)
||+++++++...+..++||||+++++|.+++.. ..+++.++..++.|+++||+|||+ .+|+||||||+|||++.
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~ 176 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTL 176 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECT
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECC
Confidence 999999999999999999999999999999853 369999999999999999999999 89999999999999999
Q ss_pred CCceEEEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHH
Q 003139 639 NFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAE 718 (845)
Q Consensus 639 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~ 718 (845)
++.+||+|||+++..... ........||+.|+|||++.+..++.++||||||+++|||++|+.||......+
T Consensus 177 ~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~------ 248 (321)
T 2c30_A 177 DGRVKLSDFGFCAQISKD--VPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ------ 248 (321)
T ss_dssp TCCEEECCCTTCEECCSS--SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------
T ss_pred CCcEEEeeeeeeeecccC--ccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------
Confidence 999999999999764321 112345679999999999999999999999999999999999999996543211
Q ss_pred HHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003139 719 WAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNL 774 (845)
Q Consensus 719 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L 774 (845)
.... .... ..+.+ .........+.+++.+||+.||++|||+.+++++-
T Consensus 249 ~~~~-~~~~-----~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp 296 (321)
T 2c30_A 249 AMKR-LRDS-----PPPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHP 296 (321)
T ss_dssp HHHH-HHHS-----SCCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred HHHH-HhcC-----CCCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 1111 1111 11111 11223456788999999999999999999998753
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=370.39 Aligned_cols=267 Identities=26% Similarity=0.387 Sum_probs=210.4
Q ss_pred cCCCcceeeeeeceEEEEEEEE-----cCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecC--CcEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTL-----DDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDER--SEMI 574 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 574 (845)
++|+..+.||+|+||.||+|++ .+++.||||++........+.|.+|++++++++||||+++++++... ...+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 5788889999999999999984 26889999999888877788999999999999999999999999553 5689
Q ss_pred EEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCC
Q 003139 575 LVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGP 654 (845)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~ 654 (845)
+||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 90 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLP 165 (295)
T ss_dssp EEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred EEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence 9999999999999996543 358999999999999999999999 999999999999999999999999999998644
Q ss_pred CCCCc-ccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcC------
Q 003139 655 ALDQT-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKG------ 727 (845)
Q Consensus 655 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~------ 727 (845)
..... .......++..|+|||.+.+..++.++||||||+++|||++|..|+...... +........
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~-------~~~~~~~~~~~~~~~ 238 (295)
T 3ugc_A 166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE-------FMRMIGNDKQGQMIV 238 (295)
T ss_dssp ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH-------HHHHHCTTCCTHHHH
T ss_pred CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH-------HHhhhcCccccchhH
Confidence 32211 2223445777899999999999999999999999999999999887532110 000000000
Q ss_pred -chhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 003139 728 -MLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779 (845)
Q Consensus 728 -~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~ 779 (845)
.+.+.+........+..++..+.+++.+||+.+|++|||+.|+++.|+.+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 239 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 0111111122223345566789999999999999999999999999998764
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=380.43 Aligned_cols=264 Identities=27% Similarity=0.331 Sum_probs=213.9
Q ss_pred cCCCcceeeeeeceEEEEEEEEc------CCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD------DGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMI 574 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 574 (845)
++|...+.||+|+||.||+|++. +++.||||++... ......++.+|+.++++++||||+++++++.+....+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 56888899999999999999853 4668999998654 4556678999999999999999999999999999999
Q ss_pred EEEEeccCCCccccccCCC-----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCC---ceEEEe
Q 003139 575 LVYEYMANGPLRSHLYGTD-----LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNF---VAKVAD 646 (845)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~---~~kl~D 646 (845)
+||||+++|+|.+++.... ...+++.+++.++.||++||+|||+ .+|+||||||+||||+.++ .+||+|
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEECC
Confidence 9999999999999986432 2469999999999999999999999 8999999999999999554 599999
Q ss_pred ccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhh
Q 003139 647 FGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQK 725 (845)
Q Consensus 647 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~ 725 (845)
||+++...............||+.|+|||.+.+..++.++|||||||++|||++ |+.||......+ .... ..
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~------~~~~-i~ 300 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE------VLEF-VT 300 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------HHHH-HH
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHH-HH
Confidence 999974221122222334567899999999999999999999999999999998 999986543211 1111 11
Q ss_pred cCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhhhccc
Q 003139 726 KGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLEETS 784 (845)
Q Consensus 726 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~~~~ 784 (845)
. ......+..++..+.+++.+||+.+|++||++.+|++.|+.+.+.....
T Consensus 301 ~---------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~~ 350 (367)
T 3l9p_A 301 S---------GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVI 350 (367)
T ss_dssp T---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHHH
T ss_pred c---------CCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhhc
Confidence 1 1111223445667899999999999999999999999999987765543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=366.00 Aligned_cols=260 Identities=25% Similarity=0.376 Sum_probs=215.1
Q ss_pred hcCCCcceeeeeeceEEEEEEEE------cCCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTL------DDGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEM 573 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 573 (845)
.++|...+.||+|+||.||+|+. .+++.||+|++... .....+++.+|++++++++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 46788889999999999999986 24578999998754 455668899999999999999999999999999999
Q ss_pred EEEEEeccCCCccccccCCCC----------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCC
Q 003139 574 ILVYEYMANGPLRSHLYGTDL----------------------PPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKT 631 (845)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~----------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~ 631 (845)
++||||+++++|.+++..... ..+++.+++.++.|+++||+|||+ ++|+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccch
Confidence 999999999999999865422 348999999999999999999999 8999999999
Q ss_pred CcEEECCCCceEEEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCC
Q 003139 632 TNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLP 710 (845)
Q Consensus 632 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~ 710 (845)
+|||+++++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999986543232223334567889999999999999999999999999999999 9999875443
Q ss_pred cccccHHHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 003139 711 REQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779 (845)
Q Consensus 711 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~ 779 (845)
.+ +.. .... ......+...+..+.+++.+||+.||++||++.++++.|+.++.
T Consensus 259 ~~---~~~----~~~~---------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 259 ER---LFN----LLKT---------GHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp GG---HHH----HHHT---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HH---HHH----Hhhc---------CCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 22 111 1111 11122334456778999999999999999999999999998765
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=370.56 Aligned_cols=248 Identities=21% Similarity=0.338 Sum_probs=207.4
Q ss_pred hcCCCcceeeeeeceEEEEEEEE-cCCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTL-DDGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
.++|...+.||+|+||.||+|++ .+|+.||||++... .....+.+.+|++++++++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 35788999999999999999997 47899999987543 4556678899999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
||+++|+|.+++... ..+++.++..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 94 e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~-- 166 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV-- 166 (328)
T ss_dssp CCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS--
T ss_pred ECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCC--
Confidence 999999999998644 469999999999999999999999 8999999999999999999999999999976332
Q ss_pred CcccccccccCCCcCChhhhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccc
Q 003139 658 QTHVSTAVKGSFGYLDPEYFRRQQLT-EKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSN 736 (845)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (845)
........||+.|+|||.+.+..+. .++|||||||++|||++|+.||......+ .... +....
T Consensus 167 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~---------i~~~~ 230 (328)
T 3fe3_A 167 -GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE------LRER---------VLRGK 230 (328)
T ss_dssp -SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHH---------HHHCC
T ss_pred -CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH------HHHH---------HHhCC
Confidence 2233456799999999999988875 89999999999999999999997543211 1111 11111
Q ss_pred cCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 737 LVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 737 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
. ..+......+.+++.+||+.||.+|||+.|++++
T Consensus 231 ~--~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 231 Y--RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp C--CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred C--CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1 1233345678899999999999999999998765
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=364.93 Aligned_cols=261 Identities=23% Similarity=0.366 Sum_probs=215.1
Q ss_pred cCCCcceeeeeeceEEEEEEEE------cCCcEEEEEEcCCCC-hHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTL------DDGTKVAVKRGNPRS-EQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERSEM 573 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 573 (845)
++|...+.||+|+||.||+|++ .+++.||+|++.... ....+.+.+|+++++++ +||||+++++++.+.+..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 102 (313)
T 1t46_A 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (313)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCc
Confidence 5788889999999999999985 246789999987553 34567899999999999 999999999999999999
Q ss_pred EEEEEeccCCCccccccCCCC----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEEC
Q 003139 574 ILVYEYMANGPLRSHLYGTDL----------------PPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLD 637 (845)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~ 637 (845)
++||||+++|+|.+++..... ..+++.+++.++.|+++||+|||+ ++|+||||||+|||++
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~ 179 (313)
T 1t46_A 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLT 179 (313)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEE
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEc
Confidence 999999999999999865432 258999999999999999999999 8999999999999999
Q ss_pred CCCceEEEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccH
Q 003139 638 DNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNI 716 (845)
Q Consensus 638 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l 716 (845)
+++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........
T Consensus 180 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--- 256 (313)
T 1t46_A 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--- 256 (313)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH---
T ss_pred CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH---
Confidence 999999999999987544333233345567889999999999999999999999999999999 9999865433221
Q ss_pred HHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhh
Q 003139 717 AEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQL 780 (845)
Q Consensus 717 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~ 780 (845)
.... +........+...+..+.+++.+||+.+|.+||++.++++.|+.++..
T Consensus 257 ---~~~~---------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 257 ---FYKM---------IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp ---HHHH---------HHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---HHHH---------hccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 1111 111111122334556789999999999999999999999999987653
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=390.37 Aligned_cols=257 Identities=25% Similarity=0.401 Sum_probs=212.7
Q ss_pred hcCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEec
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYM 580 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 580 (845)
.++|+..+.||+|+||.||+|.++++..||||++.... ...++|.+|+++|++++||||+++++++. .+..++||||+
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~ 264 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM 264 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence 45788889999999999999999888999999987644 34678999999999999999999999986 56789999999
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcc
Q 003139 581 ANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH 660 (845)
Q Consensus 581 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 660 (845)
++|+|.+++.......+++.+++.++.||++||+|||+ ++|+||||||+||||+.++.+||+|||+++.... ....
T Consensus 265 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~-~~~~ 340 (454)
T 1qcf_A 265 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIED-NEYT 340 (454)
T ss_dssp TTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC-HHHH
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCC-Ccee
Confidence 99999999975544468999999999999999999999 8999999999999999999999999999986432 1111
Q ss_pred cccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCC
Q 003139 661 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVG 739 (845)
Q Consensus 661 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 739 (845)
......+++.|+|||++..+.++.++|||||||+||||++ |+.||......+ .... ...+ ...
T Consensus 341 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~------~~~~-i~~~---------~~~ 404 (454)
T 1qcf_A 341 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE------VIRA-LERG---------YRM 404 (454)
T ss_dssp TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------HHHH-HHHT---------CCC
T ss_pred ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH------HHHH-HHcC---------CCC
Confidence 2234456788999999999999999999999999999999 999986543221 1111 1111 111
Q ss_pred CCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 003139 740 KVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779 (845)
Q Consensus 740 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~ 779 (845)
..+..++..+.+++.+||+.+|++|||+.+|++.|+.+..
T Consensus 405 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 405 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 2234556788999999999999999999999999997654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=371.09 Aligned_cols=261 Identities=28% Similarity=0.425 Sum_probs=213.8
Q ss_pred HhcCCCcceeeeeeceEEEEEEEEc------CCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Q 003139 500 ATNKFDESLLLGVGGFGRVYKGTLD------DGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSE 572 (845)
Q Consensus 500 at~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 572 (845)
..++|+..+.||+|+||.||+|+.. +++.||+|.+... .....++|.+|++++++++||||+++++++.+.+.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 4578999999999999999999975 3478999998765 44556789999999999999999999999999999
Q ss_pred EEEEEEeccCCCccccccCCC----------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCC
Q 003139 573 MILVYEYMANGPLRSHLYGTD----------------------LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVK 630 (845)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik 630 (845)
.++||||+++|+|.+++.... ...+++.+++.++.||++||+|||+ ++|+|||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlk 201 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLA 201 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCS
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCC
Confidence 999999999999999986532 2579999999999999999999999 899999999
Q ss_pred CCcEEECCCCceEEEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 003139 631 TTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVL 709 (845)
Q Consensus 631 ~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~ 709 (845)
|+|||+++++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 9999999999999999999975332222222334567899999999999999999999999999999999 999986533
Q ss_pred CcccccHHHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 003139 710 PREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779 (845)
Q Consensus 710 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~ 779 (845)
..+ .. ....++. . ...+..++..+.+++.+||+.+|++||++.++++.|+.+.+
T Consensus 282 ~~~------~~-~~~~~~~--------~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 282 HEE------VI-YYVRDGN--------I-LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp HHH------HH-HHHHTTC--------C-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred hHH------HH-HHHhCCC--------c-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 211 11 1111111 1 12334456678999999999999999999999999998765
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=369.93 Aligned_cols=260 Identities=24% Similarity=0.349 Sum_probs=207.5
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcE----EEEEEcCCCC-hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTK----VAVKRGNPRS-EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMIL 575 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 575 (845)
++|+..+.||+|+||.||+|++. +++. |++|.+.... ....+.+.+|+.++++++||||++++++|. .+..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 46888899999999999999965 4443 7888765432 333456788999999999999999999986 467999
Q ss_pred EEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCC
Q 003139 576 VYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPA 655 (845)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~ 655 (845)
||||+++|+|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 92 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 99999999999998654 3478999999999999999999999 8999999999999999999999999999987554
Q ss_pred CCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhc
Q 003139 656 LDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMD 734 (845)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (845)
...........++..|+|||.+.+..++.++|||||||++|||++ |+.||......+. .. ....+
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~----~~~~~------- 233 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV---PD----LLEKG------- 233 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH---HH----HHHTT-------
T ss_pred ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH---HH----HHHcC-------
Confidence 333334456678889999999999999999999999999999999 9999976443221 11 11111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhhhc
Q 003139 735 SNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLEE 782 (845)
Q Consensus 735 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~~ 782 (845)
.....+..+...+.+++.+||+.+|.+||++.+++++|+.+.....
T Consensus 234 --~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~~ 279 (325)
T 3kex_A 234 --ERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPP 279 (325)
T ss_dssp --CBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSHH
T ss_pred --CCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 1111222344567889999999999999999999999998866543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=370.72 Aligned_cols=262 Identities=23% Similarity=0.361 Sum_probs=211.4
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc------CCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCc
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD------DGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERSE 572 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 572 (845)
.++|+..+.||+|+||.||+|+.. ++..||+|.+... .....+.+.+|+++++++ +||||+++++++...+.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 467889999999999999999962 4567999998754 234457899999999999 89999999999999999
Q ss_pred EEEEEEeccCCCccccccCCCC---------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCC
Q 003139 573 MILVYEYMANGPLRSHLYGTDL---------------------PPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKT 631 (845)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~ 631 (845)
.++||||+++|+|.+++..... ..+++.+++.++.|++.||+|||+ ++|+||||||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp 200 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAA 200 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSG
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCh
Confidence 9999999999999999965432 348999999999999999999999 9999999999
Q ss_pred CcEEECCCCceEEEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCC
Q 003139 632 TNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLP 710 (845)
Q Consensus 632 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~ 710 (845)
+|||++.++.+||+|||+++...............||+.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 999999999999999999986433222223345567889999999999999999999999999999998 9999876543
Q ss_pred cccccHHHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhh
Q 003139 711 REQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQL 780 (845)
Q Consensus 711 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~ 780 (845)
... ... .+........+...+..+.+++.+||+.+|.+||++.++++.|+.++..
T Consensus 281 ~~~------~~~---------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 281 DAN------FYK---------LIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp SHH------HHH---------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred HHH------HHH---------HHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 221 111 1111112223344567789999999999999999999999999987653
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=392.47 Aligned_cols=258 Identities=26% Similarity=0.411 Sum_probs=216.4
Q ss_pred hcCCCcceeeeeeceEEEEEEEEcC-CcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLDD-GTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
..+|...+.||+|+||.||+|++.. +..||||.+.... ...++|.+|+++|++++||||++++++|.+.+..++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 3567888899999999999999874 7899999987543 3457899999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCc
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT 659 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~ 659 (845)
+++|+|.+++.......+++..++.|+.||++||+|||+ ++|+||||||+||||++++.+||+|||+++.... ...
T Consensus 298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~-~~~ 373 (495)
T 1opk_A 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG-DTY 373 (495)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTT-CCE
T ss_pred cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccC-Cce
Confidence 999999999976655679999999999999999999999 8999999999999999999999999999987433 122
Q ss_pred ccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccC
Q 003139 660 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLV 738 (845)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 738 (845)
.......+++.|+|||++.+..++.++|||||||+||||++ |+.||......+ +.+ .+.....
T Consensus 374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~---~~~-------------~~~~~~~ 437 (495)
T 1opk_A 374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYE-------------LLEKDYR 437 (495)
T ss_dssp ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHH-------------HHHTTCC
T ss_pred eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH---HHH-------------HHHcCCC
Confidence 22334556789999999999999999999999999999999 888886543221 111 1111222
Q ss_pred CCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 003139 739 GKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779 (845)
Q Consensus 739 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~ 779 (845)
...+..++..+.+++.+||+.+|++||++.+|++.|+.+.+
T Consensus 438 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 438 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 23345566788999999999999999999999999997754
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=382.27 Aligned_cols=252 Identities=27% Similarity=0.427 Sum_probs=210.3
Q ss_pred hcCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCC-cEEEEEEe
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERS-EMILVYEY 579 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~Ey 579 (845)
.++|+..+.||+|+||.||+|.+. |+.||||.+.... ..+.|.+|+++|++++||||++++++|.+.+ ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 356888899999999999999986 7899999987654 4578999999999999999999999987655 79999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCc
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT 659 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~ 659 (845)
+++|+|.+++.......+++..++.++.||++||+|||+ ++|+||||||+|||+++++.+||+|||+++....
T Consensus 269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~---- 341 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS---- 341 (450)
T ss_dssp CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc----
Confidence 999999999976555568999999999999999999999 8999999999999999999999999999985322
Q ss_pred ccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccC
Q 003139 660 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLV 738 (845)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 738 (845)
......+++.|+|||.+.+..++.++|||||||+||||++ |+.||......+ +.. ....+ ..
T Consensus 342 -~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~----~i~~~---------~~ 404 (450)
T 1k9a_A 342 -TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVP----RVEKG---------YK 404 (450)
T ss_dssp ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HHH----HHHTT---------CC
T ss_pred -cccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHHcC---------CC
Confidence 1122367889999999999999999999999999999998 999987544322 111 11111 11
Q ss_pred CCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 003139 739 GKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779 (845)
Q Consensus 739 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~ 779 (845)
...+..++..+.+++.+||+.+|.+|||+.++++.|+.+..
T Consensus 405 ~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 405 MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 22345566789999999999999999999999999998764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=359.86 Aligned_cols=261 Identities=25% Similarity=0.369 Sum_probs=208.4
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCC---CChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNP---RSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
++|+..+.||+|+||.||+|+.. +++.||+|++.. ......+.|.+|+.++++++||||+++++++.+.+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 57888999999999999999975 688999998643 34555678999999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
||+++++|.+++... .++++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 91 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 164 (294)
T 4eqm_A 91 EYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET- 164 (294)
T ss_dssp ECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred eCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCccccccc-
Confidence 999999999998644 469999999999999999999999 89999999999999999999999999999864321
Q ss_pred CcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcccc
Q 003139 658 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNL 737 (845)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (845)
.........||+.|+|||.+.+..++.++||||||+++|||++|+.||......+ .......... .. .
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~~~-~~-----~ 232 (294)
T 4eqm_A 165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS------IAIKHIQDSV-PN-----V 232 (294)
T ss_dssp ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH------HHHHHHSSCC-CC-----H
T ss_pred cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhhccC-CC-----c
Confidence 1122334679999999999999999999999999999999999999996543211 1111111111 00 0
Q ss_pred CCCCCHHHHHHHHHHHHHhhhhCCCCCC-CHHHHHHHHHHhhhh
Q 003139 738 VGKVNPASLKKFGETAEKCLAEHGVDRP-SMGDVLWNLEYALQL 780 (845)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~~vl~~L~~~~~~ 780 (845)
........+..+.+++.+|++.+|++|| +++++.+.|+..+..
T Consensus 233 ~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 233 TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 0112234456788999999999999998 999999998876543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=359.53 Aligned_cols=258 Identities=28% Similarity=0.377 Sum_probs=210.2
Q ss_pred hcCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEec
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYM 580 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 580 (845)
.++|+..+.||+|+||.||+|.+.++..||+|++..... ..+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 357888899999999999999999888999999875533 2367899999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcc
Q 003139 581 ANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH 660 (845)
Q Consensus 581 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 660 (845)
++++|.+++... ...+++.+++.++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.... ....
T Consensus 102 ~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~-~~~~ 176 (283)
T 3gen_A 102 ANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYT 176 (283)
T ss_dssp TTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC-HHHH
T ss_pred CCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEccccccccccc-cccc
Confidence 999999998653 2469999999999999999999999 8999999999999999999999999999976432 1112
Q ss_pred cccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCC
Q 003139 661 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVG 739 (845)
Q Consensus 661 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 739 (845)
......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+ .... ... ....
T Consensus 177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~------~~~~-~~~---------~~~~ 240 (283)
T 3gen_A 177 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE------TAEH-IAQ---------GLRL 240 (283)
T ss_dssp STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HHHH-HHT---------TCCC
T ss_pred cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH------HHHH-Hhc---------ccCC
Confidence 2234456788999999999999999999999999999998 999986543221 1111 111 1111
Q ss_pred CCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhh
Q 003139 740 KVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQL 780 (845)
Q Consensus 740 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~ 780 (845)
..+......+.+++.+||+.+|.+|||+.+++++|+.++..
T Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 241 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 12233456788999999999999999999999999988654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=366.67 Aligned_cols=265 Identities=25% Similarity=0.381 Sum_probs=198.8
Q ss_pred HhcCCCcceeeeeeceEEEEEEEEcC-C---cEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcE
Q 003139 500 ATNKFDESLLLGVGGFGRVYKGTLDD-G---TKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEM 573 (845)
Q Consensus 500 at~~f~~~~~LG~G~fg~Vy~~~~~~-g---~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 573 (845)
..++|+..+.||+|+||.||+|++.. + ..||||.+... .....+++.+|++++++++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 34679999999999999999998763 2 27999988654 345578899999999999999999999999877655
Q ss_pred ------EEEEEeccCCCccccccCC----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceE
Q 003139 574 ------ILVYEYMANGPLRSHLYGT----DLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAK 643 (845)
Q Consensus 574 ------~lV~Ey~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~k 643 (845)
++||||+++|+|.+++... ....+++.+++.++.|+++||+|||+ .+|+||||||+|||+++++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCCEE
Confidence 9999999999999988532 22368999999999999999999999 8999999999999999999999
Q ss_pred EEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHH
Q 003139 644 VADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMT 722 (845)
Q Consensus 644 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~ 722 (845)
|+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |+.||......+ +..
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~---- 250 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---IYN---- 250 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH----
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---HHH----
Confidence 999999986443232233344567889999999999999999999999999999999 899987543322 111
Q ss_pred HhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhhhcc
Q 003139 723 WQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLEET 783 (845)
Q Consensus 723 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~~~ 783 (845)
.+... .....+...+..+.+++.+||+.||++|||+.++++.|+.+++....
T Consensus 251 --------~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~ 302 (323)
T 3qup_A 251 --------YLIGG-NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSV 302 (323)
T ss_dssp --------HHHTT-CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---
T ss_pred --------HHhcC-CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhh
Confidence 11111 11123344567789999999999999999999999999999875443
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=366.21 Aligned_cols=255 Identities=24% Similarity=0.304 Sum_probs=205.4
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC-hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS-EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
++|+..+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 57889999999999999999976 78999999875443 23346788999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCc
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT 659 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~ 659 (845)
+++|+|.+++... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 87 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 87 CSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp CTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred CCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 9999999999543 469999999999999999999999 99999999999999999999999999999764322223
Q ss_pred ccccccccCCCcCChhhhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccC
Q 003139 660 HVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLV 738 (845)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 738 (845)
.......||+.|+|||++.+..+ +.++|||||||++|||++|+.||........ ....|. .. ...
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~----~~---------~~~ 227 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWK----EK---------KTY 227 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHHH----TT---------CTT
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHHh----cc---------ccc
Confidence 33445689999999999988775 7899999999999999999999975433211 111111 10 111
Q ss_pred CCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 739 GKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 739 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
..........+.+++.+||+.||++|||+.|++++-.
T Consensus 228 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~ 264 (323)
T 3tki_A 228 LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRW 264 (323)
T ss_dssp STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChh
Confidence 1111334567789999999999999999999986643
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=356.70 Aligned_cols=257 Identities=27% Similarity=0.375 Sum_probs=211.5
Q ss_pred hcCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEec
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYM 580 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 580 (845)
.++|+..+.||+|+||.||+|..+++..||+|++..... ..+++.+|++++.+++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 357888999999999999999998888999999875432 3467899999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcc
Q 003139 581 ANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH 660 (845)
Q Consensus 581 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 660 (845)
++++|.+++.... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.... ....
T Consensus 86 ~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~-~~~~ 160 (268)
T 3sxs_A 86 SNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD-DQYV 160 (268)
T ss_dssp TTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCT-TCEE
T ss_pred CCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecch-hhhh
Confidence 9999999986532 358999999999999999999999 8999999999999999999999999999986443 2222
Q ss_pred cccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCC
Q 003139 661 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVG 739 (845)
Q Consensus 661 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 739 (845)
......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ........ ...
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~~~~~----------~~~ 224 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE------VVLKVSQG----------HRL 224 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HHHHHHTT----------CCC
T ss_pred cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH------HHHHHHcC----------CCC
Confidence 2334556778999999999999999999999999999999 999986543221 11111110 011
Q ss_pred CCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 003139 740 KVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779 (845)
Q Consensus 740 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~ 779 (845)
..+...+..+.+++.+||+.+|.+|||+.++++.|+.+.+
T Consensus 225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 225 YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 1222335678899999999999999999999999987654
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=385.00 Aligned_cols=257 Identities=29% Similarity=0.433 Sum_probs=207.6
Q ss_pred hcCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEec
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYM 580 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 580 (845)
.++|...+.||+|+||.||+|.++++..||||++..... ..++|.+|+++|++++||||+++++++.+ +..++||||+
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~ 260 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 260 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence 356788889999999999999998888899999876442 34689999999999999999999999976 6789999999
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcc
Q 003139 581 ANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH 660 (845)
Q Consensus 581 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 660 (845)
++|+|.+++.......+++.+++.++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++.... ....
T Consensus 261 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~-~~~~ 336 (452)
T 1fmk_A 261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYT 336 (452)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred cCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCC-Ccee
Confidence 99999999965444568999999999999999999999 9999999999999999999999999999986432 1112
Q ss_pred cccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCC
Q 003139 661 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVG 739 (845)
Q Consensus 661 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 739 (845)
......++..|+|||.+.++.++.++|||||||+||||++ |+.||......+ .... ...+ ...
T Consensus 337 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~------~~~~-i~~~---------~~~ 400 (452)
T 1fmk_A 337 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE------VLDQ-VERG---------YRM 400 (452)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHHH-HHTT---------CCC
T ss_pred cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH------HHHH-HHcC---------CCC
Confidence 2234557789999999999999999999999999999999 899986543221 1111 1111 111
Q ss_pred CCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 003139 740 KVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779 (845)
Q Consensus 740 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~ 779 (845)
..+..++..+.+++.+||+.+|++|||+.++++.|+.+..
T Consensus 401 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 401 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 2344566788999999999999999999999999997654
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=354.09 Aligned_cols=251 Identities=20% Similarity=0.320 Sum_probs=208.9
Q ss_pred cCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecC--CcEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDER--SEMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 577 (845)
++|...+.||+|+||.||+|+++ ++.+|+|++... .....++|.+|++++++++||||+++++++.+. +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 46888899999999999999986 889999987654 455567899999999999999999999999877 7889999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCc--eeeccCCCCcEEECCCCceEEEeccccCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQS--IIHRDVKTTNILLDDNFVAKVADFGLSKTGPA 655 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDik~~NILl~~~~~~kl~DFGla~~~~~ 655 (845)
||+++|+|.+++.......+++.+++.++.|++.||+|||+ .+ |+||||||+|||+++++.++|+|||++....
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~- 164 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ- 164 (271)
T ss_dssp ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS-
T ss_pred cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceeeec-
Confidence 99999999999987655579999999999999999999998 77 9999999999999999999999999875422
Q ss_pred CCCcccccccccCCCcCChhhhccCCCCc---hhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhh
Q 003139 656 LDQTHVSTAVKGSFGYLDPEYFRRQQLTE---KSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQI 732 (845)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~---ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (845)
.....||+.|+|||.+.+..++. ++||||||+++|||++|+.||......+ .... +
T Consensus 165 ------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~---------~ 223 (271)
T 3kmu_A 165 ------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME------IGMK---------V 223 (271)
T ss_dssp ------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH------HHHH---------H
T ss_pred ------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH------HHHH---------H
Confidence 12346789999999998765544 8999999999999999999996543211 1111 1
Q ss_pred hccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhh
Q 003139 733 MDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYAL 778 (845)
Q Consensus 733 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~ 778 (845)
.........+...+..+.+++.+||+.+|++|||+.++++.|+.+.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 224 ALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp HHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 1111222334455677899999999999999999999999999864
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=364.92 Aligned_cols=264 Identities=26% Similarity=0.432 Sum_probs=215.1
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc--------CCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhC-CCCCcceEEEEEecC
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD--------DGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDER 570 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~--------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 570 (845)
.++|...+.||+|+||.||+|+.. +++.||+|++... .....+++.+|+++++++ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 367888999999999999999863 4678999998754 445677899999999999 899999999999999
Q ss_pred CcEEEEEEeccCCCccccccCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEE
Q 003139 571 SEMILVYEYMANGPLRSHLYGTD--------------LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILL 636 (845)
Q Consensus 571 ~~~~lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl 636 (845)
+..++||||+++|+|.+++.... ...+++.+++.++.|+++||+|||+ .+|+||||||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEEE
Confidence 99999999999999999987543 1348999999999999999999999 899999999999999
Q ss_pred CCCCceEEEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCccccc
Q 003139 637 DDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVN 715 (845)
Q Consensus 637 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~ 715 (845)
+.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--- 267 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 267 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH---
Confidence 9999999999999986543322223344567889999999999999999999999999999999 999986543211
Q ss_pred HHHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhhhcc
Q 003139 716 IAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLEET 783 (845)
Q Consensus 716 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~~~ 783 (845)
.... ...+ .....+..+...+.+++.+||+.+|.+||++.++++.|+.++.....
T Consensus 268 ---~~~~-~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 268 ---LFKL-LKEG---------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp ---HHHH-HHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred ---HHHH-HhcC---------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 1111 1111 11122344556789999999999999999999999999999876543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=353.78 Aligned_cols=249 Identities=29% Similarity=0.528 Sum_probs=197.0
Q ss_pred cCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCC----hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRS----EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
++|+..+.||+|+||.||+|.+. |+.+|||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 57888899999999999999976 8899999876542 233577899999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCc---eeeccCCCCcEEECC--------CCceEEEe
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQS---IIHRDVKTTNILLDD--------NFVAKVAD 646 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~---ivHrDik~~NILl~~--------~~~~kl~D 646 (845)
||+++++|.+++.. ..+++..++.++.|+++||+|||+ .+ |+||||||+|||++. ++.+||+|
T Consensus 86 e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 86 EFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp ECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 99999999999853 368999999999999999999999 66 999999999999986 77899999
Q ss_pred ccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhc
Q 003139 647 FGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKK 726 (845)
Q Consensus 647 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 726 (845)
||+++.... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ..
T Consensus 160 fg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~----- 224 (271)
T 3dtc_A 160 FGLAREWHR----TTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV------AY----- 224 (271)
T ss_dssp CCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH------HH-----
T ss_pred CCccccccc----ccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HH-----
Confidence 999976332 112345789999999999999999999999999999999999999965332110 11
Q ss_pred CchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003139 727 GMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEY 776 (845)
Q Consensus 727 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~ 776 (845)
.+.........+...+..+.+++.+||+.+|.+|||+.|++++|+.
T Consensus 225 ----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 225 ----GVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp ----HHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred ----hhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 1111122223344556789999999999999999999999999874
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=361.95 Aligned_cols=262 Identities=15% Similarity=0.157 Sum_probs=209.7
Q ss_pred cCCCcceeeeeeceEEEEEEEE-cCCcEEEEEEcCCCChHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcEEEEEEe
Q 003139 502 NKFDESLLLGVGGFGRVYKGTL-DDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
++|+..+.||+|+||.||+|+. .+|+.||||.+..... .+++.+|+++++++ +||||+++++++...+..++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 5788899999999999999996 4789999998764432 24688999999999 999999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCc-----eEEEeccccCCCC
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFV-----AKVADFGLSKTGP 654 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~-----~kl~DFGla~~~~ 654 (845)
+ +++|.+++... ...+++.+++.|+.|++.||+|||+ .+|+||||||+|||++.++. +||+|||+++...
T Consensus 87 ~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 87 L-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp C-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred C-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 9 99999998654 3479999999999999999999999 89999999999999998887 9999999998643
Q ss_pred CCCCcc-----cccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCch
Q 003139 655 ALDQTH-----VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGML 729 (845)
Q Consensus 655 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 729 (845)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.................
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 241 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI 241 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH
Confidence 221111 124567999999999999999999999999999999999999999765433221111111111111011
Q ss_pred hhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhh
Q 003139 730 DQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQL 780 (845)
Q Consensus 730 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~ 780 (845)
... ....+ .+.+++.+||+.+|.+||++.+|++.|+.+.+.
T Consensus 242 ~~~---------~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~ 282 (330)
T 2izr_A 242 EVL---------CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR 282 (330)
T ss_dssp HHH---------TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHH---------hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence 000 01123 789999999999999999999999999977653
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=354.83 Aligned_cols=259 Identities=24% Similarity=0.339 Sum_probs=201.3
Q ss_pred hcCCCcceeeeeeceEEEEEEEEcC----CcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLDD----GTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMIL 575 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 575 (845)
.++|+..+.||+|+||.||+|.... +..||+|+.... .....+.+.+|+.++++++||||+++++++. .+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 3578889999999999999998752 456999987654 4455678999999999999999999999985 467899
Q ss_pred EEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCC
Q 003139 576 VYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPA 655 (845)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~ 655 (845)
||||+++++|.+++... ...+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 93 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp EEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECccccccccCc
Confidence 99999999999998654 2468999999999999999999999 8999999999999999999999999999986433
Q ss_pred CCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhc
Q 003139 656 LDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMD 734 (845)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (845)
. .........+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ +.... ..+
T Consensus 169 ~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~---~~~~i----~~~------- 233 (281)
T 1mp8_A 169 S-TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRI----ENG------- 233 (281)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHH----HTT-------
T ss_pred c-cccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH---HHHHH----HcC-------
Confidence 1 1112234456789999999999999999999999999999996 999987543322 11111 111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhhh
Q 003139 735 SNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLE 781 (845)
Q Consensus 735 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~ 781 (845)
.....+...+..+.+++.+||+.+|++||++.++++.|+.+++.+
T Consensus 234 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 234 --ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 111233455677889999999999999999999999999887643
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=366.23 Aligned_cols=248 Identities=25% Similarity=0.326 Sum_probs=206.4
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
++|+..+.||+|+||.||+|+.. +|+.||+|.+... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 57888999999999999999976 6899999987543 2234567889999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
||+++|+|..++... ..+++.++..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++....
T Consensus 85 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~-- 157 (337)
T 1o6l_A 85 EYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-- 157 (337)
T ss_dssp ECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhccc--
Confidence 999999999988643 468999999999999999999999 8999999999999999999999999999986322
Q ss_pred CcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcccc
Q 003139 658 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNL 737 (845)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (845)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ... .+....+
T Consensus 158 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~~~---------~i~~~~~ 222 (337)
T 1o6l_A 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------LFE---------LILMEEI 222 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHH---------HHHHCCC
T ss_pred CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH------HHH---------HHHcCCC
Confidence 1222345689999999999999999999999999999999999999996532211 111 1111111
Q ss_pred CCCCCHHHHHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 003139 738 VGKVNPASLKKFGETAEKCLAEHGVDRP-----SMGDVLWN 773 (845)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~~ 773 (845)
.++......+.+++.+||+.||++|| ++.|++++
T Consensus 223 --~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 223 --RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 13344556788999999999999999 89998765
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=356.82 Aligned_cols=260 Identities=25% Similarity=0.401 Sum_probs=218.5
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
.++|+..+.||+|+||.||+|.+. +++.||+|.+.... ...+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 90 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 90 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence 467888899999999999999987 47889999987543 3467899999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCc
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT 659 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~ 659 (845)
+++++|.+++.......+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.... ...
T Consensus 91 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~-~~~ 166 (288)
T 3kfa_A 91 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTY 166 (288)
T ss_dssp CTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS-SSS
T ss_pred CCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceeccC-Ccc
Confidence 999999999977666779999999999999999999999 8999999999999999999999999999987543 222
Q ss_pred ccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccC
Q 003139 660 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLV 738 (845)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 738 (845)
.......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... +. +.+.....
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~---~~-------------~~~~~~~~ 230 (288)
T 3kfa_A 167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VY-------------ELLEKDYR 230 (288)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HH-------------HHHHTTCC
T ss_pred ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HH-------------HHHhccCC
Confidence 23345567889999999999999999999999999999999 888886543222 11 11111122
Q ss_pred CCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhhh
Q 003139 739 GKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLE 781 (845)
Q Consensus 739 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~ 781 (845)
...+...+..+.+++.+||+.+|.+||++.++++.|+.+.+..
T Consensus 231 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 231 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 2233455678899999999999999999999999999887643
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=365.53 Aligned_cols=264 Identities=25% Similarity=0.383 Sum_probs=214.1
Q ss_pred hcCCCcceeeeeeceEEEEEEEEcC-C-----cEEEEEEcCCC-ChHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCc
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLDD-G-----TKVAVKRGNPR-SEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERSE 572 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~~-g-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 572 (845)
.++|...+.||+|+||.||+|.... + ..||+|.+... .....+.+.+|+++++++ +||||+++++++.+.+.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 4678889999999999999998752 2 47999988755 345567899999999999 89999999999999999
Q ss_pred EEEEEEeccCCCccccccCCC------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCC
Q 003139 573 MILVYEYMANGPLRSHLYGTD------------LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNF 640 (845)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~ 640 (845)
.++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+ .+|+||||||+|||+++++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEEGGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEECCCC
Confidence 999999999999999986421 3468999999999999999999999 8999999999999999999
Q ss_pred ceEEEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHH
Q 003139 641 VAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEW 719 (845)
Q Consensus 641 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~ 719 (845)
.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........ +
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--~--- 276 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK--F--- 276 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH--H---
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH--H---
Confidence 999999999986432222222334567889999999999999999999999999999998 8888865433221 1
Q ss_pred HHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhhhc
Q 003139 720 AMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLEE 782 (845)
Q Consensus 720 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~~ 782 (845)
.. ++........+...+..+.+++.+||+.+|.+||++.++++.|+.+.+...
T Consensus 277 -~~---------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 329 (333)
T 2i1m_A 277 -YK---------LVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDR 329 (333)
T ss_dssp -HH---------HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred -HH---------HHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhh
Confidence 11 111111112233345678899999999999999999999999998866443
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=366.68 Aligned_cols=248 Identities=23% Similarity=0.306 Sum_probs=205.1
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCCh------HhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSE------QGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEM 573 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 573 (845)
.+.|+..+.||+|+||.||+|+.. +|+.||+|.+..... ...+.+.+|++++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 457888999999999999999976 689999998754322 1357889999999999999999999999999999
Q ss_pred EEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCC----ceEEEeccc
Q 003139 574 ILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNF----VAKVADFGL 649 (845)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~----~~kl~DFGl 649 (845)
++||||+++|+|.+++... ..+++.++..++.||+.||+|||+ .+|+||||||+|||+++++ .+||+|||+
T Consensus 91 ~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 9999999999999999543 479999999999999999999999 8999999999999998877 799999999
Q ss_pred cCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCch
Q 003139 650 SKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGML 729 (845)
Q Consensus 650 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 729 (845)
++.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ....
T Consensus 166 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~------~~~~------- 229 (361)
T 2yab_A 166 AHEIED---GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLAN------- 229 (361)
T ss_dssp CEECCT---TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHH-------
T ss_pred ceEcCC---CCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH------HHHH-------
Confidence 986432 222345679999999999999999999999999999999999999996543211 1111
Q ss_pred hhhhccccCCCCC----HHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 730 DQIMDSNLVGKVN----PASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 730 ~~~~d~~l~~~~~----~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
+..... .++ ......+.+++.+||..||.+|||+.|++++
T Consensus 230 --i~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 230 --ITAVSY--DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp --HHTTCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred --HHhcCC--CCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 111000 111 1234568899999999999999999999864
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=356.54 Aligned_cols=269 Identities=20% Similarity=0.259 Sum_probs=213.5
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC-hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCC--cEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS-EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERS--EMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~ 577 (845)
++|...++||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.... ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 56888899999999999999976 58999999987543 234577889999999999999999999997655 789999
Q ss_pred EeccCCCccccccCCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEE----CCCCceEEEeccccCC
Q 003139 578 EYMANGPLRSHLYGTD-LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILL----DDNFVAKVADFGLSKT 652 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl----~~~~~~kl~DFGla~~ 652 (845)
||+++++|.+++.... ...+++.+++.++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 9999999999997543 2349999999999999999999999 899999999999999 8888999999999986
Q ss_pred CCCCCCcccccccccCCCcCChhhhc--------cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHh
Q 003139 653 GPALDQTHVSTAVKGSFGYLDPEYFR--------RQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQ 724 (845)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~ 724 (845)
.... .......||+.|+|||++. +..++.++|||||||++|||++|+.||......... .+......
T Consensus 166 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~ 240 (319)
T 4euu_A 166 LEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKII 240 (319)
T ss_dssp CCTT---CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC--HHHHHHHH
T ss_pred cCCC---CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh--HHHHHHHh
Confidence 4332 2233467999999999986 578899999999999999999999999754433221 11122222
Q ss_pred hcCc---hhhhh-----------ccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhh
Q 003139 725 KKGM---LDQIM-----------DSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYAL 778 (845)
Q Consensus 725 ~~~~---~~~~~-----------d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~ 778 (845)
.... ...+. +-.............+.+++.+||+.||++|||+.|++++..+..
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 1111 00000 001112345678889999999999999999999999999988654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=356.25 Aligned_cols=249 Identities=24% Similarity=0.318 Sum_probs=197.1
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCCh--------------------------HhHHHHHHHHHHHHh
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSE--------------------------QGIAEFRTEIEMLSK 554 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~~ 554 (845)
++|+..+.||+|+||.||+|+.. +++.||||++..... ...+++.+|++++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 57888999999999999999875 688999998754321 123568899999999
Q ss_pred CCCCCcceEEEEEec--CCcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCC
Q 003139 555 LRHRHLVSLIGYCDE--RSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTT 632 (845)
Q Consensus 555 l~H~niv~l~g~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~ 632 (845)
++||||+++++++.+ .+..++||||+++++|.+++.. ..+++.+++.++.|+++||+|||+ .+|+||||||+
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~ 166 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPS 166 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGG
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHH
Confidence 999999999999976 5678999999999999987643 469999999999999999999999 89999999999
Q ss_pred cEEECCCCceEEEeccccCCCCCCCCcccccccccCCCcCChhhhccCC---CCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 003139 633 NILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQ---LTEKSDVYSFGVVLMEVLCTRPALNPVL 709 (845)
Q Consensus 633 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~ksDV~S~Gvvl~Elltg~~p~~~~~ 709 (845)
|||++.++.+||+|||+++..... ........||+.|+|||.+.+.. ++.++|||||||++|||++|+.||....
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGS--DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSS--SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HEEECCCCCEEEecCCCccccccc--cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 999999999999999999764321 12234567999999999998765 4789999999999999999999996432
Q ss_pred CcccccHHHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 710 PREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 710 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
. ..+.... .. ..+...........+.+++.+||+.||++||++.|++++
T Consensus 245 ~------~~~~~~~-~~--------~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 245 I------MCLHSKI-KS--------QALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp H------HHHHHHH-HH--------CCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred H------HHHHHHH-hc--------ccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 1 1111111 11 111111112345678899999999999999999998764
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=360.45 Aligned_cols=270 Identities=23% Similarity=0.338 Sum_probs=216.6
Q ss_pred HHHHHHHhcCCCcceeeeeeceEEEEEEEE------cCCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhC-CCCCcceEEE
Q 003139 494 FQEILDATNKFDESLLLGVGGFGRVYKGTL------DDGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKL-RHRHLVSLIG 565 (845)
Q Consensus 494 ~~el~~at~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g 565 (845)
..+..-..++|...+.||+|+||.||+|++ .+++.||||++... .....+.+.+|++++.++ +||||+++++
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 334444467899999999999999999984 24678999998764 344567899999999999 7999999999
Q ss_pred EEecCC-cEEEEEEeccCCCccccccCCCC--------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCC
Q 003139 566 YCDERS-EMILVYEYMANGPLRSHLYGTDL--------------PPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVK 630 (845)
Q Consensus 566 ~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik 630 (845)
++...+ ..++||||+++|+|.+++..... ..+++.+++.++.|+++||+|||+ .+|+|||||
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dik 175 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLA 175 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSCCS
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccccCc
Confidence 997654 58999999999999999975432 228999999999999999999999 899999999
Q ss_pred CCcEEECCCCceEEEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 003139 631 TTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVL 709 (845)
Q Consensus 631 ~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~ 709 (845)
|+|||++.++.+||+|||+++...............||+.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 176 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 176 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 9999999999999999999986543223233345668899999999999999999999999999999998 999986543
Q ss_pred CcccccHHHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhhh
Q 003139 710 PREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLE 781 (845)
Q Consensus 710 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~ 781 (845)
..+. .......+ .....+......+.+++.+||+.+|.+||++.+++++|+.+++..
T Consensus 256 ~~~~------~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 256 IDEE------FCRRLKEG---------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp CSHH------HHHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hhHH------HHHHhccC---------ccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 2221 11111111 111122334567889999999999999999999999999987643
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=350.32 Aligned_cols=256 Identities=29% Similarity=0.407 Sum_probs=211.6
Q ss_pred cCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEecc
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMA 581 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 581 (845)
++|+..+.||+|+||.||+|...+++.||+|++..... ..+++.+|++++++++||||+++++++.+.+..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 56888899999999999999998888999999876543 23678999999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCccc
Q 003139 582 NGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHV 661 (845)
Q Consensus 582 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 661 (845)
+++|.+++.... ..+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++.... .....
T Consensus 87 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~-~~~~~ 161 (267)
T 3t9t_A 87 HGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTS 161 (267)
T ss_dssp TCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC-HHHHS
T ss_pred CCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEccccccccccc-ccccc
Confidence 999999986542 468999999999999999999999 8999999999999999999999999999976432 11122
Q ss_pred ccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCC
Q 003139 662 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGK 740 (845)
Q Consensus 662 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 740 (845)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ..... ..+ ....
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~i-~~~---------~~~~ 225 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE------VVEDI-STG---------FRLY 225 (267)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHH-HTT---------CCCC
T ss_pred cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH------HHHHH-hcC---------CcCC
Confidence 234557788999999999999999999999999999999 898886532211 11111 111 1111
Q ss_pred CCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 003139 741 VNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779 (845)
Q Consensus 741 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~ 779 (845)
.+......+.+++.+||+.+|++||++.++++.|+.+.+
T Consensus 226 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 226 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 223345678899999999999999999999999998764
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=360.11 Aligned_cols=254 Identities=16% Similarity=0.228 Sum_probs=208.7
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
.++|...+.||+|+||.||+|... +++.+|+|.+.... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 467889999999999999999976 58889999887543 3456788999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECC--CCceEEEeccccCCCCCCC
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDD--NFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~--~~~~kl~DFGla~~~~~~~ 657 (845)
+++|+|.+++... ...+++.++..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++....
T Consensus 83 ~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~-- 156 (321)
T 1tki_A 83 ISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-- 156 (321)
T ss_dssp CCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT--
T ss_pred CCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC--
Confidence 9999999998643 2469999999999999999999999 89999999999999987 78999999999986432
Q ss_pred CcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcccc
Q 003139 658 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNL 737 (845)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (845)
........||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .... +.....
T Consensus 157 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~---------i~~~~~ 220 (321)
T 1tki_A 157 -GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ------IIEN---------IMNAEY 220 (321)
T ss_dssp -TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHH---------HHHTCC
T ss_pred -CCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH------HHHH---------HHcCCC
Confidence 222345678999999999999889999999999999999999999996543211 1111 111111
Q ss_pred CCC--CCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 003139 738 VGK--VNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYA 777 (845)
Q Consensus 738 ~~~--~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~ 777 (845)
... .....+..+.+++.+||+.||.+|||+.|++++-...
T Consensus 221 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~ 262 (321)
T 1tki_A 221 TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLK 262 (321)
T ss_dssp CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred CCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhc
Confidence 000 0012356788999999999999999999999876543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=355.95 Aligned_cols=264 Identities=23% Similarity=0.345 Sum_probs=202.0
Q ss_pred hcCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHh--CCCCCcceEEEEEec----CCcEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSK--LRHRHLVSLIGYCDE----RSEMI 574 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~----~~~~~ 574 (845)
.++|+..+.||+|+||.||+|++ +|+.||||++... ..+.+..|.+++.. ++||||+++++++.+ ....+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 35788999999999999999988 5899999998643 34556677777776 799999999998754 34589
Q ss_pred EEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----CCceeeccCCCCcEEECCCCceEEEeccc
Q 003139 575 LVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGA-----AQSIIHRDVKTTNILLDDNFVAKVADFGL 649 (845)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivHrDik~~NILl~~~~~~kl~DFGl 649 (845)
+||||+++|+|.+++.. ..+++..+++++.|++.||+|||... .++|+||||||+|||++.++.+||+|||+
T Consensus 83 lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 159 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL 159 (301)
T ss_dssp EEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCC
Confidence 99999999999999943 36999999999999999999999210 28999999999999999999999999999
Q ss_pred cCCCCCCCCc--ccccccccCCCcCChhhhccC------CCCchhHHHHHHHHHHHHHcC----------CCCCCCCCCc
Q 003139 650 SKTGPALDQT--HVSTAVKGSFGYLDPEYFRRQ------QLTEKSDVYSFGVVLMEVLCT----------RPALNPVLPR 711 (845)
Q Consensus 650 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~s~ksDV~S~Gvvl~Elltg----------~~p~~~~~~~ 711 (845)
++........ .......||+.|+|||.+.+. .++.++|||||||++|||++| +.||......
T Consensus 160 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~ 239 (301)
T 3q4u_A 160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239 (301)
T ss_dssp CEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred eeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCC
Confidence 9753321111 112345799999999999876 455799999999999999999 7777654333
Q ss_pred ccccHHHHHHHHhhcCchhhhhccccC-CCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 003139 712 EQVNIAEWAMTWQKKGMLDQIMDSNLV-GKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYA 777 (845)
Q Consensus 712 ~~~~l~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~ 777 (845)
... ............. .+.+. .......+..+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 240 ~~~-~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 240 DPS-FEDMRKVVCVDQQ-----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SCC-HHHHHHHHTTSCC-----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred Ccc-hhhhhHHHhccCC-----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 221 1111111111110 01110 011234678899999999999999999999999999864
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=352.74 Aligned_cols=258 Identities=27% Similarity=0.394 Sum_probs=211.2
Q ss_pred hcCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEec
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYM 580 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 580 (845)
.++|+..+.||+|+||.||+|...++..||+|.+.... ...+.+.+|++++++++||||+++++++.+ +..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecC
Confidence 35788889999999999999999888899999886543 235788999999999999999999999864 5689999999
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcc
Q 003139 581 ANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH 660 (845)
Q Consensus 581 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 660 (845)
++++|.+++.......+++.+++.++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.... ....
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~-~~~~ 165 (279)
T 1qpc_A 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYT 165 (279)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSS-SCEE
T ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccC-cccc
Confidence 99999999965433469999999999999999999999 9999999999999999999999999999986443 1122
Q ss_pred cccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCC
Q 003139 661 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVG 739 (845)
Q Consensus 661 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 739 (845)
......++..|+|||.+.+..++.++||||||++++||++ |+.||......+ ..... ..+ ...
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------~~~~~-~~~---------~~~ 229 (279)
T 1qpc_A 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE------VIQNL-ERG---------YRM 229 (279)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHHHH-HTT---------CCC
T ss_pred cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH------HHHHH-hcc---------cCC
Confidence 2234557889999999999999999999999999999999 898886533211 11111 111 111
Q ss_pred CCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhh
Q 003139 740 KVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQL 780 (845)
Q Consensus 740 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~ 780 (845)
..+...+..+.+++.+|++.+|++||++.++++.|+.+...
T Consensus 230 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 22334556789999999999999999999999999988653
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=359.23 Aligned_cols=263 Identities=26% Similarity=0.405 Sum_probs=207.0
Q ss_pred cCCCcceeeeeeceEEEEEEEEcC-----CcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLDD-----GTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMIL 575 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~~-----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 575 (845)
++|...+.||+|+||.||+|.+.. +..||+|.+... ......++.+|++++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 456677899999999999998652 235999998754 44556789999999999999999999999999999999
Q ss_pred EEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCC
Q 003139 576 VYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPA 655 (845)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~ 655 (845)
||||+++|+|.+++... ...+++.+++.++.|+++||+|||+ .+|+||||||+|||+++++.+||+|||+++....
T Consensus 124 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 124 ITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp EEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 99999999999998654 3479999999999999999999999 8999999999999999999999999999986433
Q ss_pred CCC-cccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhh
Q 003139 656 LDQ-THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIM 733 (845)
Q Consensus 656 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (845)
... ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ... ...++
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~------~~~-~~~~~------ 266 (333)
T 1mqb_A 200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE------VMK-AINDG------ 266 (333)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHH-HHHTT------
T ss_pred ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH------HHH-HHHCC------
Confidence 211 111223456788999999999999999999999999999999 999986533211 111 11111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhhhccc
Q 003139 734 DSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLEETS 784 (845)
Q Consensus 734 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~~~~ 784 (845)
.....+...+..+.+++.+||+.+|.+||++.++++.|+.+++.....
T Consensus 267 ---~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~ 314 (333)
T 1mqb_A 267 ---FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSL 314 (333)
T ss_dssp ---CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGG
T ss_pred ---CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhh
Confidence 111223345677899999999999999999999999999987755443
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=351.87 Aligned_cols=262 Identities=17% Similarity=0.172 Sum_probs=211.4
Q ss_pred cCCCcceeeeeeceEEEEEEEE-cCCcEEEEEEcCCCChHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcEEEEEEe
Q 003139 502 NKFDESLLLGVGGFGRVYKGTL-DDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
++|+..+.||+|+||.||+|.. .+|+.||+|++.... ..+.+.+|+++++++ +|+|++++++++.+....++||||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 87 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 87 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence 5688899999999999999996 478999999875443 224678899999999 799999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCc-----eEEEeccccCCCC
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFV-----AKVADFGLSKTGP 654 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~-----~kl~DFGla~~~~ 654 (845)
+ +++|.+++.... .++++.+++.++.|++.||+|||+ ++|+||||||+|||++.++. +||+|||+++...
T Consensus 88 ~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 88 L-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp C-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred c-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 9 999999996543 469999999999999999999998 89999999999999987776 9999999998643
Q ss_pred CCCCc-----ccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCch
Q 003139 655 ALDQT-----HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGML 729 (845)
Q Consensus 655 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 729 (845)
..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........................
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 242 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccH
Confidence 32111 1234567999999999999999999999999999999999999999765433322221111111111111
Q ss_pred hhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 003139 730 DQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779 (845)
Q Consensus 730 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~ 779 (845)
... ....+..+.+++.+||+.+|++||++.+|++.|+.+++
T Consensus 243 ~~~---------~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~ 283 (298)
T 1csn_A 243 REL---------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 283 (298)
T ss_dssp HHH---------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHH---------HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence 111 12345678899999999999999999999999998865
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=361.66 Aligned_cols=260 Identities=24% Similarity=0.384 Sum_probs=204.9
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcE----EEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTK----VAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMIL 575 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 575 (845)
++|+..+.||+|+||.||+|.+. +++. |++|.+... .....+++.+|+.++++++||||++++++|.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 57888999999999999999965 4443 578876543 3445678999999999999999999999998754 889
Q ss_pred EEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCC
Q 003139 576 VYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPA 655 (845)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~ 655 (845)
|+||+++|+|.+++.... ..+++..++.|+.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 94 v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred EEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 999999999999986543 469999999999999999999999 8999999999999999999999999999987543
Q ss_pred CCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhc
Q 003139 656 LDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMD 734 (845)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (845)
...........+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......+ +. ..+.
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~-------------~~~~ 233 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---IS-------------SILE 233 (327)
T ss_dssp ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HH-------------HHHH
T ss_pred ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HH-------------HHHH
Confidence 333333344567889999999999999999999999999999999 999997543322 11 1111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhhhc
Q 003139 735 SNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLEE 782 (845)
Q Consensus 735 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~~ 782 (845)
.......+......+.+++.+||+.+|.+||++.|+++.|+.+...+.
T Consensus 234 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 281 (327)
T 3lzb_A 234 KGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQ 281 (327)
T ss_dssp TTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSHH
T ss_pred cCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCcC
Confidence 111222334456678999999999999999999999999999876543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=363.83 Aligned_cols=253 Identities=23% Similarity=0.314 Sum_probs=206.7
Q ss_pred HhcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEE
Q 003139 500 ATNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILV 576 (845)
Q Consensus 500 at~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 576 (845)
..++|+..+.||+|+||.||+|... +|+.||+|++... .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3467999999999999999999976 6899999987543 455667899999999999999999999999999999999
Q ss_pred EEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCC---CceEEEeccccCCC
Q 003139 577 YEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDN---FVAKVADFGLSKTG 653 (845)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~---~~~kl~DFGla~~~ 653 (845)
|||+++|+|.+++... ..+++.++..++.||+.||+|||+ .+|+||||||+|||++.+ +.+||+|||+++..
T Consensus 107 ~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp ECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred EecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 9999999999988543 468999999999999999999999 899999999999999865 45999999999864
Q ss_pred CCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhh
Q 003139 654 PALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIM 733 (845)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (845)
.. ........||+.|+|||++.+..++.++|||||||++|||++|++||......+ + ... ...+...
T Consensus 182 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~---~---~~~-i~~~~~~--- 248 (362)
T 2bdw_A 182 ND---SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---L---YAQ-IKAGAYD--- 248 (362)
T ss_dssp TT---CCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H---HHH-HHHTCCC---
T ss_pred cC---CcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---H---HHH-HHhCCCC---
Confidence 32 222345679999999999999999999999999999999999999996532211 1 111 1111100
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 734 DSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 734 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
............+.+++.+||+.||++||++.+++++
T Consensus 249 ---~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 249 ---YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp ---CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ---CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000112345678899999999999999999998865
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=354.98 Aligned_cols=255 Identities=27% Similarity=0.455 Sum_probs=201.7
Q ss_pred cCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEecc
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMA 581 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 581 (845)
++|+..+.||+|+||.||+|++. ++.||+|++... ...+.|.+|++++++++||||+++++++.+ ..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 56788889999999999999986 788999998644 345789999999999999999999998874 5899999999
Q ss_pred CCCccccccCCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCc-eEEEeccccCCCCCCCCc
Q 003139 582 NGPLRSHLYGTD-LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFV-AKVADFGLSKTGPALDQT 659 (845)
Q Consensus 582 ~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~-~kl~DFGla~~~~~~~~~ 659 (845)
+|+|.+++.... ...+++..++.++.|+++||+|||+...++|+||||||+|||++.++. +||+|||+++....
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~---- 158 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT---- 158 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc----
Confidence 999999997543 235789999999999999999999854468999999999999998876 79999999975322
Q ss_pred ccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCC
Q 003139 660 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVG 739 (845)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 739 (845)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ....... .+. ..
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----~~~~~~~-~~~---------~~ 223 (307)
T 2eva_A 159 -HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF----RIMWAVH-NGT---------RP 223 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH----HHHHHHH-TTC---------CC
T ss_pred -ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH----HHHHHHh-cCC---------CC
Confidence 12334689999999999999999999999999999999999999965432211 1111111 110 11
Q ss_pred CCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhh
Q 003139 740 KVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQL 780 (845)
Q Consensus 740 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~ 780 (845)
......+..+.+++.+||+.+|++|||+.++++.|+.+.+.
T Consensus 224 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 264 (307)
T 2eva_A 224 PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264 (307)
T ss_dssp CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 12233456788999999999999999999999999987653
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=364.63 Aligned_cols=256 Identities=22% Similarity=0.329 Sum_probs=204.8
Q ss_pred hcCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCC--CChHhHHHHHHHHHHHHhCCC--CCcceEEEEEecCCcEEEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNP--RSEQGIAEFRTEIEMLSKLRH--RHLVSLIGYCDERSEMILV 576 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV 576 (845)
.++|++.+.||+|+||.||++...+++.||||++.. ......+.+.+|++++.+++| +||+++++++.+.+..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 356888999999999999999988899999998654 345667889999999999976 9999999999999999999
Q ss_pred EEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCC
Q 003139 577 YEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPAL 656 (845)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~ 656 (845)
|| +.+++|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++ ++.+||+|||+++.....
T Consensus 88 ~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EC-CCSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred Ee-CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 99 5688999999654 479999999999999999999999 8999999999999997 578999999999875433
Q ss_pred CCcccccccccCCCcCChhhhcc-----------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhh
Q 003139 657 DQTHVSTAVKGSFGYLDPEYFRR-----------QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQK 725 (845)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~ 725 (845)
..........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~------- 228 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----S------- 228 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----H-------
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH-----H-------
Confidence 33333445679999999999865 778999999999999999999999996432211 1
Q ss_pred cCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 003139 726 KGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYA 777 (845)
Q Consensus 726 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~ 777 (845)
.+..++++......+......+.+++.+||+.||.+|||+.|++++....
T Consensus 229 --~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~ 278 (343)
T 3dbq_A 229 --KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 278 (343)
T ss_dssp --HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred --HHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccc
Confidence 12233333333334444456788999999999999999999999886654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=362.30 Aligned_cols=251 Identities=22% Similarity=0.286 Sum_probs=204.4
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCCh------HhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSE------QGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMI 574 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 574 (845)
+.|...+.||+|+||.||+|... +|+.||+|.+..... ...+++.+|++++++++||||+++++++.+.+..+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 56888999999999999999976 689999997654321 13578999999999999999999999999999999
Q ss_pred EEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCC----ceEEEecccc
Q 003139 575 LVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNF----VAKVADFGLS 650 (845)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~----~~kl~DFGla 650 (845)
+||||+++++|.+++... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||+++++ .+||+|||++
T Consensus 91 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp EEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 999999999999998543 579999999999999999999999 9999999999999999887 8999999999
Q ss_pred CCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchh
Q 003139 651 KTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLD 730 (845)
Q Consensus 651 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (845)
+.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ........ .
T Consensus 166 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~~~~~-~-- 233 (326)
T 2y0a_A 166 HKIDF---GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLANVSAV-N-- 233 (326)
T ss_dssp EECCT---TSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHHHT-C--
T ss_pred eECCC---CCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH------HHHHHHhc-C--
Confidence 86432 122345679999999999999999999999999999999999999996543221 11111100 0
Q ss_pred hhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 731 QIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 731 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
..............+.+++.+||+.||++|||+.+++++
T Consensus 234 ----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 234 ----YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp ----CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ----CCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000000011234568899999999999999999999875
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=357.52 Aligned_cols=263 Identities=24% Similarity=0.291 Sum_probs=202.9
Q ss_pred hcCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCC--hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRS--EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYE 578 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 578 (845)
.++|+..+.||+|+||.||+|+..+|+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 36788999999999999999999889999999876542 2335678899999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCC
Q 003139 579 YMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQ 658 (845)
Q Consensus 579 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~ 658 (845)
|++ ++|.+++... ...+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.... .
T Consensus 100 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~--~ 172 (311)
T 3niz_A 100 FME-KDLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGI--P 172 (311)
T ss_dssp CCS-EEHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTS--C
T ss_pred CCC-CCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCC--C
Confidence 997 4787777544 3469999999999999999999999 8999999999999999999999999999976432 1
Q ss_pred cccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchh-------
Q 003139 659 THVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLD------- 730 (845)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~------- 730 (845)
........||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+.. .............
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~ 249 (311)
T 3niz_A 173 VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL---PKIFSILGTPNPREWPQVQE 249 (311)
T ss_dssp CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHH---HHHHHHHCCCCTTTSGGGTT
T ss_pred cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHHCCCChHHhhhhhc
Confidence 122344578999999999876 56899999999999999999999999765443321 1111111110000
Q ss_pred --hhhccccC--CC-----CCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 731 --QIMDSNLV--GK-----VNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 731 --~~~d~~l~--~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
...+.... .. ..+.....+.+++.+||+.||++|||+.|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 250 LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp SHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred cchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00000000 00 112234578899999999999999999999864
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=388.99 Aligned_cols=257 Identities=29% Similarity=0.430 Sum_probs=211.9
Q ss_pred hcCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEec
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYM 580 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 580 (845)
.++|+..+.||+|+||.||+|+++++..||||++..... ..++|.+|+++|++++||||+++++++.+ +..++||||+
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 356788889999999999999998888899999876442 34689999999999999999999999976 6789999999
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcc
Q 003139 581 ANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH 660 (845)
Q Consensus 581 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 660 (845)
++|+|.++|.......+++.+++.|+.||++||+|||+ ++|+||||||+||||++++.+||+|||+++.... ....
T Consensus 344 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~-~~~~ 419 (535)
T 2h8h_A 344 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYT 419 (535)
T ss_dssp TTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC-HHHH
T ss_pred cCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCC-Ccee
Confidence 99999999965434568999999999999999999999 9999999999999999999999999999986432 1111
Q ss_pred cccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCC
Q 003139 661 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVG 739 (845)
Q Consensus 661 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 739 (845)
......++..|+|||.+.+..++.++|||||||+||||++ |+.||......+ ... ....+ ...
T Consensus 420 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~------~~~-~i~~~---------~~~ 483 (535)
T 2h8h_A 420 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE------VLD-QVERG---------YRM 483 (535)
T ss_dssp TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH------HHH-HHHTT---------CCC
T ss_pred cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH------HHH-HHHcC---------CCC
Confidence 2234456789999999999999999999999999999999 899886543221 111 11111 111
Q ss_pred CCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 003139 740 KVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779 (845)
Q Consensus 740 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~ 779 (845)
..+..++..+.+++.+||+.+|++|||+.+|++.|+.+..
T Consensus 484 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 484 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 2334556788999999999999999999999999997654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=368.26 Aligned_cols=249 Identities=22% Similarity=0.341 Sum_probs=201.7
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcEEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERSEMIL 575 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 575 (845)
.++|+..+.||+|+||.||+|+.. +|+.||+|++... .....+.+.+|.+++.++ +||||+++++++.+.+..++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 467999999999999999999976 6899999987643 223456788999999988 69999999999999999999
Q ss_pred EEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCC
Q 003139 576 VYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPA 655 (845)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~ 655 (845)
||||+++|+|..++... ..+++.++..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++....
T Consensus 102 v~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 99999999999998644 469999999999999999999999 8999999999999999999999999999985322
Q ss_pred CCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcc
Q 003139 656 LDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDS 735 (845)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (845)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||......+ . ...+...
T Consensus 177 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~------~---------~~~i~~~ 239 (353)
T 3txo_A 177 --NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD------L---------FEAILND 239 (353)
T ss_dssp -----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------H---------HHHHHHC
T ss_pred --CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH------H---------HHHHHcC
Confidence 2223345689999999999999999999999999999999999999997543221 1 1111111
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCH------HHHHHH
Q 003139 736 NLVGKVNPASLKKFGETAEKCLAEHGVDRPSM------GDVLWN 773 (845)
Q Consensus 736 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~------~~vl~~ 773 (845)
.. .++......+.+++.+||+.+|.+||++ .+++++
T Consensus 240 ~~--~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 240 EV--VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp CC--CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred CC--CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 11 1233455678899999999999999998 666654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=363.41 Aligned_cols=245 Identities=24% Similarity=0.292 Sum_probs=195.0
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 577 (845)
++|+..++||+|+||.||+|+.. +|+.||||++... ......++..|+..+.++ +||||++++++|.+.+..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57999999999999999999986 7899999986543 334445566677666665 8999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
||+ +++|.+++.... ..++|.+++.|+.|++.||+|||+ .+|+||||||+||||+.++.+||+|||+++....
T Consensus 137 e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~-- 209 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT-- 209 (311)
T ss_dssp ECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred ecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeeccc--
Confidence 999 678988876543 469999999999999999999999 8999999999999999999999999999876432
Q ss_pred CcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcccc
Q 003139 658 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNL 737 (845)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (845)
........||+.|+|||++.+ .++.++|||||||++|||++|+.++.... .|. ....+....
T Consensus 210 -~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~--------~~~--~~~~~~~~~------ 271 (311)
T 3p1a_A 210 -AGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE--------GWQ--QLRQGYLPP------ 271 (311)
T ss_dssp ------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH--------HHH--HHTTTCCCH------
T ss_pred -CCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc--------HHH--HHhccCCCc------
Confidence 222345569999999999876 79999999999999999999987664311 111 111111110
Q ss_pred CCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 738 VGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
..+......+.+++.+||+.||++|||+.|++++
T Consensus 272 --~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 272 --EFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp --HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred --ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 1112335678999999999999999999999864
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=352.39 Aligned_cols=251 Identities=28% Similarity=0.483 Sum_probs=204.3
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChH----h---HHHHHHHHHHHHhCCCCCcceEEEEEecCCcE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQ----G---IAEFRTEIEMLSKLRHRHLVSLIGYCDERSEM 573 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~----~---~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 573 (845)
++|+..+.||+|+||.||+|++. +++.||+|++...... . .+++.+|++++++++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 57888899999999999999975 7899999987654321 1 167899999999999999999999997655
Q ss_pred EEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCc--eeeccCCCCcEEECCCCc-----eEEEe
Q 003139 574 ILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQS--IIHRDVKTTNILLDDNFV-----AKVAD 646 (845)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDik~~NILl~~~~~-----~kl~D 646 (845)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||+ .+ |+||||||+|||++.++. +||+|
T Consensus 97 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 7999999999998888654 3479999999999999999999998 77 999999999999988776 99999
Q ss_pred ccccCCCCCCCCcccccccccCCCcCChhhh--ccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHh
Q 003139 647 FGLSKTGPALDQTHVSTAVKGSFGYLDPEYF--RRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQ 724 (845)
Q Consensus 647 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~ 724 (845)
||+++.... ......||+.|+|||.+ ....++.++|||||||++|||++|+.||........ .+...
T Consensus 173 fg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~~~~-- 241 (287)
T 4f0f_A 173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI----KFINM-- 241 (287)
T ss_dssp CTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH----HHHHH--
T ss_pred CCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH----HHHHH--
Confidence 999975322 23456789999999998 455678999999999999999999999975443221 11111
Q ss_pred hcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003139 725 KKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEY 776 (845)
Q Consensus 725 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~ 776 (845)
+.........+...+..+.+++.+||+.||++||++.++++.|+.
T Consensus 242 -------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 242 -------IREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp -------HHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred -------HhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 111122223445556789999999999999999999999999875
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=349.35 Aligned_cols=260 Identities=23% Similarity=0.339 Sum_probs=208.8
Q ss_pred hcCCCcceeeeeeceEEEEEEEEcC----CcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLDD----GTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMIL 575 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 575 (845)
.++|...+.||+|+||.||+|++.+ +..||+|.+... .....+.|.+|++++++++||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 4578888999999999999998653 235999998765 44566789999999999999999999999865 45789
Q ss_pred EEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCC
Q 003139 576 VYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPA 655 (845)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~ 655 (845)
||||+++++|.+++... ...+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 90 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 90 IMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp EEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred EEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 99999999999998643 2468999999999999999999999 9999999999999999999999999999986433
Q ss_pred CCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhc
Q 003139 656 LDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMD 734 (845)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (845)
. .........+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ..... ..+
T Consensus 166 ~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~~~~----~~~------- 230 (281)
T 3cc6_A 166 E-DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VIGVL----EKG------- 230 (281)
T ss_dssp --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HHHHH----HHT-------
T ss_pred c-cccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HHHHH----hcC-------
Confidence 1 1122234557889999999999999999999999999999998 999986543322 11111 110
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhhhc
Q 003139 735 SNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLEE 782 (845)
Q Consensus 735 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~~ 782 (845)
.....+...+..+.+++.+||+.+|++||++.++++.|+.+.+.+.
T Consensus 231 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 276 (281)
T 3cc6_A 231 --DRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEK 276 (281)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred --CCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhhh
Confidence 0111223345678899999999999999999999999999887654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=363.35 Aligned_cols=265 Identities=26% Similarity=0.377 Sum_probs=214.4
Q ss_pred HHHHHhcCCCcceeeeeeceEEEEEEEEc------CCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEe
Q 003139 496 EILDATNKFDESLLLGVGGFGRVYKGTLD------DGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCD 568 (845)
Q Consensus 496 el~~at~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 568 (845)
++....++|+..+.||+|+||.||+|++. .++.||+|.+... ......++.+|++++++++||||+++++++.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 33345678999999999999999999864 3678999998754 3445667999999999999999999999999
Q ss_pred cCCcEEEEEEeccCCCccccccCC--------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCC
Q 003139 569 ERSEMILVYEYMANGPLRSHLYGT--------DLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNF 640 (845)
Q Consensus 569 ~~~~~~lV~Ey~~~gsL~~~l~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~ 640 (845)
+.+..++||||+++|+|.+++... ....+++.++++++.|++.||+|||+ ++|+||||||+|||++.++
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTC
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCCC
Confidence 999999999999999999998642 12467999999999999999999999 8999999999999999999
Q ss_pred ceEEEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHH
Q 003139 641 VAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEW 719 (845)
Q Consensus 641 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~ 719 (845)
.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... +.
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~~ 249 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------QV 249 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH------HH
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH------HH
Confidence 999999999976432222222334457889999999999999999999999999999999 88888643221 11
Q ss_pred HHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 003139 720 AMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779 (845)
Q Consensus 720 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~ 779 (845)
...... + .. ...+...+..+.+++.+||+.+|.+||++.++++.|+..+.
T Consensus 250 ~~~~~~-~--------~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 250 LRFVME-G--------GL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HHHHHT-T--------CC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHHc-C--------Cc-CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 111111 1 11 11234456678899999999999999999999999987754
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=365.99 Aligned_cols=253 Identities=20% Similarity=0.263 Sum_probs=208.7
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
.++|+..+.||+|+||.||+|... +|+.+|+|.+..........+.+|++++++++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 357899999999999999999976 6889999998777666667899999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECC--CCceEEEeccccCCCCCCC
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDD--NFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~--~~~~kl~DFGla~~~~~~~ 657 (845)
+++|+|.+++... ...+++.+++.++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+++....
T Consensus 130 ~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~-- 203 (387)
T 1kob_A 130 LSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP-- 203 (387)
T ss_dssp CCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT--
T ss_pred CCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCC--
Confidence 9999999998643 2468999999999999999999999 89999999999999974 57899999999986432
Q ss_pred CcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcccc
Q 003139 658 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNL 737 (845)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (845)
........||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ........ . ...
T Consensus 204 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~------~~~~i~~~-~------~~~ 269 (387)
T 1kob_A 204 -DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE------TLQNVKRC-D------WEF 269 (387)
T ss_dssp -TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHHHC-C------CCC
T ss_pred -CcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH------HHHHHHhC-C------CCC
Confidence 222334579999999999999999999999999999999999999997533211 11111110 0 011
Q ss_pred CCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 738 VGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
...........+.+++.+||+.||.+|||+.|++++
T Consensus 270 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 270 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 111223445678899999999999999999999865
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=351.93 Aligned_cols=261 Identities=30% Similarity=0.530 Sum_probs=199.2
Q ss_pred hcCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYE 578 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 578 (845)
.++|+..+.||+|+||.||+|+.. ..+|+|++... .....+.|.+|++++++++||||+++++++ ..+..++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 357888999999999999999865 35999987643 456678899999999999999999999976 4567899999
Q ss_pred eccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCC
Q 003139 579 YMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQ 658 (845)
Q Consensus 579 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~ 658 (845)
|+++++|.+++... ...+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 100 ~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 100 WCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp CCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred ecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceeccccccccc
Confidence 99999999998644 3569999999999999999999999 8999999999999999999999999999976443223
Q ss_pred cccccccccCCCcCChhhhc---cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcc
Q 003139 659 THVSTAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDS 735 (845)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (845)
........||+.|+|||.+. +..++.++||||||+++|||++|+.||......+. .......+... +
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~~~~----~ 245 (289)
T 3og7_A 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------IIEMVGRGSLS----P 245 (289)
T ss_dssp --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH------HHHHHHHTSCC----C
T ss_pred cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH------HHHHhcccccC----c
Confidence 33334567999999999986 66789999999999999999999999975443221 11111111111 1
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 003139 736 NLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779 (845)
Q Consensus 736 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~ 779 (845)
. .......++..+.+++.+||+.+|.+||++.++++.|+.+.+
T Consensus 246 ~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 246 D-LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp C-TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred c-hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 1 111233456789999999999999999999999999998753
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=347.93 Aligned_cols=261 Identities=25% Similarity=0.392 Sum_probs=212.0
Q ss_pred cCCCcce-eeeeeceEEEEEEEEc---CCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEE
Q 003139 502 NKFDESL-LLGVGGFGRVYKGTLD---DGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILV 576 (845)
Q Consensus 502 ~~f~~~~-~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 576 (845)
++|.+.. .||+|+||.||+|.+. +++.||+|.+... .....+++.+|++++++++||||+++++++ +.+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 3455555 8999999999999864 5778999998764 445678899999999999999999999999 55679999
Q ss_pred EEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCC
Q 003139 577 YEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPAL 656 (845)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~ 656 (845)
|||+++++|.+++... ...+++.+++.++.|+++||+|||+ .+|+||||||+|||+++++.+||+|||+++.....
T Consensus 88 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp EECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 9999999999998643 3569999999999999999999999 89999999999999999999999999999864332
Q ss_pred CCc-ccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhc
Q 003139 657 DQT-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMD 734 (845)
Q Consensus 657 ~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (845)
... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+ +. .....+
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~----~~i~~~------- 229 (287)
T 1u59_A 164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VM----AFIEQG------- 229 (287)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HH----HHHHTT-------
T ss_pred cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---HH----HHHhcC-------
Confidence 221 11233456889999999999999999999999999999998 999986543321 11 111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhhhcc
Q 003139 735 SNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLEET 783 (845)
Q Consensus 735 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~~~ 783 (845)
.....+...+..+.+++.+||+.+|++||++.++++.|+.+..-...
T Consensus 230 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 276 (287)
T 1u59_A 230 --KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276 (287)
T ss_dssp --CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred --CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 11223445567899999999999999999999999999998765443
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=358.75 Aligned_cols=272 Identities=26% Similarity=0.371 Sum_probs=212.8
Q ss_pred CCcceeeeeeceEEEEEEEEc-----CCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEec--CCcEEE
Q 003139 504 FDESLLLGVGGFGRVYKGTLD-----DGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDE--RSEMIL 575 (845)
Q Consensus 504 f~~~~~LG~G~fg~Vy~~~~~-----~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~l 575 (845)
|+..+.||+|+||.||++.+. +++.||||++... .....+.+.+|++++++++||||+++++++.+ ....++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 478889999999999998753 5788999998765 34556789999999999999999999999977 457899
Q ss_pred EEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCC
Q 003139 576 VYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPA 655 (845)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~ 655 (845)
||||+++|+|.+++... .+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 113 v~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp EECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 99999999999999654 48999999999999999999999 8999999999999999999999999999987543
Q ss_pred CCCc-ccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhc
Q 003139 656 LDQT-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMD 734 (845)
Q Consensus 656 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (845)
.... .......+|..|+|||.+.+..++.++||||||+++|||++|+.||....... .....+.........+.+.++
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 265 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQMTVLRLTELLE 265 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCCHHHHHHHHHHHHH
T ss_pred cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-hhhhcccccchhHHHHHHHHh
Confidence 2221 22334567888999999999999999999999999999999999885321100 000000000001111222333
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhhhc
Q 003139 735 SNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLEE 782 (845)
Q Consensus 735 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~~ 782 (845)
.......+..++..+.+++.+||+.+|++|||+.++++.|+.+.+.-.
T Consensus 266 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 266 RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313 (318)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence 333333445667789999999999999999999999999998865443
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=378.03 Aligned_cols=265 Identities=20% Similarity=0.224 Sum_probs=209.4
Q ss_pred cHHHHHHHhcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCCh---HhHHHHHHHHHHHHhCCCCCcceEEEEEe
Q 003139 493 MFQEILDATNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSE---QGIAEFRTEIEMLSKLRHRHLVSLIGYCD 568 (845)
Q Consensus 493 ~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 568 (845)
.+.++...+++|+..++||+|+||.||+|++. +++.||+|++..... ...+.+.+|..++.+++||||++++++|.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 34555566789999999999999999999987 478899998754211 12234889999999999999999999999
Q ss_pred cCCcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEecc
Q 003139 569 ERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFG 648 (845)
Q Consensus 569 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFG 648 (845)
+.+..++||||+++|+|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+||||+.++.+||+|||
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred eCCEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcchh
Confidence 999999999999999999999653 3469999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCCCcccccccccCCCcCChhhhc-----cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHH
Q 003139 649 LSKTGPALDQTHVSTAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTW 723 (845)
Q Consensus 649 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~ 723 (845)
+++.... ..........||+.|+|||++. .+.++.++|||||||++|||++|++||......+. ....
T Consensus 221 la~~~~~-~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~------~~~i 293 (437)
T 4aw2_A 221 SCLKLME-DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKI 293 (437)
T ss_dssp TCEECCT-TSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHH
T ss_pred hhhhccc-CCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH------HHhh
Confidence 9976433 2222334568999999999987 56789999999999999999999999975432221 1111
Q ss_pred hhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCC--CCCHHHHHHHH
Q 003139 724 QKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVD--RPSMGDVLWNL 774 (845)
Q Consensus 724 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~~vl~~L 774 (845)
.... ... .+ ..........+.+++.+||..+|++ ||+++|++++-
T Consensus 294 ~~~~--~~~---~~-p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hp 340 (437)
T 4aw2_A 294 MNHK--ERF---QF-PTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHP 340 (437)
T ss_dssp HTHH--HHC---CC-CSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSG
T ss_pred hhcc--ccc---cC-CcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCC
Confidence 0000 000 00 0111224567889999999888877 99999998763
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=367.10 Aligned_cols=255 Identities=22% Similarity=0.330 Sum_probs=204.3
Q ss_pred cCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCC--CChHhHHHHHHHHHHHHhCC--CCCcceEEEEEecCCcEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNP--RSEQGIAEFRTEIEMLSKLR--HRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~ 577 (845)
..|.+.+.||+|+||.||+|...+++.||||++.. ......+.+.+|+++|++++ ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 45888999999999999999988899999998754 34566788999999999996 599999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
| +.+++|.+++... ..+++.++..++.||+.||+|||+ .+|+||||||+||||+ ++.+||+|||+++......
T Consensus 136 E-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp E-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred e-cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 9 5688999998654 378999999999999999999998 8999999999999996 5799999999998754322
Q ss_pred CcccccccccCCCcCChhhhcc-----------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhc
Q 003139 658 QTHVSTAVKGSFGYLDPEYFRR-----------QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKK 726 (845)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 726 (845)
.........||+.|+|||++.+ ..++.++|||||||+||||++|+.||....... .
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-----~-------- 275 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----S-------- 275 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-----H--------
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH-----H--------
Confidence 2223345679999999999875 478999999999999999999999996532211 1
Q ss_pred CchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 003139 727 GMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYA 777 (845)
Q Consensus 727 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~ 777 (845)
.+..++++......+......+.+++.+||+.||.+||++.|++++-...
T Consensus 276 -~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~ 325 (390)
T 2zmd_A 276 -KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325 (390)
T ss_dssp -HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred -HHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcc
Confidence 12223333333233333456788999999999999999999999876543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=363.51 Aligned_cols=270 Identities=15% Similarity=0.182 Sum_probs=210.1
Q ss_pred hcCCCcceeeeeeceEEEEEEEEcC------CcEEEEEEcCCCChHhH-----------HHHHHHHHHHHhCCCCCcceE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLDD------GTKVAVKRGNPRSEQGI-----------AEFRTEIEMLSKLRHRHLVSL 563 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~H~niv~l 563 (845)
.++|.+.+.||+|+||.||+|.+.. ++.||||.+........ ..+..|+..+..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4678999999999999999998764 47899998766543211 123456667778899999999
Q ss_pred EEEEecC----CcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEEC--
Q 003139 564 IGYCDER----SEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLD-- 637 (845)
Q Consensus 564 ~g~~~~~----~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~-- 637 (845)
++++... ...++||||+ +++|.+++... ...+++.+++.|+.||+.||+|||+ .+|+||||||+||||+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEESS
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEecC
Confidence 9998664 4589999999 99999998653 3579999999999999999999999 8999999999999999
Q ss_pred CCCceEEEeccccCCCCCCCCc-----ccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcc
Q 003139 638 DNFVAKVADFGLSKTGPALDQT-----HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPRE 712 (845)
Q Consensus 638 ~~~~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~ 712 (845)
.++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||+||||++|+.||.......
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 8899999999999764321111 11234569999999999999999999999999999999999999997533221
Q ss_pred cccHHHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhhh
Q 003139 713 QVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLE 781 (845)
Q Consensus 713 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~ 781 (845)
....+..... ...+..++++.+. ....+..+.+++.+||+.+|.+||++.+|++.|+.+++..
T Consensus 269 --~~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~ 331 (364)
T 3op5_A 269 --KYVRDSKIRY-RENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI 331 (364)
T ss_dssp --HHHHHHHHHH-HHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred --HHHHHHHHHh-hhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence 1122222211 1234455554442 1233567889999999999999999999999999987643
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=348.09 Aligned_cols=259 Identities=23% Similarity=0.343 Sum_probs=207.0
Q ss_pred CCCcceeeeeeceEEEEEEEEc-CC---cEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcE-EEE
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-DG---TKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEM-ILV 576 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~g---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~-~lV 576 (845)
.|...++||+|+||.||+|++. ++ ..+|+|.+... .....+.+.+|++++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4556689999999999999864 22 36999987754 445668899999999999999999999999776655 999
Q ss_pred EEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCC
Q 003139 577 YEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPAL 656 (845)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~ 656 (845)
|||+.+|+|.+++... ...+++.+++.++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.....
T Consensus 102 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp ECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred EecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 9999999999999653 3578999999999999999999999 89999999999999999999999999999864332
Q ss_pred C--CcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhc
Q 003139 657 D--QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMD 734 (845)
Q Consensus 657 ~--~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (845)
. .........+++.|+|||.+.+..++.++||||||+++|||++|+.|+....... .+.... .
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~--~~~~~~----~--------- 242 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF--DLTHFL----A--------- 242 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG--GHHHHH----H---------
T ss_pred cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH--HHHHHh----h---------
Confidence 1 1122234567889999999999999999999999999999999666554322221 111111 1
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhh
Q 003139 735 SNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQL 780 (845)
Q Consensus 735 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~ 780 (845)
.......+...+..+.+++.+||+.+|.+|||+.++++.|+.+++.
T Consensus 243 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 288 (298)
T 3pls_A 243 QGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA 288 (298)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 1111122334456789999999999999999999999999998663
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=354.79 Aligned_cols=251 Identities=24% Similarity=0.349 Sum_probs=204.7
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CC-------cEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DG-------TKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEM 573 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 573 (845)
++|...+.||+|+||.||+|+.. ++ ..||+|.+........+.+.+|++++++++||||+++++++.+.+..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 56888899999999999999865 23 46999998776667778899999999999999999999999999999
Q ss_pred EEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCc--------eEEE
Q 003139 574 ILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFV--------AKVA 645 (845)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~--------~kl~ 645 (845)
++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++. +||+
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred EEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccccccceeeec
Confidence 99999999999999996542 348999999999999999999999 89999999999999998887 9999
Q ss_pred eccccCCCCCCCCcccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHh
Q 003139 646 DFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQ 724 (845)
Q Consensus 646 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~ 724 (845)
|||+++.... .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.|+........ ......
T Consensus 164 Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-----~~~~~~ 232 (289)
T 4fvq_A 164 DPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-----KLQFYE 232 (289)
T ss_dssp CCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-----HHHHHH
T ss_pred cCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH-----HHHHhh
Confidence 9999875322 123457899999999987 7799999999999999999996655433222111 010000
Q ss_pred hcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 003139 725 KKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779 (845)
Q Consensus 725 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~ 779 (845)
.. ...+......+.+++.+||+.||++|||+.++++.|+.++.
T Consensus 233 ~~------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 233 DR------------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp TT------------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred cc------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 00 11122224467899999999999999999999999998755
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=370.27 Aligned_cols=253 Identities=20% Similarity=0.265 Sum_probs=205.3
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC--hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS--EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
.++|+..+.||+|+||.||+|... +|+.+|+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 467899999999999999999875 78899999876543 445677899999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEEC---CCCceEEEeccccCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLD---DNFVAKVADFGLSKTGP 654 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~---~~~~~kl~DFGla~~~~ 654 (845)
||+++|+|.+.+... ..+++.++..++.||+.||+|||+ ++|+||||||+|||++ +++.+||+|||+++...
T Consensus 90 E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 90 DLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp CCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 999999999988654 469999999999999999999999 8999999999999998 56789999999997644
Q ss_pred CCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhc
Q 003139 655 ALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMD 734 (845)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (845)
.. ........||+.|+|||++.+..++.++||||+||++|||++|++||......+ + .. ....+..
T Consensus 165 ~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~---~---~~-~i~~~~~----- 230 (444)
T 3soa_A 165 GE--QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR---L---YQ-QIKAGAY----- 230 (444)
T ss_dssp TT--CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---H---HH-HHHHTCC-----
T ss_pred CC--CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH---H---HH-HHHhCCC-----
Confidence 31 222345679999999999999999999999999999999999999996533211 1 11 1111110
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 735 SNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 735 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.............+.+++.+||+.||.+|||+.|++++
T Consensus 231 -~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 231 -DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp -CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00011112345678899999999999999999999874
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=353.69 Aligned_cols=262 Identities=28% Similarity=0.408 Sum_probs=201.8
Q ss_pred HHhcCCCcceeeeeeceEEEEEEEEc----CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCC-
Q 003139 499 DATNKFDESLLLGVGGFGRVYKGTLD----DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERS- 571 (845)
Q Consensus 499 ~at~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~- 571 (845)
-..++|...+.||+|+||.||+|.+. .++.||+|++... .....+.+.+|++++++++||||+++++++.+.+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 34567888999999999999999864 2457999987654 4556678999999999999999999999997655
Q ss_pred ----cEEEEEEeccCCCccccccC----CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceE
Q 003139 572 ----EMILVYEYMANGPLRSHLYG----TDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAK 643 (845)
Q Consensus 572 ----~~~lV~Ey~~~gsL~~~l~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~k 643 (845)
..++||||+++|+|.+++.. .....+++.+++.++.|+++||.|||+ .+|+||||||+|||+++++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEE
Confidence 35999999999999998842 234579999999999999999999998 8999999999999999999999
Q ss_pred EEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHH
Q 003139 644 VADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMT 722 (845)
Q Consensus 644 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~ 722 (845)
|+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ +...
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~~--- 261 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---MYDY--- 261 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHH---
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH---HHHH---
Confidence 999999986443222222334567889999999999999999999999999999999 888886543322 1111
Q ss_pred HhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 003139 723 WQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779 (845)
Q Consensus 723 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~ 779 (845)
+... .....+...+..+.+++.+||+.+|.+||++.++++.|+.+++
T Consensus 262 ---------~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 262 ---------LLHG-HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp ---------HHTT-CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------HHcC-CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1110 0112234455678999999999999999999999999998865
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=365.64 Aligned_cols=250 Identities=23% Similarity=0.273 Sum_probs=200.1
Q ss_pred CcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEeccCC
Q 003139 505 DESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANG 583 (845)
Q Consensus 505 ~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 583 (845)
...+.||+|+||.||+|... +|+.||+|++........+++.+|++++++++||||+++++++.+.+..++||||++++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 33567999999999999875 68999999988777677788999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEE--CCCCceEEEeccccCCCCCCCCccc
Q 003139 584 PLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILL--DDNFVAKVADFGLSKTGPALDQTHV 661 (845)
Q Consensus 584 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl--~~~~~~kl~DFGla~~~~~~~~~~~ 661 (845)
+|.+++... ...+++.+++.++.||++||+|||+ .+|+||||||+|||+ ++++.+||+|||+++..... ..
T Consensus 172 ~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~---~~ 244 (373)
T 2x4f_A 172 ELFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR---EK 244 (373)
T ss_dssp EEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT---CB
T ss_pred cHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc---cc
Confidence 999888643 2468999999999999999999999 899999999999999 67789999999999864322 22
Q ss_pred ccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCC
Q 003139 662 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKV 741 (845)
Q Consensus 662 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 741 (845)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .......... .+....
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~------~~~~i~~~~~-------~~~~~~ 311 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE------TLNNILACRW-------DLEDEE 311 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHTCC-------CSCSGG
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhccC-------CCChhh
Confidence 234569999999999999999999999999999999999999996543221 1111111100 000011
Q ss_pred CHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003139 742 NPASLKKFGETAEKCLAEHGVDRPSMGDVLWNL 774 (845)
Q Consensus 742 ~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L 774 (845)
.......+.+++.+||+.+|.+||++.|++++-
T Consensus 312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp 344 (373)
T 2x4f_A 312 FQDISEEAKEFISKLLIKEKSWRISASEALKHP 344 (373)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred hccCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 123456788999999999999999999999753
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=365.25 Aligned_cols=249 Identities=22% Similarity=0.366 Sum_probs=200.4
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERSEMILV 576 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 576 (845)
++|+..++||+|+||.||+|+.. +++.+|+|++... .....+.+..|..++.++ +||||+++++++.+.+..++|
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV 131 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence 57889999999999999999976 5788999987543 233345678899999887 899999999999999999999
Q ss_pred EEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCC
Q 003139 577 YEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPAL 656 (845)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~ 656 (845)
|||+++|+|..++... ..+++..+..++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+++....
T Consensus 132 ~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~- 205 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR- 205 (396)
T ss_dssp EECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-
T ss_pred EEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeeccc-
Confidence 9999999999988643 469999999999999999999999 8999999999999999999999999999986322
Q ss_pred CCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCccc--ccHHHHHHHHhhcCchhhhhc
Q 003139 657 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQ--VNIAEWAMTWQKKGMLDQIMD 734 (845)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~--~~l~~~~~~~~~~~~~~~~~d 734 (845)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ....++.... +..
T Consensus 206 -~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~--------i~~ 276 (396)
T 4dc2_A 206 -PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV--------ILE 276 (396)
T ss_dssp -TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHH--------HHH
T ss_pred -CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHH--------Hhc
Confidence 22234467899999999999999999999999999999999999999965332211 1111111111 111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCH
Q 003139 735 SNLVGKVNPASLKKFGETAEKCLAEHGVDRPSM 767 (845)
Q Consensus 735 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 767 (845)
..+ .++......+.+++.+||+.||.+||++
T Consensus 277 ~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 277 KQI--RIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp CCC--CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred ccc--CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 111 2344456678899999999999999995
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=364.64 Aligned_cols=263 Identities=19% Similarity=0.263 Sum_probs=206.6
Q ss_pred hcCCCcceeeeee--ceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEE
Q 003139 501 TNKFDESLLLGVG--GFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMIL 575 (845)
Q Consensus 501 t~~f~~~~~LG~G--~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 575 (845)
.++|++.+.||+| +||.||+|+.. +|+.||||++... .....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3578899999999 99999999986 6899999987543 34556788899999999999999999999999999999
Q ss_pred EEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCC
Q 003139 576 VYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPA 655 (845)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~ 655 (845)
||||+++|+|.+++.......+++..+..++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||++.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 9999999999999977655679999999999999999999999 8999999999999999999999999999864221
Q ss_pred CC-----CcccccccccCCCcCChhhhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCc
Q 003139 656 LD-----QTHVSTAVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGM 728 (845)
Q Consensus 656 ~~-----~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 728 (845)
.. .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.. .... .+.
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~-----~~~ 253 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEKL-----NGT 253 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH--HHC---------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHh-----cCC
Confidence 11 1111233478999999999987 68999999999999999999999999764433211 0000 000
Q ss_pred hhhhhcc-----------------------c-------------cCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 003139 729 LDQIMDS-----------------------N-------------LVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLW 772 (845)
Q Consensus 729 ~~~~~d~-----------------------~-------------l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~ 772 (845)
...+.+. . ............+.+++.+||+.||++|||+.|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 254 VPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp ----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 0000000 0 000112234567889999999999999999999986
Q ss_pred H
Q 003139 773 N 773 (845)
Q Consensus 773 ~ 773 (845)
+
T Consensus 334 h 334 (389)
T 3gni_B 334 H 334 (389)
T ss_dssp S
T ss_pred C
Confidence 5
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=362.14 Aligned_cols=275 Identities=25% Similarity=0.328 Sum_probs=214.7
Q ss_pred cCCCcceeeeeeceEEEEEEEE-----cCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEe--cCCcEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTL-----DDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCD--ERSEMI 574 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~~~ 574 (845)
++|+..+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5788889999999999999984 367899999998887777888999999999999999999999986 456689
Q ss_pred EEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCC
Q 003139 575 LVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGP 654 (845)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~ 654 (845)
+||||+++++|.+++.... ..+++.+++.|+.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++...
T Consensus 103 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp EEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred EEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 9999999999999986432 368999999999999999999999 999999999999999999999999999998654
Q ss_pred CCCCc-ccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhh
Q 003139 655 ALDQT-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIM 733 (845)
Q Consensus 655 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (845)
..... .......||..|+|||.+.+..++.++||||||+++|||++|+.||........ ....+.........+.+.+
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFL-RMMGCERDVPALSRLLELL 257 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHCC----CCHHHHHHHHH
T ss_pred cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhh-hhcccccccccHHHHHHHh
Confidence 32221 123345678889999999999999999999999999999999998753211100 0000000000000111222
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhhh
Q 003139 734 DSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLE 781 (845)
Q Consensus 734 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~ 781 (845)
........+...+..+.+++.+||+.+|++|||+.+++++|+.+....
T Consensus 258 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 258 EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred hcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 222233344566778999999999999999999999999999875533
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=357.20 Aligned_cols=245 Identities=24% Similarity=0.354 Sum_probs=205.0
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC---hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS---EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
++|+..+.||+|+||.||+++.. +|+.||+|.+.... ....+.+.+|..+++.++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 56888999999999999999976 68999999875431 123567889999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
||+++|+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 86 e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~-- 158 (318)
T 1fot_A 86 DYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-- 158 (318)
T ss_dssp CCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCC--
Confidence 999999999999654 468999999999999999999998 9999999999999999999999999999986432
Q ss_pred CcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcccc
Q 003139 658 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNL 737 (845)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (845)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .. ..++...+
T Consensus 159 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~---------~~i~~~~~ 220 (318)
T 1fot_A 159 ---VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK------TY---------EKILNAEL 220 (318)
T ss_dssp ---CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HH---------HHHHHCCC
T ss_pred ---ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH------HH---------HHHHhCCC
Confidence 1234679999999999999999999999999999999999999996532211 11 11121111
Q ss_pred CCCCCHHHHHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 003139 738 VGKVNPASLKKFGETAEKCLAEHGVDRP-----SMGDVLWN 773 (845)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~~ 773 (845)
.++......+.+++.+||+.+|++|| ++++++++
T Consensus 221 --~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 221 --RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred --CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 13344456788999999999999999 88888754
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=360.38 Aligned_cols=252 Identities=22% Similarity=0.268 Sum_probs=191.4
Q ss_pred HhcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEE
Q 003139 500 ATNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYE 578 (845)
Q Consensus 500 at~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 578 (845)
..++|+..+.||+|+||.||+|+.. +++.||||++.... ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 3567999999999999999999986 57889999876543 34678899999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECC---CCceEEEeccccCCCCC
Q 003139 579 YMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDD---NFVAKVADFGLSKTGPA 655 (845)
Q Consensus 579 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~---~~~~kl~DFGla~~~~~ 655 (845)
|+++|+|.+++... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++....
T Consensus 129 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 129 LVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp CCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred eCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 99999999998543 468999999999999999999999 89999999999999975 88999999999986332
Q ss_pred CCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcc
Q 003139 656 LDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDS 735 (845)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (845)
........||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ......+...
T Consensus 204 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~~i~~~~~------ 268 (349)
T 2w4o_A 204 ---QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF------MFRRILNCEY------ 268 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH------HHHHHHTTCC------
T ss_pred ---ccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH------HHHHHHhCCC------
Confidence 2223456789999999999999999999999999999999999999965432211 1111111100
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 736 NLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 736 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.............+.+++.+||+.||++|||+.+++++
T Consensus 269 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 269 YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01111223455678899999999999999999999864
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=357.05 Aligned_cols=248 Identities=24% Similarity=0.358 Sum_probs=196.0
Q ss_pred cCCCcceeeeeeceEEEEEEEE----cCCcEEEEEEcCCCC----hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTL----DDGTKVAVKRGNPRS----EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEM 573 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 573 (845)
++|+..+.||+|+||.||+++. .+|+.+|+|++.... ......+.+|++++++++||||+++++++.+.+..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 5788999999999999999987 478999999887542 23456688999999999999999999999999999
Q ss_pred EEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCC
Q 003139 574 ILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTG 653 (845)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~ 653 (845)
++||||+++++|.+++... ..+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 97 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 97 YLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp EEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred EEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 9999999999999998643 468999999999999999999999 89999999999999999999999999999753
Q ss_pred CCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhh
Q 003139 654 PALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIM 733 (845)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (845)
.. .........||+.|+|||.+.+..++.++|||||||++|||++|+.||......+ ... .+.
T Consensus 172 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~---------~i~ 234 (327)
T 3a62_A 172 IH--DGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK------TID---------KIL 234 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHH---------HHH
T ss_pred cc--CCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH------HHH---------HHH
Confidence 22 1222345679999999999999999999999999999999999999996543211 111 111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 003139 734 DSNLVGKVNPASLKKFGETAEKCLAEHGVDRP-----SMGDVLWN 773 (845)
Q Consensus 734 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~~ 773 (845)
.... .++......+.+++.+||+.+|++|| ++.+++++
T Consensus 235 ~~~~--~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 235 KCKL--NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp HTCC--CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred hCCC--CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 1111 23344556788999999999999999 67777665
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=357.87 Aligned_cols=264 Identities=27% Similarity=0.344 Sum_probs=209.3
Q ss_pred hcCCCcceeeeeeceEEEEEEEE------cCCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTL------DDGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEM 573 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 573 (845)
.++|...+.||+|+||.||+|++ .+++.||||++... ......++.+|+.++++++||||+++++++.+....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 36788899999999999999984 25678999998654 455667899999999999999999999999999999
Q ss_pred EEEEEeccCCCccccccCCCC-----CCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECC---CCceEEE
Q 003139 574 ILVYEYMANGPLRSHLYGTDL-----PPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDD---NFVAKVA 645 (845)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~---~~~~kl~ 645 (845)
++||||+++++|.+++..... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999975431 458999999999999999999999 89999999999999984 4569999
Q ss_pred eccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHh
Q 003139 646 DFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQ 724 (845)
Q Consensus 646 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~ 724 (845)
|||+++...............||+.|+|||.+.+..++.++||||||+++|||++ |+.||......+ .... .
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~-~ 258 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE------VLEF-V 258 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------HHHH-H
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH------HHHH-H
Confidence 9999874322122222334567889999999999999999999999999999998 888886532211 1111 1
Q ss_pred hcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhhhcc
Q 003139 725 KKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLEET 783 (845)
Q Consensus 725 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~~~ 783 (845)
..+ .....+...+..+.+++.+||+.+|.+||++.++++.|+.+.+....
T Consensus 259 ~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 308 (327)
T 2yfx_A 259 TSG---------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 308 (327)
T ss_dssp HTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHH
T ss_pred hcC---------CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHHH
Confidence 111 11122344556788999999999999999999999999988765543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=348.22 Aligned_cols=260 Identities=28% Similarity=0.422 Sum_probs=205.1
Q ss_pred hcCCCcceeeeeeceEEEEEEEEcC----CcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEe-cCCcEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLDD----GTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCD-ERSEMI 574 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~-~~~~~~ 574 (845)
..+|+..+.||+|+||.||+|++.+ +..+|+|.+... .....+++.+|++++++++||||++++++|. ..+..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 3467888899999999999998642 235899987754 4455678999999999999999999999974 456789
Q ss_pred EEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCC
Q 003139 575 LVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGP 654 (845)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~ 654 (845)
+||||+++|+|.+++... ...+++.+++.++.|+++||+|||+ .+|+||||||+|||+++++.+||+|||+++...
T Consensus 104 ~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp EEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred EEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECccccccccc
Confidence 999999999999999653 3568999999999999999999999 899999999999999999999999999998644
Q ss_pred CCCC--cccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCC-CCCCCCCCcccccHHHHHHHHhhcCchhh
Q 003139 655 ALDQ--THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTR-PALNPVLPREQVNIAEWAMTWQKKGMLDQ 731 (845)
Q Consensus 655 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~-~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (845)
.... ........+|+.|+|||.+.+..++.++||||||+++|||++|+ +|+......+ .... ... +
T Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~~~---~~~-~---- 248 (298)
T 3f66_A 180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVY---LLQ-G---- 248 (298)
T ss_dssp CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HHHH---HHT-T----
T ss_pred ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HHHH---Hhc-C----
Confidence 3221 12233456788999999999999999999999999999999954 5554332221 1111 000 0
Q ss_pred hhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhh
Q 003139 732 IMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQL 780 (845)
Q Consensus 732 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~ 780 (845)
.....+...+..+.+++.+||+.+|++||++.++++.|+.++..
T Consensus 249 -----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 292 (298)
T 3f66_A 249 -----RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292 (298)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -----CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 01112233456789999999999999999999999999988663
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=360.12 Aligned_cols=251 Identities=24% Similarity=0.322 Sum_probs=206.0
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC---hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS---EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
++|.+.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57888999999999999999974 78999999875321 112357889999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
||+ +|+|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++....
T Consensus 89 E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~-- 160 (336)
T 3h4j_B 89 EYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD-- 160 (336)
T ss_dssp CCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT--
T ss_pred ECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceeccC--
Confidence 999 78898888543 469999999999999999999999 8999999999999999999999999999986432
Q ss_pred CcccccccccCCCcCChhhhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccc
Q 003139 658 QTHVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSN 736 (845)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (845)
........||+.|+|||.+.+..+ +.++|||||||++|||++|+.||......+. ...+...
T Consensus 161 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~---------------~~~i~~~- 223 (336)
T 3h4j_B 161 -GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL---------------FKKVNSC- 223 (336)
T ss_dssp -SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC---------------BCCCCSS-
T ss_pred -CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH---------------HHHHHcC-
Confidence 222345679999999999988776 7899999999999999999999975432221 1111110
Q ss_pred cCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhh
Q 003139 737 LVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYAL 778 (845)
Q Consensus 737 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~ 778 (845)
....+......+.+++.+||+.||.+|||+.|++++-....
T Consensus 224 -~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 264 (336)
T 3h4j_B 224 -VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV 264 (336)
T ss_dssp -CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred -CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence 11233445567889999999999999999999998766543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=352.56 Aligned_cols=264 Identities=26% Similarity=0.426 Sum_probs=208.5
Q ss_pred cCCCcceeeeeeceEEEEEEEE-----cCCcEEEEEEcCCCC-hHhHHHHHHHHHHHHhCCCCCcceEEEEEecC--CcE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTL-----DDGTKVAVKRGNPRS-EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDER--SEM 573 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 573 (845)
+.|+..+.||+|+||.||+|++ .+++.||+|++.... ....+.+.+|++++++++||||+++++++.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4578888999999999999984 368899999987543 34457899999999999999999999999776 668
Q ss_pred EEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCC
Q 003139 574 ILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTG 653 (845)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~ 653 (845)
++||||+++++|.+++.... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECcccccccc
Confidence 99999999999999985432 469999999999999999999999 99999999999999999999999999999864
Q ss_pred CCCCCc-ccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC---------cccccHHHHHHHH
Q 003139 654 PALDQT-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLP---------REQVNIAEWAMTW 723 (845)
Q Consensus 654 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~---------~~~~~l~~~~~~~ 723 (845)
...... .......||..|+|||.+.+..++.++||||||+++|||++|+.|+..... ........
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----- 251 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR----- 251 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHH-----
T ss_pred cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHH-----
Confidence 432221 223355688889999999999999999999999999999999987532110 00000000
Q ss_pred hhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 003139 724 QKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779 (845)
Q Consensus 724 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~ 779 (845)
+...+........+...+..+.+++.+||+.||.+|||+.++++.|+.+++
T Consensus 252 -----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~ 302 (302)
T 4e5w_A 252 -----LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302 (302)
T ss_dssp -----HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred -----HHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 111111112222345566789999999999999999999999999998753
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=348.02 Aligned_cols=262 Identities=21% Similarity=0.270 Sum_probs=200.6
Q ss_pred cCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCCh--HhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSE--QGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
++|+..+.||+|+||.||+|+..+|+.+|+|++..... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 46888999999999999999998899999998865432 2246788999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCc
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT 659 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~ 659 (845)
+++ +|.+++... ...+++.++..++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++.... ..
T Consensus 82 ~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~ 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGI--PV 154 (288)
T ss_dssp CSE-EHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred cCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCc--cc
Confidence 975 888887643 2568999999999999999999999 8999999999999999999999999999975322 11
Q ss_pred ccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchh---h----
Q 003139 660 HVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLD---Q---- 731 (845)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~---~---- 731 (845)
.......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+. + ............. .
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~-~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T 1ob3_A 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ--L-MRIFRILGTPNSKNWPNVTEL 231 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--H-HHHHHHHCCCCTTTSTTGGGS
T ss_pred cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--H-HHHHHHHCCCChhhchhhhcc
Confidence 12234568999999999976 4689999999999999999999999975432221 1 1111111110000 0
Q ss_pred -hhccccC-------CCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 732 -IMDSNLV-------GKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 732 -~~d~~l~-------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
..++... ..........+.+++.+||+.||++|||+.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0011100 01112345678899999999999999999999764
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=357.42 Aligned_cols=249 Identities=23% Similarity=0.368 Sum_probs=202.4
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERSEMILV 576 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 576 (845)
++|+..+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|..++.++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 46888999999999999999976 5889999987543 345567788999999988 899999999999999999999
Q ss_pred EEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCC
Q 003139 577 YEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPAL 656 (845)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~ 656 (845)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++....
T Consensus 89 ~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~- 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR- 162 (345)
T ss_dssp ECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC-
T ss_pred EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccccC-
Confidence 9999999999998643 469999999999999999999999 8999999999999999999999999999986322
Q ss_pred CCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccc--cHHHHHHHHhhcCchhhhhc
Q 003139 657 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQV--NIAEWAMTWQKKGMLDQIMD 734 (845)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~--~l~~~~~~~~~~~~~~~~~d 734 (845)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||......... ........ .+..
T Consensus 163 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~--------~i~~ 233 (345)
T 3a8x_A 163 -PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ--------VILE 233 (345)
T ss_dssp -TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHH--------HHHH
T ss_pred -CCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHH--------HHHc
Confidence 122234568999999999999999999999999999999999999999653221110 11111111 1111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCH
Q 003139 735 SNLVGKVNPASLKKFGETAEKCLAEHGVDRPSM 767 (845)
Q Consensus 735 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 767 (845)
..+ .++......+.+++.+||+.||.+||++
T Consensus 234 ~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 234 KQI--RIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp CCC--CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred CCC--CCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 111 2334456678899999999999999995
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=354.53 Aligned_cols=258 Identities=29% Similarity=0.457 Sum_probs=207.1
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcE--EEEEEcCCC-ChHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTK--VAVKRGNPR-SEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERSEMILV 576 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 576 (845)
++|+..+.||+|+||.||+|+.. ++.. +++|++... .....+++.+|+++++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57888999999999999999875 5654 488987643 344556789999999999 899999999999999999999
Q ss_pred EEeccCCCccccccCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCce
Q 003139 577 YEYMANGPLRSHLYGTD--------------LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVA 642 (845)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~ 642 (845)
|||+++++|.+++.... ...+++.+++.++.|++.||+|||+ ++|+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCeE
Confidence 99999999999986542 2479999999999999999999999 999999999999999999999
Q ss_pred EEEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHH
Q 003139 643 KVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAM 721 (845)
Q Consensus 643 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~ 721 (845)
||+|||+++.... ........+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ...
T Consensus 182 kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~------~~~ 252 (327)
T 1fvr_A 182 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LYE 252 (327)
T ss_dssp EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHH
T ss_pred EEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH------HHH
Confidence 9999999975221 112234457889999999999999999999999999999998 999986543211 111
Q ss_pred HHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhhh
Q 003139 722 TWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLE 781 (845)
Q Consensus 722 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~ 781 (845)
. ... ......+......+.+++.+||+.+|.+||++.++++.|+.++...
T Consensus 253 ~-~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 253 K-LPQ---------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp H-GGG---------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred H-hhc---------CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 1 111 1111233445577899999999999999999999999999887643
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=357.41 Aligned_cols=252 Identities=23% Similarity=0.343 Sum_probs=197.9
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCC-------
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERS------- 571 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------- 571 (845)
.++|+..+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|++++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 356888999999999999999986 7899999987643 3345678999999999999999999999986543
Q ss_pred --------------------------------------------------cEEEEEEeccCCCccccccCCC-CCCCCHH
Q 003139 572 --------------------------------------------------EMILVYEYMANGPLRSHLYGTD-LPPLSWK 600 (845)
Q Consensus 572 --------------------------------------------------~~~lV~Ey~~~gsL~~~l~~~~-~~~l~~~ 600 (845)
..++||||+++++|.+++.... ....++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 2799999999999999997543 2446777
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCc----------ccccccccCCC
Q 003139 601 QRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT----------HVSTAVKGSFG 670 (845)
Q Consensus 601 ~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~----------~~~~~~~gt~~ 670 (845)
.++.++.|++.||+|||+ .+|+||||||+||||+.++.+||+|||+++........ .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 899999999999999999 99999999999999999999999999999864432111 12234579999
Q ss_pred cCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCCHHHHHHHH
Q 003139 671 YLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFG 750 (845)
Q Consensus 671 y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 750 (845)
|+|||.+.+..++.++|||||||++|||++|..|+. +. ... .......... .........+.
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~-----~~---~~~-~~~~~~~~~~---------~~~~~~~~~~~ 303 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM-----ER---VRI-ITDVRNLKFP---------LLFTQKYPQEH 303 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH-----HH---HHH-HHHHHTTCCC---------HHHHHHCHHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh-----HH---HHH-HHHhhccCCC---------cccccCChhHH
Confidence 999999999999999999999999999999876531 00 000 0001111100 01123446678
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHH
Q 003139 751 ETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 751 ~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
+++.+||+.||++||++.|++++
T Consensus 304 ~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHccCCCCcCCCHHHHhhc
Confidence 99999999999999999999864
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=363.12 Aligned_cols=258 Identities=28% Similarity=0.429 Sum_probs=197.9
Q ss_pred cCCCcceeeeeeceEEEEEEEEc--CC--cEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEec-CCcEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD--DG--TKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDE-RSEMIL 575 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~--~g--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~l 575 (845)
..|+..+.||+|+||.||+|++. ++ ..+|+|.+... .....++|.+|+.++++++||||++++++|.+ .+..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 34667789999999999999864 22 35899987654 34567889999999999999999999999854 567899
Q ss_pred EEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCC
Q 003139 576 VYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPA 655 (845)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~ 655 (845)
||||+++|+|.+++... ...+++.+++.++.|+++||+|||+ .+|+||||||+||||++++.+||+|||+++....
T Consensus 169 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeeccccccccc
Confidence 99999999999999654 3468999999999999999999999 8999999999999999999999999999986432
Q ss_pred CCC--cccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhh
Q 003139 656 LDQ--THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQI 732 (845)
Q Consensus 656 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (845)
... ........+|+.|+|||.+.+..++.++|||||||++|||++ |.+||......+ +.... ..+.
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~~~----~~~~---- 313 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYL----LQGR---- 313 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHHHH----HTTC----
T ss_pred cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHHHH----HcCC----
Confidence 111 112234567889999999999999999999999999999999 566665433222 11111 1110
Q ss_pred hccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 003139 733 MDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779 (845)
Q Consensus 733 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~ 779 (845)
....+..++..+.+++.+||+.+|++||++.++++.|+.+..
T Consensus 314 -----~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~ 355 (373)
T 3c1x_A 314 -----RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 355 (373)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111233455678999999999999999999999999998865
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=351.08 Aligned_cols=250 Identities=27% Similarity=0.415 Sum_probs=205.7
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEec----------
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDE---------- 569 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~---------- 569 (845)
.++|+..+.||+|+||.||+|+.. +|+.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 356888999999999999999986 78999999886554 356789999999999999999998854
Q ss_pred ------CCcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceE
Q 003139 570 ------RSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAK 643 (845)
Q Consensus 570 ------~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~k 643 (845)
....++||||+++++|.+++.......+++..++.++.|++.||+|||+ .+|+||||||+|||+++++.+|
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCCCCEE
Confidence 4458999999999999999976545679999999999999999999999 8999999999999999999999
Q ss_pred EEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHH
Q 003139 644 VADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTW 723 (845)
Q Consensus 644 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~ 723 (845)
|+|||+++..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.|+... ..+.
T Consensus 163 l~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--------~~~~--- 228 (284)
T 2a19_B 163 IGDFGLVTSLKND---GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--------SKFF--- 228 (284)
T ss_dssp ECCCTTCEESSCC---SCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--------HHHH---
T ss_pred ECcchhheecccc---ccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--------HHHH---
Confidence 9999999764321 1233457899999999999999999999999999999999999776310 0111
Q ss_pred hhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhhh
Q 003139 724 QKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLE 781 (845)
Q Consensus 724 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~ 781 (845)
..+.+.. .+...+..+.+++.+||+.||.+||++.|+++.|+...+..
T Consensus 229 ------~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 229 ------TDLRDGI----ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp ------HHHHTTC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred ------HHhhccc----ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 1111111 22233456789999999999999999999999999876533
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=360.67 Aligned_cols=253 Identities=21% Similarity=0.263 Sum_probs=202.5
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC-----ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR-----SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMIL 575 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 575 (845)
++|+..+.||+|+||.||+|... +|+.||||++... .....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 56889999999999999999875 6899999986432 11235778999999999999999999999999999999
Q ss_pred EEEeccCCCccccccCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCc---eEEEecccc
Q 003139 576 VYEYMANGPLRSHLYGT--DLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFV---AKVADFGLS 650 (845)
Q Consensus 576 V~Ey~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~---~kl~DFGla 650 (845)
||||+++++|.+++... ....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 99999999998877542 23468999999999999999999999 89999999999999986654 999999999
Q ss_pred CCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchh
Q 003139 651 KTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLD 730 (845)
Q Consensus 651 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (845)
+..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.... + .+ .... ..+...
T Consensus 181 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~--~~---~~~i-~~~~~~ 250 (351)
T 3c0i_A 181 IQLGES--GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--E--RL---FEGI-IKGKYK 250 (351)
T ss_dssp EECCTT--SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH--H--HH---HHHH-HHTCCC
T ss_pred eEecCC--CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH--H--HH---HHHH-HcCCCC
Confidence 764331 222345679999999999999999999999999999999999999996521 1 11 1111 111000
Q ss_pred hhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 731 QIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 731 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
..+.. .......+.+++.+||+.||++||++.+++++
T Consensus 251 --~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 251 --MNPRQ----WSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp --CCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --CCccc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00000 01234678899999999999999999999865
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=349.88 Aligned_cols=263 Identities=19% Similarity=0.285 Sum_probs=202.8
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCC---CChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNP---RSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
++|++.+.||+|+||.||+|... +|+.||+|++.. ......+++.+|++++++++||||+++++++.+.+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 56888999999999999999974 789999998764 24556678999999999999999999999999999999999
Q ss_pred EeccCCCccccccC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCC
Q 003139 578 EYMANGPLRSHLYG--TDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPA 655 (845)
Q Consensus 578 Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~ 655 (845)
||+++++|.+++.. .....+++..++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999998854 234568999999999999999999999 8999999999999999999999999999976432
Q ss_pred CCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcc
Q 003139 656 LDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDS 735 (845)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (845)
.........|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ...+.... ....
T Consensus 189 --~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~-~~~~------- 254 (310)
T 2wqm_A 189 --KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKI-EQCD------- 254 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHHHHHHH-HTTC-------
T ss_pred --CCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHHHHHHh-hccc-------
Confidence 112223456899999999999999999999999999999999999998643221 11111111 1111
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhhhc
Q 003139 736 NLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLEE 782 (845)
Q Consensus 736 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~~ 782 (845)
............+.+++.+||+.||.+||++.+|++.|+.+.....
T Consensus 255 -~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 255 -YPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp -SCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred -CCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 1111123345678899999999999999999999999998866444
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=382.11 Aligned_cols=251 Identities=26% Similarity=0.413 Sum_probs=203.2
Q ss_pred eeeeeceEEEEEEEEc---CCcEEEEEEcCCCC-hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEeccCCC
Q 003139 509 LLGVGGFGRVYKGTLD---DGTKVAVKRGNPRS-EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGP 584 (845)
Q Consensus 509 ~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 584 (845)
.||+|+||.||+|.+. ++..||||++.... ....++|.+|+++|++++||||++++++|.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999874 45679999987653 3456889999999999999999999999976 56999999999999
Q ss_pred ccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCc-cccc
Q 003139 585 LRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT-HVST 663 (845)
Q Consensus 585 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~ 663 (845)
|.+++... ...+++.+++.|+.||++||+|||+ ++|+||||||+||||++++.+||+|||+++........ ....
T Consensus 422 L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 497 (613)
T 2ozo_A 422 LHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 497 (613)
T ss_dssp HHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----------
T ss_pred HHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeecc
Confidence 99999654 3579999999999999999999999 89999999999999999999999999999875432211 1122
Q ss_pred ccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCC
Q 003139 664 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVN 742 (845)
Q Consensus 664 ~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 742 (845)
...+++.|+|||++.++.++.++|||||||+||||++ |+.||......+ +. .....+ .....+
T Consensus 498 ~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~~----~~i~~~---------~~~~~p 561 (613)
T 2ozo_A 498 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VM----AFIEQG---------KRMECP 561 (613)
T ss_dssp ----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH---HH----HHHHTT---------CCCCCC
T ss_pred CCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HH----HHHHcC---------CCCCCC
Confidence 3446789999999999999999999999999999998 999997654322 11 111111 112234
Q ss_pred HHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhh
Q 003139 743 PASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQL 780 (845)
Q Consensus 743 ~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~ 780 (845)
..++..+.+++.+||+.+|++||++.+|++.|+.....
T Consensus 562 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 562 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 55677899999999999999999999999999987543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=373.36 Aligned_cols=260 Identities=22% Similarity=0.236 Sum_probs=208.2
Q ss_pred HHHHHHHhcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC---hHhHHHHHHHHHHHHhCCCCCcceEEEEEec
Q 003139 494 FQEILDATNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS---EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDE 569 (845)
Q Consensus 494 ~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 569 (845)
+.++....++|+..+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 3444455688999999999999999999986 58899999875321 1122357899999999999999999999999
Q ss_pred CCcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccc
Q 003139 570 RSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGL 649 (845)
Q Consensus 570 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGl 649 (845)
.+..++||||+++|+|.+++... .+++..+..++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEeccce
Confidence 99999999999999999998643 58999999999999999999999 9999999999999999999999999999
Q ss_pred cCCCCCCCCcccccccccCCCcCChhhhccCC----CCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhh
Q 003139 650 SKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQ----LTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQK 725 (845)
Q Consensus 650 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~ 725 (845)
++..... .........||+.|+|||++.+.. ++.++|||||||+||||++|+.||......+ ..
T Consensus 215 a~~~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~----- 282 (410)
T 3v8s_A 215 CMKMNKE-GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------TY----- 282 (410)
T ss_dssp CEECCTT-SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HH-----
T ss_pred eEeeccC-CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh------HH-----
Confidence 9764331 222234678999999999998765 7899999999999999999999997543221 11
Q ss_pred cCchhhhhccc--cCCCCCHHHHHHHHHHHHHhhhhCCCC--CCCHHHHHHHHH
Q 003139 726 KGMLDQIMDSN--LVGKVNPASLKKFGETAEKCLAEHGVD--RPSMGDVLWNLE 775 (845)
Q Consensus 726 ~~~~~~~~d~~--l~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~~vl~~L~ 775 (845)
..++... +...........+.+++.+||+.+|.+ ||+++||+++-.
T Consensus 283 ----~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~ 332 (410)
T 3v8s_A 283 ----SKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 332 (410)
T ss_dssp ----HHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGG
T ss_pred ----HHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCcc
Confidence 1111110 110111234567889999999999988 999999987643
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=349.26 Aligned_cols=263 Identities=21% Similarity=0.273 Sum_probs=201.6
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYE 578 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 578 (845)
++|+..+.||+|+||.||+|+.. +|+.||+|++... .....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 46888999999999999999976 6889999987543 33445788899999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCC
Q 003139 579 YMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQ 658 (845)
Q Consensus 579 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~ 658 (845)
|+++ +|.+.+... ...+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.... .
T Consensus 82 ~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~--~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGI--P 154 (292)
T ss_dssp CCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCS--C
T ss_pred cCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCC--c
Confidence 9975 555544332 3579999999999999999999999 8999999999999999999999999999976432 1
Q ss_pred cccccccccCCCcCChhhhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCch------hh
Q 003139 659 THVSTAVKGSFGYLDPEYFRRQQ-LTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGML------DQ 731 (845)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~------~~ 731 (845)
........||+.|+|||.+.+.. ++.++|||||||++|||++|+.|+........ .............. .+
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCCCCTTTCTTGGG
T ss_pred cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHHHHhCCCChhhhhhhcc
Confidence 22234557899999999998765 89999999999999999999888644332211 11111111111000 00
Q ss_pred hhc---------cccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 732 IMD---------SNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 732 ~~d---------~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
..+ ........+.....+.+++.+||+.||++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000 000011223455678899999999999999999999864
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=348.45 Aligned_cols=252 Identities=28% Similarity=0.415 Sum_probs=202.1
Q ss_pred hcCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecC-CcEEEEEEe
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDER-SEMILVYEY 579 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~Ey 579 (845)
.++|+..+.||+|+||.||+|+.. |+.||+|.+.... ..+.+.+|++++++++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 357888999999999999999876 8899999987543 457889999999999999999999997554 478999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCc
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT 659 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~ 659 (845)
+++++|.+++.......+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--- 170 (278)
T 1byg_A 97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 170 (278)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeecccccccccc---
Confidence 999999999865433348999999999999999999999 89999999999999999999999999998753321
Q ss_pred ccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccC
Q 003139 660 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLV 738 (845)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 738 (845)
.....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ +. .. ... ...
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~---~~-~~~---------~~~ 232 (278)
T 1byg_A 171 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV---PR-VEK---------GYK 232 (278)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HH---HH-HTT---------TCC
T ss_pred --ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HH---HH-Hhc---------CCC
Confidence 123457889999999999999999999999999999998 999986543221 11 11 111 111
Q ss_pred CCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 003139 739 GKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779 (845)
Q Consensus 739 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~ 779 (845)
...+...+..+.+++.+||+.+|++||++.++++.|+.+..
T Consensus 233 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 233 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 22334556788999999999999999999999999998765
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=346.33 Aligned_cols=250 Identities=19% Similarity=0.286 Sum_probs=205.4
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
.++|...+.||+|+||.||+|... ++..+|+|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 457889999999999999999976 5778999987655445567899999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEE---CCCCceEEEeccccCCCCCC
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILL---DDNFVAKVADFGLSKTGPAL 656 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl---~~~~~~kl~DFGla~~~~~~ 656 (845)
+++++|.+++... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++....
T Consensus 88 ~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~- 161 (277)
T 3f3z_A 88 CTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP- 161 (277)
T ss_dssp CCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT-
T ss_pred cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC-
Confidence 9999999988543 468999999999999999999999 899999999999999 7889999999999976432
Q ss_pred CCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccc
Q 003139 657 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSN 736 (845)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (845)
........||+.|+|||.+.+. ++.++||||||+++|||++|+.||......+ ..... .++.
T Consensus 162 --~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~-~~~~-------- 223 (277)
T 3f3z_A 162 --GKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE------VMLKI-REGT-------- 223 (277)
T ss_dssp --TSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHH-HHCC--------
T ss_pred --ccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH------HHHHH-HhCC--------
Confidence 2223445789999999998764 8999999999999999999999996533211 11111 1110
Q ss_pred cCCCCCH----HHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003139 737 LVGKVNP----ASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEY 776 (845)
Q Consensus 737 l~~~~~~----~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~ 776 (845)
. ..+. .....+.+++.+||+.+|++||++.+++++-..
T Consensus 224 ~--~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~ 265 (277)
T 3f3z_A 224 F--TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWF 265 (277)
T ss_dssp C--CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHH
T ss_pred C--CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHH
Confidence 0 1111 235678899999999999999999999876443
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=363.75 Aligned_cols=249 Identities=24% Similarity=0.320 Sum_probs=204.4
Q ss_pred HhcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC---hHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcEE
Q 003139 500 ATNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS---EQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERSEMI 574 (845)
Q Consensus 500 at~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 574 (845)
..++|...+.||+|+||.||+|+.+ +|+.||+|++.... ....+.+..|.+++.++ +||||+++++++.+.+..+
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 4578999999999999999999986 68899999876431 22346678899999877 9999999999999999999
Q ss_pred EEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCC
Q 003139 575 LVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGP 654 (845)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~ 654 (845)
+||||+++|+|.+++... ..+++.++..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++...
T Consensus 95 lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENM 169 (345)
T ss_dssp EEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence 999999999999998643 468999999999999999999999 899999999999999999999999999998632
Q ss_pred CCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhc
Q 003139 655 ALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMD 734 (845)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (845)
. .........||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .... +..
T Consensus 170 ~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~~~~---------i~~ 232 (345)
T 1xjd_A 170 L--GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE------LFHS---------IRM 232 (345)
T ss_dssp C--TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHH---------HHH
T ss_pred c--CCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH------HHHH---------HHh
Confidence 2 1122345689999999999999999999999999999999999999997543211 1111 111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHH-HHHH
Q 003139 735 SNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMG-DVLW 772 (845)
Q Consensus 735 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~-~vl~ 772 (845)
.. ..++......+.+++.+||+.+|++||++. ++++
T Consensus 233 ~~--~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 233 DN--PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp CC--CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CC--CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 11 112334456788999999999999999997 6653
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=359.84 Aligned_cols=250 Identities=27% Similarity=0.366 Sum_probs=203.1
Q ss_pred hcCCCcceeeeeeceEEEEEEEE-cCCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTL-DDGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILV 576 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 576 (845)
.+.|...+.||+|+||.||+|+. .+|+.||||++... .....+++.+|++++++++||||+++++++.+.+..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 34588889999999999999996 47899999987543 234457899999999999999999999999999999999
Q ss_pred EEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCC
Q 003139 577 YEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPAL 656 (845)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~ 656 (845)
|||++ |+|.+++... ...+++.++..++.|+++||+|||+ .+|+||||||+|||+++++.+||+|||+++....
T Consensus 133 ~e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~- 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 206 (348)
T ss_dssp EECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCC-
Confidence 99997 6787777433 2479999999999999999999999 8999999999999999999999999999976432
Q ss_pred CCcccccccccCCCcCChhhhc---cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhh
Q 003139 657 DQTHVSTAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIM 733 (845)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (845)
.....||+.|+|||++. .+.++.++|||||||++|||++|+.||......+ .........
T Consensus 207 -----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~------~~~~~~~~~------ 269 (348)
T 1u5q_A 207 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQNE------ 269 (348)
T ss_dssp -----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHSC------
T ss_pred -----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHHhcC------
Confidence 23457899999999984 5788999999999999999999999986543211 111111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003139 734 DSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEY 776 (845)
Q Consensus 734 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~ 776 (845)
.+.+ ........+.+++.+||+.+|++|||+.+++++...
T Consensus 270 ~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~ 309 (348)
T 1u5q_A 270 SPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 309 (348)
T ss_dssp CCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred CCCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhh
Confidence 0111 122345678899999999999999999999876543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=364.33 Aligned_cols=249 Identities=25% Similarity=0.332 Sum_probs=204.0
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC---hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS---EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
++|+..+.||+|+||.||++... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 56888999999999999999976 58899999875431 233567889999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
||+++|+|..++... ..+++..+..++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+++....
T Consensus 95 e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~-- 167 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR-- 167 (384)
T ss_dssp CCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCT--
T ss_pred ecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccC--
Confidence 999999999999653 469999999999999999999999 9999999999999999999999999999986432
Q ss_pred CcccccccccCCCcCChhhhcc---CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhc
Q 003139 658 QTHVSTAVKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMD 734 (845)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (845)
........||+.|+|||++.. ..++.++|||||||++|||++|+.||..........+ .... . .
T Consensus 168 -~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~---~~~~-~--------~ 234 (384)
T 4fr4_A 168 -ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEI---VHTF-E--------T 234 (384)
T ss_dssp -TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHH---HHHH-H--------H
T ss_pred -CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHH---HHHH-h--------h
Confidence 223345789999999999864 4589999999999999999999999975433221111 1111 0 0
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhhCCCCCCC-HHHHHH
Q 003139 735 SNLVGKVNPASLKKFGETAEKCLAEHGVDRPS-MGDVLW 772 (845)
Q Consensus 735 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-~~~vl~ 772 (845)
. ...++......+.+++.+||+.+|.+||+ ++++++
T Consensus 235 ~--~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 235 T--VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp C--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred c--ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 0 11233445677899999999999999998 666654
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=348.16 Aligned_cols=261 Identities=26% Similarity=0.342 Sum_probs=208.7
Q ss_pred cCCCcce-eeeeeceEEEEEEEEc---CCcEEEEEEcCCCC--hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEE
Q 003139 502 NKFDESL-LLGVGGFGRVYKGTLD---DGTKVAVKRGNPRS--EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMIL 575 (845)
Q Consensus 502 ~~f~~~~-~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 575 (845)
++|...+ .||+|+||.||+|.+. .++.||||++.... ....+++.+|++++++++||||+++++++ +.+..++
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l 94 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence 5677776 8999999999999653 46789999876543 33467899999999999999999999999 5677899
Q ss_pred EEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCC
Q 003139 576 VYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPA 655 (845)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~ 655 (845)
||||+++++|.+++... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 95 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 169 (291)
T ss_dssp EEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred EEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence 99999999999999654 469999999999999999999999 8999999999999999999999999999976443
Q ss_pred CCCc-ccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhh
Q 003139 656 LDQT-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIM 733 (845)
Q Consensus 656 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (845)
.... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ + ......+
T Consensus 170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~----~~~~~~~------ 236 (291)
T 1xbb_A 170 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---V----TAMLEKG------ 236 (291)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---H----HHHHHTT------
T ss_pred CCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---H----HHHHHcC------
Confidence 2221 11223456788999999999999999999999999999999 999986543211 1 1111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhhhccc
Q 003139 734 DSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLEETS 784 (845)
Q Consensus 734 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~~~~ 784 (845)
.....+...+..+.+++.+||+.+|.+||++.++++.|+.+.......
T Consensus 237 ---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 284 (291)
T 1xbb_A 237 ---ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE 284 (291)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHH
T ss_pred ---CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhc
Confidence 111233455678999999999999999999999999999987655443
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=362.03 Aligned_cols=258 Identities=21% Similarity=0.244 Sum_probs=198.2
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
.++|+..+.||+|+||.||+++.. +++.||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 357889999999999999999986 789999998765332 235688999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCc--eEEEeccccCCCCCCC
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFV--AKVADFGLSKTGPALD 657 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~--~kl~DFGla~~~~~~~ 657 (845)
+++|+|.+++... ..+++.++..++.|+++||+|||+ ++|+||||||+|||++.++. +||+|||+++....
T Consensus 98 ~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~-- 170 (361)
T 3uc3_A 98 ASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-- 170 (361)
T ss_dssp CCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCccccccc--
Confidence 9999999998543 369999999999999999999999 99999999999999987765 99999999975221
Q ss_pred CcccccccccCCCcCChhhhccCCCCch-hHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccc
Q 003139 658 QTHVSTAVKGSFGYLDPEYFRRQQLTEK-SDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSN 736 (845)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k-sDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (845)
........||+.|+|||++.+..++.+ +|||||||++|||++|+.||........ ...... .+....
T Consensus 171 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~~---------~~~~~~ 238 (361)
T 3uc3_A 171 -HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKTIQ---------RILSVK 238 (361)
T ss_dssp -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHHHH---------HHHTTC
T ss_pred -cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHHHH---------HHhcCC
Confidence 222344579999999999988888765 9999999999999999999975433221 111111 111111
Q ss_pred cCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhh
Q 003139 737 LVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYAL 778 (845)
Q Consensus 737 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~ 778 (845)
............+.+++.+||+.+|++|||+.|++++-....
T Consensus 239 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~ 280 (361)
T 3uc3_A 239 YSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLK 280 (361)
T ss_dssp CCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHT
T ss_pred CCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhc
Confidence 111111234567889999999999999999999998765543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=360.95 Aligned_cols=249 Identities=23% Similarity=0.308 Sum_probs=204.8
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC---hHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcEEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS---EQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERSEMIL 575 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 575 (845)
.++|+..+.||+|+||.||+|+.. +|+.||+|++.... ....+.+..|.+++..+ +||||+++++++.+.+..++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 467899999999999999999986 47889999876431 23356788999999988 89999999999999999999
Q ss_pred EEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCC
Q 003139 576 VYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPA 655 (845)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~ 655 (845)
||||+++|+|.+++... ..+++.+++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++....
T Consensus 99 v~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 99999999999998643 369999999999999999999999 8999999999999999999999999999986322
Q ss_pred CCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcc
Q 003139 656 LDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDS 735 (845)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (845)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .. ..++..
T Consensus 174 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~------~~---------~~i~~~ 236 (353)
T 2i0e_A 174 --DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE------LF---------QSIMEH 236 (353)
T ss_dssp --TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HH---------HHHHHC
T ss_pred --CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH------HH---------HHHHhC
Confidence 1222345689999999999999999999999999999999999999996532211 11 112211
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhhhCCCCCCC-----HHHHHHH
Q 003139 736 NLVGKVNPASLKKFGETAEKCLAEHGVDRPS-----MGDVLWN 773 (845)
Q Consensus 736 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~~vl~~ 773 (845)
.+ .++......+.+++.+||+.+|.+||+ +++++++
T Consensus 237 ~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 237 NV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp CC--CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred CC--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11 233445677889999999999999995 4666544
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=359.14 Aligned_cols=261 Identities=23% Similarity=0.237 Sum_probs=202.7
Q ss_pred HHHHhcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC-----ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Q 003139 497 ILDATNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR-----SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDER 570 (845)
Q Consensus 497 l~~at~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 570 (845)
+.+..++|+..+.||+|+||.||+|... +++.+|+|++... .....+.+.+|++++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 4566778999999999999999999975 6788999986432 334567899999999999999999999999999
Q ss_pred CcEEEEEEeccCCCccccccCC--------------------------------------CCCCCCHHHHHHHHHHHHHH
Q 003139 571 SEMILVYEYMANGPLRSHLYGT--------------------------------------DLPPLSWKQRLEICIGAARG 612 (845)
Q Consensus 571 ~~~~lV~Ey~~~gsL~~~l~~~--------------------------------------~~~~l~~~~~~~i~~~ia~g 612 (845)
+..++||||+++|+|.+++... ....+++..+..|+.|++.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 9999999999999999888420 01123577788999999999
Q ss_pred HHHHhhcCCCceeeccCCCCcEEECCCC--ceEEEeccccCCCCCCCC--cccccccccCCCcCChhhhcc--CCCCchh
Q 003139 613 LHYLHTGAAQSIIHRDVKTTNILLDDNF--VAKVADFGLSKTGPALDQ--THVSTAVKGSFGYLDPEYFRR--QQLTEKS 686 (845)
Q Consensus 613 L~yLH~~~~~~ivHrDik~~NILl~~~~--~~kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~s~ks 686 (845)
|+|||+ .+|+||||||+|||++.++ .+||+|||+++....... ........||+.|+|||.+.+ ..++.++
T Consensus 181 l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 999999 8999999999999998776 899999999975322111 112345679999999999975 6889999
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCC--CCHHHHHHHHHHHHHhhhhCCCCC
Q 003139 687 DVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGK--VNPASLKKFGETAEKCLAEHGVDR 764 (845)
Q Consensus 687 DV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~--~~~~~~~~l~~l~~~cl~~~p~~R 764 (845)
|||||||++|||++|+.||......+ ..... +....... ........+.+++.+||+.+|.+|
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~------~~~~~---------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 322 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDAD------TISQV---------LNKKLCFENPNYNVLSPLARDLLSNLLNRNVDER 322 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHH---------HHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTS
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHH------HHHHH---------HhcccccCCcccccCCHHHHHHHHHHcCCChhHC
Confidence 99999999999999999996543221 11111 11111100 112245678899999999999999
Q ss_pred CCHHHHHHHHH
Q 003139 765 PSMGDVLWNLE 775 (845)
Q Consensus 765 Ps~~~vl~~L~ 775 (845)
|++.+++++-.
T Consensus 323 ps~~~~l~hp~ 333 (345)
T 3hko_A 323 FDAMRALQHPW 333 (345)
T ss_dssp CCHHHHHHSHH
T ss_pred CCHHHHhcChh
Confidence 99999987643
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=343.75 Aligned_cols=254 Identities=24% Similarity=0.315 Sum_probs=206.1
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYE 578 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 578 (845)
.++|+..+.||+|+||.||+|... +++.||+|.+... .....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 357889999999999999999976 6899999987543 23445788999999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCC
Q 003139 579 YMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQ 658 (845)
Q Consensus 579 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~ 658 (845)
|+++++|.+++... ..+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 86 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 86 YCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp CCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred ecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 99999999998543 468999999999999999999999 8999999999999999999999999999975432222
Q ss_pred cccccccccCCCcCChhhhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcccc
Q 003139 659 THVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNL 737 (845)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (845)
........|++.|+|||.+.+..+ +.++||||||+++|||++|+.||........ ....|. .. ..
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~----~~---------~~ 226 (276)
T 2yex_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWK----EK---------KT 226 (276)
T ss_dssp ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHH----TT---------CT
T ss_pred hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhh----hc---------cc
Confidence 222345678999999999987765 7899999999999999999999975433221 111111 10 00
Q ss_pred CCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 738 VGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
...........+.+++.+||+.||.+|||+.|++++
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 227 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 001113345678899999999999999999998764
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=350.81 Aligned_cols=266 Identities=25% Similarity=0.354 Sum_probs=203.4
Q ss_pred HhcCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhC--CCCCcceEEEEEecC----CcE
Q 003139 500 ATNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKL--RHRHLVSLIGYCDER----SEM 573 (845)
Q Consensus 500 at~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~H~niv~l~g~~~~~----~~~ 573 (845)
..++|+..+.||+|+||.||+|+.. |+.||||++.... ...+..|.+++..+ +||||+++++++.+. ...
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 110 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL 110 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred cccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence 3468999999999999999999986 8999999875332 34455566666554 899999999999877 689
Q ss_pred EEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----CCceeeccCCCCcEEECCCCceEEEecc
Q 003139 574 ILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGA-----AQSIIHRDVKTTNILLDDNFVAKVADFG 648 (845)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivHrDik~~NILl~~~~~~kl~DFG 648 (845)
++||||+++|+|.+++... .+++.+++.++.|++.||+|||+.. ..+|+||||||+|||++.++.+||+|||
T Consensus 111 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 187 (337)
T 3mdy_A 111 YLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 187 (337)
T ss_dssp EEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCC
Confidence 9999999999999999543 5899999999999999999999810 1299999999999999999999999999
Q ss_pred ccCCCCCCCCc--ccccccccCCCcCChhhhccCCCCch------hHHHHHHHHHHHHHcC----------CCCCCCCCC
Q 003139 649 LSKTGPALDQT--HVSTAVKGSFGYLDPEYFRRQQLTEK------SDVYSFGVVLMEVLCT----------RPALNPVLP 710 (845)
Q Consensus 649 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~k------sDV~S~Gvvl~Elltg----------~~p~~~~~~ 710 (845)
+++........ .......||+.|+|||++.+...+.+ +|||||||++|||++| +.||.....
T Consensus 188 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~ 267 (337)
T 3mdy_A 188 LAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP 267 (337)
T ss_dssp TCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcC
Confidence 99754322111 11224579999999999988766654 9999999999999999 555544332
Q ss_pred cccccHHHHHHHHhhcCchhhhhccccCCCCC-----HHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhhhc
Q 003139 711 REQVNIAEWAMTWQKKGMLDQIMDSNLVGKVN-----PASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLEE 782 (845)
Q Consensus 711 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~~ 782 (845)
... ....+. .... ...+....+ ..++..+.+++.+||+.||.+|||+.+|+++|+.+++...
T Consensus 268 ~~~-~~~~~~-~~~~--------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 268 SDP-SYEDMR-EIVC--------IKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp SSC-CHHHHH-HHHT--------TSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred CCC-chhhhH-HHHh--------hhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence 221 111111 1111 111111122 3678889999999999999999999999999999876443
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=360.99 Aligned_cols=245 Identities=23% Similarity=0.312 Sum_probs=205.3
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC---hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS---EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
++|+..+.||+|+||.||+|+.. +|+.||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57888999999999999999976 68999999875432 233567889999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
||+++|+|.+++... ..+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 121 e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~-- 193 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-- 193 (350)
T ss_dssp ECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS--
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccC--
Confidence 999999999998643 368999999999999999999999 9999999999999999999999999999986432
Q ss_pred CcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcccc
Q 003139 658 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNL 737 (845)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (845)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .. ..+....+
T Consensus 194 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~~---------~~i~~~~~ 255 (350)
T 1rdq_E 194 ---RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IY---------EKIVSGKV 255 (350)
T ss_dssp ---CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HH---------HHHHHCCC
T ss_pred ---CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH------HH---------HHHHcCCC
Confidence 1234679999999999999999999999999999999999999997543211 11 11111111
Q ss_pred CCCCCHHHHHHHHHHHHHhhhhCCCCCCC-----HHHHHHH
Q 003139 738 VGKVNPASLKKFGETAEKCLAEHGVDRPS-----MGDVLWN 773 (845)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~~vl~~ 773 (845)
.++......+.+++.+||+.||.+||+ +++++++
T Consensus 256 --~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 256 --RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp --CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred --CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 133445567889999999999999998 7887655
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=355.75 Aligned_cols=258 Identities=26% Similarity=0.377 Sum_probs=197.4
Q ss_pred cCCCcceeeeeeceEEEEEEEE-cCCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCc----E
Q 003139 502 NKFDESLLLGVGGFGRVYKGTL-DDGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSE----M 573 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----~ 573 (845)
++|+..+.||+|+||.||+|+. .+++.||||++... .....+.+.+|++++++++||||+++++++..... .
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 5788899999999999999997 47889999988654 34456788999999999999999999999866543 4
Q ss_pred EEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCC
Q 003139 574 ILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTG 653 (845)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~ 653 (845)
++||||+++++|.+++... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 92 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp EEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred EEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 9999999999999998643 469999999999999999999999 89999999999999999999999999999764
Q ss_pred CCCCCc-ccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhh
Q 003139 654 PALDQT-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQI 732 (845)
Q Consensus 654 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (845)
...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+ ..............
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~~~~~~~ 240 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVREDPIPPS 240 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCCCCCHH
T ss_pred cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhcCCCCCcc
Confidence 332211 12234568999999999999999999999999999999999999996543221 11111111111000
Q ss_pred hccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH-HHHHh
Q 003139 733 MDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLW-NLEYA 777 (845)
Q Consensus 733 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~-~L~~~ 777 (845)
......+..+.+++.+||+.||++||+..+++. .+...
T Consensus 241 -------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 241 -------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp -------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred -------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 001224567889999999999999997666554 44433
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=344.51 Aligned_cols=266 Identities=19% Similarity=0.258 Sum_probs=207.0
Q ss_pred HhcCCCcceeeeeeceEEEEEEEE-cCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEE-ecCCcEEEEE
Q 003139 500 ATNKFDESLLLGVGGFGRVYKGTL-DDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYC-DERSEMILVY 577 (845)
Q Consensus 500 at~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lV~ 577 (845)
..++|+..+.||+|+||.||+|+. .+++.||+|....... .+++.+|++++++++|++++..++++ .+.+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 357899999999999999999997 4788999997544322 24578899999999998888777766 6667789999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEE---CCCCceEEEeccccCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILL---DDNFVAKVADFGLSKTGP 654 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl---~~~~~~kl~DFGla~~~~ 654 (845)
||+ +++|.+++.... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||+ ++++.+||+|||+++...
T Consensus 85 e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp ECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred Ecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 999 999999986432 469999999999999999999999 899999999999999 789999999999998643
Q ss_pred CCCCc-----ccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCch
Q 003139 655 ALDQT-----HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGML 729 (845)
Q Consensus 655 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 729 (845)
..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........................
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence 32211 1223567899999999999999999999999999999999999999865544332222211111111111
Q ss_pred hhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhhh
Q 003139 730 DQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLE 781 (845)
Q Consensus 730 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~ 781 (845)
... ....+..+.+++.+||+.+|++||++.++++.|+.+.+..
T Consensus 240 ~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~ 282 (296)
T 4hgt_A 240 EVL---------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp HHH---------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred hhh---------hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence 111 1123467889999999999999999999999999887643
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=363.38 Aligned_cols=271 Identities=23% Similarity=0.248 Sum_probs=209.6
Q ss_pred ccHHHHHHHhcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCC-----CCCcceEEE
Q 003139 492 FMFQEILDATNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLR-----HRHLVSLIG 565 (845)
Q Consensus 492 ~~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H~niv~l~g 565 (845)
+++++.....++|...+.||+|+||.||+|+.. +++.||||++.. .....+.+..|++++++++ ||||+++++
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 344444445678999999999999999999975 688999999864 3445567888999999996 999999999
Q ss_pred EEecCCcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECC-------
Q 003139 566 YCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDD------- 638 (845)
Q Consensus 566 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~------- 638 (845)
++...+..++||||+ +++|.+++.......+++.++..++.||+.||+|||+ .+|+||||||+||||+.
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~ 179 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSL 179 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCCEEE
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccccccccc
Confidence 999999999999999 9999999977666679999999999999999999999 99999999999999975
Q ss_pred ------------------CCceEEEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc
Q 003139 639 ------------------NFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC 700 (845)
Q Consensus 639 ------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt 700 (845)
++.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 254 (360)
T 3llt_A 180 ITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254 (360)
T ss_dssp EEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHH
T ss_pred cchhcccccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHH
Confidence 78999999999976332 1234678999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcccccHHH---------HHHHHhhcCchhhhhcc-ccCCCCC--------------------HHHHHHHH
Q 003139 701 TRPALNPVLPREQVNIAE---------WAMTWQKKGMLDQIMDS-NLVGKVN--------------------PASLKKFG 750 (845)
Q Consensus 701 g~~p~~~~~~~~~~~l~~---------~~~~~~~~~~~~~~~d~-~l~~~~~--------------------~~~~~~l~ 750 (845)
|+.||......+...... +....... ......+. .+....+ ......+.
T Consensus 255 g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~-~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 333 (360)
T 3llt_A 255 GSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKT-NGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFC 333 (360)
T ss_dssp SSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTS-GGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHH
T ss_pred CCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhc-cCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHH
Confidence 999997543322111100 00000000 00000000 0000000 00125678
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHH
Q 003139 751 ETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 751 ~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
+++.+||+.||++|||+.|++++
T Consensus 334 ~li~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 334 DFLYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp HHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHHhcCChhhCCCHHHHhcC
Confidence 99999999999999999999753
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=343.03 Aligned_cols=265 Identities=19% Similarity=0.257 Sum_probs=209.6
Q ss_pred hcCCCcceeeeeeceEEEEEEEE-cCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEE-ecCCcEEEEEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTL-DDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYC-DERSEMILVYE 578 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lV~E 578 (845)
.++|+..+.||+|+||.||+|+. .+|+.||+|++..... .+++.+|++++++++|++++..++++ .+.+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46789999999999999999997 4789999998654432 24688999999999998877777766 56677899999
Q ss_pred eccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEE---CCCCceEEEeccccCCCCC
Q 003139 579 YMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILL---DDNFVAKVADFGLSKTGPA 655 (845)
Q Consensus 579 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl---~~~~~~kl~DFGla~~~~~ 655 (845)
|+ +++|.+++.... ..+++.+++.++.|++.||+|||+ ++|+||||||+|||+ ++++.+||+|||+++....
T Consensus 86 ~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred ec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 99 999999986432 469999999999999999999999 899999999999999 4889999999999976433
Q ss_pred CCCc-----ccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchh
Q 003139 656 LDQT-----HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLD 730 (845)
Q Consensus 656 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (845)
.... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.........................
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 240 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH
Confidence 2211 11245679999999999999999999999999999999999999998654433222222111111111111
Q ss_pred hhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhhh
Q 003139 731 QIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLE 781 (845)
Q Consensus 731 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~ 781 (845)
. .....+..+.+++.+||+.+|.+||++.++++.|+.+.+..
T Consensus 241 ~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 241 V---------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp H---------HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred H---------HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 1 11223467889999999999999999999999999886643
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=364.27 Aligned_cols=271 Identities=21% Similarity=0.259 Sum_probs=214.7
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC-hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCC--cEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS-EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERS--EMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~ 577 (845)
++|...+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+ ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 56888899999999999999976 58999999986543 234577889999999999999999999997655 789999
Q ss_pred EeccCCCccccccCCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEE----CCCCceEEEeccccCC
Q 003139 578 EYMANGPLRSHLYGTD-LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILL----DDNFVAKVADFGLSKT 652 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl----~~~~~~kl~DFGla~~ 652 (845)
||+++|+|.+++.... ...+++.+++.++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 9999999999996543 2349999999999999999999999 899999999999999 7888899999999986
Q ss_pred CCCCCCcccccccccCCCcCChhhhcc--------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHh
Q 003139 653 GPALDQTHVSTAVKGSFGYLDPEYFRR--------QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQ 724 (845)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~ 724 (845)
... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... .+......
T Consensus 166 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~~~~~~~ 240 (396)
T 4eut_A 166 LED---DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKII 240 (396)
T ss_dssp CCC---GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HHHHHHHH
T ss_pred ccC---CCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HHHHHHHh
Confidence 432 222345679999999999875 56788999999999999999999999754332211 11122222
Q ss_pred hcCchhhh------h--------ccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhh
Q 003139 725 KKGMLDQI------M--------DSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQL 780 (845)
Q Consensus 725 ~~~~~~~~------~--------d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~ 780 (845)
.......+ . +..............+.+++.+||+.||++||++.++++.++.+++.
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 21110000 0 00111234467888999999999999999999999999999988763
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=371.59 Aligned_cols=264 Identities=21% Similarity=0.244 Sum_probs=207.7
Q ss_pred ccHHHHHHHhcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC---hHhHHHHHHHHHHHHhCCCCCcceEEEEE
Q 003139 492 FMFQEILDATNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS---EQGIAEFRTEIEMLSKLRHRHLVSLIGYC 567 (845)
Q Consensus 492 ~~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 567 (845)
+.++++....++|+..+.||+|+||.||+++.+ +|+.||+|++.... ....+.+.+|.+++.+++||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 344555556789999999999999999999986 68999999876421 22234588999999999999999999999
Q ss_pred ecCCcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEec
Q 003139 568 DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADF 647 (845)
Q Consensus 568 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DF 647 (845)
.+.+..++||||+++|+|.+++.... ..+++..+..++.||+.||+|||+ ++|+||||||+||||+.++.+||+||
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCC
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEeec
Confidence 99999999999999999999996432 368999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCCCcccccccccCCCcCChhhhc-------cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHH
Q 003139 648 GLSKTGPALDQTHVSTAVKGSFGYLDPEYFR-------RQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWA 720 (845)
Q Consensus 648 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~ 720 (845)
|+++.... ..........||+.|+|||++. ...++.++|||||||++|||++|+.||......+. .
T Consensus 207 Gla~~~~~-~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~ 279 (412)
T 2vd5_A 207 GSCLKLRA-DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET------Y 279 (412)
T ss_dssp TTCEECCT-TSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------H
T ss_pred hhheeccC-CCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH------H
Confidence 99976433 1222233568999999999987 35789999999999999999999999975432211 1
Q ss_pred HHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCC---CCHHHHHHH
Q 003139 721 MTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDR---PSMGDVLWN 773 (845)
Q Consensus 721 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~R---Ps~~~vl~~ 773 (845)
...... ..... ...........+.+++.+||. +|++| |+++|++++
T Consensus 280 ~~i~~~---~~~~~---~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 280 GKIVHY---KEHLS---LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHHHTH---HHHCC---CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred HHHHhc---ccCcC---CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 111000 00000 001122345678899999999 99998 588888655
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=350.26 Aligned_cols=262 Identities=23% Similarity=0.271 Sum_probs=200.3
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC--hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS--EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYE 578 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 578 (845)
++|+..+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57888999999999999999986 58999999875543 3445778899999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCC
Q 003139 579 YMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQ 658 (845)
Q Consensus 579 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~ 658 (845)
|+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.... .
T Consensus 83 ~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~ 155 (311)
T 4agu_A 83 YCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTG--P 155 (311)
T ss_dssp CCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred eCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccC--c
Confidence 99999999887543 468999999999999999999999 8999999999999999999999999999976432 1
Q ss_pred cccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhc-----------
Q 003139 659 THVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKK----------- 726 (845)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~----------- 726 (845)
........||..|+|||.+.+ ..++.++||||||+++|||++|+.||......+.... .......
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 232 (311)
T 4agu_A 156 SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYL---IRKTLGDLIPRHQQVFST 232 (311)
T ss_dssp ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCSCCHHHHHHHHT
T ss_pred ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhccccccccccccc
Confidence 222334578999999999876 6789999999999999999999999976543322111 1111000
Q ss_pred Cc-hhh--hhccccCCC---CCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 727 GM-LDQ--IMDSNLVGK---VNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 727 ~~-~~~--~~d~~l~~~---~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.. ... +.++..... ..+.....+.+++.+||+.||++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00 000 000000000 002345568899999999999999999999865
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=354.50 Aligned_cols=263 Identities=24% Similarity=0.308 Sum_probs=200.1
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC-----hHhHHHHHHHHHHHHhC---CCCCcceEEEEEecCC
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS-----EQGIAEFRTEIEMLSKL---RHRHLVSLIGYCDERS 571 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~ 571 (845)
.++|+..+.||+|+||.||+|+.. +|+.||+|++.... ......+.+|+++++++ +||||++++++|....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 578999999999999999999964 68999999865321 11124556677777666 5999999999997655
Q ss_pred -----cEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEe
Q 003139 572 -----EMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVAD 646 (845)
Q Consensus 572 -----~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~D 646 (845)
..++||||++ ++|.+++.......+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~D 163 (308)
T 3g33_A 88 TDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLAD 163 (308)
T ss_dssp SSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCEEECS
T ss_pred CCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEEee
Confidence 4799999996 699999977665669999999999999999999999 8999999999999999999999999
Q ss_pred ccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhc
Q 003139 647 FGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKK 726 (845)
Q Consensus 647 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 726 (845)
||+++.... ........||+.|+|||++.+..++.++|||||||++|||++|++||......+. ..........
T Consensus 164 fg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~ 237 (308)
T 3g33_A 164 FGLARIYSY---QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ---LGKIFDLIGL 237 (308)
T ss_dssp CSCTTTSTT---CCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH---HHHHHHHHCC
T ss_pred CccccccCC---CcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCC
Confidence 999986432 2223456789999999999999999999999999999999999999975433221 1111111110
Q ss_pred Cchhhhh------ccccC-------CCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 727 GMLDQIM------DSNLV-------GKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 727 ~~~~~~~------d~~l~-------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.....+. ..... ....+.....+.+++.+||+.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 0000000 00000 00112345678899999999999999999999865
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=359.23 Aligned_cols=267 Identities=26% Similarity=0.387 Sum_probs=212.2
Q ss_pred cCCCcceeeeeeceEEEEEEEE-----cCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCC--cEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTL-----DDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERS--EMI 574 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~ 574 (845)
++|+..+.||+|+||.||++++ .+|+.||+|++........+.+.+|++++++++||||+++++++...+ ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 5678889999999999999984 368899999988777777789999999999999999999999986654 789
Q ss_pred EEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCC
Q 003139 575 LVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGP 654 (845)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~ 654 (845)
+||||+++++|.+++.... ..+++.+++.++.|+++||+|||+ .+|+||||||+|||+++++.+||+|||+++...
T Consensus 121 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~ 196 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLP 196 (326)
T ss_dssp EEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence 9999999999999996543 469999999999999999999999 899999999999999999999999999998754
Q ss_pred CCCCc-ccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhc-------
Q 003139 655 ALDQT-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKK------- 726 (845)
Q Consensus 655 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~------- 726 (845)
..... .......++..|+|||.+.+..++.++||||||+++|||++|+.|+..... .+.......
T Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~-------~~~~~~~~~~~~~~~~ 269 (326)
T 2w1i_A 197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA-------EFMRMIGNDKQGQMIV 269 (326)
T ss_dssp SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH-------HHHHHHCTTCCTHHHH
T ss_pred ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH-------HHHHhhccccchhhhH
Confidence 32221 112334577789999999999999999999999999999999988743110 000000000
Q ss_pred CchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 003139 727 GMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779 (845)
Q Consensus 727 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~ 779 (845)
..+.+.+........+..++..+.+++.+||+.+|++||++.++++.|+.+..
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 270 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 00111122111222344566789999999999999999999999999998764
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=361.69 Aligned_cols=254 Identities=20% Similarity=0.304 Sum_probs=194.7
Q ss_pred cCCCcc-eeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHH-hCCCCCcceEEEEEec----CCcEE
Q 003139 502 NKFDES-LLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLS-KLRHRHLVSLIGYCDE----RSEMI 574 (845)
Q Consensus 502 ~~f~~~-~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~H~niv~l~g~~~~----~~~~~ 574 (845)
++|... ++||+|+||.||++... +|+.||||++... ..+.+|++++. ..+||||+++++++.. .+..+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 355555 68999999999999976 6889999998632 45678888875 4589999999998865 56789
Q ss_pred EEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECC---CCceEEEeccccC
Q 003139 575 LVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDD---NFVAKVADFGLSK 651 (845)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~---~~~~kl~DFGla~ 651 (845)
+||||+++|+|.+++.......+++.++..|+.||+.||+|||+ .+|+||||||+||||+. ++.+||+|||+++
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 99999999999999976655679999999999999999999999 89999999999999997 7899999999998
Q ss_pred CCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccc-cHHHHHHHHhhcCchh
Q 003139 652 TGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQV-NIAEWAMTWQKKGMLD 730 (845)
Q Consensus 652 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~ 730 (845)
.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||......... ...... ..+..
T Consensus 213 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i----~~~~~- 284 (400)
T 1nxk_A 213 ETTS---HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI----RMGQY- 284 (400)
T ss_dssp ECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH----HHTCC-
T ss_pred ccCC---CCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH----HcCcc-
Confidence 6432 22234567899999999999999999999999999999999999999765433211 111111 11100
Q ss_pred hhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003139 731 QIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEY 776 (845)
Q Consensus 731 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~ 776 (845)
.............+.+++.+||+.||++|||+.|++++-..
T Consensus 285 -----~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 325 (400)
T 1nxk_A 285 -----EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 325 (400)
T ss_dssp -----CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred -----cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccc
Confidence 00001112345678899999999999999999999987554
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=341.66 Aligned_cols=254 Identities=22% Similarity=0.300 Sum_probs=206.6
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
.++|+..+.||+|+||.||+|... +|+.||+|++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 467889999999999999999976 6889999987543 4556678899999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCc---eEEEeccccCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFV---AKVADFGLSKTGP 654 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~---~kl~DFGla~~~~ 654 (845)
||+++++|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++. +||+|||++....
T Consensus 85 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp CCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 999999998888544 468999999999999999999999 89999999999999986655 9999999997643
Q ss_pred CCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhc
Q 003139 655 ALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMD 734 (845)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (845)
. ........||+.|+|||.+.+..++.++||||||+++|||++|+.||......+ .... ...+...
T Consensus 160 ~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------~~~~-~~~~~~~---- 225 (284)
T 3kk8_A 160 D---SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR------LYAQ-IKAGAYD---- 225 (284)
T ss_dssp S---SCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHH-HHHTCCC----
T ss_pred c---CccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH------HHHH-HHhcccc----
Confidence 2 222334678999999999999999999999999999999999999996533211 1111 1111100
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 735 SNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 735 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
............+.+++.+||+.+|++|||+.|++++-.
T Consensus 226 --~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 264 (284)
T 3kk8_A 226 --YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW 264 (284)
T ss_dssp --CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHH
T ss_pred --CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCcc
Confidence 001111234567889999999999999999999988644
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=353.34 Aligned_cols=260 Identities=22% Similarity=0.304 Sum_probs=190.3
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC-hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS-EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYE 578 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 578 (845)
.++|+..+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 457888999999999999999875 68999999876443 2334678899999999999999999999999999999999
Q ss_pred eccCCCccccccCC----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCC
Q 003139 579 YMANGPLRSHLYGT----DLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGP 654 (845)
Q Consensus 579 y~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~ 654 (845)
|++ |+|.+++... ....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 6898887532 22468999999999999999999999 899999999999999999999999999997643
Q ss_pred CCCCcccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcC------
Q 003139 655 ALDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKG------ 727 (845)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~------ 727 (845)
.. ........||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+. ...........
T Consensus 160 ~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~ 234 (317)
T 2pmi_A 160 IP--VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ---LKLIFDIMGTPNESLWP 234 (317)
T ss_dssp SC--CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCTTTCG
T ss_pred CC--cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCChhHhh
Confidence 21 112234578999999999976 4689999999999999999999999975443221 11111111100
Q ss_pred ------------------chhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 728 ------------------MLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 728 ------------------~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.+.+.+.+.. .......+.+++.+||+.||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHT----KEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GGGGCTTCCTTCCCCCCCCSHHHHGGGC----SSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhhhcccccccccchhHHHhhcccc----cccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0001111111 11234578899999999999999999998765
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=368.53 Aligned_cols=249 Identities=27% Similarity=0.367 Sum_probs=206.3
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC---hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS---EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
++|...+.||+|+||.||+|++. +|+.||||++.... ....+.+.+|+++++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 56888899999999999999976 78999999876432 123467889999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
||+++|+|.+++... ..+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 96 E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~-- 168 (476)
T 2y94_A 96 EYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-- 168 (476)
T ss_dssp ECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCT--
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhccc--
Confidence 999999999999543 479999999999999999999998 8999999999999999999999999999986432
Q ss_pred CcccccccccCCCcCChhhhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccc
Q 003139 658 QTHVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSN 736 (845)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (845)
........||+.|+|||++.+..+ +.++|||||||++|||++|+.||....... ... .+.+..
T Consensus 169 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~------~~~---------~i~~~~ 232 (476)
T 2y94_A 169 -GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT------LFK---------KICDGI 232 (476)
T ss_dssp -TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH------HHH---------HHHTTC
T ss_pred -cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH------HHH---------HHhcCC
Confidence 222345679999999999988765 789999999999999999999997543221 111 111111
Q ss_pred cCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 737 LVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 737 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
. ..+......+.+++.+||+.||.+|||+.+++++-.
T Consensus 233 ~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~ 269 (476)
T 2y94_A 233 F--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEW 269 (476)
T ss_dssp C--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHH
T ss_pred c--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHH
Confidence 1 122334467889999999999999999999997543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=355.51 Aligned_cols=251 Identities=22% Similarity=0.272 Sum_probs=180.2
Q ss_pred ceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCC-CCCcceEEEEEecCCcEEEEEEeccCCC
Q 003139 507 SLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLR-HRHLVSLIGYCDERSEMILVYEYMANGP 584 (845)
Q Consensus 507 ~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~gs 584 (845)
.+.||+|+||.||+|... +|+.||||++... ....+.+|+.++++++ ||||+++++++.+....++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 468999999999999986 6899999997533 3467788999999997 9999999999999999999999999999
Q ss_pred ccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCC---ceEEEeccccCCCCCCCCccc
Q 003139 585 LRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNF---VAKVADFGLSKTGPALDQTHV 661 (845)
Q Consensus 585 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~---~~kl~DFGla~~~~~~~~~~~ 661 (845)
|.+++... ..+++.++..|+.|++.||+|||+ ++|+||||||+|||++.++ .+||+|||+++.... ....
T Consensus 93 L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~--~~~~ 165 (325)
T 3kn6_A 93 LFERIKKK--KHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP--DNQP 165 (325)
T ss_dssp HHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCC--CCCc
Confidence 99999654 479999999999999999999999 9999999999999997665 899999999986432 1222
Q ss_pred ccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCC
Q 003139 662 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKV 741 (845)
Q Consensus 662 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 741 (845)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||.....................+.. ......
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~------~~~~~~ 239 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF------SFEGEA 239 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC------CCCSHH
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC------CCCccc
Confidence 34567899999999999999999999999999999999999999754432211111111111111110 000000
Q ss_pred CHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 742 NPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 742 ~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.......+.+++.+||+.||.+|||+.+++++
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 12345678899999999999999999998654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=349.58 Aligned_cols=269 Identities=23% Similarity=0.370 Sum_probs=208.5
Q ss_pred HhcCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHh--CCCCCcceEEEEEecCC----cE
Q 003139 500 ATNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSK--LRHRHLVSLIGYCDERS----EM 573 (845)
Q Consensus 500 at~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~~----~~ 573 (845)
..++|...+.||+|+||.||+|+.. |+.||||++... ..+.+.+|.+++.. ++||||+++++++.... ..
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~ 115 (342)
T 1b6c_B 40 IARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 115 (342)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCE
T ss_pred ccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcccee
Confidence 3468999999999999999999985 899999998643 34677889999987 78999999999998776 79
Q ss_pred EEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----CCceeeccCCCCcEEECCCCceEEEecc
Q 003139 574 ILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGA-----AQSIIHRDVKTTNILLDDNFVAKVADFG 648 (845)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivHrDik~~NILl~~~~~~kl~DFG 648 (845)
++||||+++|+|.+++... .+++.+++.++.|++.||+|||... ..+|+||||||+||||+.++.+||+|||
T Consensus 116 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 192 (342)
T 1b6c_B 116 WLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 192 (342)
T ss_dssp EEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECC
Confidence 9999999999999999643 5899999999999999999999210 1899999999999999999999999999
Q ss_pred ccCCCCCCCCc--ccccccccCCCcCChhhhccC------CCCchhHHHHHHHHHHHHHcC----------CCCCCCCCC
Q 003139 649 LSKTGPALDQT--HVSTAVKGSFGYLDPEYFRRQ------QLTEKSDVYSFGVVLMEVLCT----------RPALNPVLP 710 (845)
Q Consensus 649 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~s~ksDV~S~Gvvl~Elltg----------~~p~~~~~~ 710 (845)
+++........ .......||+.|+|||.+.+. .++.++|||||||++|||++| +.||.....
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~ 272 (342)
T 1b6c_B 193 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 272 (342)
T ss_dssp TCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCc
Confidence 99753321111 122455799999999999876 334789999999999999999 667654332
Q ss_pred cccccHHHHHHHHhhcCchhhhhccccCCC-CCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhhh
Q 003139 711 REQVNIAEWAMTWQKKGMLDQIMDSNLVGK-VNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLE 781 (845)
Q Consensus 711 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~ 781 (845)
.. .....+........ ..+.+... ........+.+++.+||+.+|++|||+.+|+++|+.+.+..
T Consensus 273 ~~-~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 273 SD-PSVEEMRKVVCEQK-----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp SS-CCHHHHHHHHTTSC-----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred Cc-ccHHHHHHHHHHHH-----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 22 11222222111111 11111111 12356788999999999999999999999999999886543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=350.80 Aligned_cols=261 Identities=25% Similarity=0.316 Sum_probs=206.8
Q ss_pred hcCCCcceeeeeeceEEEEEEEE-cCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEe----cCCcEEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTL-DDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCD----ERSEMIL 575 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~----~~~~~~l 575 (845)
.++|+..+.||+|+||.||+++. .+|+.||+|++........+.+.+|++++++++||||+++++++. .....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 46789999999999999999997 478999999887667777788999999999999999999999986 3457899
Q ss_pred EEEeccCCCccccccCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCC
Q 003139 576 VYEYMANGPLRSHLYGT--DLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTG 653 (845)
Q Consensus 576 V~Ey~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~ 653 (845)
||||+++|+|.+++... ....+++.+++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 99999999999988642 34579999999999999999999999 89999999999999999999999999998753
Q ss_pred CCCCCcc-------cccccccCCCcCChhhhccCC---CCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHH
Q 003139 654 PALDQTH-------VSTAVKGSFGYLDPEYFRRQQ---LTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTW 723 (845)
Q Consensus 654 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~ 723 (845)
....... ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||........
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---------- 254 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD---------- 254 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS----------
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc----------
Confidence 2111100 112345799999999987654 68999999999999999999999843111110
Q ss_pred hhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhh
Q 003139 724 QKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYAL 778 (845)
Q Consensus 724 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~ 778 (845)
.+...................+.+++.+||+.||.+||++.++++.|+.+.
T Consensus 255 ----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 255 ----SVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp ----CHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred ----hhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 011111111111122344567899999999999999999999999998763
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=358.27 Aligned_cols=266 Identities=16% Similarity=0.186 Sum_probs=208.2
Q ss_pred cCCCcceeeeeeceEEEEEEEEcC---------CcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcce----------
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLDD---------GTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVS---------- 562 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~---------- 562 (845)
++|...+.||+|+||.||+|+... ++.||+|.+... +.+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 578899999999999999999763 789999987644 46789999999999999998
Q ss_pred -----EEEEEec-CCcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEE
Q 003139 563 -----LIGYCDE-RSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILL 636 (845)
Q Consensus 563 -----l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl 636 (845)
+++++.. .+..++||||+ +++|.+++.......+++.+++.|+.|++.||+|||+ ++|+||||||+|||+
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIFV 192 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGEEE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEE
Confidence 6777765 77889999999 9999999976544679999999999999999999999 899999999999999
Q ss_pred CCCC--ceEEEeccccCCCCCCCC-----cccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 003139 637 DDNF--VAKVADFGLSKTGPALDQ-----THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVL 709 (845)
Q Consensus 637 ~~~~--~~kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~ 709 (845)
+.++ .+||+|||+++....... ........||+.|+|||.+.+..++.++|||||||+||||++|+.||....
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 9998 999999999976432111 111234579999999999999999999999999999999999999997543
Q ss_pred CcccccHHHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhhhc
Q 003139 710 PREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLEE 782 (845)
Q Consensus 710 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~~ 782 (845)
.... .+.......... ...+.+... .....+..+.+++.+||+.+|++||++.++++.|+.+++...
T Consensus 273 ~~~~-~~~~~~~~~~~~--~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 273 PNTE-DIMKQKQKFVDK--PGPFVGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp TCHH-HHHHHHHHHHHS--CCCEECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred cCHH-HHHHHHHhccCC--hhhhhhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 2211 111111111110 111111100 011234678899999999999999999999999999876443
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=374.74 Aligned_cols=254 Identities=24% Similarity=0.356 Sum_probs=209.2
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC---hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS---EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILV 576 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 576 (845)
.++|+..+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|+++|++++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467889999999999999999976 68999999875431 22346688999999999999999999999999999999
Q ss_pred EEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCC
Q 003139 577 YEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPAL 656 (845)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~ 656 (845)
|||+++|+|.+++.......+++..++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++....
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~- 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE- 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCT-
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceeccc-
Confidence 999999999999976655569999999999999999999999 8999999999999999999999999999986432
Q ss_pred CCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccc
Q 003139 657 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSN 736 (845)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (845)
........||+.|+|||++.+..++.++|||||||++|||++|+.||......... ... ......
T Consensus 339 --~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~--~~i-~~~i~~---------- 403 (576)
T 2acx_A 339 --GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR--EEV-ERLVKE---------- 403 (576)
T ss_dssp --TCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH--HHH-HHHHHH----------
T ss_pred --CccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH--HHH-HHHhhc----------
Confidence 12233468999999999999999999999999999999999999999764332211 111 111111
Q ss_pred cCCCCCHHHHHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 003139 737 LVGKVNPASLKKFGETAEKCLAEHGVDRP-----SMGDVLWN 773 (845)
Q Consensus 737 l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~~ 773 (845)
....++......+.+++.+||+.||.+|| ++.|++++
T Consensus 404 ~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 404 VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 01123344556788999999999999999 77888765
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=358.23 Aligned_cols=254 Identities=17% Similarity=0.180 Sum_probs=206.7
Q ss_pred HhcCCCcceeeeeeceEEEEEEE------EcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCC---CCCcceEEEEEecC
Q 003139 500 ATNKFDESLLLGVGGFGRVYKGT------LDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLR---HRHLVSLIGYCDER 570 (845)
Q Consensus 500 at~~f~~~~~LG~G~fg~Vy~~~------~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~ 570 (845)
..++|.+.+.||+|+||.||+|. ...++.||+|++..... .++..|++++.+++ |+||+++++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 34678889999999999999994 34688999999876543 46777888888886 99999999999999
Q ss_pred CcEEEEEEeccCCCccccccCC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECC---------
Q 003139 571 SEMILVYEYMANGPLRSHLYGT---DLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDD--------- 638 (845)
Q Consensus 571 ~~~~lV~Ey~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~--------- 638 (845)
+..++||||+++|+|.+++... ....++|.+++.|+.||++||+|||+ .+|+||||||+||||+.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCccccc
Confidence 9999999999999999999632 34579999999999999999999998 89999999999999998
Q ss_pred --CCceEEEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccH
Q 003139 639 --NFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNI 716 (845)
Q Consensus 639 --~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l 716 (845)
++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--- 293 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC--- 293 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE---
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce---
Confidence 899999999999753322333344567899999999999999999999999999999999999999853221110
Q ss_pred HHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCC-CCHHHHHHHHHHhhhh
Q 003139 717 AEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDR-PSMGDVLWNLEYALQL 780 (845)
Q Consensus 717 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~R-Ps~~~vl~~L~~~~~~ 780 (845)
. ++..+.. . .....+.+++..|++.+|.+| |++.++.+.|+..++.
T Consensus 294 -----------~----~~~~~~~-~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 294 -----------K----PEGLFRR-L--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp -----------E----ECSCCTT-C--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred -----------e----echhccc-c--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 0 1111111 1 124567789999999999999 6889999888887653
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=351.30 Aligned_cols=259 Identities=22% Similarity=0.272 Sum_probs=205.7
Q ss_pred HHHHHhcCCCcc-eeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCC-CCCcceEEEEEecC
Q 003139 496 EILDATNKFDES-LLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLR-HRHLVSLIGYCDER 570 (845)
Q Consensus 496 el~~at~~f~~~-~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~ 570 (845)
......+.|.+. +.||+|+||.||+|... +|+.||+|++... .....+++.+|+.++.+++ ||||+++++++.+.
T Consensus 22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~ 101 (327)
T 3lm5_A 22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT 101 (327)
T ss_dssp CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence 334445667776 78999999999999976 6899999987643 2334678899999999994 69999999999999
Q ss_pred CcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECC---CCceEEEec
Q 003139 571 SEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDD---NFVAKVADF 647 (845)
Q Consensus 571 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~---~~~~kl~DF 647 (845)
+..++||||+++|+|.+++.......+++.+++.++.|++.||+|||+ .+|+||||||+|||++. ++.+||+||
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~kL~Df 178 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDF 178 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred CeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcEEEeeC
Confidence 999999999999999999976656789999999999999999999999 89999999999999998 789999999
Q ss_pred cccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcC
Q 003139 648 GLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKG 727 (845)
Q Consensus 648 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 727 (845)
|+++.... ........||+.|+|||.+.+..++.++||||||+++|||++|+.||......+. .... ...
T Consensus 179 g~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------~~~i-~~~ 248 (327)
T 3lm5_A 179 GMSRKIGH---ACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET------YLNI-SQV 248 (327)
T ss_dssp GGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHH-HHT
T ss_pred ccccccCC---ccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH------HHHH-Hhc
Confidence 99986432 2223346799999999999999999999999999999999999999965432211 0000 000
Q ss_pred chhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 728 MLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 728 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
...............+.+++.+||+.+|++|||+.+++++
T Consensus 249 ------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 249 ------NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp ------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred ------ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 0111112223455678899999999999999999998754
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=371.89 Aligned_cols=250 Identities=24% Similarity=0.317 Sum_probs=196.5
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILV 576 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 576 (845)
.++|+..+.||+|+||.||+|+.. +|+.||||++... .......+.+|++++++++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 357889999999999999999975 6899999987542 334456788999999999999999999999999999999
Q ss_pred EEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCC
Q 003139 577 YEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPAL 656 (845)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~ 656 (845)
|||+++|+|.+++... ..+++..+..++.||++||+|||+ ..+|+||||||+||||+.++.+||+|||+++....
T Consensus 227 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~- 301 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK- 301 (446)
T ss_dssp ECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred EeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceeccC-
Confidence 9999999999988543 468999999999999999999995 26899999999999999999999999999986332
Q ss_pred CCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccc
Q 003139 657 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSN 736 (845)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (845)
.........||+.|+|||++.+..++.++|||||||+||||++|+.||......+ .... +....
T Consensus 302 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~~~~---------i~~~~ 365 (446)
T 4ejn_A 302 -DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------LFEL---------ILMEE 365 (446)
T ss_dssp ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHH---------HHHCC
T ss_pred -CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH------HHHH---------HHhCC
Confidence 2222345789999999999999999999999999999999999999996533211 1111 11111
Q ss_pred cCCCCCHHHHHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 003139 737 LVGKVNPASLKKFGETAEKCLAEHGVDRP-----SMGDVLWN 773 (845)
Q Consensus 737 l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~~ 773 (845)
. .++......+.+++.+||+.||.+|| ++.|++++
T Consensus 366 ~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 366 I--RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp C--CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred C--CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 1 13344556788999999999999999 99998865
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=344.43 Aligned_cols=250 Identities=26% Similarity=0.368 Sum_probs=203.6
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC---hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS---EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILV 576 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 576 (845)
.++|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 357888999999999999999876 57789999875432 12246788999999999999999999999999999999
Q ss_pred EEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCC
Q 003139 577 YEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPAL 656 (845)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~ 656 (845)
|||+++++|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~- 161 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS- 161 (279)
T ss_dssp ECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCCc-
Confidence 9999999999988543 468999999999999999999998 8999999999999999999999999999865332
Q ss_pred CCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccc
Q 003139 657 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSN 736 (845)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (845)
.......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+ ..... ..
T Consensus 162 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~-~~---------- 221 (279)
T 3fdn_A 162 ---SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE------TYKRI-SR---------- 221 (279)
T ss_dssp ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHH-HH----------
T ss_pred ---ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH------HHHHH-Hh----------
Confidence 12234578999999999999999999999999999999999999996432211 11111 00
Q ss_pred cCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003139 737 LVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEY 776 (845)
Q Consensus 737 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~ 776 (845)
.....+......+.+++.+||+.+|++||++.|++++-..
T Consensus 222 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~ 261 (279)
T 3fdn_A 222 VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261 (279)
T ss_dssp TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHH
T ss_pred CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccc
Confidence 1112333445678899999999999999999999987553
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=357.83 Aligned_cols=264 Identities=18% Similarity=0.163 Sum_probs=199.0
Q ss_pred cCCCcceeeeeeceEEEEEEEEc----CCcEEEEEEcCCCChHh-----------HHHHHHHHHHHHhCCCCCcceEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD----DGTKVAVKRGNPRSEQG-----------IAEFRTEIEMLSKLRHRHLVSLIGY 566 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~H~niv~l~g~ 566 (845)
++|...+.||+|+||.||+|... .+..+|+|+........ .+.+.+|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 57888999999999999999975 56789999876543211 1346788899999999999999999
Q ss_pred Eec----CCcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCC--
Q 003139 567 CDE----RSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNF-- 640 (845)
Q Consensus 567 ~~~----~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~-- 640 (845)
+.. ....++||||+ +++|.+++.... .+++.+++.|+.||+.||+|||+ .+|+||||||+|||++.++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESSSTT
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccCCCC
Confidence 977 67899999999 999999996543 79999999999999999999999 8999999999999999877
Q ss_pred ceEEEeccccCCCCCCC-----CcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCccccc
Q 003139 641 VAKVADFGLSKTGPALD-----QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVN 715 (845)
Q Consensus 641 ~~kl~DFGla~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~ 715 (845)
.+||+|||+++...... .........||+.|+|||++.+..++.++|||||||++|||++|+.||........ .
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~-~ 269 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV-A 269 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH-H
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH-H
Confidence 99999999997643211 11112456799999999999999999999999999999999999999964322211 1
Q ss_pred HHHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 003139 716 IAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYA 777 (845)
Q Consensus 716 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~ 777 (845)
. ........... ...+.... .....+..+.+++.+||+.+|++||++.+|++.|+..
T Consensus 270 ~-~~~~~~~~~~~-~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 270 V-QTAKTNLLDEL-PQSVLKWA---PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp H-HHHHHHHHHTT-THHHHHHS---CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred H-HHHHHhhcccc-cHHHHhhc---cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 1 11111111111 11111100 0113456789999999999999999999999998864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=351.00 Aligned_cols=252 Identities=23% Similarity=0.289 Sum_probs=204.6
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCCh------HhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSE------QGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEM 573 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 573 (845)
.++|+..+.||+|+||.||+|+.. +|+.||+|.+..... ...+++.+|++++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 356888999999999999999976 689999998654321 1357899999999999999999999999999999
Q ss_pred EEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCC----ceEEEeccc
Q 003139 574 ILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNF----VAKVADFGL 649 (845)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~----~~kl~DFGl 649 (845)
++||||+++++|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++ .+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 9999999999999999643 468999999999999999999999 8999999999999999888 799999999
Q ss_pred cCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCch
Q 003139 650 SKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGML 729 (845)
Q Consensus 650 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 729 (845)
++.... ........||+.|+|||.+.+..++.++||||||+++|||++|+.||......+ ...... ....
T Consensus 166 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~i~-~~~~ 235 (321)
T 2a2a_A 166 AHEIED---GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLANIT-SVSY 235 (321)
T ss_dssp CEECCT---TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHH-TTCC
T ss_pred ceecCc---cccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHH-hccc
Confidence 976432 122245578999999999999999999999999999999999999996533211 111111 1000
Q ss_pred hhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 730 DQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 730 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
-.++. ........+.+++.+||+.||++|||+.|++++
T Consensus 236 --~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 236 --DFDEE----FFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp --CCCHH----HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred --ccChh----hhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 011234568899999999999999999999875
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=352.12 Aligned_cols=265 Identities=23% Similarity=0.268 Sum_probs=198.9
Q ss_pred cCCCcc-eeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcEEEEEE
Q 003139 502 NKFDES-LLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERSEMILVYE 578 (845)
Q Consensus 502 ~~f~~~-~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 578 (845)
+.|.+. ++||+|+||.||+|+.. +++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 456663 68999999999999865 7899999998766555567899999999985 79999999999999999999999
Q ss_pred eccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCc---eEEEeccccCCCCC
Q 003139 579 YMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFV---AKVADFGLSKTGPA 655 (845)
Q Consensus 579 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~---~kl~DFGla~~~~~ 655 (845)
|+++|+|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++. +||+|||+++....
T Consensus 92 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 92 KMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp CCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred cCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 99999999998654 468999999999999999999999 89999999999999998776 99999999976432
Q ss_pred CCC-----cccccccccCCCcCChhhhcc-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhh
Q 003139 656 LDQ-----THVSTAVKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQK 725 (845)
Q Consensus 656 ~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~ 725 (845)
... ........||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+.............
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 246 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence 111 111223568999999999875 5688999999999999999999999976543321100000000000
Q ss_pred cCchhhhhccccCCCCCH----HHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 726 KGMLDQIMDSNLVGKVNP----ASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 726 ~~~~~~~~d~~l~~~~~~----~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
......+..... .++. .....+.+++.+||+.||.+|||+.|++++
T Consensus 247 ~~~~~~i~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 247 NMLFESIQEGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHCCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHhccCc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 000111111111 1111 234678899999999999999999999875
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=381.67 Aligned_cols=250 Identities=26% Similarity=0.358 Sum_probs=201.2
Q ss_pred eeeeeeceEEEEEEEEc---CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEeccC
Q 003139 508 LLLGVGGFGRVYKGTLD---DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMAN 582 (845)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 582 (845)
+.||+|+||.||+|.+. .++.||||++... .....++|.+|+++|++++||||++++++|.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999753 4678999988754 33446889999999999999999999999964 568999999999
Q ss_pred CCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCC-ccc
Q 003139 583 GPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQ-THV 661 (845)
Q Consensus 583 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~-~~~ 661 (845)
|+|.+++... ..+++.+++.|+.||+.||+|||+ ++|+||||||+||||++++.+||+|||+++....... ...
T Consensus 454 g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 528 (635)
T 4fl3_A 454 GPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 528 (635)
T ss_dssp EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence 9999999643 469999999999999999999999 8999999999999999999999999999986433221 122
Q ss_pred ccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCC
Q 003139 662 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGK 740 (845)
Q Consensus 662 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 740 (845)
.....+|+.|+|||++.+..++.++|||||||+||||++ |+.||......+ +...... .....
T Consensus 529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~~---------~~~~~ 592 (635)
T 4fl3_A 529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEK---------GERMG 592 (635)
T ss_dssp ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHT---------TCCCC
T ss_pred ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHc---------CCCCC
Confidence 334557889999999999999999999999999999998 999996543221 1111111 11222
Q ss_pred CCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 003139 741 VNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779 (845)
Q Consensus 741 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~ 779 (845)
.+..++..+.+++.+||+.||++||++.+|++.|+....
T Consensus 593 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 593 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 344566789999999999999999999999999997653
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=357.63 Aligned_cols=257 Identities=23% Similarity=0.309 Sum_probs=191.4
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCC-CCCcceEEEEEe--------cC
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLR-HRHLVSLIGYCD--------ER 570 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~--------~~ 570 (845)
..+|+..+.||+|+||.||+|+.. +++.||+|++........+.+.+|+.++.++. ||||+++++++. ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 357889999999999999999975 68999999887667777788999999999996 999999999993 34
Q ss_pred CcEEEEEEeccCCCccccccC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCc--eeeccCCCCcEEECCCCceEEEec
Q 003139 571 SEMILVYEYMANGPLRSHLYG-TDLPPLSWKQRLEICIGAARGLHYLHTGAAQS--IIHRDVKTTNILLDDNFVAKVADF 647 (845)
Q Consensus 571 ~~~~lV~Ey~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDik~~NILl~~~~~~kl~DF 647 (845)
...++||||++ |+|.+++.. .....+++.+++.|+.|++.||+|||+ .+ |+||||||+|||++.++.+||+||
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEEecC
Confidence 45899999995 789888854 234579999999999999999999998 77 999999999999999999999999
Q ss_pred cccCCCCCCCCcc----------cccccccCCCcCChhhh---ccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccc
Q 003139 648 GLSKTGPALDQTH----------VSTAVKGSFGYLDPEYF---RRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQV 714 (845)
Q Consensus 648 Gla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~ 714 (845)
|+++......... ......||+.|+|||.+ .+..++.++|||||||++|||++|+.||.......
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-- 260 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR-- 260 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH--
Confidence 9998644321111 11244689999999998 56788999999999999999999999986432211
Q ss_pred cHHHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhh
Q 003139 715 NIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQL 780 (845)
Q Consensus 715 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~ 780 (845)
+++..............+.+++.+||+.+|.+||++.|+++.|+.+...
T Consensus 261 -----------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 261 -----------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp ----------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 1111111111122334578899999999999999999999999988653
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=345.11 Aligned_cols=254 Identities=24% Similarity=0.377 Sum_probs=204.7
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEe--cCCcEEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCD--ERSEMIL 575 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~~~l 575 (845)
.++|+..+.||+|+||.||+|... +|+.||+|++... .....+.+.+|++++++++||||+++++++. ..+..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 357888999999999999999976 6899999987543 4556678999999999999999999999884 4668999
Q ss_pred EEEeccCCCccccccCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCc-----eeeccCCCCcEEECCCCceEEEecc
Q 003139 576 VYEYMANGPLRSHLYGT--DLPPLSWKQRLEICIGAARGLHYLHTGAAQS-----IIHRDVKTTNILLDDNFVAKVADFG 648 (845)
Q Consensus 576 V~Ey~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-----ivHrDik~~NILl~~~~~~kl~DFG 648 (845)
||||+++++|.+++... ....+++..++.++.|++.||+|||+ .+ |+||||||+|||+++++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 99999999999998643 23469999999999999999999998 66 9999999999999999999999999
Q ss_pred ccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCc
Q 003139 649 LSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGM 728 (845)
Q Consensus 649 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 728 (845)
+++.... .........|++.|+|||.+.+..++.++||||||+++|||++|+.||......+ + . ....++.
T Consensus 162 ~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~---~-~~i~~~~ 232 (279)
T 2w5a_A 162 LARILNH--DTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---L---A-GKIREGK 232 (279)
T ss_dssp HHHHC-----CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H---H-HHHHHTC
T ss_pred hheeecc--ccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH---H---H-HHHhhcc
Confidence 9976432 1112234578999999999999999999999999999999999999986543211 1 1 1111111
Q ss_pred hhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 729 LDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 729 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
. ...+...+..+.+++.+||+.+|++||++.|+++.+.
T Consensus 233 ~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 233 F---------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp C---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred c---------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 1 1223345577899999999999999999999987654
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=343.57 Aligned_cols=255 Identities=22% Similarity=0.287 Sum_probs=203.2
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC----hHhHHHHHHHHHHHHhCCCCCcceEEEEE--ecCCcE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS----EQGIAEFRTEIEMLSKLRHRHLVSLIGYC--DERSEM 573 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~--~~~~~~ 573 (845)
.++|...+.||+|+||.||++... +++.+|+|.+.... ....+.+.+|++++++++||||+++++++ .+.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 368999999999999999999975 68899999876432 23457899999999999999999999998 455688
Q ss_pred EEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCC
Q 003139 574 ILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTG 653 (845)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~ 653 (845)
++||||++++ |.+++.......+++.+++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999876 7777765555679999999999999999999999 89999999999999999999999999999865
Q ss_pred CCCCCcccccccccCCCcCChhhhccCC--CCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhh
Q 003139 654 PALDQTHVSTAVKGSFGYLDPEYFRRQQ--LTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQ 731 (845)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (845)
.............||+.|+|||.+.+.. ++.++||||||+++|||++|+.||...... +.... ...+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~-i~~~~--- 229 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY------KLFEN-IGKGS--- 229 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHH-HHHCC---
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH------HHHHH-HhcCC---
Confidence 4323333334567899999999998654 378999999999999999999999653211 11111 11111
Q ss_pred hhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003139 732 IMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEY 776 (845)
Q Consensus 732 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~ 776 (845)
...+......+.+++.+||+.||.+||++.+++++-..
T Consensus 230 -------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 267 (305)
T 2wtk_C 230 -------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWF 267 (305)
T ss_dssp -------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHH
T ss_pred -------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCccc
Confidence 11233445678899999999999999999999987543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=349.30 Aligned_cols=261 Identities=21% Similarity=0.283 Sum_probs=202.0
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILV 576 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 576 (845)
-++|...+.||+|+||.||+|... +++.||+|.+... .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 468999999999999999999976 6889999997654 234457899999999999999999999999999999999
Q ss_pred EEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCC
Q 003139 577 YEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPAL 656 (845)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~ 656 (845)
|||+++++|.+++... ..+++.+++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 113 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 9999999999998643 469999999999999999999999 89999999999999999999999999999764331
Q ss_pred CCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccc
Q 003139 657 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSN 736 (845)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (845)
.........|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ........... .
T Consensus 188 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~----~-- 253 (309)
T 2h34_A 188 -KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQAIP----R-- 253 (309)
T ss_dssp ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSCCC----C--
T ss_pred -ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccCCC----C--
Confidence 112233456899999999999999999999999999999999999998643211 11111111100 0
Q ss_pred cCCCCCHHHHHHHHHHHHHhhhhCCCCCC-CHHHHHHHHHHhhhhh
Q 003139 737 LVGKVNPASLKKFGETAEKCLAEHGVDRP-SMGDVLWNLEYALQLE 781 (845)
Q Consensus 737 l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~~vl~~L~~~~~~~ 781 (845)
.....+..+..+.+++.+||+.+|++|| +++++++.|+.++...
T Consensus 254 -~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 254 -PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp -GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred -ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 0112234456788999999999999999 9999999999876543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=360.90 Aligned_cols=247 Identities=25% Similarity=0.347 Sum_probs=193.8
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC---hHhHHHHHHHHHH-HHhCCCCCcceEEEEEecCCcEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS---EQGIAEFRTEIEM-LSKLRHRHLVSLIGYCDERSEMILV 576 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lV 576 (845)
++|+..+.||+|+||.||+|+.+ +++.+|+|++.... ....+.+..|..+ ++.++||||+++++++.+.+..++|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 57889999999999999999986 57889999875432 2334566777776 5678999999999999999999999
Q ss_pred EEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCC
Q 003139 577 YEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPAL 656 (845)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~ 656 (845)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++....
T Consensus 118 ~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~- 191 (373)
T 2r5t_A 118 LDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE- 191 (373)
T ss_dssp EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC-
T ss_pred EeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCcccccccc-
Confidence 9999999999998643 468999999999999999999999 9999999999999999999999999999975221
Q ss_pred CCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccc
Q 003139 657 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSN 736 (845)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (845)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||......+ . ...++...
T Consensus 192 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~------~---------~~~i~~~~ 255 (373)
T 2r5t_A 192 -HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE------M---------YDNILNKP 255 (373)
T ss_dssp -CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH------H---------HHHHHHSC
T ss_pred -CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH------H---------HHHHHhcc
Confidence 1223345789999999999999999999999999999999999999996532211 1 11122211
Q ss_pred cCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 003139 737 LVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLW 772 (845)
Q Consensus 737 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~ 772 (845)
+ .+++.....+.+++.+||+.||.+||++.+.++
T Consensus 256 ~--~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~ 289 (373)
T 2r5t_A 256 L--QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFM 289 (373)
T ss_dssp C--CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHH
T ss_pred c--CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHH
Confidence 1 123345567889999999999999999864433
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=344.07 Aligned_cols=251 Identities=25% Similarity=0.328 Sum_probs=197.5
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
++|...+.||+|+||.||++... +++.+|+|++... .....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 46888899999999999999975 6889999987543 233457889999999999999999999999999999999999
Q ss_pred ccCCCccccccCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEE---CCCCceEEEeccccCCCC
Q 003139 580 MANGPLRSHLYGT--DLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILL---DDNFVAKVADFGLSKTGP 654 (845)
Q Consensus 580 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl---~~~~~~kl~DFGla~~~~ 654 (845)
+++|+|.+++... ....+++..++.|+.|+++||+|||+ .+|+||||||+|||+ +.++.+||+|||+++...
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999988542 23579999999999999999999999 899999999999999 456889999999997643
Q ss_pred CCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhc
Q 003139 655 ALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMD 734 (845)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (845)
. ........||+.|+|||.+. +.++.++||||||+++|||++|+.||......+ ........ .
T Consensus 179 ~---~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~------~~~~~~~~-------~ 241 (285)
T 3is5_A 179 S---DEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE------VQQKATYK-------E 241 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHC-------C
T ss_pred C---cccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH------HHhhhccC-------C
Confidence 2 22234567899999999886 578999999999999999999999996543211 11111110 0
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 735 SNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 735 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
+.... ........+.+++.+||+.||++|||+.|++++
T Consensus 242 ~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 242 PNYAV-ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp CCCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred ccccc-ccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01100 011134567899999999999999999999864
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=360.54 Aligned_cols=264 Identities=25% Similarity=0.347 Sum_probs=193.1
Q ss_pred HhcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCC-CCCcceEEEEEecCC--cE
Q 003139 500 ATNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLR-HRHLVSLIGYCDERS--EM 573 (845)
Q Consensus 500 at~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~--~~ 573 (845)
..++|+..+.||+|+||.||+|... +|+.||||++... .....+++.+|+.++.+++ ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 3468999999999999999999875 6899999987543 4556678889999999997 999999999996543 78
Q ss_pred EEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCC
Q 003139 574 ILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTG 653 (845)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~ 653 (845)
++|||||+ ++|..++.. ..+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 87 ~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp EEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred EEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 99999997 688888864 368999999999999999999999 89999999999999999999999999999753
Q ss_pred CCCC-------------------CcccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCccc
Q 003139 654 PALD-------------------QTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQ 713 (845)
Q Consensus 654 ~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~ 713 (845)
.... .....+...||+.|+|||++.+ ..++.++|||||||+++||++|++||......++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 239 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 2210 1112344679999999999986 6799999999999999999999999976543222
Q ss_pred ccHHHHHHHHhhcCchh-----------hhhc----------cccCC------------CCCHHHHHHHHHHHHHhhhhC
Q 003139 714 VNIAEWAMTWQKKGMLD-----------QIMD----------SNLVG------------KVNPASLKKFGETAEKCLAEH 760 (845)
Q Consensus 714 ~~l~~~~~~~~~~~~~~-----------~~~d----------~~l~~------------~~~~~~~~~l~~l~~~cl~~~ 760 (845)
... ........... ..++ ..... .........+.+++.+||+.|
T Consensus 240 ~~~---i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~d 316 (388)
T 3oz6_A 240 LER---IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFN 316 (388)
T ss_dssp HHH---HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSS
T ss_pred HHH---HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccC
Confidence 111 00110000000 0000 00000 001123456889999999999
Q ss_pred CCCCCCHHHHHHH
Q 003139 761 GVDRPSMGDVLWN 773 (845)
Q Consensus 761 p~~RPs~~~vl~~ 773 (845)
|++|||+.|++++
T Consensus 317 P~~R~t~~e~l~H 329 (388)
T 3oz6_A 317 PNKRISANDALKH 329 (388)
T ss_dssp GGGSCCHHHHTTS
T ss_pred cccCCCHHHHhCC
Confidence 9999999998865
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=342.24 Aligned_cols=250 Identities=25% Similarity=0.408 Sum_probs=184.8
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC---hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS---EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILV 576 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 576 (845)
.++|...+.||+|+||.||+|+.. +|+.||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 357888999999999999999974 78999999875432 12246789999999999999999999999999999999
Q ss_pred EEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCC
Q 003139 577 YEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPAL 656 (845)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~ 656 (845)
|||+++++|.+++... ..++++.+++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 90 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp EECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 9999999999998654 3579999999999999999999999 89999999999999999999999999999764321
Q ss_pred CCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccc
Q 003139 657 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSN 736 (845)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (845)
. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+. +..+....
T Consensus 166 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---------------~~~~~~~~ 228 (278)
T 3cok_A 166 H--EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT---------------LNKVVLAD 228 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSSC
T ss_pred C--CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH---------------HHHHhhcc
Confidence 1 112345689999999999999999999999999999999999999975432221 01111111
Q ss_pred cCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 737 LVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 737 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
...+......+.+++.+||+.||++||++.+++++
T Consensus 229 --~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 229 --YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp --CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred --cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 11233345678899999999999999999998764
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=360.95 Aligned_cols=253 Identities=26% Similarity=0.343 Sum_probs=192.3
Q ss_pred HhcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--------ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Q 003139 500 ATNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--------SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDER 570 (845)
Q Consensus 500 at~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--------~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 570 (845)
..++|...+.||+|+||.||+|... +++.||+|++... .......+.+|+++|++++||||+++++++..
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 4578999999999999999999876 6789999986532 11223458899999999999999999999854
Q ss_pred CcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCC---CceEEEec
Q 003139 571 SEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDN---FVAKVADF 647 (845)
Q Consensus 571 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~---~~~kl~DF 647 (845)
+..++||||+++|+|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.+ +.+||+||
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl~DF 286 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDF 286 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred CceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEEeec
Confidence 5689999999999999998644 479999999999999999999999 899999999999999754 45999999
Q ss_pred cccCCCCCCCCcccccccccCCCcCChhhhc---cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHh
Q 003139 648 GLSKTGPALDQTHVSTAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQ 724 (845)
Q Consensus 648 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~ 724 (845)
|+++.... ........||+.|+|||++. ...++.++|||||||++|||++|+.||........ +....
T Consensus 287 G~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~~i---- 357 (419)
T 3i6u_A 287 GHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQI---- 357 (419)
T ss_dssp STTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHHHH----
T ss_pred ccceecCC---CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHHHH----
Confidence 99987432 22334567999999999985 36788999999999999999999999975433221 11111
Q ss_pred hcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 725 KKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 725 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
..+..... +. ........+.+++.+||+.||++||++.|++++
T Consensus 358 ~~~~~~~~--~~----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 358 TSGKYNFI--PE----VWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HTTCCCCC--HH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hcCCCCCC--ch----hhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 11110000 00 001235678899999999999999999999875
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=345.65 Aligned_cols=253 Identities=22% Similarity=0.316 Sum_probs=204.8
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
.++|...+.||+|+||.||+++.. +|+.||+|.+........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 357888999999999999999976 6899999988765544556788999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEE---CCCCceEEEeccccCCCCCC
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILL---DDNFVAKVADFGLSKTGPAL 656 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl---~~~~~~kl~DFGla~~~~~~ 656 (845)
+++++|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+|||+ ++++.+||+|||+++....
T Consensus 88 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~- 161 (304)
T 2jam_A 88 VSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN- 161 (304)
T ss_dssp CCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC-
T ss_pred CCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC-
Confidence 9999999988543 368999999999999999999999 899999999999999 7889999999999976322
Q ss_pred CCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccc
Q 003139 657 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSN 736 (845)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (845)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+ .... ..++.. .
T Consensus 162 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~-i~~~~~------~ 225 (304)
T 2jam_A 162 ---GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK------LFEK-IKEGYY------E 225 (304)
T ss_dssp ---BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHH-HHHCCC------C
T ss_pred ---CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH------HHHH-HHcCCC------C
Confidence 12234568999999999999999999999999999999999999986532211 1111 111110 0
Q ss_pred cCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 737 LVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 737 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
.........+..+.+++.+||+.||++||++.+++++-.
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 264 (304)
T 2jam_A 226 FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPW 264 (304)
T ss_dssp CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcc
Confidence 111122344567889999999999999999999987643
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=342.45 Aligned_cols=252 Identities=22% Similarity=0.358 Sum_probs=200.9
Q ss_pred CCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEecc
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMA 581 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 581 (845)
+|....+||+|+||.||+|... +++.||+|.+........+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 3555668999999999999975 688999999877666667889999999999999999999999999999999999999
Q ss_pred CCCccccccCCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECC-CCceEEEeccccCCCCCCCCc
Q 003139 582 NGPLRSHLYGTD-LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDD-NFVAKVADFGLSKTGPALDQT 659 (845)
Q Consensus 582 ~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~-~~~~kl~DFGla~~~~~~~~~ 659 (845)
+++|.+++.... ...+++..+..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++..... .
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~--~ 177 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI--N 177 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCC--C
Confidence 999999987542 3457799999999999999999999 89999999999999987 899999999999764321 1
Q ss_pred ccccccccCCCcCChhhhccCC--CCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcccc
Q 003139 660 HVSTAVKGSFGYLDPEYFRRQQ--LTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNL 737 (845)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~~~--~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (845)
.......|++.|+|||.+.+.. ++.++||||||+++|||++|+.||........ ..+.... ...
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~-----------~~~ 243 (295)
T 2clq_A 178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA---AMFKVGM-----------FKV 243 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH---HHHHHHH-----------HCC
T ss_pred CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH---HHHhhcc-----------ccc
Confidence 1223457899999999997654 89999999999999999999999864322111 0000000 011
Q ss_pred CCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 738 VGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
....+......+.+++.+||+.+|++||++.+++++
T Consensus 244 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 244 HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 122334456778899999999999999999999764
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=343.29 Aligned_cols=247 Identities=26% Similarity=0.427 Sum_probs=198.0
Q ss_pred CCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEec----CCcEEE
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDE----RSEMIL 575 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~l 575 (845)
.|...+.||+|+||.||+|... ++..||+|.+... .....+.+.+|++++++++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 3666778999999999999875 6788999986543 45567789999999999999999999999865 456899
Q ss_pred EEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCc--eeeccCCCCcEEEC-CCCceEEEeccccCC
Q 003139 576 VYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQS--IIHRDVKTTNILLD-DNFVAKVADFGLSKT 652 (845)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDik~~NILl~-~~~~~kl~DFGla~~ 652 (845)
||||+++++|.+++... ..+++..++.++.|++.||+|||+ .+ |+||||||+|||++ +++.+||+|||++..
T Consensus 107 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 99999999999999643 468999999999999999999998 77 99999999999998 889999999999975
Q ss_pred CCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhh
Q 003139 653 GPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQI 732 (845)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (845)
... .......||+.|+|||.+. +.++.++||||||+++|||++|+.||....... ..... ...+....
T Consensus 182 ~~~----~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-----~~~~~-~~~~~~~~- 249 (290)
T 1t4h_A 182 KRA----SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAA-----QIYRR-VTSGVKPA- 249 (290)
T ss_dssp CCT----TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-----HHHHH-HTTTCCCG-
T ss_pred ccc----cccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH-----HHHHH-HhccCCcc-
Confidence 332 2233457899999999887 469999999999999999999999996533221 11111 11111111
Q ss_pred hccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 733 MDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 733 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
..+......+.+++.+||+.+|.+|||+.+++++
T Consensus 250 -------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 250 -------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -------ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1112223568899999999999999999999864
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=345.93 Aligned_cols=258 Identities=25% Similarity=0.347 Sum_probs=199.1
Q ss_pred cCCCcceeeeeeceEEEEEEEEc--CCc--EEEEEEcCCC---ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD--DGT--KVAVKRGNPR---SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMI 574 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~--~g~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 574 (845)
++|+..+.||+|+||.||+|++. +++ .||+|++... .....+++.+|++++++++||||+++++++.+.. .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 57888999999999999999864 333 6899987654 3345678999999999999999999999998755 89
Q ss_pred EEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCC
Q 003139 575 LVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGP 654 (845)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~ 654 (845)
+|+||+++++|.+++.... ..+++.++..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 97 ~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp EEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 9999999999999986532 468999999999999999999999 899999999999999999999999999998654
Q ss_pred CCCCc-ccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhh
Q 003139 655 ALDQT-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQI 732 (845)
Q Consensus 655 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (845)
..... .......+|..|+|||.+.+..++.++||||||+++|||++ |+.||...... +........
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~~------ 240 (291)
T 1u46_A 173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILHKIDKE------ 240 (291)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTS------
T ss_pred ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH------HHHHHHHcc------
Confidence 32221 12234567888999999999999999999999999999999 99998654321 111111111
Q ss_pred hccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 003139 733 MDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779 (845)
Q Consensus 733 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~ 779 (845)
......+...+..+.+++.+||+.+|++||++.++++.|+.+..
T Consensus 241 ---~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 241 ---GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp ---CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred ---CCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 11112233456778999999999999999999999999987653
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=352.78 Aligned_cols=270 Identities=24% Similarity=0.393 Sum_probs=198.0
Q ss_pred cCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHH--HHhCCCCCcceEEEEEec-----CCcEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEM--LSKLRHRHLVSLIGYCDE-----RSEMI 574 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~H~niv~l~g~~~~-----~~~~~ 574 (845)
++|+..+.||+|+||.||+|+. +++.||||++.... ...+..|.++ +..++||||+++++.+.. ....+
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 5788899999999999999987 48999999976433 3344445554 445899999999986532 33578
Q ss_pred EEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC---------ceeeccCCCCcEEECCCCceEEE
Q 003139 575 LVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQ---------SIIHRDVKTTNILLDDNFVAKVA 645 (845)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~---------~ivHrDik~~NILl~~~~~~kl~ 645 (845)
+||||+++|+|.+++... .+++..+++++.|+++||+|||+ . +|+||||||+||||+.++.+||+
T Consensus 89 lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHT---ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp EEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHC---CBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred EEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHh---hhccccccccceeecccccceEEEcCCCcEEEe
Confidence 999999999999999644 35899999999999999999998 6 99999999999999999999999
Q ss_pred eccccCCCCCCC------CcccccccccCCCcCChhhhcc-------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcc
Q 003139 646 DFGLSKTGPALD------QTHVSTAVKGSFGYLDPEYFRR-------QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPRE 712 (845)
Q Consensus 646 DFGla~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~-------~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~ 712 (845)
|||+++...... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.|+.......
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 242 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence 999997643211 1112234579999999999986 456789999999999999999987765433222
Q ss_pred cccHHHHHHHHhhcCch---hhh-h----ccccCCC--CCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhhhc
Q 003139 713 QVNIAEWAMTWQKKGML---DQI-M----DSNLVGK--VNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLEE 782 (845)
Q Consensus 713 ~~~l~~~~~~~~~~~~~---~~~-~----d~~l~~~--~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~~ 782 (845)
..... +.......... ... . .+.+... ........+.+++.+||+.||++|||+.|+++.|+.++...+
T Consensus 243 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~ 321 (336)
T 3g2f_A 243 EYQMA-FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWE 321 (336)
T ss_dssp CCCCT-THHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCC
T ss_pred HHHHh-hhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHH
Confidence 11000 00000000000 000 0 0111111 123467789999999999999999999999999999876443
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=364.47 Aligned_cols=260 Identities=20% Similarity=0.258 Sum_probs=196.9
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecC------C
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDER------S 571 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~ 571 (845)
.++|+..+.||+|+||.||+|... +|+.||||++... .....+++.+|++++++++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 467999999999999999999875 6889999988653 445567889999999999999999999999654 4
Q ss_pred cEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccC
Q 003139 572 EMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSK 651 (845)
Q Consensus 572 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~ 651 (845)
..++||||++++ |.+.+. ..+++.++..++.|+++||+|||+ .+|+||||||+||||+.++.+||+|||+++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred eEEEEEeCCCCC-HHHHHh----hcCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 579999999765 555553 248999999999999999999999 899999999999999999999999999998
Q ss_pred CCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcC----
Q 003139 652 TGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKG---- 727 (845)
Q Consensus 652 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~---- 727 (845)
.... ....+...||+.|+|||++.+..++.++|||||||+||||++|+.||......++.. .........
T Consensus 213 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~---~i~~~lg~p~~~~ 286 (464)
T 3ttj_A 213 TAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN---KVIEQLGTPCPEF 286 (464)
T ss_dssp -------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHHHCSCCHHH
T ss_pred ecCC---CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHhcCCCCHHH
Confidence 6432 223445689999999999999999999999999999999999999997644322110 000100000
Q ss_pred ------chhhhhc---------------cccCCCC---CHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003139 728 ------MLDQIMD---------------SNLVGKV---NPASLKKFGETAEKCLAEHGVDRPSMGDVLWNL 774 (845)
Q Consensus 728 ------~~~~~~d---------------~~l~~~~---~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L 774 (845)
.....++ ..+.... .......+.+++.+||+.||++|||+.|++++-
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp 357 (464)
T 3ttj_A 287 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 357 (464)
T ss_dssp HTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred HHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcCh
Confidence 0000010 0000000 011256789999999999999999999998763
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=355.02 Aligned_cols=244 Identities=20% Similarity=0.306 Sum_probs=202.9
Q ss_pred HhcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC--------hHhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Q 003139 500 ATNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS--------EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDER 570 (845)
Q Consensus 500 at~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 570 (845)
..++|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 3568999999999999999999865 68899999876542 11334677899999999999999999999999
Q ss_pred CcEEEEEEeccCC-CccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccc
Q 003139 571 SEMILVYEYMANG-PLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGL 649 (845)
Q Consensus 571 ~~~~lV~Ey~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGl 649 (845)
+..++||||+.+| +|.+++... ..+++..+..|+.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeeccc
Confidence 9999999999877 999988644 469999999999999999999999 8999999999999999999999999999
Q ss_pred cCCCCCCCCcccccccccCCCcCChhhhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCc
Q 003139 650 SKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGM 728 (845)
Q Consensus 650 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 728 (845)
++.... ........||+.|+|||++.+..+ +.++|||||||++|||++|+.||.....
T Consensus 177 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------------------ 235 (335)
T 3dls_A 177 AAYLER---GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------------------ 235 (335)
T ss_dssp CEECCT---TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------------------
T ss_pred ceECCC---CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------------------
Confidence 986432 222334679999999999988877 8899999999999999999999854211
Q ss_pred hhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003139 729 LDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNL 774 (845)
Q Consensus 729 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L 774 (845)
...... ..+......+.+++.+||+.+|++|||+.+++++-
T Consensus 236 ---~~~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp 276 (335)
T 3dls_A 236 ---TVEAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDP 276 (335)
T ss_dssp ---GTTTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCT
T ss_pred ---HHhhcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 111111 11222456788999999999999999999998763
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=341.32 Aligned_cols=245 Identities=21% Similarity=0.354 Sum_probs=200.2
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcEEEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERSEMILV 576 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 576 (845)
.++|+..+.||+|+||.||+|... +++.||+|++... ......++.+|+..+.++ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 467899999999999999999986 7899999987643 344567888999999999 999999999999999999999
Q ss_pred EEeccCCCccccccCCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECC----------------
Q 003139 577 YEYMANGPLRSHLYGTD--LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDD---------------- 638 (845)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~---------------- 638 (845)
|||+++++|.+++.... ...+++.+++.|+.|++.||+|||+ ++|+||||||+|||++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 99999999999986532 2568999999999999999999999 89999999999999984
Q ss_pred ---CCceEEEeccccCCCCCCCCcccccccccCCCcCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccc
Q 003139 639 ---NFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQV 714 (845)
Q Consensus 639 ---~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~ 714 (845)
...+||+|||+++..... ....||+.|+|||.+.+. .++.++|||||||++|||++|++++....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----- 235 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD----- 235 (289)
T ss_dssp ---CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH-----
T ss_pred cCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh-----
Confidence 448999999999764321 234589999999999876 66789999999999999999997763211
Q ss_pred cHHHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 715 NIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 715 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.+ .....+. ....+......+.+++.+||+.||++||++.+++++
T Consensus 236 ---~~--~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 236 ---QW--HEIRQGR---------LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp ---HH--HHHHTTC---------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ---HH--HHHHcCC---------CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 01 0111111 112333445678899999999999999999999764
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=342.61 Aligned_cols=251 Identities=20% Similarity=0.318 Sum_probs=207.2
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
++|...+.||+|+||.||++... +++.+|+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 56888899999999999999986 5788999986532 3455678899999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
||+++++|.+++... ..+++.+++.++.|+++||+|||+ .+|+||||||+|||+++++.+||+|||+++.....
T Consensus 95 e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~- 168 (294)
T 2rku_A 95 ELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD- 168 (294)
T ss_dssp ECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCST-
T ss_pred ecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecccC-
Confidence 999999999988543 468999999999999999999999 89999999999999999999999999999764321
Q ss_pred CcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcccc
Q 003139 658 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNL 737 (845)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (845)
........||+.|+|||.+.+..++.++||||||+++|||++|+.||......+ ...... ...
T Consensus 169 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~---------~~~- 231 (294)
T 2rku_A 169 -GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE------TYLRIK---------KNE- 231 (294)
T ss_dssp -TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHH---------TTC-
T ss_pred -ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHh---------hcc-
Confidence 122334678999999999999999999999999999999999999996533211 111111 111
Q ss_pred CCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003139 738 VGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEY 776 (845)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~ 776 (845)
...+......+.+++.+||+.+|++||++.+++++-..
T Consensus 232 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~ 269 (294)
T 2rku_A 232 -YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFF 269 (294)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred -CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChhe
Confidence 11233445678899999999999999999999876443
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=342.26 Aligned_cols=251 Identities=25% Similarity=0.371 Sum_probs=207.5
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC-hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS-EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
+.|+..+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 56888899999999999999875 68899999875442 34567899999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCc
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT 659 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~ 659 (845)
+++++|.+++.. ..+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..... .
T Consensus 102 ~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~--~ 173 (303)
T 3a7i_A 102 LGGGSALDLLEP---GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT--Q 173 (303)
T ss_dssp CTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT--B
T ss_pred CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCcc--c
Confidence 999999999853 468999999999999999999999 89999999999999999999999999999764321 1
Q ss_pred ccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCC
Q 003139 660 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVG 739 (845)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 739 (845)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+ .... ...+. ..
T Consensus 174 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~-~~~~~---------~~ 237 (303)
T 3a7i_A 174 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK------VLFL-IPKNN---------PP 237 (303)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHH-HHHSC---------CC
T ss_pred cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH------HHHH-hhcCC---------CC
Confidence 12234578999999999999999999999999999999999999986533211 1111 11110 11
Q ss_pred CCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003139 740 KVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEY 776 (845)
Q Consensus 740 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~ 776 (845)
..+......+.+++.+||+.+|++|||+.+++++...
T Consensus 238 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 274 (303)
T 3a7i_A 238 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFI 274 (303)
T ss_dssp CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHH
T ss_pred CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhh
Confidence 1223345678899999999999999999999987554
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=355.73 Aligned_cols=266 Identities=22% Similarity=0.322 Sum_probs=206.8
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
++|+..+.||+|+||.||+|... +++.||+|++... .....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 57888999999999999999976 6889999987654 455567899999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-ceeeccCCCCcEEECCCCceEEEeccccCCCCCCCC
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQ-SIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQ 658 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~ 658 (845)
+++++|.+++... ..+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||+++...
T Consensus 113 ~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~---- 183 (360)
T 3eqc_A 113 MDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---- 183 (360)
T ss_dssp CTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH----
T ss_pred CCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCcccc----
Confidence 9999999998654 368999999999999999999998 5 89999999999999999999999999986421
Q ss_pred cccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHH---------------------
Q 003139 659 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIA--------------------- 717 (845)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~--------------------- 717 (845)
........||+.|+|||++.+..++.++|||||||++|||++|+.||......+.....
T Consensus 184 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (360)
T 3eqc_A 184 DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263 (360)
T ss_dssp HHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred cccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence 11233457899999999999999999999999999999999999999754322110000
Q ss_pred --HHHHHHhhcCchhhhhc----cccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003139 718 --EWAMTWQKKGMLDQIMD----SNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEY 776 (845)
Q Consensus 718 --~~~~~~~~~~~~~~~~d----~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~ 776 (845)
.+...........+.++ ..............+.+++.+||+.||++|||+.|++++-..
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 328 (360)
T 3eqc_A 264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 328 (360)
T ss_dssp ----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHH
T ss_pred ccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHh
Confidence 00000000000111111 111111112345678999999999999999999999987543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=341.97 Aligned_cols=251 Identities=21% Similarity=0.301 Sum_probs=201.0
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC------hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS------EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMI 574 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 574 (845)
++|+..+.||+|+||.||+|+.. +|+.+|+|.+.... ....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 46888999999999999999986 68999999765432 123578999999999999999999999999999999
Q ss_pred EEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCC----ceEEEecccc
Q 003139 575 LVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNF----VAKVADFGLS 650 (845)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~----~~kl~DFGla 650 (845)
+||||+++++|.+++... ..+++.+++.++.|++.||+|||+ .+|+||||||+||++++++ .+||+|||++
T Consensus 85 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 999999999999998543 468999999999999999999999 8999999999999999877 8999999999
Q ss_pred CCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchh
Q 003139 651 KTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLD 730 (845)
Q Consensus 651 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (845)
+.... ........|++.|+|||.+.+..++.++||||||+++|||++|+.||......+ ..... ....
T Consensus 160 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~-~~~~-- 227 (283)
T 3bhy_A 160 HKIEA---GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE------TLTNI-SAVN-- 227 (283)
T ss_dssp EECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHH-HTTC--
T ss_pred eeccC---CCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH------HHHHh-Hhcc--
Confidence 76432 112234568999999999999999999999999999999999999996543211 11111 0000
Q ss_pred hhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 731 QIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 731 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
...........+..+.+++.+||+.+|.+||++.+++++
T Consensus 228 ----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 228 ----YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp ----CCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred ----cCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 000000011234578899999999999999999999975
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=352.59 Aligned_cols=255 Identities=22% Similarity=0.291 Sum_probs=202.9
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcEEEEEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERSEMILVYE 578 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 578 (845)
.++|+..+.||+|+||.||++... +|+.||+|.+..... .+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 467899999999999999999976 688999998765432 245688888887 79999999999999999999999
Q ss_pred eccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCC----CceEEEeccccCCCC
Q 003139 579 YMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDN----FVAKVADFGLSKTGP 654 (845)
Q Consensus 579 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~----~~~kl~DFGla~~~~ 654 (845)
|+++|+|.+++... ..+++.++..++.||+.||+|||+ .+|+||||||+|||+.++ +.+||+|||+++...
T Consensus 97 ~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 97 LMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp CCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 99999999998654 469999999999999999999999 899999999999998543 359999999998643
Q ss_pred CCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhc
Q 003139 655 ALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMD 734 (845)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (845)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||........ .+.... ...+..
T Consensus 172 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~~~~~~-i~~~~~----- 240 (342)
T 2qr7_A 172 AE--NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTP---EEILAR-IGSGKF----- 240 (342)
T ss_dssp CT--TCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCH---HHHHHH-HHHCCC-----
T ss_pred CC--CCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCH---HHHHHH-HccCCc-----
Confidence 21 1223456789999999999988899999999999999999999999975322211 111111 111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003139 735 SNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEY 776 (845)
Q Consensus 735 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~ 776 (845)
.+...........+.+++.+||+.||++||++.+++++-..
T Consensus 241 -~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~ 281 (342)
T 2qr7_A 241 -SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281 (342)
T ss_dssp -CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHH
T ss_pred -ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCee
Confidence 11111223456678899999999999999999999876543
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=360.52 Aligned_cols=263 Identities=19% Similarity=0.231 Sum_probs=208.4
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCC-CCcceEEEEEecCCcEEEEEEe
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRH-RHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~Ey 579 (845)
++|.+.++||+|+||.||+|+.. +++.||||+...... .+++..|+++++.++| +++..+..++.+.+..+|||||
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~ 84 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence 67889999999999999999964 689999998654432 2357889999999987 4555666666788889999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEE---CCCCceEEEeccccCCCCCC
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILL---DDNFVAKVADFGLSKTGPAL 656 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl---~~~~~~kl~DFGla~~~~~~ 656 (845)
+ +++|.+++.... ..+++.+++.|+.||+.||+|||+ ++|+||||||+|||| +.++.+||+|||+++.....
T Consensus 85 ~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 85 L-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp C-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred C-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 9 999999986432 469999999999999999999999 899999999999999 68899999999999864332
Q ss_pred CCc-----ccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhh
Q 003139 657 DQT-----HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQ 731 (845)
Q Consensus 657 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (845)
... .......||+.|+|||.+.+..++.++|||||||+||||++|+.||.......................+..
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEA 239 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHH
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHH
Confidence 211 112356799999999999999999999999999999999999999986554332222222211111111221
Q ss_pred hhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhh
Q 003139 732 IMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQL 780 (845)
Q Consensus 732 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~ 780 (845)
+. ..++..+.+++.+||+.+|++||++.+|++.|+.++..
T Consensus 240 l~---------~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~ 279 (483)
T 3sv0_A 240 LC---------RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279 (483)
T ss_dssp HH---------TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred Hh---------cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence 11 12346789999999999999999999999999988653
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=348.45 Aligned_cols=251 Identities=20% Similarity=0.314 Sum_probs=207.3
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILV 576 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 576 (845)
.++|...+.||+|+||.||++... +++.+|+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 367888999999999999999976 5788999986532 345567889999999999999999999999999999999
Q ss_pred EEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCC
Q 003139 577 YEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPAL 656 (845)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~ 656 (845)
|||+++++|.+++... ..+++.+++.++.|+++||+|||+ .+|+||||||+|||+++++.+||+|||+++.....
T Consensus 120 ~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 120 LELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp ECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 9999999999988543 468999999999999999999999 89999999999999999999999999999764321
Q ss_pred CCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccc
Q 003139 657 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSN 736 (845)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (845)
........||..|+|||.+.+..++.++||||||+++|||++|+.||......+ ........ .
T Consensus 195 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~~~---------~ 257 (335)
T 2owb_A 195 --GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE------TYLRIKKN---------E 257 (335)
T ss_dssp --TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHT---------C
T ss_pred --cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH------HHHHHhcC---------C
Confidence 122344678999999999999999999999999999999999999996533211 11111110 0
Q ss_pred cCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 737 LVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 737 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
...+......+.+++.+||+.||++||++.|++++-.
T Consensus 258 --~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~ 294 (335)
T 2owb_A 258 --YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEF 294 (335)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred --CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 0122334567889999999999999999999987644
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=368.87 Aligned_cols=248 Identities=25% Similarity=0.380 Sum_probs=204.1
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC---hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS---EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
++|...+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 57888899999999999999986 68999999875432 123467889999999999999999999999999999999
Q ss_pred EeccCCCccccccCCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCC
Q 003139 578 EYMANGPLRSHLYGTD--LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPA 655 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~ 655 (845)
||+++|+|.+++.... ...+++..++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 9999999999986543 4579999999999999999999999 8999999999999999999999999999986432
Q ss_pred CCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcc
Q 003139 656 LDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDS 735 (845)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (845)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...+.... +...
T Consensus 342 ~--~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~--~~~~~~~~---------i~~~ 408 (543)
T 3c4z_A 342 G--QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV--ENKELKQR---------VLEQ 408 (543)
T ss_dssp T--CCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC--CHHHHHHH---------HHHC
T ss_pred C--CcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch--hHHHHHHH---------Hhhc
Confidence 1 112234589999999999999999999999999999999999999997643221 11111111 1111
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCH
Q 003139 736 NLVGKVNPASLKKFGETAEKCLAEHGVDRPSM 767 (845)
Q Consensus 736 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 767 (845)
.. .++......+.+++.+||+.||.+||++
T Consensus 409 ~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 409 AV--TYPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp CC--CCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred cc--CCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 11 2334556778899999999999999976
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=351.40 Aligned_cols=261 Identities=27% Similarity=0.401 Sum_probs=202.1
Q ss_pred ccHHHHHHHhcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhC-CCCCcceEEEEEec
Q 003139 492 FMFQEILDATNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDE 569 (845)
Q Consensus 492 ~~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 569 (845)
+.+.++....++|+..+.||+|+||.||+|+.. +|+.||+|++.... ...+++.+|+++++++ +||||+++++++..
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 344455566788999999999999999999974 68999999876443 2346788999999999 89999999999976
Q ss_pred ------CCcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceE
Q 003139 570 ------RSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAK 643 (845)
Q Consensus 570 ------~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~k 643 (845)
.+..++||||+++++|.+++.......+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+|
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEE
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEE
Confidence 4678999999999999999976555679999999999999999999999 8999999999999999999999
Q ss_pred EEeccccCCCCCCCCcccccccccCCCcCChhhhc-----cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHH
Q 003139 644 VADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAE 718 (845)
Q Consensus 644 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~ 718 (845)
|+|||+++..... ........||+.|+|||.+. +..++.++|||||||++|||++|+.||........
T Consensus 170 l~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----- 242 (326)
T 2x7f_A 170 LVDFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA----- 242 (326)
T ss_dssp ECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----
T ss_pred EeeCcCceecCcC--ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH-----
Confidence 9999999764321 11223457899999999987 56789999999999999999999999865432111
Q ss_pred HHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 719 WAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 719 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
...... .. .+.+ .....+..+.+++.+||+.+|.+||++.+++++
T Consensus 243 -~~~~~~-~~-----~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 243 -LFLIPR-NP-----APRL---KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp -HHHHHH-SC-----CCCC---SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred -HHHhhc-Cc-----cccC---CccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 111111 11 0111 122345678899999999999999999999875
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=340.77 Aligned_cols=248 Identities=27% Similarity=0.380 Sum_probs=205.2
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC---hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS---EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
++|+..+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 56888899999999999999976 57889999875431 122467889999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
||+++++|.+++... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~-- 166 (284)
T 2vgo_A 94 EFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS-- 166 (284)
T ss_dssp CCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSS--
T ss_pred EeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCcc--
Confidence 999999999998644 368999999999999999999998 8999999999999999999999999999875332
Q ss_pred CcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcccc
Q 003139 658 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNL 737 (845)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (845)
.......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+ ... .+....
T Consensus 167 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~---------~~~~~~- 228 (284)
T 2vgo_A 167 --LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE------THR---------RIVNVD- 228 (284)
T ss_dssp --SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHH---------HHHTTC-
T ss_pred --cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH------HHH---------HHhccc-
Confidence 12234578999999999999999999999999999999999999996532211 111 111111
Q ss_pred CCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 738 VGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
..++......+.+++.+||+.+|.+||++.+++++-.
T Consensus 229 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~ 265 (284)
T 2vgo_A 229 -LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPW 265 (284)
T ss_dssp -CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHH
T ss_pred -cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHH
Confidence 1233445567889999999999999999999987644
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=342.18 Aligned_cols=254 Identities=20% Similarity=0.259 Sum_probs=189.6
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC-ChHh-HHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR-SEQG-IAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
.++|+..+.||+|+||.||+|+.. +|+.||+|++... .... .+.+.++...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 367888999999999999999974 7899999988654 2222 334445555678889999999999999999999999
Q ss_pred EeccCCCccccccC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-ceeeccCCCCcEEECCCCceEEEeccccCCCC
Q 003139 578 EYMANGPLRSHLYG--TDLPPLSWKQRLEICIGAARGLHYLHTGAAQ-SIIHRDVKTTNILLDDNFVAKVADFGLSKTGP 654 (845)
Q Consensus 578 Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDik~~NILl~~~~~~kl~DFGla~~~~ 654 (845)
||++ |+|.+++.. .....+++..++.|+.|++.||+|||+ . +|+||||||+|||++.++.+||+|||+++...
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9997 588777643 234579999999999999999999998 7 99999999999999999999999999997643
Q ss_pred CCCCcccccccccCCCcCChhhh----ccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchh
Q 003139 655 ALDQTHVSTAVKGSFGYLDPEYF----RRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLD 730 (845)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (845)
. ........||+.|+|||.+ .+..++.++||||||+++|||++|+.||........ ....
T Consensus 162 ~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~-------- 225 (290)
T 3fme_A 162 D---DVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ-----QLKQ-------- 225 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH-----HHHH--------
T ss_pred c---cccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH-----HHHH--------
Confidence 2 2222345789999999996 566789999999999999999999999964322111 1111
Q ss_pred hhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 731 QIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 731 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
.................+.+++.+||+.+|++|||+.|++++-.
T Consensus 226 -~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~ 269 (290)
T 3fme_A 226 -VVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPF 269 (290)
T ss_dssp -HHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHH
T ss_pred -HhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcc
Confidence 11111111122344567889999999999999999999988543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=349.20 Aligned_cols=267 Identities=23% Similarity=0.275 Sum_probs=199.0
Q ss_pred HHhcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChH-----hHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Q 003139 499 DATNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQ-----GIAEFRTEIEMLSKLRHRHLVSLIGYCDERSE 572 (845)
Q Consensus 499 ~at~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 572 (845)
...++|+..+.||+|+||.||+|+.. +|+.||+|++...... ..+.+.+|++++++++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999975 6899999988653221 12468899999999999999999999999999
Q ss_pred EEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCC
Q 003139 573 MILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKT 652 (845)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~ 652 (845)
.++||||+++ +|.+++... ...+++.++..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred eEEEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 9999999975 888877543 3468999999999999999999999 8999999999999999999999999999986
Q ss_pred CCCCCCcccccccccCCCcCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhh
Q 003139 653 GPALDQTHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQ 731 (845)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (845)
... .........||+.|+|||.+.+. .++.++|||||||++|||++|++||......+. +.. ............
T Consensus 162 ~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~--~~~-i~~~~~~~~~~~ 236 (346)
T 1ua2_A 162 FGS--PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ--LTR-IFETLGTPTEEQ 236 (346)
T ss_dssp TTS--CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHH-HHHHHCCCCTTT
T ss_pred ccC--CcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--HHH-HHHHcCCCChhh
Confidence 432 12223456789999999999764 589999999999999999999999865432211 111 111111100000
Q ss_pred hh------ccccCC---CCC-----HHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 732 IM------DSNLVG---KVN-----PASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 732 ~~------d~~l~~---~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
+. +..... ..+ ......+.+++.+||+.||++|||+.|++++-.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~ 294 (346)
T 1ua2_A 237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294 (346)
T ss_dssp SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChh
Confidence 00 000000 001 233467899999999999999999999987643
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=361.91 Aligned_cols=268 Identities=21% Similarity=0.261 Sum_probs=187.6
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEec-----CCc
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDE-----RSE 572 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-----~~~ 572 (845)
.++|++.+.||+|+||.||+|+.. +|+.||||++... .....+++.+|+++|++++||||+++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 367999999999999999999876 6899999987653 44556789999999999999999999999943 357
Q ss_pred EEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCC
Q 003139 573 MILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKT 652 (845)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~ 652 (845)
.++||||+ +++|.+++... ..+++..+..++.||++||+|||+ .+|+||||||+||||+.++.+||+|||+++.
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccchh
Confidence 89999998 57898888543 469999999999999999999999 8999999999999999999999999999986
Q ss_pred CCCCCCc-------------------------ccccccccCCCcCChhhh-ccCCCCchhHHHHHHHHHHHHHc------
Q 003139 653 GPALDQT-------------------------HVSTAVKGSFGYLDPEYF-RRQQLTEKSDVYSFGVVLMEVLC------ 700 (845)
Q Consensus 653 ~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~s~ksDV~S~Gvvl~Ellt------ 700 (845)
....... ...+...||+.|+|||++ ....++.++|||||||+||||++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~ 285 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence 4321110 123456789999999986 56679999999999999999999
Q ss_pred -----CCCCCCCCCCcc-----------------cccHHHHHHHHhhcCch-----------hhhhcc---cc---CCCC
Q 003139 701 -----TRPALNPVLPRE-----------------QVNIAEWAMTWQKKGML-----------DQIMDS---NL---VGKV 741 (845)
Q Consensus 701 -----g~~p~~~~~~~~-----------------~~~l~~~~~~~~~~~~~-----------~~~~d~---~l---~~~~ 741 (845)
|+++|.+..... ..+.............. ...+.. .. ....
T Consensus 286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (458)
T 3rp9_A 286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER 365 (458)
T ss_dssp SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGG
T ss_pred cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHH
Confidence 556554332100 00000001111110000 000000 00 0001
Q ss_pred CHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003139 742 NPASLKKFGETAEKCLAEHGVDRPSMGDVLWNL 774 (845)
Q Consensus 742 ~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L 774 (845)
.+.....+.+|+.+||+.||++|||+.|++++-
T Consensus 366 ~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp 398 (458)
T 3rp9_A 366 FPASSADAIHLLKRMLVFNPNKRITINECLAHP 398 (458)
T ss_dssp STTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred CCCCCHHHHHHHHHHhccCccccCCHHHHhcCH
Confidence 123356788999999999999999999998763
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=350.04 Aligned_cols=262 Identities=21% Similarity=0.292 Sum_probs=192.7
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCCh--HhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSE--QGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
.++|+..+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 467999999999999999999865 788999999865432 33467889999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEE-----CCCCceEEEeccccCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILL-----DDNFVAKVADFGLSKT 652 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl-----~~~~~~kl~DFGla~~ 652 (845)
||++ |+|.+++... ..+++.++..|+.||+.||+|||+ .+|+||||||+|||+ ++++.+||+|||+++.
T Consensus 113 e~~~-~~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 113 EYAE-NDLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp ECCS-EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred ecCC-CCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 9997 5999988654 369999999999999999999999 899999999999999 4556699999999975
Q ss_pred CCCCCCcccccccccCCCcCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCc---
Q 003139 653 GPALDQTHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGM--- 728 (845)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~--- 728 (845)
... .........||+.|+|||++.+. .++.++|||||||++|||++|+.||......+. +.... .......
T Consensus 187 ~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~~~-~~~~~~~~~~ 261 (329)
T 3gbz_A 187 FGI--PIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ--LFKIF-EVLGLPDDTT 261 (329)
T ss_dssp HC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHH-HHHCCCCTTT
T ss_pred cCC--cccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH--HHHHH-HHhCCCchhh
Confidence 322 11223345689999999999874 589999999999999999999999975432221 11111 1000000
Q ss_pred hhhhh------c--cccCCC-----CCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 729 LDQIM------D--SNLVGK-----VNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 729 ~~~~~------d--~~l~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
..... + +..... ........+.+++.+||+.||++|||+.|++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp STTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 00000 0 000000 001134678899999999999999999999764
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=352.49 Aligned_cols=263 Identities=23% Similarity=0.329 Sum_probs=196.7
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHh-HHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQG-IAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
++|...+.||+|+||.||+|+.. +++.||+|++....... ...+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 46888999999999999999976 78999999886543222 22456799999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCc
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT 659 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~ 659 (845)
++ |+|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.... ..
T Consensus 82 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~--~~ 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSI--PT 154 (324)
T ss_dssp CS-EEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred cc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccC--Cc
Confidence 97 58888876543 468999999999999999999999 8999999999999999999999999999976332 12
Q ss_pred ccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcC---chhhhhc-
Q 003139 660 HVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKG---MLDQIMD- 734 (845)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~~~~d- 734 (845)
.......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+. ........... .......
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQ---LHFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTGGGC
T ss_pred cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCChHhchhhhcc
Confidence 22334578999999999876 6789999999999999999999999976443221 11111111110 0000000
Q ss_pred --------cccCC----CCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003139 735 --------SNLVG----KVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNL 774 (845)
Q Consensus 735 --------~~l~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L 774 (845)
+.... ...+.....+.+++.+||+.||++|||+.|++++-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 283 (324)
T 3mtl_A 232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHP 283 (324)
T ss_dssp HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcCh
Confidence 00000 00122346688999999999999999999998753
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=350.90 Aligned_cols=258 Identities=24% Similarity=0.326 Sum_probs=205.3
Q ss_pred HHHHHHhcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC--------hHhHHHHHHHHHHHHhC-CCCCcceEE
Q 003139 495 QEILDATNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS--------EQGIAEFRTEIEMLSKL-RHRHLVSLI 564 (845)
Q Consensus 495 ~el~~at~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~H~niv~l~ 564 (845)
.......++|+..+.||+|+||.||+|++. +|+.||||++.... ....+.+.+|+.+++++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 334455678999999999999999999986 79999999875432 12245678999999999 799999999
Q ss_pred EEEecCCcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEE
Q 003139 565 GYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKV 644 (845)
Q Consensus 565 g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl 644 (845)
+++...+..++||||+++++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl 241 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRL 241 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEE
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEE
Confidence 9999999999999999999999998643 469999999999999999999999 89999999999999999999999
Q ss_pred EeccccCCCCCCCCcccccccccCCCcCChhhhcc------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHH
Q 003139 645 ADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRR------QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAE 718 (845)
Q Consensus 645 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~ 718 (845)
+|||++..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .
T Consensus 242 ~DfG~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~---~-- 313 (365)
T 2y7j_A 242 SDFGFSCHLEP---GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL---M-- 313 (365)
T ss_dssp CCCTTCEECCT---TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---H--
T ss_pred EecCcccccCC---CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH---H--
Confidence 99999976432 122345679999999999864 368899999999999999999999996532111 1
Q ss_pred HHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 719 WAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 719 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
... ...+.... ..+. .......+.+++.+||+.||++||++.+++++
T Consensus 314 -~~~-i~~~~~~~-~~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 314 -LRM-IMEGQYQF-SSPE-----WDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp -HHH-HHHTCCCC-CHHH-----HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -HHH-HHhCCCCC-CCcc-----cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111 11110000 0000 01224568899999999999999999999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=352.45 Aligned_cols=263 Identities=20% Similarity=0.193 Sum_probs=205.2
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCC--------CCCcceEEEEEe---
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLR--------HRHLVSLIGYCD--- 568 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------H~niv~l~g~~~--- 568 (845)
.++|++.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|++++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 367999999999999999999865 6889999998643 445678899999999985 788999999987
Q ss_pred -cCCcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-ceeeccCCCCcEEECCCC------
Q 003139 569 -ERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQ-SIIHRDVKTTNILLDDNF------ 640 (845)
Q Consensus 569 -~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDik~~NILl~~~~------ 640 (845)
+....++||||+ +++|.+.+.......+++.+++.|+.||+.||+|||+ + +|+||||||+||||+.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccchhhhhh
Confidence 566899999999 5666666655555679999999999999999999999 7 999999999999999775
Q ss_pred -------------------------------------------ceEEEeccccCCCCCCCCcccccccccCCCcCChhhh
Q 003139 641 -------------------------------------------VAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYF 677 (845)
Q Consensus 641 -------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~ 677 (845)
.+||+|||+++.... ......||+.|+|||++
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-----~~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-----HFTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB-----CSCSCCSCGGGCCHHHH
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc-----cCccCCCCCcccCChhh
Confidence 799999999976432 13345789999999999
Q ss_pred ccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHH---HHHHHhhcCchh---------hhhccc---------
Q 003139 678 RRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAE---WAMTWQKKGMLD---------QIMDSN--------- 736 (845)
Q Consensus 678 ~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~---~~~~~~~~~~~~---------~~~d~~--------- 736 (845)
.+..++.++|||||||+||||++|+.||......+...... ............ ......
T Consensus 266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (397)
T 1wak_A 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL 345 (397)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence 99999999999999999999999999997655433211111 111111110000 000000
Q ss_pred ----------cCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 737 ----------LVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 737 ----------l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
-....+......+.+++.+||+.||++|||+.|++++
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0012346677889999999999999999999999864
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=346.54 Aligned_cols=264 Identities=23% Similarity=0.332 Sum_probs=205.3
Q ss_pred ccHHHHHHHhcCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCC--CChHhHHHHHHHHHHHHhCC--CCCcceEEEEE
Q 003139 492 FMFQEILDATNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNP--RSEQGIAEFRTEIEMLSKLR--HRHLVSLIGYC 567 (845)
Q Consensus 492 ~~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~--H~niv~l~g~~ 567 (845)
+.++.+....++|...+.||+|+||.||++...+++.||+|++.. ......+.+.+|++++.+++ |+||+++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 333344444577999999999999999999988899999998754 34556788999999999997 59999999999
Q ss_pred ecCCcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEec
Q 003139 568 DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADF 647 (845)
Q Consensus 568 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DF 647 (845)
.+.+..++||| +.+++|.+++... ..+++.+++.++.|+++||+|||+ .+|+||||||+|||+++ +.+||+||
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL~Df 170 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLIDF 170 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEECCC
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEEeec
Confidence 99999999999 5688999998654 478999999999999999999999 89999999999999975 79999999
Q ss_pred cccCCCCCCCCcccccccccCCCcCChhhhcc-----------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccH
Q 003139 648 GLSKTGPALDQTHVSTAVKGSFGYLDPEYFRR-----------QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNI 716 (845)
Q Consensus 648 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l 716 (845)
|+++...............||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.......
T Consensus 171 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---- 246 (313)
T 3cek_A 171 GIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI---- 246 (313)
T ss_dssp SSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH----
T ss_pred cccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH----
Confidence 99986443222222335578999999999875 578899999999999999999999996533211
Q ss_pred HHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003139 717 AEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEY 776 (845)
Q Consensus 717 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~ 776 (845)
. .+..++++......+......+.+++.+||+.+|.+||++.|+++.-..
T Consensus 247 -~---------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~ 296 (313)
T 3cek_A 247 -S---------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296 (313)
T ss_dssp -H---------HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred -H---------HHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccc
Confidence 1 1122223322223333345678899999999999999999999987554
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=351.13 Aligned_cols=265 Identities=24% Similarity=0.351 Sum_probs=202.6
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYE 578 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 578 (845)
++|+..+.||+|+||.||+|+.. +|+.||+|++... .....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 57888999999999999999976 5899999986443 34445678899999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCC
Q 003139 579 YMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQ 658 (845)
Q Consensus 579 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~ 658 (845)
|+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 105 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 177 (331)
T 4aaa_A 105 FVDHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP-- 177 (331)
T ss_dssp CCSEEHHHHHHHST--TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred cCCcchHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCC--
Confidence 99999998876443 369999999999999999999999 89999999999999999999999999999764321
Q ss_pred cccccccccCCCcCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHH----------H-Hhhc
Q 003139 659 THVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAM----------T-WQKK 726 (845)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~----------~-~~~~ 726 (845)
........||+.|+|||.+.+. .++.++|||||||++|||++|+.||......+.. ..... . ....
T Consensus 178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 255 (331)
T 4aaa_A 178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQL--YHIMMCLGNLIPRHQELFNKN 255 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHHHHHCSCCHHHHHHHHHC
T ss_pred ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHH--HHHHHHhCCCChhhhhHhhhc
Confidence 2223345789999999999875 7899999999999999999999999764432211 11110 0 0000
Q ss_pred CchhhhhccccCCCC-----CHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 727 GMLDQIMDSNLVGKV-----NPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 727 ~~~~~~~d~~l~~~~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
........+.+.... .+.....+.+++.+||+.||++|||+.|++++-.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~ 309 (331)
T 4aaa_A 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309 (331)
T ss_dssp GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCch
Confidence 001111111111111 1234577899999999999999999999987643
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=345.36 Aligned_cols=263 Identities=23% Similarity=0.322 Sum_probs=187.7
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC-hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS-EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYE 578 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 578 (845)
.++|+..+.||+|+||.||+|... +++.||||++.... ....+++.+|++++++++||||+++++++...+..++|||
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 93 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK 93 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence 468899999999999999999864 68899999876543 3445778899999999999999999999999999999999
Q ss_pred eccCCCccccccC------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCC
Q 003139 579 YMANGPLRSHLYG------TDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKT 652 (845)
Q Consensus 579 y~~~gsL~~~l~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~ 652 (845)
|+++++|.+++.. .....+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 170 (303)
T 2vwi_A 94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAF 170 (303)
T ss_dssp CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence 9999999998853 134569999999999999999999999 8999999999999999999999999999875
Q ss_pred CCCCC---CcccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCc
Q 003139 653 GPALD---QTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGM 728 (845)
Q Consensus 653 ~~~~~---~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 728 (845)
..... .........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......... ...... .
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~~~~~-~ 243 (303)
T 2vwi_A 171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL------MLTLQN-D 243 (303)
T ss_dssp CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH------HHHHTS-S
T ss_pred eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH------HHHhcc-C
Confidence 43211 1112234578999999999876 57899999999999999999999999764432211 111111 0
Q ss_pred hhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 729 LDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 729 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
....................+.+++.+||+.||.+||++.+++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 244 PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 000000000011122344678899999999999999999999864
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=360.79 Aligned_cols=242 Identities=16% Similarity=0.171 Sum_probs=191.9
Q ss_pred hcCCCcceeeeeeceEEEEEEEE-cCCcEEEEEEcCC---CChHhHHHHHHHH---HHHHhCCCCCcceEE-------EE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTL-DDGTKVAVKRGNP---RSEQGIAEFRTEI---EMLSKLRHRHLVSLI-------GY 566 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~---~~~~~~~~~~~E~---~~l~~l~H~niv~l~-------g~ 566 (845)
.++|...+.||+|+||.||+|+. .+|+.||||++.. ......+.|.+|+ +++++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788889999999999999996 4689999998753 3344567899999 555566899999998 77
Q ss_pred EecCCc-----------------EEEEEEeccCCCccccccCCC-----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCce
Q 003139 567 CDERSE-----------------MILVYEYMANGPLRSHLYGTD-----LPPLSWKQRLEICIGAARGLHYLHTGAAQSI 624 (845)
Q Consensus 567 ~~~~~~-----------------~~lV~Ey~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 624 (845)
+.+.+. .++||||+ +|+|.+++.... ...++|..++.|+.||++||+|||+ ++|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence 765542 88999999 689999986431 1235568899999999999999999 899
Q ss_pred eeccCCCCcEEECCCCceEEEeccccCCCCCCCCcccccccccCCCcCChhhhccC-----------CCCchhHHHHHHH
Q 003139 625 IHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQ-----------QLTEKSDVYSFGV 693 (845)
Q Consensus 625 vHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~ksDV~S~Gv 693 (845)
+||||||+||||+.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999985221 2345567 999999999887 8999999999999
Q ss_pred HHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 694 VLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 694 vl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
+||||++|+.||........ ...+... ....+..+.+++.+||+.||++||++.+++++
T Consensus 302 il~elltg~~Pf~~~~~~~~---------------~~~~~~~------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGG---------------SEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHHHHHSSCCC------CC---------------SGGGGSS------CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHHHHHCCCCCcccccccc---------------hhhhhhh------ccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 99999999999965432221 1111110 12334678899999999999999999999874
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=352.65 Aligned_cols=258 Identities=21% Similarity=0.304 Sum_probs=197.2
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCC------
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERS------ 571 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 571 (845)
.++|+..+.||+|+||.||+|... +|+.||||++... .....+++.+|++++++++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 467889999999999999999975 6899999998543 4445678899999999999999999999997653
Q ss_pred cEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccC
Q 003139 572 EMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSK 651 (845)
Q Consensus 572 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~ 651 (845)
..++||||+ +++|.+++.. ..+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR 176 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence 469999999 8899998864 368999999999999999999999 899999999999999999999999999998
Q ss_pred CCCCCCCcccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcC---
Q 003139 652 TGPALDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKG--- 727 (845)
Q Consensus 652 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~--- 727 (845)
.... ......+|+.|+|||++.+ ..++.++||||+||+++||++|+.||......++. ..........
T Consensus 177 ~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l---~~i~~~~g~~~~~ 248 (367)
T 1cm8_A 177 QADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL---KEIMKVTGTPPAE 248 (367)
T ss_dssp ECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHHHCCCCHH
T ss_pred cccc-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhcCCCCHH
Confidence 6432 1334578999999999887 78999999999999999999999999754432211 1111100000
Q ss_pred --------chhhhhcc------ccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 728 --------MLDQIMDS------NLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 728 --------~~~~~~d~------~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.....+.. .-.....+.....+.+++.+||+.||.+|||+.|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 249 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 00000000 00001123345678899999999999999999999875
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=355.50 Aligned_cols=199 Identities=25% Similarity=0.341 Sum_probs=167.1
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecC-----Cc
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDER-----SE 572 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 572 (845)
.++|...+.||+|+||.||+|+.. +|+.||||++... .....+++.+|+++|++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 367899999999999999999976 6788999998653 445567899999999999999999999999766 57
Q ss_pred EEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCC
Q 003139 573 MILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKT 652 (845)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~ 652 (845)
.++||||++ ++|.+++... ..+++..+..++.||++||+|||+ .+|+||||||+||||+.++.+||+|||+++.
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 999999996 6999988643 469999999999999999999999 8999999999999999999999999999986
Q ss_pred CCCCCCc--------------------ccccccccCCCcCChhhh-ccCCCCchhHHHHHHHHHHHHHcCCCCC
Q 003139 653 GPALDQT--------------------HVSTAVKGSFGYLDPEYF-RRQQLTEKSDVYSFGVVLMEVLCTRPAL 705 (845)
Q Consensus 653 ~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~s~ksDV~S~Gvvl~Elltg~~p~ 705 (845)
....... ...+...||+.|+|||++ ....++.++|||||||++|||++|..|+
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 4332111 123566899999999986 5667999999999999999999854443
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=344.51 Aligned_cols=253 Identities=24% Similarity=0.363 Sum_probs=200.3
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
.++|++.+.||+|+||.||+|+.. +++.+|+|.+........+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 467889999999999999999986 5889999998777666778899999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCc
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT 659 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~ 659 (845)
+++++|.+++... ...+++.+++.++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++.... ...
T Consensus 98 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~--~~~ 171 (302)
T 2j7t_A 98 CPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL--KTL 171 (302)
T ss_dssp CTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHH--HHH
T ss_pred CCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCcccc--ccc
Confidence 9999999988543 2468999999999999999999999 899999999999999999999999999875311 011
Q ss_pred ccccccccCCCcCChhhh-----ccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhc
Q 003139 660 HVSTAVKGSFGYLDPEYF-----RRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMD 734 (845)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~-----~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (845)
.......||+.|+|||.+ .+..++.++||||||+++|||++|+.||....... ..........
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~------ 239 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLLKIAKSDP------ 239 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHSCC------
T ss_pred cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH------HHHHHhccCC------
Confidence 112345689999999998 46788999999999999999999999986543211 1111111110
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 735 SNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 735 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
+ ....+...+..+.+++.+||+.+|++|||+.+++++
T Consensus 240 ~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 240 P--TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp C--CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred c--ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0 001223445678899999999999999999998763
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=337.94 Aligned_cols=252 Identities=22% Similarity=0.265 Sum_probs=203.7
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC---------hHhHHHHHHHHHHHHhCC-CCCcceEEEEEec
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS---------EQGIAEFRTEIEMLSKLR-HRHLVSLIGYCDE 569 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~ 569 (845)
.++|+..+.||+|+||.||+|... +|+.||||.+.... ....+.+.+|++++++++ ||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 467889999999999999999986 68899999875432 123467889999999996 9999999999999
Q ss_pred CCcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccc
Q 003139 570 RSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGL 649 (845)
Q Consensus 570 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGl 649 (845)
.+..++||||+++++|.+++... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 170 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGF 170 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred CCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEecccc
Confidence 99999999999999999998643 468999999999999999999999 8999999999999999999999999999
Q ss_pred cCCCCCCCCcccccccccCCCcCChhhhc------cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHH
Q 003139 650 SKTGPALDQTHVSTAVKGSFGYLDPEYFR------RQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTW 723 (845)
Q Consensus 650 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~ 723 (845)
++.... ........|++.|+|||.+. ...++.++||||||+++|||++|+.||......+ .....
T Consensus 171 ~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~ 241 (298)
T 1phk_A 171 SCQLDP---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML------MLRMI 241 (298)
T ss_dssp CEECCT---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHH
T ss_pred hhhcCC---CcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH------HHHHH
Confidence 976432 12233457899999999985 4578999999999999999999999986532211 11111
Q ss_pred hhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 724 QKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 724 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
..+.. ..........+..+.+++.+||+.+|++||++.+++++
T Consensus 242 -~~~~~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 242 -MSGNY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp -HHTCC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred -hcCCc------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 11110 00011113456778999999999999999999998753
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=352.41 Aligned_cols=255 Identities=24% Similarity=0.295 Sum_probs=204.7
Q ss_pred cCCCcceeeeeeceEEEEEEEE----cCCcEEEEEEcCCCC----hHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCc
Q 003139 502 NKFDESLLLGVGGFGRVYKGTL----DDGTKVAVKRGNPRS----EQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERSE 572 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 572 (845)
++|+..+.||+|+||.||+++. .+|+.||||++.... ....+.+.+|+++++++ +||||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5789999999999999999997 368999999876432 12345677899999999 69999999999999999
Q ss_pred EEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCC
Q 003139 573 MILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKT 652 (845)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~ 652 (845)
.++||||+++|+|.+++... ..+++.++..++.|+++||+|||+ .+|+||||||+||||+.++.+||+|||+++.
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred EEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 99999999999999998653 368999999999999999999999 8999999999999999999999999999976
Q ss_pred CCCCCCcccccccccCCCcCChhhhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchh
Q 003139 653 GPALDQTHVSTAVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLD 730 (845)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (845)
... ..........||+.|+|||++.+ ..++.++|||||||+||||++|+.||........ ...........
T Consensus 209 ~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~---- 281 (355)
T 1vzo_A 209 FVA-DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRRILKS---- 281 (355)
T ss_dssp CCG-GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHHHHHHHC----
T ss_pred ccc-CCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch--HHHHHHHHhcc----
Confidence 432 22223345679999999999986 4578999999999999999999999975433221 11211111111
Q ss_pred hhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCC-----CHHHHHHHHH
Q 003139 731 QIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRP-----SMGDVLWNLE 775 (845)
Q Consensus 731 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~~L~ 775 (845)
....+......+.+++.+||+.||.+|| ++.+++++..
T Consensus 282 -------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~ 324 (355)
T 1vzo_A 282 -------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324 (355)
T ss_dssp -------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred -------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence 1123344556788999999999999999 9999887654
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=341.55 Aligned_cols=252 Identities=26% Similarity=0.324 Sum_probs=197.2
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC--------hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS--------EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERS 571 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 571 (845)
.++|...+.||+|+||.||+|+.. +++.||||.+.... ......+.+|++++++++||||+++++++....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 457899999999999999999976 57899999876432 122345889999999999999999999987654
Q ss_pred cEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCc---eEEEecc
Q 003139 572 EMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFV---AKVADFG 648 (845)
Q Consensus 572 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~---~kl~DFG 648 (845)
.++||||+++++|.+++... ..+++.++..++.|++.||+|||+ ++|+||||||+|||++.++. +||+|||
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred -eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 89999999999999988543 479999999999999999999999 89999999999999987654 9999999
Q ss_pred ccCCCCCCCCcccccccccCCCcCChhhhc---cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhh
Q 003139 649 LSKTGPALDQTHVSTAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQK 725 (845)
Q Consensus 649 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~ 725 (845)
+++.... ........||+.|+|||++. ...++.++|||||||++|||++|+.||....... .+.....
T Consensus 163 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~---- 233 (322)
T 2ycf_A 163 HSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQIT---- 233 (322)
T ss_dssp TCEECCC---CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHHHH----
T ss_pred cceeccc---ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHHHH----
Confidence 9986432 22233457899999999974 5678999999999999999999999997543322 1111111
Q ss_pred cCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 726 KGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 726 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.+.... .+. ........+.+++.+||+.||++||++.+++++
T Consensus 234 ~~~~~~--~~~----~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 234 SGKYNF--IPE----VWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp HTCCCC--CHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hCcccc--Cch----hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 111000 000 011234678899999999999999999999854
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=336.42 Aligned_cols=249 Identities=24% Similarity=0.348 Sum_probs=196.8
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC---hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS---EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
++|...+.||+|+||.||+|+.. +|+.||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 57888899999999999999986 78999999875432 123567889999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
||+++++|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 91 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~-- 163 (276)
T 2h6d_A 91 EYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-- 163 (276)
T ss_dssp ECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred eccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccCC--
Confidence 999999999998643 368999999999999999999999 8999999999999999999999999999976432
Q ss_pred CcccccccccCCCcCChhhhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccc
Q 003139 658 QTHVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSN 736 (845)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (845)
........|++.|+|||.+.+..+ +.++||||||+++|||++|+.||...... ..... ...+.
T Consensus 164 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~-~~~~~-------- 227 (276)
T 2h6d_A 164 -GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP------TLFKK-IRGGV-------- 227 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHH-HHHCC--------
T ss_pred -CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH------HHHHH-hhcCc--------
Confidence 122234568999999999988765 68999999999999999999998643211 11111 11110
Q ss_pred cCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 737 LVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 737 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
...+......+.+++.+||+.+|.+||++.+++++-.
T Consensus 228 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~ 264 (276)
T 2h6d_A 228 --FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEW 264 (276)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHH
T ss_pred --ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChh
Confidence 0122334567889999999999999999999998643
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=373.36 Aligned_cols=259 Identities=25% Similarity=0.341 Sum_probs=208.2
Q ss_pred hcCCCcceeeeeeceEEEEEEEEcC----CcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLDD----GTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMIL 575 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 575 (845)
.++|+..+.||+|+||.||+|.+.. +..||+|+.... .....+.|.+|+.++++++||||+++++++.+ +..++
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~l 467 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI 467 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEE
Confidence 4678889999999999999998742 457999987654 44556789999999999999999999999854 66899
Q ss_pred EEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCC
Q 003139 576 VYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPA 655 (845)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~ 655 (845)
||||+++|+|.+++... ...+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 468 v~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 543 (656)
T ss_dssp EEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred EEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence 99999999999999644 2468999999999999999999999 8999999999999999999999999999987543
Q ss_pred CCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhc
Q 003139 656 LDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMD 734 (845)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (845)
. .........+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......+ + .... ..+
T Consensus 544 ~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---~---~~~i-~~~------- 608 (656)
T 2j0j_A 544 S-TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---V---IGRI-ENG------- 608 (656)
T ss_dssp -----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---H---HHHH-HHT-------
T ss_pred C-cceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH---H---HHHH-HcC-------
Confidence 2 1222234557789999999999999999999999999999997 899986543221 1 1111 111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhhh
Q 003139 735 SNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLE 781 (845)
Q Consensus 735 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~ 781 (845)
.....+..++..+.+++.+||+.||.+||++.++++.|+.+++.+
T Consensus 609 --~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 609 --ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --CCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 111233455678899999999999999999999999999987543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=350.39 Aligned_cols=272 Identities=21% Similarity=0.240 Sum_probs=203.5
Q ss_pred cccHHHHHHHhcCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCC-----------ChHhHHHHHHHHHHHHhCCCCC
Q 003139 491 LFMFQEILDATNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPR-----------SEQGIAEFRTEIEMLSKLRHRH 559 (845)
Q Consensus 491 ~~~~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~-----------~~~~~~~~~~E~~~l~~l~H~n 559 (845)
.....++....++|...+.||+|+||.||+|...+|+.||||++... .....+.+.+|++++++++|||
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 90 (362)
T 3pg1_A 11 RDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPN 90 (362)
T ss_dssp HHHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTT
T ss_pred HHHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcC
Confidence 34567888899999999999999999999999888999999987532 1223478999999999999999
Q ss_pred cceEEEEEec-----CCcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcE
Q 003139 560 LVSLIGYCDE-----RSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNI 634 (845)
Q Consensus 560 iv~l~g~~~~-----~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NI 634 (845)
|+++++++.. ....++||||++ |+|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+||
T Consensus 91 iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NI 165 (362)
T 3pg1_A 91 ILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNI 165 (362)
T ss_dssp BCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGE
T ss_pred ccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHE
Confidence 9999999843 346899999997 6888877643 3479999999999999999999999 8999999999999
Q ss_pred EECCCCceEEEeccccCCCCCCCCcccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCccc
Q 003139 635 LLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQ 713 (845)
Q Consensus 635 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~ 713 (845)
|++.++.+||+|||+++.... ........||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+.
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 242 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTA---DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ 242 (362)
T ss_dssp EECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred EEcCCCCEEEEecCccccccc---ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999999999999999975322 222345678999999999877 7799999999999999999999999975432221
Q ss_pred ccHHHHHHHHhhcCchh-----------hhhccccCCC-------CCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 714 VNIAEWAMTWQKKGMLD-----------QIMDSNLVGK-------VNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 714 ~~l~~~~~~~~~~~~~~-----------~~~d~~l~~~-------~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.............. ..+...+... ..+.....+.+++.+||+.||.+|||+.|++++
T Consensus 243 ---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 243 ---LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp ---HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 11111111111111 1111111000 112234668899999999999999999999865
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=340.35 Aligned_cols=256 Identities=19% Similarity=0.234 Sum_probs=200.6
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCC-CCCcceEEEEEec--CCcEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLR-HRHLVSLIGYCDE--RSEMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~--~~~~~lV~ 577 (845)
++|+..+.||+|+||.||+|+.. +++.||+|++.... .+.+.+|++++++++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 67889999999999999999864 78999999987544 357889999999997 9999999999987 66789999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCC-ceEEEeccccCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNF-VAKVADFGLSKTGPAL 656 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~-~~kl~DFGla~~~~~~ 656 (845)
||+++++|.+++. .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++ .+||+|||+++.....
T Consensus 113 e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp ECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred eccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 9999999999873 48899999999999999999999 8999999999999999776 8999999999764321
Q ss_pred CCcccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhh----
Q 003139 657 DQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQ---- 731 (845)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~---- 731 (845)
.......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||........ .+...... .....+.+
T Consensus 185 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~-~l~~~~~~-~~~~~~~~~~~~ 259 (330)
T 3nsz_A 185 ---QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVRIAKV-LGTEDLYDYIDK 259 (330)
T ss_dssp ---CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH-HHHHHHHH-HCHHHHHHHHHH
T ss_pred ---CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH-HHHHHHHh-cCCchhhhHHHH
Confidence 22334578999999999887 6799999999999999999999999964433211 11111110 00000000
Q ss_pred -----------hhc--------cccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 732 -----------IMD--------SNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 732 -----------~~d--------~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
+.. ..............+.+++.+||+.||++|||++|++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000 001111122246788999999999999999999999875
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=365.90 Aligned_cols=252 Identities=25% Similarity=0.336 Sum_probs=205.1
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
++|+..+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 105 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG 105 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 56888999999999999999976 7899999987543 2334678999999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEE---CCCCceEEEeccccCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILL---DDNFVAKVADFGLSKTGP 654 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl---~~~~~~kl~DFGla~~~~ 654 (845)
||+++|+|.+++... ..+++.++..++.|++.||+|||+ ++|+||||||+|||+ +.++.+||+|||+++...
T Consensus 106 e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 106 EVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp CCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred ecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 999999999988654 469999999999999999999999 899999999999999 567899999999997633
Q ss_pred CCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhc
Q 003139 655 ALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMD 734 (845)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (845)
. ........||+.|+|||++.+ .++.++||||+||++|||++|++||......+ + ... ...+...
T Consensus 181 ~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~---~~~-i~~~~~~---- 245 (484)
T 3nyv_A 181 A---SKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD---I---LKK-VEKGKYT---- 245 (484)
T ss_dssp C---CCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H---HHH-HHHCCCC----
T ss_pred c---ccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH---H---HHH-HHcCCCC----
Confidence 2 222344579999999999876 69999999999999999999999997543221 1 111 1111100
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 735 SNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 735 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
............+.+++.+||+.+|.+|||+.+++++-.
T Consensus 246 --~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~ 284 (484)
T 3nyv_A 246 --FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEW 284 (484)
T ss_dssp --CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred --CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChh
Confidence 000011234567889999999999999999999997644
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=358.42 Aligned_cols=198 Identities=24% Similarity=0.270 Sum_probs=173.9
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhC------CCCCcceEEEEEecCCcEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKL------RHRHLVSLIGYCDERSEMI 574 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~H~niv~l~g~~~~~~~~~ 574 (845)
.+|++.+.||+|+||.||+|... +++.||||++... ....+++.+|+++++.+ +|+||+++++++...+..+
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 56889999999999999999876 5889999998753 34456778899888887 5779999999999999999
Q ss_pred EEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCc--eEEEeccccCC
Q 003139 575 LVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFV--AKVADFGLSKT 652 (845)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~--~kl~DFGla~~ 652 (845)
+||||++ ++|.+++.......+++..++.|+.||+.||+|||+ .+|+||||||+||||+.++. +||+|||+++.
T Consensus 176 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~ 251 (429)
T 3kvw_A 176 MTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY 251 (429)
T ss_dssp EEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeeccccee
Confidence 9999996 689998877666679999999999999999999999 89999999999999999887 99999999975
Q ss_pred CCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 003139 653 GPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVL 709 (845)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~ 709 (845)
... ......||+.|+|||++.+..++.++|||||||+||||++|++||....
T Consensus 252 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 252 EHQ-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp TTC-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCC-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 322 1234578999999999999999999999999999999999999997654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=364.00 Aligned_cols=252 Identities=23% Similarity=0.324 Sum_probs=198.9
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC--hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS--EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
.++|+..+.||+|+||.||+|+.. ++..+|+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 356888999999999999999976 68899999876432 333567899999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECC---CCceEEEeccccCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDD---NFVAKVADFGLSKTGP 654 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~---~~~~kl~DFGla~~~~ 654 (845)
||+++|+|.+++... ..+++.++..|+.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+++...
T Consensus 116 e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 116 ECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 999999999888543 468999999999999999999999 89999999999999976 4559999999997643
Q ss_pred CCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhc
Q 003139 655 ALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMD 734 (845)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (845)
. ........||+.|+|||++. +.++.++||||+||++|||++|++||......+ ..... ..+...
T Consensus 191 ~---~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i-~~~~~~---- 255 (494)
T 3lij_A 191 N---QKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE------ILRKV-EKGKYT---- 255 (494)
T ss_dssp T---TBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHH-HHTCCC----
T ss_pred C---CccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHH-HhCCCC----
Confidence 2 22234567999999999986 569999999999999999999999997543221 11111 111100
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003139 735 SNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNL 774 (845)
Q Consensus 735 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L 774 (845)
............+.+++.+||+.+|.+|||+.+++++-
T Consensus 256 --~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp 293 (494)
T 3lij_A 256 --FDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHP 293 (494)
T ss_dssp --CCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCH
T ss_pred --CCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCc
Confidence 00000123456788999999999999999999998763
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=347.98 Aligned_cols=264 Identities=24% Similarity=0.343 Sum_probs=199.5
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC--hHhHHHHHHHHHHHHhCCCCCcceEEEEEec--------C
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS--EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDE--------R 570 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--------~ 570 (845)
++|+..+.||+|+||.||+|+.. +|+.||+|++.... ......+.+|++++++++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 57889999999999999999984 78999999875543 2234578899999999999999999999976 4
Q ss_pred CcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEecccc
Q 003139 571 SEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLS 650 (845)
Q Consensus 571 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla 650 (845)
+..++||||+++ +|.+.+... ...+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred ceEEEEEeccCC-CHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 568999999975 676666543 2469999999999999999999999 89999999999999999999999999999
Q ss_pred CCCCCCC--CcccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcC
Q 003139 651 KTGPALD--QTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKG 727 (845)
Q Consensus 651 ~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 727 (845)
+...... .........||+.|+|||++.+ ..++.++|||||||++|||++|++||......+.. ..........
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---~~i~~~~~~~ 248 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL---ALISQLCGSI 248 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCC
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCC
Confidence 7643211 1222345678999999999876 56899999999999999999999999764432211 1111111110
Q ss_pred ---chhhhhcccc------C-C-CCC-HH------HHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 728 ---MLDQIMDSNL------V-G-KVN-PA------SLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 728 ---~~~~~~d~~l------~-~-~~~-~~------~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
....+-.... . . ... .. ....+.+++.+||+.||++|||+.|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 0000000000 0 0 000 00 13457899999999999999999999876
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=347.82 Aligned_cols=260 Identities=19% Similarity=0.280 Sum_probs=205.3
Q ss_pred hcCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChH-----------------hHHHHHHHHHHHHhCCCCCcceE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQ-----------------GIAEFRTEIEMLSKLRHRHLVSL 563 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~-----------------~~~~~~~E~~~l~~l~H~niv~l 563 (845)
.++|...+.||+|+||.||+|.. +|+.||+|++...... ..+.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 36789999999999999999999 7999999986532111 12789999999999999999999
Q ss_pred EEEEecCCcEEEEEEeccCCCcccc------ccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEEC
Q 003139 564 IGYCDERSEMILVYEYMANGPLRSH------LYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLD 637 (845)
Q Consensus 564 ~g~~~~~~~~~lV~Ey~~~gsL~~~------l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~ 637 (845)
++++.+.+..++||||+++++|.++ +.......+++..++.++.|++.||+|||+ ..+|+||||||+|||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMD 186 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEEC
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEEc
Confidence 9999999999999999999999999 655445789999999999999999999996 37899999999999999
Q ss_pred CCCceEEEeccccCCCCCCCCcccccccccCCCcCChhhhccC-CCCc-hhHHHHHHHHHHHHHcCCCCCCCCCCccccc
Q 003139 638 DNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQ-QLTE-KSDVYSFGVVLMEVLCTRPALNPVLPREQVN 715 (845)
Q Consensus 638 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~ 715 (845)
.++.+||+|||+++..... ......|+..|+|||.+.+. .++. ++||||||+++|||++|+.||....... .
T Consensus 187 ~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~ 260 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV--E 260 (348)
T ss_dssp TTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH--H
T ss_pred CCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH--H
Confidence 9999999999999763321 33456789999999999887 6666 9999999999999999999997544311 1
Q ss_pred HHHHHHHHhhcCchhhh------hcccc---CCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 716 IAEWAMTWQKKGMLDQI------MDSNL---VGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 716 l~~~~~~~~~~~~~~~~------~d~~l---~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
+ ... ...+..... ..+.. ...........+.+++.+||+.||.+||++.|++++
T Consensus 261 ~---~~~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 261 L---FNN-IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp H---HHH-HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred H---HHH-HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1 111 111111000 00000 000113345678999999999999999999999874
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=342.02 Aligned_cols=258 Identities=19% Similarity=0.282 Sum_probs=205.2
Q ss_pred cCCCcceeeeeeceEEEEEEEE-c-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCC------cceEEEEEecCCcE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTL-D-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRH------LVSLIGYCDERSEM 573 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~-~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~g~~~~~~~~ 573 (845)
++|++.+.||+|+||.||+|.. . +++.||+|++... ....+.+.+|++++++++|+| ++++++++.+.+..
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 5788999999999999999987 3 6889999998643 445677889999999987654 99999999999999
Q ss_pred EEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECC---------------
Q 003139 574 ILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDD--------------- 638 (845)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~--------------- 638 (845)
++||||+ +++|.+++......++++.++..++.|+++||+|||+ ++|+||||||+|||++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~ 168 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDE 168 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred EEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCcccccc
Confidence 9999999 8999999976665679999999999999999999999 89999999999999987
Q ss_pred ----CCceEEEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccc
Q 003139 639 ----NFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQV 714 (845)
Q Consensus 639 ----~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~ 714 (845)
++.+||+|||+++.... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+..
T Consensus 169 ~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 243 (339)
T 1z57_A 169 RTLINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL 243 (339)
T ss_dssp EEESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH
T ss_pred ccccCCCceEeeCcccccCcc-----ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 67899999999976322 123457899999999999999999999999999999999999999754432211
Q ss_pred cHHHHHHHHhhcCchhhh------------------------------hcccc-CCCCCHHHHHHHHHHHHHhhhhCCCC
Q 003139 715 NIAEWAMTWQKKGMLDQI------------------------------MDSNL-VGKVNPASLKKFGETAEKCLAEHGVD 763 (845)
Q Consensus 715 ~l~~~~~~~~~~~~~~~~------------------------------~d~~l-~~~~~~~~~~~l~~l~~~cl~~~p~~ 763 (845)
.. ....... ....+ ..+.. ...........+.+++.+||+.||.+
T Consensus 244 ~~---~~~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 319 (339)
T 1z57_A 244 AM---MERILGP-LPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319 (339)
T ss_dssp HH---HHHHHCS-CCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HH---HHHHhCC-CCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence 11 1110000 00000 00000 01123456778999999999999999
Q ss_pred CCCHHHHHHH
Q 003139 764 RPSMGDVLWN 773 (845)
Q Consensus 764 RPs~~~vl~~ 773 (845)
|||+.|++++
T Consensus 320 Rpt~~ell~h 329 (339)
T 1z57_A 320 RITLREALKH 329 (339)
T ss_dssp SCCHHHHTTS
T ss_pred ccCHHHHhcC
Confidence 9999999765
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=363.17 Aligned_cols=253 Identities=24% Similarity=0.309 Sum_probs=201.3
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCCh-------------HhHHHHHHHHHHHHhCCCCCcceEEEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSE-------------QGIAEFRTEIEMLSKLRHRHLVSLIGY 566 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~H~niv~l~g~ 566 (845)
.++|...+.||+|+||.||+|+.. +++.+|+|.+..... ...+.+.+|++++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 467999999999999999999976 578999998754321 235678999999999999999999999
Q ss_pred EecCCcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCC---ceE
Q 003139 567 CDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNF---VAK 643 (845)
Q Consensus 567 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~---~~k 643 (845)
+.+.+..++||||+++|+|.+++... ..+++..+..|+.||+.||+|||+ .+|+||||||+|||++.++ .+|
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSSEE
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCccEE
Confidence 99999999999999999999988543 469999999999999999999999 8999999999999998775 699
Q ss_pred EEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHH
Q 003139 644 VADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTW 723 (845)
Q Consensus 644 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~ 723 (845)
|+|||+++.... ........||+.|+|||++. +.++.++||||+||++|||++|++||......+ ....
T Consensus 190 l~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~- 258 (504)
T 3q5i_A 190 IVDFGLSSFFSK---DYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD------IIKK- 258 (504)
T ss_dssp ECCCTTCEECCT---TSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHH-
T ss_pred EEECCCCEEcCC---CCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHH-
Confidence 999999986432 22234567999999999987 469999999999999999999999997543221 1111
Q ss_pred hhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 724 QKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 724 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
...+.... +.. ........+.+++.+||+.+|.+|||+.|++++-.
T Consensus 259 i~~~~~~~--~~~----~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 304 (504)
T 3q5i_A 259 VEKGKYYF--DFN----DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRW 304 (504)
T ss_dssp HHHCCCCC--CHH----HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HHcCCCCC--Ccc----ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHh
Confidence 11111000 000 00123467889999999999999999999987643
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=347.48 Aligned_cols=264 Identities=20% Similarity=0.265 Sum_probs=195.0
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCC------c
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERS------E 572 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~ 572 (845)
++|+..+.||+|+||.||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++...+ .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 67899999999999999999875 6889999987543 4455678899999999999999999999997654 7
Q ss_pred EEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCC
Q 003139 573 MILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKT 652 (845)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~ 652 (845)
.++||||++ ++|.+.+. ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 105 ~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 105 VYIVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp EEEEEECCS-EEHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred eEEEEEcCC-CCHHHHHh----hccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 899999997 47877774 258999999999999999999999 8999999999999999999999999999986
Q ss_pred CCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccH---------HHH----
Q 003139 653 GPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNI---------AEW---- 719 (845)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l---------~~~---- 719 (845)
... ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... .++
T Consensus 177 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 253 (371)
T 2xrw_A 177 AGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred ccc---ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 332 2223456789999999999999999999999999999999999999975432211000 000
Q ss_pred ---HHHHhhc------CchhhhhccccCCCC---CHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003139 720 ---AMTWQKK------GMLDQIMDSNLVGKV---NPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEY 776 (845)
Q Consensus 720 ---~~~~~~~------~~~~~~~d~~l~~~~---~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~ 776 (845)
....... ..........+.... .......+.+++.+||+.||.+|||++|++++-..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~ 322 (371)
T 2xrw_A 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 322 (371)
T ss_dssp CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHH
T ss_pred hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcch
Confidence 0000000 000011100000000 12236778999999999999999999999987543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=362.56 Aligned_cols=252 Identities=25% Similarity=0.327 Sum_probs=201.8
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
.++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 357889999999999999999976 7899999987432 1223567899999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEEC---CCCceEEEeccccCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLD---DNFVAKVADFGLSKTGP 654 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~---~~~~~kl~DFGla~~~~ 654 (845)
||+++|+|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++ .++.+||+|||+++...
T Consensus 101 e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp CCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 999999999888544 469999999999999999999999 8999999999999995 56689999999997633
Q ss_pred CCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhc
Q 003139 655 ALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMD 734 (845)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (845)
. ........||+.|+|||++.+ .++.++||||+||++|||++|++||......+ .... ...+...
T Consensus 176 ~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~-i~~~~~~---- 240 (486)
T 3mwu_A 176 Q---NTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD------ILKR-VETGKYA---- 240 (486)
T ss_dssp C---C----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHH-HHHTCCC----
T ss_pred C---CCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHH-HHhCCCC----
Confidence 2 222345679999999999876 59999999999999999999999996543221 1111 1111100
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003139 735 SNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNL 774 (845)
Q Consensus 735 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L 774 (845)
............+.+++.+||+.+|.+|||+.+++++-
T Consensus 241 --~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp 278 (486)
T 3mwu_A 241 --FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHP 278 (486)
T ss_dssp --SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCH
T ss_pred --CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCH
Confidence 00001123456788999999999999999999998764
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=338.80 Aligned_cols=253 Identities=24% Similarity=0.354 Sum_probs=201.3
Q ss_pred HhcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEE
Q 003139 500 ATNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYE 578 (845)
Q Consensus 500 at~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 578 (845)
..++|+..+.||+|+||.||+|... +|+.||+|.+.... ..+++.+|++++++++||||+++++++.+.+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 3467889999999999999999976 58999999876543 34678999999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCC
Q 003139 579 YMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQ 658 (845)
Q Consensus 579 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~ 658 (845)
|+++++|.+++... ...+++.+++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.... .
T Consensus 105 ~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~--~ 178 (314)
T 3com_A 105 YCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD--T 178 (314)
T ss_dssp CCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBT--T
T ss_pred cCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhh--h
Confidence 99999999998532 3478999999999999999999999 9999999999999999999999999999976432 1
Q ss_pred cccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccC
Q 003139 659 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLV 738 (845)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 738 (845)
........|++.|+|||.+.+..++.++||||||+++|||++|+.||........ .... .... .+.
T Consensus 179 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~-~~~~-----~~~-- 244 (314)
T 3com_A 179 MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA------IFMI-PTNP-----PPT-- 244 (314)
T ss_dssp BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHH-HHSC-----CCC--
T ss_pred ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH------HHHH-hcCC-----Ccc--
Confidence 1223345789999999999999999999999999999999999999865332111 1111 1100 000
Q ss_pred CCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003139 739 GKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNL 774 (845)
Q Consensus 739 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L 774 (845)
...+......+.+++.+||+.+|.+||++.+++++-
T Consensus 245 ~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~ 280 (314)
T 3com_A 245 FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHP 280 (314)
T ss_dssp CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence 011233456788999999999999999999998753
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=342.12 Aligned_cols=264 Identities=23% Similarity=0.323 Sum_probs=202.1
Q ss_pred HhcCCCcceeeeeeceEEEEEEEE--cCCcEEEEEEcCCCC--hHhHHHHHHHHHHHHhC---CCCCcceEEEEEe----
Q 003139 500 ATNKFDESLLLGVGGFGRVYKGTL--DDGTKVAVKRGNPRS--EQGIAEFRTEIEMLSKL---RHRHLVSLIGYCD---- 568 (845)
Q Consensus 500 at~~f~~~~~LG~G~fg~Vy~~~~--~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~---- 568 (845)
+.++|+..+.||+|+||.||+|+. .+|+.||+|++.... ......+.+|+++++++ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999997 367889999764321 11223456677777665 8999999999987
Q ss_pred -cCCcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEec
Q 003139 569 -ERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADF 647 (845)
Q Consensus 569 -~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DF 647 (845)
.....++||||++ |+|.+++.......+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEecC
Confidence 5667899999997 699999876655679999999999999999999999 89999999999999999999999999
Q ss_pred cccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcC
Q 003139 648 GLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKG 727 (845)
Q Consensus 648 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 727 (845)
|+++.... ........||..|+|||.+.+..++.++||||||+++|||++|+.||......+. ...........
T Consensus 165 g~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~ 238 (326)
T 1blx_A 165 GLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---LGKILDVIGLP 238 (326)
T ss_dssp CSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCC
T ss_pred cccccccC---CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHHHHcCCC
Confidence 99976432 2233456789999999999999999999999999999999999999975432221 11111111100
Q ss_pred chhhh----------hcc---ccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 728 MLDQI----------MDS---NLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 728 ~~~~~----------~d~---~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
....+ ... .............+.+++.+||+.||++||++.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000 000 00011223455678899999999999999999999754
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=377.26 Aligned_cols=248 Identities=23% Similarity=0.321 Sum_probs=205.9
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcEEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERSEMIL 575 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 575 (845)
.++|+..+.||+|+||.||+|+.. +++.||||++... .....+.+..|.+++..+ +||||+++++++.+.+.++|
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 467999999999999999999976 6788999987642 123346778899999987 79999999999999999999
Q ss_pred EEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCC
Q 003139 576 VYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPA 655 (845)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~ 655 (845)
||||+++|+|..++... ..+++.+++.++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+++....
T Consensus 420 V~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred EEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 99999999999999654 469999999999999999999999 8999999999999999999999999999985332
Q ss_pred CCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcc
Q 003139 656 LDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDS 735 (845)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (845)
.........||+.|+|||++.+..++.++|||||||+||||++|++||......+ ....++..
T Consensus 495 --~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~---------------~~~~i~~~ 557 (674)
T 3pfq_A 495 --DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---------------LFQSIMEH 557 (674)
T ss_dssp --TTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---------------HHHHHHSS
T ss_pred --CCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH---------------HHHHHHhC
Confidence 1223446789999999999999999999999999999999999999997543211 11122222
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCH-----HHHHH
Q 003139 736 NLVGKVNPASLKKFGETAEKCLAEHGVDRPSM-----GDVLW 772 (845)
Q Consensus 736 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~-----~~vl~ 772 (845)
.+ .++......+.+++.+||+.||++||++ +||++
T Consensus 558 ~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 558 NV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp CC--CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred CC--CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 21 2344566788999999999999999997 55554
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=350.87 Aligned_cols=258 Identities=21% Similarity=0.297 Sum_probs=186.0
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecC------C
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDER------S 571 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~ 571 (845)
.++|+..+.||+|+||.||+|... +|+.||||++... .....+++.+|++++++++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 468899999999999999999865 6899999998653 445567889999999999999999999999654 5
Q ss_pred cEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccC
Q 003139 572 EMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSK 651 (845)
Q Consensus 572 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~ 651 (845)
..++|+|++ +++|.+++.. ..+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred eEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 689999999 7899998854 469999999999999999999999 999999999999999999999999999998
Q ss_pred CCCCCCCcccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCc--
Q 003139 652 TGPALDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGM-- 728 (845)
Q Consensus 652 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~-- 728 (845)
.... ......||..|+|||.+.+ ..++.++|||||||+++||++|+.||......+.. ...........
T Consensus 181 ~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l---~~i~~~~g~p~~~ 252 (367)
T 2fst_X 181 HTAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL---KLILRLVGTPGAE 252 (367)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCSCCHH
T ss_pred cccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCCHH
Confidence 6332 1344678999999999887 78999999999999999999999999764432211 11111111000
Q ss_pred ---------hhhhhccccC-CCCC-----HHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 729 ---------LDQIMDSNLV-GKVN-----PASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 729 ---------~~~~~d~~l~-~~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
....+..... .... +.....+.+++.+||+.||.+|||+.+++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0001100000 0000 1224568899999999999999999999876
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=351.56 Aligned_cols=254 Identities=12% Similarity=0.034 Sum_probs=184.5
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC---hHhHHHHHHHHHHHHhC--CCCCcceEE-------EEEe
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS---EQGIAEFRTEIEMLSKL--RHRHLVSLI-------GYCD 568 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l--~H~niv~l~-------g~~~ 568 (845)
.+|...+.||+|+||.||+|++. +|+.||||++.... ....+.+.+|+++++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 45788899999999999999976 78999999877643 24456777885545444 699988755 4543
Q ss_pred cC-----------------CcEEEEEEeccCCCccccccCCCCCCCCHHHH------HHHHHHHHHHHHHHhhcCCCcee
Q 003139 569 ER-----------------SEMILVYEYMANGPLRSHLYGTDLPPLSWKQR------LEICIGAARGLHYLHTGAAQSII 625 (845)
Q Consensus 569 ~~-----------------~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~iv 625 (845)
.. ...++||||++ |+|.+++.... ..+.+..+ +.++.||++||+|||+ ++|+
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~iv 216 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQS---KGLV 216 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TTEE
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHH---CCCc
Confidence 33 33899999998 89999996532 23466666 7888999999999999 9999
Q ss_pred eccCCCCcEEECCCCceEEEeccccCCCCCCCCcccccccccCCCcCChhhhcc--CCCCchhHHHHHHHHHHHHHcCCC
Q 003139 626 HRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLMEVLCTRP 703 (845)
Q Consensus 626 HrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~S~Gvvl~Elltg~~ 703 (845)
||||||+||||+.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++|||||||+||||++|+.
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~ 291 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999986432 1114456799999999987 789999999999999999999999
Q ss_pred CCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 704 ALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 704 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
||....+..... ......................+..+.+++.+||+.||++|||+.+++++
T Consensus 292 Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 292 PFGLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp STTBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred CCCCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 997654322110 00000011111111111123456788999999999999999999999864
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=356.30 Aligned_cols=259 Identities=24% Similarity=0.265 Sum_probs=193.8
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecC------CcEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDER------SEMI 574 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~ 574 (845)
.+|+..+.||+|+||.||+|++. +|+.||||++.... +.+.+|+++|++++||||+++++++... ..++
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46888899999999999999986 68999999875432 1234699999999999999999998432 2367
Q ss_pred EEEEeccCCCccccccC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCC-CceEEEeccccC
Q 003139 575 LVYEYMANGPLRSHLYG--TDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDN-FVAKVADFGLSK 651 (845)
Q Consensus 575 lV~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~-~~~kl~DFGla~ 651 (845)
+||||+++ +|.+.+.. .....+++..+..++.||++||+|||+ .+|+||||||+||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999975 55554432 234579999999999999999999998 999999999999999955 678999999998
Q ss_pred CCCCCCCcccccccccCCCcCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchh
Q 003139 652 TGPALDQTHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLD 730 (845)
Q Consensus 652 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (845)
.... ........||+.|+|||++.+. .++.++|||||||+||||++|++||......++ +..... ........
T Consensus 206 ~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~--l~~i~~-~lg~p~~~ 279 (420)
T 1j1b_A 206 QLVR---GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEIIK-VLGTPTRE 279 (420)
T ss_dssp ECCT---TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHH-HHCSCCHH
T ss_pred hccc---CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHH-HhCCCCHH
Confidence 6432 1122345789999999998764 799999999999999999999999976433221 111111 11111111
Q ss_pred hhh--c--------cccCCC-----CCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003139 731 QIM--D--------SNLVGK-----VNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNL 774 (845)
Q Consensus 731 ~~~--d--------~~l~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L 774 (845)
.+. + +.+... +.+.....+.+|+.+||+.||.+||++.|++++-
T Consensus 280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp 338 (420)
T 1j1b_A 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 338 (420)
T ss_dssp HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCH
Confidence 110 0 111000 1223456789999999999999999999998754
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=348.45 Aligned_cols=261 Identities=20% Similarity=0.251 Sum_probs=196.6
Q ss_pred HHhcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecC-------
Q 003139 499 DATNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDER------- 570 (845)
Q Consensus 499 ~at~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------- 570 (845)
...++|...+.||+|+||.||+|+.. +|+.||+|++..... ...+|++++++++||||+++++++...
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 45678999999999999999999874 789999998754422 234699999999999999999998432
Q ss_pred -------------------------------CcEEEEEEeccCCCccccccC--CCCCCCCHHHHHHHHHHHHHHHHHHh
Q 003139 571 -------------------------------SEMILVYEYMANGPLRSHLYG--TDLPPLSWKQRLEICIGAARGLHYLH 617 (845)
Q Consensus 571 -------------------------------~~~~lV~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH 617 (845)
...++||||++ |+|.+.+.. .....+++..+..++.|+++||+|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 34889999998 577776643 23457999999999999999999999
Q ss_pred hcCCCceeeccCCCCcEEEC-CCCceEEEeccccCCCCCCCCcccccccccCCCcCChhhhccC-CCCchhHHHHHHHHH
Q 003139 618 TGAAQSIIHRDVKTTNILLD-DNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVL 695 (845)
Q Consensus 618 ~~~~~~ivHrDik~~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl 695 (845)
+ .+|+||||||+|||++ +++.+||+|||+++.... ........||+.|+|||.+.+. .++.++||||+||++
T Consensus 159 ~---~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 159 S---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIP---SEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp T---TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCT---TSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred H---CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCC---CCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 8 9999999999999998 689999999999986432 2223455789999999998775 589999999999999
Q ss_pred HHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhc----------cccC-----CCCCHHHHHHHHHHHHHhhhhC
Q 003139 696 MEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMD----------SNLV-----GKVNPASLKKFGETAEKCLAEH 760 (845)
Q Consensus 696 ~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d----------~~l~-----~~~~~~~~~~l~~l~~~cl~~~ 760 (845)
|||++|+.||......+. +... ...........+.. +.+. ..++...+..+.+++.+||+.+
T Consensus 233 ~ell~g~~pf~~~~~~~~--~~~i-~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 309 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQ--LVRI-IQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE 309 (383)
T ss_dssp HHHHHSSCSSCCSSHHHH--HHHH-HHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred HHHHhCCCCCCCCChHHH--HHHH-HHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence 999999999976443221 1111 11111111111100 0000 0122334567899999999999
Q ss_pred CCCCCCHHHHHHH
Q 003139 761 GVDRPSMGDVLWN 773 (845)
Q Consensus 761 p~~RPs~~~vl~~ 773 (845)
|.+|||+.|++++
T Consensus 310 P~~R~t~~e~l~h 322 (383)
T 3eb0_A 310 PDLRINPYEAMAH 322 (383)
T ss_dssp GGGSCCHHHHHTS
T ss_pred hhhCCCHHHHhcC
Confidence 9999999999865
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=342.02 Aligned_cols=264 Identities=21% Similarity=0.318 Sum_probs=197.6
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEe------------
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCD------------ 568 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~------------ 568 (845)
++|...+.||+|+||.||+|... +|+.||+|++...+....+++.+|++++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 57888999999999999999987 48999999988777777889999999999999999999999873
Q ss_pred --cCCcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEEC-CCCceEEE
Q 003139 569 --ERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLD-DNFVAKVA 645 (845)
Q Consensus 569 --~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~-~~~~~kl~ 645 (845)
+....++||||++ |+|.+++.. .++++..++.++.|+++||+|||+ .+|+||||||+|||++ +++.+||+
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred ccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeEEEc
Confidence 4467899999997 699998853 468999999999999999999999 8999999999999997 57799999
Q ss_pred eccccCCCCCCCC-cccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHH
Q 003139 646 DFGLSKTGPALDQ-THVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTW 723 (845)
Q Consensus 646 DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~ 723 (845)
|||+++....... ........+|..|+|||.+.+ ..++.++||||||+++|||++|+.||......+.. ......
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~---~~~~~~ 240 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM---QLILES 240 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHH
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHh
Confidence 9999986432111 112234567899999998865 78999999999999999999999999764432211 000000
Q ss_pred hhc----------CchhhhhccccCCC------CCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 724 QKK----------GMLDQIMDSNLVGK------VNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 724 ~~~----------~~~~~~~d~~l~~~------~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
... ..+...+....... ..+.....+.+++.+||+.||++||++.|++++-.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 308 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPY 308 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHH
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcc
Confidence 000 00000000000000 11234567899999999999999999999987643
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=344.20 Aligned_cols=263 Identities=22% Similarity=0.310 Sum_probs=203.0
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecC-----CcE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDER-----SEM 573 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~ 573 (845)
.++|+..+.||+|+||.||+|... +++.||+|++... .....+.+.+|++++++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 467999999999999999999876 6888999998754 344557899999999999999999999999654 468
Q ss_pred EEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCC
Q 003139 574 ILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTG 653 (845)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~ 653 (845)
++||||++ |+|.+++.. ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 106 ~iv~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp EEEEECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 99999997 589888854 359999999999999999999999 89999999999999999999999999999864
Q ss_pred CCCCC-cccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchh-
Q 003139 654 PALDQ-THVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLD- 730 (845)
Q Consensus 654 ~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~- 730 (845)
..... ........||+.|+|||++.+ ..++.++|||||||++|||++|++||......+.. .............
T Consensus 179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~ 255 (364)
T 3qyz_A 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL---NHILGILGSPSQED 255 (364)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHH---HHHHHHHCSCCHHH
T ss_pred CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHH---HHHHHHhCCCCHHH
Confidence 32211 112245679999999998754 55899999999999999999999999765433321 1111111110000
Q ss_pred ----------hhhcccc-CCC-----CCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 731 ----------QIMDSNL-VGK-----VNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 731 ----------~~~d~~l-~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
....... ... ..+.....+.+++.+||+.||++|||+.|++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000 000 012234678899999999999999999999865
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=346.22 Aligned_cols=268 Identities=21% Similarity=0.229 Sum_probs=190.7
Q ss_pred HHHHHhcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCc--
Q 003139 496 EILDATNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSE-- 572 (845)
Q Consensus 496 el~~at~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-- 572 (845)
+.....++|...+.||+|+||.||+|+.. +|+.||||++.... .....+.+|++.++.++||||+++++++...+.
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 44566789999999999999999999985 68999999875432 223456788889999999999999999965443
Q ss_pred -----EEEEEEeccCCCccccccC--CCCCCCCHHHHHHHHHHHHHHHHHHh--hcCCCceeeccCCCCcEEECC-CCce
Q 003139 573 -----MILVYEYMANGPLRSHLYG--TDLPPLSWKQRLEICIGAARGLHYLH--TGAAQSIIHRDVKTTNILLDD-NFVA 642 (845)
Q Consensus 573 -----~~lV~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH--~~~~~~ivHrDik~~NILl~~-~~~~ 642 (845)
.++||||+++ +|...+.. .....+++..+..++.|++.||.||| + ++|+||||||+||||+. ++.+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTTEE
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCCcE
Confidence 7899999986 44433321 23457899999999999999999999 6 89999999999999996 8999
Q ss_pred EEEeccccCCCCCCCCcccccccccCCCcCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHH
Q 003139 643 KVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAM 721 (845)
Q Consensus 643 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~ 721 (845)
||+|||+++.... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||......+. +.....
T Consensus 172 kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~--~~~~~~ 246 (360)
T 3e3p_A 172 KLCDFGSAKKLSP---SEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ--LHEIVR 246 (360)
T ss_dssp EECCCTTCBCCCT---TSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHH
T ss_pred EEeeCCCceecCC---CCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH--HHHHHH
Confidence 9999999986433 2223355789999999998765 489999999999999999999999976443221 111111
Q ss_pred HHhhcCc---hh---------hhhc------cccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003139 722 TWQKKGM---LD---------QIMD------SNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNL 774 (845)
Q Consensus 722 ~~~~~~~---~~---------~~~d------~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L 774 (845)
...... +. ...+ ..............+.+++.+||+.||.+|||+.|++++-
T Consensus 247 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 316 (360)
T 3e3p_A 247 -VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHP 316 (360)
T ss_dssp -HHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSG
T ss_pred -HcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCc
Confidence 100000 00 0000 0001112223567899999999999999999999998653
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=351.34 Aligned_cols=259 Identities=23% Similarity=0.284 Sum_probs=193.9
Q ss_pred cCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCc------EEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSE------MIL 575 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------~~l 575 (845)
.+|...+.||+|+||.||+|++..+..+|+|++..... ...+|++++++++||||+++++++...+. .++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 46888999999999999999988777799998754322 12369999999999999999999955433 789
Q ss_pred EEEeccCCCcccccc-CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEEC-CCCceEEEeccccCCC
Q 003139 576 VYEYMANGPLRSHLY-GTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLD-DNFVAKVADFGLSKTG 653 (845)
Q Consensus 576 V~Ey~~~gsL~~~l~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~-~~~~~kl~DFGla~~~ 653 (845)
||||++++.+..... ......+++..+..++.|+++||+|||+ .+|+||||||+||||+ .++.+||+|||+++..
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 999998754443322 1223579999999999999999999999 8999999999999999 8999999999999864
Q ss_pred CCCCCcccccccccCCCcCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhh
Q 003139 654 PALDQTHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQI 732 (845)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (845)
.. ........||+.|+|||.+.+. .++.++|||||||++|||++|++||......+. +..... .........+
T Consensus 193 ~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--l~~i~~-~~g~p~~~~~ 266 (394)
T 4e7w_A 193 IA---GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ--LVEIIK-VLGTPSREQI 266 (394)
T ss_dssp CT---TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHH-HHCCCCHHHH
T ss_pred cC---CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHH-HhCCCCHHHH
Confidence 32 1223355789999999998765 599999999999999999999999976443221 111111 1110000000
Q ss_pred --hccc-----c---C-----CCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 733 --MDSN-----L---V-----GKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 733 --~d~~-----l---~-----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
+++. + . ..+.......+.+++.+||+.||.+|||+.|++++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0000 0 0 00122345678999999999999999999999865
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=340.22 Aligned_cols=260 Identities=18% Similarity=0.250 Sum_probs=201.9
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCC-----------CCCcceEEEEEec
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLR-----------HRHLVSLIGYCDE 569 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~g~~~~ 569 (845)
++|...+.||+|+||.||+|+.. +++.||||++.. .....+.+.+|++++++++ ||||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 57889999999999999999974 688999999864 3444577889999999886 8999999999876
Q ss_pred CC----cEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-ceeeccCCCCcEEEC------C
Q 003139 570 RS----EMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQ-SIIHRDVKTTNILLD------D 638 (845)
Q Consensus 570 ~~----~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDik~~NILl~------~ 638 (845)
.+ ..++||||+ +++|.+++.......+++..+..++.||+.||+|||+ + +|+||||||+||||+ .
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETTTT
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCCCcC
Confidence 54 789999999 8999999976655679999999999999999999999 7 999999999999994 4
Q ss_pred CCceEEEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHH
Q 003139 639 NFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAE 718 (845)
Q Consensus 639 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~ 718 (845)
.+.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.............
T Consensus 174 ~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 248 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 248 (373)
T ss_dssp EEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred cceEEEcccccccccCC-----CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence 55899999999976332 1234578999999999999999999999999999999999999997544321111111
Q ss_pred HHHHH---hhc--------Cc----------------------hhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCC
Q 003139 719 WAMTW---QKK--------GM----------------------LDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRP 765 (845)
Q Consensus 719 ~~~~~---~~~--------~~----------------------~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP 765 (845)
..... ... +. +..++.. ...++......+.+++.+||+.||++||
T Consensus 249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTE--KYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHH--TTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhh--cccCCcchHHHHHHHHHHHhccCccccC
Confidence 11110 000 00 0011111 1124567788999999999999999999
Q ss_pred CHHHHHHH
Q 003139 766 SMGDVLWN 773 (845)
Q Consensus 766 s~~~vl~~ 773 (845)
|+.|++++
T Consensus 327 t~~ell~h 334 (373)
T 1q8y_A 327 DAGGLVNH 334 (373)
T ss_dssp CHHHHHTC
T ss_pred CHHHHhhC
Confidence 99999875
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=339.89 Aligned_cols=201 Identities=25% Similarity=0.300 Sum_probs=173.5
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCC-CC-----CcceEEEEEecCCcE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLR-HR-----HLVSLIGYCDERSEM 573 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~l~g~~~~~~~~ 573 (845)
.++|+..+.||+|+||.||+|... +++.||||++... ....+++..|+++++.++ |+ +|+++++++...+..
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 131 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence 578999999999999999999976 6788999998743 444577888999998885 55 499999999999999
Q ss_pred EEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEEC--CCCceEEEeccccC
Q 003139 574 ILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLD--DNFVAKVADFGLSK 651 (845)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~--~~~~~kl~DFGla~ 651 (845)
++||||++ ++|.+++.......+++..+..++.|++.||.|||.+ ..+|+||||||+||||+ .++.+||+|||+++
T Consensus 132 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~ 209 (382)
T 2vx3_A 132 CLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC 209 (382)
T ss_dssp EEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCce
Confidence 99999996 5999999776656799999999999999999999952 27899999999999994 57889999999997
Q ss_pred CCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 003139 652 TGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVL 709 (845)
Q Consensus 652 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~ 709 (845)
.... ......||+.|+|||++.+..++.++|||||||++|||++|++||....
T Consensus 210 ~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 210 QLGQ-----RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp ETTC-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eccc-----ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 6432 1234678999999999999999999999999999999999999997644
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=344.51 Aligned_cols=258 Identities=23% Similarity=0.371 Sum_probs=200.1
Q ss_pred hcCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYE 578 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 578 (845)
.++|+..+.||+|+||.||+|+..+ .+|+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 109 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence 4678889999999999999998863 4899987643 23334567889999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC-
Q 003139 579 YMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD- 657 (845)
Q Consensus 579 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~- 657 (845)
|+++++|.+++... ...+++.+++.++.|++.||+|||+ .+|+||||||+|||++ ++.+||+|||+++......
T Consensus 110 ~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~ 184 (319)
T 2y4i_B 110 LCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQA 184 (319)
T ss_dssp CCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC-------
T ss_pred cccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCccccccccc
Confidence 99999999999654 3468999999999999999999999 8999999999999998 6799999999987543211
Q ss_pred --CcccccccccCCCcCChhhhcc---------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhc
Q 003139 658 --QTHVSTAVKGSFGYLDPEYFRR---------QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKK 726 (845)
Q Consensus 658 --~~~~~~~~~gt~~y~aPE~~~~---------~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 726 (845)
.........|++.|+|||.+.+ ..++.++||||||+++|||++|+.||....... .... ...
T Consensus 185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~-~~~ 257 (319)
T 2y4i_B 185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA------IIWQ-MGT 257 (319)
T ss_dssp ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH------HHHH-HHT
T ss_pred cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHH-hcc
Confidence 1122234568999999999874 457999999999999999999999986533211 1111 111
Q ss_pred CchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhh
Q 003139 727 GMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQL 780 (845)
Q Consensus 727 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~ 780 (845)
+. .+.+ .....+..+.+++.+||+.+|++|||+.++++.|+.+.+.
T Consensus 258 ~~-----~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 258 GM-----KPNL---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp TC-----CCCC---CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred CC-----CCCC---CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 11 1111 1112345688999999999999999999999999987653
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=339.76 Aligned_cols=256 Identities=20% Similarity=0.291 Sum_probs=198.0
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCc------
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSE------ 572 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------ 572 (845)
++|...+.||+|+||.||+|... +|+.||||++... .....+++.+|+.++++++||||+++++++...+.
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 57888899999999999999975 6899999987653 34456788999999999999999999999977654
Q ss_pred EEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCC
Q 003139 573 MILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKT 652 (845)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~ 652 (845)
.++||||++ ++|.+++. ..+++.++..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++.
T Consensus 104 ~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARH 175 (353)
T ss_dssp CEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred EEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence 499999997 68888773 248999999999999999999999 8999999999999999999999999999976
Q ss_pred CCCCCCcccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcC----
Q 003139 653 GPALDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKG---- 727 (845)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~---- 727 (845)
... ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+. ...........
T Consensus 176 ~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~ 247 (353)
T 3coi_A 176 ADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQILKVTGVPGTEF 247 (353)
T ss_dssp -------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH---HHHHHHHHCBCCHHH
T ss_pred CCC-----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHHH
Confidence 322 1234578999999999887 6889999999999999999999999975432211 11111100000
Q ss_pred -------chhhhhc---ccc---CCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 728 -------MLDQIMD---SNL---VGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 728 -------~~~~~~d---~~l---~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.....+. ... .....+.....+.+++.+||+.||++|||+.+++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 248 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000000 000 011223456788999999999999999999999865
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=331.16 Aligned_cols=251 Identities=26% Similarity=0.340 Sum_probs=201.2
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
.++|++.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|++++++++||||+++++++.+.+..++|+
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 467999999999999999999976 6899999986533 2334678899999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCC---CceEEEeccccCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDN---FVAKVADFGLSKTGP 654 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~---~~~kl~DFGla~~~~ 654 (845)
||+++++|.+++... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||++.+ +.+||+|||+++...
T Consensus 101 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 101 ELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp CCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 999999998888543 368999999999999999999999 899999999999999754 479999999997633
Q ss_pred CCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhc
Q 003139 655 ALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMD 734 (845)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (845)
.. .......|++.|+|||.+.+ .++.++||||||+++|||++|+.||......+ .... ...+.... +
T Consensus 176 ~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~-~~~~~~~~--~ 242 (287)
T 2wei_A 176 QN---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD------ILKR-VETGKYAF--D 242 (287)
T ss_dssp CC---SSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHH-HHHCCCCC--C
T ss_pred CC---CccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH------HHHH-HHcCCCCC--C
Confidence 21 12233458889999999876 48999999999999999999999986543211 1111 11111000 0
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 735 SNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 735 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
. ......+..+.+++.+||+.+|++|||+.++++.
T Consensus 243 --~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 243 --L--PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp --S--GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred --c--hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 0 0012335678899999999999999999999875
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=332.64 Aligned_cols=253 Identities=23% Similarity=0.370 Sum_probs=194.7
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEec----------
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDE---------- 569 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~---------- 569 (845)
.++|+..+.||+|+||.||+|+.. +|+.||+|++.. .....+.+.+|++++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 457889999999999999999975 789999998753 34556789999999999999999999998854
Q ss_pred ---CCcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEe
Q 003139 570 ---RSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVAD 646 (845)
Q Consensus 570 ---~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~D 646 (845)
.+..++||||+++|+|.+++.... ..+++.+++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEee
Confidence 456899999999999999996532 467889999999999999999999 8999999999999999999999999
Q ss_pred ccccCCCCCCC------------CcccccccccCCCcCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCccc
Q 003139 647 FGLSKTGPALD------------QTHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQ 713 (845)
Q Consensus 647 FGla~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~ 713 (845)
||+++...... .........||+.|+|||.+.+. .++.++|||||||++|||++ |+...
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~----- 231 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG----- 231 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH-----
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc-----
Confidence 99997643211 01122345689999999999864 78999999999999999998 33211
Q ss_pred ccHHHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 714 VNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 714 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
....+..... .. ....+....+...+..+.+++.+||+.||.+|||+.+++++
T Consensus 232 ~~~~~~~~~~-~~------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 232 MERVNILKKL-RS------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHHHHHH-HS------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred hhHHHHHHhc-cc------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 0111111111 11 01112223344556678899999999999999999999865
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=337.43 Aligned_cols=253 Identities=23% Similarity=0.290 Sum_probs=181.2
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC-ChHhHHHHHHHHH-HHHhCCCCCcceEEEEEecCCcEEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR-SEQGIAEFRTEIE-MLSKLRHRHLVSLIGYCDERSEMILVYE 578 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~E 578 (845)
++|...+.||+|+||.||+|... +|+.||||++... ......++..|+. +++.++||||+++++++.+.+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 57888889999999999999985 6899999987654 3444556666766 6777899999999999999999999999
Q ss_pred eccCCCccccccC---CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-ceeeccCCCCcEEECCCCceEEEeccccCCCC
Q 003139 579 YMANGPLRSHLYG---TDLPPLSWKQRLEICIGAARGLHYLHTGAAQ-SIIHRDVKTTNILLDDNFVAKVADFGLSKTGP 654 (845)
Q Consensus 579 y~~~gsL~~~l~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDik~~NILl~~~~~~kl~DFGla~~~~ 654 (845)
|+++ +|.+++.. .....+++..+..++.|++.||.|||+ . +|+||||||+|||++.++.+||+|||+++...
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 9975 77776642 224579999999999999999999998 7 99999999999999999999999999997643
Q ss_pred CCCCcccccccccCCCcCChhhh----ccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchh
Q 003139 655 ALDQTHVSTAVKGSFGYLDPEYF----RRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLD 730 (845)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (845)
. ........||+.|+|||.+ .+..++.++||||||+++|||++|+.||........ .+.
T Consensus 178 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--------------~~~ 240 (327)
T 3aln_A 178 D---SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD--------------QLT 240 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------------------C
T ss_pred c---ccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH--------------HHH
Confidence 2 1222344789999999998 566789999999999999999999999965322110 011
Q ss_pred hhhc---cccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003139 731 QIMD---SNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775 (845)
Q Consensus 731 ~~~d---~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~ 775 (845)
.+.. +.+...........+.+++.+||+.||++||++.++++.-.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~ 288 (327)
T 3aln_A 241 QVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPF 288 (327)
T ss_dssp CCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHH
T ss_pred HHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChH
Confidence 1111 11111122345567899999999999999999999987543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=338.39 Aligned_cols=258 Identities=19% Similarity=0.263 Sum_probs=202.3
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CC-cEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCC------cceEEEEEecCCcE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DG-TKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRH------LVSLIGYCDERSEM 573 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~g~~~~~~~~ 573 (845)
++|++.+.||+|+||.||+|... ++ +.||+|++... ....+.+.+|++++++++|++ ++.+.+++...+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 67899999999999999999975 34 68999998643 445577889999999997766 99999999999999
Q ss_pred EEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEE-----------------
Q 003139 574 ILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILL----------------- 636 (845)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl----------------- 636 (845)
++||||+ +++|.+++.......+++.+++.++.||+.||+|||+ ++|+||||||+|||+
T Consensus 98 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~ 173 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEE 173 (355)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred EEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecccccccccccccccc
Confidence 9999999 6677777765555679999999999999999999998 899999999999999
Q ss_pred --CCCCceEEEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccc
Q 003139 637 --DDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQV 714 (845)
Q Consensus 637 --~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~ 714 (845)
+.++.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+..
T Consensus 174 ~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 248 (355)
T 2eu9_A 174 KSVKNTSIRVADFGSATFDHE-----HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL 248 (355)
T ss_dssp EEESCCCEEECCCTTCEETTS-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred cccCCCcEEEeecCccccccc-----cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 5688999999999976322 123457899999999999999999999999999999999999999754432211
Q ss_pred cHHHHHHHHhhcCchhhhh------------------------------ccc-cCCCCCHHHHHHHHHHHHHhhhhCCCC
Q 003139 715 NIAEWAMTWQKKGMLDQIM------------------------------DSN-LVGKVNPASLKKFGETAEKCLAEHGVD 763 (845)
Q Consensus 715 ~l~~~~~~~~~~~~~~~~~------------------------------d~~-l~~~~~~~~~~~l~~l~~~cl~~~p~~ 763 (845)
. ........ ....+. .+. ............+.+++.+||+.||++
T Consensus 249 ~---~~~~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 324 (355)
T 2eu9_A 249 V---MMEKILGP-IPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324 (355)
T ss_dssp H---HHHHHHCC-CCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred H---HHHHHcCC-CcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence 1 11111100 000000 000 000112344668899999999999999
Q ss_pred CCCHHHHHHH
Q 003139 764 RPSMGDVLWN 773 (845)
Q Consensus 764 RPs~~~vl~~ 773 (845)
|||+.|++++
T Consensus 325 Rpt~~e~l~h 334 (355)
T 2eu9_A 325 RITLAEALLH 334 (355)
T ss_dssp SCCHHHHTTS
T ss_pred CcCHHHHhcC
Confidence 9999999865
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=344.58 Aligned_cols=258 Identities=21% Similarity=0.287 Sum_probs=198.3
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcE----
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEM---- 573 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~---- 573 (845)
.++|...+.||+|+||.||+|... +|+.||+|++... .....+++.+|+.++++++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 467888999999999999999875 6899999988653 444567889999999999999999999999877655
Q ss_pred --EEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccC
Q 003139 574 --ILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSK 651 (845)
Q Consensus 574 --~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~ 651 (845)
++||||++ ++|.+++. ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLAR 192 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred eEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence 99999997 68877763 348999999999999999999999 899999999999999999999999999997
Q ss_pred CCCCCCCcccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcC---
Q 003139 652 TGPALDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKG--- 727 (845)
Q Consensus 652 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~--- 727 (845)
.... ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+.. ..........
T Consensus 193 ~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~ 264 (371)
T 4exu_A 193 HADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL---TQILKVTGVPGTE 264 (371)
T ss_dssp ------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCHH
T ss_pred cccc-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCcHH
Confidence 6322 1234578999999999987 78999999999999999999999999754322211 1110000000
Q ss_pred --------chhhhhccccC---C---CCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003139 728 --------MLDQIMDSNLV---G---KVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNL 774 (845)
Q Consensus 728 --------~~~~~~d~~l~---~---~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L 774 (845)
........... . ...+.....+.+++.+||+.||++|||+.|++++-
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 325 (371)
T 4exu_A 265 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP 325 (371)
T ss_dssp HHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred HHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCc
Confidence 00000000000 0 00122356789999999999999999999998653
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=341.42 Aligned_cols=263 Identities=23% Similarity=0.281 Sum_probs=200.5
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecC-----CcE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDER-----SEM 573 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~ 573 (845)
.++|...+.||+|+||.||+|+.. +|+.||||++... ......++.+|++++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 467888999999999999999976 6889999998654 344567788999999999999999999998654 678
Q ss_pred EEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCC
Q 003139 574 ILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTG 653 (845)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~ 653 (845)
++||||++ ++|.+++.. ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 90 ~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp EEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 99999997 689888854 368999999999999999999999 89999999999999999999999999999764
Q ss_pred CCCCCcc--------cccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHh
Q 003139 654 PALDQTH--------VSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQ 724 (845)
Q Consensus 654 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~ 724 (845)
....... ......||+.|+|||++.+ ..++.++|||||||++|||++|++||......+.. .......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~ 239 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQL---LLIFGII 239 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHH
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH---HHHHHHh
Confidence 3211110 1223578999999998764 78999999999999999999999999754322211 0011110
Q ss_pred hcCc------------hhhhhccccC-C-----CCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 725 KKGM------------LDQIMDSNLV-G-----KVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 725 ~~~~------------~~~~~d~~l~-~-----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.... ..+....... . ...+.....+.+++.+||+.||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000 0000000000 0 0012345678899999999999999999999865
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=347.84 Aligned_cols=266 Identities=21% Similarity=0.261 Sum_probs=181.7
Q ss_pred CCc-ceeeeeeceEEEEEEEEc---CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEe--cCCcEEEEE
Q 003139 504 FDE-SLLLGVGGFGRVYKGTLD---DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCD--ERSEMILVY 577 (845)
Q Consensus 504 f~~-~~~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~~~lV~ 577 (845)
|+. .++||+|+||.||+|++. +++.||+|++..... .+.+.+|+++|++++||||+++++++. .....++||
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 444 457999999999999975 578899999875432 246789999999999999999999994 467899999
Q ss_pred EeccCCCccccccC-------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEE----CCCCceEEEe
Q 003139 578 EYMANGPLRSHLYG-------TDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILL----DDNFVAKVAD 646 (845)
Q Consensus 578 Ey~~~gsL~~~l~~-------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl----~~~~~~kl~D 646 (845)
||++ ++|.+++.. .....+++..++.|+.||+.||+|||+ .+|+||||||+|||| +.++.+||+|
T Consensus 100 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 100 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp ECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred eCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 9996 577776642 122359999999999999999999999 899999999999999 7789999999
Q ss_pred ccccCCCCCCCC-cccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCccc------ccHHH
Q 003139 647 FGLSKTGPALDQ-THVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQ------VNIAE 718 (845)
Q Consensus 647 FGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~------~~l~~ 718 (845)
||+++....... ........||+.|+|||++.+ ..++.++|||||||+||||++|++||........ .....
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~ 255 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence 999986432111 122345678999999999987 4599999999999999999999999975433110 00111
Q ss_pred HHHHHhhcCc---hhhh---------h---ccccCCC---------CCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003139 719 WAMTWQKKGM---LDQI---------M---DSNLVGK---------VNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNL 774 (845)
Q Consensus 719 ~~~~~~~~~~---~~~~---------~---d~~l~~~---------~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L 774 (845)
.......... ...+ . ....... ........+.+|+.+||+.||.+|||+.|++++-
T Consensus 256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp 335 (405)
T 3rgf_A 256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP 335 (405)
T ss_dssp HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 1111100000 0000 0 0000000 0001134678999999999999999999998764
Q ss_pred H
Q 003139 775 E 775 (845)
Q Consensus 775 ~ 775 (845)
.
T Consensus 336 ~ 336 (405)
T 3rgf_A 336 Y 336 (405)
T ss_dssp G
T ss_pred h
Confidence 3
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=337.22 Aligned_cols=256 Identities=19% Similarity=0.275 Sum_probs=176.5
Q ss_pred hcCCCcc-eeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEec----CCcEE
Q 003139 501 TNKFDES-LLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDE----RSEMI 574 (845)
Q Consensus 501 t~~f~~~-~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~ 574 (845)
.++|.+. ++||+|+||.||+|... +|+.||+|++... .... .+....++.++||||+++++++.. ....+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~---~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-PKAR---QEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-HHHH---HHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-HHHH---HHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 4578874 46999999999999987 6899999998643 2222 223334567799999999999865 45589
Q ss_pred EEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECC---CCceEEEeccccC
Q 003139 575 LVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDD---NFVAKVADFGLSK 651 (845)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~---~~~~kl~DFGla~ 651 (845)
+||||+++|+|.+++.......+++.+++.++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++
T Consensus 103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 99999999999999987655679999999999999999999999 89999999999999986 4559999999997
Q ss_pred CCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhh
Q 003139 652 TGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQ 731 (845)
Q Consensus 652 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (845)
.... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... . .......+
T Consensus 180 ~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~-~~~~~~~~---- 248 (336)
T 3fhr_A 180 ETTQ----NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP--G-MKRRIRLG---- 248 (336)
T ss_dssp EC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------------
T ss_pred eccc----cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh--h-HHHhhhcc----
Confidence 6332 12234578999999999999999999999999999999999999996543322100 0 00000000
Q ss_pred hhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003139 732 IMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEY 776 (845)
Q Consensus 732 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~ 776 (845)
...............+.+++.+||+.||.+|||+.|++++-..
T Consensus 249 --~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 291 (336)
T 3fhr_A 249 --QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWI 291 (336)
T ss_dssp ----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHH
T ss_pred --ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccc
Confidence 0001111113445678899999999999999999999986543
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=333.66 Aligned_cols=243 Identities=24% Similarity=0.386 Sum_probs=192.4
Q ss_pred HHhcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCCh------HhHHHHHHHHHHHHhC----CCCCcceEEEEE
Q 003139 499 DATNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSE------QGIAEFRTEIEMLSKL----RHRHLVSLIGYC 567 (845)
Q Consensus 499 ~at~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~H~niv~l~g~~ 567 (845)
...++|...+.||+|+||.||+|+.. +++.||+|++..... .....+.+|+.++.++ +||||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 34578999999999999999999864 688999999865432 1233466799999998 899999999999
Q ss_pred ecCCcEEEEEEe-ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEEC-CCCceEEE
Q 003139 568 DERSEMILVYEY-MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLD-DNFVAKVA 645 (845)
Q Consensus 568 ~~~~~~~lV~Ey-~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~-~~~~~kl~ 645 (845)
.+.+..++|+|| +++++|.+++... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||++ +++.+||+
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~ 182 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLI 182 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEEEEC
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeEEEE
Confidence 999999999999 7899999998653 369999999999999999999999 8999999999999999 88999999
Q ss_pred eccccCCCCCCCCcccccccccCCCcCChhhhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHh
Q 003139 646 DFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLT-EKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQ 724 (845)
Q Consensus 646 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~ 724 (845)
|||+++.... .......|+..|+|||++.+..+. .++||||||+++|||++|+.||....
T Consensus 183 dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------------- 243 (312)
T 2iwi_A 183 DFGSGALLHD----EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--------------- 243 (312)
T ss_dssp CCSSCEECCS----SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------------
T ss_pred Ecchhhhccc----CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH---------------
Confidence 9999986432 123345689999999999877764 59999999999999999999985310
Q ss_pred hcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 725 KKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 725 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
++.+... .++......+.+++.+||+.+|++||++.|++++
T Consensus 244 ------~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 244 ------EILEAEL--HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ------HHHHTCC--CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ------HHhhhcc--CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111111 1233445678899999999999999999999865
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=331.17 Aligned_cols=253 Identities=21% Similarity=0.274 Sum_probs=180.8
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC-hHh-HHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS-EQG-IAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
.++|+..+.||+|+||.||+|... +|+.||||++.... ... .+.+.++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 357888899999999999999986 68999999876543 222 334445556788889999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-ceeeccCCCCcEEECCCCceEEEeccccCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQ-SIIHRDVKTTNILLDDNFVAKVADFGLSKTGPAL 656 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~ 656 (845)
||+ ++.+..++ ......+++..++.++.|+++||+|||+ . +|+||||||+|||++.++.+||+|||+++....
T Consensus 104 e~~-~~~~~~l~-~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~- 177 (318)
T 2dyl_A 104 ELM-GTCAEKLK-KRMQGPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD- 177 (318)
T ss_dssp CCC-SEEHHHHH-HHHTSCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecc-CCcHHHHH-HHhccCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC-
Confidence 999 44444433 3323578999999999999999999998 5 899999999999999999999999999976332
Q ss_pred CCcccccccccCCCcCChhhhc-----cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhh
Q 003139 657 DQTHVSTAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQ 731 (845)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (845)
........||+.|+|||.+. ...++.++||||||+++|||++|+.||....... +..........
T Consensus 178 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~~~~--- 247 (318)
T 2dyl_A 178 --DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF-----EVLTKVLQEEP--- 247 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----HHHHHHHHSCC---
T ss_pred --CccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH-----HHHHHHhccCC---
Confidence 12233457899999999994 5678999999999999999999999996532211 11111111100
Q ss_pred hhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003139 732 IMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNL 774 (845)
Q Consensus 732 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L 774 (845)
+.+ ......+..+.+++.+||+.||.+||++.+++++-
T Consensus 248 ---~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~ 285 (318)
T 2dyl_A 248 ---PLL--PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHS 285 (318)
T ss_dssp ---CCC--CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred ---CCC--CccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCH
Confidence 001 01123456788999999999999999999998753
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=344.54 Aligned_cols=251 Identities=21% Similarity=0.271 Sum_probs=187.9
Q ss_pred CCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcEEEEEEecc
Q 003139 503 KFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERSEMILVYEYMA 581 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~ 581 (845)
.|...++||+|+||+||.+...+|+.||||++... ..+.+.+|++++.++ +||||+++++++.+.+..++||||++
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 34456789999999998776667999999987543 235678899999886 89999999999999999999999995
Q ss_pred CCCccccccCCCCCC-----CCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCC-------------CceE
Q 003139 582 NGPLRSHLYGTDLPP-----LSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDN-------------FVAK 643 (845)
Q Consensus 582 ~gsL~~~l~~~~~~~-----l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~-------------~~~k 643 (845)
|+|.+++....... .++..++.++.||+.||+|||+ .+|+||||||+||||+.+ +.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 69999986543211 2344668899999999999999 899999999999999654 5899
Q ss_pred EEeccccCCCCCCCCc--ccccccccCCCcCChhhhcc-------CCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCccc
Q 003139 644 VADFGLSKTGPALDQT--HVSTAVKGSFGYLDPEYFRR-------QQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQ 713 (845)
Q Consensus 644 l~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~ 713 (845)
|+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||......+.
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~ 248 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES 248 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH
Confidence 9999999874432111 11234679999999999976 678999999999999999999 8999865432211
Q ss_pred ccHHHHHHHHhhcCchhhhhc-cccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 714 VNIAEWAMTWQKKGMLDQIMD-SNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 714 ~~l~~~~~~~~~~~~~~~~~d-~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
... . ...+ +.+...........+.+++.+||+.||.+|||+.+++++
T Consensus 249 ----~i~----~-----~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 249 ----NII----R-----GIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp ----HHH----H-----TCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----HHh----c-----CCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 111 0 0000 111111235667889999999999999999999999863
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=335.52 Aligned_cols=244 Identities=23% Similarity=0.349 Sum_probs=198.8
Q ss_pred HHHhcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCCh------HhHHHHHHHHHHHHhCC--CCCcceEEEEEe
Q 003139 498 LDATNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSE------QGIAEFRTEIEMLSKLR--HRHLVSLIGYCD 568 (845)
Q Consensus 498 ~~at~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--H~niv~l~g~~~ 568 (845)
....++|+..+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++++++ |+||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 334578999999999999999999864 688999998654321 12245678999999996 599999999999
Q ss_pred cCCcEEEEEEeccC-CCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEEC-CCCceEEEe
Q 003139 569 ERSEMILVYEYMAN-GPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLD-DNFVAKVAD 646 (845)
Q Consensus 569 ~~~~~~lV~Ey~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~-~~~~~kl~D 646 (845)
+.+..++|+|++.+ ++|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+|||++ +++.+||+|
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECC
T ss_pred cCCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEEee
Confidence 99999999999976 8999988643 468999999999999999999999 9999999999999999 789999999
Q ss_pred ccccCCCCCCCCcccccccccCCCcCChhhhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhh
Q 003139 647 FGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQK 725 (845)
Q Consensus 647 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~ 725 (845)
||+++.... .......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.... .
T Consensus 194 fg~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--------~------- 254 (320)
T 3a99_A 194 FGSGALLKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------E------- 254 (320)
T ss_dssp CTTCEECCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------H-------
T ss_pred Ccccccccc----ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--------h-------
Confidence 999986432 12234568999999999987766 688999999999999999999985311 0
Q ss_pred cCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 726 KGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 726 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
+..... ..+...+..+.+++.+||+.+|++||++.++++.
T Consensus 255 ------~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 255 ------IIRGQV--FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp ------HHHCCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ------hhcccc--cccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 1223345678899999999999999999999875
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=341.77 Aligned_cols=251 Identities=25% Similarity=0.285 Sum_probs=188.8
Q ss_pred hcCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcEEEEEEe
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
..+|...++||+|+||+|+.....+|+.||||++..... +.+.+|+++++++ +||||+++++++.+.+..++||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 346888889999999997655556789999999865432 2356799999999 799999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECC-----CCceEEEeccccCCCC
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDD-----NFVAKVADFGLSKTGP 654 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~-----~~~~kl~DFGla~~~~ 654 (845)
++ |+|.+++.... ..+.+.+++.++.||++||+|||+ .+|+||||||+||||+. ...+||+|||+++...
T Consensus 100 ~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 100 CA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp CS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred CC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 96 69999987554 345566778999999999999999 89999999999999943 3468899999998644
Q ss_pred CCCC-cccccccccCCCcCChhhhc---cCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCch
Q 003139 655 ALDQ-THVSTAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGML 729 (845)
Q Consensus 655 ~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 729 (845)
.... ........||+.|+|||++. ...++.++|||||||++|||++ |+.||....... ..........
T Consensus 175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-------~~~~~~~~~~ 247 (432)
T 3p23_A 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-------ANILLGACSL 247 (432)
T ss_dssp -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-------HHHHTTCCCC
T ss_pred CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-------HHHHhccCCc
Confidence 3211 12234567999999999997 4678889999999999999999 888885432211 0111111000
Q ss_pred hhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 730 DQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 730 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
. ...........+.+++.+||+.||.+|||+.+++++
T Consensus 248 ~-------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 248 D-------CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp T-------TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred c-------ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 0 001123445668899999999999999999999843
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=355.13 Aligned_cols=240 Identities=19% Similarity=0.290 Sum_probs=196.2
Q ss_pred cCCCcceeeeeeceEEEEEEEEc--CCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCc-----E
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD--DGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSE-----M 573 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~--~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-----~ 573 (845)
++|++.+.||+|+||.||+|.+. +|+.||||++... .....+.+.+|++++++++||||+++++++...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 68999999999999999999975 5899999988654 44556788999999999999999999999987665 7
Q ss_pred EEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCC
Q 003139 574 ILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTG 653 (845)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~ 653 (845)
+|||||+++++|.+++.. .++|.+++.|+.||++||+|||+ ++|+||||||+||||+++ .+||+|||+++..
T Consensus 160 ~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp EEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred EEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence 999999999999988743 69999999999999999999999 899999999999999986 9999999999864
Q ss_pred CCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhh
Q 003139 654 PALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIM 733 (845)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (845)
... ....||+.|+|||++.++. +.++|||||||+|+||++|.+|+........
T Consensus 232 ~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~-------------------- 284 (681)
T 2pzi_A 232 NSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL-------------------- 284 (681)
T ss_dssp TCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC--------------------
T ss_pred ccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc--------------------
Confidence 321 3467999999999998765 8999999999999999999988753211100
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhhhhCCCCCC-CHHHHHHHHHHhhh
Q 003139 734 DSNLVGKVNPASLKKFGETAEKCLAEHGVDRP-SMGDVLWNLEYALQ 779 (845)
Q Consensus 734 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~~vl~~L~~~~~ 779 (845)
............+.+++.+||+.||++|| +++++.+.|...+.
T Consensus 285 ---~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 285 ---PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp ---CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred ---cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 00001112346788999999999999999 56777777776653
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=354.01 Aligned_cols=269 Identities=25% Similarity=0.339 Sum_probs=207.3
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEec------CCcE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDE------RSEM 573 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~~~ 573 (845)
++|+..+.||+|+||.||+|... +|+.||||++... .....+.+.+|++++++++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 67999999999999999999875 6899999987654 45567789999999999999999999999865 6778
Q ss_pred EEEEEeccCCCccccccCCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCc---eEEEeccc
Q 003139 574 ILVYEYMANGPLRSHLYGTD-LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFV---AKVADFGL 649 (845)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~---~kl~DFGl 649 (845)
++||||+++|+|.+++.... ...+++..++.|+.|++.||+|||+ .+|+||||||+|||++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 99999999999999997543 3469999999999999999999999 89999999999999997664 99999999
Q ss_pred cCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCch
Q 003139 650 SKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGML 729 (845)
Q Consensus 650 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 729 (845)
++.... ........||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ..|..........
T Consensus 171 a~~~~~---~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i~~~~~~ 242 (676)
T 3qa8_A 171 AKELDQ---GELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKVREKSNE 242 (676)
T ss_dssp CCBTTS---CCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTCC-----
T ss_pred cccccc---ccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhhhcccch
Confidence 987432 22234567999999999999999999999999999999999999999653211 1111111110000
Q ss_pred hhhhccc------------cCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHH-----HHHHHHHhhhhh
Q 003139 730 DQIMDSN------------LVGKVNPASLKKFGETAEKCLAEHGVDRPSMGD-----VLWNLEYALQLE 781 (845)
Q Consensus 730 ~~~~d~~------------l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~-----vl~~L~~~~~~~ 781 (845)
....... .........+..+.+++.+||..||++|||+.+ +.+.++.+++..
T Consensus 243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k 311 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311 (676)
T ss_dssp -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence 0011100 111234567889999999999999999999988 556677666543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=316.61 Aligned_cols=231 Identities=13% Similarity=0.097 Sum_probs=186.3
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC---hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS---EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
++|++.+.||+|+||.||+|+.. +|+.||||.+.... ....++|.+|+.++++++||||+++++++.+.+..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 57888999999999999999986 48999999987542 445678999999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
||+++++|.+++... ....++.+|+.|++.||+|||+ ++|+||||||+||||++++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~--------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA--------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred EecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc---------
Confidence 999999999998432 3556789999999999999999 999999999999999999999998443
Q ss_pred CcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcccc
Q 003139 658 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNL 737 (845)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (845)
|++ +++.++|||||||++|||++|+.||......+.... ....+....
T Consensus 175 -------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~------------~~~~~~~~~ 222 (286)
T 3uqc_A 175 -------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP------------AERDTAGQP 222 (286)
T ss_dssp -------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE------------CCBCTTSCB
T ss_pred -------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH------------HHHHhccCC
Confidence 333 378999999999999999999999976544321100 000000000
Q ss_pred --CCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhhh
Q 003139 738 --VGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLE 781 (845)
Q Consensus 738 --~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~ 781 (845)
........+..+.+++.+||+.||++| |+.|+++.|+.+....
T Consensus 223 ~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 223 IEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp CCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred CChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 001122345678999999999999999 9999999999886543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=336.32 Aligned_cols=242 Identities=17% Similarity=0.154 Sum_probs=182.6
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC---hHhHHHHHHHHHHHHhCCC-CCcc----------e---
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS---EQGIAEFRTEIEMLSKLRH-RHLV----------S--- 562 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H-~niv----------~--- 562 (845)
+.+|...++||+|+||.||+|++. +|+.||||++.... ....+.|.+|+.+++.++| +|.. .
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 345677789999999999999965 78999999877432 2336789999999999987 2211 1
Q ss_pred --------EEEEEec-----CCcEEEEEEeccCCCcccccc-----CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCce
Q 003139 563 --------LIGYCDE-----RSEMILVYEYMANGPLRSHLY-----GTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSI 624 (845)
Q Consensus 563 --------l~g~~~~-----~~~~~lV~Ey~~~gsL~~~l~-----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 624 (845)
+..++.. ....+++|+++ +++|.+++. ......+++..++.|+.|+++||+|||+ ++|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCc
Confidence 1111111 22457777765 689998884 2334568899999999999999999999 999
Q ss_pred eeccCCCCcEEECCCCceEEEeccccCCCCCCCCcccccccccCCCcCChhhh----------ccCCCCchhHHHHHHHH
Q 003139 625 IHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYF----------RRQQLTEKSDVYSFGVV 694 (845)
Q Consensus 625 vHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~ksDV~S~Gvv 694 (845)
+||||||+||||+.++.+||+|||+++.... ......| +.|+|||++ .+..++.++|||||||+
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTE-----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCC-----ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 9999999999999999999999999876322 1344567 999999999 55668899999999999
Q ss_pred HHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 695 LMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 695 l~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
+|||++|+.||......+ ....++... ...+..+.+++.+||+.+|++||++.++++.
T Consensus 307 l~elltg~~Pf~~~~~~~---------------~~~~~~~~~------~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALG---------------GSEWIFRSC------KNIPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHHHHHSSCCCCTTGGGS---------------CSGGGGSSC------CCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHHCCCCCCCcchhh---------------hHHHHHhhc------ccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 999999999996543222 111121111 1234678899999999999999999888654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=311.28 Aligned_cols=230 Identities=22% Similarity=0.341 Sum_probs=181.4
Q ss_pred cCCCcc-eeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHH-HhCCCCCcceEEEEEec----CCcEE
Q 003139 502 NKFDES-LLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEML-SKLRHRHLVSLIGYCDE----RSEMI 574 (845)
Q Consensus 502 ~~f~~~-~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~g~~~~----~~~~~ 574 (845)
++|... ++||+|+||.||+|... +++.||+|++... ..+.+|++++ +.++||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 456665 68999999999999975 6899999998542 4567888888 56699999999999876 67789
Q ss_pred EEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECC---CCceEEEeccccC
Q 003139 575 LVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDD---NFVAKVADFGLSK 651 (845)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~---~~~~kl~DFGla~ 651 (845)
+||||+++|+|.+++.......+++.+++.++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 99999999999999977655679999999999999999999999 99999999999999998 7899999999986
Q ss_pred CCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhh
Q 003139 652 TGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQ 731 (845)
Q Consensus 652 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (845)
... +..++.++|||||||++|||++|+.||......... ......
T Consensus 169 ~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-----------~~~~~~ 213 (299)
T 3m2w_A 169 ETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------PGMKTR 213 (299)
T ss_dssp ECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCCS
T ss_pred ccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----------HHHHHH
Confidence 422 235678999999999999999999999654322100 000000
Q ss_pred hhccccCCCCC----HHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003139 732 IMDSNLVGKVN----PASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEY 776 (845)
Q Consensus 732 ~~d~~l~~~~~----~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~ 776 (845)
+..... ..+ ......+.+++.+||+.||.+|||+.|++++-..
T Consensus 214 ~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~ 260 (299)
T 3m2w_A 214 IRMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 260 (299)
T ss_dssp SCTTCC--SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred Hhhccc--cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhh
Confidence 000000 111 2345678999999999999999999999986543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-35 Score=319.98 Aligned_cols=240 Identities=20% Similarity=0.193 Sum_probs=183.9
Q ss_pred cCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCC--------hHhHHHHHHHHHHHHhCC---------CCCcceEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRS--------EQGIAEFRTEIEMLSKLR---------HRHLVSLI 564 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------H~niv~l~ 564 (845)
++|+..+.||+|+||.||+|+. +|+.||||++.... ....+.+.+|++++++++ ||||+++.
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 5678889999999999999998 58999999875432 233477889999999885 88888888
Q ss_pred EEEe------------------------------cCCcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHH
Q 003139 565 GYCD------------------------------ERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLH 614 (845)
Q Consensus 565 g~~~------------------------------~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~ 614 (845)
+.+. +.+..++||||+++|++.+.+.. ..+++.++..|+.||+.||+
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHHH
Confidence 7642 26789999999999987777643 46899999999999999999
Q ss_pred HHh-hcCCCceeeccCCCCcEEECCCC--------------------ceEEEeccccCCCCCCCCcccccccccCCCcCC
Q 003139 615 YLH-TGAAQSIIHRDVKTTNILLDDNF--------------------VAKVADFGLSKTGPALDQTHVSTAVKGSFGYLD 673 (845)
Q Consensus 615 yLH-~~~~~~ivHrDik~~NILl~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~a 673 (845)
||| + .+|+||||||+||||+.++ .+||+|||+|+.... ....||+.|+|
T Consensus 176 ~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~a 245 (336)
T 2vuw_A 176 VAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMD 245 (336)
T ss_dssp HHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTC
T ss_pred HHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccC
Confidence 999 8 8999999999999999887 999999999986321 23479999999
Q ss_pred hhhhccCCCCchhHHHHHHHH-HHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhh-hccccCCCCCHHHHHHHHH
Q 003139 674 PEYFRRQQLTEKSDVYSFGVV-LMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQI-MDSNLVGKVNPASLKKFGE 751 (845)
Q Consensus 674 PE~~~~~~~s~ksDV~S~Gvv-l~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~-~d~~l~~~~~~~~~~~l~~ 751 (845)
||++.+.. +.++||||+|++ .+++++|..||.. ..|....... .+... ................+.+
T Consensus 246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~---------~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~d 314 (336)
T 2vuw_A 246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN---------VLWLHYLTDK-MLKQMTFKTKCNTPAMKQIKRKIQE 314 (336)
T ss_dssp SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH---------HHHHHHHHHH-HHHTCCCSSCCCSHHHHHHHHHHHH
T ss_pred hhhhcCCC-ccceehhhhhCCCCcccccccCCCcc---------hhhhhHHHHh-hhhhhccCcccchhhhhhcCHHHHH
Confidence 99998776 999999998777 7778889887731 1121111100 00000 0000111122457788999
Q ss_pred HHHHhhhhCCCCCCCHHHHH
Q 003139 752 TAEKCLAEHGVDRPSMGDVL 771 (845)
Q Consensus 752 l~~~cl~~~p~~RPs~~~vl 771 (845)
++.+||+.+ |+.|++
T Consensus 315 li~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 315 FHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHGGGSS-----SHHHHH
T ss_pred HHHHHhccC-----CHHHHH
Confidence 999999966 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-28 Score=286.98 Aligned_cols=182 Identities=20% Similarity=0.115 Sum_probs=129.0
Q ss_pred eeeeceEEEEEEEE-cCCcEEEEEEcCCC----------ChHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcEEEEE
Q 003139 510 LGVGGFGRVYKGTL-DDGTKVAVKRGNPR----------SEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 510 LG~G~fg~Vy~~~~-~~g~~vavK~~~~~----------~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 577 (845)
.+.|+.|.+..++. --|+.+++|.+... ++...++|.+|+++|+++ .|+||++++++++++++.||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 45666666655442 25888999976432 133457899999999999 7999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
||++|++|.++|... ++++.. +|+.||+.||+|||+ ++||||||||+||||++++.+||+|||+|+....
T Consensus 322 Eyv~G~~L~d~i~~~--~~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~-- 391 (569)
T 4azs_A 322 EKLPGRLLSDMLAAG--EEIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ-- 391 (569)
T ss_dssp ECCCSEEHHHHHHTT--CCCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred ecCCCCcHHHHHHhC--CCCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCCC--
Confidence 999999999999654 456654 589999999999999 9999999999999999999999999999987443
Q ss_pred CcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCC
Q 003139 658 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTR 702 (845)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~ 702 (845)
........+||++|||||++.+ .+..++|+||+|+++++|.++.
T Consensus 392 ~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 392 DCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp --CCSHHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred CCccccCceechhhccHHHhCC-CCCCcccccccccchhhhcccc
Confidence 2223345789999999999876 4677899999999998886654
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=7.9e-26 Score=263.26 Aligned_cols=184 Identities=17% Similarity=0.213 Sum_probs=146.6
Q ss_pred cceeeeeeceEEEEEEEEcCCcEEEEEEcCCCC---h-----HhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 506 ESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRS---E-----QGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 506 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~---~-----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
..++||+|+||.||+|... ++.+++|+..... . ...++|.+|++++++++||||+++..++...+..+|||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp --------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 3558999999999999554 7888998754332 1 12356899999999999999997777777778889999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
||+++++|.+++.. ++.++.|+++||+|||+ ++|+||||||+|||+++ .+||+|||+++......
T Consensus 419 E~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~ 483 (540)
T 3en9_A 419 SYINGKLAKDVIED----------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE 483 (540)
T ss_dssp ECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred ECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence 99999999999854 56899999999999999 99999999999999999 99999999998754321
Q ss_pred Ccc-----cccccccCCCcCChhhhcc--CCCCchhHHHHHHHHHHHHHcCCCCC
Q 003139 658 QTH-----VSTAVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLMEVLCTRPAL 705 (845)
Q Consensus 658 ~~~-----~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~S~Gvvl~Elltg~~p~ 705 (845)
... ......||+.|||||++.. ..|+.++|+|+..+-.+|.+.++.++
T Consensus 484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 111 1245789999999999987 67888999999999999988887654
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.2e-22 Score=216.86 Aligned_cols=154 Identities=16% Similarity=0.096 Sum_probs=123.9
Q ss_pred HHHHHHHhcCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCCh------------------HhHHHHHHHHHHHHhC
Q 003139 494 FQEILDATNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSE------------------QGIAEFRTEIEMLSKL 555 (845)
Q Consensus 494 ~~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l 555 (845)
+..+......|...+.||+|+||.||+|...+|+.||+|.+..... .....+.+|+++++++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 4455555667778899999999999999997799999998764321 2356789999999999
Q ss_pred CCCCcceEEEEEecCCcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEE
Q 003139 556 RHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNIL 635 (845)
Q Consensus 556 ~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NIL 635 (845)
+| +++.+++.. +..++||||+++++|.+ +.. .+...++.|+++||+|||+ .+|+||||||+|||
T Consensus 162 ~~---~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NIL 225 (282)
T 1zar_A 162 QG---LAVPKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVL 225 (282)
T ss_dssp TT---SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEE
T ss_pred cC---CCcCeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEE
Confidence 94 555554433 56799999999999998 421 2345799999999999999 99999999999999
Q ss_pred ECCCCceEEEeccccCCCCCCCCcccccccccCCCcCChhhhcc
Q 003139 636 LDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRR 679 (845)
Q Consensus 636 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 679 (845)
++ ++.+||+|||+++. +..++|||++..
T Consensus 226 l~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 226 VS-EEGIWIIDFPQSVE---------------VGEEGWREILER 253 (282)
T ss_dssp EE-TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred EE-CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence 99 99999999999864 234789998753
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.3e-21 Score=192.42 Aligned_cols=148 Identities=14% Similarity=0.162 Sum_probs=114.9
Q ss_pred ceEEEecCCCcccccCCceeecCCCCcccccccCC----cccccCCCCCCCcccceeEeecccceEEEeecccceEEEEE
Q 003139 34 DNYLIACGSSQKVTFQARTYVPDTEHSSLSMKSGN----STTASSNSSAPSPIYQSARIFSAAAFYKFEIEHKGRHWVRL 109 (845)
Q Consensus 34 ~~~~i~CG~~~~~~~~~~~~v~D~~~~~~~~~~~~----~~~~~~~~~~~~~~~~t~R~F~~~~cY~~~~~~~g~~~vR~ 109 (845)
..|+||||++..++..+|+|.+|..|... |... ..........++++|+|+|+|+...||.||+.++|+|+|||
T Consensus 6 ~~~~INcGg~~~~d~~gr~w~~D~~~~~~--g~~~~~~~~~~~~~~~~~~~~lY~TaR~~~~~~tY~f~v~~~G~Y~VrL 83 (174)
T 2jwp_A 6 VIWAVNAGGESHVDVHGIHYRKDPLEGRV--GRASDYGMKLPILRSNPEDQVLYQTERYNEDSFGYDIPIKEEGEYVLVL 83 (174)
T ss_dssp EEEEEEETSSSEEETTTEEECSSCSSTTC--CCCCCCCTTSCCSSSCHHHHHTTTCCCCCCSCEEEEEECCSCEEEEEEE
T ss_pred EEEEEECCCCCccCCCCCEEcCCcCcccC--CcccccccceEecccCCCCchhhhhhccCCCCeEEEEEeCCCeEEEEEE
Confidence 46999999988777799999999876422 2111 00001112234567999999999999999999899999999
Q ss_pred EeecCCCCCcCCccceEEEEeCcEEEeecccccccC--CCcceEEEEEee-------------cCCceEEEEeeCCCCcc
Q 003139 110 YFYTLPGSNQHLNSASFTVATDKFVLLSNFTFKNYN--SSFMFKEYAINV-------------NSDALTLTFIPSNNSVA 174 (845)
Q Consensus 110 ~f~~~~~~~~~~~~~~f~v~~~~~~~~~~~~~~~~~--~~~~~~e~~~~~-------------~~~~~~vc~~~~~~~~p 174 (845)
||++..+.+ .+...|+|.++|++++.+|...... ..++.++|.+.+ .++.|.|+|.|...+.|
T Consensus 84 hF~ei~~~~--~~~rvFdV~ing~~~l~~fdi~~~ag~~~~~~~~~~~~v~~~~l~i~~~~~~~~g~L~I~f~p~~~~~a 161 (174)
T 2jwp_A 84 KFAEVYFAQ--SQQKVFDVRVNGHTVVKDLDIFDRVGHSTAHDEIIPISIKKGKLSVQGEVSTFTGKLSVEFVKGYYDNP 161 (174)
T ss_dssp EEECCSCCC--SSSSCEEEEETTEEEEEEECHHHHHSSSSCEEEEEEEEEETTEEEETTEEEECCSEEEEEEECSSSCSS
T ss_pred EEeccccCC--CCCeEeEEEECCEEeecCcCHHHhhCCCeeEEEEEEEEEecCceeeeeeecccCCeEEEEEeccCCCCc
Confidence 999998764 7889999999999999999543222 346788898874 45679999998767899
Q ss_pred eeeeeEEEecC
Q 003139 175 FVNAIEVVSVP 185 (845)
Q Consensus 175 fi~~iE~~~~~ 185 (845)
|||||||++.+
T Consensus 162 ~inaIEI~~~~ 172 (174)
T 2jwp_A 162 KVCALFIMKGT 172 (174)
T ss_dssp SEEEEEEESSC
T ss_pred EEEEEEEEeCc
Confidence 99999999754
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=5.7e-20 Score=180.78 Aligned_cols=156 Identities=13% Similarity=0.195 Sum_probs=119.6
Q ss_pred eEEEEeecCCCccCCCCCcCCccccCCCCceeeCCCCceeeccCceeeeeccCCcccChHHHHHHhhhccCCCCccceee
Q 003139 211 ETVYRLNMGGPLITAQNDTLGRTWENDETYLHVNSSAVNVSVRPSAIRYTASVTAETAPNWVYATAEMMGDANVPEVNFN 290 (845)
Q Consensus 211 ~~~~r~n~g~~~i~~~~D~~~R~W~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~P~~Vy~ta~~~~~~~~~~~~~~ 290 (845)
+++|||||||+.++ |..+|+|.+|..+....... . . ...+. ....+.+|+.||+|||... .+
T Consensus 5 ~~~~~INcGg~~~~---d~~gr~w~~D~~~~~~g~~~-~-~--~~~~~---~~~~~~~~~~lY~TaR~~~--------~~ 66 (174)
T 2jwp_A 5 KVIWAVNAGGESHV---DVHGIHYRKDPLEGRVGRAS-D-Y--GMKLP---ILRSNPEDQVLYQTERYNE--------DS 66 (174)
T ss_dssp HEEEEEEETSSSEE---ETTTEEECSSCSSTTCCCCC-C-C--CTTSC---CSSSCHHHHHTTTCCCCCC--------SC
T ss_pred cEEEEEECCCCCcc---CCCCCEEcCCcCcccCCccc-c-c--ccceE---ecccCCCCchhhhhhccCC--------CC
Confidence 57999999999765 67899999998764211111 0 0 11111 1123567899999999763 25
Q ss_pred EEEEeecCCCCceEEEEEccCccccccceEEEEEEecccccCCCcchhhhcCCccceeeeeeeeeec-----------CC
Q 003139 291 ITWVLPVEPNFTYFVRVHLCDIASLSMNNLVFNLYINDDIAQPSVDLSTLTNGLNVPYYKDFVCNAS-----------AD 359 (845)
Q Consensus 291 ltw~~~~~~~~~y~vrlhf~ei~s~~~~~r~F~i~in~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~-----------~~ 359 (845)
++|.++++++.+|.|||||||+.....++|+|+|+|||+.+..++|+...+++ ..++++++.++++ ..
T Consensus 67 ~tY~f~v~~~G~Y~VrLhF~ei~~~~~~~rvFdV~ing~~~l~~fdi~~~ag~-~~~~~~~~~~~v~~~~l~i~~~~~~~ 145 (174)
T 2jwp_A 67 FGYDIPIKEEGEYVLVLKFAEVYFAQSQQKVFDVRVNGHTVVKDLDIFDRVGH-STAHDEIIPISIKKGKLSVQGEVSTF 145 (174)
T ss_dssp EEEEEECCSCEEEEEEEEEECCSCCCSSSSCEEEEETTEEEEEEECHHHHHSS-SSCEEEEEEEEEETTEEEETTEEEEC
T ss_pred eEEEEEeCCCeEEEEEEEEeccccCCCCCeEeEEEECCEEeecCcCHHHhhCC-CeeEEEEEEEEEecCceeeeeeeccc
Confidence 99999999989999999999998877899999999999999999999988876 5678888866532 13
Q ss_pred CCeeEEEecCCcccccchhccccceeeec
Q 003139 360 SNTLTVSVGPDSVADFTNATMNGLEVMKI 388 (845)
Q Consensus 360 ~~~l~v~~~P~~~~~~~~a~lngle~~~i 388 (845)
.+.|.|+..|.. ...+++|++|+++-
T Consensus 146 ~g~L~I~f~p~~---~~~a~inaIEI~~~ 171 (174)
T 2jwp_A 146 TGKLSVEFVKGY---YDNPKVCALFIMKG 171 (174)
T ss_dssp CSEEEEEEECSS---SCSSSEEEEEEESS
T ss_pred CCeEEEEEeccC---CCCcEEEEEEEEeC
Confidence 457999999863 45699999999875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=2.4e-18 Score=181.24 Aligned_cols=136 Identities=18% Similarity=0.150 Sum_probs=106.3
Q ss_pred CCCcceeeeeeceEEEEEEEE-cCCcE--EEEEEcCCCCh------------------------HhHHHHHHHHHHHHhC
Q 003139 503 KFDESLLLGVGGFGRVYKGTL-DDGTK--VAVKRGNPRSE------------------------QGIAEFRTEIEMLSKL 555 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~--vavK~~~~~~~------------------------~~~~~~~~E~~~l~~l 555 (845)
-|...+.||+|+||.||+|.. .+|+. ||||....... .....+.+|+++|.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 356778999999999999998 67888 99997543311 1123678999999999
Q ss_pred CCCCc--ceEEEEEecCCcEEEEEEeccC-C----CccccccCCCCCCCCHHHHHHHHHHHHHHHHHHh-hcCCCceeec
Q 003139 556 RHRHL--VSLIGYCDERSEMILVYEYMAN-G----PLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLH-TGAAQSIIHR 627 (845)
Q Consensus 556 ~H~ni--v~l~g~~~~~~~~~lV~Ey~~~-g----sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivHr 627 (845)
+|+++ ..++++ ...+|||||+.+ | +|.++.. ..++.++..++.|++.||.||| + .+|+||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~givHr 195 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGR-----ELKELDVEGIFNDVVENVKRLYQE---AELVHA 195 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGG-----GGGGSCHHHHHHHHHHHHHHHHHT---SCEECS
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhh-----ccChHHHHHHHHHHHHHHHHHHHH---CCEEeC
Confidence 88764 444443 367899999953 4 4444432 1235577899999999999999 7 899999
Q ss_pred cCCCCcEEECCCCceEEEeccccCC
Q 003139 628 DVKTTNILLDDNFVAKVADFGLSKT 652 (845)
Q Consensus 628 Dik~~NILl~~~~~~kl~DFGla~~ 652 (845)
||||+|||+++ .++|+|||+|..
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEE
T ss_pred CCCHHHEEEcC--cEEEEECccccc
Confidence 99999999998 999999999975
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.59 E-value=6.7e-16 Score=169.28 Aligned_cols=145 Identities=13% Similarity=0.128 Sum_probs=103.7
Q ss_pred HHHHHHhcCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCC--------------hHhHHH--------HHHHHHHH
Q 003139 495 QEILDATNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRS--------------EQGIAE--------FRTEIEML 552 (845)
Q Consensus 495 ~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~--------------~~~~~~--------~~~E~~~l 552 (845)
..+.....-|.+...||+|+||.||+|...+|+.||||.++... ...... ...|...|
T Consensus 88 ~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL 167 (397)
T 4gyi_A 88 HTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFM 167 (397)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHH
Confidence 33444444588899999999999999999899999999754320 000111 23466677
Q ss_pred HhCCCCCcceEEEEEecCCcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCC
Q 003139 553 SKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTT 632 (845)
Q Consensus 553 ~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~ 632 (845)
.++.+.++....-+.. ...+|||||+++++|..+... .....++.|++.+|.|||+ .+||||||||.
T Consensus 168 ~rL~~~gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~ 234 (397)
T 4gyi_A 168 KALYEEGFPVPEPIAQ--SRHTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLAK---HGLIHGDFNEF 234 (397)
T ss_dssp HHHHHTTCSCCCEEEE--ETTEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTT
T ss_pred HHHHhcCCCCCeeeec--cCceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHHH---CCCcCCCCCHH
Confidence 7775544322211111 234799999999998776421 2345788999999999999 89999999999
Q ss_pred cEEECCCC----------ceEEEeccccCC
Q 003139 633 NILLDDNF----------VAKVADFGLSKT 652 (845)
Q Consensus 633 NILl~~~~----------~~kl~DFGla~~ 652 (845)
||||++++ .+.|+||+-+..
T Consensus 235 NILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 235 NILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred HEEEeCCCCcccccccccceEEEEeCCccc
Confidence 99998776 389999997754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.19 E-value=3.6e-11 Score=126.28 Aligned_cols=146 Identities=15% Similarity=0.087 Sum_probs=113.5
Q ss_pred HHhcCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCC-CCCcceEEEEEecCCcEEEEE
Q 003139 499 DATNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLR-HRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 499 ~at~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 577 (845)
..-..|.....++.|+.+.||++... ++.+++|............+.+|+++++.+. |..+.++++++.+.+..++||
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 34456777778888889999999755 6889999876421122245788999999884 677889999999888999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-------------------------------------
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGA------------------------------------- 620 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------- 620 (845)
||++|.+|.+.+. +......++.+++++|..||+..
T Consensus 90 e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T 3tm0_A 90 SEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp ECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred EecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence 9999999887641 12234578999999999999811
Q ss_pred -------------------CCceeeccCCCCcEEECCCCceEEEeccccCC
Q 003139 621 -------------------AQSIIHRDVKTTNILLDDNFVAKVADFGLSKT 652 (845)
Q Consensus 621 -------------------~~~ivHrDik~~NILl~~~~~~kl~DFGla~~ 652 (845)
...++|+|+++.|||++++..+.|+||+.+..
T Consensus 163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 14589999999999998766677999997743
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.11 E-value=1e-10 Score=122.21 Aligned_cols=129 Identities=18% Similarity=0.118 Sum_probs=98.7
Q ss_pred eeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCC--cceEEEEEecCCcEEEEEEeccCCCcccc
Q 003139 511 GVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRH--LVSLIGYCDERSEMILVYEYMANGPLRSH 588 (845)
Q Consensus 511 G~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~ 588 (845)
+.|..+.||++...+|..+++|..... ....+..|+++++.+++.+ +.+++++....+..++||||++|.+|.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence 355569999998777888999986544 2245778999999886545 456889888888899999999998884
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC------------------------------------------------
Q 003139 589 LYGTDLPPLSWKQRLEICIGAARGLHYLHTGA------------------------------------------------ 620 (845)
Q Consensus 589 l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------------------ 620 (845)
... .+ ...++.++++.|..||+..
T Consensus 104 ~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 175 (264)
T 1nd4_A 104 SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLK 175 (264)
T ss_dssp TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHH
T ss_pred cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHH
Confidence 211 11 2367888888899998732
Q ss_pred -------CCceeeccCCCCcEEECCCCceEEEeccccCC
Q 003139 621 -------AQSIIHRDVKTTNILLDDNFVAKVADFGLSKT 652 (845)
Q Consensus 621 -------~~~ivHrDik~~NILl~~~~~~kl~DFGla~~ 652 (845)
...++|+|++|.|||++++..++|+|||.+..
T Consensus 176 ~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 176 ARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998876677999998754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.95 E-value=3.1e-09 Score=117.00 Aligned_cols=142 Identities=18% Similarity=0.247 Sum_probs=108.7
Q ss_pred cceeeeeeceEEEEEEEEcCCcEEEEEEcC--CCC-hHhHHHHHHHHHHHHhCC--CCCcceEEEEEecC---CcEEEEE
Q 003139 506 ESLLLGVGGFGRVYKGTLDDGTKVAVKRGN--PRS-EQGIAEFRTEIEMLSKLR--HRHLVSLIGYCDER---SEMILVY 577 (845)
Q Consensus 506 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~---~~~~lV~ 577 (845)
..+.|+.|.++.||+.... +..+++|+.. ... ......+.+|.++++.++ +..+.++++++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 4567899999999999876 4678888765 322 122356788999999997 45688899999776 4589999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-------------------------------------
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGA------------------------------------- 620 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------- 620 (845)
||++|..+.+.. ...++..++..++.++++.|..||+..
T Consensus 121 e~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 121 EFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp ECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 999998886522 234788899999999999999999721
Q ss_pred ------------------CCceeeccCCCCcEEECCCCc--eEEEeccccCC
Q 003139 621 ------------------AQSIIHRDVKTTNILLDDNFV--AKVADFGLSKT 652 (845)
Q Consensus 621 ------------------~~~ivHrDik~~NILl~~~~~--~kl~DFGla~~ 652 (845)
...++|||+++.|||+++++. +.|.||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999997653 68999999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.85 E-value=2.4e-09 Score=114.99 Aligned_cols=187 Identities=17% Similarity=0.183 Sum_probs=124.1
Q ss_pred ceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCC-CCC--cceEEEEEecCC---cEEEEEEec
Q 003139 507 SLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLR-HRH--LVSLIGYCDERS---EMILVYEYM 580 (845)
Q Consensus 507 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~n--iv~l~g~~~~~~---~~~lV~Ey~ 580 (845)
.+.++.|....||+.. ..+++|.... ......+.+|.++|+.+. +.. +.++++.+...+ ..++|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3468999999999863 5688888542 344567889999998883 333 345555544333 348899999
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC----------------------------------------
Q 003139 581 ANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGA---------------------------------------- 620 (845)
Q Consensus 581 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------------- 620 (845)
+|.+|..... ..++..++..++.++++.|..||+..
T Consensus 99 ~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 99 KGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 9988875332 24677888889999999999998611
Q ss_pred ---------------CCceeeccCCCCcEEECC--CCceEEEeccccCCCCCCCCcccccc------------cccCCCc
Q 003139 621 ---------------AQSIIHRDVKTTNILLDD--NFVAKVADFGLSKTGPALDQTHVSTA------------VKGSFGY 671 (845)
Q Consensus 621 ---------------~~~ivHrDik~~NILl~~--~~~~kl~DFGla~~~~~~~~~~~~~~------------~~gt~~y 671 (845)
...++|+|+++.||++++ +..+.|+||+.+.......+-..... .....+.
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~ 254 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKH 254 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence 135899999999999998 56688999999875322111000000 0000011
Q ss_pred CC-hhhhccCCCCchhHHHHHHHHHHHHHcCCCCC
Q 003139 672 LD-PEYFRRQQLTEKSDVYSFGVVLMEVLCTRPAL 705 (845)
Q Consensus 672 ~a-PE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~ 705 (845)
.. |+..... ....+.|+++.++|++.+|+.++
T Consensus 255 ~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 255 KDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp SCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHH
Confidence 22 2222111 22368999999999999998654
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=4e-06 Score=89.81 Aligned_cols=136 Identities=17% Similarity=0.132 Sum_probs=98.6
Q ss_pred ceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCC---CcceEEEEEe-cCCcEEEEEEeccC
Q 003139 507 SLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHR---HLVSLIGYCD-ERSEMILVYEYMAN 582 (845)
Q Consensus 507 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~-~~~~~~lV~Ey~~~ 582 (845)
...++.|....||+. |..+++|... .......+..|.++|..+.+. .+.+.+.++. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 346888888899988 5678888842 334457789999999999753 3566777774 45567899999999
Q ss_pred CCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-------------------------------------------
Q 003139 583 GPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTG------------------------------------------- 619 (845)
Q Consensus 583 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------------- 619 (845)
.+|..... ..++..++..++.++++.|..||+.
T Consensus 98 ~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 98 QILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp EECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred eECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 88865321 1345556666666666666666642
Q ss_pred --------------CCCceeeccCCCCcEEECC---CCc-eEEEeccccCC
Q 003139 620 --------------AAQSIIHRDVKTTNILLDD---NFV-AKVADFGLSKT 652 (845)
Q Consensus 620 --------------~~~~ivHrDik~~NILl~~---~~~-~kl~DFGla~~ 652 (845)
....++|+|+++.|||++. ++. ..|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2235799999999999997 355 58999998865
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.21 E-value=2.5e-06 Score=93.36 Aligned_cols=145 Identities=10% Similarity=0.027 Sum_probs=92.3
Q ss_pred eee-eeeceEEEEEEEEc-------CCcEEEEEEcCCCC---hHhHHHHHHHHHHHHhCC-C--CCcceEEEEEecC---
Q 003139 508 LLL-GVGGFGRVYKGTLD-------DGTKVAVKRGNPRS---EQGIAEFRTEIEMLSKLR-H--RHLVSLIGYCDER--- 570 (845)
Q Consensus 508 ~~L-G~G~fg~Vy~~~~~-------~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H--~niv~l~g~~~~~--- 570 (845)
+.| +.|....+|+.... ++..+++|...... ......+..|..+++.+. + -.+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 457 78888999998764 26678899754322 001245677888888874 2 3567788888665
Q ss_pred CcEEEEEEeccCCCccccccC----CCCCCCCHHHHHHHHHHHHHHHHHHh-----------------------------
Q 003139 571 SEMILVYEYMANGPLRSHLYG----TDLPPLSWKQRLEICIGAARGLHYLH----------------------------- 617 (845)
Q Consensus 571 ~~~~lV~Ey~~~gsL~~~l~~----~~~~~l~~~~~~~i~~~ia~gL~yLH----------------------------- 617 (845)
+..++||||++|..+.+.+.. .....++..++..++.++++.|.-||
T Consensus 106 g~~~~v~e~l~G~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~La~LH~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 185 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPDVMPYTFGDNWFADAPAERQRQLQDATVAALATLHSIPNAQNTFSFLTQGRTSDTTLHRHFNWV 185 (357)
T ss_dssp SSCEEEEECCCCBCCCBTTBGGGSCSTTTTSCHHHHHHHHHHHHHHHHHHTTCSSHHHHTGGGC-----CCHHHHHHHHH
T ss_pred CCceEEEEecCCCChhhcCcccccccccCCCCHHHHHHHHHHHHHHHHHHhCCCCccCChhhccCCCCCCchHHHHHHHH
Confidence 357899999999887653200 00001222333333333333333333
Q ss_pred -------------------------hc-------CCCceeeccCCCCcEEECCCCceEEEeccccCC
Q 003139 618 -------------------------TG-------AAQSIIHRDVKTTNILLDDNFVAKVADFGLSKT 652 (845)
Q Consensus 618 -------------------------~~-------~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~ 652 (845)
+. ....++|+|+++.|||++++..+.|+||+.+..
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 186 RSWYDFAVEGIGRSPLLERTFEWLQSHWPDDAAAREPVLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp HHHHHHHHHHHCCCHHHHHHHHHHHHTCCHHHHHSCCEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred HHHHHhhccCCCCChHHHHHHHHHHHhCCCcccCCCceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 11 135799999999999999655579999998754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.21 E-value=4e-06 Score=87.83 Aligned_cols=135 Identities=17% Similarity=0.149 Sum_probs=98.0
Q ss_pred eeeeeceE-EEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCC-CCCcceEEEEEecCCcEEEEEEeccCCCc
Q 003139 509 LLGVGGFG-RVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLR-HRHLVSLIGYCDERSEMILVYEYMANGPL 585 (845)
Q Consensus 509 ~LG~G~fg-~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 585 (845)
.+..|..| .||+.... ++..+++|+.... ...++..|...|+.+. +--+-++++++.+.+..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 45556555 68987765 4667899975432 3456788999998884 33467789999998999999999999887
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhc----------------------------------------------
Q 003139 586 RSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTG---------------------------------------------- 619 (845)
Q Consensus 586 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~---------------------------------------------- 619 (845)
.+.... .......++.++++.|.-||..
T Consensus 108 ~~~~~~------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 108 FQVLEE------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp HHHHHH------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred cccccC------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 665421 1233456677777777777741
Q ss_pred ---------CCCceeeccCCCCcEEECCCCceEEEeccccCC
Q 003139 620 ---------AAQSIIHRDVKTTNILLDDNFVAKVADFGLSKT 652 (845)
Q Consensus 620 ---------~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~ 652 (845)
....++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 012379999999999999887778999998754
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.84 E-value=9.4e-05 Score=79.96 Aligned_cols=140 Identities=20% Similarity=0.215 Sum_probs=80.6
Q ss_pred eeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCC-----CCCcceEE-E--EEecCCcEEEEEEe
Q 003139 508 LLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLR-----HRHLVSLI-G--YCDERSEMILVYEY 579 (845)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H~niv~l~-g--~~~~~~~~~lV~Ey 579 (845)
+.|+.|..+.||+....+| .+++|+... .. +++..|.+++..+. .|.++... | +....+..++||||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~-~~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHR-PE---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECS-CH---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCC-CH---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 3465677889999987655 588998765 22 23334555555442 34443310 0 11235678999999
Q ss_pred ccCCCccc--------------cccC--CCC----------CCCCHHHHH------------------------------
Q 003139 580 MANGPLRS--------------HLYG--TDL----------PPLSWKQRL------------------------------ 603 (845)
Q Consensus 580 ~~~gsL~~--------------~l~~--~~~----------~~l~~~~~~------------------------------ 603 (845)
++|..+.. .+|. ... ..-.|....
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 99876531 1111 000 012343211
Q ss_pred -HHHHHHHHHHHHHhh----------cCCCceeeccCCCCcEEECCCCceEEEeccccCC
Q 003139 604 -EICIGAARGLHYLHT----------GAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKT 652 (845)
Q Consensus 604 -~i~~~ia~gL~yLH~----------~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~ 652 (845)
.+...+.+++++|++ .....++|+|+++.|||++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 111223446667763 1247899999999999998888999999998754
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.75 E-value=3.9e-05 Score=85.21 Aligned_cols=75 Identities=19% Similarity=0.212 Sum_probs=49.2
Q ss_pred ceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCCh-------HhHHHHHHHHHHHHhCCC--CCcc-eEEEEEecCCcEEE
Q 003139 507 SLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSE-------QGIAEFRTEIEMLSKLRH--RHLV-SLIGYCDERSEMIL 575 (845)
Q Consensus 507 ~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~H--~niv-~l~g~~~~~~~~~l 575 (845)
.+.||.|..+.||++... +++.++||...+... ...+++..|.++++.+.+ +..+ +++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457899999999999764 467899997543211 123456778888887742 4444 55544 3445689
Q ss_pred EEEeccCC
Q 003139 576 VYEYMANG 583 (845)
Q Consensus 576 V~Ey~~~g 583 (845)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.49 E-value=0.00037 Score=73.61 Aligned_cols=79 Identities=22% Similarity=0.192 Sum_probs=58.1
Q ss_pred CCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCC---CCcceEEEEEecCCcEEEEEEe
Q 003139 503 KFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRH---RHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~g~~~~~~~~~lV~Ey 579 (845)
+......+|.|..+.||+.++.+|+.+++|+...........|..|.+.|+.+.. --+.+.+++. .-++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence 4455667999999999999999999999998655443333467889999988842 2345566553 34789999
Q ss_pred ccCCCc
Q 003139 580 MANGPL 585 (845)
Q Consensus 580 ~~~gsL 585 (845)
++++..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00098 Score=71.16 Aligned_cols=139 Identities=17% Similarity=0.149 Sum_probs=93.1
Q ss_pred CcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCC---CCCcceEEEEEecCCcEEEEEEecc
Q 003139 505 DESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLR---HRHLVSLIGYCDERSEMILVYEYMA 581 (845)
Q Consensus 505 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~Ey~~ 581 (845)
...+.|+.|....+|+.... +..+++|+.... ....|..|.+.|+.+. ...+.++++++...+..++||||++
T Consensus 39 ~~~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp CEEEEECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeeEEeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 34456899999999998764 678889975432 3467888999988874 3578889999988888999999999
Q ss_pred CCCccc-----------cccCCCC-C-------------------CCCHHHHH---HHHH----------------HHHH
Q 003139 582 NGPLRS-----------HLYGTDL-P-------------------PLSWKQRL---EICI----------------GAAR 611 (845)
Q Consensus 582 ~gsL~~-----------~l~~~~~-~-------------------~l~~~~~~---~i~~----------------~ia~ 611 (845)
+..+.. .||.... . .-+|.+.. ++.. .++.
T Consensus 115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~ 194 (312)
T 3jr1_A 115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ 194 (312)
T ss_dssp CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence 887632 1121111 0 12565322 1111 1111
Q ss_pred -HHHHHhh-cCCCceeeccCCCCcEEECCCCceEEEecc
Q 003139 612 -GLHYLHT-GAAQSIIHRDVKTTNILLDDNFVAKVADFG 648 (845)
Q Consensus 612 -gL~yLH~-~~~~~ivHrDik~~NILl~~~~~~kl~DFG 648 (845)
....|.. ...+.++|+|+.+.||+++.++ +.|.|+.
T Consensus 195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1223421 2346799999999999999887 8888874
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.25 E-value=0.00059 Score=76.26 Aligned_cols=80 Identities=18% Similarity=0.142 Sum_probs=49.8
Q ss_pred CCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcccccccccCCCcCChhhhccC---CCCchhHHHHHHHHHHH
Q 003139 621 AQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQ---QLTEKSDVYSFGVVLME 697 (845)
Q Consensus 621 ~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDV~S~Gvvl~E 697 (845)
...++|+|+++.|||+++++ ++|+||+.+...+...+-.... ..-...|++|+..... .-....++......+|+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYL-GNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHH-HHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHH-HHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 47899999999999999876 9999999987633211100000 0001235666554311 11234666788888888
Q ss_pred HHcCC
Q 003139 698 VLCTR 702 (845)
Q Consensus 698 lltg~ 702 (845)
.++++
T Consensus 309 ~y~~~ 313 (420)
T 2pyw_A 309 LFNKR 313 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 87653
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.22 E-value=0.00071 Score=72.47 Aligned_cols=157 Identities=11% Similarity=0.100 Sum_probs=87.2
Q ss_pred cHHHHHHHhcCCCc-----ceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCC--cceEEE
Q 003139 493 MFQEILDATNKFDE-----SLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRH--LVSLIG 565 (845)
Q Consensus 493 ~~~el~~at~~f~~-----~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g 565 (845)
+.+++...-..|.. .+.|+.|....+|+....+| .+++|...... ..+++..|+.++..+...+ +.+++.
T Consensus 8 ~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~ 84 (322)
T 2ppq_A 8 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP 84 (322)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccC
Confidence 34455555455554 23466688889999987755 68889876521 1134456777776664222 223332
Q ss_pred E------EecCCcEEEEEEeccCCCcccc--------------ccC--C--CCC---C---CCHHHHHHH----------
Q 003139 566 Y------CDERSEMILVYEYMANGPLRSH--------------LYG--T--DLP---P---LSWKQRLEI---------- 605 (845)
Q Consensus 566 ~------~~~~~~~~lV~Ey~~~gsL~~~--------------l~~--~--~~~---~---l~~~~~~~i---------- 605 (845)
. ....+..++++||++|..+... +|. . ... . ..|...+.-
T Consensus 85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 164 (322)
T 2ppq_A 85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 164 (322)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence 1 1123567899999998765321 111 0 000 0 124331111
Q ss_pred --HHHHHHHHHHHhhc----CCCceeeccCCCCcEEECCCCceEEEeccccCC
Q 003139 606 --CIGAARGLHYLHTG----AAQSIIHRDVKTTNILLDDNFVAKVADFGLSKT 652 (845)
Q Consensus 606 --~~~ia~gL~yLH~~----~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~ 652 (845)
...+.+.++.|++. ....++|+|+++.|||++++..+.|+||+.+..
T Consensus 165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 11244455666532 235799999999999999876668999987753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.09 E-value=0.0012 Score=74.03 Aligned_cols=73 Identities=21% Similarity=0.218 Sum_probs=50.4
Q ss_pred eeeeeeceEEEEEEEEcC--------CcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCc-ceEEEEEecCCcEEEEEE
Q 003139 508 LLLGVGGFGRVYKGTLDD--------GTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHL-VSLIGYCDERSEMILVYE 578 (845)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E 578 (845)
+.|+.|....+|+....+ +..+++|+...... .+.+..|..+++.+...++ .++++.+.+ .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 467888889999998753 47889998743211 1455679998888853344 567776643 38999
Q ss_pred eccCCCcc
Q 003139 579 YMANGPLR 586 (845)
Q Consensus 579 y~~~gsL~ 586 (845)
|++|.+|.
T Consensus 153 ~l~G~~l~ 160 (429)
T 1nw1_A 153 YIPSRPLS 160 (429)
T ss_dssp CCCEEECC
T ss_pred EeCCcccC
Confidence 99875653
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.95 E-value=0.0022 Score=69.11 Aligned_cols=141 Identities=16% Similarity=0.146 Sum_probs=73.8
Q ss_pred eeeeeceEE-EEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCC--CCcceEEEEEecCCcEEEEEEeccCCCc
Q 003139 509 LLGVGGFGR-VYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRH--RHLVSLIGYCDERSEMILVYEYMANGPL 585 (845)
Q Consensus 509 ~LG~G~fg~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~Ey~~~gsL 585 (845)
.|+.|+... +|+....+|..+++|....... +++..|+.++..+.. -.+.+++.++.+.+ ++|||++.+..+
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~l 99 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDALF 99 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCBH
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcch
Confidence 465565554 6677654467788887544321 233456666666632 23556777654443 789999976555
Q ss_pred ccccc---------------------CCC---CCCCCHHHHH-------H-------------HHHHHHHHHHHHh---h
Q 003139 586 RSHLY---------------------GTD---LPPLSWKQRL-------E-------------ICIGAARGLHYLH---T 618 (845)
Q Consensus 586 ~~~l~---------------------~~~---~~~l~~~~~~-------~-------------i~~~ia~gL~yLH---~ 618 (845)
.+.+. ... .+.++..... . ....+.+.++.|. .
T Consensus 100 ~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~ 179 (333)
T 3csv_A 100 TEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQL 179 (333)
T ss_dssp HHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHC
T ss_pred HHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcc
Confidence 33221 110 1112111100 0 0011112222221 1
Q ss_pred cCCCceeeccCCCCcEEECCC----CceEEEeccccCCCC
Q 003139 619 GAAQSIIHRDVKTTNILLDDN----FVAKVADFGLSKTGP 654 (845)
Q Consensus 619 ~~~~~ivHrDik~~NILl~~~----~~~kl~DFGla~~~~ 654 (845)
.....++|||+.+.|||++.+ ..+.|+||+.+...+
T Consensus 180 ~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 180 EGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp CSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred cCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 124679999999999999874 689999999987643
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.89 E-value=0.0021 Score=68.12 Aligned_cols=137 Identities=13% Similarity=0.075 Sum_probs=75.6
Q ss_pred ceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCc-ceEEEEEecCCcEEEEEEec-cCCC
Q 003139 507 SLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHL-VSLIGYCDERSEMILVYEYM-ANGP 584 (845)
Q Consensus 507 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~-~~gs 584 (845)
.+.|+.|....+|+. ..+++|+........ .+..+|..+++.+...++ .++++++ .+.-++|+||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence 567889999999998 568888765432211 122457777777643333 4566543 33457899999 6655
Q ss_pred cccc------------------ccCCCC---CCCC-HHHHHHHHHH--------------HHHHHH----HHhh-cCCCc
Q 003139 585 LRSH------------------LYGTDL---PPLS-WKQRLEICIG--------------AARGLH----YLHT-GAAQS 623 (845)
Q Consensus 585 L~~~------------------l~~~~~---~~l~-~~~~~~i~~~--------------ia~gL~----yLH~-~~~~~ 623 (845)
|... ||.... ...+ +.....+... +.+.+. .|.. .....
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 5320 111110 0011 1111111100 111111 1111 12345
Q ss_pred eeeccCCCCcEEECCCCceEEEeccccCC
Q 003139 624 IIHRDVKTTNILLDDNFVAKVADFGLSKT 652 (845)
Q Consensus 624 ivHrDik~~NILl~~~~~~kl~DFGla~~ 652 (845)
++|+|+.+.||+ .+++.+.|+||..+..
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 899999999999 5566789999998865
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.86 E-value=0.0073 Score=64.61 Aligned_cols=142 Identities=13% Similarity=0.171 Sum_probs=82.6
Q ss_pred eeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCC--cceEEEE-----EecCCcEEEEEEec
Q 003139 508 LLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRH--LVSLIGY-----CDERSEMILVYEYM 580 (845)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~-----~~~~~~~~lV~Ey~ 580 (845)
..|+ |....||+....+|+.+++|...+... ..+++..|..++..+.... +.+++.. ....+..++||||+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3566 888899998877787899998764311 2345666887777764222 3444432 12244568899999
Q ss_pred cCCCcccc--------------ccC----C---CCCCCCHHHH----HHHH---------------HHHHHHHHHHhh--
Q 003139 581 ANGPLRSH--------------LYG----T---DLPPLSWKQR----LEIC---------------IGAARGLHYLHT-- 618 (845)
Q Consensus 581 ~~gsL~~~--------------l~~----~---~~~~l~~~~~----~~i~---------------~~ia~gL~yLH~-- 618 (845)
+|..+... +|. . ....+++... ..++ ..+.+.++.+.+
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 88665310 110 0 0112233211 0111 111122333322
Q ss_pred --cCCCceeeccCCCCcEEECCCCceEEEeccccCCC
Q 003139 619 --GAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTG 653 (845)
Q Consensus 619 --~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~ 653 (845)
.....++|+|+++.|||++ + .+.|+||+.+...
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 1235689999999999999 4 8999999987653
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.84 E-value=0.0039 Score=68.32 Aligned_cols=140 Identities=19% Similarity=0.204 Sum_probs=84.3
Q ss_pred eeeeeeceEEEEEEEEc--------CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCC-cceEEEEEecCCcEEEEEE
Q 003139 508 LLLGVGGFGRVYKGTLD--------DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRH-LVSLIGYCDERSEMILVYE 578 (845)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~E 578 (845)
+.|..|-...+|+.... +++.+++|+.... ........+|.++++.+.-.+ ..++++.+.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 35666778889998864 2478999985332 223456678999998874322 3567776654 29999
Q ss_pred eccCCCcccc-----------------ccCCC---CCCCC--HHHHHHHHHHHHH-------------------HHHHHh
Q 003139 579 YMANGPLRSH-----------------LYGTD---LPPLS--WKQRLEICIGAAR-------------------GLHYLH 617 (845)
Q Consensus 579 y~~~gsL~~~-----------------l~~~~---~~~l~--~~~~~~i~~~ia~-------------------gL~yLH 617 (845)
|++|.+|..- ||... ..+.. |.++.++..++.. .++.|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998766421 11111 11122 4555555544322 233332
Q ss_pred h-----cCCCceeeccCCCCcEEECCC----CceEEEeccccCC
Q 003139 618 T-----GAAQSIIHRDVKTTNILLDDN----FVAKVADFGLSKT 652 (845)
Q Consensus 618 ~-----~~~~~ivHrDik~~NILl~~~----~~~kl~DFGla~~ 652 (845)
+ .....++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 123468999999999999876 7899999988754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0058 Score=68.81 Aligned_cols=74 Identities=14% Similarity=0.129 Sum_probs=48.2
Q ss_pred eeeeeeceEEEEEEEEcC-CcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCc-ceEEEEEecCCcEEEEEEeccCCCc
Q 003139 508 LLLGVGGFGRVYKGTLDD-GTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHL-VSLIGYCDERSEMILVYEYMANGPL 585 (845)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~~~gsL 585 (845)
+.|+.|-...+|+....+ +..+++|+......... +-..|..++..+...++ .++++.+.. .+||||+++.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCccC
Confidence 467788889999998765 47788887643321111 11478899998875555 467776632 359999998666
Q ss_pred c
Q 003139 586 R 586 (845)
Q Consensus 586 ~ 586 (845)
.
T Consensus 189 ~ 189 (458)
T 2qg7_A 189 S 189 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.69 E-value=0.0036 Score=68.42 Aligned_cols=73 Identities=14% Similarity=0.182 Sum_probs=44.6
Q ss_pred eeeeeeceEEEEEEEEcC---------CcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCc-ceEEEEEecCCcEEEEE
Q 003139 508 LLLGVGGFGRVYKGTLDD---------GTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHL-VSLIGYCDERSEMILVY 577 (845)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~ 577 (845)
+.|+.|....+|+....+ +..+++|....... ...+...|.++++.+...++ .++++... -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEecC----CcEEE
Confidence 357778888999998754 26788887654322 11223578888887753343 46665442 37899
Q ss_pred EeccCCCc
Q 003139 578 EYMANGPL 585 (845)
Q Consensus 578 Ey~~~gsL 585 (845)
||++|.++
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99998655
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.45 E-value=0.032 Score=60.09 Aligned_cols=31 Identities=16% Similarity=0.285 Sum_probs=28.0
Q ss_pred CceeeccCCCCcEEECCCCceEEEeccccCC
Q 003139 622 QSIIHRDVKTTNILLDDNFVAKVADFGLSKT 652 (845)
Q Consensus 622 ~~ivHrDik~~NILl~~~~~~kl~DFGla~~ 652 (845)
..++|+|+.+.||++++++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 5799999999999999888899999988765
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.29 E-value=0.038 Score=54.78 Aligned_cols=101 Identities=17% Similarity=0.119 Sum_probs=65.0
Q ss_pred CccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCccccc
Q 003139 584 PLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVST 663 (845)
Q Consensus 584 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 663 (845)
+|.+.|... ..++++++++-++.|.+++|.-+-... .+ ..+=+.|..|+|..+|.+.+.+ +.+.
T Consensus 34 SL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~~-~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~------------ 97 (229)
T 2yle_A 34 SLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARRR-QP-RHRVRSAAQIRVWRDGAVTLAP-AADD------------ 97 (229)
T ss_dssp EHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT-CC-CCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred cHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhcc-cC-CceecCCcceEEecCCceeccc-cccc------------
Confidence 677777543 368999999999999999987762101 11 1333457999999999998864 2111
Q ss_pred ccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCC
Q 003139 664 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRP 703 (845)
Q Consensus 664 ~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~ 703 (845)
.....+.|||... ...+.+.=|||+|++||.-+--..
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL 134 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL 134 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence 0112356787653 355789999999999999875443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.81 E-value=0.11 Score=57.70 Aligned_cols=139 Identities=14% Similarity=0.164 Sum_probs=84.2
Q ss_pred eeeeeeceEEEEEEEEcC--------CcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCC-cceEEEEEecCCcEEEEEE
Q 003139 508 LLLGVGGFGRVYKGTLDD--------GTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRH-LVSLIGYCDERSEMILVYE 578 (845)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~E 578 (845)
+.|..|-...+|+....+ +..+++|+........ -+-.+|..+++.+...+ ..++++.+. -++|||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~-idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF-YDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC-CCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh-cCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence 456677788999988763 5789999865433221 12246888888775333 345565432 278999
Q ss_pred eccCCCcccc-c----------------cC--------C---CCCCCCHHHHHHHHHHH-------------------HH
Q 003139 579 YMANGPLRSH-L----------------YG--------T---DLPPLSWKQRLEICIGA-------------------AR 611 (845)
Q Consensus 579 y~~~gsL~~~-l----------------~~--------~---~~~~l~~~~~~~i~~~i-------------------a~ 611 (845)
|++|..|..- + |. . ...+.-|.++.++..++ ..
T Consensus 151 fI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~ 230 (424)
T 3mes_A 151 FIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILE 230 (424)
T ss_dssp CCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHH
T ss_pred EeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHH
Confidence 9998765321 1 11 0 11122355444443322 22
Q ss_pred HHHHHhh---------------------cCCCceeeccCCCCcEEECCCCceEEEeccccCC
Q 003139 612 GLHYLHT---------------------GAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKT 652 (845)
Q Consensus 612 gL~yLH~---------------------~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~ 652 (845)
.++.|.+ .....++|+|+.+.||+ ++++.+.|+||..+..
T Consensus 231 e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 231 EIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 2333321 11345899999999999 8888999999998754
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.83 E-value=0.05 Score=38.95 Aligned_cols=29 Identities=17% Similarity=0.241 Sum_probs=13.1
Q ss_pred EEEEehhhHHHHHHHHHHhh-hhhhhhccC
Q 003139 416 GIIVGSVVGAVAAVALIGVC-YCWLLARKS 444 (845)
Q Consensus 416 ~iivg~vv~~vl~v~ll~~~-~~~~~~rr~ 444 (845)
..|++.+++.++++++++++ +++++||+.
T Consensus 11 ~~IA~gVVgGv~~~~ii~~~~~~~~RRr~~ 40 (44)
T 2ks1_B 11 PSIATGMVGALLLLLVVALGIGLFMRRRHI 40 (44)
T ss_dssp SSSTHHHHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred ceEEeehhHHHHHHHHHHHHHHHHhhhhHh
Confidence 34555555555544444433 334444433
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.53 E-value=0.041 Score=39.29 Aligned_cols=30 Identities=17% Similarity=0.438 Sum_probs=13.6
Q ss_pred EEEEehhhHHHHHHHHHHhh-hhhhhhccCC
Q 003139 416 GIIVGSVVGAVAAVALIGVC-YCWLLARKSK 445 (845)
Q Consensus 416 ~iivg~vv~~vl~v~ll~~~-~~~~~~rr~k 445 (845)
..|++.+++.++++++++++ +++++||+++
T Consensus 10 ~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~ 40 (44)
T 2l2t_A 10 PLIAAGVIGGLFILVIVGLTFAVYVRRKSIK 40 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHTTCSS
T ss_pred ceEEEeehHHHHHHHHHHHHHHHHhhhhhhh
Confidence 34555555555544444433 3344444333
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.54 E-value=0.7 Score=50.74 Aligned_cols=30 Identities=30% Similarity=0.395 Sum_probs=25.3
Q ss_pred ceeeccCCCCcEEE------CCCCceEEEeccccCC
Q 003139 623 SIIHRDVKTTNILL------DDNFVAKVADFGLSKT 652 (845)
Q Consensus 623 ~ivHrDik~~NILl------~~~~~~kl~DFGla~~ 652 (845)
-++|+|+.+.|||+ +++..++++||.+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 4567899999998754
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=90.94 E-value=0.053 Score=38.61 Aligned_cols=31 Identities=29% Similarity=0.303 Sum_probs=14.3
Q ss_pred eEEEEehhhHHHHHHHHHHhhhhhhhhccCC
Q 003139 415 IGIIVGSVVGAVAAVALIGVCYCWLLARKSK 445 (845)
Q Consensus 415 ~~iivg~vv~~vl~v~ll~~~~~~~~~rr~k 445 (845)
...|+++++|+++++++.+.+++|++||+.+
T Consensus 11 ~~~Ia~~vVGvll~vi~~l~~~~~~RRR~~~ 41 (44)
T 2jwa_A 11 LTSIISAVVGILLVVVLGVVFGILIKRRQQK 41 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHHCSC
T ss_pred ccchHHHHHHHHHHHHHHHHHHhheehhhhh
Confidence 4456666667433333333334444444443
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=90.34 E-value=0.061 Score=37.28 Aligned_cols=29 Identities=24% Similarity=0.232 Sum_probs=17.7
Q ss_pred ceEEEEehhhHHHHHHHHHHhhhhhhhhc
Q 003139 414 KIGIIVGSVVGAVAAVALIGVCYCWLLAR 442 (845)
Q Consensus 414 ~~~iivg~vv~~vl~v~ll~~~~~~~~~r 442 (845)
+.+.|.|++++.++.+++++.+.++++||
T Consensus 9 s~GaIAGiVvG~v~gv~li~~l~~~~~rr 37 (38)
T 2k1k_A 9 TGGEIVAVIFGLLLGAALLLGILVFRSRR 37 (38)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCceeeeehHHHHHHHHHHHHHHHHeec
Confidence 45667888888777666555444444333
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=80.25 E-value=5.3 Score=39.32 Aligned_cols=117 Identities=6% Similarity=0.079 Sum_probs=80.5
Q ss_pred CCCCCcceEEEEEecCCcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcE
Q 003139 555 LRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNI 634 (845)
Q Consensus 555 l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NI 634 (845)
..||++++. .+-.+.+.+.+.|+.-+ ....+- ....++...+++++.+|+...++++. =+|--|+|+||
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~---~ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL 110 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDIND--NHTPFD---NIKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDEL 110 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCT--TSEEGG---GGGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGE
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCc--ccCCHH---HHHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceE
Confidence 368988876 45666666666666543 222221 12357889999999999988876664 47778999999
Q ss_pred EECCCCceEEEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 003139 635 LLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALN 706 (845)
Q Consensus 635 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~ 706 (845)
+++.++.+++.-.|+-...++ . ..+...=.-.+=+++..+++++..|+
T Consensus 111 ~f~~~~~p~i~~RGik~~l~P-------------------~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 111 FFTRDGLPIAKTRGLQNVVDP-------------------L-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EECTTSCEEESCCEETTTBSC-------------------C-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEcCCCCEEEEEccCccCCCC-------------------C-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999988886433221 1 11222234467789999999987663
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 845 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-74 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-65 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-64 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-63 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-63 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-62 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-62 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-62 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-61 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-61 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-61 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-60 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-60 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 9e-60 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-59 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-59 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-58 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-58 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-58 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-58 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-57 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-57 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 7e-57 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 9e-57 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-56 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-56 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-55 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 8e-54 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-53 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-53 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-52 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 7e-52 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-50 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-50 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-48 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-47 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-46 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-46 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-45 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 8e-45 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-44 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-43 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-43 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-43 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 8e-43 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-42 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-42 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-42 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-42 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-41 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-40 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-40 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-38 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-38 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 8e-38 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 8e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-33 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 9e-33 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-22 | |
| d1zyla1 | 325 | d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: | 0.003 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 241 bits (617), Expect = 3e-74
Identities = 72/270 (26%), Positives = 124/270 (45%), Gaps = 19/270 (7%)
Query: 509 LLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCD 568
+G G FG VYKG V + + Q + F+ E+ +L K RH +++ +GY
Sbjct: 15 RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 74
Query: 569 ERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRD 628
++ +V ++ L HL+ + + ++I A+G+ YLH +SIIHRD
Sbjct: 75 A-PQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHA---KSIIHRD 129
Query: 629 VKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQ---LTEK 685
+K+ NI L ++ K+ DFGL+ +H + GS ++ PE R Q + +
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 686 SDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPAS 745
SDVY+FG+VL E++ + P +N + + +G L + KV
Sbjct: 190 SDVYAFGIVLYELMTGQL------PYSNINNRDQIIFMVGRGYLSPDLS-----KVRSNC 238
Query: 746 LKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775
K +CL + +RP +L ++E
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 3e-65
Identities = 71/267 (26%), Positives = 115/267 (43%), Gaps = 21/267 (7%)
Query: 509 LLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCD 568
LG G FG V+ G + TKVAVK + F E ++ +L+H+ LV L
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 569 ERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRD 628
+ + ++ EYM NG L L L+ + L++ A G+ ++ ++ IHRD
Sbjct: 79 Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRD 134
Query: 629 VKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDV 688
++ NIL+ D K+ADFGL++ ++ K + PE T KSDV
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 689 YSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKK 748
+SFG++L E++ P + +V + ++G + N P L +
Sbjct: 194 WSFGILLTEIVTHGRIPYPGMTNPEV------IQNLERG-YRMVRPDNC-----PEELYQ 241
Query: 749 FGETAEKCLAEHGVDRPSMGDVLWNLE 775
C E DRP+ + LE
Sbjct: 242 L---MRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 2e-64
Identities = 64/294 (21%), Positives = 125/294 (42%), Gaps = 27/294 (9%)
Query: 510 LGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDE 569
+G G FG V++G G +VAVK + R E+ EI LRH +++ I ++
Sbjct: 11 IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSW-FREAEIYQTVMLRHENILGFIAADNK 68
Query: 570 R----SEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQS-- 623
+++ LV +Y +G L +L ++ + +++ + A GL +LH +
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQG 125
Query: 624 ---IIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT--HVSTAVKGSFGYLDPEYFR 678
I HRD+K+ NIL+ N +AD GL+ + T G+ Y+ PE
Sbjct: 126 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 185
Query: 679 RQ------QLTEKSDVYSFGVVLMEVLCTRPALNPVL----PREQVNIAEWAMTWQKKGM 728
+ +++D+Y+ G+V E+ P + ++ ++ +K +
Sbjct: 186 DSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVV 245
Query: 729 LDQIMDSNLVGKV-NPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLE 781
+Q + N+ + + +L+ + +C +G R + + L Q E
Sbjct: 246 CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 2e-63
Identities = 71/269 (26%), Positives = 121/269 (44%), Gaps = 27/269 (10%)
Query: 509 LLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYC- 567
+G G FG V G G KVAVK +++ F E ++++LRH +LV L+G
Sbjct: 14 TIGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 70
Query: 568 DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHR 627
+E+ + +V EYMA G L +L L L+ + + YL + +HR
Sbjct: 71 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHR 127
Query: 628 DVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSD 687
D+ N+L+ ++ VAKV+DFGL+K + + K + PE R ++ + KSD
Sbjct: 128 DLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSD 182
Query: 688 VYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLK 747
V+SFG++L E+ +P ++ + + +K +D P ++
Sbjct: 183 VWSFGILLWEIYSFGR-----VPYPRIPLKDVVPRVEKGYKMDAPDGC-------PPAVY 230
Query: 748 KFGETAEKCLAEHGVDRPSMGDVLWNLEY 776
+ + C RPS + LE+
Sbjct: 231 EV---MKNCWHLDAAMRPSFLQLREQLEH 256
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 211 bits (537), Expect = 8e-63
Identities = 72/284 (25%), Positives = 122/284 (42%), Gaps = 22/284 (7%)
Query: 509 LLGVGGFGRVYKGTL-DDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYC 567
LG G +G VY+G VAVK + + + EF E ++ +++H +LV L+G C
Sbjct: 24 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 82
Query: 568 DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHR 627
++ E+M G L +L + +S L + + + YL ++ IHR
Sbjct: 83 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHR 139
Query: 628 DVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSD 687
D+ N L+ +N + KVADFGLS+ D K + PE + + KSD
Sbjct: 140 DLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 198
Query: 688 VYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLK 747
V++FGV+L E+ + P + Q + ++++ + + +
Sbjct: 199 VWAFGVLLWEIATYGMSPYPGIDLSQ---------------VYELLEKDYRMERPEGCPE 243
Query: 748 KFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLEETSSALMEPE 791
K E C + DRPS ++ E Q E + S +E E
Sbjct: 244 KVYELMRACWQWNPSDRPSFAEIHQAFETMFQ-ESSISDEVEKE 286
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (534), Expect = 1e-62
Identities = 75/270 (27%), Positives = 117/270 (43%), Gaps = 21/270 (7%)
Query: 510 LGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDE 569
+G G FG V+ G + KVA+K +F E E++ KL H LV L G C E
Sbjct: 13 IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 570 RSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDV 629
++ + LV+E+M +G L + T + + L +C+ G+ YL +IHRD+
Sbjct: 72 QAPICLVFEFMEHGCLSDY-LRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDL 127
Query: 630 KTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 689
N L+ +N V KV+DFG+++ DQ ST K + PE F + + KSDV+
Sbjct: 128 AARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 186
Query: 690 SFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKF 749
SFGV++ EV +V + G ++ L + +
Sbjct: 187 SFGVLMWEVFSEGKIPYENRSNSEV------VEDISTGF--RLYKPRLA----STHVYQI 234
Query: 750 GETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779
C E DRP+ +L L +
Sbjct: 235 ---MNHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 211 bits (537), Expect = 1e-62
Identities = 70/305 (22%), Positives = 131/305 (42%), Gaps = 36/305 (11%)
Query: 492 FMFQEILDATNKFDESL---------LLGVGGFGRVYKGTL----DDGTKVAVKRGNPR- 537
F F++ +A +F + + ++G G FG V G L VA+K
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 538 SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPL 597
+E+ +F +E ++ + H +++ L G + + ++++ E+M NG L +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLD-SFLRQNDGQF 125
Query: 598 SWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657
+ Q + + G A G+ YL + +HRD+ NIL++ N V KV+DFGLS+
Sbjct: 126 TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182
Query: 658 QTHVSTAV---KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQV 714
T+ K + PE + ++ T SDV+S+G+V+ EV+ P +
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG-----ERPYWDM 237
Query: 715 NIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNL 774
+ ++ L MD P++L + C + RP G ++ L
Sbjct: 238 TNQDVINAIEQDYRLPPPMDC-------PSALHQL---MLDCWQKDRNHRPKFGQIVNTL 287
Query: 775 EYALQ 779
+ ++
Sbjct: 288 DKMIR 292
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 3e-62
Identities = 72/266 (27%), Positives = 115/266 (43%), Gaps = 21/266 (7%)
Query: 510 LGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDE 569
LG G FG V G VA+K EF E +++ L H LV L G C +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 570 RSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDV 629
+ + ++ EYMANG L ++L +Q LE+C + YL + + +HRD+
Sbjct: 71 QRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDL 126
Query: 630 KTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 689
N L++D V KV+DFGLS+ D+ S K + PE + + KSD++
Sbjct: 127 AARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 185
Query: 690 SFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKF 749
+FGV++ E+ +P E+ +E A + + L + +K
Sbjct: 186 AFGVLMWEIYSLGK-----MPYERFTNSETA----------EHIAQGLRLYRPHLASEKV 230
Query: 750 GETAEKCLAEHGVDRPSMGDVLWNLE 775
C E +RP+ +L N+
Sbjct: 231 YTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 208 bits (529), Expect = 2e-61
Identities = 76/307 (24%), Positives = 124/307 (40%), Gaps = 47/307 (15%)
Query: 502 NKFDESLLLGVGGFGRVYKGTL------DDGTKVAVKRGNPR-SEQGIAEFRTEIEMLSK 554
N + +G G FGRV++ + T VAVK S A+F+ E ++++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 555 LRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDL-------------------- 594
+ ++V L+G C M L++EYMA G L L
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 595 --PPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKT 652
PPLS ++L I A G+ YL + +HRD+ T N L+ +N V K+ADFGLS+
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 653 GPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPRE 712
+ D ++ PE + T +SDV+++GVVL E+ + E
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 249
Query: 713 QVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLW 772
+V + + D N++ + C ++ DRPS +
Sbjct: 250 EV--------------IYYVRDGNILACPENCP-LELYNLMRLCWSKLPADRPSFCSIHR 294
Query: 773 NLEYALQ 779
L+ +
Sbjct: 295 ILQRMCE 301
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 2e-61
Identities = 74/266 (27%), Positives = 116/266 (43%), Gaps = 21/266 (7%)
Query: 510 LGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDE 569
LG G FG V+ GT + T+VA+K P F E +++ KLRH LV L
Sbjct: 25 LGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-S 82
Query: 570 RSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDV 629
+ +V EYM+ G L L G L Q +++ A G+ Y+ + +HRD+
Sbjct: 83 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDL 139
Query: 630 KTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 689
+ NIL+ +N V KVADFGL++ ++ K + PE + T KSDV+
Sbjct: 140 RAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 198
Query: 690 SFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKF 749
SFG++L E+ P + +V LDQ+ + P +
Sbjct: 199 SFGILLTELTTKGRVPYPGMVNREV--------------LDQV-ERGYRMPCPPECPESL 243
Query: 750 GETAEKCLAEHGVDRPSMGDVLWNLE 775
+ +C + +RP+ + LE
Sbjct: 244 HDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (529), Expect = 4e-61
Identities = 60/301 (19%), Positives = 119/301 (39%), Gaps = 37/301 (12%)
Query: 500 ATNKFDESLLLGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGI-AEFRTEIEMLSKLRH 557
+ F++ LG G G V+K + G +A K + + I + E+++L +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 558 RHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLH 617
++V G E+ + E+M G L L + + ++ I +GL YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLR 121
Query: 618 TGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYF 677
I+HRDVK +NIL++ K+ DFG+S ++ + G+ Y+ PE
Sbjct: 122 E--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPERL 175
Query: 678 RRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQ-----------------------V 714
+ + +SD++S G+ L+E+ R + P +E
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235
Query: 715 NIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETA----EKCLAEHGVDRPSMGDV 770
++ + M + + +++D + F KCL ++ +R + +
Sbjct: 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
Query: 771 L 771
+
Sbjct: 296 M 296
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 1e-60
Identities = 70/293 (23%), Positives = 117/293 (39%), Gaps = 30/293 (10%)
Query: 510 LGVGGFGRVYKGTL---DDGTKVAVKRGNPRSEQG-IAEFRTEIEMLSKLRHRHLVSLIG 565
LG G FG V +G VA+K +E+ E E +++ +L + ++V LIG
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 566 YCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSII 625
C + ++LV E GPL L G + E+ + G+ YL ++ +
Sbjct: 77 VC-QAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEE---KNFV 131
Query: 626 HRDVKTTNILLDDNFVAKVADFGLSK-TGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTE 684
HRD+ N+LL + AK++DFGLSK G +A K + PE ++ +
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 191
Query: 685 KSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPA 744
+SDV+S+GV + E L P +++ E ++ ++ + P
Sbjct: 192 RSDVWSYGVTMWEALSYG-----QKPYKKMKGPEVMAFIEQGKRMECPPEC-------PP 239
Query: 745 SLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLEETSSALMEPEDNSTNH 797
L C DRP V + S + E + +H
Sbjct: 240 ELYAL---MSDCWIYKWEDRPDFLTVEQRMRACYY-----SLASKVEGHHHHH 284
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (516), Expect = 5e-60
Identities = 69/298 (23%), Positives = 123/298 (41%), Gaps = 42/298 (14%)
Query: 482 SLASSNLGRLFMFQEILDATNKFDESLLLGVGGFGRVYKGTL-DDGTKVAVKRGNPR--S 538
++ SN GR F + G G F VYKG + +VA R +
Sbjct: 1 AVGMSNDGRFLKFDIEI------------GRGSFKTVYKGLDTETTVEVAWCELQDRKLT 48
Query: 539 EQGIAEFRTEIEMLSKLRHRHLVSLIGYC----DERSEMILVYEYMANGPLRSHLYGTDL 594
+ F+ E EML L+H ++V + ++LV E M +G L+++L
Sbjct: 49 KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-- 106
Query: 595 PPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDD-NFVAKVADFGLSKTG 653
+ K C +GL +LHT IIHRD+K NI + K+ D GL+
Sbjct: 107 KVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-- 163
Query: 654 PALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQ 713
L + + AV G+ ++ PE + ++ E DVY+FG+ ++E+ +
Sbjct: 164 --LKRASFAKAVIGTPEFMAPEMY-EEKYDESVDVYAFGMCMLEMATSEYP--------- 211
Query: 714 VNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVL 771
++ + ++ + ++ + E E C+ ++ +R S+ D+L
Sbjct: 212 -----YSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 9e-60
Identities = 82/311 (26%), Positives = 137/311 (44%), Gaps = 33/311 (10%)
Query: 481 ISLASSNLGRLFMFQEIL----DATNKFDESLLLGVGGFGRVYKGTLDD----GTKVAVK 532
I L++ N + Q ++ F+E ++G G FG VY GTL D AVK
Sbjct: 4 IDLSALNPELVQAVQHVVIGPSSLIVHFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVK 61
Query: 533 RGNPRSEQG-IAEFRTEIEMLSKLRHRHLVSLIGYC-DERSEMILVYEYMANGPLRSHLY 590
N ++ G +++F TE ++ H +++SL+G C ++V YM +G LR+
Sbjct: 62 SLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF-I 120
Query: 591 GTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLS 650
+ + K + + A+G+ +L + + +HRD+ N +LD+ F KVADFGL+
Sbjct: 121 RNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLA 177
Query: 651 K--TGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPV 708
+ D H T K ++ E + Q+ T KSDV+SFGV+L E++
Sbjct: 178 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA----- 232
Query: 709 LPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMG 768
P VN + + + L Q + P L + KC RPS
Sbjct: 233 PPYPDVNTFDITVYLLQGRRLLQ-------PEYCPDPLYEV---MLKCWHPKAEMRPSFS 282
Query: 769 DVLWNLEYALQ 779
+++ +
Sbjct: 283 ELVSRISAIFS 293
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 2e-59
Identities = 71/295 (24%), Positives = 125/295 (42%), Gaps = 26/295 (8%)
Query: 502 NKFDESLLLGVGGFGRVYKGTLDDGT-----KVAVKRGNP-RSEQGIAEFRTEIEMLSKL 555
+ ++G G FG VYKG L + VA+K +E+ +F E ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 556 RHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHY 615
H +++ L G + M+++ EYM NG L L D S Q + + G A G+ Y
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKY 125
Query: 616 LHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKT-GPALDQTHVSTAVKGSFGYLDP 674
L + +HRD+ NIL++ N V KV+DFGLS+ + T+ ++ K + P
Sbjct: 126 LAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182
Query: 675 EYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMD 734
E ++ T SDV+SFG+V+ EV+ L +V + ++
Sbjct: 183 EAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV---------------MKAIN 227
Query: 735 SNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLEETSSALME 789
+ +C + RP D++ L+ ++ ++ L +
Sbjct: 228 DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLAD 282
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 3e-59
Identities = 68/280 (24%), Positives = 123/280 (43%), Gaps = 26/280 (9%)
Query: 498 LDATNKFDESLLLGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLR 556
L+ + ++ LG G FG+VYK + A K + +SE+ + ++ EI++L+
Sbjct: 8 LNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCD 67
Query: 557 HRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYL 616
H ++V L+ + + ++ E+ A G + + + + PL+ Q +C L+YL
Sbjct: 68 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYL 126
Query: 617 HTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEY 676
H IIHRD+K NIL + K+ADFG+S Q + G+ ++ PE
Sbjct: 127 H---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSFIGTPYWMAPEV 181
Query: 677 F-----RRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQ 731
+ + K+DV+S G+ L+E+ P P ++N + K
Sbjct: 182 VMCETSKDRPYDYKADVWSLGITLIEMAEIEP------PHHELNPMRVLLKIAKSEPPTL 235
Query: 732 IMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVL 771
S ++ K F +KCL ++ R + +L
Sbjct: 236 AQPSRW-----SSNFKDF---LKKCLEKNVDARWTTSQLL 267
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 1e-58
Identities = 65/301 (21%), Positives = 119/301 (39%), Gaps = 43/301 (14%)
Query: 509 LLGVGGFGRVYKGTL------DDGTKVAVKRGNPRSEQG-IAEFRTEIEMLSKL-RHRHL 560
LG G FG+V + T D VAVK P + +E+++LS L H ++
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 561 VSLIGYCDERSEMILVYEYMANGPLRSHLYG----------------TDLPPLSWKQRLE 604
V+L+G C +++ EY G L + L D L + L
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 605 ICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTA 664
A+G+ +L + ++ IHRD+ NILL + K+ DFGL++ V
Sbjct: 150 FSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 665 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQ 724
+ ++ PE T +SDV+S+G+ L E+ + P +P +
Sbjct: 207 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS----------- 255
Query: 725 KKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLEETS 784
+++ + + + + C + RP+ ++ +E Q+ E++
Sbjct: 256 ---KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK--QISEST 310
Query: 785 S 785
+
Sbjct: 311 N 311
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 2e-58
Identities = 69/276 (25%), Positives = 103/276 (37%), Gaps = 27/276 (9%)
Query: 506 ESLLLGVGGFGRVYKGTLDD---GTKVAVKRGNPRSEQG--IAEFRTEIEMLSKLRHRHL 560
E LG G FG V KG VAVK + E E ++ +L + ++
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 561 VSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGA 620
V +IG C E +LV E GPL +L + K +E+ + G+ YL
Sbjct: 71 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEE-- 125
Query: 621 AQSIIHRDVKTTNILLDDNFVAKVADFGLSK-TGPALDQTHVSTAVKGSFGYLDPEYFRR 679
+ +HRD+ N+LL AK++DFGLSK + T K + PE
Sbjct: 126 -SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 680 QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVG 739
+ + KSDV+SFGV++ E P + +E +K +
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYG-----QKPYRGMKGSEVTAMLEKGERMGCPAGC---- 235
Query: 740 KVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775
P + C +RP V L
Sbjct: 236 ---PREMYDL---MNLCWTYDVENRPGFAAVELRLR 265
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 5e-58
Identities = 64/296 (21%), Positives = 120/296 (40%), Gaps = 46/296 (15%)
Query: 509 LLGVGGFGRVYKGTL------DDGTKVAVKRGNPRSEQG-IAEFRTEIEMLSKL-RHRHL 560
+LG G FG+V T +VAVK +++ +E++M+++L H ++
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 561 VSLIGYCDERSEMILVYEYMANGPLRSHLYG---------------------TDLPPLSW 599
V+L+G C + L++EY G L ++L DL L++
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 600 KQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT 659
+ L A+G+ +L +S +HRD+ N+L+ V K+ DFGL++ +
Sbjct: 164 EDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220
Query: 660 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEW 719
V + ++ PE T KSDV+S+G++L E+ P +P +
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN----- 275
Query: 720 AMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLE 775
+++ + + ++ + C A RPS ++ L
Sbjct: 276 ---------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 5e-58
Identities = 83/318 (26%), Positives = 135/318 (42%), Gaps = 40/318 (12%)
Query: 502 NKFDESLLLGVGGFGRVYKGTL-DDGTK--VAVKRGNPR-SEQGIAEFRTEIEMLSKL-R 556
N ++G G FG+V K + DG + A+KR S+ +F E+E+L KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 557 HRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLP--------------PLSWKQR 602
H ++++L+G C+ R + L EY +G L L + + LS +Q
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 603 LEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVS 662
L ARG+ YL + IHRD+ NIL+ +N+VAK+ADFGLS+ +
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK 183
Query: 663 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMT 722
T + ++ E T SDV+S+GV+L E++ P + AE
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG-----TPYCGMTCAELYEK 238
Query: 723 WQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLEE 782
+ L++ ++ + +C E +RPS +L +L L+ +
Sbjct: 239 LPQGYRLEKPLNC-------DDEVYDL---MRQCWREKPYERPSFAQILVSLNRMLEERK 288
Query: 783 TSSALMEPEDNSTNHIPC 800
T E + I C
Sbjct: 289 TYVNTTLYEKFTYAGIDC 306
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 197 bits (502), Expect = 1e-57
Identities = 68/280 (24%), Positives = 108/280 (38%), Gaps = 33/280 (11%)
Query: 499 DATNKFDESLLLGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQG---IAEFRTEIEMLSK 554
D F + +G G FG VY + + VA+K+ + +Q + E+ L K
Sbjct: 12 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 71
Query: 555 LRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLH 614
LRH + + G LV EY PL + + GA +GL
Sbjct: 72 LRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLA 129
Query: 615 YLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDP 674
YLH + ++IHRDVK NILL + + K+ DFG + + + G+ ++ P
Sbjct: 130 YLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSAS------IMAPANSFVGTPYWMAP 180
Query: 675 EYFR---RQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQ 731
E Q K DV+S G+ +E+ +P P +N L
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKP------PLFNMNAMS---------ALYH 225
Query: 732 IMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVL 771
I + + + F + CL + DRP+ +L
Sbjct: 226 IAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLL 265
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 6e-57
Identities = 69/334 (20%), Positives = 127/334 (38%), Gaps = 31/334 (9%)
Query: 494 FQEILDATNKFDESLLLGVGGFGRVYKGTLDD-----GTKVAVKRGNPR-SEQGIAEFRT 547
IL T F + +LG G FG VYKG VA+K S + E
Sbjct: 2 LLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 60
Query: 548 EIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICI 607
E +++ + + H+ L+G C S + L+ + M G L ++ + + L C+
Sbjct: 61 EAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCV 118
Query: 608 GAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKG 667
A+G++YL + ++HRD+ N+L+ K+ DFGL+K A ++ + + K
Sbjct: 119 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 175
Query: 668 SFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKG 727
++ E + T +SDV+S+GV + E++ +P +
Sbjct: 176 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------------- 221
Query: 728 MLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLEETSSAL 787
+ I++ P KC RP +++ + + +
Sbjct: 222 -ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVI 280
Query: 788 MEPE----DNSTNHIPCIQLTPLEPFDNSVSMID 817
E + T+ L E D+ V +
Sbjct: 281 QGDERMHLPSPTDSNFYRALMDEEDMDDVVDADE 314
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 7e-57
Identities = 63/274 (22%), Positives = 108/274 (39%), Gaps = 31/274 (11%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVKRGNPRS--EQGIAEFRTEIEMLSKLRHRHLVSLIG 565
+G G +GR K DG + K + S E +E+ +L +L+H ++V
Sbjct: 11 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 70
Query: 566 YCDERSE--MILVYEYMANGPLRSHL--YGTDLPPLSWKQRLEICIGAARGLHYLH--TG 619
+R+ + +V EY G L S + + L + L + L H +
Sbjct: 71 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 130
Query: 620 AAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRR 679
+++HRD+K N+ LD K+ DFGL++ T + A G+ Y+ PE R
Sbjct: 131 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN--HDTSFAKAFVGTPYYMSPEQMNR 188
Query: 680 QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNL-- 737
EKSD++S G +L E+ P P + E + +I +
Sbjct: 189 MSYNEKSDIWSLGCLLYELCALMP------PFTAFSQKE---------LAGKIREGKFRR 233
Query: 738 VGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVL 771
+ L + + L RPS+ ++L
Sbjct: 234 IPYRYSDELNEI---ITRMLNLKDYHRPSVEEIL 264
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 9e-57
Identities = 65/267 (24%), Positives = 107/267 (40%), Gaps = 30/267 (11%)
Query: 509 LLGVGGFGRVYKGTL-DDGTKVAVK---RGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLI 564
LG G FG VY +A+K + + R E+E+ S LRH +++ L
Sbjct: 13 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 72
Query: 565 GYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSI 624
GY + + + L+ EY G + L L ++ A L Y H+ + +
Sbjct: 73 GYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTATYITELANALSYCHS---KRV 127
Query: 625 IHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTE 684
IHRD+K N+LL K+ADFG S P + T + G+ YL PE + E
Sbjct: 128 IHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPEMIEGRMHDE 183
Query: 685 KSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPA 744
K D++S GV+ E L +P +E +++ ++ +
Sbjct: 184 KVDLWSLGVLCYEFLVGKPPFEANTYQET---------YKRISRVEFTFPDFV-----TE 229
Query: 745 SLKKFGETAEKCLAEHGVDRPSMGDVL 771
+ + L + RP + +VL
Sbjct: 230 GARDL---ISRLLKHNPSQRPMLREVL 253
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 2e-56
Identities = 61/274 (22%), Positives = 112/274 (40%), Gaps = 23/274 (8%)
Query: 499 DATNKFDESLLLGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRH 557
D K+ +G G G VY + G +VA+++ N + + EI ++ + ++
Sbjct: 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN 76
Query: 558 RHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLH 617
++V+ + E+ +V EY+A G L + T + Q +C + L +LH
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH 133
Query: 618 TGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYF 677
+ +IHRD+K+ NILL + K+ DFG + + + G+ ++ PE
Sbjct: 134 ---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVV 188
Query: 678 RRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNL 737
R+ K D++S G++ +E++ P P N G + L
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEP------PYLNENPLRALYLIATNGTPELQNPEKL 242
Query: 738 VGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVL 771
A + F +CL R S ++L
Sbjct: 243 -----SAIFRDF---LNRCLDMDVEKRGSAKELL 268
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 7e-56
Identities = 66/279 (23%), Positives = 108/279 (38%), Gaps = 26/279 (9%)
Query: 509 LLGVGGFGRVYKGTL----DDGTKVAVKRGNPRSEQGIAE-FRTEIEMLSKLRHRHLVSL 563
+G G FG V++G + VA+K + + E F E + + H H+V L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 564 IGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQS 623
IG E + ++ E G LRS L + + L YL + +
Sbjct: 74 IGVITEN-PVWIIMELCTLGELRSF-LQVRKYSLDLASLILYAYQLSTALAYLES---KR 128
Query: 624 IIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLT 683
+HRD+ N+L+ N K+ DFGLS+ + ++ K ++ PE ++ T
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESINFRRFT 187
Query: 684 EKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNP 743
SDV+ FGV + E+L V P + V + + L + P
Sbjct: 188 SASDVWMFGVCMWEILMHG-----VKPFQGVKNNDVIGRIENGERLPMPPNC-------P 235
Query: 744 ASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLEE 782
+L KC A RP ++ L L+ E+
Sbjct: 236 PTLYSL---MTKCWAYDPSRRPRFTELKAQLSTILEEEK 271
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 3e-55
Identities = 61/266 (22%), Positives = 102/266 (38%), Gaps = 22/266 (8%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAE-FRTEIEMLSKLRHRHLVSLIGY 566
LG G +G V VAVK + + E + EI + L H ++V G+
Sbjct: 12 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71
Query: 567 CDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIH 626
E + L EY + G L + + G+ YLH I H
Sbjct: 72 RREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLH---GIGITH 126
Query: 627 RDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQL-TEK 685
RD+K N+LLD+ K++DFGL+ ++ + + G+ Y+ PE +R++ E
Sbjct: 127 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 186
Query: 686 SDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPAS 745
DV+S G+VL +L + Q ++W +I ++
Sbjct: 187 VDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEKKTYLNPWKKI----------DSA 235
Query: 746 LKKFGETAEKCLAEHGVDRPSMGDVL 771
K L E+ R ++ D+
Sbjct: 236 PLAL---LHKILVENPSARITIPDIK 258
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 8e-54
Identities = 64/270 (23%), Positives = 98/270 (36%), Gaps = 27/270 (10%)
Query: 510 LGVGGFGRVYKGTLD----DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLRHRHLVS 562
LG G FG V +G D VAVK P + + +F E+ + L HR+L+
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 563 LIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQ 622
L G M +V E G L L + A G+ YL ++
Sbjct: 76 LYGVVLTP-PMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLE---SK 130
Query: 623 SIIHRDVKTTNILLDDNFVAKVADFGLSK-TGPALDQTHVSTAVKGSFGYLDPEYFRRQQ 681
IHRD+ N+LL + K+ DFGL + D + K F + PE + +
Sbjct: 131 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 190
Query: 682 LTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKV 741
+ SD + FGV L E+ P +N ++ +L +I
Sbjct: 191 FSHASDTWMFGVTLWEMFTYGQ-----EPWIGLNGSQ---------ILHKIDKEGERLPR 236
Query: 742 NPASLKKFGETAEKCLAEHGVDRPSMGDVL 771
+ +C A DRP+ +
Sbjct: 237 PEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 1e-53
Identities = 75/307 (24%), Positives = 127/307 (41%), Gaps = 33/307 (10%)
Query: 502 NKFDESLLLGVGGFGRVYKGTL------DDGTKVAVKRGNPR-SEQGIAEFRTEIEMLSK 554
K S LG G FG VY+G + T+VA+K N S + EF E ++ +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 555 LRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLY--------GTDLPPLSWKQRLEIC 606
H+V L+G + +++ E M G L+S+L L P S + +++
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 607 IGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVK 666
A G+ YL+ A +HRD+ N ++ ++F K+ DFG+++ D
Sbjct: 140 GEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 667 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKK 726
++ PE + T SDV+SFGVVL E+ L EQV
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV------------ 244
Query: 727 GMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLEETSSA 786
L +M+ L+ K + E C + RPS +++ +++ ++ +
Sbjct: 245 --LRFVMEGGLLDKPDNCP-DMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 301
Query: 787 LMEPEDN 793
E+N
Sbjct: 302 FYYSEEN 308
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 186 bits (474), Expect = 3e-53
Identities = 62/266 (23%), Positives = 103/266 (38%), Gaps = 23/266 (8%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYC 567
LG G FG V++ T G A K E R EI+ +S LRH LV+L
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 568 DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHR 627
++ +EM+++YE+M+ G L + +S + +E +GL ++H + +H
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHL 148
Query: 628 DVKTTNILL--DDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEK 685
D+K NI+ + K+ DFGL+ LD G+ + PE + +
Sbjct: 149 DLKPENIMFTTKRSNELKLIDFGLTA---HLDPKQSVKVTTGTAEFAAPEVAEGKPVGYY 205
Query: 686 SDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPAS 745
+D++S GV+ +L E + +D S +
Sbjct: 206 TDMWSVGVLSYILLSGLSPFGGENDDETLR-----NVKSCDWNMDDSAFSGI-----SED 255
Query: 746 LKKFGETAEKCLAEHGVDRPSMGDVL 771
K F K L R ++ L
Sbjct: 256 GKDF---IRKLLLADPNTRMTIHQAL 278
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 1e-52
Identities = 72/296 (24%), Positives = 130/296 (43%), Gaps = 42/296 (14%)
Query: 509 LLGVGGFGRVYKGTL--------DDGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKL-RHR 558
LG G FG+V + TKVAVK +E+ +++ +E+EM+ + +H+
Sbjct: 20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79
Query: 559 HLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPP--------------LSWKQRLE 604
++++L+G C + + ++ EY + G LR +L P LS K +
Sbjct: 80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139
Query: 605 ICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTA 664
ARG+ YL ++ IHRD+ N+L+ ++ V K+ADFGL++ +D +T
Sbjct: 140 CAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196
Query: 665 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQ 724
+ ++ PE + T +SDV+SFGV+L E+ P V + E +
Sbjct: 197 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG-----SPYPGVPVEELFKLLK 251
Query: 725 KKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQL 780
+ +D+ + L C RP+ ++ +L+ + L
Sbjct: 252 EGHRMDKPSNC-------TNELYMM---MRDCWHAVPSQRPTFKQLVEDLDRIVAL 297
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (459), Expect = 7e-52
Identities = 55/269 (20%), Positives = 98/269 (36%), Gaps = 30/269 (11%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLRHRHLVSLI 564
+LG G F V L + A+K R E + E +++S+L H V L
Sbjct: 15 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 74
Query: 565 GYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSI 624
+ ++ Y NG L ++ + L YLH + I
Sbjct: 75 FTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSALEYLH---GKGI 129
Query: 625 IHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTE 684
IHRD+K NILL+++ ++ DFG +K + + + G+ Y+ PE + +
Sbjct: 130 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACK 189
Query: 685 KSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLV--GKVN 742
SD+++ G ++ +++ P P N + +I+ K
Sbjct: 190 SSDLWALGCIIYQLVAGLP------PFRAGNEYL---------IFQKIIKLEYDFPEKFF 234
Query: 743 PASLKKFGETAEKCLAEHGVDRPSMGDVL 771
P + EK L R ++
Sbjct: 235 PK-ARDL---VEKLLVLDATKRLGCEEME 259
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 178 bits (452), Expect = 4e-50
Identities = 61/266 (22%), Positives = 109/266 (40%), Gaps = 23/266 (8%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYC 567
LG G FG V++ G K N + EI ++++L H L++L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 568 DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHR 627
+++ EM+L+ E+++ G L + D +S + + A GL ++H SI+H
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMH---EHSIVHL 151
Query: 628 DVKTTNILLD--DNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEK 685
D+K NI+ + K+ DFGL+ L+ + + + PE R+ +
Sbjct: 152 DIKPENIMCETKKASSVKIIDFGLAT---KLNPDEIVKVTTATAEFAAPEIVDREPVGFY 208
Query: 686 SDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPAS 745
+D+++ GV+ +L P + E T Q D D + V+P
Sbjct: 209 TDMWAIGVLGYVLLSGLS------PFAGEDDLE---TLQNVKRCDWEFDEDAFSSVSPE- 258
Query: 746 LKKFGETAEKCLAEHGVDRPSMGDVL 771
K F + L + R ++ D L
Sbjct: 259 AKDF---IKNLLQKEPRKRLTVHDAL 281
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 5e-50
Identities = 64/294 (21%), Positives = 112/294 (38%), Gaps = 40/294 (13%)
Query: 509 LLGVGGFGRVYKGT------LDDGTKVAVKRGNPRSEQG-IAEFRTEIEMLSKLRHRH-L 560
LG G FG+V + VAVK + +E+++L + H +
Sbjct: 20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79
Query: 561 VSLIGYCDERSEMI-LVYEYMANGPLRSHLYG--------------TDLPPLSWKQRLEI 605
V+L+G C + + ++ E+ G L ++L L+ + +
Sbjct: 80 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139
Query: 606 CIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAV 665
A+G+ +L + + IHRD+ NILL + V K+ DFGL++
Sbjct: 140 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 196
Query: 666 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQK 725
+ ++ PE + T +SDV+SFGV+L E+ P V I E K
Sbjct: 197 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA-----SPYPGVKIDEEFCRRLK 251
Query: 726 KGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779
+G + D + + C RP+ +++ +L LQ
Sbjct: 252 EGTRMRAPDY------TTPEMYQT---MLDCWHGEPSQRPTFSELVEHLGNLLQ 296
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 171 bits (434), Expect = 1e-48
Identities = 71/285 (24%), Positives = 118/285 (41%), Gaps = 28/285 (9%)
Query: 501 TNKFDESLLLGVGGFGRVYKGT-LDDGTKVAVKRGNP---RSEQGIAEFRTEIEMLSKLR 556
+++++ +LG GG V+ L VAVK R FR E + + L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 557 HRHLVSLIGYCDERSE----MILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARG 612
H +V++ + + +V EY+ LR ++ P++ K+ +E+ A +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQA 123
Query: 613 LHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKT-GPALDQTHVSTAVKGSFGY 671
L++ H IIHRDVK NI++ KV DFG+++ + + + AV G+ Y
Sbjct: 124 LNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 180
Query: 672 LDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQ 731
L PE R + +SDVYS G VL EVL P P ++ +
Sbjct: 181 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY-----QHVREDPIPPS 235
Query: 732 IMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRP-SMGDVLWNLE 775
L A L K LA++ +R + ++ +L
Sbjct: 236 ARHEGL-----SADLDAV---VLKALAKNPENRYQTAAEMRADLV 272
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 2e-47
Identities = 44/270 (16%), Positives = 105/270 (38%), Gaps = 32/270 (11%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYC 567
LG G FG V++ K + + EI +L+ RHR+++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70
Query: 568 DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHR 627
+ E+++++E+++ + + T L+ ++ + L +LH + +I H
Sbjct: 71 ESMEELVMIFEFISGLDIFERIN-TSAFELNEREIVSYVHQVCEALQFLH---SHNIGHF 126
Query: 628 DVKTTNILLD--DNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEK 685
D++ NI+ + K+ +FG ++ L + + Y PE + ++
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQAR---QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTA 183
Query: 686 SDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPAS 745
+D++S G ++ +L ++ +++ IM++ + +
Sbjct: 184 TDMWSLGTLVYVLLSGINPFLAETNQQ---------------IIENIMNAEY--TFDEEA 226
Query: 746 LKKFGETA----EKCLAEHGVDRPSMGDVL 771
K+ A ++ L + R + + L
Sbjct: 227 FKEISIEAMDFVDRLLVKERKSRMTASEAL 256
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 165 bits (418), Expect = 2e-46
Identities = 64/284 (22%), Positives = 104/284 (36%), Gaps = 46/284 (16%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVKRGNPRS---------EQGIAEFRTEIEMLSKLR-H 557
+LG G V + + AVK + ++ E+++L K+ H
Sbjct: 10 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 69
Query: 558 RHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLH 617
+++ L + + LV++ M G L +L LS K+ +I + LH
Sbjct: 70 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALH 127
Query: 618 TGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYF 677
+I+HRD+K NILLDD+ K+ DFG S LD V G+ YL PE
Sbjct: 128 ---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGEKLREVCGTPSYLAPEII 181
Query: 678 R------RQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQ 731
++ D++S GV++ +L P P ML
Sbjct: 182 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP------PFWHRKQML---------MLRM 226
Query: 732 IMDSNLVGKVNPASLKKFGETA----EKCLAEHGVDRPSMGDVL 771
IM N + + +T + L R + + L
Sbjct: 227 IMSGNY--QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEAL 268
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 165 bits (418), Expect = 4e-46
Identities = 58/283 (20%), Positives = 111/283 (39%), Gaps = 26/283 (9%)
Query: 494 FQEILDATNKFDESLLLGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGI-AEFRTEIEM 551
+++ D + +D +LG G F V VA+K ++ +G EI +
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 552 LSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAAR 611
L K++H ++V+L + + L+ + ++ G L + + + +
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLD 118
Query: 612 GLHYLHTGAAQSIIHRDVKTTNILL---DDNFVAKVADFGLSKTGPALDQTHVSTAVKGS 668
+ YLH I+HRD+K N+L D++ ++DFGLSK D V + G+
Sbjct: 119 AVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGT 172
Query: 669 FGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGM 728
GY+ PE ++ ++ D +S GV+ +LC P + + + +
Sbjct: 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL-----FEQILKAEYE 227
Query: 729 LDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVL 771
D ++ S K F + + R + L
Sbjct: 228 FDSPYWDDI-----SDSAKDF---IRHLMEKDPEKRFTCEQAL 262
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 2e-45
Identities = 64/294 (21%), Positives = 114/294 (38%), Gaps = 29/294 (9%)
Query: 500 ATNKFDESLLLGVGGFGRVYKGT--LDDGTKVAVK--RGNPRSEQGIAEFRTEIEMLSKL 555
A +++ +G G +G+V+K + G VA+K R E E+ +L L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 556 ---RHRHLVSLIGYC-----DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICI 607
H ++V L C D +++ LV+E++ ++L P + + ++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLT-TYLDKVPEPGVPTETIKDMMF 123
Query: 608 GAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKG 667
RGL +LH+ ++HRD+K NIL+ + K+ADFGL++ T+V
Sbjct: 124 QLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSVVV 177
Query: 668 SFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQ------VNIAEWAM 721
+ Y PE + D++S G + E+ +P +Q V
Sbjct: 178 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237
Query: 722 TWQKKGMLDQIMDSNLVGKVNPASLKKFGETA----EKCLAEHGVDRPSMGDVL 771
W + L + + + + E KCL + R S L
Sbjct: 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 291
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 8e-45
Identities = 68/330 (20%), Positives = 130/330 (39%), Gaps = 25/330 (7%)
Query: 496 EILDATNKFDESLLLGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAE-FRTEIEMLS 553
++ D ++ +G G +G V + +VA+K+ +P Q + EI++L
Sbjct: 2 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61
Query: 554 KLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYG-TDLPPLSWKQRLEICIGAARG 612
+ RH +++ + + + Y+ + + LY LS RG
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRG 121
Query: 613 LHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKT-GPALDQTHVSTAVKGSFGY 671
L Y+H+ +++HRD+K +N+LL+ K+ DFGL++ P D T T + Y
Sbjct: 122 LKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178
Query: 672 LDPEYFRRQQL-TEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLD 730
PE + T+ D++S G +L E+L RP +Q+N + + L+
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238
Query: 731 QIMDSNLVGKV------NPASLKKFGETA--------EKCLAEHGVDRPSMGDVL---WN 773
I++ + N + A +K L + R + L +
Sbjct: 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 298
Query: 774 LEYALQLEETSSALMEPEDNSTNHIPCIQL 803
+Y +E + D + +P +L
Sbjct: 299 EQYYDPSDEPIAEAPFKFDMELDDLPKEKL 328
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (404), Expect = 3e-44
Identities = 48/281 (17%), Positives = 95/281 (33%), Gaps = 26/281 (9%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYC 567
+G G FG +Y GT + G +VA+K +++ + E ++ ++ + I +C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 568 -DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIH 626
E ++V E + + + S K L + + Y+H +++ IH
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIH---SKNFIH 126
Query: 627 RDVKTTNIL---LDDNFVAKVADFGLSK-----TGPALDQTHVSTAVKGSFGYLDPEYFR 678
RDVK N L + + DFGL+K + + G+ Y
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186
Query: 679 RQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLV 738
+ + + D+ S G VLM + + E + ++ +
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKG--- 243
Query: 739 GKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779
P+ + C + D+P +
Sbjct: 244 ---YPSEFATY---LNFCRSLRFDDKPDYSYLRQLFRNLFH 278
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 158 bits (401), Expect = 1e-43
Identities = 62/281 (22%), Positives = 110/281 (39%), Gaps = 25/281 (8%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLRHRHLVSLI 564
LG G FGRV+ +G A+K + + E MLS + H ++ +
Sbjct: 11 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70
Query: 565 GYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSI 624
G + ++ ++ +Y+ G L S L + P + + L YLH+ + I
Sbjct: 71 GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV--CLALEYLHS---KDI 125
Query: 625 IHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTE 684
I+RD+K NILLD N K+ DFG +K P + T G+ Y+ PE + +
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC-----GTPDYIAPEVVSTKPYNK 180
Query: 685 KSDVYSFGVVLMEVLCTRPALNPVLPREQV-NIAEWAMTWQKK--GMLDQIMDSNLVGKV 741
D +SFG+++ E+L + I + + + ++ +
Sbjct: 181 SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLIT--R 238
Query: 742 NPAS-LKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLE 781
+ + L E H P +V+W + +E
Sbjct: 239 DLSQRLGNLQNGTEDVK-NH----PWFKEVVWEKLLSRNIE 274
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 3e-43
Identities = 55/272 (20%), Positives = 105/272 (38%), Gaps = 29/272 (10%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKL-RHRHLVSLIGY 566
+LG+G G+V + K A+K + R E+E+ + + H+V ++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVDV 73
Query: 567 CD----ERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQ 622
+ R +++V E + G L S + + ++ EI + YLH +
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SI 130
Query: 623 SIIHRDVKTTNILLD---DNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRR 679
+I HRDVK N+L N + K+ DFG +K + T + Y+ PE
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE---TTSHNSLTTPCYTPYYVAPEVLGP 187
Query: 680 QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVG 739
++ + D++S GV++ +LC P P + + + + + Q N
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYP------PFYSNHGLAISPGMKTRIRMGQYEFPNPEW 241
Query: 740 KVNPASLKKFGETAEKCLAEHGVDRPSMGDVL 771
+K L R ++ + +
Sbjct: 242 SEVSEEVKML---IRNLLKTEPTQRMTITEFM 270
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 155 bits (392), Expect = 7e-43
Identities = 53/284 (18%), Positives = 103/284 (36%), Gaps = 20/284 (7%)
Query: 502 NKFDESLLLGVGGFGRVYKGTLDDGTKVAVK--RGNPRSEQGIAEFRTEIEMLSKLRHRH 559
K+ +G G +G VYK + G A+K R E + EI +L +L+H +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 560 LVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTG 619
+V L + ++LV+E++ + L + G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCH-- 117
Query: 620 AAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRR 679
+ ++HRD+K N+L++ K+ADFGL++ + + + +
Sbjct: 118 -DRRVLHRDLKPQNLLINREGELKIADFGLARA-FGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 680 QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVG 739
++ + D++S G + E++ P V +Q+ + + +
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 740 KVNPASLKKFGETAEKCLAEHGVD------------RPSMGDVL 771
E+ K L E G+D R + L
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 157 bits (398), Expect = 8e-43
Identities = 51/231 (22%), Positives = 93/231 (40%), Gaps = 17/231 (7%)
Query: 502 NKFDESLLLGVGGFGRVYKGT-LDDGTKVAVKRGNP---RSEQGIAEFRTE---IEMLSK 554
N F ++G GGFG VY D G A+K + + +QG E + ++S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 555 LRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLH 614
+V + ++ + + M G L HL + S GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEIILGLE 121
Query: 615 YLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDP 674
++H + +++RD+K NILLD++ +++D GL+ A G+ GY+ P
Sbjct: 122 HMH---NRFVVYRDLKPANILLDEHGHVRISDLGLAC----DFSKKKPHASVGTHGYMAP 174
Query: 675 EYFRRQQ-LTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQ 724
E ++ +D +S G +L ++L +++ I +T
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA 225
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 1e-42
Identities = 52/200 (26%), Positives = 82/200 (41%), Gaps = 12/200 (6%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVK---RGNPRSEQGIAEFRTEIEMLSK-LRHRHLVSL 563
+LG G FG+V+ A+K + + + E +LS H L +
Sbjct: 9 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 68
Query: 564 IGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQS 623
+ + V EY+ G L H+ + GL +LH+ +
Sbjct: 69 FCTFQTKENLFFVMEYLNGGDLMYHIQ--SCHKFDLSRATFYAAEIILGLQFLHS---KG 123
Query: 624 IIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLT 683
I++RD+K NILLD + K+ADFG+ K D G+ Y+ PE Q+
Sbjct: 124 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAPEILLGQKYN 181
Query: 684 EKSDVYSFGVVLMEVLCTRP 703
D +SFGV+L E+L +
Sbjct: 182 HSVDWWSFGVLLYEMLIGQS 201
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 1e-42
Identities = 54/284 (19%), Positives = 106/284 (37%), Gaps = 20/284 (7%)
Query: 503 KFDESLLLGVGGFGRVYKGT-LDDGTKVAVK--RGNPRSEQGIAEFRTEIEMLSKLRHRH 559
F + +G G +G VYK G VA+K R + +E + EI +L +L H +
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 560 LVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTG 619
+V L+ +++ LV+E++ + L+ + + L + +GL + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119
Query: 620 AAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRR 679
+ ++HRD+K N+L++ K+ADFGL++ + V +
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEILLGC 177
Query: 680 QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQV-NIAEWAMTWQKKGMLDQIMDSNLV 738
+ + D++S G + E++ R +Q+ I T + +
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 739 GKVNPASLKKFGETA-----------EKCLAEHGVDRPSMGDVL 771
+ + F + + L R S L
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 281
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 154 bits (390), Expect = 2e-42
Identities = 48/283 (16%), Positives = 90/283 (31%), Gaps = 28/283 (9%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHR-HLVSLIGY 566
+G G FG +++GT L + +VA+K RS+ + R E L + ++ +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 567 CDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIH 626
E +LV + + GP L S K + +H +S+++
Sbjct: 70 GQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVY 124
Query: 627 RDVKTTNILLDDNFV-----AKVADFGLSK-----TGPALDQTHVSTAVKGSFGYLDPEY 676
RD+K N L+ V DFG+ K + G+ Y+
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184
Query: 677 FRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSN 736
++ + + D+ + G V M L + E ++ L ++
Sbjct: 185 HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAG- 243
Query: 737 LVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779
P K+ P + L+
Sbjct: 244 -----FPEEFYKY---MHYARNLAFDATPDYDYLQGLFSKVLE 278
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 4e-42
Identities = 65/281 (23%), Positives = 108/281 (38%), Gaps = 25/281 (8%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAE-----FRTEIEMLSKLRHRHLVS 562
LG G F VYK + VA+K+ + EI++L +L H +++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 563 LIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQ 622
L+ +S + LV+++M + L+ + +GL YLH
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLH---QH 119
Query: 623 SIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQL 682
I+HRD+K N+LLD+N V K+ADFGL+K+ T + Y PE ++
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFG--SPNRAYTHQVVTRWYRAPELLFGARM 177
Query: 683 -TEKSDVYSFGVVLMEVLCTRPALNPVLPREQV-NIAEWAMTWQKKGMLD--QIMDSNLV 738
D+++ G +L E+L P L +Q+ I E T ++ D + D
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 739 GKVNPASLKKFGETA--------EKCLAEHGVDRPSMGDVL 771
L A + + R + L
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 278
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 4e-41
Identities = 62/274 (22%), Positives = 111/274 (40%), Gaps = 32/274 (11%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVKR------GNPRSEQGIAEFRTEIEMLSKLRHRHLV 561
LG G F V K G + A K + R + E+ +L +++H +++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 562 SLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAA 621
+L + ++++IL+ E +A G L L + L+ ++ E G++YLH+
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLA--EKESLTEEEATEFLKQILNGVYYLHS--- 131
Query: 622 QSIIHRDVKTTNILLDDNFVA----KVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYF 677
I H D+K NI+L D V K+ DFGL+ +D + + G+ ++ PE
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPEIV 188
Query: 678 RRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNL 737
+ L ++D++S GV+ +L +E A + SN
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-----LANVSAVNYEFEDEYFSNT 243
Query: 738 VGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVL 771
A K F + L + R ++ D L
Sbjct: 244 -----SALAKDF---IRRLLVKDPKKRMTIQDSL 269
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 3e-40
Identities = 64/289 (22%), Positives = 106/289 (36%), Gaps = 30/289 (10%)
Query: 504 FDESLLLGVGGFGRVYKGTL-DDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVS 562
+ ++ ++G G FG VY+ L D G VA+K+ E++++ KL H ++V
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVR 77
Query: 563 LIGYCDERSE------MILVYEYMANGPLRSHL-YGTDLPPLSWKQRLEICIGAARGLHY 615
L + E + LV +Y+ R Y L R L Y
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 616 LHTGAAQSIIHRDVKTTNILLD-DNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDP 674
+H + I HRD+K N+LLD D V K+ DFG +K + + + +
Sbjct: 138 IH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYICSRYYRAPE 192
Query: 675 EYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQV-NIAEWAMTWQKKGM----- 728
F T DV+S G VL E+L +P +Q+ I + T ++ +
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252
Query: 729 ------LDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVL 771
QI P + + + L R + +
Sbjct: 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 4e-40
Identities = 56/274 (20%), Positives = 99/274 (36%), Gaps = 42/274 (15%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVKR------GNPRSEQGIAEFRTEIEMLSKLRHRH-- 559
LLG GGFG VY G + D VA+K + E+ +L K+
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 560 LVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTG 619
++ L+ + + +L+ E T+ L + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCHN- 128
Query: 620 AAQSIIHRDVKTTNILLD-DNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFR 678
++HRD+K NIL+D + K+ DFG L + V T G+ Y PE+ R
Sbjct: 129 --CGVLHRDIKDENILIDLNRGELKLIDFGSGA----LLKDTVYTDFDGTRVYSPPEWIR 182
Query: 679 RQQL-TEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNL 737
+ + V+S G++L +++C P E++ + +
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDI---PFEHDEEIIRGQV------------FFRQRV 227
Query: 738 VGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVL 771
+ + CLA DRP+ ++
Sbjct: 228 -----SSECQHL---IRWCLALRPSDRPTFEEIQ 253
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 1e-38
Identities = 62/302 (20%), Positives = 116/302 (38%), Gaps = 34/302 (11%)
Query: 499 DATNKFDESLLLGVGGFGRVYKGT-LDDGTKVAVKRGNPRS--EQGIAEFRTEIEMLSKL 555
D +K+++ +G G FG V+K G KVA+K+ + E EI++L L
Sbjct: 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 66
Query: 556 RHRHLVSLIGYCDERSE--------MILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICI 607
+H ++V+LI C ++ + LV+++ + L + + +
Sbjct: 67 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQ 124
Query: 608 GAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVS--TAV 665
GL+Y+H I+HRD+K N+L+ + V K+ADFGL++ + + T
Sbjct: 125 MLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 181
Query: 666 KGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQ 724
+ Y PE ++ D++ G ++ E+ P + + Q+ +
Sbjct: 182 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241
Query: 725 KKGMLDQIMDSNLVGKVN---------PASLKKFGETAE------KCLAEHGVDRPSMGD 769
+ + + L K+ LK + K L R D
Sbjct: 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 301
Query: 770 VL 771
L
Sbjct: 302 AL 303
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 1e-38
Identities = 58/206 (28%), Positives = 86/206 (41%), Gaps = 11/206 (5%)
Query: 502 NKFDESLLLGVGGFGRVYKGT-LDDGTKVAVK---RGNPRSEQGIAEFRTEIEMLSKLRH 557
N FD LLG G FG+V G A+K + ++ +A TE +L RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 558 RHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLH 617
L +L + V EY G L HL + ++ L YLH
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLH 122
Query: 618 TGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYF 677
+ + +++RD+K N++LD + K+ DFGL K G + T G+ YL PE
Sbjct: 123 S---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLAPEVL 177
Query: 678 RRQQLTEKSDVYSFGVVLMEVLCTRP 703
D + GVV+ E++C R
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRL 203
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 144 bits (364), Expect = 2e-38
Identities = 65/321 (20%), Positives = 107/321 (33%), Gaps = 29/321 (9%)
Query: 502 NKFDESLLLGVGGFGRVYKGT-LDDGTKVAVK---RGNPRSEQGIAEFRTEIEMLSKLRH 557
++FD LG G FGRV + G A+K + + I E +L +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 558 RHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLH 617
LV L + S + +V EY+A G + SHL + S YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR--RIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 618 TGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYF 677
+ +I+RD+K N+L+D +V DFG +K T + G+ L PE
Sbjct: 159 ---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEII 210
Query: 678 RRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGM---LDQIMD 734
+ + D ++ GV++ E+ P P + L ++
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 735 SNLVGKVNPAS-LKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLEETSSALMEPEDN 793
+ L +V+ H W Y ++E A P+
Sbjct: 271 NLL--QVDLTKRFGNLKNGVNDIK-NH----KWFATTDWIAIYQRKVE----APFIPKFK 319
Query: 794 STNHIPCIQLTPLEPFDNSVS 814
E S++
Sbjct: 320 GPGDTSNFDDYEEEEIRVSIN 340
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (357), Expect = 4e-38
Identities = 52/286 (18%), Positives = 105/286 (36%), Gaps = 22/286 (7%)
Query: 502 NKFDESLLLGVGGFGRVYKGT-LDDGTKVAVK--RGNPRSEQGIAEFRTEIEMLSKLRHR 558
K+++ +G G +G V+K + VA+K R + E + EI +L +L+H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 559 HLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHT 618
++V L ++ LV+E+ + + +GL + H+
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD--PEIVKSFLFQLLKGLGFCHS 119
Query: 619 GAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFR 678
++++HRD+K N+L++ N K+A+FGL++ + S V + F
Sbjct: 120 ---RNVLHRDLKPQNLLINRNGELKLANFGLARA-FGIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 679 RQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQV--NIAEWAMTWQKKGMLDQIMDSN 736
+ + D++S G + E+ L P + I T ++ +
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235
Query: 737 LVGKVNPASLKKFGETA-----------EKCLAEHGVDRPSMGDVL 771
+ + L + V R S + L
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 8e-38
Identities = 59/308 (19%), Positives = 112/308 (36%), Gaps = 40/308 (12%)
Query: 492 FMFQEILDATNKFDESL----LLGVGGFGRVYKGT-LDDGTKVAVK--RGNPRSEQGIAE 544
F QE+ + +G G +G V G KVA+K +SE
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 545 FRTEIEMLSKLRHRHLVSLIGYC------DERSEMILVYEYMANGPLRSHLYGTDLPPLS 598
E+ +L +RH +++ L+ D+ ++ LV +M + + L
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE----KLG 119
Query: 599 WKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQ 658
+ + +GL Y+H A IIHRD+K N+ ++++ K+ DFGL++
Sbjct: 120 EDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA----D 172
Query: 659 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRP--------------- 703
+ ++ V + + T+ D++S G ++ E++ +
Sbjct: 173 SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIM 232
Query: 704 ALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVD 763
+ P E V + L ++ + + AS EK L
Sbjct: 233 KVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNAS-PLAVNLLEKMLVLDAEQ 291
Query: 764 RPSMGDVL 771
R + G+ L
Sbjct: 292 RVTAGEAL 299
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 8e-33
Identities = 44/223 (19%), Positives = 89/223 (39%), Gaps = 20/223 (8%)
Query: 502 NKFDESLLLGVGGFGRVYKGT-LDDGTKVAVK--RGNPRSEQGIAEFRTEIEMLSKLRHR 558
++ +G G G V VA+K +++ E+ ++ + H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 559 HLVSLIGYC------DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARG 612
+++SL+ +E ++ LV E M + D ++ + G
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-----HERMSYLLYQMLCG 131
Query: 613 LHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYL 672
+ +LH + IIHRD+K +NI++ + K+ DFGL++ + + T + Y
Sbjct: 132 IKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 185
Query: 673 DPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVN 715
PE E D++S G ++ E++ + +Q N
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 228
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 8e-33
Identities = 61/271 (22%), Positives = 103/271 (38%), Gaps = 30/271 (11%)
Query: 509 LLGVGGFGRVYKGTL----DDGTKVAVKRGNP----RSEQGIAEFRTEIEMLSKLRHR-H 559
+LG G +G+V+ D G A+K + + RTE ++L +R
Sbjct: 31 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 90
Query: 560 LVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTG 619
LV+L +++ L+ +Y+ G L +HL + + I + L
Sbjct: 91 LVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE-----VQIYVGEIVLALEHL 145
Query: 620 AAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRR 679
II+RD+K NILLD N + DFGLSK A D+T + G+ Y+ P+ R
Sbjct: 146 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA-DETERAYDFCGTIEYMAPDIVRG 204
Query: 680 QQ--LTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNL 737
+ D +S GV++ E+L + A ++ + +
Sbjct: 205 GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-----QAEISRRILKSEPPYPQEM 259
Query: 738 VGKVNPASLKKFGETAEKCLAEHGVDRPSMG 768
A K ++ L + R G
Sbjct: 260 -----SALAKDL---IQRLLMKDPKKRLGCG 282
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 127 bits (320), Expect = 9e-33
Identities = 50/290 (17%), Positives = 110/290 (37%), Gaps = 41/290 (14%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLR-HRHLVSLIGY 566
LG G + V++ + + KV VK P ++ + + EI++L LR ++++L
Sbjct: 42 KLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNIITLADI 98
Query: 567 CDERSE--MILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSI 624
+ LV+E++ N + L+ + L Y H+ I
Sbjct: 99 VKDPVSRTPALVFEHVNNTDFKQL-----YQTLTDYDIRFYMYEILKALDYCHS---MGI 150
Query: 625 IHRDVKTTNILLD-DNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQL- 682
+HRDVK N+++D ++ ++ D+GL++ S + PE Q+
Sbjct: 151 MHRDVKPHNVMIDHEHRKLRLIDWGLAEF---YHPGQEYNVRVASRYFKGPELLVDYQMY 207
Query: 683 TEKSDVYSFGVVLMEVLCTRPALNP-VLPREQVNI------AEWAMTWQKKGMLDQIMD- 734
D++S G +L ++ + +Q+ E + K ++
Sbjct: 208 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF 267
Query: 735 SNLVGKVNPASLKKFGETA-------------EKCLAEHGVDRPSMGDVL 771
++++G+ + ++F + +K L R + + +
Sbjct: 268 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 317
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 7e-30
Identities = 53/330 (16%), Positives = 113/330 (34%), Gaps = 35/330 (10%)
Query: 493 MFQEILDATNKFDESLLLGVGGFGRVYKGT-LDDGTKVAVK--RGNPRSEQGIAEFRTEI 549
+ + I + ++ +G G +G V G +VAVK +S E+
Sbjct: 9 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 68
Query: 550 EMLSKLRHRHLVSLIGYCDERS-----EMILVYEYMANGPLRSHLYGTDLPPLSWKQRLE 604
+L ++H +++ L+ + + ++ L+
Sbjct: 69 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA---DLNNIVKCQKLTDDHVQF 125
Query: 605 ICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTA 664
+ RGL Y+H + IIHRD+K +N+ ++++ K+ DFGL++ +V+T
Sbjct: 126 LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 182
Query: 665 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQ 724
+ + D++S G ++ E+L R +Q+ + +
Sbjct: 183 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 238
Query: 725 KKGMLDQIMDSNLVGKVNPASLKKFGETA--------------EKCLAEHGVDRPSMGDV 770
+L +I + + + A EK L R +
Sbjct: 239 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
Query: 771 L---WNLEYALQLEETSSALMEPEDNSTNH 797
L + +Y +E + + S +
Sbjct: 299 LAHAYFAQYHDPDDEPVADPYDQSFESRDL 328
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 111 bits (278), Expect = 4e-27
Identities = 41/245 (16%), Positives = 81/245 (33%), Gaps = 20/245 (8%)
Query: 509 LLGVGGFGRVYKGT-LDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRH---------- 557
LG G F V+ + + T VA+K + EI++L ++
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 558 -RHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDL---PPLSWKQRLEICIGAARGL 613
H++ L+ + + + + + + L + +I GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 614 HYLHTGAAQSIIHRDVKTTNILLD-DNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYL 672
Y+H IIH D+K N+L++ + + ++ G A T + Y
Sbjct: 139 DYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 673 DPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQV-NIAEWAMTWQKKGMLDQ 731
PE +D++S ++ E++ P + A + G L
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPS 256
Query: 732 IMDSN 736
+ N
Sbjct: 257 YLLRN 261
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 91.8 bits (227), Expect = 7e-22
Identities = 31/209 (14%), Positives = 63/209 (30%), Gaps = 44/209 (21%)
Query: 509 LLGVGGFGRVYKGTLDDGTKVAVK----------RGNPRSEQGIAEFRTEIEMLSKLRHR 558
L+G G V+ + + VK + + + G F ++ R
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 559 HLVSLIGYCDER----SEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLH 614
L L G + ++ E + L + E+ +
Sbjct: 67 ALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV---------RVENPDEVLDMILEEVA 117
Query: 615 YLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDP 674
+ + I+H D+ N+L+ + + + DF S V +G L+
Sbjct: 118 KFY---HRGIVHGDLSQYNVLVSEEGI-WIIDFPQS----------VEVGEEGWREILER 163
Query: 675 ------EYFRRQQLTEKSDVYSFGVVLME 697
YF R + D+ S +++
Sbjct: 164 DVRNIITYFSRTY-RTEKDINSAIDRILQ 191
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Score = 38.6 bits (89), Expect = 0.003
Identities = 19/141 (13%), Positives = 40/141 (28%), Gaps = 11/141 (7%)
Query: 497 ILDATNKFD---ESLLLGVGGF-GRVYKGTLDDGTKVAVK--RGNPRSEQGIAEFRTEIE 550
I+DA + +S L + + RVY+ +D + VK R + I E E +
Sbjct: 13 IMDALFEHGIRVDSGLTPLNSYENRVYQFQDEDRRRFVVKFYRPERWTADQILE---EHQ 69
Query: 551 MLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAA 610
+L + + ++ + + + G + Q +
Sbjct: 70 FALQLVNDEVPVAAPVAFNGQTLLNHQGFYFA--VFPSVGGRQFEADNIDQMEAVGRYLG 127
Query: 611 RGLHYLHTGAAQSIIHRDVKT 631
R +
Sbjct: 128 RMHQTGRKQLFIHRPTIGLNE 148
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 845 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.32 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.87 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.07 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.72 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.27 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.75 | |
| d2o14a1 | 146 | Hypothetical protein YxiM {Bacillus subtilis [TaxI | 95.72 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-51 Score=428.13 Aligned_cols=257 Identities=28% Similarity=0.397 Sum_probs=202.9
Q ss_pred cCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEecc
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMA 581 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 581 (845)
++|+..+.||+|+||.||+|++.+++.||||++.... ...++|.+|++++++++|||||+++|+|.+.+..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 4678888999999999999999888999999987543 334789999999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCccc
Q 003139 582 NGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHV 661 (845)
Q Consensus 582 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 661 (845)
+|+|.+++... ...++|..++.|+.|||+||+|||+ ++|+||||||+||||++++.+||+|||+++..... ....
T Consensus 84 ~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~-~~~~ 158 (263)
T d1sm2a_ 84 HGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYTS 158 (263)
T ss_dssp TCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred CCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCC-Ccee
Confidence 99999998654 3568999999999999999999999 99999999999999999999999999999875432 2222
Q ss_pred ccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCC
Q 003139 662 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKV 741 (845)
Q Consensus 662 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 741 (845)
.....||+.|||||++.+..++.++|||||||++|||+|++.|+....... +..... ..+ .....
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~-----~~~~~i-~~~---------~~~~~ 223 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----EVVEDI-STG---------FRLYK 223 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH-----HHHHHH-HHT---------CCCCC
T ss_pred ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH-----HHHHHH-Hhc---------CCCCC
Confidence 345678999999999999999999999999999999999655443322211 111111 111 11122
Q ss_pred CHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 003139 742 NPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779 (845)
Q Consensus 742 ~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~ 779 (845)
+..++..+.+++.+||+.||++||||+||+++|+++++
T Consensus 224 p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 33445678999999999999999999999999998754
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=429.82 Aligned_cols=261 Identities=29% Similarity=0.520 Sum_probs=207.9
Q ss_pred hcCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYE 578 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 578 (845)
.++|...+.||+|+||.||+|+++ ..||||++... +.+..++|.+|+++|++++|||||+++|++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 357888899999999999999875 35999987643 45667899999999999999999999999865 56899999
Q ss_pred eccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCC
Q 003139 579 YMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQ 658 (845)
Q Consensus 579 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~ 658 (845)
|+++|+|.+++...+ .+++|.+++.|+.|||+||+|||+ ++||||||||+||||++++.+||+|||+|+.......
T Consensus 84 y~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp CCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred cCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 999999999996543 469999999999999999999999 8999999999999999999999999999987554333
Q ss_pred cccccccccCCCcCChhhhcc---CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcc
Q 003139 659 THVSTAVKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDS 735 (845)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (845)
........||+.|||||++.+ ..++.++|||||||+||||+||+.||........ .......+.. .+
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~------~~~~~~~~~~----~p 229 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------IIFMVGRGYL----SP 229 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH------HHHHHHHTSC----CC
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH------HHHHHhcCCC----CC
Confidence 344456789999999999864 4589999999999999999999999976443321 1111111111 11
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 003139 736 NLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779 (845)
Q Consensus 736 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~ 779 (845)
.+ ...+..++..+.+++.+||+.+|++||||.||+++|+.+.+
T Consensus 230 ~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 230 DL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp CG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11 12334556788999999999999999999999999998764
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-50 Score=433.27 Aligned_cols=260 Identities=24% Similarity=0.391 Sum_probs=203.2
Q ss_pred CCCcceeeeeeceEEEEEEEEc-CC---cEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-DG---TKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~g---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
.|+..++||+|+||+||+|+++ ++ ..||||++... .....++|.+|+++|++++|||||+++|+|.+.+..++||
T Consensus 27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~ 106 (299)
T d1jpaa_ 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT 106 (299)
T ss_dssp GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence 3455678999999999999975 23 25899987654 5566788999999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
|||++|+|.+++... ...++|.++++|+.|||+||+|||+ ++|+||||||+||||++++.+||+|||+++......
T Consensus 107 Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 182 (299)
T d1jpaa_ 107 EFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182 (299)
T ss_dssp ECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence 999999999988654 3479999999999999999999999 999999999999999999999999999998654322
Q ss_pred Ccc---cccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhh
Q 003139 658 QTH---VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIM 733 (845)
Q Consensus 658 ~~~---~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (845)
... ......||+.|||||.+.++.++.++|||||||+||||+| |++||......+ + ... ..
T Consensus 183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~---~---~~~-i~-------- 247 (299)
T d1jpaa_ 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD---V---INA-IE-------- 247 (299)
T ss_dssp -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---H---HHH-HH--------
T ss_pred CcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH---H---HHH-HH--------
Confidence 211 1223467899999999999999999999999999999998 899986543221 1 111 11
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhhhc
Q 003139 734 DSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLEE 782 (845)
Q Consensus 734 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~~ 782 (845)
.......+..++..+.+++.+||+.||++||||.||++.|+.+++.+.
T Consensus 248 -~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p~ 295 (299)
T d1jpaa_ 248 -QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPN 295 (299)
T ss_dssp -TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred -cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcChh
Confidence 111122345567789999999999999999999999999999877543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-50 Score=427.01 Aligned_cols=256 Identities=26% Similarity=0.394 Sum_probs=211.3
Q ss_pred cCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEecc
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMA 581 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 581 (845)
++|+..+.||+|+||.||+|++++++.||||++.... ...++|.+|+++|++++|||||+++|+|.+ +..++||||++
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~ 90 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence 5688888999999999999999988899999987543 335789999999999999999999998865 56799999999
Q ss_pred CCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCccc
Q 003139 582 NGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHV 661 (845)
Q Consensus 582 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 661 (845)
+|+|.+++......+++|.++++|+.||++||+|||+ ++|+||||||+||||++++.+||+|||+|+.... .....
T Consensus 91 ~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~-~~~~~ 166 (272)
T d1qpca_ 91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTA 166 (272)
T ss_dssp TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSS-SCEEC
T ss_pred CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccC-Ccccc
Confidence 9999998866555579999999999999999999999 9999999999999999999999999999987543 22333
Q ss_pred ccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCC
Q 003139 662 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKV 741 (845)
Q Consensus 662 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 741 (845)
.....||+.|||||++.++.++.++|||||||+||||+||+.|+.......+ +. ..... ......
T Consensus 167 ~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~--~~----~~i~~---------~~~~~~ 231 (272)
T d1qpca_ 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE--VI----QNLER---------GYRMVR 231 (272)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HH----HHHHT---------TCCCCC
T ss_pred ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH--HH----HHHHh---------cCCCCC
Confidence 4456789999999999999999999999999999999997665543322111 11 11111 111123
Q ss_pred CHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhh
Q 003139 742 NPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYAL 778 (845)
Q Consensus 742 ~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~ 778 (845)
+..++..+.+++.+||+.+|++||||++|++.|+...
T Consensus 232 p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 3445667899999999999999999999999998754
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.4e-50 Score=430.31 Aligned_cols=259 Identities=26% Similarity=0.410 Sum_probs=218.1
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
.++|+..+.||+|+||.||+|++. +|+.||||++.... ...++|.+|+++|++++|||||+++|+|.+.+..++||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 356888889999999999999986 58899999986543 3457899999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCc
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT 659 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~ 659 (845)
+++|+|.+++.......++|..++.|+.|||+||+|||+ ++|+||||||+||||++++.+||+|||+|+.... +..
T Consensus 95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~-~~~ 170 (287)
T d1opja_ 95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTY 170 (287)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS-SSS
T ss_pred ccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCC-CCc
Confidence 999999999977666789999999999999999999999 8999999999999999999999999999987543 223
Q ss_pred ccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCC
Q 003139 660 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVG 739 (845)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 739 (845)
.......|++.|||||++.++.++.++|||||||++|||++|+.|+........ +.+.+......
T Consensus 171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~---------------~~~~i~~~~~~ 235 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---------------VYELLEKDYRM 235 (287)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---------------HHHHHHTTCCC
T ss_pred eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH---------------HHHHHhcCCCC
Confidence 334456789999999999999999999999999999999998777654332211 11112222223
Q ss_pred CCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 003139 740 KVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779 (845)
Q Consensus 740 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~ 779 (845)
..+..++..+.+++.+||+.||++||||.||++.|+.+.+
T Consensus 236 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 3445566789999999999999999999999999987654
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-49 Score=421.91 Aligned_cols=263 Identities=26% Similarity=0.415 Sum_probs=208.5
Q ss_pred cCCCcceeeeeeceEEEEEEEEcCC-----cEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLDDG-----TKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMIL 575 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~~g-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 575 (845)
+.|+..++||+|+||.||+|.+++. ..||||++... .....++|.+|++++++++|||||+++|+|.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4577888999999999999997632 36999998654 45556789999999999999999999999999999999
Q ss_pred EEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCC
Q 003139 576 VYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPA 655 (845)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~ 655 (845)
||||+++++|.+++... ...++|.++++++.||+.||+|||+ ++|+||||||+||||++++.+||+|||+++....
T Consensus 87 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 87 ITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 99999999998877544 3579999999999999999999999 9999999999999999999999999999987543
Q ss_pred CCC-cccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhc
Q 003139 656 LDQ-THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMD 734 (845)
Q Consensus 656 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (845)
... ........||+.|||||++.++.++.++|||||||+||||++|+.|+.......+ + . . .+.
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~--~---~-~---------~i~ 227 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--V---M-K---------AIN 227 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--H---H-H---------HHH
T ss_pred CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH--H---H-H---------HHh
Confidence 222 2223456789999999999999999999999999999999997766544322211 1 1 1 111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhhhcc
Q 003139 735 SNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLEET 783 (845)
Q Consensus 735 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~~~ 783 (845)
.......+..++..+.+++.+||+.+|++||||.||++.|+.+++.++.
T Consensus 228 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p~~ 276 (283)
T d1mqba_ 228 DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 276 (283)
T ss_dssp TTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred ccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCccc
Confidence 1222234455667899999999999999999999999999988775543
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-50 Score=421.73 Aligned_cols=253 Identities=24% Similarity=0.306 Sum_probs=205.6
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC-hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS-EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
++|+..+.||+|+||.||+|++. +|+.||||++.... .+..+++.+|+++|++++|||||++++++.+.+..+|||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 46888999999999999999975 68999999876543 33456789999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCc
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT 659 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~ 659 (845)
+++|+|.+++... ..+++.++..++.||++||+|||+ ++|+||||||+||||++++.+||+|||+|+........
T Consensus 85 ~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 85 CSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp CTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred cCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 9999999999543 479999999999999999999999 99999999999999999999999999999875433333
Q ss_pred ccccccccCCCcCChhhhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccC
Q 003139 660 HVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLV 738 (845)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 738 (845)
.......||+.|||||++.+..+ +.++|||||||+||||++|+.||......... . . .... ....
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~---~-~~~~---------~~~~ 225 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-Y---S-DWKE---------KKTY 225 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-H---H-HHHT---------TCTT
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-H---H-HHhc---------CCCC
Confidence 44556789999999999988876 57899999999999999999999654322210 0 0 0111 1111
Q ss_pred CCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 739 GKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 739 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
..........+.+++.+||+.||++|||++|++++
T Consensus 226 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 226 LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11123345677899999999999999999998653
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-49 Score=412.12 Aligned_cols=253 Identities=28% Similarity=0.384 Sum_probs=212.7
Q ss_pred cCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEecc
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMA 581 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 581 (845)
++|+..+.||+|+||+||+|++++++.||||+++.... ..++|.+|++++++++||||++++|+|.+.+..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 57888999999999999999998888999998765433 34689999999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCccc
Q 003139 582 NGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHV 661 (845)
Q Consensus 582 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 661 (845)
+|+|.+++.... ..+++..+++++.|+++||+|||+ ++|+||||||+|||+++++.+||+|||+++..... ....
T Consensus 83 ~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~-~~~~ 157 (258)
T d1k2pa_ 83 NGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYTS 157 (258)
T ss_dssp TEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS-SCCC
T ss_pred CCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCC-Ccee
Confidence 999999875443 468999999999999999999999 89999999999999999999999999999865432 2223
Q ss_pred ccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCC
Q 003139 662 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGK 740 (845)
Q Consensus 662 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 740 (845)
.....||+.|+|||.+.+..++.|+|||||||++|||+| |+.||......+ .. ....++ ....
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~------~~-~~i~~~---------~~~~ 221 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE------TA-EHIAQG---------LRLY 221 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH------HH-HHHHTT---------CCCC
T ss_pred ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH------HH-HHHHhC---------CCCC
Confidence 345678999999999999999999999999999999998 788886543221 11 111111 1122
Q ss_pred CCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003139 741 VNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEY 776 (845)
Q Consensus 741 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~ 776 (845)
.+...+..+.+++.+||+.||++|||+++++++|.+
T Consensus 222 ~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 334456789999999999999999999999999854
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-49 Score=426.39 Aligned_cols=257 Identities=24% Similarity=0.385 Sum_probs=209.5
Q ss_pred cCCCcceeeeeeceEEEEEEEEcC-C-----cEEEEEEcCCC-ChHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLDD-G-----TKVAVKRGNPR-SEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERSEM 573 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~~-g-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 573 (845)
++|+..+.||+|+||+||+|++.. + ..||+|++... .....+.|.+|+.+|.++ +|||||+++|+|.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 578889999999999999998753 2 26899987654 334456789999999998 899999999999999999
Q ss_pred EEEEEeccCCCccccccCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCC
Q 003139 574 ILVYEYMANGPLRSHLYGTD---------------------LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTT 632 (845)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~---------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~ 632 (845)
++|||||++|+|.++|+... ...++|.+++.|+.||++||+|||+ ++|+||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCchh
Confidence 99999999999999996542 2358999999999999999999999 89999999999
Q ss_pred cEEECCCCceEEEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCc
Q 003139 633 NILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPR 711 (845)
Q Consensus 633 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~ 711 (845)
|||++.++.+||+|||+|+...............||+.|||||++.++.++.++|||||||+||||+| |++||......
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987544333333445678999999999999999999999999999999998 89998754432
Q ss_pred ccccHHHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003139 712 EQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEY 776 (845)
Q Consensus 712 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~ 776 (845)
+. + .+++........+..++..+.+|+.+||+.+|++|||++||+++|.-
T Consensus 274 ~~--~-------------~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 274 AN--F-------------YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp HH--H-------------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HH--H-------------HHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 21 1 11122222223445566789999999999999999999999999863
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=415.13 Aligned_cols=256 Identities=26% Similarity=0.413 Sum_probs=209.8
Q ss_pred cCCCccee-eeeeceEEEEEEEEc---CCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEE
Q 003139 502 NKFDESLL-LGVGGFGRVYKGTLD---DGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILV 576 (845)
Q Consensus 502 ~~f~~~~~-LG~G~fg~Vy~~~~~---~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 576 (845)
++|...+. ||+|+||.||+|.++ ++..||||++... .....++|.+|+++|++++|||||+++|+|.+ +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 34555564 999999999999864 3557999998754 45567889999999999999999999999965 568999
Q ss_pred EEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCC
Q 003139 577 YEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPAL 656 (845)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~ 656 (845)
|||+++|+|.+++... ...+++.++++|+.|||+||+|||+ ++|+||||||+||||++++.+||+|||+++.....
T Consensus 87 mE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence 9999999999987543 3579999999999999999999999 99999999999999999999999999999875432
Q ss_pred CCc-ccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhc
Q 003139 657 DQT-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMD 734 (845)
Q Consensus 657 ~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (845)
... .......||+.|||||++.++.++.++|||||||++|||+| |+.||......+ +. ....++
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~---~~----~~i~~~------- 228 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VM----AFIEQG------- 228 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HH----HHHHTT-------
T ss_pred ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH---HH----HHHHcC-------
Confidence 222 22335578999999999999999999999999999999998 899997543321 11 111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhh
Q 003139 735 SNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYAL 778 (845)
Q Consensus 735 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~ 778 (845)
.....++.++..+.+++.+||+.+|++||||.+|++.|+...
T Consensus 229 --~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 229 --KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp --CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 112344556678899999999999999999999999998664
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-49 Score=417.85 Aligned_cols=257 Identities=28% Similarity=0.414 Sum_probs=206.7
Q ss_pred cCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEecc
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMA 581 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 581 (845)
++|++.+.||+|+||.||+|++++++.||||++.... ...++|.+|+.++++++|||||+++|+|.+ ++.++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 4688899999999999999999988899999986543 345789999999999999999999999955 56899999999
Q ss_pred CCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCccc
Q 003139 582 NGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTHV 661 (845)
Q Consensus 582 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 661 (845)
+|+|..++.......++|.+++.|+.||+.||+|||+ ++|+||||||+||||++++.+||+|||+++.... .....
T Consensus 95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~-~~~~~ 170 (285)
T d1fmka3 95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTA 170 (285)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccC-CCcee
Confidence 9999998876555579999999999999999999999 8999999999999999999999999999986432 22223
Q ss_pred ccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCCC
Q 003139 662 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGKV 741 (845)
Q Consensus 662 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 741 (845)
.....||+.|+|||++..+.++.++|||||||+||||++|+.|+....... +..... . .......
T Consensus 171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~-----~~~~~i-~---------~~~~~~~ 235 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----EVLDQV-E---------RGYRMPC 235 (285)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----HHHHHH-H---------TTCCCCC
T ss_pred eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH-----HHHHHH-H---------hcCCCCC
Confidence 345678999999999999999999999999999999999776664432221 111111 1 1112234
Q ss_pred CHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 003139 742 NPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779 (845)
Q Consensus 742 ~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~ 779 (845)
+..+++.+.+++.+||+.||++||+|++|+++|+....
T Consensus 236 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 45566789999999999999999999999999887543
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-49 Score=413.25 Aligned_cols=246 Identities=27% Similarity=0.391 Sum_probs=206.8
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC---hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS---EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
++|++.+.||+|+||.||+|+.+ +|+.||+|++.... ....+.+.+|++++++++|||||++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 36888999999999999999986 68899999875321 223567899999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
||+++|+|.+++... ..+++.++..++.||++||+|||+ ++|+||||||+||||++++.+||+|||+|+....
T Consensus 86 Ey~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~-- 158 (263)
T d2j4za1 86 EYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-- 158 (263)
T ss_dssp ECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC--
T ss_pred eecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCC--
Confidence 999999999998643 469999999999999999999999 9999999999999999999999999999986432
Q ss_pred CcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcccc
Q 003139 658 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNL 737 (845)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (845)
.......||+.|||||++.+..++.++|||||||+||||++|+.||......+ ... .+....
T Consensus 159 --~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~~---------~i~~~~- 220 (263)
T d2j4za1 159 --SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE------TYK---------RISRVE- 220 (263)
T ss_dssp --CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHH---------HHHTTC-
T ss_pred --CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH------HHH---------HHHcCC-
Confidence 22345679999999999999999999999999999999999999996533211 111 111111
Q ss_pred CCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 738 VGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
..++...+..+.+++.+||+.||++|||++|++++
T Consensus 221 -~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 221 -FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 12334456678899999999999999999999864
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=417.07 Aligned_cols=250 Identities=23% Similarity=0.338 Sum_probs=209.1
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEec
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYM 580 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 580 (845)
++|+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+.+..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 47999999999999999999965 69999999876554445678999999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcc
Q 003139 581 ANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH 660 (845)
Q Consensus 581 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 660 (845)
++|+|.+++... .+++.++..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+|+.... ...
T Consensus 100 ~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~--~~~ 171 (293)
T d1yhwa1 100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQS 171 (293)
T ss_dssp TTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--TTC
T ss_pred CCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeecc--ccc
Confidence 999999887543 59999999999999999999999 9999999999999999999999999999986432 222
Q ss_pred cccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCC
Q 003139 661 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGK 740 (845)
Q Consensus 661 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 740 (845)
......||+.|||||++.++.++.++|||||||++|||++|+.||......+ ........+ .....
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~~~~~~~~--------~~~~~ 237 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNG--------TPELQ 237 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHHC--------SCCCS
T ss_pred cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH------HHHHHHhCC--------CCCCC
Confidence 3345679999999999999999999999999999999999999996543221 111111111 01112
Q ss_pred CCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 741 VNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 741 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.+......+.+++.+||+.||++|||+.|++++
T Consensus 238 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 234456778999999999999999999998754
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-48 Score=412.26 Aligned_cols=248 Identities=27% Similarity=0.375 Sum_probs=201.1
Q ss_pred eeeeeeceEEEEEEEEcC---CcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEeccC
Q 003139 508 LLLGVGGFGRVYKGTLDD---GTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMAN 582 (845)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~---g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 582 (845)
+.||+|+||.||+|.+++ ++.||||++... +....++|.+|+++|++++|||||+++|+|.+ +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998753 467999987643 33446789999999999999999999999965 567899999999
Q ss_pred CCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCc-cc
Q 003139 583 GPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT-HV 661 (845)
Q Consensus 583 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~-~~ 661 (845)
|+|.+++... ..++|.++++|+.||++||+|||+ ++|+||||||+||||+.++.+||+|||+++........ ..
T Consensus 92 g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 92 GPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence 9999998654 469999999999999999999999 89999999999999999999999999999865432222 22
Q ss_pred ccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCCC
Q 003139 662 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVGK 740 (845)
Q Consensus 662 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 740 (845)
.....||+.|||||.+.++.++.++|||||||++|||+| |+.||......+ + .....++ ....
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~---~----~~~i~~~---------~~~~ 230 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---V----TAMLEKG---------ERMG 230 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---H----HHHHHTT---------CCCC
T ss_pred ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH---H----HHHHHcC---------CCCC
Confidence 335678999999999999999999999999999999998 899987543221 1 1111111 1122
Q ss_pred CCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 003139 741 VNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYA 777 (845)
Q Consensus 741 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~ 777 (845)
.+..++..+.+++.+||+.||++|||+++|++.|+..
T Consensus 231 ~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 3455667889999999999999999999999988765
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-49 Score=414.73 Aligned_cols=254 Identities=24% Similarity=0.391 Sum_probs=195.9
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEec--CCcEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDE--RSEMILV 576 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV 576 (845)
++|++.+.||+|+||.||+|+.. +|+.||+|++... ++...+.|.+|+++|++++|||||++++++.+ .+.+++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 46889999999999999999975 6899999987654 45566789999999999999999999999864 4568999
Q ss_pred EEeccCCCccccccCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCceeeccCCCCcEEECCCCceEEEeccccCC
Q 003139 577 YEYMANGPLRSHLYGT--DLPPLSWKQRLEICIGAARGLHYLHTGA--AQSIIHRDVKTTNILLDDNFVAKVADFGLSKT 652 (845)
Q Consensus 577 ~Ey~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDik~~NILl~~~~~~kl~DFGla~~ 652 (845)
|||+++|+|.+++... ....+++.+++.++.|++.||+|||+.. ..+|+||||||+||||++++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998542 3457999999999999999999999822 23599999999999999999999999999987
Q ss_pred CCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhh
Q 003139 653 GPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQI 732 (845)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (845)
... .........||+.|||||++.+..++.++|||||||++|||++|++||......+ + . ....++
T Consensus 164 ~~~--~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~---~---~-~~i~~~----- 229 (269)
T d2java1 164 LNH--DTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---L---A-GKIREG----- 229 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---H---H-HHHHHT-----
T ss_pred ccc--CCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH---H---H-HHHHcC-----
Confidence 432 2223345789999999999999999999999999999999999999996533211 1 1 111111
Q ss_pred hccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 733 MDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 733 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.. ..++...+..+.+++.+||+.||.+|||+.|++++
T Consensus 230 ---~~-~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 230 ---KF-RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp ---CC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---CC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 11 12334455678999999999999999999998753
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=415.31 Aligned_cols=252 Identities=25% Similarity=0.367 Sum_probs=208.6
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEec
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYM 580 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 580 (845)
+.|++.+.||+|+||.||+|+.. +|+.||||++........+.|.+|+++|++++|||||++++++.+.+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 35788889999999999999975 68899999987777777788999999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcc
Q 003139 581 ANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH 660 (845)
Q Consensus 581 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 660 (845)
++|+|.+++... ...+++.++..++.||++||+|||+ ++|+||||||+||||+.++.+||+|||+|+.... ...
T Consensus 92 ~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~--~~~ 165 (288)
T d2jfla1 92 AGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--TIQ 165 (288)
T ss_dssp TTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHH--HHH
T ss_pred CCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCC--Ccc
Confidence 999999987543 2469999999999999999999999 9999999999999999999999999999975321 112
Q ss_pred cccccccCCCcCChhhhc-----cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcc
Q 003139 661 VSTAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDS 735 (845)
Q Consensus 661 ~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (845)
......||+.|||||++. +..++.++|||||||+||||++|+.||......+. ....... ..
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~------~~~i~~~-~~------ 232 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV------LLKIAKS-EP------ 232 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH------HHHHHHS-CC------
T ss_pred cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH------HHHHHcC-CC------
Confidence 234578999999999984 55689999999999999999999999976543321 1111111 00
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 736 NLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 736 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.....+...+..+.+++.+||+.||++|||+.|++++
T Consensus 233 -~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 233 -PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp -CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -CCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0111234456788999999999999999999998764
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-48 Score=407.28 Aligned_cols=245 Identities=27% Similarity=0.437 Sum_probs=196.9
Q ss_pred CcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEec----CCcEEEEE
Q 003139 505 DESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDE----RSEMILVY 577 (845)
Q Consensus 505 ~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~ 577 (845)
+..+.||+|+||.||+|++. +++.||+|++... .....+.|.+|+++|++++|||||++++++.+ ...+++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 44557999999999999976 6889999986543 45566789999999999999999999999864 34689999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCc--eeeccCCCCcEEEC-CCCceEEEeccccCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQS--IIHRDVKTTNILLD-DNFVAKVADFGLSKTGP 654 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDik~~NILl~-~~~~~kl~DFGla~~~~ 654 (845)
||+++|+|.+++... ..+++.+++.++.||++||+|||+ ++ |+||||||+||||+ +++.+||+|||+|+...
T Consensus 92 E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 999999999999643 479999999999999999999998 66 99999999999996 57899999999998632
Q ss_pred CCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhc
Q 003139 655 ALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMD 734 (845)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (845)
. .......||+.|||||++.+ +++.++|||||||++|||++|+.||........ .......+...
T Consensus 167 ~----~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~------~~~~i~~~~~~---- 231 (270)
T d1t4ha_ 167 A----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ------IYRRVTSGVKP---- 231 (270)
T ss_dssp T----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH------HHHHHTTTCCC----
T ss_pred C----CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH------HHHHHHcCCCC----
Confidence 2 22345689999999999875 699999999999999999999999964332211 11111111110
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 735 SNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 735 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
..++......+.+++.+||+.||++|||+.|++++
T Consensus 232 ----~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 232 ----ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp ----GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ----cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 01122234568899999999999999999999763
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.6e-48 Score=414.81 Aligned_cols=260 Identities=28% Similarity=0.419 Sum_probs=213.0
Q ss_pred HhcCCCcceeeeeeceEEEEEEEEc------CCcEEEEEEcCCCC-hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Q 003139 500 ATNKFDESLLLGVGGFGRVYKGTLD------DGTKVAVKRGNPRS-EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSE 572 (845)
Q Consensus 500 at~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 572 (845)
..++|+..+.||+|+||.||+|+++ +++.||||++.... .+..++|.+|+++|++++||||++++++|.+.+.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 4578999999999999999999864 35689999987653 4456789999999999999999999999999999
Q ss_pred EEEEEEeccCCCccccccCCC----------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCC
Q 003139 573 MILVYEYMANGPLRSHLYGTD----------------------LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVK 630 (845)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik 630 (845)
.++||||+++|+|.++|.... ...++|.+++.|+.|++.||+|||+ ++|||||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCS
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEeeEEc
Confidence 999999999999999885321 2358999999999999999999999 999999999
Q ss_pred CCcEEECCCCceEEEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCC-CCCCCCC
Q 003139 631 TTNILLDDNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTR-PALNPVL 709 (845)
Q Consensus 631 ~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~-~p~~~~~ 709 (845)
|+|||||.++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||+||||++|. +||....
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 999999999999999999998644333333445667899999999999999999999999999999999996 4565432
Q ss_pred CcccccHHHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhh
Q 003139 710 PREQVNIAEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYAL 778 (845)
Q Consensus 710 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~ 778 (845)
..+ .... ..++. ....+..++..+.+|+.+||+.+|++||||.||+++|++++
T Consensus 248 ~~e------~~~~-v~~~~---------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 248 HEE------VIYY-VRDGN---------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HHH------HHHH-HHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHH------HHHH-HHcCC---------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 221 1111 11111 11234455678899999999999999999999999999875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-47 Score=413.17 Aligned_cols=259 Identities=24% Similarity=0.370 Sum_probs=206.5
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCc----EEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGT----KVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMIL 575 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 575 (845)
.+|+..++||+|+||.||+|++. +|+ +||+|++... +.+..++|.+|++++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 35889999999999999999875 444 5899987653 445578899999999999999999999999864 5788
Q ss_pred EEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCC
Q 003139 576 VYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPA 655 (845)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~ 655 (845)
++||+.+|+|.+++... ...+++..+++|+.|||+||+|||+ ++|+||||||+||||+.++.+||+|||+++....
T Consensus 88 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 89999999999887654 3579999999999999999999999 8999999999999999999999999999987554
Q ss_pred CCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhc
Q 003139 656 LDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMD 734 (845)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (845)
...........||+.|||||++.++.++.++|||||||+||||+| |++||......+ +.. .+.
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~~-------------~i~ 227 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISS-------------ILE 227 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HHH-------------HHH
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HHH-------------HHH
Confidence 333333445678999999999999999999999999999999998 778876543222 111 111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhhh
Q 003139 735 SNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLE 781 (845)
Q Consensus 735 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~ 781 (845)
.......++.++..+.+++.+||+.+|.+|||+.||+++|+.+.+..
T Consensus 228 ~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~~ 274 (317)
T d1xkka_ 228 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 274 (317)
T ss_dssp HTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSH
T ss_pred cCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhCh
Confidence 11112234456678899999999999999999999999999876543
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-48 Score=404.66 Aligned_cols=251 Identities=28% Similarity=0.424 Sum_probs=201.6
Q ss_pred cCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEec-CCcEEEEEEec
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDE-RSEMILVYEYM 580 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~Ey~ 580 (845)
++|+..+.||+|+||.||+|+++ |+.||||+++... ..++|.+|++++++++||||++++|+|.+ .+.+++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 45777889999999999999986 7899999986543 34789999999999999999999999965 46689999999
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcc
Q 003139 581 ANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH 660 (845)
Q Consensus 581 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 660 (845)
++|+|.++|.......++|..+++|+.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~----- 155 (262)
T d1byga_ 84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS----- 155 (262)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCC-----
Confidence 99999999976544468999999999999999999999 8999999999999999999999999999986332
Q ss_pred cccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccCC
Q 003139 661 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLVG 739 (845)
Q Consensus 661 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 739 (845)
......+|..|+|||++.++.++.++|||||||++|||+| |++|+...... .+..++ .+ ....
T Consensus 156 ~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~~~i----~~---------~~~~ 219 (262)
T d1byga_ 156 TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRV----EK---------GYKM 219 (262)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHHH----TT---------TCCC
T ss_pred CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHHHHH----Hc---------CCCC
Confidence 1234567899999999999999999999999999999998 67776543222 122211 11 1122
Q ss_pred CCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 003139 740 KVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779 (845)
Q Consensus 740 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~ 779 (845)
..+...+..+.+++.+||+.||.+||||.+++++|+.+++
T Consensus 220 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 220 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 3445556788999999999999999999999999998765
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-48 Score=412.59 Aligned_cols=250 Identities=21% Similarity=0.308 Sum_probs=205.0
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
++|++.+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|+++|++++||||+++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 46889999999999999999975 6899999987542 1234567899999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
||+++|+|.+++... +.+++.++..++.|++.||+|||+ ++|+||||||+||||++++.+||+|||+|+......
T Consensus 88 Ey~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 999999999988544 479999999999999999999999 999999999999999999999999999998754433
Q ss_pred CcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcccc
Q 003139 658 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNL 737 (845)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (845)
.........||+.|||||++.+..++.++|||||||+||||++|+.||......+ + ...+....
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~------------~~~i~~~~- 226 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL---I------------FQKIIKLE- 226 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H------------HHHHHTTC-
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH---H------------HHHHHcCC-
Confidence 3334456789999999999999999999999999999999999999997543211 1 11111111
Q ss_pred CCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 738 VGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
..++......+.+++.+||+.||++|||++|++..
T Consensus 227 -~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 227 -YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp -CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred -CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 12334455678899999999999999999998654
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-47 Score=402.65 Aligned_cols=258 Identities=24% Similarity=0.343 Sum_probs=202.2
Q ss_pred cCCCcceeeeeeceEEEEEEEEcC----CcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLDD----GTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILV 576 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 576 (845)
++|+..+.||+|+||.||+|++.. +..||||++... .....+.|.+|+++|++++|||||+++|+|. .+..++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence 568888999999999999998752 346899988654 4455678999999999999999999999996 4678999
Q ss_pred EEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCC
Q 003139 577 YEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPAL 656 (845)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~ 656 (845)
|||+++|+|.+++... ...+++.+++.++.||++||+|||+ ++|+||||||+|||+++++.+||+|||+++....
T Consensus 86 ~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~- 160 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED- 160 (273)
T ss_dssp EECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheeccC-
Confidence 9999999999887544 3579999999999999999999999 9999999999999999999999999999987443
Q ss_pred CCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcc
Q 003139 657 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDS 735 (845)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (845)
..........||+.|+|||++.++.++.++|||||||++|||++ |++||......+ +... ..++
T Consensus 161 ~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~~~----i~~~-------- 225 (273)
T d1mp8a_ 161 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGR----IENG-------- 225 (273)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHH----HHTT--------
T ss_pred CcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HHHH----HHcC--------
Confidence 22233445678999999999999999999999999999999998 888887654322 1111 1111
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhhh
Q 003139 736 NLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLE 781 (845)
Q Consensus 736 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~ 781 (845)
.....++.++..+.+++.+||+.||++|||+.||++.|+.+++.+
T Consensus 226 -~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 226 -ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 111234556678999999999999999999999999999887644
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-48 Score=418.25 Aligned_cols=265 Identities=23% Similarity=0.324 Sum_probs=205.8
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYE 578 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 578 (845)
.++|+..+.||+|+||.||+|+.. +|+.||+|++... .....+++.+|+++|++++|||||+++++|.+.++.++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 467999999999999999999975 6899999987654 34445789999999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCC
Q 003139 579 YMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQ 658 (845)
Q Consensus 579 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~ 658 (845)
|+++|+|.+++... ..+++..+..++.|+++||+|||+ .++|+||||||+||||++++.+||+|||+|+...
T Consensus 85 y~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~---- 156 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---- 156 (322)
T ss_dssp CCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH----
T ss_pred cCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccC----
Confidence 99999999999644 469999999999999999999997 1489999999999999999999999999997522
Q ss_pred cccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHH---------H------HH---
Q 003139 659 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIA---------E------WA--- 720 (845)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~---------~------~~--- 720 (845)
........||+.|||||++.+.+++.++||||+||++|||++|+.||......+..... . +.
T Consensus 157 ~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 157 DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp HHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred CCccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence 22234568999999999999999999999999999999999999999764432210000 0 00
Q ss_pred -H----HHhhcCchhhhhccccC---CCCC-HHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 721 -M----TWQKKGMLDQIMDSNLV---GKVN-PASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 721 -~----~~~~~~~~~~~~d~~l~---~~~~-~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
. .........+..+.... ...+ ......+.+++.+||+.||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0 00000000011100000 0011 1234578899999999999999999999985
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-47 Score=411.83 Aligned_cols=246 Identities=26% Similarity=0.349 Sum_probs=202.5
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC---hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS---EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
..|+..+.||+|+||.||+|+.. +|+.||||++.... ....++|.+|+++|++++|||||++++++.+.+..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 35888999999999999999975 68899999876442 344578999999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
|||++|+|..++... .++++.+++.++.||+.||+|||+ ++|+||||||+||||++++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (309)
T ss_dssp ECCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred EecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCC--
Confidence 999999997666433 479999999999999999999999 9999999999999999999999999999986332
Q ss_pred CcccccccccCCCcCChhhhcc---CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhc
Q 003139 658 QTHVSTAVKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMD 734 (845)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (845)
.....||+.|||||++.+ ++++.++|||||||++|||++|+.||......+ ........
T Consensus 168 ----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~------~~~~i~~~-------- 229 (309)
T d1u5ra_ 168 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQN-------- 229 (309)
T ss_dssp ----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHS--------
T ss_pred ----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhC--------
Confidence 234679999999999864 468999999999999999999999996533211 11111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 735 SNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 735 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
......+...+..+.+++.+||+.||++|||+.|++++
T Consensus 230 -~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 230 -ESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp -CCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred -CCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 11111123345678899999999999999999999864
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7.3e-47 Score=413.79 Aligned_cols=252 Identities=23% Similarity=0.286 Sum_probs=210.2
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEec
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYM 580 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 580 (845)
++|++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+.+..+||||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 47899999999999999999975 68999999998777777788999999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEEC--CCCceEEEeccccCCCCCCCC
Q 003139 581 ANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLD--DNFVAKVADFGLSKTGPALDQ 658 (845)
Q Consensus 581 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~--~~~~~kl~DFGla~~~~~~~~ 658 (845)
++|+|.+++... ...+++.++..|+.||+.||+|||+ ++|+||||||+||||+ .++.+||+|||+++....
T Consensus 106 ~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~--- 178 (350)
T d1koaa2 106 SGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP--- 178 (350)
T ss_dssp CSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT---
T ss_pred CCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheeccc---
Confidence 999999988543 3469999999999999999999999 9999999999999995 468999999999986432
Q ss_pred cccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccC
Q 003139 659 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLV 738 (845)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 738 (845)
........||+.|||||++.+..++.++|||||||++|||++|+.||......+ ........ . ....
T Consensus 179 ~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~~~i~~~-~------~~~~ 245 (350)
T d1koaa2 179 KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------TLRNVKSC-D------WNMD 245 (350)
T ss_dssp TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHT-C------CCSC
T ss_pred ccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH------HHHHHHhC-C------CCCC
Confidence 233345789999999999999999999999999999999999999996543221 11111110 0 0011
Q ss_pred CCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 739 GKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 739 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
..........+.+++.+||+.||++|||+.|++++
T Consensus 246 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 246 DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11113345678899999999999999999999875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-47 Score=405.87 Aligned_cols=261 Identities=24% Similarity=0.348 Sum_probs=203.6
Q ss_pred cCCCcceeeeeeceEEEEEEEEc------CCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhC-CCCCcceEEEEEecC-Cc
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD------DGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDER-SE 572 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~-~~ 572 (845)
++|+..+.||+|+||.||+|++. +++.||||++... .....+++.+|..++.++ +|+||+.+++++.+. ..
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 57888999999999999999864 2467999998754 445567788899888877 689999999998654 56
Q ss_pred EEEEEEeccCCCccccccCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECC
Q 003139 573 MILVYEYMANGPLRSHLYGTD--------------LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDD 638 (845)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~ 638 (845)
.++|||||++|+|.++|+... ...++|.+++.++.||++||+|||+ ++|+||||||+||||++
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSE 169 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECG
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccceeECC
Confidence 899999999999999986432 2358999999999999999999999 99999999999999999
Q ss_pred CCceEEEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCC-CCCCCCCCcccccHH
Q 003139 639 NFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTR-PALNPVLPREQVNIA 717 (845)
Q Consensus 639 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~-~p~~~~~~~~~~~l~ 717 (845)
++.+||+|||+|+...............||+.|||||.+.++.++.++|||||||++|||++|. +||......+
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~----- 244 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----- 244 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH-----
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH-----
Confidence 9999999999998755434444445678999999999999999999999999999999999975 4665433221
Q ss_pred HHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhh
Q 003139 718 EWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQL 780 (845)
Q Consensus 718 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~ 780 (845)
.......++ .....+...+..+.+++.+||+.||++|||+.||+++|+.+++.
T Consensus 245 -~~~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 245 -EFCRRLKEG---------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp -HHHHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHHHHHhcC---------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 111111221 11223344566789999999999999999999999999988753
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.7e-47 Score=409.07 Aligned_cols=252 Identities=21% Similarity=0.305 Sum_probs=192.2
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC-hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS-EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYE 578 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 578 (845)
.+.|+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+.+..+||||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 456899999999999999999976 68999999876543 2334568899999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEEC---CCCceEEEeccccCCCCC
Q 003139 579 YMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLD---DNFVAKVADFGLSKTGPA 655 (845)
Q Consensus 579 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~---~~~~~kl~DFGla~~~~~ 655 (845)
||++|+|.++|... ..+++.++..++.||+.||+|||+ ++|+||||||+|||+. +++.+||+|||+++...
T Consensus 88 ~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~- 161 (307)
T d1a06a_ 88 LVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED- 161 (307)
T ss_dssp CCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred ccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEcc-
Confidence 99999999999643 479999999999999999999999 9999999999999994 57899999999998633
Q ss_pred CCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcc
Q 003139 656 LDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDS 735 (845)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (845)
.........||+.|||||++.++.++.++|||||||+||||++|+.||......+ +. .. ...+. .
T Consensus 162 --~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~---~~-i~~~~------~ 226 (307)
T d1a06a_ 162 --PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK---LF---EQ-ILKAE------Y 226 (307)
T ss_dssp -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HH---HH-HHTTC------C
T ss_pred --CCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH---HH---HH-HhccC------C
Confidence 2223345679999999999999999999999999999999999999996533211 11 11 11110 1
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 736 NLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 736 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.......+..+..+.+++.+||+.||++|||+.|++++
T Consensus 227 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 227 EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 11112223456678999999999999999999999875
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=405.15 Aligned_cols=260 Identities=23% Similarity=0.369 Sum_probs=215.1
Q ss_pred cCCCcceeeeeeceEEEEEEEEc------CCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD------DGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERSEM 573 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 573 (845)
++|+..+.||+|+||.||+|++. .++.||||++... ......+|.+|+.+++++ +|||||+++|+|.+.+..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 57888899999999999999863 4568999998764 345566899999999999 699999999999999999
Q ss_pred EEEEEeccCCCccccccCCC----------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEEC
Q 003139 574 ILVYEYMANGPLRSHLYGTD----------------LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLD 637 (845)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~ 637 (845)
++|||||++|+|.++++... ...+++..+++++.||++||+|||+ ++|+||||||+|||++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccccccccccc
Confidence 99999999999999986432 2368999999999999999999999 9999999999999999
Q ss_pred CCCceEEEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCC-CCCCCCcccccH
Q 003139 638 DNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPA-LNPVLPREQVNI 716 (845)
Q Consensus 638 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p-~~~~~~~~~~~l 716 (845)
.++.+||+|||+++...............||+.|+|||.+.++.++.++|||||||++|||+|++.| +......+.
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~--- 256 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--- 256 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH---
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH---
Confidence 9999999999999976554444445567899999999999999999999999999999999995544 433322211
Q ss_pred HHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 003139 717 AEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779 (845)
Q Consensus 717 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~ 779 (845)
+.++++.......+...+..+.+|+.+||+.||++||||.+|+++|+.++.
T Consensus 257 ------------~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 257 ------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp ------------HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------------HHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 112222222223344556789999999999999999999999999998754
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=404.55 Aligned_cols=256 Identities=30% Similarity=0.456 Sum_probs=206.0
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCc--EEEEEEcCCC-ChHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGT--KVAVKRGNPR-SEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERSEMILV 576 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 576 (845)
++|+..+.||+|+||.||+|+++ +|. .||||++... ..+..++|.+|+++|+++ +|||||+++|+|.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 56888899999999999999976 444 4788886543 444567899999999998 799999999999999999999
Q ss_pred EEeccCCCccccccCC--------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCce
Q 003139 577 YEYMANGPLRSHLYGT--------------DLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVA 642 (845)
Q Consensus 577 ~Ey~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~ 642 (845)
|||+++|+|.++|+.. ....++|.++++++.|||+||.|||+ ++|+||||||+|||+++++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCce
Confidence 9999999999998643 24579999999999999999999999 999999999999999999999
Q ss_pred EEEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCC-CCCCCCCcccccHHHHHH
Q 003139 643 KVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRP-ALNPVLPREQVNIAEWAM 721 (845)
Q Consensus 643 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~-p~~~~~~~~~~~l~~~~~ 721 (845)
||+|||+++.... ........||..|+|||.+.++.++.++|||||||++|||++|.. ||...... +..
T Consensus 167 kl~DfG~a~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~------~~~- 236 (309)
T d1fvra_ 167 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELY- 236 (309)
T ss_dssp EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHH-
T ss_pred EEccccccccccc---cccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH------HHH-
Confidence 9999999986332 222234568999999999999999999999999999999999775 45432211 111
Q ss_pred HHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 003139 722 TWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779 (845)
Q Consensus 722 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~ 779 (845)
....+ ......+..++..+.+++.+||+.||++||||+||++.|+++++
T Consensus 237 ~~i~~---------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 237 EKLPQ---------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp HHGGG---------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHh---------cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11111 11123344566789999999999999999999999999999865
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-46 Score=400.39 Aligned_cols=254 Identities=28% Similarity=0.435 Sum_probs=205.5
Q ss_pred ceeeeeeceEEEEEEEEcCC----cEEEEEEcCC-CChHhHHHHHHHHHHHHhCCCCCcceEEEEEec-CCcEEEEEEec
Q 003139 507 SLLLGVGGFGRVYKGTLDDG----TKVAVKRGNP-RSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDE-RSEMILVYEYM 580 (845)
Q Consensus 507 ~~~LG~G~fg~Vy~~~~~~g----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~Ey~ 580 (845)
.++||+|+||+||+|++.++ ..||||+++. .+....++|.+|+++|++++||||++++|+|.+ ++..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 45899999999999997532 2589998864 456677899999999999999999999999865 56899999999
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCC--
Q 003139 581 ANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQ-- 658 (845)
Q Consensus 581 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~-- 658 (845)
++|+|.+++... ...+++..+++++.|+++||.|||+ .+|+||||||+||||++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 112 KHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp TTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred ecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 999999988654 3468899999999999999999999 9999999999999999999999999999987543221
Q ss_pred cccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccC
Q 003139 659 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLV 738 (845)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 738 (845)
........||+.|+|||.+..+.++.++||||||++||||+||+.||....... .+..++ . .+. .
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~i---~-~g~---------~ 252 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYL---L-QGR---------R 252 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHH---H-TTC---------C
T ss_pred ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHHH---H-cCC---------C
Confidence 222334678999999999999999999999999999999999888875433221 111111 1 111 1
Q ss_pred CCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 003139 739 GKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779 (845)
Q Consensus 739 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~ 779 (845)
...+..++..+.+++.+||+.||++||+|.||+++|+.+++
T Consensus 253 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 253 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11233455678999999999999999999999999998865
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.3e-46 Score=410.16 Aligned_cols=252 Identities=21% Similarity=0.280 Sum_probs=210.2
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEec
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYM 580 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 580 (845)
++|++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+.+.++||||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 46889999999999999999975 79999999987776666778899999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEEC--CCCceEEEeccccCCCCCCCC
Q 003139 581 ANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLD--DNFVAKVADFGLSKTGPALDQ 658 (845)
Q Consensus 581 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~--~~~~~kl~DFGla~~~~~~~~ 658 (845)
++|+|.+++... ..++++.++..|+.||+.||+|||+ ++|+||||||+||||+ .++.+||+|||+|+....
T Consensus 109 ~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~--- 181 (352)
T d1koba_ 109 SGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP--- 181 (352)
T ss_dssp CCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT---
T ss_pred CCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCC---
Confidence 999998877543 3469999999999999999999999 9999999999999998 678999999999987432
Q ss_pred cccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccccC
Q 003139 659 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNLV 738 (845)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 738 (845)
........||+.|||||++.+..++.++||||+||+||||+||+.||......+ ..... ..+ +....
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~i-~~~------~~~~~ 248 (352)
T d1koba_ 182 DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE------TLQNV-KRC------DWEFD 248 (352)
T ss_dssp TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHH-HHC------CCCCC
T ss_pred CCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH------HHHHH-HhC------CCCCC
Confidence 233445679999999999999999999999999999999999999996543221 11111 111 01111
Q ss_pred CCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 739 GKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 739 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
..........+.+++.+||+.||.+|||+.|++++
T Consensus 249 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 249 EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 12223455678899999999999999999999864
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=402.76 Aligned_cols=260 Identities=27% Similarity=0.422 Sum_probs=209.6
Q ss_pred cCCCcceeeeeeceEEEEEEEEcC--------CcEEEEEEcCCC-ChHhHHHHHHHHHHHHhC-CCCCcceEEEEEecCC
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLDD--------GTKVAVKRGNPR-SEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDERS 571 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~~--------g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 571 (845)
++|+..+.||+|+||.||+|+... +..||||++... ......++.+|...+.++ +|||||+++++|.+++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 467888899999999999998532 246999998765 345568899999999888 8999999999999999
Q ss_pred cEEEEEEeccCCCccccccCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEEC
Q 003139 572 EMILVYEYMANGPLRSHLYGTD--------------LPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLD 637 (845)
Q Consensus 572 ~~~lV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~ 637 (845)
..++||||+++|+|.++|.... ...+++.++++++.||+.||+|||+ ++||||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceeec
Confidence 9999999999999999996542 2468999999999999999999999 9999999999999999
Q ss_pred CCCceEEEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccH
Q 003139 638 DNFVAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNI 716 (845)
Q Consensus 638 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l 716 (845)
.++.+||+|||+++...............||+.|+|||.+.++.++.++|||||||++|||++ |++||......+
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~---- 245 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---- 245 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH----
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH----
Confidence 999999999999987544333333455678999999999999999999999999999999998 677775433211
Q ss_pred HHHHHHHhhcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhh
Q 003139 717 AEWAMTWQKKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQL 780 (845)
Q Consensus 717 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~ 780 (845)
+...... ......+...+..+.+++.+||+.||++|||+.||++.|+.++.+
T Consensus 246 ---~~~~i~~---------~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 246 ---LFKLLKE---------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp ---HHHHHHT---------TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---HHHHHHc---------CCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 1111111 112233444567789999999999999999999999999988654
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-47 Score=400.90 Aligned_cols=256 Identities=26% Similarity=0.354 Sum_probs=199.3
Q ss_pred cCCCcceeeeeeceEEEEEEEEc--CC--cEEEEEEcCCC---ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD--DG--TKVAVKRGNPR---SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMI 574 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~--~g--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 574 (845)
++|++.+.||+|+||.||+|+++ ++ ..||||++... ..+..++|.+|+++|++++||||++++|+|.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 56888899999999999999864 23 36899987653 34456789999999999999999999999976 4678
Q ss_pred EEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCC
Q 003139 575 LVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGP 654 (845)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~ 654 (845)
+||||+++|+|.+++... ..++++..+++++.|+|+||+|||+ ++|+||||||+||||+.++.+||+|||+++...
T Consensus 87 lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeeeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 999999999999887643 3469999999999999999999999 899999999999999999999999999998754
Q ss_pred CCCCc-ccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCcccccHHHHHHHHhhcCchhhh
Q 003139 655 ALDQT-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLC-TRPALNPVLPREQVNIAEWAMTWQKKGMLDQI 732 (845)
Q Consensus 655 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (845)
..... .......|+..|+|||.+.+..++.++|||||||++|||+| |+.||......+ . ... +
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~---~---~~~---------i 227 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---I---LHK---------I 227 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---H---HHH---------H
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH---H---HHH---------H
Confidence 43222 22334568889999999999999999999999999999998 899986443221 1 111 1
Q ss_pred hccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 003139 733 MDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYA 777 (845)
Q Consensus 733 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~ 777 (845)
.........+..++..+.+++.+||+.||++||||.+|++.|+++
T Consensus 228 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 228 DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 111122223345567789999999999999999999999998875
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-46 Score=400.73 Aligned_cols=251 Identities=22% Similarity=0.289 Sum_probs=205.1
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC------ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR------SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMI 574 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~------~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 574 (845)
++|++.+.||+|+||.||+|+.. +|+.||||++... .....+.|.+|+++|++++|||||++++++.+.+..+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 57899999999999999999975 7899999986432 1223678999999999999999999999999999999
Q ss_pred EEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCC----ceEEEecccc
Q 003139 575 LVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNF----VAKVADFGLS 650 (845)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~----~~kl~DFGla 650 (845)
||||||++|+|.+++... ..+++.++..++.|++.||+|||+ ++|+||||||+|||++.++ .+||+|||++
T Consensus 90 iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecchhhh
Confidence 999999999999998654 479999999999999999999999 9999999999999998776 5999999999
Q ss_pred CCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchh
Q 003139 651 KTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLD 730 (845)
Q Consensus 651 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (845)
+.... ........||+.|+|||++.++.++.++|||||||++|||++|+.||......+. .... .....
T Consensus 165 ~~~~~---~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~------~~~i-~~~~~- 233 (293)
T d1jksa_ 165 HKIDF---GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET------LANV-SAVNY- 233 (293)
T ss_dssp EECTT---SCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHH-HTTCC-
T ss_pred hhcCC---CccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH------HHHH-HhcCC-
Confidence 86432 2233456789999999999999999999999999999999999999975432211 1111 11000
Q ss_pred hhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 731 QIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 731 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.......+..+..+.+++.+||+.||.+|||++|++++
T Consensus 234 -----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 234 -----EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp -----CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -----CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000112234678899999999999999999999764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-46 Score=399.73 Aligned_cols=260 Identities=25% Similarity=0.390 Sum_probs=213.6
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc------CCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD------DGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEM 573 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 573 (845)
.++|+..+.||+|+||.||+|.+. +++.||||+++.. ..+....|.+|++++++++||||++++|+|...+..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 367888899999999999999864 2578999998754 455567899999999999999999999999999999
Q ss_pred EEEEEeccCCCccccccCC--------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEE
Q 003139 574 ILVYEYMANGPLRSHLYGT--------DLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVA 645 (845)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~ 645 (845)
++||||+++|+|.+++... ....++|..+++++.|+|+||.|||+ ++|+||||||+||||++++.+||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEEe
Confidence 9999999999999987532 23468999999999999999999999 899999999999999999999999
Q ss_pred eccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCC-CCCCCCCCcccccHHHHHHHHh
Q 003139 646 DFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTR-PALNPVLPREQVNIAEWAMTWQ 724 (845)
Q Consensus 646 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~-~p~~~~~~~~~~~l~~~~~~~~ 724 (845)
|||+++...............||+.|+|||.+.++.++.++||||||+++|||+||+ +|+..... .++...
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~------~~~~~~-- 247 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------EQVLRF-- 247 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH------HHHHHH--
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH------HHHHHH--
Confidence 999998754433333345567899999999999999999999999999999999996 55543221 112211
Q ss_pred hcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 003139 725 KKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779 (845)
Q Consensus 725 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~ 779 (845)
+.+... ...+..++..+.+++.+||+.+|++||||++|+++|+..++
T Consensus 248 -------i~~~~~-~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 248 -------VMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp -------HHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred -------HHhCCC-CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 111111 12334556789999999999999999999999999987644
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=401.91 Aligned_cols=248 Identities=25% Similarity=0.327 Sum_probs=207.2
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
++|++.+.||+|+||.||+|+.. +|+.||+|++... .....+.+.+|+++|++++||||+++++++.+.+.+++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 46889999999999999999975 7899999987643 2234577899999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
|||++|+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+||||++++.+||+|||+|+....
T Consensus 85 ey~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~-- 157 (337)
T d1o6la_ 85 EYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-- 157 (337)
T ss_dssp ECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred eccCCCchhhhhhcc--cCCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeeccccccccc--
Confidence 999999999998654 468999999999999999999999 9999999999999999999999999999986432
Q ss_pred CcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcccc
Q 003139 658 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNL 737 (845)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (845)
........+||+.|||||++.++.++.++||||+||++|||++|++||......+ .... +....+
T Consensus 158 ~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~------~~~~---------i~~~~~ 222 (337)
T d1o6la_ 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------LFEL---------ILMEEI 222 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHH---------HHHCCC
T ss_pred CCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH------HHHH---------HhcCCC
Confidence 1223345789999999999999999999999999999999999999997543211 1111 111111
Q ss_pred CCCCCHHHHHHHHHHHHHhhhhCCCCCCC-----HHHHHHH
Q 003139 738 VGKVNPASLKKFGETAEKCLAEHGVDRPS-----MGDVLWN 773 (845)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~~vl~~ 773 (845)
.++......+.+++.+||+.||.+||+ ++|++++
T Consensus 223 --~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 223 --RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 233445567889999999999999995 7787764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.8e-45 Score=390.96 Aligned_cols=259 Identities=26% Similarity=0.354 Sum_probs=203.3
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCC----cE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERS----EM 573 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~ 573 (845)
++|++.+.||+|+||.||+|+.. +|+.||||++... +....++|.+|++++++++||||+++++++...+ ..
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 56889999999999999999975 7899999998643 3455678999999999999999999999986544 37
Q ss_pred EEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCC
Q 003139 574 ILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTG 653 (845)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~ 653 (845)
++||||+++++|.+++... .++++.+++.|+.||+.||+|||+ ++|+||||||+||||+.++..+|+|||.++..
T Consensus 87 ~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred EEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhhhh
Confidence 9999999999999888544 479999999999999999999999 99999999999999999999999999998754
Q ss_pred CCC-CCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhh
Q 003139 654 PAL-DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQI 732 (845)
Q Consensus 654 ~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (845)
... ..........||+.|||||++.+..++.++|||||||++|||+||++||......+ ........+..
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~~~~~~~~--- 232 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVREDPI--- 232 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCCCC---
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH------HHHHHHhcCCC---
Confidence 322 22223445689999999999999999999999999999999999999996543221 12222222111
Q ss_pred hccccCCCCCHHHHHHHHHHHHHhhhhCCCCCC-CHHHHHHHHHHhh
Q 003139 733 MDSNLVGKVNPASLKKFGETAEKCLAEHGVDRP-SMGDVLWNLEYAL 778 (845)
Q Consensus 733 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~~vl~~L~~~~ 778 (845)
.........+..+.+++.+||+.||++|| |++++++.|.++.
T Consensus 233 ----~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 233 ----PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp ----CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ----CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 00112233456788999999999999999 8999999888764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.4e-45 Score=398.28 Aligned_cols=245 Identities=24% Similarity=0.356 Sum_probs=205.5
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
++|++.+.||+|+||.||+|+.+ +|+.||||++... .....+.+.+|+.+|++++|||||++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 46888999999999999999975 6899999987532 2234578899999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
||+++|+|..++... ..+++..+..++.||+.||+|||+ ++|+||||||+||||++++.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~-- 156 (316)
T d1fota_ 84 DYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-- 156 (316)
T ss_dssp CCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred eecCCcccccccccc--ccccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEecc--
Confidence 999999999888644 468899999999999999999998 9999999999999999999999999999987432
Q ss_pred CcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcccc
Q 003139 658 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNL 737 (845)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (845)
......||+.|||||++.++.++.++|||||||+||||++|+.||......+ .. ..+.....
T Consensus 157 ---~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~---------~~i~~~~~ 218 (316)
T d1fota_ 157 ---VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK------TY---------EKILNAEL 218 (316)
T ss_dssp ---CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HH---------HHHHHCCC
T ss_pred ---ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH------HH---------HHHHcCCC
Confidence 2235689999999999999999999999999999999999999997543211 11 11111111
Q ss_pred CCCCCHHHHHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 003139 738 VGKVNPASLKKFGETAEKCLAEHGVDRP-----SMGDVLWN 773 (845)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~~ 773 (845)
.+++..+..+.+++.+||+.||.+|| |+++++++
T Consensus 219 --~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 219 --RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred --CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 23344556788999999999999996 88888764
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-46 Score=399.24 Aligned_cols=268 Identities=23% Similarity=0.306 Sum_probs=200.3
Q ss_pred CCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHH--HHHHHHhCCCCCcceEEEEEecCC----cEEEE
Q 003139 503 KFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRT--EIEMLSKLRHRHLVSLIGYCDERS----EMILV 576 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~--E~~~l~~l~H~niv~l~g~~~~~~----~~~lV 576 (845)
.|...+.||+|+||.||+|+++ |+.||||++.... .+++.. |+..+.+++|||||+++|+|.+.+ .+++|
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 4556778999999999999975 8899999986432 233444 555556789999999999997654 58999
Q ss_pred EEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----CCceeeccCCCCcEEECCCCceEEEeccccC
Q 003139 577 YEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGA-----AQSIIHRDVKTTNILLDDNFVAKVADFGLSK 651 (845)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivHrDik~~NILl~~~~~~kl~DFGla~ 651 (845)
||||++|+|.++|+.. .++|.++++++.|+|.||+|||+.. .++|+||||||+||||++++.+||+|||+++
T Consensus 80 ~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 9999999999999654 5899999999999999999999631 3699999999999999999999999999998
Q ss_pred CCCCCCCc--ccccccccCCCcCChhhhccCC------CCchhHHHHHHHHHHHHHcCCCCCCCCCCccc----c----c
Q 003139 652 TGPALDQT--HVSTAVKGSFGYLDPEYFRRQQ------LTEKSDVYSFGVVLMEVLCTRPALNPVLPREQ----V----N 715 (845)
Q Consensus 652 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~----~----~ 715 (845)
........ .......||+.|||||++.+.. ++.|+|||||||+||||+||+.|+......+. . .
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 64332221 1234567999999999987643 57799999999999999999987754322211 0 0
Q ss_pred HHHHHHHHhhcCchhhhhccccCCCC-CHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhhhh
Q 003139 716 IAEWAMTWQKKGMLDQIMDSNLVGKV-NPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQLE 781 (845)
Q Consensus 716 l~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~ 781 (845)
...........+ .+++.+.... ..+.+..+.+++.+||+.||++|||+.||++.|+++.+.+
T Consensus 237 ~~~~~~~~~~~~----~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 237 SVEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp CHHHHHHHHTTS----CCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHhcc----ccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 111111111111 1112221111 2346677999999999999999999999999999876544
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.4e-45 Score=386.19 Aligned_cols=251 Identities=22% Similarity=0.272 Sum_probs=205.1
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC---------hHhHHHHHHHHHHHHhCC-CCCcceEEEEEecC
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS---------EQGIAEFRTEIEMLSKLR-HRHLVSLIGYCDER 570 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~ 570 (845)
++|++.+.||+|+||+||+|+.. +|+.+|||++.... ....+.+.+|++++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 57889999999999999999974 78999999875432 122356889999999997 99999999999999
Q ss_pred CcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEecccc
Q 003139 571 SEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLS 650 (845)
Q Consensus 571 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla 650 (845)
+..+||||||++|+|.++|... .++++.+++.++.||++||+|||+ ++|+||||||+||||+.++.+||+|||++
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred cceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccchhe
Confidence 9999999999999999999643 479999999999999999999999 99999999999999999999999999999
Q ss_pred CCCCCCCCcccccccccCCCcCChhhhcc------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHh
Q 003139 651 KTGPALDQTHVSTAVKGSFGYLDPEYFRR------QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQ 724 (845)
Q Consensus 651 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~ 724 (845)
+.... ........||+.|+|||.+.+ ..++.++||||+||+++||++|+.||......+ .....
T Consensus 158 ~~~~~---~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-------~~~~i 227 (277)
T d1phka_ 158 CQLDP---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-------MLRMI 227 (277)
T ss_dssp EECCT---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHH
T ss_pred eEccC---CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH-------HHHHH
Confidence 86432 223345789999999999863 457889999999999999999999997543211 11111
Q ss_pred hcCchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 725 KKGMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 725 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
..+.. ..........++.+.+++.+||+.+|.+|||+.||+++
T Consensus 228 ~~~~~------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 228 MSGNY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHTCC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HhCCC------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 11111 11111223456788999999999999999999998754
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.9e-45 Score=397.80 Aligned_cols=245 Identities=23% Similarity=0.306 Sum_probs=205.5
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 577 (845)
++|++.+.||+|+||.||+|+++ +|+.||||++... .....+.+.+|+++|++++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 47899999999999999999975 7999999987532 1233567899999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~ 657 (845)
||+.+|+|..++... ..+++.++..++.||+.||+|||+ ++||||||||+||||+.++.+||+|||+|+....
T Consensus 121 e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~-- 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-- 193 (350)
T ss_dssp ECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS--
T ss_pred ccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeeccc--
Confidence 999999999998644 369999999999999999999999 9999999999999999999999999999986432
Q ss_pred CcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcccc
Q 003139 658 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNL 737 (845)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (845)
......||+.|||||++.++.++.++|||||||+||||++|+.||....... ... .+.....
T Consensus 194 ---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~~---------~i~~~~~ 255 (350)
T d1rdqe_ 194 ---RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYE---------KIVSGKV 255 (350)
T ss_dssp ---CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHH---------HHHHCCC
T ss_pred ---ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH------HHH---------HHhcCCC
Confidence 1235679999999999999999999999999999999999999996532211 111 1111111
Q ss_pred CCCCCHHHHHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 003139 738 VGKVNPASLKKFGETAEKCLAEHGVDRP-----SMGDVLWN 773 (845)
Q Consensus 738 ~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~~ 773 (845)
..+......+.+++.+||+.||.+|+ |+++++++
T Consensus 256 --~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 256 --RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp --CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred --CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 12334556788999999999999994 88998764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-44 Score=388.68 Aligned_cols=248 Identities=17% Similarity=0.264 Sum_probs=206.0
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
.++|.+.+.||+|+||.||+|... +|+.||||.+.....+ ...+.+|+++|++++|||||++++++.+.+..++||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 367889999999999999999976 6889999998765433 45688999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECC--CCceEEEeccccCCCCCCC
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDD--NFVAKVADFGLSKTGPALD 657 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~--~~~~kl~DFGla~~~~~~~ 657 (845)
|++|+|.+++... ...+++.++..|+.||+.||+|||+ ++|+||||||+|||++. ...+||+|||+++....
T Consensus 83 ~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~-- 156 (321)
T d1tkia_ 83 ISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-- 156 (321)
T ss_dssp CCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT--
T ss_pred CCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhcccc--
Confidence 9999999998644 2469999999999999999999999 99999999999999984 45899999999986432
Q ss_pred CcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhcccc
Q 003139 658 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSNL 737 (845)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (845)
........+|+.|+|||.+.+..++.++||||+||++|||++|+.||......+ .. ..+.....
T Consensus 157 -~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~------~~---------~~i~~~~~ 220 (321)
T d1tkia_ 157 -GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ------II---------ENIMNAEY 220 (321)
T ss_dssp -TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HH---------HHHHHTCC
T ss_pred -CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH------HH---------HHHHhCCC
Confidence 223345678999999999999999999999999999999999999997543221 11 11111111
Q ss_pred CCCCC----HHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 738 VGKVN----PASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 738 ~~~~~----~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.++ +.....+.+++.+||+.||.+|||+.|++++
T Consensus 221 --~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 221 --TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp --CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --CCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011 1234568899999999999999999999875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=393.09 Aligned_cols=250 Identities=21% Similarity=0.296 Sum_probs=199.0
Q ss_pred cCCCcc-eeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhC-CCCCcceEEEEEec----CCcEE
Q 003139 502 NKFDES-LLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKL-RHRHLVSLIGYCDE----RSEMI 574 (845)
Q Consensus 502 ~~f~~~-~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~----~~~~~ 574 (845)
++|.+. ++||+|+||.||+|+.. +|+.||||++... +.+.+|++++.++ +|||||++++++.+ ...++
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 467776 46999999999999974 7899999998643 4567899987654 89999999999865 46689
Q ss_pred EEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECC---CCceEEEeccccC
Q 003139 575 LVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDD---NFVAKVADFGLSK 651 (845)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~---~~~~kl~DFGla~ 651 (845)
+|||||++|+|.++|.......+++.++..|+.||+.||+|||+ ++|+||||||+|||+++ ++.+||+|||+|+
T Consensus 86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHH---cCCccccccccccccccccccccccccccceee
Confidence 99999999999999976655679999999999999999999999 99999999999999985 5679999999998
Q ss_pred CCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhh
Q 003139 652 TGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQ 731 (845)
Q Consensus 652 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (845)
.... ........||+.|||||++.+..++.++|||||||+||||+||+.||......... ... ...
T Consensus 163 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~---~~~--------~~~ 228 (335)
T d2ozaa1 163 ETTS---HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PGM--------KTR 228 (335)
T ss_dssp ECCC---CCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------------C
T ss_pred eccC---CCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH---HHH--------HHH
Confidence 6433 22234567999999999999999999999999999999999999999654332211 000 001
Q ss_pred hhccccCC--CCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 732 IMDSNLVG--KVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 732 ~~d~~l~~--~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
+....... .........+.+++.+||+.||++|||+.|++++
T Consensus 229 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 229 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp CCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 11111100 0112345678999999999999999999999875
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.2e-44 Score=395.10 Aligned_cols=249 Identities=21% Similarity=0.298 Sum_probs=199.3
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC---hHhHHHH---HHHHHHHHhCCCCCcceEEEEEecCCcEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS---EQGIAEF---RTEIEMLSKLRHRHLVSLIGYCDERSEMI 574 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~---~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 574 (845)
++|++.++||+|+||.||+|+.. +|+.||||++.... ......+ ..|+++++.++|||||++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57889999999999999999976 68999999875321 1112233 34567777888999999999999999999
Q ss_pred EEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCC
Q 003139 575 LVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGP 654 (845)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~ 654 (845)
+||||+++|+|.++|... ..+++.++..++.||+.||+|||+ ++|+||||||+||||++++.+||+|||+|+...
T Consensus 84 ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 999999999999999644 468999999999999999999999 999999999999999999999999999998643
Q ss_pred CCCCcccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhh
Q 003139 655 ALDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIM 733 (845)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (845)
. .......||+.|||||++.. ..++.++|||||||+||||++|+.||......+...+ .. ...
T Consensus 159 ~----~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~----~~--------~~~ 222 (364)
T d1omwa3 159 K----KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DR--------MTL 222 (364)
T ss_dssp S----SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHH----HH--------HSS
T ss_pred C----CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH----HH--------hcc
Confidence 2 12345679999999999975 5689999999999999999999999976443321111 00 001
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCC-----HHHHHHH
Q 003139 734 DSNLVGKVNPASLKKFGETAEKCLAEHGVDRPS-----MGDVLWN 773 (845)
Q Consensus 734 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~~vl~~ 773 (845)
.. ....+......+.+++.+||+.||++||| ++|++++
T Consensus 223 ~~--~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 223 TM--AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp SC--CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred cC--CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 00 11123345567899999999999999999 5777754
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-44 Score=385.95 Aligned_cols=257 Identities=24% Similarity=0.247 Sum_probs=195.3
Q ss_pred ceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChH-----hHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEec
Q 003139 507 SLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQ-----GIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYM 580 (845)
Q Consensus 507 ~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 580 (845)
.++||+|+||+||+|+.. +|+.||||++...... ..+.+.+|+++|++++|||||++++++.+++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 568999999999999975 6899999987654321 1346889999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCcc
Q 003139 581 ANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQTH 660 (845)
Q Consensus 581 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 660 (845)
+++++..++. ....+++.++..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++..... ..
T Consensus 83 ~~~~~~~~~~--~~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~--~~ 155 (299)
T d1ua2a_ 83 ETDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NR 155 (299)
T ss_dssp SEEHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC--CC
T ss_pred cchHHhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCC--cc
Confidence 9888776653 33568999999999999999999999 99999999999999999999999999999864332 22
Q ss_pred cccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhc-----
Q 003139 661 VSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMD----- 734 (845)
Q Consensus 661 ~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d----- 734 (845)
......||+.|+|||++.. ..++.++|||||||++|||++|++||......+.. ................+
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l---~~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL---TRIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHHHCCCCTTTSSSTTSST
T ss_pred cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHH---HHHHHhcCCCChhhccchhccc
Confidence 2334679999999999875 46799999999999999999999999754432211 11111111000000000
Q ss_pred -cccCC---CC-----CHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 735 -SNLVG---KV-----NPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 735 -~~l~~---~~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
..... .. .+.....+.+++.+||+.||++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 00000 00 11234678899999999999999999998754
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-45 Score=392.56 Aligned_cols=247 Identities=23% Similarity=0.326 Sum_probs=203.4
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC---ChHhHHHHHHHHHHHH-hCCCCCcceEEEEEecCCcEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR---SEQGIAEFRTEIEMLS-KLRHRHLVSLIGYCDERSEMILV 576 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~H~niv~l~g~~~~~~~~~lV 576 (845)
++|++.+.||+|+||+||+|+.. +|+.||||++... .....+.+..|..++. .++|||||++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 46888999999999999999976 6899999987542 1233456777777765 68999999999999999999999
Q ss_pred EEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCC
Q 003139 577 YEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPAL 656 (845)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~ 656 (845)
|||+++|+|.+++... ..+++.+++.++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~- 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENML- 155 (320)
T ss_dssp EECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-
T ss_pred EeecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhccc-
Confidence 9999999999999644 468999999999999999999999 8999999999999999999999999999986432
Q ss_pred CCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhhhhccc
Q 003139 657 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQIMDSN 736 (845)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (845)
.....+...||+.|+|||++.+..++.++|||||||++|||++|+.||......+ +......+ .
T Consensus 156 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~-------~~~~i~~~--------~ 219 (320)
T d1xjda_ 156 -GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-------LFHSIRMD--------N 219 (320)
T ss_dssp -TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHC--------C
T ss_pred -ccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH-------HHHHHHcC--------C
Confidence 2223345689999999999999999999999999999999999999997543221 11111111 1
Q ss_pred cCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHH-HHHH
Q 003139 737 LVGKVNPASLKKFGETAEKCLAEHGVDRPSMG-DVLW 772 (845)
Q Consensus 737 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~-~vl~ 772 (845)
..++...+..+.+++.+||+.||.+||++. ++++
T Consensus 220 --~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 220 --PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp --CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred --CCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 123344556789999999999999999996 6754
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-43 Score=379.98 Aligned_cols=263 Identities=21% Similarity=0.294 Sum_probs=200.1
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC--hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS--EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYE 578 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 578 (845)
++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+++.+|+++|++++|||||++++++.+.+..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 47889999999999999999975 78999999886443 2335788999999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCC
Q 003139 579 YMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQ 658 (845)
Q Consensus 579 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~ 658 (845)
|+.++ +..++.......+++.++..++.|++.||+|||+ ++||||||||+|||++.++.+||+|||+|+.... .
T Consensus 82 ~~~~~-~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~--~ 155 (298)
T d1gz8a_ 82 FLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--P 155 (298)
T ss_dssp CCSEE-HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC--C
T ss_pred ecCCc-hhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccC--C
Confidence 99654 4445544445679999999999999999999999 9999999999999999999999999999976432 2
Q ss_pred cccccccccCCCcCChhhhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhc---Cchhhhh-
Q 003139 659 THVSTAVKGSFGYLDPEYFRRQQ-LTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKK---GMLDQIM- 733 (845)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~~~~- 733 (845)
........||+.|+|||.+.... ++.++||||+||++|||++|+.||......+.. .. ....... .......
T Consensus 156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~--~~-i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL--FR-IFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HH-HHHHHCCCCTTTSTTGGG
T ss_pred cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHH--HH-HHHhcCCCchhhcccccc
Confidence 22334567999999999877655 589999999999999999999999754322211 00 0000000 0000000
Q ss_pred ccccCCC-----------CCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 734 DSNLVGK-----------VNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 734 d~~l~~~-----------~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.+..... ..+.....+.+++.+||+.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp STTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0000000 001233678899999999999999999999865
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.9e-43 Score=377.25 Aligned_cols=262 Identities=20% Similarity=0.261 Sum_probs=201.1
Q ss_pred cCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCC--hHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEEe
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRS--EQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 579 (845)
++|+..+.||+|+||+||+|++++|+.||||++.... ....+++.+|+.+|++++||||+++++++.+.+..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5788999999999999999999999999999986553 23357899999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCCc
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQT 659 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~~ 659 (845)
+.++.+..+... ...+++.++..++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||++..... ..
T Consensus 82 ~~~~~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~--~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGI--PV 154 (286)
T ss_dssp CSEEHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred ehhhhHHHHHhh--cCCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceeccc--Cc
Confidence 988777666533 3579999999999999999999999 8999999999999999999999999999976332 11
Q ss_pred ccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCc------hhhh
Q 003139 660 HVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGM------LDQI 732 (845)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~------~~~~ 732 (845)
.......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||......+.. .. ......... ....
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~--~~-i~~~~~~~~~~~~~~~~~~ 231 (286)
T d1ob3a_ 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL--MR-IFRILGTPNSKNWPNVTEL 231 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HH-HHHHHCCCCTTTSTTGGGS
T ss_pred cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHH--HH-HHHhhCCCChhhccchhhh
Confidence 22334568999999999875 45799999999999999999999999754332211 10 011010000 0000
Q ss_pred h--cccc-------CCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 733 M--DSNL-------VGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 733 ~--d~~l-------~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
. +... .....+.....+.+++.+||+.||++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0000 001122345678899999999999999999999753
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-44 Score=379.64 Aligned_cols=240 Identities=23% Similarity=0.351 Sum_probs=195.6
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCC------hHhHHHHHHHHHHHHhCC--CCCcceEEEEEecCCc
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRS------EQGIAEFRTEIEMLSKLR--HRHLVSLIGYCDERSE 572 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~ 572 (845)
++|++.++||+|+||.||+|+.. +|+.||||++.... .....++.+|+.+|++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57899999999999999999975 78999999865321 111234678999999986 8999999999999999
Q ss_pred EEEEEEeccC-CCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECC-CCceEEEecccc
Q 003139 573 MILVYEYMAN-GPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDD-NFVAKVADFGLS 650 (845)
Q Consensus 573 ~~lV~Ey~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~-~~~~kl~DFGla 650 (845)
.++||||+.+ +++.+++... ..+++.++..++.||+.||+|||+ ++|+||||||+|||++. ++.+||+|||+|
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECccccc
Confidence 9999999976 5676776433 479999999999999999999999 99999999999999985 579999999999
Q ss_pred CCCCCCCCcccccccccCCCcCChhhhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCch
Q 003139 651 KTGPALDQTHVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGML 729 (845)
Q Consensus 651 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 729 (845)
+.... ...+...||+.|||||++.+..+ +.++||||+||++|||++|+.||....
T Consensus 159 ~~~~~----~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------------------- 214 (273)
T d1xwsa_ 159 ALLKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------------------- 214 (273)
T ss_dssp EECCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------------------
T ss_pred eeccc----ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--------------------
Confidence 86332 22345689999999999988765 577999999999999999999985311
Q ss_pred hhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 730 DQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 730 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
++..... .++...+..+.+++.+||+.||++|||++|++++
T Consensus 215 -~i~~~~~--~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 215 -EIIRGQV--FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp -HHHHCCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -HHhhccc--CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0000000 1223345678899999999999999999999864
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-43 Score=379.90 Aligned_cols=263 Identities=23% Similarity=0.308 Sum_probs=197.0
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-C-CcEEEEEEcCCC--ChHhHHHHHHHHHHHHhC---CCCCcceEEEEEec----
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-D-GTKVAVKRGNPR--SEQGIAEFRTEIEMLSKL---RHRHLVSLIGYCDE---- 569 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~-g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~---- 569 (845)
.++|++.+.||+|+||.||+|+.. + ++.||||++... .......+.+|+++|+.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999974 3 567999986432 122223455677776655 89999999999842
Q ss_pred -CCcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEecc
Q 003139 570 -RSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFG 648 (845)
Q Consensus 570 -~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFG 648 (845)
....+++|||++++.+..... .....+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred cCceEEEEEEeccCCchhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecchh
Confidence 356899999998877654433 334578999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCc
Q 003139 649 LSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGM 728 (845)
Q Consensus 649 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 728 (845)
+++... .........||+.|||||++.+.+++.++||||+||++|||++|++||......+... . .........
T Consensus 162 ~~~~~~---~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~--~-i~~~~~~~~ 235 (305)
T d1blxa_ 162 LARIYS---FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG--K-ILDVIGLPG 235 (305)
T ss_dssp SCCCCC---GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--H-HHHHHCCCC
T ss_pred hhhhhc---ccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHH--H-HHHhhCCCc
Confidence 998632 2334456789999999999999999999999999999999999999997644322111 1 111100000
Q ss_pred hh----------hhhcc---ccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 729 LD----------QIMDS---NLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 729 ~~----------~~~d~---~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.. ..... .............+.+++.+||+.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 00000 00011122345678899999999999999999998764
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-41 Score=364.15 Aligned_cols=262 Identities=19% Similarity=0.229 Sum_probs=198.6
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEE-EEecCCcEEEEEEe
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIG-YCDERSEMILVYEY 579 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g-~~~~~~~~~lV~Ey 579 (845)
++|++.+.||+|+||.||+|++. +|+.||||.+..... .+++..|++++++++|+|++..++ +..+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 46889999999999999999975 689999998654432 245788999999998877666555 45777788999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEEC---CCCceEEEeccccCCCCCC
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLD---DNFVAKVADFGLSKTGPAL 656 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~---~~~~~kl~DFGla~~~~~~ 656 (845)
+ +++|...+... ...+++..++.++.|++.||+|||+ ++|+||||||+|||++ .+..+||+|||+|+.....
T Consensus 85 ~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 85 L-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp C-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred c-CCchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 9 45666555433 3479999999999999999999999 9999999999999986 4567999999999864332
Q ss_pred CC-----cccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchhh
Q 003139 657 DQ-----THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLDQ 731 (845)
Q Consensus 657 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (845)
.. ........||+.|||||.+.+..++.++|||||||++|||++|+.||..........................
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHH
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhH
Confidence 21 1223456799999999999999999999999999999999999999976544332221111111100111111
Q ss_pred hhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 003139 732 IMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779 (845)
Q Consensus 732 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~ 779 (845)
....++..+.+++.+|++.+|++||++.++.+.|+....
T Consensus 240 ---------~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 240 ---------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp ---------HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred ---------hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 112344678899999999999999999999998887654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.5e-41 Score=360.48 Aligned_cols=262 Identities=17% Similarity=0.178 Sum_probs=208.3
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCC-CCcceEEEEEecCCcEEEEEEe
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRH-RHLVSLIGYCDERSEMILVYEY 579 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~Ey 579 (845)
++|++.+.||+|+||.||+|++. +|+.||||.+..... .+++.+|++.++.++| +|++.+++++.+....++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 57899999999999999999975 688999998654332 2456789999999965 8999999999999999999999
Q ss_pred ccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECC-----CCceEEEeccccCCCC
Q 003139 580 MANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDD-----NFVAKVADFGLSKTGP 654 (845)
Q Consensus 580 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~-----~~~~kl~DFGla~~~~ 654 (845)
+ +++|.+++.... ..+++.++..++.|++.||+|||+ ++|+||||||+||||+. ++.+||+|||+|+...
T Consensus 83 ~-~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 83 L-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp C-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred c-CCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 9 689988886443 469999999999999999999999 99999999999999974 5789999999998643
Q ss_pred CCCC-----cccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCch
Q 003139 655 ALDQ-----THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGML 729 (845)
Q Consensus 655 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 729 (845)
.... ........||+.|||||.+.+..++.++|||||||++|||++|+.||........................
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh
Confidence 2211 11234567999999999999999999999999999999999999999765444322221111111111111
Q ss_pred hhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhhh
Q 003139 730 DQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWNLEYALQ 779 (845)
Q Consensus 730 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~ 779 (845)
.++ ...+++.+.+++..|++.+|++||+++.+.+.|+.+++
T Consensus 238 ~~l---------~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~ 278 (293)
T d1csna_ 238 REL---------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278 (293)
T ss_dssp HHH---------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHh---------cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence 111 12234678899999999999999999999998888764
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=369.18 Aligned_cols=264 Identities=22% Similarity=0.306 Sum_probs=196.3
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEec--------C
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDE--------R 570 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--------~ 570 (845)
++|++.+.||+|+||+||+|+.. +|+.||||++... .....+++.+|+++|++++|||++++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 68899999999999999999975 7999999987543 33345778999999999999999999999854 3
Q ss_pred CcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEecccc
Q 003139 571 SEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLS 650 (845)
Q Consensus 571 ~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla 650 (845)
...++||||++++.+.... .....++...+..++.|++.||+|||+ ++|+||||||+||||++++.+||+|||++
T Consensus 90 ~~~~iv~e~~~~~~~~~~~--~~~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLS--NVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp -CEEEEEECCCEEHHHHHT--CTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred ceEEEEEeccCCCccchhh--hcccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeeccee
Confidence 4689999999888776554 333578899999999999999999999 99999999999999999999999999999
Q ss_pred CCCCCCCC--cccccccccCCCcCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhc-
Q 003139 651 KTGPALDQ--THVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKK- 726 (845)
Q Consensus 651 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~- 726 (845)
+....... ........||+.|+|||.+.+. .++.++||||+||++|||++|+.||......+.... .......
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~---i~~~~~~~ 241 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL---ISQLCGSI 241 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCCC
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHH---HHHhcCCC
Confidence 76443221 1223345799999999998765 689999999999999999999999975433221111 1111110
Q ss_pred --Cchhhh--------hccccCCCCC-HH------HHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 727 --GMLDQI--------MDSNLVGKVN-PA------SLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 727 --~~~~~~--------~d~~l~~~~~-~~------~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
...... .......... .. ....+.+++.+||+.||++|||++|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 000000 0000000000 00 12356789999999999999999999865
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-42 Score=374.78 Aligned_cols=261 Identities=24% Similarity=0.246 Sum_probs=193.3
Q ss_pred CCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcceEEEEEecC------CcEEE
Q 003139 503 KFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDER------SEMIL 575 (845)
Q Consensus 503 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~l 575 (845)
+|+..++||+|+||+||+|+.. +|+.||||++..... .+.+|+++|++++||||+++++++... ..++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5778889999999999999976 689999998765432 234799999999999999999998543 34789
Q ss_pred EEEeccCCCccccccC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCC-ceEEEeccccCCC
Q 003139 576 VYEYMANGPLRSHLYG-TDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNF-VAKVADFGLSKTG 653 (845)
Q Consensus 576 V~Ey~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~-~~kl~DFGla~~~ 653 (845)
||||++++.+..+... .....+++.++..++.||+.||+|||+ ++|+||||||+||||+.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987654443321 234579999999999999999999998 9999999999999999775 8999999999864
Q ss_pred CCCCCcccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHH---------HHHHHH
Q 003139 654 PALDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIA---------EWAMTW 723 (845)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~---------~~~~~~ 723 (845)
.. ........||..|+|||.+.+ ..++.++||||+||++|||++|++||......+..... ++....
T Consensus 174 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 174 VR---GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp CT---TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred cC---CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence 32 222345679999999998765 57899999999999999999999999754432211100 000000
Q ss_pred hhc---CchhhhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 724 QKK---GMLDQIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 724 ~~~---~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
... ................+.....+.+++.+||+.||++|||+.|++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 00000000000011122345678899999999999999999999865
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-41 Score=370.66 Aligned_cols=261 Identities=21% Similarity=0.301 Sum_probs=194.1
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCC------
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERS------ 571 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 571 (845)
.++|+..+.||+|+||.||+|... +|+.||||++... +....+.+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 467899999999999999999975 6999999998653 4455678999999999999999999999997654
Q ss_pred cEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccC
Q 003139 572 EMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSK 651 (845)
Q Consensus 572 ~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~ 651 (845)
++++||||+ +.+|..+... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhccccccccccccccee
Confidence 579999999 5567666533 369999999999999999999999 999999999999999999999999999998
Q ss_pred CCCCCCCcccccccccCCCcCChhhhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHH-----HHhh
Q 003139 652 TGPALDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAM-----TWQK 725 (845)
Q Consensus 652 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~-----~~~~ 725 (845)
.... ..+...||+.|+|||.+.+ ..++.++||||+||++|||++|+.||................ ....
T Consensus 170 ~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (346)
T d1cm8a_ 170 QADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244 (346)
T ss_dssp ECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred ccCC-----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHh
Confidence 6432 2345679999999999876 457999999999999999999999997643222111000000 0000
Q ss_pred cCc---hhhhh--ccccC----CCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 726 KGM---LDQIM--DSNLV----GKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 726 ~~~---~~~~~--d~~l~----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
... ..... .+... ..........+.+|+.+||+.||.+|||+.|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 00000 00000 01112334567899999999999999999999875
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-40 Score=356.95 Aligned_cols=263 Identities=21% Similarity=0.258 Sum_probs=204.4
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCCcEEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYE 578 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 578 (845)
++|++.+.||+|+||+||+|+.. +|+.||||+++.. .....+++.+|+.+|++++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 47899999999999999999975 7889999986433 34556889999999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCCCCCC
Q 003139 579 YMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGPALDQ 658 (845)
Q Consensus 579 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~~~~~ 658 (845)
++.+++|..++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||.++.....
T Consensus 82 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~-- 154 (292)
T d1unla_ 82 FCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-- 154 (292)
T ss_dssp CCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC--
T ss_pred eccccccccccccc--cccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCC--
Confidence 99999988877543 578999999999999999999999 99999999999999999999999999999874432
Q ss_pred cccccccccCCCcCChhhhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcC---c---hhh
Q 003139 659 THVSTAVKGSFGYLDPEYFRRQQ-LTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKG---M---LDQ 731 (845)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~---~---~~~ 731 (845)
........++..|+|||.+.... ++.++||||+||++|||++|+.||.......+ ...-........ . ...
T Consensus 155 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCCCCTTTCTTGGG
T ss_pred CccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHH--HHHHHHhhcCCCChhhhhhhhh
Confidence 22233456788899999987665 69999999999999999999999754332221 111111111100 0 000
Q ss_pred hhcc---------ccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 732 IMDS---------NLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 732 ~~d~---------~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
..+. .-...........+.+++.+||+.||.+|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 00011223345678899999999999999999998764
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-41 Score=370.38 Aligned_cols=264 Identities=22% Similarity=0.301 Sum_probs=197.4
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC-ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecCC----cEE
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR-SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDERS----EMI 574 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~ 574 (845)
+.+|+..+.||+|+||+||+|+.. +|+.||||++... .....+++++|+++|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 357889999999999999999864 7999999998754 3455678999999999999999999999996543 235
Q ss_pred EEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCCCC
Q 003139 575 LVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKTGP 654 (845)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~~~ 654 (845)
++++|+.+|+|.+++... .+++..+..++.|++.||+|||+ ++|+||||||+||||++++.+||+|||+++...
T Consensus 87 ~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 556677799999998543 69999999999999999999999 999999999999999999999999999997643
Q ss_pred CCCC-cccccccccCCCcCChhhhc-cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchh--
Q 003139 655 ALDQ-THVSTAVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLD-- 730 (845)
Q Consensus 655 ~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~-- 730 (845)
.... ........||+.|+|||.+. +..++.++||||+||+++||++|+.||......+..... ..........
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~ 237 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI---LGILGSPSQEDL 237 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCSCCHHHH
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHH---hhhccCCChhhh
Confidence 3221 12234567999999999985 456789999999999999999999999764432211110 0000000000
Q ss_pred ---------hhhccc-cCCCC-----CHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 731 ---------QIMDSN-LVGKV-----NPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 731 ---------~~~d~~-l~~~~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
...... ..... .+.....+.+++.+||+.||.+|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000 00000 11223468899999999999999999999865
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4e-40 Score=358.43 Aligned_cols=258 Identities=18% Similarity=0.234 Sum_probs=197.3
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCC-CCCcceEEEEEec--CCcEEEEE
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLR-HRHLVSLIGYCDE--RSEMILVY 577 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~--~~~~~lV~ 577 (845)
++|++.++||+|+||+||+|+.. +|+.||||++.... .+++.+|+++|++++ ||||+++++++.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 57999999999999999999975 78999999987544 357889999999995 9999999999864 45689999
Q ss_pred EeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCC-CceEEEeccccCCCCCC
Q 003139 578 EYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDN-FVAKVADFGLSKTGPAL 656 (845)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~-~~~kl~DFGla~~~~~~ 656 (845)
||+++++|..+. ..+++.++..++.||+.||+|||+ ++|+||||||+||||+.+ +.+||+|||+|+....
T Consensus 112 e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~- 182 (328)
T d3bqca1 112 EHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP- 182 (328)
T ss_dssp ECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT-
T ss_pred eecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccC-
Confidence 999999998764 358999999999999999999999 999999999999999865 4699999999986432
Q ss_pred CCcccccccccCCCcCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCccccc--H---------HHHHHHHh
Q 003139 657 DQTHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVN--I---------AEWAMTWQ 724 (845)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~--l---------~~~~~~~~ 724 (845)
........+|+.|+|||.+.+. .++.++||||+||+++||++|+.||.......... + ..|.....
T Consensus 183 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 183 --GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp --TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred --CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence 2223456789999999998765 57999999999999999999999997544322110 0 00100000
Q ss_pred hcC--chhhhhc--------cccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 725 KKG--MLDQIMD--------SNLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 725 ~~~--~~~~~~d--------~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
... ....... ..............+.+++.+||+.||++|||++|++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 0000000 000111112344678899999999999999999999764
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-41 Score=362.10 Aligned_cols=253 Identities=24% Similarity=0.295 Sum_probs=201.8
Q ss_pred cCCCcceeeeeeceEEEEEEEEc----CCcEEEEEEcCCC----ChHhHHHHHHHHHHHHhCCC-CCcceEEEEEecCCc
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD----DGTKVAVKRGNPR----SEQGIAEFRTEIEMLSKLRH-RHLVSLIGYCDERSE 572 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~ 572 (845)
++|+..+.||+|+||+||+|+.. +|+.||||.+... .....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 46899999999999999999852 4789999987543 12234668899999999966 899999999999999
Q ss_pred EEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCC
Q 003139 573 MILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKT 652 (845)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~ 652 (845)
.++||||+.+|+|.+++.... .+.......++.|++.||+|||+ .+|+||||||+||||+.++.+||+|||+++.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 999999999999999986443 57788999999999999999999 9999999999999999999999999999986
Q ss_pred CCCCCCcccccccccCCCcCChhhhccC--CCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCchh
Q 003139 653 GPALDQTHVSTAVKGSFGYLDPEYFRRQ--QLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGMLD 730 (845)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (845)
... ..........|++.|+|||.+.+. .++.++|||||||+||||++|+.||......+... ......
T Consensus 179 ~~~-~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~--~i~~~~------- 248 (322)
T d1vzoa_ 179 FVA-DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA--EISRRI------- 248 (322)
T ss_dssp CCG-GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH--HHHHHH-------
T ss_pred hcc-cccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHhc-------
Confidence 443 222334456799999999999764 47889999999999999999999997654433211 111110
Q ss_pred hhhccccCCCCCHHHHHHHHHHHHHhhhhCCCCCCC-----HHHHHHH
Q 003139 731 QIMDSNLVGKVNPASLKKFGETAEKCLAEHGVDRPS-----MGDVLWN 773 (845)
Q Consensus 731 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~~vl~~ 773 (845)
... ...++......+.+++.+||+.||.+||+ ++|++++
T Consensus 249 --~~~--~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 249 --LKS--EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp --HHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred --ccC--CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 111 11233456678899999999999999995 7787653
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-39 Score=357.54 Aligned_cols=261 Identities=20% Similarity=0.272 Sum_probs=191.5
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEec------CCc
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDE------RSE 572 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~~ 572 (845)
++|++.++||+|+||+||+|.+. +|+.||||++... +....+++.+|+.++++++||||+++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57999999999999999999976 6999999987643 45556788999999999999999999999953 467
Q ss_pred EEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCC
Q 003139 573 MILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKT 652 (845)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~ 652 (845)
.|+||||+.++.+.. +. ..+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+|++|||+++.
T Consensus 97 ~~iv~Ey~~~~l~~~-~~----~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 97 VYLVMELMDANLCQV-IQ----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEEEECCSEEHHHH-HT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred eEEEEeccchHHHHh-hh----cCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhhc
Confidence 899999997665543 32 358999999999999999999999 9999999999999999999999999999886
Q ss_pred CCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHH---------HH----
Q 003139 653 GPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIA---------EW---- 719 (845)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~---------~~---- 719 (845)
.. .........+|+.|+|||++.+..++.++||||+||+++||++|+.||............ ++
T Consensus 169 ~~---~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (355)
T d2b1pa1 169 AG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_dssp ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred cc---cccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence 33 223344567899999999999999999999999999999999999999654321110000 00
Q ss_pred ---HHHHhhcC------chhhhhccccCCCC---CHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 720 ---AMTWQKKG------MLDQIMDSNLVGKV---NPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 720 ---~~~~~~~~------~~~~~~d~~l~~~~---~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
........ .............. .......+.+++.+||+.||++|||++|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000000 00111111111111 12356778999999999999999999999866
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-40 Score=359.28 Aligned_cols=259 Identities=20% Similarity=0.264 Sum_probs=195.7
Q ss_pred hcCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCC--ChHhHHHHHHHHHHHHhCCCCCcceEEEEEecC-----Cc
Q 003139 501 TNKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPR--SEQGIAEFRTEIEMLSKLRHRHLVSLIGYCDER-----SE 572 (845)
Q Consensus 501 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 572 (845)
.++|++.+.||+|+||+||+|+.. +|+.||||++... +....+++.+|+++|++++|||+|++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 467999999999999999999965 7999999998654 345567889999999999999999999998533 34
Q ss_pred EEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEeccccCC
Q 003139 573 MILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKT 652 (845)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~ 652 (845)
.++++||+.+|+|.+++.. ..+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+|++|||++..
T Consensus 97 ~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred eEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhcc
Confidence 5677788889999999854 369999999999999999999999 9999999999999999999999999999975
Q ss_pred CCCCCCcccccccccCCCcCChhhhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHHHHHhhcCc---
Q 003139 653 GPALDQTHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWAMTWQKKGM--- 728 (845)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~--- 728 (845)
.. .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||......... ...........
T Consensus 171 ~~-----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~---~~i~~~~~~~~~~~ 242 (348)
T d2gfsa1 171 TD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL---KLILRLVGTPGAEL 242 (348)
T ss_dssp CT-----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCHHH
T ss_pred cC-----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHH---HHHHHhcCCCChHH
Confidence 32 223456788999999987665 5689999999999999999999999754322211 11111000000
Q ss_pred --------hhhhhccccC-CCC-----CHHHHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003139 729 --------LDQIMDSNLV-GKV-----NPASLKKFGETAEKCLAEHGVDRPSMGDVLWN 773 (845)
Q Consensus 729 --------~~~~~d~~l~-~~~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~ 773 (845)
.......... ... .......+.+++.+||+.||.+|||+.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 0000000000 000 01234567899999999999999999999865
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.9e-35 Score=321.84 Aligned_cols=264 Identities=17% Similarity=0.174 Sum_probs=191.7
Q ss_pred cCCCcceeeeeeceEEEEEEEEc-CCcEEEEEEcCCCChHhHHHHHHHHHHHHhCC-----------CCCcceEEEEEec
Q 003139 502 NKFDESLLLGVGGFGRVYKGTLD-DGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLR-----------HRHLVSLIGYCDE 569 (845)
Q Consensus 502 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~g~~~~ 569 (845)
++|++.+.||+|+||.||+|+.. +|+.||||+++.. ....+.+.+|++++++++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 35889999999999999999975 7999999998754 333467788999998875 5789999998854
Q ss_pred --CCcEEEEEEeccCCCccc-cccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCC------
Q 003139 570 --RSEMILVYEYMANGPLRS-HLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNF------ 640 (845)
Q Consensus 570 --~~~~~lV~Ey~~~gsL~~-~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~------ 640 (845)
....+++++++..+.... .........+++..+..++.||++||+|||+ ..+|+||||||+||||+.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccc
Confidence 345677777765554322 2233445678999999999999999999996 37899999999999998654
Q ss_pred ceEEEeccccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCcccccHHHHH
Q 003139 641 VAKVADFGLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCTRPALNPVLPREQVNIAEWA 720 (845)
Q Consensus 641 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~Elltg~~p~~~~~~~~~~~l~~~~ 720 (845)
.+|++|||.++.... ......||+.|+|||++....++.++||||+||+++||++|+.||............+..
T Consensus 170 ~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 170 QIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred eeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 499999999875322 224567999999999999999999999999999999999999999754432211111111
Q ss_pred HH---Hhhc---------Cchhhhhcc-------------------ccCCCCCHHHHHHHHHHHHHhhhhCCCCCCCHHH
Q 003139 721 MT---WQKK---------GMLDQIMDS-------------------NLVGKVNPASLKKFGETAEKCLAEHGVDRPSMGD 769 (845)
Q Consensus 721 ~~---~~~~---------~~~~~~~d~-------------------~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~ 769 (845)
.. .... .......+. .............+.+++.+||+.||.+|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 10 0000 000000000 0011234567788999999999999999999999
Q ss_pred HHHH
Q 003139 770 VLWN 773 (845)
Q Consensus 770 vl~~ 773 (845)
++++
T Consensus 325 ~L~H 328 (362)
T d1q8ya_ 325 LVNH 328 (362)
T ss_dssp HHTC
T ss_pred HhcC
Confidence 8754
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=2.4e-22 Score=199.43 Aligned_cols=169 Identities=16% Similarity=0.122 Sum_probs=121.7
Q ss_pred cceeeeeeceEEEEEEEEcCCcEEEEEEcCCCC------------------hHhHHHHHHHHHHHHhCCCCCcceEEEEE
Q 003139 506 ESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRS------------------EQGIAEFRTEIEMLSKLRHRHLVSLIGYC 567 (845)
Q Consensus 506 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~------------------~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 567 (845)
+.+.||+|+||.||+|+..+|+.||||.+.... ......+..|...+.++.|.+++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 467899999999999998889999999754311 01123456788999999999999988764
Q ss_pred ecCCcEEEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeccCCCCcEEECCCCceEEEec
Q 003139 568 DERSEMILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTGAAQSIIHRDVKTTNILLDDNFVAKVADF 647 (845)
Q Consensus 568 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik~~NILl~~~~~~kl~DF 647 (845)
. .+++|||+++..+.+ ++.....+++.|++++|+|||+ ++|+||||||+|||++++ .++|+||
T Consensus 84 ~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 84 G----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp T----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEEECCC
T ss_pred C----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEEEEEC
Confidence 2 379999998765543 3344567899999999999999 999999999999999965 5899999
Q ss_pred cccCCCCCCCCcccccccccCCCcCChhhhccCCCCchhHHHHHHHHHH
Q 003139 648 GLSKTGPALDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLM 696 (845)
Q Consensus 648 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ 696 (845)
|+|+............... .. -.|.+ .+.|+.++|+||..--++
T Consensus 147 G~a~~~~~~~~~~~l~rd~---~~-~~~~f-~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 147 PQSVEVGEEGWREILERDV---RN-IITYF-SRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp TTCEETTSTTHHHHHHHHH---HH-HHHHH-HHHHCCCCCHHHHHHHHH
T ss_pred CCcccCCCCCcHHHHHHHH---HH-HHHHH-cCCCCCcccHHHHHHHHh
Confidence 9997643211110000000 00 01122 357788999999875554
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.32 E-value=5.7e-07 Score=91.37 Aligned_cols=150 Identities=15% Similarity=0.093 Sum_probs=101.7
Q ss_pred HHHHHHhcCCCcceeeeeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCC-CCCcceEEEEEecCCcE
Q 003139 495 QEILDATNKFDESLLLGVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLR-HRHLVSLIGYCDERSEM 573 (845)
Q Consensus 495 ~el~~at~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~ 573 (845)
.|+...-..|+..+..+.+..+.||+...+ ++.+++|+...........+.+|...+..+. +--+.++++++.+.+..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 345555566665554433445689998654 6678888866544333445677888888774 43466788888888899
Q ss_pred EEEEEeccCCCccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhhc----------------------------------
Q 003139 574 ILVYEYMANGPLRSHLYGTDLPPLSWKQRLEICIGAARGLHYLHTG---------------------------------- 619 (845)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~---------------------------------- 619 (845)
++||+++++.++.+.... ......++.++++.|..||+.
T Consensus 86 ~lv~~~l~G~~~~~~~~~-------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEEECCSSEEHHHHTTT-------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEEecccccccccccc-------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 999999999887654321 112334566666666667631
Q ss_pred ----------------------CCCceeeccCCCCcEEECCCCceEEEeccccCC
Q 003139 620 ----------------------AAQSIIHRDVKTTNILLDDNFVAKVADFGLSKT 652 (845)
Q Consensus 620 ----------------------~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~ 652 (845)
....++|+|+.|.|||++++...-|.||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 012379999999999999876677999998754
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.87 E-value=2.9e-05 Score=77.85 Aligned_cols=130 Identities=19% Similarity=0.165 Sum_probs=87.8
Q ss_pred eeeece-EEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCC--CCcceEEEEEecCCcEEEEEEeccCCCcc
Q 003139 510 LGVGGF-GRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRH--RHLVSLIGYCDERSEMILVYEYMANGPLR 586 (845)
Q Consensus 510 LG~G~f-g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 586 (845)
+..|.. +.||+...+++..+++|....... ..+..|.+.++.+.. -.+.++++++.+.+..++|||++++.++.
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 444543 679999888888899998655433 245667777776643 34567888888888999999999987765
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHHHHHHHHhh------------------------------------------------
Q 003139 587 SHLYGTDLPPLSWKQRLEICIGAARGLHYLHT------------------------------------------------ 618 (845)
Q Consensus 587 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~------------------------------------------------ 618 (845)
+.. +. ...++.++++.|.-||+
T Consensus 95 ~~~-------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (255)
T d1nd4a_ 95 SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 164 (255)
T ss_dssp TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred ccc-------cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence 421 11 11223334444444442
Q ss_pred ---c----CCCceeeccCCCCcEEECCCCceEEEeccccCC
Q 003139 619 ---G----AAQSIIHRDVKTTNILLDDNFVAKVADFGLSKT 652 (845)
Q Consensus 619 ---~----~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~ 652 (845)
. ....++|+|+.|.|||++++..+-|+||+.+..
T Consensus 165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 0 112489999999999999876778999997754
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.07 E-value=0.00046 Score=73.72 Aligned_cols=76 Identities=16% Similarity=0.141 Sum_probs=47.6
Q ss_pred eeeeeeceEEEEEEEEcC-CcEEEEEEcCCC-------ChHhHHHHHHHHHHHHhCC-C--CCcceEEEEEecCCcEEEE
Q 003139 508 LLLGVGGFGRVYKGTLDD-GTKVAVKRGNPR-------SEQGIAEFRTEIEMLSKLR-H--RHLVSLIGYCDERSEMILV 576 (845)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-H--~niv~l~g~~~~~~~~~lV 576 (845)
+.||.|....||+....+ ++.++||.-.+. -....++...|.+.|+.+. + ..+.+++.+. ....++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEEE
Confidence 368999999999998654 678999964321 1112334556787777662 2 3455566553 4456899
Q ss_pred EEeccCCCc
Q 003139 577 YEYMANGPL 585 (845)
Q Consensus 577 ~Ey~~~gsL 585 (845)
||++++..+
T Consensus 110 mE~L~~~~~ 118 (392)
T d2pula1 110 MEDLSHLKI 118 (392)
T ss_dssp ECCCTTSEE
T ss_pred EeccCCccc
Confidence 999976543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.72 E-value=0.0013 Score=68.13 Aligned_cols=136 Identities=14% Similarity=0.190 Sum_probs=79.1
Q ss_pred eEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCc--ceEEE-----EEecCCcEEEEEEeccCCCccc
Q 003139 515 FGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHL--VSLIG-----YCDERSEMILVYEYMANGPLRS 587 (845)
Q Consensus 515 fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~g-----~~~~~~~~~lV~Ey~~~gsL~~ 587 (845)
--.||+++.++|+.+++|...+... ..+++..|...+..|...++ +..+. .....+..+.++++++|..+..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 3589999999999999998765421 23556778888877743222 11111 1234566789999998755432
Q ss_pred c----c----------c----CC---CCCCCCHHH-------------------HHHHHHHHHHHHHHHh----hcCCCc
Q 003139 588 H----L----------Y----GT---DLPPLSWKQ-------------------RLEICIGAARGLHYLH----TGAAQS 623 (845)
Q Consensus 588 ~----l----------~----~~---~~~~l~~~~-------------------~~~i~~~ia~gL~yLH----~~~~~~ 623 (845)
. + + .. ....+++.. +..+...+.+.++.+. +....+
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 1 0 0 00 011222211 1112222222333332 223467
Q ss_pred eeeccCCCCcEEECCCCceEEEeccccCCC
Q 003139 624 IIHRDVKTTNILLDDNFVAKVADFGLSKTG 653 (845)
Q Consensus 624 ivHrDik~~NILl~~~~~~kl~DFGla~~~ 653 (845)
+||+|+.+.|||++++ ..+.||+-+...
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~g 221 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARNG 221 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCEE
T ss_pred eecCCCCcccEEEeCC--ceEEechhcccC
Confidence 9999999999999754 458999988753
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.27 E-value=0.0059 Score=64.79 Aligned_cols=73 Identities=22% Similarity=0.234 Sum_probs=48.8
Q ss_pred eeeeeeceEEEEEEEEcCC--------cEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCcc-eEEEEEecCCcEEEEEE
Q 003139 508 LLLGVGGFGRVYKGTLDDG--------TKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHLV-SLIGYCDERSEMILVYE 578 (845)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~g--------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~E 578 (845)
+.|+.|-.-.+|+....++ +.++++.... .... ....+|..+++.+.-.++. ++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~-idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETE-SHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCH-HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchh-hHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 4677788899999987543 4566666542 2222 3445788888888534444 67777653 68999
Q ss_pred eccCCCcc
Q 003139 579 YMANGPLR 586 (845)
Q Consensus 579 y~~~gsL~ 586 (845)
|+++.+|.
T Consensus 122 fi~g~~l~ 129 (395)
T d1nw1a_ 122 YIPSRPLS 129 (395)
T ss_dssp CCCEEECC
T ss_pred EeccccCC
Confidence 99876654
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.75 E-value=0.01 Score=60.60 Aligned_cols=157 Identities=13% Similarity=0.057 Sum_probs=83.3
Q ss_pred cHHHHHHHhcCCCcceee-----eeeceEEEEEEEEcCCcEEEEEEcCCCChHhHHHHHHHHHHHHhCCCCCc--ceEEE
Q 003139 493 MFQEILDATNKFDESLLL-----GVGGFGRVYKGTLDDGTKVAVKRGNPRSEQGIAEFRTEIEMLSKLRHRHL--VSLIG 565 (845)
Q Consensus 493 ~~~el~~at~~f~~~~~L-----G~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~g 565 (845)
+.+|+...-.+|...++. ..|---+.|+.+.++|+ +++|+...... .++...|++++..+.+.++ ...+-
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccce
Confidence 456777777778775443 34555778999887654 88998754321 2334446666666542222 11111
Q ss_pred ------EEecCCcEEEEEEeccCCCcccccc------------------CCC----CCCCC-----------------HH
Q 003139 566 ------YCDERSEMILVYEYMANGPLRSHLY------------------GTD----LPPLS-----------------WK 600 (845)
Q Consensus 566 ------~~~~~~~~~lV~Ey~~~gsL~~~l~------------------~~~----~~~l~-----------------~~ 600 (845)
+..-......++.+..+......-. ... ..... ..
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence 1122345667777776654432110 000 00000 00
Q ss_pred HHHHHHHHHHHHHHHHhh-cCCCceeeccCCCCcEEECCCCceEEEeccccCC
Q 003139 601 QRLEICIGAARGLHYLHT-GAAQSIIHRDVKTTNILLDDNFVAKVADFGLSKT 652 (845)
Q Consensus 601 ~~~~i~~~ia~gL~yLH~-~~~~~ivHrDik~~NILl~~~~~~kl~DFGla~~ 652 (845)
.....+..+...+.-.+. ....++||+|+.++||+++++...-|.||+.+..
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 111222222222222221 2456899999999999999987778999998753
|
| >d2o14a1 b.18.1.32 (A:14-159) Hypothetical protein YxiM {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Galactose-binding domain-like superfamily: Galactose-binding domain-like family: YxiM N-terminal domain-like domain: Hypothetical protein YxiM species: Bacillus subtilis [TaxId: 1423]
Probab=95.72 E-value=0.097 Score=46.42 Aligned_cols=81 Identities=16% Similarity=0.230 Sum_probs=63.5
Q ss_pred ccceEEEeecccceEEEEEEeecCCCCCcCCccceEEEEeCcEEEeecccccccCCCcceEEEEEeecCCceEEEEeeCC
Q 003139 91 AAAFYKFEIEHKGRHWVRLYFYTLPGSNQHLNSASFTVATDKFVLLSNFTFKNYNSSFMFKEYAINVNSDALTLTFIPSN 170 (845)
Q Consensus 91 ~~~cY~~~~~~~g~~~vR~~f~~~~~~~~~~~~~~f~v~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~vc~~~~~ 170 (845)
...-|.+++ +.|.|.|.++|-. .....+.+.|-..+.++. +.+.-+.|.|+|.++.|.|-|....
T Consensus 63 ~~~~f~v~v-PnG~Y~Vtv~~Gd---------~~~~~~~~eg~~~~~~~~-----g~~~~~~~~V~VtDG~L~l~ft~~~ 127 (146)
T d2o14a1 63 SNNTFNVDL-PNGLYEVKVTLGN---------TARASVAAEGVFQVINMT-----GDGAEDTFQIPVTDGQLNLLVTEGK 127 (146)
T ss_dssp CSCCEEEEC-CSEEEEEEEEESS---------CSEEEEEETTEEEEEEEE-----STTCEEEEEEEECSSEEEEEEEESS
T ss_pred CCceEEEEC-CCCeEEEEEEEec---------CCCccEEEeeEEeccccC-----CccEEEEEEEEEECCeEEEEEecCC
Confidence 345899987 7999999999874 123467788877777652 3445678999999999999998774
Q ss_pred -CCcceeeeeEEEecCC
Q 003139 171 -NSVAFVNAIEVVSVPD 186 (845)
Q Consensus 171 -~~~pfi~~iE~~~~~~ 186 (845)
...|=||+|||..+++
T Consensus 128 ~G~~~~in~l~I~~~~d 144 (146)
T d2o14a1 128 AGTAFTLSALKIKKLSD 144 (146)
T ss_dssp TTSCCEEEEEEEEEEES
T ss_pred CCCccEEEEEEEEeccc
Confidence 5789999999998765
|